PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lisewski, U; Koehncke, C; Wilck, N; Buschmeyer, B; Pieske, B; Roepke, TK				Lisewski, Ulrike; Koehncke, Clemens; Wilck, Nicola; Buschmeyer, Bastian; Pieske, Burkert; Roepke, Torsten K.			Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3(-/-) mice	FASEB JOURNAL			English	Article						arrhythmia; Kv channel; trafficking; KCNE; aldosteronism	EMERGING ROLE; CHANNELS; DELETION; EXPRESSION; LOCALIZATION; DISRUPTION; MUTATIONS; COMPONENT; MEMBRANE; RECEPTOR	Hyperaldosteronism is associated with an increased prevalence of atrial fibrillation (AF). Mutations in KCNE3 have been associated with AF, and Kcne3(-/-) mice exhibit hyperaldosteronism. In this study, we used recently developed Kcne3(-/-) mice to study atrial electrophysiology with respect to development of aldosterone-dependent AF. In invasive electrophysiology studies, Kcne3(-/-) mice displayed a reduced atrial effective refractory period (AERP) and inducible episodes of paroxysmal AF. The cellular arrhythmogenic correlate for AF pre-disposition was a significant increase in atrial Kv currents generated by the micromolar 4-aminopyridine-sensitive Kv current encoded by Kv1.5. Electrophysiological alterations in Kcne3(-/-) mice were aldosterone dependent and were associated with increased Rab4, -5, and -9-dependent recycling of Kv1.5 channels to the Z-disc/T-tubulus region and lateral membrane via activation of the Akt/AS160 pathway. Treatment with spironolactone inhibited Akt/AS160 phosphorylation, reduced Rab-dependent Kv1.5 recycling, normalized AERP and atrial Kv currents to the wild-type level, and reduced arrhythmia induction in Kcne3(-/-) mice. Kcne3 deletion in mice predisposes to AF by a heretofore unrecognized mechanism-namely, increased aldosterone-dependent Kv1.5 recycling via Rab GTPases. The findings uncover detailed molecular mechanisms underpinning a channelopathy-linked form of AF and emphasize the inevitability of considering extracardiac mechanisms in genetic arrhythmia syndromes.	[Lisewski, Ulrike; Koehncke, Clemens; Wilck, Nicola; Buschmeyer, Bastian; Roepke, Torsten K.] Expt & Clin Res Ctr, Berlin, Germany; [Koehncke, Clemens; Pieske, Burkert] Univ Med Berlin, Dept Cardiol, Campus Virchow, Berlin, Germany; [Roepke, Torsten K.] Univ Med Berlin, Dept Cardiol & Angiol, Campus Mitte, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Roepke, TK (corresponding author), Charite Univ Med Berlin, Dept Cardiol & Angiol, Campus Mitte,Charitepl 1, D-10117 Berlin, Germany.	torsten-kai.roepke@charite.de	Pieske, Burkert/M-8089-2016	Pieske, Burkert/0000-0002-6466-5306; Wilck, Nicola/0000-0003-3189-5364	Deutsche Forschungsgemeinschaft; Friede Springer Herzstiftung; Fritz-Thyssen-Stiftung; ECRC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friede Springer Herzstiftung; Fritz-Thyssen-Stiftung; ECRC	The authors thank Prof. Thomas J. Jentsch (Max Delbruck Center for Molecular Medicine, Berlin, Germany) for providing Kcne3 knockout mice, Helmut Kraus for graphic support, and Astrid Schiche, Carolin Gartner, and Nora Lange [Experimental and Clinical Research Center (ECRC)] for excellent technical expertise. This work was supported by the Deutsche Forschungsgemeinschaft, Friede Springer Herzstiftung, Fritz-Thyssen-Stiftung and intramural funding from ECRC. The authors declare no conflicts of interest.	Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011; Balse E, 2009, P NATL ACAD SCI USA, V106, P14681, DOI 10.1073/pnas.0902809106; Boycott HE, 2013, P NATL ACAD SCI USA, V110, pE3955, DOI 10.1073/pnas.1309896110; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Darbar D, 2008, HEART RHYTHM, V5, P483, DOI 10.1016/j.hrthm.2007.09.002; Eldstrom J, 2006, FEBS LETT, V580, P6039, DOI 10.1016/j.febslet.2006.09.069; Frohlich H, 2011, PFLUG ARCH EUR J PHY, V461, P45, DOI 10.1007/s00424-010-0890-5; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Kohncke C, 2013, JOVE-J VIS EXP, DOI 10.3791/50145; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; Lundby A., 2008, CELL PHYSIOL BIOCHEM, V21; Ma KJ, 2007, CHINESE MED J-PEKING, V120, P150, DOI 10.1097/00029330-200701020-00017; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Mongue-Din H, 2007, PFLUG ARCH EUR J PHY, V454, P165, DOI 10.1007/s00424-006-0197-8; Nagoshi T, 2012, HORM METAB RES, V44, P931, DOI 10.1055/s-0032-1316343; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Olesen MS, 2014, EUR J HUM GENET, V22, P297, DOI 10.1038/ejhg.2013.139; Olesen MS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-24; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Ravn LS, 2005, AM J CARDIOL, V96, P405, DOI 10.1016/j.amjcard.2005.03.086; Reil JC, 2012, EUR HEART J, V33, P2098, DOI 10.1093/eurheartj/ehr266; Roepke TK, 2006, VASC PHARMACOL, V44, P90, DOI 10.1016/j.vph.2005.07.013; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Somanna NK, 2015, CELL SIGNAL, V27, P1928, DOI 10.1016/j.cellsig.2015.07.001; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; VanWagoner DR, 1997, CIRC RES, V80, P772; Westphal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073490; Williams RS, 2011, CLIN CARDIOL, V34, P415, DOI 10.1002/clc.20914; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zhang DF, 2005, CHINESE MED J-PEKING, V118, P1735	45	7	7	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2476	2489		10.1096/fj.201600317R	http://dx.doi.org/10.1096/fj.201600317R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	26985008				2022-12-28	WOS:000379249500004
J	Kurundkar, AR; Kurundkar, D; Rangarajan, S; Locy, ML; Zhou, Y; Liu, RM; Zmijewski, J; Thannickal, VJ				Kurundkar, Ashish R.; Kurundkar, Deepali; Rangarajan, Sunad; Locy, Morgan L.; Zhou, Yong; Liu, Rui-Ming; Zmijewski, Jaroslaw; Thannickal, Victor J.			The matricellular protein CCN1 enhances TGF-beta 1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury	FASEB JOURNAL			English	Article						matrix remodeling; wound repair; myofibroblasts; idiopathic pulmonary fibrosis	IDIOPATHIC PULMONARY-FIBROSIS; IMMEDIATE-EARLY GENE; TGF-BETA; GROWTH-FACTOR; MYOFIBROBLAST DIFFERENTIATION; CELLULAR SENESCENCE; MESENCHYMAL CELLS; MESANGIAL CELLS; SMAD PROTEINS; CYR61 CCN1	Matricellular proteins mediate pleiotropic effects during tissue injury and repair. CCN1 is a matricellular protein that has been implicated in angiogenesis, inflammation, and wound repair. In this study, we identified CCN1 as a gene that is differentially up-regulated in alveolar mesenchymal cells of human subjects with rapidly progressive idiopathic pulmonary fibrosis (IPF). Elevated levels of CCN1 mRNA were confirmed in lung tissues of IPF subjects undergoing lung transplantation, and CCN1 protein was predominantly localized to fibroblastic foci. CCN1 expression in ex vivo IPF lung fibroblasts correlated with gene expression of the extracellular matrix proteins, collagen (Col)1a1, Col1a2, and fibronectin as well as the myofibroblast marker, -smooth muscle actin. RNA interference (RNAi)-mediated knockdown of CCN1 down-regulated the constitutive expression of these profibrotic genes in IPF fibroblasts. TGF-1, a known mediator of tissue fibrogenesis, induces gene and protein expression of CCN1 via a mothers against decapentaplegic homolog 3 (SMAD3)-dependent mechanism. Importantly, endogenous CCN1 potentiates TGF-1-induced SMAD3 activation and induction of profibrotic genes, supporting a positive feedback loop leading to myofibroblast activation. In vivo RNAi-mediated silencing of CCN1 attenuates fibrogenic responses to bleomycin-induced lung injury. These studies support previously unrecognized, cooperative interaction between the CCN1 matricellular protein and canonical TGF-1/SMAD3 signaling that promotes lung fibrosis.Kurundkar, A. R., Kurundkar, D., Rangarajan, S., Locy, M. L., Zhou, Y., Liu, R.-M., Zmijewski, J., Thannickal, V. J. The matricellular protein CCN1 enhances TGF-1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.	[Kurundkar, Ashish R.; Kurundkar, Deepali; Rangarajan, Sunad; Locy, Morgan L.; Zhou, Yong; Liu, Rui-Ming; Zmijewski, Jaroslaw; Thannickal, Victor J.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Thannickal, VJ (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, 429 Tinsley Harrison Tower,1900 Univ Blvd, Birmingham, AL 35294 USA.	vjthan@uab.edu	Rangarajan, Sunad/AAQ-5285-2021	Rangarajan, Sunad/0000-0001-5313-4828; Locy, Morgan/0000-0002-3812-5867	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [P01 HL114470]; U.S. National Institutes of Health (National Institute on Aging) [R01 AG046210]; U.S. Veterans Affairs Merit Grant [I01BX003056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124076, T32HL105346, P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. Veterans Affairs Merit Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by U.S. National Institutes of Health Grants P01 HL114470 (National Heart, Lung, and Blood Institute), R01 AG046210 (National Institute on Aging), and U.S. Veterans Affairs Merit Grant I01BX003056. The authors declare no conflicts of interest.	Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bartholin L, 2007, CANCER LETT, V246, P230, DOI 10.1016/j.canlet.2006.02.019; Baughman RP, 1999, SARCOIDOSIS VASC DIF, V16, P57; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen XW, 2014, J CLIN INVEST, V124, P3295, DOI 10.1172/JCI71668; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Grazioli S, 2015, AM J PHYSIOL-LUNG C, V308, pL759, DOI 10.1152/ajplung.00190.2014; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Higashiyama H, 2007, EXP MOL PATHOL, V83, P39, DOI 10.1016/j.yexmp.2006.12.003; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Horowitz JC, 2006, AM J PHYSIOL-LUNG C, V290, pL415, DOI 10.1152/ajplung.00276.2005; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Lai CF, 2014, AM J PHYSIOL-RENAL, V307, pF581, DOI 10.1152/ajprenal.00670.2013; Lai CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056481; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lundvig DMS, 2015, EXP CELL RES, V330, P429, DOI 10.1016/j.yexcr.2014.10.006; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Matute-Bello G, 2007, AM J RESP CELL MOL, V37, P210, DOI 10.1165/rcmb.2006-0471OC; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Raissadati A, 2015, TRANSPL INT, V28, P1416, DOI 10.1111/tri.12639; Roach KM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0155-5; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; Sakamoto S, 2004, PROSTATE, V61, P305, DOI 10.1002/pros.20098; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Thannickal VJ, 2014, J CLIN INVEST, V124, P4673, DOI 10.1172/JCI74368; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Uhal BD, 2007, CURR PHARM DESIGN, V13, P1247, DOI 10.2174/138161207780618885; Wahab NA, 2005, EXP CELL RES, V307, P305, DOI 10.1016/j.yexcr.2005.03.022; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	57	47	50	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2135	2150		10.1096/fj.201500173	http://dx.doi.org/10.1096/fj.201500173			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26884454	Green Published			2022-12-28	WOS:000376878300008
J	Lee, SY; Giladi, M; Bohbot, H; Hiller, R; Chung, KY; Khananshvili, D				Lee, Su Youn; Giladi, Moshe; Bohbot, Hilla; Hiller, Reuben; Chung, Ka Young; Khananshvili, Daniel			Structure-dynamic basis of splicing-dependent regulation in tissue-specific variants of the sodium-calcium exchanger	FASEB JOURNAL			English	Article						alternative splicing; HDX-MS; intrinsically disordered proteins; conformational dynamics	CA2+ BINDING DOMAINS; NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER; DISORDERED REGIONS; CRYSTAL-STRUCTURE; NCX; DETERMINANTS; FEATURES; ENERGY; SENSOR	Tissue-specific splice variants of Na+/Ca2+ exchangers contain 2 Ca2+-binding regulatory domains (CBDs), CBD1 and CBD2. Ca2+ interaction with CBD1 activates sodium-calcium exchangers (NCXs), and Ca2+ binding to CBD2 alleviates Na+-dependent inactivation. A combination of mutually exclusive (A, B) and cassette (C-F) exons in CBD2 raises functionally diverse splice variants through unknown mechanisms. Here, the effect of exons on CBDs backbone dynamics were investigated in the 2-domain tandem (CBD12) of the brain, kidney, and cardiac splice variants by using hydrogen-deuterium exchange mass spectrometry and stopped-flow techniques. Mutually exclusive exons stabilize interdomain interactions in the apoprotein, which primarily predefines the extent of responses to Ca2+ binding. Deuterium uptake levels were up to 20% lower in the cardiac vs. the brain CBD12, reveling that elongation of the CBD2 FG loop by cassette exons rigidifies the interdomain Ca2+ salt bridge at the 2-domain interface, which secondarily modulates the Ca2+-bound states. In matching splice variants, the extent of Ca2+-induced rigidification correlates with decreased (up to 10-fold) Ca2+ off rates, where the cardiac CBD12 exhibits the slowest Ca2+ off rates. Collectively, structurally disordered/dynamic segments at mutually exclusive and cassette exons have local and distant effects on the folded structures nearby the Ca2+ binding sites, which may serve as a structure-dynamic basis for splicing-dependent regulation of NCX.	[Lee, Su Youn; Chung, Ka Young] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Giladi, Moshe; Bohbot, Hilla; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Sungkyunkwan University (SKKU); Tel Aviv University	Chung, KY (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea.; Khananshvili, D (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	kychung2@skku.edu; dhanan@post.tau.ac.il	Chung, Ka Young/AAO-7984-2020	Khananshvili, Daniel/0000-0002-4202-9966; Chung, Ka Young/0000-0001-9038-9571; Giladi, Moshe/0000-0002-8589-6920	USA-Israel Binational Foundation Research Grant [2009-334]; Israel Science Foundation [825/14]; National Research Foundation of Korea [NRF-2012R1A1A1039220, NRF-2012R1A5A2A28671860, NRF-2015R1A1A1A05027473]; Fields Estate foundation	USA-Israel Binational Foundation Research Grant(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); National Research Foundation of Korea(National Research Foundation of Korea); Fields Estate foundation	This work was supported by USA-Israel Binational Foundation Research Grant 2009-334; Israel Science Foundation Grant 825/14 (to D.K.); and National Research Foundation of Korea Grants NRF-2012R1A1A1039220, NRF-2012R1A5A2A28671860, and NRF-2015R1A1A1A05027473 (to K-Y.C.). The support from the Fields Estate foundation to D.K. is highly appreciated. The authors declare no conflicts of interest.	Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Beckett D, 2012, METHODS MOL BIOL, V796, P261, DOI 10.1007/978-1-61779-334-9_14; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Buljan M, 2013, CURR OPIN STRUC BIOL, V23, P443, DOI 10.1016/j.sbi.2013.03.006; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Dixit M, 2013, J BIOL CHEM, V288, P4194, DOI 10.1074/jbc.M112.423293; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2014, CURR OPIN CHEM BIOL, V21, P34, DOI 10.1016/j.cbpa.2014.03.011; Giladi M, 2015, BIOCHEM J, V465, P489, DOI 10.1042/BJ20141036; Giladi M, 2013, J BIOL CHEM, V288, P23141, DOI 10.1074/jbc.M113.471698; Giladi M, 2012, BIOCHEMISTRY-US, V51, P7313, DOI 10.1021/bi300739z; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Giladi M, 2012, CELL CALCIUM, V51, P478, DOI 10.1016/j.ceca.2012.04.007; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Hatje K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3460; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; Hryshko L, 2008, AM J PHYSIOL-CELL PH, V295, pC869, DOI 10.1152/ajpcell.00420.2008; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Latysheva NS, 2015, PROTEIN SCI, V24, P909, DOI 10.1002/pro.2674; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Mo JJ, 2012, DRUG DISCOV TODAY, V17, P1323, DOI 10.1016/j.drudis.2012.07.006; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reilly L., 2015, FASEB J; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	43	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1356	1366		10.1096/fj.15-282251	http://dx.doi.org/10.1096/fj.15-282251			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644350				2022-12-28	WOS:000370387800030
J	Han, KH; Gonzalez-Quintial, R; Peng, YJ; Baccala, R; Theofilopoulos, AN; Lerner, RA				Han, Kyung Ho; Gonzalez-Quintial, Rosana; Peng, Yingjie; Baccala, Roberto; Theofilopoulos, Argyrios N.; Lerner, Richard A.			An agonist antibody that blocks autoimmunity by inducing anti-inflammatory macrophages	FASEB JOURNAL			English	Article						cathepsin G; CTSG; CD14; M2 macrophage	INTRACELLULAR COMBINATORIAL LIBRARIES; CATHEPSIN-G; PROTEOLYTIC ACTIVATION; MRL-FAS(LPR) MICE; RENAL-DISEASE; STEM-CELLS; LUPUS; CD14; INFLAMMATION; EXPRESSION	We have devised a method of using intracellular combinatorial libraries to select antibodies that control cell fates. Many agonist antibodies have been selected with this method, and the process appears to be limited only by the availability of a phenotypic selection system. We demonstrate the utility of this approach to discover agonist antibodies that engage an unanticipated target and regulate macrophage polarization by selective induction of anti-inflammatory M2 macrophages. This antibody was used therapeutically to block autoimmunity in a classic mouse model of spontaneous systemic lupus erythematosus.	[Han, Kyung Ho; Peng, Yingjie; Lerner, Richard A.] Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Gonzalez-Quintial, Rosana; Baccala, Roberto; Theofilopoulos, Argyrios N.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Lerner, RA (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlerner@scripps.edu		Baccala, Roberto/0000-0002-3159-8469; HAN, KYUNG HO/0000-0001-6907-1462	TSRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065919] Funding Source: NIH RePORTER	TSRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. C. Pham (Washington University, St. Louis, MO, USA) and Dr. A. Rao (La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA) for knockout mice; and Drs. T. Bartfai, B. Felding, and Y. J. Kang [The Scripps Research Institute (TSRI)] for scientific discussions. Funding was provided by TSRI. K.H. and R.A.L. are the inventors of the LKAb agonist antibody, which has been patented by TSRI. The patent has been licensed to Zebra Technologies. The remaining authors declare no conflicts of interest.	Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beaufort N, 2004, J IMMUNOL, V172, P540, DOI 10.4049/jimmunol.172.1.540; Driesbaugh KH, 2015, J BIOL CHEM, V290, P3529, DOI 10.1074/jbc.M114.628560; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Kuroiwa T, 1998, LUPUS, V7, P597, DOI 10.1191/096120398678920712; Le-Barillec K, 2000, J LEUKOCYTE BIOL, V68, P209; Lenda DM, 2004, J IMMUNOL, V173, P4744, DOI 10.4049/jimmunol.173.7.4744; Mackie EJ, 2002, IUBMB LIFE, V53, P277, DOI 10.1080/15216540213469; Orme J, 2012, DISCOV MED, V13, P151; Owen CA, 2008, INT J BIOCHEM CELL B, V40, P1246, DOI 10.1016/j.biocel.2008.01.020; Pedron T, 2000, FEMS IMMUNOL MED MIC, V28, P247; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Tesch GH, 1999, J EXP MED, V190, P1813, DOI 10.1084/jem.190.12.1813; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tundup S, 2014, INFECT IMMUN, V82, P3240, DOI 10.1128/IAI.01780-14; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; Wilson TJ, 2009, CANCER RES, V69, P3188, DOI 10.1158/0008-5472.CAN-08-1956; Xie J, 2014, CHEM BIOL, V21, P274, DOI 10.1016/j.chembiol.2013.12.006; Xie J, 2013, P NATL ACAD SCI USA, V110, P8099, DOI 10.1073/pnas.1306263110; Yang NS, 1998, KIDNEY INT, V54, P143, DOI 10.1046/j.1523-1755.1998.00978.x; Yea K, 2015, CURR OPIN CHEM BIOL, V26, P1, DOI 10.1016/j.cbpa.2015.01.002; Yea K, 2013, P NATL ACAD SCI USA, V110, P14966, DOI 10.1073/pnas.1313671110; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang HK, 2014, BIOCHEM BIOPH RES CO, V454, P251, DOI 10.1016/j.bbrc.2014.10.085; Zhang HK, 2013, CHEM BIOL, V20, P734, DOI 10.1016/j.chembiol.2013.04.012; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhou W, 2014, NAT REV CANCER, V14, P26, DOI 10.1038/nrc3622	34	10	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					738	747		10.1096/fj.15-281329	http://dx.doi.org/10.1096/fj.15-281329			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481307	Green Published			2022-12-28	WOS:000369391900024
J	Liu, ZY; Mobley, JA; DeLucas, LJ; Kahn, RA; West, AB				Liu, Zhiyong; Mobley, James A.; DeLucas, Lawrence J.; Kahn, Richard A.; West, Andrew B.			LRRK2 autophosphorylation enhances its GTPase activity	FASEB JOURNAL			English	Article						G-protein; phosphorylation; GTP-hydrolysis; ROC; Parkinson disease	DISEASE-ASSOCIATED MUTATIONS; KINASE 2 LRRK2; PARKINSONS-DISEASE; NEURONAL TOXICITY; BINDING PROTEINS; STRUCTURAL BASIS; ATP-BINDING; ROC DOMAIN; P-LOOP; DYNAMIN	The leucine-rich repeat kinase (LRRK)-2 protein contains nonoverlapping GTPase and kinase domains, and mutation in either domain can cause Parkinson disease. GTPase proteins are critical upstream modulators of many effector protein kinases. In LRRK2, this paradigm may be reversed, as the kinase domain phosphorylates its own GTPase domain. In this study, we found that the ameba LRRK2 ortholog ROCO4 phosphorylates the GTPase domain [termed Ras-of-complex (ROC) domain in this family] of human LRRK2 on the same residues as the human LRRK2 kinase. Phosphorylation of ROC enhances its rate of GTP hydrolysis [from k(cat) (catalytic constant) 0.007 to 0.016 min(-1)], without affecting GTP or GDP dissociation kinetics [k(off) = 0.093 and 0.148 min(-1) for GTP and GDP, respectively). Phosphorylation also promotes the formation of ROC dimers, although GTPase activity appears to be equivalent between purified dimers and monomers. Modeling experiments show that phosphorylation induces conformational changes at the critical p-loop structure. Finally, ROC appears to be one of many GTPases phosphorylated in p-loop residues, as revealed by alignment of LRRK2 autophosphorylation sites with GTPases annotated in the phosphoproteome database. These results provide an example of a novel mechanism for kinase-mediated control of GTPase activity.	[Liu, Zhiyong; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Liu, Zhiyong; DeLucas, Lawrence J.] Univ Alabama Birmingham, Struct Biol Ctr, Dept Optometry, Birmingham, AL USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	West, AB (corresponding author), Civitan Int Res Bldg,5th Floor,1719 6th Ave South, Birmingham, AL 35233 USA.	abwest@uab.edu	Kahn, Richard/ABD-2666-2020; liu, zhao/GXV-6141-2022	Kahn, Richard/0000-0002-0259-0601; West, Andrew/0000-0002-3034-4061	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [R01 NS064934]; NIH National Cancer Institute [P30 CA13148]; UAB Comprehensive Cancer Center Mass Spectrometry and Proteomics Shared Facility; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA13148, P30 CA013148] Funding Source: Medline; NINDS NIH HHS [R01 NS064934] Funding Source: Medline	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Comprehensive Cancer Center Mass Spectrometry and Proteomics Shared Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank C. Deivanayagam and D. Chattopadhyay [Center for Structural Biology, Department of Optometry, The University of Alabama at Birmingham (UAB)] for useful discussions and guidance in the experiments. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant R01 NS064934 (to A.B.W.); NIH National Cancer Institute Grant P30 CA13148 (to L.J.D.); and by the UAB Comprehensive Cancer Center Mass Spectrometry and Proteomics Shared Facility. The authors declare no conflicts of interest.	Anand VS, 2009, FEBS J, V276, P6428, DOI 10.1111/j.1742-4658.2009.07341.x; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Azarani A, 1996, J BIOL CHEM, V271, P14931, DOI 10.1074/jbc.271.25.14931; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BURSTEIN ES, 1992, BIOCHEM J, V282, P387, DOI 10.1042/bj2820387; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P2674, DOI 10.1073/pnas.81.9.2674; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gomez-Suaga P, 2014, HUM MOL GENET, V23, P6779, DOI 10.1093/hmg/ddu395; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Hall BE, 2002, P NATL ACAD SCI USA, V99, P12138, DOI 10.1073/pnas.192453199; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Kahn Richard A, 2011, Cell Logist, V1, P49; Kamikawaji S, 2013, BIOCHEMISTRY-US, V52, P6052, DOI 10.1021/bi400596m; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu ZY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602318; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ray S, 2014, J BIOL CHEM, V289, P13042, DOI 10.1074/jbc.M113.537811; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Stafa K, 2014, HUM MOL GENET, V23, P2055, DOI 10.1093/hmg/ddt600; Taymans JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023207; Terheyden S, 2015, BIOCHEM J, V465, P139, DOI 10.1042/BJ20141095; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	49	39	39	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					336	347		10.1096/fj.15-277095	http://dx.doi.org/10.1096/fj.15-277095			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396237	Green Published			2022-12-28	WOS:000367621000032
J	Lavatelli, F; Imperlini, E; Orru, S; Rognoni, P; Sarnataro, D; Palladini, G; Malpasso, G; Soriano, ME; Di Fonzo, A; Valentini, V; Gnecchi, M; Perlini, S; Salvatore, F; Merlini, G				Lavatelli, Francesca; Imperlini, Esther; Orru, Stefania; Rognoni, Paola; Sarnataro, Daniela; Palladini, Giuseppina; Malpasso, Giuseppe; Soriano, Maria Eugenia; Di Fonzo, Andrea; Valentini, Veronica; Gnecchi, Massimiliano; Perlini, Stefano; Salvatore, Francesco; Merlini, Giampaolo			Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis	FASEB JOURNAL			English	Article						protein-misfolding diseases; proteotoxicity; human cardiac cells; functional proteomics; protein-protein interaction	CELL-DERIVED CARDIOMYOCYTES; BRAIN NATRIURETIC PEPTIDE; ALZHEIMERS-DISEASE; CARDIAC FIBROBLASTS; BETA OLIGOMERS; ABNORMAL INTERACTION; PRECURSOR PROTEIN; CYTOCHROME-C; MOUSE MODEL; FATTY-ACID	In immunoglobulin (Ig) light-chain (LC) (AL) amyloidosis, AL deposition translates into lifethreatening cardiomyopathy. Clinical and experimental evidence indicates that soluble cardiotoxic LCs are themselves harmful for cells, by which they are internalized. Hypothesizing that interaction of soluble cardiotoxic LCs with cellular proteins contributes to damage, we characterized their interactome in cardiac cells. LCs were purified from patients with AL amyloidosis cardiomyopathy or multiplemyeloma without amyloidosis (the nonamyloidogenic/noncardiotoxic LCs served as controls) and employed at concentrations in the range observed in AL patients' sera. A functional proteomic approach, based on direct and inverse coimmunoprecipitation and mass spectrometry, allowed identifying LC-protein complexes. Findings were validated by colocalization, fluorescence lifetime imaging microscopy (FLIM)-fluorescence resonance energy transfer (FRET), and ultrastructural studies, using human primary cardiac fibroblasts (hCFs) and stem cell-derived cardiomyocytes. Amyloidogenic cardiotoxic LCs interact in vitro with specific intracellular proteins involved in viability and metabolism. Imaging confirmed that, especially in hCFs, cardiotoxic LCs (not controls) colocalize with mitochondria and spatially associate with selected interactors: mitochondrial optic atrophy 1-like protein and peroxisomal acyl-coenzyme A oxidase 1 (FLIM-FRET efficiencies 11 and 6%, respectively). Cardiotoxic LC-treated hCFs display mitochondrial ultrastructural changes, supporting mitochondrial involvement. We show that cardiotoxic LCs establish nonphysiologic protein-protein contacts in human cardiac cells, offering new clues on the pathogenesis of AL cardiomyopathy.	[Lavatelli, Francesca; Rognoni, Paola; Di Fonzo, Andrea; Valentini, Veronica; Merlini, Giampaolo] Univ Pavia, Amyloidosis Res & Treatment Ctr, I-27100 Pavia, Italy; [Lavatelli, Francesca; Rognoni, Paola; Malpasso, Giuseppe; Di Fonzo, Andrea; Valentini, Veronica; Gnecchi, Massimiliano; Merlini, Giampaolo] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Palladini, Giuseppina; Perlini, Stefano] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy; [Malpasso, Giuseppe; Gnecchi, Massimiliano] Univ Pavia, Lab Expt Cardiol Cell & Mol Therapy, Dept Cardiothorac & Vasc Sci, I-27100 Pavia, Italy; [Lavatelli, Francesca; Rognoni, Paola; Palladini, Giuseppina; Malpasso, Giuseppe; Di Fonzo, Andrea; Valentini, Veronica; Gnecchi, Massimiliano; Perlini, Stefano] Univ Pavia, I-27100 Pavia, Italy; [Merlini, Giampaolo] Fdn Ist Ricovero & Cura, Clin Chem Lab, I-27100 Pavia, Italy; [Imperlini, Esther; Orru, Stefania; Sarnataro, Daniela; Salvatore, Francesco] Ctr Ric Ingn Genet CEINGE Biotecnol Avanzate, Naples, Italy; [Orru, Stefania] Parthenope Univ Naples, Dept Movement Sci, Naples, Italy; [Sarnataro, Daniela; Salvatore, Francesco] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Soriano, Maria Eugenia] Univ Padua, Dept Biol, Padua, Italy; [Gnecchi, Massimiliano] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa	University of Pavia; University of Pavia; University of Pavia; University of Pavia; University of Pavia; CEINGE Biotecnologie Avanzate; Parthenope University Naples; University of Naples Federico II; University of Padua; University of Cape Town	Salvatore, F (corresponding author), CEINGE Biotecnol Avanzate, Via Gaetano Salvatore 486, I-80145 Naples, Italy.	salvator@unina.it; gmerlini@unipv.it	Imperlini, Esther/K-4513-2016; Perlini, Stefano/E-2670-2012; valentini, veronica/D-8653-2016; Lavatelli, Francesca/K-5741-2016; Stefania, Orrù/ABH-2178-2020; Di Fonzo, Alessio/A-5702-2013; Merlini, Giampaolo/A-3817-2008; Rognoni, Paola/P-9092-2019; Palladini, Giovanni/G-1763-2010; Sarnataro, Daniela/X-5629-2019; Gnecchi, Massimiliano/X-7095-2019; Gnecchi, Massimiliano/J-8609-2018; Palladini, Giuseppina/AAB-8694-2019; Salvatore, Francesco/A-1966-2011	Perlini, Stefano/0000-0002-0320-8574; valentini, veronica/0000-0001-6958-7493; Lavatelli, Francesca/0000-0002-7693-4825; Di Fonzo, Alessio/0000-0001-6478-026X; Merlini, Giampaolo/0000-0001-7680-3254; Rognoni, Paola/0000-0001-6350-1919; Palladini, Giovanni/0000-0001-5994-5138; Sarnataro, Daniela/0000-0002-6094-8384; Gnecchi, Massimiliano/0000-0001-7435-4328; Gnecchi, Massimiliano/0000-0001-7435-4328; Soriano, Maria Eugenia/0000-0002-7971-2961; Imperlini, Esther/0000-0002-3054-7504; Palladini, Giuseppina/0000-0003-1312-7513; Salvatore, Francesco/0000-0002-2346-3564	Italian Ministry of Health [GR-2010-2317596]; Associazione Italiana per la Ricerca sul Cancro special program "5 per mille" [9965]; Fondazione Cariplo [20130964]; Amyloidosis Foundation; Fondazione Mintas [FSE 2007/2013]; Protocollo d'intesa Regione Campania-CEINGE [D.C. n.11]	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro special program "5 per mille"(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); Amyloidosis Foundation; Fondazione Mintas(Fondazione CarifeFondazione Caritro); Protocollo d'intesa Regione Campania-CEINGE	The authors thank Andrea Raimondi, Simona Casarini, Vittorio Rosti, and Valentina Poletto for useful suggestions and technical help. The authors also thank Jean Ann Gilder (Scientific Communication srl, Naples, Italy) for editing the manuscript. This work was supported by the Italian Ministry of Health (GR-2010-2317596; to F.L., E.I., and M.G.), Associazione Italiana per la Ricerca sul Cancro special program "5 per mille" (number 9965; to G.Me.), Fondazione Cariplo (20130964; to G.Me.), Amyloidosis Foundation (to F.L.), Fondazione Mintas (Ghislieri College, Pavia, Italy; to F.L.) grant POR Campania FSE 2007/2013 (CAMPUS-Bioframe, Regione Campania, Naples, Italy; to F.S.). and Protocollo d'intesa Regione Campania-CEINGE (D.C. n.11 del 28/02/14; to F.S.).	Baarine M, 2012, NEUROSCIENCE, V213, P1, DOI 10.1016/j.neuroscience.2012.03.058; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Bolte S., 2006, J MICROSC, V224, P213; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Clements M, 2014, TOXICOL SCI, V140, P445, DOI 10.1093/toxsci/kfu084; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Diomede L, 2014, BLOOD, V123, P3543, DOI 10.1182/blood-2013-10-525634; Dispenzieri A, 2004, J CLIN ONCOL, V22, P3751, DOI 10.1200/JCO.2004.03.029; Esposito G, 2013, J BIOL CHEM, V288, P17844, DOI 10.1074/jbc.M112.448639; Fanelli F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-8; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Guan J, 2014, EMBO MOL MED, V6, P1493, DOI 10.15252/emmm.201404190; Guan J, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0378-5; Imperlini E, 2014, J NEUROCHEM, V129, P1002, DOI 10.1111/jnc.12683; Imperlini E, 2013, J CELL BIOCHEM, V114, P2577, DOI 10.1002/jcb.24600; Imperlini E, 2010, PROTEOMICS, V10, P3165, DOI 10.1002/pmic.201000079; Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Khan JM, 2013, BRIT J PHARMACOL, V169, P304, DOI 10.1111/j.1476-5381.2012.02118.x; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Landes T, 2010, SEMIN CELL DEV BIOL, V21, P593, DOI 10.1016/j.semcdb.2009.12.012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lavatelli F, 2011, BBA-PROTEINS PROTEOM, V1814, P409, DOI 10.1016/j.bbapap.2010.12.012; Levinson RT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01278; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lizard G, 2012, J ALZHEIMERS DIS, V29, P241, DOI 10.3233/JAD-2011-111163; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Meratan AA, 2012, BBA-BIOMEMBRANES, V1818, P2149, DOI 10.1016/j.bbamem.2012.04.020; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Merlini G, 2013, HAEMATOLOGICA, V98, P1492, DOI 10.3324/haematol.2013.094482; Merlini G, 2013, BLOOD, V121, P5124, DOI 10.1182/blood-2013-01-453001; Mishra S, 2013, AM J PHYSIOL-HEART C, V305, pH95, DOI 10.1152/ajpheart.00186.2013; Misumi Y, 2013, LAB INVEST, V93, P911, DOI 10.1038/labinvest.2013.83; Monis GF, 2006, AM J PATHOL, V169, P1939, DOI 10.2353/ajpath.2006.060183; Narayan P, 2012, BIOCHEMISTRY-US, V51, P9270, DOI 10.1021/bi301277k; Norton M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004374; Obici L, 2005, BBA-PROTEINS PROTEOM, V1753, P11, DOI 10.1016/j.bbapap.2005.08.014; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palladini G, 2003, CIRCULATION, V107, P2440, DOI 10.1161/01.CIR.0000068314.02595.B2; Palladini G, 2006, BLOOD, V107, P3854, DOI 10.1182/blood-2005-11-4385; Palladini G, 2012, J CLIN ONCOL, V30, P4541, DOI 10.1200/JCO.2011.37.7614; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Perfetti V, 1996, ANAL BIOCHEM, V239, P107, DOI 10.1006/abio.1996.0297; Perfetti V, 2012, BLOOD, V119, P144, DOI 10.1182/blood-2011-05-355784; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rapezzi C, 2009, CIRCULATION, V120, P1203, DOI 10.1161/CIRCULATIONAHA.108.843334; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; Rognoni P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076022; Rosales-Corral S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/843649; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Sikkink LA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.75; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Soler-Lopez M, 2011, GENOME RES, V21, P364, DOI 10.1101/gr.114280.110; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Sousa MM, 2001, AM J PATHOL, V159, P1993; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; TAO SY, 1994, AM J PHYSIOL-HEART C, V267, pH1745, DOI 10.1152/ajpheart.1994.267.5.H1745; Trinkaus-Randall V, 2005, AM J PATHOL, V166, P197, DOI 10.1016/S0002-9440(10)62244-4; Trompier D, 2014, BIOCHIMIE, V98, P102, DOI 10.1016/j.biochi.2013.09.009; Virok DP, 2011, J PROTEOME RES, V10, P1538, DOI 10.1021/pr1009096; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	81	41	43	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4614	4628		10.1096/fj.15-272179	http://dx.doi.org/10.1096/fj.15-272179			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26220173				2022-12-28	WOS:000364514700020
J	Wang, H; Semenova, S; Kuusela, S; Panula, P; Lehtonen, S				Wang, Hong; Semenova, Svetlana; Kuusela, Sara; Panula, Pertti; Lehtonen, Sanna			Tankyrases regulate glucoregulatory mechanisms and somatic growth via the central melanocortin system in zebrafish larvae	FASEB JOURNAL			English	Article						pro-opiomelanocortin; melanocortin receptor; morpholino antisense oligonucleotides; XAV939; PARylation	TELOMERE LENGTH; FOOD-INTAKE; OBESITY; RECEPTOR; ENERGY; MICE; PROOPIOMELANOCORTIN; EXPRESSION; NEURONS; INSULIN	The central melanocortin system is a key regulator of energy homeostasis. Recent studies indicate that tankyrases (TNKSs), which poly(ADP-ribosyl) ate target proteins and direct them toward proteasomal degradation, affect overall metabolism, but the exact molecular mechanisms remain unclear. We used zebrafish larvae as a model to study the mechanisms by which TNKS1b, the zebrafish ortholog of mammalian TNKS1, regulates glucose homeostasis and somatic growth. In situ hybridization revealed that TNKS1b mRNA is prominently expressed in the hypothalamus and pituitary of the embryonic and larval brain. In the pituitary, TNKS1b is coexpressed with proopiomelanocortin a (pomca) gene in corticotropes and melanotropes. Knockdown of TNKS1b reduced the linear growth of the larvae, stimulated insulin gene and glucose transporter 4 protein, and suppressed gluconeogenic phosphoenolpyruvate carboxykinase 1 gene. This result indicates rapid glucose utilization and reduction of gluconeogenesis in TNKS1b-deficient larvae. Knockdown of TNKS1b down-regulated pomca expression and diminished alpha-melanocyte-stimulating hormone in the pars intermedia. Furthermore, down-regulation of TNKS1b suppressed the expression of melanocortin receptor 3 and increased the expression of melanocortin receptor 4. The collective data suggest that TNKS1b modulates glucoregulatorymechanisms and the somatic growth of zebrafish larvae via the central melanocortin system.	[Wang, Hong; Kuusela, Sara; Lehtonen, Sanna] Univ Helsinki, Dept Pathol, FIN-00290 Helsinki, Finland; [Semenova, Svetlana; Panula, Pertti] Univ Helsinki, Inst Biomed, Anat & Neurosci Ctr, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki	Lehtonen, S (corresponding author), Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241, FIN-00290 Helsinki, Finland.	sanna.h.lehtonen@helsinki.fi	Wang, Hong/AAW-6913-2020; Lehtonen, Sanna/AAE-4545-2020; Lehtonen, Sanna/GRJ-3642-2022	Wang, Hong/0000-0001-5700-6786; Lehtonen, Sanna/0000-0003-4189-2415; Panula, Pertti/0000-0002-1189-5132; Kuusela, Sara/0000-0002-2790-5841	European Research Council [242820]; Academy of Finland [131255, 218021, 277485]; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation	The authors thank N. Ruoho, A. Wilenius (both from the Department of Pathology, University of Helsinki, Helsinki, Finland), and H. Koivula (Institute of Biomedicine/Anatomy and Neuroscience Center, University of Helsinki) for expert technical assistance; Y. Chen for kindly providing dissected brains and M. Sundvik for assistance with the locomotion assays (both from Institute of Biomedicine/Anatomy and Neuroscience Centre, University of Helsinki); and Dr. R. Cone (Vanderbilt University School of Medicine, Nashville, TN, USA) for kindly providing the pomca construct. This work was supported by the European Research Council (Grant 242820); the Academy of Finland (Grants 131255, 218021, and 277485); the Sigrid Juselius Foundation; and the Paivikki and Sakari Sohlberg Foundation (all to S.L.). H.W designed the experiments. H.W., S.S., and S.K. performed the experiments and analyzed the data. H.W. wrote the manuscript. H.W., S.S., P.P., and S.L. edited the manuscript. The authors declare no conflicts of interest.	Angotzi AR, 2011, GEN COMP ENDOCR, V171, P332, DOI 10.1016/j.ygcen.2011.02.026; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dickmeis T, 2007, PLOS BIOL, V5, P854, DOI 10.1371/journal.pbio.0050078; Dunn JS, 2006, ANN HUM GENET, V70, P587, DOI 10.1111/j.1469-1809.2005.00248.x; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Forlano PM, 2007, J COMP NEUROL, V505, P235, DOI 10.1002/cne.21447; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI [10.1038/NCHEMBIO.1136, 10.1038/nchembio.1136]; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lee M, 2008, PEPTIDES, V29, P440, DOI 10.1016/j.peptides.2007.11.005; Liu NA, 2008, DEV BIOL, V319, P192, DOI 10.1016/j.ydbio.2008.03.039; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099; Martinelli CE, 2011, J CLIN ENDOCR METAB, V96, pE181, DOI 10.1210/jc.2010-1369; Peitsaro N, 2007, BIOCHEM PHARMACOL, V73, P1205, DOI 10.1016/j.bcp.2007.01.014; Pezzolesi MG, 2004, DIABETES, V53, P486, DOI 10.2337/diabetes.53.2.486; Renquist BJ, 2013, ZEBRAFISH, V10, P343, DOI 10.1089/zeb.2012.0841; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Seth A, 2013, DIS MODEL MECH, V6, P1080, DOI 10.1242/dmm.011346; Sohn JW, 2012, MOL NEUROBIOL, V45, P225, DOI 10.1007/s12035-012-8240-6; Song Y, 2003, ENDOCRINE, V22, P257, DOI 10.1385/ENDO:22:3:257; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Tao YX, 2010, METHOD ENZYMOL, V484, P267, DOI [10.1016/S0076-6879(10)84014-5, 10.1016/B978-0-12-381298-8.00014-9]; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wang H, 2012, DIFFERENTIATION, V83, P38, DOI 10.1016/j.diff.2011.08.007; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Williams KW, 2011, EUR J PHARMACOL, V660, P2, DOI 10.1016/j.ejphar.2010.11.042; Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	49	3	4	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4435	4448		10.1096/fj.15-271817	http://dx.doi.org/10.1096/fj.15-271817			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26169937				2022-12-28	WOS:000364514700005
J	Herpin, A; Englberger, E; Zehner, M; Wacker, R; Gessler, M; Schartl, M				Herpin, Amaury; Englberger, Eva; Zehner, Mario; Wacker, Robin; Gessler, Manfred; Schartl, Manfred			Defective autophagy through epg5 mutation results in failure to reduce germ plasm and mitochondria	FASEB JOURNAL			English	Article						gonad development; medaka; primordial germ cell	MEDAKA ORYZIAS-LATIPES; P GRANULE COMPONENTS; C. ELEGANS; CAENORHABDITIS-ELEGANS; PATERNAL MITOCHONDRIA; GONAD DEVELOPMENT; DEGRADATION; CELLS; EXPRESSION; DROSOPHILA	Autophagy is an evolutionarily conserved catabolic process that transports cytoplasmic components to lysosomes for degradation. In addition to the canonical view of strict stress-response-induced autophagy, selectively programmed autophagy was recently reported in the context of gonad development of flies and worms, where autophagy seems to be necessary for clearance of germ plasm components. Similar functions have not been described in vertebrates. We used the medaka fish to study the role of autophagy in gonad formation and gametogenesis for the first time in a vertebrate organism for which thegermline is specifiedby germplasm. Using a transgenic line deficient in the Ol-epg5 gene-a new critical component of the autophagy pathway-we show that such deficiency leads to an impaired autophagic flux, possibly attributed to compromised maturation or processing of the autophagosomes. Ol-epg5 deficiency correlates with selectively impaired spermatogenesis and low allele transmission rates of the mutant allele caused by failure of germ plasm and mitochondria clearance during the process of germ cell specification and in the adult gonads. The mouse epg-5 homolog is similarly expressed in the maturating and adult testes, suggesting an at least partially conserved function of this process during spermatogenesis in vertebrates.	[Herpin, Amaury; Zehner, Mario; Wacker, Robin; Schartl, Manfred] Univ Wurzburg, Physiol Chem, Bioctr, D-97074 Wurzburg, Germany; [Englberger, Eva; Gessler, Manfred] Univ Wurzburg, Dev Biochem, Bioctr, D-97074 Wurzburg, Germany; [Herpin, Amaury] INRA, Fish Physiol & Genom, Unit Rech 1037, F-35042 Rennes, France; [Schartl, Manfred] Univ Clin Wurzburg, Ctr Comprehens Canc, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; INRAE; University of Wurzburg	Herpin, A (corresponding author), Univ Wurzburg, Physiol Chem, Bioctr, D-97074 Wurzburg, Germany.	amaury.herpin@biozentrum.uni-wurzburg.de	Herpin, Amaury/B-8950-2011	Herpin, Amaury/0000-0002-0630-4027; Schartl, Manfred/0000-0001-9882-5948; Gessler, Manfred/0000-0002-7915-6045	Deutsche Forschungsgemeinschaft (DFG) [HE 7135/2-1, SCHA 408/12-1, SFB 688]; DFG Graduate Training Program [GK 1048]; U.S. National Institutes of Health [1R01GM085318-01A2, 212791A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Graduate Training Program; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the National Institute for Basic Biology, Japan (NRBP Medaka) for providing genomic resources and BAC clones; the fish facilities at the University of Wurzburg and at the INRA Rennes (F. Borel, C. Duret); and S. Bertho for technical assistance in performing the immunohistochemistry. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) through Grants HE 7135/2-1 (to A.H.), SCHA 408/12-1 (to M.S.), and SFB 688 (TP A16) (to M.G.); the DFG Graduate Training Program Grant GK 1048, "Molecular basis of organ development in vertebrates"; and U.S. National Institutes of Health Grant 1R01GM085318-01A2, subaward No. 212791A, "Mechanisms of sex determination in zebrafish." A.H. and M.S designed the experiments and wrote the manuscript. A.H., E.E., M.Z., and R.W. performed the experiments. A.H., M.G., and M.S. discussed/commented on the results and edited the manuscript. All authors approved the manuscript. The authors declare no conflicts of interest.	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Berekelya LA, 2005, MOL BIOL+, V39, P664; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; Di Bartolomeo S, 2010, TRAFFIC, V11, P1280, DOI 10.1111/j.1600-0854.2010.01103.x; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; FURUKAWA K, 1994, EXP CELL RES, V212, P426, DOI 10.1006/excr.1994.1164; Gottlieb R. A., 2013, HEART FAIL REV; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-99; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Herpin A, 2013, MOL BIOL EVOL, V30, P2328, DOI 10.1093/molbev/mst130; Herpin A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000844; Herpin A, 2009, NUCLEIC ACIDS RES, V37, P1510, DOI 10.1093/nar/gkn1065; Hornung U, 2007, SEX DEV, V1, P197, DOI 10.1159/000102108; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Johnson CW, 2012, FUTURE MED CHEM, V4, P1715, DOI [10.4155/FMC.12.112, 10.4155/fmc.12.112]; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kluver N, 2009, DEV BIOL, V325, P179, DOI 10.1016/j.ydbio.2008.10.009; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Luo SM, 2013, AUTOPHAGY, V9, P2156, DOI 10.4161/auto.26302; Luo SM, 2013, P NATL ACAD SCI USA, V110, P13038, DOI 10.1073/pnas.1303231110; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; Nakamura S, 2008, MOL REPROD DEV, V75, P472, DOI 10.1002/mrd.20764; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103; Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Thome RG, 2009, AUTOPHAGY, V5, P117, DOI 10.4161/auto.5.1.7302; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Voronina E, 2013, MOL REPROD DEV, V80, P624, DOI 10.1002/mrd.22136; WOLF N, 1983, J EMBRYOL EXP MORPH, V73, P297; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yordy B, 2011, CURR OPIN VIROL, V1, P196, DOI 10.1016/j.coviro.2011.05.016; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhao HY, 2013, J CELL BIOL, V200, P731, DOI 10.1083/jcb.201211014; Zhao Y, 2009, AUTOPHAGY, V5, P717, DOI 10.4161/auto.5.5.8552; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182; Zhou Y, 2004, IUBMB LIFE, V56, P19, DOI 10.1080/15216540310001658886	48	25	25	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4145	4161		10.1096/fj.14-265462	http://dx.doi.org/10.1096/fj.14-265462			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26183773	Green Published			2022-12-28	WOS:000361367300006
J	Garcia, JA; Volt, H; Venegas, C; Doerrier, C; Escames, G; Lopez, LC; Acuna-Castroviejo, D				Garcia, Jose A.; Volt, Huayqui; Venegas, Carmen; Doerrier, Carolina; Escames, Germaine; Lopez, Luis C.; Acuna-Castroviejo, Dario			Disruption of the NF-kappa B/NLRP3 connection by melatonin requires retinoid-related orphan receptor-alpha and blocks the septic response in mice	FASEB JOURNAL			English	Article						innate immunity; oxidative stress; inflammasome; sirtuin-1; bmal1	NF-KAPPA-B; HIGH-RESOLUTION RESPIROMETRY; NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL DYSFUNCTION; INHIBITS EXPRESSION; SUPEROXIDE ANION; ROR-ALPHA; INFLAMMATION; ACTIVATION; SEPSIS	We determined the NF-kappa B- and NOD-like receptor (NLR) P3-dependent molecular mechanisms involved in sepsis and evaluated the role of retinoid-related orphan receptor (ROR)-alpha inmelatonin's anti-inflammatory actions. Western blot, RT-PCR, ELISA, and spectrophotometric analysis revealed that NF-kappa B and NLRP3 closely interact, leading to proinflammatory and pro-oxidant status in heart tissue of septic C57BL/6J mice. Moreover, mitochondrial oxygen consumption was reduced by 80% in septic mice. In vivo and in vitro analysis showed that melatonin administration blunts NF-kappa B transcriptional activity through a sirtuin1-dependent NF-kappa B deacetylation in septic mice. Melatonin also decreased NF-kappa B-dependent proinflammatory response and restored redox balance and mitochondrial homeostasis, thus inhibiting the NLRP3 inflammasome. In an important finding, the inhibition of NF-kappa B by melatonin, but not that of NLRP3, was blunted in ROR alpha(sg/sg) mice, indicating that functional ROR alpha transcription factor is necessary for the initiation of the innate immune response against inflammation. Our results are evidence of the NF-kappa B/NLRP3 connection during sepsis and identify NLRP3 as a novel molecular target for melatonin. The multiple molecular targets of melatonin in this study explain its potent anti-inflammatory efficacy against systemic innate immune activation and herald a promising therapeutic application for melatonin in the treatment of sepsis.	[Garcia, Jose A.; Volt, Huayqui; Venegas, Carmen; Doerrier, Carolina; Escames, Germaine; Lopez, Luis C.; Acuna-Castroviejo, Dario] Univ Granada, Ctr Invest Biomed, Fac Med, Inst Biotecnol, Granada, Spain; [Garcia, Jose A.; Volt, Huayqui; Venegas, Carmen; Doerrier, Carolina; Escames, Germaine; Lopez, Luis C.; Acuna-Castroviejo, Dario] Univ Granada, Dept Fisiol, Fac Med, Granada, Spain; [Acuna-Castroviejo, Dario] Hosp Univ San Cecilio, Unidad Gest Clin Labs, Granada, Spain	University of Granada; University of Granada; Hospital Universitario San Cecilio	Acuna-Castroviejo, D (corresponding author), Univ Granada, Ctr Invest Biomed, Parque Tecnol Ciencias Salud, Granada, Spain.	dacuna@ugr.es	Lopez, Luis Carlos/L-5129-2014; Acuña-Castroviejo, Dario/N-7456-2016; Venegas, Carmen/HIK-2268-2022; Doerrier, Carolina/AAH-3969-2021; Escames, Germaine/N-7501-2016	Lopez, Luis Carlos/0000-0003-3355-0298; Acuña-Castroviejo, Dario/0000-0002-9680-1560; Venegas, Carmen/0000-0002-8902-4986; Doerrier, Carolina/0000-0002-7969-6762; Escames, Germaine/0000-0003-1256-7656	Instituto de Salud Carlos III, Spain [PI08-1664, RD12/0043/0005]; Conserjeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain [P07-CTS-03135]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Conserjeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain	The authors thank Ana Fernandez Ibanez (Unidad de Bioanalisis, Centro de Instrumentacion Cientifica, Universidad de Granada) for technical support. This research was partially supported by grants PI08-1664 and RD12/0043/0005 from the Instituto de Salud Carlos III, Spain, and P07-CTS-03135 from the Conserjeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain. The authors declare no conflicts of interest. The results of this study constitute part of J.A.G.'s doctoral thesis under the Biotechnology Doctorate Program of the University of Granada.	ACUNACASTROVIEJO D, 1994, J PINEAL RES, V16, P100, DOI 10.1111/j.1600-079X.1994.tb00089.x; Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Crespo E, 1999, FASEB J, V13, P1537, DOI 10.1096/fasebj.13.12.1537; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Doerrier C, 2015, LIFE SCI, V121, P158, DOI 10.1016/j.lfs.2014.11.031; Escames G, 2006, J PINEAL RES, V40, P71, DOI 10.1111/j.1600-079X.2005.00281.x; Escames G, 2007, FEBS J, V274, P2135, DOI 10.1111/j.1742-4658.2007.05755.x; Escames G, 2006, J PHARM PHARMACOL, V58, P1153, DOI 10.1211/jpp.58.9.0001; Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y; Galley HF, 2010, CRIT CARE, V14, DOI 10.1186/cc9098; Gilad E, 1998, FASEB J, V12, P685, DOI 10.1096/fasebj.12.9.685; Gitto E, 2001, PEDIATR RES, V50, P756, DOI 10.1203/00006450-200112000-00021; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Horvath GL, 2011, IMMUNOL REV, V243, P119, DOI 10.1111/j.1600-065X.2011.01050.x; Hunter JD, 2010, BRIT J ANAESTH, V104, P3, DOI 10.1093/bja/aep339; JASKOT RH, 1983, J ANAL TOXICOL, V7, P86, DOI 10.1093/jat/7.2.86; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Lopez A, 2009, J PINEAL RES, V46, P188, DOI 10.1111/j.1600-079X.2008.00647.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin M, 2000, FASEB J, V14, P1677; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mohan N, 1995, BIOCHEM MOL BIOL INT, V37, P1063; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ortiz F, 2014, J PINEAL RES, V56, P71, DOI 10.1111/jpi.12099; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Radogna F, 2010, BIOCHEM PHARMACOL, V80, P1844, DOI 10.1016/j.bcp.2010.07.041; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Tsutsui H, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/641865; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; WIESENBERG I, 1995, NUCLEIC ACIDS RES, V23, P327, DOI 10.1093/nar/23.3.327; Yang Y, 2015, J PINEAL RES, V58, P61, DOI 10.1111/jpi.12193; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang LK, 2014, ARCH BIOCHEM BIOPHYS, V554, P22, DOI 10.1016/j.abb.2014.05.005; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	47	156	163	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3863	3875		10.1096/fj.15-273656	http://dx.doi.org/10.1096/fj.15-273656			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26045547				2022-12-28	WOS:000359915600022
J	Kok, MGM; Halliani, A; Moerland, PD; Meijers, JCM; Creemers, EE; Pinto-Sietsma, SJ				Kok, Maayke G. M.; Halliani, Amalia; Moerland, Perry D.; Meijers, Joost C. M.; Creemers, Esther E.; Pinto-Sietsma, Sara-Joan			Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR	FASEB JOURNAL			English	Article						coronary artery disease; platelets; serum; whole blood	GENE-EXPRESSION ANALYSIS; ENDOGENOUS CONTROL; REFERENCE RNA; IDENTIFICATION; SERUM; BIOMARKERS	Circulating microRNAs (miRNAs) have been reported as biomarkers for disease diagnosis. RT-qPCR is most commonly used to detect miRNAs; however, no consensus on the most appropriate method for data normalization exists. Via a standardized selection method, we aimed to determine separate miRNA normalization panels for RT-qPCR measurements on whole blood, platelets, and serum. Candidate miRNAs were selected from studies describing circulating miRNA microarray data in the Gene Expression Omnibus or ArrayExpress. miRNA expression data of healthy controls were retrieved from each study. For each sample type, we selected those miRNAs that were least variable and sufficiently highly expressed in multiple microarray experiments, performed on at least 2 different platforms. Stability of the candidate miRNAs was assessed using NormFinder and geNorm algorithms in a RT-qPCR cohort of 10 patients with coronary artery disease and 10 healthy controls. We selected miRNA normalization panels for RT-qPCR measurements on whole blood, platelets, and serum. As a validation, we assessed the precision of all 3 panels in 3 independent RT-qPCR cohorts and compared this with normalization for miR-16 or RNU6B. The proposed normalization panels for whole blood, platelets, and serum show better precision than normalization for miR-16 or RNU6B.	[Kok, Maayke G. M.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kok, Maayke G. M.; Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Halliani, Amalia; Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Meijers, Joost C. M.] Sanquin, Dept Plasma Prot, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pinto-Sietsma, SJ (corresponding author), Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, POB 22660, NL-1100 DD Amsterdam, Netherlands.	s.j.pinto@amc.uva.nl	Moerland, Perry/AAG-1425-2020; Meijers, J.C.M./S-5981-2019; SJ, Pinto-Sietsma/AAI-3207-2021	Moerland, Perry/0000-0002-2357-3659; Meijers, J.C.M./0000-0002-4198-6780; Creemers, Esther/0000-0002-9001-3854	project INCOAG [01C-201]; Dutch Heart Foundation	project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of the Center for Translational Molecular Medicine (www.ctmm.nl), and project INCOAG (Grant 01C-201) and was supported by the Dutch Heart Foundation.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Appaiah HN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2943; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benz F, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.81; Brattelid T, 2011, PHYSIOL GENOMICS, V43, P604, DOI 10.1152/physiolgenomics.00131.2010; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079652; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Cookson VJ, 2012, CELL ONCOL, V35, P301, DOI 10.1007/s13402-012-0089-1; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; Filkova M, 2014, ANN RHEUM DIS, V73, P1898, DOI 10.1136/annrheumdis-2012-202815; Ge W, 2014, CLIN LAB, V60, P427, DOI 10.7754/Clin.Lab.2013.130133; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hardikar AA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000792; Hu J, 2014, INT J CANCER, V135, P1187, DOI 10.1002/ijc.28757; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060932; Kagias K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-222; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; McCann SE, 2013, BRIT J NUTR, V109, P585, DOI 10.1017/S0007114512001936; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mi QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031278; Murakami Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048366; NCBI, 2015, GSE59421 NCBI; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Smith RD, 2003, BIOTECHNIQUES, V34, P88, DOI 10.2144/03341st05; Sondermeijer BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025946; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603	42	59	60	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3853	3862		10.1096/fj.15-271312	http://dx.doi.org/10.1096/fj.15-271312			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26023181				2022-12-28	WOS:000359915600021
J	Reddy, GR; Subramanian, H; Birk, A; Milde, M; Nikolaev, VO; Bunemann, M				Reddy, Gopireddy Raghavender; Subramanian, Hariharan; Birk, Alexandra; Milde, Markus; Nikolaev, Viacheslav O.; Buenemann, Moritz			Adenylyl cyclases 5 and 6 underlie PIP3-dependent regulation	FASEB JOURNAL			English	Article						cAMP; GPCR; PI3K; G alpha(i); FRET	G-PROTEIN; CA2+ CURRENT; REBOUND STIMULATION; ION CHANNELS; VENTRICULAR MYOCYTES; SMOOTH-MUSCLE; CAMP; ACETYLCHOLINE; GAMMA; RECEPTORS	Many different neurotransmitters and hormones control intracellular signaling by regulating the production of the second messenger cAMP. The function of the broadly expressed adenylyl cyclases (ACs) 5 and 6 is regulated by either stimulatory or inhibitory G proteins. By analyzing a well-known rebound stimulation phenomenon after withdrawal of G(i) protein in atrial myocytes, we discovered that AC5 and -6 are tightly regulated by the second messenger PIP3. By monitoring cAMP levels in real time by means of Forster resonance energy transfer (FRET)-based biosensors, we reproduced the rebound stimulation in a heterologous expression system specifically for AC5 or -6. Strikingly, this cAMP rebound stimulation was completely blocked by the PI3K inhibitor wortmannin, both in atrial myocytes and in transfected human embryonic kidney cells. Similar effects were observed by heterologous expression of the PIP3 phosphatase and tensin homolog (PTEN). However, general kinase inhibitors or inhibitors of Akt had no effect, suggesting a PIP3-dependent mechanism. These findings demonstrate the existence of a novel general pathway for regulation of AC5 and -6 activity via PIP3 that leads to pronounced alterations of cytosolic cAMP levels.- Reddy, G. R., Subramanian, H., Birk, A., Milde, M., Nikolaev, V. O., Bunemann, M. Adenylyl cyclases 5 and 6 underlie PIP3-dependent regulation.	[Reddy, Gopireddy Raghavender; Birk, Alexandra; Buenemann, Moritz] Univ Marburg, Fac Pharm, D-35032 Marburg, Germany; [Subramanian, Hariharan; Nikolaev, Viacheslav O.] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Milde, Markus] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany	Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen	Bunemann, M (corresponding author), Univ Marburg, Karl von Frisch Str 1, D-35032 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de	Nikolaev, Vyacheslav/AAT-7746-2020	Buenemann, Moritz/0000-0002-2259-4378	Deutsche Forschungsgemeinschaft [SFB593]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Drs. Dominik Oliver, Jin Zhang, and Kazuhiro Aoki for providing FRET- and PIP<INF>3</INF>-dependent translocation biosensors. This work was funded in part by Deutsche Forschungsgemeinschaft SFB593. The authors declare no conflicts of interest.	BANACH K, 1993, PFLUG ARCH EUR J PHY, V423, P245, DOI 10.1007/BF00374402; Belevych AE, 2000, J PHYSIOL-LONDON, V528, P279, DOI 10.1111/j.1469-7793.2000.00279.x; Belevych AE, 2001, J PHYSIOL-LONDON, V536, P677, DOI 10.1111/j.1469-7793.2001.00677.x; Bett GCL, 2002, J PHYSIOL-LONDON, V542, P107, DOI 10.1113/jphysiol.2002.017335; Bodmann EL, 2014, BIOCHEM J, V458, P131, DOI 10.1042/BJ20130782; Brady JD, 2006, P NATL ACAD SCI USA, V103, P15635, DOI 10.1073/pnas.0603344103; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; DEIGHTON NM, 1990, N-S ARCH PHARMACOL, V341, P14; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gottle M, 2009, J PHARMACOL EXP THER, V329, P1156, DOI 10.1124/jpet.109.150953; Gregg CJ, 2010, ANESTH ANALG, V111, P870, DOI 10.1213/ANE.0b013e3181ee8312; HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Hu CL, 2009, AM J PHYSIOL-HEART C, V297, pH1776, DOI 10.1152/ajpheart.00050.2009; Jungmichel S, 2014, CELL REP, V6, P578, DOI 10.1016/j.celrep.2013.12.038; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Milde M, 2013, BIOCHEM J, V454, P515, DOI 10.1042/BJ20130554; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Murthy KS, 1998, MOL PHARMACOL, V54, P122, DOI 10.1124/mol.54.1.122; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; ONO K, 1994, JPN J PHYSIOL, V44, pS193; OSAKA T, 1993, AM J PHYSIOL, V264, pH1916; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pavan B, 2009, DRUG DISCOV TODAY, V14, P982, DOI 10.1016/j.drudis.2009.07.007; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Song YJ, 1998, J CARDIOVASC ELECTR, V9, P718, DOI 10.1111/j.1540-8167.1998.tb00959.x; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; von Hayn K, 2010, AM J PHYSIOL-CELL PH, V298, pC324, DOI 10.1152/ajpcell.00197.2009; Wang YG, 1998, J GEN PHYSIOL, V111, P113, DOI 10.1085/jgp.111.1.113; WANG YG, 1995, CIRC RES, V76, P634, DOI 10.1161/01.RES.76.4.634; Wang YG, 1996, CIRC RES, V79, P109, DOI 10.1161/01.RES.79.1.109; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Zakharov SI, 1997, J PHYSIOL-LONDON, V499, P105, DOI 10.1113/jphysiol.1997.sp021914; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	50	3	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3458	3471		10.1096/fj.14-268466	http://dx.doi.org/10.1096/fj.14-268466			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25931510				2022-12-28	WOS:000358796900032
J	Funcke, JB; Zoller, V; Abd El Hay, M; Debatin, KM; Wabitsch, M; Fischer-Posovszky, P				Funcke, Jan-Bernd; Zoller, Verena; Abd El Hay, Muad; Debatin, Klaus-Michael; Wabitsch, Martin; Fischer-Posovszky, Pamela			TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation	FASEB JOURNAL			English	Article						adipose tissue homeostasis; adipocyte progenitor; noncanonical signaling; death ligand	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRAIL PROMOTES; ADIPOSE-TISSUE; THYMOCYTE APOPTOSIS; BINDING-PROTEINS; PUZZLING ROLE; CELLS; EXPRESSION; SURVIVAL	Upon obesity, adipose tissue is excessively expanded and characterized by pathologic processes like hypoxia, fibrosis, and inflammation. Death ligands belonging to the TNF superfamily such as TNF-alpha are important contributors to these derangements and exert a pronounced influence on the metabolic and cellular homeostasis of adipose tissue. Here, we sought to identify the effect of the death ligand TNF-related apoptosis-inducing ligand (TRAIL) on the adipose tissue precursor cell pool and therefore investigated its influence on preadipocyte proliferation. Treatment of human preadipocytes with TRAIL resulted in a time-and dose-dependent increase in proliferation (EC50 3.4 ng/ml) comparable to IGF-1. Although no apoptosis was observed, TRAIL triggered a rapid cleavage of caspase-8 and -3. Neither inhibition of caspase activity by zVAD.fmk (20 mu M) nor ablation of caspase-8 expression by lentivirus-delivered small hairpin RNA (shRNA) abolished the proliferative response. TRAIL triggered a delayed and sustained activation of ERK1/2, leaving Akt, p38, JNK, and NF-kappa B unaffected. Importantly, inhibition of ERK1/2 activation by PD0325901 (300 nM) or AZD6244 (5 or 10 mu M) completely abolished the proliferative response. We thus reveal a hitherto unknown function of TRAIL in regulating adipose tissue homeostasis by promoting the proliferation of tissue-resident precursor cells.	[Funcke, Jan-Bernd; Zoller, Verena; Abd El Hay, Muad; Wabitsch, Martin; Fischer-Posovszky, Pamela] Ulm Med Ctr, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Debatin, Klaus-Michael] Ulm Med Ctr, Dept Pediat & Adolescent Med, Ulm, Germany		Fischer-Posovszky, P (corresponding author), Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, Eythstr 24, D-89075 Ulm, Germany.	pamela.fischer@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886; Abd El Hay, Muad/0000-0002-5082-1216; Funcke, Jan-Bernd/0000-0002-2596-3167; Fischer-Posovszky, Pamela/0000-0003-3402-9840	International Graduate School in Molecular Medicine Ulm (IGradU)	International Graduate School in Molecular Medicine Ulm (IGradU)	The authors thank Alexandra Killian for her outstanding technical assistance and Mike Andrew Westhoff for helpful discussions throughout this project. J.B.F. and V.Z. were funded by the International Graduate School in Molecular Medicine Ulm (IGradU).	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Ashley DT, 2011, METABOLISM, V60, P994, DOI 10.1016/j.metabol.2010.10.001; Audo R, 2009, CELL DEATH DIFFER, V16, P1227, DOI 10.1038/cdd.2009.38; Azijli K, 2013, CELL DEATH DIFFER, V20, P858, DOI 10.1038/cdd.2013.28; Baer Patrick C, 2014, World J Stem Cells, V6, P256, DOI 10.4252/wjsc.v6.i3.256; Belyanskaya LL, 2008, LUNG CANCER, V60, P355, DOI 10.1016/j.lungcan.2007.11.005; Bernardi S, 2012, CLIN SCI, V123, P547, DOI 10.1042/CS20120176; Brombo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058225; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Choi JW, 2004, ANN CLIN LAB SCI, V34, P400; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P314, DOI 10.1055/s-2007-976539; Fischer-Posovszky P, 2004, ENDOCRINOLOGY, V145, P1849, DOI 10.1210/en.2003-0985; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Hauner H, 2000, METH MOL B, V155, P239; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Keuper M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.212; Keuper M., 2011, HORM RES PAEDIAT, V76, P20; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mi QS, 2003, DIABETES, V52, P1967, DOI 10.2337/diabetes.52.8.1967; Morel J, 2005, J BIOL CHEM, V280, P15709, DOI 10.1074/jbc.M414469200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Brien LA, 2008, ARTERIOSCL THROM VAS, V28, pE5, DOI 10.1161/ATVBAHA.107.158949; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Rippo MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.115; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Samocha-Bonet D, 2014, OBES REV, V15, P697, DOI 10.1111/obr.12199; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2008, ARTERIOSCL THROM VAS, V28, pE4, DOI 10.1161/ATVBAHA.107.158451; Spierings DC, 2004, J HISTOCHEM CYTOCHEM, V52, P821, DOI 10.1369/jhc.3A6112.2004; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vilimanovich U, 2008, CELL MOL LIFE SCI, V65, P814, DOI 10.1007/s00018-008-7513-8; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771	55	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3065	3075		10.1096/fj.14-267278	http://dx.doi.org/10.1096/fj.14-267278			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857555	Green Published			2022-12-28	WOS:000356859100033
J	Maity-Kumar, G; Thal, DR; Baumann, B; Scharffetter-Kochanek, K; Wirth, T				Maity-Kumar, Gandhari; Thal, Dietmar R.; Baumann, Bernd; Scharffetter-Kochanek, Karin; Wirth, Thomas			Neuronal redox imbalance results in altered energy homeostasis and early postnatal lethality	FASEB JOURNAL			English	Article						neuronal apoptosis; hypoglycemia; oxidative stress; SOD2	MANGANESE SUPEROXIDE-DISMUTASE; CORTICOTROPIN-RELEASING HORMONE; TISSUE-SPECIFIC DELETION; OXIDATIVE STRESS; COUNTERREGULATORY RESPONSES; CONDITIONAL KNOCKOUT; NITRIC-OXIDE; MODEL MICE; DEFICIENCY; SYSTEM	Redox imbalance is believed to contribute to the development and progression of several neurodegenerative disorders. Our aim was to develop an animal model that exhibits neuron-specific oxidative stress in the CNS to study the consequences and eventually find clues regarding the pathomechanisms of oxidative insults in neuronal homeostasis. We therefore generated a novel neuron-specific superoxide dismutase 2 (SOD2)-deficient mouse by deleting exon 3 of the SOD2 gene using CamKII alpha promoter-driven Cre expression. These neuron-specific SOD2 knockout (SOD2(nko)) mice, although born at normal frequencies, died at the age of 4 weeks with critical growth retardation, severe energy failure, and several neurologic phenotypes. In addition, SOD2(nko) mice exhibited severe neuronal alterations such as reactive astrogliosis, neuronal cell cycle inhibition, and induction of apoptosis. JNK activation and stabilization of p53, as a result of reactive oxygen species accumulation, are most likely the inducers of neuronal apoptosis in SOD2(nko) mice. It is remarkable that hypothalamic regulation of glucose metabolism was affected, which in turn induced necrotic brain lesions in SOD2(nko) mice. Taken together, our findings suggest that exclusive deficiency of SOD2 in neurons results in an impaired central regulation of energy homeostasis that leads to persistent hypoglycemia, hypoglycemia-related neuropathology, and an early lethality of the mutant mice.	[Maity-Kumar, Gandhari; Baumann, Bernd; Wirth, Thomas] Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany; [Thal, Dietmar R.] Univ Ulm, Neuropathol Lab, Inst Pathol, D-89069 Ulm, Germany; [Scharffetter-Kochanek, Karin] Univ Ulm, Dept Dermatol & Allergol, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Wirth, T (corresponding author), Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany.	thomas.wirth@uni-ulm.de	Thal, Dietmar R/O-7483-2018; Wirth, Thomas/X-7172-2019	Thal, Dietmar R/0000-0002-1036-1075; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	Deutsche Forschungsgemeinschaft [GC1789]; Boehringer Ingelheim Ulm University BioCenter (BIU) [N8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Ulm University BioCenter (BIU)	The authors thank Dr. Henning Beck for help with the primary neuron culture, Melanie Gerstenlauer for excellent support in histology, Nina Ushmorova for help with blood sugar testing, Ute Leschik for technical assistance, and Dr. Uta Schmidt-Strassburger for thoughtful discussions. This work was supported by Deutsche Forschungsgemeinschaft Grant GC1789 and Boehringer Ingelheim Ulm University BioCenter (BIU; N8).	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Auer RN, 2004, FORENSIC SCI INT, V146, P105, DOI 10.1016/j.forsciint.2004.08.001; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Belgardt BF, 2010, ANN NY ACAD SCI, V1212, P97, DOI 10.1111/j.1749-6632.2010.05799.x; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Choi HJ, 2011, BRIT J PHARMACOL, V162, P175, DOI 10.1111/j.1476-5381.2010.01041.x; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Devi SA, 2009, THESCIENTIFICWORLDJO, V9, P366, DOI 10.1100/tsw.2009.46; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Flanagan DE, 2003, DIABETES, V52, P605, DOI 10.2337/diabetes.52.3.605; Fridovich I, 2013, MED PRIN PRACT, V22, P131, DOI 10.1159/000339212; Friedman J, 2011, OXID STRESS APPL BAS, P19, DOI 10.1007/978-1-60327-514-9_2; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Halliwell B., 2007, FREE RADICALS BIOL M; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hayashi M, 2012, ADV EXP MED BIOL, V724, P278, DOI 10.1007/978-1-4614-0653-2_21; Holley AK, 2012, AMINO ACIDS, V42, P139, DOI 10.1007/s00726-010-0600-9; Ikegami T, 2002, BIOCHEM BIOPH RES CO, V296, P729, DOI 10.1016/S0006-291X(02)00933-6; Jacobson L, 2005, METABOLISM, V54, P1259, DOI 10.1016/j.metabol.2005.04.013; Jacobson L, 2006, AM J PHYSIOL-ENDOC M, V291, pE15, DOI 10.1152/ajpendo.00526.2005; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kuwahara H, 2010, FREE RADICAL BIO MED, V48, P1252, DOI 10.1016/j.freeradbiomed.2010.02.011; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lustgarten MS, 2011, AGING CELL, V10, P493, DOI 10.1111/j.1474-9726.2011.00695.x; Lustgarten MS, 2009, AM J PHYSIOL-CELL PH, V297, pC1520, DOI 10.1152/ajpcell.00372.2009; Marecki JC, 2014, ANTIOXID REDOX SIGN, V20, P1655, DOI 10.1089/ars.2013.5293; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Misawa H, 2006, NEUROBIOL DIS, V23, P169, DOI 10.1016/j.nbd.2006.02.014; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200; Oh SS, 2012, NEUROSCIENCE, V212, P201, DOI 10.1016/j.neuroscience.2012.03.026; Parajuli N, 2011, FREE RADICAL BIO MED, V51, P406, DOI 10.1016/j.freeradbiomed.2011.04.024; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; Sayre LM, 2001, CURR MED CHEM, V8, P721, DOI 10.2174/0929867013372922; Shimizu T, 2010, GERIATR GERONTOL INT, V10, pS70, DOI 10.1111/j.1447-0594.2010.00604.x; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009; Treiber N, 2011, AGING CELL, V10, P239, DOI 10.1111/j.1474-9726.2010.00658.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Watts AG, 2010, FRONT NEUROENDOCRIN, V31, P32, DOI 10.1016/j.yfrne.2009.10.006; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	52	10	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2843	2858		10.1096/fj.14-265157	http://dx.doi.org/10.1096/fj.14-265157			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25829510				2022-12-28	WOS:000356859100015
J	Akagi, D; Chen, MA; Toy, R; Chatterjee, A; Conte, MS				Akagi, Daisuke; Chen, Mian; Toy, Robert; Chatterjee, Anuran; Conte, Michael S.			Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice	FASEB JOURNAL			English	Article						neointimal hyperplasia; inflammation; vascular remodeling; fatty acid	PERIPHERAL ARTERIAL-DISEASE; SMOOTH-MUSCLE-CELLS; DOCOSAHEXAENOIC ACID; NEOINTIMAL FORMATION; CAROTID-ARTERY; BLOOD-FLOW; MODEL; ATHEROSCLEROSIS; RESOLUTION; PHENOTYPE	Vascular injury induces a potent inflammatory response that influences vessel remodeling and patency, limiting long-term benefits of cardiovascular interventions such as angioplasty. Specialized proresolving lipid mediators (SPMs) derived from omega-3 polyunsaturated fatty acids [eicosapentaenoic acid and docosahexaenoic acid (DHA)] orchestrate resolution in diverse settings of acute inflammation. We hypothesized that systemic administration of DHA-derived SPMs [resolvin D2 (RvD2) andmaresin1 (MaR1)] would influence vessel remodeling in a mouse model of arterial neointima formation (carotid ligation). In vitro, SPM treatment inhibited mouse aortic smooth muscle cell migration (IC50 congruent to 1 nM) to a PDGF gradient and reduced TNF-alpha-stimulated p65 translocation, superoxide production, and proinflammatory gene expression (MCP-1). In vivo, adult FVB mice underwent unilateral carotid artery ligation with administration of RvD2, MaR1, or vehicle (100 ng by intraperitoneal injection at 0, 1, 3, 5, and 7 d after ligation). In ligated carotid arteries at 4 d, SPM treatment was associated with reduced cell proliferation and neutrophil and macrophage recruitment and increased polarization of M2 macrophages in the arterial wall. Neointimal hyperplasia (at 14 d) was notably attenuated in RvD2 (62%)-and MaR1 (67%)-treatedmice, respectively. Modulation of resolution pathways may offer new opportunities to regulate the vascular injury response and promote vascular homeostasis.	[Conte, Michael S.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conte, MS (corresponding author), Univ Calif San Francisco, Dept Surg, 400 Parnassus Ave,Suite A-581, San Francisco, CA 94143 USA.	michael.conte2@ucsf.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL119508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119508] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Giorgio Mottola, who provided technical and analytic support for the scratch migration assays. This work was supported in part by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL119508 (to M.S.C.).	Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Godin D, 2000, CIRCULATION, V102, P2861; Gong J, 2014, BRIT J PHARMACOL, V171, P3539, DOI 10.1111/bph.12714; Ho KJ, 2008, AM J PHYSIOL-HEART C, V295, pH1132, DOI 10.1152/ajpheart.00079.2008; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Holt A.W., 2013, ISRN MINIM INVASIVE, V2013, DOI DOI 10.1155/2013/167407; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jones DW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000345; Katakura M, 2014, MOLECULES, V19, P3247, DOI 10.3390/molecules19033247; Khatri JJ, 2004, CIRCULATION, V109, P520, DOI 10.1161/01.CIR.0000109698.70638.2B; Klein CP, 2014, NEUROPHARMACOLOGY, V86, P57, DOI 10.1016/j.neuropharm.2014.05.043; Korshunov VA, 2006, ARTERIOSCL THROM VAS, V26, P295, DOI 10.1161/01.ATV.0000196544.73761.82; Kumar A, 1997, CIRCULATION, V96, P4333; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; McCauley LK, 2014, J IMMUNOL, V193, P26, DOI 10.4049/jimmunol.1301945; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Nosova EV, 2014, J VASC SURG, V60, P1325, DOI 10.1016/j.jvs.2014.05.040; Park CK, 2011, J NEUROSCI, V31, P18433, DOI 10.1523/JNEUROSCI.4192-11.2011; Petri MH, 2015, INT J CARDIOL, V179, P370, DOI 10.1016/j.ijcard.2014.11.010; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saw J, 2006, J AM COLL CARDIOL, V48, P1567, DOI 10.1016/j.jacc.2006.03.067; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Steffens JP, 2014, HORM METAB RES, V46, P193, DOI 10.1055/s-0034-1367031; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365	46	72	74	4	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2504	2513		10.1096/fj.14-265363	http://dx.doi.org/10.1096/fj.14-265363			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25777995	Green Published, Green Submitted			2022-12-28	WOS:000355209500027
J	Auvynet, C; de Chanville, CB; Hermand, P; Dorgham, K; Piesse, C; Pouchy, C; Carlier, L; Poupel, L; Barthelemy, S; Felouzis, V; Lacombe, C; Sagan, S; Salomon, B; Deterre, P; Sennlaub, F; Combadiere, C				Auvynet, Constance; de Chanville, Camille Baudesson; Hermand, Patricia; Dorgham, Karim; Piesse, Christophe; Pouchy, Charlotte; Carlier, Ludovic; Poupel, Lucie; Barthelemy, Sandrine; Felouzis, Virginie; Lacombe, Claire; Sagan, Sandrine; Salomon, Benoit; Deterre, Philippe; Sennlaub, Florian; Combadiere, Christophe			ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration	FASEB JOURNAL			English	Article						chemokine receptor; allosteric inhibitor; inflammation; functional selectivity	MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR CCR2; RHEUMATOID-ARTHRITIS; CCR2(-/-) MICE; BONE-MARROW; ANTAGONIST; BINDING; LIGAND; RECRUITMENT	CC chemokine receptor type 2 (CCR2) is a key molecule in inflammatory diseases and is an obvious drug target for the treatment of inflammation. A number of nonpeptidic, competitive CCR2 antagonists have been developed, but none has yet been approved for clinical use. Our aim was to identify a short peptide that showed allosteric antagonism against human and mouse CCR2. On the basis of sequence analysis and 3-dimensional modeling, we identified an original 7-d-amino acid peptidic CCR2 inhibitor that we have called extracellular loop 1 inverso (ECL1i), d(LGTFLKC). In vitro, ECL1i selectively and potently inhibits CC chemokine ligand type 2 (CCL2)-triggered chemotaxis (IC50, 2 mu M) but no other conventional CCL2-associated events. We used the classic competitive CCR2 antagonist, BMS22 {2-[(isopropylaminocarbonyl)amino]-N-[2-[[cis-2-[[4-(methylthio)benzoyl]amino]cyclohexyl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide}, as positive control and inhibited CCL2-dependent chemotaxis with an IC50 of 18 nM. As negative control, we used a peptide with the same composition as ECL1i, but in a different sequence, d(FKLTLCG). In vivo, ECL1i (4 mg/kg) interfered with CCR2-positive cell recruitment and attenuated disease progression in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. This study establishes ECL1i as the first allosteric inhibitor of CCR2 with functional selectivity. ECL1i is a promising new agent in therapeutic development, and it may, by its selective effect, increase our understanding of CCR2 signaling pathways and functions.Auvynet, C., Baudesson de Chanville, C., Hermand, P., Dorgham, K., Piesse, C., Pouchy, C., Carlier, L., Poupel, L., Barthelemy, S., Felouzis, V., Lacombe, C., Sagan, S., Salomon, B., Deterre, P., Sennlaub, F., Combadiere, C. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.	[Auvynet, Constance; de Chanville, Camille Baudesson; Hermand, Patricia; Dorgham, Karim; Pouchy, Charlotte; Poupel, Lucie; Barthelemy, Sandrine; Felouzis, Virginie; Salomon, Benoit; Deterre, Philippe; Combadiere, Christophe] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech Sci UMRS 1135,U1135, INSERM,CNRS,Equipe Rech Labellisee ERL 8255,Ctr I, Paris, France; [Piesse, Christophe] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine IBPS 3631, CNRS,Serv Synth Peptid, Paris, France; [Carlier, Ludovic; Lacombe, Claire; Sagan, Sandrine] Univ Paris 06, Sorbonne Univ, CNRS, UMR 7203,Lab Biomol, Paris, France; [Lacombe, Claire] Univ Rech Paris Sci & Lettres, Ecole Normale Super, Dept Chim, Paris, France; [Lacombe, Claire] Univ Paris Est Creteil Val de Marne, Fac Sci & Technol, Creteil, France; [Sennlaub, Florian] Univ Paris 06, Sorbonne Univ, Inst Vis, UMRS 968,INSERM,U968, Paris, France; [Sennlaub, Florian] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM, DHOS, Ctr Invest Clin 503, Paris, France; [Auvynet, Constance] Univ Paris Saclay, Univ Paris 11, INSERM, Inflammat Chemokines & Immunopathol UMR996, Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Combadiere, C (corresponding author), Ctr Immunol & Malad Infect CIMI Paris, 91 Blvd Hop, F-75013 Paris, France.	christophe.combadiere@upmc.fr	Dorgham, karim/A-2241-2016; s, s/HIK-1178-2022; s, s/HHD-0404-2022; Deterre, Philippe/O-8984-2017; S, SAGAN/I-8132-2013; Salomon, Benoit/AAP-5209-2021; Sennlaub, Florian/F-2756-2017; SAGAN, Sandrine/AAA-8537-2022; Combadiere, Christophe/I-5639-2013; QI, DANDAN/GVR-9324-2022; s, s/GYR-2278-2022; Salomon, Benoit L/M-2421-2017	Dorgham, karim/0000-0001-9539-3203; Deterre, Philippe/0000-0001-9303-0791; S, SAGAN/0000-0003-0083-4411; Salomon, Benoit/0000-0001-9673-5578; Sennlaub, Florian/0000-0003-4412-1341; Combadiere, Christophe/0000-0002-1755-4531; Salomon, Benoit L/0000-0001-9673-5578; HERMAND, Patricia/0000-0003-0628-9733; Poupel, Lucie/0000-0001-7015-8450; LACOMBE, Claire/0000-0001-9428-8145; Carlier, Ludovic/0000-0002-9036-6561	INSERM; Universite Pierre et Marie Curie; European Community [FP7-Health-2009 ENDOSTEM 241440]; Agence National de la Recherche Programme Emergence [ANR-EMMA-050]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie; European Community(European Commission); Agence National de la Recherche Programme Emergence(French National Research Agency (ANR))	The authors thank Sylvain Chemtob and Christiane Quiniou (Centre Hospitalier Universitaire Sainte Justine, Montreal, QC, Canada) for peptide design suggestions, and Yenkel Grinberg, Elodie Guyon, and Chahrazade El Amri for helpful discussions and technical assistance. This work was supported by grants from INSERM, the Universite Pierre et Marie Curie, the European Community's Seventh Framework Project FP7-Health-2009 ENDOSTEM 241440, and the Agence National de la Recherche Programme Emergence 2012 (ANR-EMMA-050).	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bayley JP, 2003, TISSUE ANTIGENS, V62, P170, DOI 10.1034/j.1399-0039.2003.00073.x; Blease K, 2000, J IMMUNOL, V165, P2603, DOI 10.4049/jimmunol.165.5.2603; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brini E, 2009, J NEUROIMMUNOL, V209, P33, DOI 10.1016/j.jneuroim.2009.01.022; Buntinx M, 2008, J PHARMACOL EXP THER, V327, P1, DOI 10.1124/jpet.108.140723; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Gavrilin MA, 2005, BIOCHEM BIOPH RES CO, V327, P533, DOI 10.1016/j.bbrc.2004.12.037; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goupil E, 2010, J BIOL CHEM, V285, P25624, DOI 10.1074/jbc.M110.115196; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Kenakin T, 2007, J RECEPT SIG TRANSD, V27, P247, DOI 10.1080/10799890701509000; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Khurana S, 2005, J VIROL, V79, P6791, DOI 10.1128/JVI.79.11.6791-6800.2005; Lacombe C, 2015, J MED CHEM, V58, P1089, DOI 10.1021/jm501018q; Loffet A, 2002, J PEPT SCI, V8, P1, DOI 10.1002/psc.366; McDonnell JM, 1996, NAT STRUCT BIOL, V3, P419, DOI 10.1038/nsb0596-419; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Monteclaro FS, 1997, J BIOL CHEM, V272, P23186, DOI 10.1074/jbc.272.37.23186; MYERS SJ, 1995, J BIOL CHEM, V270, P5786, DOI 10.1074/jbc.270.11.5786; Peri KG, 2002, SEMIN PERINATOL, V26, P389, DOI 10.1053/sper.2002.37307; Quiniou C, 2008, J IMMUNOL, V180, P6977, DOI 10.4049/jimmunol.180.10.6977; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; Rihakova L, 2009, AM J PHYSIOL-REG I, V297, pR1009, DOI 10.1152/ajpregu.90766.2008; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Waubant E, 2007, REV NEUROL-FRANCE, V163, P688, DOI 10.1016/S0035-3787(07)90481-6; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	52	20	20	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2370	2381		10.1096/fj.201500116	http://dx.doi.org/10.1096/fj.201500116			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26979087				2022-12-28	WOS:000376878300026
J	Fang, Z; He, QW; Li, Q; Chen, XL; Baral, S; Jin, HJ; Zhu, YY; Li, M; Xia, YP; Mao, L; Hu, B				Fang, Zhi; He, Quan-Wei; Li, Qian; Chen, Xiao-Lu; Baral, Suraj; Jin, Hui-Juan; Zhu, Yi-Yi; Li, Man; Xia, Yuan-Peng; Mao, Ling; Hu, Bo			MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats	FASEB JOURNAL			English	Article						apoptosis; BMEC; claudin-5; ischemic stroke	ENDOTHELIAL-CELLS; EXPRESSION; VEGF; ANGIOPOIETIN-1; DISRUPTION; ISCHEMIA; ANGIOGENESIS; VASCULOGENESIS; CONTRIBUTES; RECEPTOR	The mechanism of blood-brain barrier (BBB) disruption, involved in poststroke edema and hemorrhagic transformation, is important but elusive. We investigated microRNA-150 (miR-150)-mediated mechanism in the disruption of BBB after stroke in rats. We found that up-regulation of miR-150 increased permeability of BBB as detected by MRI after permanent middle cerebral artery occlusion in vivo as well as increased permeability of brain microvascular endothelial cells after oxygen-glucose deprivation in vitro. The expression of claudin-5, a key tight junction protein, was decreased in the ischemic boundary zone after up-regulation of miR-150. We found in brain microvascular endothelial cells that overexpression of miR-150 decreased not only cell survival rate but also the expression levels of claudin-5 after oxygen-glucose deprivation. With dual-luciferase assay, we confirmed that miR-150 could directly regulate the angiopoietin receptor Tie-2. Moreover, silencing Tie-2 with lentivirus-delivered small interfering RNA reversed the effect of miR-150 on endothelial permeability, cell survival, and claudin-5 expression. Furthermore, poststroke treatment with antagomir-150, a specific miR-150 antagonist, contributed to BBB protection, infarct volume reduction, and amelioration of neurologic deficits. Collectively, our findings suggested that miR-150 could regulate claudin-5 expression and endothelial cell survival by targeting Tie-2, thus affecting the permeability of BBB after permanent middle cerebral artery occlusion in rats, and that miR-150 might be a potential alternative target for the treatment of stroke.Fang, Z., He, Q.-W., Li, Q., Chen, X.-L., Baral, S., Jin, H.-J., Zhu, Y.-Y., Li, M., Xia, Y.-P., Mao, L., Hu, B. MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats.	[Fang, Zhi; He, Quan-Wei; Li, Qian; Chen, Xiao-Lu; Baral, Suraj; Jin, Hui-Juan; Zhu, Yi-Yi; Li, Man; Xia, Yuan-Peng; Mao, Ling; Hu, Bo] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.	hubo@mail.hust.edu.cn	xia, yuanpeng/S-7988-2019; Fang, Zhi/AGE-7582-2022	He, Quan-Wei/0000-0002-8318-6976; Fang, Zhi/0000-0002-9495-4467	National Natural Science Foundation of China [81070938, 81371311, 81400969]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded in part by Grants 81070938, 81371311, and 81400969 from the National Natural Science Foundation of China.	Alvarez-Sabin J, 2013, LANCET NEUROL, V12, P689, DOI 10.1016/S1474-4422(13)70055-3; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Desilles JP, 2013, NEUROLOGY, V80, P844, DOI 10.1212/WNL.0b013e31828406de; Ding G, 2014, NEUROSCIENCE, V271, P1, DOI 10.1016/j.neuroscience.2014.04.025; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Hoareau-Aveilla C, 2015, J CLIN INVEST, V125, P3505, DOI 10.1172/JCI78488; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kim BJ, 2015, J CLIN INVEST, V125, P2473, DOI 10.1172/JCI74159; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Liu CH, 2015, P NATL ACAD SCI USA, V112, P12163, DOI 10.1073/pnas.1508426112; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Ma YL, 2012, GUT, V61, P1447, DOI 10.1136/gutjnl-2011-301122; Mao L, 2014, CNS NEUROSCI THER, V20, P460, DOI 10.1111/cns.12238; Moss A, 2013, CYTOKINE GROWTH F R, V24, P579, DOI 10.1016/j.cytogfr.2013.05.009; Mraz M, 2014, BLOOD, V124, P84, DOI 10.1182/blood-2013-09-527234; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Saddouk F. Z., FASEB J IN PRESS; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Ullal AJ, 2010, APOPTOSIS, V15, P586, DOI 10.1007/s10495-010-0470-3; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Yan BA, 2015, CIRC RES, V116, P1143, DOI 10.1161/CIRCRESAHA.116.305510; Yu ZY, 2013, MOL MED REP, V8, P287, DOI 10.3892/mmr.2013.1493; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002	40	58	63	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2097	2107		10.1096/fj.201500126	http://dx.doi.org/10.1096/fj.201500126			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26887441				2022-12-28	WOS:000376878300004
J	Holowka, T; Castilho, TM; Garcia, AB; Sun, T; McMahon-Pratt, D; Bucala, R				Holowka, Thomas; Castilho, Tiago M.; Garcia, Alvaro Baeza; Sun, Tiffany; McMahon-Pratt, Diane; Bucala, Richard			Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence	FASEB JOURNAL			English	Article						MIF; inflammation; apoptosis; CD4 T cells; exhaustion	T-CELL EXHAUSTION; FACTOR MIF; CUTANEOUS LEISHMANIASIS; INFECTION; MICE; EXPRESSION; EFFECTOR; DIFFERENTIATION; MODULATION; MECHANISMS	Leishmania major encodes 2 orthologs of the cytokine macrophage migration inhibitory factor (MIF), whose functions in parasite growth or in the host-parasite interaction are unknown. To determine the importance of Leishmania-encoded MIF, both LmMIF genes were removed to produce an mif(-/-) strain of L. major. This mutant strain replicated normally in vitro but had a 2-fold increased susceptibility to clearance by macrophages. Mice infected with mif(-/-) L. major, when compared to the wild-type strain, also showed a 3-fold reduction in parasite burden. Microarray and functional analyses revealed a reduced ability of mif(-/-) L. major to activate antigen-presenting cells, resulting in a 2-fold reduction in T-cell priming. In addition, there was a reduction in inflammation and effector CD4 T-cell formation in mif(-/-) L. major-infected mice when compared to mice infected with wild-type L. major. Notably, effector CD4 T cells that developed during infection with mif(-/-) L. major demonstrated statistically significant differences in markers of functional exhaustion, including increased expression of IFN- and IL-7R, reduced expression of programmed death-1, and decreased apoptosis. These data support a role for LmMIF in promoting parasite persistence by manipulating the host response to increase the exhaustion and depletion of protective CD4 T cells.Holowka, T., Castilho, T. M., Baeza Garcia, A., Sun, T., McMahon-Pratt, D., Bucala, R. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.	[Holowka, Thomas; Garcia, Alvaro Baeza; Sun, Tiffany; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Castilho, Tiago M.; McMahon-Pratt, Diane; Bucala, Richard] Yale Univ, Sch Med, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA	Yale University; Yale University	Bucala, R (corresponding author), Yale Univ, Sch Med, Dept Med, 300 Cedar St, New Haven, CT 06520 USA.	richard.bucala@yale.edu	Garcia, Alvaro Baeza/AAB-7387-2021	Garcia, Alvaro Baeza/0000-0001-6032-7847	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01-AIO4230, R01-AI110452-03, 5T32AI007404]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110452, T32AI007404, R01AI093775, R56AI042310] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Yale W. M. Keck Biotechnology Resource Laboratory for the microarray analysis; X. Yan for assistance with data analyses; the Yale Research Histology Core for histological sections; Dr. E. Mougneau (University of Nice, Nice, France) for providing the LMR7.5 T-cell hybridoma; Dr. Stephen Beverley (Washington University, St. Louis, MO, USA) for the pXG, pXG-HYG, and pXG-PAC constructs; and Dr. L. Leng (Yale University School of Medicine) for thoughtful advice. Funding for this research was provided by U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grants R01-AIO4230, R01-AI110452-03, and 5T32AI007404. The authors declare no conflicts of interest.	Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brown DR, 1997, J EXP MED, V185, P31, DOI 10.1084/jem.185.1.31; Bucala R, 2007, MIF MOST INTERESTING; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Colpitts SL, 2010, J IMMUNOL, V185, P2416, DOI 10.4049/jimmunol.1000483; Colpitts SL, 2009, J IMMUNOL, V182, P5702, DOI 10.4049/jimmunol.0803450; Courret N, 1999, EUR J IMMUNOL, V29, P762, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;762::AID-IMMU762&gt;3.0.CO;2-4; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; Gigley JP, 2012, TRENDS PARASITOL, V28, P377, DOI 10.1016/j.pt.2012.07.001; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Hand TW, 2009, IMMUNOL RES, V45, P46, DOI 10.1007/s12026-008-8027-z; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hernandez-Ruiz J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000871; Joshi T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000431; Juttner S, 1998, J IMMUNOL, V161, P2383; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; LIEW FY, 1990, J IMMUNOL, V144, P4794; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mou ZR, 2013, J IMMUNOL, V190, P3380, DOI 10.4049/jimmunol.1202537; Muraille E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001154; Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002; Nogueira CV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000478; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Richardson JM, 2009, BIOCHEM BIOPH RES CO, V380, P442, DOI 10.1016/j.bbrc.2009.01.030; Rodrigues V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002567; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2004, IMMUNOL REV, V201, P225, DOI 10.1111/j.0105-2896.2004.00185.x; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Soong L, 2008, J IMMUNOL, V180, P4355, DOI 10.4049/jimmunol.180.7.4355; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Stockdale L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002278; Sun T, 2012, P NATL ACAD SCI USA, V109, pE2117, DOI 10.1073/pnas.1206573109; Tang F, 2013, J HELMINTHOL, V87, P24, DOI 10.1017/S0022149X1100068X; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Vermeire JJ, 2008, TRENDS PARASITOL, V24, P355, DOI 10.1016/j.pt.2008.04.007; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WHO Expert Committee on the Control of the Leishmaniases & World Health Organization, 2010, M WHO EXP COMM CONTR; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108	53	20	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2249	2265		10.1096/fj.201500189R	http://dx.doi.org/10.1096/fj.201500189R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26956417	Green Published			2022-12-28	WOS:000376878300017
J	Allison, BJ; Kaandorp, JJ; Kane, AD; Camm, EJ; Lusby, C; Cross, CM; Nevin-Dolan, R; Thakor, AS; Derks, JB; Tarry-Adkins, JL; Ozanne, SE; Giussani, DA				Allison, Beth J.; Kaandorp, Joepe J.; Kane, Andrew D.; Camm, Emily J.; Lusby, Ciara; Cross, Christine M.; Nevin-Dolan, Rhianon; Thakor, Avnesh S.; Derks, Jan B.; Tarry-Adkins, Jane L.; Ozanne, Susan E.; Giussani, Dino A.			Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease	FASEB JOURNAL			English	Article						cell senescence; fetal hypoxia; oxidative stress; allopurinol; xanthine oxidase	POOR MATERNAL NUTRITION; CATCH-UP GROWTH; OXIDATIVE STRESS; XANTHINE-OXIDASE; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; HEART-DISEASE; BIRTH-WEIGHT; DNA-DAMAGE; RAT MODEL	Aging and developmental programming are both associated with oxidative stress and endothelial dysfunction, suggesting common mechanistic origins. However, their interrelationship has been little explored. In a rodent model of programmed cardiovascular dysfunction we determined endothelial function and vascular telomere length in young (4 mo) and aged (15 mo) adult offspring of normoxic or hypoxic pregnancy with or without maternal antioxidant treatment. We show loss of endothelial function [maximal arterial relaxation to acetylcholine (71 +/- 3 vs. 55 +/- 3%) and increased vascular short telomere abundance (4.2-1.3 kb) 43.0 +/- 1.5 vs. 55.1 +/- 3.8%) in aged vs. young offspring of normoxic pregnancy (P < 0.05). Hypoxic pregnancy in young off-spring accelerated endothelial dysfunction (maximal arterial relaxation to acetylcholine: 42 +/- 1%, P < 0.05) but this was dissociated from increased vascular short telomere length abundance. Maternal allopurinol rescued maximal arterial relaxation to acetylcholine in aged offspring of normoxic or hypoxic pregnancy but not in young offspring of hypoxic pregnancy. Aged offspring of hypoxic allopurinol pregnancy compared with aged offspring of untreated hypoxic pregnancy had lower levels of short telomeres (vascular short telomere length abundance 35.1 +/- 2.5 vs. 48.2 +/- 2.6%) and of plasma proinflammatory chemokine (24.6 +/- 2.8 vs. 36.8 +/- 5.5 pg/ml, P < 0.05). These data provide evidence for divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease, and aging being decelerated by antioxidants even prior to birth.-Allison, B.J., Kaandorp, J.J., Kane, A.D., Camm, E.J., Lusby, C., Cross, C.M., Nevin-Dolan, R., Thakor, A.S., Derks, J.B., Tarry-Adkins, J.L., Ozanne, S.E., Giussani, D.A. Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease. www.fasebj.org	[Allison, Beth J.; Kane, Andrew D.; Camm, Emily J.; Lusby, Ciara; Cross, Christine M.; Nevin-Dolan, Rhianon; Thakor, Avnesh S.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [Kaandorp, Joepe J.; Derks, Jan B.] Univ Med Ctr, Perinatol, Utrecht, Netherlands; [Tarry-Adkins, Jane L.; Ozanne, Susan E.] Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Cambridge, England; [Tarry-Adkins, Jane L.; Ozanne, Susan E.] Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Med Reseach Council MRC Metab Dis Unit, Cambridge, England	University of Cambridge; Utrecht University; Utrecht University Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	dag26@camac.uk	Allison, Beth J/J-9441-2015; Kane, Andrew D/C-5876-2013	Allison, Beth J/0000-0002-1060-513X; Kane, Andrew D/0000-0001-9488-4086; Ozanne, Susan/0000-0001-8753-5144	Royal Society; MRC Metabolic Diseases Unit, Addenbrookes Hospital [MRC_MC_UU_12012/4]; British Heart Foundation; Wellcome Trust; Perinatal Centre Wilhelmina Children's Hospital Utrecht; Royal Dutch Academy of Sciences (Ter Meulen Fonds); Dutch Institute for Scientific Research; Dutch Society of Obstetrics and Gynecology; BBSRC [BB/E002668/1] Funding Source: UKRI; MRC [MC_UU_12012/4] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [992201, BB/E002668/1] Funding Source: researchfish; British Heart Foundation [PG/10/99/28656, FS/12/74/29778, RG/06/006/22028, RG/11/16/29260, PG/14/5/30547, FS/09/029/27902] Funding Source: researchfish; Medical Research Council [MC_UU_12012/4, MC_UU_12012/5/B] Funding Source: researchfish	Royal Society(Royal Society of London); MRC Metabolic Diseases Unit, Addenbrookes Hospital(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Perinatal Centre Wilhelmina Children's Hospital Utrecht; Royal Dutch Academy of Sciences (Ter Meulen Fonds); Dutch Institute for Scientific Research; Dutch Society of Obstetrics and Gynecology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	D.A.G. is Professor of Cardiovascular Physiology and Medicine at the Department of Physiology Development and Neuroscience at the University of Cambridge, Professorial Fellow and Director of Studies in Medicine at Gonville and Caius College, a Lister Institute Fellow, and a Royal Society Wolfson Research Merit Award Holder. S.E.O. is supported by the MRC Metabolic Diseases Unit, Addenbrookes Hospital (MRC_MC_UU_12012/4). The work was supported by The British Heart Foundation, The Wellcome Trust, The Perinatal Centre Wilhelmina Children's Hospital Utrecht, The Royal Dutch Academy of Sciences (Ter Meulen Fonds), The Dutch Institute for Scientific Research and The Dutch Society of Obstetrics and Gynecology. The authors declare no conflicts of interest.	Aiken CE, 2013, FASEB J, V27, P3959, DOI 10.1096/fj.13-234484; Alzaid F., 2014, AGING OXIDATIVE STRE, P23; Aviv H, 2001, ATHEROSCLEROSIS, V159, P281, DOI 10.1016/S0021-9150(01)00506-8; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Basson M, 2008, NATURE, V451, P903, DOI 10.1038/451903a; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bezpalko L, 2015, J PHYSIOL PHARMACOL, V66, P57; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Bourque SL, 2012, PLACENTA, V33, P449, DOI 10.1016/j.placenta.2012.01.012; Browarski S., 2010, CANADIAN HEART HLTH; Bytautiene E, 2014, AM J OBSTET GYNECOL, V210, pS30, DOI 10.1016/j.ajog.2013.10.078; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374; Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Elahi MM, 2013, ANN NUTR METAB, V62, P250, DOI 10.1159/000346037; ENGERSON TD, 1987, J CLIN INVEST, V79, P1564, DOI 10.1172/JCI112990; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GIMPEL JA, 1995, FREE RADICAL BIO MED, V19, P251, DOI 10.1016/0891-5849(94)00242-C; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 2014, ADV EXP MED BIOL, V814, P77, DOI 10.1007/978-1-4939-1031-1_7; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guan WP, 2003, J CARDIOVASC PHARM, V41, P699, DOI 10.1097/00005344-200305000-00005; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Hardikar Sheetal, 2015, BMC Obes, V2, P32, DOI 10.1186/s40608-015-0063-3; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hastings R, 2004, CELL PROLIFERAT, V37, P317, DOI 10.1111/j.1365-2184.2004.00315.x; Herrera EA, 2012, J VASC RES, V49, P50, DOI 10.1159/000330666; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Jankov RP, 2008, AM J PHYSIOL-LUNG C, V294, pL233, DOI 10.1152/ajplung.00166.2007; Kane AD, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.156; Kane AD, 2014, J PHYSIOL-LONDON, V592, P475, DOI 10.1113/jphysiol.2013.264275; Kane AD, 2013, CIRC J, V77, P2604, DOI 10.1253/circj.CJ-13-0311; Kane AD, 2012, J PHYSIOL-LONDON, V590, P323, DOI 10.1113/jphysiol.2011.217968; Kelley EE, 2006, FREE RADICAL BIO MED, V40, P952, DOI 10.1016/j.freeradbiomed.2005.11.008; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Morton JS, 2011, J APPL PHYSIOL, V110, P1073, DOI 10.1152/japplphysiol.01174.2010; Morton JS, 2010, AM J PHYSIOL-REG I, V298, pR930, DOI 10.1152/ajpregu.00641.2009; Nichols M., 2012, EUROPEAN CARDIOVASCU; Novella S, 2013, EXP GERONTOL, V48, P1329, DOI 10.1016/j.exger.2013.08.003; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Feoli AMP, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/587083; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Rodriguez-Gonzalez GL, 2015, INT J OBESITY, V39, P549, DOI 10.1038/ijo.2014.209; Rueda-Clausen CF, 2012, J DEV ORIG HLTH DIS, V3, P350, DOI 10.1017/S2040174412000219; Sambrook J, 1989, MOL CLONING LAB MANU, pE3; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Tarry-Adkins JL, 2014, P NUTR SOC, V73, P289, DOI 10.1017/S002966511300387X; Tarry-Adkins JL, 2013, MOL METAB, V2, P480, DOI 10.1016/j.molmet.2013.09.004; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005; Thakor AS, 2010, J PHYSIOL-LONDON, V588, P4235, DOI 10.1113/jphysiol.2010.196402; Thakor AS, 2015, J PINEAL RES, V59, P80, DOI 10.1111/jpi.12242; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Tracy Russell P, 2002, Am J Geriatr Cardiol, V11, P93, DOI 10.1111/j.1076-7460.2002.00997.x; Vaughan OR, 2012, REPROD FERT DEVELOP, V24, P80, DOI 10.1071/RD11909; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Wilhelmsen L, 2015, SCAND CARDIOVASC J, V49, P45, DOI 10.3109/14017431.2015.1009940; Williams SJ, 2005, J PHYSIOL-LONDON, V565, P125, DOI 10.1113/jphysiol.2005.084889; World Health Organization, 2012, WORLD HLTH STAT	69	41	42	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1968	1975		10.1096/fj.201500057	http://dx.doi.org/10.1096/fj.201500057			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26932929	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000374879400024
J	Webster, CI; Caram-Salas, N; Haqqani, AS; Thom, G; Brown, L; Rennie, K; Yogi, A; Costain, W; Brunette, E; Stanimirovic, DB				Webster, Carl I.; Caram-Salas, Nadia; Haqqani, Arsalan S.; Thom, George; Brown, Lee; Rennie, Kerry; Yogi, Alvaro; Costain, Willard; Brunette, Eric; Stanimirovic, Danica B.			Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1	FASEB JOURNAL			English	Article						pain; receptor-mediated transcytosis; brain endothelial cells; mass spectrometry	PHAGE DISPLAY; INFLAMMATORY PAIN; ENDOTHELIAL-CELLS; PHARMACOKINETICS; PROTEIN; MODELS; FRAGMENTS; SYSTEM; MECHANISMS; GENERATION	Receptor mediated transcytosis harnessing the cellular uptake and transport of natural ligands across the blood-brain barrier (BBB) has been identified as a means for antibody delivery to the CNS. In this study, we characterized bispecific antibodies in which a BBB-crossing antibody fragment FC5 was used as a BBB carrier. Cargo antibodies were either a high-affinity, selective antibody antagonist of the metabotropic glutamate receptor-1 (BBB-mGluR1), a widely abundant CNS target, or an IgG that does not bind the CNS target (BBB-NiP). Both BBB-NiP and BBB-mGluR1 demonstrated a similar 20-fold enhanced rate of transcytosis across an in vitro BBB model compared with mGluR1 IgG fused to a control antibody fragment. All 3 bispecific antibodies exhibited identical pharmacokinetics in vivo. Comparative assessment of BBB-NiP and BBB-mGluR1 revealed that, whereas their serum pharmacokinetics and BBB penetration were identical, their central disposition (brain levels) and elimination (cerebrospinal fluid levels) were widely different, due to central target-mediated removal of the mGluR1-engaging antibody. Central mGluR1 target engagement after systemic administration was demonstrated by a dose-dependent inhibition of mGluR-1-mediated thermal hyperalgesia and by colocalization of the antibody with thalamic neurons involved in mGluR1-mediated pain processing. We demonstrate the feasibility of targeting central G-protein-coupled receptors using a BBB-crossing bispecific antibody approach and emerging principles that govern brain distribution and disposition of these antibodies. These data will be important for designing safe and selective CNS antibody therapeutics.-Webster, C. I., Caram-Salas, N., Haqqani, A. S., Thom, G., Brown, L., Rennie, K., Yogi, A., Costain, W., Brunette, E., Stanimirovic, D. B. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1 www.fasebj.org	[Webster, Carl I.; Thom, George] MedImmune, Antibody Discovery & Prot Engn, Cambridge CB21 6GH, England; [Brown, Lee] MedImmune, Translat Sci, Cambridge CB21 6GH, England; [Caram-Salas, Nadia; Haqqani, Arsalan S.; Rennie, Kerry; Yogi, Alvaro; Costain, Willard; Brunette, Eric; Stanimirovic, Danica B.] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON, Canada	AstraZeneca; Medimmune; AstraZeneca; Medimmune; National Research Council Canada	Webster, CI (corresponding author), MedImmune, Milstein Bldg,Granta Pk, Cambridge CB21 6GH, England.	websterc@medimmune.com	Costain, Willard J/F-5128-2011; Caram-Salas, Nadia L/F-1977-2019; Costain, Will/M-5669-2019; Salas, Nadia Lizeth Caram/AAG-4767-2020	Costain, Willard J/0000-0002-7476-6450; Costain, Will/0000-0002-7476-6450; Salas, Nadia Lizeth Caram/0000-0002-1894-9498; Rennie, Kerry/0000-0001-9216-2514	Medimmune; NRC (Therapeutics Beyond Brain Barriers Program); NRC	Medimmune(AstraZenecaMedimmune); NRC (Therapeutics Beyond Brain Barriers Program); NRC(National Research Centre (NRC))	The authors acknowledge expert technical help of the following contributors in performing analytical, cell-based and immunochemistry assays and animal handling: Marguerite Ball, Susan Jiang, Wen Ding, Christie Delaney, Eve Boileau, Ewa Baumann, and Debbie Callaghan [all from Human Health Therapeutics, National Research Council of Canada (NRC)] and Judy Paterson and Arron Hearn (both from Medimmune). The work reported in the manuscript was funded jointly by Medimmune and the NRC (Therapeutics Beyond Brain Barriers Program). NRC and MedImmune jointly performed the work described in the submitted manuscript under a Sponsored Research Agreement. NRC coauthors have no financial or managerial interest in the company. MedImmune staff members are paid by MedImmune and may hold stock options in AstraZeneca.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Boado RJ, 2014, BIOTECHNOL BIOENG, V111, P2317, DOI 10.1002/bit.25289; Boado RJ, 2010, MOL PHARMACEUT, V7, P237, DOI 10.1021/mp900235k; Conaghan PG, 2015, RHEUMATOLOGY, V54, P270, DOI 10.1093/rheumatology/keu332; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; D'Antoni S, 2008, NEUROCHEM RES, V33, P2436, DOI 10.1007/s11064-008-9694-9; Daramola O, 2014, BIOTECHNOL PROGR, V30, P132, DOI 10.1002/btpr.1809; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Dobson CL, 2009, MABS-AUSTIN, V1, P552, DOI 10.4161/mabs.1.6.10057; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; Haqqani AS, 2013, MOL PHARMACEUT, V10, P1542, DOI 10.1021/mp3004995; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hovelso N, 2012, CURR NEUROPHARMACOL, V10, P12, DOI 10.2174/157015912799362805; Hutchings Catherine, 2001, P93; Iliff J. J., 2012, TRANSL MED, V4; Li WD, 2004, J NEUROPHYSIOL, V91, P13, DOI 10.1152/jn.00485.2003; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; MCCAFFERTY J, 1994, APPL BIOCHEM BIOTECH, V47, P157, DOI 10.1007/BF02787932; Miraglia S, 1999, J BIOMOL SCREEN, V4, P193, DOI 10.1177/108705719900400407; Miyata M, 2003, J NEUROSCI, V23, P8098; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; More L, 2007, BEHAV PHARMACOL, V18, P273; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Oganesyan V, 2008, ACTA CRYSTALLOGR D, V64, P700, DOI 10.1107/S0907444908007877; Ohshima-Hosoyama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039036; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palazzo E, 2014, EUR J NEUROSCI, V39, P444, DOI 10.1111/ejn.12398; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Pepinsky RB, 2011, J PHARMACOL EXP THER, V339, P519, DOI 10.1124/jpet.111.183483; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Phillips D., 2008, THESIS U READING REA; Picker MJ, 2011, BEHAV PHARMACOL, V22, P785, DOI 10.1097/FBP.0b013e32834d13a2; Regina A, 2015, MOL CANCER THER, V14, P129, DOI 10.1158/1535-7163.MCT-14-0399; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Salt TE, 2014, NEUROPHARMACOLOGY, V79, P405, DOI 10.1016/j.neuropharm.2013.12.016; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wolak DJ, 2015, J CONTROL RELEASE, V197, P78, DOI 10.1016/j.jconrel.2014.10.034; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	46	46	48	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1927	1940		10.1096/fj.201500078	http://dx.doi.org/10.1096/fj.201500078			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839377				2022-12-28	WOS:000374879400021
J	Aiken, CE; Tarry-Adkins, JL; Penfold, NC; Dearden, L; Ozanne, SE				Aiken, Catherine E.; Tarry-Adkins, Jane L.; Penfold, Naomi C.; Dearden, Laura; Ozanne, Susan E.			Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet	FASEB JOURNAL			English	Article						developmental programming; reproductive potential; primordial follicle; lipoxygenase	NF-KAPPA-B; X-LINKED INHIBITOR; HIGH-FAT-DIET; NATURAL MENOPAUSE; DNA-DAMAGE; OBESITY; EXPRESSION; NUTRITION; PREGNANCY; APOPTOSIS	Maternal diet during pregnancy influences the later life reproductive potential of female offspring. We investigate the molecular mechanisms underlying the depletion of ovarian follicular reserve in young adult females following exposure to obesogenic diet in early life. Furthermore, we explore the interaction between adverse maternal diet and post-weaning diet in generating reduced ovarian reserve. Female mice were exposed to either maternal obesogenic (high fat/high sugar) or maternal control diet in utero and during lactation, then weaned onto either obesogenic or control diet. At 12 wk of age, the offspring ovarian reserve was depleted following exposure to maternal obesogenic diet (P < 0.05), but not postweaning obesogenic diet. Maternal obesogenic diet was associated with increased mitochondrial DNA biogenesis (copy number P < 0.05; transcription factor A, mitochondrial expression P < 0.05), increased mitochondrial antioxidant defenses [manganese superoxide dismutase (MnSOD) P < 0.05; copper/zinc superoxide dismutase P < 0.05; glutathione peroxidase 4 P < 0.01] and increased lipoxygenase expression (arachidonate 12lipoxygenaseP< 0.05; arachidonate 15-lipoxygenase P < 0.05) in the ovary. There was also significantly increased expression of the transcriptional regulator NF-kappa B (P < 0.05). There was no effect of postweaning diet on any measured ovarian parameters. Maternal diet thus plays a central role in determining follicular reserve in adult female offspring. Our observations suggest that lipid peroxidation and mitochondrial biogenesis are the key intracellular pathways involved in programming of ovarian reserve.-Aiken, C. E., Tarry-Adkins, J. L., Penfold, N. C., Dearden, L., Ozanne, S. E. Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet. FASEB J. 30, 1548-1556 (2016). www.fasebj.org	[Aiken, Catherine E.; Tarry-Adkins, Jane L.; Penfold, Naomi C.; Dearden, Laura; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England; [Aiken, Catherine E.; Tarry-Adkins, Jane L.; Penfold, Naomi C.; Dearden, Laura; Ozanne, Susan E.] Addenbrookes Hosp, MRC Metab Dis Unit, Inst Metab Sci, Cambridge, England; [Aiken, Catherine E.] Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge, England; [Aiken, Catherine E.] Cambridge Comprehens Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Aiken, CE (corresponding author), Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England.; Aiken, CE (corresponding author), Addenbrookes Hosp, Addenbrookes Treatment Ctr, MRC Metab Dis Unit, Inst Metab Sci, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England.	cema2@cam.ac.uk		Dearden, Laura/0000-0002-0804-074X; Ozanne, Susan/0000-0001-8753-5144; Penfold, Naomi/0000-0003-0568-1194	Academy of Medical Sciences; Addenbrooke's Charitable Trust; Isaac Newton Trust/Wellcome Trust ISSF/University of Cambridge Joint Research Grant; MRC [MRC_MC_UU_12012/4]; MRC [MC_UU_12012/5, MC_UU_12012/4] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL11-AikenC] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902, PG/09/037/27387] Funding Source: researchfish; Medical Research Council [MC_UU_12012/4, MC_UU_12012/5/B, MC_UU_12012/5] Funding Source: researchfish; National Institute for Health Research [CL-2014-14-501] Funding Source: researchfish	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Addenbrooke's Charitable Trust; Isaac Newton Trust/Wellcome Trust ISSF/University of Cambridge Joint Research Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank Adrian Wayman for technical assistance. This study was funded jointly by grants from the Academy of Medical Sciences, the Addenbrooke's Charitable Trust, an Isaac Newton Trust/Wellcome Trust ISSF/University of Cambridge Joint Research Grant and the MRC (MRC_MC_UU_12012/4). The authors declare no conflicts of interest.	Aiken CE, 2015, SCI REP-UK, V5, DOI 10.1038/srep16175; Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Aiken CE, 2013, FASEB J, V27, P3959, DOI 10.1096/fj.13-234484; Aimo L, 2010, J NUTR BIOCHEM, V21, P1069, DOI 10.1016/j.jnutbio.2009.09.003; Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Boynton-Jarrett R, 2011, J WOMENS HEALTH, V20, P1193, DOI 10.1089/jwh.2010.2517; Brenseke B, 2015, ENDOCRINOLOGY, V156, P182, DOI 10.1210/en.2014-1523; Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007; Chan KA, 2015, J ENDOCRINOL, V224, pR45, DOI 10.1530/JOE-14-0469; Chan KA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124149; Connor KL, 2012, J PHYSIOL-LONDON, V590, P2167, DOI 10.1113/jphysiol.2011.223305; de Bruin JP, 1998, EARLY HUM DEV, V51, P39, DOI 10.1016/S0378-3782(97)00073-X; Eberle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045361; Field SL, 2014, MOL REPROD DEV, V81, P284, DOI 10.1002/mrd.22285; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; Forman HJ, 2014, J MOL CELL CARDIOL, V73, P2, DOI 10.1016/j.yjmcc.2014.01.018; Gardebjer EM, 2015, FASEB J, V29, P2690, DOI 10.1096/fj.14-268979; Gloire G, 2009, ANTIOXID REDOX SIGN, V11, P2209, DOI [10.1089/ars.2009.2463, 10.1089/ARS.2009.2463]; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Huang CF, 2015, NEUROSCIENCE, V286, P364, DOI 10.1016/j.neuroscience.2014.12.002; Ingvorsen C, 2015, ACTA PHYSIOL, V214, P440, DOI 10.1111/apha.12533; King V, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-73; Knight M, 2010, OBSTET GYNECOL, V115, P989, DOI 10.1097/AOG.0b013e3181da8f09; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kurusu S, 2009, REPRODUCTION, V137, P59, DOI 10.1530/REP-08-0257; Li ML, 2015, ENDOCRINOLOGY, V156, P3228, DOI 10.1210/en.2015-1041; Liang HY, 2007, BIOCHEM BIOPH RES CO, V356, P893, DOI 10.1016/j.bbrc.2007.03.045; Lismont C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00035; Liu PY, 2010, MENOPAUSE, V17, P152, DOI 10.1097/gme.0b013e3181b63c68; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Nteeba J, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121343; Reynolds CM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125047; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Skodras A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120242; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; TANAKA N, 1989, ENDOCRINOLOGY, V125, P1373, DOI 10.1210/endo-125-3-1373; Tarry-Adkins JL, 2014, FASEB J, V28, P5398, DOI 10.1096/fj.14-259473; Tarry-Adkins JL, 2013, MOL METAB, V2, P480, DOI 10.1016/j.molmet.2013.09.004; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Wang YF, 2002, ENDOCRINOLOGY, V143, P2732, DOI 10.1210/en.143.7.2732; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; Xiao WJ, 2012, MENOPAUSE, V19, P1029, DOI 10.1097/gme.0b013e31824e6160; Yamashita T, 2006, CIRC RES, V99, pE51, DOI 10.1161/01.RES.0000244003.08127.cc; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Ziko I, 2014, BRAIN BEHAV IMMUN, V41, P32, DOI 10.1016/j.bbi.2014.06.014	50	42	44	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1548	1556		10.1096/fj.15-280800	http://dx.doi.org/10.1096/fj.15-280800			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700734	Green Published, hybrid			2022-12-28	WOS:000372629100016
J	Kim, N; Yoo, JJ; Atala, A; Lee, SJ				Kim, NaJung; Yoo, James J.; Atala, Anthony; Lee, Sang Jin			Combination of small RNAs for skeletal muscle regeneration	FASEB JOURNAL			English	Article						RNAi; siRNA; miR; regeneration; tissue engineering	MYOSTATIN; TISSUE; DELIVERY; INTERFERENCE; EXPRESSION; PROGRESS; GROWTH; MASS; MICE	Selectively controlling the expression of the target genes through RNA interference (RNAi) has significant therapeutic potential for injuries or diseases of tissues. We used this strategy to accelerate and enhance skeletal muscle regeneration for the treatment of muscular atrophy. In this study, we used myostatin small interfering (si)RNA (siGDF-8), a major inhibitory factor in the development and postnatal regeneration of skeletal muscle and muscle-specific microRNAs (miR-1 and -206) to further accelerate muscle regeneration. This combination of 3 small RNAs significantly improved the gene expression of myogenic regulatory factors in vitro, suggesting myogenic activation. Moreover, cell proliferation and myotube formation improved without compromising each other, which indicates the myogenic potential of this combination of small RNAs. The recovery of chemically injured tibialis anterior muscles in rats was significantly accelerated, both functionally and structurally. This novel combination of siRNA and miRNAs has promising therapeutic potential to improve in situ skeletal muscle regeneration.	[Kim, NaJung; Yoo, James J.; Atala, Anthony; Lee, Sang Jin] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA	Wake Forest University	Lee, SJ (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sjlee@wakehealth.edu	Lee, Sang Jin/S-4056-2019; Yoo, James J./L-4850-2017	Lee, Sang Jin/0000-0002-3899-1909; 	Armed Forces Institute of Regenerative Medicine Grant [X81XWH-08-2-0032]; Musculoskeletal Transplant Foundation	Armed Forces Institute of Regenerative Medicine Grant; Musculoskeletal Transplant Foundation	The authors thank Dr. H. Hatcher for editorial assistance and Dr. S. H. Kim (both from Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine) for technical assistance. This study was supported by Armed Forces Institute of Regenerative Medicine Grant X81XWH-08-2-0032 and the Musculoskeletal Transplant Foundation. The authors declare no conflicts of interest.	Amthor H, 2002, DEV BIOL, V251, P241, DOI 10.1006/dbio.2002.0812; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008; Cheema SK, 2007, WOUND REPAIR REGEN, V15, P286, DOI 10.1111/j.1524-475X.2007.00228.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frith JE, 2014, STEM CELL TRANSL MED, V3, P969, DOI 10.5966/sctm.2014-0032; Gandhi NS, 2014, J CONTROL RELEASE, V194, P238, DOI 10.1016/j.jconrel.2014.09.001; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Ju YM, 2014, ACTA BIOMATER, V10, P4332, DOI 10.1016/j.actbio.2014.06.022; Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim N, 2012, INT J PHARMACEUT, V427, P123, DOI 10.1016/j.ijpharm.2011.08.014; Liu CM, 2007, CANCER GENE THER, V14, P945, DOI 10.1038/sj.cgt.7701091; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Nelson CE, 2013, ADV WOUND CARE, V2, P93, DOI 10.1089/wound.2011.0327; Phalon C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001584; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Salem A. K., 2010, RNA INTERFERENCE APP; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wu XW, 2012, BIORESEARCH OPEN ACC, V1, P280, DOI 10.1089/biores.2012.0271	29	9	9	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1198	1206		10.1096/fj.15-271809	http://dx.doi.org/10.1096/fj.15-271809			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26625904				2022-12-28	WOS:000370387800017
J	Ochoa, V; George, AA; Nishi, R; Whiteaker, P				Ochoa, Vanessa; George, Andrew A.; Nishi, Rae; Whiteaker, Paul			The prototoxin LYPD6B modulates heteromeric alpha 3 beta 4-containing nicotinic acetylcholine receptors, but not alpha 7 homomers	FASEB JOURNAL			English	Article						LYNX1; LYNX2; Ly6/uPAR; CHRNA5; PSCA	ALTERNATE STOICHIOMETRIES; SUBUNIT; IDENTIFICATION; PHARMACOLOGY; GENES; ASSOCIATION; EXPRESSION; NEURONS; MEMBER; LYNX1	Prototoxins are a diverse family of membrane-tethered molecules expressed in the nervous system that modulate nicotinic cholinergic signaling, but their functions and specificity have yet to be completely explored. We tested the selectivity and efficacy of leukocyte antigen, PLAUR (plasminogen activator, urokinase receptor) domain-containing (LYPD)-6B on alpha 3 beta 4-, alpha 3 alpha 5 beta 4-, and alpha 7-containing nicotinic acetylcholine receptors (nAChRs). To constrain stoichiometry, fusion proteins encoding concatemers of human alpha 3, beta 4, and alpha 5 (D and N variants) subunits were expressed in Xenopuslaevis oocytes and tested with or without LYPD6B. We used the 2-electrode voltage-clamp method to quantify responses to acetylcholine (ACh): agonist sensitivity (EC50), maximal agonist-induced current (I-max), and time constant (tau) of desensitization. For beta 4-alpha 3-alpha 3-beta 4-alpha 3 and beta 4-alpha 3-beta 4-alpha 3-alpha 3, LYPD6B decreased EC50 from 631 to 79 mu M, reduced I-max by at least 59%, and decreased . For beta 4-alpha 3-alpha 5D-beta 4-alpha 3 and beta 4-alpha 3-beta 4-alpha-alpha 5D, LYPD6B decreased I-max by 63 and 32%, respectively. Thus, LYPD6B acted only on (3)(3)(4)(2) and (3)(2)(5D)(4)(2) and did not affect the properties of (alpha 3)(2)(beta 4)(3), alpha 7, or (alpha 3)(2)(alpha 5N)(beta 4)(2) nAChRs. Therefore, LYPD6B acts as a mixed modulator that enhances the sensitivity of (alpha 3)(3)(beta 4)(2) nAChRs to ACh while reducing ACh-induced whole-cell currents. LYPD6B also negatively modulates 34 nAChRs that include the alpha 5D common human variant, but not the N variant associated with nicotine dependence.	[Ochoa, Vanessa; Nishi, Rae] Univ Vermont, Grad Program Neurosci, Burlington, VT USA; [Ochoa, Vanessa; Nishi, Rae] Univ Vermont, Dept Neurol Sci, Burlington, VT USA; [George, Andrew A.; Whiteaker, Paul] Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Nishi, Rae] Marine Biol Lab, Div Educ, 7 MBL St, Woods Hole, MA 02543 USA	University of Vermont; University of Vermont; Barrow Neurological Institute; Marine Biological Laboratory - Woods Hole	Nishi, R (corresponding author), Univ Vermont, Dept Neurol Sci, Burlington, VT USA.; Nishi, R (corresponding author), Marine Biol Lab, Div Educ, 7 MBL St, Woods Hole, MA 02543 USA.	rnishi@mbl.edu			U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants [R21 DA027070, R21 DA026627]; Men's and Women's Boards of the Barrow Neurological Foundation; NIH National Institute of Neurological Disorders and Stroke Grant [R21 NS076969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027070, R21DA026627] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants; Men's and Women's Boards of the Barrow Neurological Foundation; NIH National Institute of Neurological Disorders and Stroke Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants R21 DA027070 and R21 DA026627 (to P.W.); by endowment and capital funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P.W. and A.A.G.); and NIH National Institute of Neurological Disorders and Stroke Grant R21 NS076969 (to R.N.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Blumenthal EM, 1999, J NEUROPHYSIOL, V81, P111, DOI 10.1152/jn.1999.81.1.111; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; Fowler CD, 2013, PSYCHOPHARMACOLOGY, V229, P503, DOI 10.1007/s00213-013-3235-1; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Girod R, 1999, ANN NY ACAD SCI, V868, P578, DOI 10.1111/j.1749-6632.1999.tb11331.x; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HALVORSEN SW, 1986, J NEUROSCI, V6, P3405; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Holford M, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.021.2009; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; KEYSER KT, 1993, J NEUROSCI, V13, P442; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Morley BJ, 1998, MOL BRAIN RES, V53, P78, DOI 10.1016/S0169-328X(97)00272-6; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Rothlin CV, 2003, MOL PHARMACOL, V63, P1067, DOI 10.1124/mol.63.5.1067; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Thomsen MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130572; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7	53	19	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1109	1119		10.1096/fj.15-274548	http://dx.doi.org/10.1096/fj.15-274548			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26586467	Green Published			2022-12-28	WOS:000370387800010
J	Popov, VB; Jornayvaz, FR; Akgul, EO; Kanda, S; Jurczak, MJ; Zhang, DY; Abudukadier, A; Majumdar, SK; Guigni, B; Petersen, KF; Manchem, VP; Bhanot, S; Shulman, GI; Samuel, VT				Popov, Violeta B.; Jornayvaz, Francois R.; Akgul, Emin O.; Kanda, Shoichi; Jurczak, Michael J.; Zhang, Dongyan; Abudukadier, Abulizi; Majumdar, Sachin K.; Guigni, Blas; Petersen, Kitt Falk; Manchem, Vara Prasad; Bhanot, Sanjay; Shulman, Gerald I.; Samuel, Varman T.			Second-generation antisense oligonucleotides against beta-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance	FASEB JOURNAL			English	Article						Wnt pathway; lipid-induced insulin resistance; nonalcoholic fatty liver disease	FATTY LIVER-DISEASE; MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE-1; KINASE-C-EPSILON; DIACYLGLYCEROL ACYLTRANSFERASE; GLUCOSE-METABOLISM; SIGNALING PATHWAY; ADIPOSE-TISSUE; OBESITY; MECHANISM; ADIPOGENESIS	Although mutations in the Wnt/beta-catenin signaling pathway are linked with the metabolic syndrome and type 2 diabetes in humans, the mechanism is unclear. High-fat-fed male C57BL/6 mice were treated for 4 wk with a 2'-O-methoxyethyl chimeric antisense oligonucleotide (ASO) to decrease hepatic and adipose expression of beta-catenin. beta-Catenin mRNA decreased by approximate to 80% in the liver and by 70% in white adipose tissue relative to control ASO-treated mice. beta-Catenin ASO improved hepatic insulin sensitivity and increased insulin-stimulated whole body glucose metabolism, as assessed during hyperinsulinemic-euglycemic clamp in awake mice. beta-Catenin ASO altered hepatic lipid composition in high-fat-fed mice. There were reductions in hepatic triglyceride (44%, P < 0.05) and diacylglycerol content (60%, P < 0.01) but a 30% increase in ceramide content (P < 0.001). The altered lipid content was attributed to decreased expression of sn-1,2 diacylglycerol acyltransferase and mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase and an increase in serine palmitoyl transferase. The decrease in cellular diacyglycerol was associated with a 33% decrease in PKC epsilon activation (P < 0.05) and 64% increase in Akt2 phosphorylation (P < 0.05). In summary, Reducing-catenin expression decreases expression of enzymes involved in hepatic fatty acid esterification, ameliorates hepatic steatosis and lipid-induced insulin resistance.	[Popov, Violeta B.; Jornayvaz, Francois R.; Akgul, Emin O.; Kanda, Shoichi; Jurczak, Michael J.; Zhang, Dongyan; Abudukadier, Abulizi; Majumdar, Sachin K.; Guigni, Blas; Petersen, Kitt Falk; Shulman, Gerald I.; Samuel, Varman T.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Shulman, Gerald I.; Samuel, Varman T.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA; [Samuel, Varman T.] W Haven Vet Affairs Med Ctr, West Haven, CT USA; [Manchem, Vara Prasad; Bhanot, Sanjay] ISIS Pharmaceut, 2280 Faraday Ave, Carlsbad, CA 92008 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Isis Pharmaceuticals Inc	Samuel, VT (corresponding author), Yale Univ, Sch Med, POB 208020, New Haven, CT 06520 USA.	varman.samuel@yale.edu	Shulman, Gerald I./P-7176-2019; Jornayvaz, François/AAL-2134-2020	Shulman, Gerald I./0000-0003-1529-5668; Jornayvaz, Francois/0000-0001-9425-3137; Guigni, Blas/0000-0002-9667-8195	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK-40936, P30 DK-45735, U24 DK-059635, P30 DK-034989, T32 DK007356-31]; NIH National Institute on Aging Grant [R01 AG-23686]; Distinguished Clinical Investigator Award from the American Diabetes Association; Veterans Affairs Merit Grant [I01 BX000901]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, U24DK059635, P30DK045735, R01DK040936, T32DK007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000901] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging Grant; Distinguished Clinical Investigator Award from the American Diabetes Association; Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Mario Kahn and Aida Groszmann (Yale University School of Medicine) for their expert technical assistance with the studies. These studies were supported by grants from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases R01 DK-40936, P30 DK-45735, U24 DK-059635 (to G.I.S.), P30 DK-034989 and T32 DK007356-31 (to V.B.P.); NIH National Institute on Aging Grant R01 AG-23686 (to G.I.S.); Distinguished Clinical Investigator Award from the American Diabetes Association (to K.F.P); and a Veterans Affairs Merit Grant I01 BX000901 (to V.T.S).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Baker BF, 2001, METHODS, V23, P191, DOI 10.1006/meth.2000.1120; Behari J, 2014, AM J PATHOL, V184, P3284, DOI 10.1016/j.ajpath.2014.08.022; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Geary R S, 2001, Curr Opin Investig Drugs, V2, P562; Graham MJ, 1998, J PHARMACOL EXP THER, V286, P447; Graham MJ, 2001, BIOCHEM PHARMACOL, V62, P297, DOI 10.1016/S0006-2952(01)00669-4; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Li XF, 2012, P NATL ACAD SCI USA, V109, P11402, DOI 10.1073/pnas.1205015109; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Liu SG, 2012, HEPATOLOGY, V55, P931, DOI 10.1002/hep.24766; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Orsulic S, 1999, J CELL SCI, V112, P1237; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	54	9	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1207	1217		10.1096/fj.15-271999	http://dx.doi.org/10.1096/fj.15-271999			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644352	Green Published			2022-12-28	WOS:000370387800018
J	Rousseau, AS; Sibille, B; Murdaca, J; Mothe-Satney, I; Grimaldi, PA; Neels, JG				Rousseau, Anne-Sophie; Sibille, Brigitte; Murdaca, Joseph; Mothe-Satney, Isabelle; Grimaldi, Paul A.; Neels, Jaap G.			alpha-Lipoic acid up-regulates expression of peroxisome proliferator-activated receptor beta in skeletal muscle: involvement of the JNK signaling pathway	FASEB JOURNAL			English	Article						antioxidant; exercise; stress kinases; C2C12; mice	GAMMA-CYCLODEXTRIN COMPLEX; INDUCED INSULIN-RESISTANCE; OBESE ZUCKER RATS; PPAR-DELTA; PROTEIN EXPRESSION; KINASE ACTIVATION; OXIDATIVE STRESS; ACUTE EXERCISE; MICE; AMPK	We hypothesized that alpha-lipoic acid (alpha-LA) might interact with the transcriptional control of peroxisome proliferator-activated receptor (PPAR)beta in skeletal muscle. Molecular mechanisms were investigated using differentiated C2C12 myotubes treated with alpha-LA and/or PPAR beta agonist GW0742. In vivo studies with 3-mo-old C57Bl6 mice were realized: voluntary wheel running (VWR) training (7 wk), and a 6 wk diet containing (or not) alpha-LA (0.25% wt/wt). This last condition was combined with (or not) 1 bout of treadmill exercise (18 m/min for 1 h). Using a reporter assay, we demonstrate that alpha-LA is not an agonist of PPAR beta but regulates PPAR beta target gene expression through an active PPAR beta pathway. GW0742-induced pyruvate dehydrogenase kinase 4 mRNA is potentiated by alpha-LA. In C2C12, alpha-LA lowers the activation of the JNK signaling pathway and increases PPAR beta mRNA and protein levels (2-fold) to the same extent as with the JNK inhibitor SP600125. Similarly to VWR training effect, PPAR beta expression increases (2-fold) in vastus lateralis of animals fed an alpha-LA-enriched diet. However, alpha-LA treatment does not further stimulate the adaptive up-regulation of PPAR beta observed in response to 1 bout of exercise. We have identified a novel mechanism of regulation of PPAR beta expression/action in skeletal muscle with potential physiologic application through the action of alpha-LA, involving the JNK pathway.	Fac Med Nice, INSERM, U1065, Mediterranean Ctr Mol Med C3M, U210, F-06034 Nice, France; Univ Nice Sophia Antipolis, F-06204 Nice 3, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Rousseau, AS (corresponding author), Univ Nice Sophia Antipolis, INSERM, U1065, Mediterranean Ctr Mol Med C3M,Team Adapt Response, Batiment Univ Archimed,151 Route Ginestiere BP 2, F-06204 Nice 3, France.	anne-sophie.rousseau@unice.fr	Rousseau, Anne-Sophie/R-2494-2016; Sibille, Brigitte/Q-8240-2016; Neels, Jaap G/F-5534-2010; MOTHE-SATNEY, ISABELLE/Q-6377-2016	Rousseau, Anne-Sophie/0000-0003-3477-3872; Sibille, Brigitte/0000-0001-6806-0454; Neels, Jaap G/0000-0002-5900-8395; MOTHE-SATNEY, ISABELLE/0000-0002-2693-8385	INSERM; University of Nice Sophia Antipolis; Agence Francaise de Lutte Contre le Dopage (Appel a projet); Association Nationale pour le Traitement a Domicile des Insuffisants Respiratoires (Appel a Projet)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Nice Sophia Antipolis; Agence Francaise de Lutte Contre le Dopage (Appel a projet); Association Nationale pour le Traitement a Domicile des Insuffisants Respiratoires (Appel a Projet)	The authors thank Veronique Corcelle and the animal facility staff [Unite 1065, C3M, Institut National de la Sante et de la Recherche Medicale (INSERM)] for their excellent care of mice. This work was supported by the INSERM, University of Nice Sophia Antipolis, Agence Francaise de Lutte Contre le Dopage (Appel a projet 2010), and Association Nationale pour le Traitement a Domicile des Insuffisants Respiratoires (Appel a Projet 2014). The authors declare no conflicts of interest.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Chen W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09884; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chou TC, 2011, J AGR FOOD CHEM, V59, P3050, DOI 10.1021/jf103940u; de Matos MA, 2014, CELL STRESS CHAPERON, V19, P263, DOI 10.1007/s12192-013-0453-8; Drosatos K, 2011, J BIOL CHEM, V286, P36331, DOI 10.1074/jbc.M111.272146; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Gaudel C, 2008, AM J PHYSIOL-ENDOC M, V295, pE297, DOI 10.1152/ajpendo.00581.2007; Giordano C, 2009, PFLUG ARCH EUR J PHY, V458, P901, DOI 10.1007/s00424-009-0676-9; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Kinnunen S, 2009, FREE RADICAL RES, V43, P697, DOI 10.1080/10715760903037673; Lendoye E, 2011, MOL ENDOCRINOL, V25, P1487, DOI 10.1210/me.2010-0504; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mille-Hamard L, 2015, MOL CELL BIOCHEM, V405, P223, DOI 10.1007/s11010-015-2413-3; Naito Y, 2014, J CLIN BIOCHEM NUTR, V55, P97, DOI 10.3164/jcbn.14-56; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Neels JG, 2014, PHYSIOL REV, V94, P795, DOI 10.1152/physrev.00027.2013; Nikolai S, 2014, NUTRITION, V30, P228, DOI 10.1016/j.nut.2013.08.002; Packer L, 2011, J CLIN BIOCHEM NUTR, V48, P26, DOI 10.3164/jcbn.11-005FR; Pershadsingh H. A., 2005, Journal of Applied Research, V5, P510; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; Rochette L, 2013, MOL NUTR FOOD RES, V57, P114, DOI 10.1002/mnfr.201200608; Ropelle ER, 2006, J PHYSIOL-LONDON, V577, P997, DOI 10.1113/jphysiol.2006.120006; Russell AP, 2005, FASEB J, V19, P986, DOI 10.1096/fj.04-3168fje; Saengsirisuwan V, 2004, AM J PHYSIOL-ENDOC M, V287, pE529, DOI 10.1152/ajpendo.00013.2004; Saengsirisuwan V, 2001, J APPL PHYSIOL, V91, P145, DOI 10.1152/jappl.2001.91.1.145; Santos FR, 2012, ARCH PHYSIOL BIOCHEM, V118, P231, DOI 10.3109/13813455.2012.713366; Schnegg CI, 2012, FREE RADICAL BIO MED, V52, P1734, DOI 10.1016/j.freeradbiomed.2012.02.032; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shearer BG, 2010, J MED CHEM, V53, P1857, DOI 10.1021/jm900464j; Shen QWW, 2007, AM J PHYSIOL-CELL PH, V293, pC1395, DOI 10.1152/ajpcell.00115.2007; Stabler SP, 2009, FREE RADICAL BIO MED, V47, P1147, DOI 10.1016/j.freeradbiomed.2009.07.019; Vijayvargia R, 2010, OBESITY, V18, P1701, DOI 10.1038/oby.2009.501; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; Wang KC, 2013, CLIN SCI, V125, P329, DOI 10.1042/CS20120560; Wang Y, 2010, METABOLISM, V59, P967, DOI 10.1016/j.metabol.2009.10.018; Ying ZK, 2011, INFLAMM RES, V60, P219, DOI 10.1007/s00011-010-0256-7	45	10	11	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1287	1299		10.1096/fj.15-280453	http://dx.doi.org/10.1096/fj.15-280453			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26655383				2022-12-28	WOS:000370387800024
J	Takyar, S; Zhang, Y; Haslip, M; Jin, L; Shan, PY; Zhang, XC; Lee, PJ				Takyar, Seyedtaghi; Zhang, Yi; Haslip, Maria; Jin, Lei; Shan, Peiying; Zhang, Xuchen; Lee, Patty J.			An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury	FASEB JOURNAL			English	Article						TLR4; VEGF; HALI; lung injury	GROWTH FACTOR+936 GENOTYPE; VEGF RECEPTOR TRAFFICKING; TOLL-LIKE RECEPTORS; OXIDATIVE STRESS; CELL APOPTOSIS; TLR4; DEFICIENCY; ACTIVATION; CYTOPROTECTION; IDENTIFICATION	TLR4 deficiency causes hypersusceptibility to oxidant-induced injury. We investigated the role of TLR4 in lung protection, using used bone marrow chimeras; cell-specific transgenic modeling; and lentiviral delivery in vivo to knock down or express TLR4 in various lung compartments; and lung-specific VEGF transgenic mice to investigate the effect of TLR4 on VEGF-mediated protection. C57/BL6 mice were exposed to 100% oxygen in an enclosed chamber and assessed for survival and lung injury. Primary endothelial cells were stimulated with recombinant VEGF and exposed to hyperoxia or hydrogen peroxide. Endothelium-specific expression of human TLR4 (as opposed to its expression in epithelium or immune cells) increased the survival of TLR4-deficent mice in hyperoxia by 24 h and decreased LDH release and lung cell apoptosis after 72 h of exposure by 30%. TLR4 expression was necessary and sufficient for the protective effect of VEGF in the lungs and in primary endothelial cells in culture. TLR4 knockdown inhibited VEGF signaling through VEGF receptor 2 (VEGFR2), Akt, and ERK pathways in lungs and primary endothelial cells and decreased the availability of VEGFR2 at the cell surface. These findings demonstrate a novel mechanism through which TLR4, an innate pattern receptor, interacts with an endothelial survival pathway.	[Takyar, Seyedtaghi; Zhang, Yi; Haslip, Maria; Jin, Lei; Shan, Peiying; Lee, Patty J.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, POB 208057, New Haven, CT 06520 USA; [Zhang, Xuchen] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Zhang, Xuchen] Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Takyar, S; Lee, PJ (corresponding author), Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, POB 208057, New Haven, CT 06520 USA.	seyedtaghi.takyar@yale.edu; patty.lee@yale.edu	zhang, xu/GYE-3558-2022	Zhang, Xuchen/0000-0002-1484-4672	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [5R00HL098695-04]; NIH/NHLBI [HL 071595, HL 090660, FAMRI 82384]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090660, R00HL098695, R01HL071595] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.T. was supported by K99/R00 Grant 5R00HL098695-04 [U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)]. P.J.L. was supported by NIH/NHLBI Grants HL 071595, HL 090660, and FAMRI 82384. The authors declare no conflicts of interest.	Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Ballinger MN, 2012, J IMMUNOL, V189, P356, DOI 10.4049/jimmunol.1103124; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Britt RD, 2014, ANTIOXID REDOX SIGN, V20, P2681, DOI 10.1089/ars.2013.5332; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Corne J, 2000, J CLIN INVEST, V106, P783, DOI 10.1172/JCI9674; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Haslip M, 2015, ARTERIOSCL THROM VAS, V35, P1166, DOI 10.1161/ATVBAHA.114.304865; Hildebrandt MAT, 2012, CLIN CANCER RES, V18, P3705, DOI 10.1158/1078-0432.CCR-11-3271; Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kim JY, 2012, ANN THORAC SURG, V94, P1079, DOI 10.1016/j.athoracsur.2012.05.048; Kleeberger SR, 2001, AM J PHYSIOL-LUNG C, V280, pL326, DOI 10.1152/ajplung.2001.280.2.L326; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kolliputi N, 2009, AM J PHYSIOL-LUNG C, V297, pL6, DOI 10.1152/ajplung.90381.2008; Kumpf O, 2010, CRIT CARE, V14, DOI 10.1186/cc9047; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mantell LL, 1999, ANN NY ACAD SCI, V887, P171, DOI 10.1111/j.1749-6632.1999.tb07931.x; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Medford ARL, 2009, CHEST, V136, P457, DOI 10.1378/chest.09-0383; Medford ARL, 2005, THORAX, V60, P244, DOI 10.1136/thx.2004.034785; Minami T, 2003, ARTERIOSCL THROM VAS, V23, P2041, DOI 10.1161/01.ATV.0000089326.63053.9A; Mollen KP, 2008, J LEUKOCYTE BIOL, V83, P80, DOI 10.1189/jlb.0407201; Nakayama M, 2013, EXP CELL RES, V319, P1340, DOI 10.1016/j.yexcr.2013.03.008; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schnetzke U, 2015, GENES IMMUN, V16, P83, DOI 10.1038/gene.2014.67; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tuder RM, 2008, CURR OPIN PHARMACOL, V8, P255, DOI 10.1016/j.coph.2008.03.003; Wang HS, 2014, PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON INNOVATIVE DESIGN AND MANUFACTURING (ICIDM), P123, DOI 10.1109/IDAM.2014.6912682; Yang SY, 2011, GENET TEST MOL BIOMA, V15, P737, DOI 10.1089/gtmb.2011.0054; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225; Zhang Y, 2013, J IMMUNOL, V191, P1393, DOI 10.4049/jimmunol.1300052; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009	57	14	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1317	1327		10.1096/fj.15-275024	http://dx.doi.org/10.1096/fj.15-275024			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26655705	Green Published			2022-12-28	WOS:000370387800027
J	Yuasa, D; Ohashi, K; Shibata, R; Mizutani, N; Kataoka, Y; Kambara, T; Uemura, Y; Matsuo, K; Kanemura, N; Hayakawa, S; Hiramatsu-Ito, M; Ito, M; Ogawa, H; Murate, T; Murohara, T; Ouchi, N				Yuasa, Daisuke; Ohashi, Koji; Shibata, Rei; Mizutani, Naoki; Kataoka, Yoshiyuki; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Kanemura, Noriyoshi; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Ogawa, Hayato; Murate, Takashi; Murohara, Toyoaki; Ouchi, Noriyuki			C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart	FASEB JOURNAL			English	Article						ischemia-reperfusion injury; inflammation; apoptosis; adipokine; CTRP1	MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; REPERFUSION INJURY; CARDIAC MYOCYTES; IN-VIVO; RECEPTORS; SPHINGOSINE-1-PHOSPHATE; INFLAMMATION	Obesity is associated with an increased risk of cardiovascular disease. C1q/TNF-related protein (CTRP)-1 is a poorly characterized adipokine that is up-regulated in association with ischemic heart disease. We investigated the role of CTRP1 in myocardial ischemia injury. CTRP1-knockout mice showed increased myocardial infarct size, cardiomyocyte apoptosis, and proinflammatory gene expression after I/R compared with wild-type (WT) mice. In contrast, systemic delivery of CTRP1 attenuated myocardial damage after I/R in WT mice. Treatment of cardiomyocytes with CTRP1 led to reduction of hypoxia-reoxygenation-induced apoptosis and lipopolysaccharide-stimulated expression of proinflammatory cytokines, which was reversed by inhibition of sphingosine-1-phosphate (S1P) signaling. Treatment of cardiomyocytes with CTRP1 also resulted in the increased production of cAMP, which was blocked by suppression of S1P signaling. The antiapoptotic and anti-inflammatory actions of CTRP1 were cancelled by inhibition of adenylyl cyclase or knockdown of adiponectin receptor 1. Furthermore, blockade of S1P signaling reversed CTRP1-mediated inhibition of myocardial infarct size, apoptosis, and inflammation after I/R in vivo. These data indicate that CTRP1 protects against myocardial ischemic injury by reducing apoptosis and inflammatory response through activation of the S1P/cAMP signaling pathways in cardiomyocytes, suggesting that CTRP1 plays a crucial role in the pathogenesis of ischemic heart disease.	[Yuasa, Daisuke; Shibata, Rei; Kataoka, Yoshiyuki; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Kanemura, Noriyoshi; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Ogawa, Hayato; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan; [Mizutani, Naoki; Murate, Takashi] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4668550, Japan; [Murate, Takashi] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan; [Mizutani, Naoki] Nagoya Univ, Grad Sch Med, Mol Cardiovasc Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University; Chubu University; Nagoya University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan.; Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Mol Cardiovasc Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ohashik@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014	Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Takeda Science Foundation; AstraZeneca Research and Development; Suzuken Memorial Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); AstraZeneca Research and Development(AstraZeneca); Suzuken Memorial Foundation	The authors thank Y. Inoue and M. Tatsumi for technical assistance. This work was supported by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Challenging Exploratory Research, grants from Takeda Science Foundation and AstraZeneca Research and Development (to N.O.), and Grant-in-Aid for Scientific Research C and the Suzuken Memorial Foundation (to K.O.). The authors declare no conflicts of interest.	Barron HV, 2001, J AM COLL CARDIOL, V38, P1654, DOI 10.1016/S0735-1097(01)01613-8; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Damirin A, 2005, MOL PHARMACOL, V67, P1177, DOI 10.1124/mol.104.004317; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hla T, 2000, ANN NY ACAD SCI, V905, P16; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Karliner JS, 2001, J MOL CELL CARDIOL, V33, P1713, DOI 10.1006/jmcc.2001.1429; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Mazurais D, 2002, J HISTOCHEM CYTOCHEM, V50, P661, DOI 10.1177/002215540205000507; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Nakanishi H, 2009, METHODS MOL BIOL, V579, P287, DOI 10.1007/978-1-60761-322-0_15; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Ouchi N, 2012, CIRCULATION, V125, P3066, DOI 10.1161/CIRCULATIONAHA.112.114181; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Panda SK, 2013, GENETICS, V195, P703, DOI 10.1534/genetics.113.156570; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yan WJ, 2014, J MOL CELL CARDIOL, V74, P183, DOI 10.1016/j.yjmcc.2014.05.010; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846; Zhang JQ, 2007, AM J PHYSIOL-HEART C, V293, pH3150, DOI 10.1152/ajpheart.00587.2006	43	55	60	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1065	1075		10.1096/fj.15-279885	http://dx.doi.org/10.1096/fj.15-279885			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578687				2022-12-28	WOS:000370387800006
J	Murashov, AK; Pak, ES; Koury, M; Ajmera, A; Jeyakumar, M; Parker, M; Williams, O; Ding, J; Walters, D; Neufer, PD				Murashov, Alexander K.; Pak, Elena S.; Koury, Michael; Ajmera, Ajay; Jeyakumar, Maneesh; Parker, Matthew; Williams, Oksana; Ding, Jian; Walters, Dianne; Neufer, P. Darrell			Paternal long-term exercise programs offspring for low energy expenditure and increased risk for obesity in mice	FASEB JOURNAL			English	Article						epigenetics; transgenerational; metabolic phenotype; miRNA; spermatozoal	TRANSGENERATIONAL INHERITANCE; OXIDATIVE STRESS; PHYSICAL-EXERCISE; GENE-EXPRESSION; SPERM; METHYLATION; GENERATIONS; SPERMATOZOA; DIET; ADOLESCENTS	Obesity has more than doubled in children and tripled in adolescents in the past 30 yr. The association between metabolic disorders in offspring of obese mothers with diabetes has long been known; however, a growing body of research indicates that fathers play a significant role through presently unknown mechanisms. Recent observations have shown that changes in paternal diet may result in transgenerational inheritance of the insulin-resistant phenotype. Although diet-induced epigenetic reprogramming via paternal lineage has recently received much attention in the literature, the effect of paternal physical activity on offspring metabolism has not been adequately addressed. In the current study, we investigated the effects of long-term voluntary wheel-running in C57BL/6J male mice on their offspring's predisposition to insulin resistance. Our observations revealed that fathers subjected to wheel-running for 12 wk produced offspring that were more susceptible to the adverse effects of a high-fat diet, manifested in increased body weight and adiposity, impaired glucose tolerance, and elevated insulin levels. Long-term paternal exercise also altered expression of several metabolic genes, including Ogt, Oga, Pdk4, H19, Glut4, and Ptpn1, in offspring skeletal muscle. Finally, prolonged exercise affected gene methylation patterns and micro-RNA content in the sperm of fathers, providing a potential mechanism for the transgenerational inheritance. These findings suggest that paternal exercise produces offspring with a thrifty phenotype, potentially via miRNA-induced modification of sperm.	[Murashov, Alexander K.; Pak, Elena S.; Koury, Michael; Ajmera, Ajay; Jeyakumar, Maneesh; Parker, Matthew; Williams, Oksana; Ding, Jian; Walters, Dianne; Neufer, P. Darrell] E Carolina Univ, Dept Physiol, Greenville, NC USA; [Murashov, Alexander K.; Neufer, P. Darrell] E Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Murashov, AK (corresponding author), E Carolina Univ, Sch ofMedicine, Brody Bldg,6N-98,600 Moye Blvd, Greenville, NC 27834 USA.	murashoval@ecu.edu	Murashov, Alexander K/F-2241-2011	Murashov, Alexander K/0000-0002-8912-5891	East Carolina Diabetes and Obesity Institute, East Carolina University; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK096907]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096907] Funding Source: NIH RePORTER	East Carolina Diabetes and Obesity Institute, East Carolina University; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a seed grant from the East Carolina Diabetes and Obesity Institute, East Carolina University, and was supported in part by a U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK096907 (to P.D.N.). The authors declare no conflicts of interest.	Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Call JA, 2010, MUSCLE NERVE, V42, P871, DOI 10.1002/mus.21764; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen LQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-52; Di Luigi L, 2012, ENDOCRINE, V42, P278, DOI 10.1007/s12020-012-9655-6; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Ferland-McCollough D, 2012, CELL DEATH DIFFER, V19, P1003, DOI 10.1038/cdd.2011.183; Friedenreich CM, 2011, RECENT RESULTS CANC, V188, P125, DOI 10.1007/978-3-642-10858-7_11; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; Govindaraju A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-82; Gower BA, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-3; Gu XL, 2013, NEUROBIOL AGING, V34, P1069, DOI 10.1016/j.neurobiolaging.2012.10.013; Guth LM, 2013, EXP PHYSIOL, V98, P1469, DOI 10.1113/expphysiol.2012.070300; Hackney AC, 2008, J ENDOCRINOL INVEST, V31, P932, DOI 10.1007/BF03346444; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Ji ZL, 2014, REPRODUCTION, V147, P693, DOI 10.1530/REP-13-0656; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Knezovich Jaysen Gregory, 2012, Frontiers in Genetics, V3, P10, DOI 10.3389/fgene.2012.00010; Knight JA, 2012, ANN CLIN LAB SCI, V42, P320; Kouzmenko A, 2010, EPIGENOMICS-UK, V2, P765, DOI 10.2217/EPI.10.58; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lambard S, 2004, MOL HUM REPROD, V10, P535, DOI 10.1093/molehr/gah064; Li Y, 2012, B ENVIRON CONTAM TOX, V89, P1111, DOI 10.1007/s00128-012-0827-0; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Marczylo EL, 2012, EPIGENETICS-US, V7, P432, DOI 10.4161/epi.19794; Mathias RA, 2009, METABOLISM, V58, P1439, DOI 10.1016/j.metabol.2009.04.041; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pemberton VL, 2010, CIRCULATION, V121, P1153, DOI 10.1161/CIRCULATIONAHA.109.921544; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Safarinejad MR, 2009, J ENDOCRINOL, V200, P259, DOI 10.1677/JOE-08-0477; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Walley AJ, 2006, HUM MOL GENET, V15, pR124, DOI 10.1093/hmg/ddl215; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Wu D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00035; Xue C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026027	54	59	65	0	46	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					775	784		10.1096/fj.15-274274	http://dx.doi.org/10.1096/fj.15-274274			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26506979	Green Published			2022-12-28	WOS:000369391900027
J	Pini, M; Touch, S; Poirier, H; Dalmas, E; Niot, I; Rouault, C; Druart, C; Delzenne, N; Clement, K; Andre, S; Guerre-Millo, M				Pini, Maria; Touch, Sothea; Poirier, Helene; Dalmas, Elise; Niot, Isabelle; Rouault, Christine; Druart, Celine; Delzenne, Nathalie; Clement, Karine; Andre, Sebastien; Guerre-Millo, Michele			Adipose tissue adaptive response to trans-10, cis-12-conjugated linoleic acid engages alternatively activated M2 macrophages	FASEB JOURNAL			English	Article						lipoatrophy; hyperinsulinemia; fibrosis; lipophagy	CELLS PROMOTE INFLAMMATION; DIET-INDUCED OBESITY; INDUCED WEIGHT-LOSS; INSULIN-RESISTANCE; T-CELLS; IMMUNE-SYSTEM; MICE; FIBROSIS; MOUSE; EXPRESSION	In mice, nutritional supplementation with the trans-10, cis-12 isomer of linoleic acid (t10, c12-CLA) promotes lipoatrophy, hyperinsulinemia, and macrophage infiltration in white adipose tissue (WAT). We explored the dynamics of these interrelated responses over 2 consecutive 7 d periods of t10, c12-CLA administration and withdrawal. t10, c12-CLA down-regulated lipogenic and lipolytic gene expression and increased collagen deposition, but with no evidence of cross-linking. An abundant CD45(+) cell infiltrate, comprising prominently CD206(+)CD11c(-) macrophages, was found in WAT in association with an anti-inflammatory gene signature. Infiltration of natural killer (NK) and dendritic cells contributed to WAT's innate immune response to t10, c12-CLA. Less abundant adaptive immune cells colonized WAT, including B, NK T, gamma delta T, and alpha beta T cells. By contrast, T-regulatory cell abundance was not affected. Interruption of treatment allowed recovery of WAT mass and normalization of insulinemia, coincident with regain of WAT homeostasis owing to a coordinated reversion of genic, structural, and immune deregulations. These data revealed a striking resilience of WAT after a short-term metabolic injury induced by t10, c12-CLA, which relies on alternatively activated M2 macrophage engagement. In addition, the temporal links between variations in WAT alterations and insulinemia upon t10, c12-CLA manipulation strengthen the view that WAT dysfunctional status is critically involved in altered glucose homeostasis.	[Pini, Maria; Touch, Sothea; Dalmas, Elise; Rouault, Christine; Clement, Karine; Andre, Sebastien] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech Sante 1166, Paris, France; [Pini, Maria; Touch, Sothea; Dalmas, Elise; Rouault, Christine; Clement, Karine; Andre, Sebastien; Guerre-Millo, Michele] INSERM, Unite Mixte Rech Sante 1166, Nutri Team 6, Paris, France; [Pini, Maria; Touch, Sothea; Dalmas, Elise; Rouault, Christine; Clement, Karine; Andre, Sebastien; Guerre-Millo, Michele] Hop La Pitie Salpetriere, AP HP, Inst Cardiometabolism & Nutr, Paris, France; [Poirier, Helene; Niot, Isabelle] Univ Bourgogne, AgroSupDijon, INSERM, Unite Mixte Rech U866, Dijon, France; [Druart, Celine; Delzenne, Nathalie] Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Guerre-Millo, M (corresponding author), UMRS 1166, Nutri Team 6, 91 Blvd Hop, F-75013 Paris, France.	michele.guerre-millo@crc.jussieu.fr	Pini, Maria/AAC-2530-2021; Pini, Maria/O-8620-2019; Delzenne, Nathalie/AAC-4628-2019; Guerre-Millo, Michele/G-7253-2017; Pini, Maria/T-6292-2018; Clément, karine/R-1120-2017	Pini, Maria/0000-0002-9995-5370; Delzenne, Nathalie/0000-0003-2115-6082; Pini, Maria/0000-0002-9995-5370; Druart, Celine/0000-0002-7786-9172; ANDRE, Sebastien/0000-0002-7543-153X; Dalmas, Elise/0000-0003-0959-5648	grant (ADIPOFIB) from the National Agency of Research; French Foundation for Medical Research [FRM DEQ20120323701]; Groupe Lipides Nutrition; French government grant [ANR-10-IHU]; Ph.D. fellowship from the EU-Metacardis FP7 program; Association Francaise d'Etude et de Recherche sur l'Obesite; Fonds National de la Recherche Scientifique in Belgium [1.5121.12F]; Institut Danone Belgique	grant (ADIPOFIB) from the National Agency of Research; French Foundation for Medical Research(Fondation pour la Recherche Medicale); Groupe Lipides Nutrition; French government grant; Ph.D. fellowship from the EU-Metacardis FP7 program; Association Francaise d'Etude et de Recherche sur l'Obesite; Fonds National de la Recherche Scientifique in Belgium(Fonds de la Recherche Scientifique - FNRS); Institut Danone Belgique(Danone Nutricia)	The authors thank R. Selleslagh and S. Mutel for expert technical assistance and I. Dugail, D. Lacasa, and C. Caer for helpful discussions. This study was funded by a grant (ADIPOFIB) from the National Agency of Research (to K.C.); by the French Foundation for Medical Research Grant FRM DEQ20120323701(to K.C.); by a grant from Groupe Lipides Nutrition (to M.G.-M.); by a French government grant managed by the National Agency of Research (Institute of Cardiometabolism and Nutrition, reference ANR-10-IHU); by a Ph.D. fellowship from the EU-Metacardis FP7 program (to S.T.); by Association Francaise d'Etude et de Recherche sur l'Obesite (to M.P); by Fonds National de la Recherche Scientifique in Belgium Grant 1.5121.12F Credit aux Chercheurs (to N.D. and C.D.); and by a grant in the form of salary from Institut Danone Belgique (to C.D.). The authors declare no conflicts of interests.	Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Caron-Debarle M, 2010, TRENDS MOL MED, V16, P218, DOI 10.1016/j.molmed.2010.03.002; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Druart C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087560; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jan V, 2004, ANTIVIR THER, V9, P555; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kovacikova M, 2011, INT J OBESITY, V35, P91, DOI 10.1038/ijo.2010.112; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mehta P, 2015, J LEUKOCYTE BIOL, V97, P121, DOI 10.1189/jlb.3A0414-211RR; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pellegrinelli V, 2014, J PATHOL, V233, P183, DOI 10.1002/path.4347; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Russell JS, 2007, J NUTR, V137, P1200, DOI 10.1093/jn/137.5.1200; Shen W, 2013, J LIPID RES, V54, P909, DOI 10.1194/jlr.M030924; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Villarroya F, 2007, INT J OBESITY, V31, P1763, DOI 10.1038/sj.ijo.0803698; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2012, IMMUNOL CELL BIOL, V90, P755, DOI 10.1038/icb.2011.110; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13	52	11	11	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					241	251		10.1096/fj.15-276675	http://dx.doi.org/10.1096/fj.15-276675			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26362817				2022-12-28	WOS:000367621000024
J	Zhao, WM; Lu, HY; Wang, XY; Ransohoff, RM; Zhou, L				Zhao, Wanming; Lu, Haiyan; Wang, Xingyu; Ransohoff, Richard M.; Zhou, Lan			CX(3)CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions	FASEB JOURNAL			English	Article						chemokine; phagocytosis; IGF-1; monocyte recruitment; muscle regeneration	FRACTALKINE RECEPTOR CX3CR1; FOCAL CEREBRAL-ISCHEMIA; CHEMOKINE RECEPTOR; PHARMACOLOGICAL INHIBITION; MICROGLIAL ACTIVATION; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; MOUSE MODEL; MDX MICE; REGENERATION	Adequate inflammatory response predominated by macrophage infiltration is essential to acute skeletal muscle injury repair. The majority of intramuscular macrophages express the chemokine receptor CX(3)CR1. We studied the role of CX(3)CR1 in regulating intramuscular macrophage number and function in acute injury repair by using a loss-of-function approach. Muscle injury repair was delayed in CX(3)CR1(GFP/GFP) mice as compared with wild-type (WT) controls. CX(3)CR1 was predominantly expressed by macrophages but not by myogenic cells or capillary endothelia cells in injured muscles. Intramuscular macrophage number and subset composition were not altered by CX(3)CR1 deficiency. Intramuscular macrophage phagocytosis function was impaired by CX(3)CR1 deficiency as demonstrated by increased number of necrotic fibers (+115%) and percentage of necrotic area (+204%) at 7 d, increased number of intramuscular neutrophils at 3 (+89%) but not 1 d, reduced number of phagocytosing macrophages (-12%) and phagocytosed beads within macrophages (-15%) in CX(3)CR1(GFP/GFP) mice as compared with WT controls. The mRNA expression of CD36 (-50%), CD14 (-43%), IGF-1 (-53%), and IL-6 (-40%) was reduced in CX(3)CR1-deficient macrophages as compared with WT controls. We conclude that CX(3)CR1 is important to acute skeletal muscle injury repair by regulating macrophage phagocytosis function and trophic growth factor production.	[Zhao, Wanming; Wang, Xingyu; Zhou, Lan] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Lu, Haiyan; Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA	Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation	Zhou, L (corresponding author), Mt Sinai Sch Med, Dept Neurol, 1468 Madison Ave,Box 1052, New York, NY 10029 USA.	lan.zhou@mssm.edu			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059702]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059702] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai for the technical support. This study is supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01AR059702 (to L.Z.). The authors declare no conflicts of interest.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Begue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057141; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Blomster LV, 2011, MOL CELL NEUROSCI, V48, P236, DOI 10.1016/j.mcn.2011.08.004; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Cybulsky MI, 2003, J CLIN INVEST, V111, P1118, DOI 10.1172/JCI200318237; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Devitt A, 2004, J CELL BIOL, V167, P1161, DOI 10.1083/jcb.200410057; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Ishida Y, 2008, J IMMUNOL, V181, P4208, DOI 10.4049/jimmunol.181.6.4208; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kostadinova FI, 2010, J LEUKOCYTE BIOL, V88, P133, DOI 10.1189/jlb.1109768; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Sato E, 2010, JARO-J ASSOC RES OTO, V11, P223, DOI 10.1007/s10162-009-0198-3; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Varga T, 2013, J IMMUNOL, V191, P5695, DOI 10.4049/jimmunol.1301445; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wollberg AR, 2014, P NATL ACAD SCI USA, V111, P5409, DOI 10.1073/pnas.1316510111; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	51	39	41	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					380	393		10.1096/fj.14-270090	http://dx.doi.org/10.1096/fj.14-270090			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443824	Green Published			2022-12-28	WOS:000367621000036
J	Kurth, F; Franco-Obregon, A; Casarosa, M; Kuster, SK; Wuertz-Kozak, K; Dittrich, PS				Kurth, Felix; Franco-Obregon, Alfredo; Casarosa, Marco; Kuester, Simon K.; Wuertz-Kozak, Karin; Dittrich, Petra S.			Transient receptor potential vanilloid 2-mediated shear-stress responses in C2C12 myoblasts are regulated by serum and extracellular matrix	FASEB JOURNAL			English	Article						mechanotransduction; calcium; laminin; myogenesis; microfluidics	MECHANOSENSITIVE ION CHANNELS; VASCULAR ENDOTHELIAL-CELLS; OPERATED CALCIUM-CHANNELS; PATCH-CLAMPED MEMBRANES; SKELETAL-MUSCLE FIBERS; TRP CHANNELS; MECHANICAL STIMULATION; MUSCULAR-DYSTROPHY; CATION CHANNELS; 2-AMINOETHOXYDIPHENYL BORATE	The developmental sensitivity of skeletal muscle to mechanical forces is unparalleled in other tissues. Calcium entry via reputedly mechanosensitive transient receptor potential (TRP) channel classes has been shown to play an essential role in both the early proliferative stage and subsequent differentiation of skeletal muscle myoblasts, particularly TRP canonical (TRPC) 1 and TRP vanilloid (TRPV) 2. Here we show that C2C12 murine myoblasts respond to fluid flow-induced shear stress with increments in cytosolic calcium that are largely initiated by the mechanosensitive opening of TRPV2 channels. Response to fluid flow was augmented by growth in low extracellular serum concentration (5 vs. 20% fetal bovine serum) by greater than 9-fold and at 18 h in culture, coincident with the greatest TRPV2 channel expression under identical conditions (P < 0.02). Fluid flow responses were also enhanced by substrate functionalization with laminin, rather than with fibronectin, agreeing with previous findings that the gating of TRPV2 is facilitated by laminin. Fluid flow-induced calcium increments were blocked by ruthenium red (27%) and SKF-96365 (38%), whereas they were unaltered by 2-aminoethoxydiphenyl borate, further corroborating that TRPV2 channels play a predominant role in fluid flow mechanosensitivity over that ofTRPC1 andTRPmelastatin (TRPM) 7.	[Kurth, Felix; Kuester, Simon K.; Dittrich, Petra S.] ETH, Dept Biosyst & Sci Engn, CH-8093 Zurich, Switzerland; [Casarosa, Marco; Wuertz-Kozak, Karin] ETH, Inst Biomech, CH-8093 Zurich, Switzerland; [Franco-Obregon, Alfredo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Franco-Obregon, Alfredo] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Franco-Obregon, Alfredo] Natl Univ Singapore Hosp, Sports Ctr, Singapore 119228, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore; National University of Singapore; National University of Singapore	Franco-Obregon, A (corresponding author), Natl Univ Singapore Hosp, Dept Surg, NUHS Tower Block,Level 8,1E Kent Ridge Rd, Singapore 119228, Singapore.	suraf@nus.edu.sg; petra.dittrich@bsse.ethz.ch	Franco-Obregon, Alfredo/F-3056-2019; Obregón, Alfredo/G-1756-2014; Wuertz-Kozak, Karin/G-3144-2012; Kurth, Felix/L-5799-2019	Wuertz-Kozak, Karin/0000-0002-3281-4629; Kurth, Felix/0000-0002-3211-6820; Franco-Obregon, Alfredo/0000-0002-2514-1083	European Research Council [203428]	European Research Council(European Research Council (ERC)European Commission)	The authors kindly appreciate fabrication of the master molds by P. Kuhn and thank B. Sebastian for providing the mean squared displacement analysis-Matlab code. Funding from the European Research Council (Starting Grant n mu LIPIDS, no. 203428) is gratefully acknowledged.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; ANDO J, 1988, IN VITRO CELL DEV B, V24, P871; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Boels K, 2001, J CELL SCI, V114, P3599; Cachaco AS, 2005, DEV DYNAM, V232, P1069, DOI 10.1002/dvdy.20280; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Chin LK, 2011, LAB CHIP, V11, P1856, DOI 10.1039/c0lc00651c; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crocetti S, 2014, CYTOM PART A, V85A, P525, DOI 10.1002/cyto.a.22461; Damm TB, 2013, CELL CYCLE, V12, P3001, DOI 10.4161/cc.26029; Damm TB, 2013, FASEB J, V27, P2045, DOI 10.1096/fj.12-218693; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Ferrer-Montiel A, 2012, EXPERT OPIN THER PAT, V22, P999, DOI 10.1517/13543776.2012.711320; Flemming R, 2003, BRIT J PHARMACOL, V139, P955, DOI 10.1038/sj.bjp.0705327; Formigli L, 2007, J CELL PHYSIOL, V211, P296, DOI 10.1002/jcp.20936; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; FRANCOOBREGON A, 1994, J PHYSIOL-LONDON, V481, P299, DOI 10.1113/jphysiol.1994.sp020440; Gailly P, 2012, CURR OPIN PHARMACOL, V12, P326, DOI 10.1016/j.coph.2012.01.018; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Grossi A, 2008, CELL BIOL INT, V32, P615, DOI 10.1016/j.cellbi.2008.01.005; Grossi A, 2007, J BIOMECH, V40, P3354, DOI 10.1016/j.jbiomech.2007.05.007; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; HAMILL OP, 1992, P NATL ACAD SCI USA, V89, P7462, DOI 10.1073/pnas.89.16.7462; Harisseh R, 2013, AM J PHYSIOL-CELL PH, V304, pC881, DOI 10.1152/ajpcell.00182.2012; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Ho TC, 2012, CHANNELS, V6, P246, DOI 10.4161/chan.20719; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Juvin V, 2007, MOL PHARMACOL, V72, P1258, DOI 10.1124/mol.107.037044; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kim BJ, 2005, GASTROENTEROLOGY, V129, P1504, DOI 10.1053/j.gastro.2005.08.016; Kirber MT, 2000, J PHYSIOL-LONDON, V524, P3, DOI 10.1111/j.1469-7793.2000.t01-4-00003.x; Kobayashi Y, 2006, EXP CELL RES, V312, P3152, DOI 10.1016/j.yexcr.2006.06.026; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Kurth F, 2015, ANALYST, V140, P127, DOI 10.1039/c4an01758g; Kurth F, 2012, CURR OPIN CHEM BIOL, V16, P400, DOI 10.1016/j.cbpa.2012.03.014; LANSMAN JB, 1988, NATURE, V331, P481, DOI 10.1038/331481a0; Lansman JB, 2006, CLIN EXP PHARMACOL P, V33, P649, DOI 10.1111/j.1440-1681.2006.04393.x; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Matsumura CY, 2011, AM J PHYSIOL-CELL PH, V301, pC1344, DOI 10.1152/ajpcell.00056.2011; MCBRIDE DW, 1992, PFLUG ARCH EUR J PHY, V421, P606, DOI 10.1007/BF00375058; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park SW, 2007, BIOCHEM BIOPH RES CO, V358, P1021, DOI 10.1016/j.bbrc.2007.05.024; Peng SQ, 2005, BRAIN RES, V1045, P116, DOI 10.1016/j.brainres.2005.03.039; Pla AF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00311; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rahimzadeh J, 2011, AM J PHYSIOL-CELL PH, V301, pC646, DOI 10.1152/ajpcell.00099.2011; Rouillard AD, 2014, BIOPHYS J, V106, P932, DOI 10.1016/j.bpj.2013.12.002; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; Rychkov G., 2007, V179, P23; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; Silberberg SD, 1997, J PHYSIOL-LONDON, V505, P551, DOI 10.1111/j.1469-7793.1997.551ba.x; Slavchov RI, 2014, J PHYS CHEM B, V118, P12660, DOI 10.1021/jp506965v; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; SPITZER A, 1970, AM J PHYSIOL, V218, P1188, DOI 10.1152/ajplegacy.1970.218.4.1188; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Tidball JG, 2005, J APPL PHYSIOL, V98, P1900, DOI 10.1152/japplphysiol.01178.2004; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033; Zhou Y, 2007, BIOCHEMISTRY-US, V46, P14907, DOI 10.1021/bi701384k; Zou H, 2002, P NATL ACAD SCI USA, V99, P6404, DOI 10.1073/pnas.092654999	88	22	22	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4726	4737		10.1096/fj.15-275396	http://dx.doi.org/10.1096/fj.15-275396			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26207028				2022-12-28	WOS:000364514700028
J	Rohner, NA; McClain, J; Tuell, SL; Warner, A; Smith, B; Yun, Y; Mohan, A; Sushnitha, M; Thomas, SN				Rohner, Nathan Andrew; McClain, Jacob; Tuell, Sara Lydia; Warner, Alex; Smith, Blair; Yun, Youngho; Mohan, Abhinav; Sushnitha, Manuela; Thomas, Susan Napier			Lymph node biophysical remodeling is associated with melanoma lymphatic drainage	FASEB JOURNAL			English	Article						sentinel lymph node; cancer; tissue mechanical properties	INTERSTITIAL FLUID PRESSURE; ENDOTHELIAL GROWTH-FACTOR; TUMOR MICROENVIRONMENT; SOLID STRESS; HYALURONIC-ACID; CELL; COLLAGEN; FLOW; LYMPHANGIOGENESIS; METASTASIS	Tissue remodeling is a characteristic of many solid tumor malignancies including melanoma. By virtue of tumor lymphatic transport, remodeling pathways active within the local tumor microenvironment have the potential to be operational within lymph nodes (LNs) draining the tumor interstitium. Here, we show that lymphatic drainage from murine B16 melanomas in syngeneic, immune-competent C57Bl/6 mice is associated with LN enlargement as well as nonuniform increases in bulk tissue elasticity and viscoelasticity, as measured by the response of whole LNs to compression. These remodeling responses, which quickly manifest in tumor-draining lymph nodes (TDLNs) after tumor inoculation and before apparent metastasis, were accompanied by changes in matrix composition, including up to 3-fold increases in the abundance of soluble collagen and hyaluronic acid. Intranodal pressures were also significantly increased in TDLNs (+1 cmH(2)O) relative to both non-tumor-draining LNs (-1 cmH(2)O) and LNs from naive animals (-1 to 2 cmH(2)O). These data suggest that the reorganization of matrix structure, composition, and fluid microenvironment within LNs associated with tumor lymphatic drainage parallels remodeling seen in primary malignancies and has the potential to regulate the adhesion, proliferation, and signaling function of LN-resident cells involved in directing melanoma disease progression.	Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Thomas, SN (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr NW, Atlanta, GA 30332 USA.	susan.thomas@gatech.edu	Thomas, Susan/B-4592-2016		Georgia Institute of Technology; U.S. National Institutes of Health Cell and Tissue Engineering Training Grant [T32 GM-008433]; U.S. National Science Foundation Award [1342194]; Georgia Institute of Technology Undergraduate Research Opportunities Office, Air Products; U.S. National Science Foundation Summer Undergraduate Research in Engineering/Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008433] Funding Source: NIH RePORTER	Georgia Institute of Technology; U.S. National Institutes of Health Cell and Tissue Engineering Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation Award(National Science Foundation (NSF)); Georgia Institute of Technology Undergraduate Research Opportunities Office, Air Products; U.S. National Science Foundation Summer Undergraduate Research in Engineering/Science Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Alex Schudel, Caitlin Powell, Monica McNerney, Karan Khendry, and Rahul Rege for technical assistance as well as Sha'aqua T. Asberry and Andrew Shaw for technical advice. This work was supported by institutional funds from the Georgia Institute of Technology; U.S. National Institutes of Health Cell and Tissue Engineering Training Grant T32 GM-008433; U.S. National Science Foundation Award 1342194; Georgia Institute of Technology Undergraduate Research Opportunities Office, Air Products; and U.S. National Science Foundation Summer Undergraduate Research in Engineering/Science Program.	Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Badwe RA, 2003, NEW ENGL J MED, V349, P1968; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bastiaannet E, 2009, J CLIN ONCOL, V27, P4774, DOI 10.1200/JCO.2008.20.1822; Bobek V, 2010, ANTICANCER RES, V30, P4799; Boucher Y, 1996, CANCER RES, V56, P4264; Chung MK, 2012, ANN SURG ONCOL, V19, P1595, DOI 10.1245/s10434-011-2154-9; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; DUNN MG, 1983, CONNECT TISSUE RES, V12, P59, DOI 10.3109/03008208309005612; Egger ME, 2014, J AM COLL SURGEONS, V218, P519, DOI 10.1016/j.jamcollsurg.2013.12.014; Faffe DS, 2009, PHYSIOL REV, V89, P759, DOI 10.1152/physrev.00019.2007; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fung YC., 2013, BIOMECHANICS MECH PR; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; GUTMANN R, 1992, CANCER RES, V52, P1993; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hautmann SH, 2001, J UROLOGY, V165, P2068, DOI 10.1016/S0022-5347(05)66296-9; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Ichikawa T, 1999, J INVEST DERMATOL, V113, P935, DOI 10.1046/j.1523-1747.1999.00804.x; Insana MF, 2004, J MAMMARY GLAND BIOL, V9, P393, DOI 10.1007/s10911-004-1409-5; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Koh YX, 2014, EJSO-EUR J SURG ONC, V40, P1263, DOI 10.1016/j.ejso.2014.05.008; Korhonen RK, 2003, J BIOMECH, V36, P1373, DOI 10.1016/S0021-9290(03)00069-1; Kornuta JA, 2014, ANN BIOMED ENG, V42, P1691, DOI 10.1007/s10439-014-1024-6; Kosaki R, 1999, CANCER RES, V59, P1141; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; MAROUDAS A, 1975, BIORHEOLOGY, V12, P233; Marzo AL, 1999, J IMMUNOL, V162, P5838; Minamiya Yoshihiro, 2006, Ann Thorac Cardiovasc Surg, V12, P381; Miserocchi G, 2001, NEWS PHYSIOL SCI, V16, P66; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Miyaji K., 1997, CANCER, V80, P1920; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Mummert ME, 2003, MOL CANCER THER, V2, P295; Nathanson SD, 2015, SEMIN CELL DEV BIOL, V38, P106, DOI 10.1016/j.semcdb.2014.10.002; Nathanson SD, 2014, ANN SURG ONCOL, V21, P81, DOI 10.1245/s10434-013-3249-2; Nathanson SD, 2011, ANN SURG ONCOL, V18, P3791, DOI 10.1245/s10434-011-1796-y; O'Connor RS, 2012, J IMMUNOL, V189, P1330, DOI 10.4049/jimmunol.1102757; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Phan GQ, 2009, CANCER CONTROL, V16, P234, DOI 10.1177/107327480901600305; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Reintgen M, 2013, ANN SURG ONCOL, V20, P668, DOI 10.1245/s10434-012-2652-4; Rudrabhatla SR, 2006, J INVEST DERMATOL, V126, P1378, DOI 10.1038/sj.jid.5700255; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Rutkowski JM, 2010, AM J PATHOL, V176, P1122, DOI 10.2353/ajpath.2010.090733; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Sloothaak DAM, 2014, BRIT J SURG, V101, P701, DOI 10.1002/bjs.9451; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Thomas SN, 2015, CURR OPIN CHEM ENG, V7, P65, DOI 10.1016/j.coche.2014.11.003; Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Trochon V, 1997, FEBS LETT, V418, P6, DOI 10.1016/S0014-5793(97)01337-9; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Voutouri C, 2014, J BIOMECH, V47, P3441, DOI 10.1016/j.jbiomech.2014.09.019; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Weiler M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00215; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; Winkelmann CT, 2006, MOL IMAGING, V5, P105, DOI 10.2310/7290.2006.00011; Xu XM, 2003, CANCER RES, V63, P5685; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Yi M, 2008, CANCER-AM CANCER SOC, V113, P30, DOI 10.1002/cncr.23514	87	29	30	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4512	4522		10.1096/fj.15-274761	http://dx.doi.org/10.1096/fj.15-274761			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26178165	Green Published			2022-12-28	WOS:000364514700011
J	Pera, T; Hegde, A; Deshpande, DA; Morgan, SJ; Tiegs, BC; Theriot, BS; Choi, YH; Walker, JKL; Penn, RB				Pera, Tonio; Hegde, Akhil; Deshpande, Deepak A.; Morgan, Sarah J.; Tiegs, Brian C.; Theriot, Barbara S.; Choi, Yeon H.; Walker, Julia K. L.; Penn, Raymond B.			Specificity of arrestin subtypes in regulating airway smooth muscle G protein-coupled receptor signaling and function	FASEB JOURNAL			English	Article						asthma; desensitization; beta-2-adrenoceptor; M3 mAChR	BETA-ARRESTINS; BETA(2)-ADRENERGIC RECEPTOR; COOPERATIVE REGULATION; AGONISTS; KINASES; ASTHMA; MICE; BETA-ARRESTIN1; RESPONSIVENESS; SALMETEROL	Arrestins have been shown to regulate numerous G protein-coupled receptors (GPCRs) in studies employing receptor/arrestin overexpression in artificial cell systems. Which arrestin isoforms regulate which GPCRs in primary cell types is poorly understood. We sought to determine the effect of beta-arrestin-1 or beta-arrestin-2 inhibition or gene ablation on signaling and function of multiple GPCRs endogenously expressed in airway smooth muscle (ASM). In vitro [second messenger (calcium, cAMP generation)], ex vivo (ASM tension generation in suspended airway), and in vivo (invasive airway resistance) analyses were performed on human ASM cells and murine airways/whole animal subject to beta-arrestin-1 or -2 knockdown or knockout (KO). In both human and murine model systems, knockdown or KO of beta-arrestin-2 relative to control missense small interfering RNA or wild-type mice selectively increased (40-60%) beta(2)-adrenoceptor signaling and function. beta-arrestin-1 knockdown or KO had no effect on signaling and function of beta(2)-adrenoceptor or numerous procontractile GPCRs, but selectively inhibited M3 muscarinic acetylcholine receptor signaling (similar to 50%) and function (similar to 25% ex vivo, >50% in vivo) without affecting EC50 values. Arrestin subtypes differentially regulate ASM GPCRs and beta-arrestin-1 inhibition represents a novel approach to managing bronchospasm in obstructive lung diseases.	[Pera, Tonio; Deshpande, Deepak A.; Morgan, Sarah J.; Tiegs, Brian C.; Penn, Raymond B.] Thomas Jefferson Univ, Ctr Translat Med, Jane & Leonard Korman Lung Ctr, Dept Med,Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA; [Hegde, Akhil; Theriot, Barbara S.; Choi, Yeon H.; Walker, Julia K. L.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC USA	Jefferson University; Duke University	Penn, RB (corresponding author), Thomas Jefferson Univ, Dept Med, Rm 543 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	juliakl.walker@duke.edu; raymond.penn@jefferson.edu	Walker, Julia/R-7585-2017		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL093103]; NIH National Institute of Allergy and Infectious Diseases [AI110007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093103, R01HL058506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this study was provided by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL093103 (to R.B.P. and J.K.L.W.) and NIH National Institute of Allergy and Infectious Diseases Grant AI110007 (to R.B.P. and J.K.L.W.). The authors declare no conflicts of interest.	Abisheganaden J, 1998, AM J MED, V104, P494; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Billington CK, 2003, RESP RES, V4; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568; Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Conner DA, 1997, CIRC RES, V81, P1021; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Deshpande DA, 2014, FASEB J, V28, P956, DOI 10.1096/fj.13-240226; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drotar DE, 1998, ANN ALLERG ASTHMA IM, V80, P31, DOI 10.1016/S1081-1206(10)62935-3; Gosens R, 2003, AM J RESP CELL MOL, V28, P257, DOI 10.1165/rcmb.2002-0128OC; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hegde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116458; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Jokic R, 2001, CHEST, V119, P370, DOI 10.1378/chest.119.2.370; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Lipworth B, 1998, AM J MED, V104, P431, DOI 10.1016/S0002-9343(98)00086-2; Luttrell LM, 2002, J CELL SCI, V115, P455; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; MURRAY RK, 1993, AM J PHYSIOL, V264, pC485, DOI 10.1152/ajpcell.1993.264.2.C485; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Penn Raymond B, 2014, Handb Exp Pharmacol, V219, P387, DOI 10.1007/978-3-642-41199-1_20; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Peters SP, 1999, AM J MED, V107, P283; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Stephens NL, 2001, LUNG, V179, P333, DOI 10.1007/s004080000073; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tilley SL, 2003, AM J PHYSIOL-LUNG C, V284, pL599, DOI 10.1152/ajplung.00324.2002; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; WIDDOP S, 1993, AM J RESP CELL MOL, V9, P541, DOI 10.1165/ajrcmb/9.5.541; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798	52	15	16	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4227	4235		10.1096/fj.15-273094	http://dx.doi.org/10.1096/fj.15-273094			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26103985	Green Published			2022-12-28	WOS:000361367300012
J	Heng, S; Paule, SG; Li, Y; Rombauts, LJ; Vollenhoven, B; Salamonsen, LA; Nie, GY				Heng, Sophea; Paule, Sarah G.; Li, Ying; Rombauts, Luk J.; Vollenhoven, Beverley; Salamonsen, Lois A.; Nie, Guiying			Posttranslational removal of alpha-dystroglycan N terminus by PC5/6 cleavage is important for uterine preparation for embryo implantation in women	FASEB JOURNAL			English	Article						endometrium; receptivity; biomarker; glycoprotein; adhesion molecule	DYSTROPHIN-GLYCOPROTEIN COMPLEX; PROPROTEIN CONVERTASE 5/6; PRO-PROTEIN CONVERTASES; BETA-DYSTROGLYCAN; PROHORMONE CONVERTASES; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISM; SKELETAL-MUSCLE; IN-VITRO; MUCIN	Embryo implantation requires a healthy embryo and a receptive endometrium (inner lining of the uterus); endometrial receptivity acquisition involves considerable epithelial surface remodeling. Dystroglycan (DG), a large cell surface glycoprotein, consists of alpha- and beta-subunits; beta-DG anchors within the plasma membrane whereas alpha-DG attaches extracellularly to beta-DG. The glycosylated central alpha-DG mediates adhesion, but it is obstructed by its large N terminus (alpha-DG-N); alpha-DG-N removal enables DG's adhesive function. We demonstrate here that full-length alpha-DG in the human endometrial epithelium is a barrier for embryo attachment and that removal of alpha-DG-N by proprotein convertase 5/6 (PC6; a protease critical for implantation) regulates receptivity. This was evidenced by: 1) alpha-DG contains a PC6-cleavage site near alpha-DG-N, and PC6 cleaves a peptide harboring such a site; 2) PC6 knockdown reduces alpha-DG-N removal from endometrial epithelial cell surface and blastocyst adhesion; 3) mutating the PC6-cleavage site prevents alpha-DG-N removal, causing cell surface retention of full-length alpha-DG and loss of adhesiveness; 4) alpha-DG-N is removed from endometrial tissue in vivo for receptivity and uterine fluid alpha-DG-N reflects tissue removal and receptivity. We thus identified alpha-DGN removal as an important posttranslational control of endometrial receptivity and uterine fluid alpha-DG-N as a potential biomarker for receptivity in women.	[Heng, Sophea; Paule, Sarah G.; Li, Ying; Salamonsen, Lois A.; Nie, Guiying] Hudson Inst Med Res, Ctr Reprod Hlth, Implantat & Placental Dev Lab, Clayton, Vic 3168, Australia; [Heng, Sophea; Paule, Sarah G.; Li, Ying; Salamonsen, Lois A.; Nie, Guiying] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [Rombauts, Luk J.; Vollenhoven, Beverley] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Rombauts, Luk J.; Vollenhoven, Beverley] Monash Hlth, Womens & Childrens Programme, Clayton, Vic, Australia; [Rombauts, Luk J.; Vollenhoven, Beverley] Monash IVF, Clayton, Vic, Australia	Hudson Institute of Medical Research; Monash University; Monash University	Nie, GY (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	guiying.nie@hudson.org.au	Salamonsen, Lois/J-9822-2019	Salamonsen, Lois/0000-0003-0558-7325; Rombauts, Luk/0000-0003-2656-2792; Nie, Guiying/0000-0001-9641-087X	National Health and Medical Research Council of Australia [1044182, 1041835, 388901]; Monash IVF; Victorian Government Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash IVF; Victorian Government Operational Infrastructure Support Program	This work was supported by the National Health and Medical Research Council of Australia (Project Grant No. 1044182 and Fellowship No. 1041835 to G.N., and Fellowship No. 388901 to L.A.S.), Monash IVF, and the Victorian Government Operational Infrastructure Support Program. The authors thank Professor Masato Nishida (National Hospital Organization, Kasumigaura Medical Center, Ibaraki-ken, Japan) for providing the Ishikawa cells, and Professor Carlos Simon (Department of Obstetrics and Gynaecology, University of Valencia, Valencia, Spain) for providing the PC6 knockdown HEC-1A cells. The authors are grateful to their colleagues Drs. Andrew N. Stephens and Adam Rainczuk, for their expert assistance with the SELDI mass spectrometry analysis, Dr. Kelly Walton for her help with generating the Mut DG construct, Dr. Maree Bilandzic for the methylcellulose method of forming BeWo spheroids, and research nurse, Judi Hocking for collecting clinical materials. The authors also thank the patients who kindly donated endometrial tissues and uterine lavage fluids for this study.	Aplin JD, 2006, REPROD BIOMED ONLINE, V13, P833, DOI 10.1016/S1472-6483(10)61032-2; Bilandzic M, 2014, JOVE-J VIS EXP, DOI 10.3791/51655; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Carson DD, 1998, BIOESSAYS, V20, P577, DOI 10.1002/(SICI)1521-1878(199807)20:7<577::AID-BIES9>3.0.CO;2-H; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Freyer C, 2007, REPRODUCTION, V133, P1189, DOI 10.1530/REP-06-0285; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Heng S, 2011, ENDOCRINOLOGY, V152, P5041, DOI 10.1210/en.2011-1273; Heng S, 2011, HUM REPROD, V26, P840, DOI 10.1093/humrep/der002; Heng S, 2010, ENDOCRINOLOGY, V151, P3909, DOI 10.1210/en.2010-0326; Hesse C, 2011, BIOCHEM BIOPH RES CO, V412, P494, DOI 10.1016/j.bbrc.2011.07.129; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; James M, 1996, CELL MOTIL CYTOSKEL, V33, P163, DOI 10.1002/(SICI)1097-0169(1996)33:3<163::AID-CM1>3.0.CO;2-C; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kilpatrick LM, 2009, J PROTEOME RES, V8, P4983, DOI 10.1021/pr900381a; Lei CX, 2009, HUM REPROD, V24, P2879, DOI 10.1093/humrep/dep250; Meseguer M, 1998, MOL HUM REPROD, V4, P1089, DOI 10.1093/molehr/4.12.1089; Meseguer M, 2001, BIOL REPROD, V64, P590, DOI 10.1095/biolreprod64.2.590; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Nie GY, 2005, BIOL REPROD, V72, P1029, DOI 10.1095/biolreprod.104.036889; Nie GY, 2003, BIOL REPROD, V68, P439, DOI 10.1095/biolreprod.102.006676; Nie GY, 2002, REPRODUCTION, V124, P209, DOI 10.1530/reprod/124.2.209; Niklaus AL, 1999, ANAT REC, V255, P241; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Okada H, 2005, J CLIN ENDOCR METAB, V90, P1028, DOI 10.1210/jc.2004-0904; Paule S, 2012, HUM REPROD, V27, P2766, DOI 10.1093/humrep/des203; Paule S, 2011, J MOL HISTOL, V42, P161, DOI 10.1007/s10735-011-9319-5; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Saito F, 2008, FEBS LETT, V582, P439, DOI 10.1016/j.febslet.2008.01.006; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Thompson O, 2010, J CELL SCI, V123, P118, DOI 10.1242/jcs.047902; Toledo AG, 2012, GLYCOBIOLOGY, V22, P1413, DOI 10.1093/glycob/cws109; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831	48	16	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4011	4022		10.1096/fj.14-269456	http://dx.doi.org/10.1096/fj.14-269456			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26077903				2022-12-28	WOS:000359915600035
J	Lee, E; Jung, DY; Kim, JH; Patel, PR; Hu, XD; Lee, Y; Azuma, Y; Wang, HF; Tsitsilianos, N; Shafiq, U; Kwon, JY; Lee, HJ; Lee, KW; Kim, JK				Lee, Eunjung; Jung, Dae Young; Kim, Jong Hun; Patel, Payal R.; Hu, Xiaodi; Lee, Yongjin; Azuma, Yoshihiro; Wang, Hsun-Fan; Tsitsilianos, Nicholas; Shafiq, Umber; Kwon, Jung Yeon; Lee, Hyong Joo; Lee, Ki Won; Kim, Jason K.			Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance	FASEB JOURNAL			English	Article						capsaicin; hyperinsulinemic-euglycemic clamp; glucose metabolism; aging	IMPAIRED NOCICEPTION; SKELETAL-MUSCLE; PAIN SENSATION; MICE LACKING; CAPSAICIN; CALCIUM; TRPV1; METABOLISM; INTERVENTION; INFLAMMATION	Insulin resistance is a major characteristic of obesity and type 2 diabetes, but the underlying mechanism is unclear. Recent studies have shown a metabolic role of capsaicin that may be mediated via the transient receptor potential vanilloid type-1 (TRPV1) channel. In this study, TRPV1 knockout (KO) and wild-type (WT) mice (as controls) were fed a high-fat diet (HFD), and metabolic studies were performed to measure insulin and leptin action. The TRPV1 KO mice became more obese than the WT mice after HFD, partly attributed to altered energy balance and leptin resistance in the KO mice. The hyperinsulinemic-euglycemic clamp experiment showed that the TRPV1 KO mice were more insulin resistant after HFD because of the similar to 40% reduction inglucose metabolism in the white and brown adipose tissue, compared with that in the WT mice. Leptin treatment failed to suppress food intake, and leptin-mediated hypothalamic signal transducer and activator of transcription (STAT)-3 activity was blunted in the TRPV1 KO mice. We also found that the TRPV1 KO mice were more obese and insulin resistant than the WT mice at 9 mo of age. Taken together, these results indicate that lacking TRPV1 exacerbates the obesity and insulin resistance associated with an HFD and aging, and our findings further suggest that TRPV1 has a major role in regulating glucose metabolism and hypothalamic leptin's effects in obesity.	[Lee, Eunjung; Jung, Dae Young; Kim, Jong Hun; Patel, Payal R.; Hu, Xiaodi; Lee, Yongjin; Azuma, Yoshihiro; Wang, Hsun-Fan; Tsitsilianos, Nicholas; Shafiq, Umber; Kwon, Jung Yeon; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Lee, Eunjung; Lee, Hyong Joo; Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Eunjung; Lee, Hyong Joo; Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Lee, Eunjung] Korea Food Res Inst, Tradit Alcohol Beverage Res Team, Songnam, South Korea; [Kim, Jong Hun; Kwon, Jung Yeon; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU); Seoul National University (SNU); Korea Food Research Institute (KFRI); Seoul National University (SNU)	Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantat St,AS9-1041, Worcester, MA 01605 USA.	kiwon@snu.ac.kr; jason.kim@umassmed.edu	Lee, Ki Won/M-4114-2018	Kim, Jason/0000-0002-7185-042X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, U24-DK093000, R24-DK090963]; National Leap Research Program Grant [2010-0029233]; National Research Foundation of Korea - Ministry of Science, Information and Communications Technology, and Future Planning [2012M3A9C4048818]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090963, U24DK093000, R01DK080756] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Leap Research Program Grant; National Research Foundation of Korea - Ministry of Science, Information and Communications Technology, and Future Planning; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK080756, U24-DK093000, and R24-DK090963 to J.K.K.; National Leap Research Program Grant 2010-0029233 to K.W.L.; and National Research Foundation of Korea Grant 2012M3A9C4048818 to K.W.L. funded by the Ministry of Science, Information and Communications Technology, and Future Planning.	Abramowitz J., 2007, V179, P379; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Carruth BR, 2001, INT J OBESITY, V25, P559, DOI 10.1038/sj.ijo.0801562; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Jung DY, 2013, AM J PHYSIOL-ENDOC M, V304, pE964, DOI 10.1152/ajpendo.00462.2012; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JH, 1996, FASEB J, V10, P1646, DOI 10.1096/fasebj.10.14.9002558; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Lee E, 2013, TOXICOL APPL PHARM, V272, P12, DOI 10.1016/j.taap.2013.04.030; Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075; Mittendorfer B, 2011, DIABETES, V60, P1474, DOI 10.2337/db10-1302; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Palmer RK, 2013, CURR TOP MED CHEM, V13, P247; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Shi H, 2001, FASEB J, V15, P291; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yu Q, 2012, MOL BIOL REP, V39, P7583, DOI 10.1007/s11033-012-1592-1; Zemel M. B., 2001, J AM COLL NUTR, V20, p440S; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhang ZY, 2012, AM J PHYSIOL-ENDOC M, V302, pE807, DOI 10.1152/ajpendo.00239.2011; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5	38	90	92	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3182	3192		10.1096/fj.14-268300	http://dx.doi.org/10.1096/fj.14-268300			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888600	Green Published			2022-12-28	WOS:000358796900008
J	Yamamoto, K; Kakino, A; Takeshita, H; Hayashi, N; Li, L; Nakano, A; Hanasaki-Yamamoto, H; Fujita, Y; Imaizumi, Y; Toyama-Yokoyama, S; Nakama, C; Kawai, T; Takeda, M; Hongyo, K; Oguro, R; Maekawa, Y; Itoh, N; Takami, Y; Onishi, M; Takeya, Y; Sugimoto, K; Kamide, K; Nakagami, H; Ohishi, M; Kurtz, TW; Sawamura, T; Rakugi, H				Yamamoto, Koichi; Kakino, Akemi; Takeshita, Hikari; Hayashi, Norihiro; Li, Lei; Nakano, Atsushi; Hanasaki-Yamamoto, Hiroko; Fujita, Yoshiko; Imaizumi, Yuki; Toyama-Yokoyama, Serina; Nakama, Chikako; Kawai, Tatsuo; Takeda, Masao; Hongyo, Kazuhiro; Oguro, Ryosuke; Maekawa, Yoshihiro; Itoh, Norihisa; Takami, Yoichi; Onishi, Miyuki; Takeya, Yasushi; Sugimoto, Ken; Kamide, Kei; Nakagami, Hironori; Ohishi, Mitsuru; Kurtz, Theodore W.; Sawamura, Tatsuya; Rakugi, Hiromi			Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor by binding to the lectin-like oxLDL receptor	FASEB JOURNAL			English	Article						G protein-coupled receptor; allosteric activation; vascular dysfunction; receptor multimerization	LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; ARTERY ENDOTHELIAL-CELLS; 3RD CYTOPLASMIC LOOP; NF-KAPPA-B; OXIDATIVE STRESS; KNOCKOUT MICE; NADPH OXIDASE; EGF RECEPTOR; G-PROTEINS	The angiotensin II type 1 receptor (AT1) is a 7-transmembrane domain GPCR that when activated by its ligand angiotensin II, generates signaling events promoting vascular dysfunction and the development of cardiovascular disease. Here, we show that the single-transmembrane oxidized LDL (oxLDL) receptor (LOX-1) resides in proximity to AT1 on cell-surface membranes and that binding of oxLDL to LOX-1 can allosterically activate AT1-dependent signaling events. oxLDL-induced signaling events in human vascular endothelial cells were abolished by knockdown of AT1 and inhibited by AT1 blockade (ARB). oxLDL increased cytosolic G protein by 350% in Chinese hamster ovary (CHO) cells with genetically induced expression of AT1 and LOX-1, whereas little increase was observed in CHO cells expressing only LOX-1. Immunoprecipitation and in situ proximity ligation assay (PLA) assays in CHO cells revealed the presence of cell-surface complexes involving LOX-1 and AT1. Chimeric analysis showed that oxLDL-induced AT1 signaling events are mediated via interactions between the intracellular domain of LOX-1 and AT1 that activate AT1. oxLDL-induced impairment of endothelium-dependent vascular relaxation of vascular ring from mouse thoracic aorta was abolished by ARB or genetic deletion of AT1. These findings reveal a novel pathway for AT1 activation and suggest a new mechanism whereby oxLDL may be promoting risk for cardiovascular disease.	[Yamamoto, Koichi; Takeshita, Hikari; Hayashi, Norihiro; Hanasaki-Yamamoto, Hiroko; Imaizumi, Yuki; Toyama-Yokoyama, Serina; Nakama, Chikako; Kawai, Tatsuo; Takeda, Masao; Hongyo, Kazuhiro; Oguro, Ryosuke; Maekawa, Yoshihiro; Itoh, Norihisa; Takami, Yoichi; Onishi, Miyuki; Takeya, Yasushi; Sugimoto, Ken; Kamide, Kei; Ohishi, Mitsuru; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Kakino, Akemi; Li, Lei; Nakano, Atsushi; Fujita, Yoshiko; Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Vasc Physiol, Suita, Osaka, Japan; [Kakino, Akemi; Sawamura, Tatsuya] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Pathophysiol, Suita, Osaka 5650871, Japan; [Kakino, Akemi; Takeshita, Hikari; Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Asahi, Matsumo, Japan; [Nakagami, Hironori] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka 5650871, Japan; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University; Shinshu University; Osaka University; University of California System; University of California San Francisco	Yamamoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kyamamoto@geriat.med.osaka-u.ac.jp; ohishi@geriat.med.osaka-u.ac.jp	Sawamura, Tatsuya/E-7103-2010; Nakagami, Hironori/GLU-0570-2022; Takeshita, Hikari/L-9812-2014	Nakagami, Hironori/0000-0003-4494-3601; Takami, Yoichi/0000-0001-9018-6707; Rakugi, Hiromi/0000-0001-6508-4338; Yamamoto, Koichi/0000-0003-0107-9315	Kanae Foundation for the Promotion of Medical Science;  [23591102]; Grants-in-Aid for Scientific Research [15K01309, 25670133, 24601021] Funding Source: KAKEN	Kanae Foundation for the Promotion of Medical Science; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are most grateful to Kazuko Iwasa, Takako Baba, Asami Ihara, Aiko Kikuchi, Zhong Chongxia, and Yuka Nakao (Osaka University) for their excellent technical assistance. The authors thank Dr. Takahito Inoue (Asubio Pharma) and Takashi Shimosato (Nissei Bilis) for their technical guidance of the vascular experiments. This work was supported by a Grant-in-Aid for Scientific Research (No. 23591102) and by Kanae Foundation for the Promotion of Medical Science. K.Y. conceived of the idea of the study, designed and performed experiments, and wrote the manuscript. T.S. designed and performed experiments and helped with writing the manuscript with A.K., L.L., A.N., and Y.F. H.T. performed animal experiments. N.H., H.H.-Y., Y.I., S.T.-Y., C.N., T.K., M.T., K.H., R.O., Y.M., N.I., Y. Takami, M. Onishi, Y. Takeya, and K.S. performed experiments. K. K., H.N., M. Ohishi, and H.R. designed experiments. T.W.K. assisted with interpretation of the results and editing of the manuscript.	Aoyama T, 1999, BIOCHEM J, V339, P177, DOI 10.1042/0264-6021:3390177; Auge N, 2002, ARTERIOSCL THROM VAS, V22, P1990, DOI 10.1161/01.ATV.0000043453.21629.3B; Babnigg G, 2003, J BIOL CHEM, V278, P14872, DOI 10.1074/jbc.M210418200; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Erb L, 2001, J CELL BIOL, V153, P491, DOI 10.1083/jcb.153.3.491; Fujita Y, 2009, CLIN CHEM, V55, P285, DOI 10.1373/clinchem.2008.119750; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Haendeler J, 2000, CIRC RES, V86, P729, DOI 10.1161/01.RES.86.7.729; Heinloth A, 2000, J AM SOC NEPHROL, V11, P1819, DOI 10.1681/ASN.V11101819; Hernanz-Falcon P, 2001, IMMUNOGENETICS, V53, P288, DOI 10.1007/s002510100326; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Iwamoto S, 2011, J ATHEROSCLER THROMB, V18, P818, DOI 10.5551/jat.9142; Jing Q, 1999, CIRC RES, V84, P831; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Lanctot PM, 2005, BIOCHEM J, V390, P367, DOI 10.1042/BJ20050189; Li DY, 2000, CIRCULATION, V102, P1970, DOI 10.1161/01.CIR.102.16.1970; Li DY, 2000, ARTERIOSCL THROM VAS, V20, P1116, DOI 10.1161/01.ATV.20.4.1116; Li DY, 2003, CIRCULATION, V107, P612, DOI 10.1161/01.CIR.0000047276.52039.FB; Maziere C, 1999, FEBS LETT, V448, P49, DOI 10.1016/S0014-5793(99)00324-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Morawietz H, 1999, CIRCULATION, V100, P899, DOI 10.1161/01.CIR.100.9.899; Nakano A, 2010, J HYPERTENS, V28, P1273, DOI 10.1097/HJH.0b013e32833835d4; Nickenig G, 2002, CIRCULATION, V105, P393, DOI 10.1161/hc0302.102618; Nickenig G, 2002, CIRCULATION, V105, P530, DOI 10.1161/hc0402.102619; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Suc I, 1998, FASEB J, V12, P665, DOI 10.1096/fasebj.12.9.665; Tanigawa H, 2006, HYPERTENSION, V48, P294, DOI 10.1161/01.HYP.0000229825.98545.5e; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Wang XW, 2014, CARDIOVASC DRUG THER, V28, P441, DOI 10.1007/s10557-014-6541-x; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; WEISSER B, 1992, ARTERIOSCLER THROMB, V12, P231, DOI 10.1161/01.ATV.12.2.231; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Zhang M, 2000, J BIOL CHEM, V275, P15782, DOI 10.1074/jbc.M000198200; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	51	35	37	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3342	3356		10.1096/fj.15-271627	http://dx.doi.org/10.1096/fj.15-271627			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25877213				2022-12-28	WOS:000358796900022
J	Ordonez, A; Perez, J; Tan, L; Dickens, JA; Motamedi-Shad, N; Irving, JA; Haq, I; Ekeowa, U; Marciniak, SJ; Miranda, E; Lomas, DA				Ordonez, Adriana; Perez, Juan; Tan, Lu; Dickens, Jennifer A.; Motamedi-Shad, Neda; Irving, James A.; Haq, Imran; Ekeowa, Ugo; Marciniak, Stefan J.; Miranda, Elena; Lomas, David A.			A single-chain variable fragment intrabody prevents intracellular polymerization of Z alpha(1)-antitrypsin while allowing its antiproteinase activity	FASEB JOURNAL			English	Article						monoclonal antibody; scFv intrabody; serpin polymer; liver disease	ENDOPLASMIC-RETICULUM; SERPIN POLYMERIZATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CAUSE DEMENTIA; PRION PROTEIN; DEFICIENCY; LIVER; DISEASE; ACCUMULATION	Mutant Z alpha(1)-antitrypsin (E342K) accumulates as polymers within the endoplasmic reticulum (ER) of hepatocytes predisposing to liver disease, whereas low levels of circulating Z alpha(1)-antitrypsin lead to emphysema by loss of inhibition of neutrophil elastase. The ideal therapy should prevent polymer formation while preserving inhibitory activity. Here we used mAb technology to identify interactors with Z alpha(1)-antitrypsin that comply with both requirements. We report the generation of an mAb (4B12) that blocked alpha(1)-antitrypsin polymerization in vitro at a 1:1 molar ratio, causing a small increase of the stoichiometry of inhibition for neutrophil elastase. Asingle-chain variable fragment (scFv) intrabody was generated based on the sequence of mAb4B12. The expression of scFv4B12 within the ER (scFv4B12(KDEL)) and along the secretory pathway (scFv4B12) reduced the intracellular polymerization of Z alpha(1)-antitrypsin by 60%. The scFv4B12 intrabody also increased the secretion of Z alpha(1)-antitrypsin that retained inhibitory activity against neutrophil elastase. MAb4B12 recognizeda discontinuous epitope probably located in the region of helices A/C/G/H/I and seems to act by altering protein dynamics rather than binding preferentially to the native state. This novel approach could reveal new target sites for small-molecule intervention that may block the transition to aberrant polymers without compromising the inhibitory activity of Z alpha(1)-antitrypsin.	[Ordonez, Adriana; Tan, Lu; Dickens, Jennifer A.; Ekeowa, Ugo; Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Perez, Juan] Univ Malaga, Dept Cell Biol Genet & Physiol, E-29071 Malaga, Spain; [Motamedi-Shad, Neda; Irving, James A.; Haq, Imran; Lomas, David A.] UCL, Wolfson Inst Biomed Res, London, England; [Miranda, Elena] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Dept Biol & Biotechnol, I-00185 Rome, Italy; [Miranda, Elena] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy	University of Cambridge; Universidad de Malaga; University of London; University College London; Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Miranda, E (corresponding author), Univ Roma La Sapienza, Cenci Bolognetti Fdn, Dept Biol & Biotechnol, Ple Aldo Moro 5, I-00185 Rome, Italy.	mariaelena.mirandabanos@uniroma1.it; d.lomas@ucl.ac.uk	Irving, James A/I-8467-2015; Irving, James/P-3860-2019	Irving, James/0000-0003-3204-6356; Marciniak, Stefan/0000-0001-8472-7183	Medical Research Council (MRC; United Kingdom); Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre; Sackler Studentship; Federation of European Biochemical Studies fellowship; Marie Curie fellowship; GlaxoSmithKline; Alpha1 Foundation; MRC [G1002610]; Pasteur Institute-Cenci Bolognetti Foundation; Telethon Foundation [GGP11057B]; NIHR University College London Hospitals Biomedical Research Centre; MRC [G0901786, G0601840, G1000277] Funding Source: UKRI; Medical Research Council [G0901786, G1000277, G0601840, G1002610] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10070] Funding Source: researchfish	Medical Research Council (MRC; United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Sackler Studentship; Federation of European Biochemical Studies fellowship; Marie Curie fellowship(European Commission); GlaxoSmithKline(GlaxoSmithKline); Alpha1 Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pasteur Institute-Cenci Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Telethon Foundation(Fondazione Telethon); NIHR University College London Hospitals Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	A.O. and J.A.I. are funded by the Medical Research Council (MRC; United Kingdom). L.T. is supported by the Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre. J.A.D. is an MRC Clinical Training Fellow and the recipient of a Sackler Studentship. N.M.-S. is supported by Federation of European Biochemical Studies and Marie Curie fellowships. I.H. is funded by GlaxoSmithKline. S.J.M. is an MRC Senior Clinical Fellow. This work was supported by the Alpha1 Foundation (Pilot and Feasibility Grant 2010 to D.A.L., E.M., and J.P.), the MRC (to D.A.L. and G1002610 to S.J.M.), the Pasteur Institute-Cenci Bolognetti Foundation and the Telethon Foundation (Grant GGP11057B to E.M.), and the NIHR University College London Hospitals Biomedical Research Centre (to D.A.L.). E.M. and D.A.L. share senior authorship of this article. The authors declare no conflicts of interest.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; BIOCCA S, 1995, TRENDS CELL BIOL, V5, P248, DOI 10.1016/S0962-8924(00)89019-4; Boldicke T, 2007, J CELL MOL MED, V11, P54, DOI 10.1111/j.1582-4934.2007.00002.x; Boldicke T, 2012, METHODS, V56, P338, DOI 10.1016/j.ymeth.2011.10.008; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brocks B, 1997, IMMUNOTECHNOLOGY, V3, P173, DOI 10.1016/S1380-2933(97)00011-0; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cardinale A, 2005, J BIOL CHEM, V280, P685, DOI 10.1074/jbc.M407360200; Cardinale A, 2008, TRENDS MOL MED, V14, P373, DOI 10.1016/j.molmed.2008.07.004; Cardinale A, 2008, CURR MOL MED, V8, P2; Cardinale Alessio, 2013, Int J Cell Biol, V2013, P710406, DOI 10.1155/2013/710406; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Chang YP, 2006, AM J RESP CELL MOL, V35, P540, DOI 10.1165/rcmb.2005-0207OC; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Devlin GL, 2001, AM J RESP CELL MOL, V24, P727, DOI 10.1165/ajrcmb.24.6.4407; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; Filesi I, 2007, J NEUROCHEM, V101, P1516, DOI 10.1111/j.1471-4159.2006.04439.x; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Fra AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038405; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mahadeva R, 2002, J BIOL CHEM, V277, P6771, DOI 10.1074/jbc.C100722200; Mallyat M, 2007, J MED CHEM, V50, P5357, DOI 10.1021/jm070687z; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Sharp LK, 2006, FEBS J, V273, P2540, DOI 10.1111/j.1742-4658.2006.05262.x; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Ulrich Henning, 2005, Med Chem, V1, P199; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wooddell CI, 2008, J GENE MED, V10, P551, DOI 10.1002/jgm.1179; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078	48	35	39	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2667	2678		10.1096/fj.14-267351	http://dx.doi.org/10.1096/fj.14-267351			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757566	Green Published, hybrid			2022-12-28	WOS:000355209500041
J	Heinrich, A; Haarmann, H; Zahradnik, S; Frenzel, K; Schreiber, F; Klassert, TE; Heyl, KA; Endres, AS; Schmidtke, M; Hofmann, J; Slevogt, H				Heinrich, Annina; Haarmann, Helge; Zahradnik, Sabrina; Frenzel, Katrin; Schreiber, Frauke; Klassert, Tilman E.; Heyl, Kerstin A.; Endres, Anne-Sophie; Schmidtke, Michaela; Hofmann, Joerg; Slevogt, Hortense			Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells	FASEB JOURNAL			English	Article						bacterial colonization; viral infection; lung cancer; COPD; tumor suppressor	TOLL-LIKE RECEPTOR-3; INFLAMMATORY RESPONSE; RHINOVIRAL INFECTION; VIRAL-INFECTION; EXPRESSION; ASTHMA; DEFICIENT; BACTERIAL; DISEASE; COPD	Chronic obstructive pulmonary disease (COPD) is complicated by infectious exacerbations with acute worsening of respiratory symptoms. Coinfections of bacterial and viral pathogens are associated with more severe exacerbations. Moraxella catarrhalis is one of the most frequent lower respiratory tract pathogens detected in COPD. We therefore studied the impact of M. catarrhalis on the antiviral innate immune response that is mediated via TLR3 and p53. Molecular interactions between M. catarrhalis and normal human bronchial epithelial (NHBE) cells as well as Beas-2B cells were studied using flow cytometry, quantitative PCR analysis, chromatin immunoprecipitation, RNA interference, and ELISA. M. catarrhalis induces a significant down-regulation of TLR3 in human bronchial epithelial cells. In M. catarrhalis-infected cells, expression of p53 was decreased. We detected a reduced binding of p53 to the tlr3 promoter, resulting in reduced TLR3 gene transcription. M. catarrhalis diminished the TLR3-dependent secretion of IFN-, IFN-, and chemokine (C-X-C motif) ligand 8. In addition in M. catarrhalis infected cells, expression of rhinovirus type 1A RNA was increased compared with uninfected cells. M. catarrhalis reduces antiviral defense functions of bronchial epithelial cells, which may increase susceptibility to viral infections.Heinrich, A., Haarmann, H., Zahradnik, S., Frenzel, K., Schreiber, F., Klassert, T. E., Heyl, K. A., Endres, A.-S., Schmidtke, M., Hofmann, J., Slevogt, H. Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells.	[Heinrich, Annina; Schreiber, Frauke; Klassert, Tilman E.; Heyl, Kerstin A.; Slevogt, Hortense] Jena Univ Hosp, Sch Med, Sept Res Ctr, Jena, Germany; [Schmidtke, Michaela] Jena Univ Hosp, Sch Med, Dept Virol & Antiviral Therapy, Jena, Germany; [Haarmann, Helge] Univ Med Ctr Gottingen, Clin Cardiol & Pneumol, Gottingen, Germany; [Zahradnik, Sabrina] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Frenzel, Katrin; Hofmann, Joerg] Charite, Inst Med Virol, D-13353 Berlin, Germany; [Endres, Anne-Sophie] Evangel Geriatriezentum Berlin, Berlin, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Slevogt, H (corresponding author), Univ Hosp Jena, ZIK Sept, Host Sept, Albert Einstein Str 10, D-07745 Jena, Germany.	hortense.slevogt@med.uni-jena.de		Heyl, Kerstin/0000-0001-9659-2300; Hofmann, Joerg/0000-0003-3966-515X	German Respiratory Society; Federal Ministry for Education and Science [BMBF 03Z2JN22]	German Respiratory Society; Federal Ministry for Education and Science	This study was supported by the German Respiratory Society and by the Federal Ministry for Education and Science (BMBF 03Z2JN22) ( both to H.S.). The authors declare no conflict of interest.	Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frenzel K, 2012, MED MICROBIOL IMMUN, V201, P277, DOI 10.1007/s00430-012-0229-2; George SN, 2014, EUR RESPIR J, V44, P87, DOI 10.1183/09031936.00223113; Gielen V, 2015, J ALLERGY CLIN IMMUN, V136, P177, DOI 10.1016/j.jaci.2014.11.039; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Gulraiz F, 2015, FASEB J, V29, P849, DOI 10.1096/fj.14-254359; Gutbier B, 2015, AM J PHYSIOL-LUNG C, V309, pL250, DOI 10.1152/ajplung.00265.2014; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Matsumoto K, 2014, RESPIR INVESTIG, V52, P92, DOI 10.1016/j.resinv.2013.08.005; McManus TE, 2008, RESP MED, V102, P1575, DOI 10.1016/j.rmed.2008.06.006; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Pan ZK, 2011, INT IMMUNOL, V23, P357, DOI 10.1093/intimm/dxr019; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Parker LC, 2014, CLIN EXP ALLERGY, V44, P20, DOI 10.1111/cea.12182; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Sajjan US, 2006, FASEB J, V20, P2121, DOI 10.1096/fj.06-5806fje; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sethi Sanjay, 2008, N Engl J Med, V359, P2355, DOI 10.1056/NEJMra0800353; Singer BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094106; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Slevogt H, 2006, AM J PHYSIOL-LUNG C, V290, pL818, DOI 10.1152/ajplung.00428.2005; Slevogt H, 2006, MED MICROBIOL IMMUN, V195, P73, DOI 10.1007/s00430-005-0003-9; Spaniol V, 2008, MICROBES INFECT, V10, P3, DOI 10.1016/j.micinf.2007.09.014; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Thibaut H. J., 2015, REV MED VIROL; Vareille M, 2012, THORAX, V67, P517, DOI 10.1136/thoraxjnl-2011-200405; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2013, RESPIROLOGY, V18, P996, DOI 10.1111/resp.12099; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; World Health Organization, 2016, CHRON RESP DIS CHRON; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Zaika AI, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005099; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	46	13	13	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2426	2434		10.1096/fj.201500172R	http://dx.doi.org/10.1096/fj.201500172R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26979086				2022-12-28	WOS:000376878300030
J	Hofer, J; Forster, F; Isenman, DE; Wahrmann, M; Leitner, J; Holzl, MA; Kovarik, JJ; Stockinger, H; Bohmig, GA; Steinberger, P; Zlabinger, GJ				Hofer, Johannes; Forster, Florian; Isenman, David E.; Wahrmann, Markus; Leitner, Judith; Hoelzl, Markus A.; Kovarik, Johannes J.; Stockinger, Hannes; Boehmig, Georg A.; Steinberger, Peter; Zlabinger, Gerhard J.			Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d	FASEB JOURNAL			English	Article						homeostasis; autoimmunity; scavenger receptor; complement receptor; antibody-mediated rejection	IMMUNOGLOBULIN-LIKE RECEPTORS; RAY CRYSTAL-STRUCTURE; CELLS; ACTIVATION; DISEASE; BINDING; FAMILY; DEPOSITION; COMPONENTS; REJECTION	Complement regulation leads to the generation of complement split products (CSPs) such as complement component (C)4d, a marker for disease activity in autoimmune syndromes or antibody-mediated allograft rejection. However, the physiologic role of C4d has been unknown. By screening murine thymoma BW5147 cells expressing a cDNA library generated from human monocyte-derived dendritic cells with recombinant human C4d, we identified Ig-like transcript (ILT)4 and ILT5v2 as cellular receptors for C4d. Both receptors, expressed on monocytes, macrophages, and dendritic cells, also interacted with the CSPs C3d, C4b, C3b, and iC3b. However, C4d did not bind to classic complement receptors (CRs). Interaction between cell surface-resident ILT4 and soluble monomeric C4d resulted in endocytosis of C4d. Surprisingly, binding of soluble ILT4 to C4d covalently immobilized to a cellular surface following classic complement activation could not be detected. Remarkably, C4d immobilized to a solid phase via its intrinsic thioester conferred a dose-dependent inhibition of TNF-alpha and IL-6 secretion in monocytes activated via Fc-cross-linking of up to 50% as compared to baseline. Similarly, C4d conferred an attenuation of intracellular Ca2+ flux in monocytes activated via Fc-cross-linking. In conclusion, ILT4 represents a scavenger-type endocytotic CR for soluble monomeric C4d, whereas attenuation of monocyte activation by physiologically oriented C4d on a surface appears to be dependent on a yet to be identified C4d receptor.-Hofer, J., Forster, F., Isenman, D. E., Wahrmann, M., Leitner, J., Holzl, M. A., Kovarik, J. K., Stockinger, H., Bohmig, G. A., Steinberger, P., Zlabinger, G. J. Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d. FASEB J. 30, 1492-1503 (2016). www.fasebj.org	[Hofer, Johannes; Hoelzl, Markus A.; Kovarik, Johannes J.; Zlabinger, Gerhard J.] Med Univ Vienna, Div Clin Expt Immunol, Vienna, Austria; [Leitner, Judith; Steinberger, Peter] Med Univ Vienna, Div Immune Receptors & T Cell Activat, Inst Immunol, Vienna, Austria; [Forster, Florian; Stockinger, Hannes] Med Univ Vienna, Mol Immunol Unit, Inst Hyg & Appl Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Hofer, Johannes; Wahrmann, Markus; Kovarik, Johannes J.; Boehmig, Georg A.] Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Isenman, David E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Hoelzl, Markus A.] Columbia Univ, Coll Phys & Surg, Columbia Ctr Translat Immunol, Dept Med Surg & Microbiol Immunol, New York, NY USA	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Toronto; University of Toronto; Columbia University	Steinberger, P; Zlabinger, GJ (corresponding author), Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	peter.steinberger@meduniwien.ac.at; gerhard.zlabinger@meduniwien.ac.at	Stockinger, Hannes/E-5173-2011	Stockinger, Hannes/0000-0001-6404-4430; Steinberger, Peter/0000-0001-6848-4097; Wahrmann, Markus/0000-0002-1301-8694; Zlabinger, Gerhard/0000-0002-7478-4173; Kovarik, Johannes/0000-0002-0206-082X; Leitner, Judith/0000-0002-7156-1759	Else-Kroner-Fresenius Stiftung [P07/08//A88/07]; Jubilaumsfonds der Osterreichischen Nationalbank [10521]; Fonds zur Forderung der Wissenschaftlichen Forschung/Austrian Science Fund [21964-B20]; Austrian Science Fund (FWF) [P 21964] Funding Source: researchfish	Else-Kroner-Fresenius Stiftung; Jubilaumsfonds der Osterreichischen Nationalbank; Fonds zur Forderung der Wissenschaftlichen Forschung/Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank Margarethe Merio and Claus Wenhart (Institute of Immunology, Medical University of Vienna) for excellent technical assistance. The authors also thank Gunther Hofbauer (Core Unit Cell Sorting, Medical University of Vienna), as well as Dieter Printz (St. Anna Children's Cancer Research Institute, Vienna, Austria) for cell sorting. This project was supported by grants from the Else-Kroner-Fresenius Stiftung (Project Number P07/08//A88/07; to G.J.Z. and J.H.), Jubilaumsfonds der Osterreichischen Nationalbank (Project Number 10521; to G.A.B.), and the Fonds zur Forderung der Wissenschaftlichen Forschung/Austrian Science Fund (Project Number 21964-B20; to P.S., J.H., F.F., D.E.I., M.W., J.L., MA.H., J.J.K., GAB., P.S., GJ.Z.), who with Margarethe Merio are mentioned as inventors regarding the New European patent application on "Complement split product C4d for the treatment of inflammatory conditions" filed by the Medical University of Vienna at the European Patent Office (Application Number: EP12174644.0). J.H., P.S., and G.J.Z. conceived and designed experiments; J.H. performed most experiments; F.F. participated in Ca<SUP>2+</SUP> flux and Western blot experiments; D.E.I. generated recombinant complement split products; M.W. generated C4d from human plasma; P.S. and J.L. performed experiments; JJ.K. and M.A.H. participated in experiments; F.F., D.E.I., M.W., G.A.B., J.L., M.A.H., J.J.K., and H.S. analyzed data, provided suggestions, and critically reviewed the manuscript; and J.H., P.S., and GJ.Z. analyzed data and wrote the paper. The authors declare no conflicts of interest.	Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; Clemenza L, 2004, J IMMUNOL, V172, P1670, DOI 10.4049/jimmunol.172.3.1670; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1998, J IMMUNOL, V160, P3096; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gullstrand B, 2009, CLIN EXP IMMUNOL, V156, P303, DOI 10.1111/j.1365-2249.2009.03896.x; Haas M, 2009, J AM SOC NEPHROL, V20, P197, DOI 10.1681/ASN.2008030279; Holzl MA, 2011, CELL IMMUNOL, V267, P88, DOI 10.1016/j.cellimm.2010.12.001; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Kao AH, 2010, ARTHRITIS RHEUM-US, V62, P837, DOI 10.1002/art.27267; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kober J, 2008, EUR J IMMUNOL, V38, P2678, DOI 10.1002/eji.200838250; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; LAW SK, 1980, J IMMUNOL, V125, P634; Leitner J, 2010, J IMMUNOL METHODS, V362, P131, DOI 10.1016/j.jim.2010.09.020; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Liu CC, 2009, CTS-CLIN TRANSL SCI, V2, P300, DOI 10.1111/j.1752-8062.2009.00135.x; Munoz LE, 2010, AUTOIMMUNITY, V43, P232, DOI 10.3109/08916930903510930; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Pfistershammer K, 2009, BLOOD, V114, P2323, DOI 10.1182/blood-2008-10-183814; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ristich V, 2007, HUM IMMUNOL, V68, P264, DOI 10.1016/j.humimm.2006.11.008; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; van den Elsen JMH, 2002, J MOL BIOL, V322, P1103, DOI 10.1016/S0022-2836(02)00854-9; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang ZH, 2005, LANCET, V366, P556, DOI 10.1016/S0140-6736(05)67099-7; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	39	15	17	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1492	1503		10.1096/fj.15-275594	http://dx.doi.org/10.1096/fj.15-275594			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26678451				2022-12-28	WOS:000372629100011
J	Tie, K; Zhang, XR; Tan, Y; Deng, Y; Li, J; Ni, QB; Wang, H; Chen, LB				Tie, Kai; Zhang, Xianrong; Tan, Yang; Deng, Yu; Li, Jing; Ni, Qubo; Wang, Hui; Chen, Liaobin			Intrauterine low-functional programming of IGF1 by prenatal nicotine exposure mediates the susceptibility to osteoarthritis in female adult rat offspring	FASEB JOURNAL			English	Article						articular cartilage; glucocorticoid; extracellular matrix; Sox9	GROWTH-PLATE CHONDROCYTES; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; FACTOR-I; ACETYLCHOLINE-RECEPTOR; DEVELOPMENTAL ORIGINS; ARTICULAR-CARTILAGE; SIGNALING PATHWAY; MATRIX SYNTHESIS; SKELETAL GROWTH	This study aimed to evaluate whether female adult offspring born with intrauterine growth retardation inducedby prenatal nicotine exposure (PNE) are susceptible to osteoarthritis (OA) and to explore the underlying programming mechanisms. Pregnant rats were treated with nicotine or saline at 2.0 mg/kg/d from gestational d 11 to 20. The female adult offspring with or without PNE were forced with a strenuous treadmill running for 6 wk to induce OA. Nicotine's effects on fetal articular chondrocytes were studied by exposing chondrocytes to nicotine for 10 d, and dihydro-beta-erythroidine, a selective alpha 4b2-nicotinic acetylcholine receptor (nAChR) inhibitor, was used to identify the change of nicotine's effect. For adult offspring, increased cartilage destruction and accelerated OA progression were observed in the PNE group with running; the expression of alpha 1 chain of type II collagen(Col2A1), aggrecan, SRY-type highmobility group box 9 (Sox9), and IGF1 signaling molecules in the cartilage of PNE offspring were decreased. For fetuses, elevated serum corticosteroid and nicotine levels and suppressed IGF1 levels were observed; expression of Col2A1, aggrecan, Sox9, and IGF1 were reduced. The result of chondrocytes revealed that nicotine impeded the expression of Col2A1, aggrecan, and IGF1; blocking alpha 4 beta 2-nAChR rescued nicotine's suppression. In conclusion, PNE increases the susceptibility of adult offspring to OA; the potential mechanism involves IGF1 low-functional programming in articular cartilage caused directly by the action of nicotine on alpha 4 beta 2-nAChR.	[Tie, Kai; Tan, Yang; Deng, Yu; Ni, Qubo; Chen, Liaobin] Wuhan Univ, Zhongnan Hosp, Dept Orthopaed Surg, Wuhan 430071, Peoples R China; [Zhang, Xianrong] Wuhan Univ, Basic Med Sch, Dept Physiol, Wuhan 430072, Peoples R China; [Li, Jing; Wang, Hui] Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430071, Peoples R China; [Zhang, Xianrong; Wang, Hui] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Chen, LB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthopaed Surg, Wuhan 430071, Peoples R China.; Wang, H (corresponding author), Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430071, Peoples R China.	wanghui19@whu.edu.cn; lbchen@whu.edu.cn			National Natural Science Foundation of China [81220108026, 81430089, 81371940]; Key Grant Project and Specialized Research Fund for the Doctoral Program of the Chinese Ministry of Education [20130141110037]; National Science and Technology Pillar Program of China [2013BAI12B01-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Grant Project and Specialized Research Fund for the Doctoral Program of the Chinese Ministry of Education; National Science and Technology Pillar Program of China	The authors are grateful to staff of the Center for Animal Experiment of Wuhan University. Special thanks to L. Ma for statistical analyses and to Dr. Charles Vincent Smith for critical revision of this manuscript and comment. This work was supported by grants from the National Natural Science Foundation of China (81220108026, 81430089, and 81371940), the Key Grant Project and Specialized Research Fund for the Doctoral Program of the Chinese Ministry of Education (20130141110037), and the National Science and Technology Pillar Program of China (2013BAI12B01-3).	Agrogiannis GD, 2014, MOL MED REP, V10, P579, DOI 10.3892/mmr.2014.2258; Ameye LG, 2006, CURR OPIN RHEUMATOL, V18, P537, DOI 10.1097/01.bor.0000240369.39713.af; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; BHATNAGAR R, 1981, CAN J COMP MED, V45, P188; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; Clynes MA, 2014, J DEV ORIG HLTH DIS, V5, P453, DOI 10.1017/S2040174414000373; Dantzer B, 2012, BIOL REV, V87, P414, DOI 10.1111/j.1469-185X.2011.00204.x; Decker RS, 2014, MATRIX BIOL, V39, P5, DOI 10.1016/j.matbio.2014.08.006; Deng Y, 2013, TOXICOL APPL PHARM, V269, P25, DOI 10.1016/j.taap.2013.02.008; Deng Y, 2012, BIO-MED MATER ENG, V22, P81, DOI 10.3233/BME-2012-0692; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; Fall CHD, 2013, INDIAN J PEDIATR, V80, pS13, DOI 10.1007/s12098-012-0834-5; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; Fernandez-Cancio M, 2008, GROWTH HORM IGF RES, V18, P497, DOI 10.1016/j.ghir.2008.04.004; Da Silveira VMF, 2008, REV SAUDE PUBL, V42, P10, DOI 10.1590/S0034-89102008000100002; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; HARDICK DJ, 1995, FEBS LETT, V365, P79, DOI 10.1016/0014-5793(95)00426-A; Hardingham TE, 2006, J ANAT, V209, P469, DOI 10.1111/j.1469-7580.2006.00630.x; Hoogduijn MJ, 2009, STEM CELLS DEV, V18, P103, DOI 10.1089/scd.2008.0032; Hussain SM, 2015, ARTHRIT CARE RES, V67, P502, DOI 10.1002/acr.22475; Ishiguro Naoki, 2002, Nagoya J Med Sci, V65, P73; Jenniskens YM, 2006, OSTEOARTHR CARTILAGE, V14, P1136, DOI 10.1016/j.joca.2006.04.002; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kawakita A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003945; Kiepe D, 2005, ENDOCRINOLOGY, V146, P3096, DOI 10.1210/en.2005-0324; Klammt J, 2008, TRENDS ENDOCRIN MET, V19, P197, DOI 10.1016/j.tem.2008.03.003; Klaus G, 2000, PEDIATR NEPHROL, V14, P612, DOI 10.1007/s004670000344; Lam CSP, 2010, ARTERIOSCL THROM VAS, V30, P1479, DOI 10.1161/ATVBAHA.110.203943; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Maissadeh AM, 2009, J CHROMATOGR SCI, V47, P170, DOI 10.1093/chromsci/47.2.170; MANKIN HJ, 1981, J BONE JOINT SURG AM, V63, P131, DOI 10.2106/00004623-198163010-00017; McNeil CJ, 2007, REPRODUCTION, V133, P653, DOI 10.1530/rep.1.01198; Messai H, 2000, MECH AGEING DEV, V115, P21, DOI 10.1016/S0047-6374(00)00107-X; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Pfaffle R, 2012, ENDOCR DEV, V23, P42, DOI 10.1159/000341745; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Sehested LT, 2014, DAN MED J, V61; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Snelling S, 2014, OSTEOARTHR CARTILAGE, V22, P334, DOI 10.1016/j.joca.2013.12.009; Song YW, 2012, RHEUMATOL INT, V32, P3669, DOI 10.1007/s00296-011-2091-8; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; STOCKWELL RA, 1967, J ANAT, V101, P753; Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007; Tang T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2363; Taslim N, 2008, NEUROSCIENCE, V157, P204, DOI 10.1016/j.neuroscience.2008.08.046; Tomaszewska E, 2013, J ANIM PHYSIOL AN N, V97, P785, DOI 10.1111/j.1439-0396.2012.01319.x; VIGNON E, 1976, CLIN ORTHOP RELAT R, P303; Wang TT, 2011, TOXICOL APPL PHARM, V257, P328, DOI 10.1016/j.taap.2011.09.016; Wieland HA, 2005, NAT REV DRUG DISCOV, V4, P331, DOI 10.1038/nrd1693; Xu D, 2012, TOXICOL LETT, V209, P282, DOI 10.1016/j.toxlet.2012.01.006	54	26	29	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					785	797		10.1096/fj.15-274399	http://dx.doi.org/10.1096/fj.15-274399			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26499267				2022-12-28	WOS:000369391900028
J	Killian, ML; Thomopoulos, S				Killian, Megan L.; Thomopoulos, Stavros			Scleraxis is required for the development of a functional tendon enthesis	FASEB JOURNAL			English	Article						attachment; musculoskeletal; postnatal; supraspinatus	TO-BONE INSERTION; ROTATOR CUFF; BRACHIAL-PLEXUS; EXPRESSION; ATTACHMENT; MATRIX; PROGENITORS; INTEGRITY; SITES; CELLS	The attachment of dissimilar materials is a major engineering challenge, yet this challenge is seemingly overcome in biology. This study aimed to determine how the transcription factor Scleraxis (Scx) influences the development and maturation of the tendon-to-bone attachment (enthesis). Mice with conditional knockout (cKO) for Scx (Scx(flx/-), Prx1Cre(+)) and wild-type [(WT) Scx(flx/+) or Scx(flx/flx/)] littermates were killed at postnatal days 7-56 (P7-P56). Enthesis morphometry, histology, and collagen alignment were investigated throughout postnatal growth. Enthesis tensile mechanical properties were also assessed. Laser microdissection of distinct musculoskeletal tissues was performed at P7 for WT, cKO, and muscle-unloaded (botulinum toxin A treated) attachments for quantitative PCR. cKO mice were smaller, with altered bone shape and impaired enthesis morphology, morphometry, and organization. Structural alterations led to altered mechanical properties; cKO entheses demonstrated reduced strength and stiffness. In P7 attachments, cKOmice had reduced expression of transforming growth factor (TGF) superfamily genes in fibrocartilage compared with WT mice. In conclusion, deletion of Scx led to impairments in enthesis structure, which translated into impairedfunctional (i.e., mechanical) outcomes. These changes may be driven by transient signaling cues from mechanical loading and growth factors.	[Killian, Megan L.; Thomopoulos, Stavros] Washington Univ, Dept Orthoped Surg, St Louis, MO USA	Washington University (WUSTL)	Thomopoulos, S (corresponding author), Columbia Univ, Dept Orthoped Surg, Black Bldg,Room 1408,650 W 168 St, New York, NY 10032 USA.	sat2@columbia.edu	Killian, Megan L./K-2442-2015	Killian, Megan L./0000-0001-6868-5550	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR055580, F32AR064652]; NIH [UL1-TR000448, P30-AR057235]; Children's Discovery Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR064652, P30AR057235, R01AR055580] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01-AR055580 and F32AR064652, NIH Training Grant UL1-TR000448 to the Washington University Institute of Clinical and Translational Sciences, NIH Grant P30-AR057235 to the Washington University Musculoskeletal Research Center, and the Children's Discovery Institute. Scx<SUP>flx</SUP> mice were provided by Dr. Ronen Schweitzer. Histology was performed by Crystal Idleburg (Washington University Musculoskeletal Research Center, St. Louis, MO, USA). The authors declare no conflicts of interest.	Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Biewener AA, 1996, BONE, V19, P1, DOI 10.1016/8756-3282(96)00116-0; Birman V., 2013, ADV MAT MODELLING ST, V19, P65; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Breidenbach AP, 2015, J ORTHOP RES, V33, P1142, DOI 10.1002/jor.22899; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Galatz L, 2007, J ORTHOP RES, V25, P1621, DOI 10.1002/jor.20441; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Habernek H, 1999, BRIT J SPORT MED, V33, P430, DOI 10.1136/bjsm.33.6.430; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982, DOI 10.2106/00004623-199173070-00004; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Jost B, 2006, J BONE JOINT SURG AM, V88A, P472, DOI 10.2106/JBJS.E.00003; Killian ML, 2013, J ORTHOP RES, V31, P1240, DOI 10.1002/jor.22345; Kim HM, 2010, J ORTHOP RES, V28, P1391, DOI 10.1002/jor.21128; Kim HM, 2009, J BONE JOINT SURG AM, V91A, P879, DOI 10.2106/JBJS.H.00088; Liu YX, 2012, MECH MATER, V44, P83, DOI 10.1016/j.mechmat.2011.08.005; Liu YX, 2011, J ENG MATER-T ASME, V133, DOI 10.1115/1.4002641; Liu YX, 2014, BIOMECH MODEL MECHAN, V13, P973, DOI 10.1007/s10237-013-0548-2; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Milz S, 2002, J ANAT, V200, P145, DOI 10.1046/j.0021-8782.2001.00016.x; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nakagaki WR, 2011, BONE, V48, P372, DOI 10.1016/j.bone.2010.09.011; Neri BR, 2009, J SHOULDER ELB SURG, V18, P808, DOI 10.1016/j.jse.2009.03.013; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Schwartz AG, 2015, DEVELOPMENT, V142, P196, DOI 10.1242/dev.112714; Schwartz AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048630; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Tatara AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097375; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Thomopoulos S, 2011, TISSUE ENG PT A, V17, P1039, DOI [10.1089/ten.tea.2009.0499, 10.1089/ten.TEA.2009.0499]; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Wang MN, 2013, J BONE MINER RES, V28, P598, DOI 10.1002/jbmr.1801; Zelzer E, 2014, BIRTH DEFECTS RES C, V102, P101, DOI 10.1002/bdrc.21056	45	43	44	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					301	311		10.1096/fj.14-258236	http://dx.doi.org/10.1096/fj.14-258236			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443819	Green Published			2022-12-28	WOS:000367621000029
J	Larsen, FJ; Schiffer, TA; Ortenblad, N; Zinner, C; Morales-Alamo, D; Willis, SJ; Calbet, JA; Holmberg, HC; Boushel, R				Larsen, Filip J.; Schiffer, Tomas A.; Ortenblad, Niels; Zinner, Christoph; Morales-Alamo, David; Willis, Sarah J.; Calbet, Jose A.; Holmberg, Hans-Christer; Boushel, Robert			High-intensity sprint training inhibits mitochondrial respiration through aconitase inactivation	FASEB JOURNAL			English	Article						exercise; mitochondrial dysfunction; reactive oxygen species; citrate	HUMAN SKELETAL-MUSCLE; OXYGEN-UPTAKE; REDOX REGULATION; VITAMIN-C; EXERCISE; HUMANS; METABOLISM; INCREASES; DEHYDROGENASE; CONTRACTION	Intense exercise training is a powerful stimulus that activates mitochondrial biogenesis pathways and thus increases mitochondrial density and oxidative capacity. Moderate levels of reactive oxygen species (ROS) during exercise are considered vital in the adaptive response, but high ROS production is a serious threat to cellular homeostasis. Although biochemical markers of the transition from adaptive to maladaptive ROS stress are lacking, it is likely mediated by redox sensitive enzymes involved in oxidative metabolism. One potential enzyme mediating such redox sensitivity is the citric acid cycle enzyme aconitase. In this study, we examined biopsy specimens of vastus lateralis and triceps brachii in healthy volunteers, together with primary human myotubes. An intense exercise regimen inactivated aconitase by 55-72%, resulting in inhibition of mitochondrial respiration by 50-65%. In the vastus, the mitochondrial dysfunction was compensated for by a 15-72% increase in mitochondrial proteins, whereas H2O2 emission was unchanged. In parallel with the inactivation of aconitase, the intermediary metabolite citrate accumulated and played an integral part in cellular protection against oxidative stress. In contrast, the triceps failed to increase mitochondrial density, and citrate did not accumulate. Instead, mitochondrial H2O2 emission was decreased to 40% of the pretraining levels, together with a 6-fold increase in protein abundance of catalase. In this study, a novel mitochondrial stress response was highlighted where accumulation of citrate acted to preserve the redox status of the cell during periods of intense exercise.	[Larsen, Filip J.; Schiffer, Tomas A.] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Larsen, Filip J.; Boushel, Robert] Swedish Sch Sport & Hlth Sci, Stockholm, Sweden; [Ortenblad, Niels] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Muscle Res Cluster, Odense, Denmark; [Zinner, Christoph; Willis, Sarah J.; Holmberg, Hans-Christer] Mid Sweden Univ, Swedish Winter Sports Res Ctr, Dept Hlth Sci, Ostersund, Sweden; [Zinner, Christoph] Univ Wurzburg, Dept Sport Sci, D-97070 Wurzburg, Germany; [Morales-Alamo, David; Calbet, Jose A.] Res Inst Biomed & Hlth Sci IUIBS, Las Palmas Gran Canaria, Canary Islands, Spain; [Boushel, Robert] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada	Karolinska Institutet; Swedish School of Sport & Health Sciences; University of Southern Denmark; Mid-Sweden University; University of Wurzburg; University of British Columbia	Larsen, FJ (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Nanna Svartzvag 2, SE-17177 Stockholm, Sweden.	filip.larsen@ki.se	Ortenblad, Niels/AAN-8713-2021; Morales-Alamo, David/D-2683-2009; Schiffer, Tomas/X-1343-2018; Boushel, Robert/ABD-7840-2021; Calbet, Jose A L/H-6693-2015	Ortenblad, Niels/0000-0001-9060-4139; Morales-Alamo, David/0000-0001-8463-397X; Schiffer, Tomas/0000-0002-9077-2682; Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885; Willis, Sarah/0000-0002-0150-3182; Holmberg, Hans-Christer/0000-0002-3814-6246	Swedish National Centre for Research in Sports	Swedish National Centre for Research in Sports	This study was funded by Swedish National Centre for Research in Sports. D.M.-A. is a fellow of the Dr. Manuel Morales Foundation. The authors declare no conflicts of interest.	Andersson U, 1998, BIOCHEM BIOPH RES CO, V249, P512, DOI 10.1006/bbrc.1998.9171; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Blomstrand E, 1997, J PHYSIOL-LONDON, V501, P455, DOI 10.1111/j.1469-7793.1997.455bn.x; Boushel R, 2014, ACTA PHYSIOL, V211, P122, DOI 10.1111/apha.12258; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Brink-Elfegoun T, 2007, J APPL PHYSIOL, V102, P781, DOI 10.1152/japplphysiol.00566.2006; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cobley JN, 2015, FREE RADICAL BIO MED, V84, P65, DOI 10.1016/j.freeradbiomed.2015.03.018; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Ho KP, 2001, BIOCHEM BIOPH RES CO, V282, P264, DOI 10.1006/bbrc.2001.4536; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Hyzewicz J, 2015, FREE RADICAL BIO MED, V82, P122, DOI 10.1016/j.freeradbiomed.2015.01.023; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; JANSSON E, 1984, ACTA PHYSIOL SCAND, V122, P145, DOI 10.1111/j.1748-1716.1984.tb07492.x; Larsen FJ, 2011, FASEB J, V25, P2843, DOI 10.1096/fj.11-182139; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Narahari J, 2000, J BIOL CHEM, V275, P16227, DOI 10.1074/jbc.M910450199; Paulsen G, 2014, J PHYSIOL-LONDON, V592, P1887, DOI 10.1113/jphysiol.2013.267419; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Poole DC, 2008, MED SCI SPORT EXER, V40, P462, DOI [10.1249/mss.0b013e31815ef29b, 10.1249/MSS.0b013e31815ef29b]; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Sahlin K, 2010, J APPL PHYSIOL, V108, P780, DOI 10.1152/japplphysiol.00966.2009; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Skenderi KP, 2008, EUR J CLIN INVEST, V38, P159, DOI 10.1111/j.1365-2362.2007.01917.x; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P435, DOI 10.1046/j.1365-201X.1997.00233.x; Vina J, 2000, IUBMB LIFE, V49, P539; Westerblad H, 2011, ANTIOXID REDOX SIGN, V15, P2487, DOI 10.1089/ars.2011.3909; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1154, DOI 10.1152/ajpcell.00110.2007	35	48	49	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					417	427		10.1096/fj.15-276857	http://dx.doi.org/10.1096/fj.15-276857			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26452378	Green Submitted			2022-12-28	WOS:000367621000039
J	Wu, Q; Zhang, JJ; Koh, W; Yu, QM; Zhu, XJ; Amsterdam, A; Davis, GE; Arnaout, MA; Xiong, JW				Wu, Qing; Zhang, Jiaojiao; Koh, Wonshill; Yu, Qingming; Zhu, Xiaojun; Amsterdam, Adam; Davis, George E.; Arnaout, M. Amin; Xiong, Jing-Wei			Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish	FASEB JOURNAL			English	Article						tln1; itgb1b; cardiovascular development; cardiac sarcomere	DILATED CARDIOMYOPATHY; LUMEN FORMATION; BINDING DOMAIN; GENE; EXPRESSION; HEART; BETA-1-INTEGRIN; IDENTIFICATION; CONTRACTILITY; ACTIVATION	Talin (tln) binds and activates integrins to couple extracellular matrix-bound integrins to the cytoskeleton; however, its role in heart development is not well characterized. We identified the defective gene and the resulting cardiovascular phenotypes in zebrafish tln1(fl02k) mutants. The ethylnitrosourea-induced fl02k mutant showed heart failure, brain hemorrhage, and diminished cardiac and vessel lumens at 52 h post fertilization. Positional cloning revealed a nonsense mutation of tln1 in this mutant. tln1, but neither tln2 nor -2a, was dominantly expressed in the heart and vessels. Unlike tln1 and -2 in the mouse heart, the unique tln1 expression in the heart enabled us, for the first time, to determine the critical roles of Tln1 in the maintenance of cardiac sarcomeric Z-disks and endothelial/endocardial cell integrity, partly through regulating F-actin networks in zebrafish. The similar expression profiles of tln1 and integrin beta 1b (itgb1b) and synergistic function of the 2 genes revealed that itgb1b is a potential partner for tln1 in the stabilization of cardiac Z-disks and vessel lumens. Taken together, the results of this work suggest that Tln1-mediated Itg beta 1b plays a crucial role in maintaining cardiac sarcomeric Z-disks and endothelial/endocardial cell integrity in zebrafish and may also help to gain molecular insights into congenital heart diseases.	[Wu, Qing; Zhu, Xiaojun; Xiong, Jing-Wei] Peking Univ, Beijing Key Lab Cardiometab Mol Med, Beijing 100871, Peoples R China; [Wu, Qing] Peking Univ, Inst Mol Med, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Zhang, Jiaojiao; Yu, Qingming; Arnaout, M. Amin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nephrol,Dept Med, Boston, MA USA; [Koh, Wonshill; Davis, George E.] Univ Missouri, Sch Med, Dept Med Pharmacol, Columbia, MO USA; [Koh, Wonshill; Davis, George E.] Univ Missouri, Sch Med, Dept Physiol, Columbia, MO 65212 USA; [Amsterdam, Adam] MIT, Dept Biol, Cambridge, MA USA	Peking University; Peking University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Massachusetts Institute of Technology (MIT)	Xiong, JW (corresponding author), Peking Univ, Inst Mol Med, New Life Sci Bldg,Room 102, Beijing 100871, Peoples R China.	jingwei_xiong@pku.edu.cn			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Training Grant [T32-DK07540, DK088327, DK48549]; March of Dimes Birth Defects Foundation [1-FY2007-471]; Milton Fund from Harvard University; National Basic Research Program of China [2012CB944501, 2010CB529503]; National Natural Science Foundation of China [31430059, 81470399, 31221002, 31271549, 81270164]; NIH National Heart, Lung, and Blood Institute [HL59373]; NIH National Center for Research Resources Grant [RR012589]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012589] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549, R01DK088327, T32DK007540] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Training Grant; March of Dimes Birth Defects Foundation(March of Dimes); Milton Fund from Harvard University; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Center for Research Resources Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. W. Shou (Indiana University, Indianapolis, IN, USA) and members of the laboratory of J.-W.X. for providing critical comments on the manuscript, Dr. I. C. Bruce (Zhejiang University, Zheijang, China) for reading the manuscript, and Dr. Y. Hu (Peking University, Peking, China) for help with transmission electron microscopy. This work was funded by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Training Grant T32-DK07540 (to Q.Y.) and Grants DK088327 and DK48549 (to M.A.A.); March of Dimes Birth Defects Foundation Grant 1-FY2007-471 (to J.-W.X.); the Milton Fund from Harvard University (to J.-W.X.); the National Basic Research Program of China Grants 2012CB944501 and 2010CB529503 (to J.-W.X.); the National Natural Science Foundation of China Grants 31430059, 81470399, 31221002, 31271549, and 81270164 (to J.-W.X.); NIH National Heart, Lung, and Blood Institute Grant HL59373 (to G.E.D.); and NIH National Center for Research Resources Grant RR012589 (to M.A.A).	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; BELKIN AM, 1986, FEBS LETT, V200, P32, DOI 10.1016/0014-5793(86)80505-1; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Cheung TYS, 2009, J MOL BIOL, V387, P787, DOI 10.1016/j.jmb.2009.01.053; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Debrand E, 2012, BIOCHEM BIOPH RES CO, V426, P190, DOI 10.1016/j.bbrc.2012.08.061; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ellis SJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004756; Ellis SJ, 2011, J CELL SCI, V124, P1844, DOI 10.1242/jcs.083337; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Guan KM, 1999, EUR J CELL BIOL, V78, P813, DOI 10.1016/S0171-9335(99)80032-6; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Harston Rebecca K, 2011, J Signal Transduct, V2011, P521742, DOI 10.1155/2011/521742; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Knoll R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569628; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Krishnamurthy P, 2007, HYPERTENSION, V49, P865, DOI 10.1161/01.HYP.0000258703.36986.13; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Monkley SJ, 2011, DEV BIOL, V349, P494, DOI 10.1016/j.ydbio.2010.11.010; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Prout M, 1997, GENETICS, V146, P275; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shu XD, 2003, DEVELOPMENT, V130, P6165, DOI 10.1242/dev.00844; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; THISSE C, 1993, DEVELOPMENT, V119, P1203; TIDBALL JG, 1986, J CELL BIOL, V103, P1465, DOI 10.1083/jcb.103.4.1465; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xiao T, 2007, NAT NEUROSCI, V10, P1529, DOI 10.1038/nn2002; Yang JC, 2012, FASEB J, V26, P4230, DOI 10.1096/fj.12-207969; Zemljic-Harpf A, 2009, J INVEST MED, V57, P849, DOI 10.2310/JIM.0b013e3181c5e074; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400	65	17	17	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4989	5005		10.1096/fj.15-273409	http://dx.doi.org/10.1096/fj.15-273409			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26310270	Green Published			2022-12-28	WOS:000365523600024
J	Kassem, A; Henning, P; Kindlund, B; Lindholm, C; Lerner, UH				Kassem, Ali; Henning, Petra; Kindlund, Bert; Lindholm, Catharina; Lerner, Ulf H.			TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss	FASEB JOURNAL			English	Article						inflammation; Toll-like receptors; osteoclasts; bone resorption; flagellin	NF-KAPPA-B; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; TOLL; RESORPTION; RANKL; RECEPTORS; DIFFERENTIATION; STIMULATION; FLAGELLIN	Accumulating evidence points to the importance of the innate immune system in inflammation-induced bone loss in infectious and autoimmune diseases. TLRs are well known for being activated by ligands expressed by bacteria, viruses, and fungi. Recent findings indicate that also endogenous ligands in inflammatory processes are important, one being a TLR5 agonist present in synovial fluid from patients with rheumatoid arthritis (RA). We found that activation of TLR5 by its specific ligand, flagellin, caused robust osteoclast formation and bone loss in cultured mouse neonatal parietal bones dependent on increased receptor activator of NF-kappa B ligand (RANKL): osteoprotegerin ratio, with half-maximal stimulation at 0.01 mu g/ml. Flagellin enhanced Rankl mRNA in isolated osteoblasts by a myeloid differentiation primary response gene 88 and NF-kappa B-dependent mechanism. Injection of flagellin locally over skull bones in 5-wk-oldmice resulted in increased mRNA expression of Rankl and osteoclastic genes, robust osteoclast formation, and bone loss. The effects in vitro and in vivo were absent in Tlr5(-/-) mice. These data show that TLR5 is a novel activator of RANKL and osteoclast formation and, therefore, a potential key factor in inflammation-induced bone erosions in diseases like RA, reactive arthritis, and periodontitis. TLR5 might be a promising novel treatment target for prevention of inflammatory bone loss.	[Kassem, Ali; Lerner, Ulf H.] Umea Univ, Dept Mol Periodontol, S-90187 Umea, Sweden; [Henning, Petra; Kindlund, Bert; Lindholm, Catharina; Lerner, Ulf H.] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Lindholm, Catharina] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Umea University; University of Gothenburg; University of Gothenburg	Lerner, UH (corresponding author), Umea Univ, Dept Mol Periodontol, S-90187 Umea, Sweden.	ulf.lerner@umu.se		Kassem, Ali/0000-0002-1820-8518; Henning, Petra/0000-0002-9330-6265; Lerner, Ulf/0000-0002-3579-1960	Swedish Research Council; Swedish National Graduate School in Odontological Sciences; Swedish COMBINE (Vinnova) program; County Council of Vastra Gotaland (ALF/LUA; Gothenburg, Sweden); Lundberg Foundation; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V, County Council of Vasterbotten; Swedish Dental Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Graduate School in Odontological Sciences; Swedish COMBINE (Vinnova) program; County Council of Vastra Gotaland (ALF/LUA; Gothenburg, Sweden); Lundberg Foundation(European Commission); Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V, County Council of Vasterbotten; Swedish Dental Society	The authors are grateful for the skillful technical assistance by Mrs. Anita Lie, Mrs. Ingrid Bostrom, and Mrs. Inger Lundgren (Molecular Periodontology, Umea University, Umea, Sweden); and Ms. Anette Hansevi (Centre for Bone and Arthritis Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden). This study was supported by the Swedish Research Council, Swedish National Graduate School in Odontological Sciences, the Swedish COMBINE (Vinnova) program, the County Council of Vastra Gotaland (ALF/LUA; Gothenburg, Sweden), Lundberg Foundation, Swedish Rheumatism Association, Royal 80 Year Fund of King Gustav V, County Council of Vasterbotten, and Swedish Dental Society. The authors declare no conflicts of interest.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Beklen A, 2009, ORAL MICROBIOL IMMUN, V24, P38, DOI 10.1111/j.1399-302X.2008.00473.x; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chamberlain ND, 2012, J IMMUNOL, V189, P475, DOI 10.4049/jimmunol.1102977; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Granholm S, 2013, BONE, V52, P83, DOI 10.1016/j.bone.2012.09.019; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Ha H, 2008, J IMMUNOL, V180, P1382, DOI 10.4049/jimmunol.180.3.1382; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SJ, 2014, J IMMUNOL, V193, P3902, DOI 10.4049/jimmunol.1302998; Kim SJ, 2013, ARTHRITIS RHEUM-US, V65, P2024, DOI 10.1002/art.37992; Klingelhofer J, 2007, ARTHRITIS RHEUM-US, V56, P779, DOI 10.1002/art.22398; Koh JM, 2009, BONE, V45, P650, DOI 10.1016/j.bone.2009.06.007; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; LeirisaloRepo M, 1997, ANN RHEUM DIS, V56, P516, DOI 10.1136/ard.56.9.516; LERNER UH, 1987, J BONE MINER RES, V2, P375; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Mizel SB, 2002, J BIOL CHEM, V277, P22414, DOI 10.1074/jbc.M201762200; Nakamura H, 2008, ORAL MICROBIOL IMMUN, V23, P190, DOI 10.1111/j.1399-302X.2007.00410.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schwab AM, 2005, ENDOCRINOLOGY, V146, P4349, DOI 10.1210/en.2005-0601; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zhang X, 2004, INFECT IMMUN, V72, P7183, DOI 10.1128/IAI.72.12.7183-7189.2004; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	48	27	31	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4449	4460		10.1096/fj.15-272559	http://dx.doi.org/10.1096/fj.15-272559			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26207027				2022-12-28	WOS:000364514700006
J	Silver, MJ; Corbin, KD; Hellenthal, G; da Costa, KA; Dominguez-Salas, P; Moore, SE; Owen, J; Prentice, AM; Hennig, BJ; Zeisel, SH				Silver, Matt J.; Corbin, Karen D.; Hellenthal, Garrett; da Costa, Kerry-Ann; Dominguez-Salas, Paula; Moore, Sophie E.; Owen, Jennifer; Prentice, Andrew M.; Hennig, Branwen J.; Zeisel, Steven H.			Evidence for negative selection of gene variants that increase dependence on dietary choline in a Gambian cohort	FASEB JOURNAL			English	Article						diet and selection; adequate intake levels; phosphatidylethanolamine-N-methyltransferase; choline dehydrogenase; methylenetetrahydrofolate dehydrogenase	DNA METHYLATION; BETAINE; GENOME; FOLATE; RISK; POLYMORPHISMS; REQUIREMENT; DEFICIENCY; METABOLISM; NUTRITION	Choline is an essential nutrient, and the amount needed in the diet is modulated by several factors. Given geographical differences in dietary choline intake and disparate frequencies of single-nucleotide polymorphisms (SNPs) in choline metabolism genes between ethnic groups, we tested the hypothesis that 3 SNPs that increase dependence on dietary choline would be under negative selection pressure in settings where choline intake is low: choline dehydrogenase (CHDH) rs12676, methylenetetrahydrofolate reductase 1 (MTHFD1) rs2236225, and phosphatidylethanolamine-N-methyltransferase (PEMT) rs12325817. Evidence of negative selection was assessed in 2 populations: one in The Gambia, West Africa, where there is historic evidence of a choline-poor diet, and the other in the United States, with a comparatively choline-rich diet. We used 2 independent methods, and confirmation of our hypothesis was sought via a comparison with SNP data from the Maasai, an East African population with a genetic background similar to that of Gambians but with a traditional diet that is higher in choline. Our results show that frequencies of SNPs known to increase dependence on dietary choline are significantly reduced in the low-choline setting of The Gambia. Our findings suggest that adequate intake levels of choline may have to be reevaluated in different ethnic groups and highlight a possible approach for identifying novel functional SNPs under the influence of dietary selective pressure.	[Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Hennig, Branwen J.] Univ London London Sch Hyg & Trop Med, Med Res Council, Int Nutr Grp, London WC1E 7HT, England; [Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Hennig, Branwen J.] MRC Unit, Banjul, Gambia; [Corbin, Karen D.; Owen, Jennifer; Zeisel, Steven H.] Inst Nutr Res, Kannapolis, NC 28081 USA; [Corbin, Karen D.; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA; [Hellenthal, Garrett] UCL, Genet Inst, London WC1E 6BT, England; [da Costa, Kerry-Ann] Toxicol Serv Inc, Chapel Hill, NC USA; [Moore, Sophie E.] Med Res Council Human Nutr Res, Maternal & Child Nutr Grp, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Zeisel, SH (corresponding author), Inst Nutr Res, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Prentice, Andrew/AAG-1961-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Corbin, Karen/0000-0003-2065-0003; Hennig, Branwen J./0000-0003-4127-8386; Silver, Matt/0000-0002-3852-9677; Moore, Sophie/0000-0003-1650-3238	Wellcome Trust Grant [WT086369MA]; U.K. Medical Research Council [MC-A760-5QX00]; United Kingdom Department for the International Development (DFID) under MRC/DFID Concordat agreement; Bill and Melinda Gates Foundation; U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [DK56350]; Wellcome Trust [098386/Z/12/Z]; Royal Society [098386/Z/12/Z]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1005/1, MC_U123292700, MC_EX_MR/M01424X/1] Funding Source: researchfish; MRC [MC_U123292700, MC_EX_MR/M01424X/1, MC_UP_1005/1] Funding Source: UKRI	Wellcome Trust Grant(Wellcome Trust); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Department for the International Development (DFID) under MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the women from Kiang West, The Gambia, for their participation; their laboratory technicians, field assistants, nurses, data entry clerks, and other staff at MRC Keneba, The Gambia, and A. J. Fulford, Ph.D., for support in data management; Joseph Galanko, Ph.D., for assistance with data organization; the research subjects in the North Carolina clinical cohorts for participating; Leslie Fischer for clinical study management; and Catherine Walker for a critical reading of the manuscript. The Gambian studies that provided data for the analyses were supported by Wellcome Trust Grant WT086369MA (to B.J.H.), U.K. Medical Research Council core funding Grant MC-A760-5QX00 to the International Nutrition Group, and the United Kingdom Department for the International Development (DFID) under the MRC/DFID Concordat agreement. Work completed by Dr. Zeisel's research team was supported by grants from the Bill and Melinda Gates Foundation and Grant DK56350 from the U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases. G.H. is jointly funded by Grant 098386/Z/12/Z from the Wellcome Trust and by a Sir Henry Dale Fellowship from the Royal Society. B.J.H. and S.H.Z. share senior authorship of this article.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2013, USDA NAT NUTR DAT ST; Babbitt CC, 2011, P ROY SOC B-BIOL SCI, V278, P961, DOI 10.1098/rspb.2010.2433; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Buchman AL, 2009, GASTROENTEROLOGY, V137, pS119, DOI 10.1053/j.gastro.2009.08.010; Carroll N, 2009, HUM GENET, V125, P247, DOI 10.1007/s00439-008-0616-3; Cho E, 2006, AM J CLIN NUTR, V83, P905, DOI 10.1093/ajcn/83.4.905; Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097; Corbin KD, 2012, PROG MOL BIOL TRANSL, V108, P159, DOI 10.1016/B978-0-12-398397-8.00007-1; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; da Costa KA, 2014, FASEB J, V28, P2970, DOI 10.1096/fj.14-249557; Dalmeijer GW, 2008, EUR J CLIN NUTR, V62, P386, DOI 10.1038/sj.ejcn.1602725; Detopoulou P, 2008, AM J CLIN NUTR, V87, P424, DOI 10.1093/ajcn/87.2.424; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Dyson LK, 2000, FOOD REV, V21, P2; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fay JC, 2000, GENETICS, V155, P1405; Field MS, 2013, J NUTR, V143, P41, DOI 10.3945/jn.112.169821; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Fischer LM, 2010, AM J CLIN NUTR, V92, P1113, DOI 10.3945/ajcn.2010.30064; Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459; Gillespie J. H., 2004, POPULATION GENETICS; Horne DW, 2003, J NUTR, V133, P476, DOI 10.1093/jn/133.2.476; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; HUDSON GJ, 1995, BRIT J NUTR, V73, P551, DOI 10.1079/BJN19950058; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate Other B Vitamins and Choline, 1998, DIETARY REFERENCE IN, V1, P390; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Ivanov A, 2009, J AM DIET ASSOC, V109, P313, DOI 10.1016/j.jada.2008.10.046; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Johnson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036047; Knoll N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-141; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833; Marsters Kate Ferguson, 2000, TRAVELS INTERIOR DIS; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107; Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107; Murphy P. K., 1981, OXFORD S FODO COOKER, P290; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Oiye S., 2009, Indigenous peoples' food systems: the many dimensions of culture, diversity and environment for nutrition and health, P231; Patin E, 2008, TRENDS ECOL EVOL, V23, P56, DOI 10.1016/j.tree.2007.11.002; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; POMFRET EA, 1990, J NUTR BIOCHEM, V1, P533, DOI 10.1016/0955-2863(90)90039-N; Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Schlebusch CM, 2013, EUR J HUM GENET, V21, P550, DOI 10.1038/ejhg.2012.199; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; TAJIMA F, 1989, GENETICS, V123, P585; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wagh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044751; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weichselbaum E., 2009, 6 I FODO RES; Yonemori KM, 2013, J NUTR, V143, P894, DOI 10.3945/jn.112.171132; Zeisel SH, 2013, INT J WOMENS HEALTH, V5, P193, DOI 10.2147/IJWH.S36610; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x; Zeng FF, 2014, BRIT J CANCER, V110, P808, DOI 10.1038/bjc.2013.686; Zhang CX, 2013, CANCER SCI, V104, P250, DOI 10.1111/cas.12064	68	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3426	3435		10.1096/fj.15-271056	http://dx.doi.org/10.1096/fj.15-271056			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921832	Green Published, Green Accepted			2022-12-28	WOS:000358796900029
J	Donnarumma, D; Golfieri, G; Brier, S; Castagnini, M; Veggi, D; Bottomley, MJ; Delany, I; Norais, N				Donnarumma, Danilo; Golfieri, Giacomo; Brier, Sebastien; Castagnini, Marta; Veggi, Daniele; Bottomley, Matthew James; Delany, Isabel; Norais, Nathalie			Neisseria meningitis GNA1030 is a ubiquinone-8 binding protein	FASEB JOURNAL			English	Article						Bexsero vaccine; native mass spectrometry; NUbp	SUBCELLULAR-LOCALIZATION PREDICTION; SEROGROUP-B MENINGOCOCCUS; OUTER-MEMBRANE PROTEINS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; MASS-SPECTROMETRY; OSMOTIC-STRESS; COENZYME-Q; VACCINE; BIOSYNTHESIS	Bexsero, a new vaccine against Neisseria meningitidis serogroup B (MenB), is composed of 3 main recombinant proteins and an outer membrane vesicle component. One of the main bactericidal antigens, neisseria heparin binding antigen (NHBA), is present as a fusion protein with the accessory protein genome-derived neisserial antigen (GNA) 1030 to further increase its immunogenicity. The gene encoding for GNA1030 is present and highly conserved in all Neisseria strains, and although orthologs are present in numerous species, its biologic function is unknown. Native mass spectrometry was used to demonstrate that GNA1030 forms a homodimer associated with 2 molecules of ubiquinone-8 (Ub8), a cofactor mainly involved in the electron transport chain and with antioxidant properties. Disc diffusion assays on the wildtype and knockout mutant of GNA1030, in the presence of various compounds, suggested that GNA1030 is not involved in oxidative stress or electron chain transport per se, although it contributes to constitutive refilling of the inner membrane with Ub8. These studies shed light on an accessory protein present in Bexsero and reveal functional insights into the family of related proteins. On the basis of our findings, we propose to name the protein neisseria ubiquinone binding protein (NUbp).	[Donnarumma, Danilo; Golfieri, Giacomo; Brier, Sebastien; Castagnini, Marta; Veggi, Daniele; Bottomley, Matthew James; Delany, Isabel; Norais, Nathalie] Novartis Vaccines, Siena, Italy	Novartis	Norais, N (corresponding author), Novartis Vaccines Srl, Res Ctr, Via Fiorentina 1, I-53100 Siena, Italy.	nathalie.norais@novartis.com	Donnarumma, Danilo/AAH-1744-2021; Brier, Sébastien/E-8558-2019; Brier, Sebastien/L-7787-2019	Donnarumma, Danilo/0000-0001-9471-0254; Brier, Sebastien/0000-0003-1758-8237	Novartis fellowship from the Ph.D. program of the University of Bologna (Italy)	Novartis fellowship from the Ph.D. program of the University of Bologna (Italy)	The authors thank B. Capecchi for cloning fl-gna1030 and M. Biagini for helpful discussions. G.G. is the recipient of a Novartis fellowship from the Ph.D. program of the University of Bologna (Italy).	[Anonymous], 1991, MOL CELL PROTEOMICS; [Anonymous], 1991, MOL CELL PROTEOMICS; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Bartolini E, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20181; Bos MP, 2014, J BIOL CHEM, V289, P15602, DOI 10.1074/jbc.M113.539510; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314; Ferguson GP, 2002, J BACTERIOL, V184, P5625, DOI 10.1128/JB.184.20.5625-5632.2002; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gennis RB, 1996, CURR BIOL, V6, P36, DOI 10.1016/S0960-9822(02)00416-5; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gupta VK, 2012, VACCINE, V30, P4017, DOI 10.1016/j.vaccine.2012.04.036; Handa N, 2005, PROTEIN SCI, V14, P1004, DOI 10.1110/ps.041183305; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Martino A, 2012, VACCINE, V30, P1330, DOI 10.1016/j.vaccine.2011.12.066; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; RICH PR, 1990, BIOCHIM BIOPHYS ACTA, V1018, P29, DOI 10.1016/0005-2728(90)90106-E; Schmidt C, 2014, FEBS J, V281, P1950, DOI 10.1111/febs.12707; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Sevin DC, 2014, NAT CHEM BIOL, V10, P266, DOI 10.1038/nchembio.1437; Sisinni L, 2010, FEBS J, V277, P1896, DOI 10.1111/j.1742-4658.2010.07612.x; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Soriani M, 2010, J BIOL CHEM, V285, P30126, DOI 10.1074/jbc.M110.118513; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Vincent F, 2010, FEBS LETT, V584, P1577, DOI 10.1016/j.febslet.2010.03.015; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	36	13	14	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2260	2267		10.1096/fj.14-263954	http://dx.doi.org/10.1096/fj.14-263954			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713028	Bronze			2022-12-28	WOS:000355209500005
J	Sultana, A; Cochran, BJ; Tabet, F; Patel, M; Torres, LC; Barter, PJ; Rye, KA				Sultana, Afroza; Cochran, Blake J.; Tabet, Fatiha; Patel, Mili; Torres, Luisa Cuesta; Barter, Philip J.; Rye, Kerry-Anne			Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I	FASEB JOURNAL			English	Article						ABCA1; MAPK; NF-kappa B	HIGH-DENSITY-LIPOPROTEINS; INDUCED INSULIN-RESISTANCE; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; FREE-CHOLESTEROL ACCUMULATION; CYTOKINE-INDUCED EXPRESSION; TOLL-LIKE RECEPTORS; FACTOR-KAPPA-B; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; REGULATED KINASE	Activation of inflammatory signaling pathways links obesity with metabolic disorders. TLR4-mediated activation of MAPKs and NF-B are 2 such pathways implicated in obesity-induced inflammation. Apolipoprotein A-I (apoA-I) exerts anti-inflammatory effects on adipocytes by effluxing cholesterol from the cells via the ATP binding cassette transporter A1 (ABCA1). It is not known if these effects involve inhibition of inflammatory signaling pathways by apoA-I. This study asks if apoA-I inhibits activation of MAPKs and NF-B in mouse 3T3-L1 adipocytes and whether this inhibition is ABCA1 dependent. Incubation of differentiated 3T3-L1 adipocytes with apoA-I decreased cell surface expression of TLR4 by 16 +/- 2% and synthesis of the TLR4 adaptor protein, myeloid differentiation primary response 88, by 24 +/- 4% in an ABCA1-dependent manner. ApoA-I also inhibited downstream activation of MAPKs, such as ERK, p38MAPK, and JNK, as well as expression of proinflammatory adipokines in bacterial LPS-stimulated 3T3-L1 adipocytes in an ABCA1-dependent manner. ApoA-I, by contrast, suppressed nuclear localization of the p65 subunit of NF-B by 30 +/- 3% in LPS-stimulated 3T3-L1 adipocytes in an ABCA1-independent manner. In conclusion, apoA-I inhibits TLR4-mediated inflammatory signaling pathways in adipocytes by preventing MAPK and NF-B activation.Sultana, A., Cochran, B. J., Tabet, F., Patel, M., Cuesta Torres, L., Barter, P. J., Rye, K.-A. Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I.	[Sultana, Afroza; Cochran, Blake J.; Tabet, Fatiha; Patel, Mili; Torres, Luisa Cuesta; Barter, Philip J.; Rye, Kerry-Anne] Univ New S Wales, Fac Med, Sch Med Sci, Lipid Res Grp, Sydney, NSW 2052, Australia; [Barter, Philip J.; Rye, Kerry-Anne] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Rye, KA (corresponding author), Univ New S Wales, Sch Med Sci, Lowy Ctr, Level 3, Sydney, NSW 2052, Australia.	k.rye@unsw.edu.au		Cochran, Blake/0000-0002-9615-7939	National Health and Medical Research Council of Australia [1037903]; Australian Postgraduate Award; National Heart Foundation of Australia Future Leader Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia)	This work was supported by the National Health and Medical Research Council of Australia ( Grant 1037903). A. S. is the recipient of an Australian Postgraduate Award, and F. T. is the recipient of a National Heart Foundation of Australia Future Leader Fellowship. The authors declare no conflicts of interest.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Baker PW, 1999, J LIPID RES, V40, P345; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brenner C, 2012, SCAND J IMMUNOL, V76, P359, DOI 10.1111/j.1365-3083.2012.02744.x; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Cheng AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033917; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Cullberg KB, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.10; Di Bartolo BA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-224; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; EUGUI J, 1994, CLIN BIOCHEM, V27, P310, DOI 10.1016/0009-9120(94)90035-3; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fasshauer M, 2003, DIABETOLOGIA, V46, P1594, DOI 10.1007/s00125-003-1228-z; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fujishiro M, 2003, MOL ENDOCRINOL, V17, P487, DOI 10.1210/me.2002-0131; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoareau L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-1; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kopp A, 2010, ENDOCRINOLOGY, V151, P1097, DOI 10.1210/en.2009-1140; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim AKH, 2009, DIABETOLOGIA, V52, P347, DOI 10.1007/s00125-008-1215-5; Maekawa T, 2010, MOL CELL BIOL, V30, P613, DOI 10.1128/MCB.00685-09; MATZ CE, 1982, J BIOL CHEM, V257, P4541; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; Ostrom Rennolds S., 2007, V400, P459; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rodriguez-Calvo R, 2008, DIABETES, V57, P2149, DOI 10.2337/db08-0176; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; RYE KA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P316, DOI 10.1016/0005-2760(93)90235-2; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Van Linthout S, 2011, J MOL MED, V89, P151, DOI 10.1007/s00109-010-0690-6; Van Linthout S, 2010, ATHEROSCLEROSIS, V210, P438, DOI 10.1016/j.atherosclerosis.2010.01.001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; Wu BJ, 2014, ARTERIOSCL THROM VAS, V34, P543, DOI 10.1161/ATVBAHA.113.302832; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869	57	14	15	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2324	2335		10.1096/fj.201500026R	http://dx.doi.org/10.1096/fj.201500026R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26965683				2022-12-28	WOS:000376878300022
J	Spanjer, AIR; Baarsma, HA; Oostenbrink, LM; Jansen, SR; Kuipers, CC; Lindner, M; Postma, DS; Meurs, H; Heijink, IH; Gosens, R; Konigshoff, M				Spanjer, Anita I. R.; Baarsma, Hoeke A.; Oostenbrink, Lisette M.; Jansen, Sepp R.; Kuipers, Christine C.; Lindner, Michael; Postma, Dirkje S.; Meurs, Herman; Heijink, Irene H.; Gosens, Reinoud; Koenigshoff, Melanie			TGF-beta-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8	FASEB JOURNAL			English	Article						airway remodeling; extracellular matrix; myofi-broblast; differentiation; WNT signaling	AIRWAY SMOOTH-MUSCLE; IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX PRODUCTION; MOLECULAR-MECHANISMS; RESPONSE ELEMENT; CATENIN; CELLS; EXPRESSION; MYOFIBROBLAST	TGF-beta is important in lung injury and remodeling processes. TGF-beta and Wingless/integrase-1 (WNT) signaling are interconnected; however, the WNT ligand-receptor complexes involved are unknown. Thus, we aimed to identify Frizzled (FZD) receptors that mediate TGF-beta-induced profibrotic signaling. MRC-5 and primary human lung fibroblasts were stimulated with TGF-beta(1), WNT-5A, or WNT-5B in the presence and absence of specific pathway inhibitors. Specific small interfering RNA was used to knock down FZD8. In vivo studies using bleomycin-induced lung fibrosis were performed in wildtype and FZD8-deficient mice. TGF-beta(1) induced FZD8 specifically via Smad3-dependent signaling in MRC-5 and primary human lung fibroblasts. It is noteworthy that FZD8 knockdown reduced TGF-beta(1)-induced collagen I alpha 1, fibronectin, versican, a-smooth muscle (sm)-actin, and connective tissue growth factor. Moreover, bleomycin-induced lung fibrosis was attenuated in FZD8-deficient mice in vivo. Although inhibition of canonical WNT signaling did not affect TGF-beta(1)-induced gene expression in vitro, noncanonical WNT-5B mimicked TGF-beta(1)-induced fibroblast activation. FZD8 knockdown reduced both WNT-5B-induced gene expression of fibronectin and alpha-sm-actin, as well as WNT-5B-induced changes in cellular impedance. Collectively, our findings demonstrate a role for FZD8 in TGF-beta-induced profibrotic signaling and imply that WNT-5B may be the ligand for FZD8 in these responses.	[Spanjer, Anita I. R.; Jansen, Sepp R.; Kuipers, Christine C.; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Baarsma, Hoeke A.; Oostenbrink, Lisette M.; Koenigshoff, Melanie] Univ Munich, Univ Hosp Grosshadern, German Ctr Lung Res DZL, Comprehens Pneumol Ctr,Helmholtz Ctr Munich, Munich, Germany; [Lindner, Michael] Asklepios Fachkliniken Munchen Gauting, Munich, Germany; [Postma, Dirkje S.; Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Expt Pulmonol & Inflammat Res, Groningen, Netherlands; [Spanjer, Anita I. R.; Jansen, Sepp R.; Kuipers, Christine C.; Postma, Dirkje S.; Meurs, Herman; Heijink, Irene H.; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands	University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Groningen; University of Groningen; University of Groningen	Gosens, R (corresponding author), Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.; Konigshoff, M (corresponding author), Max Lebsche Pl 31, D-81377 Munich, Germany.	r.gosens@rug.nl; melanie.koenigshoff@hemholtz-muenchen.de	lindner, michael/AAO-8653-2020	lindner, michael/0000-0002-2106-0286; Baarsma, Hoeke/0000-0002-0792-0374; Gosens, Reinoud/0000-0002-5595-152X	Netherlands Lung Foundation (NLF) [3.2.10.042]; European Respiratory Society [LTRF 79-2012]; Helmholtz Zentrum Germany [PFP PD-135]; European Research Council [ERC-StG-LS7, 261302]	Netherlands Lung Foundation (NLF); European Respiratory Society; Helmholtz Zentrum Germany; European Research Council(European Research Council (ERC)European Commission)	The authors thank E. Schmitt (Novartis Pharma AG) for the generous gift of the PKF 115-584. They also thank M. H. Menzen and A. van den Berg for technical assistance. This work was supported in part by the Netherlands Lung Foundation (NLF; Grant 3.2.10.042). H.A.B. is supported by a postdoctoral fellowship from the European Respiratory Society (LTRF 79-2012) and a fellowship from the Helmholtz Zentrum Germany (PFP PD-135). M.K. is supported by a European Research Council Starting Grant ERC-StG-LS7; Grant No. 261302.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Camoretti-Mercado B, 2005, CELL BIOCHEM BIOPHYS, V43, P131, DOI 10.1385/CBB:43:1:131; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Gauldie Jack, 2006, Proc Am Thorac Soc, V3, P696, DOI 10.1513/pats.200605-125SF; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lam AP, 2014, AM J RESP CRIT CARE, V190, P185, DOI 10.1164/rccm.201401-0079OC; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Minke KS, 2009, EUR J HAEMATOL, V82, P165, DOI 10.1111/j.1600-0609.2008.01188.x; Moore B, 2008, CURR MOL MED, V8, P427, DOI 10.2174/156652408785160943; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Schaafsma D, 2007, BRIT J PHARMACOL, V150, P136, DOI 10.1038/sj.bjp.0706985; Schaafsma D, 2007, AM J PHYSIOL-CELL PH, V293, pC429, DOI 10.1152/ajpcell.00502.2006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; White Eric S, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS30, DOI 10.1513/AnnalsATS.201406-240MG; Wojcik KA, 2012, POL ARCH MED WEWN, V122, P326, DOI 10.20452/pamw.1343; Yeganeh B, 2013, PULM PHARMACOL THER, V26, P50, DOI 10.1016/j.pupt.2012.07.006; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079	49	46	46	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1823	1835		10.1096/fj.201500129	http://dx.doi.org/10.1096/fj.201500129			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26849959	Green Submitted			2022-12-28	WOS:000374879400013
J	van den Berg, SM; Seijkens, TTP; Kusters, PJH; Beckers, L; den Toom, M; Smeets, E; Levels, J; de Winther, MPJ; Lutgens, E				van den Berg, Susan M.; Seijkens, Tom T. P.; Kusters, Pascal J. H.; Beckers, Linda; den Toom, Myrthe; Smeets, Esther; Levels, Johannes; de Winther, Menno P. J.; Lutgens, Esther			Diet-induced obesity in mice diminishes hematopoietic stem and progenitor cells in the bone marrow	FASEB JOURNAL			English	Article						cBMT; flow cytometry; immune system	HIGH-FAT DIET; PROMOTES MYELOPOIESIS; NEGATIVE REGULATORS; INTERFERON-GAMMA; GENE-EXPRESSION; MONOCYTOSIS; HOMEOSTASIS; INHIBITORS; SUPPRESS; DORMANT	Obesity is associated with chronic low-grade inflammation, characterized by leukocytosis and inflammation in the adipose tissue. Continuous activation of the immune system is a stressor for hematopoietic stem and progenitor cells (HSPCs) in the bone marrow (BM). Here we studied how diet-induced obesity (DIO) affects HSPC population dynamics in the BM. Eight groups of age-matched C57B1/6 mice received a high-fat diet (45% kilocalories from fat) ranging from 1 d up to 18 wk. The obesogenic diet caused decreased proliferation of lineage(-)Sca-1(+) c-Kit(+) (LSK) cells in the BM and a general suppression of progenitor cell populations including common lymphoid progenitors and common myeloid progenitors. Within the LSK population, DIO induced a shift in stem cells that are capable of self-renewal toward maturing multipotent progenitor cells. The higher differentiation potential resulted in increased lymphoid and myeloid ex vivo colony-forming capacity. Ina competitive BM transplantation, BM from obese animals showed impaired multilineage reconstitution when transplanted into chow-fed mice. Our data demonstrate that obesity stimulates the differentiation and reduces proliferation of HSPCs in the BM, leading to a decreased HSPC population. This implies that the effects of obesity on HSPCs hampers proper functioning of the immune system.-Van den Berg, S. M., Seijkens, T. T. P., Kusters, P. J. H., Beckers, L., denToom, M., Smeets, E., Levels, J., de Winther, M. P. J., Lutgens, E. Diet-induced obesity in mice diminishes hematopoietic stem and progenitor cells in the bone marrow.	[van den Berg, Susan M.; Seijkens, Tom T. P.; Kusters, Pascal J. H.; Beckers, Linda; den Toom, Myrthe; Smeets, Esther; de Winther, Menno P. J.; Lutgens, Esther] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Subdiv Expt Vasc Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands; [Levels, Johannes] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lutgens, Esther] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Munich	Lutgens, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Subdiv Expt Vasc Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	e.lutgens@amc.uva.nl			Netherlands Organization for Scientific Research (NWO); Rembrandt Foundation; Netherlands Heart Foundation; Netherlands Cardio Vascular Research Initiative (CVON); Deutsche Forschungsgemeinschaft (DFG) [SFB1054-B04, SFB1123-A5]; Netherlands Organization for Scientific Research (Vici grant)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Rembrandt Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Cardio Vascular Research Initiative (CVON); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (Vici grant)(Netherlands Organization for Scientific Research (NWO))	The authors acknowledge the support from the Netherlands Organization for Scientific Research (NWO; Vici grant to E.L.), the Rembrandt Foundation (to S.B., M.W., and E.L.), the Netherlands Heart Foundation (Dr. E. Dekker programme grant to T.S.), the Netherlands Cardio Vascular Research Initiative (CVON2011-19), and the Deutsche Forschungsgemeinschaft (DFG; SFB1054-B04 to E.L., and SFB1123-A5 to E.L.). The authors declare no conflicts of interest.	Adler BJ, 2014, NAT REV ENDOCRINOL, V10, P737, DOI 10.1038/nrendo.2014.169; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bredella MA, 2011, OBESITY, V19, P49, DOI 10.1038/oby.2010.106; BURGER C, 1994, J CELL SCI, V107, P2047; Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047286; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Moldenhauer A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-56; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Quinton LJ, 2002, J INFECT DIS, V185, P1476, DOI 10.1086/340504; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; SELLERI C, 1995, J CELL PHYSIOL, V165, P538, DOI 10.1002/jcp.1041650312; Shahbazian LM, 2004, CRIT CARE MED, V32, P1740, DOI 10.1097/01.CCM.0000132900.84627.90; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zeng WH, 2006, BLOOD, V107, P167, DOI 10.1182/blood-2005-05-1884	37	53	53	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1779	1788		10.1096/fj.201500175	http://dx.doi.org/10.1096/fj.201500175			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26813974				2022-12-28	WOS:000374879400009
J	Aiken, J; Roudier, E; Ciccone, J; Drouin, G; Stromberg, A; Vojnovic, J; Olfert, IM; Haas, T; Gustafsson, T; Grenier, G; Birot, O				Aiken, Julian; Roudier, Emilie; Ciccone, Joseph; Drouin, Genevieve; Stromberg, Anna; Vojnovic, Jovana; Olfert, I. Mark; Haas, Tara; Gustafsson, Thomas; Grenier, Guillaume; Birot, Olivier			Phosphorylation of murine double minute-2 on Ser(166) is downstream of VEGF-A in exercised skeletal muscle and regulates primary endothelial cell migration and FoxO gene expression	FASEB JOURNAL			English	Article						Mdm2; physical exercise; angiogenesis	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH-FACTOR; ANGIOGENESIS; HDM2; MDM2; IDENTIFICATION; STABILIZATION; ANTAGONIST	We demonstrated in a previous study that murine double minute (Mdm)-2 is essential for exercise-induced skeletal muscle angiogenesis. In the current study, we investigated the mechanisms that regulate Mdm2 activity in response to acute exercise and identified VEGF-A as a key stimulator of Mdm2 phosphorylation on Ser(166) (p-Ser166-Mdm2). VEGF-A and p-Ser166-Mdm2 protein levels were measured in human and rodent muscle biopsy specimens after 1 bout of exercise. VEGF-A-dependent Mdm2 phosphorylation was demonstrated in vivo in mice harboring myofiber-specific deletion of VEGF-A (mVEGF(-/-)) and in vitro in primary human and rodent endothelial cells (ECs). Exercise increased VEGF-A and p-Ser166-Mdm2 protein levels respectively by 157 and 68% in human muscle vs. pre-exercise levels. Similar results were observed in exercised rodent muscles compared to sedentary controls; however, exercise-induced Mdm2 phosphorylation was significantly attenuated in mVEGF(-/-) mice. Recombinant VEGF-A elevated p-Ser166-Mdm2 by 50-125% and stimulated migration by 33% in ECs when compared to untreated cells, whereas the Mdm2 antagonist Nutlin-3a abrogated VEGF-driven EC migration. Finally, overexpression of a Ser166-Mdm2 phosphorylation mimetic increased EC migration, increased Mdm2 to FoxO1 binding (+55%), and decreased FoxO1-dependent gene expression compared with ECs overexpressing WT-Mdm2. Our results suggest that VEGF-mediated Mdm2 phosphorylation on Ser(166) is a novel proangiogenic pathway within the skeletal muscle.	[Aiken, Julian; Roudier, Emilie; Ciccone, Joseph; Vojnovic, Jovana; Haas, Tara; Birot, Olivier] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Angiogenesis Res Grp, Toronto, ON M3J 1P3, Canada; [Drouin, Genevieve; Grenier, Guillaume] Univ Sherbrooke, Dept Surg, Sherbrooke, PQ J1K 2R1, Canada; [Stromberg, Anna; Gustafsson, Thomas] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden; [Olfert, I. Mark] W Virginia Univ, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA; [Olfert, I. Mark] W Virginia Univ, Div Exercise Physiol, Morgantown, WV 26506 USA	York University - Canada; University of Sherbrooke; Karolinska Institutet; Karolinska University Hospital; West Virginia University; West Virginia University	Roudier, E (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Angiogenesis Res Grp, Norman Bethune Coll, Room 365,4700 Keele St, Toronto, ON M3J 1P3, Canada.	eroudier@yorku.ca	Gustafsson, Thomas/AAH-1056-2019	Gustafsson, Thomas/0000-0002-1559-4206	Natural Sciences and Engineering Research Council of Canada [RGPIN341258]; Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Sante (FRQS); FRQS	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); FRQS	This work was supported by Grant RGPIN341258 from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. G.D. received a scholarship from Fonds de Recherche du Quebec-Sante (FRQS). G.G. is recipient of an Investigator Award from FRQS. E.R., J.A., and O.B. formulated and designed the experiments. J.A., E.R., J.C., G.D., J.V., A.S., and O.B. performed the experiments. E.R., J.A., and O.B. analyzed the data. T.H., G.G., T.G., I.M.O., and O.B. contributed reagents, materials, and analytical tools. J.A., E.R., and O.B. wrote the manuscript. All authors contributed significantly to the editing. The authors declare no conflicts of interest.	Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Joshi S, 2014, J BIOL CHEM, V289, P22785, DOI 10.1074/jbc.M114.587493; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Lee YM, 2009, CARCINOGENESIS, V30, P1768, DOI 10.1093/carcin/bgp196; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Meek DW, 2010, SEMIN CANCER BIOL, V20, P19, DOI 10.1016/j.semcancer.2009.10.005; Milkiewicz M, 2011, AM J PATHOL, V178, P935, DOI 10.1016/j.ajpath.2010.10.042; Narasimhan M, 2008, LIFE SCI, V82, P1231, DOI 10.1016/j.lfs.2008.04.004; Olfert IM, 2011, MICROCIRCULATION, V18, P316, DOI 10.1111/j.1549-8719.2011.00092.x; Olfert IM, 2010, AM J PHYSIOL-REG I, V299, pR1059, DOI 10.1152/ajpregu.00347.2010; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Robertson E Douglas, 2014, Subcell Biochem, V85, P199, DOI 10.1007/978-94-017-9211-0_11; Roudier E, 2013, ANGIOGENESIS, V16, P759, DOI 10.1007/s10456-013-9353-x; Roudier E, 2012, FASEB J, V26, P4530, DOI 10.1096/fj.12-212720; Secchiero P, 2007, CIRC RES, V100, P61, DOI 10.1161/01.RES.0000253975.76198.ff; Shikatani EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046625; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Slopack D, 2014, J PHYSIOL-LONDON, V592, P4069, DOI 10.1113/jphysiol.2014.275867; Wagner PD, 2011, BIOCHEM SOC T, V39, P1556, DOI 10.1042/BST20110646; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	28	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1120	1134		10.1096/fj.15-276964	http://dx.doi.org/10.1096/fj.15-276964			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578686				2022-12-28	WOS:000370387800011
J	Joshi, R; Liu, S; Brown, MD; Young, SM; Batie, M; Kofron, JM; Xu, Y; Weaver, TE; Apsley, K; Varisco, BM				Joshi, Rashika; Liu, Sheng; Brown, Montell D.; Young, Sarah M.; Batie, Matthew; Kofron, J. Matthew; Xu, Yan; Weaver, Timmothy E.; Apsley, Karen; Varisco, Brian M.			Stretch regulates expression and binding of chymotrypsin-like elastase 1 in the postnatal lung	FASEB JOURNAL			English	Article						matrix remodeling; lung development; lung regeneration; elastin; mechanical strain	GROWTH; MICE; DIFFERENTIATION; DEFICIENCY; INHIBITOR; ELASTIN; MOUSE	Lung stretch is critical for normal lung development and for compensatory lung growth after pneumonectomy (PNX), but the mechanisms by which strain induces matrix remodeling are unclear. Our prior work demonstrated an association of chymotrypsin-like elastase 1 (Cela1) with lung elastin remodeling, and that strain triggered a near-instantaneous elastin-remodeling response. We sought to determine whether stretch regulates Cela1 expression and Cela1 binding to lung elastin. In C57BL/6J mice, Cela1 protein increased 176-fold during lung morphogenesis. Cela1 was covalently bound to serpin peptidase inhibitor, clade A, member 1, resulting in a higher molecular mass in lung homogenate compared to pancreas homogenate. Post-PNX, Cela1mRNA increased 6-fold, protein 3-fold, and Cela1-positive cells 2-fold. Cela1 was expressed predominantly in alveolar type II cells in the embryonic lung and predominantly in CD90-positive lungfibroblasts postnatally. During compensatory lung growth, Cela1 expression was induced in non-proliferative mesenchymal cells. In ex vivo mouse lung sections, stretch increased Cela1 binding to lung tissue by 46%. Competitive inhibition with soluble elastin completely abrogated this increase. Areas of stretch-induced elastase activity and Cela1 binding colocalized. The stretch-dependent expression and binding kinetics of Cela1 indicate an important role in stretch-dependent remodeling of the peripheral lung during development and regeneration.	[Joshi, Rashika; Liu, Sheng; Varisco, Brian M.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Kofron, J. Matthew] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Xu, Yan; Weaver, Timmothy E.; Apsley, Karen] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Batie, Matthew] Cincinnati Childrens Hosp Med Ctr, Dept Clin Engn, Cincinnati, OH 45229 USA; [Brown, Montell D.] Cincinnati Childrens Hosp Med Ctr, Biomed Res Internship Minor Students Program, Cincinnati, OH 45229 USA; [Young, Sarah M.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; Ohio State University	Varisco, BM (corresponding author), 3333 Burnet Ave,MLC 2005, Cincinnati, OH 45229 USA.	brian.varisco@cchmc.org		, Yan/0000-0003-2025-027X; Kofron, Matthew/0000-0001-6427-4148; Varisco, Brian/0000-0003-0180-2577	Proctor Scholar Program at Cincinnati Children's Hospital; Parker B. Francis Family Foundation; Biomedical Research Internship Program for Minority Students at Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028827] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL131261] Funding Source: NIH RePORTER	Proctor Scholar Program at Cincinnati Children's Hospital; Parker B. Francis Family Foundation; Biomedical Research Internship Program for Minority Students at Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Proctor Scholar Program at Cincinnati Children's Hospital, the Parker B. Francis Family Foundation, and Biomedical Research Internship Program for Minority Students at Cincinnati Children's Hospital Medical Center. Monica de Lay (Flow Cytometry Core, Cincinnati Children's Hospital Medical Center) and Anna K. Perl (Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center) provided advice with cytometry experiments. The Cincinnati Children's Hospital Medical Center confocal imaging facility provided technical support for imaging and image analysis. Ken Greis and the University of Cincinnati Proteomics Core (Cincinnati, OH, USA) provided proteomic support. Basillia Zingargelli (Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center) provided aged mouse lung homogenate samples. R.J. and S.L. are cofirst authors.	Ambalavanan N, 2008, PEDIATR RES, V63, P26, DOI 10.1203/PDR.0b013e31815b690d; Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Dane DM, 2013, J APPL PHYSIOL, V114, P99, DOI 10.1152/japplphysiol.01213.2012; De Paepe ME, 2014, PEDIATR PULM, V49, P60, DOI 10.1002/ppul.22818; Du Y., 2015, THORAX, DOI [10.1136/thoraxjnl-2015-207035, DOI 10.1136/THORAXJNL-2015-207035]; Getie M, 2005, PROTEINS, V61, P649, DOI 10.1002/prot.20643; Gill SE, 2009, DEV GROWTH DIFFER, V51, P17, DOI 10.1111/j.1440-169X.2008.01075.x; Hilgendorff A, 2012, AM J PHYSIOL-LUNG C, V303, pL215, DOI 10.1152/ajplung.00405.2011; Hoffman AM, 2010, AM J PHYSIOL-LUNG C, V298, pL158, DOI 10.1152/ajplung.90594.2008; Jesudason R, 2010, BIOPHYS J, V99, P3076, DOI 10.1016/j.bpj.2010.09.018; Kho AT, 2013, AM J PHYSIOL-LUNG C, V305, pL542, DOI 10.1152/ajplung.00403.2012; Liu S., 2014, JOVE-J VIS EXP, V1, P1; Liu S, 2014, AM J PHYSIOL-LUNG C, V306, pL1104, DOI 10.1152/ajplung.00126.2013; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009; Senior R M, 1977, Adv Exp Med Biol, V79, P249; Sharoni E, 1998, J PEDIATR SURG, V33, P1578, DOI 10.1016/S0022-3468(98)90505-X; Snowise S, 2014, AM J PERINAT, V31, P605, DOI 10.1055/s-0034-1373842; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Tang T, 2014, J MOL CELL CARDIOL, V75, P174, DOI 10.1016/j.yjmcc.2014.07.014; Varisco BM, 2012, AM J RESP CELL MOL, V46, P765, DOI 10.1165/rcmb.2011-0316OC; Wang W, 2013, AM J RESP CELL MOL, V49, P697, DOI 10.1165/rcmb.2012-0332MA; Young SM, 2015, J APPL PHYSIOL, V118, P921, DOI 10.1152/japplphysiol.00954.2014; Ysasi AB, 2013, AM J PHYSIOL-LUNG C, V305, pL439, DOI 10.1152/ajplung.00134.2013	27	7	7	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					590	600		10.1096/fj.15-277350	http://dx.doi.org/10.1096/fj.15-277350			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443822	Green Published			2022-12-28	WOS:000369391900012
J	Mattheij, NJA; Braun, A; van Kruchten, R; Castoldi, E; Pircher, J; Baaten, CCFMJ; Wulling, M; Kuijpers, MJE; Kohler, R; Poole, AW; Schreiber, R; Vortkamp, A; Collins, PW; Nieswandt, B; Kunzelmann, K; Cosemans, JMEM; Heemskerk, JWM				Mattheij, Nadine J. A.; Braun, Attila; van Kruchten, Roger; Castoldi, Elisabetta; Pircher, Joachim; Baaten, Constance C. F. M. J.; Wuelling, Manuela; Kuijpers, Marijke J. E.; Koehler, Ralf; Poole, Alastair W.; Schreiber, Rainer; Vortkamp, Andrea; Collins, Peter W.; Nieswandt, Bernhard; Kunzelmann, Karl; Cosemans, Judith M. E. M.; Heemskerk, Johan W. M.			Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage	FASEB JOURNAL			English	Article						bleeding; embryonic lethality; phosphatidylserine; Scott syndrome; TMEM16F	THROMBUS FORMATION; SCOTT SYNDROME; PHOSPHATIDYLSERINE EXPOSURE; PROCOAGULANT RESPONSE; CHLORIDE CHANNEL; LIPID SCRAMBLASE; GLYCOPROTEIN-VI; BLOOD-CELLS; TMEM16F; COAGULATION	Scott syndrome is a rare bleeding disorder, characterized by altered Ca2+-dependent platelet signaling with defective phosphatidylserine (PS) exposure and microparticle formation, and is linked to mutations in the ANO6 gene, encoding anoctamin (Ano) 6. We investigated how the complex platelet phenotype of this syndrome is linked to defective expression of Anos or other ion channels. Mice were generated with heterozygous of homozygous deficiency in Ano6, Ano1, or Ca2+-dependent K(Ca)3.1Gardos channel. Platelets from these mice were extensively analyzed on molecular functions and compared with platelets from a patient with Scott syndrome. Deficiency in Ano1 or Gardos channel did not reduce platelet responses compared with control mice (P > 0.1). In 2 mouse strains, deficiency in Ano6 resulted in reduced viability with increased bleeding time to 28.6min (control 6.4min, P< 0.05). Platelets from the surviving Ano6-deficient mice resembled platelets from patients with Scott syndrome in: 1) normal collagen-induced aggregate formation (P > 0.05) with reduced PS exposure (265 to 90%); 2) lowered Ca2+-dependent swelling (280%) and membrane blebbing (-90%); 3) reduced calpain-dependent protein cleavage (-60%); and 4) moderately affected apoptosis-dependent PS exposure. In conclusion, mouse deficiency of Ano6 but not of other channels affects viability and phenocopies the complex changes in platelets from hemostatically impaired patients with Scott syndrome.	[Mattheij, Nadine J. A.; van Kruchten, Roger; Castoldi, Elisabetta; Baaten, Constance C. F. M. J.; Kuijpers, Marijke J. E.; Cosemans, Judith M. E. M.; Heemskerk, Johan W. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Cell Biochem Thrombosis & Haemostasis Bioche, NL-6200 MD Maastricht, Netherlands; [Braun, Attila; Nieswandt, Bernhard] Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany; [Braun, Attila; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Pircher, Joachim] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Pircher, Joachim] Univ Munich, German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Koehler, Ralf] Univ Duisburg Essen, Ctr Med Biotechnol, Dept Dev Biol, Duisburg, Germany; [Wuelling, Manuela; Vortkamp, Andrea] Aragon Inst Hlth Sci I CS IIS & ARAID, Zaragoza, Spain; [Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Collins, Peter W.] Cardiff Univ, Sch Med, Arthur Bloom Haemophilia Ctr, Cardiff CF10 3AX, S Glam, Wales	Maastricht University; University of Wurzburg; University of Wurzburg; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Munich; University of Duisburg Essen; University of Bristol; University of Regensburg; Cardiff University	Heemskerk, JWM (corresponding author), Maastricht Univ, CARIM, Chair Cell Biochem Thrombosis & Haemostasis Bioch, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@maastrichtuniversity.nl	Cosemans, Judith MEM/C-8161-2016; Kuijpers, Marijke/AAN-9876-2021; Heemskerk, Johan/AAM-8323-2021	Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121; Wuelling, Manuela/0000-0003-4534-3528; Poole, Alastair/0000-0002-0868-297X; Kohler, Ralf/0000-0001-9563-2913	Cardiovascular Center Maastricht; Dutch Heart Foundation [2011T6]; Deutsche Forschungsgemeinschaft DFG [SFB699]	Cardiovascular Center Maastricht; Dutch Heart Foundation(Netherlands Heart Foundation); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by grants from the Cardiovascular Center Maastricht, and the Dutch Heart Foundation 2011T6 (to N.J.A.M., J.M.E.M.C., and J.W.M.H.), and Deutsche Forschungsgemeinschaft DFG SFB699, project A7&A12 (to R.S. and K.K.). The authors declare no conflicts of interest.	BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; De Witt S., 2014, NAT PROTOCOL EXCHANG, V2014, P3309; de Witt SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5257; Deppermann C, 2013, J CLIN INVEST, V123, P3331, DOI 10.1172/JCI69210; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Harper MT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003701; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Holme S, 1998, TRANSFUSION, V38, P31, DOI 10.1046/j.1537-2995.1998.38198141495.x; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mattheij NJA, 2013, J BIOL CHEM, V288, P13325, DOI 10.1074/jbc.M112.428359; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Satta N, 1997, PLATELETS, V8, P117, DOI 10.1080/09537109709169326; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Skals M, 2010, J BIOL CHEM, V285, P15557, DOI 10.1074/jbc.M109.082578; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; van der Meijden PEJ, 2012, CELL MOL LIFE SCI, V69, P3481, DOI 10.1007/s00018-012-1033-2; van Kruchten R, 2013, BLOOD, V121, P1850, DOI 10.1182/blood-2012-09-454314; van Kruchten R, 2012, ARTERIOSCL THROM VAS, V32, P1717, DOI 10.1161/ATVBAHA.111.243907; Van Kruchten R, 2012, PLATELETS, V23, P229, DOI 10.3109/09537104.2011.630848; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Wolfs JL, 2006, BLOOD, V108, P2223, DOI 10.1182/blood-2006-01-009613; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	45	40	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					727	737		10.1096/fj.15-280446	http://dx.doi.org/10.1096/fj.15-280446			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481309	Green Submitted			2022-12-28	WOS:000369391900023
J	Sun, LC; Zheng, JF; Wang, QQ; Song, R; Liu, H; Meng, R; Tao, T; Si, Y; Jiang, WG; He, JQ				Sun, Licui; Zheng, Junfang; Wang, Qiqi; Song, Ran; Liu, Hua; Meng, Ran; Tao, Tao; Si, Yang; Jiang, Wenguo; He, Junqi			NHERF1 regulates actin cytoskeleton organization through modulation of alpha-actinin-4 stability	FASEB JOURNAL			English	Article						protein interaction; ubiquitination; PDZ; F-actin; stress fiber	CANCER-CELL MOTILITY; F-ACTIN; RECEPTOR; EXPRESSION; DYNAMICS; EBP50; PHOSPHORYLATION; REORGANIZATION; IDENTIFICATION; PROTEINS	The actin cytoskeleton is composed of a highly dynamic network of filamentous proteins, yet the molecular mechanism that regulates its organization and remodeling remains elusive. In this study, Na+/H+ exchanger regulatory factor (NHERF)-1 loss-of-function and gain-of-function experiments reveal that polymerized actin cytoskeleton (F-actin) in HeLa cells is disorganized by NHERF1, whereas actin protein expression levels exhibit no detectable change. To elucidate the molecular mechanism underlying actin cytoskeleton disorganization by NHERF1, a combined 2-dimensional electrophoresis-matrix-assisted laser desorption/ionization-time of flight mass spectrometry approach was used to screen for proteins regulated by NHERF1 in HeLa cells. alpha-Actinin-4, an actin cross-linking protein, was identified. Glutathione S-transferase pull-down and coimmunoprecipitation studies showed the alpha-actinin-4 carboxyl-terminal region specifically interacted with the NHERF1 postsynaptic density 95/disc-large/zona occludens-1 domain. The NHERF1/alpha-actinin-4 interaction increased alpha-actinin-4 ubiquitination and decreased its expression levels, resulting in actin cytoskeleton disassembly. Our study identified alpha-actinin-4 as a novel NHERF1 interaction partner and provided new insights into the regulatory mechanism of the actin cytoskeleton by NHERF1.	[Sun, Licui; Zheng, Junfang; Wang, Qiqi; Song, Ran; Liu, Hua; Meng, Ran; Tao, Tao; Si, Yang; He, Junqi] Capital Med Univ, Dept Biochem & Mol Biol, 10 Xitoutiao, Beijing 100069, Peoples R China; [Zheng, Junfang; Song, Ran; Liu, Hua; Si, Yang; Jiang, Wenguo; He, Junqi] Capital Med Univ, Inst Canc, Capital Med Univ Cardiff Univ Joint Ctr Biomed Re, Beijing Key Lab Tumor Invas & Metastasis, Beijing, Peoples R China; [Jiang, Wenguo] Cardiff Univ, Sch Med, Dept Surg, Metastasis & Angiogenesis Res Grp, Heath Pk, Cardiff CF10 3AX, S Glam, Wales; [Sun, Licui] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Dept Nutr & Metab, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Cardiff University; Chinese Center for Disease Control & Prevention	He, JQ (corresponding author), Capital Med Univ, Dept Biochem & Mol Biol, 10 Xitoutiao, Beijing 100069, Peoples R China.	jq_he@ccmu.edu.cn	jiang, wen/GYI-9662-2022; Jiang, Wen G/B-1293-2010; Jiang, Wen G./AAF-1876-2020	Jiang, Wen G/0000-0002-3283-1111; Jiang, Wen G./0000-0002-3283-1111; Meng, Ran/0000-0002-5267-5662	National Natural Science Foundation of China [81272887, 81372739, 81572333]; Beijing Natural Science Foundation [7131003]; Foundation of Beijing Educational Committee [SQKM201210025002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Foundation of Beijing Educational Committee	This work was supported by Grants 81272887, 81372739 and 81572333 from the National Natural Science Foundation of China, Grant 7131003 from the Beijing Natural Science Foundation, and Grant SQKM201210025002 from the Foundation of Beijing Educational Committee.	Alshafie W, 2014, AM J PHYSIOL-CELL PH, V307, pC107, DOI 10.1152/ajpcell.00296.2013; Bian WH, 2013, BIOCHEM J, V453, P345, DOI 10.1042/BJ20121885; Brandhagen BN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-35; Capaldo CT, 2011, MOL BIOL CELL, V22, P1677, DOI 10.1091/mbc.E10-08-0677; Carter CA, 2009, TOXICOLOGY, V261, P89, DOI 10.1016/j.tox.2009.04.039; Chen VC, 2006, J PROTEOME RES, V5, P2123, DOI 10.1021/pr060216l; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Gong XY, 2014, ACTA BIOCH BIOPH SIN, V46, P40, DOI 10.1093/abbs/gmt126; Hansen MDH, 2013, INT REV CEL MOL BIO, V303, P1, DOI 10.1016/B978-0-12-407697-6.00001-5; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Heldin C. H., 2003, BIOCHEM J, V376, P505; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; Jung SR, 2009, TRAFFIC, V10, P392, DOI 10.1111/j.1600-0854.2009.00884.x; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Murai T, 2013, INT J MOL SCI, V14, P20809, DOI 10.3390/ijms141020809; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Samstag Y, 2013, IMMUNOL REV, V256, P30, DOI 10.1111/imr.12115; Song J, 2007, HISTOPATHOLOGY, V51, P40, DOI 10.1111/j.1365-2559.2007.02730.x; Soysa R, 2014, MOL BIOCHEM PARASIT, V195, P1, DOI 10.1016/j.molbiopara.2014.05.002; Staiger CJ, 2010, J EXP BOT, V61, P1969, DOI 10.1093/jxb/erq012; Sun CY, 2013, MOL CELLS, V36, P47, DOI 10.1007/s10059-013-0014-0; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tanaka N, 2014, ANTICANCER RES, V34, P3157; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Wang MC, 2015, J THORAC ONCOL, V10, P286, DOI 10.1097/JTO.0000000000000396; Xue Fei, 2010, Int J Cell Biol, V2010, P507821, DOI 10.1155/2010/507821; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang LY, 2011, ENDOCRINOLOGY, V152, P4537, DOI 10.1210/en.2011-1207	35	23	24	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					578	589		10.1096/fj.15-275586	http://dx.doi.org/10.1096/fj.15-275586			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26432781				2022-12-28	WOS:000369391900011
J	Donoviel, MS; Hait, NC; Ramachandran, S; Maceyka, M; Takabe, K; Milstien, S; Oravecz, T; Spiegel, S				Donoviel, Michael S.; Hait, Nitai C.; Ramachandran, Subramaniam; Maceyka, Michael; Takabe, Kazuaki; Milstien, Sheldon; Oravecz, Tamas; Spiegel, Sarah			Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases	FASEB JOURNAL			English	Article						export; lymphopenia; innate immunity; adaptive immunity	SPHINGOSINE KINASE 1; LYMPHOCYTE EGRESS; SPNS2; BLOOD; MODEL; DRUG; MICE; TNF	Sphingosine 1-phosphate (S1P) is a pleiotropic bioactive sphingolipid metabolite that regulates numerous processes important for immune responses. S1P is made within cells and must be transported out of cells to exert its effects through activation of 5 specific cell surface GPCRs in an autocrine or paracrine fashion. Spinster 2 (Spns2) transports S1P out of cells, and its deletion in mice reduces circulating levels of S1P, alters immune cell trafficking, and induces lymphopenia. Here we examined the effects of Spns2 deletion on adaptive immune responses and in autoimmune disease models. Airway inflammation and hypersensitivity as well as delayed-type contact hypersensitivity were attenuated in Spns2(-/-) mice. Similarly, Spns2 deletion reduced dextran sodium sulfate- and oxazolone-induced colitis. Intriguingly, Spns2(-/-) mice were protected from the development of experimental autoimmune encephalopathy, a model of the autoimmune disease multiple sclerosis. Deletion of Spns2 also strongly alleviated disease development in collagen-induced arthritis. These results point to a broad role for Spns2-mediated S1P transport in the initiation and development of adaptive immune related disorders.	[Donoviel, Michael S.; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX USA; [Hait, Nitai C.; Ramachandran, Subramaniam; Maceyka, Michael; Takabe, Kazuaki; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Takabe, Kazuaki] Virginia Commonwealth Univ, Sch Med, Dept Surg, Richmond, VA 23298 USA; [Takabe, Kazuaki] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Lexicon Pharmaceuticals; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, POB 980614,1101 E Marshall St, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Maceyka, Michael/B-9277-2008	Takabe, Kazuaki/0000-0002-6435-4241	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01 GM043880]; NIH National Cancer Institute Cancer Center [P30CA016059, S10RR031535]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge A. M. Digeorge-Foushee, K. Millerchip, and J. Hazelwood for their help in some of the experiments. The authors also thank the Pathology Department of Lexicon Pharmaceuticals for help in preparing slides from tissue sections. This study was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01 GM043880. The authors thank J. Allegood for skillful sphingolipid analyses and the Virginia Commonwealth University Lipidomics Core, which is supported in part by funding from NIH National Cancer Institute Cancer Center Support Grant P30CA016059 and shared resource Grant S10RR031535.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; DEARMAN RJ, 1994, IMMUNOLOGY, V81, P551; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Haberberger RV, 2009, J ALLERGY CLIN IMMUN, V124, P933, DOI 10.1016/j.jaci.2009.06.034; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Harris DP, 2011, MOL CELL BIOL, V31, P63, DOI 10.1128/MCB.00468-10; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; Salojin KV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098151; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	39	51	56	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5018	5028		10.1096/fj.15-274936	http://dx.doi.org/10.1096/fj.15-274936			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26324848	Green Published			2022-12-28	WOS:000365523600026
J	Bhat, HB; Ishitsuka, R; Inaba, T; Murate, M; Abe, M; Makino, A; Kohyama-Koganeya, A; Nagao, K; Kurahashi, A; Kishimoto, T; Tahara, M; Yamano, A; Nagamune, K; Hirabayashi, Y; Juni, N; Umeda, M; Fujimori, F; Nishibori, K; Yamaji-Hasegawa, A; Greimel, P; Kobayashi, T				Bhat, Hema Balakrishna; Ishitsuka, Reiko; Inaba, Takehiko; Murate, Motohide; Abe, Mitsuhiro; Makino, Asami; Kohyama-Koganeya, Ayako; Nagao, Kohjiro; Kurahashi, Atsushi; Kishimoto, Takuma; Tahara, Michiru; Yamano, Akinori; Nagamune, Kisaburo; Hirabayashi, Yoshio; Juni, Naoto; Umeda, Masato; Fujimori, Fumihiro; Nishibori, Kozo; Yamaji-Hasegawa, Akiko; Greimel, Peter; Kobayashi, Toshihide			Evaluation of aegerolysins as novel tools to detect and visualize ceramide phosphoethanolamine, a major sphingolipid in invertebrates	FASEB JOURNAL			English	Article						lipid binding protein; membrane lipids; poreforming toxins	RICH MEMBRANE DOMAINS; LIPID DOMAINS; PLEUROTUS-ERYNGII; EDIBLE MUSHROOM; SPHINGOMYELIN; CHOLESTEROL; BINDING; DROSOPHILA; REVEALS; PROTEIN	Ceramide phosphoethanolamine (CPE), a sphingomyelin analog, is a major sphingolipid in invertebrates and parasites, whereas only trace amounts are present in mammalian cells. In this study, mushroom-derived proteins of the aegerolysin family-pleurotolysin A2 (PlyA2; K-D = 12 nM), ostreolysin (Oly; K-D = 1.3 nM), and erylysin A (EryA; K-D = 1.3 nM)-strongly associated with CPE/cholesterol (Chol)-containing membranes, whereas their low affinity to sphingomyelin/Chol precluded establishment of the binding kinetics. Binding specificity was determined by multilamellar liposome binding assays, supported bilayer assays, and solid-phase studies against a series of neutral and negatively charged lipid classes mixed 1:1 with Chol or phosphatidylcholine. No cross-reactivity was detected with phosphatidylethanolamine. Only PlyA2 also associated with CPE, independent of Chol content (K-D = 41 mu M), rendering it a suitable tool for visualizing CPE in lipid-blotting experiments and biologic samples from sterol auxotrophic organisms. Visualization of CPE enrichment in the CNS of Drosophila larvae (by PlyA2) and in the bloodstream form of the parasite Trypanosoma brucei (by EryA) by fluorescence imaging demonstrated the versatility of aegerolysin family proteins as efficient tools for detecting and visualizing CPE.	[Bhat, Hema Balakrishna; Ishitsuka, Reiko; Inaba, Takehiko; Murate, Motohide; Abe, Mitsuhiro; Makino, Asami; Kishimoto, Takuma; Yamaji-Hasegawa, Akiko; Greimel, Peter; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Kohyama-Koganeya, Ayako; Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan; [Nagao, Kohjiro; Juni, Naoto; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Kurahashi, Atsushi; Nishibori, Kozo] Yukiguni Maitake Co Ltd, Niigata, Japan; [Tahara, Michiru; Nagamune, Kisaburo] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Yamano, Akinori; Nagamune, Kisaburo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Nagamune, Kisaburo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Fujimori, Fumihiro] Tokyo Kasei Univ, Fac Human Life Sci, Dept Environm Sci & Educ, Tokyo, Japan; [Kobayashi, Toshihide] Univ Lyon 1, INSERM, U1060, F-69622 Villeurbanne, France	RIKEN; RIKEN; Kyoto University; National Institute of Infectious Diseases (NIID); University of Tsukuba; University of Tsukuba; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kobayashi, T (corresponding author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kobayasi@riken.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019; 香山, 綾子/ABF-4396-2021; Abe, Mitsuhiro/C-3602-2017; Kishimoto, Takuma/AAP-1813-2021	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; 香山, 綾子/0000-0002-7632-7953; Inaba, Takehiko/0000-0002-8770-4662; Hirabayashi, Yoshio/0000-0002-5774-7354; Murate, Motohide/0000-0001-5715-7947; Kurahashi, Atsushi/0000-0003-4427-193X; Abe, Mitsuhiro/0000-0002-6244-1771; Greimel, Peter/0000-0002-4931-6183	Integrated Lipidology Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan [24790104, 23590251, 23790115, 24770135, 22390018, 25293015]; Naito Foundation; Grants-in-Aid for Scientific Research [15H04726] Funding Source: KAKEN	Integrated Lipidology Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Integrated Lipidology Program of RIKEN; and by Grants in Aid for Scientific Research 24790104 (to R.I.), 23590251 (to M.M.), 23790115 (to A.M.), 24770135 (to T.Ki.), and 22390018 and 25293015 (to T.Ko.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by the Naito Foundation.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Abeytunga DTU, 2004, J LIPID RES, V45, P1221, DOI 10.1194/jlr.M300392-JLR200; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Ghosh A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003980; HORI T, 1967, J BIOCHEM-TOKYO, V62, P67, DOI 10.1093/oxfordjournals.jbchem.a128637; Hursey B. S., 1995, World Animal Review, P67; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kellermann MY, 2012, ORG GEOCHEM, V43, P112, DOI 10.1016/j.orggeochem.2011.10.005; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; KUZOE FAS, 1993, ACTA TROP, V54, P153, DOI 10.1016/0001-706X(93)90089-T; Lebars I, 2008, NUCLEIC ACIDS RES, V36, P7146, DOI 10.1093/nar/gkn831; Lukoyanova N, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002049; Makino A, 2015, FASEB J, V29, P477, DOI 10.1096/fj.13-247585; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; O'Connor J. D, 1970, Biochim. biophys. Acta, V202, P195, DOI 10.1016/0005-2760(70)90234-1; Sepcic K, 2004, FEBS LETT, V575, P81, DOI 10.1016/j.febslet.2004.07.093; Shibata T, 2010, TOXICON, V56, P1436, DOI 10.1016/j.toxicon.2010.08.010; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Skocaj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092783; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Terova B, 2005, BIOPHYS J, V88, P2661, DOI 10.1529/biophysj.104.058149; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Weber DK, 2015, BIOPHYS J, V108, P1987, DOI 10.1016/j.bpj.2015.03.024; WHITE DC, 1969, BIOCHIM BIOPHYS ACTA, V187, P527, DOI 10.1016/0005-2760(69)90050-2; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; YANG TK, 1974, LIPIDS, V9, P1009, DOI 10.1007/BF02533827	40	36	36	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3920	3934		10.1096/fj.15-272112	http://dx.doi.org/10.1096/fj.15-272112			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26060215				2022-12-28	WOS:000359915600027
J	Cieslik, KA; Trial, J; Entman, ML				Cieslik, Katarzyna A.; Trial, JoAnn; Entman, Mark L.			Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart	FASEB JOURNAL			English	Article						fibrosis; RasGrf1; transendothelial migration	NF-KAPPA-B; MYOCARDIAL-INFARCTION; CARDIAC FIBROSIS; GENE-EXPRESSION; INTERLEUKIN-6; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; PRECURSORS; ARTHRITIS	Fibrosis in the oldmouse heart arises partly as a result of aberrant mesenchymal fibroblast activation. We have previously shown that endogenous mesenchymal stem cells (MSCs) in the aged heart are markedly resistant to TGF-beta signaling. Fibroblasts originating from these MSCs retain their TGF-beta unresponsiveness and become inflammatory. In current studies, we found that these inflammatory fibroblasts secreted higher levels of IL-6 (3-fold increase, P < 0.05) when compared with fibroblasts derived from the young hearts. Elevated IL-6 levels in fibroblasts derived from old hearts arose from upregulated expression of Ras protein-specific guanine nucleotide releasing factor 1 (RasGrf1), a Ras activator (5-fold, P < 0.01). Knockdown of RasGrf1 by gene silencing or pharmacologic inhibition of farnesyltransferase (FTase) or ERK caused reduction of IL-6 mRNA (more than 65%, P < 0.01) and decreased levels of secreted IL-6 (by 44%, P < 0.01). In vitro, IL-6 markedly increased monocyte chemoattractant protein-1-driven monocyte-to-myeloid fibroblast formation after transendothelial migration (TEM; 3-fold, P < 0.01). In conclusion, abnormal expression of RasGrf1 promoted production of IL-6 by mesenchymal fibroblasts in the old heart. Secreted IL-6 supported conversion of monocyte into myeloid fibroblasts. This process promotes fibrosis and contributes to the diastolic dysfunction in the aging heart.	[Cieslik, Katarzyna A.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, DeBakey Heart Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Cieslik, KA (corresponding author), Baylor Coll Med, Dept Med, Div Cardiovasc Sci, One Baylor Plaza,MS BCM620, Houston, TX 77030 USA.	cieslik@bcm.edu	Cieslik, Katarzyna/AAO-1982-2021	Cieslik, Katarzyna/0000-0002-2167-7921; Trial, JoAnn/0000-0001-7145-7786	U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01HL089792]; Medallion Foundation grant; Hankamer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089792] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medallion Foundation grant; Hankamer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jeffrey Crawford for conducting protein array experiment. They also thank Christina Sam and Dorellyn Lee for excellent technical assistance. This work was supported by U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant R01HL089792 (to M.L.E.), a Medallion Foundation grant (to K.A.C.), and the Hankamer Foundation.	Abreu JRF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2785; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Borras C, 2011, AGING-US, V3, P262, DOI 10.18632/aging.100279; Bujak M, 2008, J AM COLL CARDIOL, V51, P1384, DOI 10.1016/j.jacc.2008.01.011; Burman A, 2005, JOINT BONE SPINE, V72, P10, DOI 10.1016/j.jbspin.2004.03.009; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; Cieslik KA, 2014, J MOL CELL CARDIOL, V70, P56, DOI 10.1016/j.yjmcc.2013.10.017; Cieslik KA, 2013, FASEB J, V27, P1761, DOI 10.1096/fj.12-220145; Cieslik KA, 2011, AM J PATHOL, V179, P1792, DOI 10.1016/j.ajpath.2011.06.022; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; de Launay D, 2010, AM J PATHOL, V177, P3010, DOI 10.2353/ajpath.2010.091053; de Mora JF, 2003, EMBO J, V22, P3039, DOI 10.1093/emboj/cdg280; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Hogaboam CM, 1998, KIDNEY INT, V54, P2152, DOI 10.1046/j.1523-1755.1998.00176.x; Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McGettrick HM, 2009, EUR J IMMUNOL, V39, P113, DOI 10.1002/eji.200838232; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Ogata A, 1997, J IMMUNOL, V159, P2212; Parsonage G, 2003, THROMB HAEMOSTASIS, V90, P688, DOI 10.1160/TH03-04-0208; Plenz G, 2001, EUR J HEART FAIL, V3, P415, DOI 10.1016/S1388-9842(01)00137-4; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Ratajczak MZ, 2011, AGING-US, V3, P692, DOI 10.18632/aging.100354; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Trial JA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00287; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Weigert C, 2007, AM J PHYSIOL-CELL PH, V293, pC1139, DOI 10.1152/ajpcell.00142.2007; Williams SM, 2014, J MOL CELL CARDIOL, V67, P112, DOI 10.1016/j.yjmcc.2013.12.013; Wu L, 2014, J EXP MED, V211, P1441, DOI 10.1084/jem.20132126; Xia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077493; Yamamoto A, 2003, ARTHRITIS RHEUM, V48, P2682, DOI 10.1002/art.11214	51	20	22	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3160	3170		10.1096/fj.14-268136	http://dx.doi.org/10.1096/fj.14-268136			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888601	Green Published			2022-12-28	WOS:000358796900006
J	Giustiniani, J; Guillemeau, K; Dounane, O; Sardin, E; Huvent, I; Schmitt, A; Hamdane, M; Buee, L; Landrieu, I; Lippens, G; Baulieu, EE; Chambraud, B				Giustiniani, Julien; Guillemeau, Kevin; Dounane, Omar; Sardin, Elodie; Huvent, Isabelle; Schmitt, Alain; Hamdane, Malika; Buee, Luc; Landrieu, Isabelle; Lippens, Guy; Baulieu, Etienne Emile; Chambraud, Beatrice			The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior	FASEB JOURNAL			English	Article						microtubule; immunophilin; Tau assembly; seeding	PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; BETA-STRUCTURE; FTDP-17; TUBULIN; BRAIN; MUTATIONS; OLIGOMERS; ISOFORMS; MODEL	Tauopathies, including Alzheimer's disease (AD), are neurodegenerative diseases associated with the pathologic aggregation of human brain Tau protein. Neuronal Tau is involved in microtubule (MT) formation and stabilization. We showed previously that the immunophilin FK506-binding protein of MW similar to 52 kDa (FKBP52) interferes with this function of full-length Tau and provokes aggregation of a disease-related mutant of Tau. To dissect the molecular interaction between recombinant human FKBP52 and Tau, here, we study the effect of FKBP52 on a functional Tau fragment (Tau-F4, Ser(208)-Ser(324)) containing part of the proline-rich region and MT-binding repeats. Therefore, we perform MT assembly and light-scattering assays, blue native PAGE analysis, electron microscopy, and Tau seeding experiments in SH-SY5Y human neuroblastoma cells. We show that FKBP52 (6 mu M) prevents MT formation generated by Tau-F4 (5 mu M) and induces Tau-F4 oligomerization and aggregation. Electron microscopy analyses show granular oligomers and filaments of Tau-F4 after short-time FKBP52 incubation. We demonstrate that the terminal parts of Tau interfere with the effects of FKBP52. Finally, we find that FKBP52-induced Tau-F4 oligomers cannot only generate in vitro, direct conformational changes in full-length Tau and that their uptake into neuronal cells can equally lead to aggregation of wild-type endogenous Tau. This suggests a potential prion-like property of these particular Tau-F4 aggregates. Collectively, our results strengthen the hypothesis of FKBP52 involvement in the Tau pathogenicity process.	[Giustiniani, Julien; Guillemeau, Kevin; Dounane, Omar; Sardin, Elodie; Baulieu, Etienne Emile; Chambraud, Beatrice] Univ Paris 11, INSERM, UMR 1195, Le Kremlin Bicetre, France; [Huvent, Isabelle; Landrieu, Isabelle; Lippens, Guy] Univ Lille 1, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; [Schmitt, Alain] Inst Cochin, INSERM, U1016, Paris, France; [Schmitt, Alain] CNRS, UMR 8104, Paris, France; [Schmitt, Alain] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Hamdane, Malika; Buee, Luc] Ctr Rech Jean Pierre Aubert, INSERM, UMR 1172, Lille, France; [Hamdane, Malika; Buee, Luc] Univ Lille, Sch Med, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Chambraud, B (corresponding author), Univ Paris 11, INSERM, UMR 1195, Le Kremlin Bicetre, France.	etienne.baulieu@inserm.fr; beatrice.chambraud@inserm.fr	Landrieu, Isabelle/AAF-8495-2019; BUEE, Luc/B-3126-2010	Landrieu, Isabelle/0000-0002-4883-2637; BUEE, Luc/0000-0002-6261-4230; Huvent, Isabelle/0000-0002-7241-0290; Giustiniani, Julien/0000-0003-0373-5857; Hamdane, Malika/0000-0001-7971-8696; Lippens, Guy/0000-0002-8236-0901	Fondation Vivre Longtemps; Institut Merieux; Institut Baulieu; Agence Nationale de la Recherche [ANR] [FKBP52]; Laboratoire d'Excellence Developpement de Strategies Innovantes pour une Approche Transdisciplinaire de la Maladie d'Alzheimer (LABEX DISTALZ) grants	Fondation Vivre Longtemps; Institut Merieux; Institut Baulieu; Agence Nationale de la Recherche [ANR](French National Research Agency (ANR)); Laboratoire d'Excellence Developpement de Strategies Innovantes pour une Approche Transdisciplinaire de la Maladie d'Alzheimer (LABEX DISTALZ) grants	The authors thank Dr. M. Tawk and Dr. G. Meduri (Institut National de la Sante et de la Recherche Medicale, Unite 788, Le Kremlin-Bicetre, France) for critical reading and discussion, E. Bourrin for technical help with confocal imaging and analyses, and A. Kamah (Centre Nationale de la Recherche Scientifique - Universite de Lille 1, Unite Mixte de Reccherche 8576, Villeneuve-d'Ascq, France) for technical help for pilot experiments. The authors also thank Dr. P. Davies (Albert Einstein College of Medicine, Bronx, NY, USA) for the generous gift of MC1 and PHF-1 antibodies. E.S., O.D., and K.G. were funded by Fondation Vivre Longtemps, Institut Merieux, and Institut Baulieu. J.G. is supported by Agence Nationale de la Recherche [ANR; Program Maladie d'Alzheimer et Maladies Apparentees (MALZ): Tau Association with FKBP52 (TAF)]. The work has been supported jointly by ANR and by Laboratoire d'Excellence Developpement de Strategies Innovantes pour une Approche Transdisciplinaire de la Maladie d'Alzheimer (LABEX DISTALZ) grants. The authors declare no competing financial interests.	Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Bretteville A, 2008, J ALZHEIMERS DIS, V14, P431; Bretteville A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004843; CHAMBRAUD B, 1993, BIOCHEM BIOPH RES CO, V196, P160, DOI 10.1006/bbrc.1993.2229; Chambraud B, 2007, FASEB J, V21, P2787, DOI 10.1096/fj.06-7667com; Chambraud B, 2010, P NATL ACAD SCI USA, V107, P2658, DOI 10.1073/pnas.0914957107; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Garcia-Sierra F, 2008, J ALZHEIMERS DIS, V14, P401; Giustiniani J, 2014, P NATL ACAD SCI USA, V111, P4584, DOI 10.1073/pnas.1402645111; Giustiniani J, 2012, J ALZHEIMERS DIS, V29, P471, DOI 10.3233/JAD-2011-111895; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hanger DP, 2010, BIOCHEM SOC T, V38, P1016, DOI 10.1042/BST0381016; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Huvent I, 2014, BIOCHEM BIOPH RES CO, V445, P299, DOI 10.1016/j.bbrc.2014.01.161; Ikura T, 2013, PROTEIN ENG DES SEL, V26, P539, DOI 10.1093/protein/gzt033; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Liu M, 2004, ASSAY DRUG DEV TECHN, V2, P609, DOI 10.1089/adt.2004.2.609; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; NIETO A, 1991, BIOCHIM BIOPHYS ACTA, V1096, P197, DOI 10.1016/0925-4439(91)90005-T; Preuss U, 1997, J CELL SCI, V110, P789; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Takashima A, 2013, J ALZHEIMERS DIS, V37, P565, DOI 10.3233/JAD-130653; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015	47	25	25	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3171	3181		10.1096/fj.14-268243	http://dx.doi.org/10.1096/fj.14-268243			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888602				2022-12-28	WOS:000358796900007
J	Janssen, AWF; Kersten, S				Janssen, Aafke W. F.; Kersten, Sander			The role of the gut microbiota in metabolic health	FASEB JOURNAL			English	Review						obesity; insulin resistance; short-chain fatty acids; energy harvest; gut permeability	HIGH-FAT-DIET; BILE-ACID METABOLISM; PROTEIN-COUPLED RECEPTOR; INTESTINAL MICROBIOTA; INDUCED OBESITY; BACTERIAL METABOLISM; INSULIN SENSITIVITY; HEPATIC STEATOSIS; SATURATED FAT; L-CARNITINE	The global prevalence of obesity and related comorbidities has increased considerably over the past decades. In addition to an increase in food consumption and a reduction in physical activity, growing evidence implicates the microorganisms in our gastrointestinal tract, referred to as the gut microbiota, in obesity and related metabolic disturbances. The composition of the gut microbiota can fluctuate markedly within an individual and between individuals. Changes in gutmicrobial composition may be unfavorable and predispose an individual todisease. Studies inmice that are germfree, mice that are cohoused, and mice that are treated with antibiotics have provided some evidence that changes in gut microbiota may causally contribute tometabolic disorders. Several mechanisms have been proposed and explored that may mediate the effects of the gut microbiota on metabolic disorders. Inthis review, we carefully analyze the literature on the connection between the gut microbiota and metabolic health, with a focus on studies demonstrating a causal relation and clarifying potential underlying mechanisms. Despite a growing appreciation for a role of the gutmicrobiota inmetabolic health, more experimental evidence is needed to substantiate a cause-and-effect relationship. If a clear causal relationship between the gut microbiota and metabolic health can be established, dietary interventions can be targeted toward improving gut microbial composition in the prevention and perhaps even the treatment of metabolic diseases.	[Janssen, Aafke W. F.; Kersten, Sander] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Kersten, S (corresponding author), Div Human Nutr, Nutr Metab & Genom Grp, Bomenweg 2, NL-6703 HD Wageningen, Netherlands.	sander.kersten@wur.nl	Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734	CVON IN-CONTROL Grant [CVON2012-03]	CVON IN-CONTROL Grant	This work was supported by CVON IN-CONTROL Grant CVON2012-03 (to A.J.).	Alex S, 2013, MOL CELL BIOL, V33, P1303, DOI 10.1128/MCB.00858-12; Arora T, 2013, NUTRITION, V29, P591, DOI 10.1016/j.nut.2012.07.017; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Benoit B, 2015, NUTR RES, V35, P346, DOI 10.1016/j.nutres.2015.01.005; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BINDER HJ, 1975, AM J CLIN NUTR, V28, P119, DOI 10.1093/ajcn/28.2.119; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; D'Aversa F, 2013, INTERN EMERG MED, V8, pS11, DOI 10.1007/s11739-013-0916-z; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Matheus ASD, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/653789; de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dixon LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056100; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Fukunishi S, 2014, J CLIN BIOCHEM NUTR, V54, P39, DOI 10.3164/jcbn.13-49; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hamer HM, 2012, AM J PHYSIOL-GASTR L, V302, pG1, DOI 10.1152/ajpgi.00048.2011; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Huang Hong, 2007, J Inflamm (Lond), V4, P22; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y; Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Laugerette F, 2012, AM J PHYSIOL-ENDOC M, V302, pE374, DOI 10.1152/ajpendo.00314.2011; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lin Y, 2012, CANCER PREV RES, V5, P1090, DOI 10.1158/1940-6207.CAPR-11-0364; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Mattijssen F, 2014, MOL METAB, V3, P135, DOI 10.1016/j.molmet.2013.11.004; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Moschen AR, 2012, GUT LIVER, V6, P411, DOI 10.5009/gnl.2012.6.4.411; Mozes S, 2008, FOLIA MICROBIOL, V53, P225, DOI 10.1007/s12223-008-0031-0; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Panwar H, 2013, DIABETES-METAB RES, V29, P103, DOI 10.1002/dmrr.2376; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591; Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Swartz TD, 2013, FASEB J, V27, P1701, DOI 10.1096/fj.12-221689; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thuny F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009074; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Vrieze A, 2014, J HEPATOL, V60, P824, DOI 10.1016/j.jhep.2013.11.034; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wong JMW, 2012, J AOAC INT, V95, P24, DOI 10.5740/jaoacint.SGE_Wong; Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Ye XY, 2009, J ENDOCRINOL INVEST, V32, P568, DOI [10.1007/BF03346510, 10.3275/6111]; Yi P, 2012, VET MICROBIOL, V157, P1, DOI 10.1016/j.vetmic.2011.10.024; Yokota A, 2012, GUT MICROBES, V3, P455, DOI 10.4161/gmic.21216; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	120	118	133	1	116	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3111	3123		10.1096/fj.14-269514	http://dx.doi.org/10.1096/fj.14-269514			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921831				2022-12-28	WOS:000358796900001
J	Japtok, L; Schmitz, EI; Fayyaz, S; Kramer, S; Hsu, LJ; Kleuser, B				Japtok, Lukasz; Schmitz, Elisabeth I.; Fayyaz, Susann; Kraemer, Stephanie; Hsu, Leigh J.; Kleuser, Burkhard			Sphingosine 1-phosphate counteracts insulin signaling in pancreatic beta-cells via the sphingosine 1-phosphate receptor subtype 2	FASEB JOURNAL			English	Article						type 2 diabetes mellitus; sphingolipids; survival; proliferation; Akt signaling	FUNCTIONAL-CHARACTERIZATION; DIABETES-MELLITUS; MOLECULAR-CLONING; INDUCED APOPTOSIS; FATTY-ACIDS; ACTIVATION; GLUCOSE; PALMITATE; KINASE; RESISTANCE	Glucolipotoxic stress has been identified as a key player in the progression of pancreatic beta-cell dysfunction contributing to insulin resistance and the development of type 2 diabetes mellitus (T2D). It has been suggested that bioactive lipid intermediates, formed under lipotoxic conditions, are involved in these processes. Here, we show that sphingosine 1-phosphate (S1P) levels are not only increased in palmitate-stimulated pancreatic beta-cells but also regulate beta-cell homeostasis in a divergent manner. Although S1P possesses a prosurvival effect in beta-cells, an enhanced level of the sphingolipid antagonizes insulin-mediated cell growth and survival via the sphingosine 1-phosphate receptor subtype 2 (S1P(2)) followed by an inhibition of Akt-signaling. In an attempt to investigate the role of the S1P/S1P(2) axis in vivo, the New Zealand obese (NZO) diabetic mouse model, characterized by beta-cell loss under high-fat diet (HFD) conditions, was used. The occurrence of T2D was accompanied by an increase of plasma S1P levels. To examine whether S1P contributes to the morphologic changes of islets via S1P(2), the receptor antagonist JTE-013 was administered. Most interestingly, JTE-013 rescued beta-cell damage clearly indicating an important role of the S1P(2) in beta-cell homeostasis. Therefore, the present study provides a new therapeutic strategy to diminish beta-cell dysfunction and the development of T2D.	[Japtok, Lukasz; Schmitz, Elisabeth I.; Fayyaz, Susann; Kleuser, Burkhard] Univ Potsdam, Dept Toxicol, Inst Nutr Sci, Fac Math & Nat Sci, D-14558 Potsdam, Germany; [Kraemer, Stephanie] German Inst Human Nutr, Max Rubner Lab, Nuthetal, Germany; [Hsu, Leigh J.] Lpath Inc, San Diego, CA USA	University of Potsdam; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Kleuser, B (corresponding author), Univ Potsdam, Dept Toxicol, Inst Nutr Sci, Fac Math & Nat Sci, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	kleuser@uni-potsdam.de		Kleuser, Burkhard/0000-0002-1888-9595	Deutsche Forschungsgemeinschaft [KL988/4-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft to B.K. (KL988/4-4).	Andreozzi F, 2004, ENDOCRINOLOGY, V145, P2845, DOI 10.1210/en.2003-0939; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Blot V, 2009, SYNTHESIS-STUTTGART, P759, DOI 10.1055/s-0028-1083373; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Fayyaz S, 2014, CELL PHYSIOL BIOCHEM, V34, P134, DOI 10.1159/000362990; Fayyaz S, 2014, DIABETOLOGIA, V57, P373, DOI 10.1007/s00125-013-3123-6; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Galadari S, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-98; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Imasawa T, 2010, BIOCHEM BIOPH RES CO, V392, P207, DOI 10.1016/j.bbrc.2010.01.016; Japtok L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049427; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449; Lanuza-Masdeu J, 2013, DIABETES, V62, P2308, DOI 10.2337/db12-1097; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maris M, 2013, J PROTEOME RES, V12, P347, DOI 10.1021/pr300596g; Mastrandrea LD, 2010, J LIPID RES, V51, P2171, DOI 10.1194/jlr.M000802; Mastrandrea LD, 2005, DIABETES, V54, P1429, DOI 10.2337/diabetes.54.5.1429; Moon H, 2013, DIABETES-METAB RES, V29, P19, DOI 10.1002/dmrr.2341; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Newsholme P, 2007, CLIN SCI, V112, P27, DOI 10.1042/CS20060115; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rutti S, 2009, ENDOCRINOLOGY, V150, P4521, DOI 10.1210/en.2009-0252; Schuppel M, 2008, J INVEST DERMATOL, V128, P1747, DOI 10.1038/sj.jid.5701259; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimizu H, 2000, ENDOCR J, V47, P261, DOI 10.1507/endocrj.47.261; Sommerweiss D, 2013, BIOCHEM BIOPH RES CO, V441, P770, DOI 10.1016/j.bbrc.2013.10.130; Stanford JC, 2012, J BIOL CHEM, V287, P13457, DOI 10.1074/jbc.M111.268185; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Virally M, 2007, DIABETES METAB, V33, P231, DOI 10.1016/j.diabet.2007.07.001; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359; Zhu Q, 2009, FEBS LETT, V583, P2136, DOI 10.1016/j.febslet.2009.05.047	44	42	42	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3357	3369		10.1096/fj.14-263194	http://dx.doi.org/10.1096/fj.14-263194			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911610				2022-12-28	WOS:000358796900023
J	Nagy-Szakal, D; Mir, SAV; Harris, RA; Dowd, SE; Yamada, T; Lacorazza, HD; Tatevian, N; Smith, CW; de Zoeten, EF; Klein, J; Kellermayer, R				Nagy-Szakal, Dorottya; Mir, Sabina A. V.; Harris, R. Alan; Dowd, Scot E.; Yamada, Takeshi; Lacorazza, H. Daniel; Tatevian, Nina; Smith, C. Wayne; de Zoeten, Edwin F.; Klein, John; Kellermayer, Richard			Loss of n-6 fatty acid induced pediatric obesity protects against acute murine colitis	FASEB JOURNAL			English	Article						diet; inflammatory bowel disease; microbiome; CXCL13	INFLAMMATORY-BOWEL-DISEASE; EUROPEAN PROSPECTIVE COHORT; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; CROHNS-DISEASE; T-CELLS; GUT MICROBIOTA; COLONIC-MUCOSA; MICE; SUSCEPTIBILITY	Dietary influences may affect microbiome composition and host immune responses, thereby modulating propensity toward inflammatory bowel diseases (IBDs): Crohn disease (CD) and ulcerative colitis (UC). Dietary n-6 fatty acids have been associated with UC in prospective studies. However, the critical developmental period when (n-6) consumption may induce UC is not known. We examined the effects of transiently increased n-6 consumption during pediatric development on subsequent dextran-sulfate-sodium (DSS)-induced acute murine colitis. The animals transiently became obese then rapidly lost this phenotype. Interestingly, mice were protected against DSS colitis 40 days after n-6 consumption. The transient high n-6-induced protection against colitis was fat type-and dietary reversal-dependent and could be transferred to germ-free mice by fecal microbiota transplantation. We also detected decreased numbers of chemokine receptor (Cxcr)5(+) CD4(+) T cells in the mesenteric lymph nodes (MLNs) of transiently n-6-fed mice. Further experiments revealed that anti-chemokine ligand (Cxcl)13 (the ligand of Cxcr5) antibody treatment decreased DSS colitis severity, implicating the importance of the Cxcr5-Cxcl13 pathway in mammalian colitis. Consecutively, we found elevated CXCL13 concentrations (CD: 1.8-fold, P = 0.0077; UC: 1.9-fold, P = 0.056) in the serum of untreated pediatric IBD patients. The human serologic observations supported the translational relevance of our findings.	[Nagy-Szakal, Dorottya; Mir, Sabina A. V.; Kellermayer, Richard] Baylor Coll Med, Texas Children Hosp, Sect Pediat Gastroenterol, Houston, TX 77030 USA; [Nagy-Szakal, Dorottya; Smith, C. Wayne; Kellermayer, Richard] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Yamada, Takeshi; Lacorazza, H. Daniel] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [de Zoeten, Edwin F.] Childrens Hosp Colorado, Digest Hlth Inst, Aurora, CO USA; [Klein, John] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Children's Hospital Colorado; University of Texas System; University of Texas Health Science Center Houston	Kellermayer, R (corresponding author), Baylor Coll Med, Sect Pediat Gastroenterol Hepatol & Nutr, 6621 Fannin St,CC1010-00, Houston, TX 77030 USA.	kellerma@bcm.edu	Dowd, Scot E/M-5386-2017; Harris, R. Alan/AAI-2784-2020	Dowd, Scot E/0000-0002-6296-1427; Harris, R. Alan/0000-0002-7333-4752; de Zoeten, Edwin/0000-0002-0946-9759	Houston Men of Distinction; U.S. National Institutes of Health [P30 DK56338]; USDA ARS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Houston Men of Distinction; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Gutsy Kids Fund, including philanthropic donation from the Karen and Brock Wagner family, and the support of the Houston Men of Distinction. The authors also acknowledge support from the U.S. National Institutes of Health for the Texas Medical Center Digestive Diseases Center (P30 DK56338). Measurements of body composition were performed in the Mouse Metabolic Research Unit at the U.S. Department of Agriculture/Agricultural Research Service (USDA/ARS) Children's Nutrition Research Center, which is supported by funds from the USDA ARS (www.bcm.edu/cnrc/mmru). The authors acknowledge the assistance of the Mouse Metabolic Research Unit (Baylor College of Medicine) staff and faculty in performing these measurements. D.N.S. and R.K. developed the study concept and design; D.N.S., S.A.V.M., R.A.H., S.E.D., T.Y., H.D.L., N.T., E.Z., J.K., and R.K. acquired the data; D.N.S., R.A.H., S.E.D., and R.K. analyzed and interpreted the data; D.N.S. and R.K. drafted the manuscript; H.D.L., N.T., C.W.S., and R.K. critically revised the manuscript for important intellectual content; R.A.H., S.E.D., and R.K. performed statistical analysis; R.K. obtained funding; C.W.S. and R.K. provided material support; and T.Y., H.D.L., and N.T. provided technical support. The authors declare no conflicts of interest.	Abramson O, 2010, J PEDIATR-US, V157, P233, DOI 10.1016/j.jpeds.2010.02.024; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Barnett M, 2010, MUTAT RES-FUND MOL M, V690, P71, DOI 10.1016/j.mrfmmm.2010.02.006; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Boland BS, 2014, GASTROENTEROL CLIN N, V43, P603, DOI 10.1016/j.gtc.2014.05.011; Boyle D.L., 2014, ANN RHEUM DIS; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Chan SSM, 2013, AM J GASTROENTEROL, V108, P575, DOI 10.1038/ajg.2012.453; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Fite A, 2013, J CLIN MICROBIOL, V51, P849, DOI 10.1128/JCM.02574-12; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gruber L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071661; Gunnarsson C, 2012, DIGEST DIS SCI, V57, P3080, DOI 10.1007/s10620-012-2289-y; Gupta N, 2010, INFLAMM BOWEL DIS, V16, P638, DOI 10.1002/ibd.21099; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Halfvarson J, 2011, INFLAMM BOWEL DIS, V17, P6, DOI 10.1002/ibd.21295; Harris RA, 2014, EPIGENETICS-US, V9, P1131, DOI 10.4161/epi.29446; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Jason K., 2011, TEX MED CTR DIG DIS; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kellermayer R, 2012, CAN J GASTROENTEROL, V26, P909, DOI 10.1155/2012/526408; Kellermayer R, 2010, AM J MED GENET A, V152A, P3022, DOI 10.1002/ajmg.a.33726; Kellermayer R, 2010, HUM MOL GENET, V19, P2168, DOI 10.1093/hmg/ddq095; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Magyari L, 2014, WORLD J GASTROENTERO, V20, P3208, DOI 10.3748/wjg.v20.i12.3208; Malaty HM, 2010, J PEDIATR GASTR NUTR, V50, P27, DOI 10.1097/MPG.0b013e3181b99baa; Marion-Letellier R, 2013, INFLAMM BOWEL DIS, V19, P205, DOI [10.1097/MIB.0b013e3182810122, 10.1002/ibd.23001]; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Nagy-Szakal D, 2013, J PEDIATR GASTR NUTR, V56, P544, DOI 10.1097/MPG.0b013e3182769748; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Obermeier F, 2003, EUR J IMMUNOL, V33, P3265, DOI 10.1002/eji.200324124; PERRET V, 1977, GUT, V18, P382, DOI 10.1136/gut.18.5.382; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Sartor RB, 2011, MUCOSAL IMMUNOL, V4, P127, DOI 10.1038/mi.2010.87; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035; Szigeti R, 2012, ANN CLIN LAB SCI, V42, P401; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730	55	13	14	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3151	3159		10.1096/fj.14-267690	http://dx.doi.org/10.1096/fj.14-267690			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903104	Green Published			2022-12-28	WOS:000358796900005
J	Wang, SX; Song, KX; Srivastava, R; Dong, C; Go, GW; Li, N; Iwakiri, Y; Mani, A				Wang, Shuxia; Song, Kangxing; Srivastava, Roshni; Dong, Chao; Go, Gwang-Woong; Li, Na; Iwakiri, Yasuko; Mani, Arya			Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a	FASEB JOURNAL			English	Article						LRP6; PKC; hepatic steatosis; RhoA; ROCK	EPITHELIAL-MESENCHYMAL TRANSITION; METABOLIC SYNDROME; FIBROSIS PROGRESSION; RISK-FACTORS; TGF-BETA; MYOFIBROBLAST; ACTIVATION; CELLS; STEATOHEPATITIS; LIPOTOXICITY	Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, which begins with isolated steatosis and advances to nonalcoholic steatohepatitis (NASH), steatofibrosis, and cirrhosis. The pathways involved in disease progression are not understood. Loss-of-function mutations in Wnt coreceptor LDL receptor-related protein 6 (LRP6) underlie early-onset atherosclerosis, metabolic risk factors, and NAFLD in humans by unknown mechanisms. We generated mice with the human disease-associated LRP6(R611C) mutation and phenotypically characterized their liver. Homozygote LRP6(R611C) (LRP6(mut/mut)) mice exhibited both steatohepatitis and steatofibrosis. These traits were associated with increased activity of the noncanonical Wnt/Ras homolog family member A, Rho-associated protein kinase 2, and PKC-alpha/-mu pathways. Accordingly, there was increased TGF-beta 1 activity, coupled with enhanced expression of smooth muscle a-actin and vimentin that colocalized with albumin in LRP6(mut/mut) mouse liver. LRP6 knockdown reprogramed HepG2 cells to express both these markers, linking impaired Wnt signaling with hepatocyte transdifferentiation. The causal link between altered Wnt signaling and NASH was established by normalization of the disease pathways and rescue of the liver traits by Wnt3a administration to LRP6(mut/mut) mice. Thus, this study identifies diverse disease pathways that underlie a spectrum of NASH-related liver diseases and are linked by a single human genetic variant. LRP6 and noncanonical Wnt pathways are important potential therapeutic targets against NASH.	[Wang, Shuxia; Song, Kangxing; Srivastava, Roshni; Go, Gwang-Woong; Mani, Arya] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, New Haven, CT 06511 USA; [Dong, Chao; Iwakiri, Yasuko] Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06511 USA; [Mani, Arya] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06511 USA; [Wang, Shuxia] Chinese Peoples Liberat Army Gen Hosp & Med Sch, Dept Geriatr Cardiol, Beijing, Peoples R China; [Song, Kangxing] Chinese Peoples Liberat Army Gen Hosp & Med Sch, Dept Cardiol, Beijing, Peoples R China; [Li, Na] Kookmin Univ, Dept Food & Nutr, Seoul, South Korea	Yale University; Yale University; Yale University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Kookmin University	Mani, A (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, 300 George St,Room 759K, New Haven, CT 06511 USA.	arya.mani@yale.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL122830-01, R01HL122822-01]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082600]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122822, R01HL122830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK082600] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants R01HL122830-01 and R01HL122822-01 (to A.M.) and by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK082600 (to Y.I.).	Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Go GW, 2014, CELL METAB, V19, P209, DOI 10.1016/j.cmet.2013.11.023; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gunaratnam K, 2014, ENDOCRINOLOGY, V155, P108, DOI 10.1210/en.2013-1712; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Idilman IS, 2015, J DIABETES, V7, P279, DOI 10.1111/1753-0407.12172; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kim NH, 2014, HEART, V100, P938, DOI 10.1136/heartjnl-2013-305099; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lemoinne S, 2013, BBA-MOL BASIS DIS, V1832, P948, DOI 10.1016/j.bbadis.2013.02.019; LoGrasso PV, 2009, CURR TOP MED CHEM, V9, P704, DOI 10.2174/156802609789044452; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Morishima Y, 2001, AM J RESP CELL MOL, V24, P1; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Singh R, 2013, HUM MUTAT, V34, P1221, DOI 10.1002/humu.22360; Singh R, 2013, CELL METAB, V17, P197, DOI 10.1016/j.cmet.2013.01.009; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; Watsky MA, 2010, INT REV CEL MOL BIO, V282, P165, DOI 10.1016/S1937-6448(10)82004-0; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zeb I, 2013, J CARDIOVASC COMPUT, V7, P311, DOI 10.1016/j.jcct.2013.08.011	37	39	43	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3436	3445		10.1096/fj.15-271171	http://dx.doi.org/10.1096/fj.15-271171			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25917329	Green Published			2022-12-28	WOS:000358796900030
J	van Wijk, XM; Lawrence, R; Thijssen, VL; van den Broek, SA; Troost, R; van Scherpenzeel, M; Naidu, N; Oosterhof, A; Griffioen, AW; Lefeber, DJ; van Delft, FL; van Kuppevelt, TH				van Wijk, Xander M.; Lawrence, Roger; Thijssen, Victor L.; van den Broek, Sebastiaan A.; Troost, Ran; van Scherpenzeel, Monique; Naidu, Natasha; Oosterhof, Arie; Griffioen, Arjan W.; Lefeber, Dirk J.; van Delft, Floris L.; van Kuppevelt, Toin H.			A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino) glycan biosynthesis, as evidenced by 6F-GalNAc (Ac-3)	FASEB JOURNAL			English	Article						sugar analog; angiogenesis; growth factor signaling; glycobiology	LYMPHOCYTE-ASSOCIATED ANTIGEN; HEPARAN-SULFATE EXPRESSION; ENDOTHELIAL GROWTH-FACTOR; GALNAC SALVAGE PATHWAY; IN-VIVO; DISACCHARIDE COMPOSITION; DEVELOPING ZEBRAFISH; FACTOR BINDING; CANCER; CELLS	Glycosaminoglycan (GAG) polysaccharides have been implicated in a variety of cellular processes, and alterations in their amount and structure have been associated with diseases such as cancer. In this study, we probed 11 sugar analogs for their capacity to interfere with GAG biosynthesis. One analog, with a modification not directly involved in the glycosidic bond formation, 6F-N-acetyl-D-galactosamine (GalNAc) (Ac-3), was selected for further study on its metabolic and biologic effect. Treatment of human ovarian carcinoma cells with 50 mM 6F-GalNAc (Ac-3) inhibited biosynthesis of GAGs (chondroitin/dermatan sulfate by similar to 50-60%, heparan sulfate by similar to 35%), N-acetyl-D-glucosamine (GlcNAc)/GalNAc containing glycans recognized by the lectins Datura stramonium and peanut agglutinin (by similar to 74 and similar to 43%, respectively), and O-GlcNAc protein modification. With respect to function, 6F-GalNAc (Ac-3) treatment inhibited growth factor signaling and reduced in vivo angiogenesis by similar to 33%. Although the analog was readily transformed in cells into the uridine 59-diphosphate (UDP)-activated form, it was not incorporated into GAGs. Rather, it strongly reduced cellular UDP-GalNAc and UDP-GlcNAc pools. Together with data from the literature, these findings indicate that nucleotide sugar depletion without incorporation is a common mechanism of sugar analogs for inhibiting GAG/glycan biosynthesis.	[van Wijk, Xander M.; Troost, Ran; Oosterhof, Arie; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [van den Broek, Sebastiaan A.; van Delft, Floris L.] Radboud Univ Nijmegen, Med Ctr, Inst Mol & Mat, Dept Synthet Organ Chem, NL-6500 HB Nijmegen, Netherlands; [van Scherpenzeel, Monique; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Lawrence, Roger] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, San Diego, CA 92103 USA; [Naidu, Natasha] Univ Calif San Diego, Glycotechnol Core, San Diego, CA 92103 USA; [Thijssen, Victor L.; Griffioen, Arjan W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California San Diego; University of California System; University of California San Diego; Vrije Universiteit Amsterdam	van Kuppevelt, TH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem 280, POB 9101, NL-6500 HB Nijmegen, Netherlands.	toin.vankuppevelt@radboudumc.nl	Lefeber, Dirk DJ/A-2146-2014; Thijssen, Victor LJL/B-2792-2009; van Kuppevelt, A.H.M.S.M./L-4463-2015; van Scherpenzeel, Monique/N-7008-2015	Thijssen, Victor LJL/0000-0002-6146-1842; van Scherpenzeel, Monique/0000-0002-9696-4562	Dutch Cancer Society [2008-4058]; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM093131]; Dutch Organization for Scientific Research [40-00506-98-9001, 91713359]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093131] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. ten Dam, J. Esko, B. Choudhury, F. Bonetto, A. Pistorius, A. Swolfs, R. Wismans, E. van de Westerlo, and T. van der Velden for their analytical and technical support. Lectins were generous gifts from the Departments of Nephrology/Cell Biology (Radboud University Medical Centre, Nijmegen, The Netherlands). This work was supported by the Dutch Cancer Society (Grant 2008-4058), the U.S. National Institutes of Health, National Institute of General Medical Sciences (Grant GM093131 to R.L.), and the Dutch Organization for Scientific Research (NWO Medium Investment Grant 40-00506-98-9001 and VIDI Grant 91713359 to D.J.L.). The authors declare no conflicts of interest.	Ambrosius M, 2008, J CHROMATOGR A, V1201, P54, DOI 10.1016/j.chroma.2008.06.007; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Beahm BJ, 2014, ANGEW CHEM INT EDIT, V53, P3347, DOI 10.1002/anie.201310569; Berkin A, 2000, CARBOHYD RES, V326, P250, DOI 10.1016/S0008-6215(00)00049-5; BERNACKI RJ, 1977, J SUPRAMOL STR CELL, V7, P235, DOI 10.1002/jss.400070208; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Dimitroff CJ, 2003, BLOOD, V101, P602, DOI 10.1182/blood-2002-06-1736; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Freeze HH, 2009, ESSENTIALS GLYCOBIOL, P47; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hart G. W., 2009, ESSENTIALS GLYCOBIOL, P263; Kisilevsky R, 2004, AM J PATHOL, V164, P2127, DOI 10.1016/S0002-9440(10)63771-6; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Nishimura SI, 2012, ANGEW CHEM INT EDIT, V51, P3386, DOI 10.1002/anie.201108742; Pothacharoen P, 2006, J BIOCHEM, V140, P517, DOI 10.1093/jb/mvj181; Pouilly S, 2012, ACS CHEM BIOL, V7, P753, DOI 10.1021/cb200511t; Pouilly S, 2012, FEBS J, V279, P586, DOI 10.1111/j.1742-4658.2011.08448.x; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Song K, 2011, BIOCHEM J, V436, P271, DOI 10.1042/BJ20110297; SORRELL JM, 1993, MATRIX, V13, P351, DOI 10.1016/S0934-8832(11)80040-5; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Theocharis AD, 2002, BIOMED CHROMATOGR, V16, P157, DOI 10.1002/bmc.145; van Wijk XM, 2013, ACS CHEM BIOL, V8, P2331, DOI 10.1021/cb4004332; van Wijk XMR, 2014, BIOCHEM J, V461, P461, DOI 10.1042/BJ20140355; van Wijk XMR, 2014, ANGIOGENESIS, V17, P443, DOI 10.1007/s10456-013-9401-6; van Wijk XMR, 2012, GLYCOBIOLOGY, V22, P1666, DOI 10.1093/glycob/cws119; van Wijk XMR, 2010, EXP CELL RES, V316, P2504, DOI 10.1016/j.yexcr.2010.04.025; Zandberg WF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.403568	38	23	23	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2993	3002		10.1096/fj.14-264226	http://dx.doi.org/10.1096/fj.14-264226			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25868729	Green Published			2022-12-28	WOS:000356859100027
J	Lacalle, RA; de Karam, JC; Martinez-Munoz, L; Artetxe, I; Peregil, RM; Sot, J; Rojas, AM; Goni, FM; Mellado, M; Manes, S				Ana Lacalle, Rosa; de Karam, Juan C.; Martinez-Munoz, Laura; Artetxe, Ibai; Peregil, Rosa M.; Sot, Jesus; Rojas, Ana M.; Goni, Felix M.; Mellado, Mario; Manes, Santos			Type I phosphatidylinositol 4-phosphate 5-kinase homo- and heterodimerization determines its membrane localization and activity	FASEB JOURNAL			English	Article						PIP5K; dimerization; lipid kinase; PI(4,5)P-2	PHOSPHATE KINASE; PLASMA-MEMBRANE; PTDINS(4,5)P-2 SYNTHESIS; 4,5-BISPHOSPHATE LEVELS; NUCLEAR-LOCALIZATION; OXIDATIVE STRESS; MIGRATING CELLS; FOCAL ADHESIONS; BETA; ACTIVATION	Type I phosphatidylinositol 4-phosphate 5-kinases (PIP5KIs; alpha, beta, and gamma) are a family of isoenzymes that produce phosphatidylinositol 4,5-bisphosphate [PI(4,5)P-2] using phosphatidylinositol 4-phosphate as substrate. Their structural homology with the class II lipid kinases [type II phosphatidylinositol 5-phosphate 4-kinase (PIP4KII)] suggests that PIP5KI dimerizes, although this has not been formally demonstrated. Neither the hypothetical structural dimerization determinants nor the functional consequences of dimerization have been studied. Here, we used Forster resonance energy transfer, coprecipitation, and ELISA to show that PIP5KI beta forms homo- and heterodimers with PIP5KI gamma_i2 in vitro and in live human cells. Dimerization appears to be a general phenomenon for PIP5KI isoenzymes because PIP5KI beta/PIP5KI alpha heterodimers were also detected by mass spectrometry. Dimerization was independent of actin cytoskeleton remodeling and was also observed using purified proteins. Mutagenesis studies of PIP5KI beta located the dimerization motif at the N terminus, in a region homologous to that implicated in PIP4KII dimerization. PIP5KI beta mutants whose dimerization was impaired showed a severe decrease in PI(4,5)P-2 production and plasma membrane delocalization, although their association to lipid monolayers was unaltered. Our results identify dimerization as an integral feature of PIP5K proteins and a central determinant of their enzyme activity.	[Ana Lacalle, Rosa; de Karam, Juan C.; Martinez-Munoz, Laura; Peregil, Rosa M.; Mellado, Mario; Manes, Santos] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid 28049, Spain; [Artetxe, Ibai; Sot, Jesus; Goni, Felix M.] Univ Basque Country, Euskal Herriko Unibertsitatea, CSIC, Unidad Biofis, Leioa, Bizkaia, Spain; [Rojas, Ana M.] Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla, Computat Biol & Bioinformat Grp, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Lacalle, RA (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3,Campus Cantoblanco, Madrid 28049, Spain.	rlacalle@cnb.csic.es; smanes@cnb.csic.es	Rojas, Ana M/D-5777-2011; Goni, Felix M/M-5425-2015; Martínez-Muñoz, Laura/C-2719-2017; Manes, Santos/E-4725-2011; Mellado, Mario/M-9893-2014; Artetxe, Ibai/D-1187-2014; IBIS, BIOINFORMATICA/O-1882-2015; Rojas, Ana M./I-2882-2019	Rojas, Ana M/0000-0003-0750-9099; Goni, Felix M/0000-0001-6270-9216; Martínez-Muñoz, Laura/0000-0003-3098-279X; Mellado, Mario/0000-0001-6325-1630; Artetxe, Ibai/0000-0002-8299-4883; Rojas, Ana M./0000-0003-0750-9099; Sot, Jesus/0000-0001-9508-6596; Manes, Santos/0000-0001-8023-957X; Lacalle, Rosa Ana/0000-0003-0082-167X	Spanish Ministry of Science and Innovation [SAF2011-24453]; Comunidad de Madrid (IMMUNOTHERCAN) [S2010/BMD-2326]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (IMMUNOTHERCAN)(Comunidad de Madrid)	The authors thank S. de Lucas for the generous gift of the plasmid and advice on tandem affinity purification, members of the Centro Nacional de Biotecnologia Proteomics Facility (Madrid, Spain; ProteoRed Network member) for mass spectrometry analyses, and C. Mark for editorial assistance. J.C.d.K. is a Ph.D. fellow of the La Caixa Foundation International Fellowship Programme. This work was supported in part by the Spanish Ministry of Science and Innovation (SAF2011-24453) and the Comunidad de Madrid (IMMUNOTHERCAN; S2010/BMD-2326). The authors declare no conflicts of interest.	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Arioka M, 2004, BIOCHEM BIOPH RES CO, V319, P456, DOI 10.1016/j.bbrc.2004.04.187; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Brezesinski G, 2003, ADV COLLOID INTERFAC, V100, P563, DOI 10.1016/S0001-8686(02)00071-4; Bultsma Y, 2010, BIOCHEM J, V430, P223, DOI 10.1042/BJ20100341; Burden LM, 1999, BIOCHEMISTRY-US, V38, P15141, DOI 10.1021/bi991571a; Chen MZ, 2009, J BIOL CHEM, V284, P23743, DOI 10.1074/jbc.M109.036509; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clarke JH, 2013, BIOCHEM J, V454, P49, DOI 10.1042/BJ20130488; Clarke JH, 2010, ADV ENZYME REGUL, V50, P12, DOI 10.1016/j.advenzreg.2009.10.006; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Funakoshi Y, 2011, J CELL PHYSIOL, V226, P888, DOI 10.1002/jcp.22482; Galiano FJ, 2002, J CELL BIOCHEM, V85, P131, DOI 10.1002/jcb.10100; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hinchliffe KA, 2002, BIOCHEM J, V363, P563, DOI 10.1042/0264-6021:3630563; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kahlfeldt N, 2010, J BIOL CHEM, V285, P2734, DOI 10.1074/jbc.M109.074906; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Kisseleva M, 2005, MOL CELL BIOL, V25, P3956, DOI 10.1128/MCB.25.10.3956-3966.2005; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Kunz J, 2002, J BIOL CHEM, V277, P5611, DOI 10.1074/jbc.M110775200; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; Manes S, 2010, FASEB J, V24, P3381, DOI 10.1096/fj.09-153106; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Martinez-Munoz L, 2014, P NATL ACAD SCI USA, V111, pE1960, DOI 10.1073/pnas.1322887111; Matthews JM, 2012, ADV EXP MED BIOL, V747, P1, DOI 10.1007/978-1-4614-3229-6_1; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Shulga YV, 2012, J BIOL CHEM, V287, P35953, DOI 10.1074/jbc.M112.370155; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Szymanska E, 2008, EUR J IMMUNOL, V38, P260, DOI 10.1002/eji.200737170; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; van den Bout I, 2013, BIOCHEM J, V455, P347, DOI 10.1042/BJ20130259; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wang MC, 2010, BIOCHEM J, V430, P215, DOI 10.1042/BJ20100340; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6	59	13	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2371	2385		10.1096/fj.14-264606	http://dx.doi.org/10.1096/fj.14-264606			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713054				2022-12-28	WOS:000355209500015
J	Kim, YH; Barclay, JL; He, JJ; Luo, X; O'Neill, HM; Keshvari, S; Webster, JA; Ng, CP; Hutley, LJ; Prins, JB; Whitehead, JP				Kim, Yu-Hee; Barclay, Johanna L.; He, Jingjing; Luo, Xiao; O'Neill, Hayley M.; Keshvari, Sahar; Webster, Julie A.; Ng, Choaping; Hutley, Louise J.; Prins, Johannes B.; Whitehead, Jonathan P.			Identification of carboxypeptidase X (CPX)-1 as a positive regulator of adipogenesis	FASEB JOURNAL			English	Article						obesity; adipocyte; differentiation; extracellular matrix; collagen	METALLOCARBOXYPEPTIDASE GENE FAMILY; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REPRESSOR; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KEY REGULATOR; PROTEIN; DISCOIDIN; CELLS	Adipose tissue expansion occurs through a combination of hypertrophy of existing adipocytes and generation of new adipocytes via the process of hyperplasia, which involves the proliferation and subsequent differentiation of preadipocytes. Deficiencies in hyperplasia contribute to adipose tissue dysfunction and the association of obesity with chronic cardiometabolic diseases. Thus, increased understanding of hyperplastic pathways may be expected to afford novel therapeutic strategies. We have reported that fibroblast growth factor (FGF)-1 promotes proliferation and differentiation of human preadipocytes and recently demonstrated that bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) is a central, proximal effector. Herein, we describe the identification and characterization of carboxypeptidase X (CPX)-1, a secreted collagen-binding glycoprotein, as a novel downstream effector in human primary and Simpson-Golabi-Behmel syndrome preadipocytes. CPX-1 expression increased after treatment of preadipocytes with FGF-1, BAMBI knockdown, or induction of differentiation. CPX-1 knockdown compromised preadipocyte differentiation coincident with reduced collagen expression. Furthermore, preadipocytes differentiated on matrix derived from CPX-1 knockdown cells exhibited reduced Glut4 expression and insulin-stimulated glucose uptake. Finally, CPX-1 expression was increased in adipose tissue from obese mice and humans. Collectively, these findings establish CPX-1 as a positive regulator of adipogenesis situated downstream of FGF-1/ BAMBI that may contribute to hyperplastic adipose tissue expansion via affecting extracellular matrix remodeling.	[Kim, Yu-Hee; Barclay, Johanna L.; He, Jingjing; Luo, Xiao; O'Neill, Hayley M.; Keshvari, Sahar; Webster, Julie A.; Ng, Choaping; Hutley, Louise J.; Prins, Johannes B.; Whitehead, Jonathan P.] Univ Queensland, Translat Res Inst, Mater Res Inst, Metab Med Grp, Level 4,37 Kent St, Brisbane, Qld 4102, Australia; [Kim, Yu-Hee] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Luo, Xiao] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Xian, Peoples R China; [O'Neill, Hayley M.] Bond Univ, Inst Hlth & Sport, Robina, Qld, Australia; [Webster, Julie A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	Mater Research; University of Queensland; Ewha Womans University; Xi'an Jiaotong University; Bond University; University of Queensland	Whitehead, JP (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, Metab Med Grp, Level 4,37 Kent St, Brisbane, Qld 4102, Australia.	jon.whitehead@mater.uq.edu.au	Webster, Julie A/N-6081-2015; Prins, Johannes B/M-5884-2013; Prins, Johannes/I-3610-2019; Barclay, Johanna/G-6293-2012	Webster, Julie A/0000-0003-2879-700X; Prins, Johannes B/0000-0001-9497-927X; Prins, Johannes/0000-0001-9497-927X; Barclay, Johanna/0000-0001-5737-1775; Whitehead, Jonathan/0000-0003-3978-3148; Keshvari, Sahar/0000-0002-8116-8889; Kim, Yu-Hee/0000-0002-7804-9264; O'Neill, Hayley/0000-0001-6812-6580	Australian National Health and Medical Research Council Grants [1047625, 511104, 1074074]; Diabetes Australia; Mater Foundation; Australian Government; University of Queensland; National Natural Science Foundation of China	Australian National Health and Medical Research Council Grants(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia; Mater Foundation; Australian Government(Australian GovernmentCGIAR); University of Queensland(University of Queensland); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the Australian National Health and Medical Research Council Grants 1047625 (to J.P.W. and J.B.P.), 511104 (to J.P.W.), and 1074074 (to H.M.O.); Diabetes Australia (to J.P.W.); and the Mater Foundation. The Translational Research Institute is supported by a grant from the Australian Government. Postgraduate research scholarships were awarded from the Australian National Health and Medical Research Council Grant (to J.A.W.); the University of Queensland (to Y.H.K. and S.K.); and the National Natural Science Foundation of China (to J.H. and X.L.). The authors declare no conflicts of interest.	Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI 10.1016/j.yexcr.2003.10.020; Borza CM, 2014, MATRIX BIOL, V34, P185, DOI 10.1016/j.matbio.2013.12.002; Chang EJ, 2004, FEBS LETT, V564, P166, DOI 10.1016/S0014-5793(04)00338-2; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Gagnon A, 2005, EXP CELL RES, V308, P265, DOI 10.1016/j.yexcr.2005.04.031; Gagnon A, 2002, ENDOCRINOLOGY, V143, P2478, DOI 10.1210/en.143.7.2478; Gusinjac A, 2011, METABOLISM, V60, P782, DOI 10.1016/j.metabol.2010.07.028; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kim YH, 2015, BIOCHEM BIOPH RES CO, V468, P894, DOI 10.1016/j.bbrc.2015.11.053; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Lei YH, 1999, DNA CELL BIOL, V18, P175, DOI 10.1089/104454999315565; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Ro HS, 2007, OBESITY, V15, P288, DOI 10.1038/oby.2007.569; Sapio MR, 2014, PROTEOM CLIN APPL, V8, P327, DOI 10.1002/prca.201300090; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; Song DS, 2011, J PERIODONTAL RES, V46, P193, DOI 10.1111/j.1600-0765.2010.01328.x; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; WEINER FR, 1989, BIOCHEMISTRY-US, V28, P4094, DOI 10.1021/bi00435a070; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Williams AS, 2015, TRENDS ENDOCRIN MET, V26, P357, DOI 10.1016/j.tem.2015.05.006; Xin XN, 1998, DNA CELL BIOL, V17, P897, DOI 10.1089/dna.1998.17.897; Zhang L, 2005, MOL MED, V11, P39, DOI 10.2119/2005-00021.Ro; Zurakowski H, 2007, HORM METAB RES, V39, P575, DOI 10.1055/s-2007-985132	35	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2528	2540		10.1096/fj.201500107R	http://dx.doi.org/10.1096/fj.201500107R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006448				2022-12-28	WOS:000379249500008
J	Lee, YU; Ruiz-Rosado, JD; Mahler, N; Best, CA; Tara, S; Yi, T; Shoji, T; Sugiura, T; Lee, AY; Robledo-Avila, F; Hibino, N; Pober, JS; Shinoka, T; Partida-Sanchez, S; Breuer, CK				Lee, Yong-Ung; Ruiz-Rosado, Juan de Dios; Mahler, Nathan; Best, Cameron A.; Tara, Shuhei; Yi, Tai; Shoji, Toshihiro; Sugiura, Tadahisa; Lee, Avione Y.; Robledo-Avila, Frank; Hibino, Narutoshi; Pober, Jordan S.; Shinoka, Toshiharu; Partida-Sanchez, Santiago; Breuer, Christopher K.			TGF-beta receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation	FASEB JOURNAL			English	Article						cell seeding; congenital heart defect; Fontan operation; regenerative medicine; inflammation	TO-MESENCHYMAL TRANSITION; VALVE ENDOTHELIAL-CELLS; NEOVESSEL FORMATION; NATURAL-HISTORY; INFLAMMATION; MACROPHAGES; FIBROSIS; TRANSFORMATION; FIBROCYTES; CYTOKINES	Stenosis is a critical problemin the long-term efficacy of tissue-engineered vascular grafts (TEVGs). We previously showed that host monocyte infiltration and activation within the graft drives stenosis and that TGF-beta receptor 1 (TGF-beta R1) inhibition can prevent it, but the latter effect was attributed primarily to inhibition of mesenchymal cell expansion. In this study, we assessed the effects of TGF-beta R1 inhibition on the host monocytes. Biodegradable TEVGs were implanted as inferior vena cava interposition conduits in 2 groups of C57BL/6mice (n = 25/group): unseeded grafts and unseeded grafts with TGF-beta R1 inhibitor systemic treatment for the first 2 wk. The TGF-beta R1 inhibitor treatment effectively improved TEVG patency at 6mo compared to the untreated control group (91.7 vs. 48%, P < 0.001), which is associated with a reduction in classic activation of mononuclear phagocytes. Consistent with these findings, the addition of rTGF-beta to LPS/IFN-gamma-stimulated monocytes enhanced secretion of inflammatory cytokines TNF-alpha, IL-12, and IL-6; this effect was blocked by TGF-beta R1 inhibition (P < 0.0001). These findings suggest that the TGF-beta signaling pathway contributes to TEVG stenosis by inducing classic activation of host monocytes. Furthermore, blocking monocyte activation by TGF-beta R1 inhibition provides a viable strategy for preventingTEVGstenosiswhilemaintainingneotissue formation.-Lee, Y.-U., de Dios Ruiz-Rosado, J., Mahler, N., Best, C. A., Tara, S., Yi, T., Shoji, T., Sugiura, T., Lee, A. Y., Robledo-Avila, F., Hibino, N., Pober, J. S., Shinoka, T., Partida-Sanchez, S., Breuer, C. K. TGF-beta receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.	[Lee, Yong-Ung; Mahler, Nathan; Best, Cameron A.; Tara, Shuhei; Yi, Tai; Shoji, Toshihiro; Sugiura, Tadahisa; Lee, Avione Y.; Hibino, Narutoshi; Shinoka, Toshiharu; Breuer, Christopher K.] Nationwide Childrens Hosp, Tissue Engn Program, Columbus, OH 43205 USA; [Ruiz-Rosado, Juan de Dios; Robledo-Avila, Frank; Partida-Sanchez, Santiago] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Hibino, Narutoshi; Shinoka, Toshiharu] Nationwide Childrens Hosp, Ctr Heart, Dept Cardiothorac Surg, Columbus, OH 43205 USA; [Pober, Jordan S.] Yale Univ, Dept Immunobiol, New Haven, CT USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Yale University	Partida-Sanchez, S (corresponding author), Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	santiago.partida-sanchez@nationwidechildrens.org	Robledo-Avila, Frank/L-6013-2016; Partida-Sanchez, Santiago/B-7523-2008	Robledo-Avila, Frank/0000-0001-5583-9194; Partida-Sanchez, Santiago/0000-0003-2996-9440; Breuer, Christopher/0000-0003-0987-3898; RUIZ-ROSADO, JUAN DE DIOS/0000-0002-6429-9086	U.S National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01AI092117]; Pall Corporation; Gunze Ltd.;  [R01-HL098228]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098228, R01HL128847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092117] Funding Source: NIH RePORTER	U.S National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pall Corporation; Gunze Ltd.; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge J. Reinhardt, E. Heuer, A. Singh, E. Clark, and E. Onwuka (Tissue Engineering Program, Nationwide Children's Hospital) for their contributions to the preparation of histologic samples and surgical procedures. This research was supported by R01-HL098228 (to C.K.B.). S.P.-S. is supported by the U.S National Institutes of Health, National Institute of Allergy and Infectious Diseases (Grant R01AI092117). C.K.B. and T.S. have received grant support from the Pall Corporation and Gunze Ltd. None of the work presented in this article was funded by the Pall Corporation or Gunze Ltd.	Ashcroft GS, 1999, MICROBES INFECT, V1, P1275, DOI 10.1016/S1286-4579(99)00257-9; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Duncan DR, 2015, J AM COLL CARDIOL, V65, P512, DOI 10.1016/j.jacc.2014.08.057; Farrar EJ, 2014, ANN BIOMED ENG, V42, P149, DOI 10.1007/s10439-013-0894-3; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Lee Y. U., 2014, JOVE-J VIS EXP, V4, P51632; Mahler GJ, 2013, ARTERIOSCL THROM VAS, V33, P121, DOI 10.1161/ATVBAHA.112.300504; Merino A, 2012, NEPHROL DIAL TRANSPL, V27, P2907, DOI 10.1093/ndt/gfr767; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Naito Y, 2014, TISSUE ENG PT A, V20, P346, DOI [10.1089/ten.tea.2012.0613, 10.1089/ten.TEA.2012.0613]; Naito Y, 2012, CELLS TISSUES ORGANS, V195, P60, DOI 10.1159/000331405; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Sadler T, 2013, INFLAMM BOWEL DIS, V19, P1354, DOI 10.1097/MIB.0b013e318281f37a; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Sridurongrit S, 2008, DEV BIOL, V322, P208, DOI 10.1016/j.ydbio.2008.07.038; Vargas R, 2012, BRAIN RES, V1453, P64, DOI 10.1016/j.brainres.2012.03.021; Yang YP, 2011, ACTA PHARMACOL SIN, V32, P1259, DOI 10.1038/aps.2011.95; Zeglinski MR, 2015, AM J PHYSIOL-HEART C, V308, pH75, DOI 10.1152/ajpheart.00453.2014	27	18	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2627	2636		10.1096/fj.201500179R	http://dx.doi.org/10.1096/fj.201500179R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27059717	Green Published			2022-12-28	WOS:000379249500017
J	Feldman, RD; Ding, QM; Hussain, Y; Limbird, LE; Pickering, JG; Gros, R				Feldman, Ross D.; Ding, Qingming; Hussain, Yasin; Limbird, Lee E.; Pickering, J. Geoffrey; Gros, Robert			Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER)	FASEB JOURNAL			English	Article						mineralocorticoid; tumor; RENCA	BREAST-CANCER; OVARIAN-CANCER; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; RISK-FACTORS; GPR30; EPIDEMIOLOGY; EXPRESSION; CARCINOMA; 17-BETA-ESTRADIOL	Although aldosterone is a known regulator of renal and cardiovascular function, its role as a regulator of cancer growth and spread has not been widely considered. This study tested the hypothesis that aldosterone regulates cancer cell growth/spread via G protein-coupled estrogen receptor (GPER) activation. In vitro in murine renal cortical adenocarcinoma (RENCA) cells, a widely used murine in vitro model for the study of renal cell adenocarcinoma, aldosterone increased RENCA cell proliferation to a maximum of 125 +/- 3% of control at a concentration of 10 nM, an effect blocked by the GPER antagonist G15 or by GPER knockdown using short interfering (sh) RNA techniques. Further, aldosterone increased RENCA cell migration to a maximum of 170 +/- 20% of control at a concentration of 100 nM, an effect also blocked by G15 or by GPER down-regulation. In vivo, after orthotopic RENCA cell renal transplantation, pulmonary tumor spread was inhibited by pharmacologic blockade of aldosterone effects with spironolactone (percentage of lung occupied by metastasis: control = 68 +/- 13, spironolactone = 26 +/- 8, P < 0.05) or inhibition of aldosterone synthesis with a high dietary salt diet (percentage of lung: control = 44 +/- 6, high salt = 12 +/- 3, P < 0.05), without reducing primary tumor size. Additionally, adrenalectomy significantly reduced the extent of pulmonary tumor spread, whereas aldosterone infusion recovered pulmonary metastatic spread toward baseline levels. Finally, inhibition of GPER either with the GPER antagonist G15 or by GPER knockdown comparably inhibited RENCA cell pulmonary metastatic cancer spread. Taken together, these findings provide strong evidence for aldosterone serving a causal role in renal cell cancer regulation via its GPER receptor; thus, antagonism of GPER represents a potential new target for treatment to reduce metastatic spread.Feldman, R. D., Ding, Q., Hussain, Y., Limbird, L. E., Pickering, J. G., Gros, R. Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER).	[Feldman, Ross D.; Ding, Qingming] Mem Univ Newfoundland, Discipline Med, St John, NF, Canada; [Feldman, Ross D.; Ding, Qingming; Hussain, Yasin; Pickering, J. Geoffrey; Gros, Robert] Robarts Res Inst, Mol Med Grp, London, ON N6A 5C1, Canada; [Limbird, Lee E.] Fisk Univ, Dept Life & Phys Sci, Nashville, TN USA	Memorial University Newfoundland; Western University (University of Western Ontario); Fisk University	Feldman, RD (corresponding author), Hlth Sci Ctr, Discipline Med, Room 5306,300 Prince Philip Dr, St John, NF A1B 3V6, Canada.	ross.feldman@med.mun.ca	Pickering, J. Geoffrey/G-3341-2011; Gros, Robert/A-3010-2009; Gros, Robert/AAV-2237-2020	Pickering, J. Geoffrey/0000-0001-6474-3274; Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011	Heart and Stroke Foundation of Canada; Canadian Cancer Society [701080]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported in part by grants from the Heart and Stroke Foundation of Canada ( to R. D. F.) and the Canadian Cancer Society ( Grant 701080 to J.G.P.).	Ahola TM, 2002, ENDOCRINOLOGY, V143, P3376, DOI 10.1210/en.2001-211445; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Brailoiu GC, 2013, J PHYSIOL-LONDON, V591, P4223, DOI 10.1113/jphysiol.2013.257204; Broughton BRS, 2014, STROKE, V45, P835, DOI 10.1161/STROKEAHA.113.001499; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Cho E, 2011, HEMATOL ONCOL CLIN N, V25, P651, DOI 10.1016/j.hoc.2011.04.002; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Ding Q, 2015, MOL CELL ENDOCRINOL, V399, P60, DOI 10.1016/j.mce.2014.07.023; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Feldman RD, 2013, CLIN EXP PHARMACOL P, V40, P916, DOI 10.1111/1440-1681.12157; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fujiwara S, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-35; Gromotowicz A, 2011, J RENIN-ANGIO-ALDO S, V12, P430, DOI 10.1177/1470320310397405; Gros R, 2002, AM J PHYSIOL-HEART C, V282, pH380, DOI 10.1152/ajpheart.2002.282.1.H380; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; Guan BZ, 2018, CELL ADHES MIGR, V12, P109, DOI 10.4161/19336918.2014.990781; Hasbi A, 2005, MOL INTERV, V5, P158, DOI 10.1124/mi.5.3.5; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Heath CW, 1997, AM J EPIDEMIOL, V145, P607, DOI 10.1093/oxfordjournals.aje.a009157; HIATT RA, 1994, CANCER CAUSE CONTROL, V5, P319, DOI 10.1007/BF01804982; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Huang SM, 2009, AM J PHYSIOL-RENAL, V296, pF1323, DOI 10.1152/ajprenal.90428.2008; Isobe A, 2010, GYNECOL ENDOCRINOL, V26, P372, DOI 10.3109/09513590903511521; Kanesvaran Ravindran, 2014, J Carcinog, V13, P3, DOI 10.4103/1477-3163.127638; Kang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048185; Lin BC, 2009, CANCER RES, V69, P5415, DOI 10.1158/0008-5472.CAN-08-1622; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Luo HJ, 2011, J BREAST CANCER, V14, P185, DOI 10.4048/jbc.2011.14.3.185; McEneaney V, 2010, J STEROID BIOCHEM, V118, P18, DOI 10.1016/j.jsbmb.2009.09.014; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Ohshiro K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030725; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Queisser N, 2014, ANTIOXID REDOX SIGN, V21, P2126, DOI 10.1089/ars.2013.5565; Ren YL, 2014, AM J PHYSIOL-RENAL, V307, pF427, DOI 10.1152/ajprenal.00072.2014; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Stengel D, 2006, BIOCHEM BIOPH RES CO, V346, P693, DOI 10.1016/j.bbrc.2006.05.210; SWARTZ SL, 1980, J CLIN ENDOCR METAB, V50, P1071, DOI 10.1210/jcem-50-6-1071; Takada Y, 1997, BIOCHEM BIOPH RES CO, V240, P737, DOI 10.1006/bbrc.1997.7734; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Wendler A, 2012, STEROIDS, V77, P1002, DOI 10.1016/j.steroids.2011.12.023; Xanthakis V, 2013, CURR HYPERTENS REP, V15, P102, DOI 10.1007/s11906-013-0330-y; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Yu Qianli, 2004, Cardiovasc Toxicol, V4, P37	47	27	29	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2086	2096		10.1096/fj.15-275552	http://dx.doi.org/10.1096/fj.15-275552			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26911792				2022-12-28	WOS:000376878300003
J	Hsu, WCJ; Scala, F; Nenov, MN; Wildburger, NC; Elferink, H; Singh, AK; Chesson, CB; Buzhdygan, T; Sohail, M; Shavkunov, AS; Panova, NI; Nilsson, CL; Rudra, JS; Lichti, CF; Laezza, F				Hsu, Wei-Chun J.; Scala, Federico; Nenov, Miroslav N.; Wildburger, Norelle C.; Elferink, Hannah; Singh, Aditya K.; Chesson, Charles B.; Buzhdygan, Tetyana; Sohail, Maveen; Shavkunov, Alexander S.; Panova, Neli I.; Nilsson, Carol L.; Rudra, Jai S.; Lichti, Cheryl F.; Laezza, Fernanda			CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability	FASEB JOURNAL			English	Article						electrophysiology; bioluminescence screenings; intracellular signaling; GSK-3; mass spectrometry	AXON INITIAL SEGMENT; PROTEIN-KINASE CK2; MICE LACKING FIBROBLAST-GROWTH-FACTOR-14; CEREBELLAR PURKINJE NEURONS; GLYCOGEN-SYNTHASE KINASE-3; ANKYRIN-G; ION CHANNELS; MODULATION; PLASTICITY; ATAXIA	Recent data shows that fibroblast growth factor 14 (FGF14) binds to and controls the function of the voltage-gated sodium (Nav) channel with phenotypic outcomes on neuronal excitability. Mutations in the FGF14 gene in humans have been associated with brain disorders that are partially recapitulated in Fgf14(-/-) mice. Thus, signaling pathways that modulate the FGF14:Nav channel interaction may be important therapeutic targets. Bioluminescence-based screening of small molecule modulators of the FGF14:Nav1.6 complex identified 4,5,6,7-tetrabromobenzotriazole (TBB), a potent casein kinase 2 (CK2) inhibitor, as a strong suppressor of FGF14:Nav1.6 interaction. Inhibition of CK2 through TBB reduces the interaction of FGF14 with Nav1.6 and Nav1.2 channels. Mass spectrometry confirmed direct phosphorylation of FGF14 by CK2 at S228 and S230, and mutation to alanine at these sites modified FGF14 modulation of Nav1.6-mediated currents. In 1 d in vitro hippocampal neurons, TBB induced a reduction in FGF14 expression, a decrease in transient Na+ current amplitude, and a hyperpolarizing shift in the voltage dependence of Nav channel steady-state inactivation. In mature neurons, TBB reduces the axodendritic polarity of FGF14. In cornu ammonis area 1 hippocampal slices from wild-type mice, TBB impairs neuronal excitability by increasing action potential threshold and lowering firing frequency. Importantly, these changes in excitability are recapitulated in Fgf14(-/-) mice, and deletion of Fgf14 occludes TBB-dependent phenotypes observed in wild-type mice. These results suggest that a CK2-FGF14 axis may regulate Nav channels and neuronal excitability.Hsu, W.-C. J., Scala, F., Nenov, M. N., Wildburger, N. C., Elferink, H., Singh, A. K., Chesson, C. B., Buzhdygan, T., Sohail, M., Shavkunov, A. S., Panova, N. I., Nilsson, C. L., Rudra, J. S., Lichti, C. F., Laezza, F. CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.	[Hsu, Wei-Chun J.; Scala, Federico; Nenov, Miroslav N.; Wildburger, Norelle C.; Singh, Aditya K.; Buzhdygan, Tetyana; Shavkunov, Alexander S.; Panova, Neli I.; Nilsson, Carol L.; Rudra, Jai S.; Lichti, Cheryl F.; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA; [Elferink, Hannah] Univ Texas Med Branch, Ctr Environm Toxicol, Galveston, TX 77555 USA; [Chesson, Charles B.] Univ Texas Med Branch, Inst Translat Sci, Human Pathophysiol & Translat Med, Galveston, TX 77555 USA; [Sohail, Maveen] Univ Texas Med Branch, Grad Sch Biomed Sci, Galveston, TX 77555 USA; [Nilsson, Carol L.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Lichti, Cheryl F.; Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Scala, Federico] Univ Cattolica, Inst Human Physiol, Rome, Italy; [Wildburger, Norelle C.] Univ Sch Med, Dept Neurol, St Louis, MO USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	felaezza@utmb.edu	Buzhdygan, Tetyana/AAN-4245-2021; Laezza, Fernanda/X-4076-2019; Nenov, Miroslav/C-5252-2008; Laezza, Fernanda/L-6019-2016	Laezza, Fernanda/0000-0003-1141-1852; Nenov, Miroslav/0000-0001-6000-2372; Laezza, Fernanda/0000-0003-1141-1852; Singh, Aditya/0000-0001-7549-8163; Hsu, Wei-Chun/0000-0003-4803-4819; Wildburger, Norelle C./0000-0002-0036-8927; Shavkunov, Alexander/0000-0003-2390-9391; Lichti, Cheryl/0000-0003-4099-4954	U.S. National Institutes of Health (NIH)/National Institute of Mental Health Grant [R01MH095995]; predoctoral Kempner fellowship; Wiktor W. Nowinski Endowment Fund travel award; University of Texas Medical Branch (UTMB) Sealy Center for Molecular Medicine; UTMB Biochemistry and Molecular Biology Graduate Program; Universita a Cattolica Biophysics Graduate Program; UTMB Neuroscience Graduate Program; UTMB Bench Tutorials Program: Scientific Research and Design (NIH/National Institute of Environmental Health Sciences/Department of Health and Human Services) [P30ES006676/ES]; UTMB Summer Undergraduate Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Mental Health Grant; predoctoral Kempner fellowship; Wiktor W. Nowinski Endowment Fund travel award; University of Texas Medical Branch (UTMB) Sealy Center for Molecular Medicine; UTMB Biochemistry and Molecular Biology Graduate Program; Universita a Cattolica Biophysics Graduate Program; UTMB Neuroscience Graduate Program; UTMB Bench Tutorials Program: Scientific Research and Design (NIH/National Institute of Environmental Health Sciences/Department of Health and Human Services); UTMB Summer Undergraduate Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by U.S. National Institutes of Health (NIH)/National Institute of Mental Health Grant R01MH095995 (to F. L.), predoctoral Kempner fellowship (to W. J. H.), Wiktor W. Nowinski Endowment Fund travel award (to W. J. H.), University of Texas Medical Branch (UTMB) Sealy Center for Molecular Medicine (to W. J. H.), UTMB Biochemistry and Molecular Biology Graduate Program (to W. J. H.), Universita a Cattolica Biophysics Graduate Program (to F. S.), UTMB Neuroscience Graduate Program (to N. C. W. and T. B.), UTMB Bench Tutorials Program: Scientific Research and Design (NIH/National Institute of Environmental Health Sciences/Department of Health and Human Services Grant P30ES006676/ES) (to H. E.), and UTMB Summer Undergraduate Research Program (to M. S.). The authors declare no conflicts of interest.	Adachi R, 2015, NEUROSCIENTIST, V21, P255, DOI 10.1177/1073858414535986; Akin EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124397; Ali S, 2014, CNS NEUROL DISORD-DR, V13, P1559, DOI 10.2174/1871527313666141126103309; Bosch MK, 2015, J NEUROSCI, V35, P6752, DOI 10.1523/JNEUROSCI.2663-14.2015; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Casaday RJ, 2004, J VIROL, V78, P13501, DOI 10.1128/JVI.78.24.13501-13511.2004; Castillo MA, 2010, BIOL PSYCHIAT, V67, P208, DOI 10.1016/j.biopsych.2009.07.029; Chand AN, 2015, J NEUROSCI, V35, P1573, DOI 10.1523/JNEUROSCI.3515-14.2015; Farghaian H, 2011, J BIOL CHEM, V286, P25274, DOI 10.1074/jbc.M111.251629; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Grubb MS, 2011, J NEUROSCI, V31, P16049, DOI 10.1523/JNEUROSCI.4064-11.2011; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Hien YE, 2014, FEBS LETT, V588, P3403, DOI 10.1016/j.febslet.2014.07.032; Hong JY, 2007, ACS CHEM BIOL, V2, P171, DOI 10.1021/cb600435t; Hsu WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117246; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; James TF, 2015, BBA-GEN SUBJECTS, V1850, P832, DOI 10.1016/j.bbagen.2015.01.011; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Nenov MN, 2015, J NEUROPHYSIOL, V113, P1712, DOI 10.1152/jn.00419.2014; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Papandreou MJ, 2015, J NEUROCHEM, V134, P527, DOI 10.1111/jnc.13158; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Sanchez-Ponce D, 2011, MOL CELL NEUROSCI, V46, P222, DOI 10.1016/j.mcn.2010.09.005; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Scala F, 2015, NEUROBIOL AGING, V36, P886, DOI 10.1016/j.neurobiolaging.2014.10.034; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Shavkunov AS, 2015, METHODS MOL BIOL, V1278, P497, DOI 10.1007/978-1-4939-2425-7_33; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; St-Denis N, 2015, J PROTEOMICS, V118, P49, DOI 10.1016/j.jprot.2014.10.020; STOILOVAMCPHIE S, 2013, AUSTIN J PHARM THER, V1, P1; Tempia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00205; Thome C, 2014, NEURON, V83, P1418, DOI 10.1016/j.neuron.2014.08.013; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wildburger NC, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00080; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Xu MX, 2015, J BIOL CHEM, V290, P16619, DOI 10.1074/jbc.M115.638932; Yoshimura T, 2014, CURR OPIN NEUROBIOL, V27, P96, DOI 10.1016/j.conb.2014.03.004	51	22	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2171	2186		10.1096/fj.201500161	http://dx.doi.org/10.1096/fj.201500161			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26917740	Green Published			2022-12-28	WOS:000376878300011
J	Sigoillot, SM; Bourgeois, F; Karmouch, J; Molgo, J; Dobbertin, A; Chevalier, C; Houlgatte, R; Leger, J; Legay, C				Sigoillot, Severine M.; Bourgeois, Francine; Karmouch, Jennifer; Molgo, Jordi; Dobbertin, Alexandre; Chevalier, Catherine; Houlgatte, Remi; Leger, Jean; Legay, Claire			Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency	FASEB JOURNAL			English	Article						gene profiling; collagen Q; AChR; extracellular matrix; dystroglycan	HEPARIN-BINDING DOMAINS; COLLAGEN-TAILED FORMS; GENE-EXPRESSION; SKELETAL-MUSCLE; ANCHORING ACETYLCHOLINESTERASE; MUSCULAR-DYSTROPHY; SYNAPTIC STRUCTURE; BETA-DYSTROGLYCAN; SUBUNIT; MUTATIONS	The collagen ColQ anchors acetylcholinesterase (AChE) in the synaptic cleft of the neuromuscular junction (NMJ). It also binds MuSK and perlecan/dystroglycan, 2 signaling platforms of the postsynaptic domain. Mutations in ColQ cause a congenital myasthenic syndrome (CMS) with AChE deficiency. Because the absence of AChE does not fully explain the complexity of the syndrome and there is no curative treatment for the disease, we explored additional potential targets of ColQ by conducting a large genetic screening of ColQ-deficient mice, a model for CMS with AChE deficiency, and analyzed their NMJ and muscle phenotypes. We demonstrated that ColQ controls the development and the maturation of the postsynaptic domain by regulating synaptic gene expression. Notably, ColQ deficiency leads to an up-regulation of the 5 subunits of the nicotinic acetylcholine receptor (AChR), leading to mixed mature and immature AChRs at the NMJ of adult mice. ColQ also regulates the expression of extracellular matrix (ECM) components. However, whereas the ECM mRNAs were down-regulated in vitro, compensation seemed to occur in vivo to maintain normal levels of these mRNAs. Finally, ColQ deficiency leads to a general atrophic phenotype and hypoplasia that affect fast muscles. This study points to new specific hallmarks for this CMS.Sigoillot, S. M., Bourgeois, F., Karmouch, J., Molgo, J., Dobbertin, A., Chevalier, C., Houlgatte, R., Leger, J., Legay, C. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	[Sigoillot, Severine M.; Bourgeois, Francine; Karmouch, Jennifer; Dobbertin, Alexandre; Legay, Claire] Univ Paris 05, Sorbonne Paris Cite, CNRS, Ctr Neurophys Physiol & Pathol,Unite Mixte Rech U, F-75006 Paris, France; [Molgo, Jordi] Commissariat Energie Atom & Energies Alternat, Inst Biol & Technol Saclay, Serv Ingn Mol Prot, Gif Sur Yvette, France; [Molgo, Jordi] Univ Paris 11, CNRS, UMR 9197, Inst Neurosci Paris Saclay, Paris, France; [Chevalier, Catherine; Houlgatte, Remi; Leger, Jean] Univ Nantes, Inst Rech Therapeut, Plateforme Genom Integrat, Nantes, France; [Sigoillot, Severine M.] Coll France, CNRS UMR 7241, INSERM U1050, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Houlgatte, Remi] Fac Med, INSERM, U954, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Legay, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Ctr CNRS, Ctr Neurophys Physiol & Pathol,UMR 8119, 45 Rue St Peres, F-75006 Paris, France.	claire.legay@parisdescartes.fr	Houlgatte, Remi/P-3020-2017		INSERM; Association Francaise contre les Myopathies (AFM); Agence Nationale de la Recherche; Universite Paris Descartes; French Ministry of Research; AFM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite Paris Descartes; French Ministry of Research(Ministry of Research, FranceEuropean Commission); AFM(Association Francaise contre les Myopathies)	The authors thank Eric Krejci and Emmanuelle Girard for providing WT and ColQ<SUP>-/-</SUP> mice and Olivier Bignolais and Audrey Donnart for help with TLDA experiments. This work was funded by grants from INSERM, the Association Francaise contre les Myopathies (AFM; to C. L.), the Agence Nationale de la Recherche, and Universite Paris Descartes. S. M. S. is the recipient of a Ph.D. grant from the French Ministry of Research and AFM. The authors declare no conflicts of interest.	Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Arredondo J, 2014, HUM GENET, V133, P599, DOI 10.1007/s00439-013-1391-3; Bauche S, 2013, NEUROMUSCULAR DISORD, V23, P998, DOI 10.1016/j.nmd.2013.07.005; Cairns SP, 2015, J PHYSIOL-LONDON, V593, P4713, DOI 10.1113/JP270909; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Deprez P, 2003, J BIOL CHEM, V278, P23233, DOI 10.1074/jbc.M301384200; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Folker ES, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00363; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guo YR, 2015, NEUROMUSCULAR DISORD, V25, P257, DOI 10.1016/j.nmd.2014.11.017; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Hantai D, 2004, CURR OPIN NEUROL, V17, P539, DOI 10.1097/00019052-200410000-00004; Herlitze S, 1996, J PHYSIOL-LONDON, V492, P775, DOI 10.1113/jphysiol.1996.sp021345; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Joassard OR, 2015, J NEUROSCI, V35, P10949, DOI 10.1523/JNEUROSCI.1043-15.2015; Kang H, 2014, J NEUROSCI, V34, P6323, DOI 10.1523/JNEUROSCI.4673-13.2014; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Kimbell LM, 2004, J BIOL CHEM, V279, P10997, DOI 10.1074/jbc.M305462200; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; Krejci E, 1999, J NEUROSCI, V19, P10672, DOI 10.1523/JNEUROSCI.19-24-10672.1999; Lashley D, 2010, NEUROLOGY, V74, P1517, DOI 10.1212/WNL.0b013e3181dd43bf; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JJ, 2007, J ORTHOP RES, V25, P1498, DOI 10.1002/jor.20414; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Martin PT, 2003, GLYCOBIOLOGY, V13, p55R, DOI 10.1093/glycob/cwg076; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Mejat A, 2003, ANN NY ACAD SCI, V998, P53, DOI 10.1196/annals.1254.008; Mihaylova V, 2008, BRAIN, V131, P747, DOI 10.1093/brain/awm325; Minic J, 2003, BRIT J PHARMACOL, V138, P177, DOI 10.1038/sj.bjp.0705010; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Mueller Juliane S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000427; Nguyen-Huu T, 2005, ANESTHESIOLOGY, V103, P788, DOI 10.1097/00000542-200510000-00017; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Nicole S, 2014, BRAIN, V137, P2429, DOI 10.1093/brain/awu160; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; OWENS J, 1993, RECEPTOR CHANNEL, V1, P173; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Riemersma M, 2015, NEUROLOGY, V84, P2177, DOI 10.1212/WNL.0000000000001615; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Salih MAM, 1996, ANN NEUROL, V40, P925, DOI 10.1002/ana.410400617; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SCHOFIELD JN, 1995, DEV DYNAM, V204, P178, DOI 10.1002/aja.1002040208; Sigoillot SM, 2010, CHEM-BIOL INTERACT, V187, P84, DOI 10.1016/j.cbi.2010.02.007; Sigoillot SM, 2010, J NEUROSCI, V30, P13, DOI 10.1523/JNEUROSCI.4374-09.2010; Spillane J, 2010, J NEUROL NEUROSUR PS, V81, P850, DOI 10.1136/jnnp.2008.169367; Stum M, 2008, HUM MOL GENET, V17, P3166, DOI 10.1093/hmg/ddn213; Stum M, 2006, HUM MUTAT, V27, P1082, DOI 10.1002/humu.20388; Tang HB, 2006, J BIOL CHEM, V281, P3943, DOI 10.1074/jbc.M511317200; Tang HB, 2004, CELL SIGNAL, V16, P551, DOI 10.1016/j.cellsig.2003.09.006; VANDERKLOOT W, 1994, PFLUG ARCH EUR J PHY, V428, P114, DOI 10.1007/BF00374848; Wargon I, 2012, NEUROMUSCULAR DISORD, V22, P318, DOI 10.1016/j.nmd.2011.09.002; Yumoto N, 2005, BIOCHEM BIOPH RES CO, V331, P1522, DOI 10.1016/j.bbrc.2005.04.081	64	16	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2382	2399		10.1096/fj.201500162	http://dx.doi.org/10.1096/fj.201500162			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26993635				2022-12-28	WOS:000376878300027
J	Mumaw, CL; Levesque, S; McGraw, C; Robertson, S; Lucas, S; Stafflinger, JE; Campen, MJ; Hall, P; Norenberg, JP; Anderson, T; Lund, AK; McDonald, JD; Ottens, AK; Block, ML				Mumaw, Christen L.; Levesque, Shannon; McGraw, Constance; Robertson, Sarah; Lucas, Selita; Stafflinger, Jillian E.; Campen, Matthew J.; Hall, Pamela; Norenberg, Jeffrey P.; Anderson, Tamara; Lund, Amie K.; McDonald, Jacob D.; Ottens, Andrew K.; Block, Michelle L.			Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors	FASEB JOURNAL			English	Article						neuroinflammation; inhaled pollutants; glia	PARTICULATE MATTER; RESIDENTIAL PROXIMITY; PARKINSONS-DISEASE; COGNITIVE FUNCTION; EXPOSURE; NEUROINFLAMMATION; INFLAMMATION; CHILDREN; DEMENTIA; EXHAUST	Air pollution is implicated in neurodegenerative disease risk and progression and in microglial activation, but the mechanisms are unknown. In this study, microglia remained activated 24 h after ozone (O-3) exposure in rats, suggesting a persistent signal from lung to brain. Ex vivo analysis of serum from O-3-treated rats revealed an augmented microglial proinflammatory response and beta-amyloid 42 (A beta 42) neurotoxicity independent of traditional circulating cytokines, where macrophage-1 antigen-mediated microglia proinflammatory priming. Aged mice exhibited reduced pulmonary immune profiles and the most pronounced neuroinflammation and microglial activation in response to mixed vehicle emissions. Consistent with this premise, cluster of differentiation 36 (CD36)(-/-) mice exhibited impaired pulmonary immune responses concurrent with augmented neuroinflammation and microglial activation in response to O-3. Further, aging glia were more sensitive to the proinflammatory effects of O-3 serum. Together, these findings outline the lung-brain axis, where air pollutant exposures result in circulating, cytokine-independent signals present in serum that elevate the brain proinflammatory milieu, which is linked to the pulmonary response and is further augmented with age.-Mumaw, C. L., Levesque, S., McGraw, C., Robertson, S., Lucas, S., Stafflinger, J. E., Campen, M. J., Hall, P., Norenberg, J. P., Anderson, T., Lund, A. K., McDonald, J. D., Ottens, A. K., Block, M. L. Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors. www.fasebj.org	[Mumaw, Christen L.; Block, Michelle L.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Levesque, Shannon; McGraw, Constance; Stafflinger, Jillian E.; Ottens, Andrew K.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Campus, Richmond, VA USA; [Robertson, Sarah; Lucas, Selita; Campen, Matthew J.; Hall, Pamela] Univ New Mexico, Coll Pharm, Keck Univ New Mexico Small Anim Imaging Resource, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Norenberg, Jeffrey P.; Anderson, Tamara] Univ New Mexico, Coll Pharm, Keck Univ New Mexico Small Anim Imaging Resource, Radiopharmaceut Sci, Albuquerque, NM 87131 USA; [Lund, Amie K.] Univ N Texas, Dept Biol Sci, Adv Environm Res Inst, Denton, TX 76203 USA; [McDonald, Jacob D.] Lovelace Resp Res Inst, Albuquerque, NM USA	Indiana University System; Indiana University Bloomington; Virginia Commonwealth University; University of New Mexico; University of New Mexico; University of North Texas System; University of North Texas Denton; Lovelace Respiratory Research Institute	Block, ML (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	mlblock@iupui.edu	Lund, Amie K/L-4355-2017; Norenberg, Jeffrey/AAL-1725-2021; Hall, Pamela/O-5402-2016	Lund, Amie K/0000-0002-0878-751X; Block, Michelle/0000-0001-8303-7914; Ottens, Andrew/0000-0002-2118-3796; McGraw, Constance/0000-0001-5635-0892; Hall, Pamela/0000-0003-2367-3382	U.S. National Institutes of Health/National Institute of Environmental Health Sciences [ES016951, ES014639]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES014639, R01ES016951, R01ES014639] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the U.S. National Institutes of Health/National Institute of Environmental Health Sciences [ES016951 (to M.L.B.) and ES014639 (to M.J.C.)]. The authors declare no conflicts of interest.	Antonini JM, 2009, NEUROTOXICOLOGY, V30, P915, DOI 10.1016/j.neuro.2009.09.006; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Bedada GB, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-77; Bell ML, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-41; Bentayeb M, 2012, INT J TUBERC LUNG D, V16, P1149, DOI 10.5588/ijtld.11.0666; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Calderon-Garciduenas L, 2004, TOXICOL PATHOL, V32, P650, DOI 10.1080/01926230490520232; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/161687; Calderon-Garciduenas L, 2012, J ALZHEIMERS DIS, V28, P93, DOI 10.3233/JAD-2011-110722; Calderon-Garciduenas L, 2011, INT J DEV NEUROSCI, V29, P365, DOI 10.1016/j.ijdevneu.2011.03.007; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Campbell A, 2014, TOXICOL IN VITRO, V28, P1290, DOI 10.1016/j.tiv.2014.06.015; Campbell A, 2009, J NANOSCI NANOTECHNO, V9, P5099, DOI 10.1166/jnn.2009.GR07; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Chen MH, 2014, J AM MED DIR ASSOC, V15, P763, DOI 10.1016/j.jamda.2014.06.003; Cole MP, 2009, AM J PHYSIOL-LUNG C, V297, pL205, DOI 10.1152/ajplung.00187.2009; Dodd JW, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0116-3; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fiore AM, 2012, CHEM SOC REV, V41, P6663, DOI 10.1039/c2cs35095e; Gerlofs-Nijland ME, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-12; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Jung CR, 2015, J ALZHEIMERS DIS, V44, P573, DOI 10.3233/JAD-140855; Kioumourtzoglou MA, 2016, ENVIRON HEALTH PERSP, V124, P23, DOI 10.1289/ehp.1408973; Kirrane EF, 2015, J OCCUP ENVIRON MED, V57, P509, DOI 10.1097/JOM.0000000000000451; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Liao KM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000930; Liao WC, 2015, EUR J NEUROL, V22, P334, DOI 10.1111/ene.12573; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Lund AK, 2011, AM J RESP CRIT CARE, V184, P82, DOI 10.1164/rccm.201012-1967OC; Mauderly JL, 2010, INHAL TOXICOL, V22, P1, DOI 10.3109/08958371003793846; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Oppenheim HA, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-62; Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093; Pei Z, 2007, GLIA, V55, P1362, DOI 10.1002/glia.20545; Peng YH, 2015, J EPIDEMIOL COMMUN H, V69, P123, DOI 10.1136/jech-2014-204445; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Poria RB, 2006, CANCER BIOTHER RADIO, V21, P418, DOI 10.1089/cbr.2006.21.418; Postlethwait EM, 1998, AM J PHYSIOL-LUNG C, V274, pL1006, DOI 10.1152/ajplung.1998.274.6.L1006; Power MC, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-16; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187; Robertson S, 2013, TOXICOL SCI, V134, P304, DOI 10.1093/toxsci/kft107; Rozovsky I, 1998, NEUROBIOL AGING, V19, P97, DOI 10.1016/S0197-4580(97)00169-3; Sama P, 2007, INHAL TOXICOL, V19, P1079, DOI 10.1080/08958370701628721; Santiago-Lopez D, 2010, TOXICOL LETT, V197, P193, DOI 10.1016/j.toxlet.2010.05.020; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Takano T, 2015, DEV NEUROSCI-BASEL, V37, P195, DOI 10.1159/000398791; Thomson EM, 2013, TOXICOL SCI, V135, P169, DOI 10.1093/toxsci/kft137; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; Wellenius GA, 2012, J AM GERIATR SOC, V60, P2075, DOI 10.1111/j.1532-5415.2012.04195.x; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zhou J, 2012, CRIT CARE MED, V40, P2438, DOI 10.1097/CCM.0b013e3182546855	68	93	94	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1880	1891		10.1096/fj.201500047	http://dx.doi.org/10.1096/fj.201500047			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26864854	Green Published			2022-12-28	WOS:000374879400017
J	Thevenet, J; De Marchi, U; Domingo, JS; Christinat, N; Bultot, L; Lefebvre, G; Sakamoto, K; Descombes, P; Masoodi, M; Wiederkehr, A				Thevenet, Jonathan; De Marchi, Umberto; Domingo, Jaime Santo; Christinat, Nicolas; Bultot, Laurent; Lefebvre, Gregory; Sakamoto, Kei; Descombes, Patrick; Masoodi, Mojgan; Wiederkehr, Andreas			Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems	FASEB JOURNAL			English	Article						medium-chain triglycerides; energy metabolism; NAD(P)H; iPSC	KETOGENIC DIETS; BRAIN METABOLISM; DEPENDENT REGULATION; GLUCOSE-UTILIZATION; CHILDHOOD EPILEPSY; ENERGY-METABOLISM; ATP; TRANSPORT; OXIDATION; SEIZURES	Medium-chain triglycerides have been used as part of a ketogenic diet effective in reducing epileptic episodes. The health benefits of the derived medium-chain fatty acids (MCFAs) are thought to result from the stimulation of liver ketogenesis providing fuel for the brain. We tested whether MCFAs have direct effects on energy metabolism in induced pluripotent stem cell-derived human astrocytes and neurons. Using single-cell imaging, we observed an acute pronounced reduction of the mitochondrial electrical potential and a concomitant drop of the NAD(P)H signal in astrocytes, but not in neurons. Despite the observed effects on mitochondrial function, MCFAs did not lower intracellular ATP levels or activate the energy sensor AMP-activated protein kinase. ATP concentrations in astrocytes were unaltered, even when blocking the respiratory chain, suggesting compensation through accelerated glycolysis. The MCFA decanoic acid (300 mu M) promoted glycolysis and augmented lactate formation by 49.6%. The shorter fatty acid octanoic acid (300 mu M) did not affect glycolysis but increased the rates of astrocyte ketogenesis 2.17-fold compared with that of control cells. MCFAs may have brain health benefits through the modulation of astrocyte metabolism leading to activation of shuttle systems that provide fuel to neighboring neurons in the form of lactate and ketone bodies.-Thevenet, J., De Marchi, U., Santo Domingo, J., Christinat, N., Bultot, L., Lefebvre, G., Sakamoto, K., Descombes, P., Masoodi, M., Wiederkehr, A. Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketonebody shuttle systems. www.fasebj.org	[Thevenet, Jonathan; De Marchi, Umberto; Domingo, Jaime Santo; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, CH-1015 Lausanne, Switzerland; [Christinat, Nicolas; Masoodi, Mojgan] Nestle Inst Hlth Sci, Lipid Biol, CH-1015 Lausanne, Switzerland; [Bultot, Laurent; Sakamoto, Kei] Nestle Inst Hlth Sci, Diabet & Circadian Rhythms, CH-1015 Lausanne, Switzerland; [Lefebvre, Gregory; Descombes, Patrick] Nestle Inst Hlth Sci, Funct Genom, CH-1015 Lausanne, Switzerland	Nestle SA; Nestle SA; Nestle SA; Nestle SA	Wiederkehr, A (corresponding author), Nestle Inst Hlth Sci, EPFL Innovat Pk,Bldg G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com	Domingo, Jaime Santo/AAE-1100-2021; Domingo, Jaime Santo/AAA-4995-2020; sakamoto, kei/C-8806-2019; MASOODI, MOJGAN/P-1499-2019	Domingo, Jaime Santo/0000-0001-5501-0482; sakamoto, kei/0000-0001-8839-5980; MASOODI, MOJGAN/0000-0001-9840-1731; De Marchi, Umberto/0000-0002-6011-5446; Lefebvre, Greg/0000-0001-7519-2316; Bultot, Laurent/0000-0002-5088-0101				Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; [Anonymous], 2003, T AM CLIN CLIMATOL A; AUESTAD N, 1991, J NEUROCHEM, V56, P1376, DOI 10.1111/j.1471-4159.1991.tb11435.x; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berardi MJ, 2014, CELL METAB, V20, P541, DOI 10.1016/j.cmet.2014.07.004; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; BIXEL MG, 1995, J NEUROCHEM, V65, P2450; Cahill George F Jr, 2003, Trans Am Clin Climatol Assoc, V114, P149; Danial NN, 2013, J CHILD NEUROL, V28, P1027, DOI 10.1177/0883073813487598; DEAN HG, 1989, CLIN CHEM, V35, P1945; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Ebert D, 2003, J NEUROSCI, V23, P5928; Fuehrlein BS, 2004, J CLIN ENDOCR METAB, V89, P1641, DOI 10.1210/jc.2003-031796; Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Guzman M, 2001, TRENDS ENDOCRIN MET, V12, P169, DOI 10.1016/S1043-2760(00)00370-2; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; HASSELBALCH SG, 1994, J CEREBR BLOOD F MET, V14, P125, DOI 10.1038/jcbfm.1994.17; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HUTTENLOCHER PR, 1976, PEDIATR RES, V10, P536, DOI 10.1203/00006450-197605000-00006; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Lai YC, 2014, BIOCHEM J, V460, P363, DOI 10.1042/BJ20131673; Lambert HP, 2014, J BIOL CHEM, V289, P31014, DOI 10.1074/jbc.M114.570879; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Neal EG, 2010, J HUM NUTR DIET, V23, P113, DOI 10.1111/j.1365-277X.2010.01043.x; Neal EG, 2009, EPILEPSIA, V50, P1109, DOI 10.1111/j.1528-1167.2008.01870.x; OLSON JE, 1992, METAB BRAIN DIS, V7, P183, DOI 10.1007/BF01000245; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Pan JW, 2000, J CEREBR BLOOD F MET, V20, P1502, DOI 10.1097/00004647-200010000-00012; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Passonneau J.V., 1993, ENZYMATIC ANAL, DOI [10.1007/978-1-60327-407-4, DOI 10.1007/978-1-60327-407-4]; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; Sampol Denys, 2013, Front Neuroenergetics, V5, P5, DOI 10.3389/fnene.2013.00005; SEATON TB, 1986, AM J CLIN NUTR, V44, P630, DOI 10.1093/ajcn/44.5.630; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302	42	86	88	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1913	1926		10.1096/fj.201500182	http://dx.doi.org/10.1096/fj.201500182			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839375				2022-12-28	WOS:000374879400020
J	Liu, SB; Ikenaga, N; Peng, ZW; Sverdlov, DY; Greenstein, A; Smith, V; Schuppan, D; Popov, Y				Liu, Susan B.; Ikenaga, Naoki; Peng, Zhen-Wei; Sverdlov, Deanna Y.; Greenstein, Andrew; Smith, Victoria; Schuppan, Detlef; Popov, Yury			Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice	FASEB JOURNAL			English	Article						BAPN; CCl4; collagen cross-linking; hepatic stellate cells	HEPATIC STELLATE CELLS; ANTIFIBROTIC THERAPIES; EXTRACELLULAR-MATRIX; BILIARY FIBROSIS; CROSS-LINKING; ACTIVATION; MECHANISMS; DEPOSITION; STIFFNESS; CIRRHOSIS	Collagen stabilization through irreversible cross-linking is thought to promote hepatic fibrosis progression and limit its reversibility. However, the mechanism of this process remains poorly defined. We studied the functional contribution of lysyl oxidase (LOX) to collagen stabilization and hepatic fibrosis progression/reversal in vivo using chronic administration of irreversible LOX inhibitor beta-aminopropionitrile (BAPN, or vehicle as control) in C57Bl/6J mice with carbon tetrachloride (CCl4)-induced fibrosis. Fibrotic matrix stability was directly assessed using a stepwise collagen extraction assay and fibrotic septae morphometry. Liver cells and fibrosis were studied by histologic, biochemical methods and quantitative real-time reverse-transcription PCR. During fibrosis progression, BAPN administration suppressed accumulation of cross-linked collagens, and fibrotic septae showed widening and collagen fibrils splitting, reminiscent of remodeling signs observed during fibrosis reversal. LOX inhibition attenuated hepatic stellate cell activation markers and promoted F4/80-positive scar-associated macrophage infiltration without an increase in liver injury. In reversal experiments, BAPN-treated fibrotic mice demonstrated accelerated fibrosis reversal after CCl4 withdrawal. Our findings demonstrate for the first time that LOX contributes significantly to collagen stabilization in liver fibrosis, promotes fibrogenic activation of attenuated hepatic stellate cells, and limits fibrosis reversal. Our data support the concept of pharmacologic targeting of LOX pathway to inhibit liver fibrosis and promote its resolution.-Liu, S. B., Ikenaga, N., Peng, Z.-W., Sverdlov, D. Y., Greenstein, A., Smith, V., Schuppan, D., Popov, Y. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice. FASEB J. 30, 1599-1609 (2016). www.fasebj.org	[Liu, Susan B.; Ikenaga, Naoki; Peng, Zhen-Wei; Sverdlov, Deanna Y.; Schuppan, Detlef; Popov, Yury] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med, 330 Brookline Ave, Boston, MA 02115 USA; [Peng, Zhen-Wei] Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Greenstein, Andrew; Smith, Victoria] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Schuppan, Detlef] Univ Med Ctr, Inst Translat Immunol, Mainz, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Sun Yat Sen University; Gilead Sciences; Johannes Gutenberg University of Mainz	Popov, Y (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med, 330 Brookline Ave, Boston, MA 02115 USA.	ypopov@bidmc.harvard.edu	Popov, Yury V./A-7781-2008	Popov, Yury V./0000-0001-7973-942X; Greenstein, Andrew/0000-0002-1470-1970				Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Gaca MDA, 2003, MATRIX BIOL, V22, P229, DOI 10.1016/S0945-053X(03)00017-9; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; KAGAN HM, 1994, PATHOL RES PRACT, V190, P910; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kuramitsu K, 2013, AM J PATHOL, V183, P182, DOI 10.1016/j.ajpath.2013.03.018; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Popov Y, 2011, GASTROENTEROLOGY, V140, P1642, DOI 10.1053/j.gastro.2011.01.040; Popov Y, 2010, AM J PHYSIOL-GASTR L, V298, pG323, DOI 10.1152/ajpgi.00394.2009; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052	31	121	123	2	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1599	1609		10.1096/fj.14-268425	http://dx.doi.org/10.1096/fj.14-268425			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700732				2022-12-28	WOS:000372629100021
J	Lommel, MJ; Trairatphisan, P; Gabler, K; Laurini, C; Muller, A; Kaoma, T; Vallar, L; Sauter, T; Schaffner-Reckinger, E				Lommel, Maiti J.; Trairatphisan, Panuwat; Gaebler, Karoline; Laurini, Christina; Muller, Arnaud; Kaoma, Tony; Vallar, Laurent; Sauter, Thomas; Schaffner-Reckinger, Elisabeth			L-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway	FASEB JOURNAL			English	Article						invasion; migration; signal transduction; actin cytoskeleton	PROTEIN-KINASE-C; INTEGRIN ACTIVATION; EXPRESSION PATTERNS; MELANOMA-CELLS; LUNG-CANCER; GENE; LINES; INVASION; MODELS; CAMP	Deregulated cell migration and invasion are hallmarks of metastatic cancer cells. Phosphorylation on residue Ser5 of the actin-bundling protein L-plastin activates L-plastin and has been reported to be crucial for invasion and metastasis. Here, we investigate signal transduction leading to L-plastin Ser5 phosphorylation using 4 human breast cancer cell lines. Whole-genome microarray analysis comparing cell lines with different invasive capacities and corresponding variations in L-plastin Ser5 phosphorylation level revealed that genes of the ERK/MAPK pathway are differentially expressed. It is note-worthy that in vitro kinase assays showed that ERK/MAPK pathway downstream ribosomal protein S6 kinases alpha-1 (RSK1) and alpha-3 (RSK2) are able to directly phosphorylate L-plastin on Ser5. Small interfering RNA- or short hairpin RNA-mediated knockdown and activation/inhibition studies followed by immunoblot analysis and computational modeling confirmed that ribosomal S6 kinase (RSK) is an essential activator of L-plastin. Migration and invasion assays showed that RSK knockdown led to a decrease of up to 30% of migration and invasion of MDA-MB-435S cells. Although the presence of L-plastin was not necessary for migration/invasion of these cells, immunofluorescence assays illustrated RSK-dependent recruitment of Ser5-phosphorylated L-plastin to migratory structures. Altogether, we provide evidence that the ERK/MAPK pathway is involved in L-plastin Ser5 phosphorylation in breast cancer cells with RSK1 and RSK2 kinases able to directly phosphorylate L-plastin residue Ser5.	[Lommel, Maiti J.; Gaebler, Karoline; Laurini, Christina; Schaffner-Reckinger, Elisabeth] Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Campus Limpertsberg,162a,Ave Faiencerie, L-1511 Luxembourg, Luxembourg; [Trairatphisan, Panuwat; Sauter, Thomas] Univ Luxembourg, Life Sci Res Unit, Syst Biol Grp, L-1511 Luxembourg, Luxembourg; [Muller, Arnaud; Kaoma, Tony; Vallar, Laurent] Luxembourg Inst Hlth, Genom Res Unit, Luxembourg, Luxembourg	University of Luxembourg; University of Luxembourg; Luxembourg Institute of Health	Schaffner-Reckinger, E (corresponding author), Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Campus Limpertsberg,162a,Ave Faiencerie, L-1511 Luxembourg, Luxembourg.	elisabeth.schaffner@uni.lu		Muller, Arnaud/0000-0002-3841-4722; Trairatphisan, Panuwat/0000-0001-9015-5855; Vallar, Laurent/0000-0002-4404-1010; Sauter, Thomas/0000-0001-8225-2954	UL (Internal Research Project: PhosphoPlast); Fonds National de la Recherche (Aides a la Formation-Recherche) [2748401, 1233900]	UL (Internal Research Project: PhosphoPlast); Fonds National de la Recherche (Aides a la Formation-Recherche)(Luxembourg National Research Fund)	The authors are grateful to Alexandre Baron (University of Luxembourg, UL) for his meaningful contribution to the revision of this manuscript and to Nicolas Beaume (UL) and Aurelien Ginolhac (UL) for help with statistical data analysis. The authors thank Maria Koffa (Democritus University of Thrace, Alexandroupoli, Greece) and Serge Haan (UL) for proofreading the manuscript and constructive discussions as well as Evelyne Friederich (UL) as an initiator of this research project. The authors also thank Francois Bernardin (Luxembourg Institute of Health) and Andreas Girod (UL) for assistance with microarray and confocal microscopy experiments, respectively. In addition, the authors thank Joe W. Ramos (University of Hawaii, Honolulu, HI, USA) for providing the ribosomal protein S6 kinase alpha-3 constructs. This work was supported by a grant from the UL (Internal Research Project: PhosphoPlast). M.J.L. and P.T. are recipients of fellowships allocated by the Fonds National de la Recherche (Aides a la Formation-Recherche Grants 2748401 and 1233900, respectively). The authors declare no conflicts of interest.	Al Tanoury Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009210; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; ARPIN M, 1994, J CELL BIOL, V127, P1995, DOI 10.1083/jcb.127.6.1995; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Gawecka JE, 2012, J BIOL CHEM, V287, P43424, DOI 10.1074/jbc.M112.423046; Hagi A, 2006, MICROBIOL IMMUNOL, V50, P331, DOI 10.1111/j.1348-0421.2006.tb03801.x; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hollestelle A, 2009, CANCER RES, V69, P7893, DOI 10.1158/0008-5472.CAN-09-2396; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Janji B, 2010, J CELL MOL MED, V14, P1264, DOI 10.1111/j.1582-4934.2009.00918.x; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Klemke M, 2007, INT J CANCER, V120, P2590, DOI 10.1002/ijc.22589; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Le Goff E, 2010, CYTOSKELETON, V67, P286, DOI 10.1002/cm.20442; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Li D, 2013, J BIOL CHEM, V288, P32528, DOI 10.1074/jbc.M113.500561; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lin CS, 1998, DNA CELL BIOL, V17, P1041, DOI 10.1089/dna.1998.17.1041; MATSUSHIMA K, 1987, J IMMUNOL, V139, P3367; Mok TSK, 2011, NAT REV CLIN ONCOL, V8, P661, DOI 10.1038/nrclinonc.2011.126; Morley Sharon Celeste, 2012, Int J Cell Biol, V2012, P935173, DOI 10.1155/2012/935173; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Paclet MH, 2004, BIOCHEM J, V377, P469, DOI 10.1042/BJ20031114; Pazdrak K, 2011, J IMMUNOL, V186, P6485, DOI 10.4049/jimmunol.1001868; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Riplinger SM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-10; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Shinomiya Hiroto, 2012, Int J Cell Biol, V2012, P213492, DOI 10.1155/2012/213492; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sugita S, 1997, J NEUROSCI, V17, P7237; Sulzmaier FJ, 2013, CANCER RES, V73, P6099, DOI 10.1158/0008-5472.CAN-13-1087; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Trairatphisan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098001; Trairatphisan P, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-46; Vial D, 2012, J BIOL CHEM, V287, P40371, DOI 10.1074/jbc.M112.389577; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zheng JP, 1999, AM J PATHOL, V155, P115, DOI 10.1016/S0002-9440(10)65106-1	67	24	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1218	1233		10.1096/fj.15-276311	http://dx.doi.org/10.1096/fj.15-276311			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631483				2022-12-28	WOS:000370387800019
J	Shabrova, E; Hoyos, B; Vinogradov, V; Kim, YK; Wassef, L; Leitges, M; Quadro, L; Hammerling, U				Shabrova, Elena; Hoyos, Beatrice; Vinogradov, Valerie; Kim, Youn-Kyung; Wassef, Lesley; Leitges, Michael; Quadro, Loredana; Hammerling, Ulrich			Retinol as a cofactor for PKC delta-mediated impairment of insulin sensitivity in a mouse model of diet-induced obesity	FASEB JOURNAL			English	Article						vitamin A; PKC delta signalosome; metabolic syndrome	PROTEIN-KINASE-C; ADIPOSE-TISSUE INFLAMMATION; NECROSIS-FACTOR-ALPHA; BINDING-PROTEIN; VITAMIN-A; OXIDATIVE STRESS; GENE-EXPRESSION; SERUM RETINOL-BINDING-PROTEIN-4; MITOCHONDRIAL DYSFUNCTION; RESISTANCE	We previously defined that the mitochondria-localized PKC delta signaling complex stimulates the conversion of pyruvate to acetyl-coenzyme A by the pyruvate dehydrogenase complex. We demonstrated in vitro and ex vivo that retinol supplementation enhances ATP synthesis in the presence of the PKC delta signalosome. Here, we tested in vivo if a persistent oversupply of retinol would further impair glucose metabolism in a mouse model of diet-induced insulin resistance. We crossed mice overexpressing human retinol-binding protein (hRBP) under the muscle creatine kinase (MCK) promoter (MCKhRBP) with the PKC delta(-/-) strain to generate mice with a different status of the PKC delta signalosome and retinoid levels. Mice with a functional PKC delta signalosome and elevated retinoid levels (PKC delta(+/+)hRBP) developed the most advanced stage of insulin resistance. In contrast, elevation of retinoid levels in mice with inactive PKC delta did not affect remarkably their metabolism, resulting in phenotypic similarity between PKC delta(-/-)hRBP and PKC delta(-/-) mice. Therefore, in addition to the well-defined role of PKC delta in the etiology of metabolic syndrome, we present a novel PKC delta signaling pathway that requires retinol as a metabolic cofactor and is involved in the regulation of fuel utilization in mitochondria. The distinct role in whole-body energy homeostasis establishes the PKC delta signalosome as a promising target for therapeutic intervention in metabolic disorders.	[Shabrova, Elena; Hoyos, Beatrice; Vinogradov, Valerie; Hammerling, Ulrich] Mem Sloan Kettering Canc Ctr, Program Immunol, 425 East 68th St, New York, NY 10065 USA; [Kim, Youn-Kyung; Wassef, Lesley; Quadro, Loredana; Hammerling, Ulrich] Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, POB 231, New Brunswick, NJ 08903 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; University of Oslo	Hammerling, U (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 425 East 68th St, New York, NY 10065 USA.	uhammerling@gmail.com	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	Memorial Sloan-Kettering Cancer Center; U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD057493, R01HD057493-02S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Memorial Sloan-Kettering Cancer Center; U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge intellectual and material support by the members of the Weill-Cornell Pharmacology Department (New York, NY, USA), Drs. Lorraine Gudas, Jochen Buck, and Lonny Levine. The authors also thank Drs. Giovanni Manfredi and Anatoly Starkov (Cornell Medical College, New York, NY, USA) for manyfold advice and Dr. Malcolm Watford (Rutgers University, Piscataway, NY, USA) for critical reading of the manuscript. The authors are indebted to Dr. J. Friedman (Rockefeller University, New York, NY, USA) for help in PIXImus measurements. U.H. was supported by a grant from Memorial Sloan-Kettering Cancer Center, and L.Q. by grants from the U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD057493 and R01HD057493-02S1). E.S., L.Q., B.H., and U.H. were responsible for planning, oversight, and execution of the experiments, as well as of interpretation and validation of results. V.V., Y.-K.K., and L.W. carried out mouse breeding, maintenance and genotyping experiments, and assisted with various analytic procedures. M.L. provided breeding pairs of protein kinase C delta knockout mice. The authors declare no conflicts of interest.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; [Anonymous], [No title captured], DOI DOI 10.1016/j.febslet.2007.11.051; Avogaro A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000262; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; BOUSSIOTIS VA, 1994, P NATL ACAD SCI USA, V91, P7007, DOI 10.1073/pnas.91.15.7007; Braiman L, 1999, MOL ENDOCRINOL, V13, P2002, DOI 10.1210/me.13.12.2002; Braiman L, 2001, MOL ENDOCRINOL, V15, P565, DOI 10.1210/me.15.4.565; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056; BUCK J, 1990, J EXP MED, V171, P1613, DOI 10.1084/jem.171.5.1613; BUCK J, 1991, SCIENCE, V254, P1654, DOI 10.1126/science.1749937; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Chiu HJ, 2008, FASEB J, V22, P3878, DOI 10.1096/fj.08-112375; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; Colombo C, 2003, J BIOL CHEM, V278, P3992, DOI 10.1074/jbc.M207665200; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; de Oliveira MR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/140267; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; FARESE RV, 1992, BIOCHEM J, V288, P319, DOI 10.1042/bj2880319; Fisher-Wellman KH, 2013, FREE RADICAL BIO MED, V65, P1201, DOI 10.1016/j.freeradbiomed.2013.09.008; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Gavi S, 2007, J CLIN ENDOCR METAB, V92, P1886, DOI 10.1210/jc.2006-1815; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gong JL, 2012, FASEB J, V26, P3537, DOI 10.1096/fj.11-197376; Goodman E, 2005, CIRCULATION, V111, P1970, DOI 10.1161/01.CIR.0000161957.34198.2B; Goodpaster BH, 2013, DIABETES, V62, P1032, DOI 10.2337/db12-1612; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Halse R, 2001, DIABETES, V50, P720, DOI 10.2337/diabetes.50.4.720; Hammerling U, 2013, FASEB J, V27, P3887, DOI 10.1096/fj.13-1001ufm; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Hoyos B, 2012, BBA-MOL CELL BIOL L, V1821, P241, DOI 10.1016/j.bbalip.2011.06.014; Hu C, 2008, DIABETIC MED, V25, P11, DOI 10.1111/j.1464-5491.2007.02314.x; Imam A, 2001, FASEB J, V15, P28; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Johansson H, 2008, CANCER RES, V68, P9512, DOI 10.1158/0008-5472.CAN-08-0553; Jolliffe I.T., 2002, SPRINGER SERIES STAT; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kuehn HS, 2013, BLOOD, V121, P3117, DOI 10.1182/blood-2012-12-469544; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Manolescu DC, 2010, J NUTR, V140, P311, DOI 10.3945/jn.109.115147; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McTernan PG, 2007, J CLIN ENDOCR METAB, V92, P2430, DOI 10.1210/jc.2007-1054; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Mobbs Charles V., 2007, V35, P39; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; NOY N, 1991, BIOCHEMISTRY-US, V30, P6380, DOI 10.1021/bi00240a005; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; Opalinska M, 2014, MICROB CELL, V1, P51, DOI 10.15698/mic2014.01.127; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pagnin E, 2005, J CLIN ENDOCR METAB, V90, P1130, DOI 10.1210/jc.2004-1283; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rahimi Y, 2014, P NATL ACAD SCI USA, V111, P16508, DOI 10.1073/pnas.1419104111; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Rosenzweig T, 2002, DIABETES, V51, P1921, DOI 10.2337/diabetes.51.6.1921; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Sommer A., 1996, VITAMIN A DEFICIENCY, P62; Sorriento D., 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/604685; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; SUTHERLAND TM, 1974, GENETICS, V78, P525; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004; Tamori Y, 2006, NAT MED, V12, P30, DOI 10.1038/nm0106-30; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Valsecchi F, 2013, PHYSIOLOGY, V28, P199, DOI 10.1152/physiol.00004.2013; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970; Zhao F, 2011, ANTIOXID REDOX SIGN, V14, P757, DOI 10.1089/ars.2010.3773	108	8	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1339	1355		10.1096/fj.15-281543	http://dx.doi.org/10.1096/fj.15-281543			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26671999	Green Published			2022-12-28	WOS:000370387800029
J	Fajol, A; Chen, H; Umbach, AT; Quarles, LD; Lang, F; Foller, M				Fajol, Abul; Chen, Hong; Umbach, Anja T.; Quarles, L. Darryl; Lang, Florian; Foeller, Michael			Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by beta-blocker treatment	FASEB JOURNAL			English	Article						protein kinase B; calcitriol; propranolol; sympathetic activity	GROWTH-FACTOR 23; DOMINANT HYPOPHOSPHATEMIC RICKETS; VITAMIN-D-RECEPTOR; PHOSPHATE HOMEOSTASIS; DIETARY PHOSPHATE; FACTOR-23; SERUM; METABOLISM; PHOSPHORYLATION; GLUCOSE	Glycogen synthase kinase (GSK)-3 is a ubiquitously expressed kinase inhibited by insulin-dependent Akt/PKB/SGK. Mice expressing Akt/PKB/SGK-resistant GSK3 alpha/GSK3 beta (gsk3(KI)) exhibit enhanced sympathetic nervous activity and phosphaturia with decreased bone density. Hormones participating in phosphate homeostasis include fibroblast growth factor (FGF)-23, a bone-derived hormone that inhibits 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3; calcitriol) formation and phosphate reabsorption in the kidney and counteracts vascular calcification and aging. FGF23 secretion is stimulated by the sympathetic nervous system. We studied the role of GSK3-controlled sympathetic activity in FGF23 production and phosphate metabolism. Serum FGF23, 1,25(OH)(2)D-3, and urinary vanillylmandelic acid (VMA) were measured by ELISA, and serum and urinary phosphate and calcium were measured by photometry in gsk3(KI) and gsk3(WT) mice, before and after 1 wk of oral treatment with the beta-blocker propranolol. Urinary VMA excretion, serum FGF23, and renal phosphate and calcium excretion were significantly higher, and serum 1,25(OH)(2)D-3 and phosphate concentrations were lower in gsk3(KI) mice than in gsk3(WT) mice. Propranolol treatment decreased serum FGF23 and loss of renal calcium and phosphate and increased serum phosphate concentration in gsk3(KI) mice. We conclude that Akt/PKB/SGK-sensitive GSK3 inhibition participates in the regulation of FGF23 release, 1,25(OH)(2)D-3 formation, and thus mineral metabolism, by controlling the activity of the sympathetic nervous system.	[Fajol, Abul; Chen, Hong; Umbach, Anja T.; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Quarles, L. Darryl] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA; [Foeller, Michael] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06120 Halle, Saale, Germany	Eberhard Karls University of Tubingen; University of Tennessee System; University of Tennessee Health Science Center; Martin Luther University Halle Wittenberg	Foller, M (corresponding author), Univ Halle Wittenberg, Inst Agr & Ernahrungswissensch, Von Danckelmann Pl 2, D-06120 Halle, Saale, Germany.	michael.foeller@landw.uni-halle.de	Fajol, Abul/AAD-1605-2019	Fajol, Abul/0000-0002-3202-5697; Quarles, L. Darryl/0000-0002-5082-7896	Deutsche Forschungsgemeinschaft [Fo 695/1-1, Fo 695/1-2, La 315/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank E. Faber for technical assistance and L. Subasic for meticulous preparation of the manuscript. This study was supported by Deutsche Forschungsgemeinschaft Grants Fo 695/1-1 (to M.F.), Fo 695/1-2 (to M.F.), and La 315/15-1 (to F.L.). The authors declare no conflicts of interest.	ALLON M, 1992, J AM SOC NEPHROL, V2, P1593; Andrukhova O, 2014, EMBO MOL MED, V6, P744, DOI 10.1002/emmm.201303716; Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Bhandaru M, 2011, KIDNEY INT, V80, P61, DOI 10.1038/ki.2011.67; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Clinkenbeard EL, 2014, J BONE MINER RES, V29, P361, DOI 10.1002/jbmr.2049; de Jongh Renate T, 2013, Ned Tijdschr Geneeskd, V157, pA5908; DEFRONZO RA, 1976, J CLIN INVEST, V58, P83, DOI 10.1172/JCI108463; Fakhri H, 2014, PFLUG ARCH EUR J PHY, V466, P467, DOI 10.1007/s00424-013-1340-y; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Foller M, 2011, J AM SOC NEPHROL, V22, P873, DOI 10.1681/ASN.2010070757; Fournier C, 2014, ENDOCRINOLOGY, V155, P4305, DOI 10.1210/en.2014-1308; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hori M, 2011, ENDOCRINOLOGY, V152, P4, DOI 10.1210/en.2010-0800; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Inoue Y, 2005, BIOCHEM J, V390, P325, DOI 10.1042/BJ20041799; Kawai M, 2014, J BIOL CHEM, V289, P1457, DOI 10.1074/jbc.M113.500850; Kempe DS, 2010, ACTA PHYSIOL, V200, P75, DOI 10.1111/j.1748-1716.2010.02109.x; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lu Yongbo, 2011, Curr Osteoporos Rep, V9, P103, DOI 10.1007/s11914-011-0053-4; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marsell R, 2010, ACTA PHYSIOL, V200, P97, DOI 10.1111/j.1748-1716.2010.02163.x; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Mathew JS, 2014, CIRCULATION, V130, P298, DOI 10.1161/CIRCULATIONAHA.113.005499; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Saini RK, 2013, CALCIFIED TISSUE INT, V92, P339, DOI 10.1007/s00223-012-9683-5; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Seifert ME, 2014, AM J NEPHROL, V39, P392, DOI 10.1159/000362251; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Siraskar B, 2011, PFLUG ARCH EUR J PHY, V462, P811, DOI 10.1007/s00424-011-1006-6; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Takashi Yuichi, 2015, Clin Calcium, V25, P1037, DOI CliCa150710371042; Tenenhouse HS, 2002, PFLUG ARCH EUR J PHY, V444, P317, DOI 10.1007/s00424-002-0839-4; Voelkl J, 2013, J CLIN INVEST, V123, P812, DOI 10.1172/JCI64093; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Wyatt AW, 2006, CELL PHYSIOL BIOCHEM, V17, P137, DOI 10.1159/000092075; Yamamoto K, 2015, J CARDIOL, V66, P189, DOI 10.1016/j.jjcc.2015.02.004	60	21	21	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					994	1001		10.1096/fj.15-279943	http://dx.doi.org/10.1096/fj.15-279943			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527066	Green Published			2022-12-28	WOS:000369391900045
J	Sun, J; Xu, M; Ortsater, H; Lundeberg, E; Juntti-Berggren, L; Chen, YQ; Haeggstrom, JZ; Gudmundsson, GH; Diana, J; Agerberth, B				Sun, Jia; Xu, Meng; Ortsater, Henrik; Lundeberg, Erik; Juntti-Berggren, Lisa; Chen, Yong Q.; Haeggstrom, Jesper Z.; Gudmundsson, Gudmundur H.; Diana, Julien; Agerberth, Birgitta			Cathelicidins positively regulate pancreatic beta-cell functions	FASEB JOURNAL			English	Article						antimicrobial peptide; CRAMP; immunomodulation; endocrine cells; type 1 diabetes	ANTIMICROBIAL PEPTIDE LL-37; HOST-DEFENSE; HUMAN LUNG; EXPRESSION; GENE; APOPTOSIS; CYCLOOXYGENASE-2; ACTIVATION; MICROBIOTA; PATHWAYS	Cathelicidins are pleiotropic antimicrobial peptides largely described for innate antimicrobial defenses and, more recently, immunomodulation. They are shown to modulate a variety of immune or nonimmune host cell responses. However, how cathelicidins are expressed by beta cells and modulate beta-cell functions under steady-state or proinflammatory conditions are unknown. We find that cathelicidin-related antimicrobial peptide (CRAMP) is constitutively expressed by rat insulinoma b-cell clone INS-1 832/13. CRAMP expression is inducible by butyrate or phenylbutyric acid and its secretion triggered upon inflammatory challenges by IL-1 beta or LPS. CRAMP promotes b-cell survival in vitro via the epidermal growth factor receptor (EGFR) and by modulating expression of antiapoptotic Bcl-2 family proteins: p-Bad, Bcl-2, and Bcl-xL. Also via EGFR, CRAMP stimulates glucose-stimulated insulin secretion ex vivo by rat islets. A similar effect is observed in diabetes-prone nonobese diabetic (NOD) mice. Additional investigation under inflammatory conditions reveals that CRAMP modulates inflammatory responses and beta-cell apoptosis, asmeasured by prostaglandin E2 production, cyclooxygenases (COXs), and caspase activation. Finally, CRAMP-deficient cnlp(-/-) mice exhibit defective insulin secretion, and administration of CRAMP to prediabetic NOD mice improves blood glucose clearance upon glucose challenge. Our finding suggests that cathelicidins positively regulate beta-cell functions and may be potentially used for intervening b-cell dysfunction-associated diseases.	[Sun, Jia; Chen, Yong Q.] Jiangnan Univ, Ctr Food Safety & Nutr, Sch Food Sci & Technol & Synerget Innovat, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Xu, Meng; Haeggstrom, Jesper Z.] Uppsala Univ, Biomed Ctr, Uppsala, Sweden; [Ortsater, Henrik] Karolinska Inst, Dept Clin Sci & Educ, Diabet Res Unit, Stockholm, Sweden; [Lundeberg, Erik] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Juntti-Berggren, Lisa] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Gudmundsson, Gudmundur H.] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Diana, Julien] CNRS, INSERM, Inst Necker Enfants Malades, Paris, France; [Diana, Julien] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Agerberth, Birgitta] Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden	Jiangnan University; Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Iceland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Sun, J (corresponding author), Jiangnan Univ, Ctr Food Safety & Nutr, Sch Food Sci & Technol & Synerget Innovat, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.	jiasun@jiangnan.edu.cn	Chen, Yong Q/AAI-9864-2021; DIANA, Julien/A-2873-2014; Gudmundsson, Gudmundur H/K-9178-2015	Chen, Yong Q/0000-0003-4747-4708; DIANA, Julien/0000-0001-7542-042X; Gudmundsson, Gudmundur H/0000-0001-5793-0565	Rolf Luft Fellowship; National Natural Science Foundation of China [31400779, 31570915]; National Natural Science Foundation of China (National Youth 1000 Talents Plan); Provincial Natural Science Foundation of Jiangsu [BK20130133]; Jiangsu Provincial Shuang Chuang Innovator Plan; Icelandic Centre for Research; Juvenile Diabetes Research Foundation-Helmsley [47-2013-524, 2-SRA-2015-73]; European Foundation for the Study of Diabetes-Lilly; Swedish Research Council [20854, 10350, K2014-67X-11217-20-3]; Swedish Strategic Foundation [RBd08-0014]	Rolf Luft Fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (National Youth 1000 Talents Plan); Provincial Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Shuang Chuang Innovator Plan; Icelandic Centre for Research; Juvenile Diabetes Research Foundation-Helmsley; European Foundation for the Study of Diabetes-Lilly(Eli Lilly); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Foundation	J.S., M.X., and J.D. performed experiments and analyzed the data, with assistance from H.O., E.L., and L.J.-B., on rat and mouse islet isolation and insulin secretion studies. Y.Q.C., J.Z.H., G.H.G., and B.A. provided intellectual input and contributed to data acquisition. J.S., J.D., and B.A. designed and interpreted the experiments. J.S. and H.O. wrote the paper. The authors thank Dr. Kerstin Brismar (Karolinska Institutet, Karolinska University Hospital) for support with the Rolf Luft Fellowship, Dr. Christopher B. Newgard (Duke University, Durham, NC, USA) for kindly providing the INS-1 832/13 insulinoma clone, Dr. Malin Flodstrom-Tullberg (Karolinska Institutet, Karolinska University Hospital) for critical discussion on the insulin secretion experiment and assistance with obtaining the INS-1 832/13 insulinoma clone, Drs. Lennart Lindbom and Harvest F. Gu (Karolinska Institutet) for critical discussion on the implications of the peptides in diabetes prevention, and Liselotte Fransson (Sodersjukhuset, Stockholm, Sweden) and Chengfei Wu and Kang Chen (Jiangnan University) for assistance with islet preparation and 3-dimensional live-cell imaging experiments. This work was supported by funds from the National Natural Science Foundation of China (31400779, 31570915, and National Youth 1000 Talents Plan) and Provincial Natural Science Foundation of Jiangsu (BK20130133), Jiangsu Provincial Shuang Chuang Innovator Plan (to J.S.); Icelandic Centre for Research (to G.H.G.); Juvenile Diabetes Research Foundation-Helmsley (47-2013-524 and 2-SRA-2015-73) and European Foundation for the Study of Diabetes-Lilly (to J.D.); and Swedish Research Council (20854, Linneus grant CERIC, 10350, K2014-67X-11217-20-3) and Swedish Strategic Foundation (RBd08-0014 to B.A.). The authors declare no conflicts of interest.	Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Barlow PG, 2006, J LEUKOCYTE BIOL, V80, P509, DOI 10.1189/jlb.1005560; Brauner H., 2014, CLIN EXP IMMUNOL, V177, P478; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Colli ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002267; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Hakonen E, 2011, DIABETOLOGIA, V54, P1735, DOI 10.1007/s00125-011-2153-1; Hakonen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093651; Hober D, 2013, CURR OPIN INFECT DIS, V26, P263, DOI 10.1097/QCO.0b013e3283608300; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Parazzoli S, 2012, J BIOL CHEM, V287, P32246, DOI 10.1074/jbc.M112.364612; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Shimada S, 2002, INT J MOL MED, V10, P599; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Sun J, 2013, ALLERGY, V68, P304, DOI 10.1111/all.12087; Sun J, 2015, IMMUNITY, V43, P304, DOI 10.1016/j.immuni.2015.07.013; Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045; Termen S, 2008, MOL IMMUNOL, V45, P3947, DOI 10.1016/j.molimm.2008.06.020; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Yang F, 2004, J BIOL CHEM, V279, P35403, DOI 10.1074/jbc.M404055200; Yang YH, 2006, J PHARMACOL EXP THER, V318, P547, DOI 10.1124/jpet.106.102467; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	39	16	16	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					884	894		10.1096/fj.15-275826	http://dx.doi.org/10.1096/fj.15-275826			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527065				2022-12-28	WOS:000369391900036
J	Dai, M; Wang, X; Li, JL; Zhou, Y; Sang, M; Liu, JB; Wu, JG; Ho, WZ				Dai, Ming; Wang, Xu; Li, Jie-Liang; Zhou, Yu; Sang, Ming; Liu, Jin-Biao; Wu, Jian-Guo; Ho, Wen-Zhe			Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages	FASEB JOURNAL			English	Article						BTV; UV-inactivated BTV; IFN-lambda; microRNA	HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; CELLULAR MICRORNA; POTENT INHIBITORS; TYPE-1 INFECTION; VIRAL PRODUCTION; I INTERFERON	Bluetongue virus (BTV), a nonenveloped double-stranded RNA virus, is a potent inducer of type. interferons in multiple cell systems. In this study, we report that BTV16 treatment of primary human macrophages induced both type I and III IFN expression, resulting in the production of multiple antiviral factors, including myxovirus resistance protein A, 2',5'-oligoadenylate synthetase, and the IFN-stimulated gene 56. Additionally, BTV-treated macrophages expressed increased HIV restriction factors (apolipoprotein BmRNA-editing enzyme catalytic polypeptide 3 G/F/H) and CC chemokines (macrophage inflammatory protein 1-alpha, macrophage inflammatory protein 1-beta, regulated on activation of normal T cell expressed and secreted), the ligands for HIV entry coreceptor CC chemokine receptor type 5. BTV16 also induced the expression of tetherin, which restricts HIV release from infected cells. Furthermore, TLR3 signaling of macrophages by BTV16 resulted in the induction of several anti-HIVmicroRNAs (miRNA-28, -29a, -125b, -150, -223, and -382). More importantly, the induction of antiviral responses by BTV resulted in significant suppression of HIV in macrophages. These findings demonstrate the potential of BTV-mediated TLR3 activation in macrophage innate immunity against HIV.	[Dai, Ming; Sang, Ming; Liu, Jin-Biao; Ho, Wen-Zhe] Wuhan Univ, Anim Biol Safety Level Lab 3, Ctr Expt Anim, Wuhan 430072, Peoples R China; [Dai, Ming; Sang, Ming; Liu, Jin-Biao; Wu, Jian-Guo; Ho, Wen-Zhe] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Wang, Xu; Li, Jie-Liang; Zhou, Yu; Ho, Wen-Zhe] Temple Univ, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19140 USA	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ho, WZ (corresponding author), Temple Univ, Dept Pathol & Lab Med, Sch Med, 3500 N Broad St, Philadelphia, PA 19140 USA.	wenzheho@temple.edu	Liu, JinBiao/F-7535-2013; Sang, Ming/AAE-2187-2022; Sang, Ming/ABG-4550-2021	Sang, Ming/0000-0003-2322-0674; Wu, Jianguo/0000-0002-8326-2895	National Natural Science Foundation of China [81271334]; Foundation of Scientific and Technological Project of Hubei Province [2014CFA076]; U.S. National Institutes of Health National Institute on Drug Abuse [DA27550, DA36163]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027550, R21DA036163, R01DA022177] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Scientific and Technological Project of Hubei Province; U.S. National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the by the grants from the National Natural Science Foundation of China (81271334), Foundation of Scientific and Technological Project of Hubei Province (2014CFA076), and U.S. National Institutes of Health National Institute on Drug Abuse (DA27550 and DA36163 to H.W.-Z.).	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Buitendijk M, 2014, AIDS RES HUM RETROV, V30, P457, DOI [10.1089/aid.2013.0199, 10.1089/AID.2013.0199]; Chauveau E, 2012, J VIROL, V86, P11789, DOI 10.1128/JVI.00430-12; Cheng K, 2011, J AM CHEM SOC, V133, P3764, DOI 10.1021/ja111312h; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Elbers ARW, 2008, PREV VET MED, V87, P31, DOI 10.1016/j.prevetmed.2008.06.003; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Hu J, 2008, ACTA ONCOL, V47, P124, DOI 10.1080/02841860701403038; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jackson AC, 2006, J NEUROVIROL, V12, P229, DOI 10.1080/13550280600848399; Jakobsen MR, 2015, CURR OPIN HIV AIDS, V10, P96, DOI 10.1097/COH.0000000000000129; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Kawai S, 2008, CANCER SCI, V99, P2461, DOI 10.1111/j.1349-7006.2008.00968.x; Kelly MD, 1998, J IMMUNOL, V160, P3091; Kumar A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-26; Kumar Amit, 2014, Mol Cell Ther, V2, P10, DOI 10.1186/2052-8426-2-10; Kumar A, 2014, VIRUSES-BASEL, V6, P1837, DOI 10.3390/v6041837; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maclachlan NJ, 2011, PREV VET MED, V102, P107, DOI 10.1016/j.prevetmed.2011.04.005; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Proost P, 2002, Verh K Acad Geneeskd Belg, V64, P403; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Ruscanu S, 2012, J VIROL, V86, P5817, DOI 10.1128/JVI.06716-11; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Swaminathan S, 2012, AIDS, V26, P1325, DOI 10.1097/QAD.0b013e328352adca; Tian RR, 2012, ANTIVIR RES, V95, P57, DOI 10.1016/j.antiviral.2012.04.011; Vitour D, 2014, VIRUS RES, V182, P59, DOI 10.1016/j.virusres.2013.10.027; Wang FX, 2008, J GEN VIROL, V89, P722, DOI 10.1099/vir.0.83530-0; Wang XX, 2012, J VIROL, V86, P3777, DOI 10.1128/JVI.06594-11; Wang X, 2011, AM J PATHOL, V178, P41, DOI 10.1016/j.ajpath.2010.11.042; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x	55	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4978	4988		10.1096/fj.15-273128	http://dx.doi.org/10.1096/fj.15-273128			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26296370	Green Published			2022-12-28	WOS:000365523600023
J	Lehmann, C; Homann, J; Ball, AK; Blocher, R; Kleinschmidt, TK; Basavarajappa, D; Angioni, C; Ferreiros, N; Hafner, AK; Radmark, O; Proschak, E; Haeggstrom, JZ; Geisslinger, G; Parnham, MJ; Steinhilber, D; Kahnt, AS				Lehmann, Christoph; Homann, Julia; Ball, Ann-Katrin; Bloecher, Rene; Kleinschmidt, Thea K.; Basavarajappa, Devaraj; Angioni, Carlo; Ferreiros, Nerea; Haefner, Ann-Kathrin; Radmark, Olof; Proschak, Ewgenij; Haeggstrom, Jesper Z.; Geisslinger, Gerd; Parnham, Michael J.; Steinhilber, Dieter; Kahnt, Astrid Stefanie			Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein	FASEB JOURNAL			English	Article						cytosolic phospholipase A(2 alpha); LTA(4) hydrolase; LTC4 synthase; resolution of inflammation	ARACHIDONIC-ACID; HUMAN-PLATELETS; LEUKOTRIENE A4; INFLAMMATION; NEUTROPHIL; RESOLUTION; INHIBITOR; BINDING; D1; 15-LIPOXYGENASE	Resolution of acute inflammation is an active process coordinated by proresolving lipid mediators (SPMs) such as lipoxins (LXs) and resolvins (Rvs), which are formed by the concerted action of 2 lipoxygenases (LOs). Because the exact molecular mechanisms of SPM biosynthesis are not completely understood, we aimed to investigate LX and D-type Rv formation in human leukocytes and HEK293T cells overexpressing leukotriene (LT) pathway enzymes. Activity assays in precursor (15-hydroxyeicosatetraenoic acids, 17-HDoHE)-treated granulocytes [polymorphonuclear leukocytes (PMNLs)] showed a strict dependence of LXA(4)/RvD(1) biosynthesis on cell integrity, and incubation with recombinant human 5-LO did not lead to LX or Rv formation. Pharmacologic inhibition of 5-LO activating protein (FLAP) by MK-886 inhibited LXA(4)/RvD(1) biosynthesis in precursor-treated PMNLs (drug concentration causing 50% inhibition similar to 0.3/0.2 mu M), as did knockdown of the enzyme in MM6 cells, and precursor-treated HEK293T overexpressing 5-LO produced high amounts of LXA(4) only in the presence of FLAP. In addition, inhibition of cytosolic phospholipase A(2 alpha) (cPLA(2 alpha)) interfered with LXA(4)/RvD(1) formation from exogenous precursors in PMNLs. Furthermore, inhibition of the LT synthases LTA(4) hydrolase and LTC4 synthase in PMNL/platelet coincubations augmented LXA(4) levels. These findings show that several enzymes known to be involved in the biosynthesis of proinflammatory LTs, such as FLAP and cPLA(2 alpha), also contribute to LX and Rv formation.	[Lehmann, Christoph; Geisslinger, Gerd; Parnham, Michael J.; Kahnt, Astrid Stefanie] Goethe Univ Frankfurt, Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol, D-60438 Frankfurt, Germany; [Homann, Julia; Angioni, Carlo; Ferreiros, Nerea; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt, D-60438 Frankfurt, Germany; [Ball, Ann-Katrin; Bloecher, Rene; Haefner, Ann-Kathrin; Proschak, Ewgenij; Steinhilber, Dieter; Kahnt, Astrid Stefanie] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany; [Kleinschmidt, Thea K.; Basavarajappa, Devaraj; Radmark, Olof; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, Stockholm, Sweden	Fraunhofer Gesellschaft; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Karolinska Institutet	Kahnt, AS (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	kahnt@pharmchem.uni-frankfurt.de	Steinhilber, Dieter/J-3221-2012; Parnham, Michael J/D-8733-2014	Parnham, Michael J/0000-0002-7098-8451; Basavarajappa, Devaraj/0000-0003-0997-0196	Else Kroner-Fresenius Foundation; Research Training Group Translational Research Innovation-Pharma (TRIP); Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz (LOEWE); Schwerpunkt: Anwendungsorientierte Arzneimittelforschung [Z01, SFB 1039]; German Research Foundation (DFG); Swedish Medical Research Council	Else Kroner-Fresenius Foundation; Research Training Group Translational Research Innovation-Pharma (TRIP); Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz (LOEWE); Schwerpunkt: Anwendungsorientierte Arzneimittelforschung; German Research Foundation (DFG)(German Research Foundation (DFG)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	The authors thank S. George for the purification of TGF-beta<INF>1</INF> and S. Kretschmer for the purification of WT 5-LO and editorial help. This work was supported by the Else Kroner-Fresenius Foundation, the Research Training Group Translational Research Innovation-Pharma (TRIP), the Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz (LOEWE), Schwerpunkt: Anwendungsorientierte Arzneimittelforschung, and Projekt Z01, Grant SFB 1039, from the German Research Foundation (DFG). The work for TK04a was financially supported by the Swedish Medical Research Council.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; ANTOINE C, 1992, BIOCHIM BIOPHYS ACTA, V1128, P139, DOI 10.1016/0005-2760(92)90299-B; Back M, 2007, CIRC RES, V100, P946, DOI 10.1161/01.RES.0000264498.60702.0d; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; BREZINSKI ME, 1990, P NATL ACAD SCI USA, V87, P6248, DOI 10.1073/pnas.87.16.6248; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; CHARLESON S, 1994, EUR J PHARM-MOLEC PH, V267, P275, DOI 10.1016/0922-4106(94)90151-1; Chavis C, 1996, J EXP MED, V183, P1633, DOI 10.1084/jem.183.4.1633; EDENIUS C, 1988, BIOCHEM BIOPH RES CO, V157, P801, DOI 10.1016/S0006-291X(88)80320-6; EDENIUS C, 1988, EUR J BIOCHEM, V178, P81, DOI 10.1111/j.1432-1033.1988.tb14431.x; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Homann J, 2014, J CHROMATOGR A, V1360, P150, DOI 10.1016/j.chroma.2014.07.068; Horning C, 2005, J BIOL CHEM, V280, P26913, DOI 10.1074/jbc.M500068200; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Kaaman M, 2006, INT J OBESITY, V30, P447, DOI 10.1038/sj.ijo.0803147; Koeberle A, 2009, EUR J PHARMACOL, V608, P84, DOI 10.1016/j.ejphar.2009.02.023; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; LEVY BD, 1993, J CLIN INVEST, V92, P1572, DOI 10.1172/JCI116738; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; MACLOUF JA, 1988, J BIOL CHEM, V263, P174; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; Mancini JA, 1998, J BIOL CHEM, V273, P32842, DOI 10.1074/jbc.273.49.32842; Michel A. A., 2008, PROTEIN EXPRES PURIF, V59, P110; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Moser D, 2015, J CHEM INF MODEL, V55, P284, DOI 10.1021/ci500618u; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; Petrich K, 1996, BIOCHEM J, V314, P911, DOI 10.1042/bj3140911; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Rao NL, 2010, AM J RESP CRIT CARE, V181, P899, DOI 10.1164/rccm.200807-1158OC; Recchiuti A, 2013, PROSTAG OTH LIPID M, V107, P64, DOI 10.1016/j.prostaglandins.2013.02.004; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Schroder M, 2014, BBA-MOL CELL BIOL L, V1841, P1538, DOI 10.1016/j.bbalip.2014.07.022; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Werz O, 1996, PHARMAZIE, V51, P893; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	45	52	53	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5029	5043		10.1096/fj.15-275487	http://dx.doi.org/10.1096/fj.15-275487			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26289316				2022-12-28	WOS:000365523600027
J	Wunderlich, KA; Tanimoto, N; Grosche, A; Zrenner, E; Pekny, M; Reichenbach, A; Seeliger, MW; Pannicke, T; Perez, MT				Wunderlich, Kirsten A.; Tanimoto, Naoyuki; Grosche, Antje; Zrenner, Eberhart; Pekny, Milos; Reichenbach, Andreas; Seeliger, Mathias W.; Pannicke, Thomas; Perez, Maria-Thereza			Retinal functional alterations in mice lacking intermediate filament proteins glial fibrillary acidic protein and vimentin	FASEB JOURNAL			English	Article						GFAP; Muller glia; electroretinogram; Kir channels; retinal ischemia	MULLER CELLS; ASTROCYTE ACTIVATION; REACTIVE ASTROCYTES; GENE-EXPRESSION; K+ CHANNELS; MOUSE; DEFICIENT; KIR4.1; INTEGRATION; DETACHMENT	Vimentin (Vim) and glial fibrillary acidic protein (GFAP) are important components of the intermediate filament (IF) (or nanofilament) system of astroglial cells. We conducted full-field electroretinogram (ERG) recordings and found that whereas photoreceptor responses (a-wave) were normal in uninjured GFAP(-/-)Vim(-/-) mice, b-wave amplitudes were increased. Moreover, we found that Kir (inward rectifier K+) channel protein expression was reduced in the retinas of GFAP(-/-)Vim(-/-) mice and that Kir-mediated current amplitudes were lower in Muller glial cells isolated from these mice. Studies have shown that the IF system, in addition, is involved in the retinal response to injury and that attenuated Muller cell reactivity and reduced photoreceptor cell loss are observed in IF-deficient mice after experimental retinal detachment. We investigated whether the lack of IF proteins would affect cell survival in a retinal ischemia-reperfusion model. We found that although cell loss was induced in both genotypes, the number of surviving cells in the inner retina was lower in IF-deficient mice. Our findings thus show that the inability to produce GFAP and Vim affects normal retinal physiology and that the effect of IF deficiency on retinal cell survival differs, depending on the underlying pathologic condition.	[Wunderlich, Kirsten A.; Perez, Maria-Thereza] Lund Univ, Div Ophthalmol, Dept Clin Sci, SE-22184 Lund, Sweden; [Perez, Maria-Thereza] Lund Univ, NanoLund, Nanometer Struct Consortium, SE-22184 Lund, Sweden; [Wunderlich, Kirsten A.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Wunderlich, Kirsten A.; Zrenner, Eberhart] Univ Tubingen, CIN, Tubingen, Germany; [Tanimoto, Naoyuki; Seeliger, Mathias W.] Univ Tubingen, Div Ocular Neurodegenerat, Inst Ophthalm Res, Tubingen, Germany; [Grosche, Antje] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden; [Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Pekny, Milos] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Reichenbach, Andreas; Pannicke, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Lund University; Lund University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; University of Gothenburg; Florey Institute of Neuroscience & Mental Health; Hunter Medical Research Institute; University of Newcastle; Leipzig University	Perez, MT (corresponding author), Lund Univ, Div Ophthalmol, Dept Clin Sci Lund, BMC B11,Klin Gatan 26, SE-22184 Lund, Sweden.	maria_thereza.perez@med.lu.se	Grosche, Antje/N-1978-2014; Pannicke, Thomas/A-5078-2017; Reichenbach, Andreas/B-2510-2017	Grosche, Antje/0000-0003-0338-7530; Pannicke, Thomas/0000-0001-7435-9540; 	VELUX Stiftung; Crown Princess Margareta's Committee for the Blind; Stiftelse for Synskadade i fd Malmohus Lan; Thorsten och Elsa Segerfalks Stiftelse; European Union [020235-NEUROTRAIN, 512036-GENORET, 237956-EduGlia, 279017-TargetBraIn]; Deutsche Forschungsgemeinschaft [RE 849/16-1, SPP 1757, KFO134-Se837/5-2, Se837/6-2]; PRO RETINA-Stiftung; Center of Integrative Neuroscience [EXC 307]; Center of Excellence of the German Research Council; Bernstein Center for Computational Neuroscience, Tubingen; Swedish Medical Research Council [11548]; Avtal om Lakarutbildning och Forskning (ALF) Gothenburg [11392]; Arbetsmarknadens Forsakringsaktiebolag (AFA) Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Hjarnfonden; Hagstromer's Foundation Millennium; NanoNet COST Action Grant [BM1002]	VELUX Stiftung; Crown Princess Margareta's Committee for the Blind; Stiftelse for Synskadade i fd Malmohus Lan; Thorsten och Elsa Segerfalks Stiftelse; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); PRO RETINA-Stiftung; Center of Integrative Neuroscience; Center of Excellence of the German Research Council; Bernstein Center for Computational Neuroscience, Tubingen; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Avtal om Lakarutbildning och Forskning (ALF) Gothenburg; Arbetsmarknadens Forsakringsaktiebolag (AFA) Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Hjarnfonden; Hagstromer's Foundation Millennium; NanoNet COST Action Grant	The authors thank B. Sandstrom for maintaining the animal colonies; H. Abdshill for tissue sectioning; Drs. U. Wilhelmsson and Y. de Pablo for crossing, breeding and genotyping of some of the mice; and Dr. R. S. Molday (University of British Columbia, Vancouver, BC, Canada) for the generous gift of antibodies against rhodopsin. This work was supported by grants from the VELUX Stiftung (to M.T.P.); Crown Princess Margareta's Committee for the Blind (to M.T.P.), Stiftelse for Synskadade i fd Malmohus Lan (to M.T.P.), Thorsten och Elsa Segerfalks Stiftelse (to M.T.P.); the European Union projects 020235-NEUROTRAIN (to M.T.P), 512036-GENORET (to M.T.P.), 237956-EduGlia (to M.P.), and 279017-TargetBraIn (to M.P.); Deutsche Forschungsgemeinschaft Grants RE 849/16-1 (to A. R. and T.P.), SPP 1757 (to A.R.), KFO134-Se837/5-2 (to M.W.S. and N.T.), and Se837/6-2 (to M.W.S.); the PRO RETINA-Stiftung (to A.G.); the Center of Integrative Neuroscience (EXC 307), a Center of Excellence of the German Research Council and the Bernstein Center for Computational Neuroscience, Tubingen (to E.Z.); and Swedish Medical Research Council Grant 11548, Avtal om Lakarutbildning och Forskning (ALF) Gothenburg (11392), the Arbetsmarknadens Forsakringsaktiebolag (AFA) Research Foundation, Soderbergs Foundations, Sten A. Olsson Foundation for Research and Culture, Hjarnfonden, Hagstromer's Foundation Millennium, and NanoNet COST Action Grant BM1002 (to M.P.).	Azadi S, 2007, BRAIN RES, V1129, P116, DOI 10.1016/j.brainres.2006.10.031; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Eckes B, 1998, J CELL SCI, V111, P1897; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Frishman L. J., 2006, PRINCIPLES PRACTICE, P139; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Hirrlinger PG, 2010, NEUROSCI LETT, V472, P73, DOI 10.1016/j.neulet.2010.01.062; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Johnson LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055456; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lewis GP, 2010, MOL VIS, V16, P1361; LEWIS GP, 1989, EXP EYE RES, V49, P93, DOI 10.1016/0014-4835(89)90079-1; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Newman E. A., 2009, ENCY NEUROSCIENCE, P225, DOI 10.1016/B978-008045046-9.00919-0; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.317; Pannicke T, 2002, GLIA, V38, P268, DOI 10.1002/glia.10068; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Raz-Prag D, 2010, P NATL ACAD SCI USA, V107, P12710, DOI 10.1073/pnas.0913472107; Rehak M, 2009, INVEST OPHTH VIS SCI, V50, P2359, DOI 10.1167/iovs.08-2332; Reichenbach A., 2010, MULLER CELLS HLTH DI; Roesch Karin, 2012, Mol Vis, V18, P1197; Sarthy V., 2001, PERSP VIS R; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tatzelt J, 1996, NEUROLOGY, V47, P449, DOI 10.1212/WNL.47.2.449; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wu J, 2004, MOL VIS, V10, P650; Wunderlich KA, 2010, INVEST OPHTH VIS SCI, V51, P4809, DOI 10.1167/iovs.09-5073; Wurm A, 2006, GLIA, V54, P411, DOI 10.1002/glia.20391; Zhang Y, 2007, J NEUROSCI, V27, P4499, DOI 10.1523/JNEUROSCI.0200-07.2007; Zhang YQ, 2004, INVEST OPHTH VIS SCI, V45, P4440, DOI 10.1167/iovs.04-0165; Zhang YQ, 2003, INVEST OPHTH VIS SCI, V44, P324, DOI 10.1167/iovs.02-0132	58	21	21	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4815	4828		10.1096/fj.15-272963	http://dx.doi.org/10.1096/fj.15-272963			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26251181				2022-12-28	WOS:000365523600009
J	Xu, HB; Wang, XL; Lackner, AA; Veazey, RS				Xu, Huanbin; Wang, Xiaolei; Lackner, Andrew A.; Veazey, Ronald S.			Type 3 innate lymphoid cell depletion is mediated by TLRs in lymphoid tissues of simian immunodeficiency virus-infected macaques	FASEB JOURNAL			English	Article						SIV; HIV; GALT; ILC	ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR GATA3; NATURAL-KILLER-CELLS; ROR-GAMMA-T; INDUCER CELLS; MUCOSAL; IMMUNITY; DIFFERENTIATION; INFLAMMATION; HOMEOSTASIS	Innate lymphoid cells (ILCs) type 3, also known as lymphoid tissue inducer cells, plays a major role in both the development and remodeling of organized lymphoid tissues and the maintenance of adaptive immune responses. HIV/simian immunodeficiency virus (SIV) infection causes breakdown of intestinal barriers resulting in microbial translocation, leading to systemic immune activation and disease progression. However, the effects of HIV/SIV infection on ILC3 are unknown. Here, we analyzed ILC3 from mucosal and systemic lymphoid tissues in chronically SIV-infected macaques and uninfected controls. ILC3 cells were defined and identified in macaque lymphoid tissues as non-T, non-B (lineage-negative), c-Kit(+)IL-7R alpha(+) (CD117(+)CD127(+)) cells. These ILC3 cells highly expressed CD90 (similar to 63%) and aryl hydrocarbon receptor and produced IL-17 (similar to 63%), IL-22 (similar to 36%), and TNF-alpha (similar to 72%) but did not coexpress CD4 or NK cell markers. The intestinal ILC3 cell loss correlated with the reduction of total CD4(+) T cells and T helper (T-h) 17 and Th22 cells in the gut during SIV infection (P < 0.001). Notably, ILC3 could be induced to undergo apoptosis by microbial products through the TLR2 (lipoteichoic acid) and/or TLR4 (LPS) pathway. These findings indicated that persistent microbial translocation may result in loss of ILC3 in lymphoid tissues in SIV-infected macaques, further contributing to the HIV-induced impairment of gut-associated lymphoid tissue structure and function, especially in mucosal tissues.	[Xu, Huanbin; Wang, Xiaolei; Lackner, Andrew A.; Veazey, Ronald S.] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA	Tulane University	Xu, HB (corresponding author), Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, 18703 Three Rivers Rd, Covington, LA 70433 USA.	hxu@tulane.edu; rveazey@tulane.edu	Xu, Huanbin/S-4870-2019		U.S. National Institutes of Health (NIH) [R01 AI084793, R01 AI099795, R01 DE025432]; National Center for Research Resources; Office of Research Infrastructure Programs of the NIH [OD011104-51]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099795, R01AI084793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025432] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Julie Bruhn and Calvin Lanclos (Division of Immunology, Tulane National Primate Research Center) for flow cytometry support and Meagan Watkins, Megan Gardner, Chanjuan Shen, and Maury Duplantis (Division of Comparative Pathology, Tulane National Primate Research Center) for technical support. This work was supported by U.S. National Institutes of Health (NIH) Grants R01 AI084793, R01 AI099795 (National Institute of Allergy and Infectious Diseases), and R01 DE025432 (National Institute of Dental and Craniofacial Research), the National Center for Research Resources, and the Office of Research Infrastructure Programs of the NIH through Grant OD011104-51. The authors declare no conflicts of interest.	Behnsen J, 2013, IMMUNITY, V39, P206, DOI 10.1016/j.immuni.2013.08.012; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P277, DOI 10.1016/j.coi.2012.03.011; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Douek Daniel, 2007, Top HIV Med, V15, P114; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Hepworth MR, 2014, CURR OPIN IMMUNOL, V27, P75, DOI 10.1016/j.coi.2014.01.013; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lane PJL, 2009, MUCOSAL IMMUNOL, V2, P472, DOI 10.1038/mi.2009.111; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Pearson C, 2012, TRENDS IMMUNOL, V33, P289, DOI 10.1016/j.it.2012.04.004; Pennock JL, 2004, BLOOD, V103, P2655, DOI 10.1182/blood-2003-09-3146; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Qiu J, 2013, SEMIN IMMUNOPATHOL, V35, P657, DOI 10.1007/s00281-013-0393-5; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Shin JY, 2014, J EXP MED, V211, P217, DOI 10.1084/jem.20131128; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Withers DR, 2012, J IMMUNOL, V189, P2094, DOI 10.4049/jimmunol.1201639; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Xu Huanbin, 2014, J AIDS Clin Res, V5; Xu HB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00085; Xu HB, 2010, J IMMUNOL, V185, P7340, DOI 10.4049/jimmunol.1001642; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	49	30	32	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5072	5080		10.1096/fj.15-276477	http://dx.doi.org/10.1096/fj.15-276477			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26283536	Green Published			2022-12-28	WOS:000365523600030
J	Reilly, L; Howie, J; Wypijewski, K; Ashford, MLJ; Hilgemann, DW; Fuller, W				Reilly, Louise; Howie, Jacqueline; Wypijewski, Krzysztof; Ashford, Michael L. J.; Hilgemann, Donald W.; Fuller, William			Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signaling	FASEB JOURNAL			English	Article						acylation; patch clamp; resin-assisted capture; ion transport; heart	CARDIAC NA+/CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; NA+-CA2+ EXCHANGER; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; DYNAMIC PROPERTIES; STEADY-STATE; XIP REGION; CA2+ ENTRY; PROTEIN	The electrogenic Na/Ca exchanger (NCX) mediates bidirectional Ca movements that are highly sensitive to changes of Na gradients in many cells. NCX1 is implicated in the pathogenesis of heart failure and a number of cardiac arrhythmias. We measured NCX1 palmitoylation using resin-assisted capture, the subcellular location of yellow fluorescent protein-NCX1 fusion proteins, and NCX1 currents using whole-cell voltage clamping. Rat NCX1 is substantially palmitoylated in all tissues examined. Cysteine 739 in the NCX1 large intracellular loop is necessary and sufficient for NCX1 palmitoylation. Palmitoylation of NCX1 occurs in the Golgi and anchors theNCX1 large regulatory intracellular loop to membranes. Surprisingly, palmitoylation does not influence trafficking or localization of NCX1 to surface membranes, nor does it strongly affect the normal forward or reverse transport modes of NCX1. However, exchangers that cannot be palmitoylated do not inactivate normally (leading to substantial activity in conditions when wild-type exchangers are inactive) and do not promote cargo-dependent endocytosis that internalizes 50% of the cell surface following strong G-protein activation or large Ca transients. The palmitoylated cysteine in NCX1 is found in all vertebrate and some invertebrate NCX homologs. Thus, NCX palmitoylation ubiquitously modulates Ca homeostasis and membrane domain function in cells that express NCX proteins.	[Reilly, Louise; Howie, Jacqueline; Wypijewski, Krzysztof; Ashford, Michael L. J.; Fuller, William] Univ Dundee, Div Cardiovasc & Diabet Med, Med Res Inst, Coll Med Dent & Nursing, Dundee, Scotland; [Hilgemann, Donald W.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Dundee; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fuller, W (corresponding author), Ninewells Hosp, Div Cardiovasc & Diabet Med, Mail Box 12 Level 5, Dundee DD1 9SY, Scotland.	donald.hilgemann@utsouthwestern.edu; w.fuller@dundee.ac.uk		Reilly, Louise/0000-0002-2224-1708; Ashford, Michael/0000-0002-0861-7676; Fuller, William/0000-0002-5883-4433	British Heart Foundation [PG/12/6/29366]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [RO1HL119843-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119843] Funding Source: NIH RePORTER; British Heart Foundation [PG/10/93/28650] Funding Source: researchfish; Medical Research Council [1218481] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Dr. Lindsay Davidson for providing induced pluripotent stem cell-derived cardiac myocytes, and Mei-Jung Lin for technical assistance (University of Dundee iPSC facility, Dundee, United Kingdom). This work was supported by grants from the British Heart Foundation (PG/12/6/29366 to W.F. and M.L.J.A.) and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (RO1HL119843-01A1; to D.W.H.).	Annunziato L., 2013, ADV EXPT MED BIOL, V961; Antoons G, 2012, PHARMACOL THERAPEUT, V134, P26, DOI 10.1016/j.pharmthera.2011.12.001; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Burr AR, 2014, MOL CELL BIOL, V34, P1991, DOI 10.1128/MCB.00339-14; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cavalli A, 2007, CELL CALCIUM, V42, P313, DOI 10.1016/j.ceca.2007.01.003; Chernysh O, 2008, AM J PHYSIOL-CELL PH, V295, pC872, DOI 10.1152/ajpcell.00221.2008; Cirri E, 2013, J MEMBRANE BIOL, V246, P967, DOI 10.1007/s00232-013-9600-5; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Feng NC, 2006, J CARDIOVASC PHARM, V47, P263, DOI 10.1097/01.fjc.0000202561.69291.ac; Flesch M, 1996, CIRCULATION, V94, P992, DOI 10.1161/01.CIR.94.5.992; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; He ZP, 2000, AM J PHYSIOL-CELL PH, V278, pC661, DOI 10.1152/ajpcell.2000.278.4.C661; He ZP, 1998, J GEN PHYSIOL, V111, P857, DOI 10.1085/jgp.111.6.857; Herchuelz A, 2007, ANN NY ACAD SCI, V1099, P456, DOI 10.1196/annals.1387.048; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann Donald W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS47, DOI 10.1111/j.1540-8167.2006.00383.x; Hilgemann DW, 2013, ELIFE, V2, DOI 10.7554/eLife.01293; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; HILGEMANN DW, 1992, J PHYSIOL-LONDON, V454, P59, DOI 10.1113/jphysiol.1992.sp019254; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Ohtsuka M, 2004, BIOCHEM BIOPH RES CO, V314, P849, DOI 10.1016/j.bbrc.2003.12.165; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pignataro G, 2013, STROKE, V44, pE237, DOI 10.1161/01.str.0000436975.51525.16; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Pogwizd SM, 1999, CIRC RES, V85, P1009; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P103, DOI 10.1196/annals.1387.036; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wanichawan P, 2011, AM J PHYSIOL-CELL PH, V300, pC989, DOI 10.1152/ajpcell.00196.2010; Wypijewski KJ, 2013, J BIOL CHEM, V288, P13808, DOI 10.1074/jbc.M113.460956; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yaradanakul A, 2008, J GEN PHYSIOL, V132, P29, DOI 10.1085/jgp.200709865; Zhang YH, 2009, CELL CALCIUM, V45, P1, DOI 10.1016/j.ceca.2008.05.005	67	38	39	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4532	4543		10.1096/fj.15-276493	http://dx.doi.org/10.1096/fj.15-276493			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26174834	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000364514700013
J	Hwang, I; Park, YJ; Kim, YR; Kim, YN; Ka, S; Lee, HY; Seong, JK; Seok, YJ; Kim, JB				Hwang, Injae; Park, Yoon Jeong; Kim, Yeon-Ran; Kim, Yo Na; Ka, Sojeong; Lee, Ho Young; Seong, Je Kyung; Seok, Yeong-Jae; Kim, Jae Bum			Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity	FASEB JOURNAL			English	Article						gut hormone; insulin sensitivity; metabolites	HEPATIC STEATOSIS; GLUCOSE-TOLERANCE; DIABETIC-PATIENTS; TAUROCHOLIC ACID; HEALTHY HUMANS; RECEPTOR; INFLAMMATION; SECRETION; MICE; MECHANISMS	Firmicutes and Bacteroidetes, 2 major phyla of gut microbiota, are involved in lipid and bile acid metabolism to maintain systemic energy homeostasis in host. Recently, accumulating evidence has suggested that dietary changes promptly induce the alteration of abundance of both Firmicutes and Bacteroidetes in obesity and its related metabolic diseases. Nevertheless, the metabolic roles of Firmicutes and Bacteroidetes on such disease states remain unclear. The aim of this study was to determine the effects of antibiotic-induced depletion of Firmicutes and Bacteroidetes on dysregulation of energy homeostasis in obesity. Treatment of C57BL/6J mice with the antibiotics (vancomycin [V] and bacitracin [B]), in the drinking water, before diet-induced obesity (DIO) greatly decreased both Firmicutes and Bacteroidetes in the gut as revealed by pyrosequencing of the microbial 16S rRNA gene. Concomitantly, systemic glucose intolerance, hyperinsulinemia, and insulin resistance in DIO were ameliorated via augmentation of GLP-1 secretion (active form; 2.03-fold, total form; 5.09-fold) independently of obesity as compared with untreated DIO controls. Furthermore, there were increases in metabolically beneficial metabolites derived from the gut. Together, our data suggest that Firmicutes and Bacteroidetes potentially mediate insulin resistance through modulation of GLP-1 secretion in obesity.	[Hwang, Injae; Kim, Yeon-Ran; Ka, Sojeong; Seok, Yeong-Jae; Kim, Jae Bum] Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, Seoul 151742, South Korea; [Park, Yoon Jeong; Seok, Yeong-Jae] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Kim, Yo Na; Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Seoul 151742, South Korea; [Lee, Ho Young] Seoul Natl Univ, Coll Med, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JB (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, 1 Gwanak Ro, Seoul 151742, South Korea.	jaebkim@snu.ac.kr	Song, Minsun/I-5701-2015	Seok, Yeong-Jae/0000-0003-0379-3619; KIM, Jae Bum/0000-0003-2337-6935; Seong, Je Kyung/0000-0003-1177-6958	National Research Foundation of Korea [2011-0018312]; Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [311054-03-HD110]; Ministry of Science, Information and Communications Technology (ICT) & Future Planning [2012M3A9B6055344]; Hi Seoul Science (Humanities) Fellowship - Seoul Scholarship Foundation; World Class University (WCU) program; BK21 program	National Research Foundation of Korea(National Research Foundation of Korea); Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry and Fisheries; Ministry of Science, Information and Communications Technology (ICT) & Future Planning; Hi Seoul Science (Humanities) Fellowship - Seoul Scholarship Foundation; World Class University (WCU) program; BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the National Research Foundation of Korea (2011-0018312), the Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (311054-03-HD110), and the Ministry of Science, Information and Communications Technology (ICT) & Future Planning (2012M3A9B6055344). I.H. was supported by the BK21 program and a Hi Seoul Science (Humanities) Fellowship funded by the Seoul Scholarship Foundation. Y.J.P. was supported by the World Class University (WCU) program. The authors also thank Won-Gun Choi, Jong In Kim, and Jin Young Huh for helpful discussions.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BACON AE, 1991, ANTIMICROB AGENTS CH, V35, P582, DOI 10.1128/AAC.35.3.582; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bode C, 2005, ALCOHOL CLIN EXP RES, V29, p166S, DOI 10.1097/01.alc.0000189280.19073.28; Brubaker PL, 2006, ANN NY ACAD SCI, V1070, P10, DOI 10.1196/annals.1317.006; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Deacon CF, 2002, AM J PHYSIOL-ENDOC M, V282, pE873, DOI 10.1152/ajpendo.00452.2001; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Desmarais S, 1998, ARCH BIOCHEM BIOPHYS, V354, P225, DOI 10.1006/abbi.1998.0691; ENG RHK, 1993, J ANTIMICROB CHEMOTH, V31, P609, DOI 10.1093/jac/31.4.609; Enrique-Tarancon G, 2000, BIOCHEM J, V350, P171, DOI 10.1042/0264-6021:3500171; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; JOHNSON BA, 1945, SCIENCE, V102, P376, DOI 10.1126/science.102.2650.376; Judex S, 2010, METHODS, V50, P14, DOI 10.1016/j.ymeth.2009.05.017; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; MACDONALD MJ, 1988, DIABETES, V37, P997, DOI 10.2337/diabetes.37.7.997; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Mendez JD, 2001, BIOCHIMIE, V83, P453, DOI 10.1016/S0300-9084(00)01192-5; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Muscelli E, 2008, DIABETES, V57, P1340, DOI 10.2337/db07-1315; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Pols TWH, 2010, GASTROEN CLIN BIOL, V34, P270, DOI 10.1016/j.gcb.2010.03.009; Ranganath LR, 1996, GUT, V38, P916, DOI 10.1136/gut.38.6.916; Rao S, 2011, SCAND J INFECT DIS, V43, P386, DOI 10.3109/00365548.2010.544671; Rose WC, 1911, J BIOL CHEM, V10, P123; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; 't Eijnde BO, 2001, DIABETES, V50, P18; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VanEldere J, 1996, APPL ENVIRON MICROB, V62, P656, DOI 10.1128/AEM.62.2.656-661.1996; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Watala C, 2009, PHARMACOL REP, V61, P86, DOI 10.1016/S1734-1140(09)70010-6; Wolf M, 2004, INT J SYST EVOL MICR, V54, P871, DOI 10.1099/ijs.0.02868-0; Wu T, 2013, DIABETES OBES METAB, V15, P474, DOI 10.1111/dom.12043; Wu TZ, 2013, J CLIN ENDOCR METAB, V98, pE718, DOI 10.1210/jc.2012-3961	68	135	142	4	62	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2397	2411		10.1096/fj.14-265983	http://dx.doi.org/10.1096/fj.14-265983			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713030				2022-12-28	WOS:000355209500017
J	Plotegher, N; Stringari, C; Jahid, S; Veronesi, M; Girotto, S; Gratton, E; Bubacco, L				Plotegher, Nicoletta; Stringari, Chiara; Jahid, Sohail; Veronesi, Marina; Girotto, Stefania; Gratton, Enrico; Bubacco, Luigi			NADH fluorescence lifetime is an endogenous reporter of alpha-synuclein aggregation in live cells	FASEB JOURNAL			English	Article						Parkinson's disease; amyloid; FLIM; spectral imaging; phasor	COMPETITION BINDING EXPERIMENTS; PARKINSONS-DISEASE; IN-VIVO; MEMBRANE ASSOCIATION; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; PHASOR APPROACH; LIVING CELLS; COMPLEX-I; MICROSCOPY	alpha-Synuclein (aS) aggregation has been amply investigated for its involvement in Parkinson's disease because its amyloid fibrils are the main constituent of Lewy bodies, one of the hallmarks of the disease. aS aggregation was studied here in vitro and in cellular models to correlate aggregation products with toxicity mechanisms. Independent results published elsewhere suggested that aS overexpression and/or aggregation may impair cellular metabolism and cause mitochondrial damage. In this context, we report the characterization of changes in NADH fluorescence properties in vitro and in human embryonic kidney 293 cells upon aS aggregation. The application of the phasor approach to study NADH fluorescence lifetime and emission allowed us to identify changes that correlate with aS aggregation. In particular, the fraction of bound NADH, characterized by longer lifetimes in comparison to free NADH, is increased, and the maximum of the NADH emission is shifted toward shorter wavelengths in the presence of aggregating aS both in vitro and in cells. These data suggest that NADH binds to aggregated aS. NMR experiments in vitro substantiate such binding, which occurs during aggregation. NADH fluorescence is thus useful to detect aS aggregation and by extension the associated oxidative stress.	[Plotegher, Nicoletta; Bubacco, Luigi] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Stringari, Chiara; Jahid, Sohail; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92697 USA; [Veronesi, Marina; Girotto, Stefania] Ist Italiano Tecnol, Dept Drug Discovery & Dev, Genoa, Italy	University of Padua; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Bubacco, L (corresponding author), Univ Padua, Dept Biol, Viale G Colombo 3, I-35131 Padua, Italy.	egratton@uci.edu; luigi.bubacco@unipd.it	Bubacco, Luigi/B-5602-2012; VERONESI, MARINA/A-2749-2012	Bubacco, Luigi/0000-0001-7927-9208; VERONESI, MARINA/0000-0001-8491-8844; Plotegher, Nicoletta/0000-0001-7421-8705	U.S. National Institutes of Health [P41-GM103540, P50-GM076516]; Fondazione Ing. Aldo Gini at the Laboratory for Fluorescence Dynamics (University of California, Irvine, Irvine, CA, USA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103540, P50GM076516] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Ing. Aldo Gini at the Laboratory for Fluorescence Dynamics (University of California, Irvine, Irvine, CA, USA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are very grateful to Professor Richard M. Magliozzo for his precise and insightful critical reading of the manuscript. Part of this work was done with support from U.S. National Institutes of Health Grants P41-GM103540 and P50-GM076516 (to E.G., S.J., and C.S.). The authors acknowledge "Fondazione Ing. Aldo Gini" for funding N.P. at the Laboratory for Fluorescence Dynamics (University of California, Irvine, Irvine, CA, USA).	Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Buchner M, 2002, NEUROSCIENCE, V114, P285, DOI 10.1016/S0306-4522(02)00280-4; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dalvit C, 1998, J MAGN RESON, V131, P148, DOI 10.1006/jmre.1997.1342; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2003, J AM CHEM SOC, V125, P7696, DOI 10.1021/ja034646d; Dalvit C, 2002, COMB CHEM HIGH T SCR, V5, P605, DOI 10.2174/1386207023329923; Dalvit C, 2002, COMB CHEM HIGH T SCR, V5, P645; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Esteves AR, 2011, PARKINSONS DIS, V2011; Fereidouni F, 2012, OPT EXPRESS, V20, P12729, DOI 10.1364/OE.20.012729; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JAMESON DM, 1989, BIOCHIM BIOPHYS ACTA, V994, P187, DOI 10.1016/0167-4838(89)90159-3; Roberti MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023338; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Keller JN, 2004, INT J BIOCHEM CELL B, V36, P2376, DOI 10.1016/j.biocel.2004.05.003; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mak SK, 2011, J PARKINSON DIS, V1, P175, DOI 10.3233/JPD-2011-11025; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Palero JA, 2011, BIOMED OPT EXPRESS, V2, P1030, DOI 10.1364/BOE.2.001030; Plotegher N, 2014, BBA-GEN SUBJECTS, V1840, P2014, DOI 10.1016/j.bbagen.2014.02.013; Plotegher N, 2014, Q REV BIOPHYS, V47, P1, DOI 10.1017/S0033583513000097; Roberti MJ, 2007, NAT METHODS, V4, P345, DOI 10.1038/NMETH1026; Scott D, 2012, J NEUROSCI, V32, P10129, DOI 10.1523/JNEUROSCI.0535-12.2012; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stringari C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048014; Stringari C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00568; Stringari C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046012; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Tamagno E, 2006, FREE RADICAL BIO MED, V41, P202, DOI 10.1016/j.freeradbiomed.2006.01.021; Tosatto L, 2012, BBA-BIOMEMBRANES, V1818, P2876, DOI 10.1016/j.bbamem.2012.07.007; Vergen J, 2012, MICROSC MICROANAL, V18, P761, DOI 10.1017/S1431927612000529; Wright BK, 2012, BIOPHYS J, V103, pL07, DOI 10.1016/j.bpj.2012.05.038; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x; Yaseen MA, 2013, BIOMED OPT EXPRESS, V4, P307, DOI 10.1364/BOE.4.000307; Yu QR, 2009, J PHOTOCH PHOTOBIO B, V95, P46, DOI 10.1016/j.jphotobiol.2008.12.010; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	59	23	23	0	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2484	2494		10.1096/fj.14-260281	http://dx.doi.org/10.1096/fj.14-260281			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713058	Green Published, Green Submitted			2022-12-28	WOS:000355209500025
J	Wanders, D; Burk, DH; Cortez, CC; Van, NT; Stone, KP; Baker, M; Mendoza, T; Mynatt, RL; Gettys, TW				Wanders, Desiree; Burk, David H.; Cortez, Cory C.; Van, Nancy T.; Stone, Kirsten P.; Baker, Mollye; Mendoza, Tamra; Mynatt, Randall L.; Gettys, Thomas W.			UCP1 is an essential mediator of the effects of methionine restriction on energy balance but not insulin sensitivity	FASEB JOURNAL			English	Article						adipose tissue; amino acid; FGF21; housing temperature; obesity	WHITE ADIPOSE-TISSUE; MITOCHONDRIAL UNCOUPLING PROTEIN; LIFE-SPAN; UCP1-INDEPENDENT THERMOGENESIS; ADAPTIVE THERMOGENESIS; IN-VIVO; MICE; MOUSE; RATS; BROWN	Dietary methionine restriction (MR) by 80% increases energy expenditure (EE), reduces adiposity, and improves insulin sensitivity. We propose that the MR-induced increase in EE limits fat deposition by increasing sympathetic nervous system-dependent remodeling of white adipose tissue and increasing uncoupling protein 1 (UCP1) expression in both white and brown adipose tissue. In independent assessments of the role of UCP1 as a mediator of MR's effects on EE and insulin sensitivity, EE did not differ between wild-type (WT) and Ucp1(-/-) mice on the control diet, but MR increased EE by 31% and reduced adiposity by 25% in WT mice. In contrast, MR failed to increase EE or reduce adiposity in Ucp1(-/-) mice. However, MR was able to increase overall insulin sensitivity by 2.2-fold in both genotypes. Housing temperatures used to minimize (28 degrees C) or increase (23 degrees C) sympathetic nervous system activity revealed temperature-independent effects of the diet on EE. Metabolomics analysis showed that genotypic and dietary effects on white adipose tissue remodeling resulted in profound increases in fatty acid metabolism within this tissue. These findings establish that UCP1 is required for the MR-induced increase in EE but not insulin sensitivity and suggest that diet-induced improvements in insulin sensitivity are not strictly derived from dietary effects on energy balance.	[Wanders, Desiree; Cortez, Cory C.; Van, Nancy T.; Stone, Kirsten P.; Baker, Mollye; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Burk, David H.] Pennington Biomed Res Ctr, Cell Biol & Bioimaging Core, Baton Rouge, LA 70808 USA; [Mendoza, Tamra; Mynatt, Randall L.] Gene Nutrient Interact Pennington Biomed Res Ctr, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Mynatt, Randall L/N-1980-2017; Stone, Kirsten/AAB-3804-2019; Burk, David/D-2056-2009; Gettys, Thomas W/N-1964-2017	Mynatt, Randall L/0000-0003-4399-0019; Stone, Kirsten/0000-0001-5511-1638; Gettys, Thomas W/0000-0001-7125-7995; Wanders, Desiree/0000-0003-2638-3954	American Diabetes Association [1-12-BS-58]; U.S. National Institutes of Health (NIH) [DK096311, DK098687, DK089641]; Mouse Metabolic Phenotyping Center Consortium [NIH U24 DK059637]; NIH [P20 GM103528, 2P30 DK072476]; NIH Nutrition Obesity Research Centers Grant [2P30 DK072476]; NIH National Research Service Award [1 F32 DK098918]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, T32DK064584, R01DK098687, R01DK096311, R01DK089641, U24DK059637, F32DK098918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, P30GM118430] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mouse Metabolic Phenotyping Center Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nutrition Obesity Research Centers Grant; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank C. Tramonte for administrative support. This work was supported in part by the American Diabetes Association 1-12-BS-58 (T.W.G.), U.S. National Institutes of Health (NIH) Grants DK096311 (to T.W.G.), DK098687 (to R.L.M.), DK089641 (to R.L.M.), and the Mouse Metabolic Phenotyping Center Consortium (NIH U24 DK059637). This work also made use of the Genomics and Cell Biology and Bioimaging core facilities supported by NIH P20 GM103528 (to T.W.G.) and NIH 2P30 DK072476. This research project used the Transgenic and Animal Phenotyping core facilities that are supported in part by the NIH Nutrition Obesity Research Centers Grant 2P30 DK072476) (to R.L.M.). D.W. is supported by NIH National Research Service Award 1 F32 DK098918. The authors thank M. Orgeron, K. Dille, and A. Pierse for their technical support.	ASHWELL M, 1985, J AUTONOM NERV SYST, V14, P377, DOI 10.1016/0165-1838(85)90083-9; ASHWELL M, 1983, FEBS LETT, V161, P108, DOI 10.1016/0014-5793(83)80740-6; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Blaxter K. L., 1986, J ANIMAL SCI S2, V63, P1; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Di Buono M, 2001, AM J CLIN NUTR, V74, P761; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Ghosh S, 2014, FASEB J, V28, P2577, DOI 10.1096/fj.14-249458; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Mossenbock K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110428; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Muise ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073011; Munzberg H., 2013, HDB OBESITY, P137; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Okamatsu-Ogura Y, 2011, EXP BIOL MED, V236, P1274, DOI 10.1258/ebm.2011.011143; ORENTREICH N, 1993, J NUTR, V123, P269; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Zhao ZJ, 2010, J EXP BIOL, V213, P3988, DOI 10.1242/jeb.046821; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	43	56	57	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2603	2615		10.1096/fj.14-270348	http://dx.doi.org/10.1096/fj.14-270348			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25742717	Green Published, Green Submitted			2022-12-28	WOS:000355209500036
J	Wang, H; Sun, RQ; Camera, D; Zeng, XY; Jo, E; Chan, SMH; Herbert, TP; Molero, JC; Ye, JM				Wang, Hao; Sun, Ruo-Qiong; Camera, Daria; Zeng, Xiao-Yi; Jo, Eunjung; Chan, Stanley M. H.; Herbert, Terence P.; Molero, Juan C.; Ye, Ji-Ming			Endoplasmic reticulum stress up-regulates Nedd4-2 to induce autophagy	FASEB JOURNAL			English	Article						Nedd4l; autophagosome; UPR; ubiquitin ligase	UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; INSULIN SIGNALING TRANSDUCTION; UBIQUITIN-PROTEASOME SYSTEM; CELL-SURVIVAL; MICE; POLYUBIQUITINATION; APOPTOSIS; PROMOTES; DISEASE	The accumulation of unfolded proteins within the endoplasmic reticulum (ER) causes ER stress and activation of unfolded protein response (UPR). This response can trigger ER-associated degradation and autophagy, which clear unfolded proteins and restore protein homeostasis. Recently, it has become clear that ubiquitination plays an important role in the regulation of autophagy. In the present study, we investigated how the E3 ubiquitin ligase neural precursor cell-expressed, developmentally down-regulated protein 4-2 (Nedd4-2) interacts with ER stress and autophagy. In mice, we found that an increase in the expression of Nedd4-2, which was concomitant with the activation of the UPR and autophagy, was caused by a prolonged high-fructose and high-fat diet that induces ER stress in the liver. Pharmacologic induction of ER stress also led to an increase in Nedd4-2 expression in cultured cells, which was coincident with UPR and autophagy activation. The inhibition of inositol-requiring enzyme 1 significantly suppressed Nedd4-2 expression. Moreover, increased Nedd4-2 expression in vivo was closely associated with the activation of inositol-requiring enzyme1 and increased expression of the spliced form of X-box binding protein 1. Furthermore, knockdown of Nedd4-2 in cultured cells suppressed both basal autophagy and ER stress-induced autophagy, whereas overexpression of Nedd4-2-induced autophagy. Taken together, our findings provide evidence that Nedd4-2 is up-regulated in response to ER stress by the spliced form of X-box binding protein 1 and that this is important in the induction of an appropriate autophagic response.	[Wang, Hao; Sun, Ruo-Qiong; Camera, Daria; Zeng, Xiao-Yi; Jo, Eunjung; Chan, Stanley M. H.; Herbert, Terence P.; Molero, Juan C.; Ye, Ji-Ming] RMIT Univ, Sch Hlth & Biomed Sci, Lipid Biol & Metab Dis Lab, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Molero, JC; Ye, JM (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, POB 71, Melbourne, Vic 3083, Australia.	juan.molero@rmit.edu.au; jiming.ye@rmit.edu.au		Herbert, Terence/0000-0001-5402-0814; Wang, Hao/0000-0002-0901-5183; Chan, Stanley/0000-0002-4103-9441	Australian National Health and Medical Research Council Program Grant [535921]; Diabetes Australia Research Program; Royal Melbourne Institute of Technology (RMIT) scholarships	Australian National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Program; Royal Melbourne Institute of Technology (RMIT) scholarships	The authors thank Songpei Li and Dr. Xiu Zhou for assistance with the animal study, and Dr. Ray Helliwell for critical review of the manuscript. This study was supported by the Australian National Health and Medical Research Council Program Grant 535921 (to J.-M.Y.), by the Diabetes Australia Research Program (to J.-M.Y.), and by Royal Melbourne Institute of Technology (RMIT) scholarships (to H.W. and R.-Q.S.). J.C.M. was a RMIT Vice Chancellor Senior Research Fellow (2011-2015). The authors declare no conflicts of interest.	Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Chen ZL, 2014, J GENET GENOMICS, V41, P357, DOI 10.1016/j.jgg.2014.05.005; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Darom A, 2010, MOL BIOL CELL, V21, P1788, DOI 10.1091/mbc.E09-09-0774; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Fu JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078522; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kuang ES, 2013, TRENDS BIOCHEM SCI, V38, P453, DOI 10.1016/j.tibs.2013.06.008; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ossareh-Nazari B, 2014, J CELL BIOL, V204, P909, DOI 10.1083/jcb.201308139; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Qiagen, EPITECT CHIP QPCR PR; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Scortegagna M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004348; Sun RQ, 2015, BBA-MOL BASIS DIS, V1852, P156, DOI 10.1016/j.bbadis.2014.11.017; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tong JB, 2012, J NEUROCHEM, V123, P406, DOI 10.1111/jnc.12014; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang H, 2015, ENDOCRINOLOGY, V156, P169, DOI 10.1210/en.2014-1454; Xu CF, 2014, AUTOPHAGY, V10, P2239, DOI 10.4161/15548627.2014.981792; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	39	26	27	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2549	2556		10.1096/fj.201500119	http://dx.doi.org/10.1096/fj.201500119			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27022162				2022-12-28	WOS:000379249500010
J	Akagi, S; Kono, N; Ariyama, H; Shindou, H; Shimizu, T; Arai, H				Akagi, Sosuke; Kono, Nozomu; Ariyama, Hiroyuki; Shindou, Hideo; Shimizu, Takao; Arai, Hiroyuki			Lysophosphatidylcholine acyltransferase 1 protects against cytotoxicity induced by polyunsaturated fatty acids	FASEB JOURNAL			English	Article						phospholipid metabolism; fatty acid metabolism; membrane phospholipid homeostasis	IMAGING MASS-SPECTROMETRY; LYSOPHOSPHOLIPID ACYLTRANSFERASE; EICOSAPENTAENOIC ACID; LIPID-COMPOSITION; MBOAT FAMILY; ACYL-COA; MEMBRANE; CELLS; CHAIN; PHOSPHATIDYLCHOLINE	The degree of fatty acid unsaturation in membrane phospholipids affects many membrane-associated functions and can be influenced by dietary consumption of fatty acids such as saturated fatty acids and polyunsaturated fatty acids (PUFAs). Cells must adapt to changes in composition of membrane fatty acids by regulating lipid-metabolizing enzymes. In this study, we investigated how cells respond to loading with excess PUFAs, such as arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid. A lipidomics analysis revealed that dipalmitoylphosphatidylcholine (DPPC) was increased after the production of PUFA-containing phospholipids in cells loaded with PUFAs. An RNA interference screen of lipid-metabolizing enzymes revealed that lysophosphatidylcholine acyltransferase 1 (LPCAT1) was involved in the DPPC production. Moreover, LPCAT1 knockdown markedly enhanced the cytotoxicity induced by excess PUFAs. PUFA-induced cytotoxicity was dependent on caspase and unfolded protein response (UPR) sensor proteins inositol requiring 1 alpha and protein kinase R-like endoplasmic reticulum kinase, suggesting that excess PUFAs trigger UPR-mediated apoptosis. In murine retina, in which PUFAs are highly enriched, DPPC was produced along with increase of PUFA-containing phospholipids. In LPCAT1 knockout mice, DPPC level was reduced and UPR was activated in the retina. Our results provide insight into understanding of the retinal degeneration seen in rd11 mice that lack LPCAT1.-Akagi, S., Kono, N., Ariyama, H., Shindou, H., Shimizu, T., Arai, H. Lysophosphatidylcholine acyltransferase 1 protects against cytotoxicity induced by polyunsaturated fatty acids. www.fasebj.org	[Akagi, Sosuke; Kono, Nozomu; Ariyama, Hiroyuki; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo 1130033, Japan; [Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Res Inst, Dept Lipid Signaling, Tokyo, Japan; [Shindou, Hideo; Arai, Hiroyuki] Japan Agcy Med Res & Dev, Core Res Evolutionary Sci & Technol AMED CREST, Tokyo, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo 1130033, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan; University of Tokyo	Kono, N; Arai, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nozomu@mol.f.u-tokyo.ac.jp; harai@mol.f.u-tokyo.ac.jp	Shimizu, Takao/AAV-7052-2021; KONO, nozomu/AAM-3178-2020		Japan Society for the Promotion of Science (KAKENHI) [23227004, 25460060, 24229003]; Japan Agency for Medical Research and Development-Core Research for Evolutionary Science and Technology (AMED-CREST); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development-Core Research for Evolutionary Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry	The authors gratefully acknowledge the technical assistance from K. Mukai, H. Fukuda, M. Kamio, T. Akimura, and Y. Takada. This work was supported by Japan Society for the Promotion of Science (KAKENHI) Grants 23227004 (to H. A.), 25460060 (to N.K.), and 24229003 (to T.S.); by the Japan Agency for Medical Research and Development-Core Research for Evolutionary Science and Technology (AMED-CREST) (to H. A. and H.S.); and by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (to H.A.).	Anasagasti A, 2012, VISION RES, V75, P117, DOI 10.1016/j.visres.2012.09.012; Anderson DMG, 2014, J AM SOC MASS SPECTR, V25, P1394, DOI 10.1007/s13361-014-0883-2; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Berdeaux O, 2010, J CHROMATOGR A, V1217, P7738, DOI 10.1016/j.chroma.2010.10.039; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; CARAVAGGIO LL, 1963, EXP EYE RES, V2, P12, DOI 10.1016/S0014-4835(63)80018-4; Chen P, 2014, INVEST OPHTH VIS SCI, V55, P8031, DOI 10.1167/iovs.14-14098; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Harayama T, 2009, J LIPID RES, V50, P1824, DOI 10.1194/jlr.M800500-JLR200; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Imae R, 2010, MOL BIOL CELL, V21, P3114, DOI 10.1091/mbc.E10-03-0195; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; LANDSCHULZ KT, 1994, BIOCHEM BIOPH RES CO, V200, P763, DOI 10.1006/bbrc.1994.1516; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee S, 2012, GENES CELLS, V17, P728, DOI 10.1111/j.1365-2443.2012.01622.x; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Merendino N, 2005, NUTR CANCER, V52, P225, DOI 10.1207/s15327914nc5202_12; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Moon YA, 2014, J LIPID RES, V55, P2597, DOI 10.1194/jlr.M054353; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Pantazi D, 2013, LIPIDS, V48, P827, DOI 10.1007/s11745-013-3800-8; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Sato SB, 2011, PROSTAG LEUKOTR ESS, V84, P31, DOI 10.1016/j.plefa.2010.09.006; Sessler AM, 1996, J BIOL CHEM, V271, P29854, DOI 10.1074/jbc.271.47.29854; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stahlman MT, 2007, J HISTOCHEM CYTOCHEM, V55, P71, DOI 10.1369/jhc.6A6962.2006; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wilson R, 2001, J CHROMATOGR A, V905, P251, DOI 10.1016/S0021-9673(00)01006-2; YAMAOKA S, 1988, J NUTR, V118, P290, DOI 10.1093/jn/118.3.290; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	73	16	17	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2027	2039		10.1096/fj.201500149	http://dx.doi.org/10.1096/fj.201500149			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26887439				2022-12-28	WOS:000374879400029
J	de Meij, TGJ; Budding, AE; de Groot, EFJ; Jansen, FM; Kneepkens, CMF; Benninga, MA; Penders, J; van Bodegraven, AA; Savelkoul, PHM				de Meij, Tim G. J.; Budding, Andries E.; de Groot, Evelien F. J.; Jansen, Fenna M.; Kneepkens, C. M. Frank; Benninga, Marc A.; Penders, John; van Bodegraven, Adriaan A.; Savelkoul, Paul H. M.			Composition and stability of intestinal microbiota of healthy children within a Dutch population	FASEB JOURNAL			English	Article						core; 454-pyrosequencing; IS-pro; diversity; microbiome	16S RIBOSOMAL-RNA; INFLAMMATORY-BOWEL-DISEASE; DISTAL GUT MICROBIOTA; BACTERIAL COMMUNITIES; TEMPORAL STABILITY; CROHNS-DISEASE; DIVERSITY; INFANTS; COLONIZATION; ANTIBIOTICS	Numerous diseases linked to microbial imbalance can be traced back to childhood, illustrating the impact of the juvenile microbiota development from infancy toward adulthood. However, knowledge on this subject is currently very limited. The primary aim of this study was to characterize composition and short-and long-term stability of the intestinal microbiota in healthy children. Between November 2011 and June 2014, 61 children 2 to 18 yr of age from different areas in The Netherlands were included and instructed to collect fecal samples weekly, for 6 wk, and a followup sample after 18 mo. The intergenic spacer profiling technique (IS-pro) was used to analyze all available fecal samples. Microbial diversity was calculated by the Shannon diversity index and individual compositional stability by comparing all collection time points. Microbial stability varied per phylum (P < 0.0005), declined rapidly in a short time period, and subsequently stabilized on the long run with very gradual variation, leading to an overall compositional stability of 70% on average over a period of 18 mo. Higher species diversity was correlated to a higher overall compositional stability (P < 0.001). We observed an age-independent bacterial shared core consisting of a limited number of species. In conclusion, in this study, we showed that microbial composition stability in children varied per phylum, at both short-term and long-term intervals. Healthy children seem to share a microbiome core consisting of a limited number of species.-De Meij, T. G. J., Budding, A. E., de Groot, E. F. J., Jansen, F. M., Kneepkens, C. M. F., Benninga, M. A., Penders, J., van Bodegraven, A. A., Savelkoul, P. H. M. Composition and stability of intestinal microbiota of healthy children within a Dutch population. FASEB J. 30, 1512-1522 (2016). www.fasebj.org	[de Meij, Tim G. J.; de Groot, Evelien F. J.; Jansen, Fenna M.; Kneepkens, C. M. Frank] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Gastroenterol, Amsterdam, Netherlands; [Budding, Andries E.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [van Bodegraven, Adriaan A.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Benninga, Marc A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Gastroenterol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Penders, John; Savelkoul, Paul H. M.] Maastricht Univ, Dept Med Microbiol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [van Bodegraven, Adriaan A.] Zuyderland Med Ctr, Dept Gastroentorol Internal Med Intens Care Med &, Heerlen Sittard Geleen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	de Meij, TGJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	t.demeij@vumc.nl	van Bodegraven, Ad A/L-3180-2013; Penders, John/A-1280-2011; van Bodegraven, Ad/ABG-4367-2020	Penders, John/0000-0001-9146-5919; Budding, Andries/0000-0001-5128-5411				Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Balamurugan R, 2008, AM J CLIN NUTR, V88, P1643, DOI 10.3945/ajcn.2008.26511; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Delgado S, 2006, DIGEST DIS SCI, V51, P737, DOI 10.1007/s10620-006-3200-5; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Durban A, 2012, FEMS MICROBIOL ECOL, V81, P427, DOI 10.1111/j.1574-6941.2012.01368.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069621; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mitsue K., 2007, LECT NOTES COMPUT SC, V4551, P106; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2012, ENVIRON MICROBIOL, DOI [10.1111/1462-2920, DOI 10.1111/1462-2920]; Salminen S, 2004, GUT, V53, P1388, DOI 10.1136/gut.2004.041640; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tapiainen T, 2006, APMIS, V114, P812, DOI 10.1111/j.1600-0463.2006.apm_488.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vangay P, 2015, CELL HOST MICROBE, V17, P553, DOI 10.1016/j.chom.2015.04.006; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	53	34	34	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1512	1522		10.1096/fj.15-278622	http://dx.doi.org/10.1096/fj.15-278622			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26655704	Green Submitted			2022-12-28	WOS:000372629100013
J	Granata, C; Oliveira, RSF; Little, JP; Renner, K; Bishop, DJ				Granata, Cesare; Oliveira, Rodrigo S. F.; Little, Jonathan P.; Renner, Kathrin; Bishop, David J.			Training intensity modulates changes in PGC-1 alpha and p53 protein content and mitochondrial respiration, but not markers of mitochondrial content in human skeletal muscle	FASEB JOURNAL			English	Article						mitochondrial biogenesis; exercise; PHF20; TFAM; mitochondrial remodeling	EXERCISE INTENSITY; MESSENGER-RNA; SPRINT INTERVAL; BIOGENESIS; IMPROVEMENTS; PERFORMANCE; EXPRESSION; INCREASES; APOPTOSIS; CAPACITY	Exercise training has been associated with increased mitochondrial content and respiration. However, no study to date has compared in parallel how training at different intensities affects mitochondrial respiration and markers of mitochondrial biogenesis. Twenty-nine healthy men performed 4 wk (12 cycling sessions) of either sprint interval training [SIT; 4-10 x 30-s all-out bouts at similar to 200% of peak power output (W-Peak)], high-intensity interval training (HIIT; 4-7 x 4-min intervals at similar to 90% W-Peak), or sublactate threshold continuous training (STCT; 20-36 min at similar to 65% W-Peak). The STCT and HIIT groups were matched for total work. Resting biopsy samples (vastus lateralis) were obtained before and after training. The maximal mitochondrial respiration in permeabilized muscle fibers increased significantly only after SIT (25%). Similarly, the protein content of peroxisome proliferator-activated receptor gamma coactivator (PGC)-1 alpha, p53, and plant homeodomain finger-containing protein 20 (PHF20) increased only after SIT (60-90%). Conversely, citrate synthase activity, and the protein content of TFAM and subunits of the electron transport system complexes remained unchanged throughout. Our findings suggest that training intensity is an important factor that regulates training-induced changes in mitochondrial respiration and that there is an apparent dissociation between training-induced changes in mitochondrial respiration and mitochondrial content. Moreover, changes in the protein content of PGC-1 alpha, p53, and PHF20 are more strongly associated with training-induced changes in mitochondrial respiration than mitochondrial content.	[Granata, Cesare; Oliveira, Rodrigo S. F.; Bishop, David J.] Victoria Univ, ISEAL, Coll Sport & Exercise Sci, PB140,Footscray Pk Campus, Melbourne, Vic 3011, Australia; [Little, Jonathan P.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Renner, Kathrin] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany	Victoria University; University of British Columbia; University of British Columbia Okanagan; University of Regensburg	Bishop, DJ (corresponding author), Victoria Univ, ISEAL, Coll Sport & Exercise Sci, PB140,Footscray Pk Campus, Melbourne, Vic 3011, Australia.	david.bishop@vu.edu.au	Little, Jonathan P./T-4076-2019; Bishop, David John/X-9826-2019; Granata, Cesare/J-9738-2016; Renner, Kathrin/H-3211-2013	Little, Jonathan P./0000-0002-9796-2008; Bishop, David John/0000-0002-6956-9188; Granata, Cesare/0000-0002-3509-6001; Renner, Kathrin/0000-0002-7116-1368	ANZ-MASON foundation; Natural Sciences and Engineering Research Council of Canada [RGPIN 435807-13]	ANZ-MASON foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors thank Ms. E. Brentnall and Mr. A. Ronacher for valuable help in data collection. This study was funded by a grant from the ANZ-MASON foundation (to D.J.B.) and Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 435807-13 (to J.P.L.). The authors declare no conflicts of interest.	Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007; Baldwin J, 2000, MED SCI SPORT EXER, V32, P1648; Bartlett JD, 2013, AM J PHYSIOL-REG I, V304, pR450, DOI 10.1152/ajpregu.00498.2012; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Bishop D, 2000, MED SCI SPORT EXER, V32, P1088, DOI 10.1097/00005768-200006000-00008; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Cui GF, 2012, NAT STRUCT MOL BIOL, V19, P916, DOI 10.1038/nsmb.2353; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Edgett BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071623; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Kim SH, 2015, J PHYSIOL-LONDON, V593, P635, DOI 10.1113/jphysiol.2014.283820; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; Mai S, 2012, AUTOPHAGY, V8, P47, DOI 10.4161/auto.8.1.18174; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Park S, 2012, J BIOL CHEM, V287, P11151, DOI 10.1074/jbc.M111.333922; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Ryan TE, 2014, J PHYSIOL-LONDON, V592, P3231, DOI 10.1113/jphysiol.2014.274456; Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791; Saleem A, 2011, EXERC SPORT SCI REV, V39, P199, DOI 10.1097/JES.0b013e31822d71be; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Vigelso Andreas, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P84; Vincent G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00051; VOLLESTAD NK, 1985, ACTA PHYSIOL SCAND, V125, P395, DOI 10.1111/j.1748-1716.1985.tb07735.x; Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004	37	122	124	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					959	970		10.1096/fj.15-276907	http://dx.doi.org/10.1096/fj.15-276907			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26572168				2022-12-28	WOS:000369391900042
J	Pisani, DF; Beranger, GE; Corinus, A; Giroud, M; Ghandour, RA; Altirriba, J; Chambard, JC; Mazure, NM; Bendahhou, S; Duranton, C; Michiels, JF; Frontini, A; Rohner-Jeanrenaud, F; Cinti, S; Christian, M; Barhanin, J; Amri, EZ				Pisani, Didier F.; Beranger, Guillaume E.; Corinus, Alain; Giroud, Maude; Ghandour, Rayane A.; Altirriba, Jordi; Chambard, Jean-Claude; Mazure, Nathalie M.; Bendahhou, Said; Duranton, Christophe; Michiels, Jean-Francois; Frontini, Andrea; Rohner-Jeanrenaud, Franoise; Cinti, Saverio; Christian, Mark; Barhanin, Jacques; Amri, Ez-Zoubir			The K+ channel TASK1 modulates beta-adrenergic response in brown adipose tissue through the mineralocorticoid receptor pathway	FASEB JOURNAL			English	Article						UCP1; KCNK3; thermogenesis; aldosterone; obesity	ADIPOCYTE DYSFUNCTION; UNCOUPLING PROTEIN; GENE-EXPRESSION; COLD-EXPOSURE; WHITE; FAT; ACTIVATION; CELL; IDENTIFICATION; ALDOSTERONE	Brown adipose tissue (BAT) is essential for adaptive thermogenesis and dissipation of caloric excess through the activity of uncoupling protein (UCP)-1. BAT in humans is of great interest for the treatment of obesity and related diseases. In this study, the expression of Twik-related acid-sensitive K+ channel (TASK)-1 [a pH-sensitive potassium channel encoded by the potassium channel, 2-pore domain, subfamily K, member 3 (Kcnk3) gene] correlated highly with Ucp1 expression in obese and cold-exposed mice. In addition, Task1-nullmice, compared with their controls, became overweight, mainly because of an increase in white adipose tissue mass and BAT whitening. Task1(-/-) -mouse-derived brown adipocytes, compared with wild-typemouse-derived brown adipocytes, displayed an impaired beta 3-adrenergic receptor response that was characterized by a decrease in oxygen consumption, Ucp1 expression, and lipolysis. This phenotype was thought to be caused by an exacerbation of mineralocorticoid receptor (MR) signaling, given that it was mimicked by corticoids and reversed by an MR inhibitor. We concluded that the K+ channel TASK1 controls the thermogenic activity in brown adipocytes through modulation of beta-adrenergic receptor signaling.	[Pisani, Didier F.; Beranger, Guillaume E.; Corinus, Alain; Giroud, Maude; Ghandour, Rayane A.; Chambard, Jean-Claude; Mazure, Nathalie M.; Bendahhou, Said; Duranton, Christophe; Michiels, Jean-Francois; Barhanin, Jacques; Amri, Ez-Zoubir] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Pisani, Didier F.; Beranger, Guillaume E.; Giroud, Maude; Ghandour, Rayane A.; Chambard, Jean-Claude; Amri, Ez-Zoubir] CNRS, IBV, UMR 7277, F-06034 Nice, France; [Pisani, Didier F.; Beranger, Guillaume E.; Giroud, Maude; Ghandour, Rayane A.; Chambard, Jean-Claude; Amri, Ez-Zoubir] Fac Med Nice, INSERM, IBV, U1091, U210, F-06034 Nice, France; [Corinus, Alain; Bendahhou, Said; Duranton, Christophe; Barhanin, Jacques] CNRS, UMR 7370, F-06034 Nice, France; [Corinus, Alain; Bendahhou, Said; Duranton, Christophe; Barhanin, Jacques] CNRS, LP2M, Labs Excellence Ion Channel Sci & Therapeut, F-06034 Nice, France; [Altirriba, Jordi; Rohner-Jeanrenaud, Franoise] Univ Geneva, Fac Med, Dept Internal Med Specialties, Lab Metab, Geneva, Switzerland; [Mazure, Nathalie M.; Michiels, Jean-Francois] CNRS, Inst Res Canc & Aging Nice, INSERM, UMR 7284, F-06034 Nice, France; [Mazure, Nathalie M.; Michiels, Jean-Francois] CNRS, Inst Res Canc & Aging Nice, INSERM, U1081, F-06034 Nice, France; [Michiels, Jean-Francois] CHU Nice, Pasteur Hosp, Serv Anatomopathol, F-06202 Nice, France; [Frontini, Andrea; Cinti, Saverio] Obes Ctr, Dept Expt & Clin Med, Ancona, Italy; [Christian, Mark] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; University of Warwick	Amri, EZ (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, 28 Ave Valombrose, F-06107 Nice 2, France.; Barhanin, J (corresponding author), Lab Physiomed Mol, 28 Ave Valombrose, F-06107 Nice 2, France.	jacques.barhanin@unice.fr; amri@unice.fr	Beranger, Guillaume E/L-7554-2016; Beranger, Guillaume/AAH-2608-2019; Frontini, A/AAB-8767-2021; Pisani, Didier/AAC-2997-2019	Beranger, Guillaume E/0000-0001-8770-864X; Beranger, Guillaume/0000-0001-8770-864X; Pisani, Didier/0000-0001-5879-8527; Mazure, Nathalie/0000-0003-1350-7161; CINTI, Saverio/0000-0003-0362-5017; Christian, Mark/0000-0002-1616-4179; Frontini, Andrea/0000-0002-7381-4107	Centre National de la Recherche Scientifique; EU FP7 project DIABAT [HEALTH-F2-2011-278373]; French Agence Nationale de la Recherche (ANR) [ANR-10-BLAN-1105 miRBAT, ANR-11-BSV1-005 02 BeyondTASK]; LabEx Ion Channel Science and Therapeutics Grant [ANR-11-LABX-0015-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); EU FP7 project DIABAT; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); LabEx Ion Channel Science and Therapeutics Grant	The authors thank the Institut de Pharmacologie Moleculaire et Cellulaire, and the Institute for Research in Cancer and Aging in Nice animal core facilities. This work was supported by the Centre National de la Recherche Scientifique, EU FP7 project DIABAT (HEALTH-F2-2011-278373), French Agence Nationale de la Recherche (ANR) Grants ANR-10-BLAN-1105 miRBAT (to E.-Z.A.) and ANR-11-BSV1-005 02 BeyondTASK (to J.B.), and LabEx Ion Channel Science and Therapeutics Grant ANR-11-LABX-0015-01.	Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415; Bandulik S., 2014, PFLUGERS ARCH, V467, P1027, DOI DOI 10.1007/S00424-014-1628-6); Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Beranger GE, 2014, ENDOCRINOLOGY, V155, P1340, DOI 10.1210/en.2013-1688; Borga M, 2014, METHOD ENZYMOL, V537, P141, DOI 10.1016/B978-0-12-411619-1.00008-2; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Briones AM, 2012, HYPERTENSION, V59, P1069, DOI 10.1161/HYPERTENSIONAHA.111.190223; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dadi PK, 2014, ENDOCRINOLOGY, V155, P3757, DOI 10.1210/en.2013-2051; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fallo F, 2008, CURR DIABETES REP, V8, P42, DOI 10.1007/s11892-008-0009-y; Farman N, 2000, KIDNEY INT, V57, P1364, DOI 10.1046/j.1523-1755.2000.00976.x; Fukuhara K, 1996, J NEUROENDOCRINOL, V8, P533, DOI 10.1046/j.1365-2826.1996.04877.x; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Langin D, 2010, BBA-MOL CELL BIOL L, V1801, P372, DOI 10.1016/j.bbalip.2009.09.008; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Manieri M, 2010, NUTR METAB CARDIOVAS, V20, P567, DOI 10.1016/j.numecd.2009.04.020; Marzolla V, 2014, STEROIDS, V91, P46, DOI 10.1016/j.steroids.2014.05.001; Marzolla V, 2012, MOL CELL ENDOCRINOL, V350, P281, DOI 10.1016/j.mce.2011.09.011; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nogueira EF, 2010, CLIN ENDOCRINOL, V73, P22, DOI 10.1111/j.1365-2265.2009.03738.x; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pisani DF, 2014, MOL METAB, V3, P834, DOI 10.1016/j.molmet.2014.09.003; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; Ricquier D, 2000, INT J OBESITY, V24, pS86, DOI 10.1038/sj.ijo.0801286; Rogerson FM, 2014, FASEB J, V28, P4200, DOI 10.1096/fj.13-242479; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Soumano K, 2000, MOL CELL ENDOCRINOL, V165, P7, DOI 10.1016/S0303-7207(00)00276-8; Stow LR, 2009, J BIOL CHEM, V284, P30087, DOI 10.1074/jbc.M109.030718; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Viengchareun S, 2001, AM J PHYSIOL-ENDOC M, V280, pE640, DOI 10.1152/ajpendo.2001.280.4.E640; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	48	27	28	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					909	922		10.1096/fj.15-277475	http://dx.doi.org/10.1096/fj.15-277475			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527067	Green Published			2022-12-28	WOS:000369391900038
J	Oyewole, AO; Birch-Machin, MA				Oyewole, Anne O.; Birch-Machin, Mark A.			Mitochondria-targeted antioxidants	FASEB JOURNAL			English	Review						MitoQ; tiron; reactive oxygen species; oxidative damage	HUMAN SKIN CELLS; OXIDATIVE STRESS; DNA-DAMAGE; DERMAL FIBROBLASTS; HYDROGEN-PEROXIDE; ROS PRODUCTION; IRON; MITOQ; ULTRAVIOLET; DYSFUNCTION	Redox homeostasis is maintained by the antioxidant defense system, which is responsible for eliminating a wide range of oxidants, including reactive oxygen species (ROS), lipid peroxides, and metals. Mitochondria-localized antioxidants are widely studied because the mitochondria, the major producers of intracellular ROS, have been linked to the cause of aging and other chronic diseases. Mitochondria-targeted antioxidants have shown great potential because they cross the mitochondrial phospholipid bilayer and eliminate ROS at the heart of the source. Growing evidence has identified mitochondria-targeted antioxidants, such as MitoQ and tiron, as potentially effective antioxidant therapies against the damage caused by enhanced ROS generation. This literature review summarizes the current knowledge on mitochondria-targeted antioxidants and their contribution to the body's antioxidant defense system. In addition to addressing the concerns surrounding current antioxidant strategies, including difficulties in targeting antioxidant treatment to sites of pathologic oxidative damage, we discuss promising therapeutic agents and new strategic approaches.	[Oyewole, Anne O.; Birch-Machin, Mark A.] Newcastle Univ, Sch Med, Inst Cellular Med, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Birch-Machin, MA (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Dermatol Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	m.a.birch-machin@ncl.ac.uk			Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom); Unilever (London, United Kingdom); Medical Research Council [MC_PC_13071] Funding Source: researchfish; MRC [MC_PC_13071] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever (London, United Kingdom); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) and Unilever (London, United Kingdom). The authors declare no conflicts of interest.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Aroun A, 2012, PHOTOCH PHOTOBIO SCI, V11, P118, DOI 10.1039/c1pp05204g; Asano T, 2015, NEUROSCI LETT, V588, P29, DOI 10.1016/j.neulet.2014.12.052; BENDICH A, 1986, ADV FREE RADICAL BIO, V2, P419, DOI 10.1016/S8755-9668(86)80021-7; Birch-Machin MA, 2006, CLIN EXP DERMATOL, V31, P548, DOI 10.1111/j.1365-2230.2006.02161.x; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Chen L, 2012, J AM ACAD DERMATOL, V67, P1013, DOI 10.1016/j.jaad.2012.02.009; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; de la Roche HM, 2010, J PHOTOCH PHOTOBIO B, V101, P169, DOI 10.1016/j.jphotobiol.2010.04.006; Demirovic D, 2011, BIOGERONTOLOGY, V12, P437, DOI 10.1007/s10522-011-9326-7; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Edeas M, 2011, PHARM RES-DORDR, V28, P2771, DOI 10.1007/s11095-011-0587-2; Epe B, 2012, PHOTOCH PHOTOBIO SCI, V11, P98, DOI 10.1039/c1pp05190c; Fang Y, 2012, AUSTRALAS J DERMATOL, V53, P172, DOI 10.1111/j.1440-0960.2012.00912.x; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Genrikhs EE, 2015, J DRUG TARGET, V23, P347, DOI 10.3109/1061186X.2014.997736; Giordani A, 2000, PHOTOCHEM PHOTOBIOL, V72, P746, DOI 10.1562/0031-8655(2000)072<0746:IOIREB>2.0.CO;2; Gioscia-Ryan RA, 2014, J PHYSIOL-LONDON, V592, P2549, DOI 10.1113/jphysiol.2013.268680; Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351; Hegde ML, 2012, MECH AGEING DEV, V133, P157, DOI 10.1016/j.mad.2012.01.005; Hirota A, 2011, EXP DERMATOL, V20, P664, DOI 10.1111/j.1600-0625.2011.01292.x; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Kalra S, 2011, CANCER PREV RES, V4, P1665, DOI 10.1158/1940-6207.CAPR-11-0137; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; KRISHNA CM, 1992, ARCH BIOCHEM BIOPHYS, V294, P98, DOI 10.1016/0003-9861(92)90142-J; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Kvam E, 1997, CARCINOGENESIS, V18, P2379, DOI 10.1093/carcin/18.12.2379; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lowes DA, 2008, FREE RADICAL BIO MED, V45, P1559, DOI 10.1016/j.freeradbiomed.2008.09.003; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Maher P, 2015, NEUROCHEM RES, V40, P609, DOI 10.1007/s11064-014-1508-7; McArdle F, 2005, FREE RADICAL BIO MED, V39, P651, DOI 10.1016/j.freeradbiomed.2005.04.010; Meewes C, 2001, FREE RADICAL BIO MED, V30, P238, DOI 10.1016/S0891-5849(00)00463-9; Mena NP, 2015, MITOCHONDRION, V21, P92, DOI 10.1016/j.mito.2015.02.001; Murphy MP, 2014, FREE RADICAL BIO MED, V66, P20, DOI 10.1016/j.freeradbiomed.2013.04.010; Murphy MP, 2013, CELL METAB, V18, P145, DOI 10.1016/j.cmet.2013.07.006; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicolaou A, 2011, CHEM PHYS LIPIDS, V164, P535, DOI 10.1016/j.chemphyslip.2011.04.005; Oyewole AO, 2014, FASEB J, V28, P485, DOI 10.1096/fj.13-237008; Paz ML, 2008, PHOTODERMATOL PHOTO, V24, P115, DOI 10.1111/j.1600-0781.2008.00348.x; Rizwan M, 2011, BRIT J DERMATOL, V164, P154, DOI 10.1111/j.1365-2133.2010.10057.x; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; SHINDO Y, 1994, J INVEST DERMATOL, V102, P122, DOI 10.1111/1523-1747.ep12371744; Silveira LR, 2003, FREE RADICAL BIO MED, V35, P455, DOI 10.1016/S0891-5849(03)00271-5; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Soeur J, 2015, FREE RADICAL BIO MED, V78, P213, DOI 10.1016/j.freeradbiomed.2014.10.510; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; Supinski G, 1999, J APPL PHYSIOL, V87, P2177, DOI 10.1152/jappl.1999.87.6.2177; Supinski GS, 2009, AM J PHYSIOL-REG I, V297, pR1095, DOI 10.1152/ajpregu.90902.2008; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Swalwell H, 2012, FREE RADICAL BIO MED, V52, P626, DOI 10.1016/j.freeradbiomed.2011.11.019; Swindells K, 2004, PHOTODERMATOL PHOTO, V20, P297, DOI 10.1111/j.1600-0781.2004.00121.x; Thomsen MS, 2015, NEUROBIOL DIS, V81, P108, DOI 10.1016/j.nbd.2015.03.013; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tulah AS, 2013, MITOCHONDRION, V13, P444, DOI 10.1016/j.mito.2012.11.007; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Williams JD, 2014, J PHOTOCH PHOTOBIO B, V132, P56, DOI 10.1016/j.jphotobiol.2014.01.019; Wu Y, 2012, HUM HEALT HANDB, P69; Wu Y, 2011, CLIN EXP DERMATOL, V36, P178, DOI 10.1111/j.1365-2230.2010.03916.x	70	230	241	14	66	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4766	4771		10.1096/fj.15-275404	http://dx.doi.org/10.1096/fj.15-275404			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26253366				2022-12-28	WOS:000365523600004
J	Shi, ZY; Wang, FQ; Cui, Y; Liu, ZZ; Guo, XG; Zhang, YQ; Deng, Y; Zhao, H; Chen, YL				Shi, Zhaoying; Wang, Fengqin; Cui, Yan; Liu, Zhongzhen; Guo, Xiaogang; Zhang, Yanqi; Deng, Yi; Zhao, Hui; Chen, Yonglong			Heritable CRISPR/Cas9-mediated targeted integration in Xenopus tropicalis	FASEB JOURNAL			English	Article						concurrent cleavage; knock-in; homology independent	NUCLEASE-INDUCED MUTATIONS; ZINC-FINGER NUCLEASES; HOMOLOGOUS RECOMBINATION; TRANSGENIC XENOPUS; GENOME MODIFICATION; GENE DISRUPTION; KNOCK-IN; ZEBRAFISH; EMBRYOS; LAEVIS	Xenopus tropicalis is an emerging vertebrate genetic model. A gene knock-in method has not yet been reported in this species. Here, we report that heritable targeted integration can be achieved in this diploid frog using a concurrent cleavage strategy mediated by the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (CRISPR/Cas9) system. The key point of the strategy is the addition of a Cas9/guide RNA cleavage site in the donor vector, allowing simultaneous cutting of the chromosomal target site and circular donor DNA in vivo. For the 3 distinct loci tested, all showed efficient targeted integration that was verified by both germ-line transmission and Southern blot analyses. By designing the target sites in introns, we were able to get precise editing of the tyrosinase coding sequence and green fluorescent protein expression from endogenous n-tubulin promoter and enhancers. We were unable to detect off-target effects with the T7 endonuclease I assay. Precise editing of protein coding sequences in X. tropicalis expands the utility of this diploid frog, such as for establishing models to study human inherited diseases.	[Shi, Zhaoying; Wang, Fengqin; Cui, Yan; Guo, Xiaogang; Zhang, Yanqi; Chen, Yonglong] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Shi, Zhaoying; Wang, Fengqin; Cui, Yan; Guo, Xiaogang; Zhang, Yanqi; Chen, Yonglong] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Shi, Zhaoying; Deng, Yi; Chen, Yonglong] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China; [Wang, Fengqin] Anhui Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Cui, Yan; Zhang, Yanqi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Zhongzhen; Zhao, Hui] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China; [Zhao, Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Southern University of Science & Technology; Anhui University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Chen, YL (corresponding author), South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China.	zhaohui@cuhk.edu.hk; chenyl@sustc.edu.cn	Zhao, Hui/B-8429-2016	Zhao, Hui/0000-0001-8160-6415; Zhang, Yanqi/0000-0001-6896-8657; Deng, Yi/0000-0003-1378-015X; Zhaoying, Shi/0000-0002-4208-6581	National Basic Research Program of China [2015CB942803]; National Natural Science Foundation of China [31471367, 31271554, 31301192]; Shenzhen Key Laboratory of Cell Microenvironment [ZDSYS20140509142721429]; Research Grants Council of Hong Kong [N_CUHK413/12]; Early Career Scheme [ECS 24100414]; K. S. Lo Foundation; CAS Key Laboratory of Regenerative Biology; Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Key Laboratory of Cell Microenvironment; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Early Career Scheme; K. S. Lo Foundation; CAS Key Laboratory of Regenerative Biology; Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine	The authors thank Dr. I. Dawid for critical reading. Supported in part by the National Basic Research Program of China (2015CB942803), the National Natural Science Foundation of China (31471367, 31271554 to Y.Ch., and 31301192 to X.G.), Shenzhen Key Laboratory of Cell Microenvironment (ZDSYS20140509142721429), the Research Grants Council of Hong Kong (N_CUHK413/12 to H.Z.), Early Career Scheme (ECS 24100414 to H.Z.), K. S. Lo Foundation (to H.Z.), CAS Key Laboratory of Regenerative Biology, and Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine.	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Beck CW, 1999, MECH DEVELOP, V88, P221, DOI 10.1016/S0925-4773(99)00217-8; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; DALE L, 1987, DEVELOPMENT, V99, P527; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hagmann M, 1996, BIOL CHEM H-S, V377, P239, DOI 10.1515/bchm3.1996.377.4.239; HAMMER RE, 1987, MOL CELL BIOL, V7, P2956, DOI 10.1128/MCB.7.8.2956; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hollemann T, 1998, EMBO J, V17, P7361, DOI 10.1093/emboj/17.24.7361; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Ishibashi S, 2012, BIOL OPEN, V1, P1273, DOI 10.1242/bio.20123228; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Joseph S., 2001, MOL CLONING LAB MANU, P631; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; OSCHWALD R, 1991, International Journal of Developmental Biology, V35, P399; Pan FC, 2006, DEV DYNAM, V235, P247, DOI 10.1002/dvdy.20608; Pearl EJ, 2012, GENESIS, V50, P155, DOI 10.1002/dvg.22013; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Rankin SA, 2009, DEV DYNAM, V238, P2401, DOI 10.1002/dvdy.22043; Roose M, 2009, TRANSGENIC RES, V18, P595, DOI 10.1007/s11248-009-9253-4; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	35	44	44	0	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4914	4923		10.1096/fj.15-273425	http://dx.doi.org/10.1096/fj.15-273425			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26268927				2022-12-28	WOS:000365523600017
J	Orban, T; Johnson, WM; Dong, ZQ; Maeda, T; Maeda, A; Sakai, T; Tsuneoka, H; Mieyal, JJ; Palczewski, K				Orban, Tivadar; Johnson, William M.; Dong, Zhiqian; Maeda, Tadao; Maeda, Akiko; Sakai, Tsutomu; Tsuneoka, Hiroshi; Mieyal, John J.; Palczewski, Krzysztof			Serum levels of lipid metabolites in age-related macular degeneration	FASEB JOURNAL			English	Article						docosahexaenoic acid; arachidonic acid; risk evaluation; serum; mouse model	OPTICAL COHERENCE TOMOGRAPHY; GEOGRAPHIC ATROPHY; ANIMAL-MODELS; DARK-ADAPTATION; MOUSE RETINA; AGING BRAIN; BIOMARKERS; MUTATION; CELLS; IDENTIFICATION	Age-related macular degeneration (AMD) is a neurodegenerative disease that causes adult-onset blindness. There are 2 forms of this progressive disease: wet and dry. Currently there is no cure for AMD, but several treatment options have started to emergemaking early detection critical for therapeutic success. Analysis of the eyes of Abca4(-/-) Rdh8(-/-) mice that display light-induced retinal degeneration indicates that 11-cis-retinal and docosahexaenoic acid (DHA) levels were significantly decreased as compared with the eyes of control dark-adapted C57BL/6J mice. In addition, exposure to intense light correlated with higher levels of prostaglandin G2 in the eyes of Abca4(-/-) Rdh8(-/-) mice. Intense light exposure also loweredDHA levels in the eyes of wild-type C57BL/6J mice without discernible retinal degeneration. Analysis of human serumfrom patients with AMD recapitulated these dysregulated DHA levels and revealed dysregulation of arachidonic acid (AA) levels as well (similar to 32% increase in patients with AMDcomparedwith average levels in healthy individuals). From these observations, we then built a statistical model that included levels of DHA and AA from human serum. This model had a 74% probability of correctly identifying patients with AMD from controls. Addition of a genetic analysis for one of the most prevalent amino acid substitutions in the age-related maculopathy susceptibility 2 gene linked to AMD, Ala(69) -> Ser, did not improve the statisticalmodel. Thus, we have characterized a reliablemethod with the potential to detect AMDwithout a genetic component, paving the way for a larger-scale clinical evaluation. Our studies on mouse models along with the analysis of human serum suggest that our small molecule-based model may serve as an effective tool to estimate the risk of developing AMD.	[Orban, Tivadar; Johnson, William M.; Maeda, Akiko; Mieyal, John J.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Sch Med, Cleveland, OH 44106 USA; [Dong, Zhiqian] Polgenix Inc, Cleveland, OH USA; [Sakai, Tsutomu; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Mieyal, John J.] Louis Stokes Vet Affairs Med Res Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Jikei University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu		DONG, ZHIQIAN/0000-0002-8748-4532	U.S. National Institutes of Health, National Eye Institute [EY009339, EY021126]; Foundation Fighting Blindness; Arnold and Mabel Beckman Foundation; NATIONAL EYE INSTITUTE [R24EY021126, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Arnold and Mabel Beckman Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Leslie T. Webster, Jr., Daniel Figeys, and members of the K.P. laboratory for helpful comments on this manuscript; and Drs. Philip D. Kiser, Marcin Golczak, and Yaroslav Tsybovsky (all from Case Western Reserve University) for support and advice during this study. This work was supported by funding from the U.S. National Institutes of Health, National Eye Institute Grants EY009339 and EY021126 (to K.P.), the Foundation Fighting Blindness, and the Arnold and Mabel Beckman Foundation. K.P. is a John H. Hord Professor of Pharmacology. The authors declare no conflicts of interest.	Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Ayyagari R, 2001, Ophthalmic Genet, V22, P233, DOI 10.1076/opge.22.4.233.2219; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Carroll J, 2013, CURR EYE RES, V38, P709, DOI 10.3109/02713683.2013.784792; Chader GJ, 2002, VISION RES, V42, P393, DOI 10.1016/S0042-6989(01)00212-7; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Costa RA, 2006, PROG RETIN EYE RES, V25, P325, DOI 10.1016/j.preteyeres.2006.03.001; de Ruijter W., 2009, BMJ-BRIT MED J, V338, P1; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Dimitrov PN, 2012, INVEST OPHTH VIS SCI, V53, P5213, DOI 10.1167/iovs.11-8958; Dimitrov PN, 2011, INVEST OPHTH VIS SCI, V52, P9457, DOI 10.1167/iovs.10-7043; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Gabriele ML, 2010, PROG RETIN EYE RES, V29, P556, DOI 10.1016/j.preteyeres.2010.05.005; Gaffney AJ, 2013, DOC OPHTHALMOL, V127, P191, DOI 10.1007/s10633-013-9400-3; GELFANT S, 1972, SCIENCE, V178, P357, DOI 10.1126/science.178.4059.357; Grimm C, 2004, J NEUROSCI, V24, P5651, DOI 10.1523/JNEUROSCI.1288-04.2004; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Guarente L, 1997, SCIENCE, V275, P943, DOI 10.1126/science.275.5302.943; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Guymer RH, 2011, INVEST OPHTH VIS SCI, V52, P4639, DOI 10.1167/iovs.10-7120; Heimann H, 2013, EYE, V27, P208, DOI 10.1038/eye.2012.251; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Holz FG, 2014, OPHTHALMOLOGY, V121, P1079, DOI 10.1016/j.ophtha.2013.11.023; Hunter JJ, 2011, BIOMED OPT EXPRESS, V2, P139, DOI 10.1364/BOE.2.000139; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Keles S, 2014, CLIN OPHTHALMOL, V8, P1573, DOI 10.2147/OPTH.S66160; Kim HJ, 2014, INVEST OPHTH VIS SCI, V55, P7166, DOI 10.1167/iovs.14-15168; Kohno H, 2014, J IMMUNOL, V192, P3816, DOI 10.4049/jimmunol.1301738; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lindenberger U, 2014, SCIENCE, V346, P572, DOI 10.1126/science.1254403; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda Akiko, 2013, Drug Discov Today Dis Models, V10, pe163; Maeda A, 2014, P NATL ACAD SCI USA, V111, pE1428, DOI 10.1073/pnas.1317986111; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; McMahon A, 2007, MOL VIS, V13, P258; Merle BMJ, 2014, INVEST OPHTH VIS SCI, V55, P2010, DOI 10.1167/iovs.14-13916; Morgan J, 2005, EXP EYE RES, V80, P297, DOI 10.1016/j.exer.2004.12.010; Nassar K, 2015, GRAEF ARCH CLIN EXP, V253, P699, DOI 10.1007/s00417-014-2738-8; Ni JQ, 2009, MOL CELL PROTEOMICS, V8, P1921, DOI 10.1074/mcp.M900127-MCP200; Nussenblatt RB, 2014, AM J OPHTHALMOL, V158, P5, DOI 10.1016/j.ajo.2014.03.014; Owsley C, 2000, INVEST OPHTH VIS SCI, V41, P267; Owsley C, 2014, INVEST OPHTH VIS SCI, V55, P4776, DOI 10.1167/iovs.14-14502; Palczewska G, 2014, P NATL ACAD SCI USA, V111, pE5445, DOI 10.1073/pnas.1410162111; Palczewska G, 2014, INVEST OPHTH VIS SCI, V55, P4438, DOI 10.1167/iovs.14-14395; Palczewska G, 2014, NAT MED, V20, P785, DOI 10.1038/nm.3590; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Schmitz-Valckenberg S, 2009, INVEST OPHTH VIS SCI, V50, P3915, DOI 10.1167/iovs.08-2484; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuman SG, 2009, OPHTHALMOLOGY, V116, P488, DOI 10.1016/j.ophtha.2008.10.006; Shafto MA, 2014, SCIENCE, V346, P583, DOI 10.1126/science.1254404; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; van Velthoven MEJ, 2007, PROG RETIN EYE RES, V26, P57, DOI 10.1016/j.preteyeres.2006.10.002; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Vine AK, 2005, OPHTHALMOLOGY, V112, P2076, DOI 10.1016/j.ophtha.2005.07.004; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Yoshida T, 2007, MOL VIS, V13, P545; ZWEIG MH, 1993, CLIN CHEM, V39, P561	71	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4579	4588		10.1096/fj.15-275289	http://dx.doi.org/10.1096/fj.15-275289			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26187344	Green Published			2022-12-28	WOS:000364514700017
J	McCann, JC; Shigenaga, MK; Mietus-Snyder, ML; Lal, A; Suh, JH; Krauss, RM; Gildengorin, GL; Goldrich, AM; Block, DS; Shenvi, SV; McHugh, TH; Olson, DA; Ames, BN				McCann, Joyce C.; Shigenaga, Mark K.; Mietus-Snyder, Michele L.; Lal, Ashutosh; Suh, Jung H.; Krauss, Ronald M.; Gildengorin, Ginny L.; Goldrich, Alisa M.; Block, Devan S.; Shenvi, Swapna V.; McHugh, Tara H.; Olson, Don A.; Ames, Bruce N.			A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: chronic inflammation blunts these improvements	FASEB JOURNAL			English	Article						cardiovascular; dietary intervention; nutritional supplements; lipid particles; HDL cholesterol	C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; LIFE-STYLE INTERVENTION; PUBLIC-HEALTH PRACTICE; DIETARY FIBER INTAKE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; GUT MICROBIOTA; INTESTINAL PERMEABILITY	This study determined if twice-daily consumption of a nutrient-dense bar intended to fill gaps in Western diets, without other dietary/lifestyle requirements, favorably shifted metabolic/anthropometric indicators of dysregulation in a healthy direction. Three 8-wk clinical trials in 43 healthy lean and overweight/obese (OW/OB) adults, who served as their own controls, were pooled for analysis. In less inflamed OW/OB [high-sensitivity C-reactive protein (hsCRP) < 1.5], statistically significant decreases occurred in weight (-1.1 +/- 0.5 kg), waist circumference (-3.1 +/- 1.4 cm), diastolic blood pressure (-4.1 +/- 1.6 mmHg), heart rate [HR; -4.0 +/- 1.7 beats per minute (bpm)], triglycerides (-72 +/- 38.2 mg/dl), insulin resistance (homeostatic model of insulin resistance) (-0.72 +/- 0.3), and insulin (-2.8 +/- 1.3 mU/L); an increase in HDL-2b (+303 +/- 116 nM) and realignment of LDL lipid subfractions toward a less atherogenic profile [decreased small LDL IIIb (-44 +/- 23.5 nM), LDL IIIa (-99 +/- 43.7nM), andincreased large LDLI (+66 +/- 28.0 nM)]. In the more inflamed OW/OB (hsCRP >1.5), inflammation was reduced at 2 wk (-0.66 mg/L), and HR at 8 wk (-3.4 +/- 1.3 bpm). The large HDL subfraction (10.5-14.5 nm) increased at 8 wk (+346 +/- 126 nM). Metabolic improvements were also observed in lean participants. Thus, favorable changes in measures of cardiovascular health, insulin resistance, inflammation, and obesity were initiated within 8 wk in the OW/OB by replacing deficiencies in Western diets without requiring other dietary or lifestyle modifications; chronic inflammation blunted most improvements.	[McCann, Joyce C.; Shigenaga, Mark K.; Mietus-Snyder, Michele L.; Lal, Ashutosh; Suh, Jung H.; Krauss, Ronald M.; Gildengorin, Ginny L.; Goldrich, Alisa M.; Block, Devan S.; Shenvi, Swapna V.; Ames, Bruce N.] Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA; [Mietus-Snyder, Michele L.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [McHugh, Tara H.; Olson, Don A.] ARS, Proc Foods Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's National Health System; United States Department of Agriculture (USDA)	McCann, JC (corresponding author), Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	jmccann@chori.org; mshigenaga@chori.org		Mietus-Snyder, Michele/0000-0003-2791-9896	Children's Hospital Oakland Research Institute-Ames Foundation; S.D. Bechtel, Jr. Foundation; Quest Diagnostics	Children's Hospital Oakland Research Institute-Ames Foundation; S.D. Bechtel, Jr. Foundation; Quest Diagnostics	The authors thank Kirsten Graves for construction of the formulation table, Darryl Chow for technical assistance with the database and the serum amyloid A and adiponectin analyses, Rachelle Woods for assisting with nutrient bar sensory improvement and bar production, the staff at the Pediatric Clinical Research Center at Children's Hospital Oakland, Teresa Klask for invaluable administrative assistance, and the many volunteers who have assisted in this project over the years. R.M.K. thanks Joe Orr for conducting the lipoprotein subfraction analyses. The authors are grateful to several organizations for their generous donations of bar ingredients: Pharmachem Laboratories (Kearny, NJ, USA) for a vitamin and mineral blend; the U.S. Highbush Blueberry Council (Folsom, CA, USA) for blueberry powder; and Dow Chemical (Midland MI, USA) for hydroxypropylmethylcellulose. The authors are also grateful to Henry H. Wheeler for his generous support of their laboratory. All authors read and approved the final manuscript. This work was supported by the Children's Hospital Oakland Research Institute-Ames Foundation (to J.C.M., M.K.S., A.L., A.M.G., D.S.B., and S.V.S.), S.D. Bechtel, Jr. Foundation (to J.H.S.), and Quest Diagnostics (to R.M.K.).	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Alhassan S, 2008, INT J OBESITY, V32, P985, DOI 10.1038/ijo.2008.8; Alpers DH, 2000, CURR OPIN GASTROEN, V16, P155, DOI 10.1097/00001574-200003000-00010; Ames BN, 2006, P NATL ACAD SCI USA, V103, P17589, DOI 10.1073/pnas.0608757103; Ames BN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/725071; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Baker B, 2014, J BIOL CHEM, V289, P16262, DOI 10.1074/jbc.M114.569210; Basaki M, 2012, BIOL TRACE ELEM RES, V148, P161, DOI 10.1007/s12011-012-9360-6; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Beaufrere AM, 2014, J NUTR HEALTH AGING, V18, P814, DOI [10.1007/s12603-014-0554-9, 10.1007/s12603-014-0468-6]; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Bioletto S, 2000, AM J CLIN NUTR, V71, P443; Blackburn R, 2001, ARTERIOSCL THROM VAS, V21, P1962, DOI 10.1161/hq1201.099433; Bouchoucha M, 2011, DIABETES METAB, V37, P90, DOI 10.1016/j.diabet.2010.11.002; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Brockman DA, 2014, J NUTR, V144, P1415, DOI 10.3945/jn.114.191577; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Carrera-Bastos P, 2011, RES REP CLIN CARDIOL, V2, P15, DOI 10.2147/RRCC.S16919; dos Santos RDC, 2010, JPEN-PARENTER ENTER, V34, P408, DOI 10.1177/0148607110362530; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Chan DC, 2014, BEST PRACT RES CL EN, V28, P369, DOI 10.1016/j.beem.2013.10.001; Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607; CHRCO/CHORI, 2009, Pending U.S. Application, Patent No. [13/877,103, 13877103]; Christou GA, 2013, OBES REV, V14, P939, DOI 10.1111/obr.12064; Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149; CORNELL RP, 1985, DIABETES, V34, P1253, DOI 10.2337/diabetes.34.12.1253; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Desroches S, 2006, J NUTR, V136, P1005, DOI 10.1093/jn/136.4.1005; Di Daniele N, 2013, ACTA DIABETOL, V50, P409, DOI 10.1007/s00592-012-0445-7; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Erlinger TP, 2003, CIRCULATION, V108, P150, DOI 10.1161/01.CIR.0000080288.30567.86; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Falcao-Pires I, 2012, DRUG DISCOV TODAY, V17, P880, DOI 10.1016/j.drudis.2012.04.007; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghosh A, 2007, EUR J CLIN NUTR, V61, P412, DOI 10.1038/sj.ejcn.1602534; Ghosh A, 2007, FOOD NUTR BULL, V28, P399, DOI 10.1177/156482650702800404; Gigleux I, 2007, BRIT J NUTR, V98, P1229, DOI 10.1017/S0007114507781461; Glaros Trevor G, 2013, Front Biosci (Schol Ed), V5, P754; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Grunfeld C, 1996, J CLIN INVEST, V97, P2152, DOI 10.1172/JCI118653; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Heaney RP, 2006, AM J CLIN NUTR, V84, P471, DOI 10.1093/ajcn/84.3.471; Hellerstein M, 2014, CURR OPIN LIPIDOL, V25, P40, DOI 10.1097/MOL.0000000000000050; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hilpert KF, 2005, J NUTR, V135, P1075, DOI 10.1093/jn/135.5.1075; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Jin R, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/560620; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kassirer JP, 1998, NEW ENGL J MED, V338, P52, DOI 10.1056/NEJM199801013380109; Kelley DS, 2007, AM J CLIN NUTR, V86, P324, DOI 10.1093/ajcn/86.2.324; Kimmons Joel E, 2006, MedGenMed, V8, P59; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Kishida K, 2014, BEST PRACT RES CL EN, V28, P119, DOI 10.1016/j.beem.2013.08.006; Kong LC, 2013, AM J CLIN NUTR, V98, P1385, DOI 10.3945/ajcn.113.058099; Kranz S, 2012, ADV NUTR, V3, P47, DOI 10.3945/an.111.001362; Krauss RM, 2014, ARTERIOSCL THROM VAS, V34, P959, DOI 10.1161/ATVBAHA.114.303458; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, pE20, DOI 10.1161/01.ATV.0000038493.65177.94; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Lambert JC, 2003, J PHARMACOL EXP THER, V305, P880, DOI 10.1124/jpet.102.047852; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lim S, 2014, ATHEROSCLEROSIS, V233, P721, DOI 10.1016/j.atherosclerosis.2014.01.051; Lipina C, 2013, DIABETES, V62, P3426, DOI 10.2337/db13-0264; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Maki KC, 2007, DIABETES CARE, V30, P1039, DOI 10.2337/dc06-2344; Maki KC, 2009, J CLIN LIPIDOL, V3, P159, DOI 10.1016/j.jacl.2009.04.053; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Martins D, 2008, J NATL MED ASSOC, V100, P565, DOI 10.1016/S0027-9684(15)31304-3; Matsuda M, 2014, REV ENDOCR METAB DIS, V15, P1, DOI 10.1007/s11154-013-9271-7; McCann JC, 2011, FASEB J, V25, P1793, DOI 10.1096/fj.11-180885; McCann JC, 2009, AM J CLIN NUTR, V90, P889, DOI 10.3945/ajcn.2009.27930; McNaughton SA, 2007, J NUTR, V137, P99, DOI 10.1093/jn/137.1.99; Mietus-Snyder M, 2013, J PEDIATR-US, V163, P355, DOI 10.1016/j.jpeds.2013.01.012; Mietus-Snyder ML, 2012, FASEB J, V26, P3515, DOI 10.1096/fj.11-201558; Mosenthal AC, 2002, CRIT CARE MED, V30, P396, DOI 10.1097/00003246-200202000-00022; Mosfegh A., 2009, WHAT WE EAT AM NHANE; Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231; Munsters MJM, 2014, ANNU REV FOOD SCI T, V5, P39, DOI 10.1146/annurev-food-030212-182557; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Novotny D, 2012, LIPOPROTEINS - ROLE IN HEALTH AND DISEASES, P677, DOI 10.5772/47754; Ozata M, 2002, CLIN BIOCHEM, V35, P627, DOI 10.1016/S0009-9120(02)00363-6; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peng ZL, 2015, SHOCK, V43, P327, DOI 10.1097/SHK.0000000000000297; Pereira MA, 2009, INT J ENV RES PUB HE, V6, P2568, DOI 10.3390/ijerph6102568; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Popkin BM, 2007, SCI AM, V297, P88, DOI 10.1038/scientificamerican0907-88; Qi L, 2006, DIABETES CARE, V29, P207, DOI 10.2337/diacare.29.02.06.dc05-1903; Reinehr T, 2013, NAT REV ENDOCRINOL, V9, P607, DOI 10.1038/nrendo.2013.149; Reinehr T, 2011, P NUTR SOC, V70, P494, DOI 10.1017/S0029665111000577; Ricciardiello L, 2011, NAT REV GASTRO HEPAT, V8, P592, DOI 10.1038/nrgastro.2011.149; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; Sarafidis PA, 2008, FUND CLIN PHARMACOL, V22, P247, DOI 10.1111/j.1472-8206.2008.00568.x; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; SPAETH G, 1995, EUR J SURG, V161, P513; St-Onge MP, 2009, J NUTR, V139, P680, DOI 10.3945/jn.108.098251; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swaid F, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-53; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Toledo FGS, 2013, MOL CELL ENDOCRINOL, V379, P30, DOI 10.1016/j.mce.2013.06.018; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; US Department of Agriculture, 2007, USDA DAT FLAV CONT S; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; van Duynhoven J, 2013, AM J CLIN NUTR, V98, p1631S, DOI 10.3945/ajcn.113.058263; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Wadden TA, 2013, INT J OBESITY, V37, pS3, DOI 10.1038/ijo.2013.90; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Wijnhoven TMA, 2013, PEDIATR OBES, V8, P79, DOI 10.1111/j.2047-6310.2012.00090.x; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wilkinson MJ, 2014, BEST PRACT RES CL EN, V28, P439, DOI 10.1016/j.beem.2014.01.006; Williams L, 2007, INT J OBESITY, V31, P978, DOI 10.1038/sj.ijo.0803550; Williams PT, 2014, ATHEROSCLEROSIS, V233, P713, DOI 10.1016/j.atherosclerosis.2014.01.034; Wu GH, 2004, WORLD J GASTROENTERO, V10, P2592, DOI 10.3748/wjg.v10.i17.2592; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zeino Z, 2010, BEST PRACT RES CL GA, V24, P133, DOI 10.1016/j.bpg.2010.02.008; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009	139	8	8	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3287	3301		10.1096/fj.15-271833	http://dx.doi.org/10.1096/fj.15-271833			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25900806	Green Submitted			2022-12-28	WOS:000358796900017
J	Sciaccaluga, M; Moriconi, C; Martinello, K; Catalano, M; Bermudez, I; Stitzel, JA; Maskos, U; Fucile, S				Sciaccaluga, Miriam; Moriconi, Claudia; Martinello, Katiuscia; Catalano, Myriam; Bermudez, Isabel; Stitzel, Jerry A.; Maskos, Uwe; Fucile, Sergio			Crucial role of nicotinic alpha 5 subunit variants for Ca2+ fluxes in ventral midbrain neurons	FASEB JOURNAL			English	Article						nicotine dependence; nicotinic acetylcholine receptors; Ca2+ permeability; fractional Ca2+ current	ACETYLCHOLINE-RECEPTOR-CHANNELS; LUNG-CANCER; CALCIUM PERMEABILITY; DEPENDENCE; RISK; DESENSITIZATION; MODULATION; AVERSION; SUBTYPES; BINDING	Neuronal nicotinic acetylcholine receptors (nAChRs) containing the alpha 5 subunit modulate nicotine consumption, and the human CHRNA5 rs16969968 polymorphism, causing the replacement of the aspartic acid residue at position 398 with an asparagine (alpha 5DN), has recently been associated with increased use of tobacco and higher incidence of lung cancer. We show that in ventral midbrain neurons, the alpha 5 subunit is essential for heteromeric nAChR-induced intracellular-free Ca2+ concentration elevations and that in alpha 5(-/-) mice, a class of large-amplitude nicotine-evoked currents is lost. Furthermore, the expression of the alpha 5DN subunit is not able to restore nicotinic responses, indicating a loss of function by this subunit in native neurons. To understand how alpha 5DN impairs heteromeric nAChR functions, we coexpressed alpha 4, alpha 5, or alpha 5DN subunits with a dimeric concatemer (beta 2 alpha 4) in a heterologous system, to obtain nAChRs with fixed stoichiometry. Both alpha 5(beta 2 alpha 4)(2) and alpha 5DN(beta 2 alpha 4)(2) nAChRs yielded similar levels of functional expression and Ca2+ permeability, measured as fractional Ca2+ currents (8.2 +/- 0.7% and 8.0 +/- 1.9%, respectively), 2-fold higher than alpha 4 (beta 2 alpha 4)(2). Our results indicate that the loss of function of nicotinic responses observed in alpha 5DN-expressing ventral midbrain neurons is neither due to an intrinsic inability of this subunit to form functional nAChRs nor to an altered Ca2+ permeability but likely to intracellular modulation.	[Sciaccaluga, Miriam; Catalano, Myriam; Fucile, Sergio] Ist Ricovero & Cura Carattere Scient Neuromed, I-86077 Pozzilli, Italy; [Moriconi, Claudia] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Martinello, Katiuscia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Inst Pasteur Cenci Bolognetti Fdn, I-00185 Rome, Italy; [Bermudez, Isabel] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Stitzel, Jerry A.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Maskos, Uwe] Inst Pasteur, Neurobiol Integrat Syst Cholinerg, Paris, France; [Maskos, Uwe] Inst Pasteur, CNRS, Unites Mixtes Rech, Paris, France	Sapienza University Rome; Sapienza University Rome; Oxford Brookes University; University of Colorado System; University of Colorado Boulder; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fucile, S (corresponding author), Ist Ricovero & Cura Carattere Scient Neuromed, Via Tecn,Parco Tecnol,Localita Camerelle, I-86077 Pozzilli, Italy.	sergio.fucile@uniroma1.it	Fucile, Sergio/B-3934-2010; Sciaccaluga, Miriam/AAF-5535-2021; Martinello, Katiuscia/K-5899-2016	Fucile, Sergio/0000-0003-0698-1148; Martinello, Katiuscia/0000-0002-0423-5689; Sciaccaluga, Miriam/0000-0001-7951-8045; Bermudez, Isabel/0000-0001-7692-1509; Catalano, Myriam/0000-0003-4638-9202	European Research Area Net (ERA-NET) Neuron NicoGene project; U.S. National Institutes of Health (NIH) National Cancer Institute Grant [CA089392]; NIH National Institute on Drug Abuse Grant [DA015663]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA015663] Funding Source: NIH RePORTER	European Research Area Net (ERA-NET) Neuron NicoGene project; U.S. National Institutes of Health (NIH) National Cancer Institute Grant; NIH National Institute on Drug Abuse Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Ms. Giuseppina Chece for animal genotyping. This study has been supported by the European Research Area Net (ERA-NET) Neuron NicoGene project (to S.F. and U.M.). J.A.S. is supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant CA089392 and NIH National Institute on Drug Abuse Grant DA015663.	ADAMS DJ, 1992, J PHYSIOLOGY-PARIS, V86, P67, DOI 10.1016/S0928-4257(05)80009-9; Azam L, 2007, NEUROSCIENCE, V144, P1347, DOI 10.1016/j.neuroscience.2006.11.011; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Charpantier E, 1998, NEUROREPORT, V9, P3097, DOI 10.1097/00001756-199809140-00033; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; Fowler CD, 2014, NEUROPHARMACOLOGY, V76, P533, DOI 10.1016/j.neuropharm.2013.09.008; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Fucile S, 1997, NEUROREPORT, V8, P2433, DOI 10.1097/00001756-199707280-00005; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Girod R, 1999, ANN NY ACAD SCI, V868, P578, DOI 10.1111/j.1749-6632.1999.tb11331.x; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Guo XC, 2007, J NEUROPHYSIOL, V97, P93, DOI 10.1152/jn.01047.2005; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Morel C, 2014, MOL PSYCHIATR, V19, P930, DOI 10.1038/mp.2013.158; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Pruszak J., 2009, CURR PROTOC STEM CEL; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Tammimaki A, 2012, NEUROPHARMACOLOGY, V63, P1002, DOI 10.1016/j.neuropharm.2012.07.022; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Zhou Y, 2003, J NEUROSCI, V23, P9004; ZHOU Z, 1993, PFLUG ARCH EUR J PHY, V425, P511, DOI 10.1007/BF00374879; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	40	33	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3389	3398		10.1096/fj.14-268102	http://dx.doi.org/10.1096/fj.14-268102			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911614	Green Published			2022-12-28	WOS:000358796900026
J	Noy, PJ; Swain, RK; Khan, K; Lodhia, P; Bicknell, R				Noy, Peter J.; Swain, Rajeeb K.; Khan, Kabir; Lodhia, Puja; Bicknell, Roy			Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2)	FASEB JOURNAL			English	Article						antiangiogenic therapy; rhomboid substrates; multimerin 2; mmrn2	GROWTH-FACTOR; TUMOR-GROWTH; MARKER CLEC14A; THROMBOMODULIN; IDENTIFICATION; PROTEASES; DOMAIN; ENDOTHELIUM; ENDOSIALIN; CLEAVAGE	C-type lectin family 14, member A (CLEC14A), is a single-pass transmembrane glycoprotein that is overexpressed in tumor endothelial cells, and it promotes sprouting angiogenesis and modulates endothelial function via interactions with extracellular matrix proteins. Here, we show that CLEC14A is cleaved by rhomboid-like protein 2 (RHBDL2), one of 3 catalytic mammalian rhomboid-like (RHBDL) proteases, but that it is not cleaved by RHBDL1 or -3. Site-directed mutagenesis identified the precise site at which RHBDL2 cleaves CLEC14A, and targeted, small interfering RNAs that knockdown endogenous CLEC14A and RHBDL2 in human endothelial cells validated the specificity of CLEC14A shedding by RHBDL2. Loss of endogenous cleaved CLEC14A increased endothelial migration 2-fold, whereas that addition of recombinant cleaved CLEC14A inhibited the sprouting of human and murine endothelial cells 3-fold in several in vitro models. We assessed the in vivo role of cleaved CLEC14A in angiogenesis by using the rodent subcutaneous sponge implant model, and we found that CLEC14A protein inhibited vascular density by >50%. Finally, we show that cleaved CLEC14A binds to sprouting endothelial tip cells. Our data show that the ectodomain of CLEC14A regulates sprouting angiogenesis and suggests a role for RHBDL2 in endothelial function.Noy, P. J., Swain, R. K., Khan, K., Lodhia, P., Bicknell, R. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).	[Noy, Peter J.; Swain, Rajeeb K.; Khan, Kabir; Lodhia, Puja; Bicknell, Roy] Univ Birmingham, Inst Cardiovasc Sci & Biomed Res, Coll Med & Dent Sci, Angiogenesis Lab, Birmingham B15 2TT, W Midlands, England; [Swain, Rajeeb K.] Inst Life Sci, Bhubaneswar, Orissa, India	University of Birmingham; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Bicknell, R (corresponding author), Univ Birmingham, Sch Med, Angiogenesis Lab, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	r.bicknell@bham.ac.uk	Khan, Kabir/U-8350-2018	Khan, Kabir/0000-0001-8453-3485; Noy, Peter/0000-0001-6142-8957; Bicknell, Roy/0000-0002-0941-8919; Swain, Rajeeb/0000-0003-4815-8221	Cancer Research UK [A13027, A6766]; UK Medical Research Council; University of Birmingham; Pancreatic Cancer UK; Pancreatic Cancer UK [2013 RIF - Bicknell] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Birmingham; Pancreatic Cancer UK; Pancreatic Cancer UK	This work was supported by Project Grant A13027 from Cancer Research UK ( P. J. N.; grant awarded to R. B.), by Programme Grant A6766 from Cancer Research UK ( R. K. S.; grant awarded to R. B.), by the UK Medical Research Council and the University of Birmingham ( to P. L.), and by the University of Birmingham ( to K. K.). The authors acknowledge additional financial support from Pancreatic Cancer UK. R. B. is a named inventor of a patent filed by Cancer Research UK in the U.S. Patent and Trademark Office on September 3, 2009 ( No. 61/ 239,584, bearing Attorney Docket No. P0357.70004US00, entitled "Inhibitors"). The remaining authors declare no conflicts of interest.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Akhtar Nasim, 2002, Angiogenesis, V5, P75, DOI 10.1023/A:1021507031486; Bergbold N, 2013, BBA-BIOMEMBRANES, V1828, P2840, DOI 10.1016/j.bbamem.2013.03.025; Chen Y, 2011, BLOOD, V117, P6392, DOI 10.1182/blood-2010-12-322867; Cheng TL, 2011, J INVEST DERMATOL, V131, P2486, DOI 10.1038/jid.2011.230; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Desjobert C, 2009, BIOCHEM J, V417, P121, DOI 10.1042/BJ20080872; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Greenlee MC, 2009, INFLAMM RES, V58, P909, DOI 10.1007/s00011-009-0064-0; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Jeon JW, 2010, J IMMUNOL, V185, P4921, DOI 10.4049/jimmunol.0904011; Kao YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051647; Ki MK, 2013, ONCOGENE, V32, P5449, DOI 10.1038/onc.2013.156; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kuo CH, 2012, BLOOD, V119, P1302, DOI 10.1182/blood-2011-08-376038; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; LINDAHL AK, 1993, THROMB HAEMOSTASIS, V69, P112; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Lorenzon E, 2012, ONCOGENE, V31, P3136, DOI 10.1038/onc.2011.487; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Malarstig A, 2011, J INTERN MED, V270, P229, DOI 10.1111/j.1365-2796.2011.02364.x; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Noy PJ, 2015, ONCOGENE, V34, P5821, DOI 10.1038/onc.2015.34; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Refaat L. A., 2012, J GENET ENG BIOTECH, V10, P67; RETTIG WJ, 1992, P NATL ACAD SCI USA, V89, P10832, DOI 10.1073/pnas.89.22.10832; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shi CS, 2005, CIRCULATION, V111, P1627, DOI 10.1161/01.CIR.0000160364.05405.B5; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2014, CELL REP, V8, P1241, DOI 10.1016/j.celrep.2014.07.039; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	43	28	29	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2311	2323		10.1096/fj.201500122R	http://dx.doi.org/10.1096/fj.201500122R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26939791				2022-12-28	WOS:000376878300021
J	Son, YL; Ubuka, T; Soga, T; Yamamoto, K; Bentley, GE; Tsutsui, K				Son, You Lee; Ubuka, Takayoshi; Soga, Tomoko; Yamamoto, Kazutoshi; Bentley, George E.; Tsutsui, Kazuyoshi			Inhibitory action of gonadotropin-inhibitory hormone on the signaling pathways induced by kisspeptin and vasoactive intestinal polypeptide in GnRH neuronal cell line, GT1-7	FASEB JOURNAL			English	Article						RFamide-related peptide; GPCR; GnIH receptor signaling	RFAMIDE-RELATED PEPTIDE-3; INDUCED LUTEINIZING-HORMONE; AGED FEMALE RATS; SUPRACHIASMATIC NUCLEI; GENE-EXPRESSION; L-BETA-T2 CELLS; VIP-DEFICIENT; MESSENGER-RNA; RECEPTOR; SURGE	Gonadotropin-inhibitory hormone (GnIH) acts as a negative regulator of reproduction by acting on gonadotropes and gonadotropin-releasing hormone (GnRH) neurons. Despite its functional significance, the molecular mechanism of GnIH action in the target cells has not been fully elucidated. To expand our previous study on GnIH actions in gonadotropes, we investigated the potential signal transduction pathway that conveys the inhibitory action of GnIH in GnRH neurons by using the GnRH neuronal cell line, GT1-7. We examined whether GnIH inhibits the action of kisspeptin and vasoactive intestinal polypeptide (VIP), positive regulators of GnRH neurons. Although GnIH significantly suppressed the stimulatory effect of kisspeptin on GnRH release in hypothalamic culture, GnIH had no inhibitory effect on kisspeptin stimulation of serum response element and nuclear factor of activated T-cell response element activities and ERK phosphorylation, indicating that GnIH may not directly inhibit kisspeptin signaling in GnRH neurons. On the contrary, GnIH effectively eliminated the stimulatory effect of VIP on p38 and ERK phosphorylation, c-Fos mRNA expression, and GnRH release. The use of pharmacological modulators strongly demonstrated the specific inhibitory action of GnIH on the adenylate cyclase/cAMP/protein kinase A pathway, suggesting a common inhibitory mechanism of GnIH action in GnRH neurons and gonadotropes.Son, Y. L., Ubuka, T., Soga, T., Yamamoto, K., Bentley, G. E., Tsutsui, K. Inhibitory action of gonadotropin-inhibitory hormone on the signaling pathways induced by kisspeptin and vasoactive intestinal polypeptide in GnRH neuronal cell line, GT1-7.	[Son, You Lee; Ubuka, Takayoshi; Yamamoto, Kazutoshi; Tsutsui, Kazuyoshi] Waseda Univ, Ctr Med Life Sci, Dept Biol, Lab Integrat Brain Sci, Tokyo 1628480, Japan; [Ubuka, Takayoshi; Soga, Tomoko] Monash Univ, Sch Med & Hlth Sci, Brain Res Inst, Sunway, Malaysia; [Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Waseda University; Monash University; Monash University Sunway; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tsutsui, K (corresponding author), Waseda Univ, Lab Integrat Brain Sci, Dept Biol, Ctr Med Life Sci,Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	k-tsutsui@waseda.jp	Son, You Lee/AAM-3859-2020	Son, You Lee/0000-0002-3429-5324; Ubuka, Takayoshi/0000-0002-4731-8118; Soga, Tomoko/0000-0002-0219-430X; Yamamoto, Kazutoshi/0000-0002-7935-7015	Ministry of Education, Science and Culture-Japan [24.02082, 15F15909, 18107002, 22132004, 22227002]	Ministry of Education, Science and Culture-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Mika Kiyohara (Jikei University School of Medicine, Tokyo, Japan), Misato Narihiro, and Sonoko Okada (both from Waseda University, Tokyo, Japan) for their technical support. This work was supported by Grants-in-Aid for Japan Society for the Promotion of Science Fellows (24.02082 and 15F15909 to Y. L. S.) and Grants-in-Aid for Scientific Research (18107002, 22132004, and 22227002 to K. T.) from the Ministry of Education, Science and Culture-Japan.	Anderson GM, 2009, ENDOCRINOLOGY, V150, P1834, DOI 10.1210/en.2008-1359; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794, DOI 10.1046/j.1365-2826.2003.01062.x; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Christian CA, 2008, ENDOCRINOLOGY, V149, P3130, DOI 10.1210/en.2007-1098; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Clarke IJ, 2012, NEUROENDOCRINOLOGY, V95, P305, DOI 10.1159/000332822; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Ducret E, 2009, ENDOCRINOLOGY, V150, P2799, DOI 10.1210/en.2008-1623; Dumalska I, 2008, J NEUROSCI, V28, P8003, DOI 10.1523/JNEUROSCI.1225-08.2008; Dungan HM, 2007, J NEUROSCI, V27, P12088, DOI 10.1523/JNEUROSCI.2748-07.2007; Gerhold LM, 2005, J NEUROSCI, V25, P62, DOI 10.1523/JNEUROSCI.3598-04.2005; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harney JP, 1996, ENDOCRINOLOGY, V137, P3696, DOI 10.1210/en.137.9.3696; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Horvath TL, 1998, BRAIN RES, V795, P277, DOI 10.1016/S0006-8993(98)00208-X; Johnson MA, 2007, HORM BEHAV, V51, P171, DOI 10.1016/j.yhbeh.2006.09.009; Kauffman AS, 2014, ENDOCRINOLOGY, V155, P2222, DOI 10.1210/en.2013-1793; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Krajnak K, 1998, J NEUROSCI, V18, P4767; Krajnak K, 2001, BIOL REPROD, V64, P1160, DOI 10.1095/biolreprod64.4.1160; Kriegsfeld LJ, 2010, J NEUROENDOCRINOL, V22, P692, DOI 10.1111/j.1365-2826.2010.02031.x; Kriegsfeld LJ, 2002, J NEUROENDOCRINOL, V14, P685, DOI 10.1046/j.1365-2826.2002.00818.x; LEE WS, 1990, P NATL ACAD SCI USA, V87, P5163, DOI 10.1073/pnas.87.13.5163; McCulloch DA, 2002, BIOCHEM SOC T, V30, P441, DOI 10.1042/bst0300441; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Nichols R, 2010, PEPTIDES, V31, P2067, DOI 10.1016/j.peptides.2010.07.012; Novaira HJ, 2009, MOL CELL ENDOCRINOL, V311, P126, DOI 10.1016/j.mce.2009.06.011; OLAH Z, 1994, J NEUROSCI RES, V39, P355, DOI 10.1002/jnr.490390402; Olcese J, 1997, J NEUROENDOCRINOL, V9, P937, DOI 10.1046/j.1365-2826.1997.00663.x; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Poling MC, 2013, J NEUROENDOCRINOL, V25, P876, DOI 10.1111/jne.12084; Rizwan MZ, 2012, ENDOCRINOLOGY, V153, P3770, DOI 10.1210/en.2012-1133; Semaan SJ, 2015, MOL CELL ENDOCRINOL, V401, P84, DOI 10.1016/j.mce.2014.11.025; Smith JT, 2008, ENDOCRINOLOGY, V149, P5770, DOI 10.1210/en.2008-0581; Smith MJ, 2000, ENDOCRINOLOGY, V141, P4317, DOI 10.1210/en.141.11.4317; Son YL, 2012, ENDOCRINOLOGY, V153, P2332, DOI 10.1210/en.2011-1904; Stack CM, 2008, EXP NEUROL, V211, P67, DOI 10.1016/j.expneurol.2008.01.003; Sukhbaatar U, 2014, ENDOCR J, V61, P25, DOI 10.1507/endocrj.EJ13-0238; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Tsutsui K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00060; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; Ubuka T, 2013, GEN COMP ENDOCR, V190, P10, DOI 10.1016/j.ygcen.2013.02.030; Ubuka T, 2012, ENDOCRINOLOGY, V153, P373, DOI 10.1210/en.2011-1110; Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400; VanderBeek EM, 1997, J COMP NEUROL, V384, P569, DOI 10.1002/(SICI)1096-9861(19970811)384:4<569::AID-CNE6>3.0.CO;2-0; VANDERBEEK EM, 1994, ENDOCRINOLOGY, V134, P2636, DOI 10.1210/en.134.6.2636; Wu M, 2009, J PHYSIOL-LONDON, V587, P1401, DOI 10.1113/jphysiol.2008.166447; Yamamoto K, 2000, GEN COMP ENDOCR, V117, P103, DOI 10.1006/gcen.1999.7387	55	40	41	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2198	2210		10.1096/fj.201500055	http://dx.doi.org/10.1096/fj.201500055			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26929433				2022-12-28	WOS:000376878300013
J	Bretschneider, M; Busch, B; Mueller, D; Nolze, A; Schreier, B; Gekle, M; Grossmann, C				Bretschneider, Maria; Busch, Bianca; Mueller, Daniel; Nolze, Alexander; Schreier, Barbara; Gekle, Michael; Grossmann, Claudia			Activated mineralocorticoid receptor regulates micro-RNA-29b in vascular smooth muscle cells	FASEB JOURNAL			English	Article						vascular disease; vascular aging; post-transcriptional regulation; aldosterone	HUMAN PROXIMAL TUBULE; CARDIAC FIBROSIS; CARDIOVASCULAR-DISEASE; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; ALDOSTERONE BLOCKADE; MICRORNA EXPRESSION; GENE-TRANSCRIPTION; ENDOTHELIAL-CELLS; C-SRC	Inappropriately activated mineralocorticoid receptor (MR) is a risk factor for vascular remodeling with unclear molecular mechanism. Recent findings suggest that post-transcriptional regulation by micro-RNAs (miRs) may be involved. Our aim was to search for MR-dependent miRs in vascular smooth muscle cells (VSMCs) and to explore the underlying molecular mechanism and the pathologic relevance. We detected that aldosterone via the MR reduces miR-29b in vivo in murine aorta and in human primary and cultured VSMCs (ED50 = 0.07 nM) but not in endothelial cells [quantitative PCR (qPCR), luciferase assays]. This effect was mediated by an increased decay of miR-29b in the cytoplasm with unchanged miR-29 family member or primary-miR levels. Decreased miR-29b led to an increase in extracellular matrix measured by ELISA and qPCR and enhanced VSMC migration in single cell-tracking experiments. Additionally, cell proliferation and the apoptosis/necrosis ratio (caspase/lactate dehydrogenase assay) was modulated by miR-29b. Enhanced VSMC migration by aldosterone required miR-29b regulation. Control experiments were performed with scrambled RNA and empty plasmids, by comparing aldosterone-stimulated with vehicle-incubated cells. Overall, our findings provide novel insights into the molecular mechanism of aldosterone-mediated vascular pathogenesis by identifying miR-29b as a pathophysiologic relevant target of activated MR in VSMCs and by highlighting the importance of miR processing for miR regulation.	[Bretschneider, Maria; Mueller, Daniel; Nolze, Alexander; Schreier, Barbara; Gekle, Michael; Grossmann, Claudia] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06097 Halle, Saale, Germany; [Busch, Bianca] Univ Halle Wittenberg, Inst Mol Med, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Grossmann, C (corresponding author), Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06097 Halle, Saale, Germany.	claudia.grossmann@medizin.uni-halle.de			German research foundation (Deutsche Forschungsgemeinschaft; DFG) [RTG1591]; EU COST [BM13001]	German research foundation (Deutsche Forschungsgemeinschaft; DFG)(German Research Foundation (DFG)); EU COST(European Cooperation in Science and Technology (COST))	This work was supported by the RTG1591 of the German research foundation (Deutsche Forschungsgemeinschaft; DFG) and EU COST BM13001. The authors declare no conflicts of interest.	Albinsson S, 2013, PHARMACOL RES, V75, P28, DOI 10.1016/j.phrs.2013.04.003; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bennett M, 2012, VASC PHARMACOL, V56, P187, DOI 10.1016/j.vph.2012.01.006; Bergmeyer H.U., 1974, METHODEN ENZYMATISCH, VVolume 3, P607; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Chen D, 2013, GENE, V531, P23, DOI 10.1016/j.gene.2013.08.047; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Di Stefano V, 2011, VASC PHARMACOL, V55, P111, DOI 10.1016/j.vph.2011.08.001; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Edinger RS, 2014, J AM SOC NEPHROL, V25, P2445, DOI 10.1681/ASN.2013090931; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Elvira-Matelot E, 2010, J AM SOC NEPHROL, V21, P1724, DOI 10.1681/ASN.2009111186; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gekle M, 2007, PFLUG ARCH EUR J PHY, V454, P403, DOI 10.1007/s00424-007-0211-9; Gekle M, 2009, PFLUG ARCH EUR J PHY, V458, P231, DOI 10.1007/s00424-008-0616-0; Hartmann D, 2011, VASC PHARMACOL, V55, P92, DOI 10.1016/j.vph.2011.07.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Iwashima F, 2008, ENDOCRINOLOGY, V149, P1009, DOI 10.1210/en.2007-0864; Jaffe IZ, 2005, CIRC RES, V96, P643, DOI 10.1161/01.RES.0000159937.05502.d1; Jamaluddin MS, 2011, EXPERT REV MOL DIAGN, V11, P79, DOI [10.1586/erm.10.103, 10.1586/ERM.10.103]; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kang H, 2012, CURR OPIN HEMATOL, V19, P224, DOI 10.1097/MOH.0b013e3283523e57; Kin K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000745; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; LANE RD, 1986, J IMMUNOL METHODS, V92, P261, DOI 10.1016/0022-1759(86)90174-2; Lee J, 2015, J CELL BIOCHEM, V116, P598, DOI 10.1002/jcb.25011; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; Liu GX, 2014, CLIN SCI, V127, P195, DOI 10.1042/CS20130706; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Maron BA, 2009, J BIOL CHEM, V284, P7665, DOI 10.1074/jbc.M809460200; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Newfell BG, 2011, ARTERIOSCL THROM VAS, V31, P1871, DOI 10.1161/ATVBAHA.111.229070; Nossent AY, 2011, AM J HYPERTENS, V24, P999, DOI 10.1038/ajh.2011.92; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2004, MOL CELL ENDOCRINOL, V217, P53, DOI 10.1016/j.mce.2003.10.009; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rocha R, 2002, ENDOCRINOLOGY, V143, P4828, DOI 10.1210/en.2002-220120; Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306; Schreier B, 2011, HYPERTENS RES, V34, P623, DOI 10.1038/hr.2011.16; Schwerdt G, 2006, PEDIATR NEPHROL, V21, P60, DOI 10.1007/s00467-005-2006-6; Schwerdt G, 2007, TOXICOLOGY, V232, P57, DOI 10.1016/j.tox.2006.12.008; Shi MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146pe40; Sober S, 2010, BIOCHEM BIOPH RES CO, V391, P727, DOI 10.1016/j.bbrc.2009.11.128; Stowasser M, 2001, CLIN EXP PHARMACOL P, V28, P783, DOI 10.1046/j.1440-1681.2001.03523.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; von Lueder TG, 2013, CARDIOVASC DRUG THER, V27, P171, DOI 10.1007/s10557-012-6424-y; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Whitley GSJ, 2010, PLACENTA, V31, P465, DOI 10.1016/j.placenta.2010.03.002; World Health Organization: Regional Office for Europe, 2012, EUR HLTH REP 2012 CH; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhang Z, 2012, WIRES RNA, V3, P593, DOI 10.1002/wrna.1114; Zhang Z, 2011, NUCLEIC ACIDS RES, V39, P4387, DOI 10.1093/nar/gkr020	65	18	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1610	1622		10.1096/fj.15-271254	http://dx.doi.org/10.1096/fj.15-271254			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26728178				2022-12-28	WOS:000372629100022
J	Fernandez-Calotti, P; Casulleras, O; Antolin, M; Guarner, F; Pastor-Anglada, M				Fernandez-Calotti, Paula; Casulleras, Olga; Antolin, Maria; Guarner, Francisco; Pastor-Anglada, Marcal			Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its function	FASEB JOURNAL			English	Article						membrane transporter; CNT; protein interaction; IBD; Crohn's disease	TRANS-RETINOIC ACID; PLASMA-MEMBRANE; FLUDARABINE SENSITIVITY; PROTEINS HCNT3; GLYCOSYLATION; GLYCOPROTEINS; INVOLVEMENT; TRAFFICKING; ASSOCIATION; EXPRESSION	The intracellular N-terminal domain of the nucleoside and drug transporter human concentrative nucleoside transporter (hCNT) 3 was used as bait in a glutathione S-transferase pull-down approach, to identify hCNT3 protein partners, using human colon homogenates as a prey source. Galectin (Gal)-4 was identified as a potential hCNT3 partner in the colon. The biochemical validation of the Gal-4-hCNT3 interaction was verified by targeted pull-down assays and coimmunoprecipitation experiments in HT-29 cells, which endogenously express hCNT3 and Gal-4. Furthermore, Gal-4 was shown to colocalize with hCNT3 in HT-29 cells. The biologic significance of this interaction was obtained from experiments in which Gal-4 was knocked down, showing that this protein is a regulator of hCNT3 trafficking and retention at the cell membrane, reducing its plasma membrane location by 70%. Conversely, the addition of Gal-4 increased hCNT3 location at the plasma membrane by 77%, thereby demonstrating that this lectin modulates hCNT3 function in colonic cells. The integrity of this partnership may be clinically relevant, because hCNT3 may be responsible for the translocation of thiopurines, such as 6-mercaptopurine, a front-line treatment in inflammatory bowel disease. The expression of Gal-4 and hCNT3 proteins is not impaired in inflamed colon from patients with Crohn's disease, thereby anticipating the integrity of this system for drug targeting.	[Fernandez-Calotti, Paula; Casulleras, Olga; Pastor-Anglada, Marcal] Univ Barcelona, Dept Biochem & Mol Biol, Inst Biomed IBUB, Barcelona, Spain; [Fernandez-Calotti, Paula; Casulleras, Olga; Pastor-Anglada, Marcal] Inst Salud Carlos III, Natl Biomed Res Inst Liver & Gastrointestinal Dis, Oncol Program, CIBER EHD, Madrid, Spain; [Antolin, Maria; Guarner, Francisco] Univ Autonoma Barcelona, Inst Recerca Vall dHebron, Univ Hosp Vall dHebron, Dept Gastroenterol,Digest Syst Res Unit,CIBER EHD, E-08193 Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Fernandez-Calotti, P; Pastor-Anglada, M (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, IBUB, E-08028 Barcelona, Spain.; Fernandez-Calotti, P; Pastor-Anglada, M (corresponding author), CIBER EHD, Diagonal 645, Barcelona 08028, Spain.	pfernandezcalotti@gmail.com; mpastor@ub.edu	Guarner, Francisco/ABF-1192-2020; Pastor Anglada, Marcal/C-3730-2017	Guarner, Francisco/0000-0002-4051-0836; Pastor Anglada, Marcal/0000-0003-3712-1773	Plan Nacional de Biomedicina, Ministerio de Economia y Competitividad, Spain [SAF2014-52067-R]; Generalitat de Catalunya, Spain [2009SGR624]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain [PI12/00263]; National Biomedical Research Institute of Liver and Gastrointestinal Diseases (CIBER EHD) (CIBER is an initiative of the Instituto de Salud Carlos III, Spain); Researcher Training Program (APIF; University of Barcelona)	Plan Nacional de Biomedicina, Ministerio de Economia y Competitividad, Spain; Generalitat de Catalunya, Spain(Generalitat de Catalunya); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); National Biomedical Research Institute of Liver and Gastrointestinal Diseases (CIBER EHD) (CIBER is an initiative of the Instituto de Salud Carlos III, Spain); Researcher Training Program (APIF; University of Barcelona)	This study was supported by Grant SAF2014-52067-R from the Plan Nacional de Biomedicina, Ministerio de Economia y Competitividad, Spain; Grant 2009SGR624 from the Generalitat de Catalunya, Spain; Grant PI12/00263 from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain; and National Biomedical Research Institute of Liver and Gastrointestinal Diseases (CIBER EHD) (CIBER is an initiative of the Instituto de Salud Carlos III, Spain). O.C. holds a Ph.D. training grant from the Researcher Training Program (APIF; University of Barcelona). P.F.-C. performed the experiments and the statistics analysis; P.F.-C. and M.P.-A. designed the study and wrote the manuscript; M.C. and F.G. recruited the patient samples and contributed to the editing and review of the article. The authors declare no conflicts of interest.	BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bouhnik Y, 1996, LANCET, V347, P215, DOI 10.1016/S0140-6736(96)90402-X; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; CANDY S, 1995, GUT, V37, P674, DOI 10.1136/gut.37.5.674; Castillon GA, 2013, MOL BIOL CELL, V24, P2021, DOI 10.1091/mbc.E13-03-0160; Cronstein BN, 1999, OSTEOARTHR CARTILAGE, V7, P361, DOI 10.1053/joca.1998.0236; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Delacour D, 2003, J BIOL CHEM, V278, P37799, DOI 10.1074/jbc.M305755200; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Dragan Y, 2000, HEPATOLOGY, V32, P239, DOI 10.1053/jhep.2000.9546; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Errasti-Murugarren E, 2007, J PHYSIOL-LONDON, V582, P1249, DOI 10.1113/jphysiol.2007.130138; Errasti-Murugarren E, 2012, MOL PHARMACOL, V82, P59, DOI 10.1124/mol.111.076992; Errasti-Murugarren E, 2010, MOL PHARMACOL, V78, P795, DOI 10.1124/mol.110.065920; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Farre X, 2004, INT J CANCER, V112, P959, DOI 10.1002/ijc.20524; Fernandez-Calotti P, 2010, J BIOL CHEM, V285, P13589, DOI 10.1074/jbc.M109.055673; Fernandez-Calotti PX, 2012, HAEMATOL-HEMATOL J, V97, P943, DOI 10.3324/haematol.2011.051557; Fernandez-Calotti PX, 2011, NUCLEOS NUCLEOT NUCL, V30, P1324, DOI 10.1080/15257770.2011.597372; Fotoohi AK, 2006, BIOCHEM BIOPH RES CO, V343, P208, DOI 10.1016/j.bbrc.2006.02.134; Gerich ME, 2014, NAT REV GASTRO HEPAT, V11, P287, DOI 10.1038/nrgastro.2013.242; Godoy V, 2014, J HEPATOL, V61, P1337, DOI 10.1016/j.jhep.2014.06.036; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hokama A, 2004, IMMUNITY, V20, P681, DOI 10.1016/j.immuni.2004.05.009; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jahnel J, 2014, DRUG METAB DISPOS, V42, P1423, DOI 10.1124/dmd.114.058065; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Llopis M, 2009, INFLAMM BOWEL DIS, V15, P275, DOI 10.1002/ibd.20736; Minuesa G, 2011, PHARMACOL THERAPEUT, V132, P268, DOI 10.1016/j.pharmthera.2011.06.007; Morelle W, 2009, BIOL CHEM, V390, P529, DOI 10.1515/BC.2009.075; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Paclik D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002629; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Pastor-Anglada M, 2008, XENOBIOTICA, V38, P972, DOI 10.1080/00498250802069096 ; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Pinilla-Macua I, 2012, BIOCHEM J, V442, P517, DOI 10.1042/BJ20110605; Rajasekaran SA, 2004, MOL BIOL CELL, V15, P3224, DOI 10.1091/mbc.e04-03-0222; Ritzel MWL, 2001, MOL MEMBR BIOL, V18, P65, DOI 10.1080/09687680010026313; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Tsang RY, 2008, MODERN PATHOL, V21, P1387, DOI 10.1038/modpathol.2008.110; Wojtal KA, 2009, DRUG METAB DISPOS, V37, P1871, DOI 10.1124/dmd.109.027367	45	7	7	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					544	554		10.1096/fj.15-272773	http://dx.doi.org/10.1096/fj.15-272773			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481311				2022-12-28	WOS:000369391900008
J	Meyers, FJ; Mathur, A; Fuhrmann, CN; O'Brien, TC; Wefes, I; Labosky, PA; Duncan, DS; August, A; Feig, A; Gould, KL; Friedlander, MJ; Schaffer, CB; Van Wart, A; Chalkley, R				Meyers, Frederick J.; Mathur, Ambika; Fuhrmann, Cynthia N.; O'Brien, Theresa C.; Wefes, Inge; Labosky, Patricia A.; Duncan, D'Anne S.; August, Avery; Feig, Andrew; Gould, Kathleen L.; Friedlander, Michael J.; Schaffer, Chris B.; Van Wart, Audra; Chalkley, Roger			The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiative	FASEB JOURNAL			English	Article						professional development; career development; Ph. D.; postdoctoral trainee		Recent national reports and commentaries on the current status and needs of the U.S. biomedical research workforce have highlighted the limited career development opportunities for predoctoral and postdoctoral trainees in academia, yet little attention is paid to preparation for career pathways outside of the traditional faculty path. Recognizing this issue, in 2013, the U.S. National Institutes of Health (NIH) Common Fund issued a request for application titled" NIH Director's Biomedical Research Workforce Innovation Award: Broadening Experiences in Scientific Training (BEST)." These 5-yr 1-time grants, awarded to 17 single or partnering institutions, were designed to develop sustainable approaches to broaden graduate and postgraduate training, aimed at creating training programs that reflect the range of career options that trainees may ultimately pursue. These institutions have formed a consortium in order to work together to develop, evaluate, share, and disseminate best practices and challenges. This is a first report on the early experiences of the consortium and the scope of participating BEST programs. In this report, we describe the state of the U.S. biomedical workforce and development of the BEST award, variations of programmatic approaches to assist with program design without BEST funding, and novel approaches to engage faculty in career development programs. To test the effectiveness of these BEST programs, external evaluators will assess their outcomes not only over the 5 yr grant period but also for an additional 10 yr beyond award completion.	[Meyers, Frederick J.] Univ Calif Davis, Hlth Syst, Sacramento, CA 95817 USA; [Mathur, Ambika; Feig, Andrew] Wayne State Univ, Grad Sch, Detroit, MI USA; [Fuhrmann, Cynthia N.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA USA; [O'Brien, Theresa C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wefes, Inge] Univ Colorado, Grad Sch, Anschutz Med Campus, Denver, CO 80202 USA; [Labosky, Patricia A.] NIH, Div Program Coordinat Planning & Strateg Initiat, Bldg 10, Bethesda, MD 20892 USA; [Duncan, D'Anne S.; Gould, Kathleen L.; Chalkley, Roger] Vanderbilt Univ, Sch Med, Biomed Res Educ & Training, Nashville, TN 37232 USA; [Gould, Kathleen L.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [August, Avery] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY USA; [Schaffer, Chris B.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Friedlander, Michael J.; Van Wart, Audra] Virginia Tech Caril Sch Med & Res Inst, Roanoke, VA USA	University of California System; University of California Davis; Wayne State University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; Vanderbilt University; Vanderbilt University; Cornell University; Cornell University	Chalkley, R (corresponding author), Vanderbilt Univ, Sch Med, Biomed Res Educ & Training, Nashville, TN 37232 USA.	roger.g.chalkley@vanderbilt.edu	Schaffer, Chris B./A-7409-2008	Schaffer, Chris B./0000-0002-7800-9596; Feig, Andrew/0000-0002-5783-1097; Gould, Kathleen/0000-0002-3810-4070; Labosky, Patricia/0000-0001-5880-2194	NIGMS NIH HHS [R25 GM062459] Funding Source: Medline; NIH HHS [DP7 OD018426, DP7 OD018420, DP7 OD018425, DP7 OD018428, DP7 OD018422, DP7 OD018423, DP7 OD018421, DP7 OD018427] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP7OD018421, DP7OD018423, DP7OD018422, DP7OD018420, DP7OD018426, DP7OD018428, DP7OD018425, DP7OD018427] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Burroughs Wellcome Fund, 2014, CAR GUID TRAIN; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Freedman T., 2009, CAREER OPPORTUNITIES; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gamse B, 2010, EVALUATION NATL SCI; Harris R, 2014, NATL PUBLIC RADIO MO; Johnson CY, 2014, BOSTON GLOBE; Mathur A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8200; National Academies, 1998, TRENDS EARL CAR LIF; National Institutes of Health, 2012, BIOM RES WORKF WORK; National Institutes of Health, 2013, RL KIRSCHST NAT RES; National Institutes of Health, 2013, NIH DIR BIOM WORKF I; National Institutes of Health General Medical Sciences, 2014, INN PROGR ENH RES TR; National Institutes of Health General Medical Sciences, 2015, ADM SUPPL NIGMS PRED; National Research Council, 2011, RES TRAIN BIOM BEH C; National Science Foundation, 2014, NAT SCI FDN RES TRAI; Rybarczyk B, 2011, BIOSCIENCE, V61, P699, DOI 10.1525/bio.2011.61.9.8; The Royal Society, 2014, DOCT STUD CAR EXP PR	19	40	40	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					507	514		10.1096/fj.15-276139	http://dx.doi.org/10.1096/fj.15-276139			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26432783	Green Published			2022-12-28	WOS:000369391900004
J	Grosbellet, E; Zahn, S; Arrive, M; Dumont, S; Gourmelen, S; Pevet, P; Challet, E; Criscuolo, F				Grosbellet, Edith; Zahn, Sandrine; Arrive, Mathilde; Dumont, Stephanie; Gourmelen, Sylviane; Pevet, Paul; Challet, Etienne; Criscuolo, Francois			Circadian desynchronization triggers premature cellular aging in a diurnal rodent	FASEB JOURNAL			English	Article						circadian rhythm; telomere shortening; chronic jet lag; shift work; diabetes	CHRONIC JET-LAG; DNA-DAMAGE-RESPONSE; OXIDATIVE STRESS; TELOMERE LENGTH; FOOD RESTRICTION; CLOCK GENES; SHIFT WORK; BODY-MASS; LIGHT; LIFE	Chronic jet lag or shift work is deleterious to human metabolic health, in that such circadian desynchronization is associated with being overweight and the prevalence of altered glucose metabolism. Similar metabolic changes are observed with age, suggesting that chronic jet lag and accelerated cell aging are intimately related, but the association remains to be determined. We addressed whether jet lag induces metabolic and cell aging impairments in young grass rats (2-3 mo old), using control old grass rats (12-18 mo old) as an aging reference. Desynchronized young and control old subjects had impaired glucose tolerance (+60 and +280%) when compared with control young animals. Despite no significant variation in liver DNA damage, shorter telomeres were characterized, not only in old animal liver cells (-18%), but also at an intermediate level in desynchronized young rats (-9%). The same pattern was found for deacetylase sirtuin (SIRT)-1 (-57 and -29%), confirming that jet-lagged young rats have an intermediate aging profile. Our data indicate that an experimental circadian desynchronization in young animals is associated with a precocious aging profile based on 3 well-known markers, as well as a prediabetic phenotype. Such chronic jet lag-induced alterations observed in a diurnal species constitute proof of principle of the need to develop preventive treatments in jet-lagged persons and shift workers.	[Grosbellet, Edith; Dumont, Stephanie; Gourmelen, Sylviane; Pevet, Paul; Challet, Etienne] Univ Strasbourg, CNRS, Inst Cellular & Integrat Neurosci, Unite Propres Rech 3212, Strasbourg, France; [Grosbellet, Edith; Zahn, Sandrine; Arrive, Mathilde; Criscuolo, Francois] Univ Strasbourg, CNRS, Hubert Curien Pluridisciplinary Inst, Dept Ecol Physiol & Ethol,Unite Mixte Rech 7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Challet, E (corresponding author), Inst Cellular & Integrat Neurosci, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	challet@inci-cnrs.unistra.fr; francois.criscuolo@iphc.cnrs.fr	Challet, Etienne/ABF-7553-2020	Challet, Etienne/0000-0001-9416-9496	Centre National de la Recherche Scientifique; University of Strasbourg; University of Strasbourg, Strasbourg, France; French Ministry of Higher Education and Research	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; University of Strasbourg, Strasbourg, France; French Ministry of Higher Education and Research	The authors thank Dr. M. P. Felder, J. G. Lorentz, S. Sen, and A. Dumont for help with the Western blots, and Dr. D. Sage-Ciocca for expert assistance with the actimetry. This research was supported by grants from Centre National de la Recherche Scientifique (to F.C. and E.C.), the University of Strasbourg (to F.C. and E.C.), and ProjEx H2E "Contributions of exotic animal models in the discovery of new therapeutic approaches in human pathophysiology" (University of Strasbourg, Strasbourg, France; to F.C. and E.C.), and by a doctoral fellowship from the French Ministry of Higher Education and Research (to E.G.). E.C. and F.C. share senior authorship. The authors declare no conflicts of interest.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Akerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046; Arendt J, 2009, SLEEP MED REV, V13, P249, DOI 10.1016/j.smrv.2008.07.011; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barclay JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037150; Bartol-Munier I, 2006, INT J OBESITY, V30, P60, DOI 10.1038/sj.ijo.0803048; Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747; Bendix L, 2014, J GERONTOL A-BIOL, V69, P231, DOI 10.1093/gerona/glt153; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2012, NATURE, V490, P169, DOI 10.1038/490169a; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen WD, 2014, BIOCHEM BIOPH RES CO, V451, P408, DOI 10.1016/j.bbrc.2014.07.138; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Costantini D., 2014, OXIDATIVE STRESS HOR; Criscuolo F, 2005, AM NAT, V166, P686, DOI 10.1086/497439; Cuesta M, 2009, HORM BEHAV, V55, P338, DOI 10.1016/j.yhbeh.2008.10.015; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241; Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gale JE, 2011, J BIOL RHYTHM, V26, P423, DOI 10.1177/0748730411416341; Gardano L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00146; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Halliwell B., 2007, FREE RADICALS BIOL M; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hubbard J, 2015, SLEEP, V38, P979, DOI 10.5665/sleep.4754; Inui T, 2002, EXP CELL RES, V273, P147, DOI 10.1006/excr.2001.5446; Iwamoto A, 2014, CHRONOBIOL INT, V31, P189, DOI 10.3109/07420528.2013.837478; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Katona C, 1997, PHYSIOL BEHAV, V61, P365, DOI 10.1016/S0031-9384(96)00407-6; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kiecolt-Glaser JK, 2013, BRAIN BEHAV IMMUN, V34, P29, DOI 10.1016/j.bbi.2013.08.004; Kirkwood TBL, 2012, BIOESSAYS, V34, P692, DOI 10.1002/bies.201200014; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Kunieda T, 2006, CIRC RES, V98, P532, DOI 10.1161/01.RES.0000204504.25798.a8; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Liu JL, 2014, CURR BIOL, V24, pR610, DOI 10.1016/j.cub.2014.05.057; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; Pesic V, 2010, PHYSIOL BEHAV, V101, P672, DOI 10.1016/j.physbeh.2010.08.005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Reichert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081496; Ribeiro DCO, 1998, J ENDOCRINOL, V158, P305, DOI 10.1677/joe.0.1580305; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Seluanov A, 2007, AGING CELL, V6, P45, DOI 10.1111/j.1474-9726.2006.00262.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shuboni DD, 2012, J BIOL RHYTHM, V27, P299, DOI 10.1177/0748730412449723; SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; Tahara Y, 2013, NEUROSCIENCE, V253, P78, DOI 10.1016/j.neuroscience.2013.08.049; Tevy MF, 2013, TRENDS ENDOCRIN MET, V24, P229, DOI 10.1016/j.tem.2012.12.002; Tsai LL, 2005, AM J PHYSIOL-ENDOC M, V289, pE212, DOI 10.1152/ajpendo.00603.2004; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x	85	24	24	0	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4794	4803		10.1096/fj.14-266817	http://dx.doi.org/10.1096/fj.14-266817			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26260033				2022-12-28	WOS:000365523600007
J	Le Billan, F; Khan, JA; Lamribet, K; Viengchareun, S; Bouligand, J; Fagart, J; Lombes, M				Le Billan, Florian; Khan, Junaid A.; Lamribet, Khadija; Viengchareun, Say; Bouligand, Jerome; Fagart, Jerome; Lombes, Marc			Cistrome of the aldosterone-activated mineralocorticoid receptor in human renal cells	FASEB JOURNAL			English	Article						chromatin immunoprecipitation sequencing; sodium; nuclear receptor; transcription factor	EPITHELIAL SODIUM-CHANNEL; TRANSCRIPTION FACTORS; GLUCOCORTICOID-RECEPTOR; ANDROGEN RECEPTOR; BREAST-CANCER; TARGET GENES; GENOME; BINDING; PROTEIN; ALPHA	Aldosterone exerts its effects mainly by activating the mineralocorticoid receptor (MR), a transcription factor that regulates gene expression through complex and dynamic interactions with coregulators and transcriptional machinery, leading to fine-tuned control of vectorial ionic transport in the distal nephron. To identify genome-wide aldosterone-regulated MR targets in human renal cells, we set up a chromatin immunoprecipitation (ChIP) assay by using a specific anti-MR antibody in a differentiated human renal cell line expressing green fluorescent protein (GFP)-MR. This approach, coupled with high-throughput sequencing, allowed identification of 974 genomic MR targets. Computational analysis identified an MR response element (MRE) including single or multiple half-sites and palindromic motifs in which the AGtA-CAgxatGTtCt sequence was the most prevalent motif. Most genomic MR-binding sites (MBSs) are located > 10 kb from the transcriptional start sites of target genes (84%). Specific aldosterone-induced recruitment of MR on the first most relevant genomic sequences was further validated by ChIP-quantitative (q) PCR and correlated with concomitant and positive aldosterone-activated transcriptional regulation of the corresponding gene, as assayed by RT-qPCR. It was notable that most MBSs lacked MREs but harbored DNA recognition motifs for other transcription factors (FOX, EGR1, AP1, PAX5) suggesting functional interaction. This work provides new insights into aldosterone MR-mediated renal signaling and opens relevant perspectives for mineralocorticoid-related pathophysiology.	[Le Billan, Florian; Khan, Junaid A.; Lamribet, Khadija; Viengchareun, Say; Bouligand, Jerome; Fagart, Jerome; Lombes, Marc] INSERM, U1185, F-94275 Le Kremlin Bicetre, France; [Le Billan, Florian; Khan, Junaid A.; Lamribet, Khadija; Viengchareun, Say; Bouligand, Jerome; Fagart, Jerome; Lombes, Marc] Univ Paris 11, Fac Med Paris Sud, Unite Mixte Rech S1185, F-94276 Le Kremlin Bicetre, France; [Bouligand, Jerome] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Lombes, M (corresponding author), Univ Paris 11, Fac Med Paris Sud, INSERM, U1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	jerome.fagart@inserm.fr; marc.lombes@u-psud.fr	Khan, Junaid/AAE-3522-2019; Viengchareun, Say/GOV-6812-2022; Khan, Junaid Ali/ABG-2756-2020; Viengchareun, Say/M-6612-2017; Lombes, Marc/L-5933-2018; Khan, Junaid Ali/ABG-6129-2020; BOULIGAND, Jérôme/S-5716-2018; Fagart, Jerome/S-4581-2018	Khan, Junaid Ali/0000-0003-2630-1744; Lombes, Marc/0000-0003-3189-023X; Fagart, Jerome/0000-0002-7965-0553; Le Billan, Florian/0000-0002-3400-9295; viengchareun, say/0000-0003-4280-3250	INSERM, Universite Paris Sud; Agence Nationale de la Recherche (ANR) [11-BSV1-028-01]; France Genomique national infrastructure; ANR [11-BSV1-028-01, ANR-10-INBS-0009]; Ministere de l'Enseignement Superieur et de la Recherche (MESR)	INSERM, Universite Paris Sud; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); France Genomique national infrastructure; ANR(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France)	The authors thank Stephane Le Crom (Ecole Normale Superieure, Institut de Biologie de l'ENS, IBENS, Plateforme Genomique, Paris, F-75005 France), Juliette Pouch (INSERM, U1024, Paris, F-75005 France), Sophie Lemoine (CNRS, UMR 8197, Paris, F-75005 France), and their genomic platform for their help in the genomic sequencing and initial analysis of the results; and Florian Nadal (INSERM U1185 and Assistance Publique-Hopitaux de Paris, Service de Pharmacogenetique, Genetique Moleculaire et Hormonologie, Hopital de Bicetre, F-94275 Le Kremlin Bicetre, France) for invaluable contributions to the initial analysis of the ChIP-seq data. This work was supported by grants from INSERM, Universite Paris Sud and by Grant 11-BSV1-028-01 Agence Nationale de la Recherche (ANR). The ChIP-Seq was supported by the France Genomique national infrastructure, funded as part of the "Investissements d'Avenir" program managed by ANR contract ANR-10-INBS-0009. F.L.B. is the recipient of a doctoral fellowship from Ministere de l'Enseignement Superieur et de la Recherche (MESR), and J.A.K. received ANR postdoctoral fellowship 11-BSV1-028-01. The authors declare no conflicts of interest.	Amasaki Y, 2000, J ALLERGY CLIN IMMUN, V106, pS1; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dakour J, 1997, GENE, V185, P153, DOI 10.1016/S0378-1119(96)00587-2; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Hellal-Levy C, 2000, MOL ENDOCRINOL, V14, P1210, DOI 10.1210/me.14.8.1210; Hou CH, 2012, CHROMOSOMA, V121, P107, DOI 10.1007/s00412-011-0352-7; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Hudson WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107000; JOHNSON JP, 1992, PHARMACOL THERAPEUT, V53, P1, DOI 10.1016/0163-7258(92)90042-X; Jourdren L, 2012, BIOINFORMATICS, V28, P1542, DOI 10.1093/bioinformatics/bts165; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Naray-Fejes-Toth A, 2008, AM J PHYSIOL-RENAL, V295, pF18, DOI 10.1152/ajprenal.00573.2007; Need EF, 2012, MOL ENDOCRINOL, V26, P1941, DOI 10.1210/me.2011-1314; PALMER LG, 1990, J GEN PHYSIOL, V96, P23, DOI 10.1085/jgp.96.1.23; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Pearce D, 2003, VITAM HORM, V66, P29, DOI 10.1016/S0083-6729(03)01002-1; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Petrovich E, 2014, J STEROID BIOCHEM, V139, P78, DOI 10.1016/j.jsbmb.2013.10.006; Polman JAE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-118; PRIE D, 1995, KIDNEY INT, V47, P1310, DOI 10.1038/ki.1995.186; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Richards J, 2014, J BIOL CHEM, V289, P11791, DOI 10.1074/jbc.M113.531095; Richards J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00253; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Rossier B C, 1994, Curr Opin Nephrol Hypertens, V3, P487, DOI 10.1097/00041552-199409000-00003; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Sekizawa N, 2011, MOL CELL ENDOCRINOL, V341, P78, DOI 10.1016/j.mce.2011.05.029; Ueda K, 2014, BIOCHEM BIOPH RES CO, V445, P132, DOI 10.1016/j.bbrc.2014.01.125; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Wang XK, 2010, CANCER GENET CYTOGEN, V196, P64, DOI 10.1016/j.cancergencyto.2009.09.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	42	44	44	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3977	3989		10.1096/fj.15-274266	http://dx.doi.org/10.1096/fj.15-274266			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26054365	Green Submitted			2022-12-28	WOS:000359915600032
J	Marques-Rocha, JL; Samblas, M; Milagro, FI; Bressan, J; Martinez, JA; Marti, A				Marques-Rocha, Jose Luiz; Samblas, Mirian; Milagro, Fermin I.; Bressan, Josefina; Alfredo Martinez, J.; Marti, Amelia			Noncoding RNAs, cytokines, and inflammation-related diseases	FASEB JOURNAL			English	Review						circular RNA; lincRNA; microRNA; lncRNA; obesity	CELL-ADHESION MOLECULE-1; BLOOD MONONUCLEAR-CELLS; REGULATES TNF-ALPHA; METABOLIC SYNDROME; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; DOWN-REGULATION; ADIPOSE-TISSUE; CIRCULATING MICRORNAS; EPIGENETIC REGULATION	Chronic inflammation is involved in the onset and development of many diseases, including obesity, atherosclerosis, type 2 diabetes, osteoarthritis, autoimmune and degenerative diseases, asthma, periodontitis, and cirrhosis. The inflammation process is mediated by chemokines, cytokines, and different inflammatory cells. Although the molecules and mechanisms that regulate this primary defense mechanism are not fully understood, recent findings offer a putative role of noncoding RNAs, especially microRNAs (miRNAs), in the progression and management of the inflammatory response. These noncoding RNAs are crucial for the stability and maintenance of gene expression patterns that characterize some cell types, tissues, and biologic responses. Several miRNAs, such as miR-126, miR-132, miR-146, miR-155, and miR-221, have emerged as important transcriptional regulators of some inflammation-related mediators. Additionally, little is known about the involvement of long noncoding RNAs, long intergenic noncoding RNAs, and circular RNAs in inflammation-mediated processes and the homeostatic imbalance associated with metabolic disorders. These noncoding RNAs are emerging as biomarkers with diagnosis value, in prognosis protocols, or in the personalized treatment of inflammation-related alterations. In this context, this review summarizes findings in the field, highlighting those noncoding RNAs that regulate inflammation, with emphasis on recognized mediators such as TNF-alpha, IL-1, IL-6, IL-18, intercellular adhesion molecule 1, VCAM-1, and plasminogen activator inhibitor 1. The down-regulation or antagonism of the noncoding RNAs and the administration of exogenous miRNAs could be, in the near future, a promising therapeutic strategy in the treatment of inflammation-related diseases.	[Marques-Rocha, Jose Luiz; Bressan, Josefina] Univ Fed Vicosa, Dept Nutr & Hlth, Vicosa, MG, Brazil; [Samblas, Mirian; Milagro, Fermin I.; Alfredo Martinez, J.; Marti, Amelia] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Samblas, Mirian; Milagro, Fermin I.; Alfredo Martinez, J.; Marti, Amelia] Univ Navarra, Ctr Nutr Res, E-31080 Pamplona, Spain; [Milagro, Fermin I.; Alfredo Martinez, J.; Marti, Amelia] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Alfredo Martinez, J.; Marti, Amelia] Inst Invest Sanitaria Navarra, Pamplona, Spain	Universidade Federal de Vicosa; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Marti, A (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, C Irunlarrea 1, Navarra 31008, Spain.	amarti@unav.es	Marti, Amelia/M-2709-2019; Milagro, Fermin/F-2315-2015; Martí, Amelia/H-1192-2017	Marti, Amelia/0000-0001-9832-7981; Milagro, Fermin/0000-0002-3228-9916; Martí, Amelia/0000-0001-9832-7981; Bressan, Josefina/0000-0002-4993-9436; Samblas-Garcia, Mirian/0000-0003-0866-2300; Marques-Rocha, Jose Luiz/0000-0002-0783-5807	government of Spain (Ministerio de Economia y Competitividad) [AGL2013-45554-R]; Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CNPq Foundation [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)]; CAPES Foundation (Ministry of Education of Brazil, Brasilia, DF) [process 6409-13-0]; Center for Nutrition Research of University of Navarra	government of Spain (Ministerio de Economia y Competitividad); Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CNPq Foundation [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation (Ministry of Education of Brazil, Brasilia, DF)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Center for Nutrition Research of University of Navarra	The authors thank the government of Spain (Ministerio de Economia y Competitividad, ref. AGL2013-45554-R), Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion (CIBERobn), and the CNPq Foundation [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)] for financial support, and the CAPES Foundation (Ministry of Education of Brazil, Brasilia, DF 70040-020) for providing J.L.M.-R. with a research grant (process 6409-13-0). M.S. has a predoctoral fellowship from the Center for Nutrition Research of the University of Navarra.	Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Altinova AE, 2008, CYTOKINE, V42, P217, DOI 10.1016/j.cyto.2008.02.006; Andersen MH, 2013, CELL CYCLE, V12, P2171, DOI 10.4161/cc.25549; Aranda JF, 2013, FREE RADICAL BIO MED, V64, P31, DOI 10.1016/j.freeradbiomed.2013.07.014; Arner P, 2015, NAT REV ENDOCRINOL, V11, P276, DOI 10.1038/nrendo.2015.25; Asgeirsdottir SA, 2012, AM J PHYSIOL-RENAL, V302, pF1630, DOI 10.1152/ajprenal.00400.2011; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Billeter AT, 2014, FASEB J, V28, P5322, DOI 10.1096/fj.14-258335; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Borjigin N, 2012, BIOCHEM BIOPH RES CO, V427, P355, DOI 10.1016/j.bbrc.2012.09.063; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chafin CB, 2013, AUTOIMMUNITY, V46, P351, DOI 10.3109/08916934.2013.773976; Chen L, 2013, GUT LIVER, V7, P335, DOI 10.5009/gnl.2013.7.3.335; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chiou GY, 2013, MOL CELL, V52, P693, DOI 10.1016/j.molcel.2013.11.009; Chizzolini C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2767; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Cui HC, 2014, EUR J IMMUNOL, V44, P2085, DOI 10.1002/eji.201344126; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Dave RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068306; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Doberstein K, 2013, NEOPLASIA, V15, P218, DOI 10.1593/neo.121222; Dou L, 2013, J BIOL CHEM, V288, P22596, DOI 10.1074/jbc.M112.423145; Duan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060170; EMEIS JJ, 1986, J EXP MED, V163, P1260, DOI 10.1084/jem.163.5.1260; Esau CC, 2007, ADV DRUG DELIVER REV, V59, P101, DOI 10.1016/j.addr.2007.03.007; Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Fasanaro P., 2013, CURR VASC PHARM; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Ferretti C, 2014, CELL MOL IMMUNOL, V11, P215, DOI 10.1038/cmi.2014.5; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Foley NH, 2012, J LEUKOCYTE BIOL, V92, P521, DOI 10.1189/jlb.0312160; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Garg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077249; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Ge Q, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/987285; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HAKKERT BC, 1990, BLOOD, V76, P2272; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Hanieh H, 2013, EUR J IMMUNOL, V43, P2771, DOI 10.1002/eji.201343486; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; HATTORI M, 1993, AM J PHYSIOL, V264, pG95, DOI 10.1152/ajpgi.1993.264.1.G95; He Y, 2014, INFLAMMATION, V37, P71, DOI 10.1007/s10753-013-9713-0; HEEB MJ, 1987, J BIOL CHEM, V262, P15813; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hu GK, 2010, AM J PHYSIOL-GASTR L, V298, pG542, DOI 10.1152/ajpgi.00490.2009; Hu YW, 2014, J LIPID RES, V55, P681, DOI 10.1194/jlr.M044669; HUANG JH, 1994, MOL CELL BIOL, V14, P4475, DOI 10.1128/MCB.14.7.4475; Huang YQ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-142; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Hulsmans M, 2013, CURR PHARM DESIGN, V19, P5704, DOI 10.2174/13816128113199990364; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; IADEMARCO MF, 1993, P NATL ACAD SCI USA, V90, P3943, DOI 10.1073/pnas.90.9.3943; IDF, 2014, IDF CONS WORLDW DEF; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jacobs M, 2009, EUR J CLIN INVEST, V39, P437, DOI 10.1111/j.1365-2362.2009.02129.x; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jin HM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4531; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Jura J, 2011, ACUTE PHASE PROTEINS - REGULATION AND FUNCTIONS OF ACUTE PHASE PROTEINS, P61; Kang JG, 2011, J PATHOL, V225, P378, DOI 10.1002/path.2962; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kim C, 2013, FEBS LETT, V587, P3853, DOI 10.1016/j.febslet.2013.10.018; Kim E, 2012, ARTHRITIS RHEUM-US, V64, P3809, DOI 10.1002/art.34606; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Koh KK, 2005, J AM COLL CARDIOL, V46, P1978, DOI 10.1016/j.jacc.2005.06.082; Koning GA, 2002, ENDOTHELIUM-J ENDOTH, V9, P161, DOI 10.1080/10623320213631; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Kumar V, 2014, LEUKEMIA, V28, P2324, DOI 10.1038/leu.2014.133; Kutty RK, 2010, BIOCHEM BIOPH RES CO, V402, P390, DOI 10.1016/j.bbrc.2010.10.042; Lee YH, 2011, BIOCELL, V35, pB43; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071568; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072477; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu M, 2011, INT J ONCOL, V38, P1013, DOI 10.3892/ijo.2011.924; Liu YC, 2014, ARTERIOSCL THROM VAS, V34, P902, DOI 10.1161/ATVBAHA.113.303123; Lorente-Cebrian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086800; Lukiw Walter J., 2012, Frontiers in Genetics, V3, P166, DOI 10.3389/fgene.2012.00166; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Ma XC, 2013, HEART LUNG CIRC, V22, P811, DOI 10.1016/j.hlc.2013.05.651; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Magenta A, 2013, INT J MOL SCI, V14, P17319, DOI 10.3390/ijms140917319; Maharshak N, 2013, INFLAMM BOWEL DIS, V19, P1346, DOI 10.1097/MIB.0b013e318281f47d; Marchand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044532; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McKiernan PJ, 2013, INT J NANOMED, V8, P3907, DOI 10.2147/IJN.S47551; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Meiler S, 2015, ARTERIOSCL THROM VAS, V35, P323, DOI 10.1161/ATVBAHA.114.304878; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Milagro FI, 2011, FASEB J, V25, P1378, DOI 10.1096/fj.10-170365; Muth M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-33; Muthiah M, 2013, EXPERT OPIN DRUG DEL, V10, P1259, DOI 10.1517/17425247.2013.798640; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Nicoletti F, 2001, DIABETOLOGIA, V44, P309, DOI 10.1007/s001250051619; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001; Olivieri Fabiola, 2013, Frontiers in Genetics, V4, P121, DOI 10.3389/fgene.2013.00121; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Pai P, 2013, CURR DRUG TARGETS, V14, P1101, DOI 10.2174/13894501113149990181; Palma G, 2013, BBA-REV CANCER, V1836, P296, DOI 10.1016/j.bbcan.2013.09.001; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Peschon JJ, 1998, J IMMUNOL, V160, P943; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rasmussen S., 2007, NAT METHODS, V4; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Ross SA, 2014, ANNU REV NUTR, V34, P305, DOI 10.1146/annurev-nutr-071813-105729; Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Saleem U, 2009, J CLIN ENDOCR METAB, V94, P2558, DOI 10.1210/jc.2008-2278; Santini P, 2014, RHEUMATOL INT, V34, P711, DOI 10.1007/s00296-013-2754-8; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Scarpellini E, 2012, DIGEST DIS, V30, P148, DOI 10.1159/000336664; Schroen B, 2012, CARDIOVASC RES, V93, P605, DOI 10.1093/cvr/cvr268; Sedimbi SK, 2013, CELL MOL LIFE SCI, V70, P4795, DOI 10.1007/s00018-013-1425-y; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Shi CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066814; Shi H., 2014, PATHWAYS CYTOKINES I; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Son DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4000; Son YH, 2014, ENDOCRINOL METAB, V29, P122, DOI 10.3803/EnM.2014.29.2.122; Sonntag KC, 2012, EXP NEUROL, V235, P427, DOI 10.1016/j.expneurol.2011.11.035; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Sturgeon CM, 2012, DEV CELL, V23, P45, DOI 10.1016/j.devcel.2012.05.021; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Sun CX, 2012, CIRC RES, V111, P1054, DOI [10.1161/circresaha.112.270314, 10.1161/CIRCRESAHA.112.270314]; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Sun YP, 2013, J IMMUNOL, V190, P4005, DOI 10.4049/jimmunol.1202911; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Sung SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071637; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Tsimikas S, 2009, EUR HEART J, V30, P107, DOI 10.1093/eurheartj/ehn502; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang Zhiguo, 2010, World J Biol Chem, V1, P41, DOI 10.4331/wjbc.v1.i4.41; Washburn Newell R, 2013, Biomatter, V3, DOI 10.4161/biom.25597; Williams MD, 2012, EXP DIABETES RES, DOI 10.1155/2012/484696; Wong TY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-426; Xi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082330; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xie YF, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-20; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Xu LL, 2014, CELL BIOCHEM BIOPHYS, V70, P771, DOI 10.1007/s12013-014-9980-x; Ye JP, 2011, CURR DIABETES REP, V11, P203, DOI 10.1007/s11892-011-0183-1; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	210	326	335	5	208	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3595	3611		10.1096/fj.14-260323	http://dx.doi.org/10.1096/fj.14-260323			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26065857	Green Published			2022-12-28	WOS:000359915600001
J	Noubissi, FK; Harkness, T; Alexander, CM; Ogle, BM				Noubissi, Felicite K.; Harkness, Ty; Alexander, Caroline M.; Ogle, Brenda M.			Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis	FASEB JOURNAL			English	Article						hybrid; hypoxia; migration; mesenchymal stem cell; bimolecular fluorescence complementation	MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; ENDOTHELIAL-CELLS; MACROPHAGE FUSION; CARCINOMA CELLS; TUMOR; BONE; HYBRIDS; HYPOXIA; MEMBRANE	Although cancer cell fusion has been suggested as a mechanism of cancer metastasis, the underlying mechanisms defining this process are poorly understood. In a recent study, apoptotic cells were newly identified as a type of cue that induces signaling via phosphatidylserine receptors to promote fusion of myoblasts. The microenvironment of breast tumors is often hypoxic, and because apoptosis is greatly increased in hypoxic conditions, we decided to investigate whether the mechanism of breast cancer cell fusion with mesenchymal stem/multipotent stromal cells (MSCs) involves apoptosis. We used a powerful tool for identification and tracking of hybrids based on bimolecular fluorescence complementation (BiFC) and found that breast cancer cells fused spontaneously with MSCs. This fusion was significantly enhanced with hypoxia and signaling associated with apoptotic cells, especially between nonmetastatic breast cancer cells and MSCs. In addition, the hybrids showed a significantly higher migratory capacity than did the parent cells. Taken together, these findings describe a mechanism by which hypoxia-induced apoptosis stimulates fusion between MSCs and breast tumor cells resulting in hybrids with an enhanced migratory capacity that may enable their dissemination to distant sites or metastases. In the long run, this study may provide new strategies for developing novel drugs for preventing cancer metastasis.	[Noubissi, Felicite K.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Stem Cell Inst, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Noubissi, Felicite K.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Harkness, Ty; Alexander, Caroline M.; Ogle, Brenda M.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Alexander, Caroline M.] Univ Wisconsin, Dept Oncol, Madison, WI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ogle, BM (corresponding author), Univ Minnesota Twin Cities, 312 Church St SE, Minneapolis, MN 55455 USA.	ogle@umn.edu			U.S. Department of Defense, Idea Award [11-1-0205]	U.S. Department of Defense, Idea Award(United States Department of Defense)	The authors thank Dr. Peiman Hematti (Division of Hematology and Oncology, University of Wisconsin, Madison, WI, USA) for the gift of MSCs, Dr. Thomas Kerppola (Professor of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA) for the gift of BiFC constructs, Louis Prahl (University of Minnesota, Minneapolis, MN, USA) for help with the time-lapse microscopy, Dr. Philip Jung (University of Minnesota, Minneapolis, MN, USA) for help with ANOVA with Tukey's HSD post hoc test, and Brian Freeman (University of Minnesota, Minneapolis, MN, USA) for help with the coculture analyses. This work was supported by U.S. Department of Defense, Idea Award 11-1-0205. F.N.K. participated in the study design, performed all the experiments, analyzed the data, and participated in writing the manuscript. T.H. developed molecular tools and protocols for coculture studies and helped to edit the manuscript. C.A. participated in study design, offered helpful consultation in the course of the studies, and helped to edit the manuscript. B.O. participated in study design, offered helpful consultation in the course of the studies and participated in writing the manuscript. All authors read and approved the final manuscript. The authors declare no conflicts of interest.	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Aichel O., 1911, VORTRAGE AUFSATZE EN, P92; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Berndt B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063711; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Chakraborty A, 2004, BONE MARROW TRANSPL, V34, P183, DOI 10.1038/sj.bmt.1704547; Chakraborty AK, 2001, CELL GROWTH DIFFER, V12, P623; Chakraborty AK, 2000, CANCER RES, V60, P2512; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; DEFENDI V, 1967, P NATL ACAD SCI USA, V57, P299, DOI 10.1073/pnas.57.2.299; Dittmar T, 2011, CLIN EXP METASTAS, V28, P75, DOI 10.1007/s10585-010-9359-3; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; ERIKSON J, 1981, NATURE, V294, P173, DOI 10.1038/294173a0; Fan H, 2014, NEOPLASMA, V61, P540, DOI [10.4149/neo_2014066, 10.4149/neo_2014_066]; GOLDENBERG DM, 1968, KLIN WOCHENSCHR, V46, P898, DOI 10.1007/BF01746251; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hafez IM, 2000, BIOPHYS J, V79, P1438, DOI 10.1016/S0006-3495(00)76395-8; HARRIS H, 1988, CANCER RES, V48, P3302; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Jegou A, 2011, P NATL ACAD SCI USA, V108, P10946, DOI 10.1073/pnas.1017400108; Jezkova J, 2002, MOL CELL BIOCHEM, V232, P49; Kaji K, 2002, DEV BIOL, V247, P327, DOI 10.1006/dbio.2002.0694; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kemp K, 2014, ACTA NEUROPATHOL, V128, P629, DOI 10.1007/s00401-014-1303-1; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Lazova R, 2011, ADV EXP MED BIOL, V714, P151, DOI 10.1007/978-94-007-0782-5_8; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; McDonald DM, 2000, CANCER METAST REV, V19, P109, DOI 10.1023/A:1026529222845; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P80; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Mortensen K, 2004, CELL MOL LIFE SCI, V61, P2125, DOI 10.1007/s00018-004-4200-2; Ozel C, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-10; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Paltsyn AA, 2014, EXP BIOL MED, V239, P595, DOI 10.1177/1535370214523898; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Ramakrishnan M, 2013, CANCER RES, V73, P5360, DOI 10.1158/0008-5472.CAN-13-0896; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Roy SM, 2011, J LIPIDS, V2011, DOI 10.1155/2011/528784; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; Trivedi P, 2007, EXP HEMATOL, V35, P146, DOI 10.1016/j.exphem.2006.09.003; VANBLITTERSWIJK WJ, 1987, LIPIDS, V22, P820, DOI 10.1007/BF02535537; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; Xu MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087893; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388; Yang Johnny J, 2010, Drug Metab Lett, V4, P201; Yilmaz Y, 2005, BONE MARROW TRANSPL, V35, P1021, DOI 10.1038/sj.bmt.1704939; Zhao M, 2012, CANCER BIOL THER, V13, P782, DOI 10.4161/cbt.20561	59	59	61	4	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4036	4045		10.1096/fj.15-271098	http://dx.doi.org/10.1096/fj.15-271098			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26085132	Bronze			2022-12-28	WOS:000359915600037
J	Shao, BY; Liao, L; Yu, Y; Shuai, Y; Su, XX; Jing, H; Yang, DQ; Jin, Y				Shao, Bingyi; Liao, Li; Yu, Yang; Shuai, Yi; Su, Xiaoxia; Jing, Huan; Yang, Deqin; Jin, Yan			Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance	FASEB JOURNAL			English	Article						apoptosis; osteoclast; osteoporosis; gene regulation; cell transplantation	RECEPTOR-ALPHA; OSTEOBLAST PROGENITORS; APOPTOSIS; TRANSPLANTATION; EXPRESSION; RESORPTION; GROWTH; CXCR4; RANK; MASS	Estrogen protects bone loss by promoting Fas ligand (FasL) transcription in osteoclasts and osteoblasts to induce apoptosis of osteoclasts. Bone marrow-derived mesenchymal stem cells (BMMSCs) express FasL protein, which is necessary for BMMSCs to induce T-cell apoptosis in cell therapy. However, the physiologic function of FasL in BMMSCs is unknown. In this study, using an in vitro coculture system and an in vivo BMMSC transplantation assay, we found that BMMSCs potently induced apoptosis of osteoclasts through the FasL/Fas pathway. Estrogen was necessary for this process as a promoter of FasL protein accumulation in BMMSCs. Furthermore, estrogen elevated FasL protein accumulation, not by increasing FasL gene transcription, but through microRNA-mediated posttranscriptional regulation. In brief, estrogen down-regulated expression of miR-181a, a negative modulator of FasL targeting the 3'-UTR of FasL mRNA. Estrogen deficiency resulted in excessive miR-181a, which decreased FasL protein levels to suppress BMMSC-induced osteoclast apoptosis. Furthermore, knockdown of miR-181a recovered the BMMSC defect to induce osteoclast apoptosis during estrogen deficiency. Taken together, our results showed that estrogen preserves FasL protein accumulation by inhibiting miR-181a expression in BMMSCs to maintain bone remodeling balance, suggesting a novel mechanism by which estrogen preserves bone mass.	[Shao, Bingyi; Liao, Li; Yu, Yang; Shuai, Yi; Jing, Huan; Jin, Yan] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; [Liao, Li; Shuai, Yi; Jing, Huan] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Histol & Pathol, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China; [Liao, Li; Shuai, Yi; Jing, Huan; Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; [Shao, Bingyi; Yu, Yang; Yang, Deqin] Chongqing Med Univ, Affiliated Hosp Stomatol, Chongqing, Peoples R China; [Shao, Bingyi; Yu, Yang; Yang, Deqin] Chongqing Res Ctr Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Su, Xiaoxia] Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol Environm & Genes Related Dis, Key Lab,Educ Minist, Xian 710049, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chongqing Medical University; Xi'an Jiaotong University	Jin, Y (corresponding author), Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Ctr Tissue Engn, 145 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.	yangdeqin@gmail.com; yanjin@fmmu.edu.cn	Jin, Yan/I-4204-2013; Liao, Li/U-6866-2017	Liao, Li/0000-0003-0030-1009; Yang, Deqin/0000-0002-2579-8384	National Major Scientific Research Program of China [2011CB964700]; Nature Science Foundation of China [31030033, 81470710]	National Major Scientific Research Program of China; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2011CB964700 from the National Major Scientific Research Program of China, and Grants 31030033 and 81470710 from the Nature Science Foundation of China. The authors declare no conflicts of interest.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liao L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.130; Lien CY, 2009, J BONE MINER RES, V24, P837, DOI [10.1359/jbmr.081257, 10.1359/JBMR.081257]; Liu YL, 2011, STEM CELLS, V29, P1804, DOI 10.1002/stem.728; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Manavalan TT, 2011, CANCER LETT, V313, P26, DOI 10.1016/j.canlet.2011.08.018; Modder UI, 2011, BONE, V49, P202, DOI 10.1016/j.bone.2011.04.015; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2007, CELL METAB, V6, P254, DOI 10.1016/j.cmet.2007.09.007; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798	37	31	38	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3935	3944		10.1096/fj.15-272823	http://dx.doi.org/10.1096/fj.15-272823			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062603				2022-12-28	WOS:000359915600028
J	D'Avanzo, C; Sliwinski, C; Wagner, SL; Tanzi, RE; Kim, DY; Kovacs, DM				D'Avanzo, Carla; Sliwinski, Christopher; Wagner, Steven L.; Tanzi, Rudolph E.; Kim, Doo Yeon; Kovacs, Dora M.			gamma-Secretase modulators reduce endogenous amyloid beta(42) levels in human neural progenitor cells without altering neuronal differentiation	FASEB JOURNAL			English	Article						presenilin; Alzheimer's disease; SGSM; Notch; ReNcell VM	ALZHEIMERS-DISEASE; STEM-CELLS; INHIBITOR; ADULT; MODEL; TRIAL; SEMAGACESTAT; MAINTENANCE; PRESENILINS; MECHANISMS	Soluble gamma-secretase modulators (SGSMs) selectively decrease toxic amyloid beta (A beta) peptides (A beta(42)). However, their effect on the physiologic functions of gamma-secretase has not been tested in human model systems. gamma-Secretase regulates fate determination of neural progenitor cells. Thus, we studied the impact of SGSMs on the neuronal differentiation of ReNcell VM (ReN) human neural progenitor cells (hNPCs). Quantitative PCR analysis showed that treatment of neurosphere-like ReN cell aggregate cultures with gamma-secretase inhibitors (GSIs), but not SGSMs, induced a 2- to 4-fold increase in the expression of the neuronal markers Tuj1 and doublecortin. GSI treatment also induced neuronal marker protein expression, as shown by Western blot analysis. In the same conditions, SGSM treatment selectively reduced endogenous A beta(42) levels by similar to 80%. Mechanistically, we found that Notch target gene expressions were selectively inhibited by a GSI, not by SGSM treatment. We can assert, for the first time, that SGSMs do not affect the neuronal differentiation of hNPCs while selectively decreasing endogenous A beta(42) levels in the same conditions. Our results suggest that our hNPC differentiation system can serve as a useful model to test the impact of GSIs and SGSMs on both endogenous A beta levels and gamma-secretase physiologic functions including endogenous Notch signaling.	[D'Avanzo, Carla; Sliwinski, Christopher; Tanzi, Rudolph E.; Kim, Doo Yeon; Kovacs, Dora M.] Harvard Univ, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit,Med Sch, Charlestown, MA USA; [Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego	Kim, DY (corresponding author), 114 16th St, Charlestown, MA 02129 USA.	dkim@helix.mgh.harvard.edu; dora_kovacs@hms.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	U.S. National Institutes of Health, National Institute on Aging [5P01AG015379, 1RF1AG048080-01, 2R01AG014713]; Cure Alzheimer's Fund (Cure Alzheimer's Grant Stem Cell Consortium); NATIONAL INSTITUTE ON AGING [RF1AG048080, P50AG005134, R01AG014713, P01AG015379] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cure Alzheimer's Fund (Cure Alzheimer's Grant Stem Cell Consortium); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Se Hoon Choi and Ms. Jenna Garr for revising and editing the manuscript. This study was supported by the U.S. National Institutes of Health, National Institute on Aging (Grants 5P01AG015379 and 1RF1AG048080-01 to D.Y.K. and R.E.T., and Grant 2R01AG014713 to D.Y.K.), and from Cure Alzheimer's Fund (Cure Alzheimer's Grant Stem Cell Consortium; to D.Y.K., R.E.T. and S.L.W.). C.D. performed immunochemistry studies, immunofluorescence studies, analyzed data, and wrote the manuscript; C.S. performed quantitative RT-PCR studies, analyzed data, and reviewed the manuscript; S.L.W. and R.E.T. designed the soluble gamma-secretase modulators and tested for their efficacy; and D.Y.K. and D.M.K. designed the study and wrote the manuscript. The authors declare no conflicts of interest.	Ben-Shushan E, 2015, STEM CELLS, V33, P403, DOI 10.1002/stem.1873; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chaudhry ZL, 2013, NEUROL RES, V35, P435, DOI 10.1179/1743132812Y.0000000135; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Gadadhar A, 2011, J NEUROSCI, V31, P2615, DOI 10.1523/JNEUROSCI.4767-10.2011; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henley DB, 2014, CURR MED RES OPIN, V30, P2021, DOI 10.1185/03007995.2014.939167; Hu YY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-82; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Ledford H, 2010, NATURE, V466, P1031, DOI 10.1038/4661031a; Liao HJ, 2012, TRAFFIC, V13, P1106, DOI 10.1111/j.1600-0854.2012.01371.x; Miljan E. A., 2008, RENCELL HUMAN NEURAL, P1; Morgan PJ, 2009, NEUROREPORT, V20, P1225, DOI 10.1097/WNR.0b013e32832fbf49; Niva C, 2013, EUR J CLIN PHARMACOL, V69, P1247, DOI 10.1007/s00228-012-1459-3; Ogura A, 2013, STEM CELLS DEV, V22, P374, DOI 10.1089/scd.2012.0198; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tesco G, 2000, ANN NY ACAD SCI, V920, P227; Tesco G, 1998, J BIOL CHEM, V273, P33909, DOI 10.1074/jbc.273.51.33909; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010; Wagner SL, 2014, BIOCHEMISTRY-US, V53, P702, DOI 10.1021/bi401537v; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922	33	7	7	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3335	3341		10.1096/fj.15-271015	http://dx.doi.org/10.1096/fj.15-271015			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903103	Green Published			2022-12-28	WOS:000358796900021
J	Kraus, BJ; Sartoretto, JL; Polak, P; Hosooka, T; Shiroto, T; Eskurza, I; Lee, SA; Jiang, HF; Michel, T; Kahn, BB				Kraus, Bettina J.; Sartoretto, Juliano L.; Polak, Pazit; Hosooka, Tetsuya; Shiroto, Takashi; Eskurza, Iratxe; Lee, Seung-Ah; Jiang, Hongfeng; Michel, Thomas; Kahn, Barbara B.			Novel role for retinol-binding protein 4 in the regulation of blood pressure	FASEB JOURNAL			English	Article						angiotensin II; hypertension; obesity; endothelial NO-synthase	CORONARY-HEART-DISEASE; METABOLIC SYNDROME; VITAMIN-A; CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; PLASMA RETINOL; BETA-CAROTENE; MICE	Elevated levels of serum retinol-binding protein 4 (RBP4) contribute to insulin resistance and correlate with increased prevalence of hypertension and myocardial infarction. We sought to determine whether lowering RBP4 would improve blood pressure (BP) and protect against obesity-or angiotensin (Ang)-II-induced hypertension. Systolic and diastolic BP were lower in the RBP4-knockout (RBP4-KO) mice and higher in the RBP4-overexpressing (RBP4-Tg) mice compared with BP in the wild-type (WT) littermates. Carbachol-induced vasodilatation was increased in arteries from the RBP4-KO compared with the WT mice and was impaired in the RBP4-Tg mice. Aortic eNOS(Ser1177) phosphorylation was enhanced similar to 50% in the RBP4-KO mice, with no change in total eNOS protein. Feeding a high-fat diet increased BP in the RBP4-KO mice only to the level in the WT mice fed chow and had no effect on aortic eNOS(Ser1177) phosphorylation. Ang-II infusion resulted in 22 mmHg lower systolic BP in the RBP4-KO than in the WT mice, although the relative BP increase over saline infusion was similar to 30% in both. Ang-II treatment decreased aortic eNOS(Ser1177) phosphorylation in the WT and RBP4-KO mice, but phosphorylation remained higher in the RBP4-KO mice. Cardiac hypertrophy with Ang-II treatment was diminished by 56% in the RBP4-KO mice. Thus, elevated serum RBP4 raises BP and lack of RBP4 reduces it, with commensurate changes in aortic eNOS(Ser1177) phosphorylation. Lowering RBP4 may reduce BP through enhanced eNOS-mediated vasodilatation and may be a novel therapeutic approach for hypertension.	[Kraus, Bettina J.; Polak, Pazit; Hosooka, Tetsuya; Eskurza, Iratxe; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kraus, Bettina J.; Sartoretto, Juliano L.; Polak, Pazit; Hosooka, Tetsuya; Shiroto, Takashi; Eskurza, Iratxe; Michel, Thomas; Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Sartoretto, Juliano L.; Shiroto, Takashi; Michel, Thomas] Brigham & Womens Hosp, Cardiovasc Med Div, Boston, MA 02115 USA; [Lee, Seung-Ah; Jiang, Hongfeng] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Columbia University	Kahn, BB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	jiang, hongfeng/I-6188-2013	Polak, Pazit/0000-0001-8363-0734	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R37DK43051, R24DK83938, P30DK57521]; NIH National Heart, Lung, and Blood Institute [HL46457, HL48743]; German Cardiac Society; MSD Sharp Dohme, GmbH; EMBO long-term fellowship; Manpei Suzuki Diabetes Foundation; Japan Heart Foundation; Uehara Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046457, T32HL007343, P01HL048743, R29HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043051, P30DK057521, R37DK043051, R24DK083938] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Cardiac Society; MSD Sharp Dohme, GmbH; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Manpei Suzuki Diabetes Foundation; Japan Heart Foundation; Uehara Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank William Blaner (Columbia Medical School, New York, NY, USA) for helpful discussions; Odile Peroni, Anna Lee, and Ed Hadro (Beth Israel Deaconess Medical Center, Boston, MA, USA) for technical assistance with mouse breeding, phenotyping, and euthanasia; Anthony Rosenzweig (Beth Israel Deaconess Medical Center) for use of his echo machine; and Pratik Aryal (Beth Israel Deaconess Medical Center) for kindly providing the recombinant RBP4 that was used for cell culture studies. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R37DK43051, R24DK83938, and P30DK57521 (to B.B.K.); NIH National Heart, Lung, and Blood Institute Grants HL46457 and HL48743 (to T.M.); a postdoctoral Bayer fellowship from the German Cardiac Society and a research grant from MSD Sharp & Dohme, GmbH (to B.J.K.); an EMBO long-term fellowship (to P.P.); a research grant from the Manpei Suzuki Diabetes Foundation (to T.H.); and the Japan Heart Foundation and Uehara Medical Foundation (to T.S.). B.B. Kahn is an inventor on a patent related to RBP4 and insulin resistance.	BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bobbert T, 2010, ATHEROSCLEROSIS, V213, P549, DOI 10.1016/j.atherosclerosis.2010.07.063; Brazionis L, 2012, NUTR METAB CARDIOVAS, V22, P914, DOI 10.1016/j.numecd.2011.08.009; Chavarria N, 2012, CIRC J, V76, P2148, DOI 10.1253/circj.CJ-12-0350; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; Dantas APV, 2003, AM J PHYSIOL-HEART C, V284, pH2045, DOI 10.1152/ajpheart.01089.2002; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forstermann U., 2012, EUR HEART J, V33, p837a; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Ingelsson E, 2009, DIABETES CARE, V32, P733, DOI 10.2337/dc08-1656; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lambadiari V, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0121-z; Maier LS, 2008, AM J PHYSIOL-HEART C, V294, pH588, DOI 10.1152/ajpheart.00002.2008; Mallat Z, 2009, J CLIN ENDOCR METAB, V94, P255, DOI 10.1210/jc.2008-0253; Meisinger C, 2011, DIABETES CARE, V34, P1648, DOI 10.2337/dc11-0118; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; NORSEEN J, 1932, MOL CELL BIOL, V4, P2010; Park SE, 2009, ATHEROSCLEROSIS, V204, P23, DOI 10.1016/j.atherosclerosis.2008.08.012; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Rhee EJ, 2012, BBA-MOL CELL BIOL L, V1821, P230, DOI 10.1016/j.bbalip.2011.07.001; Romero JC, 1999, HYPERTENSION, V34, P943, DOI 10.1161/01.HYP.34.4.943; Solini A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-103; Solini A, 2009, AM J HYPERTENS, V22, P1001, DOI 10.1038/ajh.2009.116; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Sun Q, 2013, CIRCULATION, V127, P1938, DOI 10.1161/CIRCULATIONAHA.113.002073; Takebayashi K, 2011, BIOCHEM BIOPH RES CO, V408, P58, DOI 10.1016/j.bbrc.2011.03.116; Tan Y, 2011, BBA-MOL CELL BIOL L, V1811, P1045, DOI 10.1016/j.bbalip.2011.09.011; Tornwall ME, 2004, EUR HEART J, V25, P1171, DOI 10.1016/j.ehj.2004.05.007; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wongsiriroj N, 2014, J LIPID RES, V55, P104, DOI 10.1194/jlr.M043844; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yu X., 2008, 68 SCI SESS M	41	26	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3133	3140		10.1096/fj.14-266064	http://dx.doi.org/10.1096/fj.14-266064			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911613	Green Published			2022-12-28	WOS:000358796900003
J	Steinmann, ME; Gonzalez-Salgado, A; Butikofer, P; Maser, P; Sigel, E				Steinmann, Michael E.; Gonzalez-Salgado, Amaia; Buetikofer, Peter; Maeser, Pascal; Sigel, Erwin			A heteromeric potassium channel involved in the modulation of the plasma membrane potential is essential for the survival of African trypanosomes	FASEB JOURNAL			English	Article						Trypanosoma brucei; electrophysiology; Xenopus laevis oocytes	BLOOD-STREAM FORMS; DRUG-RESISTANCE; GENE-EXPRESSION; SODIUM; BRUCEI; TRANSPORTER; GROWTH; SENSITIVITY; SELECTION; CLONING	Discovery of novel drug targetsmay lead to improved treatment of trypanosomiasis. We characterize here 2 gene products of Trypanosoma brucei that are essential for the growth of bloodstream form (BSF) parasites, as shown by RNA interference (RNAi)-mediated down-regulation of the individual mRNAs. The primary sequences of the 2 proteins-protein encoded by gene Tb927.1.4450 (TbK1) and protein encoded by gene Tb927.9.4820 (TbK2)-indicate that both belong to the family of putative, Ca2+-activated potassium channels. The proteins were expressed in Xenopus laevis oocytes and their functions investigated by use of electrophysiological techniques. Only combined expression of TbK1 and TbK2 results in the formation of sizeable currents, indicating that these proteins probably assemble into a heteromeric ion channel. The current mediated by this channel shows little time and voltage dependence and displays a permeability ratio of K+/Na+ of > 20. The known potassium channel blocker barium inhibits this channel with a half-maximal inhibitory concentration (IC50) of 98 +/- 15 mu M. The membrane potential of trypanosomes was measured with a fluorescent dye. Individual RNAi-mediated downregulation of TbK1 or TbK2 eliminates a potassium conductance in the plasma membrane of BSF. Thus, this heteromeric potassium channel is involved in the modulation of the plasma membrane potential and represents a novel drug target in T. brucei.	[Steinmann, Michael E.; Gonzalez-Salgado, Amaia; Buetikofer, Peter; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Maeser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Maeser, Pascal] Univ Basel, Basel, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	sigel@ibmm.unibe.ch		Maser, Pascal/0000-0003-3122-1941	Swiss National Science Foundation [CRSII3_141913/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. V. Niggli for help with microscopy and carefully reading the manuscript and Dr. J. Gertsch for help with flow cytometry experiments. This work was supported by Sinergia Grant CRSII3_141913/1 from the Swiss National Science Foundation.	Alexander S. P. H., 2008, BRIT J PHARMACOL, V153, pS112, DOI [10.1038/sj.bjp.0707755, DOI 10.1038/SJ.BJP.0707755]; Anene BM, 2001, VET PARASITOL, V96, P83, DOI 10.1016/S0304-4017(00)00427-1; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baur R, 2007, J NEUROCHEM, V103, P2556, DOI 10.1111/j.1471-4159.2007.04982.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Burchmore RJS, 2003, J BIOL CHEM, V278, P23502, DOI 10.1074/jbc.M301252200; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; DefriseQuertain F, 1996, BIOCHEM J, V314, P595, DOI 10.1042/bj3140595; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEE JD, 1975, J EXP BIOL, V63, P381; GEE JD, 1976, J EXP BIOL, V64, P357; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Gonzalez-Salgado A, 2012, J BIOL CHEM, V287, P13313, DOI 10.1074/jbc.M112.344812; Greganova E, 2013, GENOME BIOL EVOL, V5, P1902, DOI 10.1093/gbe/evt134; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; Jimenez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002750; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Legros D, 2002, LANCET INFECT DIS, V2, P437, DOI 10.1016/S1473-3099(02)00321-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maser P, 2003, DRUG RESIST UPDATE, V6, P281, DOI 10.1016/j.drup.2003.09.001; Mosimann M, 2010, EUKARYOT CELL, V9, P539, DOI 10.1128/EC.00314-09; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ortiz D, 2009, MOL BIOCHEM PARASIT, V163, P67, DOI 10.1016/j.molbiopara.2008.09.011; PRATAP PR, 1990, BIOPHYS J, V57, P835, DOI 10.1016/S0006-3495(90)82603-5; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; TETAUD E, 1994, P NATL ACAD SCI USA, V91, P8278, DOI 10.1073/pnas.91.17.8278; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van der Heyden N, 2002, J EUKARYOT MICROBIOL, V49, P407, DOI 10.1111/j.1550-7408.2002.tb00220.x; Van Der Heyden N, 2002, MOL BIOCHEM PARASIT, V120, P127, DOI 10.1016/S0166-6851(01)00444-3; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	49	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3228	3237		10.1096/fj.15-271353	http://dx.doi.org/10.1096/fj.15-271353			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25868728				2022-12-28	WOS:000358796900012
J	Freeman, JJ; Feng, YJ; Demehri, FR; Dempsey, PJ; Teitelbaum, DH				Freeman, Jennifer J.; Feng, Yongjia; Demehri, Farokh R.; Dempsey, Peter J.; Teitelbaum, Daniel H.			TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways	FASEB JOURNAL			English	Article						apoptosis; epidermal growth factor; epithelial cell proliferation; mucosal atrophy; total parenteral nutrition	TOTAL PARENTERAL-NUTRITION; NF-KAPPA-B; MOUSE MODEL; BARRIER FUNCTION; INTRAEPITHELIAL LYMPHOCYTES; NECROTIZING ENTEROCOLITIS; INDUCED APOPTOSIS; EGF RECEPTOR; PROLIFERATION; TRANSACTIVATION	Recent studies suggest a close interaction between epidermal growth factor (EGF) and TLR signaling in the modulation of intestinal epithelial cell (IEC) proliferation; however, how these signaling pathways adjust IEC proliferation is poorly understood. We utilized a model of total parenteral nutrition (TPN), or enteral nutrient deprivation, to study this interaction as TPN results in mucosal atrophy due to decreased IEC proliferation and increased apoptosis. We identified the novel finding of decreased mucosal atrophy in TLR4 knockout (TLR4KO) mice receiving TPN. We hypothesized that EGF signaling is preserved in TLR4KO-TPN mice and prevents mucosal atrophy. C57Bl/6 and strain-matched TLR4KO mice were provided either enteral feeding or TPN. IEC proliferation and apoptosis were measured. Cytokine and growth factor abundances were detected in both groups. To examine interdependence of these pathways, ErbB1 pharmacologic blockade was used. The marked decline in IEC proliferation with TPN was nearly prevented in TLR4KO mice, and intestinal length was partially preserved. EGF was significantly increased, and TNF-alpha decreased in TLR4KO-TPN versus wild-type (WT)TPN mice. Apoptotic positive crypt cells were 15-fold higher in WT-TPN versus TLR4KO-TPN mice. Bcl-2 was significantly increased in TLR4KO-TPN mice, while Bax decreased 10-fold. ErbB1 blockade prevented this otherwise protective effect in TLR4KO-sTPN mice. TLR4 blockade significantly prevented TPN-associated atrophy by preserving proliferation and preventing apoptosis. This is driven by a reduction in TNF-alpha abundance and increased EGF. Potential manipulation of this regulatory pathway may have significant clinical potential to prevent TPN-associated atrophy.	[Freeman, Jennifer J.; Feng, Yongjia; Demehri, Farokh R.; Teitelbaum, Daniel H.] Univ Michigan, Dept Surg, Pediat Surg Sect, Ann Arbor, MI 48109 USA; [Freeman, Jennifer J.; Teitelbaum, Daniel H.] Univ Michigan, Ctr Organogenesis, Ann Arbor, MI 48109 USA; [Dempsey, Peter J.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Teitelbaum, DH (corresponding author), Univ Michigan, Mott Childrens Hosp, Pediat Surg Sect, 1540 E Hosp Dr,SPC 4211, Ann Arbor, MI 48109 USA.	dttlbm@umich.edu		Freeman, Jennifer/0000-0001-9144-2645	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [2R01AI-44076-15]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK093697]; Center for Organogenesis [T32-HD7505]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093697] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Organogenesis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (2R01AI-44076-15), the NIH National Institute of Diabetes and Digestive and Kidney Diseases (5R01DK093697), and the Center for Organogenesis (T32-HD7505). The authors declare no conflicts of interest.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bhattacharyya S, 2008, AM J PHYSIOL-GASTR L, V295, pG784, DOI 10.1152/ajpgi.90434.2008; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Duro D, 2008, J PEDIATR GASTR NUTR, V47, pS33, DOI 10.1097/MPG.0b013e3181819007; Feng YJ, 2013, J PHYSIOL-LONDON, V591, P3709, DOI 10.1113/jphysiol.2013.253518; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Feng YJ, 2010, AM J PHYSIOL-GASTR L, V298, pG833, DOI 10.1152/ajpgi.00030.2010; Feng YJ, 2009, J PHYSIOL-LONDON, V587, P641, DOI 10.1113/jphysiol.2008.162719; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Grossmann J, 1998, AM J PATHOL, V153, P53, DOI 10.1016/S0002-9440(10)65545-9; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; McElroy SJ, 2008, AM J PHYSIOL-GASTR L, V295, pG285, DOI 10.1152/ajpgi.00425.2007; Miyasaka EA, 2013, J IMMUNOL, V190, P6607, DOI 10.4049/jimmunol.1201746; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun XY, 2008, AM J PHYSIOL-GASTR L, V294, pG139, DOI 10.1152/ajpgi.00386.2007; Sun XY, 2006, JPEN-PARENTER ENTER, V30, P474, DOI 10.1177/0148607106030006474; Wildhaber BE, 2002, PEDIATR SURG INT, V18, P570, DOI 10.1007/s00383-002-0869-1; Wildhaber BE, 2003, J SURG RES, V112, P144, DOI 10.1016/S0022-4804(03)00160-4; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yang H, 2003, AM J PHYSIOL-GASTR L, V284, pG629, DOI 10.1152/ajpgi.00290.2002; Yang H, 2002, ANN SURG, V236, P226, DOI 10.1097/00000658-200208000-00011; Yang H, 2008, ANN SURG, V248, P849, DOI 10.1097/SLA.0b013e31818a1522; Yu XY, 2009, GASTROENTEROLOGY, V137, P221, DOI 10.1053/j.gastro.2009.03.060; Zhang CJ, 2009, J NUTR, V139, P1315, DOI 10.3945/jn.108.096669	35	22	23	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2943	2958		10.1096/fj.14-269480	http://dx.doi.org/10.1096/fj.14-269480			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782989	Green Submitted, Green Published			2022-12-28	WOS:000356859100023
J	Krumova, P; Reyniers, L; Meyer, M; Lobbestael, E; Stauffer, D; Gerrits, B; Muller, L; Hoving, S; Kaupmann, K; Voshol, J; Fabbro, D; Bauer, A; Rovelli, G; Taymans, JM; Bouwmeester, T; Baekelandt, V				Krumova, Petranka; Reyniers, Lauran; Meyer, Marc; Lobbestael, Evy; Stauffer, Daniela; Gerrits, Bertran; Muller, Lionel; Hoving, Sjouke; Kaupmann, Klemens; Voshol, Johannes; Fabbro, Doriano; Bauer, Andreas; Rovelli, Giorgio; Taymans, Jean-Marc; Bouwmeester, Tewis; Baekelandt, Veerle			Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate	FASEB JOURNAL			English	Article						cellular signaling; gatekeeper kinase; neuroscience; Parkinson's disease	PARKINSONS-DISEASE; DOMINANT PARKINSONISM; LRRK2 PHOSPHORYLATES; TAU; MUTATIONS; PROTEINS; STABILITY; PATHOGENESIS; INHIBITORS; ISOFORMS	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of autosomal-dominant forms of Parkinson's disease. LRRK2 is a modular, multidomain protein containing 2 enzymatic domains, including a kinase domain, as well as several protein-protein interaction domains, pointing to a role in cellular signaling. Although enormous efforts have been made, the exact pathophysiologic mechanisms of LRRK2 are still not completely known. In this study, we used a chemical genetics approach to identify LRRK2 substrates from mouse brain. This approach allows the identification of substrates of 1 particular kinase in a complex cellular environment. Several of the identified peptides are involved in the regulation of microtubule (MT) dynamics, including microtubule-associating protein (MAP)/microtubule affinity-regulating kinase 1 (MARK1). MARK1 is a serine/threonine kinase known to phosphorylate MT-binding proteins such as Tau, MAP2, and MAP4 at KXGS motifs leading to MT destabilization. In vitro kinase assays and metabolic-labeling experiments in living cells confirmed MARK1 as an LRRK2 substrate. Moreover, we also showed that LRRK2 and MARK1 are interacting in eukaryotic cells. Our findings contribute to the identification of physiologic LRRK2 substrates and point to a potential mechanism explaining the reported effects of LRRK2 on neurite morphology.	[Krumova, Petranka; Meyer, Marc; Stauffer, Daniela; Gerrits, Bertran; Muller, Lionel; Hoving, Sjouke; Kaupmann, Klemens; Voshol, Johannes; Fabbro, Doriano; Bauer, Andreas; Rovelli, Giorgio; Bouwmeester, Tewis] Novartis Inst Biomed Res, Basel, Switzerland; [Reyniers, Lauran; Lobbestael, Evy; Taymans, Jean-Marc; Baekelandt, Veerle] Katholieke Univ KU Leuven, Res Grp Neurobiol & Gene Therapy, Dept Neurosci, Leuven, Belgium	Novartis; KU Leuven	Taymans, JM (corresponding author), Katholieke Univ Leuven, Res Grp Neurobiol & Gene Therapy, Dept Neurosci, Kapucijnenvoer 33 VCTB 5, B-3000 Louvain, Flanders, Belgium.	jean-marc.taymans@inserm.fr; veerle.baekelandt@med.kuleuven.be	Taymans, Jean-Marc/M-9175-2018; Lobbestael, Evy/H-7537-2018; Baekelandt, Veerle/ABB-9736-2020	Taymans, Jean-Marc/0000-0001-5503-5524; Lobbestael, Evy/0000-0002-6417-4670; Baekelandt, Veerle/0000-0001-8966-2921; Kaupmann, Klemens/0000-0001-8903-2508	Fonds Wetenschappelijk Onderzoek-Vlaanderen (Research Foundation-Flanders) [G.0666.09, KAN2012 1.5.216.12]; Agency for Innovation by Science and Technology [SBO/100042]; European Community under the 7th Framework Programme for RTD-Grant [HEALTH-2009-241791]; Fund Druwe-Eerdekens-managed by the King Baudouin Foundation	Fonds Wetenschappelijk Onderzoek-Vlaanderen (Research Foundation-Flanders)(FWO); Agency for Innovation by Science and Technology; European Community under the 7th Framework Programme for RTD-Grant; Fund Druwe-Eerdekens-managed by the King Baudouin Foundation	Cyclin-dependent kinase 2F80A gatekeeper kinase was kindly provided by Yong Chi (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). The authors thank the Leuven Viral Vector Core (http://www.kuleuven.be/molmed/lvvc/vectorproduction.html) for the production of lentiviral vectors. The authors also thank the Fonds Wetenschappelijk Onderzoek-Vlaanderen (Research Foundation-Flanders)-project G.0666.09, research credit KAN2012 1.5.216.12, and fellowships to L.R. and J.-M.T., and the Agency for Innovation by Science and Technology SBO/100042. This study was supported by the European Community under the 7th Framework Programme for RTD-Grant Agreement HEALTH-2009-241791 (European Project on Mendelian Forms of Parkinson's Disease). This research was also supported in part by the Fund Druwe-Eerdekens-managed by the King Baudouin Foundation.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Biernacka JM, 2011, PARKINSONISM RELAT D, V17, P730, DOI 10.1016/j.parkreldis.2011.07.001; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Chen HF, 2012, J MED CHEM, V55, P5536, DOI 10.1021/jm300452p; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Cravatt BF, 2005, NAT METHODS, V2, P411, DOI 10.1038/nmeth0605-411; Dachsel JC, 2010, PARKINSONISM RELAT D, V16, P650, DOI 10.1016/j.parkreldis.2010.08.018; Daniels V, 2011, NEUROSIGNALS, V19, P1, DOI 10.1159/000324488; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Gan-Or Z, 2012, J MOL NEUROSCI, V46, P541, DOI 10.1007/s12031-011-9641-0; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Giordana MT, 2007, MOVEMENT DISORD, V22, P275, DOI 10.1002/mds.21281; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2012, BIOCHEM SOC T, V40, P1058, DOI 10.1042/BST20120054; Herzig MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036581; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; HIRIYANNA KT, 1994, ANAL BIOCHEM, V223, P51, DOI 10.1006/abio.1994.1545; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Law BMH, 2014, J BIOL CHEM, V289, P895, DOI 10.1074/jbc.M113.507913; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lobbestael E, 2012, BIOCHEM SOC T, V40, P1102, DOI 10.1042/BST20120128; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Ohta E, 2011, FEBS LETT, V585, P2165, DOI 10.1016/j.febslet.2011.05.044; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Puschmann A, 2012, PARKINSONISM RELAT D, V18, P332, DOI 10.1016/j.parkreldis.2011.11.019; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Rideout HJ, 2014, NEUROCHEM RES, V39, P576, DOI 10.1007/s11064-013-1073-5; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Schulte C, 2011, APPL CLIN GENET, V4, P67, DOI 10.2147/TACG.S11639; Sengle G, 2000, BIOORGAN MED CHEM, V8, P1317, DOI 10.1016/S0968-0896(00)00080-8; Sepulveda B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061986; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Taymans JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50523; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Tsuboi Yoshio, 2012, Exp Neurobiol, V21, P123, DOI 10.5607/en.2012.21.3.123; Ujiie S, 2012, PARKINSONISM RELAT D, V18, P819, DOI 10.1016/j.parkreldis.2012.03.024; Vancraenenbroeck R, 2011, CNS NEUROL DISORD-DR, V10, P724, DOI 10.2174/187152711797247858; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	68	14	14	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2980	2992		10.1096/fj.14-262329	http://dx.doi.org/10.1096/fj.14-262329			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25854701				2022-12-28	WOS:000356859100026
J	Digiacomo, G; Ziche, M; Dello Sbarba, P; Donnini, S; Rovida, E				Digiacomo, Graziana; Ziche, Marina; Dello Sbarba, Persio; Donnini, Sandra; Rovida, Elisabetta			Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2	FASEB JOURNAL			English	Article						monocytes/macrophages; cytokine receptors; signal transduction; inflammation	DENDRITIC CELLS; GROWTH; ANGIOGENESIS; PROLIFERATION; ENHANCEMENT; MOTILITY; ADHESION; ACID; INOS; EP4	Prostaglandin E2 (PGE2), a key mediator of immunity, inflammation, and cancer, acts through 4 G-protein-coupled E-prostanoid receptors (EPs 1-4). Crosstalk between EPs and receptor tyrosine kinases also occurs. Colony-stimulating factor-1 receptor (CSF-1R) is an RTK that sustains the survival, proliferation, and motility of monocytes/macrophages, which are an essential component of innate immunity and cancer development. The aim of this study was to investigate on a possible crosstalk between EP and CSF-1R. In BAC1.2F5 and RAW264.7 murine macrophages, CSF-1 (EC50 = 18.1 and 10.2 ng/ml, respectively) and PGE2 (EC50 = 1.5 and 5.5 nM, respectively) promoted migration. PGE2 induced rapid CSF-1R phosphorylation that was dependent on Src family kinases (SFKs). CSF-1R inhibition reduced PGE2-elicited ERK1/2 phosphorylation and macrophage migration, indicating that CSF-1R plays a role in PGE2-mediated immunoregulation. EP4 appeared responsible for functional PGE2/CSF-1R crosstalk. Furthermore, PGE2 synergized with CSF-1 in inducing ERK1/2 phosphorylation and macrophage migration. ERK1/2 inhibition completely blocked migration induced by the combination CSF-1/PGE2. CSF-1/PGE2 functional interaction with respect to migration also occurred in bone marrow-derived murine macrophages (EC50 CSF-1, 6.7 ng/ml; EC50 PGE2, 16.7 nM). These results indicated that PGE2 transactivates CSF-1R and synergizes with its signaling at ERK1/2 level in promoting macrophage migration.	[Digiacomo, Graziana; Dello Sbarba, Persio; Rovida, Elisabetta] Univ Florence, Dipartimento Sci Biomed Sperimentali & Clin Mario, I-50134 Florence, Italy; [Digiacomo, Graziana; Ziche, Marina; Dello Sbarba, Persio; Donnini, Sandra; Rovida, Elisabetta] Univ Siena, Dipartimento Sci Vita, I-53100 Siena, Italy; [Ziche, Marina; Donnini, Sandra] Ist Toscano Tumori, Florence, Italy	University of Florence; University of Siena; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Rovida, E (corresponding author), Univ Florence, Dipartimento Sci Biomed Sperimentali & Clin Mario, Sez Patol & Oncol Sperimentali, Viale GB Morgagni 50, I-50134 Florence, Italy.	erovida@unifi.it	Rovida, Elisabetta/F-3565-2015; Donnini, Sandra/K-9252-2019; Dello Sbarba, Persio/AAX-9887-2020	Rovida, Elisabetta/0000-0002-5949-3239; Donnini, Sandra/0000-0001-6617-1644; Ziche, Marina/0000-0002-9564-214X	Associazione Italiana per la Ricerca sul Cancro [IG5220, IG13466, IG15282, IG10731]; Istituto Toscano Tumori; Ministero della Salute (Ricerca Finalizzata) [RF-TOS-2008-1163728]; Regione Toscana (Programma per la Ricerca in Materia di Salute); Fondazione Cassa di Risparmio di Volterra	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori; Ministero della Salute (Ricerca Finalizzata)(Ministry of Health, Italy); Regione Toscana (Programma per la Ricerca in Materia di Salute)(Regione Toscana); Fondazione Cassa di Risparmio di Volterra	The authors are grateful to Dr. Ignazia Tusa for her help in performing the experiments. This work was supported by Associazione Italiana per la Ricerca sul Cancro (Grants IG5220 and IG13466 to P.D.S., IG15282 to E.R., and IG10731 to M.Z.), Istituto Toscano Tumori (to P.D.S. and M.Z.), Ministero della Salute (Ricerca Finalizzata, Grant RF-TOS-2008-1163728, to P.D.S.), Regione Toscana (Programma per la Ricerca in Materia di Salute, to P.D.S.), and Fondazione Cassa di Risparmio di Volterra (to P.D.S.).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alexander LD, 2014, AM J PHYSIOL-RENAL, V307, pF287, DOI 10.1152/ajprenal.00094.2014; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Barbetti V, 2014, ONCOGENE, V33, P4359, DOI 10.1038/onc.2013.542; Barbetti V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.49; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Han C, 2006, J CELL PHYSIOL, V207, P261, DOI 10.1002/jcp.20560; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim JI, 2010, MOL CANCER RES, V8, P569, DOI 10.1158/1541-7786.MCR-09-0511; Korade-Mirnics Z, 2000, J LEUKOCYTE BIOL, V68, P603; Li XL, 2007, ARCH BIOCHEM BIOPHYS, V467, P20, DOI 10.1016/j.abb.2007.08.005; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Majumder M, 2014, CANCER SCI, V105, P1142, DOI 10.1111/cas.12475; Mayoral R, 2005, CARCINOGENESIS, V26, P753, DOI 10.1093/carcin/bgi022; Medeiros A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/327568; Morandi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027450; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; RALPH P, 1977, J IMMUNOL, V119, P950; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Tajima T, 2012, AM J PHYSIOL-GASTR L, V302, pG524, DOI 10.1152/ajpgi.00264.2011; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Zaslona Z, 2012, BLOOD, V119, P2358, DOI 10.1182/blood-2011-08-374207	37	21	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2545	2554		10.1096/fj.14-258939	http://dx.doi.org/10.1096/fj.14-258939			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757564				2022-12-28	WOS:000355209500031
J	Liu, NA; Sun, JY; Kono, K; Horikoshi, Y; Ikura, T; Tong, X; Haraguchi, T; Tashiro, S				Liu, Ning-Ang; Sun, Jiying; Kono, Kazuteru; Horikoshi, Yasunori; Ikura, Tsuyoshi; Tong, Xing; Haraguchi, Tokuko; Tashiro, Satoshi			Regulation of homologous recombinational repair by lamin B1 in radiation-induced DNA damage	FASEB JOURNAL			English	Article						B-type lamins; nuclear envelope; progeria syndrome; RAD51; recombinational DNA repair	STRAND BREAK REPAIR; A-TYPE LAMINS; RAD51 GENE; CELL-CYCLE; DEFECTIVE MATURATION; NUCLEAR LAMINS; EXPRESSION; PROGERIA; PROTEIN; ORGANIZATION	DNA double-strand breaks (DSBs) are the major lethal lesion induced by ionizing radiation (IR). RAD51-dependent homologous recombination (HR) is one of the most important pathways in DSB repair and genome integrity maintenance. However, the mechanism of HR regulation by RAD51 remains unclear. To understand the mechanism of RAD51-dependent HR, we searched for interacting partners of RAD51 by a proteomics analysis and identified lamin B1 in human cells. Lamins are nuclear lamina proteins that play important roles in the structural organization of the nucleus and the regulation of chromosome functions. Immunoblotting analyses revealed that siRNA-mediated lamin B1 depletion repressed the DNA damage-dependent increase of RAD51 after IR. The repression was abolished by the proteasome inhibitor MG132, suggesting that lamin B1 stabilizes RAD51 by preventing proteasome-mediated degradation in cells with IR-induced DNA damage. We also showed that lamin B1 depletion repressed RAD51 focus formation and decreased the survival rates after IR. On the basis of these results, we propose that lamin B1 promotes DSB repair and cell survival by maintaining the RAD51 protein levels for HR upon DSB induction after IR.	[Liu, Ning-Ang; Sun, Jiying; Kono, Kazuteru; Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima, Hiroshima 7348553, Japan; [Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam RcMcD, Hiroshima, Hiroshima 7348553, Japan; [Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Dept Mutagenesis, Lab Chromatin Dynam, Kyoto, Japan; [Tong, Xing] Soochow Univ, Coll Med, Lab Ctr, Suzhou, Peoples R China; [Haraguchi, Tokuko] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo, Japan	Hiroshima University; Hiroshima University; Kyoto University; Soochow University - China; National Institute of Information & Communications Technology (NICT) - Japan	Tashiro, S (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Minami Ku, Kasumi 1-2-3, Hiroshima, Hiroshima 7348553, Japan.	ktashiro@hiroshima-u.ac.jp	Horikoshi, Yasunori/G-8988-2019; Liu, Ning-Ang/GLN-4757-2022		Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank M. Jasin, J. Kobayashi, and K. Komatsu for providing the U2OS-DRGFP cells and are grateful to K. Fujioka for technical assistance with the SCE assay. This work was supported by Grants-in-Aid and the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Atwell S, 2012, NUCLEIC ACIDS RES, V40, P11769, DOI 10.1093/nar/gks1131; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Butin-Israeli V., 2014, MOL CELL BIOL; Butin-Israeli V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069169; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Constantinescu D, 2010, EXP CELL RES, V316, P2747, DOI 10.1016/j.yexcr.2010.05.015; Daboussi F, 2002, CELL SIGNAL, V14, P969, DOI 10.1016/S0898-6568(02)00052-9; De Vos WH, 2010, BBA-GEN SUBJECTS, V1800, P448, DOI 10.1016/j.bbagen.2010.01.002; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dreesen O, 2013, NUCLEUS-AUSTIN, V4, P283, DOI 10.4161/nucl.25808; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Du LQ, 2011, MED ONCOL, V28, P1481, DOI 10.1007/s12032-010-9605-1; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Fojo T, 2001, J NATL CANCER I, V93, P1434, DOI 10.1093/jnci/93.19.1434; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gonzalo S, 2014, ADV EXP MED BIOL, V773, P377, DOI 10.1007/978-1-4899-8032-8_17; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Hosoya N, 2012, EMBO REP, V13, P44, DOI 10.1038/embor.2011.221; Huang S, 2008, EXP CELL RES, V314, P82, DOI 10.1016/j.yexcr.2007.08.004; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kobayashi J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-34; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nishibuchi I, 2014, INT J RADIAT ONCOL, V89, P736, DOI 10.1016/j.ijrobp.2014.03.031; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierce Andrew J, 2005, Methods Mol Biol, V291, P373; Raderschall E, 2002, CANCER RES, V62, P219; Redwood AB, 2011, CELL CYCLE, V10, P3652, DOI 10.4161/cc.10.21.18201; Redwood AB, 2011, CELL CYCLE, V10, P2549, DOI 10.4161/cc.10.15.16531; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; ROBER RA, 1989, DEVELOPMENT, V105, P365; Russell JS, 2003, CANCER RES, V63, P7377; Sakogawa K, 2013, CANCER SCI, V104, P1593, DOI 10.1111/cas.12281; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shi L, 2012, RADIAT RES, V177, P533, DOI 10.1667/RR2849.1; Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yamamoto A, 1996, MOL GEN GENET, V251, P1	69	17	18	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2514	2525		10.1096/fj.14-265546	http://dx.doi.org/10.1096/fj.14-265546			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25733566	Green Submitted			2022-12-28	WOS:000355209500028
J	Stathopoulou, K; Wittig, I; Heidler, J; Piasecki, A; Richter, F; Diering, S; van der Velden, J; Buck, F; Donzelli, S; Schroder, E; Wijnker, PJM; Voigt, N; Dobrev, D; Sadayappan, S; Eschenhagen, T; Carrier, L; Eaton, P; Cuello, F				Stathopoulou, Konstantina; Wittig, Ilka; Heidler, Juliana; Piasecki, Angelika; Richter, Florian; Diering, Simon; van der Velden, Jolanda; Buck, Friedrich; Donzelli, Sonia; Schroder, Ewald; Wijnker, Paul J. M.; Voigt, Niels; Dobrev, Dobromir; Sadayappan, Sakthivel; Eschenhagen, Thomas; Carrier, Lucie; Eaton, Philip; Cuello, Friederike			S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure	FASEB JOURNAL			English	Article						redox proteomics; post-translational modifications; cross-bridge cycling; contractile function; cardiac disease	HYPERTROPHIC CARDIOMYOPATHY; MICROSCALE THERMOPHORESIS; SARCOMERIC PROTEINS; OXIDATIVE STRESS; ACTIVATES SERCA; TROPONIN-I; KINASE-A; CMYBP-C; MYBP-C; PHOSPHORYLATION	Cardiac myosin-binding protein C (cMyBPC) regulates actin-myosin interaction and thereby cardiac myocyte contraction and relaxation. This physiologic function is regulated by cMyBP-C phosphorylation. In our study, reduced site-specific cMyBP-C phosphorylation coincided with increased S-glutathiolation in ventricular tissue from patients with dilated or ischemic cardiomyopathy compared to nonfailing donors. We used redox proteomics, to identify constitutive and disease-specific S-glutathiolation sites in cMyBP-C in donor and patient samples, respectively. Among those, a cysteine cluster in the vicinity of the regulatory phosphorylation sites within the myosin S2 interaction domain C1-M-C2 was identified and showed enhanced S-glutathiolation in patients. In vitro S-glutathiolation of recombinant cMyBP-C C1-M-C2 occurred predominantly at Cys(249), which attenuated phosphorylation by protein kinases. Exposure to glutathione disulfide induced cMyBP-C S-glutathiolation, which functionally decelerated the kinetics of Ca2+-activated force development in ventricular myocytes from wild-type, but not those from Mybpc3-targeted knockout mice. These oxidation events abrogate protein kinase-mediated phosphorylation of cMyBP-C and therefore potentially contribute to the reduction of its phosphorylation and the contractile dysfunction observed in human heart failure.	[Stathopoulou, Konstantina; Piasecki, Angelika; Richter, Florian; Diering, Simon; Donzelli, Sonia; Wijnker, Paul J. M.; Eschenhagen, Thomas; Carrier, Lucie; Cuello, Friederike] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, D-20246 Hamburg, Germany; [Buck, Friedrich] Univ Med Ctr Hamburg Eppendorf, Cent Labs, Dept Clin Chem, D-20246 Hamburg, Germany; [Stathopoulou, Konstantina; Piasecki, Angelika; Diering, Simon; Donzelli, Sonia; Wijnker, Paul J. M.; Eschenhagen, Thomas; Carrier, Lucie; Cuello, Friederike] Partner Site Hamburg Kiel Lubeck, German Ctr Cardiovasc Res DZHK, Frankfurt, Germany; [Wittig, Ilka; Heidler, Juliana; Richter, Florian] Partner Site Rhein Main, Frankfurt, Germany; [Wittig, Ilka; Heidler, Juliana; Richter, Florian] Goethe Univ Frankfurt, Fac Med, Funct Prote, SFB Core Unit 815, D-60054 Frankfurt, Germany; [Wittig, Ilka; Heidler, Juliana; Richter, Florian] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60054 Frankfurt, Germany; [van der Velden, Jolanda; Wijnker, Paul J. M.] VU Univ Med Ctr Amsterdam, Inst Cardiovasc Res ICaR VU, Dept Physiol, Amsterdam, Netherlands; [van der Velden, Jolanda] ICIN, Utrecht, Netherlands; [Schroder, Ewald; Eaton, Philip] Kings Coll London, Kings British Heart Fdn Ctr, London WC2R 2LS, England; [Voigt, Niels; Dobrev, Dobromir] Univ Duisburg Essen, Inst Pharmacol, Fac Med, Essen, Germany; [Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Goethe University Frankfurt; Goethe University Frankfurt; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; King's College London; University of Duisburg Essen; Loyola University Chicago	Cuello, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Martinistr 52, D-20246 Hamburg, Germany.	f.cuello@uke.de	Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/AAS-1666-2020; Stathopoulou, Konstantina/H-5684-2019; Voigt, Niels/AAS-1038-2020; Eaton, Philip/I-5444-2015	Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/0000-0002-4612-117X; Stathopoulou, Konstantina/0000-0002-3746-3055; Voigt, Niels/0000-0001-8230-2341; van der Velden, Jolanda/0000-0001-5224-5788; Eaton, Philip/0000-0003-0748-2367; Sadayappan, Sakthivel/0000-0003-2006-7678	German Center for Cardiovascular Research (DZHK); German Ministry of Research and Education (BMBF); Deutsche Forschungsgemeinschaft (DFG) [CU 53/2-1]; Faculty of Medicine-University medical Center Hamburg-Eppendorf; Werner Otto Foundation; DFG [SFB815]; U.S. National Institutes of Health, National Heart, Lung and Blood Institute [R01HL105826, K02HL114749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL114749, R01HL105826] Funding Source: NIH RePORTER; MRC [G0700320, MR/K003232/1, MR/L009684/1, G1000458, G0600785] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [PG/10/98/28655, RG/12/12/29872, PG/15/26/31373, PG/13/13/30018, FS/11/45/28859] Funding Source: researchfish; Medical Research Council [MR/K003232/1, G0700320, 998501, MR/L009684/1, G0600785, G1000458] Funding Source: researchfish	German Center for Cardiovascular Research (DZHK); German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Faculty of Medicine-University medical Center Hamburg-Eppendorf; Werner Otto Foundation; DFG(German Research Foundation (DFG)); U.S. National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Prof. Dieter Braun and Susanne Seidel (Department of Systems Biophysics Ludwig Maximilian University of Munich, Munich, Germany) for introducing them to MST technology. The authors also thank Jana Meisterknecht (Goethe University, Frankfurt am Main, Germany) for excellent technical assistance with redox proteomics. F.C., K.S., Si. D., A.P., So. D., L.C., T.E. are supported by the German Center for Cardiovascular Research (DZHK) and the German Ministry of Research and Education (BMBF). This study was supported by Deutsche Forschungsgemeinschaft (DFG) Grant CU 53/2-1, the Faculty of Medicine-University medical Center Hamburg-Eppendorf, and the Werner Otto Foundation. I.W. was supported by DFG Grant SFB815, project Z01. S.S. was supported by U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grants R01HL105826 and K02HL114749). The authors declare no conflicts of interest.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Bardswell SC, 2012, J MUSCLE RES CELL M, V33, P53, DOI 10.1007/s10974-011-9276-3; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; BRISTOW M R, 1988, European Heart Journal, V9, P35; Burgoyne JR, 2013, J PHARMACOL TOX MET, V68, P297, DOI 10.1016/j.vascn.2013.07.001; Carrier L, 2004, CARDIOVASC RES, V63, P293, DOI 10.1016/j.cardiores.2004.04.009; Carrier L, 2015, GENE, V573, P188, DOI 10.1016/j.gene.2015.09.008; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Ertl G, 2014, EUR HEART J, V35, P470, DOI 10.1093/eurheartj/eht555; Flenner F, 2016, CARDIOVASC RES, V109, P90, DOI 10.1093/cvr/cvv247; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Hamdani N, 2010, J MUSCLE RES CELL M, V31, P289, DOI 10.1007/s10974-010-9231-8; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Janssen-Heininger YMW, 2013, J CELL BIOCHEM, V114, P1962, DOI 10.1002/jcb.24551; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kuster DWD, 2013, CIRC RES, V112, P633, DOI 10.1161/CIRCRESAHA.112.275602; Kuster DWD, 2012, J MUSCLE RES CELL M, V33, P43, DOI 10.1007/s10974-011-9280-7; Lancel S, 2009, CIRC RES, V104, P720, DOI 10.1161/CIRCRESAHA.108.188441; Lecarpentier Y, 2008, BIOPHYS J, V95, P720, DOI 10.1529/biophysj.107.127787; Lovelock JD, 2012, CIRC RES, V110, P841, DOI 10.1161/CIRCRESAHA.111.258251; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Passarelli C, 2010, CYTOSKELETON, V67, P81, DOI 10.1002/cm.20425; Patel BG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00336; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Steinberg SF, 2013, CIRC RES, V112, P393, DOI 10.1161/CIRCRESAHA.111.300496; Stelzer JE, 2006, CIRC RES, V98, P1212, DOI 10.1161/01.RES.0000219863.94390.ce; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; van Dijk SJ, 2012, CIRC-HEART FAIL, V5, P36, DOI 10.1161/CIRCHEARTFAILURE.111.963702; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wittkopper K, 2011, CARDIOVASC RES, V91, P392, DOI 10.1093/cvr/cvr058; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891	53	21	22	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1849	1864		10.1096/fj.201500048	http://dx.doi.org/10.1096/fj.201500048			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839380	Green Published			2022-12-28	WOS:000374879400015
J	Monickaraj, F; McGuire, PG; Nitta, CF; Ghosh, K; Das, A				Monickaraj, Finny; McGuire, Paul G.; Nitta, Carolina Franco; Ghosh, Kaustabh; Das, Arup			Cathepsin D: an M phi-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy	FASEB JOURNAL			English	Article						Rho/ROCK pathway; inflammation; DME	TIGHT JUNCTION TRAFFICKING; ISCHEMIA-INDUCED CLEAVAGE; II BINDING-SITE; OCCLUDIN PHOSPHORYLATION; 6-PHOSPHATE RECEPTOR; CATALYTIC-ACTIVITY; LYSOSOMAL-ENZYMES; RHO-KINASE; NRK CELLS; IGF-II	Inflammation plays an important role in the pathogenesis of diabetic retinopathy (DR). We have previously reported increased monocyte (Mono) trafficking into the retinas of diabetic animals. In this study, we have examined the effect of activated Monos on retinal endothelial cells (ECs). The U937 M phi-conditioned medium (CM) significantly decreased the transendothelial resistance of EC monolayers as measured by electric cell-substrate impedance sensing (P = 0.007). The CM was fractioned, and the effective fraction (30-100 kDa) was analyzed by liquid chromatography-mass spectrometry, and cathepsin D (CD) was identified as a major secreted product. Immunoprecipitated CD resulted in decreased resistance in ECs (P = 0.006). The specificity of CD in mediating alterations of the EC barrier was confirmed using small interfering RNA. The decreased resistance correlated with a significantly increased gap between ECs. CD altered the Ras homolog gene family, member A/Rho-associated kinase pathway with increased stress actin filament formation in the EC layer. Increased CD levels were found in the retinas of diabetic mice (3-fold) and serum samples of patients with diabetic macular edema (1.6-fold) measured by Western blot and ELISA. These findings suggest an important role for M phi-derived CD in altering the blood-retinal barrier and reveal a potential therapeutic target in the treatment of DR.	[Monickaraj, Finny; Nitta, Carolina Franco; Das, Arup] Univ New Mexico, Sch Med, Dept Surg, MSC 10-5610,1 Univ New Mexico, Albuquerque, NM 87131 USA; [McGuire, Paul G.] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Monickaraj, Finny; Nitta, Carolina Franco; Das, Arup] New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA; [Ghosh, Kaustabh] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of New Mexico; University of New Mexico; University of California System; University of California Riverside	Das, A (corresponding author), Univ New Mexico, Sch Med, Dept Surg, MSC 10-5610,1 Univ New Mexico, Albuquerque, NM 87131 USA.	adas@unm.edu			U.S. National Institutes of Health (NIH) National Eye Institute [RO1 EY022327]; NATIONAL EYE INSTITUTE [R01EY022327] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank the U.S. National Institutes of Health (NIH) National Eye Institute for grant support (RO1 EY022327) and Tamara Howard (NIH) for technical assistance in confocal microscopy and immunofluorescence. The authors declare no conflicts of interest.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Ahmad Jamal, 2012, Foot (Edinb), V22, P194, DOI 10.1016/j.foot.2012.03.015; Aiello LP, 2010, OPHTHALMOLOGY, V117, P946, DOI 10.1016/j.ophtha.2009.10.002; Allgayer H, 1997, CANCER, V80, P179, DOI 10.1002/(SICI)1097-0142(19970715)80:2<179::AID-CNCR2>3.0.CO;2-P; Barouch FC, 2000, INVEST OPHTH VIS SCI, V41, P1153; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; Brouillet JP, 1997, CANCER, V79, P2132, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2132::AID-CNCR10>3.3.CO;2-L; Chen YH, 2012, J PROTEOMICS, V77, P111, DOI 10.1016/j.jprot.2012.07.014; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Cooper JB, 2002, CURR DRUG TARGETS, V3, P155, DOI 10.2174/1389450024605382; Covington MD, 2006, AM J PHYSIOL-RENAL, V290, pF43, DOI 10.1152/ajprenal.00179.2005; Covington MD, 2005, AM J PHYSIOL-RENAL, V289, pF280, DOI 10.1152/ajprenal.00351.2004; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Feron D, 2009, PEPTIDES, V30, P256, DOI 10.1016/j.peptides.2008.11.004; Garmroudi F, 1996, MOL ENDOCRINOL, V10, P642, DOI 10.1210/me.10.6.642; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Glondu M, 2001, ONCOGENE, V20, P6920, DOI 10.1038/sj.onc.1204843; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; KORNFELD S, 1990, BIOCHEM SOC T, V18, P367, DOI 10.1042/bst0180367; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Losch A, 2004, GYNECOL ONCOL, V92, P545, DOI 10.1016/j.ygyno.2003.11.016; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445; Marron-Terada PG, 2000, BIOCHEMISTRY-US, V39, P2243, DOI 10.1021/bi992226o; Masson O, 2010, BIOCHIMIE, V92, P1635, DOI 10.1016/j.biochi.2010.05.009; MATHIEU M, 1990, MOL ENDOCRINOL, V4, P1327, DOI 10.1210/mend-4-9-1327; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Murphy Frank, 2004, Comp Hepatol, V3 Suppl 1, pS8, DOI 10.1186/1476-5926-2-S1-S8; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Noe V, 2001, J CELL SCI, V114, P111; POWELL EDU, 1964, LANCET, V2, P17; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; Rochefort H, 1999, APMIS, V107, P86, DOI 10.1111/j.1699-0463.1999.tb01530.x; Sanchez-Reyes K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/683068; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; SCHRODER S, 1991, AM J PATHOL, V139, P81; Shiba Y, 2013, CURR BIOL, V23, P1945, DOI 10.1016/j.cub.2013.07.087; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	62	15	16	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1670	1682		10.1096/fj.15-279802	http://dx.doi.org/10.1096/fj.15-279802			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26718887	Green Published			2022-12-28	WOS:000372629100027
J	Lavallard, V; Armanet, M; Parnaud, G; Meyer, J; Barbieux, C; Montanari, E; Meier, R; Morel, P; Berney, T; Bosco, D				Lavallard, Vanessa; Armanet, Mathieu; Parnaud, Geraldine; Meyer, Jeremy; Barbieux, Charlotte; Montanari, Elisa; Meier, Raphael; Morel, Philippe; Berney, Thierry; Bosco, Domenico			Cell rearrangement in transplanted human islets	FASEB JOURNAL			English	Article						architecture; vascularization; extracellular matrix	HUMAN PANCREATIC-ISLETS; INDIVIDUAL B-CELLS; HUMAN BETA-CELLS; INSULIN-SECRETION; BASEMENT-MEMBRANE; LANGERHANS; ADHESION; MICE; CA2+; HETEROGENEITY	The major feature of the human pancreatic islet architecture is the organization of endocrine cells into clusters comprising central beta cells and peripheral a cells surrounded by vasculature. To have an insight into the mechanisms that govern this unique islet architecture, islet cells were isolated, and reaggregation of a and b cells into islet-like structures (pseudoislets) after culture or transplantation into mice was studied by immunohistology. The pseudoislets formed in culture displayed an unusual cell arrangement, contrasting with the transplanted pseudoislets, which exhibited a cell arrangement similar to that observed in native pancreatic islet subunits. The pattern of revascularization and the distribution of extracellular matrix around transplanted pseudoislets were alike to those observed in native pancreatic islets. This organization of transplanted pseudoislets occurred also when revascularization was abolished by treating mice with an anti-VEGF antibody, but not when contact with extracellular matrix was prevented by encapsulation of pseudoislets within alginate hydrogel. These results indicate that the maintenance of islet cell arrangement is dependent on in vivo features such as extracellular matrix but independent of vascularization.	[Lavallard, Vanessa; Parnaud, Geraldine; Meyer, Jeremy; Barbieux, Charlotte; Montanari, Elisa; Meier, Raphael; Morel, Philippe; Berney, Thierry; Bosco, Domenico] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Lavallard, Vanessa; Parnaud, Geraldine; Meyer, Jeremy; Barbieux, Charlotte; Montanari, Elisa; Meier, Raphael; Morel, Philippe; Berney, Thierry; Bosco, Domenico] Univ Geneva, Geneva, Switzerland; [Armanet, Mathieu] Hop St Louis, AP HP, Cell Therapy Unit, Paris, France; [Armanet, Mathieu] Univ Paris 07, Paris, France; [Armanet, Mathieu] Ctr Rech Cordeliers, INSERM, Unite Mixte Rech Sci 1138, Paris, France	University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Lavallard, V (corresponding author), Cell Isolat & Transplantat Ctr, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	vanessa.lavallard@unige.ch	Berney, Thierry/ABE-9450-2021; Meier, Raphaël P H/AAR-7882-2021; Meyer, Jeremy/AAP-3367-2020	Berney, Thierry/0000-0002-4230-9378; Meier, Raphaël P H/0000-0001-9050-0436; Bosco, Domenico/0000-0003-3453-9613; Meyer, Jeremy/0000-0003-3381-9146; Lavallard, Vanessa/0000-0001-7328-7549	Swiss National Science Foundation [310030_143462/1]; Insuleman Foundation; Juvenile Diabetes Research Foundation [31-2012-783]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Insuleman Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The authors thank Corinne Sinigaglia, David Matthey-Doret, Caroline Rouget, Solange Masson, and Nadine Pernin for their excellent technical work (Geneva University Hospitals and Department of Surgery, University of Geneva, Geneva, Switzerland). This work was supported by a grant from the Swiss National Science Foundation (310030_143462/1) and a grant from the Insuleman Foundation. Human islets for research were provided thanks to the European Consortium for Islet Transplantation funded by Juvenile Diabetes Research Foundation (31-2012-783). D.B. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. V.L. researched data and wrote the manuscript. J.M. and C.B. reviewed the manuscript. G.P., M.A., E.M., and R.M. researched data. P.M. and T.B. contributed to discussion and reviewed the manuscript. D.B. designed the study, researched data, and reviewed the manuscript. The authors declare no conflicts of interest.	Armanet M, 2009, FASEB J, V23, P4046, DOI 10.1096/fj.08-127142; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bonner-Weir S, 2008, DIABETES, V57, P2899, DOI 10.2337/db07-1842; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; BOSCO D, 1995, AM J PHYSIOL-CELL PH, V268, pC611, DOI 10.1152/ajpcell.1995.268.3.C611; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; CIRULLI V, 1993, J CLIN INVEST, V91, P1868, DOI 10.1172/JCI116403; EMONARD H, 1987, J CELL PHYSIOL, V133, P95, DOI 10.1002/jcp.1041330112; ERLANDSEN SL, 1976, J HISTOCHEM CYTOCHEM, V24, P883, DOI 10.1177/24.7.60437; GRUBE D, 1983, ARCH HISTOL JAPON, V46, P327, DOI 10.1679/aohc.46.327; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HIRIART M, 1991, ENDOCRINOLOGY, V128, P3193, DOI 10.1210/endo-128-6-3193; Hughes SJ, 2006, TRANSPLANTATION, V81, P423, DOI 10.1097/01.tp.0000197482.91227.df; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Koma YI, 2008, GASTROENTEROLOGY, V134, P1544, DOI 10.1053/j.gastro.2008.01.081; Maffi Paola, 2011, Rev Diabet Stud, V8, P44, DOI 10.1900/RDS.2011.8.44; Merani S, 2006, TRANSPLANTATION, V82, P1472, DOI 10.1097/01.tp.0000243166.64244.3d; MONTESANO R, 1983, J CELL BIOL, V97, P935, DOI 10.1083/jcb.97.3.935; Muller YD, 2013, AM J TRANSPLANT, V13, P1093, DOI 10.1111/ajt.12138; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Parnaud G, 2011, ENDOCRINOLOGY, V152, P4601, DOI 10.1210/en.2011-1286; Pedersen MG, 2005, BIOPHYS J, V89, P107, DOI 10.1529/biophysj.104.055681; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Rackham CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057844; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ris F, 2010, CELL TRANSPLANT, V19, P1573, DOI 10.3727/096368910X515863; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; STARICH GH, 1991, ACTA HISTOCHEM, V90, P93, DOI 10.1016/S0065-1281(11)80167-4; Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9; Wojtusciszyn A, 2008, DIABETOLOGIA, V51, P1843, DOI 10.1007/s00125-008-1103-z	39	20	20	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					748	760		10.1096/fj.15-273805	http://dx.doi.org/10.1096/fj.15-273805			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26534832				2022-12-28	WOS:000369391900025
J	Gerstmeier, J; Weinigel, C; Rummler, S; Radmark, O; Werz, O; Garscha, U				Gerstmeier, Jana; Weinigel, Christina; Rummler, Silke; Radmark, Olof; Werz, Oliver; Garscha, Ulrike			Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes	FASEB JOURNAL			English	Article						eicosanoids; proximity-ligation assay; lipoxygenases; inflammation	HUMAN POLYMORPHONUCLEAR LEUKOCYTES; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONIC-ACID; ENZYME-ACTIVITY; BIOSYNTHESIS INHIBITOR; HUMAN NEUTROPHILS; MOLECULAR-BASIS; MEMBRANE; TRANSLOCATION; INACTIVATION	5-Lipoxygenase (5-LO) catalyzes the initial steps in the biosynthesis of proinflammatory leukotrienes. Upon cell activation, 5-LO translocates to the nuclear membrane where arachidonic acid is transferred by 5-LO-activating protein (FLAP) to 5-LO for metabolism. Although previous data indicate association of 5-LO with FLAP, the in situ assembly of native 5-LO/FLAP complexes remains elusive. Here, we show time-resolved 5-LO/FLAP colocalization by immunofluorescence microscopy and in situ 5-LO/FLAP interaction by proximity ligation assay at the nuclearmembrane of Ca2+-ionophoreA23187-activated human monocytes and neutrophils in relation to 5-LO activity. Although 5-LO translocation and product formation is completed within 1.5-3 min, 5-LO/FLAP interaction is delayed and proceeds up to 30 min. Though monocytes and neutrophils contain comparable amounts of 5-LO protein, neutrophils produce 3-5 times higher levels of 5-LO products due to prolonged activity, accompanied by delayed 5-LO nuclear membrane translocation. Arachidonic acid seemingly acts as adaptor for 5-LO/FLAP assembly, whereas FLAP inhibitors (MK886, 100 nM; BAY X 1005, 3 mu M) disrupt the complex. We conclude that FLAP may regulate 5-LO activity in 2 ways: first by inducing an initial flexible association for efficient 5-LO product synthesis, followed by the formation of a tight 5-LO/FLAP complex that terminates 5-LO activity.	[Gerstmeier, Jana; Werz, Oliver; Garscha, Ulrike] Univ Jena, Inst Pharm, Pharmaceut Med Chem, D-07743 Jena, Germany; [Weinigel, Christina; Rummler, Silke] Jena Univ Hosp, Inst Transfus Med, Jena, Germany; [Radmark, Olof] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Karolinska Institutet	Werz, O (corresponding author), Univ Jena, Inst Pharm, Pharmaceut Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	oliver.werz@uni-jena.de; ulrike.garscha@uni-jena.de	Garscha, Ulrike/G-3559-2018	Garscha, Ulrike/0000-0002-3645-7833	Deutsche Forschungsgemeinschaft (DFG) [SFB1127]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Heiner Atze for technical assistance. This work was supported by Deutsche Forschungsgemeinschaft (DFG) within the SFB1127, Chemical Mediators in complex Biosystems (ChemBioSys).	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; AHARONY D, 1987, PROSTAGLANDINS, V33, P85, DOI 10.1016/0090-6980(87)90307-8; Allain EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132607; Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; DeCarolis E, 1996, EUR J BIOCHEM, V235, P416; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; KARGMAN S, 1992, J CELL BIOL, V119, P1701, DOI 10.1083/jcb.119.6.1701; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; LEPLEY RA, 1994, J BIOL CHEM, V269, P2627; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Molina DM, 2008, CURR OPIN STRUC BIOL, V18, P442, DOI 10.1016/j.sbi.2008.04.005; MULLERPEDDINGHAUS R, 1993, J LIPID MEDIATOR, V6, P245; PANOSSIAN A, 1982, FEBS LETT, V150, P511, DOI 10.1016/0014-5793(82)80801-6; Pergola C, 2014, BRIT J PHARMACOL, V171, P3051, DOI 10.1111/bph.12625; Pergola C, 2011, FASEB J, V25, P3377, DOI 10.1096/fj.11-182758; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; POWELL WS, 1984, J BIOL CHEM, V259, P3082; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; ROUZER CA, 1985, P NATL ACAD SCI USA, V82, P6040, DOI 10.1073/pnas.82.18.6040; ROUZER CA, 1988, J BIOL CHEM, V263, P10980; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schaible AM, 2013, PROSTAG LEUKOTR ESS, V89, P245, DOI 10.1016/j.plefa.2013.06.004; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; SHAK S, 1984, J BIOL CHEM, V259, P181; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strid T, 2009, BIOCHEM BIOPH RES CO, V381, P518, DOI 10.1016/j.bbrc.2009.02.074; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; VICKERS PJ, 1992, MOL PHARMACOL, V42, P94; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Werz O, 2003, ADV EXP MED BIOL, V525, P129; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030	48	42	42	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					276	285		10.1096/fj.15-278010	http://dx.doi.org/10.1096/fj.15-278010			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396238				2022-12-28	WOS:000367621000027
J	Nemeth, B; Doczi, J; Csete, D; Kacso, G; Ravasz, D; Adams, D; Kiss, G; Nagy, AM; Horvath, G; Tretter, L; Mocsai, A; Csepanyi-Komi, R; Iordanov, I; Adam-Vizi, V; Chinopoulos, C				Nemeth, Beata; Doczi, Judit; Csete, Daniel; Kacso, Gergely; Ravasz, Dora; Adams, Daniel; Kiss, Gergely; Nagy, Adam M.; Horvath, Gergo; Tretter, Laszlo; Mocsai, Attila; Csepanyi-Koemi, Roland; Iordanov, Iordan; Adam-Vizi, Vera; Chinopoulos, Christos			Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage	FASEB JOURNAL			English	Article						succinate-CoA ligase; cadA; lipopolysaccharide	IMMUNE-RESPONSIVE GENE-1; SUCCINYL-COA SYNTHETASE; ISOCITRATE LYASE; ACTIVATED MACROPHAGES; COENZYME-A; METABOLISM; ATP; PROTEIN; INHIBITION; DEHYDROGENASE	Itaconate is a nonamino organic acid exhibiting antimicrobial effects. It has been recently identified in cells of macrophage lineage as a product of an enzyme encoded by immunoresponsive gene 1 (Irg1), acting on the citric acid cycle intermediate cis-aconitate. In mitochondria, itaconate can be converted by succinate-coenzyme A (CoA) ligase to itaconyl-CoA at the expense of ATP (or GTP), and is also a weak competitive inhibitor of complex II. Here, we investigated specific bioenergetic effects of increased itaconate production mediated by LPS-induced stimulation of Irg1 in murine bone marrow-derived macrophages (BMDM) and RAW-264.7 cells. In rotenone-treatedmacrophage cells, stimulation by LPS led to impairment in substrate-level phosphorylation (SLP) of in situ mitochondria, deduced by a reversal in the directionality of the adenine nucleotide translocase operation. In RAW-264.7 cells, the LPS-induced impairment in SLP was reversed by short-interfering RNA(siRNA)-but not scrambled siRNA-treatment directed against Irg1. LPS dose-dependently inhibited oxygen consumption rates (61-91%) and elevated glycolysis rates (>21%) in BMDM but not RAW-264.7 cells, studied under various metabolic conditions. In isolated mouse liver mitochondria treated with rotenone, itaconate dose-dependently (0.5-2 mM) reversed the operation of adenine nucleotide translocase, implying impairment in SLP, an effect that was partially mimicked by malonate. However, malonate yielded greater ADP-induced depolarizations (3-19%) than itaconate. We postulate that itaconate abolishes SLP due to 1) a "CoA trap" in the form of itaconyl-CoA that negatively affects the upstream supply of succinyl-CoA from the a-ketoglutarate dehydrogenase complex; 2) depletion of ATP (or GTP), which are required for the thioesterification by succinate-CoA ligase; and 3) inhibition of complex II leading to a buildup of succinate which shifts succinate-CoA ligase equilibrium toward ATP (or GTP) utilization. Our results support the notion that Irg1-expressing cells of macrophage lineage lose the capacity of mitochondrial SLP for producing itaconate during mounting of an immune defense.	[Nemeth, Beata; Doczi, Judit; Kacso, Gergely; Ravasz, Dora; Adams, Daniel; Kiss, Gergely; Nagy, Adam M.; Horvath, Gergo; Tretter, Laszlo; Iordanov, Iordan; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary; [Csete, Daniel; Mocsai, Attila; Csepanyi-Koemi, Roland] Semmelweis Univ, Dept Physiol, H-1094 Budapest, Hungary; [Nemeth, Beata; Doczi, Judit; Kacso, Gergely; Ravasz, Dora; Adams, Daniel; Kiss, Gergely; Chinopoulos, Christos] Hungarian Acad Sci, Lendulet Neurobiochem Res Grp, Budapest, Hungary; [Csete, Daniel; Mocsai, Attila] Hungarian Acad Sci, Lendulet Inflammat Physiol Res Grp, Budapest, Hungary; [Nagy, Adam M.; Horvath, Gergo; Tretter, Laszlo; Adam-Vizi, Vera] Hungarian Acad Sci, Neurochem Lab, Budapest, Hungary; [Iordanov, Iordan] Hungarian Acad Sci, Lendulet Ion Channel Res Grp, Budapest, Hungary	Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Academy of Sciences	Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto St 37-47, H-1094 Budapest, Hungary.	chinopoulos.christos@eok.sote.hu	Horvath, Gergo/E-6656-2016; Tretter, Laszlo/ACI-2689-2022; Iordanov, Iordan/O-1892-2019; Csepanyi-Komi, Roland/B-2954-2010	Horvath, Gergo/0000-0001-5386-9509; Iordanov, Iordan/0000-0001-8251-5857; Chinopoulos, Christos/0000-0003-0183-4149; Adam-Vizi, Vera/0000-0002-8350-8701; Csepanyi-Komi, Roland/0000-0001-6825-7142; Kacso, Gergely/0000-0003-0428-3645; Ravasz, Dora/0000-0002-0510-3282	Lendulet program of the Hungarian Academy of Sciences [LP2013-66]; Wellcome Trust [087782]; MTA-SE Lendulet Grant [LP2012-39/2012]; Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) [81983]; Hungarian Academy of Sciences [02001]; Hungarian Brain Research Program [KTIA_13_NAP-A-III/6]; MTA-SE Lendulet Neurobiochemistry Research Division [95003]; OTKA NNF [78905]; OTKA NNF2 [85658]; OTKA K [100918]	Lendulet program of the Hungarian Academy of Sciences; Wellcome Trust(Wellcome TrustEuropean Commission); MTA-SE Lendulet Grant; Orszagos Tudomanyos Kutatasi Alapprogram (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Brain Research Program; MTA-SE Lendulet Neurobiochemistry Research Division; OTKA NNF(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); OTKA NNF2; OTKA K(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The authors thank Dr. Erzsebet Marothy-Toth for helpful discussions and Drs. Karsten Hiller and Thekla Cordes for generously providing the pCMV6-FLAG-Irg1 plasmid. This work was supported by the Lendulet program of the Hungarian Academy of Sciences (LP2013-66) and the Wellcome Trust International Senior Research Fellowship Grant 087782 (to A.M.), the MTA-SE Lendulet Grant LP2012-39/2012 (to Laszlo Csanady), the Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) Grant 81983, the Hungarian Academy of Sciences Grant 02001, the Hungarian Brain Research Program KTIA_13_NAP-A-III/6 (to V.A.-V.), and Grants MTA-SE Lendulet Neurobiochemistry Research Division 95003, OTKA NNF 78905, OTKA NNF2 85658, and OTKA K 100918 (to C.C.).	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; ADLER J, 1957, J BIOL CHEM, V229, P865; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Berg IA, 2002, FEMS MICROBIOL LETT, V216, P49, DOI 10.1111/j.1574-6968.2002.tb11413.x; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BOOTH AN, 1952, J BIOL CHEM, V195, P697; Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Cordes T, 2015, ANNU REV NUTR, V35, P451, DOI 10.1146/annurev-nutr-071714-034243; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; FRANKE W, 1957, LIEBIGS ANN CHEM, V608, P168; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HILLIER S, 1981, J BACTERIOL, V145, P452, DOI 10.1128/JB.145.1.452-458.1981; HILZ H, 1958, BIOCHEM Z, V329, P476; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoentjen F, 2005, BLOOD, V105, P689, DOI 10.1182/blood-2004-04-1309; Hunger-Glaser I, 1999, MOL BIOCHEM PARASIT, V100, P53, DOI 10.1016/S0166-6851(99)00032-8; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss G, 2014, FASEB J, V28, P1682, DOI 10.1096/fj.13-243030; Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kvitvang HFN, 2011, ANAL CHEM, V83, P2705, DOI 10.1021/ac103245b; LABBE RF, 1965, BIOCHIM BIOPHYS ACTA, V111, P403, DOI 10.1016/0304-4165(65)90050-4; Lee Y, 2004, EUR J BIOCHEM, V271, P1094, DOI 10.1111/j.1432-1033.2004.04011.x; Liu Y, 2012, MOL MED REP, V6, P1343, DOI 10.3892/mmr.2012.1072; MCFADDEN BA, 1977, J BACTERIOL, V131, P136, DOI 10.1128/JB.131.1.136-144.1977; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Nolte JC, 2014, APPL ENVIRON MICROB, V80, P166, DOI 10.1128/AEM.03075-13; Okabe M, 2009, APPL MICROBIOL BIOT, V84, P597, DOI 10.1007/s00253-009-2132-3; OTTAWAY JH, 1981, INT J BIOCHEM, V13, P401, DOI 10.1016/0020-711X(81)90111-7; PATEL TR, 1978, EXP PARASITOL, V44, P262, DOI 10.1016/0014-4894(78)90107-8; Riboldi E, 2013, INT IMMUNOL, V25, P67, DOI 10.1093/intimm/dxs110; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sakai A, 2004, NUTRITION, V20, P997, DOI 10.1016/j.nut.2004.08.007; SANADI DR, 1954, BIOCHIM BIOPHYS ACTA, V14, P434, DOI 10.1016/0006-3002(54)90205-X; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steiger MG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00023; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Sugimoto M, 2012, METABOLOMICS, V8, P624, DOI 10.1007/s11306-011-0353-9; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tavakoli S, 2013, J NUCL MED, V54, P1661, DOI 10.2967/jnumed.112.119099; Theodoulou FL, 2014, BIOCHEM SOC T, V42, P1025, DOI 10.1042/BST20140176; Traves PG, 2012, J IMMUNOL, V188, P1402, DOI 10.4049/jimmunol.1101781; Tyler D. D., 1967, METHOD ENZYMOL, V10, P75, DOI DOI 10.1016/0076-6879(67)10014-1; WANG SF, 1961, J BIOL CHEM, V236, P26; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Wibom C, 2010, J PROTEOME RES, V9, P2909, DOI 10.1021/pr901088r; Willke T, 2001, APPL MICROBIOL BIOT, V56, P289, DOI 10.1007/s002530100685; Xaus J, 2000, BLOOD, V95, P3823; Xiao W, 2011, MOL CELL BIOCHEM, V353, P177, DOI 10.1007/s11010-011-0784-7; Xu LY, 2012, AM J PHYSIOL-ENDOC M, V302, pE788, DOI 10.1152/ajpendo.00337.2011; Zeng W, 2015, CANCER LETT, V356, P263, DOI 10.1016/j.canlet.2014.01.032; Zhu LN, 2015, INT REV IMMUNOL, V34, P82, DOI 10.3109/08830185.2014.969421	65	82	82	0	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					286	300		10.1096/fj.15-279398	http://dx.doi.org/10.1096/fj.15-279398			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26358042				2022-12-28	WOS:000367621000028
J	Hornigold, N; Mooney, A				Hornigold, Nick; Mooney, Andrew			Extracellular matrix-induced Hic-5 expression in glomerular mesangial cells leads to a prosclerotic phenotype independent of TGF-beta	FASEB JOURNAL			English	Article						collagen; glomerulosclerosis; scarring	GROWTH-FACTOR-BETA; FOCAL ADHESION PROTEIN; KIDNEY-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; EXPERIMENTAL GLOMERULONEPHRITIS; POSSIBLE INVOLVEMENT; COLLAGEN EXPRESSION; RENAL FIBROSIS; WESTERN BLOTS; LIM PROTEIN	Chronic fibroproliferative diseases account for approximately 45% of all deaths in the developed world. In the kidney, glomerulosclerosis is the underlying pathology in approximately half of patients with renal failure receiving dialysis. Mesangial cell expression of the LIM protein hydrogen peroxide-induced clone-5 (Hic-5) is important in its pathogenesis. Hic-5 expression increases following mesangial cell attachment to collagen I, associated with increased collagen I expression and increased susceptibility to apoptosis both in vitro and in experimental glomerulosclerosis. TGF-beta has an established role in many fibrotic diseases, including glomerulosclerosis, where it increases collagen I deposition in vivo and promotesmesangial cell apoptosis in vitro. Inothercell types, TGF-beta induces Hic-5 expression. We investigated whether Hic-5-induced changes in mesangial cell phenotype were TGF-beta-dependent. Adding exogenous TGF-beta to mesangial cell cultures failed to increase Hic-5 expression; blocking TGF-beta signaling did not reduce Hic-5 expression. However, inducing Hic-5 expression in mesangial cells by adhesion to collagen I led to TGF-beta expression, which was abolished by small interfering RNA (siRNA) Hic-5 knockdown. Mesangial cells expressing Hic-5 showed altered latent TGF-beta-binding protein expression and Smad signaling, with enhanced susceptibility to TGF-beta-induced apoptosis. Mesangial cell attachment to collagen I led to increased Hic-5 expression within 2-4 h and increased procollagen I transcription within 12 h, whereas adding TGF-beta to siRNA Hic-5 knockdown mesangial cells increased procollagen I transcription to a lesser degree after 48 h. Mesangial cell Hic-5 expression was associated with increased alpha-smooth muscle actin and plasminogen activator inhibitor-1 expression. Taken together, these data indicate that there is a prosclerotic feedback loop in mesangial cells dependent on matrix-derived signals in which Hic-5 is a pivotal signaling protein. This feedback loop is TGF-beta-independent. The role of TGF-beta-dependent and -independent sclerotic pathways merit further investigation.	[Hornigold, Nick] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; [Mooney, Andrew] St James Univ Hosp, Renal Unit, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital; University of Leeds; Saint James's University Hospital	Mooney, A (corresponding author), St James Univ Hosp, Renal Unit, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	andrew.mooney2@nhs.net			UK National Kidney Research Fund [R/51/01]; Kidney Research UK [18/2/2005]; Special Trustees of Leeds Teaching Hospitals NHS Trust; Yorkshire Kidney Research Fund	UK National Kidney Research Fund(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK)); Special Trustees of Leeds Teaching Hospitals NHS Trust; Yorkshire Kidney Research Fund	The gift of the RMCs from Dr. Masanori Kitamura (University College London, London, United Kingdom) is gratefully acknowledged. This work was generously supported by the UK National Kidney Research Fund (Grant R/51/01), Kidney Research UK (Grant 18/2/2005), The Special Trustees of Leeds Teaching Hospitals NHS Trust, and the Yorkshire Kidney Research Fund. The authors declare no conflicts of interest.	Akagi Y, 1996, KIDNEY INT, V50, P148, DOI 10.1038/ki.1996.297; BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; BORDER WA, 1995, KIDNEY INT, V47, pS59; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Constam DB, 2014, SEMIN CELL DEV BIOL, V32, P85, DOI 10.1016/j.semcdb.2014.01.008; COUCHMAN JR, 1994, KIDNEY INT, V45, P328, DOI 10.1038/ki.1994.42; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukuda N, 2009, J NEPHROL, V22, P708; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gao ZL, 2005, FEBS LETT, V579, P5651, DOI 10.1016/j.febslet.2005.08.086; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Ghosh R, 2014, EXPERT REV PROTEOMIC, V11, P549, DOI 10.1586/14789450.2014.939635; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Greenhalgh Stephen N, 2013, F1000Prime Rep, V5, P37, DOI 10.12703/P5-37; Guerrero-Santoro J, 2004, J CELL BIOCHEM, V92, P810, DOI 10.1002/jcb.20109; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Hornigold N, 2013, LAB INVEST, V93, P553, DOI 10.1038/labinvest.2013.42; Hornigold N, 2010, KIDNEY INT, V77, P329, DOI 10.1038/ki.2009.417; Hu YH, 1999, P NATL ACAD SCI USA, V96, P10218, DOI 10.1073/pnas.96.18.10218; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Ishino K, 2000, J CELL BIOCHEM, V76, P411, DOI 10.1002/(SICI)1097-4644(20000301)76:3<411::AID-JCB9>3.0.CO;2-J; Jia YF, 2001, J BIOL CHEM, V276, P39911, DOI 10.1074/jbc.M103510200; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Johnson TS, 2007, J AM SOC NEPHROL, V18, P3078, DOI 10.1681/ASN.2006070690; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khera T, 2006, LAB INVEST, V86, P566, DOI 10.1038/labinvest.3700418; Kim-Kaneyama J, 2002, BIOCHEM BIOPH RES CO, V299, P360, DOI 10.1016/S0006-291X(02)02644-X; Kitamura M, 1997, J CLIN INVEST, V100, P1394, DOI 10.1172/JCI119659; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; LOVETT DH, 1986, KIDNEY INT, V30, P246, DOI 10.1038/ki.1986.176; Ma LJ, 2007, SEMIN IMMUNOPATHOL, V29, P385, DOI 10.1007/s00281-007-0087-y; Mollica JP, 2009, ANAL BIOCHEM, V386, P270, DOI 10.1016/j.ab.2008.12.029; Mooney A, 1999, AM J PATHOL, V155, P599, DOI 10.1016/S0002-9440(10)65155-3; Mooney A, 1997, J IMMUNOL, V159, P3949; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Panetti TS, 2004, J THROMB HAEMOST, V2, P1645, DOI 10.1111/j.1538-7836.2004.00902.x; Patel P, 2000, J INVEST MED, V48, P403; Poncelet AC, 1998, AM J PHYSIOL-RENAL, V275, pF458; Savill J, 1996, KIDNEY INT, V49, pS14; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Shibanuma M, 2002, CELL STRUCT FUNCT, V27, P21, DOI 10.1247/csf.27.21; Suga K, 2012, NEPHRON EXP NEPHROL, V120, pE59, DOI 10.1159/000335780; Sugiyama H, 1996, KIDNEY INT, V49, P103, DOI 10.1038/ki.1996.14; Thomas SM, 1999, J CELL SCI, V112, P181; THROCKMORTON DC, 1995, KIDNEY INT, V48, P111, DOI 10.1038/ki.1995.274; Todorovic V, 2012, J CELL BIOCHEM, V113, P410, DOI 10.1002/jcb.23385; Uchida Keiko, 2000, Molecular Cell Biology Research Communications, V4, P98, DOI 10.1006/mcbr.2000.0258; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAMOTO T, 1994, KIDNEY INT, V45, P916, DOI 10.1038/ki.1994.122; Yokoo T, 1997, J IMMUNOL, V159, P2886; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413	69	2	2	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4956	4967		10.1096/fj.14-269894	http://dx.doi.org/10.1096/fj.14-269894			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26405299				2022-12-28	WOS:000365523600021
J	Mathur, R; Das, RP; Ranjan, A; Shaha, C				Mathur, Radhika; Das, Rajeev Patrick; Ranjan, Archana; Shaha, Chandrima			Elevated ergosterol protects Leishmania parasites against antimony-generated stress	FASEB JOURNAL			English	Article						fatty acids; cell death; sterol; reactive oxygen species	FATTY-ACID; DONOVANI PROMASTIGOTES; VISCERAL LEISHMANIASIS; AMPHOTERICIN-B; METABOLISM; APOPTOSIS; INHIBITION; MEMBRANE; CHOLESTEROL; RESISTANCE	Parasite lipids can serve as signaling molecules, important membrane components, energy suppliers, and pathogenesis factors critical for survival. Functional roles of lipid changes in response to drug-generated stress in parasite survival remains unclear. To investigate this, Leishmania donovani parasites, the causative agents of kala-azar, were exposed to the antileishmanial agent potassium antimony tartrate (PAT) (half-maximal inhibitory concentration similar to 284 mu g/ml). Analysis of cell extracts using gas chromatography-mass spectrometry showed significant increases in very long-chain fatty acids (VLCFAs) prior to an increase in ergosterol in PAT-treated parasites as compared with vehicle-treated controls. Ergosterol biosynthesis inhibition during PAT treatment decreased cell viability. VLCFA inhibition with specific inhibitors completely abrogated ergosterol upsurge followed by a reduction in cell viability. Following PAT-induced VLCFA increase, an upsurge in reactive oxygen species (ROS) occurred and inhibition of this ROS with antioxidants abrogated ergosterol increase. Genetically engineered parasites expressing low constitutive ergosterol levels showed more susceptibility to PAT as compared with wild-type control cells but ergosterol supplementation during PAT treatment increased cell viability. In conclusion, we propose that during antimony treatment, the susceptibility of parasites is determined by the levels of cellular ergosterol that are regulated by oxidative stress generated by VLCFAs.	[Mathur, Radhika; Das, Rajeev Patrick; Ranjan, Archana; Shaha, Chandrima] Natl Inst Immunol, Cell Death & Differentiat Res Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Shaha, C (corresponding author), Natl Inst Immunol, Cell Death & Differentiat Res Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	cshaha@nii.ac.in			Department of Biotechnology (New Delhi, India) [DBT.BT/PR11330/BRB/10/651/2008]; Centre for Molecular Medicine (New Delhi, India) [BT/PR14549/MED/14/1291/2010]; Life Science Research Board of Defense Research Development Organization (New Delhi, India) [DLS/81/48222/LSRB-169/1D/2008]; Council of Scientific and Industrial Research (India) [09/485(0219)/2011-EMR-I]	Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India); Centre for Molecular Medicine (New Delhi, India); Life Science Research Board of Defense Research Development Organization (New Delhi, India); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology (New Delhi, India; http://dbtindia.nic.in/index.asp) to the Indian National Institute of Immunology (Grant No. DBT.BT/PR11330/BRB/10/651/2008), Centre for Molecular Medicine (New Delhi, India; Grant BT/PR14549/MED/14/1291/2010), and Life Science Research Board of Defense Research Development Organization (New Delhi, India; Grant DLS/81/48222/LSRB-169/1D/2008). R.M. was supported by a fellowship from the Council of Scientific and Industrial Research (India; Award 09/485(0219)/2011-EMR-I). The authors acknowledge the receipt of the resistant parasite strains from Dr. Syamal Roy and Dr. Chitra Mandal (Indian Institute of Chemical Biology, Kolkata, India). Technical assistance from Mr. G. S. Neelaram is also acknowledged.	Aich A, 2013, MOL CELL BIOL, V33, P4579, DOI 10.1128/MCB.00829-13; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Artwohl M, 2004, FASEB J, V18, P146, DOI 10.1096/fj.03-0301fje; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; Brochu C, 2003, ANTIMICROB AGENTS CH, V47, P3073, DOI 10.1128/AAC.47.10.3073-3079.2003; CHANG KP, 1983, INT REV CYTOL, P267; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; Das M, 2001, J CELL SCI, V114, P2461; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; Falkowski PG, 2006, SCIENCE, V311, P1724, DOI 10.1126/science.1125937; Galea AM, 2009, FREE RADICAL BIO MED, V47, P880, DOI 10.1016/j.freeradbiomed.2009.06.027; Gotz T, 2004, Z NATURFORSCH C, V59, P549; Griebel T, 2010, PLANT J, V63, P254, DOI 10.1111/j.1365-313X.2010.04235.x; Haldar Arun Kumar, 2011, Mol Biol Int, V2011, P571242, DOI 10.4061/2011/571242; Iyer JP, 2008, MOL MICROBIOL, V68, P372, DOI 10.1111/j.1365-2958.2008.06154.x; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; Kanupriya Prasad D, 2007, TOXICOL IN VITRO, V21, P846, DOI DOI 10.1016/J.TIV.2007.02.007; Ko FN, 1997, FREE RADICAL BIO MED, V22, P215, DOI 10.1016/S0891-5849(96)00295-X; Konig J, 2007, FEBS J, V274, P5643, DOI 10.1111/j.1742-4658.2007.06087.x; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Li Y, 2014, INT J CARDIOL, V176, P62, DOI 10.1016/j.ijcard.2014.06.044; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Miliutina N P, 1992, Biull Eksp Biol Med, V113, P474; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Paila YD, 2010, BIOCHEM BIOPH RES CO, V399, P429, DOI 10.1016/j.bbrc.2010.07.099; Perry MR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003518; Pucadyil TJ, 2004, MOL BIOCHEM PARASIT, V133, P145, DOI 10.1016/j.molbiopara.2003.10.002; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Rakotomanga M, 2007, ANTIMICROB AGENTS CH, V51, P1425, DOI 10.1128/AAC.01123-06; Rakotomanga M, 2005, ANTIMICROB AGENTS CH, V49, P2677, DOI 10.1128/AAC.49.7.2677-2686.2005; RAMOS H, 1994, ANTIMICROB AGENTS CH, V38, P1079, DOI 10.1128/AAC.38.5.1079; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P2064, DOI 10.1128/AAC.45.7.2064-2069.2001; Singh N, 2007, PARASITOLOGY, V134, P777, DOI 10.1017/S0031182007002284; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Sundar S, 2006, INDIAN J MED RES, V123, P345; Trenkamp S, 2004, P NATL ACAD SCI USA, V101, P11903, DOI 10.1073/pnas.0404600101; Verma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025273; Widomska J, 2007, BBA-BIOMEMBRANES, V1768, P2635, DOI 10.1016/j.bbamem.2007.06.018; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Yokozawa T, 2000, J AGR FOOD CHEM, V48, P5068, DOI 10.1021/jf000253b; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zhu Y, 2005, NEUROCHEM INT, V46, P127, DOI 10.1016/j.neuint.2004.08.003	48	22	22	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4201	4213		10.1096/fj.15-272757	http://dx.doi.org/10.1096/fj.15-272757			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26116701				2022-12-28	WOS:000361367300010
J	Xie, ZL; Feng, J; Yang, WS; Xiang, F; Yang, F; Zhao, YH; Cao, ZJ; Li, WX; Chen, ZY; Wu, YL				Xie, Zili; Feng, Jing; Yang, Weishan; Xiang, Fang; Yang, Fan; Zhao, Yonghui; Cao, Zhijian; Li, Wenxin; Chen, Zongyun; Wu, Yingliang			Human alpha-defensins are immune-related Kv1.3 channel inhibitors: new support for their roles in adaptive immunity	FASEB JOURNAL			English	Article						HNP1; HD5; potassium channel modifier; immune modulation; interaction mechanism	SEA-ANEMONE TOXIN; POTASSIUM CHANNEL; PEPTIDE; SELECTIVITY; RESIDUES; SHK	Defensins form a major family of antimicrobial peptides. Recently, human beta-defensin 2 and fungal plectasin were shown to be immune-related potassium voltage-gated channel subfamily A member 3 (Kv1.3) channel inhibitors. This work continued to show that the human alpha-defensins human neutrophil peptide (HNP) 1 and human defensin (HD) 5 are selective Kv1.3 channel inhibitors with 50% inhibition concentration values of 102.0 +/- 30.3 nM and 2.2 +/- 0.2 mM, respectively. Furthermore, HNP1 was found to inhibit Kv1.3 currents and IL-2 secretion in human CD3(+) T cells. Despite the structural similarity between HNP1 and HD5, HNP1 could simultaneously bind to the S1-S2 linker and the pore region of the Kv1.3 channel as both a toxinlike blocker and a novel modifier, whereas HD5 could only bind to the channel pore region as a toxinlike blocker. As a channel modifier, HNP1 could shift the conductance-voltage relationship curve of the Kv1.3 channel by similar to 9.5 mV in the positive direction and could increase the time constant for channel activation through the electrostatic repulsion between the cationic HNP1 anchored in the S1-S2 linker and the positively charged S4 domain of the Kv1.3 channel. Together, these findings reveal that human alpha-defensins are novel endogenous inhibitors of Kv1.3 channels with distinct interaction mechanisms, which facilitates future research into their adaptive immune functions.	[Xie, Zili; Feng, Jing; Yang, Weishan; Xiang, Fang; Yang, Fan; Zhao, Yonghui; Cao, Zhijian; Li, Wenxin; Chen, Zongyun; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Ctr BioDrug Res, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Chen, ZY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	chenzy2005@126.com; ylwu@whu.edu.cn	Feng, Jing/C-1729-2018	Feng, Jing/0000-0001-6726-7912	National Natural Sciences Foundation of China [31470812, 31170789]; National Science Fund for Excellent Young Scholars [31422049]; Wuhan University Natural Sciences Foundation [2042015kf0168]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Wuhan University Natural Sciences Foundation	This work was supported by grants from the National Natural Sciences Foundation of China (31470812 and 31170789), National Science Fund for Excellent Young Scholars (31422049), and Wuhan University Natural Sciences Foundation (2042015kf0168).	Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Beisner J, 2014, AM J PHYSIOL-GASTR L, V307, pG487, DOI 10.1152/ajpgi.00347.2013; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chen ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035154; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Chen ZY, 2014, BIOCHEM BIOPH RES CO, V447, P70, DOI 10.1016/j.bbrc.2014.03.101; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Ding J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076038; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Feller M, 2010, CLIN INFECT DIS, V50, P473, DOI 10.1086/649923; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Furci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045208; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Kubo S, 2008, INT J PEPT RES THER, V14, P341, DOI 10.1007/s10989-008-9146-z; Li Z, 2012, J BIOL CHEM, V287, P29479, DOI 10.1074/jbc.M112.379594; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084903; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; PARTISETI M, 1992, J IMMUNOL, V148, P3361; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Xiang F, 2015, TOXINS, V7, P34, DOI 10.3390/toxins7010034; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Zsiros E, 2009, J IMMUNOL, V183, P4483, DOI 10.4049/jimmunol.0803003	28	20	21	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4324	4333		10.1096/fj.15-274787	http://dx.doi.org/10.1096/fj.15-274787			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148969				2022-12-28	WOS:000361367300021
J	Park, HG; Park, WJ; Kothapalli, KSD; Brenna, JT				Park, Hui Gyu; Park, Woo Jung; Kothapalli, Kumar S. D.; Brenna, J. Thomas			The fatty acid desaturase 2 (FADS2) gene product catalyzes Delta 4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells	FASEB JOURNAL			English	Article						metabolism; nutrition; polyunsaturated fatty acids; Delta 6 desaturation	TANDEM MASS-SPECTROMETRY; DOUBLE-BOND LOCALIZATION; ALPHA-LINOLENIC ACID; ACYL-COA OXIDASE; METHYL-ESTERS; FUNCTIONAL-CHARACTERIZATION; NUTRITIONAL REGULATION; PEROXISOMAL DISORDERS; ARACHIDONIC-ACID; RAT-LIVER	Docosahexaenoic acid (DHA) is a Delta 4-desaturated C22 fatty acid and the limiting highly unsaturated fatty acid (HUFA) in neural tissue. The biosynthesis of Delta 4-desaturated docosanoid fatty acids 22:6n-3 and 22:5n-6 are believed to proceed via a circuitous biochemical pathway requiring repeated use of a fatty acid desaturase 2 (FADS2) protein to perform Delta 6 desaturation on C24 fatty acids in the endoplasmic reticulum followed by 1 round of beta-oxidation in the peroxisomes. We demonstrate here that the FADS2 gene product can directly Delta 4-desaturate 22:5n-3-->22:6n-3 (DHA) and 22:4n-6-->22:5n-6. Human MCF-7 cells lacking functional FADS2-mediated Delta 6-desaturase were stably transformed with FADS2, FADS1, or empty vector. When incubated with 22:5n-3 or 22:4n-6, FADS2 stable cells produce 22:6n-3 or 22:5n-6, respectively. Similarly, FADS2 stable cells when incubated with d5-18:3n-3 show synthesis of d5-22:6n-3 with no labeling of 24:5n-3 or 24:6n-3 at 24 h. Further, both C24 fatty acids are shown to be products of the respective C22 fatty acids via elongation. Our results demonstrate that the FADS2 classical transcript mediates direct Delta 4 desaturation to yield 22:6n-3 and 22:5n-6 in human cells, as has been widely shown previously for desaturation by fish and many other organisms.	[Park, Hui Gyu; Park, Woo Jung; Kothapalli, Kumar S. D.; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Brenna, J. Thomas] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Park, Woo Jung] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangwon, South Korea	Cornell University; Cornell University; Kangnung Wonju National University	Brenna, JT (corresponding author), Cornell Univ, Div Nutr Sci, 244 Garden Ave, Ithaca, NY 14853 USA.	ksk25@cornell.edu; jtb4@cornell.edu		Brenna, James Thomas/0000-0001-9494-4245	U.S. National Institutes of Health (NIH) from National Center for Complementary and Integrative Health [R01 AT007003]; Office of Dietary Supplements; National Center for Complementary & Integrative Health [R01AT007003] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) from National Center for Complementary and Integrative Health; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health (NIH) Grant R01 AT007003 from the National Center for Complementary and Integrative Health (formerly the National Center for Complementary and Alternative Medicine) and the Office of Dietary Supplements. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	[Anonymous], 2014, PROTEIN MOL WEIGHT C; BRECKENR.WC, 1971, BRAIN RES, V33, P581, DOI 10.1016/0006-8993(71)90143-0; Brenna JT, 2013, CURR OPIN CLIN NUTR, V16, P548, DOI 10.1097/MCO.0b013e328363bc0a; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Brenna JT, 2002, CURR OPIN CLIN NUTR, V5, P127, DOI 10.1097/00075197-200203000-00002; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Fonseca-Madrigal J, 2014, J LIPID RES, V55, P1408, DOI 10.1194/jlr.M049791; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Gibson RA, 2013, PROSTAG LEUKOTR ESS, V88, P139, DOI 10.1016/j.plefa.2012.04.003; GRAMMATIKOS SI, 1994, BRIT J CANCER, V70, P219, DOI 10.1038/bjc.1994.283; HUGHES S, 1985, BIOCHEM J, V225, P307, DOI 10.1042/bj2250307; Infante JP, 1997, MOL CELL BIOCHEM, V168, P101, DOI 10.1023/A:1006895209833; Infante JP, 2002, MOL GENET METAB, V75, P108, DOI 10.1006/mgme.2001.3279; Infante JP, 1998, FEBS LETT, V431, P1, DOI 10.1016/S0014-5793(98)00720-0; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; JAKOBSSON A, 1990, BIOCHIM BIOPHYS ACTA, V1046, P277, DOI 10.1016/0005-2760(90)90242-P; Kaduce TL, 2008, J NEUROCHEM, V105, P1525, DOI 10.1111/j.1471-4159.2008.05274.x; Kuah MK, 2015, BBA-MOL CELL BIOL L, V1851, P248, DOI 10.1016/j.bbalip.2014.12.012; Lapillonne A, 2013, J PEDIATR-US, V162, pS37, DOI 10.1016/j.jpeds.2012.11.052; Lawrence P, 2006, ANAL CHEM, V78, P1312, DOI 10.1021/ac0516584; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Lin YH, 2005, J LIPID RES, V46, P1962, DOI 10.1194/jlr.M500127-JLR200; MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6; Meyer A, 2003, BIOCHEMISTRY-US, V42, P9779, DOI 10.1021/bi034731y; Michaud AL, 2005, RAPID COMMUN MASS SP, V19, P363, DOI 10.1002/rcm.1797; Michaud AL, 2003, ANAL CHEM, V75, P4925, DOI 10.1021/ac034221+; Michaud AL, 2002, ANAL BIOCHEM, V307, P348, DOI 10.1016/S0003-2697(02)00037-4; Mohammed BS, 1997, BIOCHEM J, V326, P425, DOI 10.1042/bj3260425; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; MOORE SA, 1995, J LIPID RES, V36, P2433; Morais S, 2012, BBA-MOL CELL BIOL L, V1821, P660, DOI 10.1016/j.bbalip.2011.12.011; Morale SE, 2005, EARLY HUM DEV, V81, P197, DOI 10.1016/j.earlhumdev.2004.09.008; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Park WJ, 2012, J LIPID RES, V53, P1502, DOI 10.1194/jlr.M025312; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Park WJ, 2010, MOL BIOL REP, V37, P2403, DOI 10.1007/s11033-009-9750-9; Park WJ, 2009, GENE, V446, P28, DOI 10.1016/j.gene.2009.06.016; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; Qiu X, 2001, J BIOL CHEM, V276, P31561, DOI 10.1074/jbc.M102971200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P1545, DOI 10.1515/bchm2.1970.351.2.1545; STOFFEL W, 1966, NATURWISSENSCHAFTEN, V53, P621, DOI 10.1007/BF00602718; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Su HM, 1998, ANAL BIOCHEM, V261, P43, DOI 10.1006/abio.1998.2706; Su HM, 2001, J BIOL CHEM, V276, P38115; Tonon T, 2003, FEBS LETT, V553, P440, DOI 10.1016/S0014-5793(03)01078-0; Trevizan L, 2012, LIPIDS, V47, P413, DOI 10.1007/s11745-011-3651-0; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Van Pelt CK, 1999, ANAL CHEM, V71, P1981, DOI 10.1021/ac981387f; Van Pelt CK, 1999, J AM SOC MASS SPECTR, V10, P1253; VESLOSADA A, 1995, MOL CELL BIOCHEM, V142, P163, DOI 10.1007/BF00928937; VOSS A, 1991, J BIOL CHEM, V266, P19995; WANG N, 1993, BIOCHEMISTRY-US, V32, P13703, DOI 10.1021/bi00212a040; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zhou YH, 2008, LIPIDS, V43, P525, DOI 10.1007/s11745-008-3186-1	60	94	95	0	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3911	3919		10.1096/fj.15-271783	http://dx.doi.org/10.1096/fj.15-271783			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26065859	Green Published			2022-12-28	WOS:000359915600026
J	Greineder, CF; Brenza, JB; Carnemolla, R; Zaitsev, S; Hood, ED; Pan, DC; Ding, BS; Esmon, CT; Chacko, AM; Muzykantov, VR				Greineder, Colin F.; Brenza, Jacob B.; Carnemolla, Ronald; Zaitsev, Sergei; Hood, Elizabeth D.; Pan, Daniel C.; Ding, Bi-Sen; Esmon, Charles T.; Chacko, Ann Marie; Muzykantov, Vladimir R.			Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect	FASEB JOURNAL			English	Article						drug delivery; PECAM-1; thrombomodulin; EPCR	PROTEIN-C RECEPTOR; SOLUBLE THROMBOMODULIN ART-123; SEVERE SEPSIS; IN-VITRO; ESCHERICHIA-COLI; DRUG-DELIVERY; ACTIVATION; MODEL; COAGULATION; RELEASE	Anchoring pharmacologic agents to the vascular lumen has the potential to modulate critical processes at the blood-tissue interface, avoiding many of the off-target effects of systemically circulating agents. We report a novel strategy for endothelial dual targeting of therapeutics, which both enhances drug delivery and enables targeted agents to partner enzymatically to generate enhanced biologic effect. Based on the recent discovery that paired antibodies directed to adjacent epitopes of platelet endothelial cell adhesion molecule (PECAM)-1 stimulate each other's binding, we fused single-chain fragments (scFv) of paired anti-mouse PECAM-1 antibodies to recombinant murine thrombomodulin (TM) and endothelial protein C receptor (EPCR), endothelial membrane proteins that partner in activation of protein C (PC). scFv/TM and scFv/EPCR bound to mouse endothelial PECAM-1 with high affinity (EC50 1.5 and 3.8 nM, respectively), and codelivery induced a 5-fold increase in PC activation not seen when TM and EPCR are anchored to distinct cell adhesion molecules. In a mouse model of acute lung injury, dual targeting reduces both the expression of lung inflammatory markers and trans-endothelial protein leak by as much as 40%, as compared to either agent alone. These findings provide proof of principle for endothelial dual targeting, an approach with numerous potential biomedical applications.-Greineder, C. F., Brenza, J. B., Carnemolla, R., Zaitsev, S., Hood, E. D., Pan, D. C., Ding, B.-S., Esmon, C. T., Chacko, A. M., Muzykantov, V. R. Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.	[Greineder, Colin F.; Carnemolla, Ronald; Zaitsev, Sergei; Hood, Elizabeth D.; Pan, Daniel C.; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Greineder, Colin F.; Brenza, Jacob B.; Carnemolla, Ronald; Zaitsev, Sergei; Hood, Elizabeth D.; Pan, Daniel C.; Chacko, Ann Marie; Muzykantov, Vladimir R.] Univ Penn, Inst Translat Med & Therapeut, Ctr Targeted Therapeut & Translat Nanomed, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chacko, Ann Marie] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Greineder, Colin F.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Ding, Bi-Sen] Weill Cornell Med Coll, Howard Hughes Med Inst, Dept Med Genet, New York, NY USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Cornell University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Muzykantov, VR (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Translat Res Ctr, Perelman Sch Med, TRC 10-125,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu		Greineder, Colin/0000-0001-9740-7672	Institute of Translational Medicine and Therapeutics at the University of Pennsylvania; American Heart Association Fellow-to-Faculty Grant [10FTF4150053]; U. S. National Institutes of Health Grant from the National Heart, Lung, and Blood Institute [R01-HL091950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091950, P01HL110860, T32HL007915, T32HL007439] Funding Source: NIH RePORTER	Institute of Translational Medicine and Therapeutics at the University of Pennsylvania; American Heart Association Fellow-to-Faculty Grant; U. S. National Institutes of Health Grant from the National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Annunciata Vecchi (Mario Negri Institute of Pharmacology Research, Milan, Italy) for her generous gift of Mec13 hybridoma lysate. This work was supported by a Junior Investigator Preliminary/Feasibility Grant Program grant from the Institute of Translational Medicine and Therapeutics at the University of Pennsylvania (to C.F.G.), as well as an American Heart Association Fellow-to-Faculty Grant 10FTF4150053 (to C.F.G.), and a U. S. National Institutes of Health Grant R01-HL091950 from the National Heart, Lung, and Blood Institute (to V.R.M.).	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Carnemolla R, 2012, J IMMUNOL METHODS, V384, P21, DOI 10.1016/j.jim.2012.06.012; Carnemolla R, 2010, SEMIN THROMB HEMOST, V36, P332, DOI 10.1055/s-0030-1253455; Chacko AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034958; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; DUBEL S, 1994, J IMMUNOL METHODS, V175, P89, DOI 10.1016/0022-1759(94)90334-4; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Greineder CF, 2013, BLOOD, V122, P1565, DOI 10.1182/blood-2013-03-453498; Gu JM, 2000, BLOOD, V95, P1687, DOI 10.1182/blood.V95.5.1687.005k08_1687_1693; Han HS, 2001, J BIOMAT SCI-POLYM E, V12, P1075, DOI 10.1163/15685620152691869; Kador KE, 2011, ACTA BIOMATER, V7, P2508, DOI 10.1016/j.actbio.2011.03.015; Kearon C, 2005, J THROMB HAEMOST, V3, P962, DOI 10.1111/j.1538-7836.2005.01251.x; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; KISHIDA A, 1994, BIOMATERIALS, V15, P848, DOI 10.1016/0142-9612(94)90041-8; Koren E, 2011, IUBMB LIFE, V63, P586, DOI 10.1002/iub.496; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909; Muzykantov VR, 2013, ISRN VASC MED, V2013, DOI [10.1155/2013/916254, DOI 10.1155/2013/916254]; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Opal SM, 2013, AM J RESP CRIT CARE, V187, P1041, DOI 10.1164/rccm.201303-0505ED; REDL H, 1995, J INFECT DIS, V171, P1522, DOI 10.1093/infdis/171.6.1522; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Schouten M, 2014, THROMB HAEMOSTASIS, V111, P970, DOI 10.1160/TH13-10-0859; SOLIS MM, 1991, J VASC SURG, V14, P599; Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Sun J, 2000, J CELL SCI, V113, P1459; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Tseng PY, 2006, BIOMATERIALS, V27, P2768, DOI 10.1016/j.biomaterials.2005.11.032; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038; Zhang HL, 2013, BIOCONJUGATE CHEM, V24, P550, DOI 10.1021/bc300399f	46	22	22	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3483	3492		10.1096/fj.15-271213	http://dx.doi.org/10.1096/fj.15-271213			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25953848	Green Published			2022-12-28	WOS:000358796900034
J	Wege, N; Schutkowski, A; Boenn, M; Bialek, J; Schlitt, A; Noack, F; Grosse, I; Stangl, GI				Wege, Nicole; Schutkowski, Alexandra; Boenn, Markus; Bialek, Joanna; Schlitt, Axel; Noack, Frank; Grosse, Ivo; Stangl, Gabriele I.			Men and women differ in their diurnal expression of monocyte peroxisome proliferator-activated receptor-alpha in the fed but not in the fasted state	FASEB JOURNAL			English	Article						caloric intake; nuclear receptor; circadian pacemaker	PPAR-ALPHA; THERAPEUTIC TARGET; SEXUAL SELECTION; ANGIOGENESIS; INVOLVEMENT; METABOLISM; MUSCLE; CLOCK; MODEL	Peroxisome proliferator-activated receptor-alpha (PPAR alpha) plays a pivotal role in regulating metabolic response to fasting and is an inhibitor of inflammatory pathways in immune cells. It represents a therapeutic target for treatment of several diseases, mainly hyperlipidemia. To shed light on PPAR alpha expression changes in response to fasting, young healthy male and female volunteers were fed or fasted for 24 hours. Monocytes were analyzed every 2 hours to compile both profiles of mRNA and protein expression of PPAR alpha and its interactive partner, the circadian pacemaker brain and muscle aryl hydrocarbon receptor nuclear translocator like-1 (BMAL1). We found that women change their diurnal expression profiles of PPAR alpha and BMAL1 when switching from the fed to the fasted state, whereas men do not. Interestingly, the PPAR alpha and BMAL1 profiles of men and women in the fed state are different, whereas the profiles in the fasted state are virtually identical. The finding of diametrically opposite responses of male and female PPAR alpha expression in the fed state might have practical implication in human medicine as PPAR alpha activators like fibrates are used for the therapy of chronic lymphocytic leukemia, microvascular complications in diabetes, and kidney diseases.	[Wege, Nicole; Schutkowski, Alexandra; Bialek, Joanna; Stangl, Gabriele I.] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06120 Halle, Germany; [Boenn, Markus; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Germany; [Schlitt, Axel; Noack, Frank] Univ Halle Wittenberg, Univ Clin Halle Saale, D-06120 Halle, Germany; [Boenn, Markus] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Schlitt, Axel] Paracelsus Harz Clin Bad Suderode, Quedlinburg, Germany; [Grosse, Ivo] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Stangl, GI (corresponding author), Univ Halle Wittenberg, Human Nutr Grp, Inst Agr & Nutr Sci, Von Danckelmann Pl 2, D-06120 Halle, Germany.	gabriele.stangl@landw.uni-halle.de	Bialek, Joanna/ABD-5772-2020	Bialek, Joanna/0000-0001-9766-6244; Schutkowski, Alexandra/0000-0002-9387-7869				Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3605, DOI 10.1093/nar/gkg517; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; Dunn SE, 2007, J EXP MED, V204, P321, DOI 10.1084/jem.20061839; Erol A, 2007, PPAR RES, V2007, DOI 10.1155/2007/39654; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-81; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V279, pE348, DOI 10.1152/ajpendo.2000.279.2.E348; Jalouli M, 2003, ENDOCRINOLOGY, V144, P101, DOI 10.1210/en.2002-220630; Jun M, 2012, J AM COLL CARDIOL, V60, P2061, DOI 10.1016/j.jacc.2012.07.049; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin C, 2001, BIOCHEM J, V355, P509, DOI 10.1042/0264-6021:3550509; Masternak MM, 2007, PPAR RES, V2007, DOI 10.1155/2007/28436; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Nakamura K, 2008, PPAR RES, V2008, DOI 10.1155/2008/348610; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ringseis R, 2013, BBA-GEN SUBJECTS, V1830, P2105, DOI 10.1016/j.bbagen.2012.09.024; Ruan XZ, 2009, NAT REV NEPHROL, V5, P713, DOI 10.1038/nrneph.2009.184; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Spaner DE, 2013, LEUKEMIA, V27, P1090, DOI 10.1038/leu.2012.329; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Trottier J, 2011, CLIN PHARMACOL THER, V90, P279, DOI 10.1038/clpt.2011.124; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yang Q, 2002, BIOCHEM PHARMACOL, V63, P1893, DOI 10.1016/S0006-2952(02)00923-1; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	41	8	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2905	2911		10.1096/fj.14-267575	http://dx.doi.org/10.1096/fj.14-267575			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25825462				2022-12-28	WOS:000356859100020
J	Yang, Z; Hong, LK; Follett, J; Wabitsch, M; Hamilton, NA; Collins, BM; Bugarcic, A; Teasdale, RD				Yang, Zhe; Hong, Lee Kian; Follett, Jordan; Wabitsch, Martin; Hamilton, Nicholas A.; Collins, Brett M.; Bugarcic, Andrea; Teasdale, Rohan D.			Functional characterization of retromer in GLUT4 storage vesicle formation and adipocyte differentiation	FASEB JOURNAL			English	Article						adipogenesis; endosome; plasma membrane; protein trafficking	INSULIN-RECEPTOR SUBSTRATE-1; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; ADIPOSE DIFFERENTIATION; GLUCOSE TRANSPORTERS; PROTEOMIC ANALYSIS; TRAFFICKING; SORTILIN; CELLS; ASSOCIATION	Insulin-stimulated translocation of glucose transporter 4 (GLUT4) storage vesicles (GSVs), the specialized intracellular compartments within mature adipocytes, to the plasma membrane (PM) is a fundamental cellular process for maintaining glucose homeostasis. Using 2 independent adipocyte cell line models, human primary Simpson-Golabi-Behmel syndrome and mouse 3T3-L1 fibroblast cell lines, we demonstrate that the endosome-associated protein-sorting complex retromer colocalizes with GLUT4 on the GSVs by confocal microscopy in mature adipocytes. By use of both confocal microscopy and differential ultracentrifugation techniques, retromer is redistributed to the PM of mature adipocytes upon insulin stimulation. Furthermore, stable knockdown of the retromer subunit-vacuolar protein-sorting 35, or the retromer-associated protein sorting nexin 27, by lentivirus-delivered small hairpin RNA impaired the adipogenesis process when compared to nonsilence control. The knockdown of retromer decreased peroxisome proliferator activated receptor gamma expression during differentiation, generating adipocytes with decreased levels of GSVs, lipid droplet accumulation, and insulin-stimulated glucose uptake. In conclusion, our study demonstrates a role for retromer in the GSV formation and adipogenesis.	[Yang, Zhe; Hong, Lee Kian; Follett, Jordan; Hamilton, Nicholas A.; Collins, Brett M.; Bugarcic, Andrea; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany	University of Queensland; Ulm University	Teasdale, RD (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.teasdale@uq.edu.au	Teasdale, Rohan D/B-2538-2009; Hamilton, Nicholas A/A-6033-2010; Teasdale, Rohan/AAD-6698-2019; Yang, Zhe/O-3489-2019; Bugarcic, Andrea/AAN-8952-2021; Collins, Brett/J-1563-2014	Teasdale, Rohan D/0000-0001-7455-5269; Hamilton, Nicholas A/0000-0003-0331-3427; Teasdale, Rohan/0000-0001-7455-5269; Yang, Zhe/0000-0002-7987-0855; Collins, Brett/0000-0002-6070-3774; Bugarcic, Andrea/0000-0003-2525-2450	National Health and Medical Research Council of Australia [606788, 1042082]; Australian Research Council Grant [DP120103930]; National Health and Medical Research Council Senior Research Fellowship [APP1041929]; National Health and Medical Research Council Career Development Fellowship [APP1061574]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Grant(Australian Research Council); National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Professors D. James (The University of Sydney, Sydney, NSW, Australia) and J. Whitehead (Mater Research, South Brisbane, QLD, Australia) for supplying reagents and technical advice. This work was supported by National Health and Medical Research Council of Australia Grants 606788 and 1042082 and Australian Research Council Grant DP120103930. R.D.T. is supported by National Health and Medical Research Council Senior Research Fellowship APP1041929, and B.M.C. is supported by National Health and Medical Research Council Career Development Fellowship APP1061574. Microscopy was carried out at the Australian Cancer Research Foundation/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology (Sydney, NSW, Australia). The authors declare no conflicts of interest.	Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bridges D, 2012, CURR TOP MICROBIOL, V362, P61, DOI 10.1007/978-94-007-5025-8_3; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Chen Y, 2009, BIOCHEM J, V422, P229, DOI 10.1042/BJ20090624; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Ghai R, 2015, J CELL SCI, V128, P553, DOI 10.1242/jcs.158204; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; Kim JH, 2005, TOXICOL SCI, V85, P585, DOI 10.1093/toxsci/kfi118; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Langhorst Matthias F., 2009, Biotechnology Journal, V4, P858, DOI 10.1002/biot.200900025; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Ngo S, 2009, MOL CELL ENDOCRINOL, V302, P33, DOI 10.1016/j.mce.2008.10.020; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ralston E, 1996, J CELL SCI, V109, P2967; Rincon E, 2011, J CELL SCI, V124, P776, DOI 10.1242/jcs.072447; Roccisana J, 2013, MOL BIOL CELL, V24, P2389, DOI 10.1091/mbc.E13-01-0011; Ross SA, 1997, BIOCHEM BIOPH RES CO, V239, P247, DOI 10.1006/bbrc.1997.7459; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Spiegelman B M, 1997, Eur J Med Res, V2, P457; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Thomas EC, 2006, INT J BIOCHEM CELL B, V38, P1686, DOI 10.1016/j.biocel.2006.03.009; Tiller G, 2011, INT J OBESITY, V35, P208, DOI 10.1038/ijo.2010.126; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; VOLDSTEDLUND M, 1995, EUR J ENDOCRINOL, V133, P626, DOI 10.1530/eje.0.1330626; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	64	20	20	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1037	1050		10.1096/fj.15-274704	http://dx.doi.org/10.1096/fj.15-274704			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26581601				2022-12-28	WOS:000370387800004
J	Singh, N; Hassan, A; Bose, K				Singh, Nitu; Hassan, Ali; Bose, Kakoli			Molecular basis of death effector domain chain assembly and its role in caspase-8 activation	FASEB JOURNAL			English	Article						FADD; DED chain; apoptosis; activation; hot spot	CRYSTAL-STRUCTURE; HUMAN FADD; PROTEIN; BINDING; MECHANISM; COMPLEX; LIFE; FLIP; MUTATIONS; APOPTOSIS	Assembly of a death-inducing signaling complex is a key event in the extrinsic apoptotic pathway, enabling activation of the caspase cascade and subsequent cell death. However, the molecular events governing DISC assembly have remained largely elusive because of the lack of information on mechanism and specificity regulating the death effector domain (DED)-DED interaction network. Using molecular modeling, mutagenesis, and biochemical and ex vivo experiments, we identified the precise binding interface and hot spots crucial for intermolecular DED chain assembly. Mutation of key interface residues (Leu42/Phe45) in procaspase-8 DED-A completely abrogated DED chain formation in HEK293 cells and prevented its association with FADD. A significant 2.6-3.6-fold reduction in procaspase-8 activation was observed in functional cell-death assays after substitution of the interfacial residues. Based on our results we propose a new model for DISC formation that refines the current understanding of the activation mechanism. Upon stimulation, FADD selfassociates weakly via reciprocal interaction between helices alpha 1/ alpha 4 and alpha 2/alpha 3 of the DED to form an oligomeric signaling platform that provides a stage for the initial recruitment of procaspase-8 through direct interaction with alpha 1/alpha 4 of DED-A, followed by sequential interaction mediated by helices alpha 2/alpha 5 of DED-B, to form the procaspase-8 DED chain that is crucial for its activation and subsequent cell death.-Singh, N., Hassan, A., Bose, K. Molecular basis of death effector domain chain assembly and its role in caspase-8 activation. FASEB J. 30, 186-200 (2016). www.fasebj.org	[Singh, Nitu; Hassan, Ali; Bose, Kakoli] Adv Ctr Treatment Res & Educ Canc, Integrated Biophys & Struct Biol Lab, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Bose, K (corresponding author), Tata Mem Hosp, ACTREC, IBSB Lab, Navi Mumbai 410210, India.	kbose@actrec.gov.in			ACTREC	ACTREC	The authors thank Prof. G. Salvesen (Sanford-Burnham Medical Research Institute, La Jolla, CA, USA) for providing the pcDNA3 caspase-8 wild-type and pET29b FADD constructs, Prof. M. J. Lenardo (U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases) for pEGFP n1 constructs of catalytically inactive caspase-8 and its prodomain, and Dr. D. Bhattacharyya [Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC), Navi Mumbai, India] for the mCherry n1 empty vector. This work was supported by institutional funding from the ACTREC. The authors declare no conflicts of interest.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Ando M, 2013, CANCER SCI, V104, P1002, DOI 10.1111/cas.12191; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barnhart BC, 2003, ONCOGENE, V22, P8634, DOI 10.1038/sj.onc.1207103; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Garvey TL, 2002, J VIROL, V76, P697, DOI 10.1128/JVI.76.2.697-706.2002; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Kasibhatla S., 2006, COLD SPRING HARB PRO, V2006; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavrik IN, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.160; Lavrik IN, 2009, ACTA NATURAE, V1, P80, DOI 10.32607/20758251-2009-1-1-80-83; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Majkut J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4350; Marikar FMMT, 2008, CELL MOL IMMUNOL, V5, P471, DOI 10.1038/cmi.2008.59; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Singh N, 2014, FEBS J, V281, P2456, DOI 10.1111/febs.12799; Soung YH, 2005, CANCER RES, V65, P815; Soung YH, 2005, ONCOGENE, V24, P141, DOI 10.1038/sj.onc.1208244; Thierry F, 2008, CELL DEATH DIFFER, V15, P1356, DOI 10.1038/cdd.2008.53; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Tsukumo S, 1999, GENES CELLS, V4, P541, DOI 10.1046/j.1365-2443.1999.00280.x; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Yuan RT, 2012, APOPTOSIS, V17, P229, DOI 10.1007/s10495-011-0677-y; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	65	14	17	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					186	200		10.1096/fj.15-272997	http://dx.doi.org/10.1096/fj.15-272997			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26370846				2022-12-28	WOS:000367621000020
J	Chang, TT; Spurlock, SM; Candelario, TLT; Grenon, SM; Hughes-Fulford, M				Chang, Tammy T.; Spurlock, Sandra M.; Candelario, Tara Lynne T.; Grenon, S. Marlene; Hughes-Fulford, Millie			Spaceflight impairs antigen-specific tolerance induction in vivo and increases inflammatory cytokines	FASEB JOURNAL			English	Article						inflammation; microgravity; T-cell memory; T-cell tolerance; transgenic model	T-CELL-ACTIVATION; MICROBIAL CHARACTERIZATION; SPACE-STATION; MEMORY CELLS; INTERLEUKIN-2; MICROGRAVITY; EXPRESSION; RESPONSES; RECEPTOR; MICE	The health risks of a dysregulated immune response during spaceflight are important to understand as plans emerge for humans to embark on long-term space travel to Mars. In this first-of-its-kind study, we used adoptive transfer of T-cell receptor transgenic OT-II CD4 T cells to track an in vivo antigen-specific immune response that was induced during the course of spaceflight. Experimental mice destined for spaceflight and mice that remained on the ground received transferred OT-II cells and cognate peptide stimulation with ovalbumin (OVA) 323-339 plus the inflammatory adjuvant, monophosphoryl lipid A. Control mice in both flight and ground cohorts received monophosphoryl lipid A alone without additional OVA stimulation. Numbers of OT-II cells in flight mice treated with OVA were significantly increased by 2-fold compared with ground mice treated with OVA, suggesting that tolerance induction was impaired by spaceflight. Production of proinflammatory cytokines were significantly increased in flight compared with ground mice, including a 5-fold increase in IFN-gamma and a 10-fold increase in IL-17. This study is the first to show that immune tolerance may be impaired in spaceflight, leading to excessive inflammatory responses.	[Chang, Tammy T.; Grenon, S. Marlene] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Hughes-Fulford, Millie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Spurlock, Sandra M.; Candelario, Tara Lynne T.; Hughes-Fulford, Millie] Northern Calif Inst Res & Educ, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northern California Institute for Research & Education	Chang, TT (corresponding author), Univ Calif San Francisco, Dept Surg, 521 Parnassus Ave,C341, San Francisco, CA 94143 USA.	tammy.chang@ucsf.edu		Hughes-Fulford, Millie/0000-0002-0756-068X	U.S. National Aeronautics and Space Administration (NASA) [NNH07ZTT001N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL122446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UH3AG037628] Funding Source: NIH RePORTER	U.S. National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Aeronautics and Space Administration (NASA) Grant NNH07ZTT001N. The authors thank P. M. Dumars for science integration with NASA operations and S. Litherland (Sanford-Burnham Medical Research Institute, Orlando, FL, USA) for providing access their flow cytometer. The authors also thank S. Keating (Blood Systems Research Institute, San Francisco, CA, USA) for excellent technical assistance in processing the multiplex cytokine assays, Q. Tang and A. Abbas for thoughtful scientific feedback, and P. Derish for editorial work.	Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; COGOLI A, 1993, J LEUKOCYTE BIOL, V53, P569, DOI 10.1002/jlb.53.5.569; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Gridley DS, 2006, RADIAT RES, V165, P78, DOI 10.1667/RR3490.1; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hashemi BB, 1999, FASEB J, V13, P2071, DOI 10.1096/fasebj.13.14.2071; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; Mehta SK, 2014, BRAIN BEHAV IMMUN, V41, P210, DOI 10.1016/j.bbi.2014.05.014; Naidu S, 1995, J Gravit Physiol, V2, pP140; Ott CM, 2004, MICROBIAL ECOL, V47, P133, DOI 10.1007/s00248-003-1038-3; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stowe RP, 2008, AVIAT SPACE ENVIR MD, V79, P117, DOI 10.3357/ASEM.2205.2008; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129; Walther I, 1998, FEBS LETT, V436, P115, DOI 10.1016/S0014-5793(98)01107-7; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329	35	20	20	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4122	4132		10.1096/fj.15-275073	http://dx.doi.org/10.1096/fj.15-275073			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26085131	Green Published			2022-12-28	WOS:000361367300004
J	Benesch, MGK; Tang, XY; Dewald, J; Dong, WF; Mackey, JR; Hemmings, DG; McMullen, TPW; Brindley, DN				Benesch, Matthew G. K.; Tang, Xiaoyun; Dewald, Jay; Dong, Wei-Feng; Mackey, John R.; Hemmings, Denise G.; McMullen, Todd P. W.; Brindley, David N.			Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression	FASEB JOURNAL			English	Article						chemokines; cytokines; lysophosphatidate; syngeneic mouse model; tumor stroma	LPA AXIS; IN-VIVO; RESISTANCE; LYSOPHOSPHATIDATE; DIFFERENTIATION; PROMOTES; INHIBITION; RECEPTOR; BINDING; OBESITY	Compared to normal tissues, many cancer cells overexpress autotaxin (ATX). This secreted enzyme produces extracellular lysophosphatidate, which signals through 6 GPCRs to drive cancer progression. Our previous work showed that ATX inhibition decreases 4T1 breast tumor growth in BALB/c mice by 60% for about 11 d. However, 4T1 cells do not produce significant ATX. Instead, the ATX is produced by adjacent mammary adipose tissue. We investigated the molecular basis of this interaction in human and mouse breast tumors. Inflammatory mediators secreted by breast cancer cells increased ATX production in adipose tissue. The increased lysophosphatidate signaling further increased inflammatory mediator production in adipose tissue and tumors. Blocking ATX activity in mice bearing 4T1 tumors with 10 mg/kg/d ONO-8430506 (a competitive ATX inhibitor, IC90 = 100 nM; Ono Pharma Co., Ltd., Osaka, Japan) broke this vicious inflammatory cycle by decreasing 20 inflammatory mediators by 1.5-8-fold in cancer-inflamed adipose tissue. There was no significant decrease in inflammatory mediator levels in fat pads that did not bear tumors. ONO-8430506 also decreased plasma TNF-alpha and G-CSF cytokine levels by >70% and leukocyte infiltration in breast tumors and adjacent adipose tissue by >50%. Hence, blocking tumor-driven inflammation by ATX inhibition is effective in decreasing tumor growth in breast cancers where the cancer cells express negligible ATX.	[Benesch, Matthew G. K.; Tang, Xiaoyun; Dewald, Jay; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada; [Dong, Wei-Feng] Univ Alberta, Dept Lab Med, Edmonton, AB T6G 2S2, Canada; [Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2S2, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB T6G 2S2, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [McMullen, Todd P. W.] Univ Alberta, Dept Surg, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, 357 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Benesch, Matthew/0000-0002-1326-684X	Vanier Canada Graduate Scholarship (Government of Canada); Canadian Institutes of Health Research (CIHR); Alberta Innovates-Health Solutions; Killam Trust Award; Canadian Breast Cancer Foundation (CBCF); CBCF; Women and Children's Health Research Institute of the University of Alberta; Ono Pharma, Ltd.	Vanier Canada Graduate Scholarship (Government of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Killam Trust Award; Canadian Breast Cancer Foundation (CBCF); CBCF; Women and Children's Health Research Institute of the University of Alberta(University of Alberta); Ono Pharma, Ltd.	The authors thank the University of Alberta Department of Oncology Cell Imaging Facility and Alberta Diabetes Institute HistoCore for assistance. M.G.K.B. received a Vanier Canada Graduate Scholarship (Government of Canada), a Canadian Institutes of Health Research (CIHR) M.D./Ph.D. Studentship, an M.D./Ph.D. Studentship from Alberta Innovates-Health Solutions, and a Killam Trust Award. X.T. held a research fellowship from the Canadian Breast Cancer Foundation (CBCF). The work was supported by grants from CBCF and the Women and Children's Health Research Institute of the University of Alberta and by Ono Pharma, Ltd. D.N.B. and T.P.W.M. have received consulting fees from Ono Pharma, Ltd. The other authors declare no conflicts of interest.	Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Bekele RT, 2012, CLIN LIPIDOL, V7, P313, DOI 10.2217/CLP.12.30; Benesch MGK, 2015, ENDOCR-RELAT CANCER, V22, P593, DOI 10.1530/ERC-15-0045; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Bernardi M, 2014, J CLIN EXP HEPATOL, V4, P302, DOI 10.1016/j.jceh.2014.08.007; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Brindley D. N., 2015, MELANOMA CURRENT CLI, P297, DOI [10.5772/59013, DOI 10.5772/59013]; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Brown KA, 2014, J MAMMARY GLAND BIOL, V19, P183, DOI 10.1007/s10911-014-9321-0; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Euer N, 2002, ANTICANCER RES, V22, P733; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Germain DR, 2011, BREAST CANCER RES TR, V127, P53, DOI 10.1007/s10549-010-0943-7; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Houben AJS, 2013, J BIOL CHEM, V288, P510, DOI 10.1074/jbc.M112.358416; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; Ikeda H, 2012, CLIN CHIM ACTA, V413, P1817, DOI 10.1016/j.cca.2012.07.014; Jankowski Maciej, 2011, Enzyme Res, V2011, P194857, DOI 10.4061/2011/194857; Kawalec P, 2015, CLIN BREAST CANCER, V15, P90, DOI 10.1016/j.clbc.2014.10.006; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Lai SL, 2012, DEVELOPMENT, V139, P4439, DOI 10.1242/dev.081745; Lawlor KE, 2004, P NATL ACAD SCI USA, V101, P11398, DOI 10.1073/pnas.0404328101; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Popnikolov NK, 2012, TUMOR BIOL, V33, P2237, DOI 10.1007/s13277-012-0485-1; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; Samadi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020608; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tang N, 2014, J CELL MOL MED, V18, P156, DOI 10.1111/jcmm.12178; Teo K, 2014, BIOCHEM J, V463, P157, DOI 10.1042/BJ20140680; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Venkatraman G, 2015, FASEB J, V29, P772, DOI 10.1096/fj.14-262659; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; Yuelling LW, 2012, GLIA, V60, P1605, DOI 10.1002/glia.22381; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhang JD, 2012, J PATHOL, V228, P241, DOI 10.1002/path.4069; Zhang RH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-11; Zhao CQ, 2011, J LIPID RES, V52, P1307, DOI 10.1194/jlr.M008045	66	71	72	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3990	4000		10.1096/fj.15-274480	http://dx.doi.org/10.1096/fj.15-274480			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26071407				2022-12-28	WOS:000359915600033
J	Jerkic, M; Letarte, M				Jerkic, Mirjana; Letarte, Michelle			Increased endothelial cell permeability in endoglin-deficient cells	FASEB JOURNAL			English	Article						RhoA; TGF-beta 1; VEGF; TSP-1	HEREDITARY HEMORRHAGIC TELANGIECTASIA; ATRIAL-NATRIURETIC-PEPTIDE; VASCULAR-PERMEABILITY; TYROSINE PHOSPHORYLATION; PARACELLULAR PATHWAY; BETA RECEPTOR; MURINE MODEL; VE-CADHERIN; KINASE; GROWTH	Endoglin (ENG) is a TGF-beta superfamily coreceptor essential for vascular endothelium integrity. ENG mutations lead to a vascular dysplasia associated with frequent hemorrhages in multiple organs, whereas ENG null mouse embryos die at midgestation with impaired heart development and leaky vasculature. ENG interacts with several proteins involved in cell adhesion, and we postulated that it regulates vascular permeability. The current study assessed the permeability of ENG homozygous null (Eng(-/-)), heterozygous (Eng(+/-)), and normal (Eng(+/+)) mouse embryonic endothelial cell (EC) lines. Permeability, measured by passage of fluorescent dextran through EC monolayers, was increased 2.9- and 1.7-fold for Eng(-/-) and Eng(+/-) ECs, respectively, compared to control ECs and was not increased by TGF-beta 1 or VEGF. Prolonged starvation increased Eng(-/-) EC permeability by 3.7-fold with no effect on control ECs; neutrophils transmigrated faster through Eng(-/-) than Eng(+/+) monolayers. Using a pull-down assay, we demonstrate that Ras homolog gene family (Rho) A is constitutively active in Eng(-/-) and Eng(+/-) ECs. We show that the endothelial barrier destabilizing factor thrombospondin-1 and its receptor-like protein tyrosine phosphatase are increased, whereas stabilizing factors VEGF receptor 2, vascular endothelial-cadherin, p21-activated kinase, and Ras-related C3 botulinum toxin substrate 2 are decreased in Eng(-/-) cells. Our findings indicate that ENG deficiency leads to EC hyper-permeability through constitutive activation of RhoA and destabilization of endothelial barrier function.	[Jerkic, Mirjana; Letarte, Michelle] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Jerkic, Mirjana; Letarte, Michelle] Univ Toronto, St Michaels Hosp, Dept Immunol, Toronto, ON M5B 1T8, Canada; [Jerkic, Mirjana] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Anesthesia Res, Toronto, ON M5B 1T8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Jerkic, M (corresponding author), Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Anesthesia Res, 209 Victoria St,Lab 653, Toronto, ON M5B 1T8, Canada.	jerkicm@smh.ca			Heart and Stroke Foundation of Canada [T5598]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors thank Albert Zhe Liang and Zobia Jawed for help with experiments. Special thanks are due to Dr. Katalin Szaszi for helpful discussion about design of the permeability experiments. M.J. made significant contributions to the concept and design of the experiments and was involved in acquisition of the data, their analysis, and interpretation. She has been critically involved in drafting and revising the manuscript for important intellectual content. M.L. made significant contributions to the concept of the experiments and was critically involved in data analysis and interpretation. She has been involved in drafting and especially revising the manuscript for important intellectual content. Both authors have given final approval of the submitted version of the manuscript and agreed to be accountable for all aspects of the work. This work was supported by Grant T5598 from the Heart and Stroke Foundation of Canada (to M.L.). The authors declare no conflicts of interest.	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Ardelean DS, 2014, ANGIOGENESIS, V17, P129, DOI 10.1007/s10456-013-9383-4; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bei Y, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.105; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Bourdeau A, 2000, AM J PATHOL, V156, P911, DOI 10.1016/S0002-9440(10)64960-7; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Duong-Quy S, 2013, PHARMACOL THERAPEUT, V137, P352, DOI 10.1016/j.pharmthera.2012.12.003; Dupuis-Girod S, 2007, CLIN INFECT DIS, V44, P841, DOI 10.1086/511645; Garg P, 2011, AM J PHYSIOL-LUNG C, V301, pL79, DOI 10.1152/ajplung.00287.2010; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Gregory AL, 2014, PLACENTA, V35, pS93, DOI 10.1016/j.placenta.2013.10.020; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hordijk PL, 1999, J CELL SCI, V112, P1915; Hornburger MC, 2014, FASEB J, V28, P1938, DOI 10.1096/fj.13-235754; Jerkic M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/686972; Karabegovic A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022079; Kim MH, 2009, AM J PHYSIOL-CELL PH, V296, pC848, DOI 10.1152/ajpcell.00520.2008; Kondrikov D, 2011, FREE RADICAL BIO MED, V50, P1689, DOI 10.1016/j.freeradbiomed.2011.03.020; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Liu A, 2009, MICROVASC RES, V77, P13, DOI 10.1016/j.mvr.2008.08.008; Maharjan S, 2013, BIOCHEM BIOPH RES CO, V435, P420, DOI 10.1016/j.bbrc.2013.04.104; Mathis S, 2012, CLIN NEUROL NEUROSUR, V114, P235, DOI 10.1016/j.clineuro.2011.10.036; Meng Y, 2015, ANTIOXID REDOX SIGN, V22, P241, DOI 10.1089/ars.2013.5818; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Peter MR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/767185; Qin HY, 2013, CELL STEM CELL, V13, P577, DOI 10.1016/j.stem.2013.08.010; Rossi E, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00457; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Rudini N, 2008, EMBO J, V27, P993, DOI 10.1038/emboj.2008.46; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Seghers L, 2012, J CELL MOL MED, V16, P2440, DOI 10.1111/j.1582-4934.2012.01561.x; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Souchet M, 2002, J CELL SCI, V115, P629; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Takahashi K, 2012, P NATL ACAD SCI USA, V109, P1985, DOI 10.1073/pnas.1106171109; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tong L, 2014, BIOSCIENCE REP, V34, P283, DOI 10.1042/BSR20140021; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Toporsian M, 2010, ARTERIOSCL THROM VAS, V30, P509, DOI 10.1161/ATVBAHA.109.200121; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Varon C, 2006, EXP CELL RES, V312, P3604, DOI 10.1016/j.yexcr.2006.08.006; Xu GX, 2014, MOL CELL PROTEOMICS, V13, P489, DOI 10.1074/mcp.M113.033464; Yuan SY, 2012, MICROVASC RES, V83, P82, DOI 10.1016/j.mvr.2011.06.015	60	24	24	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3678	3688		10.1096/fj.14-269258	http://dx.doi.org/10.1096/fj.14-269258			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25972355				2022-12-28	WOS:000359915600007
J	Palekar, RU; Jallouk, AP; Goette, MJ; Chen, JJ; Myerson, JW; Allen, JS; Akk, A; Yang, LH; Tu, YZ; Miller, MJ; Pham, CTN; Wickline, SA; Pan, H				Palekar, Rohun U.; Jallouk, Andrew P.; Goette, Matthew J.; Chen, Junjie; Myerson, Jacob W.; Allen, John S.; Akk, Antonina; Yang, Lihua; Tu, Yizheng; Miller, Mark J.; Pham, Christine T. N.; Wickline, Samuel A.; Pan, Hua			Quantifying progression and regression of thrombotic risk in experimental atherosclerosis	FASEB JOURNAL			English	Article						nanoparticles; endothelium; thrombosis; MRI	CIRCULATING ENDOTHELIAL-CELLS; EVANS-BLUE UPTAKE; PERMEABILITY; DYSFUNCTION; MORPHOLOGY; ANGIOGENESIS; AREAS; AORTA	Currently, there are no generally applicable noninvasive methods for defining the relationship between atherosclerotic vascular damage and risk of focal thrombosis. Herein, we demonstrate methods to delineate the progression and regression of vascular damage in response to an atherogenic diet by quantifying the in vivo accumulation of semipermeable 200-300 nm perfluorocarbon core nanoparticles (PFC-NP) in ApoE null mouse plaques with [F-19] magnetic resonance spectroscopy (MRS). Permeability to PFC-NP remained minimal until 12 weeks on diet, then increased rapidly following 12 weeks, but regressed to baseline within 8 weeks after diet normalization. Markedly accelerated clotting (53.3% decrease in clotting time) was observed in carotid artery preparations of fat-fed mice subjected to photochemical injury as defined by the time to flow cessation. For all mice on and off diet, an inverse linear relationship was observed between the permeability to PFC-NP and accelerated thrombosis (P = 0.02). Translational feasibility for quantifying plaque permeability and vascular damage in vivo was demonstrated with clinical 3 T MRI of PFC-NP accumulating in plaques of atherosclerotic rabbits. These observations suggest that excessive permeability to PFC-NPmay indicate prothrombotic risk in damaged atherosclerotic vasculature, which resolves within weeks after dietary wtherapy.	[Palekar, Rohun U.; Goette, Matthew J.; Myerson, Jacob W.; Wickline, Samuel A.] Washington Univ, Dept Biomed Engn, St Louis, MO 63108 USA; [Jallouk, Andrew P.; Chen, Junjie; Allen, John S.; Akk, Antonina; Yang, Lihua; Tu, Yizheng; Miller, Mark J.; Pham, Christine T. N.; Wickline, Samuel A.; Pan, Hua] Washington Univ, Dept Med, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Wickline, SA (corresponding author), Washington Univ, Ctr Translat Res Adv Imaging & Nanomed C TRAIN, Campus Box 8215,4320 Forest Pk Ave, St Louis, MO 63108 USA.	wicklines@aol.com; hpan@dom.wustl.edu	Pan, Hua/C-7662-2011		U.S. National Institutes of Healthn (National Heart, Lung, and Blood Institute) [HL073646, HL112303]; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK095555]; U.S. National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [AR056223]; James R. Hornsby Family Dream Garden Investment Partnership; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, R01HL073646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056223, R01AR067491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK095555, R01DK102691] Funding Source: NIH RePORTER	U.S. National Institutes of Healthn (National Heart, Lung, and Blood Institute); U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); James R. Hornsby Family Dream Garden Investment Partnership; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Todd A. Williams for MRI assistance; Mike Scott, Xiaoxia Yang, and Chandu Vemuri for animal experiment and NP formulation assistance; and Noriko Yanaba for cryostat sectioning. This work was supported in part by U.S. National Institutes of Health Grants HL073646 and HL112303 (National Heart, Lung, and Blood Institute), DK095555 (National Institute of Diabetes and Digestive and Kidney Diseases), and AR056223 (National Institute of Arthritis and Musculoskeletal and Skin Diseases); and the James R. Hornsby Family Dream Garden Investment Partnership (to S.A.W.).	Abela GS, 2010, J CLIN LIPIDOL, V4, P156, DOI 10.1016/j.jacl.2010.03.003; Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Ambrose JA, 2008, J AM COLL CARDIOL, V51, P1539, DOI 10.1016/j.jacc.2007.12.041; Arbustini E, 2000, TRANSPLANTATION, V69, P1095, DOI 10.1097/00007890-200003270-00013; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; CAPLAN BA, 1974, EXP MOL PATHOL, V21, P102, DOI 10.1016/0014-4800(74)90082-3; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Damani S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003451; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Demetz G, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/860301; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Eriksson EE, 2005, ARTERIOSCL THROM VAS, V25, P723, DOI 10.1161/01.ATV.0000157578.51417.6f; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; GERRITY RG, 1977, AM J PATHOL, V89, P313; Hockett FD, 2011, IEEE T MED IMAGING, V30, P22, DOI 10.1109/TMI.2010.2056689; Keupp J, 2011, MAGN RESON MED, V66, P1116, DOI 10.1002/mrm.22877; Kircher MF, 2008, CIRCULATION, V117, P388, DOI 10.1161/CIRCULATIONAHA.107.719765; Lampka M, 2010, KARDIOL POL, V68, P1100; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Makin AJ, 2004, EUR HEART J, V25, P371, DOI 10.1016/j.ehj.2003.04.001; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Mousa SA, 2010, METHODS MOL BIOL, V663, P29, DOI 10.1007/978-1-60761-803-4_2; Myerson J, 2011, J THROMB HAEMOST, V9, P1292, DOI 10.1111/j.1538-7836.2011.04339.x; Palekar RU, 2013, MOL PHARMACEUT, V10, P4168, DOI 10.1021/mp400210q; Pham CTN, 2011, J BIOL CHEM, V286, P123, DOI 10.1074/jbc.M110.180760; Phinikaridou A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000402; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; Poredos R, 2007, INT ANGIOL, V26, P306; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Saric M, 2012, CURR CARDIOL REP, V14, P342, DOI 10.1007/s11886-012-0261-2; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95; Zhang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026385; ZIMMERMAN M, 1986, ATHEROSCLEROSIS, V59, P277, DOI 10.1016/0021-9150(86)90123-1; Zinselmeyer BH, 2009, METHOD ENZYMOL, V461, P349, DOI 10.1016/S0076-6879(09)05416-0	37	14	15	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3100	3109		10.1096/fj.14-269084	http://dx.doi.org/10.1096/fj.14-269084			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857553	Green Published			2022-12-28	WOS:000356859100036
J	Visa, M; Alcarraz-Vizan, G; Montane, J; Cadavez, L; Castano, C; Villanueva-Penacarrillo, ML; Servitja, JM; Novials, A				Visa, Montse; Alcarraz-Vizan, Gema; Montane, Joel; Cadavez, Lisa; Castano, Carlos; Luisa Villanueva-Penacarrillo, Maria; Servitja, Joan-Marc; Novials, Anna			Islet amyloid polypeptide exerts a novel autocrine action in beta-cell signaling and proliferation	FASEB JOURNAL			English	Article						type 2 diabetes; amylin; pancreatic islets; Erk1/2; Akt	STIMULATED INSULIN-SECRETION; COMPENSATORY GROWTH; AMYLIN; TYPE-2; EXPRESSION; RECEPTORS; APOPTOSIS; PHOSPHORYLATION; ADRENOMEDULLIN; HOMEOSTASIS	The toxic effects of human islet amyloid polypeptide (IAPP) on pancreatic islets have been widely studied. However, much less attention has been paid to the physiologic actions of IAPP on pancreatic beta cells, which secrete this peptide together with insulin upon glucose stimulation. Here, we aimed to explore the signaling pathways and mitogenic actions of IAPP on beta cells. We show that IAPP activated Erk1/2 and v-akt murine thymoma viral oncogene homolog 1 (Akt) at the picomolar range (10-100 pM) in mouse pancreatic islets and MIN6 beta cells cultured at low glucose concentrations. In contrast, IAPP decreased the induction of these pathways by high glucose levels. Consistently, IAPP induced a 1.7-fold increase of beta-cell proliferation at low-glucose conditions, whereas it reduced beta-cell proliferation at high glucose levels. Strikingly, the specific antagonist of the IAPP receptor AC187 (100 nM) decreased the activation of Erk1/2 and Akt and reduced beta-cell proliferation by 24% in glucose-stimulated b cells, uncovering a key role of endogenously released IAPP in beta-cell responses to glucose. We conclude that exogenously added IAPP exerts a dual effect on beta-cell mitogenic signaling and proliferation, depending on the glucose concentration. Importantly, secreted IAPP contributes to the signaling and mitogenic response of beta cells to glucose through an autocrine mechanism.	[Visa, Montse; Alcarraz-Vizan, Gema; Montane, Joel; Cadavez, Lisa; Castano, Carlos; Servitja, Joan-Marc; Novials, Anna] Inst Invest Biomed August Pi I Sunyer, Diabet & Obes Res Lab, Barcelona 08036, Spain; [Visa, Montse; Alcarraz-Vizan, Gema; Montane, Joel; Cadavez, Lisa; Castano, Carlos; Luisa Villanueva-Penacarrillo, Maria; Servitja, Joan-Marc; Novials, Anna] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Luisa Villanueva-Penacarrillo, Maria] Fdn Jimenez Diaz, Inst Invest Sanitaria, Dept Metab Nutr & Hormones, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Fundacion Jimenez Diaz	Servitja, JM (corresponding author), Inst Invest Biomed August Pi I Sunyer, Diabet & Obes Res Lab, C Rossello 149-153,5th Floor, Barcelona 08036, Spain.	servitja@clinic.ub.es; anovials@clinic.ub.es	Montane, Joel/ABE-6021-2021; Castaño, Carlos/AAS-3591-2021; Visa, Montse/AAQ-8529-2021	Castaño, Carlos/0000-0003-1671-7826; Novials, Anna/0000-0003-0465-2949; Montane, Joel/0000-0001-9531-9580; Alcarraz-Vizan, Gema/0000-0002-2429-0597; SERVITJA, JOAN-MARC/0000-0002-1241-8004	Intituto de Salud Carlos III; Ministerio de Economia y Competitividad [PI11/00679, PI14/00447, BFU2010-17639]; Fondo Europeo de Desarrollo Regional, Union Europea, Una Manera de Hacer Europa; Centro de Investigacion Biomedica en Red (Proyecto Integrado de Excelencia) [PIE1400061]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas; Institut d'Investigacions Biomediques August Pi i Sunyer Predoctoral Fellowship; Sarda Farriol Research Programme	Intituto de Salud Carlos III; Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional, Union Europea, Una Manera de Hacer Europa; Centro de Investigacion Biomedica en Red (Proyecto Integrado de Excelencia); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas; Institut d'Investigacions Biomediques August Pi i Sunyer Predoctoral Fellowship; Sarda Farriol Research Programme	The authors thank Kimberly Katte of Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas for technical manuscript correction. This work was funded by grants from the Intituto de Salud Carlos III and Ministerio de Economia y Competitividad (PI11/00679 and PI14/00447 to A.N.; BFU2010-17639 to J.-M.S.), cofunded by Fondo Europeo de Desarrollo Regional, Union Europea, Una Manera de Hacer Europa, the Centro de Investigacion Biomedica en Red (Proyecto Integrado de Excelencia PIE1400061), and the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas. M.V. is a recipient of an Institut d'Investigacions Biomediques August Pi i Sunyer Predoctoral Fellowship. The Diabetes and Obesity Research Laboratory at the Institut d'Investigacions Biomediques August Pi i Sunyer is supported by the Sarda Farriol Research Programme. This work was developed at the Centre Esther Koplowitz, Barcelona, Spain.	Akesson B, 2003, REGUL PEPTIDES, V111, P55, DOI 10.1016/S0167-0115(02)00252-5; Alcarraz-Vizan G, 2015, FASEB J, V29, P95, DOI 10.1096/fj.14-255489; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; BENNET WM, 1994, DIABETOLOGIA, V37, P436; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; BRODERICK CL, 1991, BIOCHEM BIOPH RES CO, V177, P932, DOI 10.1016/0006-291X(91)90628-K; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; CIARALDI TP, 1992, DIABETES, V41, P975, DOI 10.2337/diabetes.41.8.975; COOPER GJS, 1988, P NATL ACAD SCI USA, V85, P7763, DOI 10.1073/pnas.85.20.7763; Cornish J, 2004, BIOCHEM BIOPH RES CO, V318, P240, DOI 10.1016/j.bbrc.2004.04.020; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; DATTA H, 1990, BIOCHEM SOC T, V18, P1276, DOI 10.1042/bst0181276; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Fucini RV, 1999, J BIOL CHEM, V274, P18651, DOI 10.1074/jbc.274.26.18651; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; Gedulin BR, 2006, REGUL PEPTIDES, V137, P121, DOI 10.1016/j.regpep.2006.06.004; GILL AM, 1991, LIFE SCI, V48, P703, DOI 10.1016/0024-3205(91)90546-N; Harris PJ, 1997, AM J PHYSIOL-RENAL, V272, pF13; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hay DL, 2004, BIOCHEM SOC T, V32, P865, DOI 10.1042/BST0320865; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; HUANG HJS, 1992, HYPERTENSION, V19, pI101, DOI 10.1161/01.HYP.19.1_Suppl.I101; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Karlsson E, 2001, DIABETOLOGIA, V44, P1015, DOI 10.1007/s001250100601; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Leckstrom A, 1999, PANCREAS, V18, P266, DOI 10.1097/00006676-199904000-00008; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Lutz TA, 2012, CELL MOL LIFE SCI, V69, P1947, DOI 10.1007/s00018-011-0905-1; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; MOORE CX, 1991, BIOCHEM BIOPH RES CO, V179, P1, DOI 10.1016/0006-291X(91)91325-7; Moreno P, 2011, PEPTIDES, V32, P2077, DOI 10.1016/j.peptides.2011.09.007; Moreno-Asso A, 2013, DIABETOLOGIA, V56, P1761, DOI 10.1007/s00125-013-2930-0; Mulder H, 2000, AM J PHYSIOL-ENDOC M, V278, pE684, DOI 10.1152/ajpendo.2000.278.4.E684; NAGAMATSU S, 1990, DIABETES, V39, P871, DOI 10.2337/diabetes.39.7.871; OHSAWA H, 1989, BIOCHEM BIOPH RES CO, V160, P961, DOI 10.1016/0006-291X(89)92529-1; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Reidelberger RD, 2001, AM J PHYSIOL-REG I, V280, pR605, DOI 10.1152/ajpregu.2001.280.3.R605; SALAS M, 1995, DIABETES METAB, V21, P269; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; WANG ZL, 1993, DIABETES, V42, P330, DOI 10.2337/diabetes.42.2.330; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Wookey PJ, 2006, THESCIENTIFICWORLDJO, V6, P1642, DOI 10.1100/tsw.2006.263; Wookey Peter J, 2003, ScientificWorldJournal, V3, P163; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	51	21	22	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2970	2979		10.1096/fj.15-270553	http://dx.doi.org/10.1096/fj.15-270553			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25808537				2022-12-28	WOS:000356859100025
J	Chan, PC; Hsiao, FC; Chang, HM; Wabitsch, M; Hsieh, PS				Chan, Pei-Chi; Hsiao, Fone-Ching; Chang, Hao-Ming; Wabitsch, Martin; Hsieh, Po Shiuan			Importance of adipocyte cyclooxygenase-2 and prostaglandin E-2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance	FASEB JOURNAL			English	Article						adipocyte hypertrophy; cyclooxygenase-2 activation; EP3	OXIDATIVE STRESS; GENE-EXPRESSION; INNATE IMMUNITY; LEPTIN RELEASE; FATTY-ACIDS; INHIBITION; MACROPHAGES; DEFICIENCY; ACTIVATION; LIPOLYSIS	We examined the involvement of adipocyte cyclooxygenase-2 (COX-2) and prostaglandin E-2 (PGE(2))-prostaglandin E receptor (EP)3-mediated signaling during hypertrophy and hypoxia in the development of obesity-associated adipose tissue (AT) inflammation and insulin resistance. The experiments were conducted with high-fat diet (HFD)-induced obese rats, db/db mice, human subjects, and 3T3-L1 and the human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes; the groups were treated with selective inhibitors of COX-2 [celecoxib 30 mg/kg, half maximal inhibitory concentration (IC50) approximate to 0.04 mu M] and EP3 (L-798106 100 mu g/kg, IC50 approximate to 0.5 mu M) or a short interfering RNA. There were strong, positive correlations between adipocyte COX-2 and EP3 gene expressions and the AT TNF- and monocyte chemotactic protein-1 contents and the homeostatic model assessment for insulin resistance in HFD-induced obese rats, as well as body mass index in human subjects. Treatment with COX-2 and EP3 inhibitors significantly reversed AT inflammatory gene and protein expressions (-50%) and impaired glucose and insulin tolerance in db/db mice. COX-2 inhibition diminished the chemotaxis of adipocytes isolated from HFD rats to macrophages and T cells. Targeting inhibition of adipocyte COX-2 and EP3 during hypertrophy and hypoxia reversed the release of the augmented proinflammatory adipokines and the diminished adiponectin and also suppressed NF-B and hypoxia-inducible factor-1 transcription activation. These findings suggest that adipocyte COX-2 PGE(2)-EP3-mediated signaling is crucially involved in the development of obesity-associated AT inflammation and insulin resistance.Chan, P.-C., Hsiao, F.-C., Chang, H.-M., Wabitsch, M., Hsieh, P. S. Importance of adipocyte cyclooxygenase-2 and prostaglandin E-2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance.	[Chan, Pei-Chi; Hsieh, Po Shiuan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Hsieh, Po Shiuan] Natl Def Med Ctr, Dept Physiol & Biophys, 161,Sect 6 Min Chuan East Rd, Taipei 114, Taiwan; [Hsieh, Po Shiuan] Natl Def Med Ctr, Inst Prevent Med, Taipei 114, Taiwan; [Hsiao, Fone-Ching] Triserv Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan; [Chang, Hao-Ming] Triserv Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Hsieh, Po Shiuan] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; Tri-Service General Hospital; Ulm University	Hsieh, PS (corresponding author), Natl Def Med Ctr, Dept Physiol & Biophys, 161,Sect 6 Min Chuan East Rd, Taipei 114, Taiwan.	pshsieh@hotmail.com	Hsieh, Po-Shiuan/AAF-4173-2020	Hsieh, Po-Shiuan/0000-0002-3402-9851	National Science Council (NSC) of the Republic of China [NSC 101-2320-B-016-001-MY3]; Tri-Service General Hospital [TSGH-C103-007-S01]	National Science Council (NSC) of the Republic of China(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	The authors acknowledge Dr. C. C. Juan (Yang-Ming University, Taipei City, Taiwan) for technical assistance with the 3T3-L1 adipocyte culture. This research was supported by the National Science Council (NSC) of the Republic of China (NSC 101-2320-B-016-001-MY3) and the Tri-Service General Hospital (TSGH-C103-007-S01).	Arai T, 2002, BIOCHEM BIOPH RES CO, V297, P1291, DOI 10.1016/S0006-291X(02)02376-8; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Buras ED, 2015, FASEB J, V29, P3537, DOI 10.1096/fj.15-271452; Dalmas E, 2015, NAT MED, V21, P610, DOI 10.1038/nm.3829; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Fain JN, 2000, PROSTAG OTH LIPID M, V62, P343, DOI 10.1016/S0090-6980(00)00088-5; Fain JN, 2001, METABOLISM, V50, P921, DOI 10.1053/meta.2001.24927; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; FORGET G, 1983, ENVIRON HEALTH PERSP, V51, P131, DOI 10.2307/3429740; Garcia GE, 2003, AM J PATHOL, V162, P1061, DOI 10.1016/S0002-9440(10)63903-X; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; Granado M, 2009, EUR J PHARMACOL, V608, P97, DOI 10.1016/j.ejphar.2009.02.030; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hauner H, 2004, PHYSIOL BEHAV, V83, P653, DOI 10.1016/j.physbeh.2004.09.016; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; Hellmann J, 2013, J IMMUNOL, V191, P1383, DOI 10.4049/jimmunol.1203369; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hsieh PS, 2010, EUR J CLIN INVEST, V40, P164, DOI 10.1111/j.1365-2362.2009.02239.x; Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674; Ikeda-Matsuo Y, 2011, J NEUROIMMUNOL, V238, P34, DOI 10.1016/j.jneuroim.2011.06.014; Iyer A, 2015, FASEB J, V29, P3612, DOI 10.1096/fj.15-271155; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang JH, 2007, FEBS LETT, V581, P4389, DOI 10.1016/j.febslet.2007.07.082; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Matter CM, 2007, CIRCULATION, V115, P946, DOI 10.1161/CIRCULATIONAHA.106.685230; Morimoto K, 2014, J IMMUNOL, V192, P1130, DOI 10.4049/jimmunol.1300290; Nagai Hiroichi, 2008, Allergol Int, V57, P187, DOI 10.2332/allergolint.R-08-161; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Park S, 2014, FASEB J, V28, P5337, DOI 10.1096/fj.14-258384; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Pellegrinelli V, 2015, DIABETES, V64, P3121, DOI 10.2337/db14-0796; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shintani M, 2000, METABOLISM, V49, P326, DOI 10.1016/S0026-0495(00)90154-9; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Takahashi K, 2013, OBESITY, V21, P1625, DOI 10.1002/oby.20206; Tang EHC, 2015, J LIPID RES, V56, P358, DOI 10.1194/jlr.M054817; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu HZ, 2004, J IMMUNOL, V173, P297, DOI 10.4049/jimmunol.173.1.297; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yoshino T, 2005, ARZNEIMITTELFORSCH, V55, P394; Zhou DQ, 2012, FASEB J, V26, P4733, DOI 10.1096/fj.12-206862	51	67	70	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2282	2297		10.1096/fj.201500127	http://dx.doi.org/10.1096/fj.201500127			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26932930				2022-12-28	WOS:000376878300019
J	Mackey, AL; Rasmussen, LK; Kadi, F; Schjerling, P; Helmark, IC; Ponsot, E; Aagaard, P; Durigan, JLQ; Kjaer, M				Mackey, Abigail L.; Rasmussen, Lotte K.; Kadi, Fawzi; Schjerling, Peter; Helmark, Ida C.; Ponsot, Elodie; Aagaard, Per; Durigan, Joao Luiz Q.; Kjaer, Michael			Activation of satellite cells and the regeneration of human skeletal muscle are expedited by ingestion of nonsteroidal anti-inflammatory medication	FASEB JOURNAL			English	Article						Pax7; electrical stimulation; telomere length; extracellular matrix; Notch signaling pathway	TELOMERE LENGTH; STEM-CELLS; EXERCISE; NOTCH; INJURY; PROLIFERATION; HYPERTROPHY; MYOGENESIS; DAMAGE; DRUGS	With this study we investigated the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in human skeletal muscle regeneration. Young men ingested NSAID [1200 mg/d ibuprofen (IBU)] or placebo (PLA) daily for 2 wk before and 4 wk after an electrical stimulation-induced injury to the leg extensor muscles of one leg. Muscle biopsies were collected from the vastus lateralis muscles before and after stimulation (2.5 h and 2, 7, and 30 d) and were assessed for satellite cells and regeneration by immunohistochemistry and real-time RT-PCR, and we also measured telomere length. After injury, and compared with PLA, IBU was found to augment the proportion of ActiveNotch1(+) satellite cells at 2 d [IBU, 29 +/- 3% vs. PLA, 19 +/- 2% (means +/- sem)], satellite cell content at 7 d [IBU, 0.16 +/- 0.01 vs. PLA, 0.12 +/- 0.01 (Pax7(+) cells/fiber)], and to expedite muscle repair at 30 d. The PLA group displayed a greater proportion of embryonic myosin(+) fibers and a residual approximate to 2-fold increase in mRNA levels of matrix proteins (all P < 0.05). Endomysial collagen was also elevated with PLA at 30 d. Minimum telomere length shortening was not observed. In conclusion, ingestion of NSAID has a potentiating effect on Notch activation of satellite cells and muscle remodeling during large-scale regeneration of injured human skeletal muscle.Mackey, A. L., Rasmussen, L. K., Kadi, F., Schjerling, P., Helmark, I. C., Ponsot, E., Aagaard, P., Durigan, J. L. Q., Kjaer, M. Activation of satellite cells and the regeneration of human skeletal muscle are expedited by ingestion of nonsteroidal anti-inflammatory medication.	[Mackey, Abigail L.; Rasmussen, Lotte K.; Schjerling, Peter; Helmark, Ida C.; Kjaer, Michael] Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthopaed Surg M, DK-2400 Copenhagen NV, Denmark; [Mackey, Abigail L.; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Kadi, Fawzi; Ponsot, Elodie] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Aagaard, Per] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Muscle Res Cluster, Odense, Denmark; [Durigan, Joao Luiz Q.] Univ Brasilia, Div Phys Therapy, Brasilia, DF, Brazil	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Orebro University; University of Southern Denmark; Universidade de Brasilia	Mackey, AL (corresponding author), Bispebjerg Hosp, Inst Sports Med M81, Bldg 8,Level 1,Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	abigailmac@sund.ku.dk	Kjaer, Michael/W-6842-2019; Durigan, João Luiz Quagliotti/D-1110-2012; Mackey, Abigail/D-1060-2009; Schjerling, Peter/F-6194-2011	Kjaer, Michael/0000-0002-4582-8755; Durigan, João Luiz Quagliotti/0000-0002-7511-5289; Mackey, Abigail/0000-0002-2017-4580; Schjerling, Peter/0000-0001-7138-3211; Aagaard, Per/0000-0002-9773-7361; kadi, fawzi/0000-0002-9831-0896	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Nordea Foundation [223576]; European Commission; Danish Rheumatism Association; Team Danmark; Anti Doping Danmark; Oster-Jorgensen og Romhild Andersen Fonden; King Christian IX and Queen Louise's Anniversary grant (Kong Christian IX og Dronning Louises Jubilaeumslegat); Danish Agency for Science Technology and Innovation (Medical Research Council); Lundbeck Foundation; Lundbeck Foundation [R198-2015-207] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0012491] Funding Source: researchfish	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Nordea Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Rheumatism Association; Team Danmark; Anti Doping Danmark; Oster-Jorgensen og Romhild Andersen Fonden; King Christian IX and Queen Louise's Anniversary grant (Kong Christian IX og Dronning Louises Jubilaeumslegat); Danish Agency for Science Technology and Innovation (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Camilla Hansen (Institute of Sports Medicine Copenhagen, Bispebjerg Hospital) for excellent technical assistance in taking the blood samples and preparing the muscle biopsies and Anja Jokipii (Institute of Sports Medicine Copenhagen, Bispebjerg Hospital) for the mRNA analysis. The authors also thank Mathias Ekstrand (School of Health and Medical Sciences, Orebro University) for excellent technical assistance with the telomere analysis. The F1.652 and A4.951 antibodies developed by Helen M. Blau were obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA, USA), developed under the auspices of the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development and maintained by the Department of Biological Sciences, University of Iowa. This work was supported by the Nordea Foundation (Healthy Aging grant), MYOAGE (# 223576), which is funded by the European Commission under FP7, the Danish Rheumatism Association, Team Danmark, Anti Doping Danmark, Oster-Jorgensen og Romhild Andersen Fonden, King Christian IX and Queen Louise's Anniversary grant (Kong Christian IX og Dronning Louises Jubilaeumslegat), the Danish Agency for Science Technology and Innovation (Medical Research Council), and the Lundbeck Foundation.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Acharjee S, 2014, J CELL SCI, V127, P599, DOI 10.1242/jcs.136648; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Chiquet M, 2014, INT J BIOCHEM CELL B, V53, P51, DOI 10.1016/j.biocel.2014.04.020; Collins M, 2003, MED SCI SPORT EXER, V35, P1524, DOI 10.1249/01.MSS.0000084522.14168.49; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; Fry CS, 2014, FASEB J, V28, P1654, DOI 10.1096/fj.13-239426; Grounds MD, 2014, INT J BIOCHEM CELL B, V56, P56, DOI 10.1016/j.biocel.2014.09.010; Jarvinen Tero Ah, 2013, Muscles Ligaments Tendons J, V3, P337; Kadi F, 2008, MED SCI SPORT EXER, V40, P82, DOI 10.1249/mss.0b013e3181596695; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Mackey AL, 2012, SCAND J MED SCI SPOR, V22, pE8, DOI 10.1111/j.1600-0838.2012.01463.x; Mackey AL, 2008, J APPL PHYSIOL, V105, P1620, DOI 10.1152/japplphysiol.90952.2008; Mackey AL, 2007, J APPL PHYSIOL, V103, P425, DOI 10.1152/japplphysiol.00157.2007; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Mackey AL, 2010, J APPL PHYSIOL, V109, P1920, DOI 10.1152/japplphysiol.00789.2010; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Ponsot E, 2008, ELECTROPHORESIS, V29, P542, DOI 10.1002/elps.200700290; Ponsot E, 2012, EXP PHYSIOL, V97, P774, DOI 10.1113/expphysiol.2011.063818; Rae DE, 2010, EUR J APPL PHYSIOL, V109, P323, DOI 10.1007/s00421-010-1353-6; Redmond EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084122; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Trappe TA, 2013, J APPL PHYSIOL, V115, P909, DOI 10.1152/japplphysiol.00061.2013; Urso ML, 2013, J APPL PHYSIOL, V115, P920, DOI 10.1152/japplphysiol.00036.2013; Zeng QJ, 2014, POULTRY SCI, V93, P138, DOI 10.3382/ps.2013-03300	34	56	56	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2266	2281		10.1096/fj.201500198R	http://dx.doi.org/10.1096/fj.201500198R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26936358	Green Published			2022-12-28	WOS:000376878300018
J	Li, N; Mruk, DD; Mok, KW; Li, MWM; Wong, CKC; Lee, WM; Han, DS; Silvestrini, B; Cheng, CY				Li, Nan; Mruk, Dolores D.; Mok, Ka-Wai; Li, Michelle W. M.; Wong, Chris K. C.; Lee, Will M.; Han, Daishu; Silvestrini, Bruno; Cheng, C. Yan			Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption	FASEB JOURNAL			English	Article						gap junction; spermatogenesis; actin microfilaments; seminiferous epithelial cycle; tight junction	F-ACTIN ORGANIZATION; CELL-SPECIFIC KNOCKOUT; ECTOPLASMIC SPECIALIZATION; SEMINIFEROUS EPITHELIUM; SERTOLI-CELLS; GAP-JUNCTION; RAT TESTIS; PROTEIN COMPLEX; SPERMATOGENESIS; ADHESION	Earlier studies have shown that rats treated with an acute dose of 1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide (adjudin, a male contraceptive under development) causes permanent infertility due to irreversible blood-testis barrier (BTB) disruption even though the population of undifferentiated spermatogonia remains similar to normal rat testes, because spermatogonia fail to differentiate into spermatocytes to enter meiosis. Since other studies have illustrated the significance of connexin 43 (Cx43)-based gap junction in maintaining the homeostasis of BTB in the rat testis and the phenotypes of Sertoli cell-conditional Cx43 knockout mice share many of the similarities of the adjudin-treated rats, we sought to examine if overexpression of Cx43 in these adjudin-treated rats would reseal the disrupted BTB and reinitiate spermatogenesis. A full-length Cx43 cloned into mammalian expression vector pCI-neo was used to transfect testes of adjudin-treated rats versus empty vector. It was found that overexpression of Cx43 indeed resealed the Sertoli cell tight junction-permeability barrier based on a functional in vivo assay in tubules displaying signs of meiosis as noted by the presence of round spermatids. Thus, these findings suggest that overexpression of Cx43 reinitiated spermatogenesis at least through the steps ofmeiosis to generate round spermatids in testes of rats treated with an acute dose of adjudin that led to aspermatogenesis. It was also noted that the round spermatids underwent eventual degeneration with the formation of multinucleated cells following Cx43 overexpression due to the failure of spermiogenesis because no elongating/elongated spermatids were detected in any of the tubules examined. The mechanism by which overexpression of Cx43 reboots meiosis and rescues BTB function was also examined. In summary, overexpression of Cx43 in the testis with aspermatogenesis reboots meiosis and reseals toxicant-induced BTB disruption, even though it fails to support round spermatids to enter spermiogenesis.-Li, N., Mruk, D. D., Mok, K.-W., Li, M. W. M., Wong, C. K. C., Lee, W. M., Han, D., Silvestrini, B., Cheng, C. Y. Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption. FASEB J. 30, 1436-1452 (2016). www.fasebj.org	[Li, Nan; Mruk, Dolores D.; Mok, Ka-Wai; Li, Michelle W. M.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Han, Daishu] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Peking Union Med Coll, Beijing 100730, Peoples R China; [Silvestrini, Bruno] SBM Srl Pharmaceut, Rome, Italy	Population Council; Hong Kong Baptist University; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Lee, Will M/D-2357-2009; wong, chris/GSN-0962-2022; Li, Michelle W M/N-4914-2019; Li, Wing Man Michelle/B-8295-2008	Li, Michelle W M/0000-0002-9778-984X; Li, Wing Man Michelle/0000-0002-9778-984X; Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54-HD029990, R01-HD056034]; National Natural Science Foundation of China/Hong Kong Research Grants Council Joint Research Scheme [N_HKU 717/12]; Hong Kong Research Grants Council General Research Fund [771513]; Committee for Research and Conference Grants of the University of Hong Kong Seed Funding Grant; Hong Kong Lee Siu Kee Foundation [LSK/14-15/P06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056034, U54HD029990] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Natural Science Foundation of China/Hong Kong Research Grants Council Joint Research Scheme; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Committee for Research and Conference Grants of the University of Hong Kong Seed Funding Grant; Hong Kong Lee Siu Kee Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants U54-HD029990 (Project 5 to C.Y.C.) and R01-HD056034 (to C.Y.C.); National Natural Science Foundation of China/Hong Kong Research Grants Council Joint Research Scheme Grant N_HKU 717/12 (to W.M.L.); Hong Kong Research Grants Council General Research Fund Grant 771513 (to W.M.L.); and the Committee for Research and Conference Grants of the University of Hong Kong Seed Funding Grant (to W.M.L.); and The Hong Kong Lee Siu Kee Foundation Grant LSK/14-15/P06 (to C.K.C.W.). The authors declare no conflicts of interest.	Bao BA, 2012, J BIOL CHEM, V287, P8407, DOI 10.1074/jbc.M111.306522; BERGMANN M, 1983, ANAT EMBRYOL, V168, P269, DOI 10.1007/BF00315821; Brehm R, 2007, AM J PATHOL, V171, P19, DOI 10.2353/ajpath.2007.061171; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Carette D, 2010, DEV BIOL, V346, P54, DOI 10.1016/j.ydbio.2010.07.014; CHAPIN RE, 1983, EXP MOL PATHOL, V38, P149, DOI 10.1016/0014-4800(83)90082-5; Cheng C.Y., 2014, SPERMATOGENESIS, V4, pe981485, DOI [10.4161/21565562.2014.9814895, DOI 10.4161/21565562.2014.9814895, 10.4161/21565562.2014.981485, DOI 10.4161/21565562.2014.981485]; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2005, CONTRACEPTION, V72, P251, DOI 10.1016/j.contraception.2005.03.008; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Fukuda R, 2000, J Toxicol Sci, V25 Spec No, P233; Gerner L, 2013, EXP DERMATOL, V22, P754, DOI 10.1111/exd.12234; Greco Steven J, 2013, Methods Mol Biol, V1024, P87, DOI 10.1007/978-1-62703-453-1_7; Gunther S, 2013, TRANSGENIC RES, V22, P631, DOI 10.1007/s11248-012-9668-1; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Johnson KJ., 2014, SPERMATOGENESIS, V4, DOI [10.4161/21565562.2014.979106, DOI 10.4161/21565562.2014.979106]; Kaneko Y, 2015, J PHARMACOL EXP THER, V353, P192, DOI 10.1124/jpet.114.220210; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Li MWM, 2013, ADV EXP MED BIOL, V763, P260; Li MWM, 2010, P NATL ACAD SCI USA, V107, P17998, DOI 10.1073/pnas.1007047107; Li MWM, 2009, P NATL ACAD SCI USA, V106, P10213, DOI 10.1073/pnas.0901700106; Li N, 2015, ENDOCRINOLOGY, V156, P2969, DOI 10.1210/en.2015-1161; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Machtaler S, 2014, FEBS LETT, V588, P1249, DOI 10.1016/j.febslet.2014.01.027; Mok KW, 2012, INT J ANDROL, V35, P86, DOI 10.1111/j.1365-2605.2011.01183.x; Mok Ka-Wai, 2011, Spermatogenesis, V1, P270; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Narayana K., 2007, Morphologie, V91, P173; Pointis Georges, 2011, Spermatogenesis, V1, P303; Pointis G, 2010, PHILOS T R SOC B, V365, P1607, DOI 10.1098/rstb.2009.0114; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Risley MS, 2000, BIOL REPROD, V62, P748, DOI 10.1095/biolreprod62.3.748; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; SETCHELL BP, 1970, J ENDOCRINOL, V47, P81, DOI 10.1677/joe.0.0470081; Siu ER, 2009, ENDOCRINOLOGY, V150, P3336, DOI 10.1210/en.2008-1741; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212; Toyama Y, 2001, J ANDROL, V22, P413; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Valiunas V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12286; Higa GSV, 2014, MOL NEUROBIOL, V49, P1309, DOI 10.1007/s12035-013-8603-7; Wan HT, 2014, ENDOCRINOLOGY, V155, P249, DOI 10.1210/en.2013-1657; Wan HT, 2013, AM J PHYSIOL-ENDOC M, V305, pE687, DOI 10.1152/ajpendo.00254.2013; Wiebe JP, 2000, J ANDROL, V21, P625; WIEBE JP, 1984, CONTRACEPTION, V29, P291, DOI 10.1016/S0010-7824(84)80009-8; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Xia WL, 2006, J BIOL CHEM, V281, P16799, DOI 10.1074/jbc.M601618200; Xiao X, 2014, HUM REPROD, V29, P1279, DOI 10.1093/humrep/deu011; Zhang SS, 2014, FEBS LETT, V588, P1439, DOI 10.1016/j.febslet.2014.01.002; Zhang SZ, 2015, J CELL PHYSIOL, V230, P2476, DOI 10.1002/jcp.24982	58	30	30	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1436	1452		10.1096/fj.15-276527	http://dx.doi.org/10.1096/fj.15-276527			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26678449	Green Published			2022-12-28	WOS:000372629100007
J	Liu, Z; Kennedy, OD; Cardoso, L; Basta-Pljakic, J; Partridge, NC; Schaffler, MB; Rosen, CJ; Yakar, S				Liu, Zhongbo; Kennedy, Oran D.; Cardoso, Luis; Basta-Pljakic, Jelena; Partridge, Nicola C.; Schaffler, Mitchell B.; Rosen, Clifford J.; Yakar, Shoshana			DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH	FASEB JOURNAL			English	Article						growth hormone receptor; parathyroid hormone; fibroblast growth factor-23; osteocyte; microcomputed tomography	GROWTH-FACTOR-I; INCREASED BONE-FORMATION; PARATHYROID-HORMONE; IGF-I; OSTEOPROGENITOR CELLS; OVARIECTOMIZED RATS; PTH/PTHRP RECEPTOR; MINERAL METABOLISM; ANABOLIC ACTIONS; CORTICAL BONE	Bone minerals are acquired during growth and are key determinants of adult skeletal health. During puberty, the serumlevels of growth hormone (GH) and its downstream effector IGF-1 increase and play critical roles in bone acquisition. The goal of the current study was to determine how bone cells integrate signals from the GH/IGF-1 to enhance skeletal mineralization and strength during pubertal growth. Osteocytes, the most abundant bone cells, were shown to orchestrate bone modeling during growth. We used dentin matrix protein (Dmp)-1-mediated Ghr knockout (DMP-GHRKO) mice to address the role of the GH/IGF axis in osteocytes. We found that DMP-GHRKO did not affect linear growth but compromised overall bone accrual. DMP-GHRKO mice exhibited reduced serum inorganic phosphate and parathyroid hormone (PTH) levels and decreased bone formation indices and were associated with an impaired response to intermittent PTH treatment. Using an osteocyte-like cell line along with in vivo studies, we found that PTH sensitized the response of bone to GH by increasing Janus kinase-2 and IGF-1R protein levels. We concluded that endogenously secreted PTH and GHR signaling in bone are necessary to establish radial bone growth and optimize mineral acquisition during growth.	[Liu, Zhongbo; Partridge, Nicola C.; Yakar, Shoshana] NYU, Coll Dent, David B Kriser Dent Ctr, Dept Basic Sci & Craniofacial Biol, 345 East 24th St, New York, NY 10010 USA; [Kennedy, Oran D.; Cardoso, Luis; Basta-Pljakic, Jelena; Schaffler, Mitchell B.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA; [Kennedy, Oran D.; Cardoso, Luis; Basta-Pljakic, Jelena; Schaffler, Mitchell B.] New York Univ Hosp Joint Dis, New York, NY USA	New York University; City University of New York (CUNY) System; City College of New York (CUNY); Maine Medical Center; New York University	Yakar, S (corresponding author), NYU, Coll Dent, David B Kriser Dent Ctr, Dept Basic Sci & Craniofacial Biol, 345 East 24th St, New York, NY 10010 USA.	sy1007@nyu.edu	Liu, Zhongbo/U-3004-2017	Partridge, Nicola/0000-0002-5406-4814; Kennedy, Oran D./0000-0003-3343-2873	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases [DK100246]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR041210, AR057139]; Binational Science Foundation [2013282]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057139, R01AR041210, R29AR041210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420, R01DK100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106391] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [1333560] Funding Source: National Science Foundation	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grant DK100246 (to S.Y.); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR041210 and AR057139 (to M.B.S.); and Binational Science Foundation Grant 2013282 (to S.Y.). The respective roles of the authors: Z.L. conducted all biochemical and gene expression studies, including serum hormone measurements and iPTH treatment; O.K. performed histomorphometry and micro-CT; L.C. and J.B.P. performed and analyzed micro-CT data; M.B.S. and C.J.R. consulted on study design, data analyses, and interpretation; and S.Y. was principle investigator, oversaw all experiments and data collection, and wrote the paper. All authors concurred with the contents of the manuscript. The material submitted for publication has not been reported and is not under consideration for publication elsewhere. The authors declare no conflicts of interest.	Ahmad AM, 2003, J CLIN ENDOCR METAB, V88, P2860, DOI 10.1210/jc.2002-021787; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bikle DD, 2002, J BONE MINER RES, V17, P1570, DOI 10.1359/jbmr.2002.17.9.1570; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brennan-Speranza TC, 2011, BONE, V49, P1073, DOI 10.1016/j.bone.2011.07.039; COOPER C, 1995, J BONE MINER RES, V10, P940; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dennison EM, 2004, J CLIN ENDOCR METAB, V89, P4898, DOI 10.1210/jc.2004-0151; DiGirolamo DJ, 2007, J BIOL CHEM, V282, P31666, DOI 10.1074/jbc.M705219200; Drake MT, 2010, J CLIN ENDOCR METAB, V95, P5056, DOI 10.1210/jc.2010-0720; Elis S, 2010, J BONE MINER RES, V25, P2051, DOI 10.1002/jbmr.100; Elis S, 2010, J BONE MINER RES, V25, P1257, DOI 10.1002/jbmr.20; Erlandson MC, 2012, J BONE MINER RES, V27, P2298, DOI 10.1002/jbmr.1689; Ferrari S, 1998, J CLIN ENDOCR METAB, V83, P358, DOI 10.1210/jc.83.2.358; Gan YJ, 2014, ENDOCRINOLOGY, V155, P1000, DOI 10.1210/en.2013-1732; Gan YJ, 2013, MOL ENDOCRINOL, V27, P1969, DOI 10.1210/me.2013-1178; Gan YJ, 2010, MOL ENDOCRINOL, V24, P644, DOI 10.1210/me.2009-0357; Gooi JH, 2010, BONE, V46, P1486, DOI 10.1016/j.bone.2010.02.018; Guevarra MSN, 2010, HORM RES PAEDIAT, V73, P248, DOI 10.1159/000284389; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Huang Y, 2004, MOL ENDOCRINOL, V18, P1471, DOI 10.1210/me.2003-0418; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Joseph F, 2008, J BONE MINER RES, V23, P721, DOI 10.1359/JBMR.071117; Kasukawa Y, 2003, ENDOCRINOLOGY, V144, P4682, DOI 10.1210/en.2003-0745; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Khosla S, 2013, J GERONTOL A-BIOL, V68, P1226, DOI 10.1093/gerona/gls163; Kostenuik PJ, 1999, J BONE MINER RES, V14, P21, DOI 10.1359/jbmr.1999.14.1.21; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Kravchenko IV, 2012, MOL CELL BIOCHEM, V363, P347, DOI 10.1007/s11010-011-1187-5; Kravchenko IV, 2011, ARCH BIOCHEM BIOPHYS, V507, P323, DOI 10.1016/j.abb.2010.12.028; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lau KHW, 2013, AM J PHYSIOL-ENDOC M, V305, pE271, DOI 10.1152/ajpendo.00092.2013; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Ma FX, 2011, MOL ENDOCRINOL, V25, P2119, DOI 10.1210/me.2011-1052; McCarthy TL, 2001, GROWTH HORM IGF RES, V11, P213, DOI 10.1054/ghir.2001.0236; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P4349, DOI 10.1210/en.142.10.4349; Mosekilde L, 2000, BONE, V26, P643, DOI 10.1016/S8756-3282(00)00276-3; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; NISHIDA S, 1994, BONE, V15, P717, DOI 10.1016/8756-3282(94)90322-0; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Shah Reshma, 2012, Pituitary, V15 Suppl 1, pS17, DOI 10.1007/s11102-010-0286-8; Sheng Matilda H C, 2014, J Bone Metab, V21, P41, DOI 10.11005/jbm.2014.21.1.41; Sheng MHC, 2013, BONE, V52, P133, DOI 10.1016/j.bone.2012.09.027; Silvestrini G, 2007, J MOL HISTOL, V38, P261, DOI 10.1007/s10735-007-9096-3; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Tylavsky FA, 2007, J AM COLL NUTR, V26, P462, DOI 10.1080/07315724.2007.10719637; Vijayakumar A, 2013, ENDOCRINOLOGY, V154, P3776, DOI 10.1210/en.2013-1209; Vijayakumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044777; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; Wang YM, 2007, J BONE MINER RES, V22, P1329, DOI 10.1359/JBMR.070517; Warden SJ, 2013, OSTEOPOROSIS INT, V24, P1869, DOI 10.1007/s00198-012-2174-8; WATSON P, 1995, BONE, V16, P357, DOI 10.1016/8756-3282(94)00051-4; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Wu YJ, 2011, J CLIN INVEST, V121, P2422, DOI 10.1172/JCI45027; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2009, FASEB J, V23, P709, DOI 10.1096/fj.08-118976; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674	70	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					635	652		10.1096/fj.15-275859	http://dx.doi.org/10.1096/fj.15-275859			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481310	Green Published			2022-12-28	WOS:000369391900016
J	Shi, J; Miralles, F; Birnbaumer, L; Large, WA; Albert, AP				Shi, Jian; Miralles, Francesc; Birnbaumer, Lutz; Large, William A.; Albert, Anthony P.			Store depletion induces Gaq-mediated PLCb1 activity to stimulate TRPC1 channels in vascular smooth muscle cells	FASEB JOURNAL			English	Article						electrophysiology; PLC activity; Ca2+ signaling; phosphoinositol signaling	PROTEIN-KINASE-C; OPERATED CA2+ CHANNELS; PORTAL-VEIN MYOCYTES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CALCIUM-CHANNELS; ARTERY MYOCYTES; ANGIOTENSIN-II; ACTIVATION; ENTRY; STIM1	Depletion of sarcoplasmic reticulum (SR) Ca2+ stores activates store-operated channels (SOCs) composed of canonical transient receptor potential (TRPC) 1 proteins in vascular smooth muscle cells (VSMCs), which contribute to important cellular functions. We have previously shown that PKC is obligatory for activation of TRPC1 SOCs in VSMCs, and the present study investigates if the classic phosphoinositol signaling pathway involving Gaq-mediated PLC activity is responsible for driving PKC-dependent channel gating. The G-protein inhibitor GDP beta-S, anti-Gaq antibodies, the PLC inhibitor U73122, and the PKC inhibitor GF109203X all inhibited activation of TRPC1 SOCs, and U73122 and GF109203X also reduced storeoperated PKC-dependent phosphorylation of TRPC1 proteins. Three distinct SR Ca2+ store-depleting agents, 1,2-bis(2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid acetoxymethyl ester, cyclopiazonic acid, and N, N, N', N'-tetrakis(2-pyridylmethyl) ethane-1,2-diamineed, induced-translocations of the fluorescent biosensor GFP-PLCd1-PH from the cell membrane to the cytosol, which were inhibited by U73122. Knockdown of PLC beta 1 with small hairpin RNA reduced both store-operated PLC activity and stimulation of TRPC1 SOCs. Immunoprecipitation studies and proximity ligation assays revealed that store depletion induced interactions between TRPC1 and Gaq, and TRPC1 and PLC beta 1. We propose a novel activation mechanism for TRPC1 SOCs in VSMCs, in which store depletion induces formation of TRPC1-Gaq-PLC beta 1 complexes that lead to PKC stimulation and channel gating.	[Shi, Jian; Miralles, Francesc; Large, William A.; Albert, Anthony P.] Univ London, Inst Cardiovasc & Cell Sci, Vasc Biol Res Ctr, Cranmer Terrace, London SW17 0RE, England; [Miralles, Francesc] Univ London, Inst Med & Biomed Educ, London, England; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Neurobiol Lab, Res Triangle Pk, NC USA	St Georges University London; University of London; University of London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Shi, J (corresponding author), Univ London, Inst Cardiovasc & Cell Sci, Vasc Biol Res Ctr, Cranmer Terrace, London SW17 0RE, England.	jshi@sgul.ac.uk		Miralles, Francesc/0000-0003-3069-2725; Albert, Anthony/0000-0002-3596-9634	Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) [BB/J007226/1, BB/M018350/1]; U.S. National Institutes of Health Intramural Research Program [Z01-ES-101684]; Biotechnology and Biological Sciences Research Council [BB/M018350/1, BB/J007226/1] Funding Source: researchfish; BBSRC [BB/M018350/1, BB/J007226/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101684] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Elena Sviderskaya for assistance with electroporation. This work was supported by the Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) (BB/J007226/1 and BB/M018350/1 to A.P.A.) and was also supported in part by the U.S. National Institutes of Health Intramural Research Program (Project Z01-ES-101684 to L.B.).	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Albert AP, 2006, BRIT J PHARMACOL, V148, P1001, DOI 10.1038/sj.bjp.0706797; Albert AP, 2011, ADV EXP MED BIOL, V704, P391, DOI 10.1007/978-94-007-0265-3_22; Albert AP, 2009, CURR MED CHEM, V16, P1158, DOI 10.2174/092986709787581815; Albert AP, 2002, J PHYSIOL-LONDON, V544, P113, DOI 10.1113/jphysiol.2002.022574; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Asanov A, 2015, CELL CALCIUM, V57, P1, DOI 10.1016/j.ceca.2014.10.011; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Beech DJ, 2012, PFLUG ARCH EUR J PHY, V463, P635, DOI 10.1007/s00424-012-1090-2; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Cooley N, 2014, MOL PHARMACOL, V86, P399, DOI 10.1124/mol.114.093690; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Large WA, 2009, CELL CALCIUM, V45, P574, DOI 10.1016/j.ceca.2009.02.007; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Litjens T, 2007, BIOCHEM J, V405, P269, DOI 10.1042/BJ20061762; Ng LC, 2009, J PHYSIOL-LONDON, V587, P2429, DOI 10.1113/jphysiol.2009.172254; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Saleh SN, 2008, J PHYSIOL-LONDON, V586, P2463, DOI 10.1113/jphysiol.2008.152157; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P531, DOI 10.1113/jphysiol.2008.166678; Shi J, 2010, J PHYSIOL-LONDON, V588, P3671, DOI 10.1113/jphysiol.2010.194621; Shi J, 2014, FASEB J, V28, P244, DOI 10.1096/fj.13-238022; Shi J, 2012, FASEB J, V26, P409, DOI 10.1096/fj.11-185611; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Trebak M, 2012, J PHYSIOL-LONDON, V590, P4201, DOI 10.1113/jphysiol.2012.233353; Tu CL, 2005, J INVEST DERMATOL, V124, P187, DOI 10.1111/j.0022-202X.2004.23544.x; Wang M, 2007, J NEUROCHEM, V101, P411, DOI 10.1111/j.1471-4159.2006.04377.x; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Xu SZ, 2006, AM J PHYSIOL-HEART C, V291, pH2653, DOI 10.1152/ajpheart.00495.2006; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Yang B, 2012, AM J PHYSIOL-CELL PH, V302, pC748, DOI 10.1152/ajpcell.00312.2011; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198	53	22	23	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					702	715		10.1096/fj.15-280271	http://dx.doi.org/10.1096/fj.15-280271			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26467792	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000369391900021
J	Ferrari, D; Gambari, R; Idzko, M; Muller, T; Albanesi, C; Pastore, S; La Manna, G; Robson, SC; Cronstein, B				Ferrari, Davide; Gambari, Roberto; Idzko, Marco; Mueller, Tobias; Albanesi, Cristina; Pastore, Saveria; La Manna, Gaetano; Robson, Simon C.; Cronstein, Bruce			Purinergic signaling in scarring	FASEB JOURNAL			English	Review						adenosine; COPD; Crohn's disease; extracellular nucleotides; fibrosis	HEPATIC STELLATE CELLS; ATP RELEASE; ADENOSINE RECEPTOR; EXTRACELLULAR ATP; CELLULAR MECHANISMS; COLLAGEN PRODUCTION; PULMONARY-FIBROSIS; LUNG INFLAMMATION; PREDICTIVE-VALUE; P2X(7) RECEPTOR	Adenosine (ADO) and nucleotides such as ATP, ADP, and uridine 5'-triphosphate (UTP), among others, may serve as extracellular signaling molecules. These mediators activate specific cell-surface receptors-namely, purinergic 1 and 2 (P1 and P2)-to modulate crucial pathophysiological responses. Regulation of this process is maintained by nucleoside and nucleotide transporters, as well as the ectonucleotidases ectonucleoside triphosphate diphosphohydrolase [ENTPD; cluster of differentiation (CD)39] and ecto-5'-nucleotidase (5'-NT; CD73), among others. Cells involved in tissue repair, healing, and scarring respond to both ADO and ATP. Our recent investigations have shown that modulation of purinergic signaling regulates matrix deposition during tissue repair and fibrosis in several organs. Cells release adenine nucleotides into the extracellular space, where these mediators are converted by CD39 and CD73 into ADO, which is anti-inflammatory in the short term but may also promote dermal, heart, liver, and lung fibrosis with repetitive signaling under defined circumstances. Extracellular ATP stimulates cardiac fibroblast proliferation, lung inflammation, and fibrosis. P2Y(2) (UTP/ATP) and P2Y(6) [ADP/UTP/uridine 5'-diphosphate (UDP)] have been shown to have profibrotic effects, as well. Modulation of purinergic signaling repre-sents a novel approach to preventing or diminishing fibro-sis. We provide an overview of the current understanding of purinergic signaling in scarring and discuss its potential to prevent or decrease fibrosis.-Ferrari, D., Gambari, R., Idzko, M., Muller, T., Albanesi, C., Pastore, S., La Manna, G., Robson, S. C., Cronstein, B. Purinergic signaling in scarring. FASEB J. 30, 3-12 (2016). www.fasebj.org	[Ferrari, Davide; Gambari, Roberto] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Idzko, Marco; Mueller, Tobias] Univ Freiburg, Dept Pneumol, D-79106 Freiburg, Germany; [Pastore, Saveria] IRCCS, Immunol Lab, Ist Dermopat Immacolata, Rome, Italy; [Albanesi, Cristina] IRCCS, Lab Tissue Engn & Cutaneous Physiopathol, Ist Dermopat Immacolata, Rome, Italy; [La Manna, Gaetano] Univ Bologna, Dept Specialized Diagnost & Expt Med, Bologna, Italy; [Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Cronstein, Bruce] NYU, Dept Med, New York, NY 10016 USA	University of Ferrara; University of Freiburg; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Bologna; Harvard University; Beth Israel Deaconess Medical Center; New York University	Ferrari, D (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Ctr Biotechnol, Via Fossato di Mortara 64 b, I-44100 Ferrara, Italy.	dfr@unife.it	Albanesi, Cristina/K-4699-2016; Cronstein, Bruce N/D-4678-2011; Müller, Tobias/ABH-7263-2020; Robson, Simon C./AAA-8537-2021; Ferrari, Davide/F-5644-2015	Albanesi, Cristina/0000-0002-7537-6833; Cronstein, Bruce N/0000-0002-4295-7383; Müller, Tobias/0000-0002-9801-3496; La Manna, Gaetano/0000-0001-5473-8551; Ferrari, Davide/0000-0002-5727-9204	U.S. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR568593]; New York University-Health and Hospitals Corporation Clinical and Translational Science Institute [UL1TR000038]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR056672, R01AR056672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103723] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York University-Health and Hospitals Corporation Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR56672 and AR568593; and New York University-Health and Hospitals Corporation Clinical and Translational Science Institute Grant UL1TR000038.	Alcolado R, 1997, CLIN SCI, V92, P103, DOI 10.1042/cs0920103; Andrade CMB, 2011, CELL TISSUE RES, V344, P279, DOI 10.1007/s00441-011-1140-7; Artlett CM, 2015, ANTIOXID REDOX SIGN, V22, P1162, DOI 10.1089/ars.2014.6148; Azancot MA, 2014, KIDNEY INT, V85, P1161, DOI 10.1038/ki.2013.461; BARBUL A, 1989, ANN SURG, V209, P479, DOI 10.1097/00000658-198904000-00015; Barr TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056744; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Betjes M. G., 2015, NEPHROL DIAL TRANSPL, V1, P1; Blume C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037100; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; Burnstock G, 2014, PURINERG SIGNAL, V10, P51, DOI 10.1007/s11302-013-9398-8; Burnstock G, 2014, PURINERG SIGNAL, V10, P71, DOI 10.1007/s11302-013-9400-5; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Burnstock G, 2012, J INVEST DERMATOL, V132, P526, DOI 10.1038/jid.2011.344; Cabibbo G, 2012, SEMIN ONCOL, V39, P374, DOI 10.1053/j.seminoncol.2012.05.006; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Chan ESL, 2006, ARTHRITIS RHEUM-US, V54, P2632, DOI 10.1002/art.21974; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen RJ, 2015, ARCH TOXICOL, V89, P1727, DOI 10.1007/s00204-015-1525-6; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Corriden R, 2012, PURINERG SIGNAL, V8, P587, DOI 10.1007/s11302-012-9311-x; Costabel U, 2012, EUR RESPIR REV, V21, P140, DOI 10.1183/09059180.00000712; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; De Vusser K, 2013, J AM SOC NEPHROL, V24, P1913, DOI 10.1681/ASN.2012111081; Della Latta V, 2013, PHARMACOL RES, V76, P182, DOI 10.1016/j.phrs.2013.08.004; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dong XL, 2014, INT J CLIN EXP PATHO, V7, P3596; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Dubey RK, 1996, HYPERTENSION, V27, P786, DOI 10.1161/01.HYP.27.3.786; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Ebeling G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100282; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fausther M, 2012, AM J PHYSIOL-GASTR L, V303, pG904, DOI 10.1152/ajpgi.00015.2012; Fernandez P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024; Forman MB, 2014, DIGEST DIS SCI, V59, P2118, DOI 10.1007/s10620-014-3139-x; Fredholm BB, 1997, TRENDS PHARMACOL SCI, V18, P79, DOI 10.1016/S0165-6147(96)01038-3; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gao W, 2015, RESPIROLOGY, V20, P722, DOI 10.1111/resp.12542; Garcia GE, 2011, KIDNEY INT, V80, P378, DOI 10.1038/ki.2011.101; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Goncalves RG, 2006, KIDNEY INT, V70, P1599, DOI 10.1038/sj.ki.5001804; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; GSELL F, 1984, AESTHET PLAST SURG, V8, P51, DOI 10.1007/BF01572785; Guo X., 2015, J INVEST DERMATOL, P20; Harada H, 2000, KIDNEY INT, V57, P949, DOI 10.1046/j.1523-1755.2000.00911.x; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Huang CS, 2014, MOL MED REP, V9, P57, DOI 10.3892/mmr.2013.1807; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jacob F, 2013, PURINERG SIGNAL, V9, P285, DOI 10.1007/s11302-013-9357-4; Janssen LJ, 2009, INT J BIOCHEM CELL B, V41, P2477, DOI 10.1016/j.biocel.2009.08.004; Jumper N, 2015, HISTOL HISTOPATHOL, V30, P1033, DOI 10.14670/HH-11-624; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kukulski F, 2011, J IMMUNOL, V187, P644, DOI 10.4049/jimmunol.1002680; Lederer DJ, 2015, CHEST, V148, P196, DOI 10.1378/chest.14-2817; Lee J, 2013, AM J PATHOL, V183, P1488, DOI 10.1016/j.ajpath.2013.07.010; Li P, 2014, J DERMATOL, V41, P903, DOI 10.1111/1346-8138.12600; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lu D, 2014, AM J PHYSIOL-CELL PH, V306, pC779, DOI 10.1152/ajpcell.00381.2013; Lu D, 2013, J BIOL CHEM, V288, P19040, DOI 10.1074/jbc.M113.466102; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Marriott S, 2014, AM J PHYSIOL-CELL PH, V307, pC684, DOI 10.1152/ajpcell.00114.2014; Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00212; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Nakamura T, 2011, EUR J PHARMACOL, V657, P152, DOI 10.1016/j.ejphar.2011.01.047; Nakav S, 2009, NEPHROL DIAL TRANSPL, V24, P2392, DOI 10.1093/ndt/gfp041; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; Ohara H, 2010, J DERMATOL SCI, V58, P143, DOI 10.1016/j.jdermsci.2010.02.007; Onami K, 2014, J INVEST DERMATOL, V134, P1951, DOI 10.1038/jid.2014.93; Pan BX, 2015, CELL PHYSIOL BIOCHEM, V35, P1062, DOI 10.1159/000373932; Park WD, 2010, J AM SOC NEPHROL, V21, P1987, DOI 10.1681/ASN.2010010049; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Perez-Aso M, 2014, FASEB J, V28, P802, DOI 10.1096/fj.13-241646; Perez-Aso M, 2013, PURINERG SIGNAL, V9, P573, DOI 10.1007/s11302-013-9368-1; Perez-Aso M, 2012, FASEB J, V26, P4254, DOI 10.1096/fj.12-209627; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Rudich N, 2015, MOL IMMUNOL, V65, P25, DOI 10.1016/j.molimm.2014.12.015; Ryzhov S, 2014, PURINERG SIGNAL, V10, P477, DOI 10.1007/s11302-014-9410-y; Schneider DJ, 2010, FASEB J, V24, P70, DOI 10.1096/fj.09-140772; Solini A, 2005, KIDNEY INT, V67, P875, DOI 10.1111/j.1523-1755.2005.00152.x; Spinelli A, 2010, CURR DRUG TARGETS, V11, P242, DOI 10.2174/138945010790309984; Squadrito F, 2014, J CLIN ENDOCR METAB, V99, pE746, DOI 10.1210/jc.2013-3569; Stoll M, 2012, GASTROENTEROLOGY, V142, pS974; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Takahashi T, 2013, J INVEST DERMATOL, V133, P2407, DOI 10.1038/jid.2013.163; Tang J, 2015, MOL MED REP, V11, P4397, DOI 10.3892/mmr.2015.3320; Torres IB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/750602; Trojanowska Maria, 2012, Open Rheumatol J, V6, P70, DOI 10.2174/1874312901206010070; van der Vliet A, 2011, SUBCELL BIOCHEM, V55, P139, DOI 10.1007/978-94-007-1217-1_6; VANBELLE H, 1987, AM J PHYSIOL, V252, pH886, DOI 10.1152/ajpheart.1987.252.5.H886; WARD PA, 1988, LAB INVEST, V58, P37; Wei J, 2010, CURR OPIN RHEUMATOL, V22, P671, DOI 10.1097/BOR.0b013e32833de1a7; Xiao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060173; Xiao H, 2013, J BURN CARE RES, V34, pE161, DOI 10.1097/BCR.0b013e3182644e55; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhong H, 2007, J HEPATOL, V46, pS135, DOI 10.1016/S0168-8278(07)61943-6; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	117	43	44	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					3	12		10.1096/fj.15-274563	http://dx.doi.org/10.1096/fj.15-274563			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26333425	Green Published, Green Submitted			2022-12-28	WOS:000367621000002
J	Spaethling, JM; Sanchez-Alavez, M; Lee, J; Xia, FC; Dueck, H; Wang, WS; Fisher, SA; Sul, JY; Seale, P; Kim, J; Bartfai, T; Eberwine, J				Spaethling, Jennifer M.; Sanchez-Alavez, Manuel; Lee, JaeHee; Xia, Feng C.; Dueck, Hannah; Wang, Wenshan; Fisher, Stephen A.; Sul, Jai-Yoon; Seale, Patrick; Kim, Junhyong; Bartfai, Tamas; Eberwine, James			Single-cell transcriptomics and functional target validation of brown adipocytes show their complex roles in metabolic homeostasis	FASEB JOURNAL			English	Article						brown fat; thermogenesis; drug targets; in vivo validation; GPCR	BETA(3)-ADRENERGIC RECEPTOR AGONISTS; CORE BODY-TEMPERATURE; ADIPOSE-TISSUE; GW427353 SOLABEGRON; FAT; THERMOGENESIS; MICE; INSULIN; ADIPONECTIN; RECRUITMENT	Brown adipocytes (BAs) are specialized for adaptive thermogenesis and, upon sympathetic stimulation, activate mitochondrial uncoupling protein (UCP)-1 and oxidize fatty acids to generate heat. The capacity for brown adipose tissue (BAT) to protect against obesity and metabolic disease is recognized, yet information about which signals activate BA, besides beta 3-adrenergic receptor stimulation, is limited. Using single-cell transcriptomics, we confirmed the presence of mRNAs encoding traditional BAT markers (i.e., UCP1, expressed in 100% of BAs Adrb3, expressed in < 50% of BAs) in mouse and have shown singlecell variability (> 1000-fold) in their expression at both the mRNA and protein levels. We further identified mRNAs encoding novel markers, orphan GPCRs, and many receptors that bind the classic neurotransmitters, neuropeptides, chemokines, cytokines, and hormones. The transcriptome variability between BAs suggests a much larger range of responsiveness of BAT than previously recognized and that not all BAs function identically. We examined the in vivo functional expression of 12 selected receptors by microinjecting agonists into live mouse BAT and analyzing the metabolic response. In this manner, we expanded the number of known receptors on BAs at least 25-fold, while showing that the expression of classic BA markers is more complex and variable than previously thought.-Spaethling, J. M., Sanchez-Alavez, M., Lee, J., Xia, F. C., Dueck, H., Wang, W., Fisher, S. A., Sul, J.-Y., Seale, P., Kim, J., Bartfai, T., Eberwine, J. Single-cell transcriptomics and functional target validation of brown adipocytes show their complex roles in metabolic homeostasis. FASEB J. 30, 81-92 (2016). www.fasebj.org	[Spaethling, Jennifer M.; Lee, JaeHee; Sul, Jai-Yoon; Eberwine, James] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Dueck, Hannah] Univ Penn, Dept Genom & Computat Biol, Philadelphia, PA 19104 USA; [Wang, Wenshan; Seale, Patrick] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Fisher, Stephen A.; Kim, Junhyong] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA; [Sanchez-Alavez, Manuel; Xia, Feng C.; Bartfai, Tamas] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Scripps Research Institute	Eberwine, J (corresponding author), Univ Penn, Dept Pharmacol, 3620 Hamilton Walk,37 John Morgan Bldg, Philadelphia, PA 19104 USA.	eberwine@upenn.edu		Sanchez-Alavez, Manuel/0000-0002-8164-8452	National Science Foundation; Health Research Formula Funds from the Commonwealth of Pennsylvania	National Science Foundation(National Science Foundation (NSF)); Health Research Formula Funds from the Commonwealth of Pennsylvania	The authors thank J. LaFontaine and J.R. Hadcock (Pfizer) for the gift of CP-722221. This work was funded in part by a National Science Foundation Graduate Research Fellowship Program grant (to H.D.); and in part by Health Research Formula Funds from the Commonwealth of Pennsylvania. The funding bodies had no role in study design, in collection, analysis, interpretation of data, or in the writing of the manuscript. J.M.S. performed the transcriptome analysis. M.S.A. and F.C.X. preformed the functional validation of receptors in mice. H.D., S.A.F., and J.K. performed bioinformatics analysis of transcriptome data. W.W. and P.S. provided BAT primary cells and performed the beta 3-AR / UCP1 immuno. J.H.L. and J.Y.S. imaged the beta 3-AR / UCP1 immuno. M.S.A., J.M.S., T.B., and J.E. wrote the manuscript and developed the experimental plan. The authors declare no conflicts of interest.	Akin JA., 2011, NATURE ED KNOWLEDGE, P3; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Bartfai Tamas, 2012, Frontiers in Genetics, V3, P184, DOI 10.3389/fgene.2012.00184; Bartfai T, 2012, TRENDS PHARMACOL SCI, V33, P9, DOI 10.1016/j.tips.2011.09.006; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Benedict C, 2011, DIABETES, V60, P114, DOI 10.2337/db10-0329; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; BORST SE, 1994, GEN PHARMACOL-VASC S, V25, P1703, DOI 10.1016/0306-3623(94)90375-1; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 1998, ANN NY ACAD SCI, V856, P171, DOI 10.1111/j.1749-6632.1998.tb08325.x; Cannon B, 2010, NAT MED, V16, P965, DOI 10.1038/nm0910-965; Canto C, 2012, SCIENCE, V336, P675, DOI 10.1126/science.1222646; Desai NA, 2015, J CHILD NEUROL, V30, P1819, DOI 10.1177/0883073815583335; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dow R L, 1997, Expert Opin Investig Drugs, V6, P1811, DOI 10.1517/13543784.6.12.1811; Dubins JS, 2012, METABOLISM, V61, P1486, DOI 10.1016/j.metabol.2012.03.015; Dunmore SJ, 2013, J ENDOCRINOL, V216, pT37, DOI 10.1530/JOE-12-0278; Eberwine J, 2001, CURRENT PROTOCOLS NE; Eberwine J, 2011, PHARMACOL THERAPEUT, V129, P241, DOI 10.1016/j.pharmthera.2010.09.010; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fujimoto N, 2005, BBA-GENE STRUCT EXPR, V1731, P1, DOI 10.1016/j.bbaexp.2005.06.013; GRIFFITHS EC, 1988, EXPERIENTIA, V44, P40, DOI 10.1007/BF01960238; Guennoun A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0480-6; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hermann GE, 2006, BRAIN RES, V1117, P118, DOI 10.1016/j.brainres.2006.08.018; Hicks A, 2007, J PHARMACOL EXP THER, V323, P202, DOI 10.1124/jpet.107.125757; Jin ZH, 2009, PROG MOL BIOL TRANSL, V89, P1, DOI 10.1016/S1877-1173(09)89001-7; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Kuzawa CW, 1998, YEARB PHYS ANTHROPOL, V41, P177; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Lafontaine JA, 2007, BIOORG MED CHEM LETT, V17, P5245, DOI 10.1016/j.bmcl.2007.06.072; Langin D, 2010, BBA-MOL CELL BIOL L, V1801, P372, DOI 10.1016/j.bbalip.2009.09.008; LEPPALUOTO J, 1991, ARCTIC, V44, P139; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lowell BB, 1997, ANNU REV MED, V48, P307; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Mattsson CL, 2011, AM J PHYSIOL-ENDOC M, V301, pE1108, DOI 10.1152/ajpendo.00085.2011; Morris J, 2011, JOVE-J VIS EXP, DOI 10.3791/2634; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751; Park JW, 2015, J NUCL MED, V56, P153, DOI 10.2967/jnumed.114.147603; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Qiao LP, 2014, DIABETOLOGIA, V57, P1027, DOI 10.1007/s00125-014-3180-5; ROTHWELL NJ, 1988, INT J OBESITY, V12, P93; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Sanchez-Alavez M, 2006, P NATL ACAD SCI USA, V103, P2904, DOI 10.1073/pnas.0510960103; Sanchez-Alavez M, 2011, J BIOL CHEM, V286, P14983, DOI 10.1074/jbc.M110.188540; Sanchez-Alavez M, 2010, DIABETES, V59, P43, DOI 10.2337/db09-1128; Sasaki N, 1998, J VET MED SCI, V60, P465, DOI 10.1292/jvms.60.465; Schemann M, 2010, GASTROENTEROLOGY, V138, P266, DOI 10.1053/j.gastro.2009.09.046; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; SMITH RE, 1969, PHYSIOL REV, V49, P330, DOI 10.1152/physrev.1969.49.2.330; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Tatsumi M, 2004, J NUCL MED, V45, P1189; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Wada Y, 2015, J MED CHEM, V58, P6048, DOI 10.1021/acs.jmedchem.5b00638; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White JP, 2014, P NATL ACAD SCI USA, V111, P15756, DOI 10.1073/pnas.1417898111; Wilson SM, 1999, J GEN PHYSIOL, V113, P125, DOI 10.1085/jgp.113.1.125; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163; Yoneshiro T, 2013, INT J OBESITY, V37, P993, DOI 10.1038/ijo.2012.161; Zhang YY, 2014, J BIOL CHEM, V289, P22063, DOI 10.1074/jbc.M114.559104; Zhao J, 2001, CAN J PHYSIOL PHARM, V79, P585, DOI 10.1139/cjpp-79-7-585	74	25	25	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					81	92		10.1096/fj.15-273797	http://dx.doi.org/10.1096/fj.15-273797			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26304220				2022-12-28	WOS:000367621000010
J	Xiao, F; Deng, JL; Yu, JJ; Guo, YJ; Chen, SH; Guo, FF				Xiao, Fei; Deng, Jiali; Yu, Junjie; Guo, Yajie; Chen, Shanghai; Guo, Feifan			A novel function of B-cell translocation gene 1 (BTG1) in the regulation of hepatic insulin sensitivity in mice via c-Jun	FASEB JOURNAL			English	Article						liver; insulin signaling; high-carbohydrate diet; leucine deprivation	EXPRESSION; PROTEIN; HYPERGLYCEMIA; INDUCTION; INTERACT; GLUCOSE; LIVER	Insulin resistance is one of the major factors contributing to metabolic diseases, but the underlying mechanisms are still poorly understood. As an important cofactor, B-cell translocation gene 1 (BTG1) is involved in many physiologic processes; however, the direct effect of BTG1 on insulin sensitivity has not been described. In our study, BTG1 overexpression or knockdown improved or impaired insulin signaling in vitro, respectively. In addition, adenovirus-mediated BTG1 overexpression improved insulin sensitivity in wild-type (WT) and insulin-resistant leptin-receptor mutated (db/db) mice. In addition, transgenic BTG1-overexpressing mice were resistant to high-carbohydrate diet-induced insulin resistance. Adenovirus-mediated BTG1 knockdown consistently impaired insulin sensitivity in WT and insulin sensitive leucine-deprived mice. Moreover, hepatic BTG1 expression was increased by leucine deprivation via the mammalian target of rapamycin/ribosomal protein S6 kinase 1 pathway. Furthermore, c-Jun expression was up-regulated by BTG1, and adenovirus-mediated c-Jun knockdown blocked BTG1-improved insulin signaling and insulin sensitivity in vitro and in vivo. Finally, BTG1 promoted c-Jun expression via stimulating c-Jun and retinoic acid receptor activities. Taken together, these results identify a novel function for BTG1 in the regulation of hepatic insulin sensitivity and provide important insights into the nutritional regulation of BTG1 expression.	[Xiao, Fei; Deng, Jiali; Yu, Junjie; Guo, Yajie; Chen, Shanghai; Guo, Feifan] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Guo, FF (corresponding author), Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	ffguo@sibs.ac.cn			National Natural Science Foundation [81130076, 81325005, 31271269, 81100615, 81390350, 81300659, 81570777]; Shanghai Science and Technology Commission [13JC1409000]; International Science and Technology Cooperation Program of China (Singapore) [2014DFG32470]; the International Partnership Program for Creative Research Teams (CAS/SAFEA); Chinese Academy of Sciences; China Postdoctoral Science Foundation [2012M520950]; Chinese Academy of Sciences [2013T60473, 2013KIP310]; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS)	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); International Science and Technology Cooperation Program of China (Singapore); the International Partnership Program for Creative Research Teams (CAS/SAFEA); Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS)	This work was supported by National Natural Science Foundation Grants 81130076, 81325005, 31271269, 81100615, 81390350, 81300659, and 81570777; Basic Research Project of the Shanghai Science and Technology Commission Grant 13JC1409000; International Science and Technology Cooperation Program of China (Singapore) Grant 2014DFG32470; the International Partnership Program for Creative Research Teams (CAS/SAFEA); the One Hundred Talents Program of the Chinese Academy of Sciences (F.G.); China Postdoctoral Science Foundation Grant 2012M520950; Chinese Academy of Sciences Grants 2013T60473 and 2013KIP310 (to F.X.); and by the Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program (F.X.). The authors declare no conflicts of interest.	[Anonymous], INT J PHOTOENERGY, DOI DOI 10.1186/1476-511X-13-189; Bessesen DH, 2001, J NUTR, V131, p2782S, DOI 10.1093/jn/131.10.2782S; Busson M, 2005, ONCOGENE, V24, P1698, DOI 10.1038/sj.onc.1208373; Camina-Tato M, 2009, J NEUROIMMUNOL, V213, P142, DOI 10.1016/j.jneuroim.2009.05.010; Cho IJ, 2005, FREE RADICAL BIO MED, V39, P1523, DOI 10.1016/j.freeradbiomed.2005.07.017; DEGROOT RP, 1991, NUCLEIC ACIDS RES, V19, P1585, DOI 10.1093/nar/19.7.1585; Duriez Cyril, 2004, Bull Cancer, V91, pE242; Farioli-Vecchioli S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00124; Hunter ZR, 2014, BLOOD, V123, P1637, DOI 10.1182/blood-2013-09-525808; Kim YD, 2014, DIABETES, V63, P1870, DOI 10.2337/db13-1368; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee AK, 2002, MOL CELL BIOCHEM, V231, P163, DOI 10.1023/A:1014481319278; Li HK, 2011, BIOCHEM J, V438, P283, DOI 10.1042/BJ20110263; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Ma XR, 2011, J HEPATOL, V55, P445, DOI 10.1016/j.jhep.2010.11.022; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Takahashi A, 2012, MOL CELL BIOL, V32, P5067, DOI 10.1128/MCB.00610-12; Takitani K, 2003, LEUKEMIA, V17, P646, DOI 10.1038/sj.leu.2402818; Ueda H, 2000, DIABETOLOGIA, V43, P932, DOI 10.1007/s001250051472; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246	30	12	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					348	359		10.1096/fj.15-278689	http://dx.doi.org/10.1096/fj.15-278689			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396236				2022-12-28	WOS:000367621000033
J	Londino, JD; Lazrak, A; Noah, JW; Aggarwal, S; Bali, V; Woodworth, BA; Bebok, Z; Matalon, S				Londino, James David; Lazrak, Ahmed; Noah, James W.; Aggarwal, Saurabh; Bali, Vedrana; Woodworth, Bradford A.; Bebok, Zsuzsanna; Matalon, Sadis			Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection	FASEB JOURNAL			English	Article						DsiRNA; patch clamp; NHBE cells; short circuit current; amantadine	ION-CHANNEL ACTIVITY; LIQUID INTERFACE CULTURES; UNFOLDED PROTEIN RESPONSE; A VIRUS; MESSENGER-RNA; SELECTIVE PERTURBATION; MATRIX PROTEIN-2; CFTR EXPRESSION; CELL-SURFACE; MEMBRANE	We sought to determine the mechanisms by which influenza infection of human epithelial cells decreases cystic fibrosis transmembrane conductance regulator (CFTR) expression and function. We infected human bronchial epithelial (NHBE) cells and murine nasal epithelial (MNE) cells with various strains of influenza A virus. Influenza infection significantly reduced CFTR short circuit currents (I-sc) and protein levels at 8 hours postinfection. We then infected CFTR expressing human embryonic kidney (HEK)-293 cells (HEK-293 CFTRwt) with influenza virus encoding a green fluorescent protein (GFP) tag and performed whole-cell and cell-attached patch clamp recordings. Forskolin-stimulated, GlyH-101-sensitive CFTR conductances, and CFTR open probabilities were reduced by 80% in GFP-positive cells; Western blots also showed significant reduction in total and plasma membrane CFTR levels. Knockdown of the influenza matrix protein 2 (M2) with siRNA, or inhibition of its activity by amantadine, prevented the decrease in CFTR expression and function. Lysosome inhibition (bafilomycin-A1), but not proteasome inhibition (lactacystin), prevented the reduction in CFTR levels. Western blots of immunoprecipitated CFTR from influenza-infected cells, treated with BafA1, and probed with antibodies against lysine 63-linked (K-63) or lysine 48-linked (K-48) polyubiquitin chains supported lysosomal targeting. These results highlight CFTR damage, leading to early degradation as an important contributing factor to influenza infection-associated ion transport defects.	[Londino, James David; Lazrak, Ahmed; Aggarwal, Saurabh; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, Birmingham, AL 35294 USA; [Londino, James David; Lazrak, Ahmed; Noah, James W.; Aggarwal, Saurabh; Bebok, Zsuzsanna; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Pulm Injury & Repair Ctr, Birmingham, AL 35294 USA; [Londino, James David; Bali, Vedrana; Bebok, Zsuzsanna; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Noah, James W.] So Res Inst, Birmingham, AL 35255 USA; [Woodworth, Bradford A.] Univ Alabama Birmingham, Sch Med, Dept Surg, Div Otolaryngol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, 901 19th St South,BMRII 242, Birmingham, AL 35294 USA.	sadis@uab.edu	Londino, James/GXH-2306-2022; Londino, James/GXH-4404-2022	Londino, James/0000-0001-7647-6927; , Vedrana/0000-0002-8881-8717; Lazrak, Ahmed/0000-0002-4127-1937	U.S. National Institutes of Health; National Heart, Lung, and Blood Institute [HL031197, HL076587]; National Institute of Environmental Health Sciences [5U01ES015676]; National Institute of Diabetes and Digestive and Kidney Diseases [DK60065]; Cystic Fibrosis Foundation [Bebok14PO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587, R01HL031197, R37HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK060065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Adolfo Garcia-Sastre for providing the GFP-tagged NS1 influenza virus, John Riordan, Ph.D., University of North Carolina-Chapel Hill, and the Cystic Fibrosis Foundation Therapeutics for providing anti-CFTR antibody 596, and Dr. Ji-Bin Peng for providing cRNA encoding TRPV5. Sequencing was performed by the Heflin Center Genomics Core Facility, University of Alabama Birmingham. Funding provided by the U.S. National Institutes of Health, HL031197 and HL076587 (National Heart, Lung, and Blood Institute), 5U01ES015676 (National Institute of Environmental Health Sciences), DK60065 (National Institute of Diabetes and Digestive and Kidney Diseases), and Bebok14PO (Cystic Fibrosis Foundation).	Aeffner F, 2013, J INFECT DIS, V208, P780, DOI 10.1093/infdis/jit251; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Chen L, 2009, AM J RESP CELL MOL, V40, P588, DOI 10.1165/rcmb.2008-0034OC; Collawn JF, 2012, AM J PHYSIOL-LUNG C, V302, pL1141, DOI 10.1152/ajplung.00036.2012; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gerlach RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078912; Gould NS, 2012, FREE RADICAL BIO MED, V52, P1201, DOI 10.1016/j.freeradbiomed.2012.01.001; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Henkel JR, 1999, J BIOL CHEM, V274, P9854, DOI 10.1074/jbc.274.14.9854; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072981; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590; Lee S, 2014, MOL CELL BIOL, V34, P2554, DOI 10.1128/MCB.01042-13; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; Londino JD, 2013, P NATL ACAD SCI USA, V110, P10055, DOI 10.1073/pnas.1307480110; Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; McCown M, 2003, VIROLOGY, V313, P514, DOI 10.1016/S0042-6822(03)00341-6; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Renk H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078583; Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; TAKEUCHI K, 1994, J VIROL, V68, P911, DOI 10.1128/JVI.68.2.911-919.1994; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Tripathi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.89; VALCARCEL J, 1991, J GEN VIROL, V72, P1301, DOI 10.1099/0022-1317-72-6-1301; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Waugh T, 2013, BIOCHEM BIOPH RES CO, V438, P581, DOI 10.1016/j.bbrc.2013.08.012; Woodworth BA, 2007, AM J RHINOL, V21, P533, DOI 10.2500/ajr.2007.21.3068; Xu WL, 2006, J INTERF CYTOK RES, V26, P609, DOI 10.1089/jir.2006.26.609; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984	54	30	31	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2712	2725		10.1096/fj.14-268755	http://dx.doi.org/10.1096/fj.14-268755			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25795456	Green Published			2022-12-28	WOS:000356859100004
J	Talaber, G; Tuckermann, JP; Okret, S				Talaber, Gergely; Tuckermann, Jan Peter; Okret, Sam			ACTH controls thymocyte homeostasis independent of glucocorticoids	FASEB JOURNAL			English	Article						adrenalectomy; glucocorticoid receptor ablation; glucocorticoid resistance; thymus	DOUBLE SUPRARENALECTOMY; THYMUS; GLAND; HETEROGENEITY; REGENERATION; SUBPOPULATIONS; MACROPHAGES; EXPRESSION; RECEPTORS; PROTECTS	It has been known for decades that lowering the circulating glucocorticoid (GC) concentration as in Addison's disease or after removing the adrenals results in thymus enlargement, largely due to thymocyte expansion. This has been attributed to the loss of the proapoptotic effects on thymocytes by adrenal GCs. Here, we test this concept and report that ACTH directly controls thymic growth post-adrenalectomy (ADX) independent of the proapoptotic effect of GCs. This was supported by the finding that ADX caused thymus enlargement and a 1.7-fold (P < 0.001) increase in thymocyte number in GR(LckCre) mice resistant to GC-induced thymocyte apoptosis, similar to the increase seen in wildtype mice (2.2-fold; P < 0.01). We show by immunostaining that melanocortin receptor subtype 2, which selectively binds ACTH, is partly expressed on the thymic epithelium. Furthermore, ACTH in comparison to vehicle induced a 2.0-fold (P < 0.01) increase in fetal thymic organ culture thymocyte numbers in vitro and enhanced 2.2-fold (P < 0.05) the expression of delta-like ligand 4, a factor that supports T-cell development. Additionally, adrenalectomized GRLckCre mice treated with ACTH under conditions that repressed endogenous ACTH secretion showed increased thymocyte cellularity (1.9-fold; P < 0.01) and splenic naive T-cell numbers (2.5-fold; P < 0.001) compared to when treated with PBS. Altogether, our results show that ACTH directly controls thymocyte homeostasis independent of GCs. These results revise the old paradigm behind compensatory thymus growth following ADX, now demonstrating that ACTH has a central role in regulating thymocyte expansion when systemic GC concentration is low.	[Talaber, Gergely; Okret, Sam] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Tuckermann, Jan Peter] Univ Ulm, Inst Comparat Mol Endocrinol, D-89069 Ulm, Germany	Karolinska Institutet; Ulm University	Okret, S (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7-9, S-14183 Huddinge, Sweden.	sam.okret@ki.se			Swedish Cancer Society; Deutsche Forschungsgemeinschaft [DFG Tu220/6-2, SPP 1468]	Swedish Cancer Society(Swedish Cancer Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge the expert help of Dr. Jose Inzunza (Department of Biosciences and Nutrition, Karolinska Institutet, Novum, Huddinge, Sweden) in performing adrenalectomy. This study was funded by the Swedish Cancer Society and the Deutsche Forschungsgemeinschaft (DFG Tu220/6-2) in the priority program SPP 1468 Immunobone.	BATANERO E, 1992, BRAIN BEHAV IMMUN, V6, P249, DOI 10.1016/0889-1591(92)90047-R; Benjamins JA, 2013, GLIA, V61, P1206, DOI 10.1002/glia.22504; Berki T, 2002, INT IMMUNOL, V14, P463, DOI 10.1093/intimm/14.5.463; Boehm T, 2013, NAT REV IMMUNOL, V13, P831, DOI 10.1038/nri3534; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Cooray SN, 2011, MOL CELL ENDOCRINOL, V331, P215, DOI 10.1016/j.mce.2010.07.015; Esashi E, 2003, J IMMUNOL, V171, P2773, DOI 10.4049/jimmunol.171.6.2773; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; Ferrando-Martinez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2; Ferrero I, 2013, EUR J IMMUNOL, V43, P2845, DOI 10.1002/eji.201343527; Garcia-Peydro M, 2006, J IMMUNOL, V177, P3711, DOI 10.4049/jimmunol.177.6.3711; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gray DHD, 2007, J IMMUNOL, V178, P4956, DOI 10.4049/jimmunol.178.8.4956; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hoeflich A, 2009, J MOL ENDOCRINOL, V42, P191, DOI 10.1677/JME-08-0160; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Jaffe HL, 1924, J EXP MED, V40, P753, DOI 10.1084/jem.40.6.753; Jaffe HL, 1924, J EXP MED, V40, P619, DOI 10.1084/jem.40.5.619; Jaffe HL, 1924, J EXP MED, V40, P325, DOI 10.1084/jem.40.3.325; Johnson EW, 2001, J BIOL REG HOMEOS AG, V15, P156; Kawiak J, 1996, FOLIA HISTOCHEM CYTO, V34, P75; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kyrou I, 2009, CURR OPIN PHARMACOL, V9, P787, DOI 10.1016/j.coph.2009.08.007; Liddicoat DR, 2014, IMMUNOL CELL BIOL, V92, P148, DOI 10.1038/icb.2013.76; Padgett EL, 2000, INT J IMMUNOPHARMACO, V22, P285, DOI 10.1016/S0192-0561(99)00083-1; Pazirandeh A, 1999, FASEB J, V13, P893, DOI 10.1096/fasebj.13.8.893; Pruett Stephen B., 2004, BMC Immunology, V5; Qiao SJ, 2009, ENDOCRINOLOGY, V150, P4163, DOI 10.1210/en.2009-0195; ROCHA B, 1985, EUR J IMMUNOL, V15, P1131, DOI 10.1002/eji.1830151112; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Si J, 2013, KIDNEY INT, V83, P635, DOI 10.1038/ki.2012.447; Stojic-Vukanic Z, 2009, EXP BIOL MED, V234, P1067, DOI 10.3181/0902-RM-63; Talaber G, 2013, MOL CELL ENDOCRINOL, V380, P89, DOI 10.1016/j.mce.2013.05.007; Taves MD, 2011, AM J PHYSIOL-ENDOC M, V301, pE11, DOI 10.1152/ajpendo.00100.2011; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Weyand CM, 2003, EXP GERONTOL, V38, P833, DOI 10.1016/S0531-5565(03)00090-1; Wiegers GJ, 2001, EUR J IMMUNOL, V31, P2293, DOI 10.1002/1521-4141(200108)31:8<2293::AID-IMMU2293>3.0.CO;2-I; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Xing YW, 2010, J MOL ENDOCRINOL, V45, P59, DOI 10.1677/JME-10-0006; Zaidi M, 2010, P NATL ACAD SCI USA, V107, P8782, DOI 10.1073/pnas.0912176107	42	23	27	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2526	2534		10.1096/fj.14-268508	http://dx.doi.org/10.1096/fj.14-268508			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25733567				2022-12-28	WOS:000355209500029
J	Clouard, C; Kemp, B; Val-Laillet, D; Gerrits, WJJ; Bartels, AC; Bolhuis, JE				Clouard, Caroline; Kemp, Bas; Val-Laillet, David; Gerrits, Walter J. J.; Bartels, Andrea C.; Bolhuis, J. Elizabeth			Prenatal, but not early postnatal, exposure to a Western diet improves spatial memory of pigs later in life and is paired with changes in maternal prepartum blood lipid levels	FASEB JOURNAL			English	Article						cholesterol; cognition; fat; prenatal programming; refined sugar	SYNAPTIC PLASTICITY; COGNITIVE HOLEBOARD; INDUCED OBESITY; SUS-SCROFA; CHOLESTEROL; PREGNANCY; FAT; DISCRIMINATION; CONSEQUENCES; PERFORMANCE	Maternal obesity and perinatal high-fat diets are known to affect cognitive development. We examined the effects of late prenatal and/or early postnatal exposure to a Western-type diet, high in both fat and refined sugar, on the cognition of pigs (Sus scrofa) in the absence of obesity. Thirty-six sows and their offspring were assigned to 1 of 4 treatments in a 2 3 2 factorial arrangement, with 8 wk prenatal and 8 wk postnatal exposure to a Western diet (enriched in fat, sucrose, and cholesterol) or control diets as factors. Compared to controls, piglets exposed to the prenatal Western diet showed enhanced working and reference memory during the acquisition and reversal phases of a spatial hole-board task. Mothers fed the prenatal Western diet had higher prepartum blood cholesterol and free fatty acid levels. Postnatal exposure to the Western diet did not affect piglet cognitive performance, but it did increase postpartum maternal and postweaning piglet cholesterol levels. The Western diet had no effect on maternal or offspring insulin sensitivity or leptin levels. In conclusion, a prenatal Western diet improved memory function in pigs, which was paired with changes in prepartum maternal blood cholesterol levels. These findings highlight the key role of late fetal nutrition for long-term programming of cognition.	[Clouard, Caroline; Kemp, Bas; Bartels, Andrea C.; Bolhuis, J. Elizabeth] Wageningen Univ, Adaptat Physiol Grp, Dept Anim Sci, Wageningen, Netherlands; [Gerrits, Walter J. J.] Wageningen Univ, Anim Nutr Grp, Dept Anim Sci, Wageningen, Netherlands; [Val-Laillet, David] INRA, Nerveuses & Comporteme, Unite Rech Alimentat & Adaptat Digest 1341, St Gilles, France	Wageningen University & Research; Wageningen University & Research; INRAE	Clouard, C (corresponding author), Wageningen Univ, Adaptat Physiol Grp, POB 338, NL-6700 AH Wageningen, Netherlands.	caroline.clouard@wur.nl	Val-Laillet, David/B-4328-2008; VAL-LAILLET, David/AAH-6454-2021; Clouard, Caroline/K-1255-2014	Val-Laillet, David/0000-0002-6256-7737; Clouard, Caroline/0000-0002-5562-6057	Fyssen Foundation	Fyssen Foundation	This work was supported in part by a postdoctoral study grant from the Fyssen Foundation (to C.C.). The authors thank M. Ooms, J. Wijnen, M. van der Vosse, and M. Brouwers for their help with the experiment, and R. Koopmans (Adaptation Physiology group of Wageningen University) for his assistance with laboratory analyses. The authors gratefully acknowledge S.J. Koopmans [Wageningen University and Research Center (UR) Livestock Research] for his advice on the experimental setup. The authors also thank P. Peters from the experimental farm of Sterksel [Swine Innovation Centre (VIC) Wageningen UC], and R. Ernste, B. van den Top, and A. Jansen from the animal research facilities in Wageningen (CARUS) for taking care of the animals and for their technical assistance. Scientific interactions with the Institut National de la Recherche Agronomique Diet Impacts and Determinants: Interactions and Transitions Meta-programme made it possible to share insights on the methodology and interpretation of result.	Antonides A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00043; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Barker DJP, 1992, FETAL INFANT ORIGINS; Bateson P, 2014, J PHYSIOL-LONDON, V592, P2357, DOI 10.1113/jphysiol.2014.271460; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boleman SL, 1998, J NUTR, V128, P2498, DOI 10.1093/jn/128.12.2498; Bolhuis JE, 2013, ANIM COGN, V16, P845, DOI 10.1007/s10071-013-0646-7; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Convention Bureau Netherlands, 2007, CVB SER, V36; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Goh VHH, 2014, AGING MALE, V17, P216, DOI 10.3109/13685538.2014.968772; Haagensen AMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079429; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Horgan GW, 2012, NUTR BULL, V37, P213, DOI 10.1111/j.1467-3010.2012.01977.x; Jurdak N, 2008, NUTR NEUROSCI, V11, P48, DOI 10.1179/147683008X301333; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; O'Reilly JR, 2013, CLIN ENDOCRINOL, V78, P9, DOI 10.1111/cen.12055; Page KC, 2014, AM J PHYSIOL-REG I, V306, pR527, DOI 10.1152/ajpregu.00319.2013; Pere MC, 2003, REPROD NUTR DEV, V43, P1, DOI 10.1051/rnd:2003002; Reynolds CA, 2010, J AM GERIATR SOC, V58, P501, DOI 10.1111/j.1532-5415.2010.02739.x; Rodriguez JS, 2012, INT J DEV NEUROSCI, V30, P75, DOI 10.1016/j.ijdevneu.2011.12.012; Rooke JA, 2000, ANIM SCI, V71, P289, DOI 10.1017/S1357729800055132; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; SCHOKNECHT PA, 1994, J NUTR, V124, P305, DOI 10.1093/jn/124.2.305; Sokal RR, 1995, BIOMETRY; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; THULIN AJ, 1989, J ANIM SCI, V67, P738; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; van der Staay FJ, 2012, NEUROSCI BIOBEHAV R, V36, P379, DOI 10.1016/j.neubiorev.2011.07.008; Van Lieshout RJ, 2013, NUTR REV, V71, pS95, DOI 10.1111/nure.12059; Vannucci RC, 2000, SEMIN PERINATOL, V24, P107, DOI 10.1053/sp.2000.6361; Wang DS, 2015, BRAIN RES, V1622, P350, DOI 10.1016/j.brainres.2015.06.049; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Winocur G, 2005, NEUROBIOL AGING, V26, pS46, DOI 10.1016/j.neurobiolaging.2005.09.003; Wright TM, 2014, BRIT J NUTR, V112, P1933, DOI 10.1017/S0007114514003134; Ya BL, 2013, NEUROL SCI, V34, P1355, DOI 10.1007/s10072-012-1241-4; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001	45	16	17	0	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2466	2475		10.1096/fj.201500208R	http://dx.doi.org/10.1096/fj.201500208R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	26985006				2022-12-28	WOS:000379249500003
J	Yu, S; Li, SJ; Henke, A; Muse, ED; Cheng, B; Welzel, G; Chatterjee, AK; Wang, DL; Roland, J; Glass, CK; Tremblay, M				Yu, Shan; Li, Sijia; Henke, Adam; Muse, Evan D.; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Glass, Christopher K.; Tremblay, Matthew			Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases	FASEB JOURNAL			English	Article						LXR; traumatic brain injury; ulcerative colitis; drug discovery	ELEMENT-BINDING PROTEIN-1C; LIPID-METABOLISM; LXR AGONIST; GENE; MICE; OXYSTEROLS; PATHWAYS; TRANSREPRESSION; INTEGRATION; LIPOGENESIS	Liver X receptor (LXR), a nuclear hormone receptor, is an essential regulator of immune responses. Activation of LXR-mediated transcription by synthetic agonists, such as T0901317 and GW3965, attenuates progression of inflammatory disease in animal models. However, the adverse effects of these conventional LXR agonists in elevating liver lipids have impeded exploitation of this intriguing mechanism for chronic therapy. Here, we explore the ability of a series of sterol-based LXR agonists to alleviate inflammatory conditions in mice without hepatotoxicity. We show that oral treatment with sterol-based LXR agonists in mice significantly reduces dextran sulfate sodium colitis-induced body weight loss, which is accompanied by reduced expression of inflammatory markers in the large intestine. The anti-inflammatory property of these agonists is recapitulated in vitro in mouse lamina propria mononuclear cells, human colonic epithelial cells, and human peripheral blood mononuclear cells. In addition, treatment with LXR agonists dramatically suppresses inflammatory cytokine expression in a model of traumatic brain injury. Importantly, in both disease models, the sterol-based agonists do not affect the liver, and the conventional agonist T0901317 results in significant liver lipid accumulation and injury. Overall, these results provide evidence for the development of sterol-based LXR agonists as novel therapeutics for chronic inflammatory diseases.	[Yu, Shan; Li, Sijia; Henke, Adam; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Tremblay, Matthew] Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA; [Muse, Evan D.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Muse, Evan D.] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Tremblay, M (corresponding author), Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA.; Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, GPL Rm 217,9500 Gilman Dr,Mail Code 0651, La Jolla, CA 92093 USA.	cglass@ucsd.edu; mtremblay@calibr.org	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	Crohn's and Colitis Foundation of America Research Fellowship Award [368561]; U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award [UL1-TR001114]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America Research Fellowship Award; U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Crohn's and Colitis Foundation of America Research Fellowship Award (368561; to S.Y.), and by a U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award (UL1-TR001114; to Scripps Translational Science Institute).	Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Cheng O, 2010, NEUROSCIENCE, V166, P1101, DOI 10.1016/j.neuroscience.2010.01.024; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hu BH, 2010, J MED CHEM, V53, P3296, DOI 10.1021/jm100034x; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakobsson T, 2014, MUCOSAL IMMUNOL, V7, P1416, DOI 10.1038/mi.2014.31; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Katz A, 2009, J CLIN PHARMACOL, V49, P643, DOI 10.1177/0091270009335768; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lim RKV, 2015, BIOCONJUGATE CHEM, V26, P2216, DOI 10.1021/acs.bioconjchem.5b00203; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Quinet EM, 2009, J LIPID RES, V50, P2358, DOI 10.1194/jlr.M900037-JLR200; Quinet EM, 2004, J LIPID RES, V45, P1929, DOI 10.1194/jlr.M400257-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Temml V, 2014, J CHEM INF MODEL, V54, P367, DOI 10.1021/ci400682b; Tice CM, 2014, J MED CHEM, V57, P7182, DOI 10.1021/jm500442z; Traversari C, 2014, EUR J IMMUNOL, V44, P1896, DOI 10.1002/eji.201344292; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	33	17	17	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2570	2579		10.1096/fj.201600244R	http://dx.doi.org/10.1096/fj.201600244R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27025962	Green Published			2022-12-28	WOS:000379249500012
J	Haggie, PM; Phuan, PW; Tan, JA; Zlock, L; Finkbeiner, WE; Verkman, AS				Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Zlock, Lorna; Finkbeiner, Walter E.; Verkman, A. S.			Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis	FASEB JOURNAL			English	Article						ASL; drug discovery; high-throughput screening; inflammatory airway disease	SYNDROME GENE PDS; CHRONIC RHINOSINUSITIS; INNER-EAR; TRANSPORTER PENDRIN; IODIDE TRANSPORT; SMOOTH-MUSCLE; NASAL POLYPS; MOUSE MODELS; RAT LUNGS; DISEASE	Pendrin (SLC26A4) is a Cl-/anion exchanger expressed in the epithelium of inflamed airways where it is thought to facilitate Cl- absorption and HCO3- secretion. Studies using pendrin knockout mice and airway epithelial cells from hearing-impaired subjects with pendrin loss of function suggest involvement of pendrin in inflammatory lung diseases, including cystic fibrosis (CF), perhaps by regulation of airway surface liquid (ASL) volume. Here we identified small-molecule pendrin inhibitors and demonstrated their efficacy in increasing ASL volume. A cell-based, functional high-throughput screen of approximate to 36,000 synthetic small molecules produced 3 chemical classes of inhibitors of human pendrin. After structure-activity studies, tetrahydropyrazolopyridine and pyrazolothiophenesulfonamide compounds reversibly inhibited pendrin-facilitated Cl- exchange with SCN-, I-, NO3-, and HCO3- with drug concentration causing 50% inhibition down to approximate to 2.5 M. In well-differentiated primary cultures of human airway epithelial cells from non-CF and CF subjects, treatment with IL-13, which causes inflammation with strong pendrin up-regulation, strongly increased Cl-/HCO3- exchange and the increase was blocked by pendrin inhibition. Pendrin inhibition significantly increased ASL depth (by approximate to 8 m) in IL-13-treated non-CF and CF cells but not in untreated cells. These studies implicate the involvement of pendrin-facilitated Cl-/HCO3- in the regulation of ASL volume and suggest the utility of pendrin inhibitors in inflammatory lung diseases, including CF.Haggie, P. M., Phuan, P.-W., Tan, J.-A., Zlock, L., Finkbeiner, W. E., Verkman, A. S. Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis.	[Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Verkman, A. S.] Univ Calif San Francisco, Dept Med, 1246 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA; [Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, 1246 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA; [Zlock, Lorna; Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA.; Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Physiol, 1246 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072517, DK101373]; NIH National Institute of Biomedical Imaging and Bioengineering [R37 EB000415]; NIH National Institute of Allergy and Infectious Diseases [AI111634]; Research Development Program grant from the Cystic Fibrosis Foundation; NIH National Cancer Institute [P30CA082103]; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099803, R01DK101373, P30DK072517] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research Development Program grant from the Cystic Fibrosis Foundation; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank W. Namkung (Yonsei University, Seoul, South Korea) for providing cDNA encoding human pendrin. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants P30 DK072517, DK101373, NIH National Institute of Biomedical Imaging and Bioengineering Grant R37 EB000415, NIH National Institute of Allergy and Infectious Diseases Grant AI111634, and by a Research Development Program grant from the Cystic Fibrosis Foundation. The University of California, San Francisco Helen Diller Cancer Center Genome Analysis Core is supported by NIH National Cancer Institute Grant P30CA082103.	Adams KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103263; Anderson WH, 2015, AM J RESP CRIT CARE, V192, P182, DOI 10.1164/rccm.201412-2230OC; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Brvar M, 2012, J MED CHEM, V55, P6413, DOI 10.1021/jm300395d; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Carraro S, 2005, ALLERGY, V60, P476, DOI 10.1111/j.1398-9995.2005.00718.x; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Comandini A, 2009, RESP MED, V103, P1592, DOI 10.1016/j.rmed.2009.06.002; Derichs N, 2011, FASEB J, V25, P2325, DOI 10.1096/fj.10-179549; Donaldson SH, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009787; Donovan C., TRENDS PHAR IN PRESS; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fujita K, 2010, TOXICOLOGY, V274, P34, DOI 10.1016/j.tox.2010.05.004; Geldenhuys WJ, 2010, J MED CHEM, V53, P8080, DOI 10.1021/jm1010012; Ghosh A, 2015, CELL MOL LIFE SCI, V72, P3637, DOI 10.1007/s00018-015-1946-7; Gour N, 2015, CYTOKINE, V75, P68, DOI 10.1016/j.cyto.2015.05.014; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Ishida A, 2012, ALLERGOL INT, V61, P589, DOI 10.2332/allergolint.11-OA-0370; Kopp P, 2008, TRENDS ENDOCRIN MET, V19, P260, DOI 10.1016/j.tem.2008.07.001; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Lazo-Fernandez Y, 2015, AM J PHYSIOL-ENDOC M, V309, pE534, DOI 10.1152/ajpendo.00035.2015; Lee HJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12480; Lee JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-64; Lewis CC, 2008, AM J RESP CRIT CARE, V177, P376, DOI 10.1164/rccm.200702-333OC; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; May RD, 2015, CYTOKINE, V75, P89, DOI 10.1016/j.cyto.2015.05.018; McCuaig S, 2013, LANCET RESP MED, V1, P137, DOI 10.1016/S2213-2600(12)70058-9; Milonski J, 2015, DNA CELL BIOL, V34, P342, DOI 10.1089/dna.2014.2712; Nakagami Y, 2008, J IMMUNOL, V181, P2203, DOI 10.4049/jimmunol.181.3.2203; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Nofziger C, 2011, CELL PHYSIOL BIOCHEM, V28, P571, DOI 10.1159/000335115; Oh JH, 2012, TOXICOL IND HEALTH, V28, P203, DOI 10.1177/0748233711410906; Okoye-Okafor UC, 2015, NAT CHEM BIOL, V11, P878, DOI 10.1038/nchembio.1930; Pedemonte N, 2007, J IMMUNOL, V178, P5144, DOI 10.4049/jimmunol.178.8.5144; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Rubin Bruce K, 2014, Transl Respir Med, V2, P6, DOI 10.1186/2213-0802-2-6; Scanlon KM, 2014, INFECT IMMUN, V82, P4212, DOI 10.1128/IAI.02222-14; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Seshadri S, 2015, J ALLERGY CLIN IMMUN, V136, P1548, DOI 10.1016/j.jaci.2015.05.024; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wall SM, 2015, ANNU REV PHYSIOL, V77, P363, DOI 10.1146/annurev-physiol-021014-071854; Wangemann P, 2013, CELL PHYSIOL BIOCHEM, V32, P157, DOI 10.1159/000356635; Wangemann P, 2011, CELL PHYSIOL BIOCHEM, V28, P527, DOI 10.1159/000335113; Yick CY, 2013, EUR RESPIR J, V42, P662, DOI 10.1183/09031936.00115412; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155; Zhu J, 2015, J MED CHEM, V58, P5637, DOI 10.1021/acs.jmedchem.5b00753	66	33	36	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2187	2197		10.1096/fj.201600223R	http://dx.doi.org/10.1096/fj.201600223R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26932931	Green Published			2022-12-28	WOS:000376878300012
J	Philip, F; Sahu, S; Golebiewska, U; Scarlata, S				Philip, Finly; Sahu, Shriya; Golebiewska, Urszula; Scarlata, Suzanne			RNA-induced silencing attenuates G protein-mediated calcium signals	FASEB JOURNAL			English	Article						calcium signaling; G protein signaling; phospholipase C beta	PHOSPHOLIPASE C-BETA; C3PO; INTERFERENCE; C-BETA(2); SUBUNITS; BINDING	Phospholipase C beta (PLC beta) is activated by G protein subunits in response to environmental stimuli to increase intracellular calcium. In cells, a significant portion of PLC beta is cytosolic, where it binds a protein complex required for efficient RNA-induced silencing called C3PO (component 3 promoter of RISC). Binding between C3PO and PLC beta raises the possibility that RNA silencing activity can affect the ability of PLC beta to mediate calcium signals. By use of human and rat neuronal cell lines (SK-N-SH and PC12), we show that overexpression of one of the main components of C3PO diminishes Ca2+ release in response to G alpha(q)/PLC beta stimulation by 30 to 40%. In untransfected SK-N-SH or PC12 cells, the introduction of siRNA(GAPDH) [small interfering RNA(glyceraldehyde 3-phosphate dehydrogenase)] reduces PLC beta-mediated calcium signals by similar to 30%, but addition of siRNA(Hsp90) (heat shock protein 90) had little effect. Fluorescence imaging studies suggest an increase in PLC beta-C3PO association in cells treated with siRNA(GAPDH) but not siRNA(Hsp90). Taken together, our studies raise the possibility that Ca2+ responses to extracellular stimuli can be modulated by components of the RNA silencing machinery.-Philip, F., Sahu, S., Golebiewska, U., Scarlata, S. RNA-induced silencing attenuates G protein-mediated calcium signals. www.fasebj.org	[Philip, Finly; Sahu, Shriya; Golebiewska, Urszula; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Golebiewska, Urszula] Queensborough Community Coll, Dept Biol Sci, Bayside, NY USA; [Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Worcester Polytechnic Institute	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [GM116187]	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to P. Brink for providing the HNC2 morpholino, B. Calizo for help with the fluorescence correlation spectroscopy instrument, Drs. Yerramelli and Guo for their helpful comments, and O. Garwain for sharing his PLC beta localization data. This study was supported by the U.S. National Institutes of Health, National Institute of General Medical Sciences Grant GM116187.	Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Bading H, 1997, BIOCHEM BIOPH RES CO, V236, P541, DOI 10.1006/bbrc.1997.7037; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Kim TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109378; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Oka T, 2002, BRIT J PHARMACOL, V135, P1959, DOI 10.1038/sj.bjp.0704662; Philip Finly, 2013, Advances in Biological Regulation, V53, P319, DOI 10.1016/j.jbior.2013.07.002; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Sahu S, 2014, J BIOL CHEM, V289, P5134, DOI 10.1074/jbc.M113.531467; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tuschl Thomas, 2003, P265; Ullu E, 2002, PHILOS T ROY SOC B, V357, P65, DOI 10.1098/rstb.2001.0952; Valiunas V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12286; Wang J, 2004, BIOCHEMISTRY-US, V43, P13424, DOI 10.1021/bi048847l; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032	25	8	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1958	1967		10.1096/fj.201500140	http://dx.doi.org/10.1096/fj.201500140			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26862135	Green Published			2022-12-28	WOS:000374879400023
J	Wang, YY; Surzenko, N; Friday, WB; Zeisel, SH				Wang, Yanyan; Surzenko, Natalia; Friday, Walter B.; Zeisel, Steven H.			Maternal dietary intake of choline in mice regulates development of the cerebral cortex in the offspring	FASEB JOURNAL			English	Article						neurogenesis; EGFR; cortical development	EPIDERMAL-GROWTH-FACTOR; EMBRYONIC-DEVELOPMENT ALTERS; AVAILABILITY ALTERS; MOUSE HIPPOCAMPUS; PROGENITOR CELLS; DNA METHYLATION; GENE-EXPRESSION; FACTOR RECEPTOR; MESSENGER-RNA; EGF RECEPTOR	Maternal diets low in choline, an essential nutrient, increase the risk of neural tube defects and lead to low performance on cognitive tests in children. However, the consequences of maternal dietary choline deficiency for the development and structural organization of the cerebral cortex remain unknown. In this study, we fed mouse dams either control (CT) or low-choline (LC) diets and investigated the effects of choline on cortical development in the offspring. As a result of a low choline supply between embryonic day (E) 11 and E17 of gestation, the number of 2 types of cortical neural progenitor cells (NPCs)-radial glial cells and intermediate progenitor cells-was reduced in fetal brains (P < 0.01). Furthermore, the number of upper layer cortical neurons was decreased in the offspring of dams fed an LC diet at both E17 (P < 0.001) and 4mo of age (P < 0.001). These effects of LC maternal diet were mediated by a decrease in epidermal growth factor receptor (EGFR) signaling in NPCs related to the disruption of EGFR posttranscriptional regulation. Our findings describe a novel mechanism whereby low maternal dietary intake of choline alters brain development.-Wang, Y., Surzenko, N., Friday, W. B., Zeisel, S. H. Maternal dietary intake of choline in mice regulates development of the cerebral cortex in the offspring. FASEB J. 30, 1566-1578 (2016). www.fasebj.org	[Wang, Yanyan; Surzenko, Natalia; Friday, Walter B.; Zeisel, Steven H.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Wang, Yanyan] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Surzenko, Natalia; Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Army Medical University; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu			North Carolina Biotechnology Center [2012-CFG-8005]; U.S. National Institutes of Health, Diabetes and Digestive and Kidney Diseases [DK056350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	North Carolina Biotechnology Center; U.S. National Institutes of Health, Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. G. Enikolopov for the Nestin-CFP mouse line; Dr. S. Rosenfeld for the EGFR-eGFP and CLE-eGFP; S. Orena for help with flow cytometry; M. G. Mehedint for help with the NPC culture; K. D. Corbin for help with Western blot and immunoprecipitation analysis; and the other members of the Zeisel laboratory for technical assistance. This work was supported by North Carolina Biotechnology Center Grant 2012-CFG-8005 and U.S. National Institutes of Health, Diabetes and Digestive and Kidney Diseases Grant DK056350. S.H.Z. owns equity in Nutrigene Sciences, and is a consultant for Dupont, Metabolon and Nestle. None of these activities are in conflict with this paper. The authors declare no conflicts of interest.	Albright CD, 2005, DEV BRAIN RES, V159, P149, DOI 10.1016/j.devbrainres.2005.07.002; Albright CD, 2005, CELL PHYSIOL BIOCHEM, V15, P59, DOI 10.1159/000083653; Albright CD, 2003, NUTR NEUROSCI, V6, P129, DOI 10.1080/1028415031000084418; Albright CD, 2001, DEV NEUROSCI-BASEL, V23, P100, DOI 10.1159/000048701; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Burrows RT, 2000, DEV NEUROSCI-BASEL, V22, P7, DOI 10.1159/000017422; Caric D, 2001, DEVELOPMENT, V128, P4203; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Eagleson KL, 1996, CEREB CORTEX, V6, P540, DOI 10.1093/cercor/6.3.540; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gebhardt ML, 2014, NUCLEIC ACIDS RES, V42, P5436, DOI 10.1093/nar/gku231; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Gossell-Williams M, 2005, W INDIAN MED J, V54, P355; Guo-Ross SX, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0005.2002; Henson RNA, 2002, NEUROIMAGE, V17, P543, DOI 10.1006/nimg.2002.1229; Holmes GL, 2002, EPILEPSY RES, V48, P3, DOI 10.1016/S0920-1211(01)00321-7; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Jones M. W., 2002, Current Molecular Medicine (Hilversum), V2, P639, DOI 10.2174/1566524023361989; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LAZAR LM, 1992, J NEUROSCI, V12, P1688; Lemcke H, 2013, CELL SIGNAL, V25, P2676, DOI 10.1016/j.cellsig.2013.08.030; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-12; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2005, MOL BRAIN RES, V134, P309, DOI 10.1016/j.molbrainres.2004.11.001; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Resseguie M. E., 2011, J BIOL CHEM, V286, P1649; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; SEROOGY KB, 1995, BRAIN RES, V670, P157, DOI 10.1016/0006-8993(94)01300-7; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Thomas JD, 2007, BEHAV NEUROSCI, V121, P120, DOI 10.1037/0735-7044.121.1.120; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; ZEISEL SH, 1995, J NUTR, V125, P3049; Zeisel SH, 2006, J PEDIATR-US, V149, pS131, DOI 10.1016/j.jpeds.2006.06.065; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	61	36	37	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1566	1578		10.1096/fj.15-282426	http://dx.doi.org/10.1096/fj.15-282426			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700730	Green Published, Green Submitted			2022-12-28	WOS:000372629100018
J	Kim, C; Smith, KE; Castillejos, A; Diaz-Aguilar, D; Saint-Geniez, M; Connor, KM				Kim, Clifford; Smith, Kaylee E.; Castillejos, Alexandra; Diaz-Aguilar, Daniel; Saint-Geniez, Magali; Connor, Kip M.			The alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathy	FASEB JOURNAL			English	Article						Cd55; Cd59; factor b; innate immune system; OIR; Vegf	ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; NEOVASCULARIZATION; ANGIOGENESIS; MOUSE; INHIBITION; IMMUNOLOGY; ANTIBODY; SYSTEM; CELLS	Proliferative retinopathic diseases often progress in 2 phases: initial regression of retinal vasculature (phase 1) followed by subsequent neovascularization (NV) (phase 2). The immune system has been shown to aid in vascular pruning in such retinopathies; however, little is known about the role of the alternative complement pathway in the initial vascular regression phase. Using a mouse model of oxygen-induced retinopathy (OIR), we observed that alternative complement pathway-deficient mice (Fb(-/-)) exhibited a mild decrease in vascular loss at postnatal day (P)8 compared with age- and strain-matched controls (P = 0.035). Laser capture microdissection was used to isolate the retinal blood vessels. Expression of the complement inhibitors Cd55 and Cd59 was significantly decreased in blood vessels isolated from hyperoxic retinas compared with those from normoxic control mice. Vegf expression was measured at P8 and found to be significantly lower in OIR mice than in normoxic control mice (P = 0.0048). Further examination of specific Vegf isoform expression revealed a significant decrease in Vegf120 (P = 0.00032) and Vegf188 (P = 0.0092). In conjunction with the major modulating effects of Vegf during early retinal vascular development, our data suggest a modest involvement of the alternative complement pathway in targeting vessels for regression in the initial vaso-obliteration stage of OIR.	[Kim, Clifford; Smith, Kaylee E.; Castillejos, Alexandra; Diaz-Aguilar, Daniel; Connor, Kip M.] Massachusetts Eye & Ear Infirm, Angiogenesis Lab, Boston, MA 02114 USA; [Kim, Clifford; Smith, Kaylee E.; Castillejos, Alexandra; Diaz-Aguilar, Daniel; Saint-Geniez, Magali; Connor, Kip M.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [Saint-Geniez, Magali] Schepens Eye Res Inst, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Schepens Eye Research Institute	Connor, KM (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol,Angiogenesis Lab, 243 Cambridge St, Boston, MA 02114 USA.	kip_connor@meei.harvard.edu	SAINT-GENIEZ, MAGALI/P-3509-2019	SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; Connor, Kip/0000-0002-2048-9080	U.S. National Institutes of Health/National Eye Institute [R01EY022084/S1, P30EY014104]; Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; March of Dimes Foundation [5-FY09-535]; Fight for Sight, Inc. Student Fellowship Award; Research to Prevent Blindness (RPB) Special Research Scholar Award; NATIONAL EYE INSTITUTE [R01EY022084, P30EY014104] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; March of Dimes Foundation(March of Dimes); Fight for Sight, Inc. Student Fellowship Award; Research to Prevent Blindness (RPB) Special Research Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by U.S. National Institutes of Health/National Eye Institute Grants R01EY022084/S1 (to K.M.C.) and P30EY014104; the Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; the March of Dimes Foundation Grant 5-FY09-535; a Fight for Sight, Inc. Student Fellowship Award; and a Research to Prevent Blindness (RPB) Special Research Scholar Award (to K.M.C.). The authors declare no conflicts of interest.	Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Darland DC, 2011, DEV BIOL, V358, P9, DOI 10.1016/j.ydbio.2011.06.045; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Fischetti F, 2006, AUTOIMMUNITY, V39, P417, DOI 10.1080/08916930600739712; FLYNN JT, 1987, PEDIATR CLIN N AM, V34, P1487; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Good WV, 2001, OPHTHALMOLOGY, V108, P1013, DOI 10.1016/S0161-6420(01)00540-1; HAMILTON KK, 1990, BLOOD, V76, P2572; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Harris CL, 1999, BIOCHEM J, V341, P821, DOI 10.1042/0264-6021:3410821; Langer HF, 2010, BLOOD, V116, P4395, DOI 10.1182/blood-2010-01-261503; Mechoulam Hadas, 2003, Am J Pharmacogenomics, V3, P261, DOI 10.2165/00129785-200303040-00004; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stem MS, 2013, CURR MED CHEM, V20, P3241, DOI 10.2174/09298673113209990027; Sweigard JH, 2014, FASEB J, V28, P3171, DOI 10.1096/fj.14-251041; Taylor PR, 1998, J BIOL CHEM, V273, P1699, DOI 10.1074/jbc.273.3.1699; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	27	7	8	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1300	1305		10.1096/fj.15-280834	http://dx.doi.org/10.1096/fj.15-280834			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631482	Green Published			2022-12-28	WOS:000370387800025
J	Sampson, LL; Davis, AK; Grogg, MW; Zheng, Y				Sampson, Leesa L.; Davis, Ashley K.; Grogg, Matthew W.; Zheng, Yi			mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice	FASEB JOURNAL			English	Article						intestinal enteroid; mouse genetics; radiation-induced injury	CRE-MEDIATED RECOMBINATION; ADULT STEM-CELLS; PROTEIN-KINASE; PANETH CELLS; DIFFERENTIATION; GENE; ABLATION; CANCER; DOWNSTREAM; REVEALS	Intestinal stem cells (ISCs) drive small intestinal epithelial homeostasis and regeneration. Mechanistic target of rapamycin (mTOR) regulates stem and progenitor cell metabolism and is frequently dysregulated in human disease, but its physiologic functions in the mammalian small intestinal epithelium remain poorly defined. We disrupted the genes mTOR, Rptor, Rictor, or both Rptor and Rictor in mouse ISCs, progenitors, and differentiated intestinal epithelial cells (IECs) using Villin-Cre. Mutant tissues and wild-type or heterozygous littermate controls were analyzed by histologic immunostaining, immunoblots, and proliferation assays. A total of 10 Gy irradiation was used to injure the intestinal epithelium and induce subsequent crypt regeneration. We report that mTOR supports absorptive enterocytes and secretory Paneth and goblet cell function while negatively regulating chromogranin A-positive enteroendocrine cell number. Through additional Rptor, Rictor, and Rptor/Rictor mutant mouse models, we identify mechanistic target of rapamycin complex 1 as the major IEC regulatory pathway, but mechanistic target of rapamycin complex 2 also contributes to ileal villus maintenance and goblet cell size. Homeostatic adult small intestinal crypt cell proliferation, survival, and canonical wingless-int (WNT) activity are not mTOR dependent, but Olfm4(+) ISC/progenitor population maintenance and crypt regeneration postinjury require mTOR. Overall, we conclude that mTOR regulates multiple IEC lineages and promotes stem and progenitor cell activity during intestinal epithelium repair post-injury.	[Sampson, Leesa L.; Davis, Ashley K.; Grogg, Matthew W.; Zheng, Yi] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Zheng, Y (corresponding author), Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org		Kuenzi Davis, Ashley/0000-0003-1162-3994	U.S. National Institutes of Health (NIH) National Cancer Institute Grant [5T32CA117846-05]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [F32DK097879-01, P30DK090971]; NIH National Institute on Aging Grant [R01AG040118]; NIH NIDDK Grant of the Digestive Disease Research Core Center [P30DK078392]; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK097879, P30DK090971, P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute Grant; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging Grant; NIH NIDDK Grant of the Digestive Disease Research Core Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ming Liu (Sichuan University, Chengdu, China), Yuan-Hung Lo (Baylor University, Waco, TX, USA), and James Johnson and Jeff Vallance (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA) for sharing protocols and providing technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant 5T32CA117846-05 (to L.L.S.), NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants F32DK097879-01 (to L.L.S.) and P30DK090971 (to Y.Z.), and NIH National Institute on Aging Grant R01AG040118 (to Y.Z.). This project was supported in part by NIH NIDDK Grant P30DK078392 (Pathology Core) of the Digestive Disease Research Core Center. L.L.S. designed and performed experiments, analyzed data, wrote the manuscript, and obtained funding. A.K.D. and M.W.G. performed experiments, analyzed data, and edited the manuscript. Y.Z. designed experiments, analyzed data, wrote the manuscript, and obtained funding.	Ables ET, 2012, WIRES DEV BIOL, V1, P657, DOI 10.1002/wdev.48; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bates MD, 2002, GASTROENTEROLOGY, V122, P1467, DOI 10.1053/gast.2002.32975; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Dailey MJ, 2014, PHYSIOL BEHAV, V136, P74, DOI 10.1016/j.physbeh.2014.03.026; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Driver I, 2014, DEVELOPMENT, V141, P1848, DOI 10.1242/dev.104018; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Francipane MG, 2014, ONCOTARGET, V5, P49, DOI 10.18632/oncotarget.1548; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fuller MK, 2012, J SURG RES, V178, P48, DOI 10.1016/j.jss.2012.03.037; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gonzalez-Estevez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002619; Gregorieff A, 2010, CURR PROTOC STEM CEL; Guo FK, 2013, HAEMATOLOGICA, V98, P1353, DOI 10.3324/haematol.2012.080424; Hansen CF, 2014, REGUL PEPTIDES, V189, P31, DOI 10.1016/j.regpep.2014.01.002; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hoist JJ, 2013, CURR OPIN PHARMACOL, V13, P983, DOI 10.1016/j.coph.2013.09.014; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Klement RJ, 2014, CANCER METAST REV, V33, P217, DOI 10.1007/s10555-014-9495-3; Kong SF, 1998, PATHOL RES PRACT, V194, P741, DOI 10.1016/S0344-0338(98)80063-0; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; LaFever L, 2010, DEVELOPMENT, V137, P2117, DOI 10.1242/dev.050351; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Moran-Ramos S, 2012, ADV NUTR, V3, P8, DOI 10.3945/an.111.000976; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Rachdi L, 2012, DIABETES, V61, P409, DOI 10.2337/db11-0765; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; ShawSmith CJ, 1997, GUT, V40, P5, DOI 10.1136/gut.40.1.5; Shepherd NA, 2013, MORSON DAWSONS GASTR; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wang X, 2015, NATURE, V522, P173, DOI 10.1038/nature14484; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005	61	60	62	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1263	1275		10.1096/fj.15-278606	http://dx.doi.org/10.1096/fj.15-278606			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631481	Green Published			2022-12-28	WOS:000370387800022
J	Roy, A; Dakroub, M; Tezini, GCSV; Liu, Y; Guatimosim, S; Feng, QP; Salgado, HC; Prado, VF; Prado, MAM; Gros, R				Roy, Ashbeel; Dakroub, Mouhamed; Tezini, Geisa C. S. V.; Liu, Yin; Guatimosim, Silvia; Feng, Qingping; Salgado, Helio C.; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert			Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions	FASEB JOURNAL			English	Article						heart disease; choline acetyltransferase; heart failure; nonneuronal acetylcholine; VAChT	CONGESTIVE-HEART-FAILURE; RECEPTOR-DEFICIENT MICE; LONG-TERM SURVIVAL; ANGIOTENSIN-II; SYMPATHETIC CONTROL; INDUCED HYPERTROPHY; ACTIVATION; RESPONSES; VAGAL; STIMULATION	Autonomic dysfunction is a characteristic of cardiac disease and decreased vagal activity is observed in heart failure. Rodent cardiomyocytes produce de novo ACh, which is critical in maintaining cardiac homeostasis. We report that this nonneuronal cholinergic system is also found in human cardiomyocytes, which expressed choline acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT). Furthermore, VAChT expression was increased 3-and 1.5-fold at the mRNA and protein level, respectively, in ventricular tissue from patients with heart failure, suggesting increased ACh secretion in disease. We used mice with genetic deletion of cardiomyocyte specific VAChT or ChAT and mice overexpressing VAChT to test the functional significance of cholinergic signaling. Mice deficient for VAChT displayed an 8% decrease in fractional shortening and 13% decrease in ejection fraction compared with angiotensin II (Ang II)-treated control animals, suggesting enhanced ventricular dysfunction and pathologic remodeling in response to Ang II. Similar results were observed in ChAT-deficient mice. Conversely, no decline in ventricular function was observed in Ang II-treated VAChT overexpressors. Furthermore, the fibrotic area was significantly greater (P < 0.05) in Ang II-treated VAChT-deficient mice (3.61 6 0.64%) compared with wild-type animals (2.24 +/- 0.11%). In contrast, VAChT overexpressing mice did not display an increase in collagen deposition. Our results provide new insight into cholinergic regulation of cardiac function, suggesting that a compensatory increase in cardiomyocyte VAChT levels may help offset cardiac remodeling in heart failure.	[Roy, Ashbeel; Dakroub, Mouhamed; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Univ Western Ontario, Robarts Res Inst, 1151 Richmond St N, London, ON N6A 5B7, Canada; [Roy, Ashbeel; Dakroub, Mouhamed; Liu, Yin; Feng, Qingping; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Feng, Qingping; Gros, Robert] Univ Western Ontario, Dept Med, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Tezini, Geisa C. S. V.; Salgado, Helio C.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, BR-14049 Ribeirao Preto, Brazil; [Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Prado, MAM; Gros, R (corresponding author), Univ Western Ontario, Robarts Res Inst, 1151 Richmond St N, London, ON N6A 5B7, Canada.	mprado@robarts.ca; rgros@robarts.ca	Guatimosim, Silvia/AAN-7441-2021; Prado, Marco Antonio Maximo/K-7638-2013; Gros, Robert/A-3010-2009; Gros, Robert/AAV-2237-2020; Prado, Vania/K-7630-2013	Guatimosim, Silvia/0000-0001-8386-3722; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011; Prado, Vania/0000-0003-4994-6393; Feng, Qingping/0000-0001-9739-2765	Heart and Stroke Foundation of Ontario [NA6656, G-13-0002843]; Canadian Institutes for Health Research [MOP-82756, MOP-89919]; Canadian Foundation for Innovation; Ontario Research Fund; U.S. National Institutes for Health Fogarty International Center [R03TW008425]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); Heart and Stroke Foundation of Canada; Ontario Graduate Scholarship; FAPESP; FOGARTY INTERNATIONAL CENTER [R03TW008425] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; U.S. National Institutes for Health Fogarty International Center; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ontario Graduate Scholarship(Ontario Graduate Scholarship); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors thank M. Watson (Duke Human Heart Repository) for assistance in obtaining human HF samples. This work was supported by the Heart and Stroke Foundation of Ontario (NA6656 and G-13-0002843), Canadian Institutes for Health Research (MOP-82756 and MOP-89919), Canadian Foundation for Innovation, the Ontario Research Fund, and the U.S. National Institutes for Health Fogarty International Center Grant R03TW008425 to S.G. S.G. was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). H.C.S. was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). R.G. was supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. A.R. was supported by an Ontario Graduate Scholarship. G.C.S.V.T. received a FAPESP postdoctoral fellowship.	Beraldo FH, 2013, FASEB J, V27, P3594, DOI 10.1096/fj.13-232280; BINKLEY PF, 1991, J AM COLL CARDIOL, V18, P464, DOI 10.1016/0735-1097(91)90602-6; Braunwald E, 2000, CIRCULATION, V102, P14; Bravo DT, 2005, NEUROCHEM INT, V47, P243, DOI 10.1016/j.neuint.2005.05.002; Bravo DT, 2004, J NEUROCHEM, V91, P766, DOI 10.1111/j.1471-4159.2004.02746.x; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Coso OA, 1996, J BIOL CHEM, V271, P3963; Crittenden JR, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00057; DiPiro J., 2008, PHARMACOTHERAPY PATH, V1; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Fujii T, 1996, J NEUROSCI RES, V44, P66, DOI 10.1002/(SICI)1097-4547(19960401)44:1<66::AID-JNR9>3.0.CO;2-G; Gavioli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100179; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; GRASSI G, 1995, CIRCULATION, V92, P3206, DOI 10.1161/01.CIR.92.11.3206; Grassi G, 2001, CLIN SCI, V101, P141, DOI 10.1042/CS20000326; Gutkind JS, 1997, LIFE SCI, V60, P999; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Kakinuma Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004887; Kakinuma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050761; Kanazawa H, 2010, J CLIN INVEST, V120, P408, DOI 10.1172/JCI39778; KENT KM, 1974, CIRCULATION, V50, P948, DOI 10.1161/01.CIR.50.5.948; KINUGAWA T, 1995, AM J PHYSIOL-REG I, V268, pR310, DOI 10.1152/ajpregu.1995.268.2.R310; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lataro RM, 2013, AM J PHYSIOL-REG I, V305, pR908, DOI 10.1152/ajpregu.00102.2013; Lau JK, 2013, CANCER RES, V73, P1328, DOI 10.1158/0008-5472.CAN-12-3190; Laursen JB, 1997, CIRCULATION, V95, P588, DOI 10.1161/01.CIR.95.3.588; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Li MH, 2013, CIRC J, V77, P2519, DOI 10.1253/circj.CJ-13-0476; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Marano G, 1997, J HYPERTENS, V15, P1019, DOI 10.1097/00004872-199715090-00013; Marti CN, 2014, CIRC-HEART FAIL, V7, P5, DOI 10.1161/CIRCHEARTFAILURE.113.000344; MASSIE BM, 1988, J AM COLL CARDIOL, V12, P547, DOI 10.1016/0735-1097(88)90433-0; Nishiyama A, 2001, HYPERTENSION, V37, P77, DOI 10.1161/01.HYP.37.1.77; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Oliverio MI, 1997, AM J PHYSIOL-RENAL, V272, pF515, DOI 10.1152/ajprenal.1997.272.4.F515; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; RINNER I, 1993, J NEUROSCI RES, V35, P188, DOI 10.1002/jnr.490350209; Rocha-Resende C, 2012, J MOL CELL CARDIOL, V53, P206, DOI 10.1016/j.yjmcc.2012.05.003; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Roy A, 2014, MOL MED, V20, P527, DOI 10.2119/molmed.2014.00125; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039997; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Shanmugam P, 2011, J MOL CELL CARDIOL, V50, P928, DOI 10.1016/j.yjmcc.2011.02.012; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	57	23	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					688	701		10.1096/fj.15-277046	http://dx.doi.org/10.1096/fj.15-277046			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481308	Green Published, Green Submitted			2022-12-28	WOS:000369391900020
J	Crump, SM; Hu, ZY; Kant, R; Levy, DI; Goldstein, SAN; Abbott, GW				Crump, Shawn M.; Hu, Zhaoyang; Kant, Ritu; Levy, Daniel I.; Goldstein, Steve A. N.; Abbott, Geoffrey W.			Kcne4 deletion sex- and age-specifically impairs cardiac repolarization in mice	FASEB JOURNAL			English	Article							MINK-RELATED PEPTIDES; ATRIAL-FIBRILLATION; POTASSIUM CHANNELS; INHIBITORY SUBUNIT; K+ CURRENTS; HUMAN HEART; MOUSE; HORMONES; KCNQ1; TRAFFICKING	Myocardial repolarization capacity varies with sex, age, and pathology; the molecular basis for this variation is incompletely understood. Here, we show that the transcript for KCNE4, a voltage-gated potassium (K-v) channel beta subunit associated with human atrial fibrillation, was 8-fold more highly expressed in the male left ventricle compared with females in young adult C57BL/6 mice (P < 0.05). Similarly, K-v current density was 25% greater in ventricular myocytes from young adult males (P < 0.05). Germ-line Kcne4 deletion eliminated the sex-specific K-v current disparity by diminishing ventricular fast transient outward current (I-to,I-f) and slowly activating K+ current (I-K,I- slow1). Kcne4 deletion also reduced K-v currents in male mouse atrial myocytes, by >45% (P < 0.001). As we previously found for K(v)4.2 (which generates mouse I-to,I-f), heterologously expressed KCNE4 functionally regulated K(v)1.5 (the K-v alpha subunit that generates I-Kslow1 in mice). Ofnote, inpostmenopausal female mice, ventricular repolarization was impaired by Kcne4 deletion, and ventricular Kcne4 expression increased to match that of males. Moreover, castration diminished male ventricular Kcne4 expression 2.8-fold, whereas 5 alpha-dihydrotestosterone (DHT) implants in castrated mice increased Kcne4 expression >3-fold (P = 0.01) to match noncastrated levels. KCNE4 is thereby shown to be a DHT-regulated determinant of cardiac excitability and a molecular substrate for sex- and age-dependent cardiac arrhythmogenesis.	[Crump, Shawn M.; Kant, Ritu; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92697 USA; [Crump, Shawn M.; Kant, Ritu; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Hu, Zhaoyang] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610064, Peoples R China; [Hu, Zhaoyang] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu 610064, Peoples R China; [Levy, Daniel I.] Univ Chicago, Dept Med, Nephrol Sect, Chicago, IL 60637 USA; [Goldstein, Steve A. N.] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Sichuan University; Sichuan University; University of Chicago; Brandeis University	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, A-360 Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061; Levy, Daniel/0000-0003-0603-0297	U.S. National Institutes of Health National Heart, Lung and Blood Institute (NHLBI) [HL079275, HL105949]; NHLBI [HL079275-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105949, R01HL079275] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung and Blood Institute (NHLBI); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Daniel Neverisky and Soo Min Lee (University of California, Irvine) for expert technical assistance. This work was funded by U.S. National Institutes of Health National Heart, Lung and Blood Institute (NHLBI) Grants HL079275 (to G.W.A.) and HL105949 (to S.A.N.G.). S.M.C. was supported by NHLBI Postdoctoral Diversity Supplement HL079275-S1 (to G.W.A.).	Abbott GW, 2006, CURR PHARM DESIGN, V12, P3631, DOI 10.2174/138161206778522065; Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bou-Abboud E, 2000, J PHYSIOL-LONDON, V529, P345, DOI 10.1111/j.1469-7793.2000.00345.x; Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012; Crump SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00003; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Fulop L, 2006, ACTA PHYSIOL, V188, P163, DOI 10.1111/j.1748-1716.2006.01618.x; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; Grunnet M, 2003, BIOPHYS J, V85, P1525, DOI 10.1016/S0006-3495(03)74585-8; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Kanda VA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00231; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kundu P, 2008, MOL CELL ENDOCRINOL, V292, P50, DOI 10.1016/j.mce.2008.06.003; Kurokawa Junko, 2012, Handb Exp Pharmacol, P237, DOI 10.1007/978-3-642-30726-3_12; Levy DI, 2008, AM J PHYSIOL-RENAL, V295, pF380, DOI 10.1152/ajprenal.00598.2007; Levy DI, 2010, J PHYSIOL-LONDON, V588, P2657, DOI 10.1113/jphysiol.2010.191395; Ma KJ, 2007, CHINESE MED J-PEKING, V120, P150, DOI 10.1097/00029330-200701020-00017; Magnani JW, 2014, CIRC-ARRHYTHMIA ELEC, V7, P307, DOI 10.1161/CIRCEP.113.001322; Mao Ting, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P916; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Nerbonne JM, 2001, CIRC RES, V89, P944, DOI 10.1161/hh2301.100349; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yang PC, 2010, J CARDIOVASC PHARM, V56, P123, DOI 10.1097/FJC.0b013e3181d6f7dd; Zeng Zhi-yu, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P987; Zeng ZY, 2007, CARDIOLOGY, V108, P97, DOI 10.1159/000095943	38	19	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					360	369		10.1096/fj.15-278754	http://dx.doi.org/10.1096/fj.15-278754			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26399785	Green Submitted, Green Published			2022-12-28	WOS:000367621000034
J	Nahas, GR; Murthy, RG; Patel, SA; Ganta, T; Greco, SJ; Rameshwar, P				Nahas, George R.; Murthy, Raghav G.; Patel, Shyam A.; Ganta, Teja; Greco, Steven J.; Rameshwar, Pranela			The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth	FASEB JOURNAL			English	Article						miRNA; neurokinin-1; REST; substance P; cancer stem cell	TRUNCATED NEUROKININ-1 RECEPTOR; MESENCHYMAL STEM-CELLS; BONE-MARROW STROMA; SUBSTANCE-P; TACHYKININ RECEPTORS; TUMOR PROGRESSION; KAPPA-B; EXPRESSION; ACTIVATION; GENE	Substance P and its truncated receptor exert oncogenic effects. The high production of substance P in breast cancer cells (BCCs) is caused by the enhancement of tachykinin (TAC) 1 translation by cytosolic factor. In vitro translational studies and mRNA stabilization analyses indicate that BCCs contain the factor needed to increase TAC1 translation and to stabilize the mRNA. Prediction of protein folding, RNA-shift analysis, and proteomic analysis identified a 40 kDa molecule that interacts with the non-coding exon 7. Western blot analysis and RNA supershift identified Musashi 1 (Msi1) as the binding protein. Ectopic expression of TAC1 in nontumorigenic breast cells (BCs) indicates that TAC1 regulates its stability by increasing Msi1. Using a reporter gene system, we showed that Msi1 competes with microRNA (miR) 130a and -206 for the 3 ' UTR of exon 7/TAC1. In the absence of Msi1 and miR130a and -206, reporter gene activity decreased, indicating that Msi1 expression limits TAC1 expression. Tumor growth was significantly decreased when nude BALB/c mice were injected with Msi1-knockdown BCCs. In summary, the RNA-binding protein Msi1 competes with miR130a and -206 for interaction with TAC1 mRNA, to stabilize and increase its translation. Consequently, these interactions increase tumor growth.-Nahas, G. R., Murthy, R. G., Patel, S. A., Ganta, T., Greco, S. J., Rameshwar P. The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth. FASEB J. 30, 149-159 (2016). www.fasebj.org	[Nahas, George R.; Murthy, Raghav G.; Patel, Shyam A.; Ganta, Teja; Greco, Steven J.; Rameshwar, Pranela] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rameshwar, P (corresponding author), Rutgers New Jersey Med Sch, 185 South Orange Ave,MSB E-585, Newark, NJ 07103 USA.	rameshwa@njms.rutgers.edu		Ganta, Teja/0000-0003-2441-4104	New Jersey Cancer Commission	New Jersey Cancer Commission	This study was funded by the New Jersey Cancer Commission. The authors declare no conflicts of interest.	Aalto Y, 1998, PEPTIDES, V19, P231, DOI 10.1016/S0196-9781(97)00323-9; Ansquer C, 2009, CURR PHARM DESIGN, V15, P2453, DOI 10.2174/138161209788682262; Bandari PS, 2002, NEUROPEPTIDES, V36, P13, DOI 10.1054/npep.2002.0869; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Castano Z, 2011, INT J DEV BIOL, V55, P889, DOI 10.1387/ijdb.113366zc; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Corcoran KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002563; Eberhardt W, 2012, CURR PROTEIN PEPT SC, V13, P380, DOI 10.2174/138920312801619439; Garcia-Recio S, 2013, CANCER RES, V73, P6424, DOI 10.1158/0008-5472.CAN-12-4573; Gillespie E, 2011, P NATL ACAD SCI USA, V108, P17420, DOI 10.1073/pnas.1114275108; Glazer RI, 2008, CELL CYCLE, V7, P2635, DOI 10.4161/cc.7.17.6522; Greco SJ, 2007, J BIOL CHEM, V282, P30039, DOI 10.1074/jbc.M703026200; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Greco SJ, 2007, J IMMUNOL, V179, P3342, DOI 10.4049/jimmunol.179.5.3342; Klassert TE, 2008, J NEUROIMMUNOL, V196, P27, DOI 10.1016/j.jneuroim.2008.02.010; Klassert TE, 2010, J RECEPT LIGAND CH R, V3, P51; Lagadec C, 2014, STEM CELLS, V32, P135, DOI 10.1002/stem.1537; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lu XY, 2011, HISTOL HISTOPATHOL, V26, P1127, DOI 10.14670/HH-26.1127; Mancino M, 2011, BBA-REV CANCER, V1816, P105, DOI 10.1016/j.bbcan.2011.04.005; Mayordomo C, 2012, J CELL PHYSIOL, V227, P1358, DOI 10.1002/jcp.22848; Moharita AL, 2006, BLOOD, V108, P3245, DOI 10.1182/blood-2006-01-017459; Navarro P, 2012, EXP CELL RES, V318, P2604, DOI 10.1016/j.yexcr.2012.09.002; Nikpour P, 2011, J CELL MOL MED, V15, P1210, DOI 10.1111/j.1582-4934.2010.01090.x; Nowicki M, 2008, LEUKEMIA RES, V32, P97, DOI 10.1016/j.leukres.2007.05.006; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Page NM, 2005, PEPTIDES, V26, P1356, DOI 10.1016/j.peptides.2005.03.030; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Patel HJ, 2005, P NATL ACAD SCI USA, V102, P17436, DOI 10.1073/pnas.0506351102; Patel SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00906; Pavlovic S, 2011, J IMMUNOL, V186, P848, DOI 10.4049/jimmunol.0903878; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Pinto FM, 2004, EUR J PHARMACOL, V494, P233, DOI 10.1016/j.ejphar.2004.05.016; Rameshwar Pranela, 2012, Recent Pat CNS Drug Discov, V7, P173; Ramkissoon SH, 2006, EXPERT OPIN BIOL TH, V6, P109, DOI 10.1517/14712598.6.2.109; Ramkissoon SH, 2007, CANCER RES, V67, P1653, DOI 10.1158/0008-5472.CAN-06-3813; Rao G, 2004, CANCER RES, V64, P2874, DOI 10.1158/0008-5472.CAN-03-3121; Reddy Bobby Y, 2008, Curr Drug Discov Technol, V5, P15; Rodriguez PL, 2014, INT J CANCER, V134, P1034, DOI 10.1002/ijc.28433; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Sugiyama-Nakagiri Y, 2006, AM J PATHOL, V168, P80, DOI 10.2353/ajpath.2006.050469; Todd AJ, 2002, EXP PHYSIOL, V87, P245, DOI 10.1113/eph8702351; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Zhou YL, 2013, BREAST CANCER RES TR, V140, P49, DOI 10.1007/s10549-013-2599-6	48	18	19	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					149	159		10.1096/fj.15-278770	http://dx.doi.org/10.1096/fj.15-278770			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26373800				2022-12-28	WOS:000367621000017
J	Olshina, MA; Baumann, H; Willison, KR; Baum, J				Olshina, Maya A.; Baumann, Hella; Willison, Keith R.; Baum, Jake			Plasmodium actin is incompletely folded by heterologous protein-folding machinery and likely requires the native Plasmodium chaperonin complex to enter a mature functional state	FASEB JOURNAL			English	Article						malaria; apicomplexa; gliding motility; in vitro translation; rabbit reticulocyte lysate	PARASITE TOXOPLASMA-GONDII; MALARIA PARASITE; BETA-ACTIN; EUKARYOTIC CHAPERONIN; CYTOSOLIC CHAPERONIN; FILAMENT STRUCTURE; BINDING-SITES; C-TERMINUS; FALCIPARUM; GENE	Actin filament turnover underpins several processes in the life cycle of the malaria parasite, Plasmodium falciparum. Polymerization and depolymerization are especially important for gliding motility, a substrate-dependent form of cell movement that underpins the protozoan parasite's ability to disseminate and invade host cells. To date, given difficulties in extraction of native actins directly from parasites, much of our biochemical understanding of malarial actin has instead relied on recombinant protein extracted and purified from heterologous protein expression systems. Here, using in vitro transcription-translation methodologies and quantitative protein-binding assays, we explored the folding state of heterologously expressed P. falciparum actin 1 (PfACTI) with the aim of assessing the reliability of current recombinant-protein-based data. We demonstrate that PfACTI, when expressed in non-native systems, is capable of binding to and release from bacterial, yeast, and mammalian chaperonin complexes but appears to be incompletely folded. Characterization of the native Plasmodium folding machinery in silico, the chaperonin containing t-complex protein-1 complex, highlights key divergences between the different chaperonin systems that likely underpins this incomplete folded state. These results highlight the importance of characterizing actin's folded state and raise concerns about the interpretation of actin polymerization kinetics based solely on protein derived from heterologous expression systems.	[Olshina, Maya A.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Olshina, Maya A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Baumann, Hella; Baum, Jake] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Willison, Keith R.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Imperial College London; Imperial College London	Baum, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Alexander Fleming Bldg Level 6, London SW7 2AZ, England.	jake.baum@imperial.ac.uk		Baum, Jake/0000-0002-0275-352X	Human Frontier Science Program Young Investigator Program [RGY0071/2011]; Australia National Health and Medical Research Council Dora Lush Scholarship [APP1018002]; Australian Society for Biochemistry and Molecular Biology; Wellcome Trust [100993/Z/13/Z]	Human Frontier Science Program Young Investigator Program(Human Frontier Science Program); Australia National Health and Medical Research Council Dora Lush Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Society for Biochemistry and Molecular Biology; Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Jacqui Gulbis for ongoing support and advice throughout the project's duration. Supported by Human Frontier Science Program Young Investigator Program Grant RGY0071/2011 (to J.B.). M.A.O. is supported through Australia National Health and Medical Research Council Dora Lush Scholarship APP1018002 and was supported in the United Kingdom with a travel award from the Australian Society for Biochemistry and Molecular Biology. J.B. is supported by the Wellcome Trust, through New Investigator Award 100993/Z/13/Z. The authors declare no conflicts of interest.	Altschuler GM, 2009, FEBS LETT, V583, P782, DOI 10.1016/j.febslet.2009.01.031; Amit M, 2010, J MOL BIOL, V401, P532, DOI 10.1016/j.jmb.2010.06.037; Angrisano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032188; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Das A, 1997, MOL BIOCHEM PARASIT, V88, P95, DOI 10.1016/S0166-6851(97)00081-9; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Deligianni E, 2011, CELL MICROBIOL, V13, P1714, DOI 10.1111/j.1462-5822.2011.01652.x; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; DREWES G, 1993, EUR J BIOCHEM, V212, P247, DOI 10.1111/j.1432-1033.1993.tb17656.x; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; FIELD SJ, 1993, CELL MOTIL CYTOSKEL, V25, P43, DOI 10.1002/cm.970250106; Grantham J, 2000, J BIOL CHEM, V275, P4587, DOI 10.1074/jbc.275.7.4587; Hliscs M, 2015, CELL MICROBIOL, V17, P207, DOI 10.1111/cmi.12359; HOLLOWAY SP, 1994, MOL BIOCHEM PARASIT, V64, P25, DOI 10.1016/0166-6851(94)90131-7; Hynes GM, 2000, J BIOL CHEM, V275, P18985, DOI 10.1074/jbc.M910297199; JOHANNES FJ, 1991, EMBO J, V10, P3951, DOI 10.1002/j.1460-2075.1991.tb04965.x; Kudryashev Mikhail, 2010, PMC Biophys, V3, P6, DOI 10.1186/1757-5036-3-6; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; Lee JY, 2012, J PHYS CHEM B, V116, P1677, DOI 10.1021/jp209340y; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Mizuno Y, 2002, PARASITOL RES, V88, P844, DOI 10.1007/s00436-002-0666-8; Neirynck K, 2006, J MOL BIOL, V355, P124, DOI 10.1016/j.jmb.2005.10.051; ODONOGHUE SI, 1992, ARCH BIOCHEM BIOPHYS, V293, P110, DOI 10.1016/0003-9861(92)90372-4; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Rommelaere H, 1999, BIOCHEMISTRY-US, V38, P3246, DOI 10.1021/bi9815905; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Skillman KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3285; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Smythe WA, 2008, CELL MICROBIOL, V10, P452, DOI 10.1111/j.1462-5822.2007.01058.x; STOURNARAS C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P86, DOI 10.1016/0167-4838(90)90105-O; STOURNARAS C, 1988, BIOCHEM BIOPH RES CO, V155, P962, DOI 10.1016/S0006-291X(88)80590-4; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; Stuart SF, 2011, J BIOL CHEM, V286, P178, DOI 10.1074/jbc.M110.166256; TIAN GL, 1995, NATURE, V375, P250, DOI 10.1038/375250a0; Tsapara A, 1999, FEBS LETT, V455, P117, DOI 10.1016/S0014-5793(99)00848-0; Vahokoski J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004091; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; WESSELING JG, 1988, MOL BIOCHEM PARASIT, V30, P143, DOI 10.1016/0166-6851(88)90107-7; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; XIA D, 1995, CELL MOTIL CYTOSKEL, V32, P163, DOI 10.1002/cm.970320302; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	57	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					405	416		10.1096/fj.15-276618	http://dx.doi.org/10.1096/fj.15-276618			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443825	hybrid, Green Published			2022-12-28	WOS:000367621000038
J	Sundermeier, TR; Palczewski, K				Sundermeier, Thomas R.; Palczewski, Krzysztof			The impact of microRNA gene regulation on the survival and function of mature cell types in the eye	FASEB JOURNAL			English	Review						retina; RPE; photoreceptor; retinal degeneration; gene therapy	RETINAL-PIGMENT EPITHELIUM; SMALL RNAS; ALU RNA; THERAPEUTIC TARGET; NLRP3 INFLAMMASOME; MOUSE RETINA; DIFFERENTIATION; DICER; IDENTIFICATION; ROLES	MicroRNAs (miRNAs) regulate multiple genes, often within the same pathway, fine-tuning expression of key factors and stabilizing gene networks against aberrant fluctuations. The demanding physiologic functions of photoreceptor cells and the retinal pigmented epithelium necessitate precise gene regulation to maintain their homeostasis and function, thus rendering these postmitotic cells vulnerable to premature death in retinal degenerative disorders. Recent studies of the physiologic impact of miRNAs in these cells clearly demonstrate that miRNAs are an essential component of that gene regulation. These important advances provide the foundation for future exploration of miRNA-regulated gene networks in the eye to facilitate the development of miRNA-targeted therapeutics to combat blinding diseases.-Sundermeier, T. R., Palczewski, K. The impact of microRNA gene regulation on the survival and function of mature cell types in the eye. FASEB J. 30, 23-33 (2016). www.fasebj.org	[Sundermeier, Thomas R.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Sundermeier, TR (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	trs7@case.edu; kxp65@case.edu			U.S. National Institutes of Health; National Eye Institute [EY022326]; Arnold and Mabel Beckman Foundation; NATIONAL EYE INSTITUTE [R01EY022326] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Arnold and Mabel Beckman Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Susie Suh (Case Western Reserve University) for comments on this manuscript. This work was supported by funding from the U.S. National Institutes of Health, National Eye Institute (EY022326), and the Arnold and Mabel Beckman Foundation. K.P. is John H. Hord Professor of Pharmacology. The authors declare no conflicts of interest.	Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Chen Y, 2016, ANNU REV PHARMACOL, V56, P273, DOI 10.1146/annurev-pharmtox-010715-103033; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Conte I, 2015, P NATL ACAD SCI USA, V112, pE3236, DOI 10.1073/pnas.1401464112; Conte I, 2014, NUCLEIC ACIDS RES, V42, P7793, DOI 10.1093/nar/gku498; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis N, 2011, DEVELOPMENT, V138, P127, DOI 10.1242/dev.053637; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Decembrini S, 2008, INT J DEV BIOL, V52, P1099, DOI 10.1387/ijdb.082646sd; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Emde A, 2014, EMBO J, V33, P1428, DOI 10.15252/embj.201488142; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gelfand BD, 2015, CELL REP, V11, P1686, DOI 10.1016/j.celrep.2015.05.023; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Georgi SA, 2011, DEV NEUROBIOL, V71, P1153, DOI 10.1002/dneu.20899; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hou Q, 2013, INVEST OPHTH VIS SCI, V54, P6481, DOI 10.1167/iovs.13-11873; Hu QD, 2012, NAT STRUCT MOL BIOL, V19, P1168, DOI 10.1038/nsmb.2400; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P611, DOI 10.1167/iovs.10-6115; Jaskiewicz L, 2012, METHODS, V58, P106, DOI 10.1016/j.ymeth.2012.09.006; Jin ZB, 2009, MOL VIS, V15, P523; Jo MH, 2015, MOL CELL, V59, P117, DOI 10.1016/j.molcel.2015.04.027; Kandalam MM, 2012, MOL VIS, V18, P2279; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Krol J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8305; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Kutty RK, 2013, MOL VIS, V19, P737; Kutty RK, 2010, BIOCHEM BIOPH RES CO, V402, P390, DOI 10.1016/j.bbrc.2010.10.042; Kutty RK, 2010, MOL VIS, V16, P1475; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Makarev E, 2006, MOL VIS, V12, P1386; Marler KJ, 2014, J NEUROSCI, V34, P969, DOI 10.1523/JNEUROSCI.1910-13.2014; Murad N, 2014, FEBS J, V281, P5251, DOI 10.1111/febs.13066; Ohana R, 2015, DEVELOPMENT, V142, P2487, DOI 10.1242/dev.121533; Pandi SPS, 2013, INVEST OPHTH VIS SCI, V54, P8140, DOI 10.1167/iovs.13-12631; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Ryan D, 2006, MOL VIS, V12, P1175; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Schober A, 2015, NAT REV CARDIOL, V12, P361, DOI 10.1038/nrcardio.2015.38; Shaham O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003357; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Sundermeier TR, 2014, FASEB J, V28, P3780, DOI 10.1096/fj.14-254292; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028	78	32	33	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					23	33		10.1096/fj.15-279745	http://dx.doi.org/10.1096/fj.15-279745			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26399786	Green Published			2022-12-28	WOS:000367621000004
J	Liu, YB; Huang, XG; He, X; Zhou, YQ; Jiang, XG; Chen-Kiang, S; Jaffrey, SR; Xu, GQ				Liu, Yaobin; Huang, Xiangao; He, Xian; Zhou, Yanqing; Jiang, Xiaogang; Chen-Kiang, Selina; Jaffrey, Samie R.; Xu, Guoqiang			A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function	FASEB JOURNAL			English	Article						cullin RING ligase; multiple myeloma; lenalidomide; pomalidomide	RING E3 LIGASE; LENALIDOMIDE; PROTEIN; DEGRADATION; AUTOUBIQUITINATION; IDENTIFICATION; EXPRESSION; CHANNEL; ARCHITECTURE; SURVIVAL	The immunomodulatory drug (IMiD) thalidomide and its structural analogs lenalidomide and pomalidomide are highly effective in treating clinical indications. Thalidomide binds to cereblon (CRBN), a substrate receptor of the cullin-4 really interesting new gene (RING) E3 ligase complex. Here, we examine the effect of thalidomide and its analogs on CRBN ubiquitination and its functions in human cell lines. We find that the ubiquitin modification of CRBN includes K48-linked polyubiquitin chains and that thalidomide blocks the formation of CRBN-ubiquitin conjugates. Furthermore, we show that ubiquitinated CRBN is targeted for proteasomal degradation. Treatment of human myeloma cell lines such as MM1.S, OPM2, and U266 with thalidomide (100 mu M) and its structural analog lenalidomide (10 mu M) results in stabilization of CRBN and elevation of CRBN protein levels. This in turn leads to the reduced level of CRBN target proteins and enhances the sensitivity of human multiple myeloma cells to IMiDs. Our results reveal a novel mechanism by which thalidomide and its analogs modulate the CRBN function in cells. Through inhibition of CRBN ubiquitination, thalidomide and its analogs allow CRBN to accumulate, leading to the increased cullin-4 RING E3 ligase-mediated degradation of target proteins.	[Liu, Yaobin; He, Xian; Zhou, Yanqing; Jiang, Xiaogang; Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Suzhou, Jiangsu, Peoples R China; [Liu, Yaobin; He, Xian; Zhou, Yanqing; Jiang, Xiaogang; Xu, Guoqiang] Soochow Univ, Coll Pharmaceut Sci, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China; [Huang, Xiangao; Chen-Kiang, Selina] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA	Soochow University - China; Soochow University - China; Cornell University; Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu; gux2002@suda.edu.cn		Jaffrey, Samie/0000-0003-3615-6958; Xu, Guoqiang/0000-0002-4753-4769	National Basic Research Program of China [2012CB947602]; National Natural Science Foundation of China [31270874]; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases [BM2013003]; Priority Academic Program Development of Jiangsu Higher Education Institutions; U.S. National Institutes of Health (NIH) National Institute of Mental Health [MH086128]; U.S. NIH National Cancer Institute [R01 CA188794]; NATIONAL CANCER INSTITUTE [R01CA188794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086128] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases; Priority Academic Program Development of Jiangsu Higher Education Institutions; U.S. National Institutes of Health (NIH) National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Pengbo Zhou (Weill Medical College, Cornell University, New York, NY, USA) for kindly providing Cul4A and DN-Cul4A plasmids. This work was supported by the National Basic Research Program of China (973 Program, 2012CB947602), the National Natural Science Foundation of China (31270874), Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases (BM2013003), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (to G.X.), U.S. National Institutes of Health (NIH) National Institute of Mental Health (MH086128; to S.R.J.), and U.S. NIH National Cancer Institute (R01 CA188794; to S.C.-K.).	Aizawa M, 2011, NEUROSCI RES, V69, P343, DOI 10.1016/j.neures.2010.12.019; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Broyl A, 2013, BLOOD, V121, P624, DOI 10.1182/blood-2012-06-438101; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Christian MS, 2007, BIRTH DEFECTS RES B, V80, P188, DOI 10.1002/bdrb.20115; Diaz-Rodriguez E, 2016, LEUKEMIA LYMPHOMA, V57, P167, DOI 10.3109/10428194.2015.1037752; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Higgins JJ, 2010, J NEUROGENET, V24, P18, DOI 10.3109/01677060903567849; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lai ZH, 2002, P NATL ACAD SCI USA, V99, P14734, DOI 10.1073/pnas.212428599; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sui YY, 2015, BIOCHEM BIOPH RES CO, V461, P653, DOI 10.1016/j.bbrc.2015.04.085; Suppiah R, 2006, CLIN LYMPHOMA MYELOM, V6, P301, DOI 10.3816/CLM.2006.n.004; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063; Zou YD, 2013, LEUKEMIA LYMPHOMA, V54, P2219, DOI 10.3109/10428194.2013.774393	35	31	32	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4829	4839		10.1096/fj.15-274050	http://dx.doi.org/10.1096/fj.15-274050			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26231201	Green Published			2022-12-28	WOS:000365523600010
J	Nordmaj, MA; Munthe-Fog, L; Hein, E; Skjoedt, MO; Garred, P				Nordmaj, Mie Anemone; Munthe-Fog, Lea; Hein, Estrid; Skjoedt, Mikkel-Ole; Garred, Peter			Genetically engineered fusion of MAP-1 and factor H domains 1-5 generates a potent dual upstream inhibitor of both the lectin and alternative complement pathways	FASEB JOURNAL			English	Article						complement therapeutics; regulation; chimeric molecules; recombinant protein; inflammation	MANNAN-BINDING LECTIN; CRYSTAL-STRUCTURE; ACTIVATION; PROTEIN; IMMUNE; INITIATION; FICOLIN-3; DISEASE; SYSTEM; MBL	Inhibition of the complement cascade has emerged as an option for treatment of a range of diseases. Mannose-binding lectin/ficolin/collectin-associated protein (MAP-1) is a pattern recognition molecule (PRM)-associated inhibitor of the lectin pathway. The central regulator of the alternative pathway (AP) is complement factor H (FH). Our aim was to design a dual upstream inhibitor of both human lectin and APs by fusing MAP-1 with a part of FH. There were 2 different recombinant chimeric proteins comprising full-length human MAP-1 and the first 5N-terminal domains of human FHdesigned. The FH domains were orientated either in the N- or C-terminal part of MAP-1. The complement inhibition potential in human serum was assessed. Both chimeric constructs displayed the characteristics of the native molecules and bound to the PRMs with an EC50 of similar to 2 nM. However, when added to serum diluted 1:4 in a solid-phase functional assay, only the first 5 N-terminal domains of complement FH fused to the C-terminal part of full-length MAP-1 chimeric construct were able to combine inhibition of lectin and AP activation with an half maximal inhibitory concentration of similar to 100 and 20 nM, respectively. No effect was seen on the classical pathway. Fusion of MAP-1 with FH domains represents a novel therapeutic approach for selective targeting upstream and central complement activation at sites of inflammation.	[Nordmaj, Mie Anemone; Munthe-Fog, Lea; Hein, Estrid; Skjoedt, Mikkel-Ole; Garred, Peter] Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, Dept Clin Immunol 7631,Lab Mol Med, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Garred, P (corresponding author), Rigshosp, Mol Med Lab, Dept Clin Immunol 7631, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk		Nordmaj, Mie Anemone/0000-0001-5312-3432; Munthe-Fog, Lea/0000-0003-1345-176X; Garred, Peter/0000-0002-2876-8586; Skjodt, Mikkel-Ole/0000-0003-1306-6482	Novo Nordisk Research Foundation; Svend Andersen Research Foundation; Research Foundation of The Capital Region Denmark; Danish Medical Research Council; Rigshospitalet (Copenhagen, Denmark)	Novo Nordisk Research Foundation(Novo Nordisk Foundation); Svend Andersen Research Foundation; Research Foundation of The Capital Region Denmark; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rigshospitalet (Copenhagen, Denmark)	The technical assistance of Ms. Jytte Bryde Clausen (University of Copenhagen, Copenhagen, Denmark) is highly appreciated. This work was supported by The Novo Nordisk Research Foundation, Svend Andersen Research Foundation, Research Foundation of The Capital Region Denmark, Danish Medical Research Council, and Rigshospitalet (Copenhagen, Denmark). M.-O.S. and P.G. are listed as inventors in an application from the Capital Region of Denmark regarding the use of mannose-binding lectin/ficolin/collectin-associated protein chimeric molecules (patent application number WO2011107591).	ALSENZ J, 1984, BIOCHEM J, V224, P389, DOI 10.1042/bj2240389; Banda NK, 2014, J IMMUNOL, V193, P2455, DOI 10.4049/jimmunol.1400752; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; GORDON DL, 1995, J IMMUNOL, V155, P348; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; HARRISON RA, 1980, MOL IMMUNOL, V17, P9, DOI 10.1016/0161-5890(80)90119-4; Hebecker M, 2013, J IMMUNOL, V191, P912, DOI 10.4049/jimmunol.1300269; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Kjaer TR, 2015, STRUCTURE, V23, P342, DOI 10.1016/j.str.2014.10.024; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; Mastellos DC, 2014, EXPERT REV HEMATOL, V7, P583, DOI 10.1586/17474086.2014.953926; Matsushita M, 1998, CURR OPIN IMMUNOL, V10, P29, DOI 10.1016/S0952-7915(98)80027-7; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pavlov VI, 2012, CIRCULATION, V126, P2227, DOI 10.1161/CIRCULATIONAHA.112.123968; Pickering M, 2011, CURR OPIN NEPHROL HY, V20, P271, DOI 10.1097/MNH.0b013e328345848b; Qiao Q, 2014, FASEB J, V28, P4986, DOI 10.1096/fj.14-258046; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; de Cordoba SR, 2012, IMMUNOBIOLOGY, V217, P1034, DOI 10.1016/j.imbio.2012.07.021; Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sekine H, 2013, ADV EXP MED BIOL, V735, P41, DOI 10.1007/978-1-4614-4118-2_3; Skjoedt MO, 2012, J BIOL CHEM, V287, P32913, DOI 10.1074/jbc.M112.386680; Skjoedt MO, 2011, IMMUNOBIOLOGY, V216, P625, DOI 10.1016/j.imbio.2010.09.011; Skjoedt MO, 2010, IMMUNOBIOLOGY, V215, P921, DOI 10.1016/j.imbio.2009.10.006; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Stover CM, 1999, J IMMUNOL, V162, P3481; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Whaley K, 1997, SEMIN LIVER DIS, V17, P297, DOI 10.1055/s-2007-1007206; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015	50	7	7	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4945	4955		10.1096/fj.15-277103	http://dx.doi.org/10.1096/fj.15-277103			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26260032				2022-12-28	WOS:000365523600020
J	Yester, JW; Bryan, L; Waters, MR; Mierzenski, B; Biswas, DD; Gupta, AS; Bhardwaj, R; Surace, MJ; Eltit, JM; Milstien, S; Spiegel, S; Kordula, T				Yester, Jessie W.; Bryan, Lauren; Waters, Michael R.; Mierzenski, Bartosz; Biswas, Debolina D.; Gupta, Angela S.; Bhardwaj, Reetika; Surace, Michael J.; Eltit, Jose M.; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz			Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-beta amplification loop	FASEB JOURNAL			English	Article						astrocytes; chemokines; GPCR; inflammation	NF-KAPPA B; SPHINGOSINE 1-PHOSPHATE; MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTORS; GENE-TRANSCRIPTION; SIGNALING PATHWAYS; LYMPHOCYTE EGRESS; RANTES PRODUCTION; CHEMOKINE RANTES; PROMOTER MODULE	The neuroinflammation associated with multiple sclerosis involves activation of astrocytes that secrete and respond to inflammatory mediators such as IL-1. IL-1 stimulates expression of many chemokines, including C-C motif ligand (CCL) 5, that recruit immune cells, but it also stimulates sphingosine kinase-1, an enzyme that generates sphingosine-1-phosphate (S1P), a bioactive lipid mediator essential for inflammation. We found that whereas S1P promotes IL-1-induced expression of IL-6, it inhibits IL-1-induced CCL5 expression in astrocytes. This inhibition is mediated by the S1P receptor (S1PR)-2 via an inhibitory G-dependent mechanism. Consistent with this surprising finding, infiltration of macrophages into sites of inflammation increased significantly in S1PR2(-/-) animals. However, activation of NF-kappa B, IFN regulatory factor-1, and MAPKs, all of which regulate CCL5 expression in response to IL-1, was not diminished by the S1P in astrocytes. Instead, S1PR2 stimulated inositol 1,4,5-trisphosphate-dependent Ca++ release and Elk-1 phosphorylation and enhanced c-Fos expression. In our study, IL-1 induced the IFN beta production that supports CCL5 expression. An intriguing finding was that S1P induced c-Fos-inhibited CCL5 directly and also indirectly through inhibition of the IFN-beta amplification loop. We propose that in addition to S1PR1, which promotes inflammation, S1PR2 mediates opposing inhibitory functions that limit CCL5 expression and diminish the recruitment of immune cells.	[Yester, Jessie W.; Bryan, Lauren; Waters, Michael R.; Mierzenski, Bartosz; Biswas, Debolina D.; Gupta, Angela S.; Bhardwaj, Reetika; Surace, Michael J.; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [Eltit, Jose M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA; [Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	tkordula@vcu.edu			U.S. National Institutes of Health (NIH) National Institute on Allergy and Infectious Diseases Grant [R01AI093718]; NIH National Institute of General Medical Sciences Grant [R01GM043880]; NIH National Cancer Institute Fellowship [F30CA174231]; NATIONAL CANCER INSTITUTE [F30CA174231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Allergy and Infectious Diseases Grant; NIH National Institute of General Medical Sciences Grant; NIH National Cancer Institute Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute on Allergy and Infectious Diseases Grant R01AI093718 (to T.K.); NIH National Institute of General Medical Sciences Grant R01GM043880 (to S.S.); and NIH National Cancer Institute Fellowship F30CA174231 (to J.Y.). The authors declare no conflicts of interest.	Bhardwaj R, 2015, J IMMUNOL, V194, P2862, DOI 10.4049/jimmunol.1400874; Boehlk S, 2000, EUR J IMMUNOL, V30, P1102, DOI 10.1002/(SICI)1521-4141(200004)30:4<1102::AID-IMMU1102>3.0.CO;2-X; Borzani I, 2010, EUR J NEUROL, V17, P930, DOI 10.1111/j.1468-1331.2010.02952.x; BOUTILLIER AL, 1992, J BIOL CHEM, V267, P23520; BRANDI ML, 1984, ACTA ENDOCRINOL-COP, V107, P225, DOI 10.1530/acta.0.1070225; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; Edling Y, 2007, GLIA, V55, P328, DOI 10.1002/glia.20464; El-Dahr SS, 1998, AM J PHYSIOL-RENAL, V275, pF343, DOI 10.1152/ajprenal.1998.275.3.F343; Fessele S, 2001, FASEB J, V15, P577; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Glass WG, 2004, J IMMUNOL, V172, P4018, DOI 10.4049/jimmunol.172.7.4018; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Huang CD, 2005, J BIOMED SCI, V12, P763, DOI 10.1007/s11373-005-9008-z; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Kawata T, 2005, BIOCHEM BIOPH RES CO, V331, P640, DOI 10.1016/j.bbrc.2005.03.223; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kim W, 2015, J CLIN NEUROL, V11, P9, DOI 10.3988/jcn.2015.11.1.9; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Kulakowska A, 2010, NEUROSCI LETT, V477, P149, DOI 10.1016/j.neulet.2010.04.052; Leon LR, 1996, AM J PHYSIOL-REG I, V271, pR1668, DOI 10.1152/ajpregu.1996.271.6.R1668; Li QJ, 2000, BLOOD, V96, P3696, DOI 10.1182/blood.V96.12.3696.h8003696_3696_3706; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mann CLA, 2002, J NEUROIMMUNOL, V129, P197, DOI 10.1016/S0165-5728(02)00181-9; Manni A, 1996, BIOCHEM BIOPH RES CO, V220, P120, DOI 10.1006/bbrc.1996.0367; Mao DL, 1998, MOL ENDOCRINOL, V12, P492, DOI 10.1210/me.12.4.492; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuzaki S, 2010, J IMMUNOL, V185, P4863, DOI 10.4049/jimmunol.1000904; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Okada S, 2003, INT IMMUNOL, V15, P1275, DOI 10.1093/intimm/dxg126; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Proudfoot AEI, 2008, J NEUROIMMUNOL, V198, P27, DOI 10.1016/j.jneuroim.2008.04.007; Ren ZH, 2011, J NEUROIMMUNOL, V233, P147, DOI 10.1016/j.jneuroim.2011.01.001; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Stefano L, 2007, J CELL PHYSIOL, V213, P36, DOI 10.1002/jcp.21085; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Szczucinski A, 2011, NEUROIMMUNOMODULAT, V18, P67, DOI 10.1159/000317394; Tada Y, 1997, J EXP MED, V185, P231, DOI 10.1084/jem.185.2.231; Tseng JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50690; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x	62	13	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4853	4865		10.1096/fj.15-275180	http://dx.doi.org/10.1096/fj.15-275180			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26246404	Green Published			2022-12-28	WOS:000365523600012
J	Lazzarin, M; Cozzi, R; Malito, E; Martinelli, M; D'Onofrio, M; Maione, D; Margarit, I; Rinaudo, CD				Lazzarin, Maddalena; Cozzi, Roberta; Malito, Enrico; Martinelli, Manuele; D'Onofrio, Mariapina; Maione, Domenico; Margarit, Immaculada; Rinaudo, C. Daniela			Noncanonical sortase-mediated assembly of pilus type 2b in group B Streptococcus	FASEB JOURNAL			English	Article						crystal structure; backbone protein; ancillary protein; FRET assay	PROTEIN; SURFACE; IDENTIFICATION; FEATURES; VACCINE	Group B Streptococcus (GBS) expresses 3 structurally distinct pilus types (1, 2a, and 2b) identified as important virulence factors and vaccine targets. These pili are heterotrimeric polymers, covalently assembled on the cell wall by sortase (Srt) enzymes. We investigated the pilus-2b biogenesis mechanism by using a multidisciplinary approach integrating genetic, biochemical, and structural studies to dissect the role of the 2 pilus-2b-associated Srts. We show that only 1 sortase (SrtC1-2b) is responsible for pilus protein polymerization, whereas the second one (Srt2-2b) does not act as a pilin polymerase, but similarly to the housekeeping class A Srt (SrtA), it is involved in cell-wall pilus anchoring by targeting the minor ancillary subunit. Based on its function and sequence features, Srt2-2b does not belong to class C Srts (SrtCs), nor is it a canonical member of any other known family of Srts. We also report the crystal structure of SrtC1-2b at 1.9 angstrom resolution. The overall fold resembles the typical structure of SrtCs except for the N-terminal lid region that appears in an open conformation displaced from the active site. Our findings reveal that GBS pilus type 2b biogenesis differs significantly from the current model of pilus assembly in gram-positive pathogens.	[Lazzarin, Maddalena; Cozzi, Roberta; Malito, Enrico; Martinelli, Manuele; Maione, Domenico; Margarit, Immaculada; Rinaudo, C. Daniela] GlaxoSmithKline, Novartis Vaccines & Diagnost, Siena, Italy; [D'Onofrio, Mariapina] Univ Verona, Nucl Magnet Resonance Lab, Dept Biotechnol, I-37100 Verona, Italy	GlaxoSmithKline; Novartis; University of Verona	Rinaudo, CD (corresponding author), Novartis Vaccines & Diagnost, Via Fiorentina 1, I-53100 Siena, Italy.	daniela.rinaudo@novartis.com		D'ONOFRIO, Mariapina/0000-0002-8699-0847; martinelli, manuele/0000-0002-9371-076X	University of Verona; Novartis Vaccines and Diagnostics	University of Verona; Novartis Vaccines and Diagnostics	The authors thank R. Rosini and E. Campisi (Novartis Vaccines and Diagnostics, GlaxoSmithKline) for critical and useful discussion. This work was supported by the Joint Research Project 2010 between the University of Verona and Novartis Vaccines and Diagnostics.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Chaiswing L, 2010, ANTIOXID REDOX SIGN, V13, P449, DOI 10.1089/ars.2009.3020; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cozzi R, 2013, FASEB J, V27, P3144, DOI 10.1096/fj.13-227793; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Levin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059175; Lu GW, 2011, PROTEINS, V79, P2764, DOI 10.1002/prot.23093; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Necchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025300; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Shaik MM, 2014, J BIOL CHEM, V289, P16988, DOI 10.1074/jbc.M114.555854; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	45	9	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4629	4640		10.1096/fj.15-272500	http://dx.doi.org/10.1096/fj.15-272500			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26202865				2022-12-28	WOS:000364514700021
J	Amadio, P; Baldassarre, D; Tarantino, E; Zacchi, E; Gianellini, S; Squellerio, I; Amato, M; Weksler, BB; Tremoli, E; Barbieri, SS				Amadio, Patrizia; Baldassarre, Damiano; Tarantino, Eva; Zacchi, Elena; Gianellini, Sara; Squellerio, Isabella; Amato, Mauro; Weksler, Babette B.; Tremoli, Elena; Barbieri, Silvia S.			Production of prostaglandin E-2 induced by cigarette smoke modulates tissue factor expression and activity in endothelial cells	FASEB JOURNAL			English	Article						thrombosis; prostanoids; EP1 receptor; SIRT1	TOBACCO-SMOKE; IN-VIVO; CARDIOVASCULAR-DISEASE; PROSTANOID RECEPTORS; ARTERIAL THROMBOSIS; VASCULAR WALL; E METABOLITE; SIRT1; PROSTACYCLIN; GENERATION	Cigarette smoke (CS) increases the incidence of atherothrombosis, the release of prostaglandin (PG) E-2, and the amount of tissue factor (TF). The link between PGE(2) and TF, and the impact of this interaction on CS-induced thrombosis, is unknown. Plasma from active smokers showed higher concentration of PGE(2), TF total antigen, and microparticle-associated TF (MP-TF) activity compared with never smokers. Similar results were obtained in mice and in mouse cardiac endothelial cells (MCECs) after treatment with aqueous CS extracts (CSEs) plus IL-1 beta [CSE (6.4 puffs/L)/IL-1 beta (2 mu g/L)]. A significant correlation between PGE(2) and TF total antigen or MP-TF activity were observed in both human and mouse plasma or tissue. Inhibition of PGE synthase reduced TF in vivo and in vitro and prevented the arterial thrombosis induced by CSE/IL-1 beta. Only PG E receptor 1 (EP1) receptor antagonists (SC51089:IC50 similar to 1 mu M, AH6809:IC50 similar to 7.5 mu M) restored the normal TF and sirtuin 1 (SIRT1) levels in MCECs before PGE(2) (EC50 similar to 2.5 mM) or CSE/IL-1 beta exposure. Similarly, SIRT1 activators (CAY10591:IC50 similar to 10 mu M, resveratrol: IC50 similar to 5 mu M) or prostacyclin analogs (IC50 similar to 5 mM) prevented SIRT1 inhibition and reduced TF induced by CSE/IL-1 beta or by PGE2. In conclusion, PGE2 increases both TF expression and activity through the regulation of the EP1/SIRT1 pathway. These findings suggest that EP1 may represent a possible target to prevent prothrombotic states.	[Amadio, Patrizia; Baldassarre, Damiano; Tarantino, Eva; Zacchi, Elena; Tremoli, Elena] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Amadio, Patrizia; Baldassarre, Damiano; Gianellini, Sara; Squellerio, Isabella; Amato, Mauro; Tremoli, Elena; Barbieri, Silvia S.] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Weksler, Babette B.] Weill Cornell Med Coll, Div Hematol Med Oncol, New York, NY USA	University of Milan; IRCCS Centro Cardiologico Monzino; Cornell University	Barbieri, SS (corresponding author), IRCCS, Ctr Cardiol Monzino, Via Parea 4, Milan, Italy.	silvia.barbieri@ccfm.it	Barbieri, Silvia Stella/K-2130-2018; AMATO, Mauro/N-2058-2019; Amato, Mauro/J-3289-2016; Amadio, Patrizia/K-3937-2018; Baldassarre, Damiano/J-3295-2016; TREMOLI, ELENA/I-8126-2018	Barbieri, Silvia Stella/0000-0002-7486-2637; Amato, Mauro/0000-0002-0118-5719; Amadio, Patrizia/0000-0002-7439-2778; Baldassarre, Damiano/0000-0002-2766-8882; TREMOLI, ELENA/0000-0002-0929-6106	Italian Ministry of Health (Ricerca Corrente) [BIO51-2011, BIO35-2012, BIO35-2013]	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	The authors thank Dr. Luciana Mussoni and Alessandro Ieraci (both from Universita degli Studi di Milano, Milan, Italy) for useful discussions, Dr. Viviana Cavalca (Universita degli Studi di Milano and Centro Cardiologico Monzino, Milan, Italy) and Donatella Caruso (Universita degli Studi di Milano, Milan, Italy) for their useful suggestions. This work was supported by the Italian Ministry of Health (Ricerca Corrente BIO51-2011; BIO35-2012; BIO35-2013).	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Arunachalam G, 2010, BIOCHEM BIOPH RES CO, V393, P66, DOI 10.1016/j.bbrc.2010.01.080; Barbieri SS, 2008, ARTERIOSCL THROM VAS, V28, P732, DOI 10.1161/ATVBAHA.107.159434; Barbieri SS, 2007, FASEB J, V21, P1831, DOI 10.1096/fj.06-7557com; Barbieri SS, 2012, CIRCULATION, V126, P1373, DOI 10.1161/CIRCULATIONAHA.112.097295; Barbieri SS, 2011, FASEB J, V25, P3731, DOI 10.1096/fj.11-181776; Barbieri SS, 2011, CARDIOVASC RES, V90, P475, DOI 10.1093/cvr/cvr032; Barua RS, 2013, ARTERIOSCL THROM VAS, V33, P1460, DOI 10.1161/ATVBAHA.112.300154; Barua RS, 2010, ARTERIOSCL THROM VAS, V30, P75, DOI 10.1161/ATVBAHA.109.195024; Barua RS, 2002, J AM COLL CARDIOL, V39, P1758, DOI 10.1016/S0735-1097(02)01859-4; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; Breitenstein A, 2011, CARDIOVASC RES, V89, P464, DOI 10.1093/cvr/cvq339; BUSACCA M, 1984, AM J OBSTET GYNECOL, V148, P1127, DOI 10.1016/0002-9378(84)90640-9; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cavar I, 2010, HISTOL HISTOPATHOL, V25, P819, DOI 10.14670/HH-25.819; Cipollone F, 2008, PHARMACOL THERAPEUT, V118, P161, DOI 10.1016/j.pharmthera.2008.01.002; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Duffield-Lillico AJ, 2009, CANCER PREV RES, V2, P322, DOI 10.1158/1940-6207.CAPR-09-0005; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Gross ND, 2005, CLIN CANCER RES, V11, P6087, DOI 10.1158/1078-0432.CCR-05-0733; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Heptinstall S, 2008, PLATELETS, V19, P605, DOI 10.1080/09537100802351073; Holschermann H, 1999, THROMB HAEMOSTASIS, V82, P1614; Kaneshiro T, 2009, PROSTAG OTH LIPID M, V90, P31, DOI 10.1016/j.prostaglandins.2009.07.003; Kotani T, 2006, J PHARMACOL EXP THER, V316, P547, DOI 10.1124/jpet.105.093195; Li MZ, 2010, ARTERIOSCL THROM VAS, V30, P1818, DOI 10.1161/ATVBAHA.110.209577; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Matetzky S, 2000, CIRCULATION, V102, P602, DOI 10.1161/01.CIR.102.6.602; Menter David G, 2012, Int J Cell Biol, V2012, P723419, DOI 10.1155/2012/723419; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Moreno JJ, 2009, J PHARMACOL EXP THER, V331, P1111, DOI 10.1124/jpet.109.157891; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Norel X, 2007, THESCIENTIFICWORLDJO, V7, P1359, DOI 10.1100/tsw.2007.184; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Petrucci G, 2011, J PHARMACOL EXP THER, V336, P391, DOI 10.1124/jpet.110.174821; PITTILO RM, 1982, THROMB HAEMOSTASIS, V48, P173; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Ruggeri ZM, 2000, J CLIN INVEST, V105, P699, DOI 10.1172/JCI9604; Sambola A, 2003, CIRCULATION, V107, P973, DOI 10.1161/01.CIR.0000050621.67499.7D; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Smith JP, 2010, THROMB RES, V126, pE23, DOI 10.1016/j.thromres.2010.04.003; Swystun LL, 2011, J THROMB HAEMOST, V9, P767, DOI 10.1111/j.1538-7836.2011.04232.x; Vayssier-Taussat M, 2001, AM J PHYSIOL-HEART C, V280, pH1293, DOI 10.1152/ajpheart.2001.280.3.H1293; Yang C, 2010, PROSTAG OTH LIPID M, V93, P44, DOI 10.1016/j.prostaglandins.2010.06.004; Yang YM, 2004, BIOMED ENVIRON SCI, V17, P121; Zeng L, 1998, J PHARMACOL EXP THER, V286, P1420	50	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4001	4010		10.1096/fj.14-268383	http://dx.doi.org/10.1096/fj.14-268383			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26065856				2022-12-28	WOS:000359915600034
J	Malini, E; Zampieri, S; Deganuto, M; Romanello, M; Sechi, A; Bembi, B; Dardis, A				Malini, Erika; Zampieri, Stefania; Deganuto, Marta; Romanello, Milena; Sechi, Annalisa; Bembi, Bruno; Dardis, Andrea			Role of LIMP-2 in the intracellular trafficking of beta-glucosidase in different human cellular models	FASEB JOURNAL			English	Article						lysosomal disease; Gaucher disease; AMRF syndrome	PROGRESSIVE MYOCLONUS EPILEPSY; LIVER LYSOSOMAL MEMBRANES; RENAL FAILURE SYNDROME; GAUCHER-DISEASE; GLUCOCEREBROSIDASE; RECEPTOR; CELLS; MUTATION; SCARB2; SIALOGLYCOPROTEIN	Acid beta-glucosidase (GCase), the enzyme deficient in Gaucher disease (GD), is transported to lysosomes by the lysosomal integral membrane protein (LIMP)-2. In humans, LIMP-2 deficiency leads to action myoclonus-renal failure (AMRF) syndrome. GD and AMRF syndrome share some clinical features. However, they are different from clinical and biochemical points of view, suggesting that the role of LIMP-2 in the targeting of GCase would be different in different tissues. Besides, the role of LIMP-2 in the uptake and trafficking of the human recombinant (hr) GCase used in the treatment of GD is unknown. Thus, we compared GCase activity and intracellular localization in immortalized lymphocytes, fibroblasts, and a neuronal model derived from multi-potent adult stem cells, from apatient with AMRF syndrome, patients with GD, and control subjects. In fibroblasts and neuronlike cells, GCase targeting to the lysosomes is completely dependent on LIMP-2, whereas in blood cells, GCase is partially targeted to lysosomes by a LIMP-2-independent mechanism. Although hrGCase cellular uptake is independent of LIMP-2, its trafficking to the lysosomes is mediated by this receptor. These data provide new insights into the mechanisms involved in the intracellular trafficking of GCase and in the pathogeneses of GD and AMRF syndrome.	[Malini, Erika; Zampieri, Stefania; Deganuto, Marta; Romanello, Milena; Sechi, Annalisa; Bembi, Bruno; Dardis, Andrea] Univ Hosp Santa Maria della Misericordia, Reg Coordinator Ctr Rare Dis, I-33100 Udine, Italy	Hospital Santa Maria della Misericordia	Dardis, A (corresponding author), Univ Hosp Santa Maria della Misericordia, Reg Coordinator Ctr Rare Dis, Ple Santa Maria della Misericordia 15, I-33100 Udine, Italy.	dardis.andrea@aoud.sanita.fvg.it	Zampieri, Stefania/AAC-2314-2022; Sechi, Annalisa/AAC-1497-2019; Dardis, Andrea/AAB-9900-2022	Sechi, Annalisa/0000-0003-1708-7563; zampieri, stefania/0000-0003-3921-8405	Ministero della Salute [PRF 37/08]; Fondazione Telethon Funding Source: Custom	Ministero della Salute(Ministry of Health, Italy); Fondazione Telethon(Fondazione Telethon)	The authors thank Silvia Cattarossi for technical assistance and Federica Benvenuti for technical advice. This work was supported by Grant PRF 37/08 (clinical history and long-term cost-effectiveness of enzyme replacement therapy for Gaucher disease in Italy) from the Ministero della Salute. Some samples were obtained from the Cell Line and DNA Biobank from Patients Affected by Genetic Diseases (Giananni Gaslini Institute, Genoa, Italy), a Telethon Network of Genetic Biobanks (Project No. GTB12001A). The authors declare no conflicts of interest.	Badhwar A, 2004, BRAIN, V127, P2173, DOI 10.1093/brain/awh263; Balreira A, 2008, HUM MOL GENET, V17, P2238, DOI 10.1093/hmg/ddn124; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bergamin N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-34; Beutler E., 2001, METABOLIC MOL BASES, VIII, P3635; Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Chaves J, 2011, SEIZURE-EUR J EPILEP, V20, P738, DOI 10.1016/j.seizure.2011.06.018; Cox TM, 2010, BIOL-TARGETS THER, V4, P299, DOI 10.2147/BTT.S7582; Dardis A, 2009, MOL GENET METAB, V97, P309, DOI 10.1016/j.ymgme.2009.04.011; Dibbens LM, 2009, ANN NEUROL, V66, P532, DOI 10.1002/ana.21765; Dibbens LM, 2011, ARCH NEUROL-CHICAGO, V68, P812, DOI 10.1001/archneurol.2011.120; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Friedman BA, 1999, BLOOD, V93, P2807; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V178, P444, DOI 10.1016/0006-291X(91)90127-S; Gaspar P, 2014, J LIPID RES, V55, P138, DOI 10.1194/jlr.M043802; Guerrero-Lopez R, 2012, MOVEMENT DISORD, V27, P1826, DOI 10.1002/mds.25114; Higashiyama Y, 2013, MOVEMENT DISORD, V28, P552, DOI 10.1002/mds.25296; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Liou B, 2014, J BIOL CHEM, V289, P30063, DOI 10.1074/jbc.M114.593616; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Miocic Snjezana, 2005, Hum Mutat, V25, P100, DOI 10.1002/humu.9301; Mistry PK, 1996, LANCET, V348, P1555, DOI 10.1016/S0140-6736(96)04451-0; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; OKAZAKI I, 1992, J BIOCHEM, V111, P763, DOI 10.1093/oxfordjournals.jbchem.a123833; Park JK, 2003, PEDIATR RES, V53, P387, DOI 10.1203/01.PDR.0000049515.79882.94; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rubboli G, 2011, EPILEPSIA, V52, P2356, DOI 10.1111/j.1528-1167.2011.03307.x; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; SUAREZQUIAN CA, 1987, TISSUE CELL, V19, P495, DOI 10.1016/0040-8166(87)90043-7; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; VANWEELY S, 1990, EUR J BIOCHEM, V191, P669; Zhao YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5321	34	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3839	3852		10.1096/fj.15-271148	http://dx.doi.org/10.1096/fj.15-271148			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018676				2022-12-28	WOS:000359915600020
J	Krementsov, DN; Case, LK; Hickey, WF; Teuscher, C				Krementsov, Dimitry N.; Case, Laure K.; Hickey, William F.; Teuscher, Cory			Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific	FASEB JOURNAL			English	Article						environment; experimental autoimmune encephalomyelitis; mouse model; multiple sclerosis; risk factor	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; RENIN-ANGIOTENSIN SYSTEM; PATHOGENIC T(H)17 CELLS; HIGH-SALT DIET; MULTIPLE-SCLEROSIS; CIRCUMVENTRICULAR ORGANS; BLOOD-PRESSURE; DISEASE; MICE	Multiple sclerosis (MS) is a debilitating autoimmune neuroinflammatory disease influenced by genetics and the environment. MSincidence in female subjects has approximately tripled in the last century, suggesting a sex-specific environmental influence. Recent animal and human studies have implicated dietary sodium as a risk factor in MS, whereby high sodium augmented the generation of T helper (T-h) 17 cells and exacerbated experimental autoimmune encephalomyelitis (EAE), the principal model of MS. However, whether dietary sodium interacts with sex or genetics remains unknown. Here, we show that high dietary sodium exacerbates EAE in a strain- and sex-specific fashion. In C57BL6/J mice, exposure to a high-salt diet exacerbated disease in both sexes, while in SJL/JCrHsd mice, it did so only in females. In further support of a genetic component, we found that sodium failed to modify EAE course in C57BL6/J mice carrying a 129/Sv-derived interval on chromosome 17. Furthermore, we found that the high-sodium diet did not augment T(h)17 or T(h)1 responses, but it did result in increased blood-brain barrier permeability and brain pathology. Our results demonstrate that the effects of dietary sodium on autoimmune neuroinflammation are sex specific, genetically controlled, and CNS mediated.-Krementsov, D. N., Case, L. K., Hickey, W. F., Teuscher, C. Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific.	[Krementsov, Dimitry N.; Case, Laure K.; Teuscher, Cory] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Hickey, William F.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pathol, Hanover, NH 03756 USA	University of Vermont; Dartmouth College	Krementsov, DN (corresponding author), Univ Vermont, D305 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	dkrement@uvm.edu; c.teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019	Krementsov, Dimitry/0000-0003-2709-7466	U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke [NS069628, NS076200]; U.S. National Multiple Sclerosis Society [FG1911-A-1, PP2123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069628, R21NS076200] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke Grants NS069628 and NS076200 (to C.T). This work was also supported postdoctoral Fellowship FG1911-A-1 from the U.S. National Multiple Sclerosis Society to (D.N.K.), and Pilot Project Grant PP2123 from the U.S. National Multiple Sclerosis Society (to C.T.).	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; ARTZT K, 1986, HUM IMMUNOL, V15, P374, DOI 10.1016/0198-8859(86)90014-5; Bearoff F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117993; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Brown I. J., 2009, INT J EPIDEMIOL, V467, P465; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Engelhardt B, 2008, CURR PHARM DESIGN, V14, P1555, DOI 10.2174/138161208784705432; Farez MF, 2015, J NEUROL NEUROSUR PS, V86, P26, DOI 10.1136/jnnp-2014-307928; Friedman M, 1939, J AM STAT ASSOC, V34, P109, DOI 10.2307/2279169; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Gene J. R., 1972, REV EDUC RES, V42, P237, DOI DOI 10.3102/00346543042003237; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; HAMMER MF, 1989, P NATL ACAD SCI USA, V86, P3261, DOI 10.1073/pnas.86.9.3261; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Krementsov DN, 2014, ANN NEUROL, V75, P50, DOI 10.1002/ana.24020; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu L., 2008, J VIS EXP; Lyon M., 1989, GENETIC VARIANTS STR; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; McGuire S, 2010, ADV NUTR, V1, P49, DOI 10.3945/an.110.1002; Miller RL, 2013, AM J PHYSIOL-REG I, V305, pR1141, DOI 10.1152/ajpregu.00242.2013; Mostafavi S, 2014, J IMMUNOL, V193, P4485, DOI 10.4049/jimmunol.1401280; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Noda M., 2015, PFLUGERS ARCH; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Ochoa-Reparaz J, 2011, ANN NEUROL, V69, P240, DOI 10.1002/ana.22344; Paling D, 2013, BRAIN, V136, P2305, DOI 10.1093/brain/awt149; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Ramagopalan SV, 2011, NEUROL CLIN, V29, P207, DOI 10.1016/j.ncl.2010.12.010; Schlote J, 2013, KIDNEY BLOOD PRESS R, V37, P379, DOI 10.1159/000355716; Schulz Martina, 2005, Cerebrospinal Fluid Res, V2, P8, DOI 10.1186/1743-8454-2-8; Spach KM, 2009, J IMMUNOL, V182, P7776, DOI 10.4049/jimmunol.0900142; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wuerfel E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-70	49	40	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3446	3457		10.1096/fj.15-272542	http://dx.doi.org/10.1096/fj.15-272542			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25917331	Green Published			2022-12-28	WOS:000358796900031
J	Margolin, DA; Myers, T; Zhang, X; Bertoni, DM; Reuter, BA; Obokhare, I; Borgovan, T; Grimes, C; Green, H; Driscoll, T; Lee, CG; Davis, NK; Li, L				Margolin, David A.; Myers, Tamara; Zhang, Xin; Bertoni, Danielle M.; Reuter, Brian A.; Obokhare, Izi; Borgovan, Theodor; Grimes, Chelsea; Green, Heather; Driscoll, Tiffany; Lee, Chung-Gi; Davis, Nancy K.; Li, Li			The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model	FASEB JOURNAL			English	Article						cancer stem cell; intrarectal injection; xenograft; HK cell	FOLLICULAR DENDRITIC CELLS; HUMAN-COLON-CANCER; ACID INHIBITS GROWTH; STEM-CELLS; NUDE-MOUSE; SCID MICE; CHEMOSENSITIVITY; PROLIFERATION; REQUIREMENT; EXPRESSION	Colorectal cancer (CRC) is the second-most common cause of cancer-related mortality. The most important prognostic factors are lymph node (LN) involvement and extranodal metastasis. Our objective is to investigate the interactions between CD133(+)CXCR4(+) (CXC receptor 4) colorectal cancer tumor-initiating cells (Co-TICs) and the LN stromal microenvironment in human CRC extranodal metastasis. We established a unique humanized orthotopic xenograft model. Luciferase-tagged CRC cell lines and human cancer cells were injected intrarectally into nonobese diabetic/SCID mice. Mesenteric LN stromal cells, stromal cell line HK, or CXCL12 knockdownHK (HK-KD-A3) cells were coinoculated with CRC cells. Tumor growth and metastasis were monitored by bioluminescent imaging and immunohistochemistry. We found that this model mimics the human CRC metastatic pattern with CRC cell lines or patient specimens. Adding LN stromal cells promotes CRC tumor growth and extranodal metastasis (P < 0.001). Knocking down CXCL12 impaired HK cell support of CRC tumor formation and extranodal metastasis. When HK cells were added, sorted CD133(+)CXCR4(+) Co-TICs showed increased tumor formation and extranodal metastasis capacities compared to unseparated and non-Co-TIC populations. In conclusion, both Co-TIC and LN stromal factors play crucial roles in CRC metastasis through the CXCL12/CXCR4 axis. Blocking Co-TIC/LN-stromal interactions may lead to effective therapy to prevent extranodal metastasis.	[Margolin, David A.; Myers, Tamara; Bertoni, Danielle M.; Obokhare, Izi; Green, Heather] Ochsner Hlth Syst, Dept Colon Rectal Surg, New Orleans, LA USA; [Davis, Nancy K.] Ochsner Hlth Syst, Dept Pathol, New Orleans, LA USA; [Zhang, Xin; Reuter, Brian A.; Borgovan, Theodor; Grimes, Chelsea; Driscoll, Tiffany; Lee, Chung-Gi; Li, Li] Ochsner Hlth Syst, Lab Translat Canc Res, New Orleans, LA USA; [Margolin, David A.; Li, Li] Univ Queensland, Sch Med, Ochsner Clin Sch, Brisbane, Qld, Australia	Ochsner Health System; Ochsner Health System; Ochsner Health System; University of Queensland	Li, L (corresponding author), Ochsner Clin Fdn, Lab Translat Canc Res, 1514 Jefferson Highway, New Orleans, LA 70121 USA.	lli@ochsner.org	Lee, Chung-Gi/AAT-4964-2020; Margolin, David/A-6017-2011	Lee, Chung-Gi/0000-0003-3821-1316; 	Ochsner Translational Medicine Research Initiative Grant	Ochsner Translational Medicine Research Initiative Grant	The authors thank Yong Sung Choi and David Beck for scientific discussion, Grace Maresh, Linh Hellmers, and Peter Miller for excellent technical assistance, and Kim Darensbourg for pathology expertise. This study is partially supported by Ochsner Translational Medicine Research Initiative Grant 2014. The authors declare no conflicts of interest.	Abedini Fatemeh, 2011, Cancer Manag Res, V3, P301, DOI 10.2147/CMR.S11678; Bellizzi A, 2013, J CELL PHYSIOL, V228, P408, DOI 10.1002/jcp.24145; BRESALIER RS, 1987, INT J CANCER, V39, P625, DOI 10.1002/ijc.2910390514; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Donigan M, 2009, J SURG RES, V154, P299, DOI 10.1016/j.jss.2008.05.028; Fan F, 2015, BRIT J CANCER, V112, P539, DOI 10.1038/bjc.2014.620; FU XY, 1992, ANTICANCER RES, V12, P1395; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; GIAVAZZI R, 1986, CANCER RES, V46, P1928; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Heckmann D, 2014, CLIN CANCER RES, V20, P604, DOI 10.1158/1078-0432.CCR-13-0582; Heijstek MW, 2005, DIGEST SURG, V22, P16, DOI 10.1159/000085342; Kashtan H, 1992, Surg Oncol, V1, P251, DOI 10.1016/0960-7404(92)90072-S; KIM HS, 1995, J IMMUNOL, V155, P1101; KIM HS, 1994, J IMMUNOL, V153, P2951; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; KUO TH, 1993, ANTICANCER RES, V13, P627; Lee CG, 2012, BRIT J HAEMATOL, V158, P79, DOI 10.1111/j.1365-2141.2012.09123.x; Lee IY, 2005, J IMMUNOL, V175, P1658, DOI 10.4049/jimmunol.175.3.1658; Li L, 2004, BLOOD, V104, P815, DOI 10.1182/blood-2004-01-0292; Lim SH, 2014, J GASTROINTEST ONCOL, V5, P447, DOI 10.3978/j.issn.2078-6891.2014.071; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Margolin DA, 2011, NEOPLASIA, V13, P874, DOI 10.1593/neo.11324; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Mueller SN, 2008, IMMUNOL REV, V224, P284, DOI 10.1111/j.1600-065X.2008.00657.x; Munoz-Fernandez R, 2006, J IMMUNOL, V177, P280, DOI 10.4049/jimmunol.177.1.280; National Cancer Institute, 2014, SEER STAT FACT SHEET; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Overdevest JB, 2011, CANCER RES, V71, P3802, DOI 10.1158/0008-5472.CAN-11-0519; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pocard M, 1996, IN VIVO, V10, P463; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silinsky J, 2013, J SURG RES, V185, P113, DOI 10.1016/j.jss.2013.05.049; Sundlisxter E, 2007, INT J CANCER, V121, P1401, DOI 10.1002/ijc.22996; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Yadav VR, 2012, INT J CANCER, V130, P2176, DOI 10.1002/ijc.26251; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85	51	18	19	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3571	3581		10.1096/fj.14-268938	http://dx.doi.org/10.1096/fj.14-268938			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25962655				2022-12-28	WOS:000358796900042
J	Cai, RQ; Xue, WL; Liu, SS; Petersen, RB; Huang, K; Zheng, L				Cai, Ruiqi; Xue, Weili; Liu, Shanshan; Petersen, Robert B.; Huang, Kun; Zheng, Ling			Overexpression of glyceraldehyde 3-phosphate dehydrogenase prevents neurovascular degeneration after retinal injury	FASEB JOURNAL			English	Article						I/R injury; energy failure; necroptosis; DNA damage	ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; DIABETIC-RETINOPATHY; PROGRAMMED NECROSIS; ENERGY-METABOLISM; GANGLION-CELLS; IN-VITRO; APOPTOSIS; PROTEIN; DAMAGE	Ischemia and reperfusion (I/R) injury is a common cause of many vascular and neuronal diseases. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been found down-regulated or dysfunctional in several tissues upon I/R injury. To investigate the role of GAPDH in retinal I/R injury-induced neurovascular degeneration, the injured retinas of GAPDH transgenic (Tg) mice and wild-type (WT) littermates were analyzed. I/R injury induced neurovascular degeneration, energy failure, DNA damage, and necroptosis in the retinas of WT mice. In contrast, the GAPDH Tg mice showed resistance to all of these injury-induced abnormalities. In addition, I/R-induced effects were further examined in a neuroblastoma cell line and an endothelial cell line, which were transfected with a vector encoding human GAPDH or a control vector. After I/R challenge, energy failure, DNA damage, and elevation of receptor-interacting serine/threonine-protein kinase (RIP) 1/3 were observed in the cells transfected with the control vector. However, overexpression of GAPDH in these cells prevented the injury-induced RIP3 up-regulation by restoring energy production and preventing DNA damage. Together, the protective role of GAPDH in retinal neurovascular degeneration after I/R injury provides a better understanding of the underlying mechanism of I/R injury and a potential therapeutic target to attenuate I/R injuryrelated diseases.	[Cai, Ruiqi; Xue, Weili; Liu, Shanshan; Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Petersen, Robert B.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Huang, Kun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Huazhong University of Science & Technology	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	lzheng217@hotmail.com		Liu, Shanshan/0000-0002-7301-5196; Zheng, Ling/0000-0002-6545-4180; Huang, Kun/0000-0002-0808-2325	National Basic Research Program of China [2012CB524901]; Natural Science Foundation of China [31471208, 31271370, 81100687]; Fundamental Research Funding of Central University	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funding of Central University	This work was supported by the National Basic Research Program of China (2012CB524901), the Natural Science Foundation of China (number 31471208, 31271370, and 81100687), and the Fundamental Research Funding of Central University. R.C. performed experiments, analyzed data, and wrote the manuscript; W.X. performed experiments and analyzed data; S.L. genotyped the mice; R.B.P. provided critical discussions and edited the manuscript; K.H. analyzed data and edited the manuscript; and L.Z. designed the experiments, supervised the project, and wrote the manuscript. The authors declare no conflicts of interest.	Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Berg J. M., 2002, BIOCHEMISTRY-US, P443; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Campello L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074439; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Casson RJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P361, DOI 10.1001/archopht.122.3.361; Castilho MS, 2003, BIOCHEMISTRY-US, V42, P7143, DOI 10.1021/bi0206107; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chen H, 2014, J PHYSIOL-LONDON, V592, P505, DOI 10.1113/jphysiol.2013.266411; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cohen Jeffrey E, 2006, Heart Lung Circ, V15, P119, DOI 10.1016/j.hlc.2005.12.004; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; D'Amours D, 2001, J CELL SCI, V114, P3771; Ding Y, 2014, INT J OBESITY, V38, P198, DOI 10.1038/ijo.2013.98; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Dvoriantchikova G, 2014, EXP EYE RES, V123, P1, DOI 10.1016/j.exer.2014.04.009; Dvoriantchikova G, 2010, MOL VIS, V16, P2882; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; HOYER S, 1986, NEUROBIOL AGING, V7, P23, DOI 10.1016/0197-4580(86)90022-9; Huang J, 2015, EPIGENETICS-US, V10, P62, DOI 10.4161/15592294.2014.990780; JENNINGS RB, 1991, ANNU REV MED, V42, P225, DOI 10.1146/annurev.med.42.1.225; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Kern TS, 2001, DIABETES, V50, P1636, DOI 10.2337/diabetes.50.7.1636; Li CZ, 2012, INVEST OPHTH VIS SCI, V53, P3241, DOI 10.1167/iovs.11-8406; Manning NW, 2014, STROKE, V45, P640, DOI 10.1161/STROKEAHA.113.003798; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Neufeld AH, 1999, P NATL ACAD SCI USA, V96, P9944, DOI 10.1073/pnas.96.17.9944; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Tian H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116453; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Winkler BS, 1997, INVEST OPHTH VIS SCI, V38, P62; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Yoo MH, 2004, INVEST OPHTH VIS SCI, V45, P1523, DOI 10.1167/iovs.03-1315; Yoshizawa K, 2012, J TOXICOL PATHOL, V25, P27, DOI 10.1293/tox.25.27; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao XL, 2014, J PROTEOME RES, V13, P2175, DOI 10.1021/pr500040a; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, PROTEOMICS, V9, P1869, DOI 10.1002/pmic.200701071; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170	51	23	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2749	2758		10.1096/fj.14-265801	http://dx.doi.org/10.1096/fj.14-265801			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805836				2022-12-28	WOS:000356859100007
J	Franceschini, A; Capece, M; Chiozzi, P; Falzoni, S; Sanz, JM; Sarti, AC; Bonora, M; Pinton, P; Di Virgilio, F				Franceschini, Alessia; Capece, Marina; Chiozzi, Paola; Falzoni, Simonetta; Sanz, Juana Maria; Sarti, Alba Clara; Bonora, Massimo; Pinton, Paolo; Di Virgilio, Francesco			The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein	FASEB JOURNAL			English	Article						purinergic receptors; extracellular ATP; inflammation	P2X(7) RECEPTOR; EXTRACELLULAR ATP; PLASMA-MEMBRANE; ACTIVATION; IMMUNITY; CELLS; MECHANISMS; RELEASE; TOXINS; BETA	The P2X7 receptor (P2X7R) is a known and powerful activator of the NOD-like receptor (NLR) P3 inflammasome; however, the underlying pathways are poorly understood. Thus, we investigated the molecular mechanisms involved. The effect of P2X7R expression and activation on NLRP3 expression and recruitment was investigated by Western blot, RT-PCR, coimmunoprecipitation, and confocal microscopy in microglial mouse cell lines selected for reduced P2X7R expression and in primary cells from P2X7R(-/-) C57BL/6 mice. We show here that P2X7R activation by ATP (EC50 = 1 mM) or benzoyl-ATP (EC50 = 300 mM) and P2X7R down-modulation caused a 2- to 8-fold up-regulation of NLRP3 mRNA in mouse N13 microglial cells. Moreover, NLRP3 mRNA was also up-regulated in primary microglial and macrophage cells from P2X7R(-/-) mice. Confocal microscopy and immunoprecipitation assays showed that P2X7R and NLRP3 closely interacted at discrete subplasmalemmal sites. Finally, P2X7R stimulation caused a transient (3-4 min) cytoplasmic Ca2+ increase localized to small (2-3 mu m wide) discrete subplasmalemmal regions. The Ca2+ increase drove P2X7R recruitment and a 4-fold increase in P2X7R/NLRP3 association within 1-2 min. These data show a close P2X7R and NLRP3 interaction and highlight the role of P2X7R in the localized cytoplasmic ion changes responsible for both NLRP3 recruitment and activation.	[Franceschini, Alessia; Capece, Marina; Chiozzi, Paola; Falzoni, Simonetta; Sarti, Alba Clara; Bonora, Massimo; Pinton, Paolo; Di Virgilio, Francesco] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy; [Sanz, Juana Maria] Univ Ferrara, Sect Internal Med Gerontol & Clin Nutr, Dept Med Sci, I-44121 Ferrara, Italy; [Bonora, Massimo; Pinton, Paolo; Di Virgilio, Francesco] Univ Ferrara, Lab Technol Adv Therapies, I-44121 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara	Di Virgilio, F (corresponding author), Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, Via Borsari 46, I-44121 Ferrara, Italy.	fdv@unife.it	Bonora, Massimo/AAC-3609-2022; DI VIRGILIO, Francesco/O-4634-2019; Pinton, Paolo/J-8025-2012; Sanz, Juana/AAF-7941-2020; Franceschini, Alessia/H-4992-2017; Franceschini, Alessia/K-3426-2018; Sarti, Alba Clara/AAO-7737-2020; Di Virgilio, Francesco/J-3754-2018	Bonora, Massimo/0000-0002-5752-3318; DI VIRGILIO, Francesco/0000-0003-3566-1362; Pinton, Paolo/0000-0001-7108-6508; Franceschini, Alessia/0000-0001-7122-6232; Franceschini, Alessia/0000-0001-7122-6232; Di Virgilio, Francesco/0000-0003-3566-1362; Chiozzi, Paola/0000-0003-4952-334X; Sanz, Juana M/0000-0003-3372-2758; Falzoni, Simonetta/0000-0002-6594-0357	Italian Association for Cancer Research Grant [IG 5354, IG 14442]; Telethon of Italy [GGP06070]; European Research Area Network Neuron Joint Transnational Project "Nanostroke" grant; Ministry of Health of Italy [RF-2011-02348435]; Italian Ministry of Education, University and Research Grant [RBAP11FXBC_001]; University of Ferrara; Commission of European Communities (7th Framework Program) [HEALTH-F2-2007-202231]; Italian Ministry of Education, University and Research [20129JLHSY_002, RBAP11FXBC_002, RBFR10EGVP_001]	Italian Association for Cancer Research Grant(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); European Research Area Network Neuron Joint Transnational Project "Nanostroke" grant; Ministry of Health of Italy(Ministry of Health, Italy); Italian Ministry of Education, University and Research Grant; University of Ferrara; Commission of European Communities (7th Framework Program)(European Commission); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	F.D.V. is supported by Italian Association for Cancer Research Grant IG 5354, Telethon of Italy Grant GGP06070, an European Research Area Network Neuron Joint Transnational Project "Nanostroke" grant, Ministry of Health of Italy Grant RF-2011-02348435, Italian Ministry of Education, University and Research Grant RBAP11FXBC_001, and institutional funds from the University of Ferrara. F.D.V. was also supported by a grant from the Commission of European Communities (7th Framework Program HEALTH-F2-2007-202231 "ATPBone"). P.P. is supported by Italian Association for Cancer Research Grant IG 14442 and grants from the Italian Ministry of Education, University and Research (Progetti Ricerca Interesse Nazionale 20129JLHSY_002, and RBAP11FXBC_002, and Futuro in Ricerca RBFR10EGVP_001).	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Ferrari D, 1996, J IMMUNOL, V156, P1531; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	31	131	141	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2450	2461		10.1096/fj.14-268714	http://dx.doi.org/10.1096/fj.14-268714			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690658	Green Submitted			2022-12-28	WOS:000355209500022
J	Mao, F; Xu, M; Zuo, XS; Yu, J; Xu, WG; Moussalli, MJ; Elias, E; Li, HYS; Watowich, SS; Shureiqi, I				Mao, Fei; Xu, Min; Zuo, Xiangsheng; Yu, Jiang; Xu, Weiguo; Moussalli, Micheline J.; Elias, Elias; Li, Haiyan S.; Watowich, Stephanie S.; Shureiqi, Imad			15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway	FASEB JOURNAL			English	Article						15-LOX-1; PPAR-delta; CAC; IL-6 expression; STAT3 phosphorylation	INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-DELTA; DRUG-INDUCED APOPTOSIS; COLORECTAL-CANCER; ULCERATIVE-COLITIS; STAT3 ACTIVATION; EPITHELIAL-CELLS; TRANSGENIC EXPRESSION; DIFFERENTIATION; TUMORIGENESIS	The IL-6/signal transducer and activator of transcription 3 (STAT3) pathway is a critical signaling pathway for colitis-associated colorectal cancer (CAC). Peroxisome proliferator-activated receptor (PPAR)-delta, a lipid nuclear receptor, up-regulates IL-6. 15-Lipoxygenase-1 (15-LOX-1), which is crucial to production of lipid signaling mediators to terminate inflammation, down-regulates PPAR-delta. 15-LOX-1 effects on IL-6/STAT3 signaling and CAC tumorigenesis have not been determined. We report that intestinally targeted transgenic 15-LOX-1 expression in mice inhibited azoxymethane- and dextran sodium sulfate-induced CAC, IL-6 expression, STAT3 phosphorylation, and IL-6/STAT3 downstream target (Notch3 and MUC1) expression. 15-LOX-1 down-regulation was associated with IL-6 up-regulation in human colon cancer mucosa. Reexpression of 15-LOX-1 in human colon cancer cells suppressed IL-6 mRNA expression, STAT3 phosphorylation, IL-6 promoter activity, and PPAR-delta mRNA and protein expression. PPAR-delta overexpression in colonic epithelial cells promoted CAC tumorigenesis in mice and increased IL-6 expression and STAT3 phosphorylation, whereas concomitant 15-LOX-1 expression in colonic epithelial cells (15-LOX-1-PPAR-delta-Gut mice) suppressed these effects: the number of tumors per mouse (mean +/- SEM) was 4.22 +/- 0.68 in wild-type littermates, 6.67 +/- 0.83 in PPAR-delta-Gut mice (P = 0.026), and 2.25 +/- 0.25 in 15-LOX-1-PPAR-delta-Gut mice (P = 0.0006). Identification of 15-LOX-1 suppression of PPAR-delta to inhibit IL-6/STAT3 signaling-driven CAC tumorigenesis provides mechanistic insights that can be used to molecularly target CAC.	[Mao, Fei; Xu, Min; Zuo, Xiangsheng; Yu, Jiang; Xu, Weiguo; Elias, Elias; Shureiqi, Imad] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Moussalli, Micheline J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Li, Haiyan S.; Watowich, Stephanie S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Mao, Fei; Xu, Min] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Jiangsu University	Shureiqi, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426,1515 Holcombe Blvd, Houston, TX 77030 USA.	xzuo@mdanderson.org; ishureiqi@mdanderson.org	Shureiqi, imad/T-6214-2019	Watowich, Stephanie/0000-0003-1969-659X; Zuo, Xiangsheng/0000-0002-8593-1132; Shureiqi, Imad/0000-0003-2019-938X	U.S. National Institutes of Health (NIH) National Cancer Institute [R01CA137213, R01CA142969]; University of Texas MD Anderson Cancer Center; Cancer Center Support Grant from NIH National Cancer Institute [CA016672]; MD Anderson Cancer Center Genetically Engineered Mouse Facility; DNA Analysis Facility; Chemistry Synthetic Core; Research Animal Support Facility-Smithville; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA142969, R01CA137213] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas MD Anderson Cancer Center; Cancer Center Support Grant from NIH National Cancer Institute; MD Anderson Cancer Center Genetically Engineered Mouse Facility; DNA Analysis Facility; Chemistry Synthetic Core; Research Animal Support Facility-Smithville; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Rui Tian for technical assistance. This study was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grants R01CA137213 and R01CA142969 (to I.S.), and an institutional research grant from The University of Texas MD Anderson Cancer Center (to I.S.). The study was also supported by Cancer Center Support Grant CA016672 from the NIH National Cancer Institute, the MD Anderson Cancer Center Genetically Engineered Mouse Facility, DNA Analysis Facility, Chemistry Synthetic Core, and the Research Animal Support Facility-Smithville. The authors declare no conflicts of interest.	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Breynaert C, 2008, ACTA GASTRO-ENT BELG, V71, P367; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Gaemers IC, 2001, J BIOL CHEM, V276, P6191, DOI 10.1074/jbc.M009449200; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kathiria AS, 2012, CANCER RES, V72, P5778, DOI 10.1158/0008-5472.CAN-12-0603; Klil-Drori AJ, 2013, PROSTAG OTH LIPID M, V106, P16, DOI 10.1016/j.prostaglandins.2013.07.006; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Mangino MJ, 2006, PROSTAG OTH LIPID M, V79, P84, DOI 10.1016/j.prostaglandins.2005.10.004; MATSUMOTO H, 1990, GASTROENTEROLOGY, V98, P1199, DOI 10.1016/0016-5085(90)90334-W; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Moussalli MJ, 2011, CANCER PREV RES, V4, P1961, DOI 10.1158/1940-6207.CAPR-10-0280; Munger KA, 1999, P NATL ACAD SCI USA, V96, P13375, DOI 10.1073/pnas.96.23.13375; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; NOTCH3 Gene, 2014, NOTCH3 GEN; Palkar PS, 2010, MOL PHARMACOL, V78, P419, DOI 10.1124/mol.110.065508; Pasto A, 2014, CANCER RES, V74, P2106, DOI 10.1158/0008-5472.CAN-13-2022; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shureiqi I, 2000, J NATL CANCER I, V92, P1136, DOI 10.1093/jnci/92.14.1136; Shureiqi I, 2000, CANCER RES, V60, P6846; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Shureiqi I, 2005, CANCER RES, V65, P11486, DOI 10.1158/0008-5472.CAN-05-2180; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; Shureiqi I, 2010, CANCER PREV RES, V3, P829, DOI 10.1158/1940-6207.CAPR-09-0110; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Tanaka T, 2001, CANCER RES, V61, P2424; van Schaik FDM, 2009, NAT REV GASTRO HEPAT, V6, P671, DOI 10.1038/nrgastro.2009.162; Wang DZ, 2014, P NATL ACAD SCI USA, V111, P7084, DOI 10.1073/pnas.1324233111; Wu Y, 2008, MOL THER, V16, P886, DOI 10.1038/mt.2008.44; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yuri M, 2007, HISTOPATHOLOGY, V51, P520, DOI 10.1111/j.1365-2559.2007.02799.x; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160; Zuo XS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju052; Zuo XS, 2012, J NATL CANCER I, V104, P709, DOI 10.1093/jnci/djs187; Zuo XS, 2009, JNCI-J NATL CANCER I, V101, P762, DOI 10.1093/jnci/djp078	57	30	33	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2359	2370		10.1096/fj.14-264515	http://dx.doi.org/10.1096/fj.14-264515			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713055	Green Published			2022-12-28	WOS:000355209500014
J	Zhang, WX; Wang, P; Chen, SY; Zhang, Z; Liang, TM; Liu, C				Zhang, Wenxiang; Wang, Peng; Chen, Siyu; Zhang, Zhao; Liang, Tingming; Liu, Chang			Rhythmic expression of miR-27b-3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver	FASEB JOURNAL			English	Article						circadian clock; miRNAs; restricted feeding; energy metabolism	ORPHAN NUCLEAR RECEPTOR; CIRCADIAN-CLOCK; LIPID-METABOLISM; TIME; MICRORNAS; INTERPLAY; GENOMICS; ALPHA; WEB	Circadian clocks orchestrate daily oscillations in mammalian behaviors, physiology, and gene expression. MicroRNAs (miRNAs) play a crucial role in fine-tuning of the circadian system. However, little is known about the direct regulation of the clock genes by specific miRNAs. In this study, we found that miR-27b-3p exhibits rhythmic expression in the metabolic tissues of the mice subjected to constant darkness. MiR-27b-3p's expression is induced in livers of unfed and ob/ob mice. In addition, the oscillation phases of miR-27b-3p can be reversed by restricted feeding, suggesting a role of peripheral clock in regulating its rhythmicity. Bioinformatics analysis indicated that aryl hydrocarbon receptor nuclear translocator-like (also known as Bmal1) may be a direct target of miR-27b-3p. Luciferase reporter assay showed that miR-27b-3p suppressed Bmal1 3 UTR activity in a dose-dependent manner, and mutagenesis of their binding site abolished this suppression. Furthermore, overexpression of miR-27b-3p dose-dependently reduced the protein expression levels of BMAL1 and impaired the endogenous BMAL1 and gluconeogenic protein rhythmicity. Collectively, our results suggest that miR-27b-3p plays an important role in the posttranscriptional regulation of BMAL1 protein in the liver. MiR-27b-3p may serve as a novel node to integrate the circadian clock and energy metabolism.Zhang, W., Wang, P., Chen, S., Zhang, Z., Liang, T., Liu, C. Rhythmic expression of miR-27b-3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver.	[Zhang, Wenxiang; Wang, Peng; Chen, Siyu; Zhang, Zhao; Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Liang, TM; Liu, C (corresponding author), 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.	tmliang@njnu.edu.cn; changliu@njnu.edu.cn	Liang, Tingming/ACL-6141-2022	Chen, Siyu/0000-0002-3809-1062; Zhang, Wenxiang/0000-0002-1077-8014	National Basic Research Program of China (973 Program) [2012CB947600, 2013CB911600]; National Natural Science Foundation of China (NSF) [31422028, 31271261, 31401009]; Ten Thousand Talents Program; Jiangsu Province of China [NSF (BK20140041)]; Jiangsu Province of China [Six Talents Summit Project]; Jiangsu Province of China [333 Talents Project] [BRA2015323]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions; innovative Projects of Scientific Research for Graduate Students of Jiangsu Province [KYZZ15_0216]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC)); Ten Thousand Talents Program; Jiangsu Province of China; Jiangsu Province of China [Six Talents Summit Project]; Jiangsu Province of China [333 Talents Project]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions; innovative Projects of Scientific Research for Graduate Students of Jiangsu Province	This work is supported by grants from the National Basic Research Program of China (973 Program; 2012CB947600, 2013CB911600), the National Natural Science Foundation of China (NSF; 31422028, 31271261, 31401009), Ten Thousand Talents Program, programs issued by Jiangsu Province of China [NSF (BK20140041), Six Talents Summit Project, and 333 Talents Project (BRA2015323)], the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University) and the Priority Academic Program Development of Jiangsu Higher Education Institutions, the innovative Projects of Scientific Research for Graduate Students of Jiangsu Province (KYZZ15_0216). The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen KD, 2014, TRANSPL P, V46, P1198, DOI 10.1016/j.transproceed.2013.12.013; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HYM, 2007, CELL CYCLE, V6, P3034, DOI 10.4161/cc.6.24.5106; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gnocchi Davide, 2015, Biology-Basel, V4, P104, DOI 10.3390/biology4010104; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080774; Loher P, 2012, BIOINFORMATICS, V28, P3322, DOI 10.1093/bioinformatics/bts615; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mu WJ, 2015, CELL RES, V25, P477, DOI 10.1038/cr.2015.23; Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510; Paschos GK, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00112; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Santoro MM, 2013, EXP CELL RES, V319, P1324, DOI 10.1016/j.yexcr.2012.12.009; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Singaravelu R, 2014, HEPATOLOGY, V59, P98, DOI 10.1002/hep.26634; Staiger D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-208; Sun XJ, 2015, J BIOL CHEM, V290, P2189, DOI 10.1074/jbc.M114.612358; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang X, 2015, CURR MED CHEM, V22, P1582, DOI 10.2174/0929867322666150227155009; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603	46	26	27	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2151	2160		10.1096/fj.201500120	http://dx.doi.org/10.1096/fj.201500120			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26919869				2022-12-28	WOS:000376878300009
J	Sun, XF; Park, CB; Deng, WB; Potter, SS; Dey, SK				Sun, Xiaofei; Park, Craig B.; Deng, Wenbo; Potter, S. Steven; Dey, Sudhansu K.			Uterine inactivation of muscle segment homeobox (Msx) genes alters epithelial cell junction proteins during embryo implantation	FASEB JOURNAL			English	Article						uterus; receptivity; adhesion; claudin; Sprr2	BLASTOCYST IMPLANTATION; EXTRACELLULAR-MATRIX; EXPRESSION ANALYSIS; BINDING-PROTEIN; MOUSE; RECEPTIVITY; UTERUS; FAMILY; MICE; DYNAMICS	Embryo implantation requires that the uterus differentiate into the receptive state. Failure to attain uterine receptivity will impede blastocyst attachment and result in a compromised pregnancy. The molecular mechanism by which the uterus transitions from the pre-receptive to the receptive stage is complex, involving an intricate interplay of various molecules. We recently found that mice with uterine deletion of Msx genes (Msx1(d/d/)Msx2(d/d)) are infertile because of implantation failure associated with heightened apicobasal polarity of luminal epithelial cells during the receptive period. However, information on Msx's roles in regulating epithelial polarity remains limited. To gain further insight, we analyzed cell-type-specific gene expression by RNA sequencing of separated luminal epithelial and stromal cells by laser capture microdissection from Msx1(d/d)/Msx2(d/d) and floxed mouse uteri on d 4 of pseudopregnancy. We found that claudin-1, a tight junction protein, and small proline-rich (Sprr2) protein, a major component of cornified envelopes in keratinized epidermis, were substantially up-regulated in Msx1(d/d)/Msx2(d/d) uterine epithelia. These factors also exhibited unique epithelial expression patterns at the implantation chamber (crypt) in Msx1(f/f)/Msx2(f/f) females; the patterns were lost in Msx1(d/d)/Msx2(d/d) epithelia on d 5, suggesting important roles during implantation. The results suggest that Msx genes play important roles during uterine receptivity including modulation of epithelial junctional activity.-Sun, X., Park, C. B., Deng, W., Potter, S. S., Dey, S. K. Uterine inactivation of muscle segment homeobox (Msx) genes alters epithelial cell junction proteins during embryo implantation. FASEB J. 30, 1425-1435 (2016). www.fasebj.org	[Sun, Xiaofei; Park, Craig B.; Deng, Wenbo; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA; [Potter, S. Steven; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dey, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, MLC 7045,3333 Burnet Ave, Cincinnati, OH 45229 USA.	sk.dey@cchmc.org			U.S. National Institutes of Health (NIH) National Institute of Child Health and Human Development [HD068524]; NIH National Cancer Institute [P01-CA77839]; March of Dimes [3-FY12-127, 3-FY13-543]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068524] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Child Health and Human Development; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes(March of Dimes); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank J. Lydon and F. DeMayo (Baylor College of Medicine, Houston, TX, USA) for initially providing the Pgr<SUP>Cre/+</SUP> mice, and R. Maxson (University of Southern California, Los Angeles, CA, USA) for the Msx1<SUP>loxP/loxP</SUP>/Msx2<SUP>loxP/loxP</SUP> mice. This study was supported in part by U.S. National Institutes of Health (NIH) National Institute of Child Health and Human Development Grant HD068524, NIH National Cancer Institute Grant P01-CA77839, and March of Dimes Grants 3-FY12-127 and 3-FY13-543 (to S.K.D). C.B.P. was supported by a fellowship from the Canadian Institutes of Health Research. The authors declare no conflicts of interest.	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027; Cha J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130035; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; Dey SK, 2004, REPRODUCTION, V128, P655, DOI 10.1530/rep.1.00537; ENDERS AC, 1975, ANAT REC, V182, P137, DOI 10.1002/ar.1091820202; Finnerty JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-18; Franco HL, 2010, BIOL REPROD, V82, P991, DOI 10.1095/biolreprod.109.081513; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Hong SH, 2010, REPROD TOXICOL, V30, P469, DOI 10.1016/j.reprotox.2010.04.009; Hong SH, 2004, MOL CELLS, V17, P477; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; MADARA JL, 1988, CELL, V53, P497, DOI 10.1016/0092-8674(88)90562-4; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Song H, 2002, DEVELOPMENT, V129, P2879; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Sun XF, 2012, P NATL ACAD SCI USA, V109, P1145, DOI 10.1073/pnas.1118411109; Tan YF, 2006, REPROD NUTR DEV, V46, P641, DOI 10.1051/rnd:2006037; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764; Zhong YF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-169	43	15	18	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1425	1435		10.1096/fj.15-282798	http://dx.doi.org/10.1096/fj.15-282798			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26667042	Green Published			2022-12-28	WOS:000372629100006
J	Hifumi, E; Matsumoto, S; Nakashima, H; Itonaga, S; Arakawa, M; Katayama, Y; Kato, R; Uda, T				Hifumi, Emi; Matsumoto, Shingo; Nakashima, Hiroki; Itonaga, Shogo; Arakawa, Mitsue; Katayama, Yoshiki; Kato, Ryuichi; Uda, Taizo			A novel method of preparing the monoform structure of catalytic antibody light chain	FASEB JOURNAL			English	Article						charge heterogeneity; 2D electrophoresis; pI; copper ion	MONOCLONAL-ANTIBODY; GEL-ELECTROPHORESIS; FACTOR-VIII; HETEROGENEITY; SITES; TRASTUZUMAB; HEMOPHILIA; HYDROLYSIS; CLEAVAGE; FEATURES	Along with the development of antibody drugs and catalytic antibodies, the structural diversity (heterogeneity) of antibodies has been given attention. For > 20 yr, detailed studies on the subject have not been conducted, because the phenomenon presents many difficult and complex problems. Structural diversity provides some (or many) isoforms of an antibody distinguished by different charges, different molecular sizes, and modifications of amino acid residues. For practicaluse, the antibody and the subunits must have a defined structure. In recent work, we have found that the copper (Cu) ion plays a substantial role in solving the diversity problem. In the current study, we used several catalytic antibody light chains to examine the effect of the Cu ion. In all cases, the different electrical charges of the molecule converged to a single charge, giving 1 peak in cation-exchange chromatography, as well as a single spot in 2-dimensional gel electrophoresis. The Cu-binding site was investigated by using mutagenesis, ultraviolet-visible spectroscopy, atomic force microscope analysis, and molecular modeling, which suggested that histidine and cysteine residues close to the C-terminus are involved with the binding site. The constant region domain of the antibody light chain played an important role in the heterogeneity of the light chain. Our findings may be a significant tool for preparing a single defined, not multiple, isoform structure.	[Hifumi, Emi] Oita Univ, Res Promot Inst, 700 Dan Noharu, Oita, Oita 8701192, Japan; [Matsumoto, Shingo; Nakashima, Hiroki; Itonaga, Shogo; Uda, Taizo] Oita Univ, Dept Appl Chem, Fac Engn, Oita 87011, Japan; [Hifumi, Emi; Uda, Taizo] Inst Syst Informat Technol & Nanotechnol ISIT, Nanotechnol Lab, Fukuoka, Japan; [Matsumoto, Shingo; Katayama, Yoshiki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Arakawa, Mitsue] Tottori Coll Nursing, Tottori, Japan; [Kato, Ryuichi] High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan	Oita University; Oita University; Kyushu University; High Energy Accelerator Research Organization (KEK)	Hifumi, E (corresponding author), Oita Univ, Res Promot Inst, 700 Dan Noharu, Oita, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902; Kato, Ryuichi/0000-0003-2087-2896	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24350085]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Dr. H. Sugasawa (Oxford Instruments KK, Tokyo, Japan), Ms. E. Saito, Ms. S. Takemoto, and Ms. Y. Akiyoshi (Oita University) for assistance. This study was supported by the Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience; Super Highway: accelerated research to bridge university intellectual properties and practical use), and Grant-in-Aid 24350085 for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E. H. and T.U.). The authors declare no conflicts of interest.	Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; Buneva VN, 1998, APPL BIOCHEM BIOTECH, V75, P63, DOI 10.1007/BF02787709; Dick LW, 2008, BIOTECHNOL BIOENG, V100, P1132, DOI 10.1002/bit.21855; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2000, BIOMETALS, V13, P289, DOI 10.1023/A:1009252200231; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2013, J BIOL CHEM, V288, P19558, DOI 10.1074/jbc.M113.454579; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hifumi E, 2010, FEBS J, V277, P3823, DOI 10.1111/j.1742-4658.2010.07785.x; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hunt G, 1996, J CHROMATOGR A, V744, P295, DOI 10.1016/0021-9673(96)00437-2; Kotia RB, 2010, ANAL BIOCHEM, V399, P190, DOI 10.1016/j.ab.2010.01.008; Kou JH, 2015, MOL NEUROBIOL, V51, P43, DOI 10.1007/s12035-014-8691-z; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V243, P719, DOI 10.1006/bbrc.1998.8164; Nebija D, 2014, INT J MOL SCI, V15, P6399, DOI 10.3390/ijms15046399; Nebija D, 2011, J PHARMACEUT BIOMED, V56, P684, DOI 10.1016/j.jpba.2011.07.006; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; Ouerghi O, 2002, SENSOR ACTUAT B-CHEM, V84, P167, DOI 10.1016/S0925-4005(02)00020-5; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Ponomarenko N., ACTA CRYSTALLOGR D, V70, P708; Ponomarenko NA, 2006, BIOCHEMISTRY-US, V45, P324, DOI 10.1021/bi050675k; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Saveliev AN, 2003, IMMUNOL LETT, V86, P291, DOI 10.1016/S0165-2478(03)00042-7; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; STEVENS FJ, 1988, P NATL ACAD SCI USA, V85, P6895, DOI 10.1073/pnas.85.18.6895; Wootla B, 2009, FEBS LETT, V583, P2565, DOI 10.1016/j.febslet.2009.07.009	34	6	9	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					895	908		10.1096/fj.15-276394	http://dx.doi.org/10.1096/fj.15-276394			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527062				2022-12-28	WOS:000369391900037
J	Theurl, M; Song, DL; Clark, E; Sterling, J; Grieco, S; Altamura, S; Galy, B; Hentze, M; Muckenthaler, MU; Dunaief, JL				Theurl, Milan; Song, Delu; Clark, Esther; Sterling, Jacob; Grieco, Steve; Altamura, Sandro; Galy, Bruno; Hentze, Matthias; Muckenthaler, Martina U.; Dunaief, Joshua L.			Mice with hepcidin-resistant ferroportin accumulate iron in the retina	FASEB JOURNAL			English	Article						retinal pigment epithelium; vascular endothelium; iron transport; blood-brain barrier	MACULAR DEGENERATION; HEREDITARY HEMOCHROMATOSIS; TARGETED DISRUPTION; PIGMENT EPITHELIUM; KNOCKOUT MICE; OVERLOAD; HOMEOSTASIS; MUTATION; FEATURES; BINDING	Because ferroportin (Fpn) is theonlyknown mammalian cellular iron exporter, understanding its localization and regulation within the retina would shed light on the direction of retinal iron flux. The hormone hepcidin may regulate retinal Fpn, as it triggers Fpn degradation in the gut. Immunofluorescence was used to label Fpn in retinas of mice with 4 different genotypes (wild type; Fpn C326S, a hepcidin-resistant Fpn; hepcidin knockout; and ceruloplasmin/hephaestin double knockout). No significant difference in Fpn levels was observed in these retinas. Fpn localized to the abluminal side of the outer plexiform vascular endothelial cells, Muller glia cells, and the basolateral side of the retinal pigment epithelium. Adeno-associated virus (AAV)-hepcidin was injected into the eyes of hepcidin knockout mice, while AAV-lacZ was injected into the contralateral eyes as a control. AAV-hepcidin injected eyes had increased ferritin immunolabeling in retinal vascular endothelial cells. Fpn C326S mice had systemic iron overload compared to wild type and had the fastest retinal iron accumulation of any hereditary model studied to date. The results suggest that physiologic hepcidin levels are insufficient to alter Fpn levels within the retinal pigment epithelium and Muller cells, but may limit iron transport into the retina from vascular endothelial cells.	[Theurl, Milan; Song, Delu; Clark, Esther; Sterling, Jacob; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Theurl, Milan] Med Univ Innsbruck, Dept Ophthalmol & Optometry, A-6020 Innsbruck, Austria; [Grieco, Steve] Univ Florida, Dept Psychiat & Behav Sci, Gainesville, FL USA; [Grieco, Steve] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL USA; [Altamura, Sandro; Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, Heidelberg, Germany; [Altamura, Sandro; Hentze, Matthias; Muckenthaler, Martina U.] Mol Med Partnership Unit, Heidelberg, Germany; [Galy, Bruno; Hentze, Matthias] European Mol Biol Lab, Heidelberg, Germany	University of Pennsylvania; Pennsylvania Medicine; Medical University of Innsbruck; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Dunaief, JL (corresponding author), Univ Penn, Perelman Sch Med, FM Kirby Ctr Mol Ophthalmol, Scheie Eye Inst,Stellar Chance Lab 305, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jdunaief@upenn.edu	Hentze, Matthias W/V-3980-2017; Altamura, Sandro/R-1195-2016	Hentze, Matthias W/0000-0002-4023-7876; Altamura, Sandro/0000-0002-6781-1073; Galy, Bruno/0000-0002-0501-6357; Muckenthaler, Martina/0000-0002-3778-510X; Sterling, Jacob/0000-0001-7535-1073	U.S. National Institutes of Health, National Eye Institute Grant [NEI EY015240]; Research to Prevent Blindness; F. M. Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; Deutsche Forschungsgemeinschaft [SFB1118]; Max Kade Foundation; NATIONAL EYE INSTITUTE [P30EY001583, R01EY015240] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); F. M. Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Kade Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health, National Eye Institute Grant NEI EY015240; Research to Prevent Blindness; the F. M. Kirby Foundation, a gift in memory of L. F. Mauger; and the Paul and Evanina Bell Mackall Foundation Trust. M.U.M. acknowledges funding from the Deutsche Forschungsgemeinschaft and Grant SFB1118 (to S.A.); and M.T. acknowledges funding from the Max Kade Foundation.	Altamura S, 2014, CELL METAB, V20, P359, DOI 10.1016/j.cmet.2014.07.007; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dunaief JL, 2005, OPHTHALMOLOGY, V112, P1062, DOI 10.1016/j.ophtha.2004.12.029; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Finkenstedt A, 2010, J HEPATOL, V53, P1101, DOI 10.1016/j.jhep.2010.04.039; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Gnana-Prakasam JP, 2008, BIOCHEM J, V411, P79, DOI 10.1042/BJ20071377; Hadziahmetovic M, 2008, INVEST OPHTH VIS SCI, V49, P2728, DOI 10.1167/iovs.07-1472; Hadziahmetovic M, 2011, AM J PATHOL, V179, P335, DOI 10.1016/j.ajpath.2011.03.033; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P959, DOI 10.1167/iovs.10-6207; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Itkonen O, 2012, CLIN CHEM, V58, P1158, DOI 10.1373/clinchem.2012.186916; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Peslova G, 2009, BLOOD, V113, P6225, DOI 10.1182/blood-2009-01-201590; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Sham RL, 2005, BLOOD CELL MOL DIS, V34, P157, DOI 10.1016/j.bcmd.2004.12.002; Sham RL, 2009, BLOOD, V114, P493, DOI 10.1182/blood-2009-04-216226; Syrbu SI, 2011, METHODS MOL BIOL, V717, P101, DOI 10.1007/978-1-61779-024-9_6; Theurl M, 2014, HAEMATOLOGICA, V99, P1516, DOI 10.3324/haematol.2013.099481; Wong RW, 2007, RETINA-J RET VIT DIS, V27, P997, DOI 10.1097/IAE.0b013e318074c290; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zhao LL, 2014, AM J PATHOL, V184, P2862, DOI 10.1016/j.ajpath.2014.07.008; Zoller H, 2002, BLOOD CELL MOL DIS, V29, P488, DOI 10.1006/bcmd.2002.0587; Zumerle S, 2014, BLOOD, V123, P3646, DOI 10.1182/blood-2014-01-550467	32	28	28	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					813	823		10.1096/fj.15-276758	http://dx.doi.org/10.1096/fj.15-276758			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26506980	Green Published			2022-12-28	WOS:000369391900030
J	Wang, W; Degroote, J; Van Ginneken, C; Van Poucke, M; Vergauwen, H; Dam, TMT; Vanrompay, D; Peelman, LJ; De Smet, S; Michiels, J				Wang, Wei; Degroote, Jeroen; Van Ginneken, Chris; Van Poucke, Mario; Vergauwen, Hans; Thi Minh Tho Dam; Vanrompay, Daisy; Peelman, Luc J.; De Smet, Stefaan; Michiels, Joris			Intrauterine growth restriction in neonatal piglets affects small intestinal mucosal permeability and mRNA expression of redox-sensitive genes	FASEB JOURNAL			English	Article						intestinal tight junction; IUGR; occludin; antioxidant capacity	BIRTH-WEIGHT PIGLETS; OXIDATIVE STRESS; HEME OXYGENASE; NEWBORN PIGS; GLUTATHIONE; TRANSPORT; PERFORMANCE; PLASMA; RATS; MALONDIALDEHYDE	Neonates with intrauterine growth restriction (IUGR) show lower efficiency of nutrient utilization compared to normal birth weight (NBW) newborns. This study was conducted using neonatal piglets as a model to test the hypothesis that IUGR affects the intestinal barrier function, intestinal structure, and antioxidant system development during the suckling period. The small intestinal mucosae were obtained from IUGR and NBW littermates in the suckling period (d 0, 3, 8, and 19 postnatal). The epithelial barrier function was assessed by FITC-dextran 4 (FD4) and horseradish peroxidase (HRP) fluxes across the epithelium, histomorphologic measurements, and expression of tight-junction proteins. Redox status represented by the glutathione disulfide/glutathione ratio and malondialdehyde concentrations was determined, whereas mRNA expressions of some redox-sensitive proteins were quantified. Results showed that IUGR piglets exhibited a 2-fold higher intestinal permeability in the proximal small intestine on d 0 (P < 0.05), and this difference between IUGR and NBW piglets was widened to 3 and 4 times for FD4 and HRP, respectively (P < 0.05), on d 3. In accordance, expression of occludin was down-regulated at the transcriptional level in IUGR pigletsat d 0 and 19 (P < 0.01). Furthermore, the transcription of heme oxygenase 1, catalase, and thioredoxin reductase genes was down-regulated in IUGR piglets, mainly on postnatal d 0 and 19 (P < 0.01). It appears that IUGR subjects have a lower capacity to mount an antioxidant response in the early postnatal period. Collectively, these results add to our understanding of the mechanisms responsible for intestinal dysfunction in IUGR neonates.	[Wang, Wei; De Smet, Stefaan] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium; [Wang, Wei; Degroote, Jeroen; Michiels, Joris] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, Valentin Vaerwyckweg 1, B-9000 Ghent, Belgium; [Thi Minh Tho Dam; Vanrompay, Daisy] Univ Ghent, Lab Immunol & Anim Biotechnol, Dept Anim Prod, Fac Biosci Engn, B-9000 Ghent, Belgium; [Van Ginneken, Chris; Vergauwen, Hans] Univ Antwerp, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium; [Van Poucke, Mario; Peelman, Luc J.] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; University of Antwerp; Ghent University	Michiels, J (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, Valentin Vaerwyckweg 1, B-9000 Ghent, Belgium.	joris.michiels@ugent.be	DeSmet, Stefaan/N-7576-2017; Van Ginneken, Chris/AAK-2559-2020	DeSmet, Stefaan/0000-0003-1422-805X; Van Ginneken, Chris/0000-0002-1622-9120; Van Poucke, Mario/0000-0002-4316-8984	Agency for Innovation by Science and Technology [IWT-LO100856]; Ghent University Special Research Funding [BOF-01SC1034]	Agency for Innovation by Science and Technology; Ghent University Special Research Funding	The authors thank Sabine Coolsaet, Erik Claeys, Anneke Ovyn, Tessa Van Der Eecken (Laboratory of Animal Nutrition and Animal Product Quality, Ghent University), Katty Huybrechts, Gunther Vrolix, and Karen Jennes (Laboratory of Applied Veterinary Morphology, University of Antwerp) for their excellent technical support. This work was supported by the Agency for Innovation by Science and Technology (IWT-LO100856) and Ghent University Special Research Funding (BOF-01SC1034).	Aw TY, 2005, TOXICOL APPL PHARM, V204, P320, DOI 10.1016/j.taap.2004.11.016; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Boudry G, 2005, ANIM RES, V54, P219, DOI 10.1051/animres:2005014; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; D'Inca R, 2010, LIVEST SCI, V133, P20, DOI 10.1016/j.livsci.2010.06.015; D'Inca R, 2011, NEONATOLOGY, V99, P208, DOI 10.1159/000314919; DARMON N, 1993, J NUTR, V123, P1068; De Vos M, 2014, LIVEST SCI, V159, P165, DOI 10.1016/j.livsci.2013.11.012; Degroote J, 2012, J ANIM SCI, V90, P359, DOI 10.2527/jas.53809; Dixit P, 2012, EUR J DRUG METAB PH, V37, P203, DOI 10.1007/s13318-012-0099-4; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Fanca-Berthon P, 2009, PEDIATR RES, V66, P47, DOI 10.1203/PDR.0b013e3181a2047e; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Friel JK, 2004, PEDIATR RES, V56, P878, DOI 10.1203/01.PDR.0000146032.98120.43; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; He QH, 2011, MOL BIOSYST, V7, P2147, DOI 10.1039/c1mb05024a; Huygelen V, 2014, J ANIM SCI, V92, P3398, DOI 10.2527/jas.2014-7742; JOLMA VM, 1980, AM J ANAT, V158, P211, DOI 10.1002/aja.1001580209; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Maeda T, 2010, CANCER CHEMOTH PHARM, V65, P1117, DOI 10.1007/s00280-009-1119-1; Martin F, 2004, J CLIN INVEST, V113, P591, DOI 10.1172/JCI200419557; MARTIN MG, 1993, J CLIN INVEST, V91, P2844, DOI 10.1172/JCI116528; Martin MG, 1997, DIGEST DIS SCI, V42, P1062, DOI 10.1023/A:1018853506830; McKie AT, 1999, GUT, V45, P879, DOI 10.1136/gut.45.6.879; Michiels J, 2013, BRIT J NUTR, V109, P65, DOI 10.1017/S0007114512000670; Mickiewicz M, 2012, J PHYSIOL PHARMACOL, V63, P225; Nielsen F, 1997, CLIN CHEM, V43, P1209; Oates PS, 2006, WORLD J GASTROENTERO, V12, P4281, DOI 10.3748/wjg.v12.i27.4281; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Quesnel H, 2012, LIVEST SCI, V146, P105, DOI 10.1016/j.livsci.2012.03.010; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Robles R, 2001, EARLY HUM DEV, V65, pS75, DOI 10.1016/S0378-3782(01)00209-2; SHAN XQ, 1990, PHARMACOL THERAPEUT, V47, P61, DOI 10.1016/0163-7258(90)90045-4; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; TELEMO E, 1987, BIOL NEONATE, V52, P141, DOI 10.1159/000242703; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergauwen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120485; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Walter JK, 2009, ANN NY ACAD SCI, V1165, P19, DOI 10.1111/j.1749-6632.2009.04058.x; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang XQ, 2010, J PROTEOME RES, V9, P924, DOI 10.1021/pr900747d; WESTROM BR, 1984, BIOL NEONATE, V46, P20; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yuan TL, 2015, J ZHEJIANG UNIV-SC B, V16, P417, DOI 10.1631/jzus.B1500010; Zabielski R, 2008, J PHYSIOL PHARMACOL, V59, P35; Zhang B, 2011, BLOOD, V117, P4569, DOI 10.1182/blood-2010-09-304931; Zhang H, 2014, BRIT J NUTR, V112, P876, DOI 10.1017/S000711451400155X; Zhang HH, 2014, ANTIOXID REDOX SIGN, V21, P669, DOI 10.1089/ars.2013.5499; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	51	59	0	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					863	873		10.1096/fj.15-274779	http://dx.doi.org/10.1096/fj.15-274779			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26514167				2022-12-28	WOS:000369391900034
J	Wilde, C; Fischer, L; Lede, V; Kirchberger, J; Rothemund, S; Schoneberg, T; Liebscher, I				Wilde, Caroline; Fischer, Liane; Lede, Vera; Kirchberger, Juergen; Rothemund, Sven; Schoeneberg, Torsten; Liebscher, Ines			The constitutive activity of the adhesion GPCR GPR114/ADGRG5 is mediated by its tethered agonist	FASEB JOURNAL			English	Article						peptide agonist; receptor activation; tissue-specific splicing; receptor structure-function; signal transduction	PROTEIN-COUPLED RECEPTORS; GPR126; IDENTIFICATION; ANGIOGENESIS; REPERTOIRE; ACTIVATION; VARIANTS; POLARITY; FAMILY; DOMAIN	Adhesion GPCRs aGPCRs) form the second largest, yet most enigmatic class of the GPCR superfamily. Although the physiologic importance of aGPCRs was demonstrated in several studies, the majority of these receptors is still orphan with respect to their agonists and signal transduction. Recent studies reported that aGPCRs are activated through a tethered peptide agonist, coined the Stachel sequence. The Stachel sequence is the most C-terminal part of the highly conserved GPCR autoproteolysis-inducing domain. Here, we used cell culture-based assays to investigate 2 natural splice variants within the Stachel sequence of the orphan Gs coupling aGPCR GPR114/ADGRG5. There is 1 variant constitutively active in cAMP assays (similar to 25-fold over empty vector) and sensitive to mechano-activation. The other variant has low basal activity in cAMP assays 6-fold over empty vector) and is insensitive to mechano-activation. In-depth mutagenesis studies of these functional differences revealed that the N-terminal half of the Stachel sequence confers the agonistic activity, whereas the C-terminal part orientates the agonistic core sequence to the transmembranedomain. Sequence comparison and functional testing suggest that the proposed mechanism of Stachel-mediated activation is relevant not only to GPR114 but to aGPCRs in general.	[Wilde, Caroline; Fischer, Liane; Lede, Vera; Kirchberger, Juergen; Schoeneberg, Torsten; Liebscher, Ines] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany; [Rothemund, Sven] Univ Leipzig, Fac Med, Core Unit Peptide Technol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Liebscher, I (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Mol Biol, Johannisallee 30, D-04103 Leipzig, Germany.	ines.liebscher@medizin.uni-leipzig.de	Lede, Vera/C-7258-2014; Liebscher, Ines/AAX-7478-2020	Liebscher, Ines/0000-0003-4480-8987; Wilde, Caroline/0000-0003-4548-1760; Lede, Vera/0000-0001-6045-2605	Deutsche Forschungsgemeinschaft [FOR 2149]; BMBF (Integrated Research and Treatment Center Adipositas Diseases Leipzig) [ADI-K767]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (Integrated Research and Treatment Center Adipositas Diseases Leipzig)	The authors thank Dr. Doreen Thor for critical reading of the manuscript and helpful suggestions. They are grateful to Susann Lautenschlager and Kay-Uwe Simon for technical assistance. The work was supported by the Deutsche Forschungsgemeinschaft (FOR 2149) and the BMBF (Integrated Research and Treatment Center Adipositas Diseases Leipzig, ADI-K767). The authors declare no conflicts of interest.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Bjarnadottir TK, 2007, GENE, V387, P38, DOI 10.1016/j.gene.2006.07.039; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Engelman CD, 2010, J STEROID BIOCHEM, V122, P186, DOI 10.1016/j.jsbmb.2010.06.013; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Karpus ON, 2013, J IMMUNOL, V190, P3740, DOI 10.4049/jimmunol.1202192; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Luo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100043; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Preissler J, 2015, GLIA, V63, P206, DOI 10.1002/glia.22744; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rompler H, 2006, GENOMICS, V87, P724, DOI 10.1016/j.ygeno.2006.02.009; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schioth HB, 2010, ADV EXP MED BIOL, V706, P1; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	35	70	70	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					666	673		10.1096/fj.15-276220	http://dx.doi.org/10.1096/fj.15-276220			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26499266				2022-12-28	WOS:000369391900018
J	Fan, Y; Bi, RY; Densmore, MJ; Sato, T; Kobayashi, T; Yuan, Q; Zhou, XD; Erben, RG; Lanske, B				Fan, Yi; Bi, Ruiye; Densmore, Michael J.; Sato, Tadatoshi; Kobayashi, Tatsuya; Yuan, Quan; Zhou, Xuedong; Erben, Reinhold G.; Lanske, Beate			Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis	FASEB JOURNAL			English	Article						calcium/phosphate metabolism; kidney-bone mineral diseases; Galnt3	FIBROBLAST GROWTH FACTOR-23; (PTH)/PTH-RELATED PEPTIDE RECEPTOR; FAMILIAL TUMORAL CALCINOSIS; PTH/PTHRP RECEPTOR; INDIAN HEDGEHOG; METAPHYSEAL CHONDRODYSPLASIA; BLOMSTRAND-CHONDRODYSPLASIA; HYPOPHOSPHATEMIC RICKETS; TARGETED EXPRESSION; IN-VIVO	Parathyroid-hormone-type 1 receptor (PTH1R) is extensively expressed in key regulatory organs for systemic mineral ion homeostasis, including kidney and bone. We investigated the bone-specific functions of PTH1R in modulating mineral ion homeostasis by generating a novel mouse model in which PTH1R is ablated in the limb mesenchyme using Prx1Cre transgenic mice. Such ablation decreased FGF23 protein and serum levels by 50%, despite normal Fgf23 mRNA levels in long bones. Circulating calcium and PTH levels were unchanged, but inorganic phosphate and 1,25(OH)(2)D-3 levels were significantly decreased and accompanied by elevated urinary calcium and phosphate wasting. Key renal genes for balancing mineral ion homeostasis, calbindin D-28k, Klotho, and Napi2a were suppressed by 30-40%. Intermittent hPTH(1-34) injections increased Fgf23 mRNA (7.3-fold), Nurr1 mRNA(3.1-fold), and serum intact-FGF23 (1.6-fold) in controls, but failed to induce Fgf23, Nurr1 mRNA, or intact FGF23 production in mutants. Moreover, a significant elevation in serum C-terminal-FGF23 levels (4-fold) was detected in both genotypes. PTH markedly down-regulated Galnt3 expression (2.7-fold) in controls but not in mutants. These results demonstrate the pivotal role of PTH1R in long bones to regulate systemic mineral ion homeostasis and the direct induction of FGF23 by PTH1R signaling.	[Fan, Yi; Densmore, Michael J.; Sato, Tadatoshi; Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Fan, Yi; Bi, Ruiye; Yuan, Quan; Zhou, Xuedong] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Sichuan, Peoples R China; [Bi, Ruiye] Sichuan Univ, West China Sch Stomatol, Chengdu 610064, Sichuan, Peoples R China; [Bi, Ruiye; Kobayashi, Tatsuya; Lanske, Beate] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Bi, Ruiye; Kobayashi, Tatsuya; Lanske, Beate] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Erben, Reinhold G.] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Dept Biomed Sci, Vienna, Austria	Harvard University; Harvard School of Dental Medicine; Sichuan University; Sichuan University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Veterinary Medicine Vienna	Lanske, B (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Res & Educ Bldg,Room 303,188 Longwood Ave, Boston, MA 02115 USA.	beate_lanske@hsdm.harvard.edu	ZHOU, XUE/F-6129-2013; Erben, Reinhold/AAG-8007-2020; yuan, quan/GZM-5597-2022	Erben, Reinhold/0000-0003-0801-6958; Kobayashi, Tatsuya/0000-0003-4264-5117; Yuan, Quan/0000-0002-2836-1081; Bi, Ruiye/0000-0002-8297-9691; Lanske, Beate/0000-0003-4638-804X; Zhou, Xuedong/0000-0002-9319-7302	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK097105]; Harvard School of Dental Medicine; State Key Laboratory of Oral Diseases [SKLOD2015OF01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097105] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard School of Dental Medicine; State Key Laboratory of Oral Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Amgen for providing the FGF23 antibody and The Center for Skeletal Research Core for the measurement of urinary cAMP levels. Study design: Y.F. and B.L; study conduct: Y.F., R.B., T.S., R.E., and M.D; data collection: Y.F., T.S., R.B., and T.K; data interpretation: Y.F., T.K., Q.Y., X.Z., and B.L; manuscript draft: Y.F; and manuscript revision: M.D. B.L. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant DK097105 (to B.L.), the Harvard School of Dental Medicine, and by State Key Laboratory of Oral Diseases Open Funding Grant SKLOD2015OF01. The authors declare no conflicts of interest.	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Bounoutas GS, 2006, ENDOCRINOLOGY, V147, P4674, DOI 10.1210/en.2006-0301; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Gok DE, 2011, J ENDOCRINOL INVEST, V34, P3, DOI [10.1007/BF03346687, 10.3275/6902]; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; Katai K, 1999, BIOCHEM J, V343, P705, DOI 10.1042/0264-6021:3430705; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Lanske B, 1999, J CLIN INVEST, V104, P399, DOI 10.1172/JCI6629; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lanske B, 1998, ENDOCRINOLOGY, V139, P5194, DOI 10.1210/en.139.12.5194; Lanske B, 2014, KIDNEY INT, V86, P1071, DOI 10.1038/ki.2014.316; Larsson T, 2005, J CLIN ENDOCR METAB, V90, P2424, DOI 10.1210/jc.2004-2238; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; MOSEKILDE L, 1991, CRIT REV ONCOL HEMAT, V11, P1, DOI 10.1016/1040-8428(91)90015-5; Murray TM, 2005, ENDOCR REV, V26, P78, DOI 10.1210/er.2003-0024; Nelson AE, 2001, BONE, V28, P430, DOI 10.1016/S8756-3282(01)00417-3; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Shoback D, 2007, J CLIN ENDOCR METAB, V92, P747, DOI 10.1210/jc.2007-0042; Soegiarto DW, 2001, ENDOCRINOLOGY, V142, P5303, DOI 10.1210/en.142.12.5303; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yuan Q, 2014, J BONE MINER RES, V29, P693, DOI 10.1002/jbmr.2079; Yuan Q, 2011, J BONE MINER RES, V26, P2026, DOI 10.1002/jbmr.433	47	35	39	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					428	440		10.1096/fj.15-278184	http://dx.doi.org/10.1096/fj.15-278184			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26428657	Green Published			2022-12-28	WOS:000367621000040
J	McCarthy, CG; Webb, RC				McCarthy, Cameron G.; Webb, R. Clinton			The toll of the gridiron: damage-associated molecular patterns and hypertension in American football	FASEB JOURNAL			English	Article						musculoskeletal trauma; inflammation; blood; pressure	DISEASE RISK-FACTORS; BODY-MASS INDEX; LEAGUE PLAYERS; BLOOD-PRESSURE; RECURRENT CONCUSSION; CREATINE-KINASE; CARDIAC MARKERS; NFL PLAYERS; MARATHON; EXERCISE	American football has unequivocally been linked to elevations in blood pressure and hypertension, especially in linemen. However, the mechanisms of this increase cannot be attributed solely to increased body weight and associated cardiometabolic risk factors (e.g., dyslipidemia or hyperglycemia). Therefore, understanding the etiology of football-associated hypertension is essential for improving the quality of life in this mostly young population, as well as for lowering the potential for chronic disease in the future. We propose that inflammatogenic damage-associated molecular patterns (DAMPs) released into the circulation from football-induced musculoskeletal trauma activate pattern-recognition receptors of the innate immune system-specifically, high mobility group box 1 protein (HMGB1) and mitochondrial (mt) DNA which activate Toll-like receptor (TLR)4 and -9, respectively. Previously, we observed that circulating levels of these 2 DAMPs are increased in hypertension, and activation of TLR4 and -9 causes endothelial dysfunction and hypertension. Therefore, our novel hypothesis is that musculoskeletal injury from repeated hits in football players, particularly in linemen, leads to elevated circulating HMGB1 and mtDNA to activate TLRs on endothelial cells leading to impaired endothelium-dependent vasodilation, increased vascular tone, and hypertension.-McCarthy, C. G., Webb, R. C. The toll of the gridiron: damage-associated molecular patterns and hypertension in American football. FASEB J. 30, 34-40 (2016). www.fasebj.org	[McCarthy, Cameron G.; Webb, R. Clinton] Georgia Regents Univ, Dept Physiol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	McCarthy, CG (corresponding author), Georgia Regents Univ, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	cmccarthy@gru.edu			American Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL071138]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK083685]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083685] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. T. Szasz and C. F. Wenceslau (Department of Physiology, Georgia Regents University, Augusta, GA, USA) and Drs. N. Jenkins and K. McCully (Department of Kinesiology, University of Georgia, Athens, GA, USA), for their critical evaluation of the manuscript and editorial expertise. The preparation of this report was supported in part by a predoctoral fellowship (to C.G.M.) and a grant-in-aid (to R.C.W.) from the American Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01HL071138 (to R.C.W.); and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK083685 (to R.C.W.). The authors declare no conflicts of interest.	Allen TW, 2010, PHYSICIAN SPORTSMED, V38, P21, DOI 10.3810/psm.2010.04.1758; Basra SS, 2014, AM J CARDIOL, V114, P1836, DOI 10.1016/j.amjcard.2014.09.021; Biderman D., 2010, WALL STREET J; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Croft LB, 2008, AM J CARDIOL, V102, P343, DOI 10.1016/j.amjcard.2008.03.065; D'Andrea A, 2007, INT J CARDIOL, V115, P342, DOI 10.1016/j.ijcard.2006.03.041; Doucleff M., 2013, NPR             0201; Ehlers GG, 2002, J ATHL TRAINING, V37, P151; Fisman EZ, 1997, AM J CARDIOL, V79, P355, DOI 10.1016/S0002-9149(96)00761-8; Fisman EZ, 2002, AM J CARDIOL, V89, P887, DOI 10.1016/S0002-9149(02)02210-5; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Garrido-Chamorro RP, 2009, J SPORT MED PHYS FIT, V49, P278; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Harp JB, 2005, JAMA-J AM MED ASSOC, V293, P1061, DOI 10.1001/jama.293.9.1061-b; Hoffman JR, 2008, INTJ SPORT PHYSIOL, V3, P387, DOI 10.1123/ijspp.3.3.387; Jee H, 2013, AM J PHYS MED REHAB, V92, P513, DOI 10.1097/PHM.0b013e31829232db; Kahanov L., 2012, ONLINE J MED MED SCI, V1, P96; KANNEL WB, 1967, ANN INTERN MED, V67, P48, DOI 10.7326/0003-4819-67-1-48; Kaplan NM, 2005, J AM COLL CARDIOL, V45, P1346, DOI 10.1016/j.jacc.2005.02.012; Karpinos AR, 2013, CIRC-CARDIOVASC QUAL, V6, P716, DOI 10.1161/CIRCOUTCOMES.113.000463; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Kim JH, 2015, AM J CARDIOL, V115, P262, DOI 10.1016/j.amjcard.2014.10.033; Kim YJ, 2012, INT J SPORTS MED, V33, P171, DOI 10.1055/s-0031-1285930; Kim YJ, 2015, J CLIN HYPERTENS, V17, P868, DOI 10.1111/jch.12591; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kraemer WJ, 2013, J STRENGTH COND RES, V27, P434, DOI 10.1519/JSC.0b013e318281d1b0; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe9; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McCarthy CG, 2015, CARDIOVASC RES, V107, P119, DOI 10.1093/cvr/cvv137; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Meredith PA, 2006, J RENIN-ANGIO-ALDO S, V7, P64, DOI 10.3317/jraas.2006.012; NISHIZAWA T, 1976, AM J CLIN NUTR, V29, P1167, DOI 10.1093/ajcn/29.10.1167; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Owoeye OB, 2013, AM J HYPERTENSION RE, V3, P26; Pincivero DM, 1997, SPORTS MED, V23, P247, DOI 10.2165/00007256-199723040-00004; Pokharel Y, 2014, SOUTH MED J, V107, P633, DOI 10.14423/SMJ.0000000000000173; Rehm K, 2015, INT J SPORTS MED, V36, P832, DOI 10.1055/s-0035-1547218; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Selden MA, 2009, AM J MED, V122, P811, DOI 10.1016/j.amjmed.2009.03.027; Selden MA, 2009, AM J CARDIOL, V103, P969, DOI 10.1016/j.amjcard.2008.12.046; Seys SF, 2015, ALLERGY, V70, P187, DOI 10.1111/all.12540; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Siegel AJ, 2012, AM J MED, V125, P630, DOI 10.1016/j.amjmed.2011.11.008; Smith LL, 2000, MED SCI SPORT EXER, V32, P317, DOI 10.1097/00005768-200002000-00011; Smith LL, 2004, J STRENGTH COND RES, V18, P185, DOI 10.1519/00124278-200402000-00028; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Vaneckova I, 2014, J ENDOCRINOL, V223, pR63, DOI 10.1530/JOE-14-0368; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Vinereanu D, 2002, CLIN SCI, V103, P249, DOI 10.1042/cs1030249; Virani SS, 2012, ATHEROSCLEROSIS, V222, P551, DOI 10.1016/j.atherosclerosis.2012.03.031; Weiner RB, 2013, CIRCULATION, V128, P524, DOI 10.1161/CIRCULATIONAHA.113.003522	58	19	20	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					34	40		10.1096/fj.15-279588	http://dx.doi.org/10.1096/fj.15-279588			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26316270	Green Published			2022-12-28	WOS:000367621000005
J	Sharma, BK; Kolhe, R; Black, SM; Keller, JR; Mivechi, NF; Satyanarayana, A				Sharma, Bal Krishan; Kolhe, Ravindra; Black, Stephen M.; Keller, Jonathan R.; Mivechi, Nahid F.; Satyanarayana, Ande			Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells	FASEB JOURNAL			English	Article						glucose metabolism; glutamine metabolism; liver cancer; c-Myc; Hif1 alpha	LOOP-HELIX PROTEINS; C-MYC; ID PROTEINS; CANCER; EXPRESSION; HYPOXIA; GROWTH; HIF; TRANSACTIVATION; GLUTAMINE	Reprograming of metabolism is one of the central hallmarks of cancer. The majority of cancer cells depend on high rates of glycolysis and glutaminolysis for their growth and survival. A number of oncogenes and tumor suppressors have been connected to the regulation of altered glucose and glutamine metabolism in cancer cells. For example, the oncogene c-Myc plays vital roles in cancer cell metabolic adaptation by directly regulating various genes that participate in aerobic glycolysis and glutaminolysis. Inhibitor of differentiation 1 (Id1) is a helix-loop-helix transcription factor that plays important roles in cell proliferation, differentiation, and cell fate determination. Overexpression of Id1 causes intestinal adenomas and thymic lymphomas in mice, suggesting that Id1 could function as an oncogene. Despite it being an oncogene, whether Id1 plays any prominent role in cancer cell metabolic reprograming is unknown. Here, we demonstrate that Id1 is strongly expressed in human and mouse liver tumors and in hepatocellular carcinoma (HCC) cell lines, whereas its expression is very low or undetectable in normal liver tissues. In HCC cells, Id1 expression is regulated by the MAPK/ERK pathway at the transcriptional level. Knockdown of Id1 suppressed aerobic glycolysis and glutaminolysis, suggesting that Id1 promotes a metabolic shift toward aerobic glycolysis. At the molecular level, Id1 mediates its metabolic effects by regulating the expression levels of c-Myc. Knockdown of Id1 resulted in down-regulation (similar to 75%) of c-Myc, whereas overexpression of Id1 strongly induced (3-fold) c-Myc levels. Interestingly, knockdown of c-Myc resulted in down-regulation (similar to 60%) of Id1, suggesting a positive feedback-loop regulatory mechanism between Id1 and c-Myc. Under anaerobic conditions, both Id1 and c-Myc are down-regulated (50-70%), and overexpression of oxygen-insensitive hypoxia-inducible factor 1 alpha (Hif1 alpha) or its downstream target Mxi1 resulted in a significant reduction of c-Myc and Id1 (similar to 70%), suggesting that Hif1 alpha suppresses Id1 and c-Myc under anaerobic conditions via Mxi1. Together, our findings indicate a prominent novel role for Id1 in liver cancer cell metabolic adaptation.	[Sharma, Bal Krishan; Satyanarayana, Ande] Georgia Regents Univ, Mol Oncol & Biomarkers Program, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Mivechi, Nahid F.] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA; [Kolhe, Ravindra] Georgia Regents Univ, Dept Pathol, Augusta, GA 30912 USA; [Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Program Pulm Vasc Dis, Augusta, GA 30912 USA; [Keller, Jonathan R.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Mouse Canc & Genet Program, Basic Sci Program, Frederick, MD USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Satyanarayana, A (corresponding author), Georgia Regents Univ, Ctr Canc, Dept Biochem & Mol Biol, Mol Oncol & Biomarkers Program, 1410 Laney Walker Blvd,Room CN3150, Augusta, GA 30912 USA.	sande@gru.edu	Keller, Jonathan R./O-6677-2018; Sharma, Bal Krishan/AAF-6935-2020	KOLHE, RAVINDRA/0000-0002-8283-2403	U.S. National Institutes of Health (NIH) National Cancer Institute [K22CA168828]; NIH National Heart, Lung, and Blood Institute [HL060190]; NATIONAL CANCER INSTITUTE [R01CA132640, R01CA062130, ZIABC010001, K22CA168828] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060190, R01HL067841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK105565] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jingling Yuan, Ashis Mondal, and Kimya Jones for technical help and Dr. Rhea-Beth Markowitz for reviewing and editing the manuscript. This research is supported by a grant from the U.S. National Institutes of Health (NIH) National Cancer Institute Grant K22CA168828 to A.S. and NIH National Heart, Lung, and Blood Institute Grant HL060190 to S.M.B. The authors declare no conflicts of interest.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1, DOI 10.1111/j.1749-6632.1990.tb42359.x; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Corn PG, 2005, CANCER BIOL THER, V4, P1285, DOI 10.4161/cbt.4.11.2299; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Kim D, 1999, MOL CELL BIOL, V19, P8240; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Manrique I, 2015, CANCER LETT, V356, P899, DOI 10.1016/j.canlet.2014.10.035; Maruyama H, 1999, AM J PATHOL, V155, P815, DOI 10.1016/S0002-9440(10)65180-2; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Norton JD, 2000, J CELL SCI, V113, P3897; O'Toole PJ, 2003, J BIOL CHEM, V278, P45770, DOI 10.1074/jbc.M306056200; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Schindl M, 2001, CANCER RES, V61, P5703; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Wagner K, 2006, P NATL ACAD SCI USA, V103, P6338, DOI 10.1073/pnas.0508143103; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wice BM, 1998, J BIOL CHEM, V273, P25310, DOI 10.1074/jbc.273.39.25310; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	40	24	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					262	275		10.1096/fj.15-277749	http://dx.doi.org/10.1096/fj.15-277749			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26330493	Green Published			2022-12-28	WOS:000367621000026
J	Ben-Eliezer, I; Pomerantz, Y; Galiani, D; Nevo, N; Dekel, N				Ben-Eliezer, Inbal; Pomerantz, Yael; Galiani, Dalia; Nevo, Nava; Dekel, Nava			Appropriate expression of Ube2C and Ube2S controls the progression of the first meiotic division	FASEB JOURNAL			English	Article						oocyte; spindle; proteasome; spindle assembly checkpoint	ANAPHASE-PROMOTING COMPLEX; SPINDLE ASSEMBLY CHECKPOINT; FEMALE MOUSE MEIOSIS; METAPHASE-I ARREST; CYCLIN-B; PROTEASOMAL DEGRADATION; UBIQUITIN CHAINS; MITOTIC EXIT; OOCYTES; PROTEIN	Timely degradation of protein regulators of the cell cycle is essential for the completion of cell division. This degradation is promoted by the E3 anaphase-promoting complex/cyclosome(APC/C) and mediated by the E2 ubiquitin-conjugating enzymes (Ube2s). Unlike the ample information gathered regarding the meiotic E3 APC/C, the E2s participating in this cell division have never been studied. We identified Ube2C, -S, and -D3 as the E2 enzymes that regulate APC/C activity during meiosis of mouse oocytes. Their depletion reduces the levels of the first meiotic cytokinesis by 50%, and their overexpression doubles and accelerates its completion (50% as compared with 4% at 11 h). We also demonstrated that these E2s take part in ensuring appropriate spindle formation. It is noteworthy that high levels of Ube2C bring about the resumption of the first meiotic division, regardless of the formation of the spindle, overriding the spindle assembly checkpoint. Thus, alongside their canonical function in protein degradation, Ube2C and -S also control the extrusion of the first polar body. Overall, our study characterizes new regulators and unveils the novel roles they play during the meiotic division. These findings shed light on faithful chromosome segregation in oocytes and may contribute to better understanding of aneuploidy and its consequent genetic malformations.	[Ben-Eliezer, Inbal; Pomerantz, Yael; Galiani, Dalia; Nevo, Nava; Dekel, Nava] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dekel, N (corresponding author), Weizmann Inst Sci, 234 Herzl St, IL-76100 Rehovot, Israel.	nava.dekel@weizmann.ac.il	DEKEL, NAVA/R-8817-2019					Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; CHOI T, 1991, DEVELOPMENT, V113, P789; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; HAMPL A, 1995, DEVELOPMENT, V121, P925; Hao ZL, 2012, TUMOR BIOL, V33, P723, DOI 10.1007/s13277-011-0291-1; HASHIMOTO N, 1988, DEV BIOL, V126, P242, DOI 10.1016/0012-1606(88)90135-2; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoermanseder E, 2011, EMBO REP, V12, P436, DOI 10.1038/embor.2011.32; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Homer H, 2013, REPRODUCTION, V146, pR61, DOI 10.1530/REP-13-0163; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Horikoshi Y, 2013, CELL CYCLE, V12, P961, DOI 10.4161/cc.23946; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Jones KT, 2011, RESULTS PROBL CELL D, V53, P343, DOI 10.1007/978-3-642-19065-0_15; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kitagawa R, 2002, CURR BIOL, V12, P2118, DOI 10.1016/S0960-9822(02)01392-1; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Li S, 2012, CELL CYCLE, V11, P3211, DOI 10.4161/cc.21553; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Pomerantz Y, 2012, FASEB J, V26, P4495, DOI 10.1096/fj.12-209866; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sako K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4667; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; Song L, 2014, MOL CELL, V53, P179, DOI 10.1016/j.molcel.2013.12.022; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; Sun SC, 2011, CELL CYCLE, V10, P2419, DOI 10.4161/cc.10.15.15932; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4; Zhang QH, 2010, CELL CYCLE, V9, P2230, DOI 10.4161/cc.9.11.11895	55	19	23	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4670	4681		10.1096/fj.15-274522	http://dx.doi.org/10.1096/fj.15-274522			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26207029				2022-12-28	WOS:000364514700024
J	Brook, MS; Wilkinson, DJ; Mitchell, WK; Lund, JN; Szewczyk, NJ; Greenhaff, PL; Smith, K; Atherton, PJ				Brook, Matthew S.; Wilkinson, Daniel J.; Mitchell, William K.; Lund, Jonathan N.; Szewczyk, Nathaniel J.; Greenhaff, Paul L.; Smith, Ken; Atherton, Philip J.			Skeletal muscle hypertrophy adaptations predominate in the early stages of resistance exercise training, matching deuterium oxide-derived measures of muscle protein synthesis and mechanistic target of rapamycin complex 1 signaling	FASEB JOURNAL			English	Article						stable isotopes; anabolic signaling; D2O	TIME-COURSE; SYNTHESIS RATES; THICKNESS MEASUREMENTS; MOLECULAR RESPONSES; INDUCED INCREASE; FED STATE; STRENGTH; VOLUME; YOUNG; ULTRASOUND	Resistance exercise training (RET) is widely used to increase muscle mass in athletes and also aged/cachectic populations. However, the time course and metabolic and molecular control of hypertrophy remain poorly defined. Using newly developed deuterium oxide (D2O)-tracer techniques, we investigated the relationship between long-term muscle protein synthesis (MPS) and hypertrophic responses to RET. A total of 10 men (2361 yr) undertook 6 wk of unilateral (1-legged) RET [6 x 8 repetitions, 75% 1 repetition maximum (1-RM) 3/wk], rendering 1 leg untrained (UT) and the contralateral, trained (T). After baseline bilateral vastus lateralis (VL) muscle biopsies, subjects consumed 150 ml D2O (70 atom percentage; thereafter 50 ml/wk) with regular body water monitoring in saliva via high-temperature conversion elemental analyzer:isotope ratio mass spectrometer. Further bilateral VL muscle biopsies were taken at 3 and 6 wk to temporally quantify MPS via gas chromatography: pyrolysis: isotope ratio mass spectrometer. Expectedly, only the T leg exhibited marked increases in function [i.e., 1-RM/maximal voluntary contraction (60 degrees)] and VL thickness (peaking at 3 wk). Critically, whereas MPS remained unchanged in the UT leg (e.g., similar to 1.35 +/- 0.08%/d), the T leg exhibited increased MPS at 0-3wk(1.6 +/- 0.01%/d), but not at3-6wk(1.29 +/- 0.11%/d); this was reflected by dampened acute mechanistic target of rapamycin complex 1 signaling responses to RET, beyond 3 wk. Therefore, hypertrophic remodeling is most active during the early stages of RET, reflecting longer-term MPS. Moreover, D2O heralds promise for coupling MPS and muscle mass and providing insight into the control of hypertrophy and efficacy of anabolic interventions.	[Brook, Matthew S.; Wilkinson, Daniel J.; Mitchell, William K.; Lund, Jonathan N.; Szewczyk, Nathaniel J.; Greenhaff, Paul L.; Smith, Ken; Atherton, Philip J.] Univ Nottingham, Arthrit Res UK Ctr Excellence Musculoskeletal Age, Div Clin Metab & Mol Physiol,Royal Derby Hosp, Med Res Council,Postgrad Entry Med Sch, Derby DE22 3DT, England; [Mitchell, William K.; Lund, Jonathan N.] Royal Derby Hosp, Dept Surg, Derby, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; University of Nottingham	Atherton, PJ (corresponding author), Univ Nottingham, Arthrit Res UK Ctr Excellence Musculoskeletal Age, Div Clin Metab & Mol Physiol,Royal Derby Hosp, Med Res Council,Postgrad Entry Med Sch, Derby DE22 3DT, England.	philip.atherton@nottingham.ac.uk	Lund, Jonathan/K-6631-2019; Brook, Matthew/W-4689-2019	Lund, Jonathan/0000-0001-5195-2181; Szewczyk, Nathaniel/0000-0003-4425-9746; Greenhaff, Paul/0000-0003-4403-0490; Brook, Matthew/0000-0002-9245-3095; Atherton, Philip/0000-0002-7286-046X	Physiological Society; Dunhill Medical Trust [R264/1112]; Medical Research Council [CIC12019]; Medical Research Council-Arthritis Research United Kingdom (MRC-ARUK) Centre; University of Nottingham Ph.D. studentship; MRC-ARUK Centre; BBSRC [BB/K019104/1] Funding Source: UKRI; EPSRC [EP/J015687/1] Funding Source: UKRI; MRC [MC_PC_12019, MR/K00414X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019104/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J015687/1] Funding Source: researchfish; Medical Research Council [MR/K00414X/1, MC_PC_12019] Funding Source: researchfish; The Dunhill Medical Trust [R264/1112] Funding Source: researchfish	Physiological Society; Dunhill Medical Trust(Dunhill Medical Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council-Arthritis Research United Kingdom (MRC-ARUK) Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Nottingham Ph.D. studentship; MRC-ARUK Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported by a grant from The Physiological Society (to P.J.A. and K.S.), a project grant from the Dunhill Medical Trust (R264/1112) (to K.S., P.J.A., and D.J.W.), and a Medical Research Council Confidence in Concept award (CIC12019; to P.J.A., P.L.G., N.J.S., and K.S.). D.J.W. is a Medical Research Council-Arthritis Research United Kingdom (MRC-ARUK) Centre-funded postdoctoral research fellow, and M.S.B. is supported by a University of Nottingham Ph.D. studentship. Equipment was funded through monies provided from an award by the MRC-ARUK Centre to the Universities of Nottingham and Birmingham. The authors are also thankful for the technical and administrative support of Margaret Baker, Amanda Gates, Tanya Fletcher, and Professor Marco Narici for his guidance in obtaining ultrasound measures.	Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Abe T, 1997, J Gravit Physiol, V4, pS10; Abe T, 2000, EUR J APPL PHYSIOL O, V81, P174, DOI 10.1007/s004210050027; Ahtiainen JP, 2003, EUR J APPL PHYSIOL, V89, P555, DOI 10.1007/s00421-003-0833-3; ALWAY SE, 1992, J APPL PHYSIOL, V72, P1512, DOI 10.1152/jappl.1992.72.4.1512; Baroni BM, 2013, MUSCLE NERVE, V48, P498, DOI 10.1002/mus.23785; Bemben MG, 2002, J STRENGTH COND RES, V16, P103, DOI 10.1519/00124278-200202000-00016; Bickel CS, 2005, J APPL PHYSIOL, V98, P482, DOI 10.1152/japplphysiol.00895.2004; Burd NA, 2011, J NUTR, V141, P568, DOI 10.3945/jn.110.135038; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Cheek D., 1968, HUMAN GROWTH BODY CO, P260; CHESLEY A, 1992, J APPL PHYSIOL, V73, P1383, DOI 10.1152/jappl.1992.73.4.1383; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; Crossland H, 2013, AM J PHYSIOL-ENDOC M, V305, pE183, DOI 10.1152/ajpendo.00541.2012; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; DeFreitas JM, 2011, EUR J APPL PHYSIOL, V111, P2785, DOI 10.1007/s00421-011-1905-4; DIETRICHSON P, 1987, J NEUROL NEUROSUR PS, V50, P1461, DOI 10.1136/jnnp.50.11.1461; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Esformes JI, 2002, EUR J APPL PHYSIOL, V87, P90, DOI 10.1007/s00421-002-0592-6; FORSBERG AM, 1991, CLIN SCI, V81, P249, DOI 10.1042/cs0810249; Franchi MV, 2014, ACTA PHYSIOL, V210, P642, DOI 10.1111/apha.12225; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; Gasier HG, 2012, METABOLISM, V61, P153, DOI 10.1016/j.metabol.2011.07.001; Giles LS, 2015, PHYS THER SPORT, V16, P45, DOI 10.1016/j.ptsp.2014.04.002; GOLDBERG AL, 1967, NATURE, V216, P1219, DOI 10.1038/2161219a0; GOLDBERG AL, 1975, MED SCI SPORT EXER, V7, P185; Gonzalez AM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12268; Haddad F, 2005, J APPL PHYSIOL, V98, P46, DOI 10.1152/japplphysiol.00553.2004; Hakkinen K, 1998, J GERONTOL A-BIOL, V53, pB415, DOI 10.1093/gerona/53A.6.B415; Heymsfield SB, 1997, ANNU REV NUTR, V17, P527, DOI 10.1146/annurev.nutr.17.1.527; Heymsfield SB, 2014, J CACHEXIA SARCOPENI, V5, P9, DOI 10.1007/s13539-014-0130-5; Kasumov T, 2013, AM J PHYSIOL-HEART C, V304, pH1201, DOI 10.1152/ajpheart.00933.2012; Kasumov T, 2011, ANAL BIOCHEM, V412, P47, DOI 10.1016/j.ab.2011.01.021; Kim PL, 2005, J PHYSIOL-LONDON, V568, P283, DOI 10.1113/jphysiol.2005.093708; Kumar V, 2012, J GERONTOL A-BIOL, V67, P1170, DOI 10.1093/gerona/gls141; Kumar V, 2009, J APPL PHYSIOL, V106, P2026, DOI 10.1152/japplphysiol.91481.2008; Kumar V, 2009, J PHYSIOL-LONDON, V587, P211, DOI 10.1113/jphysiol.2008.164483; LAURENT GJ, 1977, GROWTH, V41, P249; MacDonald AJ, 2013, RAPID COMMUN MASS SP, V27, P1769, DOI 10.1002/rcm.6622; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Mitchell CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089431; Miyatani M, 2004, EUR J APPL PHYSIOL, V91, P264, DOI 10.1007/s00421-003-0974-4; Miyatani M, 2002, EUR J APPL PHYSIOL, V86, P203, DOI 10.1007/s00421-001-0533-9; MORITANI T, 1979, AM J PHYS MED REHAB, V58, P115; Murton AJ, 2014, J APPL PHYSIOL, V116, P113, DOI 10.1152/japplphysiol.00426.2013; Nader GA, 2014, J APPL PHYSIOL, V116, P693, DOI 10.1152/japplphysiol.01366.2013; Ogasawara R, 2013, EUR J APPL PHYSIOL, V113, P975, DOI 10.1007/s00421-012-2511-9; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips BE, 2012, CURR OPIN CLIN NUTR, V15, P58, DOI 10.1097/MCO.0b013e32834d19bc; Phillips SM, 1999, AM J PHYSIOL-ENDOC M, V276, pE118; Rabita G, 2000, EUR J APPL PHYSIOL, V83, P531, DOI 10.1007/s004210000325; Reeves ND, 2004, EUR J APPL PHYSIOL, V91, P116, DOI 10.1007/s00421-003-0961-9; Robinson MM, 2011, FASEB J, V25, P3240, DOI 10.1096/fj.11-186437; Seynnes OR, 2007, J APPL PHYSIOL, V102, P368, DOI 10.1152/japplphysiol.00789.2006; Smith GI, 2011, J APPL PHYSIOL, V110, P480, DOI 10.1152/japplphysiol.00125.2010; STARON RS, 1994, J APPL PHYSIOL, V76, P1247, DOI 10.1152/jappl.1994.76.3.1247; Tang JE, 2008, AM J PHYSIOL-REG I, V294, pR172, DOI 10.1152/ajpregu.00636.2007; Tesch PA, 2004, ACTA PHYSIOL SCAND, V180, P89, DOI 10.1046/j.0001-6772.2003.01225.x; Thomaes T, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-7; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wernbom M, 2007, SPORTS MED, V37, P225, DOI 10.2165/00007256-200737030-00004; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wilkinson SB, 2006, EUR J APPL PHYSIOL, V98, P546, DOI 10.1007/s00421-006-0300-z; Witard OC, 2014, AM J CLIN NUTR, V99, P86, DOI 10.3945/ajcn.112.055517; Woolstenhulme MT, 2006, J APPL PHYSIOL, V100, P1876, DOI 10.1152/japplphysiol.01592.2005	70	134	136	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4485	4496		10.1096/fj.15-273755	http://dx.doi.org/10.1096/fj.15-273755			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26169934				2022-12-28	WOS:000364514700009
J	Deng, HY; Fung, G; Shi, JY; Xu, SW; Wang, C; Yin, MM; Hou, J; Zhang, JC; Jin, ZG; Luo, HL				Deng, Haoyu; Fung, Gabriel; Shi, Junyan; Xu, Suowen; Wang, Chen; Yin, Meimei; Hou, Jun; Zhang, Jingchun; Jin, Zheng-Gen; Luo, Honglin			Enhanced enteroviral infectivity via viral protease-mediated cleavage of Grb2-associated binder 1	FASEB JOURNAL			English	Article						coxsackievirus B3; viral protease 2A(pro); ERK1/2; signal transduction	GROWTH-FACTOR; COXSACKIEVIRUS; KINASE; GAB1; INHIBITION; RECEPTOR; ACTIVATION; APOPTOSIS; CYTOKINE; BINDING	Coxsackievirus B3 (CVB3), an important human causative pathogen for viral myocarditis, pancreatitis, and meningitis, has evolved different strategies to manipulate the host signaling machinery to ensure successful viral infection. We previously revealeda crucial role for the ERK1/2 signaling pathway in regulating viral infectivity. However, the detail mechanism remains largely unknown. Grb2-associated binder 1 (GAB1) is an important docking protein responsible for intracellular signaling assembly and transduction. In this study, we demonstrated that GAB1 was proteolytically cleaved after CVB3 infection at G175 and G436 by virus-encoded protease 2A(pro), independent of caspase activation. Knockdown of GAB1 resulted in a significant reduction of viral protein expression and virus titers. Moreover, we showed that virus-induced cleavage of GAB1 is beneficial to viral growth as the N-terminal proteolytic product of GAB1 (GAB1-N1-174) further enhances ERK1/2 activation and promotes viral replication. Our results collectively suggest that CVB3 targets host GAB1 to generate a GAB1-N1-174 fragment that enhances viral infectivity, at least in part, via activation of the ERK pathway. The findings in this study suggest a novel mechanism that CVB3 employs to subvert the host signaling and facilitate consequent viral replication.	[Deng, Haoyu; Fung, Gabriel; Shi, Junyan; Wang, Chen; Hou, Jun; Zhang, Jingchun; Luo, Honglin] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada; [Deng, Haoyu; Fung, Gabriel; Shi, Junyan; Wang, Chen; Hou, Jun; Zhang, Jingchun; Luo, Honglin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Yin, Meimei; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Xu, Suowen; Yin, Meimei; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Rochester; University of Rochester	Luo, HL (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	zheng-gen_jin@urmc.rochester.edu; honglin.luo@hli.ubc.ca	Shi, Junyan/T-1777-2019; Yin, Meimei/I-8090-2016	Xu, Suowen/0000-0002-5488-5217	Canadian Institutes of Health Research [MOP-119274, CCI-125685]; U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01HL109502, R01HL114570]; American Diabetes Association [1-12-BS-92-R1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114570, R01HL109502] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grants MOP-119274 and CCI-125685 to H.L., U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grants R01HL109502 and R01HL114570 to Z.G.J., and American Diabetes Association Grant 1-12-BS-92-R1 to Z.G.J. The authors declare no conflicts of interest.	Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Eulenfeld R, 2009, J CELL SCI, V122, P55, DOI 10.1242/jcs.037226; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Fung G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079546; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Jensen KJ, 2013, CELL HOST MICROBE, V13, P67, DOI 10.1016/j.chom.2012.11.009; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Kerekatte V, 1999, J VIROL, V73, P709, DOI 10.1128/JVI.73.1.709-717.1999; Kim SO, 2002, ENDOCRINOLOGY, V143, P4856, DOI 10.1210/en.2002-220565; Knowlton KU, 2008, CURR TOP MICROBIOL, V323, P315; Krebs JF, 1999, J CELL BIOL, V144, P915, DOI 10.1083/jcb.144.5.915; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Lim BK, 2013, J CLIN INVEST, V123, P5146, DOI 10.1172/JCI66271; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Luo HH, 2010, CARDIOVASC RES, V85, P347, DOI 10.1093/cvr/cvp225; Marchant D, 2008, CURR TOP MICROBIOL, V323, P177; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Nakaoka Y, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/141068; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Shi J, 2014, CELL DEATH DIFFER, V21, P1432, DOI 10.1038/cdd.2014.58; Shi JY, 2013, AUTOPHAGY, V9, P1591, DOI 10.4161/auto.26059; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang WY, 2015, INT J CARDIOL, V181, P180, DOI 10.1016/j.ijcard.2014.10.148; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Wong J, 2013, FASEB J, V27, P2777, DOI 10.1096/fj.12-226498; Wong J, 2012, CELL RES, V22, P360, DOI 10.1038/cr.2011.114; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652	32	18	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4523	4531		10.1096/fj.15-274829	http://dx.doi.org/10.1096/fj.15-274829			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26183772	Green Published			2022-12-28	WOS:000364514700012
J	Saupe, F; Huijbers, EJM; Hein, T; Femel, J; Cedervall, J; Olsson, AK; Hellman, L				Saupe, Falk; Huijbers, Elisabeth J. M.; Hein, Tobias; Femel, Julia; Cedervall, Jessica; Olsson, Anna-Karin; Hellman, Lars			Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters	FASEB JOURNAL			English	Article						cancer; ED-B of fibronectin; adjuvant; CpG; type I IFN	THERAPEUTIC VACCINATION; TUMOR; FIBRONECTIN; CANCER; IMMUNOCYTOKINE; NEOVASCULATURE; INTERLEUKIN-12; INTERFERONS; COMBINATION; PROGRESSION	We recently showed that it is possible to compromise tumor vessel function and, as a consequence, suppress growth of aggressive preclinical tumors by immunizing against the tumor vascular markers extra domain-A (ED-A) or -B (ED-B) of fibronectin, using a fusion protein consisting of the ED-A or ED-B peptide fused to bacterial thioredoxin. To address the mechanism behind fusion protein-induced immunization and the specific contribution of the different vaccine constituents to elicit an anti-self-antibody response, we immunized mice with modified or unmodified self-antigens, combined with different adjuvant components, and analyzed antibody responses by ELISA in sera. Several essential requirements to circumvent tolerance were identified: (1) a potent pattern recognition receptor agonist like an oligonucleotide containing unmethylated cytosine and guanine dinucleotides (CpG); (2) a depot adjuvant to keep the CpG at the site of injection; and (3) the presence of foreign sequences in the vaccine protein. Lack of either of these factors abolished the anti-self-response (P = 0.008). In mice genetically deficient for type I IFN signaling, there was a 60% reduction in the anti-self-response compared with wildtype (P = 0.011), demonstrating a key role of this pathway in CpG-induced circumvention of self-tolerance. Identification of these mechanistic requirements to generate a potent anti-self-immune response should significantly aid the design of efficient, specific, and safe therapeutic cancer vaccines.	[Saupe, Falk; Huijbers, Elisabeth J. M.; Femel, Julia; Cedervall, Jessica; Olsson, Anna-Karin] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Hein, Tobias; Hellman, Lars] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, S-75123 Uppsala, Sweden	Uppsala University; Uppsala University	Olsson, AK (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Biomed Ctr, Husargatan 3, S-75123 Uppsala, Sweden.	anna-karin.olsson@imbim.uu.se	Huijbers, Elisabeth J.M./K-7764-2013	Huijbers, Elisabeth J.M./0000-0002-7742-9839	Swedish Research Council (Medicine and Health); Swedish Cancer Society; Medical Faculty, Uppsala University	Swedish Research Council (Medicine and Health)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty, Uppsala University	This work was supported by grants to A.-K.O. from the Swedish Research Council (Medicine and Health), the Swedish Cancer Society, and the Medical Faculty, Uppsala University, and by grants to L.H. from the Swedish Research Council (Medicine and Health). The authors declare no conflicts of interest.	Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Berndt A, 2010, HISTOCHEM CELL BIOL, V133, P467, DOI 10.1007/s00418-010-0685-y; Borg FAY, 2007, CURR OPIN RHEUMATOL, V19, P61, DOI 10.1097/BOR.0b013e328010c547; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Danielli R, 2015, CANCER IMMUNOL IMMUN, V64, P113, DOI 10.1007/s00262-014-1621-0; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Eigentler TK, 2011, CLIN CANCER RES, V17, P7732, DOI 10.1158/1078-0432.CCR-11-1203; Erba PA, 2012, J NUCL MED, V53, P922, DOI 10.2967/jnumed.111.101006; Femel J, 2014, ONCOTARGET, V5, P12418, DOI 10.18632/oncotarget.2628; Halin C, 2003, CANCER RES, V63, P3202; Hancz A, 2012, IMMUNOL LETT, V143, P77, DOI 10.1016/j.imlet.2012.02.006; HELLMAN L, 1994, EUR J IMMUNOL, V24, P415, DOI 10.1002/eji.1830240222; Hellman L, 2008, EXPERT REV VACCINES, V7, P193, DOI 10.1586/14760584.7.2.193; Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010; Huijbers EJM, 2010, FASEB J, V24, P4535, DOI 10.1096/fj.10-163022; Joester A, 1999, J BIOL CHEM, V274, P17144, DOI 10.1074/jbc.274.24.17144; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; Matejuk A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-7; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Moschetta M, 2012, CANCER RES, V72, P1814, DOI 10.1158/0008-5472.CAN-11-1919; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Olsson AK, 2014, BIOCHEM SOC T, V42, P1653, DOI 10.1042/BST20140196; Ozcan E, 2011, J ALLERGY CLIN IMMUN, V128, P601, DOI 10.1016/j.jaci.2011.04.052; Papadia F, 2013, J SURG ONCOL, V107, P173, DOI 10.1002/jso.23168; Pasche N, 2012, CLIN CANCER RES, V18, P4092, DOI 10.1158/1078-0432.CCR-12-0282; Ringvall M, 2009, VACCINE, V28, P48, DOI 10.1016/j.vaccine.2009.09.122; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; Ruiz C, 2004, CANCER RES, V64, P7377, DOI 10.1158/0008-5472.CAN-04-1234; Schoenfeld JD, 2011, HUM VACCINES, V7, P976, DOI 10.4161/hv.7.9.16407; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Viti F, 1999, CANCER RES, V59, P347	35	12	13	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3253	3262		10.1096/fj.15-271502	http://dx.doi.org/10.1096/fj.15-271502			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25868727				2022-12-28	WOS:000358796900014
J	Shabalina, IG; Landreh, L; Edgar, D; Hou, M; Gibanova, N; Atanassova, N; Petrovic, N; Hultenby, K; Soder, O; Nedergaard, J; Svechnikov, K				Shabalina, Irina G.; Landreh, Luise; Edgar, Daniel; Hou, Mi; Gibanova, Natalia; Atanassova, Nina; Petrovic, Natasa; Hultenby, Kjell; Soder, Olle; Nedergaard, Jan; Svechnikov, Konstantin			Leydig cell steroidogenesis unexpectedly escapes mitochondrial dysfunction in prematurely aging mice	FASEB JOURNAL			English	Article						cytochrome b5; reactive oxygen species; respiratory chain deficiency; testosterone synthesis	MTDNA MUTATOR MICE; TESTOSTERONE SYNTHESIS; LIVER-MITOCHONDRIA; ADIPOSE-TISSUE; DNA POLYMERASE; PROTEIN; MEMBRANE; OUTER; RAT; MUTATIONS	Point mutations and deletions of mitochondrial DNA (mtDNA) accumulate in tissues during aging in animals and humans and are the basis for mitochondrial diseases. Testosterone synthesis occurs in the mitochondria of Leydig cells. Mitochondrial dysfunction (as induced here experimentally in mtDNA mutator mice that carry a proofreading-deficient form of mtDNA polymerase gamma, leading to mitochondrial dysfunction in all cells types so far studied) would therefore be expected to lead to low testosterone levels. Although mtDNA mutator mice showed a dramatic reduction in testicle weight (only 15% remaining) and similar decreases in number of spermatozoa, testosterone levels in mt DNA mutator mice were unexpectedly fully unchanged. Leydig cell did not escape mitochondrial damage (only 20% of complex I and complex IV remaining) and did show high levels of reactive oxygen species (ROS) production (>5-fold increased), and permeabilized cells demonstrated absence of normal mitochondrial function. Nevertheless, within intact cells, mitochondrial membrane potential remained high, and testosterone production was maintained. This implies development of a compensatory mechanism. A rescuing mechanism involving electronsfrom the pentose phosphate pathway transferred via a 3-fold up-regulated cytochrome b5 to cytochrome c, allowing for mitochondrial energization, is suggested. Thus, the Leydig cells escape mitochondrial dysfunction via a unique rescue pathway. Such a pathway, bypassing respiratory chain dysfunction, may be of relevance with regard to mitochondrial disease therapy and to managing ageing in general.	[Shabalina, Irina G.; Edgar, Daniel; Gibanova, Natalia; Petrovic, Natasa; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Landreh, Luise; Hou, Mi; Soder, Olle; Svechnikov, Konstantin] Astrid Lindgrens Children Hosp, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Edgar, Daniel; Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Atanassova, Nina] Pathol & Anthropol Museum, Inst Expt Morphol, Sofia, Bulgaria	Stockholm University; Karolinska Institutet; Bulgarian Academy of Sciences	Nedergaard, J (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Arrhenius Labs F3, SE-10691 Stockholm, Sweden.	jan.nedergaard@su.se	Nedergaard, Jan/A-1706-2010; Atanassova, Nina/AAH-2722-2021; Nedergaard, Jan/Q-8286-2019; Shabalina, Irina/AAC-3720-2019; Shabalina, Irina G/A-4225-2011	Atanassova, Nina/0000-0002-9032-3588; Shabalina, Irina/0000-0002-2915-6450; Shabalina, Irina G/0000-0002-2915-6450; Nedergaard, Jan/0000-0003-2070-1587	Swedish Research Council; Children's Cancer Fund; European Union; Karolinska Institutet Research Fund; Frimurare Barnhuset Foundation; Olle Engkvist Byggmastare Foundation; Gunvor och Josef Aners Foundation; EU-FP7 collaborative project DIABAT [HEALTH-F2-2011-278373]; Knut and Alice Wallenberg's Foundation; Mitoengineering Research Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Children's Cancer Fund; European Union(European Commission); Karolinska Institutet Research Fund; Frimurare Barnhuset Foundation; Olle Engkvist Byggmastare Foundation; Gunvor och Josef Aners Foundation; EU-FP7 collaborative project DIABAT; Knut and Alice Wallenberg's Foundation(Knut & Alice Wallenberg Foundation); Mitoengineering Research Institute	The authors thank Aleksandra Trifunovic for providing the initial breeding pair of mtDNA mutator mice, and Barbara Cannon for stimulating discussions. Financial support was received from the Swedish Research Council, Children's Cancer Fund, the European Union, Karolinska Institutet Research Fund and Frimurare Barnhuset Foundation (to O.S.), Olle Engkvist Byggmastare and Gunvor och Josef Aners Foundations (to K.S.), the Swedish Research Council, the EU-FP7 collaborative project DIABAT (HEALTH-F2-2011-278373), the Knut and Alice Wallenberg's Foundation (to J.N.) and the Mitoengineering Research Institute (to I.G.S. and N.G.).	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; ARCHAKOV AI, 1974, FEBS LETT, V39, P239, DOI 10.1016/0014-5793(74)80059-1; BARNARD T, 1969, J ULTRA MOL STRUCT R, V29, P311, DOI 10.1016/S0022-5320(69)90109-9; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bodrova ME, 1998, FEBS LETT, V435, P269, DOI 10.1016/S0014-5793(98)01072-2; Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006; Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; ERNSTER L, 1981, FEBS LETT, V132, P6, DOI 10.1016/0014-5793(81)80415-2; Fox R, 2011, P NATL ACAD SCI USA, V108, P8779, DOI 10.1073/pnas.1106344108; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kukat A, 2011, BIOCHEM BIOPH RES CO, V409, P394, DOI 10.1016/j.bbrc.2011.04.145; Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Midzak AS, 2007, ENDOCRINOLOGY, V148, P2583, DOI 10.1210/en.2006-1488; Mito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055789; Nieschlag E, 1999, CLIN ENDOCRINOL, V51, P139, DOI 10.1046/j.1365-2265.1999.00846.x; Ogishima T, 2003, J BIOL CHEM, V278, P21204, DOI 10.1074/jbc.M301698200; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharpe RM, 2000, BIOL REPROD, V62, P1685, DOI 10.1095/biolreprod62.6.1685; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Svechnikov K, 2003, J MOL ENDOCRINOL, V30, P59, DOI 10.1677/jme.0.0300059; Svechnikov KV, 2001, MOL CELL ENDOCRINOL, V182, P193, DOI 10.1016/S0303-7207(01)00554-8; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; WEIBEL ER, 1978, J CELL BIOL, V77, P584, DOI 10.1083/jcb.77.2.584; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505	39	12	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3274	3286		10.1096/fj.15-271825	http://dx.doi.org/10.1096/fj.15-271825			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25900807				2022-12-28	WOS:000358796900016
J	Philippou, A; Minozzo, FC; Spinazzola, JM; Smith, LR; Lei, HQ; Rassier, DE; Barton, ER				Philippou, Anastassios; Minozzo, Fabio C.; Spinazzola, Janelle M.; Smith, Lucas R.; Lei, Hanqin; Rassier, Dilson E.; Barton, Elisabeth R.			Masticatory muscles of mouse do not undergo atrophy in space	FASEB JOURNAL			English	Article						atrogenes; microgravity; muscle adaptations	MURINE SKELETAL-MUSCLE; THIN FILAMENT DENSITY; SOLEUS MUSCLE; MYOSTATIN INHIBITION; DIAPHRAGM MUSCLES; UBIQUITIN LIGASES; GENE-EXPRESSION; LIMB MUSCLE; FIBER SIZE; SPACEFLIGHT	Muscle loading is important for maintaining muscle mass; when load is removed, atrophy is inevitable. However, in clinical situations such as critical care myopathy, masticatory muscles do not lose mass. Thus, their properties may be harnessed to preserve mass. We compared masticatory and appendicular muscles responses to microgravity, using mice aboard the space shuttle Space Transportation System-135. Age- and sex-matched controls remained on the ground. After 13 days of space flight, 1 masseter (MA) and tibialis anterior (TA) were frozen rapidly for biochemical and functional measurements, and the contralateral MA was processed for morphologic measurements. Flight TA muscles exhibited 20 +/- 3% decreased muscle mass, 2-fold decreased phosphorylated (P)-Akt, and 4- to 12-fold increased atrogene expression. In contrast, MAs had no significant change in mass but a 3-fold increase in P-focal adhesion kinase, 1.5-fold increase in P-Akt, and 50-90% lower atrogene expression compared with limb muscles, which were unaltered in microgravity. Myofibril force measurements revealed that microgravity caused a 3-fold decrease in specific force and maximal shortening velocity in TA muscles. It is surprising that myofibril-specific force from both control and flight MAs were similar to flight TA muscles, yet power was compromised by 40% following flight. Continued loading in microgravity prevents atrophy, but masticatory muscles have a different set point that mimics disuse atrophy in the appendicular muscle.	[Philippou, Anastassios] Univ Athens, Sch Med, Dept Physiol, Goudi, Greece; [Philippou, Anastassios; Spinazzola, Janelle M.; Smith, Lucas R.; Lei, Hanqin; Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Kinesiol, Montreal, PQ, Canada; [Spinazzola, Janelle M.; Smith, Lucas R.; Barton, Elisabeth R.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Lei, Hanqin; Barton, Elisabeth R.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	National & Kapodistrian University of Athens; University of Pennsylvania; McGill University; University of Pennsylvania; State University System of Florida; University of Florida	Barton, ER (corresponding author), Univ Florida, 1864 Stadium Rd,124 Florida Gym, Gainesville, FL 32611 USA.	erbarton@ufl.edu	Smith, Lucas R/S-2157-2018; Philippou, Anastassios/H-2748-2019	Smith, Lucas R/0000-0002-7610-4231; Philippou, Anastassios/0000-0003-0047-3003	NASA Space Biology Grant [NNX09AH44G]; U.S. National Institutes of Health [R052646]; Canadian Institutes for Health Research; Natural Science and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	NASA Space Biology Grant; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors gratefully acknowledge NASA for allowing access to the animals of the CBTM-3 payload of the STS-135 shuttle mission and for providing technical support and equipment in the Space Life Sciences Laboratory in Kennedy Space Center. The study was supported, in part, by NASA Space Biology Grant NNX09AH44G (to E.R.B.), U.S. National Institutes of Health Grant R052646 (to E.R.B.), the Canadian Institutes for Health Research (to D.E.R.), and the Natural Science and Engineering Research Council of Canada (to D.E.R.).	Aare S, 2011, PHYSIOL GENOMICS, V43, P1334, DOI 10.1152/physiolgenomics.00116.2011; Akkad H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092622; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Barton ER, 2010, J BIOL CHEM, V285, P17263, DOI 10.1074/jbc.M109.063990; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; Carson JA, 2000, J APPL PHYSIOL, V88, P337, DOI 10.1152/jappl.2000.88.1.337; Daniels DW, 2008, ARCH ORAL BIOL, V53, P187, DOI 10.1016/j.archoralbio.2007.09.006; Dapp C, 2004, PHYSIOL GENOMICS, V20, P97, DOI 10.1152/physiolgenomics.00100.2004; Desplanches D, 1990, Physiologist, V33, pS84; Evans M, 2008, PHYSIOL GENOMICS, V35, P86, DOI 10.1152/physiolgenomics.00232.2007; Fan YY, 2013, J MOL HISTOL, V44, P75, DOI 10.1007/s10735-012-9445-8; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Fitts RH, 2000, AM J PHYSIOL-REG I, V279, pR1546, DOI 10.1152/ajpregu.2000.279.5.R1546; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harada H, 2002, CONNECT TISSUE RES, V43, P201, DOI 10.1080/030082002900000989; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Howard J., 2001, MECH MOTOR PROTEINS; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; MacDonald EM, 2014, DIS MODEL MECH, V7, P471, DOI 10.1242/dmm.014126; MARTIN TP, 1988, CELL TISSUE RES, V254, P251; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Monemi M, 1999, ACTA PHYSIOL SCAND, V167, P339; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Murphy KT, 2011, J APPL PHYSIOL, V110, P1065, DOI 10.1152/japplphysiol.01183.2010; Norman H, 2006, ACTA ANAESTH SCAND, V50, P1058, DOI 10.1111/j.1399-6576.2006.01105.x; Ochala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020558; Ohira Y, 2002, ADV SPACE RES, V30, P777, DOI 10.1016/S0273-1177(02)00395-2; OHIRA Y, 1992, J APPL PHYSIOL, V73, pS51, DOI 10.1152/jappl.1992.73.2.S51; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Ribeiro PAB, 2013, INT J CARDIOL, V168, P3564, DOI 10.1016/j.ijcard.2013.05.069; Riley DA, 2005, AM J PHYSIOL-CELL PH, V288, pC360, DOI 10.1152/ajpcell.00386.2004; Riley DA, 2000, J APPL PHYSIOL, V88, P567, DOI 10.1152/jappl.2000.88.2.567; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Schuenke MD, 2009, EUR J APPL PHYSIOL, V106, P885, DOI 10.1007/s00421-009-1091-9; Skorokhod A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-265; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Ulanova A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104735; Urushiyama T, 2004, CELL TISSUE RES, V315, P97, DOI 10.1007/s00441-003-0787-0; Yoshida T, 1998, J BIOL CHEM, V273, P1583, DOI 10.1074/jbc.273.3.1583; Yu LM, 2003, EXP CELL RES, V289, P162, DOI 10.1016/S0014-4827(03)00252-0	52	15	15	4	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2769	2779		10.1096/fj.14-267336	http://dx.doi.org/10.1096/fj.14-267336			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25795455	Green Published			2022-12-28	WOS:000356859100009
J	Wagener, BM; Hu, M; Zheng, AN; Zhao, XK; Che, PL; Brandon, A; Anjum, N; Snapper, S; Creighton, J; Guan, JL; Han, QM; Cai, GQ; Han, XS; Pittet, JF; Ding, Q				Wagener, Brant M.; Hu, Meng; Zheng, Anni; Zhao, Xueke; Che, Pulin; Brandon, Angela; Anjum, Naseem; Snapper, Scott; Creighton, Judy; Guan, Jun-Lin; Han, Qimei; Cai, Guo-Qiang; Han, Xiaosi; Pittet, Jean-Francois; Ding, Qiang			Neuronal Wiskott-Aldrich syndrome protein regulates TGF-beta 1-mediated lung vascular permeability	FASEB JOURNAL			English	Article						acute lung injury; FAK; small Rho GTPases; cytoskeletal dynamics; IL-1 beta	FOCAL ADHESION KINASE; RESPIRATORY-DISTRESS-SYNDROME; ENDOTHELIAL GROWTH-FACTOR; N-WASP; PSEUDOMONAS-AERUGINOSA; ACTIN-FILAMENTS; PULMONARY-EDEMA; RAT LUNG; TRANSFORMING GROWTH-FACTOR-BETA-1; MYOFIBROBLAST DIFFERENTIATION	TGF-beta 1 induces an increase in paracellular permeability and actin stress fiber formation in lung microvascular endothelial and alveolar epithelial cells via small Rho GTPase. The molecular mechanism involved is not fully understood. Neuronal Wiskott-Aldrich syndrome protein (N-WASP) has an essential role in actin structure dynamics. We hypothesized that N-WASP plays a critical role in these TGF-beta 1-induced responses. In these cell monolayers, we demonstrated that N-WASP down-regulation by short hairpin RNA prevented TGF-beta 1-mediated disruption of the cortical actin structure, actin stress filament formation, and increased permeability. Furthermore, N-WASP down-regulation blocked TGF-beta 1 activation mediated by IL-1 beta in alveolar epithelial cells, which requires actin stress fiber formation. Control short hairpin RNA had no effect on these TGF-beta 1-induced responses. TGF-beta 1-induced phosphorylation of Y256 of N-WASP via activation of small Rho GTPase and focal adhesion kinase mediates TGF-beta 1-induced paracellular permeability and actin cytoskeleton dynamics. In vivo, compared with controls, N-WASP down-regulation increases survival and prevents lung edema in mice induced by bleomycin exposure-a lung injury model in which TGF-beta 1 plays a critical role. Our data indicate that N-WASP plays a crucial role in the development of TGF-beta 1-mediated acute lung injury by promoting pulmonary edema via regulation of actin cytoskeleton dynamics.	[Wagener, Brant M.; Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Crit Care, Birmingham, AL 35294 USA; [Wagener, Brant M.; Brandon, Angela; Anjum, Naseem; Creighton, Judy; Pittet, Jean-Francois] Univ Alabama Birmingham, Div Mol & Translat Biomed, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Hu, Meng; Zheng, Anni; Zhao, Xueke; Han, Qimei; Cai, Guo-Qiang; Ding, Qiang] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, Birmingham, AL 35294 USA; [Che, Pulin; Han, Xiaosi] Univ Alabama Birmingham, Dept Med, Div Neurol, Birmingham, AL 35294 USA; [Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Pittet, Jean-Francois; Ding, Qiang] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Zhao, Xueke] Guizhou Med Univ, Affiliated Hosp, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Snapper, Scott] Harvard Univ, Dept Pathol, Boston, MA 02115 USA; [Guan, Jun-Lin] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Guizhou Medical University; Harvard University; University System of Ohio; University of Cincinnati	Pittet, JF (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Crit Care, Birmingham, AL 35294 USA.; Ding, Q (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, Birmingham, AL 35294 USA.	jpittet@uabmc.edu; qding@uab.edu	Wagener, Brant/AAI-7480-2020	Han, Qimei/0000-0003-4874-8862	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant [R01-HL085324]; Flight Attendant Medical Research Institute; Mentored Research Training Grant from Foundation for Anesthesia Education and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095451, R01HL127338, R01HL085324] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant; Flight Attendant Medical Research Institute; Mentored Research Training Grant from Foundation for Anesthesia Education and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant R01-HL085324, the Flight Attendant Medical Research Institute (to Q.D.), and by a Mentored Research Training Grant from the Foundation for Anesthesia Education and Research (to B.M.W.).	Bai YS, 2014, INT J MOL MED, V34, P1473, DOI 10.3892/ijmm.2014.1946; Bechara RI, 2004, AM J RESP CRIT CARE, V170, P188, DOI 10.1164/rccm.200304-478OC; Bhattacharya S, 2003, AM J RESP CELL MOL, V28, P218, DOI 10.1165/rcmb.4763; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Carles M, 2010, ANESTHESIOLOGY, V113, P1134, DOI 10.1097/ALN.0b013e3181f4171b; Che PL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08453; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2002, CANCER RES, V62, P5336; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Duluc L, 2014, CELL TISSUE RES, V355, P675, DOI 10.1007/s00441-014-1805-0; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Frank J, 2003, J BIOL CHEM, V278, P43939, DOI 10.1074/jbc.M304882200; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ganter MT, 2009, AM J RESP CELL MOL, V40, P108, DOI 10.1165/rcmb.2007-0454OC; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; Goolaerts A, 2011, THORAX, V66, P788, DOI 10.1136/thx.2010.155788; Greenlee MM, 2013, AM J PHYSIOL-LUNG C, V305, pL878, DOI 10.1152/ajplung.00008.2013; Infante JR, 2012, J CLIN ONCOL, V30, P1527, DOI 10.1200/JCO.2011.38.9346; Infusino GA, 2012, MICROVASC RES, V83, P89, DOI 10.1016/j.mvr.2011.09.011; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Jian MY, 2013, AM J PHYSIOL-LUNG C, V305, pL844, DOI 10.1152/ajplung.00173.2013; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779; Konrad FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121725; LEWIS JF, 1993, AM REV RESPIR DIS, V147, P218, DOI 10.1164/ajrccm/147.1.218; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Misra A, 2007, BIOCHEM BIOPH RES CO, V364, P908, DOI 10.1016/j.bbrc.2007.10.086; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pittet JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063907; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Sturge J, 2002, J CELL SCI, V115, P699; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Usatyuk PV, 2005, AM J PHYSIOL-LUNG C, V289, pL999, DOI 10.1152/ajplung.00211.2005; Wagener BM, 2015, ANESTHESIOLOGY, V122, P1084, DOI 10.1097/ALN.0000000000000595; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Wu MH, 2003, J PHYSIOL-LONDON, V552, P691, DOI 10.1113/jphysiol.2003.048405; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200	68	7	7	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2557	2569		10.1096/fj.201600102R	http://dx.doi.org/10.1096/fj.201600102R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27025963	Green Published			2022-12-28	WOS:000379249500011
J	Honn, KV; Guo, YD; Cai, YL; Lee, MJ; Dyson, G; Zhang, WL; Tucker, SC				Honn, Kenneth V.; Guo, Yande; Cai, Yinlong; Lee, Menq-Jer; Dyson, Gregory; Zhang, Wenliang; Tucker, Stephanie C.			12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression	FASEB JOURNAL			English	Article						12(S)-HETE; arachidonate metabolism in malignancy; inflammatory pathway	PLATELET-TYPE 12-LIPOXYGENASE; LIPOXYGENASE METABOLITE; TRANSCRIPTION FACTORS; CARCINOMA-CELLS; MELANOMA-CELLS; GENE-EXPRESSION; BINDING-SITES; GENOMICS DATA; TUMOR-GROWTH; HUMAN BREAST	Previously we identified and deorphaned G-protein-coupled receptor 31 (GPR31) as the high-affinity 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptor (12-HETER1). Here we have determined its distribution in prostate cancer tissue and its role in prostate tumorigenesis using in vitro and in vivo assays. Data-mining studies strongly suggest that 12-HETER1 expression positively correlates with the aggressiveness and progression of prostate tumors. This was corroborated with real-time PCR analysis of human prostate tumor tissue arrays that revealed the expression of 12-HETER1 positively correlates with the clinical stages of prostate cancers and Gleason scores. Immunohistochemistry analysis also proved that the expression of 12-HETER1 is positively correlated with the grades of prostate cancer. Knockdown of 12-HETER1 in prostate cancer cells markedly reduced colony formation and inhibited tumor growth in animals. To discover the regulatory factors, 5 candidate 12-HETER1 promoter cis elements were assayed as luciferase reporter fusions in Chinese hamster ovary (CHO) cells, where the putative cis element required for gene regulation was mapped 2 kb upstream of the 12-HETER1 transcriptional start site. The data implicate 12-HETER1 in a critical new role in the regulation of prostate cancer progression and offer a novel alternative target for therapeutic intervention.Honn, K. V., Guo, Y., Cai, Y., Lee, M.-J., Dyson, G., Zhang, W., Tucker, S. C. 12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression.	[Honn, Kenneth V.; Guo, Yande; Cai, Yinlong; Lee, Menq-Jer; Zhang, Wenliang; Tucker, Stephanie C.] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Honn, Kenneth V.; Dyson, Gregory] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [Honn, Kenneth V.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Dyson, Gregory] Barbara Ann Karmanos Canc Inst, Biostat Core, Detroit, MI USA; [Guo, Yande] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL USA; [Guo, Yande] Simmons Canc Inst, Springfield, IL USA; [Zhang, Wenliang] Univ North Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Southern Illinois University System; Southern Illinois University; University of North Carolina; University of North Carolina Greensboro	Tucker, SC (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Bioact Lipids Res Program, Detroit, MI 48202 USA.	stucker@med.wayne.edu			U.S. National Institutes of Health (NIH) National Cancer Institute [CA029997]; Department of Defense [W81XWH-06-1-0226, W81XWH-11-1-0519]; NIH National Heart, Lung, and Blood Institute [HL071071]; NATIONAL CANCER INSTITUTE [R01CA029997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by U.S. National Institutes of Health (NIH) National Cancer Institute Grants CA029997, Department of Defense Grants W81XWH-06-1-0226 and W81XWH-11-1-0519 (to K. V. H.), and NIH National Heart, Lung, and Blood Institute Grant HL071071 (to M.-J.L.). Results are in part based on data generated by The Cancer Genome Atlas Research Network (http://cancergenome.nih.gov/). The authors declare no conflicts of interest.	ARENBERGER P, 1993, SKIN PHARMACOL, V6, P148; ARENBERGER P, 1993, EPITHELIAL CELL BIOL, V2, P1; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHEN YQ, 1994, CANCER RES, V54, P1574; Cho YS, 2002, CLIN CANCER RES, V8, P607; CHOPRA H, 1991, INT J CANCER, V49, P774, DOI 10.1002/ijc.2910490524; Christensen GB, 2010, PROSTATE, V70, P735, DOI 10.1002/pros.21106; Cole BK, 2013, PROSTAG OTH LIPID M, V104, P84, DOI 10.1016/j.prostaglandins.2012.07.004; Coller HA, 2014, P NATL ACAD SCI USA, V111, P16238, DOI 10.1073/pnas.1418976111; Dilly AK, 2013, INT J CANCER, V133, P1784, DOI 10.1002/ijc.28165; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fitzgerald KA, 2014, EXPERT OPIN THER TAR, V18, P633, DOI 10.1517/14728222.2014.896904; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GAO X, 1995, UROLOGY, V46, P227, DOI 10.1016/S0090-4295(99)80198-8; Gasi D, 2011, METHODS MOL BIOL, V776, P335, DOI 10.1007/978-1-61779-243-4_19; Guo AM, 2011, CANCER CHEMOTH PHARM, V68, P1273, DOI 10.1007/s00280-011-1595-y; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; HERBERTSSON H, 1992, FEBS LETT, V298, P249, DOI 10.1016/0014-5793(92)80069-S; HONN KV, 1994, CANCER METAST REV, V13, P365, DOI 10.1007/BF00666105; HONN KV, 1994, EXP CELL RES, V214, P120, DOI 10.1006/excr.1994.1240; HONN KV, 1994, CANCER RES, V54, P565; HONN KV, 1992, CANCER METAST REV, V11, P325, DOI 10.1007/BF01307186; Kamitani H, 1999, ARCH BIOCHEM BIOPHYS, V368, P45, DOI 10.1006/abbi.1999.1284; Karagianni N, 2005, GENOMICS, V85, P231, DOI 10.1016/j.ygeno.2004.09.005; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Klampfl T, 2012, EXP CELL RES, V318, P768, DOI 10.1016/j.yexcr.2011.12.017; Liao ZY, 2011, AM J TRANSL RES, V3, P133; LIU B, 1995, P NATL ACAD SCI USA, V92, P9323, DOI 10.1073/pnas.92.20.9323; LIU B, 1994, LAB INVEST, V70, P314; Liu F., 2012, BIOPROTOC, V2, pe220, DOI DOI 10.21769/BioProtoc.220; Liu XH, 1996, CLIN EXP METASTAS, V14, P145, DOI 10.1007/BF00121211; Matsuyama M, 2004, INT J ONCOL, V24, P821; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Morgan R, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-17; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Natarajan R, 1997, AM J PHYSIOL-HEART C, V273, pH2224, DOI 10.1152/ajpheart.1997.273.5.H2224; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nie D, 1998, CANCER RES, V58, P4047; Nie DT, 2006, J BIOL CHEM, V281, P18601, DOI 10.1074/jbc.M601887200; Nie DT, 2003, CLIN EXP METASTAS, V20, P657, DOI 10.1023/A:1027302408187; Peng XJ, 2004, CANCER RES, V64, P8911, DOI 10.1158/0008-5472.CAN-04-1810; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Piao YS, 2008, CARCINOGENESIS, V29, P440, DOI 10.1093/carcin/bgm274; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Piogeon GP, 2003, INT J CANCER, V105, P459, DOI 10.1002/ijc.11134; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rusthoven CG, 2014, UROL ONCOL-SEMIN ORI, V32, P707, DOI 10.1016/j.urolonc.2014.01.004; Sankpal UT, 2011, MED CHEM, V7, P518; Steele VE, 1999, CANCER EPIDEM BIOMAR, V8, P467; Szekeres CK, 2000, J BIOL CHEM, V275, P38831, DOI 10.1074/jbc.M002673200; Tajima Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-68; Tang DG, 1997, ADV EXP MED BIOL, V400, P349; TANG DG, 1995, J CELL SCI, V108, P2629; Tang DG, 1996, P NATL ACAD SCI USA, V93, P5241, DOI 10.1073/pnas.93.11.5241; Tang KQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0382-5; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor-Fishwick DA, 2015, DIABETOLOGIA, V58, P549, DOI 10.1007/s00125-014-3452-0; TIMAR J, 1993, INT J CANCER, V55, P1003, DOI 10.1002/ijc.2910550621; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tucker SC, 2013, BIOCHEM PHARMACOL, V85, P673, DOI 10.1016/j.bcp.2012.11.028; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Xu J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.86; YAMAOKA M, 1993, CANCER RES, V53, P5233; Yoshimoto T, 2002, PROSTAG OTH LIPID M, V68-9, P245, DOI 10.1016/S0163-7827(97)00002-7; Zingoni A, 1997, GENOMICS, V42, P519, DOI 10.1006/geno.1997.4754	72	19	19	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2360	2369		10.1096/fj.201500076	http://dx.doi.org/10.1096/fj.201500076			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26965684	Green Published			2022-12-28	WOS:000376878300025
J	Paul, CD; Shea, DJ; Mahoney, MR; Chai, A; Laney, V; Hung, WC; Konstantopoulos, K				Paul, Colin D.; Shea, Daniel J.; Mahoney, Megan R.; Chai, Andreas; Laney, Victoria; Hung, Wei-Chien; Konstantopoulos, Konstantinos			Interplay of the physical microenvironment, contact guidance, and intracellular signaling in cell decision making	FASEB JOURNAL			English	Article						cell migration; microfluidics; confinement	MYOSIN-II; CONFINED MICROENVIRONMENTS; CANCER-CELLS; MIGRATION; INVASION; ADHESION; PLASTICITY; REORGANIZATION; ACTIVATION; COLLAGEN	The peritumoral physical microenvironment consists of complex topographies that influence cell migration. Cell decision making, upon encountering anisotropic, physiologically relevant physical cues, has yet to be elucidated. By integrating microfabrication with cell and molecular biology techniques, we provide a quantitative and mechanistic analysis of cell decision making in a variety of well-defined physical microenvironments. We used MDA-MB-231 breast carcinoma and HT1080 fibrosarcoma as cell models. Cell decision making after lateral confinement in 2-dimensional microcontact printed lines is governed by branch width at bifurcations. Cells confined in narrow feeder microchannels prefer to enter wider branches at bifurcations. In contrast, in feeder channels that are wider than the cell body, cells elongate along one side wall of the channel and are guided by contact with the wall to the contiguous branch channel independent of its width. Knockdown of 1-integrins or inhibition of cellular contractility suppresses contact guidance. Concurrent, but not individual, knockdown of nonmuscle myosin isoforms IIA and IIB also decreases contact guidance, which suggests the existence of a compensatory mechanism between myosin IIA and myosin IIB. Conversely, knockdown or inhibition of cell division control protein 42 homolog promotes contact guidance-mediated decision making. Taken together, the dimensionality, length scales of the physical microenvironment, and intrinsic cell signaling regulate cell decision making at intersections.Paul, C. D., Shea, D. J., Mahoney, M. R., Chai, A., Laney, V., Hung, W.-C., Konstantopoulos, K. Interplay of the physical microenvironment, contact guidance, and intracellular signaling in cell decision making.	[Paul, Colin D.; Shea, Daniel J.; Mahoney, Megan R.; Chai, Andreas; Laney, Victoria; Hung, Wei-Chien; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomol & Chem Engn, 3400 North Charles St,Maryland Hall Room 221, Baltimore, MD 21218 USA; [Paul, Colin D.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Biomol & Chem Engn, 3400 North Charles St,Maryland Hall Room 221, Baltimore, MD 21218 USA.	konstant@jhu.edu		Chai, Andreas/0000-0001-8651-0164	U.S. National Institutes of Health, National Cancer Institute [R01-CA183804, R01-CA186286]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA183804, R01CA186286] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Denis Wirtz (The Johns Hopkins University) for providing HT1080 cells. This study was supported by the U.S. National Institutes of Health, National Cancer Institute Grants R01-CA183804 and R01-CA186286 (to K. K.), and by a National Science Foundation Graduate Research Fellowship (to C. D. P.). The authors declare no conflicts of interest.	Alexander S, 2013, CURR OPIN CELL BIOL, V25, P659, DOI 10.1016/j.ceb.2013.07.001; Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Chang SS, 2013, BIOPHYS J, V104, P313, DOI 10.1016/j.bpj.2012.12.001; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Mak M, 2014, LAB CHIP, V14, P964, DOI 10.1039/c3lc51173a; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Prentice-Mott HV, 2013, P NATL ACAD SCI USA, V110, P21006, DOI 10.1073/pnas.1317441110; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Raman PS, 2013, LAB CHIP, V13, P4599, DOI 10.1039/c3lc50802a; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Scherber C, 2012, INTEGR BIOL-UK, V4, P259, DOI 10.1039/c2ib00106c; Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513; Stroka KM, 2014, CURR OPIN CELL BIOL, V30, P41, DOI 10.1016/j.ceb.2014.06.001; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Wang P, 2015, ONCOGENE, V34, P4558, DOI 10.1038/onc.2014.397; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Zuo YF, 2012, J CELL PHYSIOL, V227, P1399, DOI 10.1002/jcp.22853	45	33	34	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2161	2170		10.1096/fj.201500199R	http://dx.doi.org/10.1096/fj.201500199R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26902610	Green Published			2022-12-28	WOS:000376878300010
J	Gerstmeier, J; Newcomer, ME; Dennhardt, S; Romp, E; Fischer, J; Werz, O; Garscha, U				Gerstmeier, Jana; Newcomer, Marcia E.; Dennhardt, Sophie; Romp, Erik; Fischer, Jana; Werz, Oliver; Garscha, Ulrike			5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formation	FASEB JOURNAL			English	Article						arachidonic acid; HEK293; inflammation; leukotriene A(4); translocation	BETA-BARREL DOMAIN; LEUKOTRIENE BIOSYNTHESIS; FLAP; 11R-LIPOXYGENASE; TRANSLOCATION; LOCALIZATION; LIPOXYGENASE; ORGANIZATION; SPECIFICITY; INHIBITORS	Leukotrienes (LTs) are proinflammatory lipid mediators formed from arachidonic acid in a 2-step reaction catalyzed by 5-lipoxygenase (5-LOX) requiring the formation of 5-HPETE [5(S)-hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid] and its subsequent transformation to LTA(4). 5-LOX is thought to receive arachidonic acid from the nuclear membrane-embedded 5-LOX-activating protein (FLAP). The crystal structure of 5-LOX revealed an active site concealed by F177 and Y181 (FY cork). We examined the influence of the FY cork on 5-LOX activity and membrane binding in HEK293 cells in the absence and presence of FLAP. Uncapping the 5-LOX active site by mutation of F177 and/or Y181 to alanine (5-LOX-F177A, 5-LOX-Y181A, 5-LOX-F177/Y181A) resulted in delayed and diminished 5-LOX membrane association in A23187-stimulated cells. For 5-LOX-F177A and 5-LOX-F177/Y181A, formation of 5-LOX products was dramatically reduced relative to 5-LOX-wild type (wt). Strikingly, coexpression of FLAP in A23187-activated HEK293 cells effectively restored formation of 5-H(p)ETE (5-hydroxy- and 5-peroxy-6-trans-8,11,14-cis-eicosatetraenoic acid) by these same 5-LOX mutants (approximate to 60-70% 5-LOX-wt levels) but not of LTA(4) hydrolysis products. Yet 5-LOX-Y181A generated 5-H(p) ETE at levels comparable to 5-LOX-wt but reduced LTA(4) hydrolysis products. Coexpression of FLAP partially restored LTA(4) hydrolysis product formation by 5-LOX-Y181A. Together, the data suggest that the concealed FY cork impacts membrane association and that FLAP may help shield an uncapped active site.-Gerstmeier, J., Newcomer, M. E., Dennhardt, S., Romp, E., Fischer, J., Werz, O., Garscha, U. 5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formation. www.fasebj.org	[Gerstmeier, Jana; Dennhardt, Sophie; Romp, Erik; Fischer, Jana; Werz, Oliver; Garscha, Ulrike] Univ Jena, Inst Pharm, Dept Pharmaceut & Med Chem, Philosophenweg 14, D-07743 Jena, Germany; [Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Friedrich Schiller University of Jena; Louisiana State University System; Louisiana State University	Garscha, U (corresponding author), Univ Jena, Inst Pharm, Dept Pharmaceut & Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	ulrike.garscha@uni-jena.de	Garscha, Ulrike/G-3559-2018	Garscha, Ulrike/0000-0002-3645-7833	Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Centres: Chemical Mediators in complex Biosystems [SFB 1127]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL 107887]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Centres: Chemical Mediators in complex Biosystems; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Centres (SFB 1127): Chemical Mediators in complex Biosystems (to O.W.) and the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (HL 107887; to M.E.N.) for financial support.	Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Coic YM, 2005, EUR BIOPHYS J BIOPHY, V35, P27, DOI 10.1007/s00249-005-0002-1; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Grauffel C, 2013, J AM CHEM SOC, V135, P5740, DOI 10.1021/ja312656v; Hafner AK, 2011, BIOL CHEM, V392, P1097, DOI [10.1515/BC.2011.200, 10.1515/BC-2011-200]; HILL E, 1992, J BIOL CHEM, V267, P22048; Jarving R, 2012, BIOCHEMISTRY-US, V51, P3310, DOI 10.1021/bi201690z; KARGMAN S, 1992, J CELL BIOL, V119, P1701, DOI 10.1083/jcb.119.6.1701; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Mandal AK, 2004, P NATL ACAD SCI USA, V101, P6587, DOI 10.1073/pnas.0308523101; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; MirAfzali Z, 2006, J BIOL CHEM, V281, P28354, DOI 10.1074/jbc.M605206200; Mitra S, 2015, BIOCHEMISTRY-US, V54, P6333, DOI 10.1021/acs.biochem.5b00930; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; NOGUCHI M, 1994, BBA-LIPID LIPID MET, V1215, P300, DOI 10.1016/0005-2760(94)90057-4; PANOSSIAN A, 1982, FEBS LETT, V150, P511, DOI 10.1016/0014-5793(82)80801-6; Pergola C, 2014, BRIT J PHARMACOL, V171, P3051, DOI 10.1111/bph.12625; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; SAMUELSSON B, 1983, ADV PROSTAG THROMB L, V11, P1; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WISEMAN JS, 1987, BIOCHEMISTRY-US, V26, P5684, DOI 10.1021/bi00392a016	35	24	25	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1892	1900		10.1096/fj.201500210R	http://dx.doi.org/10.1096/fj.201500210R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26842853	Green Published, Green Submitted			2022-12-28	WOS:000374879400018
J	Chen, JC; Hoey, DA; Chua, M; Bellon, R; Jacobs, CR				Chen, Julia C.; Hoey, David A.; Chua, Mardonn; Bellon, Raymond; Jacobs, Christopher R.			Mechanical signals promote osteogenic fate through a primary cilia-mediated mechanism	FASEB JOURNAL			English	Article						mesenchymal stem cell; ulna loading; primary cilium; bone; homing	DIRECTIONAL CELL-MIGRATION; BONE-MARROW; STROMAL CELLS; MECHANOTRANSDUCTION; DIFFERENTIATION; PROLIFERATION; RECRUITMENT; OSTEOCYTES; KIF3A	It has long been suspected, but never directly shown, that bone formed to accommodate an increase in mechanical loading is related to the creation of osteoblasts from skeletal stem cells. Indeed, biophysical stimuli potently regulate osteogenic lineage commitment in vitro. In this study, we transplanted bone marrow cells expressing green fluorescent protein, to enable lineage tracing, and subjected mice to a biophysical stimulus, to elicit a bone-forming response. We detected cells derived from transplanted progenitors embedded within the bone matrix near active bone-forming surfaces in response to loading, demonstrating for thefirst time, that mechanical signals enhance the homing and attachment of bone marrow cells to bone surfaces and the commitment to an osteogenic lineage of these cells in vivo. Furthermore, we used an inducible Cre/Lox recombination system to delete kinesin family member 3A (Kif3a), a gene that is essential for primary cilia formation, at will in transplanted cells and their progeny, regardless of which tissue may have incorporated them. Disruption of the mechanosensing organelle, the primary cilium in a progenitor population, significantly decreased the amount of bone formed in response to mechanical stimulation. The collective results of our study directly demonstrate that, in a novel experimental stem cell mechanobiology model, mechanical signals enhance osteogenic lineage commitment in vivo and that the primary cilium contributes to this process.-Chen, J. C., Hoey, D. A., Chua, M., Bellon, R., Jacobs, C. R. Mechanical signals promote osteogenic fate through a primary cilia-mediated mechanism. FASEB J. 30, 1504-1511 (2016). www.fasebj.org	[Chen, Julia C.; Hoey, David A.; Jacobs, Christopher R.] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Bellon, Raymond] Columbia Univ, Dept Chem Engn, New York, NY USA; [Hoey, David A.] Trinity Coll Dublin, Trinity Ctr Bioengn, Trin Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland; [Hoey, David A.] Trinity Coll Dublin, Dept Mech & Mfg Engn, Sch Engn, Dublin, Ireland; [Hoey, David A.] Univ Limerick, Dept Mech Aeronaut & Biomed Engn, Ctr Appl Biomed Engn Res, Mat & Surface Sci Inst, Limerick, Ireland; [Chua, Mardonn] Univ British Columbia, Dept Biotechnol, Vancouver, BC V5Z 1M9, Canada	Columbia University; Columbia University; Trinity College Dublin; Trinity College Dublin; University of Limerick; University of British Columbia	Hoey, DA (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Trin Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland.	david.hoey@ul.ie	Hoey, David/A-7587-2012; Hoey, David/X-9231-2019	Hoey, David/0000-0001-5898-0409; 	New York State Stem Cell Grant [N089-210]; U.S. National Institutes of Health, Institute of Arthritis and Musculoskeletal and Skin Disease [AR054156, AR062177, AR059038]; European Research Council [336882]; Science Foundation Ireland European Research Council (ERC) [SFI 13/ERC/L2864]; Irish Reseach Council (IRCSET)-Marie Curie International Mobility Fellowship in Science, Engineering and Technology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062177, T32AR059038, R21AR054156] Funding Source: NIH RePORTER	New York State Stem Cell Grant; U.S. National Institutes of Health, Institute of Arthritis and Musculoskeletal and Skin Disease; European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland European Research Council (ERC)(Science Foundation Ireland); Irish Reseach Council (IRCSET)-Marie Curie International Mobility Fellowship in Science, Engineering and Technology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank K. Lee, A. Nguyen, H. Li, B. Shelton, S. Bhumiratana, C. Hue, K. Yamada, and K. Prestia for technical assistance, and K. Lee and A. Nguyen for helpful discussions (all from Columbia University). This work was supported by New York State Stem Cell Grant N089-210 (to C. R. J.); U.S. National Institutes of Health, Institute of Arthritis and Musculoskeletal and Skin Disease Grants AR054156, AR062177, and AR059038 (to C. R. J.); European Research Council Grant 336882 (to D.A.H.); Science Foundation Ireland European Research Council (ERC) Support Grant SFI 13/ERC/L2864 (to D.A.H.); and an Irish Reseach Council (IRCSET)-Marie Curie International Mobility Fellowship in Science, Engineering and Technology (to D.A.H). J.C.C. and D.A.H. designed and performed experiments, interpreted the data, and wrote the manuscript; M.C. and R.B. performed experiments; and C.R.J. designed experiments, interpreted the data, and wrote the manuscript. The authors declare no conflicts of interest.	Arnsdorf EJ, 2010, J BIOMECH, V43, P2881, DOI 10.1016/j.jbiomech.2010.07.033; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Brady RT, 2015, BIOCHEM BIOPH RES CO, V459, P118, DOI 10.1016/j.bbrc.2015.02.080; Castillo Alesha B, 2010, Curr Osteoporos Rep, V8, P98, DOI 10.1007/s11914-010-0015-2; Chen JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt318; Christensen ST, 2013, METHOD ENZYMOL, V525, P45, DOI 10.1016/B978-0-12-397944-5.00003-1; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Coughlin TR, 2015, CALCIFIED TISSUE INT, V96, P65, DOI 10.1007/s00223-014-9928-6; Cui YZ, 2002, BONE MARROW TRANSPL, V30, P843, DOI 10.1038/sj.bmt.1703766; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hoey DA, 2011, BIOCHEM BIOPH RES CO, V412, P182, DOI 10.1016/j.bbrc.2011.07.072; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthres.2004.04.002; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Paridaen JTML, 2013, CELL, V155, P333, DOI 10.1016/j.cell.2013.08.060; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Taguchi K, 2005, BIOCHEM BIOPH RES CO, V331, P31, DOI 10.1016/j.bbrc.2005.03.119; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Temiyasathit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033368; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; Wang LP, 2005, BLOOD, V106, P3650, DOI 10.1182/blood-2005-02-0582	35	60	60	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1504	1511		10.1096/fj.15-276402	http://dx.doi.org/10.1096/fj.15-276402			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26675708	Green Published, Green Submitted			2022-12-28	WOS:000372629100012
J	Hehle, VK; Paul, MJ; Roberts, VA; van Dolleweerd, CJ; Ma, JKC				Hehle, Verena K.; Paul, Matthew J.; Roberts, Victoria A.; van Dolleweerd, Craig J.; Ma, Julian K. -C.			Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants	FASEB JOURNAL			English	Article						antibody engineering; degradation; proteolysis	PROTEOLYTIC DEGRADATION; SUSCEPTIBILITY; IDENTIFICATION; MOLECULE; CLEAVAGE; HIV-1; 2G12	This study examined the degradation pattern of amurine IgG1 kappa monoclonal antibody expressed in and extracted from transformed Nicotiana tabacum. Gel electrophoresis of leaf extracts revealed a consistent pattern of recombinant immunoglobulin bands, including intact and full-length antibody, as well as smaller antibody fragments. N-terminal sequencing revealed these smaller fragments to be proteolytic cleavage products and identified a limited number of protease-sensitive sites in the antibody light and heavy chain sequences. No strictly conserved target sequence was evident, although the peptide bonds that were susceptible to proteolysis were predominantly and consistently located within or near to the interdomain or solvent-exposed regions in the antibody structure. Amino acids surrounding identified cleavage sites were mutated in an attempt to increase resistance. Different Guy's 13 antibody heavy and light chain mutant combinations were expressed transiently in N. tabacum and demonstrated intensity shifts in the fragmentation pattern, resulting in alterations to the full-length antibody-tofragment ratio. The work strengthens the understanding of proteolytic cleavage of antibodies expressed in plants and presents a novel approach to stabilize full-length antibody by site-directed mutagenesis.-Hehle, V. K., Paul, M. J., Roberts, V. A., van Dolleweerd, C. J., Ma, J. K.-C. Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants. FASEB J. 30, 1590-1598 (2016). www.fasebj.org	[Hehle, Verena K.; Paul, Matthew J.; Roberts, Victoria A.; van Dolleweerd, Craig J.; Ma, Julian K. -C.] Univ London, Inst Infect & Immun, Mol Immunol Unit, Cranmer Terrace, London SW17 0RE, England; [Roberts, Victoria A.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	St Georges University London; University of London; University of California System; University of California San Diego	Ma, JKC (corresponding author), Univ London, Inst Infect & Immun, Mol Immunol Unit, Cranmer Terrace, London SW17 0RE, England.	jma@sgul.ac.uk		Paul, Mathew/0000-0002-0852-8788; van Dolleweerd, Craig/0000-0002-1380-6930; Ma, Julian/0000-0003-0767-0042	European Union; European Research Council Future-Pharma Advanced grant [AdG 2010 269110]; Molecular Farming COST Action [FA804]; Wellcome Trust [WT093092MA]; Hotung Foundation	European Union(European Commission); European Research Council Future-Pharma Advanced grant; Molecular Farming COST Action; Wellcome Trust(Wellcome TrustEuropean Commission); Hotung Foundation	The authors are grateful to M. Weldon (University of Cambridge) for performing the N-terminal sequence analyses. The authors gratefully acknowledge the European Union Framework 6 Pharma-Planta project, a European Research Council Future-Pharma Advanced grant (AdG 2010 269110), the Molecular Farming COST Action (FA804), the Wellcome Trust (Grant WT093092MA), and the Hotung Foundation for supporting for this research project.	Arcalis E, 2013, PLANT MOL BIOL, V83, P105, DOI 10.1007/s11103-013-0049-9; BAUMAL R, 1973, TRANSPLANT REV, V14, P163; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Delannoy M, 2008, PROTEOMICS, V8, P2285, DOI 10.1002/pmic.200700507; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Floss DM, 2009, PLANT BIOTECHNOL J, V7, P899, DOI 10.1111/j.1467-7652.2009.00452.x; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Goulet C, 2012, PLANT BIOTECHNOL J, V10, P83, DOI 10.1111/j.1467-7652.2011.00643.x; Gutierrez RA, 1999, TRENDS PLANT SCI, V4, P429, DOI 10.1016/S1360-1385(99)01484-3; Hehle VK, 2015, PLANT BIOTECHNOL J, V13, P235, DOI 10.1111/pbi.12266; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Kabat E., 1991, SEQUENCES PROTEINS I, V2; Kim NS, 2008, PLANT MOL BIOL, V68, P263, DOI 10.1007/s11103-008-9367-8; Komarnytsky S, 2006, PLANT PHYSIOL, V141, P1185, DOI 10.1104/pp.105.074419; Koziel MG, 1996, PLANT MOL BIOL, V32, P393, DOI 10.1007/BF00039392; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MA JKC, 1994, EUR J IMMUNOL, V24, P131, DOI 10.1002/eji.1830240120; Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416; Niemer M, 2014, BIOTECHNOL J, V9, P493, DOI 10.1002/biot.201300207; Obregon P, 2006, PLANT BIOTECHNOL J, V4, P195, DOI 10.1111/j.1467-7652.2005.00171.x; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Peters SJ, 2012, J BIOL CHEM, V287, P24525, DOI 10.1074/jbc.M112.369744; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rivard D, 2006, PLANT BIOTECHNOL J, V4, P359, DOI 10.1111/j.1467-7652.2006.00187.x; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Senior BW, 2005, INFECT IMMUN, V73, P1515, DOI 10.1128/IAI.73.3.1515-1522.2005; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; Taha TA, 2006, FEBS LETT, V580, P6047, DOI 10.1016/j.febslet.2006.09.070; Tekoah Y, 2013, BIOSCIENCE REP, V33, P771, DOI 10.1042/BSR20130081; Tuse D, 2011, HUM VACCINES, V7, P322, DOI 10.4161/hv.7.3.14213; Wongsamuth R, 1997, BIOTECHNOL BIOENG, V54, P401, DOI 10.1002/(SICI)1097-0290(19970605)54:5&lt;401::AID-BIT1&gt;3.0.CO;2-I	34	15	15	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1590	1598		10.1096/fj.15-283226	http://dx.doi.org/10.1096/fj.15-283226			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26712217	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000372629100020
J	Saddouk, FZ; Sun, LY; Liu, YF; Jiang, M; Singer, DV; Backs, J; Van Riper, D; Ginnan, R; Schwarz, JJ; Singer, HA				Saddouk, Fatima Z.; Sun, Li-Yan; Liu, Yong Feng; Jiang, Miao; Singer, Diane V.; Backs, Johannes; Van Riper, Dee; Ginnan, Roman; Schwarz, John J.; Singer, Harold A.			Ca2+/calmodulin-dependent protein kinase II-gamma (CaMKII gamma) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling	FASEB JOURNAL			English	Article						Camk2g; Camk2d; restenosis	DELTA ISOFORM REGULATION; NEOINTIMA FORMATION; TUMOR-SUPPRESSOR; CAROTID-ARTERY; ACTIVATION; EXPRESSION; P53; CYCLE; GENE; INHIBITION	Vascular smooth muscle (VSM) expresses calcium/calmodulin-dependent protein kinase II (CaMKII)-delta and -gamma isoforms. CaMKII delta promotes VSM proliferation and vascular remodeling. We tested CaMKII gamma function in vascular remodeling after injury. CaMKII gamma protein decreased 90% 14 d after balloon injury in rat carotid artery. Intraluminal transduction of adenovirus encoding CaMKII gamma(c) rescued expression to 35% of uninjured controls, inhibited neointima formation (>70%), inhibited VSM proliferation (>60%), and increased expression of the cell-cycle inhibitor p21 (>2-fold). Comparable doses of CaMKII delta(2) adenovirus had no effect. Similar dynamics in CaMKII gamma mRNA and protein expression were observed in ligated mouse carotid arteries, correlating closely with expression of VSM differentiation markers. Targeted deletion of CaMKII gamma in smooth muscle resulted in a 20-fold increase in neointimal area, with a 3-fold increase in the cell proliferation index, no change in apoptosis, and a 60% decrease in p21 expression. In cultured VSM, CaMKII gamma overexpression induced p53 mRNA (1.7 fold) and protein (1.8-fold) expression; induced the p53 target gene p21 (3-fold); decreased VSM cell proliferation (>50%); and had no effect on expression of apoptosis markers. We conclude that regulated CaMKII gamma isoform composition is an important determinant of the injury-induced vasculoproliferative response and that CaMKII gamma and -delta isoforms have nonequivalent, opposing functions.	[Saddouk, Fatima Z.; Sun, Li-Yan; Liu, Yong Feng; Jiang, Miao; Singer, Diane V.; Van Riper, Dee; Ginnan, Roman; Schwarz, John J.; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, MC-8,47 New Scotland Ave, Albany, NY 12208 USA; [Backs, Johannes] Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany	Albany Medical College; Ruprecht Karls University Heidelberg	Singer, HA (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, MC-8,47 New Scotland Ave, Albany, NY 12208 USA.	singerh@mail.amc.edu		Schwarz, John/0000-0002-8713-4778	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL049426, R01HL092510]; Albany Medical College Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049426, R01HL092510] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Albany Medical College Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Grants R01HL049426 and R01HL092510 from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (to H.A.S.) and by the Albany Medical College Weir Fund.	Abraham ST, 1996, J BIOL CHEM, V271, P2506, DOI 10.1074/jbc.271.5.2506; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Althoff TF, 2012, J EXP MED, V209, P2277, DOI 10.1084/jem.20120350; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Backs J, 2010, P NATL ACAD SCI USA, V107, P81, DOI 10.1073/pnas.0912658106; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Ginnan R, 2013, J BIOL CHEM, V288, P29703, DOI 10.1074/jbc.M113.477257; Gray CBB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00015; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kitchen CM, 2013, GENE, V513, P82, DOI 10.1016/j.gene.2012.10.073; Krause K, 2001, BIOCHEM BIOPH RES CO, V284, P743, DOI 10.1006/bbrc.2001.5040; Kreusser MM, 2014, CIRCULATION, V130, P1262, DOI 10.1161/CIRCULATIONAHA.114.006185; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Liu YF, 2013, J BIOL CHEM, V288, P33519, DOI 10.1074/jbc.M113.490870; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; O'Carroll SJ, 2000, BIOTECHNIQUES, V28, P408, DOI 10.2144/00283bm03; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Saha K, 2014, J BIOL CHEM, V289, P11443, DOI 10.1074/jbc.M113.543165; Saura M, 2014, FASEB J, V28, P4719, DOI 10.1096/fj.14-252460; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Scott JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071550; Scott JA, 2012, AM J PHYSIOL-HEART C, V302, pH1953, DOI 10.1152/ajpheart.00978.2011; Singer HA, 1997, J BIOL CHEM, V272, P9393; Singer HA, 2012, J PHYSIOL-LONDON, V590, P1349, DOI 10.1113/jphysiol.2011.222232; Skelding KA, 2011, CELL CYCLE, V10, P631, DOI 10.4161/cc.10.4.14798; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Weinreuter M, 2014, EMBO MOL MED, V6, P1231, DOI 10.15252/emmm.201403848; Wu XJ, 2011, ARTERIOSCL THROM VAS, V31, P2000, DOI 10.1161/ATVBAHA.111.225144; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zhang M, 2015, HYPERTENSION, V65, P335, DOI 10.1161/HYPERTENSIONAHA.114.04467; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhang W, 2011, CIRC RES, V109, P534, DOI 10.1161/CIRCRESAHA.111.246777; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhu LJ, 2014, VASC PHARMACOL, V60, P75, DOI 10.1016/j.vph.2014.01.001; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	68	22	23	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1051	1064		10.1096/fj.15-279158	http://dx.doi.org/10.1096/fj.15-279158			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26567004	Green Published			2022-12-28	WOS:000370387800005
J	Ishii, Y; Saeki, K; Liu, M; Sasaki, F; Koga, T; Kitajima, K; Meno, C; Okuno, T; Yokomizo, T				Ishii, Yumiko; Saeki, Kazuko; Liu, Min; Sasaki, Fumiyuki; Koga, Tomoaki; Kitajima, Keiko; Meno, Chikara; Okuno, Toshiaki; Yokomizo, Takehiko			Leukotriene B-4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins	FASEB JOURNAL			English	Article						GPCR; G protein; p38 MAPK; claudin-4	UP-REGULATION; 12-HYDROXYHEPTADECATRIENOIC ACID; EXPRESSION; AFADIN; MODULATION; ACTIVATION; ADHESION; BINDING; GENE; INVOLVEMENT	GPCRs are involved in numerous physiologic functions and are important drug targets. Although the epithelial barrier is important for protection from invading pathogens, the correlation between GPCRs and epithelial barrier function remains unknown. Leukotriene B-4 (LTB4) receptor type 2 (BLT2), mainly expressed in epithelial cells, is a GPCR for 12(S)-hydroxyheptadeca-5Z, 8E, 10E-trienoic acid (12-HHT) and LTB4. In our study, BLT2 localized at the lateral membrane in BLT2-overexpressing Madin-Darby canine kidney (MDCK) II cells and in the small intestine of BLT2-transgenic mice. BLT2-deficient mice exhibited higher transepidermal water loss and were more sensitive to epicutaneous sensitization. MDCK-BLT2 cells recovered transepithelial electrical resistance (TER) after a calcium switch faster than did MDCK-Mock cells, and 12-HHT stimulation accelerated TER recovery only in MDCK-BLT2 cells. Quantitative PCR and immunoblot analyses revealed that the 12-HHT/BLT2 axis up-regulated claudin-4 (CLDN4) expression in MDCK-BLT2 cells and human primary keratinocytes, and CLDN4 knockdown abolished 12-HHT-dependent TER recovery. Acceleration of TER recovery and induction of CLDN4 expression by 12-HHT stimulation were abolished by inhibition of G alpha(i) protein or p38 MAPK. These results show that 12-HHT/BLT2 enhances epithelial barrier function by increasing CLDN4 expression via the Gai protein-p38 MAPK pathway.	[Ishii, Yumiko; Saeki, Kazuko; Liu, Min; Sasaki, Fumiyuki; Koga, Tomoaki; Okuno, Toshiaki; Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 812, Japan; [Ishii, Yumiko] Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 812, Japan; [Kitajima, Keiko; Meno, Chikara] Kyushu Univ, Grad Sch Med Sci, Dept Dev Biol, Fukuoka 812, Japan; [Saeki, Kazuko; Liu, Min; Sasaki, Fumiyuki; Koga, Tomoaki; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Liu, Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Endocrinol, Shanghai 200030, Peoples R China	Kyushu University; Kyushu University; Kyushu University; Juntendo University; Shanghai Jiao Tong University	Saeki, K; Yokomizo, T (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	ksaeki@juntendo.ac.jp; yokomizo-tky@umin.ac.jp	Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553; Ishii, Yumiko/0000-0002-7438-3695	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22116001, 22116002, 15H05901, 15H05904, 15H04708, 24590386, 15K08316, 24102522, 25460374]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Takeda Science Foundation; Foundation of Strategic Research Projects in Private Universities from the MEXT [S1311011]; institutional grant for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation of Strategic Research Projects in Private Universities from the MEXT; institutional grant for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Y. Taketomi and M. Murakami (Tokyo Metropolitan Institute of Medical Science), H. Katoh (Kyoto University), S. Nakajima (Kyoto University), M. Koike (Juntendo University), and T. Ito (Kyushu University) for technical support; J. Hayase (Kyushu University) and the members of our laboratories for advice and helpful discussions; the Support Center for Education and Research (Kyushu University) for technical support; and J. Miyazaki (Osaka University) for supplying the pCXN2 expression vector. This work was supported by Grants-in-Aid for Scientific Research 22116001, 22116002, 15H05901, 15H05904, and 15H04708 (to T. Y.) and 24590386 and 15K08316 (to K.S.) and Grants-in Aid 24102522 and 25460374 (to T.O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); the Naito Foundation; the Ono Medical Research Foundation; the Uehara Memorial Foundation; the Mitsubishi Foundation; the Takeda Science Foundation; and in part by Grant-in-Aid S1311011 from the Foundation of Strategic Research Projects in Private Universities from the MEXT and an institutional grant for Environmental and Gender-Specific Medicine. The authors declare no conflicts of interest.	Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Cho KJ, 2010, AM J RESP CELL MOL, V42, P294, DOI 10.1165/rcmb.2008-0445OC; Dalmasso AP, 2014, J BIOL CHEM, V289, P838, DOI 10.1074/jbc.M113.455766; Das P, 2012, VIRCHOWS ARCH, V460, P261, DOI 10.1007/s00428-012-1195-1; DEALMEIDA JB, 1994, J CELL SCI, V107, P507; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; Dufresne J, 2007, BIOL REPROD, V76, P825, DOI 10.1095/biolreprod.106.057430; Fujita-Yoshigaki J, 2008, AM J PHYSIOL-CELL PH, V294, pC774, DOI 10.1152/ajpcell.00472.2007; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Hayashi D, 2012, GASTROENTEROLOGY, V142, P292, DOI 10.1053/j.gastro.2011.10.040; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Honda H, 2007, CANCER BIOL THER, V6, P1733, DOI 10.4161/cbt.6.11.4832; Hopkins AM, 2000, ADV DRUG DELIVER REV, V41, P329, DOI 10.1016/S0169-409X(00)00050-8; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Ikari A, 2013, BBA-MOL CELL RES, V1833, P2617, DOI 10.1016/j.bbamcr.2013.06.016; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Khan N, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/219843; Kim GY, 2010, J IMMUNOL, V184, P3946, DOI 10.4049/jimmunol.0901735; Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063; Luk JM, 2004, FEBS LETT, V578, P251, DOI 10.1016/j.febslet.2004.11.010; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsunaga Y, 2013, FASEB J, V27, P3306, DOI 10.1096/fj.12-217000; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; Merritt AJ, 2002, MOL CELL BIOL, V22, P5846, DOI 10.1128/MCB.22.16.5846-5858.2002; Monteiro AC, 2013, MOL BIOL CELL, V24, P2849, DOI 10.1091/mbc.E13-06-0298; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Raiko L, 2012, EXP DERMATOL, V21, P586, DOI 10.1111/j.1600-0625.2012.01520.x; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Saha C, 1998, J BIOL CHEM, V273, P21629, DOI 10.1074/jbc.273.34.21629; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shao WH, 2006, J IMMUNOL, V176, P6254, DOI 10.4049/jimmunol.176.10.6254; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Stahley SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087809; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Yamamoto K., 2015, J EXP MED; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	64	32	32	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					933	947		10.1096/fj.15-279653	http://dx.doi.org/10.1096/fj.15-279653			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527063	Green Accepted			2022-12-28	WOS:000369391900040
J	Saha, S; Chakraborty, PK; Xiong, XH; Dwivedi, SKD; Mustafi, SB; Leigh, NR; Ramchandran, R; Mukherjee, P; Bhattacharya, R				Saha, Sounik; Chakraborty, Prabir K.; Xiong, Xunhao; Dwivedi, Shailendra Kumar Dhar; Mustafi, Soumyajit Banerjee; Leigh, Noah R.; Ramchandran, Ramani; Mukherjee, Priyabrata; Bhattacharya, Resham			Cystathionine beta-synthase regulates endothelial function via protein S-sulfhydration	FASEB JOURNAL			English	Article						angiogenesis; VEGFRs; signal transduction; metabolism	ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; HYDROGEN-SULFIDE; GROWTH-FACTOR; HOMOCYSTEINE METABOLISM; VASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; REDOX REGULATION; TRANSCRIPTION	Deficiencies of the human cystathionine beta-synthase (CBS) enzyme are characterized by a plethora of vascular disorders and hyperhomocysteinemia. However, several clinical trials demonstrated that despite reduction in homocysteine levels, disease outcome remained unaffected, thus the mechanism of endothelial dysfunction is poorly defined. Here, we show that the loss of CBS function in endothelial cells (ECs) leads to a significant down-regulation of cellular hydrogen sulfide (H2S) by 50% and of glutathione (GSH) by 40%. Silencing CBS in ECs compromised phenotypic and signaling responses to the VEGF that were potentiated by decreased transcription of VEGF receptor (VEGFR)-2 and neuropilin (NRP)-1, the primary receptors regulating endothelial function. Transcriptional down-regulation of VEGFR-2 and NRP-1 was mediated by a lack in stability of the transcription factor specificity protein 1 (Sp1), which is a sulfhydration target of H2S at residues Cys68 and Cys755. Reinstating H2S but not GSH in CBS-silenced ECs restored Sp1 levels and its binding to the VEGFR-2 promoter and VEGFR-2, NRP-1 expression, VEGF-dependent proliferation, and migration phenotypes. Thus, our study emphasizes the importance of CBS-mediated protein S-sulfhydration in maintaining vascular health and function.	[Saha, Sounik; Chakraborty, Prabir K.; Xiong, Xunhao; Mukherjee, Priyabrata; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA; [Dwivedi, Shailendra Kumar Dhar; Mustafi, Soumyajit Banerjee; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Leigh, Noah R.; Ramchandran, Ramani] Med Coll Wisconsin, Dept Obstet & Gynecol, Dev Vasc Biol Program & Zebrafish Drug Screening, Milwaukee, WI 53226 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Medical College of Wisconsin	Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA.	priyabrata-mukherjee@ouhsc.edu; resham-bhattacharya@ouhsc.edu	Dwivedi, Shailendra Kumar Dhar/Q-2204-2019		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [RO1HL120585]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120585] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant RO1HL120585. The authors thank Dr. Virginie Sjoelund (Mass Spectrometry Facility, University of Oklahoma Health Sciences Center Core Laboratories) for Sp1 sulfhydration analysis.	Altaany Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005478; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Beltowski Jerzy, 2005, Postepy Hig Med Dosw (Online), V59, P392; Bhattacharya R, 2009, J CELL SCI, V122, P1025, DOI 10.1242/jcs.041913; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brattstrom L, 2000, AM J CLIN NUTR, V72, P315; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Castro R, 2005, J MOL MED, V83, P831, DOI 10.1007/s00109-005-0679-8; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Chompoosor A, 2010, SMALL, V6, P2246, DOI 10.1002/smll.201000463; Durand P, 2001, LAB INVEST, V81, P645, DOI 10.1038/labinvest.3780275; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ganapathy PS, 2009, INVEST OPHTH VIS SCI, V50, P4460, DOI 10.1167/iovs.09-3402; Hoefer IE, 2007, CARDIOVASC RES, V76, P1, DOI 10.1016/j.cardiores.2007.07.010; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kondo S, 2006, MOL CANCER THER, V5, P129, DOI 10.1158/1535-7163.MCT-05-0097; Kraus JP, 1999, HUM MUTAT, V13, P362; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Paul BD, 2015, METHOD ENZYMOL, V555, P79, DOI 10.1016/bs.mie.2014.11.021; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Qipshidze N, 2012, INT J BIOL SCI, V8, P430, DOI 10.7150/ijbs.3632; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Szabo C, 2011, BRIT J PHARMACOL, V164, P853, DOI 10.1111/j.1476-5381.2010.01191.x; Van Campenhout A, 2009, ATHEROSCLEROSIS, V202, P557, DOI 10.1016/j.atherosclerosis.2008.05.031; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; Wallace JL, 2015, NAT REV DRUG DISCOV, V14, P329, DOI 10.1038/nrd4433; Wang H, 1997, J BIOL CHEM, V272, P25380, DOI 10.1074/jbc.272.40.25380; Wang MJ, 2010, ANTIOXID REDOX SIGN, V12, P1065, DOI 10.1089/ars.2009.2945; Wang R, 2011, CURR OPIN NEPHROL HY, V20, P107, DOI 10.1097/MNH.0b013e3283430651; Warren CM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004235; Weiss N, 2002, ARTERIOSCL THROM VAS, V22, P34, DOI 10.1161/hq1201.100456; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Wu XS, 1996, MOL CELL BIOL, V16, P1035; Yap S, 2000, SEMIN THROMB HEMOST, V26, P335, DOI 10.1055/s-2000-8100; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200	61	81	85	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					441	456		10.1096/fj.15-278648	http://dx.doi.org/10.1096/fj.15-278648			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26405298	Green Published			2022-12-28	WOS:000367621000041
J	Yang, XD; Yan, WJ; Tian, Y; Ma, P; Opperman, LA; Wang, XF				Yang, Xiudong; Yan, Wenjuan; Tian, Ye; Ma, Pan; Opperman, Lynne A.; Wang, Xiaofang			Family with sequence similarity member 20C is the primary but not the only kinase for the small-integrin-binding ligand N-linked glycoproteins in bone	FASEB JOURNAL			English	Article						phosphorylation; biomineralization; mass spectrometry; hypophosphatemic rickets; ASARM	DENTIN MATRIX PROTEIN-1; O-GLYCOSYLATION SITES; POSTTRANSLATIONAL MODIFICATIONS; IN-VITRO; RAT BONE; BIOLOGICAL IMPLICATIONS; SIBLING PROTEINS; PHOSPHORYLATION; OSTEOPONTIN; SIALOPROTEIN	Recent studies have identified family with sequence similarity member 20C (FAM20C) as a kinase that phosphorylates the Ser in Ser-X-Glu/phospho-Ser (pSer) motifs in the small-integrin-binding ligand N-linked glycoproteins (SIBLINGs). There is no in vivo evidence that validates this finding, and it is unclear whether FAM20C is the only kinase for SIBLINGs. We extracted bone noncollagenous proteins (NCPs) from Fam20C-knockout (KO) mice and analyzed the phosphorylation levels. The total NCPs were separated into osteopontin-, bone sialoprotein-, and dentin matrix protein-1-enriched fractions by anion-exchange chromatography and analyzed by SDS-PAGE, native PAGE, and Western immunoblot analysis. The NCP phosphorylation level in the KO mice was lower than that in the wild-type (WT). On the native gel, the SIBLINGs from KO mice showed a lower migration rate (M-r) than those from the WT. Calf intestine phosphatase treatment shifted SIBLINGs from the WT mice to the level adjacent to the KO, but failed to shift the latter, suggesting a phosphorylation loss of SIBLINGs in the KO mice. Mass spectrometry identified less pSers in the SIBLINGs from the KO mice [ including the region of the acidic Ser- and aspartate-richmotif (ASARM) peptides]. In an intriguing finding, several pSers in the Ser-X-Glu motifs in the KO mice maintained their phosphorylation, whereas several others in non-Ser-X-Glumotifs did not. Phospho-Tyrs and phospho-Thrs in the SIBLINGs did not appear to be associated with FAM20C. Our results indicate that FAM20C is the primary, but not the only, kinase for the SIBLINGs.-Yang, X., Yan, W., Tian, Y., Ma, P., Opperman, L. A., Wang, X. Familywith sequence similarity member 20C is the primary but not the only kinase for the small-integrin-binding ligand N-linked glycoproteins in bone. FASEB J. 30, 121-128 (2016). www.fasebj.org	[Yang, Xiudong; Yan, Wenjuan; Tian, Ye; Ma, Pan; Opperman, Lynne A.; Wang, Xiaofang] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Yang, Xiudong; Yan, Wenjuan; Tian, Ye; Ma, Pan; Opperman, Lynne A.; Wang, Xiaofang] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX 75246 USA; [Yan, Wenjuan] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Tian, Ye] Sichuan Univ, Chengdu, Sichuan, Peoples R China; [Ma, Pan] Capital Med Univ, Beijing, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Southern Medical University - China; Sichuan University; Capital Medical University	Wang, XF (corresponding author), Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	xwang@bcd.tamhsc.edu		Wang, Xiaofang/0000-0002-7370-7192; Opperman, Lynne/0000-0002-6200-7799	U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research [R03DE23873-01]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE023873] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. C. Qin (Texas A&M University Baylor College of Dentistry) for critical review of the manuscript, and J. Santa Cruz for assistance with the editing of the article. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant R03DE23873-01 (to X.W.). The authors declare no conflicts of interest.	Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Baht GS, 2010, BIOCHEM J, V428, P385, DOI 10.1042/BJ20091864; Barros NMT, 2013, J BONE MINER RES, V28, P688, DOI 10.1002/jbmr.1766; Bordoli MR, 2014, CELL, V158, P1033, DOI 10.1016/j.cell.2014.06.048; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Curtin P, 2009, BIOCHEMISTRY-US, V48, P6876, DOI 10.1021/bi900066b; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; LINDE A, 1980, J BIOL CHEM, V255, P5931; Liu SG, 2007, J ENDOCRINOL, V192, P261, DOI 10.1677/joe.1.07059; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2001, EUR J ORAL SCI, V109, P133, DOI 10.1034/j.1600-0722.2001.00001.x; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; Ramos-Molina B, 2015, MOL ENDOCRINOL, V29, P756, DOI 10.1210/me.2014-1394; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; RICHARDSON WS, 1978, J BIOL CHEM, V253, P8042; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Salih E, 2004, J BIOL CHEM, V279, P19808, DOI 10.1074/jbc.M310299200; Salih E, 1996, J BIOL CHEM, V271, P16897, DOI 10.1074/jbc.271.28.16897; SFEIR C, 1995, J BONE MINER RES, V10, P607; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Sun Y, 2010, J BIOL CHEM, V285, P31713, DOI 10.1074/jbc.M110.137059; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Veis A, 1997, CRIT REV ORAL BIOL M, V8, P360, DOI 10.1177/10454411970080040101; Wang XF, 2012, J BIOL CHEM, V287, P35934, DOI 10.1074/jbc.M112.386862; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wang XF, 2010, J HISTOCHEM CYTOCHEM, V58, P957, DOI 10.1369/jhc.2010.956565; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738	42	20	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					121	128		10.1096/fj.15-273607	http://dx.doi.org/10.1096/fj.15-273607			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26324849	Green Published			2022-12-28	WOS:000367621000014
J	Jiang, L; Tam, BM; Ying, GX; Wu, S; Hauswirth, WW; Frederick, JM; Moritz, OL; Baehr, W				Jiang, Li; Tam, Beatrice M.; Ying, Guoxing; Wu, Sen; Hauswirth, William W.; Frederick, Jeanne M.; Moritz, Orson L.; Baehr, Wolfgang			Kinesin family 17 (osmotic avoidance abnormal-3) is dispensable for photoreceptor morphology and function	FASEB JOURNAL			English	Article						anterograde intraflagellar transport; kinesin-2 truncation mutants; photoreceptor degeneration; rhodopsin trafficking	SENSORY CILIA; MOTOR PROTEIN; CHEMOSENSORY NEURONS; RHODOPSIN TRANSPORT; IFT-PARTICLES; KIF17; CONE; AUTOINHIBITION; ARCHITECTURE; TRAFFICKING	In Caenorhabditis elegans, homodimeric [kinesin family (KIF) 17, osmotic avoidance abnormal-3 (OSM-3)] and heterotrimeric (KIF3) kinesin-2 motors are required to establish sensory cilia by intraflagellar transport (IFT) where KIF3 and KIF17 cooperate to build the axoneme core and KIF17 builds the distal segments. However, the function of KIF17 in vertebrates is unresolved. We expressed full-length and motorless KIF17 constructs in mouse rod photoreceptors using adeno-associated virus in Xenopus laevis rod photoreceptors using a transgene and in ciliated IMCD3 cells. We found that tagged KIF17 localized along the rod outer segment axoneme when expressed in mouse and X. laevis photoreceptors, whereas KIF3A was restricted to the proximal axoneme. Motorless KIF3A and KIF17 mutants caused photoreceptor degeneration, likely through dominant negative effects on IFT. KIF17 mutant lacking the motor domain translocated to nuclei after exposure of a C-terminal nuclear localization signal. Germ-line deletion of Kif17 in mouse did not affect photoreceptor function. A rod-specific Kif3/Kif17 double knockout mouse demonstrated that KIF17 and KIF3 do not act synergistically and did not prevent rhodopsin trafficking to rod outer segments. In summary, the nematode model of KIF3/KIF17 cooperation apparently does not apply to mouse photoreceptors in which the photosensory cilium is built exclusively by KIF3.	[Jiang, Li; Ying, Guoxing; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Tam, Beatrice M.; Moritz, Orson L.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Wu, Sen] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of British Columbia; China Agricultural University; State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah	Jiang, L (corresponding author), Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.	li.jiang@hsc.utah.edu; wbaehr@hsc.utah.edu			U.S. National Institutes of Health [EY08123, EY019298]; National Eye Institute [EY014800-039003]; Canadian Institutes of Health Research [MOP-64400]; Foundation Fighting Blindness (Toronto, ON, Canada); Research to Prevent Blindness (New York, NY, USA); Research to Prevent Blindness; Nelson Trust Award; NATIONAL EYE INSTITUTE [P30EY014800, R01EY008123, R01EY019298] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation Fighting Blindness (Toronto, ON, Canada); Research to Prevent Blindness (New York, NY, USA)(Research to Prevent Blindness (RPB)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Nelson Trust Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health Grants EY08123, EY019298 (to W.B.), EY014800-039003 (National Eye Institute core grant to the Department of Ophthalmology, University of Utah), and Canadian Institutes of Health Research MOP-64400, as well as the Foundation Fighting Blindness (Toronto, ON, Canada) (to O.M.) and unrestricted grants to the Department of Ophthalmology, University of Utah, from Research to Prevent Blindness (New York, NY, USA). W.B. is a recipient of a Research to Prevent Blindness Senior Investigator and a Nelson Trust Award.	Audas TE, 2012, CELL CYCLE, V11, P2059, DOI 10.4161/cc.20140; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Bader JR, 2012, VISION RES, V75, P37, DOI 10.1016/j.visres.2012.10.009; Besharse JC., 1990, CILIARY FLAGELLAR ME, P389; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Deretic D, 2012, VISION RES, V75, P5, DOI 10.1016/j.visres.2012.07.015; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Imanishi M, 2006, J CELL BIOL, V174, P931, DOI 10.1083/jcb.200605179; Inglis PN., 2007, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.126.2, 10.1895/wormbook.1.126.2]; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Insinna C, 2009, METHOD CELL BIOL, V93, P219, DOI 10.1016/S0091-679X(08)93012-0; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Karan S, 2011, VISION RES, V51, P2304, DOI 10.1016/j.visres.2011.09.001; Kayadjanian N, 2007, MOL CELL NEUROSCI, V34, P219, DOI 10.1016/j.mcn.2006.11.001; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Malicki J, 2012, VISION RES, V75, P33, DOI 10.1016/j.visres.2012.10.008; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Moritz OL, 2002, TRANSGENIC RES, V11, P315, DOI 10.1023/A:1015612022976; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Scholey JM, 2012, VISION RES, V75, P44, DOI 10.1016/j.visres.2012.06.015; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Ye F, 2013, ELIFE, V2, DOI 10.7554/eLife.00654; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	46	32	32	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4866	4880		10.1096/fj.15-275677	http://dx.doi.org/10.1096/fj.15-275677			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26229057	Green Published			2022-12-28	WOS:000365523600013
J	Young, KR; Arthus-Cartier, G; Yam, KK; Lavoie, PO; Landry, N; D'Aoust, MA; Vezina, LP; Couture, MMJ; Ward, BJ				Young, Katie R.; Arthus-Cartier, Guillaume; Yam, Karen K.; Lavoie, Pierre-Olivier; Landry, Nathalie; D'Aoust, Marc-Andre; Vezina, Louis-Philippe; Couture, Manon M-J.; Ward, Brian J.			Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP)	FASEB JOURNAL			English	Article						fluorescent particle; H5 hemagglutinin; immune response; particle assembly	TRANSIENT EXPRESSION; IMMUNE-RESPONSE; VACCINE DEVELOPMENT; DRUG-DELIVERY; HEMAGGLUTININ; CELLS; ANTIGEN; GFP; NANOPARTICLES; TRAFFICKING	Medicago, Inc. has developed an efficient virus-like particle (VLP) vaccine production platform using the Nicotiana benthamiana expression system, and currently has influenza-based products targeting seasonal/pandemic hemagglutinin (HA) proteins in advanced clinical trials. We wished to generate a trackable HA-based VLP that would allow us to study both particle assembly in plants and VLP interactions within the mammalian immune system. To this end, a fusion protein was designed, composed of H5 (from influenza A/Indonesia/05/2005 [H5N1]) with enhanced green fluorescent protein (eGFP). Expression of H5-eGFP in N. benthamiana produced brightly fluorescent similar to 160 nm particles resembling H5-VLPs. H5-eGFP-VLPs elicited anti-H5 serologic responses in mice comparable to those elicited by H5-VLPs in almost all assays tested (hemagglutination inhibition/IgG(total)/IgG1/IgG2b/IgG2a: IgG1 ratio), as well as a superior anti-GFP IgG response (mean optical density = 2.52 +/- 0.16 SEM) to that elicited by soluble GFP (mean optical density = 0.12 6 +/- 0.06 SEM). Confocal imaging of N. benthamiana cells expressing H5-eGFP displayed large fluorescent accumulations at the cell periphery, and draining lymph nodes from mice given H5-eGFP-VLPs via footpad injection demonstrated bright fluorescence shortly after administration (10 min), providing proof of concept that the H5-eGFP-protein/VLPs could be used to monitor both VLP assembly and immune trafficking. Given these findings, this novel fluorescent reagent will be a powerful tool to gain further fundamental insight into the biology of influenza VLP vaccines.	[Young, Katie R.; Yam, Karen K.; Ward, Brian J.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Young, Katie R.; Yam, Karen K.] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Arthus-Cartier, Guillaume; Lavoie, Pierre-Olivier; Landry, Nathalie; D'Aoust, Marc-Andre; Vezina, Louis-Philippe; Couture, Manon M-J.] Medicago Inc, Quebec City, PQ, Canada	McGill University; McGill University	Ward, BJ (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Glen Site,1001 Decarie Blvd,Room EM3-3248, Montreal, PQ, Canada.	brian.ward@mcgill.ca			Canadian Institutes of Health Research (CIHR) industry grant [UI 301202]; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (Doctoral Award); Public Health Agency of Canada-CIHR Influenza Research Network (PCIRN) Student Training Award	Canadian Institutes of Health Research (CIHR) industry grant; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (Doctoral Award)(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada-CIHR Influenza Research Network (PCIRN) Student Training Award	The authors thank F. Sainsbury and his team at Universite Laval (Quebec City, QC, Canada), for discussions and technical assistance with all in planta confocal microscopy experiments. This work was supported in part by a Canadian Institutes of Health Research (CIHR) industry grant (UI 301202) to B.J.W. While writing this article, K.R.Y. held a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (Doctoral Award), and subsequently, a Public Health Agency of Canada-CIHR Influenza Research Network (PCIRN) Student Training Award. B.J.W. has been a principal investigator of vaccine trials for several manufacturers, including Medicago, Inc., for which his institution obtained research contracts. Since 2010, B.J.W. has served as Medical Officer for Medicago, Inc. In addition, B.J.W. has held and continues to hold peer-reviewed support from CIHR and other sources for collaborative, basic science work with Medicago, Inc. B.J.W. has received honoraria from several vaccine manufacturers for participation on Scientific Advisory Boards (including Medicago, Inc.). P.-O.L., N.L., M.-A.D., and M.M.-J.C. are current employees of Medicago, Inc. G.A.-C. and L.P.V. are former employees of Medicago, Inc.	Bachmann MF, 1997, J IMMUNOL, V158, P5106; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Boevink P, 1996, PLANT J, V10, P935, DOI 10.1046/j.1365-313X.1996.10050935.x; BOOY FP, 1985, J MOL BIOL, V184, P667, DOI 10.1016/0022-2836(85)90312-2; Cervarix Prescribing Information, 2015, CERV PRESCR INF; Cervera L, 2013, J BIOTECHNOL, V166, P152, DOI 10.1016/j.jbiotec.2013.05.001; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; D'Aoust Marc-Andre, 2009, V483, P41, DOI 10.1007/978-1-59745-407-0_3; Darveau A., 1995, PCR NEUROSCIENCE, P3; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; EBERSOLE JL, 1978, IMMUNOLOGY, V34, P969; FELDMANN M, 1971, J EXP MED, V134, P103, DOI 10.1084/jem.134.1.103; Galloway AL, 2013, NANOMED-NANOTECHNOL, V9, P523, DOI 10.1016/j.nano.2012.11.001; Garcea RL, 2004, CURR OPIN BIOTECH, V15, P513, DOI 10.1016/j.copbio.2004.10.002; Gilbert L, 2005, BIOCHEM BIOPH RES CO, V331, P527, DOI 10.1016/j.bbrc.2005.03.208; Gilbert L, 2004, BIOCHEM BIOPH RES CO, V313, P878, DOI 10.1016/j.bbrc.2003.11.176; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Grigsby IF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-75; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hardham AR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-63; Herman L, 2010, EUR J IMMUNOL, V40, P3075, DOI 10.1002/eji.201040571; Herzog C, 2009, VACCINE, V27, P4381, DOI 10.1016/j.vaccine.2009.05.029; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; Kapur N, 2012, J VIRAL HEPATITIS, V19, P436, DOI 10.1111/j.1365-2893.2011.01559.x; Karthikeyan M, 2014, J BIOMOL STRUCT DYN, V32, P816, DOI 10.1080/07391102.2013.793211; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Kohler RH, 1998, TRENDS PLANT SCI, V3, P317, DOI 10.1016/S1360-1385(98)01276-X; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Kueng HJ, 2010, FASEB J, V24, P1572, DOI 10.1096/fj.09-137281; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Landry N, 2014, CLIN IMMUNOL, V154, P164, DOI 10.1016/j.clim.2014.08.003; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Le Mauff F, 2015, PLANT BIOTECHNOL J, V13, P717, DOI 10.1111/pbi.12301; Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516; Ma YJ, 2012, ADV DRUG DELIVER REV, V64, P811, DOI 10.1016/j.addr.2012.01.005; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Miller JS, 2005, CLIN IMMUNOL, V117, P144, DOI 10.1016/j.clim.2005.07.005; Moser C, 2011, EXPERT REV VACCINES, V10, P437, DOI [10.1586/erv.11.15, 10.1586/ERV.11.15]; Olenych S.G., 2007, CURR PROTOC CELL BIO, V36, P1; Pan YS, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/506363; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Peng S, 1999, J Tongji Med Univ, V19, P170; Peng S., 1999, J TONGJI MED U, V19, P180; Quinn A, 2002, VACCINE, V20, P3187, DOI 10.1016/S0264-410X(02)00253-0; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Rhee JK, 2011, BIOMACROMOLECULES, V12, P3977, DOI 10.1021/bm200983k; Rodriguez-Limas WA, 2013, CURR OPIN BIOTECH, V24, P1089, DOI 10.1016/j.copbio.2013.02.008; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rurup WF, 2014, BIOMACROMOLECULES, V15, P558, DOI 10.1021/bm4015792; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Slifka MK, 2014, VACCINE, V32, P2948, DOI 10.1016/j.vaccine.2014.03.078; Stano A, 2013, BIOMATERIALS, V34, P4339, DOI 10.1016/j.biomaterials.2013.02.024; Storni T, 2005, ADV DRUG DELIVER REV, V57, P333, DOI 10.1016/j.addr.2004.09.008; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vezina LP, 2011, BIOPHARM INT, pS27; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Windram OP, 2008, ARCH VIROL, V153, P585, DOI 10.1007/s00705-007-0025-2; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	72	11	11	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3817	3827		10.1096/fj.15-270421	http://dx.doi.org/10.1096/fj.15-270421			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26038124				2022-12-28	WOS:000359915600018
J	Radhakrishnan, J; Bazarek, S; Chandran, B; Gazmuri, RJ				Radhakrishnan, Jeejabai; Bazarek, Stanley; Chandran, Bala; Gazmuri, Raul J.			Cyclophilin-D: a resident regulator of mitochondrial gene expression	FASEB JOURNAL			English	Article						respiratory complexes; membrane potential; transcription; oxygen consumption	PERMEABILITY TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSLOCASE; CELL-DEATH; CYCLOSPORINE-A; BINDING-PROTEIN; RNA GRANULES; TRANSCRIPTION; METABOLISM; INHIBITOR; COMPLEXES	Cyclophilin-D (Cyp-D) is a mitochondrial matrix peptidyl-prolyl isomerase. Because cyclophilins can regulate nuclear gene expression, we examined whether Cyp-D could regulate mitochondrial gene expression. We demonstrated in HEK 293T cells that transfected Cyp-D interacts with mitochondrial transcription factors B1 and B2 (TFB2M) but not with mitochondrial transcription factor A. We also demonstrated that Cyp-D interacts in vivo with TFB2M. Genetic silencing of Cyp-D and pharmacologic inhibition of Cyp-D markedly reduced mitochondrial transcription to 18 +/- 5% (P < 0.05) and 24 +/- 3% (P < 0.05) of respective controls. The level of interaction between Cyp-D and TFB2M correlated with the level of nascent mitochondrial RNA intensity (r = 0.896; P = 0.0156). Cyp-D silencing down-regulated mitochondrial transcripts initiated from the heavy strand promoter 2 [i.e., NADH dehydrogenase 1 (ND1) by 11-fold, P < 0.005; cytochrome oxidase 1 (COX1) by 4-fold, P < 0.001; and ATP synthase subunit 6 (ATP6) by 6.5-fold, P < 0.005); but not NADH dehydrogenase6 (ND6)], which is initiated from the light strand promoter. Cyp-D silencing reduced mitochondrial membrane potential and cellular oxygen consumption (from 59 +/- 5 to 34 +/- 1 mu mol oxygen/min/10(6) cells, P < 0.001); the latter without a statistically significant reversal after uncoupling electrontransport from ATP synthesis, consistent with downregulation of electron transport complexes. Accordingly, these studies provide novel evidence that Cyp-D could play a key role in regulating mitochondrial gene expression.	[Radhakrishnan, Jeejabai; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL 60064 USA; [Radhakrishnan, Jeejabai; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60064 USA; [Bazarek, Stanley] Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, Dept Neurosci, N Chicago, IL 60064 USA; [Chandran, Bala] Rosalind Franklin Univ Med & Sci, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, N Chicago, IL 60064 USA; [Gazmuri, Raul J.] Captain James A Lovell Fed Hlth Care Ctr, N Chicago, IL USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Radhakrishnan, J (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Med, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	jeejabai.radhakrishnan@rosalindfranklin.edu; raul.gazmuri@rosalindfranklin.edu		Gazmuri, Raul J./0000-0002-3848-7227	U.S. Veterans Affairs Merit Review grant entitled "Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest"	U.S. Veterans Affairs Merit Review grant entitled "Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest"	The authors thank Dr. Bala Chandran [Professor and Chair, Director, H. M. Cancer Research Laboratories, Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science (RFUMS)], for the support with cell culture and lentiviral facility and for the help with equipment including the Applied Biosystems Real-Time PCR machine. The authors also thank Dr. Daniel Peterson (Department of Neuroscience, RFUMS) for the anti-BrU antibody, the Alexa 488-conjugated secondary antibody, and support with the confocal microscope facility. The authors thank Dr. Patricia Loomis (Confocal Microscopy Core Facility, RFUMS) for assisting with confocal studies. This work was partially supported by a U.S. Veterans Affairs Merit Review grant entitled "Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest," a gift for cardiovascular research administered by the Hines VA Research Service entitled "Mechanisms of Cytochrome c Release during Resuscitation-Adeno-Associated Viral Gene Transfer (Pilot Grant)," and a DePaul-Rosalind Franklin University Collaborative Pilot Research Grant entitled" Molecular Mechanisms by which Cyclophilin-D Modulates Transcription of Mitochondrial Genes. "The authors declare no conflicts of interest.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hangen E, 2010, CELL DEATH DIFFER, V17, P1155, DOI 10.1038/cdd.2009.211; Iborra FJ, 1998, J CELL SCI, V111, P2269; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Leon C, 2008, J PHARM SCI-US, V97, P2350, DOI 10.1002/jps.21141; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; Menazza S, 2013, J MOL CELL CARDIOL, V56, P81, DOI 10.1016/j.yjmcc.2012.12.004; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Nagao A, 2008, METHOD ENZYMOL, V447, P489, DOI 10.1016/S0076-6879(08)02223-4; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shoubridge EA, 2002, NAT GENET, V31, P227, DOI 10.1038/ng0702-227; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tavecchio M, 2013, J BIOL CHEM, V288, P5553, DOI 10.1074/jbc.M112.433045; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	44	16	16	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2734	2748		10.1096/fj.14-263855	http://dx.doi.org/10.1096/fj.14-263855			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837584				2022-12-28	WOS:000356859100006
J	Hadi, T; Bardou, M; Mace, G; Sicard, P; Wendremaire, M; Barrichon, M; Richaud, S; Demidov, O; Sagot, P; Garrido, C; Lirussi, F				Hadi, Tarik; Bardou, Marc; Mace, Guillaume; Sicard, Pierre; Wendremaire, Maeva; Barrichon, Marina; Richaud, Sarah; Demidov, Oleg; Sagot, Paul; Garrido, Carmen; Lirussi, Frederic			Glutathione prevents preterm parturition and fetal death by targeting macrophage-induced reactive oxygen species production in the myometrium	FASEB JOURNAL			English	Article						inflammation; preterm labor; antioxidant; chorioamnionitis	SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; COCULTURE MODEL; NADPH OXIDASE; LABOR; INFLAMMATION; PREGNANCY; BIRTH	Preterm birth is an inflammatory process resulting from the massive infiltration of innate immune cells and the production of proinflammatory cytokines in the myometrium. However, proinflammatory cytokines, which induce labor in vivo, fail to induce labor-associated features in humanmyometrial cells (MCs). We thus aimed to investigate if reactive oxygen species (ROS) production could be the missing step between immune cell activation and MC response. Indeed, we found that ROS production is increased in the human preterm laboring myometrium (27% ROS producing cells, respectively, versus 2% in nonlaboring controls), with 90% ROS production in macrophages. Using LPS-stimulated myometrial samples and cell coculture experiments, we demonstrated that ROS production is required for labor onset. Furthermore, we showed that ROS are required first in the NADPH oxidase (NADPHox)-2/NF-kappa B-dependent macrophage response to inflammatory stimuli but, more importantly, to trigger macrophage-inducedMCs transactivation. Remarkably, in a murine model of LPS-induced preterm labor (inducing delivery within 17 hours, with no pup survival), cotreatment with glutathione delayed labor onset up to 94 hours and prevented in utero fetal distress, allowing 46% pups to survive. These results suggest that targeting ROS production with the macrophage-permeable antioxidant glutathione could constitute a promising strategy to prevent preterm birth.	[Hadi, Tarik; Bardou, Marc; Wendremaire, Maeva; Barrichon, Marina; Richaud, Sarah; Demidov, Oleg; Garrido, Carmen; Lirussi, Frederic] INSERM, U866, Lipides Nutr Canc, Dijon, France; [Hadi, Tarik; Bardou, Marc; Wendremaire, Maeva; Barrichon, Marina; Richaud, Sarah; Demidov, Oleg; Garrido, Carmen; Lirussi, Frederic] Univ Bourgogne, Dijon, France; [Bardou, Marc; Mace, Guillaume; Wendremaire, Maeva; Sagot, Paul; Lirussi, Frederic] Ctr Hosp Univ Dijon, Dijon, France; [Bardou, Marc; Lirussi, Frederic] INSERM, Ctr Invest Clin 1432, Dijon, France; [Mace, Guillaume; Sagot, Paul] Serv Gynecol & Obstet, Dijon, France; [Sicard, Pierre] Fac Med Toulouse, INSERM, Unite Mixte Rech 1048, Inst Metab & Cardiovasc Dis, F-31073 Toulouse, France; [Sicard, Pierre] Univ Toulouse 3, Ctr Hosp Univ Toulouse, Claudius Regaud Inst, F-31062 Toulouse, France; [Garrido, Carmen] Ctr Georges Francois Leclerc, Anticanc Ctr George Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Centre Georges-Francois Leclerc	Lirussi, F (corresponding author), CHU Dijon, CRI U866, Fac Med, 7 Bd Jeanne dArc,BP 87900, F-21079 Dijon, France.	frederic.lirussi@u-bourgogne.fr	Demidov, Oleg/U-2050-2017; Demidov, Oleg/AAC-4462-2021; Lirussi, Frederic/AAM-8186-2020; Garrido, carmen/G-1633-2018; Sicard, Pierre/N-7310-2018; Garrido, Carolina/GWM-5557-2022	Demidov, Oleg/0000-0003-4323-7174; Demidov, Oleg/0000-0003-4323-7174; Lirussi, Frederic/0000-0002-0649-6719; Garrido, carmen/0000-0003-1368-1493; Sicard, Pierre/0000-0001-5837-3916; Wendremaire, Maeva/0000-0001-9532-5702	French Regional Council of Burgundy (Conseil Regional de Bourgogne) [AOI STRESSOX]	French Regional Council of Burgundy (Conseil Regional de Bourgogne)(Region Bourgogne-Franche-Comte)	This work was funded in part by the French Regional Council of Burgundy (Conseil Regional de Bourgogne, Grant AOI STRESSOX).	Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; ANDERSON ME, 1990, FASEB J, V4, P3251, DOI 10.1096/fasebj.4.14.2227215; Asikainen TM, 2006, FASEB J, V20, P1698, DOI 10.1096/fj.06-5887fje; Bartfai L, 2012, J MATERN-FETAL NEO M, V25, P575, DOI 10.3109/14767058.2011.587060; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beloosesky R, 2006, AM J OBSTET GYNECOL, V194, P268, DOI 10.1016/j.ajog.2005.06.082; Bevilacqua E, 2012, REPROD BIOMED ONLINE, V25, P31, DOI 10.1016/j.rbmo.2012.03.016; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Chai M, 2012, PLACENTA, V33, P604, DOI 10.1016/j.placenta.2012.04.014; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Chevillard G, 2007, REPRODUCTION, V134, P811, DOI 10.1530/REP-07-0289; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Clerici G, 2012, J OBSTET GYNAECOL, V32, P124, DOI 10.3109/01443615.2011.637139; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Daneshmand SS, 2002, AM J OBSTET GYNECOL, V187, P1131, DOI 10.1067/mob.2002.127145; Elnakish MT, 2013, J PATHOL, V231, P290, DOI 10.1002/path.4255; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Esplin MS, 2005, J MATERN-FETAL NEO M, V17, P365, DOI 10.1080/14767050500141329; FAN YY, 1995, IN VITRO CELL DEV-AN, V31, P492; Fetalvero Kristina M, 2008, J Clin Invest, V118, P3966, DOI 10.1172/JCI33800; Fidel PL, 1997, J SOC GYNECOL INVEST, V4, P22, DOI 10.1016/S1071-5576(96)00060-3; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fruhwirth Gilbert O., 2008, V49, P351, DOI 10.1007/978-1-4020-8831-5_13; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gloire G, 2009, ANTIOXID REDOX SIGN, V11, P2209, DOI [10.1089/ars.2009.2463, 10.1089/ARS.2009.2463]; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gross G, 2000, AM J PHYSIOL-REG I, V278, pR1415, DOI 10.1152/ajpregu.2000.278.6.R1415; Hadi T, 2013, BBA-MOL CELL RES, V1833, P1041, DOI 10.1016/j.bbamcr.2013.01.019; Han YM, 2007, J PATHOL, V211, P489, DOI 10.1002/path.2131; Hauth JC, 2010, OBSTET GYNECOL, V116, P653, DOI 10.1097/AOG.0b013e3181ed721d; Heller DS, 2012, J LOW GENIT TRACT DI, V16, P4, DOI 10.1097/LGT.0b013e31822bb004; Helmer H, 2002, J SOC GYNECOL INVEST, V9, P15, DOI 10.1016/S1071-5576(01)00142-3; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hutchinson JL, 2014, FASEB J, V28, P94, DOI 10.1096/fj.13-237040; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kimura T, 1999, REV REPROD, V4, P73, DOI 10.1530/ror.0.0040073; Kindzelskii AL, 2004, J IMMUNOL, V172, P6373, DOI 10.4049/jimmunol.172.10.6373; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; LEE E, 1995, ARTERIOSCL THROM VAS, V15, P2284, DOI 10.1161/01.ATV.15.12.2284; Lehner C, 2011, ANTIOXID REDOX SIGN, V15, P1305, DOI 10.1089/ars.2011.3923; Lin CC, 2010, FREE RADICAL BIO MED, V48, P240, DOI 10.1016/j.freeradbiomed.2009.10.047; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Lirussi F, 2010, BRIT J PHARMACOL, V159, P1354, DOI 10.1111/j.1476-5381.2009.00616.x; Lirussi F, 2008, BIOL REPROD, V78, P497, DOI 10.1095/biolreprod.107.064444; LUFT BJ, 1984, CELL IMMUNOL, V85, P94, DOI 10.1016/0008-8749(84)90281-8; MacIntyre DA, 2014, FASEB J, V28, P2358, DOI 10.1096/fj.13-247783; Mensink A, 1998, ENVIRON TOXICOL PHAR, V5, P197, DOI 10.1016/S1382-6689(98)00002-7; Moore RM, 2009, BIOL REPROD, V80, P781, DOI 10.1095/biolreprod.108.073205; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Ogge G, 2011, J PATHOL, V223, P553, DOI 10.1002/path.2825; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Scirocco A, 2010, J CELL PHYSIOL, V223, P442, DOI 10.1002/jcp.22053; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; Shynlova O, 2010, REPRODUCTION, V139, P247, DOI 10.1530/REP-09-0260; Sundrani DP, 2011, MED HYPOTHESES, V77, P878, DOI 10.1016/j.mehy.2011.08.001; Taggart MJ, 2008, J CLIN INVEST, V118, P3829, DOI 10.1172/JCI37785; Tinkel J, 2012, CARDIOL REV, V20, P77, DOI 10.1097/CRD.0b013e31823dbbad; Trollmann R, 2008, AM J PHYSIOL-REG I, V295, pR1973, DOI 10.1152/ajpregu.00053.2008; Ustun C, 2001, INT J GYNECOL OBSTET, V72, P109, DOI 10.1016/S0020-7292(00)00280-0; Wong BW, 2012, CAN J CARDIOL, V28, P631, DOI 10.1016/j.cjca.2012.06.023; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	69	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2653	2666		10.1096/fj.14-266783	http://dx.doi.org/10.1096/fj.14-266783			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757563				2022-12-28	WOS:000355209500040
J	Hifumi, E; Arakawa, M; Matsumoto, S; Yamamoto, T; Katayama, Y; Uda, T				Hifumi, Emi; Arakawa, Mitsue; Matsumoto, Shingo; Yamamoto, Tatsuhiro; Katayama, Yoshiki; Uda, Taizo			Biochemical features and antiviral activity of a monomeric catalytic antibody light-chain 23D4 against influenza A virus	FASEB JOURNAL			English	Article						suppression; infection; hydrolysis; AFM image	FACTOR-VIII; PROTEOLYTIC ANTIBODIES; HYDROLYSIS; DNA; PEPTIDE; ABILITY; GP41; RNA	Catalytic antibodies have exhibited interesting functions against some infectious viruses such as HIV, rabies virus, and influenza virus in vitro as well as in vivo. In some cases, a catalytic antibody light chain takes on several structures from the standpoint of molecular size (monomer, dimer, etc.) and/or isoelectronic point. In this study, we prepared a monomeric 23D4 light chain by mutating the C-terminal Cys to Ala of the wild-type. The mutated 23D4 molecule took a simple monomeric form, which could hydrolyze synthetic 4-methyl-coumaryl-7-amide substrates and a plasmid DNA. Because the monomeric 23D4 light chain suppressed the infection of influenza virus A/Hiroshima/37/2001 in an in vitro assay, the corresponding experiments were conducted in vivo, after the virus strain (which was taken from a human patient) was successfully adapted into BALB/cN Sea mice. In the experiments, a mixture of the monomeric 23D4 and the virus was nasally administered 1) with preincubation and 2) without preincubation. As a result, the monomeric 23D4 clearly exhibited the ability to suppress the influenza virus infection in both cases, indicating a potential drug for preventing infection of the influenza A virus.	[Hifumi, Emi] Oita Univ, Res Promot Inst, Oita, Oita 8701192, Japan; [Hifumi, Emi; Arakawa, Mitsue; Matsumoto, Shingo; Yamamoto, Tatsuhiro; Uda, Taizo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Arakawa, Mitsue] Oita Univ, Fac Med, Yufu City, Oita, Japan; [Matsumoto, Shingo; Uda, Taizo] Oita Univ, Dept Appl Chem, Oita, Oita 8701192, Japan; [Matsumoto, Shingo; Katayama, Yoshiki] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka 812, Japan; [Yamamoto, Tatsuhiro; Uda, Taizo] Inst Syst Informat Technol & Nanotechnol, Nanotechnol Lab, Fukuoka, Japan	Oita University; Japan Science & Technology Agency (JST); Oita University; Oita University; Kyushu University	Hifumi, E (corresponding author), Oita Univ, Res Promot Inst, 700 Dan Noharu, Oita, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902	Japan Science and Technology Agency (Core Research for Evolutional Science and Technology/"Establishment of Innovative Manufacturing Technology Based on Nanoscience"); Ministry of Education, Culture, Sports, Science and Technology of Japan [24350085]	Japan Science and Technology Agency (Core Research for Evolutional Science and Technology/"Establishment of Innovative Manufacturing Technology Based on Nanoscience"); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank AVSS Company Limited (Drs. T. Haruyama and N. Kobayashi), Oxford Instruments KK (Dr. H. Sugasawa), and Ms. N. Fujimoto and Ms. E. Saito for their assistance with this study. This study was supported by the Japan Science and Technology Agency (Core Research for Evolutional Science and Technology/"Establishment of Innovative Manufacturing Technology Based on Nanoscience") and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24350085).	Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; GAO QS, 1994, J BIOL CHEM, V269, P32389; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2000, APPL BIOCHEM BIOTECH, V83, P209, DOI 10.1385/ABAB:83:1-3:209; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2013, J BIOL CHEM, V288, P19558, DOI 10.1074/jbc.M113.454579; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hifumi E, 2011, J AM CHEM SOC, V133, P15015, DOI 10.1021/ja203922r; Hifumi E, 2010, J BIOSCI BIOENG, V109, P598, DOI 10.1016/j.jbiosc.2009.11.020; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Kotsovilis S, 2014, METHODS MOL BIOL, V1060, P37, DOI 10.1007/978-1-62703-586-6_3; Kou JH, 2015, MOL NEUROBIOL, V51, P43, DOI 10.1007/s12035-014-8691-z; Kozyr AV, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/683829; Krasnorutskii MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1065, DOI 10.1134/S0006297911090124; Krasnorutskii MA, 2008, INT IMMUNOL, V20, P1031, DOI 10.1093/intimm/dxn061; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; MEI S, 1991, J BIOL CHEM, V266, P15571; Nevinsky GA, 2002, J IMMUNOL METHODS, V269, P235, DOI 10.1016/S0022-1759(02)00234-X; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; Ohara K, 2004, BIOCHEM BIOPH RES CO, V315, P612, DOI 10.1016/j.bbrc.2004.01.094; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Ponomarenko NA, 2007, BIOCHEMISTRY-US, V46, P14598, DOI 10.1021/bi7013954; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rodkey LS, 2000, APPL BIOCHEM BIOTECH, V83, P95, DOI 10.1385/ABAB:83:1-3:95; Schmidt NJ, 1989, DIAGNOSTIC PROCEDURE, V6th, P51; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Stanley WM, 1944, J EXP MED, V79, P267, DOI 10.1084/jem.79.3.267; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8; Wootla B, 2009, CLIN REV ALLERG IMMU, V37, P97, DOI 10.1007/s12016-009-8116-3; Wootla B, 2009, FEBS LETT, V583, P2565, DOI 10.1016/j.febslet.2009.07.009	39	11	11	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2347	2358		10.1096/fj.14-264275	http://dx.doi.org/10.1096/fj.14-264275			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713031				2022-12-28	WOS:000355209500013
J	Sandberg, K; Umans, JG				Sandberg, Kathryn; Umans, Jason G.		Georgetown Consensus Conference Wo	Recommendations concerning the new US National Institutes of Health initiative to balance the sex of cells and animals in preclinical research	FASEB JOURNAL			English	Article						gender; sexual dimorphism; sex differences; sex bias; over-reliance	CLINICAL-TRIALS; GENDER BIAS; T-CELL; PARTICIPATION; WOMEN; NIH	The U.S. National Institutes of Health (NIH) announced last May that steps will be taken to address the over-reliance on male cells and animals in preclinical research. To further address this announcement, in September 2014, scientists with varying perspectives came together at Georgetown University to discuss the following questions. (1) What metrics should the NIH use to assess tangible progress on policy changes designed to address the over-reliance on male cells and animals in preclinical research? (2) How effective can education be in reducing the over-reliance on male cells and animals in preclinical research and what educational initiatives sponsored by the NIH would most likely effect change? (3) What criteria should the NIH use to determine rigorously defined exceptions to the future proposal requirement of a balance of male and female cells and animals in preclinical studies? (4) What additional strategies in addition to proposal requirements should NIH use to reduce the overreliance of male cells and animals in preclinical research? The resulting consensus presented herein includes input from researchers not only from diverse disciplines of basic and translational science including biology, cell and molecular biology, biochemistry, physiology, pharmacology, neuroscience, cardiology, endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and population health. We offer our recommendations to aid the NIH as it selects, implements, monitors, and optimizes strategies to correct the over-reliance on male cells and animals in preclinical research.	[Sandberg, Kathryn; Umans, Jason G.] Georgetown Univ, Ctr Study Sex Differences Hlth Aging & Dis, Washington, DC USA; [Sandberg, Kathryn; Umans, Jason G.] Georgetown Univ, Div Nephrol & Hypertens, Dept Med, Washington, DC USA; [Umans, Jason G.] Georgetown Univ, Dept Med, Div Endocrinol & Metab, Washington, DC USA; [Sandberg, Kathryn; Umans, Jason G.] Georgetown Howard Univ, Ctr Clin & Translat Sci, Washington, DC USA; [Umans, Jason G.] MedStar Hlth Res Inst, Hyattsville, MD USA	Georgetown University; Georgetown University; Georgetown University; MedStar Health Research Institute	Sandberg, K (corresponding author), Suite 232 Bldg D,4000 Reservoir Rd,NW, Washington, DC 20057 USA.	sandberg@georgetown.edu	McCarthy, Margaret/O-2059-2017; Clarke, Robert/A-6485-2008; Molina, Patricia E./AAK-9814-2021; Mann, Janet/L-2311-2019; O'Brien, Edward/J-6621-2013	McCarthy, Margaret/0000-0003-2243-4726; Clarke, Robert/0000-0002-9278-0854; Molina, Patricia E./0000-0002-3598-384X; Darsow, Tamara/0000-0002-6650-6368; O'Brien, Edward/0000-0003-1039-9425; Woolley, Catherine/0000-0002-8069-2646	NHLBI NIH HHS [R01 HL119380] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119380] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; BERKLEY KJ, 1992, TRENDS NEUROSCI, V15, P331, DOI 10.1016/0166-2236(92)90048-D; BLANCHARD DC, 1995, J PSYCHOPHARMACOL, V9, P79, DOI 10.1177/026988119500900201; Blaustein JD, 2012, ENDOCRINOLOGY, V153, P2539, DOI 10.1210/en.2012-1365; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Ebert SN, 1998, J WOMENS HEALTH, V7, P547, DOI 10.1089/jwh.1998.7.547; Falconnet C, 2004, J HYPERTENS, V22, P1213, DOI 10.1097/00004872-200406000-00023; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Ji H, 2014, HYPERTENSION, V64, P573, DOI 10.1161/HYPERTENSIONAHA.114.03663; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; McCullough LD, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0015-5; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Pinnow E, 2009, WOMEN HEALTH ISS, V19, P89, DOI 10.1016/j.whi.2008.09.009; Pollow DP, 2014, HYPERTENSION, V64, P384, DOI 10.1161/HYPERTENSIONAHA.114.03581; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Sandberg K, 2015, CELL IMMUNOL, V294, P95, DOI 10.1016/j.cellimm.2014.12.001; Sandberg K, 2014, AM J PHYSIOL-REG I, V307, pR361, DOI 10.1152/ajpregu.00251.2014; SECHZER JA, 1994, ANN NY ACAD SCI, V736, P21, DOI 10.1111/j.1749-6632.1994.tb12816.x; Wadman M, 2013, NATURE, V500, P14, DOI 10.1038/500014a; Yang YS, 2009, J WOMENS HEALTH, V18, P303, DOI 10.1089/jwh.2008.0971	20	49	50	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1646	1652		10.1096/fj.14-269548	http://dx.doi.org/10.1096/fj.14-269548			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25713032	Green Published			2022-12-28	WOS:000354114600004
J	Kim, CS; Mitchell, IP; Desotell, AW; Kreeger, PK; Masters, KS				Kim, Chloe S.; Mitchell, Isaiah P.; Desotell, Anthony W.; Kreeger, Pamela K.; Masters, Kristyn S.			Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLC gamma 1	FASEB JOURNAL			English	Article						collective migration; EGFR trafficking; PLC gamma 1 signaling; wound healing	MESENCHYMAL STEM-CELLS; HUMAN SKIN; EXTRACELLULAR-MATRIX; CHRONIC WOUNDS; TISSUE-REPAIR; FACTOR-BETA; RECEPTOR; REGENERATION; PROTEIN; EGFR	Epidermal growth factor (EGF) is a critical element in dermal repair, but EGF-containing wound dressings have not been successful clinically. However, these dressings have delivered only soluble EGF, and the native environment provides both soluble and matrix-bound EGF. To address our hypothesis that tethered EGF can stimulate cell behaviors not achievable with soluble EGF, we examined single-cell movement and signaling in human immortalized HaCaT keratinocytes treated with soluble or immobilized EGF. Although both EGF treatments increased collective sheet displacement and individual cell speed, only cells treated with immobilized EGF exhibited directed migration, as well as 2-fold greater persistence compared with soluble EGF. Immunofluorescence showed altered EGF receptor (EGFR) trafficking, where EGFR remained membrane-localized in the immobilized EGF condition. Cells treated with soluble EGF demonstrated higher phosphorylated ERK1/2, and cells on immobilized EGF exhibited higher pPLC gamma 1, which was localizedat the leading edge. Treatment with U0126 inhibited migration in both conditions, demonstrating that ERK1/2 activity was necessary but not responsible for the observed differences. In contrast, PLC gamma 1 inhibition with U73122 significantly decreased persistence on immobilized EGF. Combined, these results suggest that immobilized EGF increases collective keratinocyte displacement via an increase in single-cell migration persistence resulting from altered EGFR trafficking and PLCg1 activation.	[Kim, Chloe S.; Mitchell, Isaiah P.; Desotell, Anthony W.; Kreeger, Pamela K.; Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Kreeger, PK (corresponding author), 4553 Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53705 USA.; Masters, KS (corresponding author), 1550 Engn Dr,ECB 2152, Madison, WI 53706 USA.	kreeger@wisc.edu; kmasters@wisc.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [R01-GM099031]; Wisconsin Distinguished Graduate Fellowship Award; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099031] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wisconsin Distinguished Graduate Fellowship Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge Min Sung Kim (Department of Biomedical Engineering, University of Wisconsin-Madison) for her assistance with cell culture and fluorescent immunostaining and the University of Wisconsin-Madison Vision Research Core (P30 EY0166650) for use of the confocal microscope. This work was supported by a grant from the U.S. National Institutes of Health, National Institute of General Medical Sciences (R01-GM099031), and a Wisconsin Distinguished Graduate Fellowship Award.	Anderson SM, 2011, BIOMATERIALS, V32, P7432, DOI 10.1016/j.biomaterials.2011.06.027; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Braund Rhiannon, 2007, Current Drug Delivery, V4, P195; BROWN GL, 1986, J EXP MED, V163, P1319; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Chambon JP, 2007, DEVELOPMENT, V134, P1203, DOI 10.1242/dev.002220; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; GAME SM, 1992, INT J CANCER, V52, P461, DOI 10.1002/ijc.2910520322; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haase I, 1997, J INVEST DERMATOL, V108, P748, DOI 10.1111/1523-1747.ep12292135; Haugh JM, 1999, J BIOL CHEM, V274, P8958, DOI 10.1074/jbc.274.13.8958; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Iyer AKV, 2008, J CELL PHYSIOL, V214, P504, DOI 10.1002/jcp.21232; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; JIN WZ, 1994, BRAIN RES, V642, P237, DOI 10.1016/0006-8993(94)90927-X; Jones S, 2014, INT J BIOCHEM CELL B, V51, P23, DOI 10.1016/j.biocel.2014.03.014; Koria P, 2012, BIODRUGS, V26, P163, DOI 10.2165/11631850-000000000-00000; Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022; Kuhlman W, 2007, BIOMACROMOLECULES, V8, P3206, DOI 10.1021/bm070237o; Li SW, 2009, MOL ENDOCRINOL, V23, P901, DOI 10.1210/me.2008-0368; Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505; McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2; Mehta G, 2010, BIOMATERIALS, V31, P4657, DOI 10.1016/j.biomaterials.2010.01.138; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Papanas N, 2010, DRUG SAFETY, V33, P455, DOI 10.2165/11534570-000000000-00000; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Puccinelli TJ, 2010, ACTA BIOMATER, V6, P3415, DOI 10.1016/j.actbio.2010.04.006; Reddy CC, 1996, J CELL PHYSIOL, V166, P512, DOI 10.1002/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S; Robson Martin C., 1997, Wound Repair and Regeneration, V5, P12, DOI 10.1046/j.1524-475X.1997.50106.x; Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Seeger MA, 2015, ADV WOUND CARE, V4, P213, DOI 10.1089/wound.2014.0540; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sridhar BV, 2014, J BIOMED MATER RES A, V102, P4464, DOI 10.1002/jbm.a.35115; Stefonek-Puccinelli TJ, 2009, IEEE ENG MED BIO, P1167, DOI 10.1109/IEMBS.2009.5332607; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Tian D, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0098-y; Wang Y, 2003, TRAFFIC, V4, P618, DOI 10.1034/j.1600-0854.2003.00121.x; Wang Y, 2014, CELL RES, V24, P959, DOI 10.1038/cr.2014.89; Wickert LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep20139; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; YU W, 1994, LASER SURG MED, V15, P281, DOI 10.1002/lsm.1900150308	54	9	9	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2580	2590		10.1096/fj.201600252	http://dx.doi.org/10.1096/fj.201600252			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27025961	Green Published			2022-12-28	WOS:000379249500013
J	Flores, AM; Casey, SD; Felix, CM; Phuan, PW; Verkman, AS; Levin, MH				Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Phuan, Puay W.; Verkman, A. S.; Levin, Marc H.			Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease	FASEB JOURNAL			English	Article						ocular surface; chloride channels; cornea; conjunctiva	BASOLATERAL K+ CONDUCTANCE; CYSTIC-FIBROSIS; CHLORIDE TRANSPORT; OCULAR SURFACE; DIQUAFOSOL TETRASODIUM; OPHTHALMIC SOLUTION; RABBIT; CONJUNCTIVAL; MODEL; MICE	Dry eye disorders, including Sjogren's syndrome, constitute a common problem in the aging population, with limited effective therapeutic options available. The cAMP-activated Cl- channel cystic fibrosis transmembrane conductance regulator (CFTR) is a major prosecretory channel at the ocular surface. We investigated whether compounds that target CFTR can correct the abnormal tear film in dry eye. Small-molecule activators of human wild-type CFTR identified by high-throughput screening were evaluated in cell culture and in vivo assays, to select compounds that stimulate Cl--driven fluid secretion across the ocular surface in mice. An aminophenyl-1,3,5-triazine, CFTRact-K089, fully activated CFTR in cell cultures with EC50 similar to 250 nM and produced an similar to 8.5 mV hyperpolarization in ocular surface potential difference. When delivered topically, CFTRact-K089 doubled basal tear volume for 4 h and had no effect in CF mice. CFTRact-K089 showed sustained tear film bio-availability without detectable systemic absorption. In a mouse model of aqueous-deficient dry eye produced by lacrimal ablation, topical administration of 0.1 nmol CFTRact-K089 3 times daily restored tear volume to basal levels, preventing corneal epithelial disruption when initiated at the time of surgery and reversing it when started after development of dry eye. Our results support the potential utility of CFTR-targeted activators as a novel prosecretory treatment for dry eye.-Flores, A. M., Casey, S. D., Felix, C. M., Phuan, P. W., Verkman, A. S., Levin, M. H. Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease.	[Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Phuan, Puay W.; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Phuan, Puay W.; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Levin, Marc H.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Levin, MH (corresponding author), Univ Calif San Francisco, 10 Koret Way,Room K203, San Francisco, CA 94143 USA.	marc.levin@ucsf.edu		Casey, Scott/0000-0001-6733-2155	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Sciences-UCSF-Clinical and Translational Science Institute Grant [UL1 TR000004]; Research to Prevent Blindness Career Development Award; NIH National Eye Institute Grant [EY023981, EY13574, EY002162]; National Institute of Biomedical Imaging and Bioengineering Grant [EB00415]; National Institute of Diabetes and Digestive and Kidney Diseases [DK72517, DK35124, DK101373]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013574, P30EY002162, K08EY023981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, R01DK101373] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Sciences-UCSF-Clinical and Translational Science Institute Grant; Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); NIH National Eye Institute Grant; National Institute of Biomedical Imaging and Bioengineering Grant; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. N. A. McNamara, Dr. D. N. Stephens, and F.Y.T. Chen [Francis I. Proctor Foundation, UCSF (N.A.M., D.N.S., and F.Y.T.C.); and Departments of Anatomy and Ophthalmology, UCSF, and University of California, Berkeley School of Optometry and Vision Science Graduate Group (N.A.M.)] for expert advice in evaluation of rodent dry eye models and Dr. T. Porco (Frances I. Proctor Foundation and Departments of Ophthalmology and Epidemiology & Biostatistics, UCSF) for statistical assistance. This project was supported by U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Sciences-UCSF-Clinical and Translational Science Institute Grant UL1 TR000004 (to M.H.L. and A.S.V), a Research to Prevent Blindness Career Development Award and NIH National Eye Institute Grant EY023981 (to M.H.L); NIH National Eye Institute Grant EY13574, National Institute of Biomedical Imaging and Bioengineering Grant EB00415, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK72517, DK35124, and DK101373 (to A.S.V.); and NIH National Eye Institute Grant EY002162 (to the UCSF Core Grant for Vision Research). Provisional U.S. patents have been filed on the use of the CFTR activators reported here for dry eye therapy and alternative applications. The authors declare no additional conflicts of interest.	Al-Nakkash L, 2001, INVEST OPHTH VIS SCI, V42, P2364; Alves M, 2013, OCUL SURF, V11, P181, DOI 10.1016/j.jtos.2013.02.002; Ansari EA, 1999, BRIT J OPHTHALMOL, V83, P688, DOI 10.1136/bjo.83.6.688; Asbell PA, 2010, EYE CONTACT LENS, V36, P33, DOI 10.1097/ICL.0b013e3181c739ad; BOTELHO SY, 1973, J PEDIATR-US, V83, P601, DOI 10.1016/S0022-3476(73)80221-5; Chen YT, 2009, MOL VIS, V15, P563; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Esteva-Font C, 2014, FASEB J, V28, P3878, DOI 10.1096/fj.14-253872; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; GILBARD JP, 1984, OPHTHALMOLOGY, V91, P1205; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; KOMPELLA UB, 1993, CURR EYE RES, V12, P1041, DOI 10.3109/02713689309033501; Lemp MA, 2007, OCUL SURF, V5, P75; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P306, DOI 10.1167/iovs.05-1082; Levin MH, 2005, INVEST OPHTH VIS SCI, V46, P1428, DOI 10.1167/iovs.04-1314; Levin MH, 2004, INVEST OPHTH VIS SCI, V45, P4423, DOI 10.1167/iovs.04-0816; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Lu M, 2012, CURR EYE RES, V37, P671, DOI 10.3109/02713683.2012.675613; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; MORKEBERG JC, 1995, GRAEF ARCH CLIN EXP, V233, P709, DOI 10.1007/BF00164674; Mrugacz M, 2006, J INTERF CYTOK RES, V26, P71, DOI 10.1089/jir.2006.26.71; Nandoskar P, 2012, CORNEA, V31, P273, DOI 10.1097/ICO.0b013e3182254b42; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/13543784.13.1.47; RALPH RA, 1975, INVEST OPHTH VISUAL, V14, P299; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Sheppard JD, 2014, OPHTHALMOLOGY, V121, P475, DOI 10.1016/j.ophtha.2013.09.015; Shiue MHI, 2002, CAN J PHYSIOL PHARM, V80, P533, DOI 10.1139/Y02-066; Smith JA, 2007, OCUL SURF, V5, P93; Stevenson W, 2014, CORNEA, V33, P1336, DOI 10.1097/ICO.0000000000000264; Sullivan DA, 1999, INVEST OPHTH VIS SCI, V40, P1261; Sung MS, 2015, INVEST OPHTH VIS SCI, V56, P3149, DOI 10.1167/iovs.14-16153; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Tauber J, 2004, CORNEA, V23, P784, DOI 10.1097/01.ico.0000133993.14768.a9; Thelin WR, 2012, J OCUL PHARMACOL TH, V28, P433, DOI 10.1089/jop.2011.0157; Turner HC, 2002, CURR EYE RES, V24, P182, DOI 10.1076/ceyr.24.3.182.8297; Turner HC, 2000, EXP EYE RES, V70, P295, DOI 10.1006/exer.1999.0792; Van Goor F, 2008, TOP MED CHEM SER, V3, P91, DOI 10.1007/7355_2008_022; Vertex Pharmaceuticals, 2012, KAL PROD MON; Villareal Arturo L, 2006, Eye Contact Lens, V32, P272, DOI 10.1097/01.icl.0000224360.10319.b1; WATSKY MA, 1988, CURR EYE RES, V7, P483, DOI 10.3109/02713688809031801; WOLOSIN JM, 1987, AM J PHYSIOL, V253, pC555, DOI 10.1152/ajpcell.1987.253.4.C555; Yao CJ, 2012, J AM SOC NEPHROL, V23, P1210, DOI 10.1681/ASN.2011070751; Yu DF, 2012, AM J PHYSIOL-CELL PH, V303, pC767, DOI 10.1152/ajpcell.00195.2012; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363	51	21	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1789	1797		10.1096/fj.201500180	http://dx.doi.org/10.1096/fj.201500180			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26842854	Green Published			2022-12-28	WOS:000374879400010
J	Shelar, SB; Narasimhan, M; Shanmugam, G; Litovsky, SH; Gounder, SS; Karan, G; Arulvasu, C; Kensler, TW; Hoidal, JR; Darley-Usmar, VM; Rajasekaran, NS				Shelar, Sandeep Balu; Narasimhan, Madhusudhanan; Shanmugam, Gobinath; Litovsky, Silvio Hector; Gounder, Sellamuthu S.; Karan, Goutam; Arulvasu, Cinnasamy; Kensler, Thomas W.; Hoidal, John R.; Darley-Usmar, Victor M.; Rajasekaran, Namakkal S.			Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscle	FASEB JOURNAL			English	Article						TA muscle; Pax7; Nrf2/ARE; satellite cell; cardiotoxin	ISCHEMIA-REPERFUSION INJURY; SATELLITE CELLS; MYOGENIC DIFFERENTIATION; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; GENE-EXPRESSION; PRECURSOR CELLS; SELF-RENEWAL; AGED MUSCLE; MOUSE MODEL	Recently we have reported that age-dependent decline in antioxidant levels accelerated apoptosis and skeletal muscle degeneration. Here, we demonstrate genetic ablation of the master cytoprotective transcription factor, nuclear factor (erythroid-derived-2)-like 2 (Nrf2), aggravates cardiotoxin (CTX)-induced tibialis anterior (TA) muscle damage. Disruption of Nrf2 signaling sustained the CTX-induced burden of reactive oxygen species together with compromised expression of antioxidant genes and proteins. Transcript/protein expression of phenotypic markers of muscle differentiation, namely paired box 7 (satellite cell) and early myogenic differentiation and terminal differentiation (myogenin and myosin heavy chain 2) were increased on d 2 and 4 postinjury but later returned to baseline levels on d 8 and 15 in wild-type (WT) mice. In contrast, these responses were persistently augmented in Nrf2-null mice suggesting that regulation of the regeneration-related signaling mechanisms require Nrf2 for normal functioning. Furthermore, Nrf2-null mice displayed slower regeneration marked by dysregulation of embryonic myosin heavy chain temporal expression. Histologic observations illustrated that Nrf2-null mice displayed smaller, immature TA muscle fibers compared with WT counterparts on d 15 after CTX injury. Improvement in TA muscle morphology and gain in muscle mass evident in the WT mice was not noticeable in the Nrf2-null animals. Taken together these data show that the satellite cell activation, proliferation, and differentiation requires a functional Nrf2 system for effective healing following injury.-Shelar, S. B., Narasimhan, M., Shanmugam, G., Litovsky, S. H., Gounder, S. S., Karan, G., Arulvasu, C., Kensler, T. W., Hoidal, J. R., Darley-Usmar, V. M., Rajasekaran, N. S. Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscle. www.fasebj.org	[Shelar, Sandeep Balu; Shanmugam, Gobinath; Rajasekaran, Namakkal S.] Univ Alabama Birmingham, Cardiac Aging & Redox Signaling Lab, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Litovsky, Silvio Hector] Univ Alabama Birmingham, Div Anat Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Darley-Usmar, Victor M.; Rajasekaran, Namakkal S.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Narasimhan, Madhusudhanan] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Gounder, Sellamuthu S.; Hoidal, John R.; Rajasekaran, Namakkal S.] Univ Utah, Sch Med, Dept Med, Div Cardiovasc Med Pulm Med, Salt Lake City, UT USA; [Karan, Goutam] Mirx Pharmaceut, Lexington, KY USA; [Arulvasu, Cinnasamy] Univ Madras, Dept Zool, Madras 600025, Tamil Nadu, India; [Kensler, Thomas W.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Utah System of Higher Education; University of Utah; University of Madras; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rajasekaran, NS (corresponding author), Univ Alabama Birmingham, Cardiac Aging & Redox Signaling Lab, Div Mol & Cellular Pathol, Ctr Free Rad Biol,Dept Pathol, BMR2 Room 533,901 19th St South, Birmingham, AL 35294 USA.	rajnsr@uab.edu	Kensler, Thomas W/D-8686-2014; Shanmugam, Gobinath/ACL-0604-2022	Kensler, Thomas W/0000-0002-6676-261X; Darley-Usmar, Victor/0000-0001-8921-7086	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL118067]; NIH National Institute on Aging [1R03AG042860-01]; American Heart Association [BGIA-0865015F]; University of Utah Center for Aging; University of Utah; University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE [R35CA197222] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042860, P30AG050886] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); University of Utah Center for Aging; University of Utah; University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by awards/research funds from the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (R01HL118067), NIH National Institute on Aging (1R03AG042860-01), the American Heart Association (BGIA-0865015F), University of Utah Center for Aging (Pilot Grant-2009), the University of Utah, and the University of Alabama at Birmingham startup funds (to N.S.R.). The authors thank Ms. Indira Guevera, Ms. Jennifer Hong, and Ms. Nancy Atieno (University of Utah School of Medicine, Salt Lake City, Utah, USA) for their technical assistance, including animal colony maintenance and genotyping. The authors also thank Dr. Christopher Davidson for his review and critiques to strengthen the manuscript.	Al-Sawaf O, 2014, J PATHOL, V234, P538, DOI 10.1002/path.4418; Al-Sawaf O, 2014, SCI REP-UK, V4, DOI 10.1038/srep03625; Angione AR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-33; Aoi Wataru, 2011, Curr Aging Sci, V4, P101; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Armand AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027283; ARRINGTON ED, 1995, ORTHOP CLIN N AM, V26, P411; Bismuth K, 2010, EXP CELL RES, V316, P3081, DOI 10.1016/j.yexcr.2010.08.018; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen CN, 2008, J GERONTOL A-BIOL, V63, P461, DOI 10.1093/gerona/63.5.461; Chien CM, 2010, TOXICON, V56, P508, DOI 10.1016/j.toxicon.2010.05.007; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Di Stasi SL, 2010, PHYS THER, V90, P1530, DOI 10.2522/ptj.20090251; FUCHTBAUER EM, 1992, DEV DYNAM, V193, P34; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; IRINTCHEV A, 1987, CELL TISSUE RES, V249, P509; Islam KN, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001986; Judson RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059622; Karalaki M, 2009, IN VIVO, V23, P779; Komaravelli N, 2015, FREE RADICAL BIO MED, V88, P391, DOI 10.1016/j.freeradbiomed.2015.05.043; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; LEFAUCHEUR JP, 1995, NEUROMUSCULAR DISORD, V5, P501, DOI 10.1016/0960-8966(95)00012-C; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Narasimhan M, 2014, FREE RADICAL BIO MED, V71, P402, DOI 10.1016/j.freeradbiomed.2014.02.023; ONTELL M, 1993, DEVELOPMENT, V117, P1435; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Putman CT, 2001, J GERONTOL A-BIOL, V56, pB510, DOI 10.1093/gerona/56.12.B510; Rajasekaran NS, 2011, ANTIOXID REDOX SIGN, V14, P957, DOI 10.1089/ars.2010.3587; Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Schultz E, 2006, DEV DYNAM, V235, P3230, DOI 10.1002/dvdy.20976; Sestili P, 2009, MOL NUTR FOOD RES, V53, P1187, DOI 10.1002/mnfr.200800504; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shrier I, 2004, BRIT J SPORT MED, V38, P526, DOI 10.1136/bjsm.2003.011262; SNOW MH, 1983, ANAT REC, V207, P593, DOI 10.1002/ar.1092070407; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; WATT DJ, 1987, ANAT EMBRYOL, V175, P527, DOI 10.1007/BF00309688; Wu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088450; Xiu JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-215; Yang JCS, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0147-x; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	64	22	24	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1865	1879		10.1096/fj.201500153	http://dx.doi.org/10.1096/fj.201500153			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839378	Green Published			2022-12-28	WOS:000374879400016
J	Panfoli, I; Ravera, S; Podesta, M; Cossu, C; Santucci, L; Bartolucci, M; Bruschi, M; Calzia, D; Sabatini, F; Bruschettini, M; Ramenghi, LA; Romantsik, O; Marimpietri, D; Pistoia, V; Ghiggeri, G; Frassoni, F; Candiano, G				Panfoli, Isabella; Ravera, Silvia; Podesta, Marina; Cossu, Claudia; Santucci, Laura; Bartolucci, Martina; Bruschi, Maurizio; Calzia, Daniela; Sabatini, Federica; Bruschettini, Matteo; Ramenghi, Luca Antonio; Romantsik, Olga; Marimpietri, Danilo; Pistoia, Vito; Ghiggeri, Gianmarco; Frassoni, Francesco; Candiano, Giovanni			Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants	FASEB JOURNAL			English	Article						ATP synthesis; oxidative phosphorylation; umbilical cord; electron transport chain; energy metabolism	STROMAL CELLS; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIA; MYELIN; STRESS	Exosomes are secreted nanovesicles that are able to transfer RNA and proteins to target cells. The emerging role ofmesenchymal stemcell (MSC) exosomes as promoters of aerobic ATP synthesis restoration in damaged cells, prompted us to assess whether they contain an extramitochondrial aerobic respiration capacity. Exosomes were isolated from culture medium of human MSCs from umbilical cord of >= 37-wk-old newborns or between 28- to 30-wk-old newborns (i.e., term or preterm infants). Characterization of samples was conducted by cytofluorometry. Oxidative phosphorylation capacity was assessed by Western blot analysis, oximetry, and luminometric and fluorometric analyses. MSC exosomes express functional respiratory complexes I, IV, and V, consuming oxygen. ATP synthesis was only detectable in exosomes from term newborns, suggestive of a specific mechanism that is not completed at an early gestational age. Activities are outward facing and comparable to those detected in mitochondria isolated from term MSCs. MSC exosomes display an unsuspected aerobic respiratory ability independent of whole mitochondria. This may be relevant for their ability to rescue cell bioenergetics. The differential oxidative metabolism of pretermvs. term exosomes sheds new light on the preterm newborn's clinical vulnerability. A reduced ability to repair damaged tissue and an increased capability to cope with anoxic environment for preterm infants can be envisaged.-Panfoli, I., Ravera, S., Podesta, M., Cossu, C., Santucci, L., Bartolucci, M., Bruschi, M., Calzia, D., Sabatini, F., Bruschettini, M., Ramenghi, L. A., Romantsik, O., Marimpietri, D., Pistoia, V., Ghiggeri, G., Frassoni, F., Candiano, G. Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants. FASEB J. 30, 1416-1424 (2016). www.fasebj.org	[Panfoli, Isabella; Bartolucci, Martina; Calzia, Daniela] Univ Genoa, Dipartimento Farm, Lab Biochim, Genoa, Italy; [Ravera, Silvia; Podesta, Marina; Cossu, Claudia; Sabatini, Federica; Frassoni, Francesco] Ist Giannina Gaslini, Lab Cellule Staminali Postnatali & Terapie Cellul, I-16148 Genoa, Italy; [Santucci, Laura; Bruschi, Maurizio; Ghiggeri, Gianmarco; Candiano, Giovanni] Ist Giannina Gaslini, Lab Pathophysiol Uremia, I-16148 Genoa, Italy; [Bruschettini, Matteo; Ramenghi, Luca Antonio; Romantsik, Olga] Ist Giannina Gaslini, Neonatal Intens Care Unit, I-16148 Genoa, Italy; [Marimpietri, Danilo; Pistoia, Vito] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy; [Bruschettini, Matteo; Romantsik, Olga] Lund Univ, Inst Clin Sci, Lund, Sweden	University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Lund University	Ravera, S (corresponding author), Ist Giannina Gaslini, UOC Lab Cellule Staminali Postnatali & Terapie Ce, Via Gerolamo Gaslini 5, I-16147 Genoa, Italy.	silvia.ravera@gmail.com	Ghiggeri, Gian Marco/N-4712-2015; Candiano, Giovanni/J-9357-2018; matteo, bruschettini/J-6030-2019; Frassoni, Francesco/K-3971-2018; Ravera, Silvia/AAA-7982-2019; Bartolucci, Martina/AAA-6582-2019; Marimpietri, Danilo/AAA-7283-2020; Podestà, Marina/K-3875-2016; Sabatini, Federica/J-5984-2016; Bruschi, Maurizio/E-7090-2016; Ramenghi, Luca/AAB-4067-2020; Panfoli, Isabella/X-1247-2019; Marimpietri, Danilo/J-5975-2016	Ghiggeri, Gian Marco/0000-0003-3659-9062; Candiano, Giovanni/0000-0002-7385-2787; matteo, bruschettini/0000-0002-4775-872X; Frassoni, Francesco/0000-0003-1262-0648; Ravera, Silvia/0000-0002-0803-1042; Bartolucci, Martina/0000-0001-5289-4219; Marimpietri, Danilo/0000-0001-6360-1661; Podestà, Marina/0000-0002-6755-613X; Sabatini, Federica/0000-0003-2271-2597; Bruschi, Maurizio/0000-0001-6036-1500; Ramenghi, Luca/0000-0003-0065-762X; Panfoli, Isabella/0000-0002-6261-1128; santucci, laura/0000-0003-2516-7889; Romantsik, Olga/0000-0003-1414-9386	Cinque per mille e Ricerca Corrente, Ministero della Salute, to Istituto Giannina Gaslini; Compagnia di San Paolo [2014AAI637.U/812/AR pv 2013.0958]; Associazione Italiana per la Ricerca sul Cancro [IG 13013]; Renal Child Foundation	Cinque per mille e Ricerca Corrente, Ministero della Salute, to Istituto Giannina Gaslini; Compagnia di San Paolo(Compagnia di San Paolo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Renal Child Foundation	This work was supported by funds from Cinque per mille e Ricerca Corrente, Ministero della Salute, to Istituto Giannina Gaslini; a Compagnia di San Paolo grant (2014AAI637.U/812/AR pv 2013.0958 to F.F); an Associazione Italiana per la Ricerca sul Cancro grant (IG 13013 to V.P); and funds from the Renal Child Foundation.	Almgren M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.014; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bruschi M, 2003, PROTEOMICS, V3, P821, DOI 10.1002/pmic.200300361; Bruschi M, 2015, EXPERT REV PROTEOMIC, V12, P425, DOI 10.1586/14789450.2015.1055324; Burnstock G, 2015, PURINERG SIGNAL, V11, P277, DOI 10.1007/s11302-015-9452-9; Capelli C, 2011, CYTOTHERAPY, V13, P786, DOI 10.3109/14653249.2011.563294; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lai RC, 2015, SEMIN CELL DEV BIOL, V40, P82, DOI 10.1016/j.semcdb.2015.03.001; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Panfoli I, 2011, EXPERT REV PROTEOMIC, V8, P231, DOI [10.1586/EPR.11.1, 10.1586/epr.11.1]; Panfoli I, 2009, INT J BIOCHEM CELL B, V41, P2555, DOI 10.1016/j.biocel.2009.08.013; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Ravera S, 2013, BIOCHIMIE, V95, P1991, DOI 10.1016/j.biochi.2013.07.003; Ravera S, 2013, J NEUROCHEM, V126, P82, DOI 10.1111/jnc.12253; Ravera S, 2011, CELL MOL NEUROBIOL, V31, P313, DOI 10.1007/s10571-010-9624-7; Ravera S, 2009, INT J BIOCHEM CELL B, V41, P1581, DOI 10.1016/j.biocel.2009.01.009; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142	43	55	57	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1416	1424		10.1096/fj.15-279679	http://dx.doi.org/10.1096/fj.15-279679			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26655706				2022-12-28	WOS:000372629100005
J	Hams, E; Bermingham, R; Wurlod, FA; Hogan, AE; O'Shea, D; Preston, RJ; Rodewald, HR; McKenzie, ANJ; Fallon, PG				Hams, Emily; Bermingham, Rachel; Wurlod, Felicity A.; Hogan, Andrew E.; O'Shea, Donal; Preston, Roger J.; Rodewald, Hans-Reimer; McKenzie, Andrew N. J.; Fallon, Padraic G.			The helminth T2 RNase omega 1 promotes metabolic homeostasis in an IL-33-and group 2 innate lymphoid cell-dependent mechanism	FASEB JOURNAL			English	Article						obesity; adipocytes; inflammation	ADIPOSE-TISSUE INFLAMMATION; SCHISTOSOMA-MANSONI EGGS; TH2 POLARIZATION; CUTTING EDGE; TYPE-2; MACROPHAGES; GLYCOPROTEIN; RIBONUCLEASE; EOSINOPHILS; OBESITY	Induction of a type 2 cellular response in the white adipose tissue leads to weight loss and improves glucose homeostasis in obese animals. Injection of obese mice with recombinant helminth-derived Schistosoma mansoni egg-derived v1 (v1), a potent inducer of type 2 activation, improves metabolic status involving a mechanism reliant upon release of the type 2 initiator cytokine IL-33. IL-33 initiates the accumulation of group 2 innate lymphoid cells (ILC2s), eosinophils, and alternatively activated macrophages in the adipose tissue. IL-33 release from cells in the adipose tissue is mediated by the RNase activity of v1; however, the ability of v1 to improve metabolic status is reliant upon effective binding of v1 to CD206. We demonstrate a novel mechanism for RNase-mediated release of IL-33 inducing ILC2-dependent improvements in the metabolic status of obese animals.	[Hams, Emily; Bermingham, Rachel; Wurlod, Felicity A.; Fallon, Padraic G.] Trinity Coll Dublin, Sch Med, Trinity Biomed Sci Inst, Dublin, Ireland; [Hams, Emily; Wurlod, Felicity A.; Preston, Roger J.; Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Hogan, Andrew E.; O'Shea, Donal] Univ Coll Dublin, St Vincents Univ Hosp, Obes Immunol Educ & Res Ctr, Dublin 2, Ireland; [Hogan, Andrew E.; O'Shea, Donal] St Vincents Univ Hosp, Dept Endocrinol, Dublin 4, Ireland; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany; [McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); MRC Laboratory Molecular Biology	Fallon, PG (corresponding author), Trinity Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland.	pfallon@tcd.ie		Preston, Roger/0000-0003-0108-4077; Hams, Emily/0000-0002-9745-3246; Hogan, Andrew/0000-0001-5875-230X	Science Foundation Ireland; National Children's Research Centre; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Children's Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Science Foundation Ireland and the National Children's Research Centre.	Abdulla MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001368; Bando JK, 2013, J LEUKOCYTE BIOL, V94, P877, DOI 10.1189/jlb.0213084; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; DUNNE DW, 1981, T ROY SOC TROP MED H, V75, P54, DOI 10.1016/0035-9203(81)90013-4; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fitzsimmons CM, 2005, MOL BIOCHEM PARASIT, V144, P123, DOI 10.1016/j.molbiopara.2005.08.003; Garcia-Ortega L, 2005, FEBS J, V272, P2536, DOI 10.1111/j.1742-4658.2005.04674.x; Hamilton JV, 1999, PARASITOLOGY, V118, P83, DOI 10.1017/S0031182098003461; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Han JM, 2015, J IMMUNOL, V194, P4777, DOI 10.4049/jimmunol.1500020; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mirchandani AS, 2012, TRENDS IMMUNOL, V33, P389, DOI 10.1016/j.it.2012.04.005; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Smith Philip, 2009, V517, P401, DOI 10.1007/978-1-59745-541-1_24; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	36	52	54	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					824	835		10.1096/fj.15-277822	http://dx.doi.org/10.1096/fj.15-277822			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26490658	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000369391900031
J	Latchney, SE; Jiang, YD; Petrik, DP; Eisch, AJ; Hsieh, J				Latchney, Sarah E.; Jiang, Yindi; Petrik, David P.; Eisch, Amelia J.; Hsieh, Jenny			Inducible knockout of Mef2a, -c, and -d from nestin-expressing stem/progenitor cells and their progeny unexpectedly uncouples neurogenesis and dendritogenesis in vivo	FASEB JOURNAL			English	Article						hippocampus; dentate gyrus; transcription factor; transgenic mouse; doublecortin	ENHANCER FACTOR 2C; TRANSCRIPTION FACTOR; ADULT NEUROGENESIS; STRUCTURAL PLASTICITY; NEURONAL-ACTIVITY; GENE-EXPRESSION; SITE; MATURATION; SYNAPSES; PROMOTER	Myocyte enhancer factor (Mef)-2 transcription factors are implicated in activity-dependent neuronal processes during development, but the role of MEF2 in neural stem/progenitor cells (NSPCs) in the adult brain is unknown. We used a transgenic mouse in which Mef2a, -c, and -d were inducibly deleted in adult nestin-expressing NSPCs and their progeny. Recombined cells in the hippocampal granule cell layer were visualized and quantified by yellow fluorescent protein (YFP) expression. In control mice, postmitotic neurons expressed Mef2a, -c, and -d, whereas type 1 stem cells and proliferating progenitors did not. Based on this expression, we hypothesized that Mef2a, -c, and -d deletion in adult nestin-expressing NSPCs and their progeny would result in fewer mature neurons. Control mice revealed an increase in YFP+ neurons and dendrite formation over time. Contrary to our hypothesis, inducible Mef2 KO mice also displayed an increase in YFP+ neurons over time-but with significantly stunted dendrites-suggesting an uncoupling of neuron survival and dendritogenesis. We also found non-cell-autonomous effects after Mef2a, -c, and -d deletion. These in vivo findings indicate a surprising functional role for Mef2a, -c, and -d in cell-and non-cell-autonomous control of adult hippocampal neurogenesis that is distinct from its role during development.	[Latchney, Sarah E.; Petrik, David P.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Jiang, Yindi; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Eisch, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	amelia.eisch@utsouthwestern.edu; jenny.hsieh@utsouthwestern.edu	Latchney, Sarah/AAQ-2957-2021; Latchney, Sarah/M-4740-2019	Latchney, Sarah/0000-0002-4070-1165; Eisch, Amelia/0000-0001-6476-5385; Petrik, David/0000-0003-3026-0770	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse [016765, 023555]; NIH National Institute of Mental Health [107945]; U.S. National Aeronautics and Space Administration [NNX12AB55G, NNX15AE09G]; NIH National Institute on Aging [032383, 041815]; NIH National Institute of Neurological Disorders and Stroke [076775, 038572, 081203]; Welch Foundation [I-1660]; Texas Institute for Brain Injury and Repair; NIH National Institute on Drug Abuse [T32DA00722]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG041815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016765, K02DA023555, T32DA007290] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Welch Foundation(The Welch Foundation); Texas Institute for Brain Injury and Repair; NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Dr. E. Olson (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing the Mef2a<SUP>f/f</SUP>, Mef2c<SUP>f/f</SUP>, and Mef2d<SUP>f/f</SUP> mice. This work was funded by grants from the U.S. National Institutes of Health (NIH) National Institute on Drug Abuse (016765, 023555), the NIH National Institute of Mental Health (107945), the U.S. National Aeronautics and Space Administration (NNX12AB55G, NNX15AE09G) (all to A.J.E.), and grants from the NIH National Institute on Aging (032383, 041815), the NIH National Institute of Neurological Disorders and Stroke (076775, 038572, 081203), the Welch Foundation (I-1660), and the Texas Institute for Brain Injury and Repair (all to J.H.). S.E.L. was supported by an institutional training grant from NIH National Institute on Drug Abuse (T32DA00722; Principle Investigator, A.J.E.).	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Akhtar MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034863; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Barkis WB, 2010, P NATL ACAD SCI USA, V107, P22302, DOI 10.1073/pnas.1008775108; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Kannangara TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103155; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kessels MM, 2011, EUR J CELL BIOL, V90, P926, DOI 10.1016/j.ejcb.2010.08.011; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Korets-Smith E, 2004, GENESIS, V40, P131, DOI 10.1002/gene.20074; Krainc D, 1998, J BIOL CHEM, V273, P26218, DOI 10.1074/jbc.273.40.26218; Krebs J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00106, 10.3389/fnins.2011.00107]; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ninkovic J, 2013, BIOESSAYS, V35, P242, DOI 10.1002/bies.201200108; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Simo S, 2012, GENE DEV, V26, P1653, DOI 10.1101/gad.199034.112; Song J, 2013, NAT NEUROSCI, V16, P1728, DOI 10.1038/nn.3572; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yau SY, 2014, CELL TRANSPLANT, V23, P471, DOI 10.3727/096368914X678283; Yau SY, 2011, CELL TRANSPLANT, V20, P99, DOI 10.3727/096368910X532846; Zang T, 2013, MOL CELL NEUROSCI, V56, P39, DOI 10.1016/j.mcn.2013.03.002	58	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5059	5071		10.1096/fj.15-275651	http://dx.doi.org/10.1096/fj.15-275651			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26286136	Green Published			2022-12-28	WOS:000365523600029
J	Xi, G; Shen, XC; Wai, C; Vilas, CK; Clemmons, DR				Xi, Gang; Shen, Xinchun; Wai, Christine; Vilas, Caroline K.; Clemmons, David R.			Hyperglycemia stimulates p62/PKC zeta interaction, which mediates NF-kappa B activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle	FASEB JOURNAL			English	Article						PDK1; p65 rel; diabetes; TNF-alpha; IGF-I	PROTEIN-KINASE-C; PKC-ZETA; HIGH GLUCOSE; SRC ACTIVATION; NADPH OXIDASE; DYSFUNCTION; RECEPTOR; BINDING; PHOSPHORYLATION; ASSOCIATION	Hyperglycemia leads to vascular smooth muscle cell (VSMC) dedifferentiation and enhances responses to IGF-I. Prior studies showed that hyperglycemia stimulated NADPH oxidase 4 (Nox4) synthesis, and IGF-I facilitated its recruitment to a signaling complex where it oxidized src, leading to AKT and MAPK activation. To determine the mechanism that led to these changes, we analyzed the roles of p62 (sequestrosome1) and PKC zeta. Hyperglycemia induced a 4.9 +/- 1.0-fold increase in p62/PKC zeta association, and disruption of PKC zeta/p62 using a peptide inhibitor or p62 knockdown reduced PKC zeta activation (786 +/- 6%). 3-Phosphoinoside-dependent protein kinase 1 was also recruited to the p62 complex and directly phosphorylated PKC zeta, leading to its activation (3.1 +/- 0.4-fold). Subsequently, activated PKC zeta phosphorylated p65 rel, which led to increased Nox4 synthesis. Studies in diabetic mice confirmed these findings (6.0 +/- 0.4-fold increase in p62/PKC zeta) and their disruption of attenuated Nox4 synthesis (7669% reduction). PKC zeta/p62 activation stimulated inflammatory cytokine production and enhanced IGF-I-stimulated VSMC proliferation. These results define the molecular mechanism by which PKC zeta is activated in response to hyperglycemia and suggest that this could be a mechanism by which other stimuli such as cytokines or metabolic stress function to stimulate NF-kappa B activation, thereby altering VSMC sensitivity to IGF-I.	[Xi, Gang; Wai, Christine; Vilas, Caroline K.; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Shen, Xinchun] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing University of Finance & Economics	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu		Vilas, Caroline/0000-0002-8080-3035	U.S. National Institutes of Health [AG-02331]; National Natural Science Foundation of China [31271983]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG002331, R01AG002331] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ms. Laura Lindsey (University of North Carolina, Chapel Hill) for her help in preparing the manuscript. This work was supported by a grant (AG-02331) from the U.S. National Institutes of Health. D.R.C. is a guarantor of this manuscript. X.S. was supported by a grant from the National Natural Science Foundation of China (No. 31271983). G.X. contributed to research design, performed the experiments, and wrote/edited the manuscript. X.S., C.W., and C.K.V. performed the experiments. D.R.C. wrote and edited the manuscript, and contributed to research design and discussion of the results. The authors declare no conflicts of interest.	Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Huang CL, 2014, LAB INVEST, V94, P309, DOI 10.1038/labinvest.2014.2; Huang HC, 2009, MOL CARCINOGEN, V48, P517, DOI 10.1002/mc.20490; Kai M, 2009, FEBS LETT, V583, P3265, DOI 10.1016/j.febslet.2009.09.017; Kim GY, 2012, ARTERIOSCL THROM VAS, V32, P2974, DOI 10.1161/ATVBAHA.112.300054; Kwan J, 2005, KIDNEY INT, V68, P2526, DOI 10.1111/j.1523-1755.2005.00660.x; Lan TH, 2013, CARDIOVASC PATHOL, V22, P401, DOI 10.1016/j.carpath.2013.01.003; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Li H, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/265895; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000476; McManus Stephen, 2012, J Mol Signal, V7, P1, DOI 10.1186/1750-2187-7-1; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Radhakrishnan Y, 2010, J BIOL CHEM, V285, P15682, DOI 10.1074/jbc.M109.092270; Ren J, 2014, SCI CHINA LIFE SCI, V57, P69, DOI 10.1007/s11427-013-4592-z; Shen XC, 2010, J BIOL CHEM, V285, P29416, DOI 10.1074/jbc.M110.155325; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Sugimoto R, 2010, J CELL MOL MED, V14, P1546, DOI 10.1111/j.1582-4934.2009.00914.x; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Wedgwood S, 2013, ANTIOXID REDOX SIGN, V18, P1765, DOI 10.1089/ars.2012.4766; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2013, J BIOL CHEM, V288, P15641, DOI 10.1074/jbc.M113.456046; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Zhang LY, 2012, INT J BIOCHEM CELL B, V44, P629, DOI 10.1016/j.biocel.2012.01.001; Zhang MA, 2011, ARTERIOSCL THROM VAS, V31, P125, DOI 10.1161/ATVBAHA.110.207712; Zhang P, 2005, EMBO REP, V6, P531, DOI 10.1038/sj.embor.7400433	40	23	24	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4772	4782		10.1096/fj.15-275453	http://dx.doi.org/10.1096/fj.15-275453			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26231202	Green Published			2022-12-28	WOS:000365523600005
J	Yu, X; Guan, PP; Guo, JW; Wang, Y; Cao, LL; Xu, GB; Konstantopoulos, K; Wang, ZY; Wang, P				Yu, Xin; Guan, Pei-Pei; Guo, Jing-Wen; Wang, Yue; Cao, Long-Long; Xu, Guo-Biao; Konstantopoulos, Konstantinos; Wang, Zhan-You; Wang, Pu			By suppressing the expression of anterior pharynx-defective-1 alpha and-1 beta and inhibiting the aggregation of beta-amyloid protein, magnesium ions inhibit the cognitive decline of amyloid precursor protein/presenilin 1 transgenic mice	FASEB JOURNAL			English	Article						ERK1/2; magnesium-L-threonate; PPAR gamma; cerebrospinal fluid; Alzheimer's disease	DISEASE MOUSE MODEL; ALZHEIMERS-DISEASE; BRAIN MAGNESIUM; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; CHONDROCYTES; IMPAIRMENT; CORTEX; NEUROINFLAMMATION; ELEVATION	Alzheimer's disease (AD) is associated with a magnesium ion (Mg2+) deficit in the serum or brain. However, the mechanisms regulating the roles of Mg2+ in the pathologic condition of AD remain unknown. We studied whether brain Mg2+ can decrease beta-amyloid (Ab) deposition and ameliorate the cognitive decline in a model of AD, the APPswe/PS1DE9 transgenic (Tg) mouse. We used a recently developed compound, magnesium-L-threonate (MgT), for a treatment that resulted in enhanced clearance of Ab in an anterior pharynx-defective (APH)-1 alpha/-1 beta-dependent manner. To further explore how MgT treatment inhibits cognitive decline in APP/PS1 Tg mice, the critical molecules for amyloid precursor protein (APP) cleavage and signaling pathways were investigated. In neurons, ERK1/2 and PPAR gamma signaling pathways were activated by MgT treatment, which in turn suppressed (by >80%) the expression of APH-1 alpha/-1 beta, which is responsible for the deposition of Ab and potentially contributes to the memory deficit that occurs in AD. More important, A beta oligomers in the cerebrospinal fluid (CSF) further promoted the expression of APH-1 alpha/-1 beta (by >2.5-fold), which enhances the gamma-cleavage of APP and Ab deposition during AD progression. These findings provide new insights into the mechanisms of AD progression and are instrumental for developing better strategies to combat the disease.	[Yu, Xin; Guan, Pei-Pei; Guo, Jing-Wen; Wang, Yue; Cao, Long-Long; Xu, Guo-Biao; Wang, Zhan-You; Wang, Pu] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110819, Peoples R China; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD USA	Northeastern University - China; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wang, P (corresponding author), Northeastern Univ, Coll Life & Hlth Sci, 3-11 Wenhua Rd, Shenyang 110819, Peoples R China.	wangzy@mail.neu.edu.cn; wangpu@mail.neu.edu.cn		Wang, Zhan-You/0000-0003-0807-9916	Natural Science Foundation of China [31300777, 31371091]; Fundamental Research Funds of China [N142004002, N130120002, N141008001/7, N120820001]; Liaoning Provincial Talent Support Program [LJQ2013029]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of China; Liaoning Provincial Talent Support Program	The authors thank Dr. J.-Y. Li for kindly providing brain samples from human donors with AD, and A. C. McCourt for critical reading and linguistic revision of the manuscript. This work was supported in part or in whole by Grants 31300777 and 31371091 from the Natural Science Foundation of China; Grants N142004002, N130120002, N141008001/7, and N120820001 from the Fundamental Research Funds of China; and Grant LJQ2013029 from the Liaoning Provincial Talent Support Program. The authors declare no conflicts of interest.	Abumaria N, 2011, J NEUROSCI, V31, P14871, DOI 10.1523/JNEUROSCI.3782-11.2011; Andrasi E, 2005, J ALZHEIMERS DIS, V7, P273; de Oliveira LDB, 2011, ARQ NEURO-PSIQUIAT, V69, P349, DOI 10.1590/S0004-282X2011000300016; Cheng B, 2014, MICROB PATHOGENESIS, V69-70, P1, DOI 10.1016/j.micpath.2014.03.001; Cilliler AE, 2007, GERONTOLOGY, V53, P419, DOI 10.1159/000110873; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; Corsonello A, 2001, MAGNESIUM RES, V14, P273; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; EHMANN WD, 1986, NEUROTOXICOLOGY, V7, P197; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; Huang CY, 2010, CHINESE J PHYSIOL, V53, P299, DOI 10.4077/CJP.2010.AMK063; Ikari A, 2010, LIFE SCI, V86, P766, DOI 10.1016/j.lfs.2010.03.016; Kummer MP, 2015, MOL NEUROBIOL, V51, P661, DOI 10.1007/s12035-014-8743-4; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li ST, 2000, NEUROSCI LETT, V283, P141, DOI 10.1016/S0304-3940(00)00938-1; Li W, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0065-y; Lin XL, 2014, DNA CELL BIOL, V33, P514, DOI 10.1089/dna.2013.2290; Liu L, 2004, NEUROBIOL DIS, V17, P516, DOI 10.1016/j.nbd.2004.08.005; Lopez-Gonzalez I, 2015, J NEUROPATH EXP NEUR, V74, P319, DOI 10.1097/NEN.0000000000000176; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Mo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116802; Morales-Corraliza J, 2013, NEUROBIOL AGING, V34, P137, DOI 10.1016/j.neurobiolaging.2012.04.007; Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Prakash A, 2014, NEUROTOX RES, V25, P335, DOI 10.1007/s12640-013-9437-9; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; SQUADRITO F, 1990, JPN J PHARMACOL, V53, P495, DOI 10.1254/jjp.53.495; Wang P, 2013, FASEB J, V27, P4664, DOI 10.1096/fj.13-234542; Wang P, 2012, J BIOL CHEM, V287, P31877, DOI 10.1074/jbc.M112.362731; Wang P, 2011, FASEB J, V25, P3401, DOI 10.1096/fj.11-184861; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wang X, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-46; Xu SJ, 2014, J ALZHEIMERS DIS, V39, P239, DOI 10.3233/JAD-130680; Xu ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108645; Yaksh TL, 1999, SPINAL DRUG DELIVERY, P216	40	22	23	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5044	5058		10.1096/fj.15-275578	http://dx.doi.org/10.1096/fj.15-275578			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26293690				2022-12-28	WOS:000365523600028
J	Burtey, A; Wagner, M; Hodneland, E; Skaftnesmo, KO; Schoelermann, J; Mondragon, IR; Espedal, H; Golebiewska, A; Niclou, SP; Bjerkvig, R; Kogel, T; Gerdes, HH				Burtey, Anne; Wagner, Marek; Hodneland, Erlend; Skaftnesmo, Kai Ove; Schoelermann, Julia; Mondragon, Ivan Rios; Espedal, Heidi; Golebiewska, Anna; Niclou, Simone P.; Bjerkvig, Rolf; Kogel, Tanja; Gerdes, Hans-Hermann			Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes	FASEB JOURNAL			English	Article						cell-cell communication; organelle exchange; tumor microenvironment; endosomes	CANCER-CELLS; SIDE POPULATION; TNT FORMATION; KIDNEY-CELLS; RAB8 GTPASE; STEM-CELL; H-RAS; TRANSPORT; EXOSOMES; COMMUNICATION	Intercellular communication between cancer cells, especially between cancer and stromal cells, plays an important role in disease progression. We examined the intercellular transfer of organelles and proteins in vitro and in vivo and the role of tunneling nanotubes (TNTs) in this process. TNTs are membrane bridges that facilitate intercellular transfer of organelles of unclear origin. Using 3-dimensional quantitative and qualitative confocal microscopy, we showed that TNTs contain green fluorescent protein (GFP)-early endosome antigen (EEA) 1, GFP Rab5, GFP Rab11, GFP Rab8, transferrin (Tf), and Tf receptor (Tf-R) fused to mCherry (Tf-RmCherry). Tf-RmCherry was transferred between cancer cells by a contact-dependent but secretion-independent mechanism. Live cell imaging showed TNT formation preceding the transfer of Tf-RmCherry and involving the function of the small guanosine triphosphatase (GTPase) Rab8, which colocalized with Tf-RmCherry in the TNTs and was cotransferred to acceptor cells. Tf-RmCherry was transferred from cancer cells to fibroblasts, a noteworthy finding that suggests that this process occurs between tumor and stromal cells in vivo. We strengthened this hypothesis in a xenograft model of breast cancer using enhanced (e) GFP-expressing mice. Tf-RmCherry transferred from tumor to stromal cells and this process correlated with an increased opposite transfer of eGFP from stromal to tumor cells, together pointing toward complex intercellular communication at the tumor site.	[Burtey, Anne; Wagner, Marek; Skaftnesmo, Kai Ove; Schoelermann, Julia; Mondragon, Ivan Rios; Espedal, Heidi; Bjerkvig, Rolf; Kogel, Tanja; Gerdes, Hans-Hermann] Univ Bergen, Dept Biomed, Bergen, Norway; [Schoelermann, Julia] Univ Bergen, Biomat, Dept Clin Dent, Bergen, Norway; [Niclou, Simone P.; Bjerkvig, Rolf] Univ Bergen, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway; [Wagner, Marek] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Hodneland, Erlend] Haukeland Hosp, Dept Clin Med, N-5021 Bergen, Norway; [Golebiewska, Anna; Niclou, Simone P.; Bjerkvig, Rolf] Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, Luxembourg, Luxembourg	University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Luxembourg Institute of Health	Burtey, A (corresponding author), Univ Oslo, Sect Biochem & Mol Biol, Dept Biosci, Blindernveien 31, N-0371 Oslo, Norway.	a.p.burtey@ibv.uio.no	Golebiewska, Anna/E-1332-2015; Skaftnesmo, kai ove/AAF-6071-2021; Wagner, Marek/AAV-9589-2020; Niclou, Simone/P-2304-2018; Schoelermann, Julia/J-1593-2014; Espedal, Heidi/ABE-1829-2020	Golebiewska, Anna/0000-0002-4160-2521; Niclou, Simone/0000-0002-3417-9534; Schoelermann, Julia/0000-0001-5911-9688; Espedal, Heidi/0000-0002-0190-8999; Kogel, Tanja/0000-0002-3507-3395; Burtey, Anne/0000-0003-4548-8807; Wagner, Marek/0000-0003-3967-9527	Marie Sklodowska-Curie Individual European Fellowship FP7 TNTFUNCTION [209404]; MarieCurie Alumni Association [204921/F20, 102244]; Norwegian Research Council [642251]; Western Norway Regional Health Authority [303385, 911532, 911574, 911623]	Marie Sklodowska-Curie Individual European Fellowship FP7 TNTFUNCTION; MarieCurie Alumni Association; Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority	The authors thank Dr. A. Benmerah and Prof. I. F. Pryme for critical reading of the manuscript. Imaging was performed at the Molecular Imaging Center, University of Bergen. A.B. was supported by a Marie Sklodowska-Curie Individual European Fellowship FP7 TNTFUNCTION (project 209404). This work was supported by a Micro Media grant from the MarieCurie Alumni Association (to A.B.); Grants 204921/F20, project 102244 (to T.K.) and 642251 (to I.R.M.) from The Norwegian Research Council; and Grants 303385 (to T.K.), 911532 (to M.W. and R.B.), and 911574 and 911623 (to H.-H.G.) from the Western Norway Regional Health Authority.	Ady JW, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00400; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Benmerah A, 1999, J CELL SCI, V112, P1303; Bloemendal S, 2013, NATURWISSENSCHAFTEN, V100, P3, DOI 10.1007/s00114-012-0988-z; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Golebiewska A, 2013, BRAIN, V136, P1462, DOI 10.1093/brain/awt025; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Gousset K, 2013, J CELL SCI, V126, P4424, DOI 10.1242/jcs.129239; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kadiu I, 2011, J PROTEOME RES, V10, P3225, DOI 10.1021/pr200262q; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; Kucharzewska P., 2013, J EXTRACELL VESICLES, V5, P2; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt Bjorn, 2005, Sci STKE, V2005, ppe55, DOI 10.1126/stke.3132005pe55; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rainy N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.245; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rechavi O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001204; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SHIH YJ, 1990, J BIOL CHEM, V265, P19077; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stieber D, 2014, ACTA NEUROPATHOL, V127, P203, DOI 10.1007/s00401-013-1196-4; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Vidulescu C, 2004, J CELL MOL MED, V8, P388, DOI 10.1111/j.1582-4934.2004.tb00328.x	46	36	38	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4695	4712		10.1096/fj.14-268615	http://dx.doi.org/10.1096/fj.14-268615			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26220176				2022-12-28	WOS:000364514700026
J	Wotring, VE				Wotring, Virginia E.			Medication use by US crewmembers on the International Space Station	FASEB JOURNAL			English	Article						spaceflight; microgravity; pharmaceutical; astronaut; medicine	ASTRONAUTS; SLEEP; SPACEFLIGHT; HEADACHE; VIRUS	The environment on the International Space Station (ISS) includes a variety of potential physiologic stressors, including low gravity, elevated exposure to radiation, confined living and working quarters, a heavy workload, and high public visibility. This retrospective study examined medication use during long-duration spaceflights (>30 d). Medication records from 24 crewmembers on 20 missions longer than 30 d over a 10 yr period were examined for trends in usage rates, efficacy, and indication, as well as adverse event quality, frequency, and severity. Results were compared with those from crewmembers on shorter space shuttle missions (>16 d) and other reports of medication use by healthy adults. The most frequently used medications on the ISS were for sleep problems, pain, congestion, or allergy. Medication use during spaceflight missions was similar to that noted on the Space Shuttle and in adult ambulatory medicine, except that usage of sleep aids was about 10 times higher during spaceflight missions. There were also 2 apparent treatment failures in cases of skin rash, raising questions about the efficacy or suitability of the treatments used. Many spaceflight-related medication uses (at least 10%) were linked to extravehicular activities, exercise protocols, or equipment and operationally driven schedule changes. It seems likely that alterations in spaceflight mission operations (schedule-shifting and lighting) or hardware (extravehicular activity suits and exercise equipment) could reduce the need for a sizable fraction of medication uses.	[Wotring, Virginia E.] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA	Universities Space Research Association (USRA)	Wotring, VE (corresponding author), Baylor Coll Med, Ctr Space Med, 6500 Main St,Suite 910, Houston, TX 77030 USA.	virginia.wotring@bcm.edu		Wotring, Virginia/0000-0002-3391-3899	Human Research Program of the U.S. National Aeronautics and Space Administration (NASA)	Human Research Program of the U.S. National Aeronautics and Space Administration (NASA)	The author thanks the staff of the Johnson Space Center Lifetime Surveillance of Astronaut Health, especially J. Charvat, for supplying deidentified data for research purposes, P. Norsk for helpful discussions, J. Krauhs for manuscript editing, and K. So for library services. This study was funded by the Human Research Program of the U.S. National Aeronautics and Space Administration (NASA).	Barger LK, 2014, LANCET NEUROL, V13, P904, DOI 10.1016/S1474-4422(14)70122-X; BRUNNER LJ, 1995, J PHARMACOL EXP THER, V274, P345; Buckey JC, 2006, SPACE PHYSL; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Clement G, 2003, FUNDAMENTALS SPACE M; Crucian B., 2009, RISK CREW ADVERSE HL; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Cucinotta FA, 2008, RADIAT RES, V170, P127, DOI 10.1667/RR1330.1; CZEISLER CA, 1991, EXP GERONTOL, V26, P217, DOI 10.1016/0531-5565(91)90014-D; DAVIS JR, 1988, AVIAT SPACE ENVIR MD, V59, P1185; DeMers G., 2009, ASSESSMENT HEADACHE; French DP, 2008, PHARM WORLD SCI, V30, P79, DOI 10.1007/s11096-007-9146-7; GRAYBIEL A, 1976, AVIAT SPACE ENVIR MD, V47, P873; Hargens AR, 2009, RESP PHYSIOL NEUROBI, V169, pS30, DOI 10.1016/j.resp.2009.07.005; Hargens AR, 1996, MED SCI SPORT EXER, V28, P977, DOI 10.1097/00005768-199608000-00007; Horn WG, 2003, AVIAT SPACE ENVIR MD, V74, P858; James J., 2011, 41 INT C ENV SYST; Jan MH, 2002, UNDERSEA HYPERBAR M, V29, P294; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kelly TH, 2005, J EXP ANAL BEHAV, V84, P227, DOI 10.1901/jeab.2005.77-04; Margel D, 2003, CHEST, V124, P1716, DOI 10.1378/chest.124.5.1716; Martelletti P, 2007, J HEADACHE PAIN, V8, P149, DOI 10.1007/s10194-007-0382-y; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Ortega H., 2019, PRINCIPLES CLIN MED, P221, DOI [10.1007/978-0-387-68164-1_10, DOI 10.1007/978-0-387-68164-1_10]; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Platts S., 2010, RISK CARDIAC RHYTHM; Putcha L, 1999, AVIAT SPACE ENVIR MD, V70, P705; Scheuring RA, 2009, AVIAT SPACE ENVIR MD, V80, P117, DOI 10.3357/ASEM.2270.2009; Steiner TJ, 2007, J HEADACHE PAIN, V8, pS3; Strauss S, 2005, AVIAT SPACE ENVIR MD, V76, P469; WING PC, 1991, ORTHOP CLIN N AM, V22, P255	32	44	47	3	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4417	4423		10.1096/fj.14-264838	http://dx.doi.org/10.1096/fj.14-264838			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26187345	Green Submitted			2022-12-28	WOS:000364514700003
J	Kesler, CT; Pereira, ER; Cui, CH; Nelson, GM; Masuck, DJ; Baish, JW; Padera, TP				Kesler, Cristina T.; Pereira, Ethel R.; Cui, Cheryl H.; Nelson, Gregory M.; Masuck, David J.; Baish, James W.; Padera, Timothy P.			Angiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation	FASEB JOURNAL			English	Article						endothelial; TIE2; lymphangiography; 2-photon microscopy	ENDOTHELIAL GROWTH-FACTOR; INTERSTITIAL FLUID PRESSURE; VEGF-D PROMOTES; FACTOR-C; BREAST-CANCER; IN-VIVO; TUMOR LYMPHANGIOGENESIS; CELL-CELL; ANGIOGENESIS; METASTASIS	The angiopoietin (Ang) ligands are potential therapeutic targets for lymphatic related diseases, which include lymphedema and cancer. Ang-1 and Ang-2 functions are established, but those of Ang-4 are poorly understood. We used intravital fluorescence microscopy to characterize Ang-4 actions on T241 murine fibrosarcoma-associated vessels in mice. The diameters of lymphatic vessels draining Ang-4- or VEGF-C (positive control)expressing tumors increased to 123 and 135 mu m, respectively, and parental, mock-transduced (negative controls) and tumors expressing Ang-1 or Ang-2 remained at baseline (similar to 60 mu m). Ang-4 decreased human dermal lymphatic endothelial cell (LEC) monolayer permeability by 27% while increasing human dermal blood endothelial cell (BEC) monolayer permeability by 200%. In vivo, Ang-4 stimulated a 4.5-fold increase in tumor-associated blood vessel permeability compared with control when measured using intravital quantitative multiphoton microscopy. Ang-4 activated receptor signaling in both LECs and BECs, evidenced by tyrosine kinase with Ig and endothelial growth factor homology domains-2 (TIE2) receptor, protein kinase B, and Erk1,2 phosphorylation detectable by immunoblotting. These data suggest that Ang-4 actions are mediated through cell-type-specific networks and that lymphatic vessel dilation occurs secondarily to increased vascular leakage. Ang-4 also promoted survival of LECs. Thus, blocking Ang-4 may prune the draining lymphatic vasculature and decrease interstitial fluid pressure (IFP) by reducing vascular permeability.	[Kesler, Cristina T.; Pereira, Ethel R.; Cui, Cheryl H.; Masuck, David J.; Padera, Timothy P.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin Steele Lab Tumor Biol, Boston, MA 02114 USA; [Nelson, Gregory M.] Brigham Young Univ, Harold B Lee Lib, Provo, UT 84602 USA; [Baish, James W.] Bucknell Univ, Dept Biomed Engn, Lewisburg, PA 17837 USA	Harvard University; Massachusetts General Hospital; Brigham Young University; Bucknell University	Padera, TP (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Cox 7,100 Blossom St, Boston, MA 02114 USA.	tpadera@steele.mgh.harvard.edu	Nelson, Gregory M./H-6315-2011; Padera, Timothy/R-2982-2019	Nelson, Gregory M./0000-0002-8382-910X; Padera, Timothy/0000-0002-3453-9384; Pereira, Ethel/0000-0003-0562-4536	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant [R00CA137167]; NIH Office of the Director Grant [DP2OD008780]; NCI Federal Share/Massachusetts General Hospital Proton Beam Income Grant [C06 CA059267]; NATIONAL CANCER INSTITUTE [R00CA137167, C06CA059267] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008780] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant; NIH Office of the Director Grant; NCI Federal Share/Massachusetts General Hospital Proton Beam Income Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant R00CA137167 (to T.P.P.), NIH Office of the Director Grant DP2OD008780 (to T.P.P.), and NCI Federal Share/Massachusetts General Hospital Proton Beam Income Grant C06 CA059267 (to T.P.P.). The authors thank Dr. Dai Fukumura, Dr. Jay Loeffler, Dr. Rakesh Jain, Dr. Vikash Chuahan, Julia Kahn, Anna Khachatryan, and members of the Edwin L. Steele Laboratories for support, technical assistance, and helpful discussions.	Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G; Andersen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019773; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Chae SS, 2010, CLIN CANCER RES, V16, P3618, DOI 10.1158/1078-0432.CCR-09-3073; Currie MJ, 2001, CLIN CANCER RES, V7, P918; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavrilovskaya IN, 2013, J VIROL, V87, P12999, DOI 10.1128/JVI.02103-13; Goel S, 2013, JNCI-J NATL CANCER I, V105, P1188, DOI 10.1093/jnci/djt164; Hoshida T, 2006, CANCER RES, V66, P8065, DOI 10.1158/0008-5472.CAN-06-1392; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Kadambi A, 2001, CANCER RES, V61, P2404; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Karpanen T, 2001, CANCER RES, V61, P1786; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Kim KE, 2007, ARTERIOSCL THROM VAS, V27, P564, DOI 10.1161/01.ATV.0000256458.82320.be; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; LEUNIG M, 1992, CANCER RES, V52, P487; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lund EL, 2004, INT J CANCER, V108, P833, DOI 10.1002/ijc.11662; Lyu TJ, 2013, EPIGENETICS-US, V8, P1330, DOI 10.4161/epi.26675; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Olsen MWB, 2006, NEOPLASIA, V8, P364, DOI 10.1593/neo.06127; Padera TP, 2002, MOL IMAGING, V1, P9, DOI 10.1162/153535002753395662; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Peters S, 2007, CYTOKINE, V40, P144, DOI 10.1016/j.cyto.2007.09.001; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Wong SY, 2005, CANCER RES, V65, P9789, DOI 10.1158/0008-5472.CAN-05-0901; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Yao LC, 2012, AM J PATHOL, V180, P2561, DOI 10.1016/j.ajpath.2012.02.019	39	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3668	3677		10.1096/fj.14-268920	http://dx.doi.org/10.1096/fj.14-268920			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25977256	Green Published			2022-12-28	WOS:000359915600006
J	Pourie, G; Martin, N; Bossenmeyer-Pourie, C; Akchiche, N; Gueant-Rodriguez, RM; Geoffroy, A; Jeannesson, E; Chehadeh, SE; Mimoun, K; Brachet, P; Koziel, V; Alberto, JM; Helle, D; Debard, R; Leininger, B; Daval, JL; Gueant, JL				Pourie, Gregory; Martin, Nicolas; Bossenmeyer-Pourie, Carine; Akchiche, Nassila; Gueant-Rodriguez, Rosa Maria; Geoffroy, Andrea; Jeannesson, Elise; Chehadeh, Sarah El Hajj; Mimoun, Khalid; Brachet, Patrick; Koziel, Violette; Alberto, Jean-Marc; Helle, Deborah; Debard, Renee; Leininger, Brigitte; Daval, Jean-Luc; Gueant, Jean-Louis			Folate- and vitamin B-12-deficient diet during gestation and lactation alters cerebellar synapsin expression via impaired influence of estrogen nuclear receptor alpha	FASEB JOURNAL			English	Article						epigenomics; methyl donor; neuroplasticity	METHYL DONOR DEFICIENCY; COGNITIVE IMPAIRMENT; ARGININE METHYLATION; BRAIN-DEVELOPMENT; TRANSCRIPTION; GENE; DIFFERENTIATION; PGC-1-ALPHA; ACTIVATION; PLASTICITY	Deficiency in the methyl donors vitamin B-12 and folate during pregnancy and postnatal life impairs proper brain development. We studied the consequences of this combined deficiency on cerebellum plasticity in offspring from rat mothers subjected to deficient diet during gestation and lactation and in rat neuroprogenitor cells expressing cerebellum markers. The major proteomic change in cerebellum of 21-d-old deprived females was a 2.2-fold lower expression of synapsins, which was confirmed in neuroprogenitors cultivated in the deficient condition. A pathway analysis suggested that these proteomic changes were related to estrogen receptor a (ER-alpha)/Src tyrosine kinase. The influence of impaired ER-alpha pathway was confirmed by abnormal negative geotaxis test at d 19-20 and decreased phsophorylation of synapsins in deprived females treated by ER-alpha antagonist 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy) phenol]-1H-pyrazole dihydrochloride (MPP). This effect was consistent with 2-fold decreased expression and methylation of ER-a and subsequent decreased ER-alpha/PPAR-gamma coactivator 1 alpha (PGC-1 alpha) interaction in deficiency condition. The impaired ER-a pathway led to decreased expression of synapsins through 2-fold decreased EGR-1/Zif-268 transcription factor and to 1.7-fold reduced Src-dependent phosphorylation of synapsins. The treatment of neuroprogenitors with either MPP or PP1 (4-(4'-phenoxyanilino)-6,7-dimethoxyquinazoline, 6,7-dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine, SKI-1, Src-11) Src inhibitor produced similar effects. In conclusion, the deficiency during pregnancy and lactation impairs the expression of synapsins through a deregulation of ER-alpha pathway.	[Pourie, Gregory; Martin, Nicolas; Bossenmeyer-Pourie, Carine; Akchiche, Nassila; Gueant-Rodriguez, Rosa Maria; Geoffroy, Andrea; Jeannesson, Elise; Chehadeh, Sarah El Hajj; Mimoun, Khalid; Koziel, Violette; Alberto, Jean-Marc; Helle, Deborah; Debard, Renee; Leininger, Brigitte; Daval, Jean-Luc; Gueant, Jean-Louis] Nancy Univ, Fac Med, INSERM, Nutr Genet & Environm Exposure U954, F-54500 Vandoeuvre Les Nancy, France; [Pourie, Gregory; Martin, Nicolas; Bossenmeyer-Pourie, Carine; Akchiche, Nassila; Gueant-Rodriguez, Rosa Maria; Geoffroy, Andrea; Jeannesson, Elise; Chehadeh, Sarah El Hajj; Mimoun, Khalid; Koziel, Violette; Alberto, Jean-Marc; Helle, Deborah; Debard, Renee; Leininger, Brigitte; Daval, Jean-Luc; Gueant, Jean-Louis] Nancy Univ, Univ Hosp Ctr, F-54500 Vandoeuvre Les Nancy, France; [Brachet, Patrick] Univ Auvergne, INRA, Ctr Theix, Human Nutr Unit,Unite Mixte Rech 1019, St Genes Champanelle, France; [Gueant, Jean-Louis] Oasi Maria Santissima Inst Res Mental Retardat &, Ist Ricovero & Cura Carattere Sci, Troina, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine; INRAE; Universite Clermont Auvergne (UCA)	Gueant, JL (corresponding author), Nancy Univ, Fac Med, INSERM, Nutr Genet & Environm Exposure U954, F-54500 Vandoeuvre Les Nancy, France.	gregory.pourie@iutnb.uhp-nancy.fr; jean-louis.gueant@univ-lorraine.fr	Bossenmeyer-Pourié, Carine/F-7695-2019; Daval, Jean-Luc/G-6502-2014	Bossenmeyer-Pourié, Carine/0000-0003-3831-4809; 	French National Agency for Research (ANR Nutrivigene project); Region of Lorraine (France)	French National Agency for Research (ANR Nutrivigene project)(French National Research Agency (ANR)); Region of Lorraine (France)(Region Grand-Est)	Institutional grants were received from the French National Agency for Research (ANR Nutrivigene project) and the Region of Lorraine (France).	Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Battaglia-Hsu SF, 2009, P NATL ACAD SCI USA, V106, P21930, DOI 10.1073/pnas.0811794106; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chanson A, 2005, J NUTR, V135, P2524, DOI 10.1093/jn/135.11.2524; Chintala S, 2009, BRAIN RES, V1266, P18, DOI 10.1016/j.brainres.2009.02.035; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; Gueant J. L., 2013, TRENDS ENDOCRINOL ME, V24, P279; Gueant JL, 2014, PFLUG ARCH EUR J PHY, V466, P833, DOI 10.1007/s00424-013-1339-4; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hatanaka Y, 2009, BIOCHEM BIOPH RES CO, V381, P728, DOI 10.1016/j.bbrc.2009.02.130; Hedges VL, 2012, FRONT NEUROENDOCRIN, V33, P403, DOI 10.1016/j.yfrne.2012.08.005; Kerek R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.278; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; McCaddon A, 2013, BIOCHIMIE, V95, P1066, DOI 10.1016/j.biochi.2012.11.017; Messa M, 2010, J CELL SCI, V123, P2256, DOI 10.1242/jcs.068445; Murphy BC, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-115; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Ohtani-Kaneko R, 2010, NEUROSCI RES, V66, P180, DOI 10.1016/j.neures.2009.10.012; Paonessa F, 2013, J BIOL CHEM, V288, P3227, DOI 10.1074/jbc.M112.399782; PETERSOHN D, 1995, J BIOL CHEM, V270, P24361, DOI 10.1074/jbc.270.41.24361; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; Suarez I, 2004, DEV NEUROSCI-BASEL, V26, P45, DOI 10.1159/000080711; Tang BQ, 2010, NUTRITION, V26, P1170, DOI 10.1016/j.nut.2009.10.006; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Teyssier C, 2010, TRENDS ENDOCRIN MET, V21, P181, DOI 10.1016/j.tem.2009.11.002; THIEL G, 1994, J BIOL CHEM, V269, P15294; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Wessler S, 2006, J STEROID BIOCHEM, V98, P25, DOI 10.1016/j.jsbmb.2005.08.003; Zeisel SH, 2012, ANN NUTR METAB, V60, P19, DOI 10.1159/000337310	45	22	22	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3713	3725		10.1096/fj.14-264267	http://dx.doi.org/10.1096/fj.14-264267			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018677				2022-12-28	WOS:000359915600010
J	Li, J; Yu, Q; Ahooghalandari, P; Gribble, FM; Reimann, F; Tengholm, A; Gylfe, E				Li, Jia; Yu, Qian; Ahooghalandari, Parvin; Gribble, Fiona M.; Reimann, Frank; Tengholm, Anders; Gylfe, Erik			Submembrane ATP and Ca2+ kinetics in alpha-cells: unexpected signaling for glucagon secretion	FASEB JOURNAL			English	Article						oscillations; islet of Langerhans; signal transduction; paracrine	BETA-CELLS; PULSATILE INSULIN; SOMATOSTATIN RECEPTOR; CYTOPLASMIC CA2+; INTACT ISLETS; DELTA-CELLS; GLUCOSE; OSCILLATIONS; RELEASE; CHANNELS	Cytoplasmic ATP and Ca2+ are implicated in current models of glucose's control of glucagon and insulin secretion from pancreatic alpha- and beta-cells, respectively, but little is known about ATP and its relation to Ca2+ in alpha-cells. We therefore expressed the fluorescent ATP biosensor Perceval in mouse pancreatic islets and loaded them with a Ca2+ indicator. With total internal reflection fluorescence microscopy, we recorded subplasma membrane concentrations of Ca2+ and ATP ([Ca2+](pm); [ATP](pm)) in superficial alpha- and beta-cells of intact islets and related signaling to glucagon and insulin secretion by immunoassay. Consistent with ATP's controlling glucagon and insulin secretion during hypo- and hyperglycemia, respectively, the dose-response relationship for glucoseinduced [ATP](pm) generation was left shifted in alpha-cells compared to beta-cells. Both cell types showed [Ca2+](pm) and [ATP](pm) oscillations in opposite phase, probably reflecting energy-consuming Ca2+ transport. Although pulsatile insulin and glucagon release are in opposite phase, [Ca2+](pm) synchronized in the same phase between alpha- and beta-cells. This paradox can be explained by the overriding of Ca2+ stimulation by paracrine inhibition, because somatostatin receptor blockade potently stimulated glucagon release with little effect on Ca2+. The data indicate that an alpha-cell-intrinsic mechanism controls glucagon in hypoglycemia and that paracrine factors shape pulsatile secretion in hyperglycemia.	[Li, Jia; Yu, Qian; Ahooghalandari, Parvin; Tengholm, Anders; Gylfe, Erik] Uppsala Univ, Dept Med Cell Biol, SE-75123 Uppsala, Sweden; [Gribble, Fiona M.; Reimann, Frank] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England	Uppsala University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gylfe, E (corresponding author), Uppsala Univ, Dept Med Cell Biol, BMC Box 571, SE-75123 Uppsala, Sweden.	erik.gylfe@mcb.uu.se		Gribble, Fiona/0000-0002-4232-2898; YU, QIAN/0000-0003-4888-9446; Reimann, Frank/0000-0001-9399-6377	European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Novo Nordisk Foundation; Swedish Diabetes Association; Swedish Research Council [67X-14643, 67P-21262, 325-2012-6778, 12X-6240]; MRC [MC_UU_12012/3] Funding Source: UKRI; Medical Research Council [MC_UU_12012/3] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010363] Funding Source: researchfish; European Foundation for the Study of Diabetes [MSD 2014_2] Funding Source: researchfish	European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	The authors thank Dr. Limin Yang for implementing the MATLAB routine for asymmetric sliding-filament cross-correlation and Dr. Oleg Dyachok for advice regarding the implementation. This work was supported by grants from the European Foundation for the Study of Diabetes/MSD, the Family Ernfors Foundation, the Novo Nordisk Foundation, the Swedish Diabetes Association and Grants 67X-14643, 67P-21262, 325-2012-6778, and 12X-6240 from the Swedish Research Council.	Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Backer A., ASYMMETRIC SLIDING W; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Bavamian S, 2007, DIABETES OBES METAB, V9, P118, DOI 10.1111/j.1463-1326.2007.00780.x; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bode HP, 1999, PFLUG ARCH EUR J PHY, V437, P324, DOI 10.1007/s004240050786; Braun M, 2014, VITAM HORM, V95, P165, DOI 10.1016/B978-0-12-800174-5.00007-7; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; GOODNER CJ, 1977, SCIENCE, V195, P177, DOI 10.1126/science.401543; GOODNER CJ, 1988, DIABETES, V37, P1316, DOI 10.2337/diabetes.37.10.1316; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; Gylfe E, 2014, DIABETES RES CLIN PR, V103, P1, DOI 10.1016/j.diabres.2013.11.019; Hellman B, 2012, BIOCHEM BIOPH RES CO, V417, P1219, DOI 10.1016/j.bbrc.2011.12.113; Hellman B, 2009, ENDOCRINOLOGY, V150, P5334, DOI 10.1210/en.2009-0600; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kailey B, 2012, AM J PHYSIOL-ENDOC M, V303, pE1107, DOI 10.1152/ajpendo.00207.2012; KLAFF LJ, 1987, DIABETES, V36, P592, DOI 10.2337/diabetes.36.5.592; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; Le Marchand SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047084; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Leclerc I, 2011, DIABETOLOGIA, V54, P125, DOI 10.1007/s00125-010-1929-z; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; MATTHEWS DR, 1987, BIOCHEM SOC T, V15, P1021, DOI 10.1042/bst0151021; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; OSTENSON CG, 1979, DIABETOLOGIA, V17, P325, DOI 10.1007/BF01235889; Parker HE, 2012, DIABETOLOGIA, V55, P2445, DOI 10.1007/s00125-012-2585-2; Ramracheya R, 2010, DIABETES, V59, P2198, DOI 10.2337/db09-1505; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rohrer S, 2012, J CLIN ENDOCR METAB, V97, pE791, DOI 10.1210/jc.2011-3439; Rui CX, 2013, DIABETES, V62, P1612, DOI 10.2337/db12-0347; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014	53	47	49	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3379	3388		10.1096/fj.14-265918	http://dx.doi.org/10.1096/fj.14-265918			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911612	Green Published			2022-12-28	WOS:000358796900025
J	Strandgren, C; Nasser, HA; McKenna, T; Koskela, A; Tuukkanen, J; Ohlsson, C; Rozell, B; Eriksson, M				Strandgren, Charlotte; Nasser, Hasina Abdul; McKenna, Tomas; Koskela, Antti; Tuukkanen, Juha; Ohlsson, Claes; Rozell, Bjorn; Eriksson, Maria			Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects	FASEB JOURNAL			English	Article						lamin A/C; nuclear lamina; osteoblasts; premature aging; osteocytes	MOUSE MODEL; FARNESYLTRANSFERASE INHIBITOR; LAMIN-A; NUCLEAR ABNORMALITIES; GENE-EXPRESSION; DISEASE; LEADS; FARNESYLATION; PROGRESSION; PREVENTS	Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder that is most commonly caused by a de novo point mutation in exon 11 of the LMNA gene, c.1824C>T, which results in an increased production of a truncated form of lamin A known as progerin. In this study, we used a mouse model to study the possibility of recovering from HGPS bone disease upon silencing of the HGPS mutation, and the potential benefits from treatment with resveratrol. We show that complete silencing of the transgenic expression of progerin normalized bone morphology and mineralization already after 7 weeks. The improvements included lower frequencies of rib fractures and callus formation, an increased number of osteocytes in remodeled bone, and normalized dentinogenesis. The beneficial effects from resveratrol treatment were less significant and to a large extent similar to mice treated with sucrose alone. However, the reversal of the dental phenotype of overgrown and laterally displaced lower incisors in HGPS mice could be attributed to resveratrol. Our results indicate that the HGPS bone defects were reversible upon suppressed transgenic expression and suggest that treatments targeting aberrant progerin splicing give hope to patients who are affected by HGPS.	[Strandgren, Charlotte; Nasser, Hasina Abdul; McKenna, Tomas; Eriksson, Maria] Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Rozell, Bjorn] Karolinska Inst, Dept Lab Med, S-14183 Huddinge, Sweden; [Koskela, Antti; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Rozell, Bjorn] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; University of Oulu; University of Gothenburg; University of Copenhagen	Eriksson, M (corresponding author), Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.	maria.eriksson.2@ki.se	Ohlsson, Claes/HIR-6959-2022; Tuukkanen, Juha/R-3728-2018; Ohlsson, Claes/AGP-3544-2022	Ohlsson, Claes/0000-0002-9633-2805; Tuukkanen, Juha/0000-0002-1723-6461; Ohlsson, Claes/0000-0002-9633-2805; Koskela, Antti/0000-0001-7371-2488	Swedish Research Council; Progeria Research Foundation; Karolinska Institutet; Novo Nordisk Fonden [NNF14OC0010513, NNF13OC0005785] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Progeria Research Foundation; Karolinska Institutet(Karolinska Institutet); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Raoul Kuiper for pathology advisement, Asa-Lena Dackland for fluorescence-activated cell sorting analysis, Per Larshammar and Robin Chatterjee for technical consultation on droplet digital PCR, and Eva Schmidt for technical assistance. This study was supported by the Swedish Research Council, The Progeria Research Foundation, and Karolinska Institutet. This study was in part performed at the Live Cell Imaging Unit, Department of Biosciences and Nutrition, Karolinska Institutet.	Baek JH, 2015, HUM MOL GENET, V24, P1305, DOI 10.1093/hmg/ddu541; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; COADY JM, 1967, J DENT RES, V46, P384, DOI 10.1177/00220345670460021201; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Finley J, 2014, MED HYPOTHESES, V83, P580, DOI 10.1016/j.mehy.2014.08.016; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; GALL G A E, 1968, Theoretical and Applied Genetics, V38, P304, DOI 10.1007/BF01297571; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Gordon CM, 2011, J BONE MINER RES, V26, P1670, DOI 10.1002/jbmr.392; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Karimian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067859; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mansour A, 2012, J EXP MED, V209, P537, DOI 10.1084/jem.20110994; McKenna T, 2014, AGING CELL, V13, P292, DOI 10.1111/acel.12173; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Sagelius H, 2008, J MED GENET, V45, P794, DOI 10.1136/jmg.2008.060772; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt E, 2012, J BIOL CHEM, V287, P33512, DOI 10.1074/jbc.M112.366450; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Zegarelli EV, 1944, AM J PATHOL, V20, P23; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	39	19	19	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3193	3205		10.1096/fj.14-269217	http://dx.doi.org/10.1096/fj.14-269217			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25877214				2022-12-28	WOS:000358796900009
J	Ahmad, T; Sundar, IK; Lerner, CA; Gerloff, J; Tormos, AM; Yao, HW; Rahman, I				Ahmad, Tanveer; Sundar, Isaac K.; Lerner, Chad A.; Gerloff, Janice; Tormos, Ana M.; Yao, Hongwei; Rahman, Irfan			Impaired mitophagy leads to cigarette smoke stress-induced cellular senescence: implications for chronic obstructive pulmonary disease	FASEB JOURNAL			English	Article						Parkin; Pink1; reactive oxygen species; perinuclear mitochondrial clustering; DNA damage	MITOCHONDRIAL DYSFUNCTION; OXIDATIVE DAMAGE; SIRT1 PROTECTS; DNA-DAMAGE; PARKIN; PINK1; CELLS; PROMOTES; ROS; FRAGMENTATION	Cigarette smoke (CS)-induced cellular senescence is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). The molecular mechanism by which CS induces cellular senescence is unknown. Here, we show that CS stress (exposure of primary lung cells to CS extract 0.2-0.75% with a halfmaximal inhibitory concentration of similar to 0.5%) led to impaired mitophagy and perinuclear accumulation of damaged mitochondria associated with cellular senescence in both human lung fibroblasts and small airway epithelial cells (SAECs). Impaired mitophagy was attributed to reduced Parkin translocation to damaged mitochondria, which was due to CS-induced cytoplasmic p53 accumulation and its interaction with Parkin. Impaired Parkin translocation to damaged mitochondria was also observed in mouse lungs with emphysema (6 months CS exposure, 100 mg TPM/m(3)) as well as in lungs of chronic smokers and patients with COPD. Primary SAECs from patients with COPD also exhibited impaired mitophagy and increased cellular senescence via suborganellar signaling. Mitochondria-targeted antioxidant (Mito-Tempo) restored impaired mitophagy, decreased mitochondrial mass accumulation, and delayed cellular senescence in Parkin-overexpressing cells. In conclusion, defective mitophagy leads to CS stress-induced lung cellular senescence, and restoring mitophagy delays cellular senescence, which provides a promising therapeutic intervention in chronic airway diseases.	[Ahmad, Tanveer; Sundar, Isaac K.; Lerner, Chad A.; Gerloff, Janice; Tormos, Ana M.; Yao, Hongwei; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA	University of Rochester	Yao, HW (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	hongwei_yao@urmc.rochester.edu; irfan_rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012; Yao, Hongwei/G-6444-2010	Sundar, Isaac K/0000-0001-6742-3460; Ahmad, Tanveer/0000-0002-8384-5273; Yao, Hongwei/0000-0003-0948-0111	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [2R01HL085613, 1R01HL092842]; American Lung Association [RG-266456-N, RG-305393]; NIH National Institute of Environmental Health Sciences [P30-ES01247]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092842, R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Christian Sell for providing the WI-38 cells expressing microtubule-associated protein light-chain 3-green fluorescent protein. They also thank Dr. Thomas L. Schwarz from the Department of Neuroscience, Harvard Medical School (Boston, MA, USA), for providing the yellow fluorescent protein-Parkin, mCherry-Parkin, and FLAG-Pink1 constructs. The authors thank the late Dr. Vuokko L. Kinnula for providing the human tissue samples from smokers and patients with chronic obstructive pulmonary disease, which were previously used in our published studies. This study was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants 2R01HL085613 and 1R01HL092842 (to I.R.), American Lung Association Grants RG-266456-N (to H.Y.) and RG-305393 (to I.K.S.), and NIH National Institute of Environmental Health Sciences Grant P30-ES01247. T.A. contributed to the experiment design, data analysis, and manuscript writing. T.A., I.K.S., C.L., J.G., H.Y., and A.M.T. performed the experiments. H.Y. analyzed the data and participated in manuscript writing/editing. I.R. contributed significantly to the experimental design and manuscript writing/editing. The authors declare no conflicts of interest.	Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Aravamudan B, 2014, AM J PHYSIOL-LUNG C, V306, pL840, DOI 10.1152/ajplung.00155.2013; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Ballweg K, 2014, AM J PHYSIOL-LUNG C, V307, pL895, DOI 10.1152/ajplung.00180.2014; Bernhardt D, 2015, SCI REP-UK, V5, DOI 10.1038/srep07885; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463; Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC; Davis CHO, 2014, AUTOPHAGY, V10, P2383, DOI 10.4161/15548627.2014.981920; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guo LL, 2012, BBA-MOL BASIS DIS, V1822, P852, DOI 10.1016/j.bbadis.2012.02.004; Hackett TL, 2014, AM J RESP CELL MOL, V51, P830, DOI 10.1165/rcmb.2013-0369OC; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; Hara H, 2013, AM J PHYSIOL-LUNG C, V305, pL737, DOI 10.1152/ajplung.00146.2013; Hara H, 2012, AM J RESP CELL MOL, V46, P306, DOI 10.1165/rcmb.2011-0214OC; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Jia LH, 2007, INVEST OPHTH VIS SCI, V48, P339, DOI 10.1167/iovs.06-0248; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Morse D, 2014, ANNU REV PHYSIOL, V76, P493, DOI 10.1146/annurev-physiol-021113-170411; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Narendra DP, 2013, HUM MOL GENET, V22, P2572, DOI 10.1093/hmg/ddt106; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nyunoya T, 2014, AM J RESP CELL MOL, V50, P471, DOI 10.1165/rcmb.2013-0348TR; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11; Samara KD, 2011, PULM MED, V2011, DOI 10.1155/2011/461439; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Trainor C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043326; Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wu J, 2013, CLIN CANCER RES, V19, P721, DOI 10.1158/1078-0432.CCR-12-2529; Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612; Yao HW, 2014, AM J PHYSIOL-LUNG C, V306, pL816, DOI 10.1152/ajplung.00323.2013; Yao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080007; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2010, J BIOL CHEM, V285, P5405, DOI 10.1074/jbc.M109.041418; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	60	152	154	5	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2912	2929		10.1096/fj.14-268276	http://dx.doi.org/10.1096/fj.14-268276			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25792665	Green Published			2022-12-28	WOS:000356859100021
J	Salama, MF; Carroll, B; Adada, M; Pulkoski-Gross, M; Hannun, YA; Obeid, LM				Salama, Mohamed F.; Carroll, Brittany; Adada, Mohamad; Pulkoski-Gross, Michael; Hannun, Yusuf A.; Obeid, Lina M.			A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma	FASEB JOURNAL			English	Article						sphingosine 1-phosphate; S1P receptor; focal adhesion kinase; HIF-2	FOCAL ADHESION KINASE; TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTOR; SMALL-MOLECULE INHIBITOR; BREAST-CANCER; COLON-CANCER; SPHINGOLIPID METABOLISM; ENDOTHELIAL-CELLS; 1-PHOSPHATE; GROWTH	Sphingosine kinase 1 (SK1), the enzyme responsible for sphingosine 1-phosphate (S1P) production, is overexpressed in many human solid tumors. However, its role in clear cell renal cell carcinoma (ccRCC) has not been described previously. ccRCC cases are usually associated with mutations in vonHippel-Lindau (VHL) and subsequent normoxic stabilization of hypoxia-inducible factor (HIF). We previously showed that HIF-2 alpha up-regulates SK1 expression during hypoxia in glioma cells. Therefore, we hypothesized that the stabilized HIF in ccRCC cells will be associated with increased SK1 expression. Here, we demonstrate that SK1 is overexpressed in 786-0 renal carcinoma cells lacking functional VHL, with concomitant high S1P levels that appear to be HIF-2 alpha mediated. Moreover, examining the TCGA RNA seq database shows that SK1 expression was similar to 2.7-fold higher in solid tumor tissue from ccRCC patients, and this was associated with less survival. Knockdown of SK1 in 786-0 ccRCC cells had no effect on cell proliferation. On the other hand, this knockdown resulted in an similar to 3.5-fold decrease in invasion, less phosphorylation of focal adhesion kinase (FAK), and an similar to 2-fold decrease in angiogenesis. Moreover, S1P treatment of SK1 knockdown cells resulted in phosphorylation of FAK and invasion, and this was mediated by S1P receptor 2. These results suggest that higher SK1 and S1P levels in VHL-defective ccRCC could induce invasion in an autocrine manner and angiogenesis in a paracrine manner. Accordingly, targeting SK1 could reduce both the invasion and angiogenesis of ccRCC and therefore improve the survival rate of patients.	[Salama, Mohamed F.; Carroll, Brittany; Adada, Mohamad; Pulkoski-Gross, Michael; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Salama, Mohamed F.; Carroll, Brittany; Adada, Mohamad; Pulkoski-Gross, Michael; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Salama, Mohamed F.] Mansoura Univ, Dept Biochem, Fac Vet Med, Mansoura, Egypt; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Egyptian Knowledge Bank (EKB); Mansoura University	Obeid, LM (corresponding author), SUNY Stony Brook, Dept Med, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Salama, Mohamed F/C-9010-2017; Salama, Mohamed/S-3493-2019	Salama, Mohamed F/0000-0002-0002-9108; Salama, Mohamed/0000-0002-0002-9108; Pulkoski-Gross, Michael/0000-0003-4644-1795; Adada, Mohamad/0000-0002-2988-2081	Science and Technology Development Fund, Egypt; U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [GM062887]; NIH National Cancer Institute [P01CA097132, F31CA186547-01]; NIH NIGMS [T32 GM007518]; NATIONAL CANCER INSTITUTE [P01CA097132, F31CA186547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518, R01GM062887] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	Science and Technology Development Fund, Egypt(Science and Technology Development Fund (STDF)); U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank the Science and Technology Development Fund, Egypt, for providing travel funding for M.F.S. The authors thank Dr. Jizu Zhi (Department of Pathology, Health Sciences Center, Stony Brook Medicine, Stony Brook, NY, USA) for help with TCGA RNA seq database analysis and Dr. Masayuki Wada and Dr. Jean-Phillip Truman (Stony Brook Medicine) for valuable help and discussions. The authors also thank Dr. Leah Siskind (University of Louisville School of Medicine, Louisville, KY, USA) for providing shRNA plasmids used for production of lentiviral particles. This work was supported by a U.S. Veterans Affairs Merit Award (to L.M.O.), U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grant GM062887 (to L.M.O.), NIH National Cancer Institute Grants P01CA097132 (to L.M.O. and Y.A.H.) and F31CA186547-01 (to B.L.C.), and NIH NIGMS Training Grant T32 GM007518 (M.P.G.). Lipid analyses were provided by the Lipidomics Core Facility at Stony Brook University.	Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Aust S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-67; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Cingolani F, 2014, J LIPID RES, V55, P1711, DOI 10.1194/jlr.M049759; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Facchinetti MM, 2010, CELLS TISSUES ORGANS, V192, P314, DOI 10.1159/000318173; French KJ, 2003, CANCER RES, V63, P5962; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Gandy KAO, 2013, BBA-MOL CELL BIOL L, V1831, P157, DOI 10.1016/j.bbalip.2012.07.002; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao HF, 2009, WORLD J GASTROENTERO, V15, P5916, DOI 10.3748/wjg.15.5916; Hao HF, 2009, ONCOL REP, V22, P973, DOI 10.3892/or_00000524; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim S, 2011, ANTICANCER RES, V31, P3767; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu SQ, 2013, INT J ONCOL, V42, P617, DOI 10.3892/ijo.2012.1733; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Megison ML, 2014, MOL CANCER RES, V12, P514, DOI 10.1158/1541-7786.MCR-13-0505; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2011, ANTI-CANCER AGENT ME, V11, P799; Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Schraml P, 2002, J PATHOL, V196, P186, DOI 10.1002/path.1034; Schwock J, 2010, EXPERT OPIN THER TAR, V14, P77, DOI 10.1517/14728220903460340; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Tamashiro PM, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0076-x; Tolan D, 1999, CELL SIGNAL, V11, P349, DOI 10.1016/S0898-6568(99)00005-4; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wattenberg Binks W, 2010, World J Biol Chem, V1, P362, DOI 10.4331/wjbc.v1.i12.362; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002; Zhuge Yong-hua, 2011, Zhonghua Yi Xue Za Zhi, V91, P2765; Zimmer M, 2004, MOL CANCER RES, V2, P89	65	36	36	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2803	2813		10.1096/fj.15-270413	http://dx.doi.org/10.1096/fj.15-270413			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805832	Green Published			2022-12-28	WOS:000356859100012
J	Patrick, RP; Ames, BN				Patrick, Rhonda P.; Ames, Bruce N.			Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior	FASEB JOURNAL			English	Review						eicosapentaenoic acid; docahexaenoic acid; mental illness	ACUTE TRYPTOPHAN DEPLETION; ESSENTIAL FATTY-ACIDS; DEFICIT HYPERACTIVITY DISORDER; MESSENGER-RNA EXPRESSION; CEREBROSPINAL-FLUID; PREPULSE INHIBITION; BRAIN-SEROTONIN; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; SUICIDE ATTEMPTS	Serotonin regulates a wide variety of brain functions and behaviors. Here, we synthesize previous findings that serotonin regulates executive function, sensory gating, and social behavior and that attention deficit hyperactivity disorder, bipolar disorder, schizophrenia, and impulsive behavior all share in common defects in these functions. It has remained unclear why supplementation with omega-3 fatty acids and vitamin D improve cognitive function and behavior in these brain disorders. Here, we propose mechanisms by which serotonin synthesis, release, and function in the brain are modulated by vitamin D and the 2 marine omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Brain serotonin is synthesized from tryptophan by tryptophan hydroxylase 2, which is transcriptionally activated by vitamin D hormone. Inadequate levels of vitamin D (similar to 70% of the population) and omega-3 fatty acids are common, suggesting that brain serotonin synthesis is not optimal. We propose mechanisms by which EPA increases serotonin release from presynaptic neurons by reducing E-2 series prostaglandins and DHA influences serotonin receptor action by increasing cell membrane fluidity in postsynaptic neurons. We propose a model whereby insufficient levels of vitamin D, EPA, or DHA, in combination with genetic factors and at key periods during development, would lead to dysfunctional serotonin activation and function and may be one underlying mechanism that contributes to neuropsychiatric disorders and depression. This model suggests that optimizing vitamin D and marine omega-3 fatty acid intake may help prevent and modulate the severity of brain dysfunction.	[Patrick, Rhonda P.; Ames, Bruce N.] Childrens Hosp Oakland, Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Patrick, RP (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 ML King Jr Way, Oakland, CA 94609 USA.	rpatrick@chori.org; bames@chori.org			David and Annette Jorgensen Foundation; Children's Hospital Oakland Research Institute-Ames Supporting Foundation	David and Annette Jorgensen Foundation; Children's Hospital Oakland Research Institute-Ames Supporting Foundation	R.P.P. is grateful for support from the David and Annette Jorgensen Foundation and to the Children's Hospital Oakland Research Institute-Ames Supporting Foundation for the earlier part of this project. The authors thank Henry Wheeler Jr. for generous support of our laboratory. The authors thank Giovanna Ferro-Luzzi Ames, Sam Barondes, Georganne Garfinkel, Mark Haussler, Ron Krauss, Joyce McCann, Daniel Patrick, Margie Profet, and Robert Ryan for comments and suggestions on the manuscript.	aan het Rot M, 2006, J PSYCHIATR NEUROSCI, V31, P253; Abbar M, 2001, MOL PSYCHIATR, V6, P268, DOI 10.1038/sj.mp.4000846; Ahmad A, 2002, PEDIATR NEUROL, V26, P210, DOI 10.1016/S0887-8994(01)00383-6; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amin Z, 2006, NEUROPSYCHOPHARMACOL, V31, P2489, DOI 10.1038/sj.npp.1301114; Amminger GP, 2012, NEUROPSYCHOPHARMACOL, V37, P309, DOI 10.1038/npp.2011.187; Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Angoa-Perez M, 2014, ACS CHEM NEUROSCI, V5, P908, DOI 10.1021/cn500096g; Annweiler C, 2013, MOL NUTR FOOD RES, V57, P267, DOI 10.1002/mnfr.201200418; Appleton KM, 2011, BRIT J NUTR, V105, P1145, DOI 10.1017/S0007114510004861; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; ASBERG M, 1973, CLIN PHARMACOL THER, V14, P277; Bailey RL, 2012, J ACAD NUTR DIET, V112, P657, DOI 10.1016/j.jand.2012.01.026; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Batshaw M.L., 2013, DIAGNOSIS DEV DISABI, V7; Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015; Bellivier F, 1998, ARCH GEN PSYCHIAT, V55, P33, DOI 10.1001/archpsyc.55.1.33; Berg AO, 2010, J CLIN PSYCHIAT, V71, P1598, DOI 10.4088/JCP.09m05299yel; Bethea CL, 2000, BIOL PSYCHIAT, V47, P562, DOI 10.1016/S0006-3223(99)00156-0; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Bloch MH, 2012, MOL PSYCHIATR, V17, P1272, DOI 10.1038/mp.2011.100; Bloom G, 2005, EVOL HUM BEHAV, V26, P301, DOI 10.1016/j.evolhumbehav.2004.10.002; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Bond AJ, 2001, PSYCHOPHARMACOLOGY, V156, P477, DOI 10.1007/s002130100795; Bradbury J, 2011, NUTRIENTS, V3, P529, DOI 10.3390/nu3050529; BROWN GL, 1990, J CLIN PSYCHIAT, V51, P31; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Buydens-Branchey L, 2008, PROG NEURO-PSYCHOPH, V32, P568, DOI 10.1016/j.pnpbp.2007.10.020; Byrdwell WC, 2008, AM J CLIN NUTR, V88, p554S, DOI 10.1093/ajcn/88.2.554S; Byrne JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071593; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Capute A J, 1980, J Dev Behav Pediatr, V1, P66; CARLSSON M, 1985, J NEURAL TRANSM, V63, P297, DOI 10.1007/BF01252033; CARLSSON M, 1988, N-S ARCH PHARMACOL, V338, P345; CARLSSON M, 1988, PROG NEURO-PSYCHOPH, V12, P53, DOI 10.1016/0278-5846(88)90061-9; Chalon S, 1998, J NUTR, V128, P2512, DOI 10.1093/jn/128.12.2512; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chan EJ, 2009, CLEV CLIN J MED, V76, P245, DOI 10.3949/ccjm.76a.08042; Chotai J, 2005, NEUROPSYCHOBIOLOGY, V51, P3, DOI 10.1159/000082849; Chotai J, 2003, PSYCHIAT RES, V119, P99, DOI 10.1016/S0165-1781(03)00112-4; Cichon S, 2008, HUM MOL GENET, V17, P87, DOI 10.1093/hmg/ddm286; CLEARE AJ, 1995, PSYCHOPHARMACOLOGY, V118, P72, DOI 10.1007/BF02245252; Conklin SM, 2007, PSYCHIAT RES, V152, P1, DOI 10.1016/j.psychres.2006.10.006; COOPER SJ, 1992, LANCET, V340, P940, DOI 10.1016/0140-6736(92)92819-2; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Crockett MJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2244, DOI 10.1038/npp.2012.75; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Crockett MJ, 2009, ANN NY ACAD SCI, V1167, P76, DOI 10.1111/j.1749-6632.2009.04506.x; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dayer A, 2014, DIALOGUES CLIN NEURO, V16, P29; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Epperson CN, 2012, PSYCHONEUROENDOCRINO, V37, P372, DOI 10.1016/j.psyneuen.2011.07.007; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Evans J, 2000, PSYCHOL MED, V30, P1327, DOI 10.1017/S0033291799002822; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Faraone SV, 2010, PSYCHIAT CLIN N AM, V33, P159, DOI 10.1016/j.psc.2009.12.004; Fearon P., 2004, SCHIZOPHR RES, V67; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Fikke LT, 2013, HUM PSYCHOPHARM CLIN, V28, P61, DOI 10.1002/hup.2283; Flory JD, 2007, BRIT J PSYCHIAT, V190, P410, DOI 10.1192/bjp.bp.106.027847; Georgieff MK, 2005, PEDIATR RES, V57, p99R, DOI 10.1203/01.PDR.0000160542.69840.0F; GIBBONS JL, 1979, BRAIN RES, V169, P139, DOI 10.1016/0006-8993(79)90380-9; Gilmore JH, 2008, BIOL PSYCHIAT, V64, P1069, DOI 10.1016/j.biopsych.2008.07.031; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Gogos A, 2006, NEUROPSYCHOPHARMACOL, V31, P885, DOI 10.1038/sj.npp.1300933; Gogos A, 2004, J PHARMACOL EXP THER, V309, P267, DOI 10.1124/jpet.103.061432; Goksugur SB, 2014, PEDIATR INT, V56, P515, DOI 10.1111/ped.12286; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Greenberg BD, 2000, AM J MED GENET, V96, P202, DOI 10.1002/(SICI)1096-8628(20000403)96:2<202::AID-AJMG16>3.0.CO;2-J; Greenberg James A, 2008, Rev Obstet Gynecol, V1, P162; Groves NJ, 2013, BEHAV BRAIN RES, V241, P120, DOI 10.1016/j.bbr.2012.12.001; Grudet C, 2014, PSYCHONEUROENDOCRINO, V50, P210, DOI 10.1016/j.psyneuen.2014.08.016; Gunther J, 2010, N-S ARCH PHARMACOL, V381, P21, DOI 10.1007/s00210-009-0478-9; Hallahan B, 2007, BRIT J PSYCHIAT, V190, P118, DOI 10.1192/bjp.bp.106.022707; Hamazaki T, 2008, PROG LIPID RES, V47, P221, DOI 10.1016/j.plipres.2008.02.001; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Heinrichs SC, 2010, MOL NUTR FOOD RES, V54, P447, DOI 10.1002/mnfr.200900201; HERON DS, 1980, P NATL ACAD SCI-BIOL, V77, P7463, DOI 10.1073/pnas.77.12.7463; Hibbeln JR, 1998, BIOL PSYCHIAT, V44, P235, DOI 10.1016/S0006-3223(98)00141-3; Hiroi R, 2011, NEUROSCIENCE, V176, P120, DOI 10.1016/j.neuroscience.2010.12.019; Hiroi R, 2006, BIOL PSYCHIAT, V60, P288, DOI 10.1016/j.biopsych.2005.10.019; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Holstein DH, 2013, PSYCHIAT RES, V205, P117, DOI 10.1016/j.psychres.2012.08.013; Hossein-nezhad A, 2012, CURR OPIN CLIN NUTR, V15, P567, DOI 10.1097/MCO.0b013e3283594978; Hovatta I, 2008, ANN MED, V40, P92, DOI 10.1080/07853890701747096; Huan MM, 2004, BIOL PSYCHIAT, V56, P490, DOI 10.1016/j.biopsych.2004.06.028; Hudson C, 2007, CAN J PHYSIOL PHARM, V85, P928, DOI 10.1139/Y07-082; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Jarvis E., 1998, TRANSCULT PSYCHIATRY, V35, P39, DOI DOI 10.1177/136346159803500102; Javanbakht A, 2006, MED HYPOTHESES, V67, P1173, DOI 10.1016/j.mehy.2006.03.054; Jiang P, 2014, NUTRIENTS, V6, P6048, DOI 10.3390/nu6126048; Jones CR, 1997, NEUROCHEM RES, V22, P663, DOI 10.1023/A:1027341707837; Jovanovic T, 2004, PSYCHOPHYSIOLOGY, V41, P401, DOI 10.1111/1469-8986.2004.00166.x; Kalueff AV, 2006, NEUROSCI RES, V54, P254, DOI 10.1016/j.neures.2005.12.008; Kelly E, 2010, EXPERT REV NEUROTHER, V10, P1045, DOI [10.1586/ern.10.81, 10.1586/ern.10.79, 10.1586/ERN.10.81]; Kennel KA, 2010, MAYO CLIN PROC, V85, P752, DOI 10.4065/mcp.2010.0138; Kiank C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011825; King M, 2005, SOC PSYCH PSYCH EPID, V40, P375, DOI 10.1007/s00127-005-0900-7; Kinney Dennis K, 2009, Schizophr Bull, V35, P582, DOI 10.1093/schbul/sbp023; Kuriyama S, 2002, DEV MED CHILD NEUROL, V44, P284; Lakhan SE, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-2; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lesch KP, 2012, PHILOS T R SOC B, V367, P2426, DOI 10.1098/rstb.2012.0039; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levant Beth, 2011, Depress Res Treat, V2011, P467349, DOI 10.1155/2011/467349; Li N, 2011, AM J PATHOL, V178, P662, DOI 10.1016/j.ajpath.2010.10.028; LIDBERG L, 1985, ACTA PSYCHIAT SCAND, V71, P230, DOI 10.1111/j.1600-0447.1985.tb01279.x; Lijffijt M, 2009, J NEUROPSYCH CLIN N, V21, P328, DOI 10.1176/appi.neuropsych.21.3.328; Lijffijt M, 2009, PSYCHIAT RES, V167, P191, DOI 10.1016/j.psychres.2008.04.001; Lopez VA, 2007, BIOL PSYCHIAT, V61, P181, DOI 10.1016/j.biopsych.2006.03.028; Lukkes JL, 2013, NEUROSCIENCE, V237, P139, DOI 10.1016/j.neuroscience.2013.01.070; M' Bailara K, 2006, PSYCHONEUROENDOCRINO, V31, P407, DOI 10.1016/j.psyneuen.2005.10.001; Mahmood T, 2001, J AFFECT DISORDERS, V66, P1, DOI 10.1016/S0165-0327(00)00226-3; Mann C, 2008, NEUROPSYCHOPHARMACOL, V33, P1653, DOI 10.1038/sj.npp.1301556; Mansbach JM, 2009, PEDIATRICS, V124, P1404, DOI 10.1542/peds.2008-2041; Martins JG, 2012, MOL PSYCHIATR, V17, P1144, DOI 10.1038/mp.2012.25; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 2003, SCHIZOPHR RES, V63, P73, DOI 10.1016/S0920-9964(02)00435-8; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; McNamara RK, 2007, SCHIZOPHR RES, V91, P37, DOI 10.1016/j.schres.2006.11.027; McNamara RK, 2009, J PSYCHIATR RES, V43, P656, DOI 10.1016/j.jpsychires.2008.09.011; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; MEHLMAN PT, 1994, AM J PSYCHIAT, V151, P1485; Mischoulon D, 2011, J CLIN PSYCHIAT, V72, P1574, DOI 10.4088/JCP.11com07463; Miyagawa K, 2011, NEUROSCI RES, V70, P111, DOI 10.1016/j.neures.2011.02.002; MOLINA V, 1987, PHARMACOL BIOCHEM BE, V27, P123, DOI 10.1016/0091-3057(87)90486-2; MORAND C, 1983, BIOL PSYCHIAT, V18, P575; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Moskowitz DS, 2001, NEUROPSYCHOPHARMACOL, V25, P277, DOI 10.1016/S0893-133X(01)00219-6; Mousain-Bosc M, 2006, MAGNESIUM RES, V19, P46; Murri MB, 2013, SCHIZOPHR RES, V150, P235, DOI 10.1016/j.schres.2013.07.017; Nantel-Vivier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020304; National Collaborating Centre for Mental Health, 2006, BIP DIS MAN BIP DIS; National Collaborating Centre for Mental Health, 2010, ANT PERS DIS NIC GUI; NIELSEN DA, 1994, ARCH GEN PSYCHIAT, V51, P34; Olincy A, 2005, AM J PSYCHIAT, V162, P43, DOI 10.1176/appi.ajp.162.1.43; Osipova DV, 2009, J NEUROSCI RES, V87, P1168, DOI 10.1002/jnr.21928; Owens SD, 1999, J NUTR, V129, P2088, DOI 10.1093/jn/129.11.2088; Paila YD, 2010, BIOCHEMISTRY-US, V49, P2389, DOI 10.1021/bi1001536; Parletta N, 2013, J NUTR BIOCHEM, V24, P725, DOI 10.1016/j.jnutbio.2013.01.002; Passamonti L, 2012, BIOL PSYCHIAT, V71, P36, DOI 10.1016/j.biopsych.2011.07.033; Patrick RP, 2014, FASEB J, V28, P2398, DOI 10.1096/fj.13-246546; PecinsThompson M, 1996, J NEUROSCI, V16, P7021; Peet M, 2002, J PSYCHIAT RES, V36, P7, DOI 10.1016/S0022-3956(01)00048-6; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Phillips MA, 2000, J PSYCHOPHARMACOL, V14, P258, DOI 10.1177/026988110001400308; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Placidi GPA, 2001, BIOL PSYCHIAT, V50, P783, DOI 10.1016/S0006-3223(01)01170-2; Pomponi M, 2013, J PSYCHIATR RES, V47, P337, DOI 10.1016/j.jpsychires.2012.11.004; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Rees D, 2006, AM J CLIN NUTR, V83, P331; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Reilly JG, 1997, J PSYCHOPHARMACOL, V11, P381, DOI 10.1177/026988119701100416; RENNER KJ, 1985, EXP BRAIN RES, V58, P198; Retz W, 2004, BEHAV SCI LAW, V22, P415, DOI 10.1002/bsl.589; Robbins TW, 2010, HBK BEHAV NEUROSCI, V21, P415, DOI 10.1016/B978-0-12-374634-4.00025-3; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rogers RD, 2003, NEUROPSYCHOPHARMACOL, V28, P153, DOI 10.1038/sj.npp.1300001; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Rucklidge JJ, 2014, BRIT J PSYCHIAT, V204, P306, DOI 10.1192/bjp.bp.113.132126; Rucklidge JJ, 2014, PROG NEURO-PSYCHOPH, V50, P163, DOI 10.1016/j.pnpbp.2013.12.014; Rujescu D, 2002, MOL PSYCHIATR, V7, P1023, DOI 10.1038/sj.mp.4001128; Rylander M, 2013, J PSYCHIATR PRACT, V19, P296, DOI 10.1097/01.pra.0000432599.24761.c1; Sacher J, 2010, ARCH GEN PSYCHIAT, V67, P468, DOI 10.1001/archgenpsychiatry.2010.32; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sanchez RL, 2005, MOL BRAIN RES, V135, P194, DOI 10.1016/j.molbrainres.2004.12.011; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; SCHLICKER E, 1987, N-S ARCH PHARMACOL, V335, P646, DOI 10.1007/BF00166981; Schmidt CW, 2007, ENVIRON HEALTH PERSP, V115, pA404, DOI 10.1289/ehp.115-a404; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; Seo DJ, 2008, AGGRESS VIOLENT BEH, V13, P383, DOI 10.1016/j.avb.2008.06.003; Sharma V, 2008, BIPOLAR DISORD, V10, P742, DOI 10.1111/j.1399-5618.2008.00606.x; Shelton D, 2009, BEHAV SCI LAW, V27, P787, DOI 10.1002/bsl.889; Sinn N, 2010, NUTRIENTS, V2, P128, DOI 10.3390/nu2020128; Sit D, 2006, J WOMENS HEALTH, V15, P352, DOI 10.1089/jwh.2006.15.352; SJOSTROM R, 1972, EUR J CLIN PHARMACOL, V4, P170, DOI 10.1007/BF00561141; Sorgi PJ, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-16; Stanley B, 2000, AM J PSYCHIAT, V157, P609, DOI 10.1176/appi.ajp.157.4.609; Stevens HE, 2013, PSYCHONEUROENDOCRINO, V38, P509, DOI 10.1016/j.psyneuen.2012.07.011; Su KP, 2014, BIOL PSYCHIAT, V76, P559, DOI 10.1016/j.biopsych.2014.01.008; Su KP, 2010, BIOL PSYCHIAT, V67, P550, DOI 10.1016/j.biopsych.2009.11.005; Sublette ME, 2006, AM J PSYCHIAT, V163, P1100, DOI 10.1176/appi.ajp.163.6.1100; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; Tanaka SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001333; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041575; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040097; Traskman-Bendz L, 1986, Ann N Y Acad Sci, V487, P168, DOI 10.1111/j.1749-6632.1986.tb27896.x; Turner EH, 2006, PHARMACOL THERAPEUT, V109, P325, DOI 10.1016/j.pharmthera.2005.06.004; Turner KM, 2013, BEHAV BRAIN RES, V242, P47, DOI 10.1016/j.bbr.2012.12.029; Ubbenhorst A, 2011, PSYCHOPHARMACOLOGY, V215, P733, DOI 10.1007/s00213-011-2175-x; US Department of Agriculture ARS, 2014, NUTR INT FOOD MEAN A; Van den Bogaert A, 2006, ARCH GEN PSYCHIAT, V63, P1103, DOI 10.1001/archpsyc.63.10.1103; Vancassel S, 2008, J LIPID RES, V49, P340, DOI 10.1194/jlr.M700328-JLR200; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Vedin I, 2010, J LIPID RES, V51, P1179, DOI 10.1194/jlr.M002667; VIRKKUNEN M, 1989, ARCH GEN PSYCHIAT, V46, P600; VOLAVKA J, 1990, BIOL PSYCHIAT, V28, P728, DOI 10.1016/0006-3223(90)90459-F; Vyssoki B, 2014, JAMA PSYCHIAT, V71, P1231, DOI 10.1001/jamapsychiatry.2014.1198; Vyssoki B, 2012, COMPR PSYCHIAT, V53, P535, DOI 10.1016/j.comppsych.2011.06.003; Wang T. T., 2005, MOL ENDOCRINOL, V19, P2685; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Way BM, 2007, NEUROSCIENCE, V148, P937, DOI 10.1016/j.neuroscience.2007.06.038; Wood RM, 2006, NEUROPSYCHOPHARMACOL, V31, P1075, DOI 10.1038/sj.npp.1300932; Yehuda S, 1999, J NEUROSCI RES, V56, P565, DOI 10.1002/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.0.CO;2-H; Young S. N., 2007, INT C SER, V1304, P133; Young SN, 2007, J PSYCHIATR NEUROSCI, V32, P394; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; Zalsman G, 2011, WORLD J BIOL PSYCHIA, V12, P33, DOI 10.3109/15622975.2010.518628; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P43, DOI 10.1002/hup.896; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	227	229	239	13	137	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2207	2222		10.1096/fj.14-268342	http://dx.doi.org/10.1096/fj.14-268342			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713056				2022-12-28	WOS:000355209500001
J	Chen, WM; Li, SS; Li, JW; Zhou, W; Wu, SH; Xu, SM; Cui, K; Zhang, DD; Liu, B				Chen, Weimin; Li, Shanshan; Li, Jinwei; Zhou, Wen; Wu, Shouhai; Xu, Shengmei; Cui, Ke; Zhang, Donna D.; Liu, Bo			Artemisitene activates the Nrf2-dependent antioxidant response and protects against bleomycin-induced lung injury	FASEB JOURNAL			English	Article						Nrf2 activator; Keap1-Nrf2 pathway; oxidative damage	NRF2-KEAP1 SIGNALING PATHWAY; TRANSCRIPTION FACTOR NRF2; CANCER CHEMOPREVENTION; OXIDATIVE STRESS; KEAP1; MECHANISM; FIBROSIS; SYSTEM; LIGASE; MICE	The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is a crucial regulator of the cellular antioxidant response and xenobiotic metabolism. Activation of the Nrf2 signaling pathway has been demonstrated to confer protection against environmental insults and prevent disease or inhibit the progression of diseases related to oxidative stress. In an attempt to identify novel improved Nrf2 inducers for systemic protection against tissue damage by environmental insults, we identified art emisitene as a novel Nrf2 activator using antioxidant responsive element luciferase assay in MDA-MB-231 cells. Further studies suggest that art emisitene activates Nrf2 by decreasing Nrf2 ubiquitination and increasing its stability. In Nrf2 wild-type mice, systemic administration of artemisitene strongly inhibits bleomycin-induced lung damage. Artemisitene represents a novel class of Nrf2 inducer, and artemisitene-based therapeutic approach targeting Nrf2 may also provide antioxidant protection for humans against tissue damage by toxic chemicals.	[Chen, Weimin; Li, Shanshan; Li, Jinwei; Zhou, Wen; Wu, Shouhai; Xu, Shengmei; Cui, Ke; Liu, Bo] Guangdong Prov Acad Chinese Med Sci, Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zhang, Donna D.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ USA; [Liu, Bo] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China	Guangzhou University of Chinese Medicine; University of Arizona; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chen, WM (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Ctr Regenerat & Translat Med, Guangzhou 510006, Guangdong, Peoples R China.; Chen, WM (corresponding author), Guangdong Prov Acad Chinese Med Sci, Guangzhou 510006, Guangdong, Peoples R China.	wmchen8@yahoo.com			National Natural Science Foundation of China [81473294, 81202398]; Chinese Ministry of Science and Technology [2013CB966902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This study is supported by the National Natural Science Foundation of China (Nos. 81473294 and 81202398), and a grant from Chinese Ministry of Science and Technology (2013CB966902). The authors declare no conflicts of interest.	Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Du Y, 2008, ENVIRON HEALTH PERSP, V116, P1154, DOI 10.1289/ehp.11464; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Jiang T, 2014, KIDNEY INT, V85, P333, DOI 10.1038/ki.2013.343; Jiang T, 2009, TOXICOL APPL PHARM, V240, P8, DOI 10.1016/j.taap.2009.06.010; Kilic T, 2014, INFLAMMATION, V37, P1167, DOI 10.1007/s10753-014-9841-1; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Li QK, 2011, J HUM GENET, V56, P230, DOI 10.1038/jhg.2010.172; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Nishinaka T, 2007, TOXICOL LETT, V170, P238, DOI 10.1016/j.toxlet.2007.03.011; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Tao SS, 2013, ANTIOXID REDOX SIGN, V19, P1647, DOI 10.1089/ars.2012.5117; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2014, FREE RADICAL BIO MED, V70, P68, DOI 10.1016/j.freeradbiomed.2014.02.010; Weiskirchen R, 2009, FRONT BIOSCI, V14, P4992, DOI 10.2741/3583; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang DD, 2013, ANTIOXID REDOX SIGN, V19, P517, DOI 10.1089/ars.2012.5118; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807; Zheng Y, 2012, TOXICOL APPL PHARM, V265, P292, DOI 10.1016/j.taap.2012.08.028	39	26	27	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2500	2510		10.1096/fj.201500109R	http://dx.doi.org/10.1096/fj.201500109R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006451				2022-12-28	WOS:000379249500006
J	Goetzl, EJ; Goetzl, L; Karliner, JS; Tang, N; Pulliam, L				Goetzl, Edward J.; Goetzl, Laura; Karliner, Joel S.; Tang, Norina; Pulliam, Lynn			Human plasma platelet-derived exosomes: effects of aspirin	FASEB JOURNAL			English	Article						chemokines; glycoproteins; HMGB1; intercellular communication; atherosclerosis	BLOOD EXOSOMES; MICROPARTICLES; PROTEINS; HMGB1; ATHEROSCLEROSIS; MICROVESICLES; RELEASE; DISEASE; ROLES	Platelet-derived exosomes mediate platelet atherogenic interactions with endothelial cells and monocytes. A new method for isolation of plasma platelet derived exosomes is described and used to examine effects of aging and aspirin on exosome cargo proteins. Exosome secretion by purified platelets in vitro did not increase after exposure to thrombin or collagen, as assessed by exosome counts and quantification of the CD81 exosome marker. Thrombin and collagen increased exosome content of a-granule chemokines CXCL4 and CXCL7 and cytoplasmic high-mobility group box 1 (HMGB1) protein, but not membrane platelet glycoprotein VI (GPVI), with dependence on extracellular calcium. Aspirin consumption significantly blocked thrombin-and collagen-induced increases in exosome cargo levels of chemokines and HMGB1, without altering total exosome secretion or GPVI cargo. Plasma platelet-derived exosomes, enriched by absorption with mouse antihuman CD42b [platelet glycoprotein Ib (GPIb)] mAb, had sizes and cargo protein contents similar to those of exosomes from purified platelets. The plasma platelet-derived exosome number is lower and its chemokine and HMGB1 levels higher after age 65 yr. Aspirin consumption significantly suppressed cargo protein levels of plasma platelet-derived exosomes without altering total levels of exosomes. Cargo proteins of human plasma platelet-derived exosomes may biomark platelet abnormalities and in vivo effects of drugs.-Goetzl, E. J., Goetzl, L., Karliner, J. S., Tang, N., Pulliam, L. Human plasma platelet-derived exosomes: effects of aspirin. www.fasebj.org	[Goetzl, Edward J.; Karliner, Joel S.; Pulliam, Lynn] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Goetzl, Edward J.] Jewish Home San Francisco, San Francisco, CA USA; [Goetzl, Laura] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA; [Karliner, Joel S.; Tang, Norina; Pulliam, Lynn] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Goetzl, EJ (corresponding author), JHSF, Geriatr Res Ctr, 302 Silver Ave, San Francisco, CA 94112 USA.	edward.goetzl@ucsf.edu		Goetzl, Laura/0000-0003-4130-2809	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL129853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129853] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Judith H. Goetzl (Geriatric Research Center, Jewish Home of San Francisco) for expert preparation of the graphic illustrations. These studies were supported, in part, by Grant HL129853 (to L.P.) from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute. E.J.G. has filed a provisional patent application involving the methodology for isolation and analyses of platelet exosomes from plasma, and has also developed the methodology, obtained blood, performed exosome isolations and ELISAs, analyzed data, and drafted the manuscript; L.G. participated in study design and edited the manuscript; J.S.K. participated in study design and edited the manuscript; N.T. performed exosome counts; and L.P. analyzed data and edited the manuscript.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Burnouf T, 2014, BLOOD REV, V28, P155, DOI 10.1016/j.blre.2014.04.002; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huber HJ, 2015, CURR OPIN LIPIDOL, V26, P412, DOI 10.1097/MOL.0000000000000214; KAPLAN KL, 1979, BLOOD, V53, P604; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Lievens D, 2011, THROMB HAEMOSTASIS, V106, P827, DOI 10.1160/TH11-08-0592; Lukasik M, 2013, PLATELETS, V24, P63, DOI 10.3109/09537104.2011.654292; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Vogel S, 2015, J CLIN INVEST, V125, P4638, DOI 10.1172/JCI81660; von Hundelshausen P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00294; Yang XY, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0348-3	19	67	70	3	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2058	2063		10.1096/fj.201500150R	http://dx.doi.org/10.1096/fj.201500150R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26873936	Green Published			2022-12-28	WOS:000374879400031
J	Wilson, C; Saunter, CD; Girkin, JM; McCarron, JG				Wilson, Calum; Saunter, Christopher D.; Girkin, John M.; McCarron, John G.			Clusters of specialized detector cells provide sensitive and high fidelity receptor signaling in the intact endothelium	FASEB JOURNAL			English	Article						endothelial calcium signalling; microendoscopy; gradient index; calcium imaging; endothelial heterogeneity	SMOOTH-MUSCLE; IN-VIVO; DEPENDENT HYPERPOLARIZATION; ELECTRICAL-CONDUCTION; INTRACELLULAR CALCIUM; CAROTID-ARTERY; CA2+ WAVES; CHANNELS; TUBES; ACTIVATION	Agonist-mediated signaling by the endothelium controls virtually all vascular functions. Because of the large diversity of agonists, each with varying concentrations, background noise often obscures individual cellular signals. How the endothelium distinguishes low-level fluctuations from noise and decodes and integrates physiologically relevant information remains unclear. Here, we recorded changes in intracellular Ca2+ concentrations in response to acetylcholine in areas encompassing hundreds of endothelial cells from inside intact pressurized arteries. Individual cells responded to acetylcholine with a concentration-dependent increase in Ca2+ signals spanning a single order of magnitude. Interestingly, however, intercellular response variation extended over 3 orders of magnitude of agonist concentration, thus crucially enhancing the collective bandwidth of endothelial responses to agonists. We also show the accuracy of this collective mode of detection is facilitated by spatially restricted clusters of comparably sensitive cells arising from heterogeneous receptor expression. Simultaneous stimulation of clusters triggered Ca2+ signals that were transmitted to neighboring cells in a manner that scaled with agonist concentration. Thus, the endothelium detects agonists by acting as a distributed sensing system. Specialized clusters of detector cells, analogous to relay nodes in modern communication networks, integrate population wide inputs, and enable robust noise filtering for efficient high-fidelity signaling.-Wilson, C., Saunter, C. D., Girkin, J. M., McCarron, J. G. Clusters of specialized detector cells provide sensitive and high fidelity receptor signaling in the intact endothelium. www.fasebj.org	[Wilson, Calum; McCarron, John G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland; [Saunter, Christopher D.; Girkin, John M.] Univ Durham, Dept Phys, Biophys Sci Inst, Ctr Adv Instrumentat, Durham, England	University of Strathclyde; Durham University	McCarron, JG (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	john.mccarron@strath.ac.uk	Wilson, Calum/AAI-1541-2019; Wilson, Calum/AAC-9114-2020	Wilson, Calum/0000-0003-2500-0632; Girkin, John/0000-0003-2568-3576	Wellcome Trust [092292/Z/10/Z]; British Heart Foundation [PG/11/70/29086]; British Heart Foundation [Research Excellence Award (Edinburgh-Durham University, Edinburgh, United Kingdom)	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation [Research Excellence Award (Edinburgh-Durham University, Edinburgh, United Kingdom)	The authors thank M. E. Sandison, C. Kennedy, and S. Chalmers (University of Strathclyde) for useful discussion and comments on the manuscript. This work was funded by the Wellcome Trust (092292/Z/10/Z) and British Heart Foundation [PG/11/70/29086 and Research Excellence Award (Edinburgh-Durham University, Edinburgh, United Kingdom)], whose support is gratefully acknowledged.	Behringer EJ, 2012, CIRC RES, V110, P1311, DOI 10.1161/CIRCRESAHA.111.262592; Behringer EJ, 2012, BRIT J PHARMACOL, V166, P774, DOI 10.1111/j.1476-5381.2011.01814.x; Billaud M, 2014, PHARMACOL REV, V66, P513, DOI 10.1124/pr.112.007351; Blottiere HM, 1996, BRIT J PHARMACOL, V117, P775, DOI 10.1111/j.1476-5381.1996.tb15259.x; Boettcher M, 2011, HYPERTENSION, V57, P802, DOI 10.1161/HYPERTENSIONAHA.110.165894; Bradley KN, 2003, J CELL SCI, V116, P4291, DOI 10.1242/jcs.00713; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; BUUS NH, 1994, BRIT J PHARMACOL, V112, P579, DOI 10.1111/j.1476-5381.1994.tb13114.x; CARTER TD, 1994, PFLUG ARCH EUR J PHY, V428, P476, DOI 10.1007/BF00374568; Chalmers S, 2012, J AM CHEM SOC, V134, P758, DOI 10.1021/ja2077922; Chataigneau T, 1998, BRIT J PHARMACOL, V123, P968, DOI 10.1038/sj.bjp.0701690; Chataigneau T, 1998, BRIT J PHARMACOL, V123, P574, DOI 10.1038/sj.bjp.0701629; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20, DOI [10.1002/0471142727.mb1420s92, DOI 10.1002/0471142727.MB1420S92]; Emerson GG, 2000, CIRC RES, V86, P94, DOI 10.1161/01.RES.86.1.94; FALLOON BJ, 1995, AM J PHYSIOL-HEART C, V268, pH670, DOI 10.1152/ajpheart.1995.268.2.H670; FARACI FM, 1994, STROKE, V25, P178, DOI 10.1161/01.STR.25.1.178; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Grol MW, 2013, J CELL SCI, V126, P3615, DOI 10.1242/jcs.122705; Huang TY, 2000, FASEB J, V14, P797, DOI 10.1096/fasebj.14.5.797; Iglesias RM, 2012, NEUROCHEM RES, V37, P1355, DOI 10.1007/s11064-012-0720-6; Jung K, 2013, CIRC RES, V112, P891, DOI 10.1161/CIRCRESAHA.111.300484; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Lamping KG, 2001, ARTERIOSCL THROM VAS, V21, P523, DOI 10.1161/01.ATV.21.4.523; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; Lennie P, 2003, CURR BIOL, V13, pR216, DOI 10.1016/S0960-9822(03)00153-2; LITTLE TL, 1995, CIRC RES, V76, P498, DOI 10.1161/01.RES.76.3.498; Marie I, 2002, J VASC RES, V39, P260, DOI 10.1159/000063691; McCarron JG, 2010, J CELL PHYSIOL, V224, P334, DOI 10.1002/jcp.22103; McCarron JG, 2009, J GEN PHYSIOL, V133, P439, DOI 10.1085/jgp.200810189; McGeown JG, 1996, J PHYSIOL-LONDON, V497, P321, DOI 10.1113/jphysiol.1996.sp021771; McSherry IN, 2005, CELL CALCIUM, V38, P23, DOI 10.1016/j.ceca.2005.03.007; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Ohashi M, 2005, AM J PHYSIOL-HEART C, V289, pH2244, DOI 10.1152/ajpheart.00254.2005; OHTA T, 1994, BRIT J PHARMACOL, V112, P972, DOI 10.1111/j.1476-5381.1994.tb13176.x; Plane F, 1998, BRIT J PHARMACOL, V123, P1351, DOI 10.1038/sj.bjp.0701746; Regan ER, 2012, CIRC RES, V111, P110, DOI 10.1161/CIRCRESAHA.111.261701; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Saunter CD, 2012, BIOMED OPT EXPRESS, V3, P1274, DOI 10.1364/BOE.3.001274; Socha MJ, 2012, MICROCIRCULATION, V19, P757, DOI 10.1111/micc.12000; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Tallini YN, 2007, CIRC RES, V101, P1300, DOI 10.1161/CIRCRESAHA.107.149484; Taylor MS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00447; Thurley K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005237; Tran CHT, 2012, AM J PHYSIOL-CELL PH, V302, pC1226, DOI 10.1152/ajpcell.00418.2011; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Wilson C, 2015, J PHYSIOL-LONDON, V593, P5231, DOI 10.1113/JP271157; Ying XY, 1996, CIRC RES, V79, P898, DOI 10.1161/01.RES.79.4.898	51	26	26	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2000	2013		10.1096/fj.201500090	http://dx.doi.org/10.1096/fj.201500090			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26873937	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000374879400027
J	Jung, G; Fajardo, G; Ribeiro, AJS; Kooiker, KB; Coronado, M; Zhao, MM; Hu, DQ; Reddy, S; Kodo, K; Sriram, K; Insel, PA; Wu, JC; Pruitt, BL; Bernstein, D				Jung, Gwanghyun; Fajardo, Giovanni; Ribeiro, Alexandre J. S.; Kooiker, Kristina Bezold; Coronado, Michael; Zhao, Mingming; Hu, Dong-Qing; Reddy, Sushma; Kodo, Kazuki; Sriram, Krishna; Insel, Paul A.; Wu, Joseph C.; Pruitt, Beth L.; Bernstein, Daniel			Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation	FASEB JOURNAL			English	Article						beta-adrenergic receptor; cell signaling maturation; cardiotoxicity testing	PROTEIN-COUPLED RECEPTORS; RAT VENTRICULAR MYOCYTES; CHRONIC HEART-FAILURE; CARDIAC MYOCYTES; KINASE-II; BETA(1)-ADRENERGIC STIMULATION; BETA(2)-ADRENERGIC RECEPTORS; DILATED CARDIOMYOPATHY; BETA-ARRESTINS; CA2+ LEAK	Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a powerful platform for uncovering disease mechanisms and assessing drugs for efficacy/toxicity. However, the accuracy with which hiPSC-CMs recapitulate the contractile and remodeling signaling of adult cardiomyocytes is not fully known. We used beta-adrenergic receptor (beta-AR) signaling as a prototype to determine the evolution of signaling component expression and function during hiPSC-CM maturation. In "early" hiPSC-CMs (less than or equal to d 30), beta 2-ARs are a primary source of cAMP/PKA signaling. With longer culture, beta 1-AR signaling increases: from 0% of cAMP generation at d 30 to 56.8 +/- 6.6% by d 60. PKA signaling shows a similar increase: 15.7+/-5.2%(d 30), 49.8+/-0.5%(d 60), and 71.0+/-6.1% (d 90). cAMP generation increases 9-fold from d 30 to 60, with enhanced coupling to remodeling pathways (e.g., Akt and Ca2+/calmodulin-dependent protein kinase type II) and development of caveolin-mediated signaling compartmentalization. By contrast, cardiotoxicity induced by chronic beta-AR stimulation, a major component of heart failure, develops much later: 5% cell death at d 30 vs. 55% at d 90. Moreover, beta-AR maturation can be accelerated by biomechanical stimulation. The differential maturation of beta-AR functional vs. remodeling signaling in hiPSC-CMs has important implications for their use in disease modeling and drug testing. We propose that assessment of signaling be added to the indices of phenotypic maturation of hiPSC-CMs.-Jung, G., Fajardo, G., Ribeiro, A. J. S., Kooiker, K. B., Coronado, M., Zhao, M., Hu, D.-Q., Reddy, S., Kodo, K., Sriram, K., Insel, P. A., Wu, J. C., Pruitt, B. L., Bernstein, D. Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation. FASEB J. 30, 1464-1479 (2016). www.fasebj.org	[Jung, Gwanghyun; Fajardo, Giovanni; Kooiker, Kristina Bezold; Coronado, Michael; Zhao, Mingming; Hu, Dong-Qing; Reddy, Sushma; Bernstein, Daniel] Stanford Univ, Dept Pediat, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [Jung, Gwanghyun; Fajardo, Giovanni; Kooiker, Kristina Bezold; Coronado, Michael; Zhao, Mingming; Hu, Dong-Qing; Reddy, Sushma; Kodo, Kazuki; Wu, Joseph C.; Bernstein, Daniel] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA; [Kodo, Kazuki; Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Ribeiro, Alexandre J. S.; Pruitt, Beth L.] Stanford Univ, Dept Mech Engn, Sch Engn, Stanford, CA 94305 USA; [Sriram, Krishna; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Sriram, Krishna; Insel, Paul A.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego	Bernstein, D (corresponding author), 750 Welch Rd,Suite 325, Palo Alto, CA 94304 USA.	danb@stanford.edu	; Wu, Joseph/H-1067-2013	Pruitt, Beth L./0000-0002-4861-2124; Bernstein, Daniel/0000-0001-7761-5853; Wu, Joseph/0000-0002-6068-8041	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [HL123655, HL11708301, HL11300604, F32 HL126348]; Stanford Child Health Research Institute; American Heart Association [14POST18360018]; National Science Foundation Emerging Frontiers in Research and Innovation Multicellular and Inter-kingdom Signaling [1136790]; Department of Defense [W81XWH-14-1-0372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL126348, T32HL094274, R21HL123655, R33HL123655] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford Child Health Research Institute; American Heart Association(American Heart Association); National Science Foundation Emerging Frontiers in Research and Innovation Multicellular and Inter-kingdom Signaling; Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Jared Chunko (Division of Cardiovascular Medicine, Department of Medicine, Stanford Cardiovascular Institute) and Euan Ashley (Division of Cardiovascular Medicine and Genetics, Department of Medicine, Stanford Cardiovascular Institute) who assisted in obtaining human heart samples. They are grateful for the support of the Neuroscience Microscopy Service at the Institute for Stem Cell Biology and Regenerative Medicine, Stanford University. This work was supported by U.S. National Institutes of Health/National Heart, Lung, and Blood Institute Grants HL123655 and HL11708301 (to D.B.), HL11300604 (to J.C.W.), and F32 HL126348 (to G.J.); Stanford Child Health Research Institute postdoctoral grant (to G.J.); American Heart Association postdoctoral fellowship 14POST18360018 (to A.J.S.R.); National Science Foundation Emerging Frontiers in Research and Innovation Multicellular and Inter-kingdom Signaling 1136790 (to B.L.P.); and Department of Defense Award W81XWH-14-1-0372 (to P.A.I.).	Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bernstein D, 2011, PROG PEDIATR CARDIOL, V31, P35, DOI 10.1016/j.ppedcard.2010.11.007; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRODDE OE, 1991, PHARMACOL REV, V43, P203; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; DELMONTE F, 1993, CIRCULATION, V88, P854, DOI 10.1161/01.CIR.88.3.854; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Godier-Furnemont AFG, 2015, BIOMATERIALS, V60, P82, DOI 10.1016/j.biomaterials.2015.03.055; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Grisanti LA, 2014, J MOL CELL CARDIOL, V72, P39, DOI 10.1016/j.yjmcc.2014.02.009; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hirt MN, 2014, J MOL CELL CARDIOL, V74, P151, DOI 10.1016/j.yjmcc.2014.05.009; Huang NF, 2013, BIOMATERIALS, V34, P2928, DOI 10.1016/j.biomaterials.2013.01.017; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; KUZNETSOV V, 1995, CIRC RES, V76, P40, DOI 10.1161/01.RES.76.1.40; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Mangmool S, 2010, J CELL BIOL, V189, P573, DOI 10.1083/jcb.200911047; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Metrich M, 2008, CIRC RES, V102, P959, DOI 10.1161/CIRCRESAHA.107.164947; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Pereira L, 2013, CIRCULATION, V127, P913, DOI 10.1161/CIRCULATIONAHA.12.148619; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Rao C, 2013, BIOMATERIALS, V34, P2399, DOI 10.1016/j.biomaterials.2012.11.055; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SLOTKIN TA, 1995, TOXICOL APPL PHARM, V133, P188, DOI 10.1006/taap.1995.1141; SLOTKIN TA, 1994, TOXICOL APPL PHARM, V129, P223, DOI 10.1006/taap.1994.1247; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Wu HD, 2015, CELL STEM CELL, V17, P89, DOI 10.1016/j.stem.2015.04.020; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; XIAO RP, 1994, J BIOL CHEM, V269, P19151; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang SJ, 2000, J BIOL CHEM, V275, P21773, DOI 10.1074/jbc.M909484199; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	59	43	44	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1464	1479		10.1096/fj.15-280982	http://dx.doi.org/10.1096/fj.15-280982			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26675706	Green Published, Green Submitted			2022-12-28	WOS:000372629100009
J	Mercatelli, R; Lana, D; Bucciantini, M; Giovannini, MG; Cerbai, F; Quercioli, F; Zecchi-Orlandini, S; Delfino, G; Wenk, GL; Nosi, D				Mercatelli, Raffaella; Lana, Daniele; Bucciantini, Monica; Giovannini, Maria Grazia; Cerbai, Francesca; Quercioli, Franco; Zecchi-Orlandini, Sandra; Delfino, Giovanni; Wenk, Gary L.; Nosi, Daniele			Clasmatodendrosis and beta-amyloidosis in aging hippocampus	FASEB JOURNAL			English	Article						central nervous system; cell-cell interactions; clearance mechanism	NECROSIS-FACTOR-ALPHA; ASTROCYTIC PROCESSES; PRECURSOR PROTEIN; PHASOR APPROACH; FIBRILS; DISEASE; GAMMA; INTERLEUKIN-1-BETA; NEUROINFLAMMATION; TRANSMISSION	Alterations of the tightly interwoven neuron/astrocyte interactions are frequent traits of aging, but also favor neurodegenerative diseases, such as Alzheimer disease (AD). These alterations reflect impairments of the innate responses to inflammation-related processes, such as beta-amyloid (Ab) burdening. Multidisciplinary studies, spanning from the tissue to the molecular level, are needed to assess how neuron/astrocyte interactions are influenced by aging. Our study addressed this requirement by joining fluorescence-lifetime imaging microscopy/phasor multiphoton analysis with confocalmicroscopy, implemented with a novel method to separate spectrally overlapped immunofluorescence and Ab autofluorescence. By comparing data from young control rats, chronically inflamed rats, and old rats, we identified age-specific alterations of neuron/astrocyte interactions in the hippocampus. We found a correlation between Ab aggregation (+300 and +800% of aggregated Ab peptide in chronically inflamed and old vs. control rats, respectively) and fragmentation (clasmatodendrosis) of astrocyte projections (APJs) (+250 and +1300% of APJ fragments in chronically inflamed and old vs. control rats, respectively). Clasmatodendrosis, in aged rats, associates with impairment of astrocyte-mediated Ab clearance (-45% of Ab deposits on APJs, and +33% of Ab deposits on neurons in old vs. chronically inflamed rats). Furthermore, APJ fragments colocalize with Ab deposits and are involved in novel A beta-mediated adhesions between neurons. These data define the effects of Ab deposition on astrocyte/neuron interactions as a key topic in AD biology.-Mercatelli, R., Lana, D., Bucciantini, M., Giovannini, M. G., Cerbai, F., Quercioli, F., Zecchi-Orlandini, S., Delfino, G., Wenk, G. L., Nos, D. Clasmatodendrosis and beta-amyloidosis in aging hippocampus. FASEB J. 30, 1480-1491 (2016). www.fasebj.org	[Mercatelli, Raffaella] Univ Florence, Dept Chem Ugo Schiff, Florence, Italy; [Lana, Daniele; Giovannini, Maria Grazia; Cerbai, Francesca] Univ Florence, Dept Hlth Sci, Florence, Italy; [Bucciantini, Monica] Univ Florence, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy; [Zecchi-Orlandini, Sandra; Nosi, Daniele] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Delfino, Giovanni] Univ Florence, Dept Biol, Florence, Italy; [Quercioli, Franco] Natl Res Council CNR, Natl Inst Opt, Florence, Italy; [Wenk, Gary L.] Ohio State Univ, Dept Psychol, Columbus, OH USA	University of Florence; University of Florence; University of Florence; University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University System of Ohio; Ohio State University	Nosi, D (corresponding author), Largo Brambilla 3, I-50134 Florence, Italy.	daniele.nosi@unifi.it	mercatelli, raffaella/P-8392-2018; mercatelli, raffaella/GPG-0897-2022	mercatelli, raffaella/0000-0002-3231-0527; Lana, Daniele/0000-0002-5193-0019; bucciantini, monica/0000-0002-5243-9301				Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Ashley NT, 2012, ANNU REV ECOL EVOL S, V43, P385, DOI 10.1146/annurev-ecolsys-040212-092530; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Blasko I, 1999, FASEB J, V13, P63, DOI 10.1096/fasebj.13.1.63; Blasko I, 2000, NEUROBIOL DIS, V7, P682, DOI 10.1006/nbdi.2000.0321; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Frenkel D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3030; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; HOFFMAN WE, 1985, STROKE, V16, P860, DOI 10.1161/01.STR.16.5.860; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Ito U, 2009, STROKE, V40, P2173, DOI 10.1161/STROKEAHA.108.534990; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; KOWALSKA MA, 1994, BIOCHEM BIOPH RES CO, V205, P1829, DOI 10.1006/bbrc.1994.2883; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Marksteiner J, 2008, MOL PSYCHIATR, V13, P939, DOI 10.1038/sj.mp.4002072; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Mostaert AS, 2006, J BIOL PHYS, V32, P393, DOI 10.1007/s10867-006-9023-y; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Penfield W., 1928, SPECIAL CYTOLOGY FOR, P1445; Pluta R, 2013, MOL NEUROBIOL, V47, P425, DOI 10.1007/s12035-012-8360-z; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Sahlas DJ, 2002, ANN NEUROL, V52, P378, DOI 10.1002/ana.10310; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675; Sastre M, 2003, J NEUROSCI, V23, P9796; Spitzer N, 2011, J NEUROSCI METH, V197, P48, DOI 10.1016/j.jneumeth.2011.01.029; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Su Y, 2001, BRAIN RES, V893, P287, DOI 10.1016/S0006-8993(00)03322-9; Thaler C, 2006, CYTOM PART A, V69A, P904, DOI 10.1002/cyto.a.20267; Thiel A, 2014, STROKE, V45, P2825, DOI 10.1161/STROKEAHA.114.004285; Tomimoto H, 1997, ACTA NEUROPATHOL, V94, P146, DOI 10.1007/s004010050686; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	55	11	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1480	1491		10.1096/fj.15-275503	http://dx.doi.org/10.1096/fj.15-275503			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26722005				2022-12-28	WOS:000372629100010
J	Naini, SM; Choukroun, GJ; Ryan, JR; Hentschel, DM; Shah, JV; Bonventre, JV				Naini, Said Movahedi; Choukroun, Gabriel J.; Ryan, James R.; Hentschel, Dirk M.; Shah, Jagesh V.; Bonventre, Joseph V.			Cytosolic phospholipase A(2)alpha regulates G(1) progression through modulating FOXO1 activity	FASEB JOURNAL			English	Article						zebrafish; cell cycle; p27(Kip1); cyclin D1; PGE(2)	DEPENDENT KINASE INHIBITOR; FORKHEAD TRANSCRIPTION FACTORS; MESANGIAL CELL-PROLIFERATION; ARACHIDONIC-ACID METABOLISM; CYCLIN D1; CANCER CELLS; PROTEIN-KINASES; MAP KINASE; P27(KIP1); A(2)	Group IVA phospholipase A(2)alpha [cytosolic phospholipase A(2)alpha (cPLA(2))] is a key mediator of inflammation and tumorigenesis. In this study, by using a combination of chemical inhibition and genetic approaches in zebrafish and murine cells, we identify a mechanism by which cPLA(2) promotes cell proliferation. We identified 2 cpla(2)alpha genes in zebrafish, cpla(2)alpha a and cpla(2)alpha b, with conserved phospholipase activity. In zebrafish, loss of cpla(2)alpha expression or inhibition of cpla(2)alpha activity diminished G(1) progression through the cell cycle. This phenotype was also seen in both mouse embryonic fibroblasts and mesangial cells. G(1) progression was rescued by the addition of arachidonic acid or prostaglandin E-2 (PGE(2)), indicating a phospholipase-dependent mechanism. We further show that PGE(2), through PI3K/AKT activation, promoted Forkhead box protein O1 (FOXO1) phosphorylation and FOXO1 nuclear export. This led to up-regulation of cyclin D1 and down-regulation of p27(Kip1), thus promoting G(1) progression. Finally, using pharmacologic inhibitors, we show that cPLA(2)alpha, rapidly accelerated fibrosarcoma (RAF)/MEK/ERK, and PI3K/AKT signaling pathways cooperatively regulate G(1) progression in response to platelet-derived growth factor stimulation. In summary, these data indicate that cPLA(2)alpha, through its phospholipase activity, is a critical effector of G(1) phase progression through the cell cycle and suggest that pharmacological targeting of this enzyme may have important therapeutic benefits in disease mechanisms that involve excessive cell proliferation, in particular, cancer and proliferative glomerulopathies.	[Naini, Said Movahedi; Ryan, James R.; Hentschel, Dirk M.; Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Med, Renal Div,Brigham & Womens Hosp, Boston, MA 02115 USA; [Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Choukroun, Gabriel J.] Amiens Southern Hosp, Div Renal, Amiens, France; [Bonventre, Joseph V.] Harvard Stem Cell Inst, Cambridge, MA USA; [Shah, Jagesh V.; Bonventre, Joseph V.] Harvard MIT, Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Harvard University; Harvard University	Bonventre, JV (corresponding author), Harvard Univ, Inst Med, Div Renal, 4 Blackfan Circle, Boston, MA 02115 USA.	joseph_bonventre@hms.harvard.edu	Gabriel, Choukroun/AAL-4969-2021		U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK054741, DKD072381, DK039773]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054741, R01DK054741, R37DK039773, R01DK039773, R01DK072381] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Chuan Wu (Center for Neurological Diseases, Brigham and Women's Hospital) for FOXO1-Luc and Martin McMahon (University of California, San Francisco, Comprehensive Cancer Center, San Francisco, CA, USA) for EGFP Delta Raf-1:AR plasmid. This work was supported by U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054741, DKD072381, and DK039773 (to J.V.B.). All authors have read and approved the manuscript. This manuscript has not been published or submitted in any format in part or in its entirety elsewhere. S.M.N., G.J.C., J.R.R., J.V.S., and J.V.B. designed the experiments. S.M.N. and G.J.C. performed experiments and collected and analyzed data. S.M.N. and J.V.B. wrote the manuscript. All the authors discussed the results and commented on the manuscript. The authors declare no conflicts of interest.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Antoniotti S, 2003, J CELL PHYSIOL, V197, P370, DOI 10.1002/jcp.10359; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BONVENTRE JV, 1991, KIDNEY INT, V39, P438, DOI 10.1038/ki.1991.55; BONVENTRE JV, 1992, J AM SOC NEPHROL, V3, P128; BONVENTRE JV, 1988, AM J PHYSIOL, V254, pF87, DOI 10.1152/ajprenal.1988.254.1.F87; Bunt G, 1997, J CELL SCI, V110, P2449; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Choukroun GJ, 2000, J CLIN INVEST, V106, P983, DOI 10.1172/JCI8914; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dubey RK, 1997, CURR OPIN NEPHROL HY, V6, P88, DOI 10.1097/00041552-199701000-00016; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; George RJ, 2007, PROSTAG OTH LIPID M, V83, P112, DOI 10.1016/j.prostaglandins.2006.10.005; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Inoue CN, 1997, P SOC EXP BIOL MED, V216, P370; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Kang SS, 2000, INVEST OPHTH VIS SCI, V41, P2164; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; MENE P, 1990, KIDNEY INT, V37, P1256, DOI 10.1038/ki.1990.109; MENE P, 1990, KIDNEY INT, V38, P232, DOI 10.1038/ki.1990.191; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; MONTROSE DC, 2015, PROSTAG OTH LIPID M, V117, P26; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; Ono T, 2002, BIOCHEM J, V363, P727, DOI 10.1042/0264-6021:3630727; Postlethwait J, 2004, METHOD CELL BIOL, V77, P255; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang Y, 2011, INVEST OPHTH VIS SCI, V52, P8231, DOI 10.1167/iovs.11-7542; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yarden A, 1995, BBA-GENE STRUCT EXPR, V1264, P257, DOI 10.1016/0167-4781(95)00175-1; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zharkikh A, 1995, MOL PHYLOGENET EVOL, V4, P44, DOI 10.1006/mpev.1995.1005	53	17	18	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1155	1170		10.1096/fj.15-278416	http://dx.doi.org/10.1096/fj.15-278416			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644349	Green Published			2022-12-28	WOS:000370387800014
J	Eletto, D; Eletto, D; Boyle, S; Argon, Y				Eletto, Daniela; Eletto, Davide; Boyle, Sarah; Argon, Yair			PDIA6 regulates insulin secretion by selectively inhibiting the RIDD activity of IRE1	FASEB JOURNAL			English	Article						beta-cell metabolism; unfolded protein response; GSIS	UNFOLDED-PROTEIN-RESPONSE; PANCREATIC BETA-CELL; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; ER STRESS; SMALL-MOLECULE; KINASE IRE1; PERK; IRE1-ALPHA; DEATH	Protein disulfide isomerase A6 (PDIA6) interacts with protein kinase RNA-like endoplasmic reticulum kinase (PERK) and inositol requiring enzyme (IRE)-1 and inhibits their unfolded protein response signaling. In this study, shRNA silencing of PDIA6 expression in insulin-producing mouse cells reduced insulin production (5-fold) and, consequently, glucose-stimulated insulin secretion (3-4-fold). This inhibition of insulin release was independent of the PDIA6-PERK interaction or PERK activity. Acute inhibition of PERK did not change the short-term response of beta cells to glucose. Rather, PDIA6 affected insulin secretion by modulating one of the activities of IRE1. At 11 mM glucose and lower, the regulated IRE1-dependent decay (RIDD) of the mRNA activity of IRE1 was activated, but not its X-box binding protein (XBP)-1 splicing activity. In the absence of PDIA6, RIDD activity toward insulin transcripts was enhanced up to 4-fold, as shown by molecular assays in cultured cells and the use of a fluorescent reporter in intact islets. Such physiologic activation of IRE1 by glucose contrasted with IRE1 activation by chemical stress, when both IRE1 activities were induced. Thus, whereas the stimulus determines the quality of IRE1 signaling, PDIA6 attenuates multiple enzymatic activities of IRE1, maintaining its signaling within a physiologically tolerable range.	Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Eletto, Davide] Univ Cambridge, Cambridge, England	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Cambridge	Argon, Y (corresponding author), Childrens Hosp Philadelphia, 3615 Civ Ctr Blvd,816B ARC, Philadelphia, PA 19104 USA.	yargon@mail.med.upenn.edu		Eletto, Daniela/0000-0001-6967-1812	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI-18001]; University of Pennsylvania's Diabetes Research Center; University Research Foundation; American-Italian Cancer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018001] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Pennsylvania's Diabetes Research Center; University Research Foundation; American-Italian Cancer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. D. C. Fan (The Children's Hospital of Philadelphia, Philadelphia, PA, USA) for help with some of the experiments; Drs. D. Ron (University of Cambridge, Cambridge, United Kingdom), A. Volchuk (University of Toronto, Toronto, ON, Canada), N. Bulleid (University of Glasgow, Glasgow, United Kingdom), E. Snapp (Albert Einstein College of Medicine of Yeshiva University, New York, NY, USA), T.P. Herbert (University of Leicester, Leicester, United Kingdom), and T. Iwawaki (Gumna University, Maebashi, Japan) for generous gifts of cell lines, plasmids, and antibodies; Dr. H.-E. Hohmeier (Duke University School of Medicine, Durham, NC, USA) for the glucose-responsive INS1 832/13 cells and help in their culture; and Drs. T. Gidalevitz, J. Burkhardt, and D. Dersh for comments and suggestions during the work and on the manuscript. This work was supported by U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant AI-18001 and pilot grants from the University of Pennsylvania's Diabetes Research Center and the University Research Foundation (to Y.A.), and by a postdoctoral fellowship from the American-Italian Cancer Foundation (to Dan.E.). The authors declare no conflicts of interest.	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bright MD, 2015, MOL CELL BIOL, V35, P2186, DOI 10.1128/MCB.00013-15; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cunha DA, 2014, CELL DEATH DIFFER, V21, P1313, DOI 10.1038/cdd.2014.53; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Durocher F, 2006, CLIN GENET, V70, P34, DOI 10.1111/j.1399-0004.2006.00632.x; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Eletto D, 2012, J CELL SCI, V125, P4865, DOI 10.1242/jcs.108928; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Groenendyk J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004983; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Herbert TP, 2007, BIOCHEM SOC T, V35, P1205, DOI 10.1042/BST0351205; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Moore CE, 2011, MOL ENDOCRINOL, V25, P315, DOI 10.1210/me.2010-0309; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Teodoro T, 2012, AM J PHYSIOL-CELL PH, V302, pC992, DOI 10.1152/ajpcell.00160.2011; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Volchuk A, 2010, DIABETES OBES METAB, V12, P48, DOI 10.1111/j.1463-1326.2010.01271.x; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	62	38	39	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					653	665		10.1096/fj.15-275883	http://dx.doi.org/10.1096/fj.15-275883			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26487694	Green Published			2022-12-28	WOS:000369391900017
J	Luo, FY; Le, NB; Mills, T; Chen, NY; Karmouty-Quintana, H; Molina, JG; Davies, J; Philip, K; Volcik, KA; Liu, H; Xia, Y; Eltzschig, HK; Blackburn, MR				Luo, Fayong; Le, Ngoc-Bao; Mills, Tingting; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Molina, Jose G.; Davies, Jonathan; Philip, Kemly; Volcik, Kelly A.; Liu, Hong; Xia, Yang; Eltzschig, Holger K.; Blackburn, Michael R.			Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis	FASEB JOURNAL			English	Article						bleomycin; dipyridamole; IPF; IL-17; IL-6	CEREBRAL-BLOOD-FLOW; S-ADENOSYLMETHIONINE; RECEPTOR; INFLAMMATION; PROMOTES; MICE; DIPYRIDAMOLE; CONTRIBUTES; REPRESSION; RESOLUTION	Idiopathic pulmonary fibrosis is a devastating lung disease with limited treatment options. The signaling molecule adenosine is produced in response to injury and serves a protective role in early stages of injury and is detrimental during chronic stages of disease such as seen in lung conditions such as pulmonary fibrosis. Understanding the association of extracellular adenosine levels and the progression of pulmonary fibrosis is critical for designing adenosine based approaches to treat pulmonary fibrosis. The goal of this study was to use various models of experimental lung fibrosis to understand when adenosine levels are elevated during pulmonary fibrosis and whether these elevations were associated with disease progression and severity. To accomplish this, extracellular adenosine levels, defined as adenosine levels found in bronchioalveolar lavage fluid, were determined in mouse models of resolvable and progressive pulmonary fibrosis. We found that relative bronchioalveolar lavage fluid adenosine levels are progressively elevated in association with pulmonary fibrosis and that adenosine levels diminish in association with the resolution of lung fibrosis. In addition, treatment of these models with dipyridamole, an inhibitor of nucleoside transporters that potentiates extracellular adenosine levels, demonstrated that the resolution of lung fibrosis is blocked by the failure of adenosine levels to subside. Furthermore, exacerbating adenosine levels led to worse fibrosis in a progressive fibrosis model. Increased adenosine levels were associated with elevation of IL-6 and IL-17, which are important inflammatory cytokines in pulmonary fibrosis. These results demonstrate that extracellular adenosine levels are closely associated with the progression of experimental pulmonary fibrosis and that this signaling pathway maymediate fibrosis by regulating IL-6 and IL-17 production.	[Luo, Fayong; Le, Ngoc-Bao; Mills, Tingting; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Molina, Jose G.; Philip, Kemly; Volcik, Kelly A.; Liu, Hong; Xia, Yang; Blackburn, Michael R.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin, Houston, TX 77030 USA; [Davies, Jonathan] Baylor Coll Med, Dept Pediat, Div Neonatal Perinatal Med, Houston, TX 77030 USA; [Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Blackburn, MR (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin, Houston, TX 77030 USA.	michael.r.blackburn@uth.tmc.edu	Karmouty-Quintana, Harry/ABC-9144-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; liu, hong/0000-0001-9976-2985; Blackburn, Michael/0000-0002-1394-9966; Philip, Kemly/0000-0002-7749-9781	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01-HL070952, P01-HL114457]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113574, R01HL070952, P01HL114457, R01HL119837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097075] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants R01-HL070952 and P01-HL114457 (to M.R.B.).	Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Bouma MG, 1996, AM J PHYSIOL-CELL PH, V270, pC522, DOI 10.1152/ajpcell.1996.270.2.C522; CHAN TCK, 1988, CANCER RES, V48, P215; Chen CJ, 2013, NEW ENGL J MED, V368, P1260, DOI 10.1056/NEJMc1300259; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Davies J, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12155; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Fernandez P, 2008, AM J PATHOL, V172, P1675, DOI 10.2353/ajpath.2008.070952; Fernandez P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Karmouty-Quintana H, 2012, FASEB J, V26, P2546, DOI 10.1096/fj.11-200907; Kim HH, 2008, J CEREBR BLOOD F MET, V28, P1285, DOI 10.1038/jcbfm.2008.24; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KO KR, 1990, AM J PHYSIOL, V259, pH1703, DOI 10.1152/ajpheart.1990.259.6.H1703; Kuroki M, 2003, J IMMUNOL, V170, P567, DOI 10.4049/jimmunol.170.1.567; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Luo FY, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-51; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; MILLS DCB, 1971, BIOCHEM J, V121, P185, DOI 10.1042/bj1210185; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Morote-Garcia JC, 2013, AM J RESP CELL MOL, V49, P296, DOI 10.1165/rcmb.2012-0457OC; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Peng ZS, 2008, NUCLEOS NUCLEOT NUCL, V27, P821, DOI 10.1080/15257770802146403; Pfalzer AC, 2014, PHYSIOL GENOMICS, V46, P617, DOI 10.1152/physiolgenomics.00056.2014; PHAN SH, 1983, CHEST, V83, pS44; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Song ZY, 2005, BBA-MOL CELL RES, V1743, P205, DOI 10.1016/j.bbamcr.2004.12.001; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; WAKAMIYA M, 1995, P NATL ACAD SCI USA, V92, P3673, DOI 10.1073/pnas.92.9.3673; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003; Zimmerman MA, 2013, HEPATOLOGY, V58, P1766, DOI 10.1002/hep.26505	56	31	31	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					874	883		10.1096/fj.15-274845	http://dx.doi.org/10.1096/fj.15-274845			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527068	Green Published			2022-12-28	WOS:000369391900035
J	Miyake, M; Nomura, A; Ogura, A; Takehana, K; Kitahara, Y; Takahara, K; Tsugawa, K; Miyamoto, C; Miura, N; Sato, R; Kurahashi, K; Harding, HP; Oyadomari, M; Ron, D; Oyadomari, S				Miyake, Masato; Nomura, Akitoshi; Ogura, Atsushi; Takehana, Kenji; Kitahara, Yoshihiro; Takahara, Kazuna; Tsugawa, Kazue; Miyamoto, Chinobu; Miura, Naoko; Sato, Ryosuke; Kurahashi, Kiyoe; Harding, Heather P.; Oyadomari, Miho; Ron, David; Oyadomari, Seiichi			Skeletal muscle-specific eukaryotic translation initiation factor 2 alpha phosphorylation controls amino acid metabolism and fibroblast growth factor 21-mediated non-cell-autonomous energy metabolism	FASEB JOURNAL			English	Article						ER stress; ATF4; glutathione; obesity; small molecule	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; OXIDATIVE STRESS; GENE-EXPRESSION; GLUTATHIONE; EXERCISE; INHIBITION; PATHWAY; FGF21	The eukaryotic translation initiation factor 2 alpha (eIF2 alpha) phosphorylation-dependent integrated stress response (ISR), a component of the unfolded protein response, has long been known to regulate intermediary metabolism, but the details are poorly worked out. We report that profiling of mRNAs of transgenic mice harboring a ligand-activated skeletal muscle-specific derivative of the eIF2 alpha protein kinase R-like ER kinase revealed the expected up-regulation of genes involved in amino acid biosynthesis and transport but also uncovered the induced expression and secretion of a myokine, fibroblast growth factor 21 (FGF21), that stimulates energy consumption and prevents obesity. The link between the ISR and FGF21 expression was further reinforced by the identification of a small-molecule ISR activator that promoted Fgf21 expression in cell-based screens and by implication of the ISR-inducible activating transcription factor 4 in the process. Our findings establish that eIF2 alpha phosphorylation regulates not only cell-autonomous proteostasis and amino acid metabolism, but also affects non-cell-autonomous metabolic regulation by induced expression of a potent myokine.	[Miyake, Masato; Nomura, Akitoshi; Ogura, Atsushi; Takahara, Kazuna; Tsugawa, Kazue; Miyamoto, Chinobu; Miura, Naoko; Sato, Ryosuke; Kurahashi, Kiyoe; Oyadomari, Miho; Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Div Mol Biol, Tokushima 770, Japan; [Miyake, Masato; Nomura, Akitoshi; Ogura, Atsushi; Takahara, Kazuna; Tsugawa, Kazue; Miyamoto, Chinobu; Miura, Naoko; Sato, Ryosuke; Kurahashi, Kiyoe; Oyadomari, Miho; Oyadomari, Seiichi] Univ Tokushima, Diabet Therapeut & Res Ctr, Dept Mol Res, Tokushima 770, Japan; [Takehana, Kenji; Kitahara, Yoshihiro] Ajinomoto Pharmaceut Co Ltd, Res Ctr, Exploratory Res Labs, Kawasaki, Kanagawa, Japan; [Harding, Heather P.; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	Tokushima University; Tokushima University; Ajinomoto Co Inc; University of Cambridge	Oyadomari, S (corresponding author), Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.	oyadomar@tokushima-u.ac.jp	Oyadomari, Seiichi/GZA-7157-2022; Oyadomari, Seiichi/GZA-7072-2022	Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636; Miyake, Masato/0000-0003-2242-1706	Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan; Inoue Foundation for Science; Mitsubishi Foundation; Uehara Memorial Foundation; Naito Foundation; Cell Science Research Foundation; Takeda Science Foundation; Sankyo Foundation; Ono Medical Research Foundation; Mochida Memorial Foundation; Ube Foundation; Kowa Life Science Foundation; Suzuken Memorial Foundation; Kanae Foundation; Japan Diabetes Foundation; Japan Society for Promotion of Science (JSPS); EU FP7 Beta-Bat Grant [277713]; Wellcome Trust [084812/Z/08/Z]; Grants-in-Aid for Scientific Research [26670270] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Inoue Foundation for Science(Inoue Foundation for Science); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sankyo Foundation; Ono Medical Research Foundation; Mochida Memorial Foundation; Ube Foundation(UBE Foundation); Kowa Life Science Foundation; Suzuken Memorial Foundation; Kanae Foundation; Japan Diabetes Foundation; Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EU FP7 Beta-Bat Grant; Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank C. Kimura (The University of Tokushima) for manuscript preparation, J. Zhang (The University of Tokushima) for technical assistance, and E. Hardeman (University of New South Wales, Sydney, NSW, Australia) for providing the human skeletal muscle alpha-actin promoter fragment. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan (to S.O. and M.M.); from the Inoue Foundation for Science, the Mitsubishi Foundation, the Uehara Memorial Foundation, the Naito Foundation, the Cell Science Research Foundation, Takeda Science Foundation, Sankyo Foundation, Ono Medical Research Foundation, Mochida Memorial Foundation, the Ube Foundation, Kowa Life Science Foundation, Suzuken Memorial Foundation, Kanae Foundation, and Japan Diabetes Foundation (to S.O.); and from Grants-in-Aid for Young Scientist from Japan Society for Promotion of Science (JSPS) (to M.M.); and by EU FP7 Beta-Bat Grant 277713 and Wellcome Trust Grant 084812/Z/08/Z (to D.R). S.O. contributed to the study concept and experimental design. M.M., A.N., K.Take., Y.K., K.Taka., K.Ts., C.M., N.M., R.S., K.K., and M.O. conducted the experimental research. S.O., M.M., A.N., A.O., H.P.H., and D.R. contributed to the data analysis. S.O. and M.M. contributed to writing the manuscript with input from all coauthors. S.O. is the guarantor of this work, and as such, had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. The authors declare no conflicts of interest.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bai HJ, 2013, CHEMBIOCHEM, V14, P1255, DOI 10.1002/cbic.201300177; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim HJ, 2011, MED SCI SPORT EXER, V43, P18, DOI 10.1249/MSS.0b013e3181e4c5d1; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; LEW H, 1985, FEBS LETT, V185, P262, DOI 10.1016/0014-5793(85)80919-4; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mamady H, 2008, ARCH BIOCHEM BIOPHYS, V477, P77, DOI 10.1016/j.abb.2008.05.006; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nelson BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053574; Nguyen D, 2013, AGING CELL, V12, P415, DOI 10.1111/acel.12073; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SEN CK, 1994, J APPL PHYSIOL, V77, P2177, DOI 10.1152/jappl.1994.77.5.2177; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003	45	33	33	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					798	812		10.1096/fj.15-275990	http://dx.doi.org/10.1096/fj.15-275990			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26487695	Green Published, hybrid			2022-12-28	WOS:000369391900029
J	Rother, S; Bartels, M; Schweda, AT; Resch, K; Pallua, N; Nourbakhsh, M				Rother, Sascha; Bartels, Myriam; Schweda, Aike Torben; Resch, Klaus; Pallua, Norbert; Nourbakhsh, Mahtab			NF-kappa B-repressing factor phosphorylation regulates transcription elongation via its interactions with 5 '-> 3 ' exoribonuclease 2 and negative elongation factor	FASEB JOURNAL			English	Article						NKRF; gene regulation; transcription initiation; NELF-E; XRN2	RNA-POLYMERASE-II; MESSENGER-RNA; BASAL REPRESSION; EXPRESSION; NRF; ACTIVATION; PROMOTER; BINDING; INFECTION; DSIF	NF-kappa B-repressing factor (NKRF) inhibits transcription elongation by binding to specific sequences in target promoters. Stimuli such as IL-1 have been shown to overcome this inhibitory action and enable the resumption of transcription elongation machinery by an unknown mechanism. Using mass spectrometry and in vitro phosphorylation analyses, we demonstrate that NKRF is phosphorylated within 3 different domains in unstimulated HeLa cells. Phosphoamino acid mapping and mutation analysis of NKRF further suggest that only Ser phosphorylation within aa 421-429 is regulated by IL-1 stimulation. In copurification studies, aa 421-429 is required for interactions between NKRF, 5 '-> 3 ' exoribonuclease 2 (XRN2) and the negative elongation factor (NELF)-E in HeLa cells. Chromatin immunoprecipitation experiments further show that IL-1 stimulation leads to decrease in NKRF aa 421-429 phosphorylation and dissociation of NELF-E and XRN2 by concomitant resumption of transcription elongation of a synthetic reporter or the endogenous NKRF target gene, IL-8. Together, NKRF phosphorylation modulates promoter-proximal transcription elongation of NF-kappa kB/NKRF-regulated genes via direct interactions with elongation complex in response to specific stimuli.-Rother, S., Bartels, M., Schweda, A. T., Resch, K., Pallua, N., Nourbakhsh, M. NF-kappa B-repressing factor phosphorylation regulates transcription elongation via its interactions with 5 '-> 3 ' exoribonuclease 2 and negative elongation factor. FASEB J. 30, 174-185 (2016). www.fasebj.org	[Rother, Sascha; Bartels, Myriam; Schweda, Aike Torben; Resch, Klaus] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Pallua, Norbert; Nourbakhsh, Mahtab] RWTH Aachen Univ Hosp, Hand Surg & Burn Ctr, Dept Plast & Reconstruct Surg, D-52074 Aachen, Germany	Hannover Medical School; RWTH Aachen University; RWTH Aachen University Hospital	Nourbakhsh, M (corresponding author), RWTH Aachen Univ Hosp, Hand Surg & Burn Ctr, Dept Plast & Reconstruct Surg, Pauwelsstr 30, D-52074 Aachen, Germany.	mnourbakhsh@ukaachen.de	Nourbakhsh, Mahtab/U-8818-2019	Nourbakhsh, Mahtab/0000-0003-4102-0748; Nourbakhsh, Mahtab/0000-0003-0918-1736	Deutsche Forschungsgemeinschaft [SFB 566, NO457]; European Research Council (APPI) [PIOFGA-2008-221359]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (APPI)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 566 and NO457) and the European Research Council (APPI, PIOFGA-2008-221359).	Bartels M, 2007, J IMMUNOL, V179, P7605, DOI 10.4049/jimmunol.179.11.7605; Bian JC, 2011, ARCH VIROL, V156, P1335, DOI 10.1007/s00705-011-0987-y; Bjorkegren JLM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004201; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Diamant G, 2012, CELL REP, V2, P722, DOI 10.1016/j.celrep.2012.08.041; Dreikhausen U, 2005, MOL CELL BIOL, V25, P7473, DOI 10.1128/MCB.25.17.7473-7483.2005; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Gaertner B, 2014, DEVELOPMENT, V141, P1179, DOI 10.1242/dev.088492; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Huang KH, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0071-5; Huang LS, 2013, IMMUNOLOGY, V140, P314, DOI 10.1111/imm.12139; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li YA, 2010, ENVIRON HEALTH PERSP, V118, P936, DOI 10.1289/ehp.0901677; Ling C, 2015, J VIROL, V89, P952, DOI 10.1128/JVI.02581-14; Lu Y, 2010, ONCOGENE, V29, P1041, DOI 10.1038/onc.2009.396; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Miki TS, 2014, MOL CELL, V53, P351, DOI 10.1016/j.molcel.2014.01.001; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Niedick I, 2004, J CELL SCI, V117, P3447, DOI 10.1242/jcs.01129; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Omnus DJ, 2011, J MOL BIOL, V407, P492, DOI 10.1016/j.jmb.2011.01.050; Oumard A, 2000, MOL CELL BIOL, V20, P2755, DOI 10.1128/MCB.20.8.2755-2759.2000; Reboll MR, 2011, J BIOCHEM, V150, P553, DOI 10.1093/jb/mvr099; Reboll MR, 2007, RNA, V13, P1328, DOI 10.1261/rna.545407; Ritter B, 2011, J CLIN IMMUNOL, V31, P60, DOI 10.1007/s10875-010-9467-5; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Yung TMC, 2009, EXP CELL RES, V315, P1693, DOI 10.1016/j.yexcr.2009.02.013; Zhou QQ, 2015, GASTROENTEROLOGY, V148, P158, DOI 10.1053/j.gastro.2014.09.037; Zhu YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035147	43	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					174	185		10.1096/fj.15-270256	http://dx.doi.org/10.1096/fj.15-270256			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26340924	Green Published			2022-12-28	WOS:000367621000019
J	Bastakoty, D; Saraswati, S; Cates, J; Lee, E; Nanney, LB; Young, PP				Bastakoty, Dikshya; Saraswati, Sarika; Cates, Justin; Lee, Ethan; Nanney, Lillian B.; Young, Pampee P.			Inhibition of Wnt/beta-catenin pathway promotes regenerative repair of cutaneous and cartilage injury	FASEB JOURNAL			English	Article						wound healing; scar; skin; hair follicle	HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; STEM-CELL; CHONDROCYTE DIFFERENTIATION; AGGRESSIVE FIBROMATOSIS; WOUND REPAIR; TGF-BETA; WNT; EXPRESSION; FIBROSIS	Wound healing in mammals is a fibrotic process. The mechanisms driving fibrotic (as opposed to regenerative) repair are poorly understood. Herein we report that therapeutic Wnt inhibition with topical application of small-molecule Wnt inhibitors can reduce fibrosis and promote regenerative cutaneous wound repair. In the naturally stented model of ear punch injury, we found that Wnt/beta-catenin pathway is activated most notably in the dermis of the wound bed early (d 2) after injury and subsides to baseline levels by d10. Topical application of either of 2 mechanistically distinct small-molecule Wnt pathway inhibitors (a tankyrase inhibitor, XAV-939, and the U.S. Food and Drug Administration-approved casein kinase activator, pyrvinium) in C57Bl/6J mice resulted in significantly increased rates of wound closure (72.3 +/- 14.7% with XAV-939; and 52.1 +/- 20.9% with pyrvinium) compared with contralateral controls (38.1 +/- 23.0 and 40.4. +/- 16.7%, respectively). Histologically, Wnt inhibition reduced fibrosis as measured by alpha-smooth muscle actin positive myofibroblasts and collagen type I alpha 1 synthesis. Wnt inhibition also restored skin architecture including adnexal structures in ear wounds and dermal-epidermal junction with rete pegs in excisional wounds. Additionally, in ear punch injury Wnt inhibitor treatment enabled regeneration of auricular cartilage. Our study shows that pharmacologic Wnt inhibition holds therapeutic utility for regenerative repair of cutaneous wounds.	[Bastakoty, Dikshya; Saraswati, Sarika; Cates, Justin; Nanney, Lillian B.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Lee, Ethan] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Internal Med, Nashville, TN 37232 USA; [Young, Pampee P.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, 1161 21st Ave South C2217A MCN, Nashville, TN 37232 USA.	pampee.young@vanderbilt.edu	Cates, Justin/D-5927-2014	Cates, Justin/0000-0002-7336-5196	U.S. Veterans Affairs Merit Award; Vanderbilt University Clinical and Translational Science Award from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [UL1-RR024975-01]; American Heart Association [3PRE16080004]; NIH NIGMS Grants [R01GM081635, R01GM103926]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB019509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103926, R01GM081635, R01GM118300] Funding Source: NIH RePORTER	U.S. Veterans Affairs Merit Award; Vanderbilt University Clinical and Translational Science Award from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); American Heart Association(American Heart Association); NIH NIGMS Grants; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. Veterans Affairs Merit Award (to P.P.Y.); a Vanderbilt University Clinical and Translational Science Award from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grant UL1-RR024975-01 to P.P.Y.; American Heart Association Predoctoral Fellowship 3PRE16080004 to D.B.; and NIH NIGMS Grants R01GM081635 and R01GM103926 to E.L. P.P.Y. and E.L. are listed as inventors on a patent application related to wound healing owned by Vanderbilt University.	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Alman BA, 1997, AM J PATHOL, V151, P329; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Atala A, 2010, MRS BULL, V35, P597, DOI 10.1557/mrs2010.528; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Beyer C, 2013, ANN RHEUM DIS, V72, P1255, DOI 10.1136/annrheumdis-2012-202544; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Department for Education, 2022, SUMMARY CO2 MONITORS; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gourevitch D, 2003, DEV DYNAM, V226, P377, DOI 10.1002/dvdy.10243; Gourevitch D, 2014, ADV WOUND CARE, V3, P592, DOI 10.1089/wound.2014.0528; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Heber-Katz E, 2004, PHILOS T ROY SOC B, V359, P785, DOI 10.1098/rstb.2004.1468; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Heydemann Ahlke, 2012, Front Biol (Beijing), V7, P522; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kim TH, 2011, TOHOKU J EXP MED, V223, P45, DOI 10.1620/tjem.223.45; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; McGowan KM, 2000, J INVEST DERMATOL, V114, P1101, DOI 10.1046/j.1523-1747.2000.00986.x; Nguyen DT, 2009, WOODHEAD PUBL MATER, P25, DOI 10.1533/9781845695545.1.25; Oikonomopoulos A, 2011, CIRC RES, V109, P1363, DOI 10.1161/CIRCRESAHA.111.250282; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Rai MF, 2012, ARTHRITIS RHEUM-US, V64, P2300, DOI 10.1002/art.34396; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rudnicki JA, 1997, DEV BIOL, V185, P104, DOI 10.1006/dbio.1997.8536; Russell SB, 2010, J INVEST DERMATOL, V130, P2489, DOI 10.1038/jid.2010.162; Saraswati S, 2012, WOUND REPAIR REGEN, V20, P185, DOI 10.1111/j.1524-475X.2012.00767.x; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tsai SY, 2014, DEV BIOL, V385, P179, DOI 10.1016/j.ydbio.2013.11.023; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Whyte JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076883; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhu XJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004687	60	32	36	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4881	4892		10.1096/fj.15-275941	http://dx.doi.org/10.1096/fj.15-275941			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26268926	Green Published			2022-12-28	WOS:000365523600014
J	Lin, CR; Wei, TYW; Tsai, HY; Wu, YT; Wu, PY; Chen, ST				Lin, Chih-Ru; Wei, Tong-You Wade; Tsai, Hsien-Yu; Wu, Ying-Ta; Wu, Pei-Yu; Chen, Shui-Tein			Glycosylation-dependent interaction between CD69 and S100A8/S100A9 complex is required for regulatory T-cell differentiation	FASEB JOURNAL			English	Article						ligand; hPBMCs; immune homeostasis	LECTIN-LIKE DOMAIN; CARBOXYLATED GLYCANS; N-GLYCOSYLATION; S100A9; PROTEINS; EXPRESSION; ACTIVATION; INFLAMMATION; MIGRATION; COLITIS	Cluster of differentiation (CD) 69 is a leukocyte activation receptor involved in the maintenance of immune homeostasis and is positively selected in activated regulatory T (T-reg)cells, implicating its role during T-reg-cell differentiation. By RNA interference, we show that CD69 is not sufficient to support the conversion of CD4(+) naive T cells into Treg cells, whereas it does that of human peripheral blood mononuclear cells (hPBMCs) (P < 0.01), suggesting that a ligand-receptor interaction is required for CD69 function. Using immunoprecipitation and mass spectrometry, we identified the S100A8/S100A9 complex as the natural ligand of CD69 in hPBMCs. CD69 specifically associates with S100A8/S100A9 complex as confirmed by in vitro binding and competition assay, and the treatment of CD69 with peptide-N-glycosidase significantly abolishes such association. In agreement, the glycomics analysis determines the glycosylation site and the N-glycan composition of CD69, and terminal removal of sialic acid from that N-linked glycans reverses the generation of forkhead box P3-positive T-reg cells (23.21%; P < 0.05). More specifically, we showed that CD69-S100A8/S100A9 association is required for the up-regulation of suppressor of cytokine signaling 3 resulting in inhibited signaling of signal transducer and activator of transcription 3 (36.54% increase upon CD69 silencing; P < 0.01). This might in turn support the secretion of key regulator TGF-beta (similar to 3.28-fold decrease upon CD69 silencing; P < 0.05), leading to reduced production of IL-4 in hPBMCs. Our results demonstrate the functional and mechanistic interplays between CD69 and S100A8/S100A9 in supporting T-reg-cell differentiation.	[Lin, Chih-Ru; Wei, Tong-You Wade; Chen, Shui-Tein] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei 10764, Taiwan; [Lin, Chih-Ru; Wei, Tong-You Wade; Tsai, Hsien-Yu; Wu, Pei-Yu; Chen, Shui-Tein] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Wu, Ying-Ta; Chen, Shui-Tein] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Wu, PY (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	gabriel@gate.sinica.edu.tw; bcchen@gate.sinica.edu.tw		Tsai, Hsien-Yu/0000-0003-2842-1133	National Health Research Institute (Miaoli, Taiwan) [NHRI-EX104-10002NI]	National Health Research Institute (Miaoli, Taiwan)(National Health Research Institutes - Taiwan)	The authors thank Dr. Ming-Daw Tsai (Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan) for full support of this project, the RNAi Core Facility Platform (National Core Facility Program/Genomic Research Center, Academia Sinica, Taipei, Taiwan) for lentivirus-based small hairpin RNA preparation, the Genomics Research Center Mass Spectrometry Facility for glycopeptide composition analysis, the Mass Spectrometry Facility for protein identification, the Biophysics Core Facility for providing instrumental and experimental suggestions, and the Imaging and Cell Biology Facility (all at the Institute of Biological Chemistry) for the instrumental services. T.-Y.W.W. and P.-Y.W. were supported by National Health Research Institute (Miaoli, Taiwan) Grant NHRI-EX104-10002NI.	Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Beal AM, 2012, NAT IMMUNOL, V13, P77, DOI 10.1038/ni.2154; BEZOUSKA K, 1995, BIOCHEM BIOPH RES CO, V208, P68, DOI 10.1006/bbrc.1995.1306; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Cortes JR, 2014, J AUTOIMMUN, V55, P51, DOI 10.1016/j.jaut.2014.05.007; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; Cummings R.D., 2009, ANTIBODIES LECTINS G; de la Fuente H, 2014, MOL CELL BIOL, V34, P2479, DOI 10.1128/MCB.00348-14; Diercks BP, 2013, SCAND J IMMUNOL, V77, P169, DOI 10.1111/sji.12015; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Ellis GI, 2012, JOVE-J VIS EXP, DOI 10.3791/3738; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Hsu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103629; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LAGASSE E, 1992, BLOOD, V79, P1907; Llera AS, 2001, J BIOL CHEM, V276, P7312, DOI 10.1074/jbc.M008573200; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; Lynn KS, 2015, ANAL CHEM, V87, P2466, DOI 10.1021/ac5044829; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martin-Gayo E, 2010, BLOOD, V115, P5366, DOI 10.1182/blood-2009-10-248260; Marzio R, 1999, IMMUNOPHARM IMMUNOT, V21, P565, DOI 10.3109/08923979909007126; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Passey RJ, 1999, J IMMUNOL, V163, P2209; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005981; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Shevach EM, 2011, ADV IMMUNOL, V112, P137, DOI 10.1016/B978-0-12-387827-4.00004-8; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Srikrishna G, 2005, J IMMUNOL, V175, P5412, DOI 10.4049/jimmunol.175.8.5412; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vance BA, 1999, ARCH BIOCHEM BIOPHYS, V368, P214, DOI 10.1006/abbi.1999.1322; Vega-Ramos J, 2010, IMMUNOL CELL BIOL, V88, P707, DOI 10.1038/icb.2010.62; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	50	35	39	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5006	5017		10.1096/fj.15-273987	http://dx.doi.org/10.1096/fj.15-273987			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26296369				2022-12-28	WOS:000365523600025
J	Speed, JS; Heimlich, JB; Hyndman, KA; Fox, BM; Patel, V; Yanagisawa, M; Pollock, JS; Titze, JM; Pollock, DM				Speed, Joshua S.; Heimlich, J. Brett; Hyndman, Kelly A.; Fox, Brandon M.; Patel, Vivek; Yanagisawa, Masashi; Pollock, Jennifer S.; Titze, Jens M.; Pollock, David M.			Endothelin-1 as a master regulator of whole-body Na+ homeostasis	FASEB JOURNAL			English	Article						skin; endothelium; vascular; inflammation	BLOOD-PRESSURE; MEDULLARY OSMOLALITY; HIGH-SALT; HYPERTENSION; SODIUM; EXPRESSION; INCREASES; RATS; PHYSIOLOGY; RECEPTOR	The current study was designed to determine whether vascular endothelial-derived endothelin-1 (ET-1) is important for skin Na+ buffering. In control mice (C57BL/6J), plasma Na+ and osmolarity were significantly elevated in animals on high-vs. low-salt (HS and LS, respectively) intake. The increased plasma Na+ and osmolarity were associated with increased ET-1 mRNA in vascular tissue. There was no detectable difference in skin Na+: H2O in HS fed mice (0.119 +/- 0.005 mM vs. 0.127 +/- 0.007 mM; LS vs. HS); however, skin Na+: H2O was significantly increased by blockade of the endothelin type A receptor with ABT-627 (0.116 +/- 0.006 mM vs. 0.137 +/- 0.007 mM; LS vs. HS; half-maximal inhibitory concentration, 0.055 nM). ET-1 peptide content in skin tissue was increasedinfloxed control animalsonHS(85.9 +/- 0.9 pg/mg vs. 106.4 +/- 6.8 pg/mg; P < 0.05), but not in vascular endothelial cell endothelin-1 knockout (VEET KO) mice (76.46 5.7 pg/mgvs. 65.7 +/- 7.9 pg/mg; LS vs. HS). VEET KO mice also had a significantly elevated skin Na+: H2O (0.113 +/- 0.007 mM vs. 0.137 +/- 0.005 mM; LS vs. HS; P < 0.05). Finally, ET-1 production was elevated in response to increasing extracellular osmolarity in cultured human endothelial cells. These data support the hypothesis that increased extrarenal vascular ET-1 production in response to HS intake is mediated by increased extracellular osmolarity and plays a critical role in regulating skin storage of Na+.	[Speed, Joshua S.; Hyndman, Kelly A.; Fox, Brandon M.; Patel, Vivek; Pollock, Jennifer S.; Pollock, David M.] Univ Alabama Birmingham, Div Nephrol, Dept Med, Cardiorenal Physiol & Med, Birmingham, AL 35233 USA; [Heimlich, J. Brett] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Yanagisawa, Masashi] Univ Tsukuba, Ctr Behav Mol Genet, Tsukuba, Ibaraki, Japan; [Titze, Jens M.] Vanderbilt Univ, Dept Med, Nashville, TN USA	University of Alabama System; University of Alabama Birmingham; University System of Georgia; Augusta University; University of Tsukuba; Vanderbilt University	Pollock, DM (corresponding author), Univ Alabama Birmingham, Div Nephrol, Dept Med, Cardiorenal Physiol & Med, Birmingham, AL 35233 USA.	dpollock@uab.edu	Titze, Jens/GXV-1636-2022	Fox, Brandon/0000-0003-2242-2477; Hyndman, Kelly/0000-0002-8465-2588; Titze, Jens/0000-0001-8463-8404	American Heart Association; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK079337]; NIH National Heart, Lung, and Blood Institute [HL69999, HL95499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL127178, P01HL069999, P01HL095499, R01HL118579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007545, P30DK079337, F30DK107194] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ABT-627 was provided as a gift from AbbVie Inc. (North Chicago, IL, USA). This work was financially supported by a fellowship from the American Heart Association (to J.S.S.), an institutional training grant from U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK079337 to J.S.S.), and program project grants from the NIH National Heart, Lung, and Blood Institute (HL69999 and HL95499 to D.M.P. and J.S.P., respectively).	Boesen EI, 2007, AM J PHYSIOL-RENAL, V292, pF185, DOI 10.1152/ajprenal.00021.2006; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Dahlmann A, 2015, KIDNEY INT, V87, P434, DOI 10.1038/ki.2014.269; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; KOHAN DE, 1993, J CLIN INVEST, V91, P1235, DOI 10.1172/JCI116286; Kohan DE, 2011, COMPR PHYSIOL, V1, P883, DOI 10.1002/cphy.c100039; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Kopp C, 2013, HYPERTENSION, V61, P635, DOI 10.1161/HYPERTENSIONAHA.111.00566; Machnik A, 2010, HYPERTENSION, V55, P755, DOI 10.1161/HYPERTENSIONAHA.109.143339; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollock DM, 2001, AM J PHYSIOL-RENAL, V281, pF144, DOI 10.1152/ajprenal.2001.281.1.F144; Saleh MA, 2010, HYPERTENSION, V56, P942, DOI 10.1161/HYPERTENSIONAHA.110.156570; Sasser JM, 2002, AM J PHYSIOL-REG I, V283, pR243, DOI 10.1152/ajpregu.00086.2002; Stuart D, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-166; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Titze J, 2003, AM J PHYSIOL-RENAL, V285, pF1108, DOI 10.1152/ajprenal.00200.2003; Titze J, 2002, AM J PHYSIOL-RENAL, V283, pF134, DOI 10.1152/ajprenal.00323.2001; Titze J, 2010, CURR OPIN NEPHROL HY, V19, P385, DOI 10.1097/MNH.0b013e32833aeb3b; Titze J, 2009, SEMIN DIALYSIS, V22, P253, DOI 10.1111/j.1525-139X.2009.00569.x; Tsai YH, 2006, EXP BIOL MED, V231, P813; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Winn M, 1996, J MED CHEM, V39, P1039, DOI 10.1021/jm9505369	26	20	20	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4937	4944		10.1096/fj.15-276584	http://dx.doi.org/10.1096/fj.15-276584			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26268928	Green Published			2022-12-28	WOS:000365523600019
J	Kramer, R; Bielawski, J; Kistner-Griffin, E; Othman, A; Alecu, I; Ernst, D; Kornhauser, D; Hornemann, T; Spassieva, S				Kramer, Rita; Bielawski, Jacek; Kistner-Griffin, Emily; Othman, Alaa; Alecu, Irina; Ernst, Daniela; Kornhauser, Drew; Hornemann, Thorsten; Spassieva, Stefka			Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy	FASEB JOURNAL			English	Article						chemotherapy; 1-deoxyceramide; sphingolipid; serine palmitoyltransferase	TANDEM MASS-SPECTROMETRY; L-SERINE; THERAPY; SPHINGOLIPIDS; METABOLISM; MUTATIONS; SUBUNIT; TYPE-1; AGENT; PHASE	Peripheral neuropathy is a major doselimiting side effect of paclitaxel and cisplatin chemotherapy. In the current study, we tested the involvement of a novel class of neurotoxic sphingolipids, the 1-deoxy sphingolipids. 1-Deoxysphingolipids are produced when the enzyme serine palmitoyltransferase uses L-alanine instead of L-serine as its amino acid substrate. We tested whether treatment of cells with paclitaxel (250 nM, 1 mu M) and cisplatin (250 nM, 1 mu M) would result in elevated cellular levels of 1-deoxysphingolipids. Our results revealed that paclitaxel, but not cisplatin treatment, caused a dose-dependent elevation of 1-deoxysphingolipids levels and an increase in the message and activity of serine palmitoyltransferase (P < 0.05). We also tested whether there is an association between peripheral neuropathy symptoms [evaluated by the European Organization for Research and Treatment of Cancer (EORTC) QLQ-chemotherapy-induced peripheral neuropathy-20 (CIPN20) instrument] and the 1-deoxysphingolipid plasma levels (measured by mass spectrometry) in 27 patients with breast cancer who were treated with paclitaxel chemotherapy. Our results showed that there was an association between the incidence and severity of neuropathy and the levels of very-long-chain 1-deoxyceramides such as C-24 (P < 0.05), with the strongest association being with motor neuropathy (P < 0.001). Our data from cells and from patients with breast cancer suggest that 1-deoxysphingolipids, the very-long-chain in particular, play a role as molecular intermediates of paclitaxel-induced peripheral neuropathy.	[Kramer, Rita; Kornhauser, Drew; Spassieva, Stefka] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Bielawski, Jacek] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Kistner-Griffin, Emily] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Othman, Alaa; Alecu, Irina; Ernst, Daniela; Hornemann, Thorsten] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Zurich; University Zurich Hospital	Spassieva, S (corresponding author), Med Univ S Carolina, BSB, 173 Ashley Ave,Suite 104 MSC 635, Charleston, SC 29425 USA.	thorsten.hornemann@usz.ch; spassisd@musc.edu	Othman, Alaa/K-1388-2015; Othman, Alaa/AAE-5897-2019	Othman, Alaa/0000-0002-0092-5594; Othman, Alaa/0000-0002-0092-5594; Alecu, Irina/0000-0002-7659-9190	U.S. National Institutes of Health (NIH) National Cancer Institute [P30 CA138313]; Specialized Centers of Research (SCOR) Grant from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [5P50DA016511]; Zurich Center of Integrated Human Physiology (ZIHP; University of Zurich); 7th Framework Program of the European Commission ("RESOLVE") [305707]; Rare Disease Initiative Zurich (RADIZ; University of Zurich); NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA016511] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Specialized Centers of Research (SCOR) Grant from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases; Zurich Center of Integrated Human Physiology (ZIHP; University of Zurich); 7th Framework Program of the European Commission ("RESOLVE"); Rare Disease Initiative Zurich (RADIZ; University of Zurich); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Clinical Trials office at the Hollings Cancer Center (Medical University of South Carolina; MUSC) for providing help with administering the clinical trial in patients with breast cancer who were receiving paclitaxel chemotherapy; Drs. Brescia and Christiansen from the Department of Medicine (MUSC) for assisting in recruiting patients for the clinical trial; and the Lipidomics Core Facility (MUSC) for processing the lipid samples. The research was supported in part by pilot research funding from U.S. National Institutes of Health (NIH) National Cancer Institute Support Grant P30 CA138313 to the Hollings Cancer Center and Specialized Centers of Research (SCOR) Grant 5P50DA016511 from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (to R.K. and S.S.); the Zurich Center of Integrated Human Physiology (ZIHP; University of Zurich); the 7th Framework Program of the European Commission ("RESOLVE", Project 305707); and Rare Disease Initiative Zurich (RADIZ; University of Zurich) (to T.H.). A.O., I.A., D.E., D.K., and S.S. performed experiments and analyzed data; R.K. and S.S. designed and supervised the clinical trial with patients with breast cancer; R.K. recruited patients and evaluated neuropathy symptoms; J.B. developed the MS methods for quantifying individual deoxysphingolipid species; J.B. and A.O. performed MS analyses of sphingolipids; E.K.G. provided statistical analyses; and R.K., T.H., and S.S. designed the study and wrote the manuscript. The authors declare no conflicts of interest.	Auer-Grumbach M, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-7; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; Baird RD, 2009, MOL CANCER THER, V8, P1430, DOI 10.1158/1535-7163.MCT-08-1167; Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; EISEMAN JL, 1994, CANCER CHEMOTH PHARM, V34, P465, DOI 10.1007/BF00685656; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Janes K, 2014, J BIOL CHEM, V289, P21082, DOI 10.1074/jbc.M114.569574; Kaley TJ, 2009, BRIT J HAEMATOL, V145, P3, DOI 10.1111/j.1365-2141.2008.07558.x; Kiya T, 2011, NEUROSCIENCE, V174, P190, DOI 10.1016/j.neuroscience.2010.11.046; Ksiazek M, 2015, J LIPID RES, V56, P1271, DOI 10.1194/jlr.R059543; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Loprinzi CL, 2011, J CLIN ONCOL, V29, P1472, DOI 10.1200/JCO.2010.33.0308; Massard C, 2012, INVEST NEW DRUG, V30, P2318, DOI 10.1007/s10637-011-9772-8; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Missmer SA, 2006, ENVIRON HEALTH PERSP, V114, P237, DOI 10.1289/ehp.8221; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Postma TJ, 2005, EUR J CANCER, V41, P1135, DOI 10.1016/j.ejca.2005.02.012; Reeves BN, 2012, CANCER-AM CANCER SOC, V118, P5171, DOI 10.1002/cncr.27489; Rotthier A, 2011, HUM MUTAT, V32, pE2211, DOI 10.1002/humu.21481; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schneider BP, 2012, J CLIN ONCOL, V30, P3051, DOI 10.1200/JCO.2011.39.8446; Schoffski P, 2011, CANCER CHEMOTH PHARM, V68, P1397, DOI 10.1007/s00280-011-1612-1; SEEWALDT VL, 1994, GYNECOL ONCOL, V55, P456, DOI 10.1006/gyno.1994.1322; Shayman JA, 2014, J LIPID RES, V55, P993, DOI 10.1194/jlr.E049817; Speck RM, 2013, J ONCOL PRACT, V9, pE234, DOI 10.1200/JOP.2012.000863; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6	35	51	53	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4461	4472		10.1096/fj.15-272567	http://dx.doi.org/10.1096/fj.15-272567			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26198449	Green Published			2022-12-28	WOS:000364514700007
J	Thievessen, I; Fakhri, N; Steinwachs, J; Kraus, V; McIsaac, RS; Gao, L; Chen, BC; Baird, MA; Davidson, MW; Betzig, E; Oldenbourg, R; Waterman, CM; Fabry, B				Thievessen, Ingo; Fakhri, Nikta; Steinwachs, Julian; Kraus, Viola; McIsaac, R. Scott; Gao, Liang; Chen, Bi-Chang; Baird, Michelle A.; Davidson, Michael W.; Betzig, Eric; Oldenbourg, Rudolf; Waterman, Clare M.; Fabry, Ben			Vinculin is required for cell polarization, migration, and extracellular matrix remodeling in 3D collagen	FASEB JOURNAL			English	Article						3D cell migration; cell morphodynamics; traction force generation; integrin	ADHESION; TISSUE; MORPHOGENESIS; RECRUITMENT; MOVEMENT; SURVIVAL; INVASION; DEFECTS; TENSION	Vinculin is filamentous (F)-actin-binding protein enriched in integrin-based adhesions to the extracellular matrix (ECM). Whereas studies in 2-dimensional (2D) tissue culture models have suggested that vinculin negatively regulates cell migration by promoting cytoskeleton-ECM coupling to strengthen and stabilize adhesions, its role in regulating cell migration in more physiologic, 3-dimensional (3D) environments is unclear. To address the role of vinculin in 3D cell migration, we analyzed the morphodynamics, migration, and ECM remodeling of primary murine embryonic fibroblasts (MEFs) with cre/loxP-mediated vinculin gene disruption in 3D collagen I cultures. We found that vinculin promoted 3D cell migration by increasing directional persistence. Vinculin was necessary for persistent cell protrusion, cell elongation, and stable cell orientation in 3D collagen, but was dispensable for lamellipodia formation, suggesting that vinculin-mediated cell adhesion to the ECM is needed to convert actin-based cell protrusion into persistent cell shape change and migration. Consistent with this finding, vinculin was necessary for efficient traction force generation in 3D collagen without affecting myosin II activity and promoted 3D collagen fiber alignment and macroscopical gel contraction. Our results suggest that vinculin promotes directionally persistent cell migration and tension-dependent ECM remodeling in complex 3D environments by increasing cell-ECM adhesion and traction force generation.	[Thievessen, Ingo; Waterman, Clare M.] NHLBI, Lab Cell & Tissue Morphodynam, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Thievessen, Ingo; Steinwachs, Julian; Kraus, Viola; Fabry, Ben] Univ Erlangen Nurnberg, Biophys Grp, Dept Phys, D-91054 Erlangen, Germany; [Thievessen, Ingo; Fakhri, Nikta; McIsaac, R. Scott; Gao, Liang; Chen, Bi-Chang; Baird, Michelle A.; Davidson, Michael W.; Betzig, Eric; Waterman, Clare M.] Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA; [Oldenbourg, Rudolf] Marine Biol Lab, Cellular Dynam Program, Woods Hole, MA 02543 USA; [Fakhri, Nikta] Univ Gottingen, Phys Inst Biophys 3, D-37073 Gottingen, Germany; [Fakhri, Nikta] MIT, Dept Phys, Phys Living Syst, Cambridge, MA 02139 USA; [McIsaac, R. Scott] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [McIsaac, R. Scott] Calif Life Co, San Francisco, CA USA; [Gao, Liang; Chen, Bi-Chang; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA USA; [Gao, Liang] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Chen, Bi-Chang] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Erlangen Nuremberg; Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole; University of Gottingen; Massachusetts Institute of Technology (MIT); Princeton University; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Academia Sinica - Taiwan; State University System of Florida; Florida State University	Thievessen, I (corresponding author), Univ Erlangen Nurnberg, Biophys Grp, Dept Phys, Henkestr 91, D-91054 Erlangen, Germany.	ithievessen@biomed.uni-erlangen.de	Chen, Bi-Chang/F-3480-2014; Fabry, Ben/AAT-5717-2020; Fakhri, Nikta/B-4657-2008; Fabry, Ben/C-5496-2013	Chen, Bi-Chang/0000-0002-1876-7432; Fabry, Ben/0000-0003-1737-0465; Fakhri, Nikta/0000-0003-1261-7465; Fabry, Ben/0000-0003-1737-0465	NIH NHLBI Division of Intramural Research; Deutsche Forschungsgemeinschaft; Human Frontier Science Program Fellowship; U.S. National Science Foundation Graduate Research Fellowship Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104, ZIAHL005105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM085967] Funding Source: NIH RePORTER	NIH NHLBI Division of Intramural Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Fellowship(Human Frontier Science Program); U.S. National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) Flow Cytometry Core Facility, for fluorescence-activated cell sorting, Silvio Gutkind for adenovirus, and Robert Fischer for helpful discussion. This work was supported by the NIH NHLBI Division of Intramural Research (C.M.W. and I.T.), Deutsche Forschungsgemeinschaft (B.F., I.T., and J.S.), the Human Frontier Science Program Fellowship (N.F.), and the U.S. National Science Foundation Graduate Research Fellowship Program (R.S.M.).	Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bradbury P, 2012, CELL ADHES MIGR, V6, P424, DOI 10.4161/cam.21559; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Haigo SL, 2011, SCIENCE, V331, P1071, DOI 10.1126/science.1199424; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lang NR, 2015, ACTA BIOMATER, V13, P61, DOI 10.1016/j.actbio.2014.11.003; Lang NR, 2013, BIOPHYS J, V105, P1967, DOI 10.1016/j.bpj.2013.09.038; Legant WR, 2012, INTEGR BIOL-UK, V4, P1164, DOI 10.1039/c2ib20059g; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; OLDENBOURG R, 1995, J MICROSC-OXFORD, V180, P140, DOI 10.1111/j.1365-2818.1995.tb03669.x; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Shin W.D., 2010, LIVE CELL IMAGING LA, Vsecond; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Wen Q, 2013, EXP CELL RES, V319, P2481, DOI 10.1016/j.yexcr.2013.05.017; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Xu WM, 1998, DEVELOPMENT, V125, P327	41	60	61	3	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4555	4567		10.1096/fj.14-268235	http://dx.doi.org/10.1096/fj.14-268235			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26195589	Green Published			2022-12-28	WOS:000364514700015
J	Tora, AS; Rovira, X; Dione, I; Bertrand, HO; Brabet, I; De Koninck, Y; Doyon, N; Pin, JP; Acher, F; Goudet, C				Tora, Amelie S.; Rovira, Xavier; Dione, Ibrahima; Bertrand, Hugues-Olivier; Brabet, Isabelle; De Koninck, Yves; Doyon, Nicolas; Pin, Jean-Philippe; Acher, Francine; Goudet, Cyril			Allosteric modulation of metabotropic glutamate receptors by chloride ions	FASEB JOURNAL			English	Article						allostery; GABA; GPCR; PAM; anion	CALCIUM-SENSING RECEPTOR; BINDING-SITE; MOLECULAR DETERMINANTS; EXTRACELLULAR-SPACE; LIGAND-BINDING; IDENTIFICATION; NEURONS; GABA(A); AGONIST; DOMAIN	Metabotropic glutamate receptors (mGluRs) play key roles in the modulation of many synapses. Chloride (Cl-) is known to directly bind and regulate the function of different actors of neuronal activity, and several studies have pointed to the possible modulation of mGluRs by Cl-. Herein, we demonstrate that Cl- behaves as a positive allosteric modulator of mGluRs. For example, whereas glutamate potency was 3.08 +/- 0.33 mM on metabotropic glutamate (mGlu) 4 receptors in high-Cl- buffer, signaling activity was almost abolished in low Cl- in cell-based assays. Cl- potency was 78.6 +/- 3.5 mM. Cl- possesses a high positive cooperativity with glutamate (Hill slope approximate to 6 on mGlu4), meaning that small variations in [Cl-] lead to large variations in glutamate action. Using molecular modeling and mutagenesis, we have identified 2 well-conserved Cl- binding pockets in the extracellular domain of mGluRs. Moreover, modeling of activity-dependent Cl- variations at GABAergic synapses suggests that these variations may be compatible with a dynamic modulation of the most sensitive mGluRs present in these synapses. Taken together, these data reveal a necessary role of Cl- for the glutamate activation of many mGluRs. Exploiting Cl- binding pockets may yield to the development of innovative regulators of mGluR activity.	[Tora, Amelie S.; Rovira, Xavier; Brabet, Isabelle; Pin, Jean-Philippe; Goudet, Cyril] Univ Montpellier, Inst Genom Fonctionnelle, CNRS, UMR 5203, F-34059 Montpellier, France; [Tora, Amelie S.; Rovira, Xavier; Brabet, Isabelle; Pin, Jean-Philippe; Goudet, Cyril] INSERM, U1191, Montpellier, France; [Dione, Ibrahima; De Koninck, Yves; Doyon, Nicolas] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Dione, Ibrahima; De Koninck, Yves; Doyon, Nicolas] Univ Laval, Quebec City, PQ, Canada; [Bertrand, Hugues-Olivier] Biovia Dassault Syst, Orsay, France; [Acher, Francine] Univ Paris 05, Sorbonne Paris Cite, Lab Chim & Biochim Pharmacol & Toxicol, CNRS,UMR 8601, F-75270 Paris 6, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Acher, F (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Lab Chim & Biochim Pharmacol & Toxicol, CNRS,UMR 8601, 45 Rue St Peres, F-75270 Paris 6, France.	francine.acher@parisdescartes.fr; cyril.goudet@igf.cnrs.fr	De Koninck, Yves/C-2659-2008; Pin, Jean-Philippe/Y-6668-2019; Goudet, Cyril/AAE-3415-2020; Algans, Xavier Rovira/M-4669-2015	De Koninck, Yves/0000-0002-5779-9330; Pin, Jean-Philippe/0000-0002-1423-345X; Goudet, Cyril/0000-0002-8255-3535; Algans, Xavier Rovira/0000-0002-9764-9927	Fondation Recherche Medicale [DEQ20130326522, FDT20140931071]; Fundacio La Marato de TV3 [110232]; Eranet Neuron; Agence Nationale de la Recherche [ANR-12-NEUR-0003, ANR-13-BSV1-006]; Natural Sciences and Engineering Council of Canada; Fonds de Recherche Quebec Nature et Technologie; Ministere de l'Education Nationale et de la Recherche; Centre National de la Recherche Scientifique; Canadian Institutes of Health Neurophysics training program	Fondation Recherche Medicale; Fundacio La Marato de TV3; Eranet Neuron; Agence Nationale de la Recherche(French National Research Agency (ANR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Quebec Nature et Technologie; Ministere de l'Education Nationale et de la Recherche; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Canadian Institutes of Health Neurophysics training program(Canadian Institutes of Health Research (CIHR))	The authors thank Ebba L. Lagerqvist and Thierry Durroux from the Institut de Genomique Fonctionnelle for helpful discussions and critical reading of the manuscript. This work was supported by grants from the Fondation Recherche Medicale (team DEQ20130326522), the Fundacio La Marato de TV3 (reference 110232), Eranet Neuron, the Agence Nationale de la Recherche (ANR-12-NEUR-0003 and ANR-13-BSV1-006), the Natural Sciences and Engineering Council of Canada (to Y.D.K.), and the Fonds de Recherche Quebec Nature et Technologie (to N.D.). Cell-based pharmacologic assays were performed on the ARPEGE (Pharmacology Screening-Interactome) platform facility at the Institut de Genomique Fonctionnelle. The Institut de Genomique Fonctionnelle belongs to the Laboratories of Excellence, Ion Channel Science and Therapeutics, and EpiGenMed. A.S.T. was supported by a Ph.D. fellowship from the Ministere de l'Education Nationale et de la Recherche and by the Fondation Recherche Medicale (FDT20140931071) and X.R. by the Beatriu de Pinos program of Agencia de Gestio d'Ajuts Universitaris i de Recerca. I.B., J.-P.P., F.A., and C.G. were supported by the Centre National de la Recherche Scientifique. I.D. was supported by a fellowship from the Canadian Institutes of Health Neurophysics training program. A.S.T., X.R., N.D., F.A., and C.G. designed the research. A.S.T., X.R., I.D., H.-O.B., I.B.,and N.D. performed the research. F.A., H.-O.B., and N.D. contributed new reagents or analytic tools. A.S.T., X.R., I.D., H.-O.B., I.B., Y.D.K., N.D., J.-P.P., F.A., and C.G. analyzed the data. A.S.T., N.D., J.-P.P., F.A., and C.G. wrote the paper. The authors declare no conflicts of interest.	Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; Acher FC, 2011, NEUROPHARMACOLOGY, V60, P102, DOI 10.1016/j.neuropharm.2010.07.002; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bertrand HO, 2002, J MED CHEM, V45, P3171, DOI 10.1021/jm010323l; Blahos J, 1998, J BIOL CHEM, V273, P25765, DOI 10.1074/jbc.273.40.25765; Bois R, 2012, COMPUT METHOD APPL M, V209, P12, DOI 10.1016/j.cma.2011.10.001; Borre L, 2014, J BIOL CHEM, V289, P25764, DOI 10.1074/jbc.M114.574269; Brooks BR, 1983, J COMPUT CHEM, V4, P187; Brumback AC, 2008, J NEUROSCI, V28, P1301, DOI 10.1523/JNEUROSCI.3378-07.2008; Carnevale NT, 2006, NEURON BOOK; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dhingra Anuradha, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P641; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Eriksen L, 1995, BRIT J PHARMACOL, V116, P3279, DOI 10.1111/j.1476-5381.1995.tb15136.x; Ferraguti F, 2005, J NEUROSCI, V25, P10520, DOI 10.1523/JNEUROSCI.2547-05.2005; Francesconi A, 2004, J NEUROSCI RES, V75, P472, DOI 10.1002/jnr.10853; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Goudet C, 2012, FASEB J, V26, P1682, DOI 10.1096/fj.11-195941; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; Jiang JY, 2014, J BIOL CHEM, V289, P1649, DOI 10.1074/jbc.M113.507665; Jiang YS, 2010, J BIOL CHEM, V285, P33463, DOI 10.1074/jbc.M110.147033; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kinney J. P., 2009, THESIS U CALIFORNIA; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kuang D, 2006, BIOCHEM BIOPH RES CO, V345, P1, DOI 10.1016/j.bbrc.2006.04.064; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Lopreore CL, 2008, BIOPHYS J, V95, P2624, DOI 10.1529/biophysj.108.132167; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Luu P, 2004, J NEUROSCI, V24, P10128, DOI 10.1523/JNEUROSCI.3117-04.2004; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Miyashita T, 2000, RECEPTOR CHANNEL, V7, P25; Monn JA, 2015, J MED CHEM, V58, P1776, DOI 10.1021/jm501612y; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nash MS, 2001, J BIOL CHEM, V276, P19286, DOI 10.1074/jbc.M007600200; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ogawa H, 2010, PROTEIN SCI, V19, P544, DOI 10.1002/pro.332; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Preobraschenski J, 2014, NEURON, V84, P1287, DOI 10.1016/j.neuron.2014.11.008; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Rovira X, 2015, FASEB J, V29, P116, DOI 10.1096/fj.14-257287; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders R, 1998, NEUROPHARMACOLOGY, V37, P273, DOI 10.1016/S0028-3908(98)00027-6; Selvam C, 2010, J MED CHEM, V53, P2797, DOI 10.1021/jm901523t; Somogyi P, 2003, EUR J NEUROSCI, V17, P2503, DOI 10.1046/j.1460-9568.2003.02697.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tabata T, 2002, MOL CELL NEUROSCI, V20, P56, DOI 10.1006/mcne.2002.1118; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; VANHARREVELD A, 1965, J CELL BIOL, V25, P117, DOI 10.1083/jcb.25.1.117; Wright RA, 2001, J PHARMACOL EXP THER, V298, P453; Wright RA, 2000, N-S ARCH PHARMACOL, V362, P546, DOI 10.1007/s002100000305; Zhang C, 2014, J BIOL CHEM, V289, P5296, DOI 10.1074/jbc.M113.537357	72	21	22	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4174	4188		10.1096/fj.14-269746	http://dx.doi.org/10.1096/fj.14-269746			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26116702				2022-12-28	WOS:000361367300008
J	Bruban, J; Voloudakis, G; Huang, Q; Kajiwara, Y; Al Rahim, M; Yoon, Y; Shioi, J; Sosa, MAG; Shao, ZP; Georgakopoulos, A; Robakis, NK				Bruban, Julien; Voloudakis, Georgios; Huang, Qian; Kajiwara, Yuji; Al Rahim, Md; Yoon, Yonejung; Shioi, Junichi; Sosa, Miguel A. Gama; Shao, Zhiping; Georgakopoulos, Anastasios; Robakis, Nikolaos K.			Presenilin 1 is necessary for neuronal, but not glial, EGFR expression and neuroprotection via gamma-secretase-independent transcriptional mechanisms	FASEB JOURNAL			English	Article						Alzheimer disease; EGFR mRNA; neurodegeneration; survival signaling	GROWTH-FACTOR RECEPTOR; AMYLOID PRECURSOR PROTEIN; MICE LACKING; PHOSPHATIDYLINOSITOL 3-KINASE; SYNAPTIC PLASTICITY; IN-VITRO; BINDING; PHOSPHORYLATION; SURVIVAL; MEMORY	Epidermal growth factor receptor (EGFR) plays pivotal roles in cell proliferation, differentiation, and tissue development, while EGFs protect neurons from toxic insults by binding EGFR and stimulating survival signaling. Furthermore, recent evidence implicates this receptor in neurometabolic disorders like Alzheimer disease and aging. Here we show that absence of presenilin 1 (PS1) results in dramatic decrease (>95%) of neuronal EGFR and that PS1-null (PS1(-/-)) brains have reduced amounts of this receptor. PS1(-/-) cortical neurons contain little EGFR and show no epidermal growth factor-induced survival signaling or protection against excitotoxicity, but exogenous EGFR rescues both functions even in absence of PS1. EGFR mRNA is greatly reduced (>95%) in PS1(-/-) neurons, and PS1(-/-) brains contain decreased amounts of this mRNA, although PS1 affects the stability of neither EGFR nor its mRNA. Exogenous PS1 increases neuronal EGFR mRNA, while down-regulation of PS1 decreases this mRNA. These effects are neuron specific, as PS1 affects the EGFR of neither glial nor fibroblast cells. In addition, PS1 controls EGFR through novel mechanisms shared with neither gamma-secretase nor PS2. Our data reveal that PS1 functions as a positive transcriptional regulator of neuronal EGFR controlling its expression in a cell-specific manner. Severe downregulation of EGFR may contribute to developmental abnormalities and lethal phenotype found in PS1, but not PS2, null mice. Furthermore, PS1 may affect neuroprotection and Alzheimer disease by controlling survival signaling of neuronal EGFR.	[Bruban, Julien; Voloudakis, Georgios; Huang, Qian; Kajiwara, Yuji; Al Rahim, Md; Yoon, Yonejung; Shioi, Junichi; Shao, Zhiping; Georgakopoulos, Anastasios; Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Dept Psychiat, Ctr Mol Biol & Genet Neurodegenerat, New York, NY 10029 USA; [Bruban, Julien; Voloudakis, Georgios; Huang, Qian; Kajiwara, Yuji; Al Rahim, Md; Yoon, Yonejung; Shioi, Junichi; Shao, Zhiping; Georgakopoulos, Anastasios; Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Dept Neurosci, Ctr Mol Biol & Genet Neurodegenerat, New York, NY 10029 USA; [Voloudakis, Georgios] Univ Crete, Sch Med, Iraklion, Crete, Greece; [Sosa, Miguel A. Gama] James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Crete	Robakis, NK (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, Ctr Mol Biol & Genet Neurodegenerat, Box 1229,One Gustave L Levy Pl, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Robakis, Nikolaos/AAA-1838-2021; Voloudakis, Georgios/B-8858-2019	Voloudakis, Georgios/0000-0002-5729-632X; Georgakopoulos, Anastasios/0000-0001-8241-6306; kajiwara, yuji/0000-0002-9307-8215; Yoon, YoneJung/0000-0002-1608-2122	U.S. National Institutes of Health (NIH) from National Institute on Aging [AG-17926, AG-08200, AG-05138]; NIH from National Institute of Neurological Disorders and Stroke [NS047229]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG017926, R01AG008200, P50AG005138, R01AG017926] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) from National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by U.S. National Institutes of Health (NIH) Grants AG-17926, AG-08200, and AG-05138 from the National Institute on Aging, and NIH NS047229 from the National Institute of Neurological Disorders and Stroke.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Berasain Carmen, 2011, Cancers (Basel), V3, P2444, DOI 10.3390/cancers3022444; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; Conejero-Goldberg C, 2011, MOL PSYCHIATR, V16, P836, DOI 10.1038/mp.2010.57; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Farkas LM, 2002, J NEURAL TRANSM, V109, P267, DOI 10.1007/s007020200022; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Gadadhar A, 2011, J NEUROSCI, V31, P2615, DOI 10.1523/JNEUROSCI.4767-10.2011; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hanke M, 2004, NEUROSCIENCE, V124, P757, DOI 10.1016/j.neuroscience.2003.12.033; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jin KL, 2005, J NEUROSCI RES, V81, P497, DOI 10.1002/jnr.20510; Kim HJ, 2011, METHODS MOL BIOL, V793, P63, DOI 10.1007/978-1-61779-328-8_4; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Opanashuk LA, 1999, J NEUROSCI, V19, P133, DOI 10.1523/JNEUROSCI.19-01-00133.1999; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Rocher-Ros V, 2010, ONCOGENE, V29, P2950, DOI 10.1038/onc.2010.57; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Siddiqui S, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/739428; Song X, 2012, HEAD NECK ONCOL, V4, P47; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Xuan Z, 2013, J BIOL CHEM, V288, P30495, DOI 10.1074/jbc.M113.499004; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	53	16	19	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3702	3712		10.1096/fj.15-270645	http://dx.doi.org/10.1096/fj.15-270645			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25985800	Green Published			2022-12-28	WOS:000359915600009
J	Sutherland, JM; Sobinoff, AP; Fraser, BA; Redgrove, KA; Davidson, TL; Siddall, NA; Koopman, P; Hime, GR; McLaughlin, EA				Sutherland, Jessie M.; Sobinoff, Alexander P.; Fraser, Barbara A.; Redgrove, Kate A.; Davidson, Tara-Lynne; Siddall, Nicole A.; Koopman, Peter; Hime, Gary R.; McLaughlin, Eileen A.			RNA binding protein Musashi-1 directly targets Msi2 and Erh during early testis germ cell development and interacts with IPO5 upon translocation to the nucleus	FASEB JOURNAL			English	Article						MSI1; posttranscriptional regulation; RBP; spermatogenesis	MESSENGER-RNA; IMPORTIN BETA; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; TRANSLATION; ENHANCER; ABSENCE; NEURONS; CYCLE; FATE	Controlled gene regulation during gamete development is vital for maintaining reproductive potential. During the process of gamete development, male germ cells experience extended periods of inactive transcription despite requirements for continued growth and differentiation. Spermatogenesis therefore provides an ideal model to study the effects of posttranscriptional control on gene regulation. During spermatogenesis posttranscriptional regulation is orchestrated by abundantly expressed RNA-binding proteins. One such group of RNA binding proteins is the Musashi family, previously identified as a critical regulator of testis germ cell development and meiosis in Drosophila and also shown to be vital to sperm development and reproductive potential in the mouse. We focus in depth on the role and function of the vertebrate Musashi ortholog Musashi-1 (MSI1). Through detailed expression studies and utilizing our novel transgenic Msi1 testis-specific overexpression model, we have identified 2 unique RNA-binding targets of MSI1 in spermatogonia, Msi2 and Erh, and have demonstrated a role for MSI1 in translational regulation. We have also provided evidence to suggest that nuclear import protein, IPO5, facilitates the nuclear translocation of MSI1 to the transcriptionally silenced XY chromatin domain in meiotic pachytene spermatocytes, resulting in the release of MSI1 RNA-binding targets. This firmly establishes MSI1 as a master regulator of posttranscriptional control during early spermatogenesis and highlights the significance of the subcellular localization of RNA binding proteins in relation to their function.	[Sutherland, Jessie M.; Sobinoff, Alexander P.; Fraser, Barbara A.; Redgrove, Kate A.; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Davidson, Tara-Lynne; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Siddall, Nicole A.; Hime, Gary R.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia	University of Newcastle; University of Queensland; University of Melbourne	McLaughlin, EA (corresponding author), Univ Newcastle, Prior Res Ctr Chem Biol, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	eileen.mclaughlin@newcastle.edu.au	McLaughlin, Eileen/AAF-5588-2021; Koopman, Peter A/C-9416-2009; McLaughlin, Eileen A/G-7620-2013; Hime, Gary/B-7162-2015	Koopman, Peter A/0000-0001-6939-0914; McLaughlin, Eileen/0000-0002-5837-3876; Sobinoff, Alexander/0000-0001-6679-5211; Redgrove, Kate/0000-0002-9229-299X; Hime, Gary/0000-0003-4732-3184; Sutherland, Jessie/0000-0001-9672-2371	Australian Research Council; National Health and Medical Research Council; Hunter Medical Research Institute; ARC Centre of Excellence in Biotechnology; Australian Postgraduate Award Ph.D. scholarship	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; ARC Centre of Excellence in Biotechnology(Australian Research Council); Australian Postgraduate Award Ph.D. scholarship	Financial assistance was provided to E.A.M. and G.R.H. by the Australian Research Council, National Health and Medical Research Council, and Hunter Medical Research Institute. Additional support was provided the ARC Centre of Excellence in Biotechnology (to E.A.M., P.K., and G.R.H.). J.M.S. is supported by an Australian Postgraduate Award Ph.D. scholarship.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Akindahunsi AA, 2005, COMPUT BIOL CHEM, V29, P13, DOI 10.1016/j.compbiolchem.2004.11.002; Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Cragle C, 2014, J BIOL CHEM, V289, P14239, DOI 10.1074/jbc.M114.548271; Davies RG, 2013, BBA-MOL CELL RES, V1833, P3436, DOI 10.1016/j.bbamcr.2013.05.015; Fineberg K, 2003, BIOCHEMISTRY-US, V42, P2625, DOI 10.1021/bi0206199; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Gotte M, 2011, INT J CANCER, V129, P2042, DOI 10.1002/ijc.25856; GU W, 1995, MOL REPROD DEV, V40, P273, DOI 10.1002/mrd.1080400303; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Itman C, 2009, SEMIN CELL DEV BIOL, V20, P607, DOI 10.1016/j.semcdb.2009.05.002; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawase S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-14; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Li SM, 1998, J BIOL CHEM, V273, P31191, DOI 10.1074/jbc.273.47.31191; MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528; Major AT, 2011, BBA-MOL CELL RES, V1813, P1668, DOI 10.1016/j.bbamcr.2011.03.008; Nickerson PEB, 2011, EXP EYE RES, V92, P344, DOI 10.1016/j.exer.2011.02.002; Nishimoto Y, 2010, CELL RES, V20, P1083, DOI 10.1038/cr.2010.122; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Sobinoff AP, 2013, TOXICOL APPL PHARM, V271, P156, DOI 10.1016/j.taap.2013.05.009; Sobinoff AP, 2010, TOXICOL SCI, V118, P653, DOI 10.1093/toxsci/kfq272; Sutherland JM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115261; Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3; Weng MT, 2012, P NATL ACAD SCI USA, V109, pE3659, DOI 10.1073/pnas.1207673110	49	20	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2759	2768		10.1096/fj.14-265868	http://dx.doi.org/10.1096/fj.14-265868			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782991				2022-12-28	WOS:000356859100008
J	Yoo, SW; Motari, MG; Susuki, K; Prendergast, J; Mountney, A; Hurtado, A; Schnaar, RL				Yoo, Seung-Wan; Motari, Mary G.; Susuki, Keiichiro; Prendergast, Jillian; Mountney, Andrea; Hurtado, Andres; Schnaar, Ronald L.			Sialylation regulates brain structure and function	FASEB JOURNAL			English	Article						animal models; behavior; gangliosides; myelin; oligodendrocyte precursor cells	MYELIN-ASSOCIATED GLYCOPROTEIN; LACKING COMPLEX GANGLIOSIDES; GM3 SYNTHASE DEFICIENCY; GROWTH-FACTOR RECEPTOR; CRUCIAL ROLE; CELL-GROWTH; MICE; EXPRESSION; DIFFERENTIATION; BIOSYNTHESIS	Every cell expresses a molecularly diverse surface glycan coat (glycocalyx) comprising its interface with its cellular environment. In vertebrates, the terminal sugars of the glycocalyx are often sialic acids, 9-carbon backbone anionic sugars implicated in intermolecular and intercellular interactions. The vertebrate brain is particularly enriched in sialic acid-containing glycolipids termed gangliosides. Human congenital disorders of ganglioside biosynthesis result in paraplegia, epilepsy, and intellectual disability. To better understand sialoglycan functions in the nervous system, we studied brain anatomy, histology, biochemistry, and behavior in mice with engineered mutations in St3gal2 and St3gal3, sialyltransferase genes responsible for terminal sialylation of gangliosides and some glycoproteins. St3gal2/3 double-null mice displayed dysmyelination marked by a 40% reduction in major myelin proteins, 30% fewer myelinated axons, a 33% decrease in myelin thickness, and molecular disruptions at nodes of Ranvier. In part, these changes may be due to dysregulation of ganglioside-mediated oligodendroglial precursor cell proliferation. Neuronal markers were also reduced up to 40%, and hippocampal neurons had smaller dendritic arbors. Young adult St3gal2/3 double-nullmice displayed impaired motor coordination, disturbed gait, and profound cognitive disability. Comparisons among sialyltransferase mutant mice provide insights into the functional roles of brain gangliosides and sialoglycoproteins consistent with related human congenital disorders.	[Yoo, Seung-Wan; Motari, Mary G.; Prendergast, Jillian; Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hurtado, Andres] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Susuki, Keiichiro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mountney, Andrea] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD USA; [Hurtado, Andres] Kennedy Krieger, Hugo W Moser Res Inst, Int Ctr Spinal Cord Injury, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Baylor College of Medicine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Schnaar, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 725 North Wolfe St, Baltimore, MD 21205 USA.	schnaar@jhu.edu	Schnaar, Ronald L/S-8967-2016	Schnaar, Ronald L/0000-0002-7701-5484; Prendergast, Jillian/0000-0001-7965-4143	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS037096, NS057338]; U.S. National Multiple Sclerosis Society grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057338, R37NS037096, R01NS037096] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Multiple Sclerosis Society grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Jamey D. Marth (University of California, Santa Barbara, Santa Barbara, CA, USA) for providing founder mice for these studies and Alison Nairn (University of Georgia, Athens, GA, USA) for expert transcript analyses. This work was supported by U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS037096 and NS057338 (to R.L.S.) and a U.S. National Multiple Sclerosis Society grant (to Dr. Matthew N. Rasband, Department of Neuroscience, Baylor College of Medicine in support of K.S.). The views of the authors do not purport or reflect the position of the U.S. Department of the Army or the U.S. Department of Defense (para 4-3, AR 360-5). All research was conducted in compliance with the Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals (U.S. National Research Council), and other federal statutes and regulations relating to animals and experiments involving animals.	ABE A, 1995, J LIPID RES, V36, P611; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Boukhris A, 2013, AM J HUM GENET, V93, P118, DOI 10.1016/j.ajhg.2013.05.006; Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; Cummings RD, 2014, CHEM BIOL, V21, P1, DOI 10.1016/j.chembiol.2013.12.010; Edvardson S, 2013, EPILEPSIA, V54, pe24, DOI 10.1111/epi.12050; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Farrer RG, 1999, J NEUROSCI RES, V57, P371, DOI 10.1002/(SICI)1097-4547(19990801)57:3<371::AID-JNR9>3.0.CO;2-O; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hu H, 2011, AM J HUM GENET, V89, P407, DOI 10.1016/j.ajhg.2011.08.008; Kaucic K, 2006, METHOD ENZYMOL, V417, P168, DOI 10.1016/S0076-6879(06)17013-5; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Liu YH, 2004, J BIOL CHEM, V279, P36481, DOI 10.1074/jbc.M402880200; Matsuhashi H, 2003, J NEUROCHEM, V84, P53, DOI 10.1046/j.1471-4159.2003.01257.x; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Rodriguiz RM., 2006, ANIMAL MODELS COGNIT, P223; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; Schnaar RL, 2014, HDB GLYCOSYLTRANSFER, P657; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Sun J, 2004, GLYCOBIOLOGY, V14, P851, DOI 10.1093/glycob/cwh107; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; Susuki K, 2013, NEURON, V78, P469, DOI 10.1016/j.neuron.2013.03.005; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR11; Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; van der Voorn JP, 2004, ACTA NEUROPATHOL, V107, P539, DOI 10.1007/s00401-004-0848-9; Varki A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005462; Wang H, 2013, AM J MED GENET A, V161A, P875, DOI 10.1002/ajmg.a.35826; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; Yao DG, 2014, J NEUROSCI, V34, P880, DOI 10.1523/JNEUROSCI.3996-13.2014; YIM SH, 1995, DEV NEUROSCI-BASEL, V17, P171, DOI 10.1159/000111285; Zhu Q, 2014, DEVELOPMENT, V141, P548, DOI 10.1242/dev.095323	58	54	54	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3040	3053		10.1096/fj.15-270983	http://dx.doi.org/10.1096/fj.15-270983			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25846372	Green Published			2022-12-28	WOS:000356859100031
J	Henique, C; Mansouri, A; Vavrova, E; Lenoir, V; Ferry, A; Esnous, C; Ramond, E; Girard, J; Bouillaud, F; Prip-Buus, C; Cohen, I				Henique, Carole; Mansouri, Abdelhak; Vavrova, Eliska; Lenoir, Veronique; Ferry, Arnaud; Esnous, Catherine; Ramond, Elodie; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle			Increasing mitochondrial muscle fatty acid oxidation induces skeletal muscle remodeling toward an oxidative phenotype	FASEB JOURNAL			English	Article						skeletal muscle plasticity; carnitine palmitoyltransferase 1; oxidative capacity; aging	CARNITINE PALMITOYLTRANSFERASE-I; INSULIN SENSITIVITY; GENE-EXPRESSION; FIBER TYPES; PPAR-BETA; EXERCISE; METABOLISM; MICE; ADAPTATION; MOUSE	Adult skeletal muscle is a dynamic, remarkably plastic tissue, which allows myofibers to switch from fast/glycolytic to slow/oxidative types and to increase mitochondrial fatty acid oxidation (mFAO) capacity and vascularization in response to exercise training. mFAO is the main muscle energy source during endurance exercise, with carnitine palmitoyltransferase 1 (CPT1) being the key regulatory enzyme. Whether increasing muscle mFAO affects skeletal muscle physiology in adulthood actually remains unknown. To investigate this, we used in vivo electrotransfer technology to express in mouse tibialis anterior (TA), a fast/glycolytic muscle, a mutated CPT1 form (CPT1mt) that is active but insensitive to malonyl-CoA, its physiologic inhibitor. In young (2-mo-old) adult mice, muscle CPT1mt expression enhanced mFAO (+40%), but also increased the percentage of oxidative fibers (+28%), glycogen content, and capillary-to-fiber density (+45%). This CPT1mt-induced muscle remodeling, which mimicked exercise-induced oxidative phenotype, led to a greater resistance to muscle fatigue. In the context of aging, characterized by sarcopenia and reduced oxidative capacity, CPT1mt expression in TAs from aged (20-mo-old) mice partially reversed aging-associated sarcopenia and fiber-type transition, and increased muscle capillarity. These findings provide evidence that mFAO regulates muscle phenotype and may be a potential target to combat age-related decline in muscle function.	[Henique, Carole; Mansouri, Abdelhak; Vavrova, Eliska; Lenoir, Veronique; Esnous, Catherine; Ramond, Elodie; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle] INSERM, Inst Cochin, U1016, Paris, France; [Henique, Carole; Mansouri, Abdelhak; Vavrova, Eliska; Lenoir, Veronique; Esnous, Catherine; Ramond, Elodie; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle] CNRS, UMR 8104, F-75014 Paris, France; [Henique, Carole; Mansouri, Abdelhak; Vavrova, Eliska; Lenoir, Veronique; Ferry, Arnaud; Esnous, Catherine; Ramond, Elodie; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Ferry, Arnaud] Univ Paris 06, INSERM, CNRS, Inst Myol,UMR 7215,UMRS 974,U974, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Prip-Buus, C (corresponding author), CNRS, Inst Cochin, INSERM, Dept Endocrinol Metab & Diabet,UMR8104,U1016, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	carina.prip-buus@inserm.fr	HENIQUE, Carole/AAR-2476-2020; Bouillaud, Frédéric R/L-3238-2017; Mansouri, Abdelhak/D-9100-2013; ferry, arnaud/D-2816-2019; PRIP-BUUS, Carina/P-9084-2017	Bouillaud, Frédéric R/0000-0002-7518-9237; Mansouri, Abdelhak/0000-0003-4471-7276; ferry, arnaud/0000-0002-6050-4556; Ramond, Elodie/0000-0003-4775-7070; HENIQUE GRECIET, Carole/0000-0001-5441-8662; Prip-Buus, Carina/0000-0002-2153-7857	Association Francaise contre les Myopathies; Ministere de l'Education Nationale de la Recherche et de la Technologie; Region Ile-de-France; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ministere de l'Education Nationale de la Recherche et de la Technologie; Region Ile-de-France(Region Ile-de-France); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques	The authors thank N. Geary (Zurich, Switzerland) for critical review of the manuscript, A. Sotiropoulos (Institut Cochin, Paris, France) for helpful IVE expertise, V. Zammit (Warwick Medical School, Coventry, United Kingdom) for kindly supplying the anti-rat CPT1B antibody, P. Maire (Institut Cochin, Paris, France) for the anti-MyHC isoforms antibodies, M. Favier from the Cochin HistIM (Histology, Immunostaining, Laser Microdissection) Facility for muscle cryo-sections, and the Cochin Imaging Facility for image acquisition. This research was supported by a grant from the Association Francaise contre les Myopathies. C.H. was supported by a graduate fellowship from the Ministere de l'Education Nationale de la Recherche et de la Technologie, E.V. by a graduate fellowship from the Region Ile-de-France, and A.M. by a postdoctoral award from the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques. The authors declare no conflicts of interest.	Akkaoui M, 2009, BIOCHEM J, V420, P429, DOI 10.1042/BJ20081932; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bertrand A, 2003, AM J PHYSIOL-CELL PH, V285, pC1071, DOI 10.1152/ajpcell.00104.2003; Carnevali LC, 2012, BRAZ J MED BIOL RES, V45, P777, DOI 10.1590/S0100-879X2012007500105; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P927, DOI 10.1093/gerona/glp066; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gaudel C, 2008, AM J PHYSIOL-ENDOC M, V295, pE297, DOI 10.1152/ajpendo.00581.2007; Giordano C, 2009, PFLUG ARCH EUR J PHY, V458, P901, DOI 10.1007/s00424-009-0676-9; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2009, AM J PHYSIOL-REG I, V297, pR960, DOI 10.1152/ajpregu.91021.2008; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; McFarlan JT, 2012, J BIOL CHEM, V287, P23502, DOI 10.1074/jbc.M111.315358; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Mouisel E, 2006, NEUROSCI RES, V55, P389, DOI 10.1016/j.neures.2006.05.002; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Niu YM, 2010, INT J SPORT NUTR EXE, V20, P370, DOI 10.1123/ijsnem.20.5.370; Philp A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1343, DOI 10.1152/ajpendo.00004.2012; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; RANDLE PJ, 1963, LANCET, V1, P785; Regnault TRH, 2010, PPAR RES, V2010, DOI 10.1155/2010/129173; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; SIECK GC, 1986, J APPL PHYSIOL, V60, P1284, DOI 10.1152/jappl.1986.60.4.1284; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001; van der Leij FR, 2002, J BIOL CHEM, V277, P26994, DOI 10.1074/jbc.M203189200; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yuan H, 2014, ACTA PHYSIOL, V212, P283, DOI 10.1111/apha.12395; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	54	31	33	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2473	2483		10.1096/fj.14-257717	http://dx.doi.org/10.1096/fj.14-257717			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713059				2022-12-28	WOS:000355209500024
J	Christensen, PM; Liu, CH; Swendeman, SL; Obinata, H; Qvortrup, K; Nielsen, LB; Hla, T; Di Lorenzo, A; Christoffersen, C				Christensen, Pernille M.; Liu, Catherine H.; Swendeman, Steven L.; Obinata, Hideru; Qvortrup, Klaus; Nielsen, Lars B.; Hla, Timothy; Di Lorenzo, Annarita; Christoffersen, Christina			Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1	FASEB JOURNAL			English	Article						vascular permeability; endothelium; inflammation	SPHINGOSINE 1-PHOSPHATE; PAW EDEMA; MOUSE; INFLAMMATION; REVEALS	Apolipoprotein M (ApoM) transports sphingosine-1-phosphate (S1P) in plasma, and ApoM-deficient mice (Apom(-/-)) have approximate to 50% reduced plasma S1P levels. There are 5 known S1P receptors, and S1P induces adherens junction formation between endothelial cells through the S1P(1) receptor, which in turn suppresses vascular leak. Increased vascular permeability is a hallmark of inflammation. The purpose of this study was to explore the relationships between vascular leakage in ApoM deficiency and S1P(1) function in normal physiology and in inflammation. Vascular permeability in the lungs was assessed by accumulation of dextran molecules (70 kDa) and was increased approximate to 40% in Apom(-/-) mice compared to WT (C57Bl6/j) mice. Reconstitution of plasma ApoM/S1P or treatment with an S1P(1) receptor agonist (SEW2871) rapidly reversed the vascular leakage to a level similar to that in WT mice, suggesting that it is caused by decreased plasma levels of S1P and reduced S1P(1) stimulation. In a carrageenan-induced model of inflammation, Apom(-/-) mice had increased vascular leakage compared with that in WT mice. Adenoviral overexpression of ApoM in Apom(-/-) mice decreased the vascular leakage compared to adenoviral overexpression of green fluorescent protein. The study suggests that vascular leakage of albumin-sized particles in ApoM deficiency is S1P- and S1P(1)-dependent and this dependency exacerbates the response to inflammatory stimuli.Christensen, P. M., Liu, C. H., Swendeman, S. L., Obinata, H., Qvortrup, K., Nielsen, L B., Hla, T., Di Lorenzo, A., Christoffersen, C. Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.	[Christensen, Pernille M.; Nielsen, Lars B.; Christoffersen, Christina] Rigshosp, Dept Clin Biochem, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Christensen, Pernille M.; Qvortrup, Klaus; Christoffersen, Christina] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Nielsen, Lars B.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Liu, Catherine H.; Swendeman, Steven L.; Obinata, Hideru; Hla, Timothy; Di Lorenzo, Annarita] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10021 USA	Rigshospitalet; University of Copenhagen; University of Copenhagen; Cornell University	Christoffersen, C (corresponding author), Rigshosp, Dept Clin Biochem, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.; Hla, T (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, 445 East 69th St, New York, NY 10021 USA.	tih2002@med.cornell.edu; christina.christoffersen@regionh.dk	; Hla, Timothy/G-5873-2012	Christoffersen, Christina/0000-0003-3751-5203; Qvortrup, Klaus/0000-0001-8811-0260; Di Lorenzo, Annarita/0000-0003-1239-4222; Hla, Timothy/0000-0001-8355-4065	Danish Research Council; Novo Nordisk Foundation; U.S. National Institutes of Health, Heart, Lung and Blood Institute [HL89934, R01HL126913-01]; Foundation Leducq; Harold S. Geneen Charitable Trust Award for Coronary Heart Disease Research; Faculty of Health and Medical Sciences (University of Copenhagen); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126913, R01HL089934] Funding Source: NIH RePORTER	Danish Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); U.S. National Institutes of Health, Heart, Lung and Blood Institute; Foundation Leducq(Leducq Foundation); Harold S. Geneen Charitable Trust Award for Coronary Heart Disease Research; Faculty of Health and Medical Sciences (University of Copenhagen); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Zhila Nikrozi for preparation of the specimens for electron microscopy and the Core Facility for Integrated Microscopy (Faculty of Health and Medical Sciences, University of Copenhagen) for use of the electron microscopes. This work was supported by grants from The Danish Research Council (to L. B. N.); The Novo Nordisk Foundation (to C. C.); U.S. National Institutes of Health, Heart, Lung and Blood Institute Grant HL89934 (to T. H.) and R01HL126913-01 (to A. D. L.); Foundation Leducq (to T. H.); Harold S. Geneen Charitable Trust Award for Coronary Heart Disease Research (to A. D. L.), and a Ph.D. scholarship from the Faculty of Health and Medical Sciences (University of Copenhagen) (to P. M. C.). The authors declare no conflicts of interest.	Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; Blaho VA, 2015, NATURE, V523, P342, DOI 10.1038/nature14462; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Cantalupo A, 2015, NAT MED, V21, P1028, DOI 10.1038/nm.3934; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Faber K, 2004, J LIPID RES, V45, P1272, DOI 10.1194/jlr.M300451-JLR200; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; HENRIQUES MGMO, 1987, BRAZ J MED BIOL RES, V20, P243; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kumaraswamy SB, 2012, CRIT CARE, V16, DOI 10.1186/cc11305; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sevvana M, 2009, J MOL BIOL, V393, P920, DOI 10.1016/j.jmb.2009.08.071; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Zhang XY, 2004, ACTA HISTOCHEM, V106, P123, DOI 10.1016/j.acthis.2003.11.004; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC	32	72	77	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2351	2359		10.1096/fj.201500064	http://dx.doi.org/10.1096/fj.201500064			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26956418	Green Published			2022-12-28	WOS:000376878300024
J	Svensson, K; Albert, V; Cardel, B; Salatino, S; Handschin, C				Svensson, Kristoffer; Albert, Verena; Cardel, Bettina; Salatino, Silvia; Handschin, Christoph			Skeletal muscle PGC-1 alpha modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice	FASEB JOURNAL			English	Article						ketone body metabolism; diabetes; exercise; ketoacidosis; transcriptional regulation	TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; PROLIFERATOR-ACTIVATED RECEPTOR; ENERGY-METABOLISM; REGULATORY SITES; GENE-EXPRESSION; ERR-ALPHA; EXERCISE; RATS; KETOACIDOSIS; DISORDERS	Ketone bodies (KBs) are crucial energy substrates during states of low carbohydrate availability. However, an aberrant regulation of KB homeostasis can lead to complications such as diabetic ketoacidosis. Exercise and diabetes affect systemic KB homeostasis, but the regulation of KB metabolism is still enigmatic. In our study in mice with either knockout or overexpression of the peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha in skeletal muscle, PGC-1 alpha regulated ketolytic gene transcription in muscle. Furthermore, KB homeostasis of these mice was investigated during withholding of food, exercise, and ketogenic diet feeding, and after streptozotocin injection. In response to these ketogenic stimuli, modulation of PGC-1 alpha levels in muscle affected systemic KB homeostasis. Moreover, the data demonstrate that skeletal muscle PGC-1 alpha is necessary for the enhanced ketolytic capacity in response to exercise training and overexpression of PGC-1 alpha in muscle enhances systemic ketolytic capacity and is sufficient to ameliorate diabetic hyperketonemia in mice. In cultured myotubes, the transcription factor estrogen-related receptor-a was a partner of PGC-1 alpha In the regulation of ketolytic gene transcription. These results demonstrate a central role of skeletal muscle PGC-1 alpha in the transcriptional regulation of systemic ketolytic capacity.-Svensson, K., Albert, V., Cardel, B., Salatino, S., Handschin, C. Skeletal muscle PGC-1 alpha modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice. www.fasebj.org	[Svensson, Kristoffer; Albert, Verena; Cardel, Bettina; Salatino, Silvia; Handschin, Christoph] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	University of Basel	Handschin, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	christoph.handschin@unibas.ch	Handschin, Christoph/E-6886-2015	Handschin, Christoph/0000-0003-0603-1097; Salatino, Silvia/0000-0003-1286-3076	ERC [616830-MUSCLE_NET]; Swiss National Science Foundation, SystemsX.ch; Swiss Society for Research on Muscle Diseases (SSEM); Novartis Foundation for Medical-Biological Research; University of Basel; Biozentrum	ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation, SystemsX.ch(Swiss National Science Foundation (SNSF)); Swiss Society for Research on Muscle Diseases (SSEM); Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Basel; Biozentrum	The authors thank Prof. A. Kralli (Scripps Research Institute, La Jolla, CA, USA) for the providing the shERR alpha adenovirus. This project was funded by ERC Consolidator Grant 616830-MUSCLE_NET, the Swiss National Science Foundation, SystemsX.ch, the Swiss Society for Research on Muscle Diseases (SSEM), the Novartis Foundation for Medical-Biological Research, the University of Basel, and the Biozentrum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. K.S. and C.H. designed research and wrote the manuscript; K.S., V.A., B.C., and S.S. performed research and analyzed data. The authors declare no conflicts of interest.	ADAMS JH, 1988, J PHYSIOL-LONDON, V407, P453, DOI 10.1113/jphysiol.1988.sp017425; Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Baresic M, 2014, MOL CELL BIOL, V34, P2996, DOI 10.1128/MCB.01710-13; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; El Midaoui A, 2005, AM J PHYSIOL-ENDOC M, V288, pE748, DOI 10.1152/ajpendo.00515.2004; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; JOHNSON RH, 1972, Q J EXP PHYSIOL CMS, V57, P73, DOI 10.1113/expphysiol.1972.sp002139; JOHNSON RH, 1969, LANCET, V2, P452; Kamel KS, 2015, NEW ENGL J MED, V372, P546, DOI 10.1056/NEJMra1207788; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; McNeill J. H, 1999, EXPT MODELS DIABETES; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OHMORI H, 1990, ENDOCRINOL JAPON, V37, P421; Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145; Perez-Schindler J, 2013, P NATL ACAD SCI USA, V110, P20314, DOI 10.1073/pnas.1312039110; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pugliese G, 2009, DIABETES-METAB RES, V25, pS11, DOI 10.1002/dmrr.982; Shafqat N, 2013, J INHERIT METAB DIS, V36, P983, DOI 10.1007/s10545-013-9589-z; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Westerberg DP, 2013, AM FAM PHYSICIAN, V87, P337; WINDER WW, 1974, EUR J BIOCHEM, V47, P461, DOI 10.1111/j.1432-1033.1974.tb03713.x; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	32	25	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1976	1986		10.1096/fj.201500128	http://dx.doi.org/10.1096/fj.201500128			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26849960	Green Accepted			2022-12-28	WOS:000374879400025
J	Szarek, D; Marycz, K; Lis, A; Zawada, Z; Tabakow, P; Laska, J; Jarmundowicz, W				Szarek, Dariusz; Marycz, Krzysztof; Lis, Anna; Zawada, Zbigniew; Tabakow, Pawel; Laska, Jadwiga; Jarmundowicz, Wlodzimierz			Lizard tail spinal cord: a new experimental model of spinal cord injury without limb paralysis	FASEB JOURNAL			English	Article						gecko; animal laboratory model; rat; SCI; implant	PERIPHERAL-NERVE REGENERATION; GLIAL-CELLS; ENHANCES ELONGATION; ALGINATE; AXONS; TRANSLATION; SYSTEM; GECKO	Spinal cord injury (SCI) is a well-known devastating lesion that sadly is very resistant to all treatment attempts. This fact has stimulated the exploration of multiple regenerative strategies that are examined at both the basic and clinical level. For laboratory research, different in vivo models are used, but each has many important limitations. The main limitation of these models is the high level of animal suffering related to the inflicted neurologic injury. It has caused a growing tendency to limit the injury, but this, in turn, produces incomplete SCI models and uncertainties in the neuroregeneration interpretation. To overcome such limitations, a new experimental SCI model is proposed. Geckos have been extensively examined as a potential animal model of SCI. Their spinal cord extends into the tail and can be transected without causing the typical neurologic consequences observed in rat models. In this study, we compared the gecko tail SCI model with the rat model of thoracic SCI. Anatomic and histologic analyses showed comparability between the gecko and rat in diameter of spinal canal and spinal cord, as well as applicability of multiple staining techniques (hematoxylin and eosin, immunostaining, and scanning and transmission electron microscopy). We tested the suitability of in vivo study with 3 prototype implants for the reconstruction of SCI: a multichannel sponge, a multilaminar tube, and a gel cylinder. These were compared with a spinal cord excision (control). A 20-wk observation revealed no adverse effects of SCI on the animals' well-being. The animals were easily housed and observed. Histologic analysis showed growth of nervous tissue elements on implant surface and implant cellular colonization. The study showed that the gecko SCI model can be used as a primary model for the assessment of SCI treatment methods. It provides a platform for testing multiple solutions with limited animal suffering before performing tests on mammals. Detailed results of the experimental conditions and testing techniques are provided.-Szarek, D., Marycz, K., Lis, A., Zawada, Z., Tabakow, P., Laska, J., Jarmundowicz, W. Lizard tail spinal cord: a new experimental model of spinal cord injury without limb paralysis. FASEB J. 30, 1391-1403 (2016). www.fasebj.org	[Szarek, Dariusz] Lower Silesia Specialist Hosp T Marciniak, Dept Neurosurg, Ctr Emergency Med, Gen AE Fieldorfa 2, PL-54049 Wroclaw, Poland; [Marycz, Krzysztof] Univ Environm & Life Sci, Dept Electron Microscopy, Wroclaw, Poland; [Lis, Anna; Laska, Jadwiga] AGH Akad Gorniczo Hutnicza Univ Sci & Technol, Dept Biomat, Krakow, Poland; [Zawada, Zbigniew] Univ Zielona Gora, Dept Biol, Zielona Gora, Poland; [Tabakow, Pawel; Jarmundowicz, Wlodzimierz] Wroclaw Med Univ, Dept Neurosurg, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; AGH University of Science & Technology; University of Zielona Gora; Wroclaw Medical University	Szarek, D (corresponding author), Lower Silesia Specialist Hosp T Marciniak, Dept Neurosurg, Ctr Emergency Med, Gen AE Fieldorfa 2, PL-54049 Wroclaw, Poland.	szarekdariusz@gmail.com	Laska, Jadwiga/AAI-7319-2021; Tabakow, Pawel/AAY-1039-2020; Lis, Anna/X-8139-2018; Marycz, Krzysztof/A-2249-2017; Szarek, Dariusz/ABB-2655-2020	Laska, Jadwiga/0000-0002-7230-3882; Lis, Anna/0000-0001-7775-3981; Tabakow, Pawel/0000-0001-8638-3871	Polish National Center for Science (Narodowe Cetrum Nauki) Grant [NN403 176540]; Medical University Wroclaw Grant [GR 756]; Wroclaw Centre of Biotechnology Programme; Leading National Research Centre (KNOW)	Polish National Center for Science (Narodowe Cetrum Nauki) Grant; Medical University Wroclaw Grant; Wroclaw Centre of Biotechnology Programme; Leading National Research Centre (KNOW)	This study was supported by Polish National Center for Science (Narodowe Cetrum Nauki) Grant NN403 176540, Medical University Wroclaw Grant GR 756, and Wroclaw Centre of Biotechnology Programme, the Leading National Research Centre (KNOW) for years 2014-2018.	Basso DM, 2000, PHYS THER, V80, P808, DOI 10.1093/ptj/80.8.808; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Cristino L, 2000, BRAIN RES, V871, P83, DOI 10.1016/S0006-8993(00)02445-8; Grzesiak J, 2015, MAT SCI ENG C-MATER, V52, P163, DOI 10.1016/j.msec.2015.03.050; Grzesiak J, 2015, INT J POLYM SCI, V2015, DOI 10.1155/2015/908328; Grzesiak J, 2013, INT J MORPHOL, V31, P826, DOI 10.4067/S0717-95022013000300008; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.3.CO;2-H; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Marycz K, 2014, BIO-MED MATER ENG, V24, P1625, DOI 10.3233/BME-140966; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Meyer V, 2002, HERPETOLOGICA, V58, P75, DOI 10.1655/0018-0831(2002)058[0075:POOARL]2.0.CO;2; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Santos-Benito FF, 2006, J NEUROTRAUM, V23, P521, DOI 10.1089/neu.2006.23.521; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sharif-Alhoseini M., 2014, TOPICS IN PARAPLEGIA, P209; SIMPSON SB, 1994, PROG BRAIN RES, V103, P229; Stephan K, 2015, SPINE J, V15, P1994, DOI 10.1016/j.spinee.2015.04.041; Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; Szarek D., 2012, J BIOMATER NANOBIOTE, V3, P20, DOI DOI 10.4236/JBNB.2012.31004; Szarek D, 2013, BIOTECHNOL APPL BIOC, V60, P547, DOI 10.1002/bab.1096; Takeda A, 2015, NEUROSCIENCE, V284, P134, DOI 10.1016/j.neuroscience.2014.09.066; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Young W, 2002, PROG BRAIN RES, V137, P231	29	14	14	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1391	1403		10.1096/fj.15-272468	http://dx.doi.org/10.1096/fj.15-272468			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26667043				2022-12-28	WOS:000372629100003
J	Bae, YU; Choi, JH; Nagy, A; Sung, HK; Kim, JR				Bae, Yun-Ui; Choi, Joon-Hyuk; Nagy, Andras; Sung, Hoon-Ki; Kim, Jae-Ryong			Antisenescence effect of mouse embryonic stem cell conditioned medium through a PDGF/FGF pathway	FASEB JOURNAL			English	Article						cellular senescence; conditioned medium; embryonic stem cells; PDGF-BB	PLASMINOGEN-ACTIVATOR INHIBITOR-1; GROWTH-FACTOR BB; REPLICATIVE SENESCENCE; LIFE-SPAN; ENDOTHELIAL-CELLS; PROGENITOR CELLS; IN-VITRO; ANGIOGENESIS; MICE; FIBROBLASTS	Cellular senescence, an irreversible state of growth arrest, underlies organismal aging and age-related diseases. Recent evidence suggests that aging intervention based on inhibition of cellular senescence might be a promising strategy for treatment of aging and age-related diseases. Embryonic stem cells (ESCs) and ESC conditioned medium (CM) have been suggested as a desirable source for regenerative medicine. However, effects of ESC-CM on cellular senescence remain to be determined. We found that treatment of senescent human dermal fibroblasts with CM from mouse ESCs (mESCs) decreases senescence phenotypes. We found that platelet-derived growth factor BB in mESC-CM plays a critical role in antisenescence effect of mESC-CM through up-regulation of fibroblast growth factor 2. We confirmed that mESC-CM treatment accelerates the wound-healing process by down-regulating senescence-associated p53 expression in in vivo models. Taken together, our results suggest that mESC-CM has the ability to suppress cellular senescence and maintain proliferative capacity. Therefore, this strategy might emerge as a novel therapeutic strategy for aging and age-related diseases.	[Bae, Yun-Ui; Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 170 Hyunchung Ro, Daegu 705717, South Korea; [Bae, Yun-Ui; Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu 705717, South Korea; [Choi, Joon-Hyuk] Yeungnam Univ, Coll Med, Dept Pathol, Daegu 705717, South Korea; [Nagy, Andras; Sung, Hoon-Ki] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Sung, Hoon-Ki] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, Toronto, ON M5G 0A4, Canada	Yeungnam University; Yeungnam University; Yeungnam University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kim, JR (corresponding author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 170 Hyunchung Ro, Daegu 705717, South Korea.; Sung, HK (corresponding author), Hosp Sick Children, Res Inst, Peter Gilgan Ctr Res & Learning, Physiol & Expt Med Program, 686 Bay St,Room 10-9710, Toronto, ON M5G 0A4, Canada.	hoon-ki.sung@sickkids.ca; kimjr@ynu.ac.kr	Nagy, Andras/G-6465-2013; Sung, Hoon-Ki/A-1922-2016; Choi, Joon Hyuk/AFK-3005-2022; Choi, Joon Hyuk/AAG-1437-2022	Nagy, Andras/0000-0003-4311-0413; Sung, Hoon-Ki/0000-0001-6677-9385; 	Basic Science Research Program [2013R1A1A2060930]; Bio and Medical Technology Development Program [2013M3A9B6076413]; Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2015R1A5A2009124]	Basic Science Research Program; Bio and Medical Technology Development Program; Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by Basic Science Research Program (2013R1A1A2060930), Bio and Medical Technology Development Program (2013M3A9B6076413), and Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Choi HR, 2011, AGING CELL, V10, P148, DOI 10.1111/j.1474-9726.2010.00654.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2011, AGING-US, V3, P555, DOI 10.18632/aging.100333; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P303, DOI 10.3109/10520295.2011.649785; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Kim JM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2313; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Kim KS, 2009, MECH AGEING DEV, V130, P179, DOI 10.1016/j.mad.2008.11.004; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Landgren E, 1996, EXP CELL RES, V223, P405, DOI 10.1006/excr.1996.0095; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee MJ, 2011, CYTOTHERAPY, V13, P165, DOI 10.3109/14653249.2010.512632; Li XY, 2007, CELL TISSUE RES, V327, P607, DOI 10.1007/s00441-006-0354-6; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Michael IP, 2014, EMBO MOL MED, V6, P604, DOI 10.1002/emmm.201303708; Moon SH, 2011, BIOMATERIALS, V32, P6445, DOI 10.1016/j.biomaterials.2011.05.026; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Park JS, 2001, FASEB J, V15, P1625, DOI 10.1096/fj.00-0723fje; Park SJ, 2013, BIOMATERIALS, V34, P995, DOI 10.1016/j.biomaterials.2012.10.039; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209; Telgenhoff D, 2005, CELL DEATH DIFFER, V12, P695, DOI 10.1038/sj.cdd.4401632; Tomishima M., 2012, STEMBOOK; Vande Berg JS, 2005, WOUND REPAIR REGEN, V13, P76, DOI 10.1111/j.1067-1927.2005.130110.x; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Wu LC, 1997, PLAST RECONSTR SURG, V99, P815, DOI 10.1097/00006534-199703000-00030; Yamamoto S, 2008, J BIOL CHEM, V283, P23139, DOI 10.1074/jbc.M710308200	49	21	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1276	1286		10.1096/fj.15-278846	http://dx.doi.org/10.1096/fj.15-278846			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26675707				2022-12-28	WOS:000370387800023
J	Clayton, JA				Clayton, Janine Austin			Studying both sexes: a guiding principle for biomedicine	FASEB JOURNAL			English	Article						gender; NIH; sex-based biology; inclusion; SABV	RECEPTOR KNOCKOUT; BALANCE SEX; GENDER; CELL; MICE; NIH; REPRODUCIBILITY; CHROMOSOME; BEHAVIOR; SCIENCE	In May 2014, the U.S. National Institutes of Health (NIH) announced that it will ensure that investigators account for sex as a biological variable (SABV) in NIH-funded preclinical research as part of the agency's rigor and transparency initiative. Herein, I describe in more detail the rationale behind the SABV policy component and provide additional detail about policy goals. In short, studying both sexes is a guiding principle in biomedical research that will expand knowledge toward turning discovery into health. NIH expects that considering SABV in preclinical research will help to build a knowledge base that better informs the design of clinical research and trials in humans. Integrating the practice of studying both sexes in preclinical research will, over time, expand our currently incomplete knowledge base that plays a critical role in informing the development of sex- and gender-appropriate medical care for women and men.	[Clayton, Janine Austin] NIH, Off Res Womens Hlth, 6707 Democracy Blvd,Suite 400, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Clayton, JA (corresponding author), NIH, Off Res Womens Hlth, 6707 Democracy Blvd,Suite 400, Bethesda, MD 20892 USA.	janine.clayton@nih.gov						Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Augenstein J, 2005, P 19 INT TECHN C ENH; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; BECKER JB, 1982, EUR J PHARMACOL, V80, P65, DOI 10.1016/0014-2999(82)90178-9; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Canadian Institutes of Health Research, THE CIHR INSTITUTE O; Canadian Institutes of Health Research Institute of Gender and Health, STRAT RES PRIOR; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Collins LM, 2009, PSYCHOL METHODS, V14, P202, DOI 10.1037/a0015826; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Farkas RH, 2013, NEW ENGL J MED, V369, P689, DOI 10.1056/NEJMp1307972; Feder H. H., 1981, Neuroendocrinology of reproduction. Physiology and behavior., P279; Festing MFW, 2014, ILAR J, V55, P472, DOI 10.1093/ilar/ilu045; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Holderoft A, 2007, GENDER MED, V4, pS64, DOI 10.1016/S1550-8579(07)80048-9; Irish Research Council, IR RES COUNC GEND ST; Jackson Laboratories, 2007, BREED STRAT MAINT CO; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; Klinge I, 2007, GENDER MED, V4, pS59, DOI 10.1016/S1550-8579(07)80047-7; Laura W., Y DOES X MAK DIFF ON; Legato MJ, 2010, PRINCIPLES OF GENDER-SPECIFIC MEDICINE, 2ND EDITION, P1; Liang-Chu MMY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116218; Lorsch JR, 2014, SCIENCE, V346, P1452, DOI 10.1126/science.1259110; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; McCullough LD, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0015-5; Miller VM, 2013, J WOMENS HEALTH, V22, P194, DOI 10.1089/jwh.2012.4193; National Centre for the Replacement Refinement & Reduction of Animals in Research, ARRIVE GUID; National Research Council (US) Institute for Laboratory Animal Research, 2011, GUID DESCR AN RES SC; Oertelt-Prigione S, 2012, SEX AND GENDER ASPECTS IN CLINICAL MEDICINE, P9, DOI 10.1007/978-0-85729-832-4_3; Pardue M. L., 2001, EXPLORING BIOL CONTR; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Rabesandratana Tania, 2014, SCIENCE; Regitz-Zagrosek V., 2012, SEX GENDER DIFFERENC; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Ritz SA, 2014, FASEB J, V28, P4, DOI 10.1096/fj.13-233395; SchenckGustafsson K, 2012, HANDBOOK OF CLINICAL GENDER MEDICINE, P1; Sex and Gender Womens Health Collaborative, CURR TRAIN; Shaw Robert, 2002, ILAR J, V43, P223; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Stanford University, GEND INN; Stanford University and European Union, GEND INN TISS CELLS; U. S. Food and Drug Administration Center for Devices and Radiological Health, EV SEX SPEC DAT MED; U. S. National Institutes of Health, NOTOD15102 US NIH; U. S. National Institutes of Health, NIH REQ INF CONS SEX; U. S. National Institutes of Health, PRINC GUID REP PRECL; U. S. National Institutes of Health Office of Research on Womens Health, ONL ED SEX GEND DIFF; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Walker VR, 2004, ILAR J, V45, P455, DOI 10.1093/ilar.45.4.455; Yoon DY, 2014, SURGERY, V156, P508, DOI 10.1016/j.surg.2014.07.001; Young EA, 2009, J PSYCHIATR RES, V43, P503, DOI 10.1016/j.jpsychires.2008.07.002; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012	57	176	176	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					519	524		10.1096/fj.15-279554	http://dx.doi.org/10.1096/fj.15-279554			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26514164	Green Published			2022-12-28	WOS:000369391900006
J	Bali, V; Lazrak, A; Guroji, P; Fu, LW; Matalon, S; Bebok, Z				Bali, Vedrana; Lazrak, Ahmed; Guroji, Purushotham; Fu, Lianwu; Matalon, Sadis; Bebok, Zsuzsanna			A synonymous codon change alters the drug sensitivity of Delta F508 cystic fibrosis transmembrane conductance regulator	FASEB JOURNAL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; NUCLEOTIDE-BINDING DOMAIN; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; THERMAL-INSTABILITY; MUTANT PROTEIN; CELL-SURFACE; IN-VITRO; CFTR; MUTATIONS	Synonymous mutations, such as I507-ATC -> ATT, in deletion of Phe508 in cystic fibrosis transmembrane conductance regulator (Delta F508 CFTR), the most frequent disease-associated mutant of CFTR, may affect protein biogenesis, structure, and function and contribute to an altered disease phenotype. Small-molecule drugs are being developed to correct Delta F508 CFTR. To understand correction mechanisms and the consequences of synonymous mutations, we analyzed the effect of mechanistically distinct correctors, corrector 4a (C4) and lumacaftor (VX-809), on I507-ATT and I507-ATC Delta F508 CFTR biogenesis and function. C4 stabilized I507-ATT Delta F508 CFTR band B, but without considerable biochemical and functional correction. VX-809 biochemically corrected similar to 10% of both of the variants, leading to stable, forskolin+3isobutyl-1-methylxanthine (IBMX)-activated whole-cell currents in the presence of the corrector. Omitting VX-809 during whole-cell recordings led to a spontaneous decline of the currents, suggesting posttranslational stabilization by VX-809. Treatment of cells with the C4+VX-809 combination resulted in enhanced rescue and 2-fold higher forskolin+IBMX-activated currents of both I507-ATT and I507-ATC Delta F508 CFTR, compared with VX-809 treatment alone. The lack of an effect of C4 on I507-ATC Delta F508 CFTR, but its additive effect in combination with VX-809, implies that C4 acted on VX-809-modified I507-ATC Delta F508 CFTR. Our results suggest that binding of C4 and VX-809 to Delta F508 CFTR is conformation specific and provide evidence that synonymous mutations can alter the drug sensitivity of proteins.-Bali, V., Lazrak, A., Guroji, P., Fu, L., Matalon, S., Bebok, Z. A synonymous codon change alters the drug sensitivity of Delta F508 cystic fibrosis transmembrane conductance regulator. FASEB J. 30, 201-213 (2016). www.fasebj.org	[Bali, Vedrana; Guroji, Purushotham; Fu, Lianwu; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA; [Lazrak, Ahmed; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Lung Injury & Repair Res Ctr, Birmingham, AL 35294 USA; [Fu, Lianwu; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bebok, Z (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd,MCLM 350A, Birmingham, AL 35294 USA.	bebok@uab.edu		Lazrak, Ahmed/0000-0002-4127-1937; Fu, Karl/0000-0001-5386-9429; Guroji, Purushotham/0000-0001-9331-5711	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [2R01-HL076587, 2R01HL031197-24A1]; Cystic Fibrosis Foundation [CFF14P0]; CounterACT Program, NIH Office of the Director; NIH National Institute of Neurological Disorders and Stroke [5R21 ES024027 02, 1R21ES025423 01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587, R01HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES026458, R21ES024027, R21ES025423] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); CounterACT Program, NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Drs. E. Sorscher and J. F. Collawn for helpful discussions and Mrs. N. Brissie for excellent technical support. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant 2R01-HL076587 (to Z.B.) and Grant 2R01HL031197-24A1 (to S.M.); Cystic Fibrosis Foundation Grant CFF14P0 (to Z.B.); the CounterACT Program, NIH Office of the Director (to S.M.); and NIH National Institute of Neurological Disorders and Stroke Grants 5R21 ES024027 02 and 1R21ES025423 01 (to S.M.). The authors declare no conflicts of interest.	Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Elena C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00021; Fu LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123131; Fung KL, 2014, CANCER RES, V74, P598, DOI 10.1158/0008-5472.CAN-13-2064; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jia HY, 1999, HYPERTENSION, V34, P8, DOI 10.1161/01.HYP.34.1.8; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES OW, 1966, BIOCHIM BIOPHYS ACTA, V119, P400, DOI 10.1016/0005-2787(66)90198-5; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kimchi-Sarfaty C, 2013, TRENDS PHARMACOL SCI, V34, P534, DOI 10.1016/j.tips.2013.08.005; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lee S, 2014, MOL CELL BIOL, V34, P2554, DOI 10.1128/MCB.01042-13; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059706; Liu XH, 2014, BIOCHEMISTRY-US, V53, P5613, DOI 10.1021/bi501007v; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Londino JD, 2015, FASEB J, V29, P2712, DOI 10.1096/fj.14-268755; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; O'Brien EP, 2014, ACCOUNTS CHEM RES, V47, P1536, DOI 10.1021/ar5000117; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pizzo L, 2015, MUTAT RES-FUND MOL M, V775, P19, DOI 10.1016/j.mrfmmm.2015.03.005; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shah K, 2015, J MOL BIOL, V427, P1464, DOI 10.1016/j.jmb.2015.02.003; Sondo E, 2011, AM J PHYSIOL-CELL PH, V301, pC872, DOI 10.1152/ajpcell.00507.2010; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Sroubek J, 2013, FASEB J, V27, P3039, DOI 10.1096/fj.12-227009; Straley KS, 1998, MOL BIOL CELL, V9, P1683, DOI 10.1091/mbc.9.7.1683; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WEISBLUM B, 1962, P NATL ACAD SCI USA, V48, P1449, DOI 10.1073/pnas.48.8.1449	72	6	6	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					201	213		10.1096/fj.15-273714	http://dx.doi.org/10.1096/fj.15-273714			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26336913	Green Published			2022-12-28	WOS:000367621000021
J	Kirkby, NS; Reed, DM; Edin, ML; Rauzi, F; Mataragka, S; Vojnovic, I; Bishop-Bailey, D; Milne, GL; Longhurst, H; Zeldin, DC; Mitchell, JA; Warner, TD				Kirkby, Nicholas S.; Reed, Daniel M.; Edin, Matthew L.; Rauzi, Francesca; Mataragka, Stefania; Vojnovic, Ivana; Bishop-Bailey, David; Milne, Ginger L.; Longhurst, Hilary; Zeldin, Darryl C.; Mitchell, Jane A.; Warner, Timothy D.			Inherited human group IVA cytosolic phospholipase A(2) deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation	FASEB JOURNAL			English	Article						cardiovascular; thromboxane A(2); prostacyclin; inflammation	12-HYDROXYEICOSATETRAENOIC ACID; CARDIOVASCULAR-SYSTEM; ARACHIDONIC-ACID; GLYCOPROTEIN-VI; BLOOD; 12-LIPOXYGENASE; BIOSYNTHESIS; PROSTACYCLIN; ACTIVATION; RECEPTOR	Eicosanoids are important vascular regulators, but the phospholipase A(2) (PLA(2)) isoforms supporting their production within the cardiovascular system are not fully understood. To address this, we have studied platelets, endothelial cells, and leukocytes from 2 siblings with a homozygous loss-of-function mutation in group IVA cytosolic phospholipase A(2) (cPLA(2)alpha). Chromatography/mass spectrometry was used to determine levels of a broad range of eicosanoids produced by isolated vascular cells, and in plasma and urine. Eicosanoid release data were paired with studies of cellular function. Absence of cPLA(2)alpha almost abolished eicosanoid synthesis in platelets (e.g., thromboxane A(2), control 20.5 +/- 1.4 ng/ml vs. patient 0.1 ng/ml) and leukocytes [e.g., prostaglandin E-2 (PGE(2)), control 21.9 +/- 7.4 ng/ml vs. patient 1.9 ng/ml], and this was associated with impaired platelet activation and enhanced inflammatory responses. cPLA(2)alpha-deficient endothelial cells showed reduced, but not absent, formation of prostaglandin I-2 (prostacyclin; control 956 +/- 422 pg/ml vs. patient 196 pg/ml) and were primed for inflammation. In the urine, prostaglandin metabolites were selectively influenced by cPLA(2)alpha deficiency. For example, prostacyclin metabolites were strongly reduced (18.4% of control) in patients lacking cPLA(2)alpha, whereas PGE(2) metabolites (77.8% of control) were similar to healthy volunteer levels. These studies constitute a definitive account, demonstrating the fundamental role of cPLA(2)alpha to eicosanoid formation and cellular responses within the human circulation.	[Kirkby, Nicholas S.; Reed, Daniel M.; Mataragka, Stefania; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kirkby, Nicholas S.; Rauzi, Francesca; Vojnovic, Ivana; Warner, Timothy D.] Queen Mary Univ London, William Harvey Res Inst, London, England; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Bishop-Bailey, David] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Milne, Ginger L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Milne, Ginger L.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Longhurst, Hilary] Barts Hlth, Immunol Dept, London, England; [Longhurst, Hilary] London Natl Hlth Serv Trust, London, England	Imperial College London; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; University of London Royal Veterinary College; Vanderbilt University; Vanderbilt University; Barts Health NHS Trust	Warner, TD (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	t.d.warner@qmul.ac.uk	Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019; Warner, Timothy D/A-1980-2009; Milne, Ginger/D-7648-2014	Zeldin, Darryl C/0000-0002-2087-7307; Warner, Timothy D/0000-0003-3988-4408; Milne, Ginger/0000-0003-3890-151X; Kirkby, Nicholas/0000-0003-3509-8549; Edin, Matthew/0000-0002-7042-500X; Bishop-Bailey, David/0000-0003-2455-596X	Imperial College Junior Research Fellowship; Wellcome Trust program grant [0852551Z108/Z]; British Heart Foundation Ph.D. studentship [FS/10/033/28271]; British Heart Foundation project grant [PG/11/39/28890]; Intramural Research Program of the U.S. National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES025034]; British Heart Foundation [PG/11/39/28890, FS/10/33/28271] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034, ZIAES025034] Funding Source: NIH RePORTER	Imperial College Junior Research Fellowship; Wellcome Trust program grant(Wellcome Trust); British Heart Foundation Ph.D. studentship; British Heart Foundation project grant(British Heart Foundation); Intramural Research Program of the U.S. National Institutes of Health, National Institute of Environmental Health Sciences; British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors acknowledge the cytosolic phospholipase A2-deficient individuals who made these studies possible by volunteering to provide blood samples. This research was supported by an Imperial College Junior Research Fellowship (to N.S.K.), Wellcome Trust program grant (0852551Z108/Z to J.A.M. and T.D.W.), British Heart Foundation Ph.D. studentship (FS/10/033/28271 to F.R.), British Heart Foundation project grant (PG/11/39/28890 to D.B.-B.), and by the Intramural Research Program of the U.S. National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES025034 to D.C.Z.).	Adler DH, 2008, J CLIN INVEST, V118, P2121, DOI 10.1172/JCI30473; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BARTOLI F, 1994, J BIOL CHEM, V269, P15625; Ben-Amor N, 2006, J PHYSIOL-LONDON, V570, P309, DOI 10.1113/jphysiol.2005.100800; Blache D, 2012, FASEB J, V26, P927, DOI 10.1096/fj.11-191593; Boisvert WA, 2000, IMMUNOL RES, V21, P129, DOI 10.1385/IR:21:2-3:129; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; Brooke MA, 2014, GUT, V63, P96, DOI 10.1136/gutjnl-2012-303581; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Coffey MJ, 2004, FEBS LETT, V576, P165, DOI 10.1016/j.febslet.2004.09.007; Coffey MJ, 2004, CIRC RES, V94, P1598, DOI 10.1161/01.RES.0000132281.78948.65; DANIEL VC, 1994, J CHROMATOGR B, V653, P117, DOI 10.1016/0378-4347(93)E0432-P; DEFORGE LE, 1992, J IMMUNOL, V148, P2133; Faioni EM, 2014, THROMB HAEMOSTASIS, V112, P1182, DOI 10.1160/TH14-04-0352; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Houliston RA, 2001, BIOCHEM BIOPH RES CO, V287, P881, DOI 10.1006/bbrc.2001.5681; Huang ZH, 1997, CIRC RES, V80, P149, DOI 10.1161/01.RES.80.2.149; Iyu D, 2010, PLATELETS, V21, P329, DOI 10.3109/09537101003718065; Katoh A, 1998, CIRCULATION, V98, P2891, DOI 10.1161/01.CIR.98.25.2891; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; MAIS DE, 1990, EICOSANOIDS, V3, P121; Marshall J, 2000, J IMMUNOL, V164, P2084, DOI 10.4049/jimmunol.164.4.2084; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Polgar J, 1997, BIOCHEM J, V327, P259, DOI 10.1042/bj3270259; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Reed DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091119; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Sharma J, 2010, BIOCHEMISTRY-US, V49, P5473, DOI 10.1021/bi100752u; Smith JP, 2012, HYPERTENSION, V59, P719, DOI 10.1161/HYPERTENSIONAHA.111.181404; Song WL, 2012, J CLIN INVEST, V122, P1459, DOI 10.1172/JCI59262; Starke RD, 2013, BLOOD, V121, P2773, DOI 10.1182/blood-2012-06-435727; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; TERNOWITZ T, 1988, Skin Pharmacology, V1, P93; Vijil C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088546; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Warner TD, 2011, BRIT J CLIN PHARMACO, V72, P619, DOI 10.1111/j.1365-2125.2011.03943.x; Wong DA, 2002, J EXP MED, V196, P349, DOI 10.1084/jem.20011443; Wong MSK, 2010, AM J PHYSIOL-HEART C, V298, pH1260, DOI 10.1152/ajpheart.01068.2009; Yeung J, 2013, THROMB HAEMOSTASIS, V110, P569, DOI 10.1160/TH13-01-0014	46	22	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4568	4578		10.1096/fj.15-275065	http://dx.doi.org/10.1096/fj.15-275065			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26183771	hybrid, Green Published			2022-12-28	WOS:000364514700016
J	Gicquel, T; Robert, S; Loyer, P; Victoni, T; Bodin, A; Ribault, C; Gleonnec, F; Couillin, I; Boichot, E; Lagente, V				Gicquel, Thomas; Robert, Sacha; Loyer, Pascal; Victoni, Tatiana; Bodin, Aude; Ribault, Catherine; Gleonnec, Florence; Couillin, Isabelle; Boichot, Elisabeth; Lagente, Vincent			IL-1 beta production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages	FASEB JOURNAL			English	Article						cytokines; NLRP3 inflammasome; uric acid; P2X7 receptor	NALP3 INFLAMMASOME; P2X(7) RECEPTOR; DANGER SIGNAL; URIC-ACID; CASPASE-1 ACTIVATION; CYTOKINE PRODUCTION; LUNG INFLAMMATION; ATP RELEASE; TOLL-LIKE; SECRETION	The Nod-like receptor family protein 3 (NLRP3)-inflammasome pathway is known to be activated by danger signals such as monosodium urate (MSU). We investigated the role of P2 purinergic receptors in the activation of NLRP3-inflammasome pathway after MSU treatment of primary human monocyte-derived macrophages (MDMs). After initial stimulation with a low concentration of LPS (0.1 mu g/ml), a 6 h treatment withMSUcrystals (250, 500, and 1000 mu g/ml) induced theMDMs to release IL-1 beta, IL-1 alpha, and IL-6 in adose-dependent manner. Moreover, the caspase 1 inhibitor Z-YVAD-FMK and the cathepsin B inhibitor CA-074Me reduced production of IL-1 beta in a dose-dependent manner after LPS + MSU treatment. We used real-time reverse transcription-quantitative PCR to show that treatment with LPS and MSU (500 mu g/ml) induced significantly greater expression of NLRP3 and IL-1 beta than after treatment with LPS. We also found that MSU treatment induced P2X purinergic receptor 7 (P2X7R) mRNA and protein expression. Furthermore, addition of the P2X7 purinergic receptor antagonist A-740003 significantly impeded IL-1 beta production and pro-IL-1 beta cleavage after treatment with LPS + MSU. Remarkably, RNA silencing of P2X7R (but not P2X4R) inhibited the release of IL-1 beta and other M1 macrophage cytokines (such as IL-1 alpha, IL-6, and TNF-a) fromMDMs stimulated with LPS + MSU. Taken as a whole, our results show that P2 purinergic receptors and the NLRP3 inflammasome pathway are involved in the secretion of IL-1 beta from MSU-stimulated human macrophages. This pathway may constitute a novel therapeutic target for controlling the inflammatory process in several associated pathologies.	[Gicquel, Thomas; Robert, Sacha; Loyer, Pascal; Victoni, Tatiana; Bodin, Aude; Ribault, Catherine; Gleonnec, Florence; Boichot, Elisabeth; Lagente, Vincent] Univ Rennes 1, Unite Mixte Rech 991, Inst Natl Sante & Rech Med, F-35043 Rennes, France; [Gicquel, Thomas] Univ Rennes, Lab Toxicol Biol & Medicolegale, Ctr Hosp, Rennes, France; [Couillin, Isabelle] Univ Orleans, Expt & Mol Immunol & Neurogenet, Ctr Natl Rech Sci, Unit Mixte Rech 7355, Orleans, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Gicquel, T (corresponding author), Univ Rennes 1, Fac Pharm, INSERM, UMR991, 2 Ave Prof Leon Bernard, F-35043 Rennes, France.	thomas.gicquel@univ-rennes1.fr	Gicquel, Thomas/Q-1880-2019; Victoni, Tatiana/AAX-2629-2020; LOYER, Pascal/K-1838-2019	Gicquel, Thomas/0000-0002-2354-1884; Victoni, Tatiana/0000-0001-7263-8300; Lagente, Vincent/0000-0003-4920-009X; LORANT, Elisabeth/0000-0002-4914-0122; LOYER, PASCAL/0000-0002-5656-2673	French Agence Nationale de la Recherche [ANR2010 MIDI01202]; Institut National de la Sante et de la Recherche Medicale	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	This study was funded by the French Agence Nationale de la Recherche (ANR2010 MIDI01202) and Institut National de la Sante et de la Recherche Medicale. The authors thank A. Sharanek and F. Rassendren (Institut of Functional Genomic, Centre National de la Recherche Scientifique, Unite Mixte de Recherche 5203 and Institut National de la Sante et de la Recherche Medicale 661, Universite de Montpellier, Montpellier, France) for their helpful contributions and the Biogenouest SynNanoVect facility (IBiSA; ISO 9001) for technical assistance with the electroporation experiments.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Baron L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.576; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brone B, 2007, IMMUNOL LETT, V113, P83, DOI 10.1016/j.imlet.2007.07.015; Casas-Pruneda G, 2009, J PHYSIOL-LONDON, V587, P2887, DOI 10.1113/jphysiol.2008.167395; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eleftheriadis T, 2013, HIPPOKRATIA, V17, P141; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gicquel T, 2014, CLIN EXP PHARMACOL P, V41, P279, DOI 10.1111/1440-1681.12214; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070210; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Laurent V, 2010, BIOTECHNOL J, V5, P314, DOI 10.1002/biot.200900255; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Schotte P, 2001, J BIOL CHEM, V276, P21153, DOI 10.1074/jbc.M102239200; Scott P, 2006, J IMMUNOL, V177, P6370, DOI 10.4049/jimmunol.177.9.6370; Seil M, 2010, PURINERG SIGNAL, V6, P405, DOI 10.1007/s11302-010-9205-8; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Tao JH, 2013, SEMIN ARTHRITIS RHEU, V43, P376, DOI 10.1016/j.semarthrit.2013.04.007; Uratsuji H, 2012, J IMMUNOL, V188, P436, DOI 10.4049/jimmunol.1003746; Vaccari JPD, 2012, J NEUROSCI, V32, P3058, DOI 10.1523/JNEUROSCI.4930-11.2012; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860	51	93	102	3	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4162	4173		10.1096/fj.14-267393	http://dx.doi.org/10.1096/fj.14-267393			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26116704				2022-12-28	WOS:000361367300007
J	Shen, CC; Wang, DL; Liu, XY; Gu, B; Du, YP; Wei, FZ; Cao, LL; Song, BY; Lu, XP; Yang, QY; Zhu, Q; Hou, TY; Li, MT; Wang, LN; Wang, HY; Zhao, Y; Yang, Y; Zhu, WG				Shen, Changchun; Wang, Donglai; Liu, Xiangyu; Gu, Bo; Du, Yipeng; Wei, Fu-Zheng; Cao, Lin-Lin; Song, Boyan; Lu, Xiaopeng; Yang, Qiaoyan; Zhu, Qian; Hou, Tianyun; Li, Meiting; Wang, Lina; Wang, Haiying; Zhao, Ying; Yang, Yang; Zhu, Wei-Guo			SET7/9 regulates cancer cell proliferation by influencing beta-catenin stability	FASEB JOURNAL			English	Article						oxidative stress; Wnt/beta-catenin signaling; lysine methylation	HISTONE METHYLTRANSFERASE SET7/9; NF-KAPPA-B; LYSINE METHYLATION; P53 ACTIVITY; TRANSCRIPTIONAL ACTIVITY; FUNCTIONAL INTERACTION; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; DOWN-REGULATION; CYCLIN D1	beta-Catenin, which is a key mediator of the wingless-integration site (Wnt)/beta-catenin signaling pathway, plays an important role in cell proliferation, cell fate determination, and tumorigenesis, by regulating the expression of a wide range of target genes. Although a variety of posttranslational modifications are involved in beta-catenin activity, the role of lysine methylation in beta-catenin activity is largely unknown. In this study, su(var) 3-9, enhancer-of-zeste, trithorax (SET) domain-containing protein 7 (SET7/9), a lysine methyltransferase, interacted with andmethylated beta-catenin, as demonstrated both in vitro and in vivo. The interaction and methylation were significantly enhanced in response to H2O2 stimulation. A mutagenesis assay and mass spectrometric analyses revealed that beta-catenin was monomethylated by SET7/9 at lysine residue 180. Methylated beta-catenin was easily recognized by phosphokinase glycogen synthase kinase (GSK)-3 beta for degradation. Consistent with this finding, the mutated beta-catenin (K180R) that cannot be methylated exhibited a longer half-life than did the methylated beta-catenin. The consequent depletion of SET7/9 by shRNA or the mutation of the beta-catenin (K180R) significantly enhanced the expression of Wnt/beta-catenin target genes such as c-myc and cyclin D1 and promoted the growth of cancer cells. Together, these results provide a novel mechanism by which Wnt/beta-catenin signaling is regulated in response to oxidativ stress.	[Shen, Changchun; Wang, Donglai; Liu, Xiangyu; Gu, Bo; Du, Yipeng; Wei, Fu-Zheng; Cao, Lin-Lin; Song, Boyan; Lu, Xiaopeng; Yang, Qiaoyan; Zhu, Qian; Hou, Tianyun; Li, Meiting; Wang, Lina; Wang, Haiying; Zhao, Ying; Yang, Yang; Zhu, Wei-Guo] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Hlth Sci Ct, State Key Lab Nat & Biomimet Drugs,Minist Educ, Beijing 100191, Peoples R China; [Zhu, Wei-Guo] Tsinghua Univ, Peking Univ, Ctr Sci, Beijing 100084, Peoples R China	Peking University; Peking University; Tsinghua University	Zhu, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu.cn	Du, Yipeng/O-1223-2013	Hou, Tianyun/0000-0003-1457-5692; Yang, Yang/0000-0002-8737-590X; Li, meiting/0000-0003-0937-2946; Lu, Xiaopeng/0000-0001-7746-5322; Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Haiying/0000-0001-7729-0649	National Key Basic Research Program of China [2011CB504200, 2013CB911000]; National Natural Science Foundation of China [31070691, 81321003, 91319302]; Ministry of Education of China "111 Project"	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China "111 Project"	This work was supported by National Key Basic Research Program of China Grants 2011CB504200 and 2013CB911000; National Natural Science Foundation of China Grants 31070691, 81321003, and 91319302; and Ministry of Education of China "111 Project." The authors declare no conflicts of interest.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calnan DR, 2012, AGING-US, V4, P462, DOI 10.18632/aging.100471; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Condello S, 2013, FASEB J, V27, P3100, DOI 10.1096/fj.12-222620; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Hu HY, 2013, ACTA PHARMACOL SIN, V34, P157, DOI 10.1038/aps.2012.161; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kajla S, 2012, FASEB J, V26, P2049, DOI 10.1096/fj.11-196360; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Korswagen HC, 2006, DEV CELL, V10, P687, DOI 10.1016/j.devcel.2006.05.007; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Shin SY, 2004, CANCER LETT, V212, P225, DOI 10.1016/j.canlet.2004.03.003; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xie Q, 2012, EMBO REP, V13, P371, DOI 10.1038/embor.2012.25; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55	60	47	53	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4313	4323		10.1096/fj.15-273540	http://dx.doi.org/10.1096/fj.15-273540			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26116705				2022-12-28	WOS:000361367300020
J	Clugston, RD; Huang, LS; Blaner, WS				Clugston, Robin D.; Huang, Li-Shin; Blaner, William S.			Chronic alcohol consumption has a biphasic effect on hepatic retinoid loss	FASEB JOURNAL			English	Article						liver; vitamin A; ethanol; retinoid mobilization; retinoid catabolism	CHRONIC ETHANOL-CONSUMPTION; VITAMIN-A DEPLETION; BINDING-PROTEIN; SCAVENGER RECEPTOR; STELLATE CELLS; FATTY-ACID; RAT-LIVER; METABOLISM; MICE; CD36	The alcohol-induced depletion of hepatic retinoid stores correlates with the progression of liver injury; however, the mechanisms underlying alcohol's effects have not been fully elucidated. Our goal was to gain a mechanistic understanding of alcohol-induced hepatic retinoid depletion. Wild-type and mutant mice were continuously fed alcohol through Lieber-DeCarli liquid diets, with matched control animals pair fed an isocaloric alcohol-free diet to ensure equal nutrient and calorie intake between groups. A systematic analysis of tissue retinol and retinyl ester levels was performed with HPLC, complemented by gene and protein expression analyses. Our results delineated 2 phases of alcohol-induced depletion of hepatic retinoid. Initially, similar to 15% of hepatic retinoid content was mobilized from the liver, causing extrahepatic tissue retinoid levels to increase. Subsequently, there was a precipitous drop in hepatic retinoid content (>60%), without further retinoid accumulation in the periphery. Follow-up studies in mutant mice revealed roles for RBP, CRBP1, and CD36 in retinoid mobilization and extrahepatic retinoid uptake, as well as a role for CYP2E1 in the catabolism of hepatic retinoid. In summary, alcohol has a biphasic effect on hepatic retinoid stores, characterized by an initial phase of rapid mobilization to extrahepatic tissues followed by extensive catabolism within the liver.	[Clugston, Robin D.; Huang, Li-Shin; Blaner, William S.] Columbia Univ, New York, NY 10032 USA	Columbia University	Clugston, RD (corresponding author), Columbia Univ, 914 Black Bldg,650 West 168th St, New York, NY 10032 USA.	rdc2132@columbia.edu	Clugston, Robin/ABC-8350-2020	Clugston, Robin/0000-0003-0264-9594	U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism [RC2 AA019413, R21 AA021336, R21 AA020561, K99 AA022652]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK068437, R01 DK079221]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079221, R01DK068437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021336, RC2AA019413, R21AA020561, K99AA022652] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grants RC2 AA019413 and R21 AA021336 (to W.S.B.), R21 AA020561 (to L.S.H.), and K99 AA022652 (to R.D.C.), and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants R01 DK068437 and R01 DK079221 (to W.S.B.).	Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bechmann LP, 2014, HEPATOLOGY, V59, P1662, DOI 10.1002/hep.26896; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Clugston RD, 2014, J LIPID RES, V55, P239, DOI 10.1194/jlr.M041863; Clugston RD, 2013, BBA-MOL CELL BIOL L, V1831, P1276, DOI 10.1016/j.bbalip.2013.04.006; Clugston RD, 2012, NUTRIENTS, V4, P356, DOI 10.3390/nu4050356; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; ERIKSSON U, 1984, J BIOL CHEM, V259, P3464; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; FORKERT PG, 1991, CARCINOGENESIS, V12, P2259, DOI 10.1093/carcin/12.12.2259; FUTTERMAN S, 1972, J BIOL CHEM, V247, P5168; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Hall PDM, 2001, ALCOHOL CLIN EXP RES, V25, p254S, DOI 10.1111/j.1530-0277.2001.tb02405.x; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lee YS, 2012, J GASTROEN HEPATOL, V27, P75, DOI 10.1111/j.1440-1746.2011.07007.x; LEO MA, 1982, NEW ENGL J MED, V307, P597, DOI 10.1056/NEJM198209023071006; LEO MA, 1986, ALCOHOL CLIN EXP RES, V10, P487, DOI 10.1111/j.1530-0277.1986.tb05128.x; Liu C, 2002, ALCOHOL CLIN EXP RES, V26, P1703, DOI 10.1097/01.ALC.0000037135.09289.69; Liu C, 2001, GASTROENTEROLOGY, V120, P179, DOI 10.1053/gast.2001.20877; Morais AD, 2007, INT J MOL MED, V19, P105; MUTO Y, 1972, J BIOL CHEM, V247, P2533; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Ouziel R, 2014, LIVER INT, V34, P343, DOI 10.1111/liv.12249; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; SATO M, 1982, ARCH BIOCHEM BIOPHYS, V213, P557, DOI 10.1016/0003-9861(82)90584-7; SATO M, 1982, J NUTR, V112, P1188, DOI 10.1093/jn/112.6.1188; SATO M, 1981, J NUTR, V111, P2015, DOI 10.1093/jn/111.11.2015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneiderhan W, 2001, HEPATOLOGY, V34, P729, DOI 10.1053/jhep.2001.27828; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Vroegrijk IOCM, 2013, OBESITY, V21, P2037, DOI 10.1002/oby.20354; Wang XD, 1999, NUTR REV, V57, P51, DOI 10.1111/j.1753-4887.1999.tb01778.x; Wongsiriroj N, 2014, J LIPID RES, V55, P104, DOI 10.1194/jlr.M043844; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13	41	16	16	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3654	3667		10.1096/fj.14-266296	http://dx.doi.org/10.1096/fj.14-266296			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25985802	Green Published			2022-12-28	WOS:000359915600005
J	Hakkarainen, J; Jokela, H; Pakarinen, P; Heikela, H; Katkanaho, L; Vandenput, L; Ohlsson, C; Zhang, FP; Poutanen, M				Hakkarainen, Janne; Jokela, Heli; Pakarinen, Pirjo; Heikela, Hanna; Katkanaho, Laura; Vandenput, Liesbeth; Ohlsson, Claes; Zhang, Fu-Ping; Poutanen, Matti			Hydroxysteroid (17 beta)-dehydrogenase 1-deficient female mice present with normal puberty onset but are severely subfertile due to a defect in luteinization and progesterone production	FASEB JOURNAL			English	Article						ovary; estrogen; fertility; HSD17B enzymes	RAT 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; FOLLICLE-STIMULATING-HORMONE; ESTROGEN-RECEPTORS ALPHA; GRANULOSA-CELLS; MESSENGER-RNA; SEX REVERSAL; ER-ALPHA; DEHYDROGENASE; EXPRESSION; ESTRADIOL	Hydroxysteroid (17 beta)-dehydrogenase type 1 (HSD17B1) catalyzes the conversion of low active 17-ketosteroids, androstenedione (A-dione) and estrone (E1) to highly active 17-hydroxysteroids, testosterone (T) and E2, respectively. In this study, the importance of HSD17B1 in ovarian estrogen production was determined using Hsd17b1 knockout (HSD17B1KO) mice. In these mice, the ovarian HSD17B enzyme activity was markedly reduced, indicating a central role of HSD17B1 in ovarian physiology. The lack of Hsd17b activity resulted in increased ovarian E1: E2 and A-dione: T ratios, but we also observed reduced progesterone concentration in HSD17B1KO ovaries. Accordingly with the altered steroid production, altered expression of Star, Cyp11a1, Lhcgr, Hsd17b7, and especially Cyp17a1 was observed. The ovaries of HSD17B1KO mice presented with all stages of folliculogenesis, while the corpus luteums tructure was less defined and number reduced. Surprisingly, bundles of large granular cells of unknown origin appeared in the stroma of the KO ovaries. The HSD17B1KO mice presented with severe subfertility and failed to initiate pseudopregnancy. However, the HSD17B1KO females presented with normal estrous cycle defined by vaginal smears and normal puberty appearance. This study indicates that HSD17B1 is a key enzyme in ovarian steroidogenesis and has a novel function in initiation and stabilization of pregnancy.	[Hakkarainen, Janne; Jokela, Heli; Pakarinen, Pirjo; Heikela, Hanna; Katkanaho, Laura; Zhang, Fu-Ping; Poutanen, Matti] Univ Turku, Inst Biomed, Dept Physiol, FI-20520 Turku, Finland; [Hakkarainen, Janne; Jokela, Heli; Pakarinen, Pirjo; Heikela, Hanna; Katkanaho, Laura; Zhang, Fu-Ping; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, FI-20520 Turku, Finland; [Vandenput, Liesbeth; Ohlsson, Claes] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden	University of Turku; University of Turku; University of Gothenburg	Poutanen, M (corresponding author), Univ Turku, Inst Biomed, Dept Physiol, Kiinamyllynkatu 10, FI-20520 Turku, Finland.	matti.poutanen@utu.fi	Ohlsson, Claes/HIR-6959-2022; Poutanen, Matti/I-1700-2018; Ohlsson, Claes/AGP-3544-2022; Vandenput, Liesbeth/AAP-3655-2020; Vandenput, Liesbeth/AAI-4100-2021	Ohlsson, Claes/0000-0002-9633-2805; Poutanen, Matti/0000-0002-8953-1734; Ohlsson, Claes/0000-0002-9633-2805; Vandenput, Liesbeth/0000-0002-1712-6131; Vandenput, Liesbeth/0000-0002-1712-6131; Jokela, Heli/0000-0003-1839-7870	Academy of Finland; Sigrid Juselius Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; Salhgrenska University Hospital; Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF13OC0004839, NNF14OC0010513, NNF13OC0005785, NNF14OC0009883] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Salhgrenska University Hospital; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank N. Messner, H. Niittymaki, K. Hovirinta, T. Kirjonen, J. Palmu, M. Niiranen, E. Nyman, and T. Poikkipuoli for technical assistance. This work was supported in part by the Academy of Finland, the Sigrid Juselius Foundation, the Swedish Research Council, the Swedish Foundation for Strategic Research, a research grant from Salhgrenska University Hospital, the Lundberg Foundation, the Torsten and Ragnar Soderberg Foundation, and the Novo Nordisk Foundation.	Akinola LA, 1997, ENDOCRINOLOGY, V138, P2886, DOI 10.1210/en.138.7.2886; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Clement P. B., 2007, HISTOLOGY PATHOLOGIS, P1064; Cornel KMC, 2012, J CLIN ENDOCR METAB, V97, pE591, DOI 10.1210/jc.2011-2994; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Duan WR, 1997, ENDOCRINOLOGY, V138, P3216, DOI 10.1210/en.138.8.3216; Dupont S, 2000, DEVELOPMENT, V127, P4277; FOURNETDULGUEROV N, 1987, J CLIN ENDOCR METAB, V65, P757, DOI 10.1210/jcem-65-4-757; GHERSEVICH S, 1994, ENDOCRINOLOGY, V135, P1963, DOI 10.1210/en.135.5.1963; GHERSEVICH S, 1994, ENDOCRINOLOGY, V135, P1477, DOI 10.1210/en.135.4.1477; GHERSEVICH SA, 1994, J ENDOCRINOL, V140, P409, DOI 10.1677/joe.0.1400409; GHERSEVICH SA, 1994, J ENDOCRINOL, V143, P139, DOI 10.1677/joe.0.1430139; Gibori G., 1993, OVARY, P261; Gunnarsson C, 2008, BREAST CANCER RES TR, V108, P35, DOI 10.1007/s10549-007-9579-7; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Huhtinen K, 2012, J CLIN ENDOCR METAB, V97, P4228, DOI 10.1210/jc.2012-1154; Husen B, 2006, ENDOCRINOLOGY, V147, P5333, DOI 10.1210/en.2006-0778; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Lukacik P, 2006, MOL CELL ENDOCRINOL, V248, P61, DOI 10.1016/j.mce.2005.12.007; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; MAENTAUSTA O, 1992, CANCER, V70, P1551, DOI 10.1002/1097-0142(19920915)70:6<1551::AID-CNCR2820700618>3.0.CO;2-#; McLean M P, 1990, Chin J Physiol, V33, P353; MCLEAN MP, 1990, ENDOCRINOLOGY, V126, P1796, DOI 10.1210/endo-126-4-1796; Moeller G, 2006, MOL CELL ENDOCRINOL, V248, P47, DOI 10.1016/j.mce.2005.11.031; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Nilsson M., 2015, ENDOCRINOLOGY; Nokelainen P, 1996, EUR J BIOCHEM, V236, P482, DOI 10.1111/j.1432-1033.1996.00482.x; Nokelainen P, 2000, ENDOCRINOLOGY, V141, P772, DOI 10.1210/en.141.2.772; PARMER TG, 1992, ENDOCRINOLOGY, V131, P2213, DOI 10.1210/en.131.5.2213; Pelletier G, 2004, J MOL ENDOCRINOL, V33, P459, DOI 10.1677/jme.1.01567; Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001; POUTANEN M, 1993, ENDOCRINOLOGY, V133, P2639, DOI 10.1210/en.133.6.2639; POUTANEN M, 1992, INT J CANCER, V50, P386, DOI 10.1002/ijc.2910500310; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Saloniemi T, 2007, MOL ENDOCRINOL, V21, P2627, DOI 10.1210/me.2007-0144; Saloniemi T, 2010, AM J PATHOL, V176, P1443, DOI 10.2353/ajpath.2010.090325; SEGALOFF DL, 1990, MOL ENDOCRINOL, V4, P1856, DOI 10.1210/mend-4-12-1856; Shehu A, 2011, MOL ENDOCRINOL, V25, P754, DOI 10.1210/me.2010-0261; Taniguchi F, 2007, FASEB J, V21, P586, DOI 10.1096/fj.06-6681com; Torn S, 2003, BIOCHEM BIOPH RES CO, V305, P37, DOI 10.1016/S0006-291X(03)00694-6; TSENG L, 1974, ENDOCRINOLOGY, V94, P419, DOI 10.1210/endo-94-2-419; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; WU L, 1993, J BIOL CHEM, V268, P12964; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006; Zhu SJ, 2002, J ENDOCRINOL, V172, P31, DOI 10.1677/joe.0.1720031	47	29	29	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3806	3816		10.1096/fj.14-269035	http://dx.doi.org/10.1096/fj.14-269035			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018678				2022-12-28	WOS:000359915600017
J	Parham, KA; Zebol, JR; Tooley, KL; Sun, WY; Moldenhauer, LM; Cockshell, MP; Gliddon, BL; Moretti, PA; Tigyi, G; Pitson, SM; Bonder, CS				Parham, Kate A.; Zebol, Julia R.; Tooley, Katie L.; Sun, Wai Y.; Moldenhauer, Lachlan M.; Cockshell, Michaelia P.; Gliddon, Briony L.; Moretti, Paul A.; Tigyi, Gabor; Pitson, Stuart M.; Bonder, Claudine S.			Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-gamma that regulates neoangiogenesis	FASEB JOURNAL			English	Article						transcription factor; endothelial; neovascularization	HUMAN ENDOTHELIAL-CELLS; LOW-DENSITY-LIPOPROTEIN; STAT5/PPAR-GAMMA TRANSCRIPTIONAL COMPLEX; PPAR-GAMMA; IN-VIVO; LYSOPHOSPHATIDIC ACID; PROGENITOR-CELL; BREAST-CANCER; LIPID-METABOLISM; INCREASES NUMBER	Sphingosine 1-phosphate (S1P) is a bioactive lipid that can function both extracellularly and intracellularly to mediate a variety of cellular processes. Using lipid affinity matrices and a radiolabeled lipid binding assay, we reveal that S1P directly interacts with the transcription factor peroxisome proliferator-activated receptor (PPAR)gamma. Herein, we show that S1P treatment of human endothelial cells (ECs) activated a luciferase-tagged PPAR gamma-specific gene reporter by similar to 12-fold, independent of the S1P receptors. More specifically, in silico docking, gene reporter, and binding assays revealed that His323 of the PPAR gamma ligand binding domain is important for binding to S1P. PPAR gamma functions when associated with coregulatory proteins, and herein we identify that peroxisome proliferator-activated receptor-gamma coactivator 1 (PGC1)beta binds to PPAR gamma in ECs and their progenitors (nonadherent endothelial forming cells) and that the formation of this PPAR gamma:PGC1 beta complex is increased in response to S1P. ECs treated with S1P selectively regulated known PPAR gamma target genes with PGC1 beta and plasminogen-activated inhibitor-1 being increased, no change to adipocyte fatty acid binding protein 2 and suppression of CD36. S1P-induced in vitro tube formation was significantly attenuated in the presence of the PPAR gamma antagonist GW9662, and in vivo application of GW9662 also reduced vascular development in Matrigel plugs. Interestingly, activation of PPAR gamma by the synthetic ligand troglitazone also reduced tube formation in vitro and in vivo. To support this, Sphk1(-/-) Sphk2(+/-) mice, with low circulating S1P levels, demonstrated a similar reduction in vascular development. Taken together, our data reveal that the transcription factor, PPAR gamma, is a bona fide intracellular target for S1P and thus suggest that the S1P:PPAR gamma:PGC1 beta complex may be a useful target to manipulate neovascularization.	[Parham, Kate A.; Zebol, Julia R.; Tooley, Katie L.; Sun, Wai Y.; Moldenhauer, Lachlan M.; Cockshell, Michaelia P.; Gliddon, Briony L.; Moretti, Paul A.; Pitson, Stuart M.; Bonder, Claudine S.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Parham, Kate A.; Zebol, Julia R.; Tooley, Katie L.; Sun, Wai Y.; Moldenhauer, Lachlan M.; Cockshell, Michaelia P.; Gliddon, Briony L.; Moretti, Paul A.; Pitson, Stuart M.; Bonder, Claudine S.] Univ S Australia, Adelaide, SA 5000, Australia; [Parham, Kate A.; Sun, Wai Y.; Bonder, Claudine S.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Parham, Kate A.; Tooley, Katie L.; Sun, Wai Y.; Moldenhauer, Lachlan M.; Cockshell, Michaelia P.; Pitson, Stuart M.; Bonder, Claudine S.] La Trobe Univ, Cooperat Res Ctr Biomarker Translat, Melbourne, Vic, Australia; [Tigyi, Gabor] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	Centre for Cancer Biology; SA Pathology; University of South Australia; University of Adelaide; La Trobe University; University of Tennessee System; University of Tennessee Health Science Center	Bonder, CS (corresponding author), SA Pathol, Ctr Canc Biol, POB 14, Adelaide, SA 5000, Australia.	claudine.bonder@unisa.edu.au	Pitson, Stuart/B-9342-2009	Pitson, Stuart/0000-0002-9527-2740; Parham, Kate/0000-0001-8558-791X; Bonder, Claudine S./0000-0001-9875-967X; Cockshell, Michaelia/0000-0002-1350-2988	Heart Foundation Fellowship [CR 10A 4983]; Australian Postgraduate Award; Co-operative Research Centre for Biomarker Translation; National Health and Medical Research Council of Australia [1042589]; Fay Fuller Foundation; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER	Heart Foundation Fellowship; Australian Postgraduate Award(Australian Government); Co-operative Research Centre for Biomarker Translation(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fay Fuller Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. David Dimasi for preparing the ECs, Samantha Escarbe for preparing the nonadherent endothelial forming cells, Lorena Davies for technical assistance with sphingosine 1-phosphate analysis, Dr. James Fells for his assistance with the in silico docking experiments, Dr. Melissa Pitman for assistance with interpretation of the in silico docking data, and the staff and consenting donors at Women's and Children's Hospital (North Adelaide, Adelaide, SA, Australia) and Burnside Memorial Hospital (Burnside, Adelaide, SA, Australia) for the donation and collection of the umbilical cords and UCB. This work and C.S.B. were supported by a Heart Foundation Fellowship (CR 10A 4983). K.A.P. was supported by an Australian Postgraduate Award and the Co-operative Research Centre for Biomarker Translation. S.M.P. was supported by a Senior Research Fellowship (1042589) from the National Health and Medical Research Council of Australia and the Fay Fuller Foundation. The authors declare no conflicts of interest.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Appleby SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046996; Asami-Miyagishi R, 2004, BIOCHEM BIOPH RES CO, V315, P497, DOI 10.1016/j.bbrc.2004.01.074; Asano T, 2000, BBA-MOL CELL RES, V1497, P148, DOI 10.1016/S0167-4889(00)00054-9; Barrett JM, 2011, MICROCIRCULATION, V18, P583, DOI 10.1111/j.1549-8719.2011.00119.x; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bonder CS, 2009, BLOOD, V113, P2108, DOI 10.1182/blood-2008-07-166942; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Bryan L, 2008, MOL CANCER RES, V6, P1469, DOI 10.1158/1541-7786.MCR-08-0082; Chang CL, 2008, PROSTAG OTH LIPID M, V87, P20, DOI 10.1016/j.prostaglandins.2008.05.002; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Christiaens V, 2012, BBA-GEN SUBJECTS, V1820, P949, DOI 10.1016/j.bbagen.2012.04.001; Cicha I, 2011, CLIN HEMORHEOL MICRO, V48, P65, DOI 10.3233/CH-2011-1394; Daugherty A, 1997, ARTERIOSCL THROM VAS, V17, P2369, DOI 10.1161/01.ATV.17.11.2369; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Dentelli P, 2009, ARTERIOSCL THROM VAS, V29, P114, DOI 10.1161/ATVBAHA.108.172247; Feilchenfeldt J, 2004, CANCER LETT, V203, P25, DOI 10.1016/j.canlet.2003.08.024; Fu YC, 2006, ATHEROSCLEROSIS, V188, P102, DOI 10.1016/j.atherosclerosis.2005.10.041; Gamble JR, 2009, AM J PATHOL, V175, P2217, DOI 10.2353/ajpath.2009.090076; Garcia-Pacios M, 2009, BIOPHYS J, V97, P1398, DOI 10.1016/j.bpj.2009.07.001; Gealekman O, 2012, DIABETOLOGIA, V55, P2794, DOI 10.1007/s00125-012-2658-2; Ghelfi E, 2013, AM J PATHOL, V182, P1425, DOI 10.1016/j.ajpath.2012.12.009; Giaginis C, 2007, EXPERT OPIN INV DRUG, V16, P1561, DOI 10.1517/13543784.16.10.1561; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Guo YH, 2013, J BIOL CHEM, V288, P4625, DOI 10.1074/jbc.M112.407452; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Handt S, 1996, BLOOD, V87, P4204, DOI 10.1182/blood.V87.10.4204.bloodjournal87104204; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Jung Y, 2008, IMMUNOL LETT, V117, P63, DOI 10.1016/j.imlet.2007.12.002; Kawabe-Yako R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024646; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Koch A, 2012, BRIT J PHARMACOL, V166, P1018, DOI 10.1111/j.1476-5381.2012.01824.x; Leclercq TM, 2008, J BIOL CHEM, V283, P9606, DOI 10.1074/jbc.M708782200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Limaye V, 2008, ENDOTHELIUM-J ENDOTH, V15, P101, DOI 10.1080/10623320802125342; Lin CI, 2007, BIOCHEM BIOPH RES CO, V355, P895, DOI 10.1016/j.bbrc.2007.02.043; Litwin M, 1997, J CELL BIOL, V139, P219, DOI 10.1083/jcb.139.1.219; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Margeli A., 2003, Angiogenesis, V6, P165, DOI 10.1023/B:AGEN.0000021377.13669.c0; Marx N, 1999, ARTERIOSCL THROM VAS, V19, P546, DOI 10.1161/01.ATV.19.3.546; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Norazmi MN, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/849195; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Panetti TS, 2002, BBA-MOL CELL BIOL L, V1582, P190, DOI 10.1016/S1388-1981(02)00155-5; Pistrosch F, 2005, ATHEROSCLEROSIS, V183, P163, DOI 10.1016/j.atherosclerosis.2005.03.039; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rowe GC, 2011, AM J PHYSIOL-ENDOC M, V301, pE155, DOI 10.1152/ajpendo.00681.2010; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Schwalm S, 2008, BIOCHEM BIOPH RES CO, V368, P1020, DOI 10.1016/j.bbrc.2008.01.132; Segawa Y, 2002, PROSTATE, V51, P108, DOI 10.1002/pros.10058; Shen ZX, 2014, CELL STRESS CHAPERON, V19, P541, DOI 10.1007/s12192-013-0480-5; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Sun WY, 2012, AM J PATHOL, V180, P1740, DOI 10.1016/j.ajpath.2011.12.024; Sun WY, 2010, AM J PATHOL, V177, P436, DOI 10.2353/ajpath.2010.091016; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trombetta A, 2013, DIABETES, V62, P1245, DOI 10.2337/db12-0646; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Wang CH, 2004, CIRCULATION, V109, P1392, DOI 10.1161/01.CIR.0000123231.49594.21; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Werner C, 2007, DIABETES, V56, P2609, DOI 10.2337/db07-0069; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Yan GJ, 2008, CARDIOVASC RES, V78, P308, DOI 10.1093/cvr/cvn006; Yatomi Y, 1997, J BIOCHEM, V121, P969	91	59	61	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3638	3653		10.1096/fj.14-261289	http://dx.doi.org/10.1096/fj.14-261289			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25985799	Green Published, Green Accepted			2022-12-28	WOS:000359915600004
J	Han, XR; Yang, F; Cao, HQ; Liang, ZC				Han, Xiaorui; Yang, Feng; Cao, Huiqing; Liang, Zicai			Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis	FASEB JOURNAL			English	Article						long noncoding RNA; microRNA; sponge	LONG NONCODING RNA; CARDIAC-MUSCLE DEVELOPMENT; NUCLEAR SPECKLES; GENE-EXPRESSION; LNCRNA MALAT1; LUNG-CANCER; MICRORNAS; SKELETAL; CELLS; DIFFERENTIATION	Metastasis-associated lung adenocarcinoma transcript 1 (Malat1) is an example of a functional long noncoding RNA involved in many biologic processes. However, the mechanisms for Malat1 in myogenesis are unclear. Serum response factor (SRF) is a pivotal transcription factor for muscle proliferation and differentiation and is reported to be a target gene for muscle-specific microRNA-133 (miR-133). In this study, we initially found that silencing Malat1 in the mouse myoblast C2C12 cell line inhibited myocyte differentiation and decreased Srf at both the RNA and protein levels. Srf silencing decreased Malat1 expression as well. Further study revealed that Malat1 contained an miR-133 functional target site, and the interplay between Malat1 and Srf was miR-133 dependent. We demonstrated that Malat1 modulates Srf through miR-133 as a competing endogenous RNA and established a novel connection among Malat1, miR-133, and Srf in myoblast differentiation.	[Han, Xiaorui; Yang, Feng; Cao, Huiqing; Liang, Zicai] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Peking University	Yang, F (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	feng_yang@pku.edu.cn; caohuiqing@pku.edu.cn	Yang, Feng/A-4770-2017		National High-Tech R&D Program of China [2012AA022501]; National Natural Science Foundation of China [81273422, 81170097]	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Chujun Liu for her contribution to the bioinformatics analysis in this article. This work was supported by the National High-Tech R&D Program of China (Grant 2012AA022501) and the National Natural Science Foundation of China (Grants 81273422 and 81170097). The authors declare no conflicts of interest.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bradley RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006478; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dodd DW, 2013, NUCLEIC ACID THER, V23, P188, DOI 10.1089/nat.2013.0427; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fang L, 2013, FASEB J, V27, P907, DOI 10.1096/fj.12-220905; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li BZ, 2014, J BIOL CHEM, V289, P29365, DOI 10.1074/jbc.M114.572693; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watts R, 2013, AM J PHYSIOL-CELL PH, V304, pC995, DOI 10.1152/ajpcell.00392.2012; Yang F, 2013, FEBS LETT, V587, P3175, DOI 10.1016/j.febslet.2013.07.048; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003	49	103	120	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3054	3064		10.1096/fj.14-259952	http://dx.doi.org/10.1096/fj.14-259952			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25868726				2022-12-28	WOS:000356859100032
J	Hyldahl, RD; Nelson, B; Xin, L; Welling, T; Groscost, L; Hubal, MJ; Chipkin, S; Clarkson, PM; Parcell, AC				Hyldahl, Robert D.; Nelson, Brad; Xin, Ling; Welling, Tyson; Groscost, Logan; Hubal, Monica J.; Chipkin, Stuart; Clarkson, Priscilla M.; Parcell, Allen C.			Extracellular matrix remodeling and its contribution to protective adaptation following lengthening contractions in human muscle	FASEB JOURNAL			English	Article						eccentric exercise; satellite cell; repeated-bout effect; muscle damage	SKELETAL-MUSCLE; ECCENTRIC EXERCISE; SATELLITE CELLS; SINGLE BOUT; CONNECTIVE-TISSUE; SYSTEMS-ANALYSIS; GROWTH-FACTORS; RAT TENDON; COLLAGEN; DAMAGE	This study determined the contribution of extracellular matrix (ECM) remodeling to the protective adaptation of human skeletal muscle known as the repeated-bout effect (RBE). Muscle biopsies were obtained 3 hours, 2 days, and 27 days following an initial bout (B1) of lengthening contractions (LCs) and 2 days following a repeated bout (B2) in 2 separate studies. Biopsies from the nonexercised legs served as controls. In the first study, global transcriptomic analysis indicated widespread changes in ECM structural, deadhesive, and signaling transcripts, 3 hours following LC. To determine if ECM remodeling is involved in the RBE, we conducted a second study by use of a repeated-bout paradigm. TNC immunoreactivity increased 10.8-fold following B1, was attenuated following B2, and positively correlated with LC-induced strength loss (r(2) = 0.45; P = 0.009). Expression of collagen I, III, and IV (COL1A1, COL3A1, COL4A1) transcripts was unchanged early but increased 5.7 +/- 2.5-, 3.2 +/- 0.9-, and 2.1 +/- 0.4-fold (P < 0.05), respectively, 27 days post-B1 and were unaffected by B2. Likewise, TGF-beta signaling demonstrated a delayed response following LC. Satellite cell content increased 80% (P < 0.05) 2 days post-B1 (P < 0.05), remained elevated 27 days post-B1, and was unaffected by B2. Collectively, the data suggest sequential ECM remodeling characterized by early deadhesion and delayed reconstructive activity that appear to contribute to the RBE.	[Hyldahl, Robert D.; Welling, Tyson; Groscost, Logan; Parcell, Allen C.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Nelson, Brad] Ohio Dominican Univ, Dept Nat Sci, Columbus, OH USA; [Xin, Ling; Chipkin, Stuart; Clarkson, Priscilla M.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Hubal, Monica J.] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA	Brigham Young University; Ohio Dominican University; University of Massachusetts System; University of Massachusetts Amherst; George Washington University	Hyldahl, RD (corresponding author), Brigham Young Univ, Dept Exercise Sci, 106 SFH, Provo, UT 84602 USA.	robhyldahl@byu.edu	Nelson, Brad/P-8771-2016; Hyldahl, Robert/AAZ-3960-2020	Nelson, Brad/0000-0003-0793-2006; Hubal, Monica/0000-0001-6579-6036				Beaton LJ, 2002, J PHYSIOL-LONDON, V544, P849, DOI 10.1113/jphysiol.2002.022350; Boppart MD, 2008, AM J PHYSIOL-REG I, V295, pR1623, DOI 10.1152/ajpregu.00089.2008; Boppart MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1660, DOI 10.1152/ajpcell.00317.2005; Breen EC, 1996, J APPL PHYSIOL, V81, P355, DOI 10.1152/jappl.1996.81.1.355; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Crameri RM, 2004, MATRIX BIOL, V23, P259, DOI 10.1016/j.matbio.2004.05.009; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Gavin TP, 2001, J APPL PHYSIOL, V90, P1219, DOI 10.1152/jappl.2001.90.4.1219; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2013, SCAND J MED SCI SPOR, V23, pe150, DOI 10.1111/j.1600-0838.2011.01414.x; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Hubal MJ, 2008, AM J PHYSIOL-REG I, V294, pR1628, DOI 10.1152/ajpregu.00853.2007; Hyldahl RD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00485; Hyldahl RD, 2014, MUSCLE NERVE, V49, P155, DOI 10.1002/mus.24077; Hyldahl RD, 2011, FASEB J, V25, P2956, DOI 10.1096/fj.10-177105; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; LAPIER TK, 1995, J APPL PHYSIOL, V78, P1065, DOI 10.1152/jappl.1995.78.3.1065; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Macaluso F, 2013, MUSCLE NERVE, V48, P109, DOI 10.1002/mus.23721; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Mackey AL, 2004, J APPL PHYSIOL, V97, P197, DOI 10.1152/japplphysiol.01174.2003; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Mukund K, 2014, MUSCLE NERVE, V50, P744, DOI 10.1002/mus.24211; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; NOSAKA K, 1995, MED SCI SPORT EXER, V27, P1263; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Paulsen G, 2010, MED SCI SPORT EXER, V42, P75, DOI 10.1249/MSS.0b013e3181ac7adb; Raastad T, 2010, MED SCI SPORT EXER, V42, P86, DOI 10.1249/MSS.0b013e3181ac7afa; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Smith LR, 2013, WIRES SYST BIOL MED, V5, P55, DOI 10.1002/wsbm.1197; Stupka N, 2001, J APPL PHYSIOL, V91, P1669, DOI 10.1152/jappl.2001.91.4.1669; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang Y, 2012, J APPL PHYSIOL, V113, P1884, DOI 10.1152/japplphysiol.01514.2011; WATT DJ, 1987, ANAT EMBRYOL, V175, P527, DOI 10.1007/BF00309688	43	81	83	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2894	2904		10.1096/fj.14-266668	http://dx.doi.org/10.1096/fj.14-266668			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25808538				2022-12-28	WOS:000356859100019
J	Jank, T; Trillhaase, C; Brozda, N; Steinemann, M; Schwan, C; Suss, R; Aktories, K				Jank, Thomas; Trillhaase, Christoph; Brozda, Natalia; Steinemann, Marcus; Schwan, Carsten; Suess, Regine; Aktories, Klaus			Intracellular plasma membrane guidance of Photorhabdus asymbiotica toxin is crucial for cell toxicity	FASEB JOURNAL			English	Article						Rho GTPase; heterotrimeric G protein; glycosyltransferase; deamidation; membrane localization domain	PASTEURELLA-MULTOCIDA TOXIN; CLOSTRIDIUM-DIFFICILE TOXIN; LEGIONELLA-PNEUMOPHILA; LIVING CELLS; RHO-PROTEINS; GLUCOSYLATION; BINDING; HOST; LOCALIZATION; LUMINESCENS	The bacterial toxin Photorhabdus asymbiotica toxin (PaTox) modifies Rho proteins by tyrosine GlcNAcylation and heterotrimeric G alpha proteins by deamidation. Inactivation of Rho proteins results in F-actin disassembly in host cells. Here, we analyzed the subcellular distribution of PaTox and show that the glycosyltransferase domain of PaTox associates with the negatively charged inner surface of the plasma membrane. Localization studies with site-directed mutants, liposome precipitation analysis, lipid overlay assays, and confocal time-lapse microscopy revealed that a patch of positively charged lysine and arginine residues located on helix alpha 1 of the glycosyltransferase is essential for membrane attachment. Using a helix1 deletion mutant, we show that plasma membrane localization of PaTox is essential for cytotoxicity and proved this by substitution of helix1 by an N-terminal myristoylation signal peptide, which restored plasma membrane localization and cytotoxicity. Furthermore, we also show that the intracellular deamidase activity of PaTox depends on the presence of the membrane localization domain. Comparison of PaTox membrane-binding domain with the 4-helix-bundle membrane-binding domain of Pasteurella multocida toxin, Vibrio cholerae multifunctional autoprocessing repeats-in-toxin, and clostridial glucosylating toxins revealed similar spatial geometry and charge distribution but different structural topology, indicating convergent evolution of toxin domains for optimized host target interaction.	[Jank, Thomas; Trillhaase, Christoph; Brozda, Natalia; Steinemann, Marcus; Schwan, Carsten; Aktories, Klaus] Univ Freiburg, Dept Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Suess, Regine] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, D-79104 Freiburg, Germany; [Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Jank, T (corresponding author), Univ Freiburg, Dept Expt & Clin Pharmacol & Toxicol, Albertstr 25, D-79104 Freiburg, Germany.	jank@pharmakol.uni-freiburg.de; klaus.aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Schwan, Carsten/0000-0003-3876-8739	Deutsche Forschungsgemeinschaft [Collaborative Research Center 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	The authors thank Peter Gebhardt for excellent technical assistance, Birgit Erhard for liposome preparation, Thilo Nolke for supporting microscopic analysis, and Frederick Schlosser for help in initial cloning. This work was supported by the Deutsche Forschungsgemeinschaft Collaborative Research Center 746 and the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS.	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Antic I, 2014, PROTEINS, V82, P2643, DOI 10.1002/prot.24628; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; FARMER JJ, 1989, J CLIN MICROBIOL, V27, P1594, DOI 10.1128/JCM.27.7.1594-1600.1989; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Hicks SW, 2013, NAT REV MICROBIOL, V11, P316, DOI 10.1038/nrmicro3009; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jank T, 2012, CELL MICROBIOL, V14, P852, DOI 10.1111/j.1462-5822.2012.01761.x; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kamitani S, 2011, FEBS J, V278, P2702, DOI 10.1111/j.1742-4658.2011.08197.x; Kamitani S, 2010, J BIOL CHEM, V285, P25467, DOI 10.1074/jbc.M110.102285; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Peel MM, 1999, J CLIN MICROBIOL, V37, P3647, DOI 10.1128/JCM.37.11.3647-3653.1999; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Vogler O, 2008, BBA-BIOMEMBRANES, V1778, P1640, DOI 10.1016/j.bbamem.2008.03.008; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	52	3	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2789	2802		10.1096/fj.14-269381	http://dx.doi.org/10.1096/fj.14-269381			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782990				2022-12-28	WOS:000356859100011
J	Widdows, KL; Panitchob, N; Crocker, IP; Please, CP; Hanson, MA; Sibley, CP; Johnstone, ED; Sengers, BG; Lewis, RM; Glazier, JD				Widdows, Kate L.; Panitchob, Nuttanont; Crocker, Ian P.; Please, Colin P.; Hanson, Mark A.; Sibley, Colin P.; Johnstone, Edward D.; Sengers, Bram G.; Lewis, Rohan M.; Glazier, Jocelyn D.			Integration of computational modeling with membrane transport studies reveals new insights into amino acid exchange transport mechanisms	FASEB JOURNAL			English	Article						antiporters; facilitated transport; LAT2 (SLC7A8); overshoot phenomena	PLASMA-MEMBRANE; HUMAN-PLACENTA; SYSTEM L; ACTIVE-TRANSPORT; BRUSH-BORDER; HEAVY-CHAIN; IN-VITRO; VESICLES; EXPRESSION; LAT2	Uptake of system L amino acid substrates into isolated placental plasma membrane vesicles in the absence of opposing side amino acid (zero-trans uptake) is incompatible with the concept of obligatory exchange, where influx of amino acid is coupled to efflux. We therefore hypothesized that system L amino acid exchange transporters are not fully obligatory and/or that amino acids are initially present inside the vesicles. To address this, we combined computational modeling with vesicle transport assays and transporter localization studies to investigate the mechanisms mediating [C-14] L-serine (a system L substrate) transport into human placental microvillous plasma membrane (MVM) vesicles. The carrier model provided a quantitative framework to test the 2 hypotheses that L-serine transport occurs by either obligate exchange or nonobligate exchange coupled with facilitated transport (mixed transport model). The computational model could only account for experimental [C-14] L-serine uptake data when the transporter was not exclusively in exchange mode, best described by the mixed transport model. MVM vesicle isolates contained endogenous amino acids allowing for potential contribution to zerotrans uptake. Both L-type amino acid transporter (LAT) 1 and LAT2 subtypes of system L were distributed to MVM, with L-serine transport attributed to LAT2. These findings suggest that exchange transporters do not function exclusively as obligate exchangers.	[Widdows, Kate L.; Crocker, Ian P.; Sibley, Colin P.; Johnstone, Edward D.; Glazier, Jocelyn D.] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Widdows, Kate L.; Sibley, Colin P.; Johnstone, Edward D.; Glazier, Jocelyn D.] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Widdows, Kate L.; Sibley, Colin P.; Johnstone, Edward D.; Glazier, Jocelyn D.] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Panitchob, Nuttanont; Sengers, Bram G.] Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England; [Please, Colin P.] Univ Oxford, Math Inst, Oxford, England; [Hanson, Mark A.; Lewis, Rohan M.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Sengers, Bram G.; Lewis, Rohan M.] Univ Southampton, Inst Life Sci, Southampton SO9 5NH, Hants, England	University of Manchester; University of Manchester; University of Manchester; University of Southampton; University of Oxford; University of Southampton; University of Southampton	Lewis, RM (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, Inst Dev Sci MP887, Southampton SO16 6YD, Hants, England.	rohan.lewis@soton.ac.uk	Hanson, Mark/AAE-8236-2019; Lewis, Rohan/C-9350-2011	Hanson, Mark/0000-0002-6907-613X; Lewis, Rohan/0000-0003-4044-9104; Johnstone, Ed/0000-0001-9732-8544; Sengers, Bram/0000-0001-5859-6984; Please, Colin/0000-0001-8917-8574	Biotechnology and Biological Sciences Research Council [BB/I011315/1, BB/I011250/1]; British Heart Foundation; BBSRC [BB/I011315/1, BB/I011250/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Claire McGuire (Research Practitioner), the midwives, and participating women at St Mary's Hospital (Manchester, United Kingdom), for generous assistance in obtaining placentas for our study. The authors also thank Teresa Wu-Hoyee at Genetic Medicine (Manchester, United Kingdom), who kindly performed the HPLC analyses. This study was supported by Biotechnology and Biological Sciences Research Council Grants BB/I011315/1 and BB/I011250/1. M.A.H. was supported by the British Heart Foundation. The authors declare no conflicts of interest.	Ayuk PTY, 2000, AM J PHYSIOL-CELL PH, V278, pC1162, DOI 10.1152/ajpcell.2000.278.6.C1162; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Berman MC, 2001, BBA-BIOMEMBRANES, V1513, P95, DOI 10.1016/S0005-2736(01)00356-X; Brand AP, 2010, PLACENTA, V31, P456, DOI 10.1016/j.placenta.2010.01.016; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Broer A, 2002, J PHYSIOL-LONDON, V539, P3, DOI 10.1013/jphysiol.2001.013303; Broer S, 2002, PFLUG ARCH EUR J PHY, V444, P457, DOI 10.1007/s00424-002-0840-y; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CHRISTENSEN HN, 1969, J BIOL CHEM, V244, P1510; Chrostowski MK, 2010, PLACENTA, V31, P528, DOI 10.1016/j.placenta.2009.12.010; Chrostowski MK, 2009, PLACENTA, V30, P270, DOI 10.1016/j.placenta.2008.12.015; Cleal JK, 2008, J NEUROENDOCRINOL, V20, P419, DOI 10.1111/j.1365-2826.2008.01662.x; Cleal JK, 2007, J PHYSIOL-LONDON, V582, P871, DOI 10.1113/jphysiol.2007.130690; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P13231, DOI 10.1021/bi961208t; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; GANAPATHY ME, 1986, BIOCHEM J, V238, P201, DOI 10.1042/bj2380201; GLAZIER JD, 1988, BIOCHIM BIOPHYS ACTA, V945, P127, DOI 10.1016/0005-2736(88)90475-0; Glazier JD, 2006, METH MOLEC MED, V122, P241; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; HEINZ E, 1984, BIOCHIM BIOPHYS ACTA, V776, P83, DOI 10.1016/0005-2736(84)90253-0; HOELTZLI SD, 1989, AM J PHYSIOL, V256, pC630, DOI 10.1152/ajpcell.1989.256.3.C630; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Kim CS, 2008, BIOL PHARM BULL, V31, P1096, DOI 10.1248/bpb.31.1096; KRUPKA RM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P105, DOI 10.1016/0005-2728(93)90009-5; Kudo Y, 2001, J PHYSIOL-LONDON, V531, P405, DOI 10.1111/j.1469-7793.2001.0405i.x; KURUVILLA AG, 1994, J CLIN INVEST, V94, P689, DOI 10.1172/JCI117386; Lewis RM, 2007, PLACENTA, V28, P445, DOI 10.1016/j.placenta.2006.06.014; Lewis RM, 2013, PLACENTA, V34, pS46, DOI 10.1016/j.placenta.2012.10.010; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHENDRAN D, 1993, PEDIATR RES, V34, P661; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; MURER H, 1980, J MEMBRANE BIOL, V55, P81, DOI 10.1007/BF01871151; Okamoto Y, 2002, AM J PHYSIOL-CELL PH, V282, pC196, DOI 10.1152/ajpcell.2002.282.1.C196; Panitchob N, 2015, J THEOR BIOL, V365, P352, DOI 10.1016/j.jtbi.2014.10.042; PHILIPPS AF, 1978, AM J OBSTET GYNECOL, V131, P881, DOI 10.1016/S0002-9378(16)33136-2; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Sengers BG, 2010, EXP PHYSIOL, V95, P829, DOI 10.1113/expphysiol.2010.052902; Tsitsiou E, 2009, J PHYSIOL-LONDON, V587, P4001, DOI 10.1113/jphysiol.2009.173393; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z	46	23	23	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2583	2594		10.1096/fj.14-267773	http://dx.doi.org/10.1096/fj.14-267773			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25761365	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000355209500034
J	Eclarinal, JD; Zhu, SY; Baker, MS; Piyarathna, DB; Coarfa, C; Fiorotto, ML; Waterland, RA				Eclarinal, Jesse D.; Zhu, Shaoyu; Baker, Maria S.; Piyarathna, Danthasinghe B.; Coarfa, Cristian; Fiorotto, Marta L.; Waterland, Robert A.			Maternal exercise during pregnancy promotes physical activity in adult offspring	FASEB JOURNAL			English	Article						developmental programming; activity-stat; metabolic imprinting	ENERGY-EXPENDITURE; VOLUNTARY EXERCISE; LOCOMOTOR-ACTIVITY; OBESITY; LIFE; DETERMINANTS; HIPPOCAMPUS; EXPRESSION; PHENOTYPES; PREVENTS	Previous rodent studies have shown that maternal voluntary exercise during pregnancy leads to metabolic changes in adult offspring. We set out to test whether maternal voluntary exercise during pregnancy also induces persistent changes in voluntary physical activity in the offspring. Adult C57BL/6J female mice were randomly assigned to be caged with an unlocked (U) or locked (L) running wheel before and during pregnancy. Maternal running behavior was monitored during pregnancy, and body weight, body composition, food intake, energy expenditure, total cage activity, and running wheel activity were measured in the offspring at various ages. U offspring were slightly heavier at birth, but no group differences in body weight or composition were observed at later ages (when mice were caged without access to running wheels). Consistent with our hypothesis, U offspring were more physically active as adults. This effect was observed earlier in female offspring (at sexual maturation). Remarkably, at 300 d of age, U females achieved greater fat loss in response to a 3-wk voluntary exercise program. Our findings show for the first time that maternal physical activity during pregnancy affects the offspring's lifelong propensity for physical activity and may have important implications for combating the worldwide epidemic of physical inactivity and obesity.	[Eclarinal, Jesse D.; Zhu, Shaoyu; Baker, Maria S.; Fiorotto, Marta L.; Waterland, Robert A.] USDA ARS, Childrens Nutr Res Ctr, Houston, TX USA; [Eclarinal, Jesse D.; Zhu, Shaoyu; Baker, Maria S.; Fiorotto, Marta L.; Waterland, Robert A.] Baylor Coll Med, Dept Pediat, Houston, TX USA; [Piyarathna, Danthasinghe B.; Coarfa, Cristian] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX USA; [Waterland, Robert A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA	United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Waterland, RA (corresponding author), USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Dept Pediat, 1100 Bates St,Suite 5080, Houston, TX 77030 USA.; Waterland, RA (corresponding author), USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Dept Mol & Human Genet, 1100 Bates St,Suite 5080, Houston, TX 77030 USA.	waterland@bcm.edu		Piyarathna, Danthasinghe Waduge Badrajee/0000-0002-7240-216X	U.S. Department of Agriculture (USDA) Grants [CRIS 6250-51000-055, CRIS 3092-5-001-059]; U.S. National Institutes of Health (NIH) Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [AR46308]; USDA/Agricultural Research Service (ARS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR046308, R01AR046308] Funding Source: NIH RePORTER	U.S. Department of Agriculture (USDA) Grants; U.S. National Institutes of Health (NIH) Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; USDA/Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Mr. Firoz Vohra [U.S. Department of Agriculture (USDA) Children's National Research Center (CNRC), Baylor College of Medicine] for expert assistance with the CLAMS studies, and Mr. Adam Gillum (USDA CNRC) for assistance in creating the figures. This work was funded by U.S. Department of Agriculture (USDA) Grants CRIS 6250-51000-055 and CRIS 3092-5-001-059 (to R.A.W.) and U.S. National Institutes of Health (NIH) Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR46308 (to M.L.F.). Measurements of body composition, energy expenditure, and food intake were conducted in the Mouse Metabolic Research Unit (USDA CNRC), which is supported by funds from the USDA/Agricultural Research Service (ARS) (www.bcm.edu/cnrc/mmru). The authors declare no conflicts of interest.	Acosta W, 2015, PHYSIOL BEHAV, V149, P279, DOI 10.1016/j.physbeh.2015.06.020; Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Atkinson RL, 2012, INT J OBESITY, V36, P1259, DOI 10.1038/ijo.2012.149; Baker MS, 2015, INT J OBESITY, V39, P98, DOI 10.1038/ijo.2013.146; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Carter LG, 2013, MED SCI SPORT EXER, V45, P832, DOI 10.1249/MSS.0b013e31827de953; Carter LG, 2012, AM J PHYSIOL-ENDOC M, V303, pE1061, DOI 10.1152/ajpendo.00213.2012; CEDERHOLM J, 1985, ACTA MED SCAND, V217, P373; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Dorner G, 1974, Prog Brain Res, V41, P221; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gluckman PD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002554; Guth LM, 2013, EXP PHYSIOL, V98, P1469, DOI 10.1113/expphysiol.2012.070300; Hesketh KR, 2014, PEDIATRICS, V133, pE973, DOI 10.1542/peds.2013-3153; Hopkins SA, 2010, J CLIN ENDOCR METAB, V95, P2080, DOI 10.1210/jc.2009-2255; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kelly SA, 2015, J NEGAT RESULTS BIOM, V14, DOI 10.1186/s12952-015-0032-x; Kelly SA, 2013, TRENDS GENET, V29, P348, DOI 10.1016/j.tig.2012.12.007; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kriska AM, 2001, DIABETES CARE, V24, P1787, DOI 10.2337/diacare.24.10.1787; Laker RC, 2014, DIABETES, V63, P1605, DOI [10.2337/db14-0135, 10.2337/db13-1614]; Lee HH, 2006, BRAIN DEV-JPN, V28, P147, DOI 10.1016/j.braindev.2005.05.007; Li G, 2013, DIABETES, V62, P2773, DOI 10.2337/db12-1306; Mattocks C, 2008, BRIT J SPORT MED, V42, P721; Murashov AK, 2016, FASEB J, V30, P775, DOI 10.1096/fj.15-274274; Parnpiansil P, 2003, NEUROSCI LETT, V352, P45, DOI 10.1016/j.neulet.2003.08.023; Pollock KE, 2015, ENDOCRINOLOGY, V156, P3777, DOI 10.1210/en.2015-1247; Ronca AE, 2008, BEHAV NEUROSCI, V122, P224, DOI 10.1037/0735-7044.122.1.224; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Stanford KI, 2015, DIABETES, V64, P427, DOI 10.2337/db13-1848; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Takito MY, 2010, REV SAUDE PUBL, V44, P90, DOI 10.1590/S0034-89102010000100010; Vega CC, 2015, INT J OBESITY, V39, P712, DOI 10.1038/ijo.2013.150; Vickers MH, 2014, ANN NUTR METAB, V64, P26, DOI 10.1159/000360506; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Waterland RA, 2014, ANNU REV NUTR, V34, P337, DOI 10.1146/annurev-nutr-071813-105315; Wiebe HW, 2015, OBSTET GYNECOL, V125, P1185, DOI 10.1097/AOG.0000000000000801; Yin MM, 2013, BEHAV BRAIN RES, V253, P297, DOI 10.1016/j.bbr.2013.07.040	42	41	43	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2541	2548		10.1096/fj.201500018R	http://dx.doi.org/10.1096/fj.201500018R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27033262	Green Published			2022-12-28	WOS:000379249500009
J	Tabe, S; Hikiji, H; Ariyoshi, W; Hashidate-Yoshida, T; Shindou, H; Okinaga, T; Shimizu, T; Tominaga, K; Nishihara, T				Tabe, Shirou; Hikiji, Hisako; Ariyoshi, Wataru; Hashidate-Yoshida, Tomomi; Shindou, Hideo; Okinaga, Toshinori; Shimizu, Takao; Tominaga, Kazuhiro; Nishihara, Tatsuji			Lysophosphatidylethanolamine acyltransferase 1/membrane-bound O-acyltransferase 1 regulates morphology and function of P19C6 cell-derived neurons	FASEB JOURNAL			English	Article						remodeling pathway; lysophospholipid; neuronal differentiation; phospholipid metabolism; oleoyl-CoA	LYSOPHOSPHOLIPID ACYLTRANSFERASES; MAMMALIAN-CELLS; MEMBRANE; DIFFERENTIATION; EXPRESSION; DIVERSITY; RECEPTOR; PROTEIN; PHOSPHOLIPIDS; METABOLISM	Glycerophospholipids, which are components of biomembranes, are formed de novo by the Kennedy pathway and subsequently mature through the Lands cycle. Lysophospholipid acyltransferases (LPLATs) are key enzymes in both pathways and influence the fatty acid composition of biomembranes. Neuronal differentiation is characterized by neurite outgrowth, which requires biomembrane biosynthesis. However, the role of LPLATs in neuronal differentiation remains unknown. In this study, we examined whether LPLATs are involved in neuronal differentiation using all-trans-retinoic acid (ATRA)-treated P19C6 cells. In these cells, mRNA levels of lysophosphatidylethanolamine acyltransferase (LPEAT)-1/membrane-bound O-acyltransferase (MBOAT)-1 were higher than those in undifferentiated cells. LPEAT enzymatic activity increased with 16: 0- and 18: 1-CoA as acyl donors. When LPEAT1/MBOAT1 was knocked down with small interfering RNA (siRNA), outgrowth of neurites and expression of neuronal markers decreased in ATRA-treated P19C6 cells. Voltage-dependent calcium channel activity was also suppressed in these cells transfected with LPEAT1/MBOAT1 siRNA. These results suggest that LPEAT1/MBOAT1 plays an important role in neurite outgrowth and function.	[Tabe, Shirou; Ariyoshi, Wataru; Okinaga, Toshinori; Nishihara, Tatsuji] Kyushu Dent Univ, Dept Hlth Promot, Div Infect & Mol Biol, Kitakyushu, Fukuoka, Japan; [Tabe, Shirou; Tominaga, Kazuhiro] Kyushu Dent Univ, Div Oral & Maxillofacial Surg, Dept Sci Phys Funct, Kitakyushu, Fukuoka, Japan; [Hikiji, Hisako] Kyushu Dent Univ, Dept Oral Funct Management, Kitakyushu, Fukuoka, Japan; [Hashidate-Yoshida, Tomomi; Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo, Japan; [Shindou, Hideo] Agcy Med Res & Dev Core Res Evolutionary Sci & Te, Tokyo, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo, Japan	Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; National Center for Global Health & Medicine - Japan; University of Tokyo	Hikiji, H (corresponding author), Kyushu Dent Univ, Dept Oral Funct Management, Sch Oral Hlth Sci, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka, Japan.	r09hikiji@fa.kyu-dent.ac.jp	Shimizu, Takao/AAV-7052-2021	Nishihara, Tatsuji/0000-0001-7075-9678	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [23390467, 24659841, 24229003, 26460380, 26870879]; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST); Shimadzu Corp.; Ono Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [15K15746, 15K11083] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Shimadzu Corp.; Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI; 23390467) (to H.H.), 24659841 (to T.N.), 24229003 (to T.S.), 26460380 (to H.S.), and 26870879 (to T.H.Y.); and by the Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (to H.S.). The Department of Biochemistry and Molecular Biology (Lipidomics), Faculty of Medicine (The University of Tokyo) is financially supported by Shimadzu Corp., and Ono Pharmaceutical Co., Ltd. The authors declare no conflicts of interest.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CHEUN JE, 1991, INT J DEV NEUROSCI, V9, P391, DOI 10.1016/0736-5748(91)90061-P; Dauwerse JG, 2007, EUR J HUM GENET, V15, P743, DOI 10.1038/sj.ejhg.5201833; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Dustin P., 1984, MICROTUBULES; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Hao N, 2013, NUCLEIC ACIDS RES, V41, P5626, DOI 10.1093/nar/gkt206; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Hishikawa D, 2013, FASEB J, V27, P5131, DOI 10.1096/fj.13-237941; Huang HS, 2012, J NEUROCHEM, V120, P667, DOI 10.1111/j.1471-4159.2011.07332.x; Iga M, 1997, BIOCHEM BIOPH RES CO, V231, P852, DOI 10.1006/bbrc.1997.6202; Imae R, 2012, J LIPID RES, V53, P335, DOI 10.1194/jlr.M018655; Ishibashi M, 2013, ARTERIOSCL THROM VAS, V33, P1171, DOI 10.1161/ATVBAHA.112.300812; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Kuge H, 2014, J BIOL CHEM, V289, P26783, DOI 10.1074/jbc.M114.571075; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lin PX, 1996, J NEUROCHEM, V66, P233; Nishina A, 2006, J LIPID RES, V47, P1434, DOI 10.1194/jlr.M600045-JLR200; Park KS, 2007, FEBS LETT, V581, P4411, DOI 10.1016/j.febslet.2007.08.014; Park SW, 2005, J NEUROSCI, V25, P3350, DOI 10.1523/JNEUROSCI.0186-05.2005; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Viviani B, 1996, BIOCHEM BIOPH RES CO, V223, P712, DOI 10.1006/bbrc.1996.0960; Voronova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019174; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056997; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1	43	4	4	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2591	2601		10.1096/fj.201500097R	http://dx.doi.org/10.1096/fj.201500097R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27048541				2022-12-28	WOS:000379249500014
J	Fischer, HJ; Witte, AK; Walter, L; Grone, HJ; van den Brandt, J; Reichardt, HM				Fischer, Henrike J.; Witte, Ann-Kathrin; Walter, Lutz; Groene, Hermann-Josef; van den Brandt, Jens; Reichardt, Holger M.			Distinct roles of T-cell lymphopenia and the microbial flora for gastrointestinal and CNS autoimmunity	FASEB JOURNAL			English	Article						experimental autoimmune encephalomyelitis; eosinophilic bowel disease; rat; T-cell receptor repertoire; T-cell transfer	RECONSTITUTION INFLAMMATORY SYNDROME; MULTIPLE-SCLEROSIS; BB RAT; EXPANSION; MODEL; GENE; MICE; ALEMTUZUMAB; ANTIGENS; SURVIVAL	T-cell lymphopenia is a major risk factor for autoimmunity. Here we describe congenic Lewis (LEW) rats with a loss-of-function mutation in the Gimap5 gene, leading to a 92% reduction in peripheral T-cell numbers. Gimap5-deficient LEW rats developed eosinophilic autoimmune gastroenteritis accompanied by a 40-fold increase in IgE serum levels. This phenotype was ameliorated by antibiotic treatment, indicating a critical role of the microbial flora in the development of inflammatory bowel disease. Interestingly, Gimap5-deficient LEW rats showed strongly aggravated experimental autoimmune encephalomyelitis (EAE) after immunization with guinea pig myelin basic protein. This phenotype, however, persisted after antibiosis, confirming that the enhanced CNS autoimmune response in T-cell lymphopenic Gimap5-deficient LEW rats was unrelated to the composition of the microbial flora. Rather, it seems that it was caused by the 7-fold increase in the percentage of activated T cells producing IL-17 and IFN-gamma, and the skewed T-cell receptor (TCR) repertoire, both of which were the result of T-cell lymphopenia and not affected by antibiosis. This notion was supported by the observation that adoptive T-cell transfer corrected the TCR repertoire and improved EAE. Collectively, our findings confirm a critical albeit differential role of T-cell lymphopenia in the susceptibility to organ-specific autoimmune responses.-Fischer, H.J., Witte, A.-K., Walter, L., Grone, H.-J., van den Brandt, J., Reichardt, H.M. Distinct roles of T-cell lymphopenia and the microbial flora for gastrointestinal and CNS autoimmunity.	[Fischer, Henrike J.; Witte, Ann-Kathrin; van den Brandt, Jens; Reichardt, Holger M.] Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, Humboldtallee 34, D-37073 Gottingen, Germany; [Walter, Lutz] Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Mol Pathol, Heidelberg, Germany; [van den Brandt, Jens] Univ Med Ctr, Dept Lab Anim Sci, Greifswald, Germany	University of Gottingen; Deutsches Primatenzentrum (DPZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Reichardt, HM (corresponding author), Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, Humboldtallee 34, D-37073 Gottingen, Germany.	hreichardt@med.uni-goettingen.de	Walter, Lutz/I-2606-2017; Reichardt, Holger/AAF-3048-2020	Walter, Lutz/0000-0001-9408-3131; Reichardt, Holger/0000-0003-4647-057X	Deutsche Forschungsgemeinschaft [SFB/TRR43, RE 1631/10-1]; Deutsche Forschungsgemeinschaft (project B13)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (project B13)	The authors thank Amina Bassibas and Julian Koch (University Medical Center Gottingen, Gottingen, Germany) for expert technical help, and Dr. Verena Reupke (University Medical Center Gottingen) for advice concerning animal experimentation. This work was supported by the Deutsche Forschungsgemeinschaft (Grants SFB/TRR43, project B13, and RE 1631/10-1).	Aksoylar HI, 2012, J IMMUNOL, V188, P146, DOI 10.4049/jimmunol.1101206; Aranha AA, 2013, ENDOCR PRACT, V19, P821, DOI 10.4158/EP13020.RA; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Camara M, 2013, J NEUROIMMUNOL, V260, P17, DOI 10.1016/j.jneuroim.2013.04.014; Costelloe L, 2012, EXPERT REV NEUROTHER, V12, P335, DOI [10.1586/ERN.12.5, 10.1586/ern.12.5]; Cousins L, 2006, GASTROENTEROLOGY, V131, P1475, DOI 10.1053/j.gastro.2006.09.023; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gupta M, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0499-4; Hellings N, 2001, J NEUROSCI RES, V63, P290, DOI 10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4; Hellquist A, 2007, J MED GENET, V44, P314, DOI 10.1136/jmg.2006.046185; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; Jones JL, 2013, P NATL ACAD SCI USA, V110, P20200, DOI 10.1073/pnas.1313654110; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; Lang JA, 2004, EUR J IMMUNOL, V34, P2396, DOI 10.1002/eji.200324751; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lopez-Cadenas C, 2013, CURR DRUG METAB, V14, P1042, DOI 10.2174/1389200214666131118234935; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rojewska E, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-47; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Schulze-Koops H, 2004, ARTHRITIS RES THER, V6, P178, DOI 10.1186/ar1208; Sinha A, 2013, THYROID, V23, P1010, DOI 10.1089/thy.2012.0618; Tischner D, 2006, BRAIN, V129, P2635, DOI 10.1093/brain/awl213; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; van den Brandt J, 2010, J IMMUNOL, V185, P2285, DOI 10.4049/jimmunol.1000462; Wiede F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4073	32	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1724	1732		10.1096/fj.15-277384	http://dx.doi.org/10.1096/fj.15-277384			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26740263				2022-12-28	WOS:000374879400004
J	Dias-Teixeira, KL; Calegari-Silva, TC; Dos Santos, GRRM; dos Santos, JV; Lima, C; Medina, JM; Aktas, BH; Lopes, UG				Dias-Teixeira, Karina Luiza; Calegari-Silva, Teresa Cristina; Dos Santos, Guilherme R. R. M.; dos Santos, Jose Vitorino; Lima, Carolina; Medina, Jorge Mansur; Aktas, Bertal Huseyin; Lopes, Ulisses G.			The integrated endoplasmic reticulum stress response in Leishmania amazonensis macrophage infection: the role of X-box binding protein 1 transcription factor	FASEB JOURNAL			English	Article						ER stress; XBP1; thapsigargin IRE1; IFN1-beta; oxidative stress	IFN-BETA INDUCTION; CUTANEOUS LEISHMANIASIS; SENSOR IRE1-ALPHA; ER STRESS; PARASITES; XBP1; SUBVERSION; ACTIVATION; VIRUS	Endoplasmic reticulum (ER) stress triggers the integrated ER-stress response (IERSR) that ensures cellular survival of ER stress and represents a primordial form of innate immunity. We investigated the role of IERSR during Leishmania amazonensis infection. Treatment of RAW 264.7 infected macrophages with the ER stress-inducing agent thapsigargin (TG; 1 mu M) increased L. amazonensis infectivity in an IFN1-alpha receptor (IFNAR)-dependent manner. In Western blot assays, we showed that L. amazonensis activates the inositol-requiring enzyme (IRE1)/X-box binding protein (XBP)-1-splicing arms of the IERSR in host cells. In chromatin immunoprecipitation (ChIP) assays, we showed an increased occupancy of enhancer and promoter sequences for the Ifnb gene by XBP1 in infected RAW 264.7 cells. Knocking down XBP1 expression by transducing RAW 264.7 cells with the short hairpin XBP1 lentiviral vector significantly reduced the parasite proliferation associated with impaired translocation of phosphorylated IFN regulatory transcription factor (IRF)-3 to the nucleus and a decrease in IFN1-beta expression. Knocking down XBP1 expression also increased NO concentration, as determined by Griess reaction and reduced the expression of antioxidant genes, such as heme oxygenase (HO)-1, that protect parasites from oxidative stress. We conclude that L. amazonensis activation of XBP1 plays a critical role in infection by protecting the parasites from oxidative stress and increasing IFN1-beta expression.-Dias-Teixeira, K. L., Calegari-Silva, T. C., Dos Santos, G. R. R. M., Vitorino dos Santos, J., Lima, C., Medina, J. M., Aktas, B. H., Lopes, U. G. The integrated endoplasmic reticulum stress response in Leishmania amazonensis macrophage infection: the role of X-box binding protein 1 transcription factor. FASEB J. 30, 1557-1565 (2016). www.fasebj.org	[Dias-Teixeira, Karina Luiza; Calegari-Silva, Teresa Cristina; Dos Santos, Guilherme R. R. M.; dos Santos, Jose Vitorino; Lima, Carolina; Lopes, Ulisses G.] Univ Fed Rio de Janeiro, Lab Parasitol Mol, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Medina, Jorge Mansur] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Ciencias Saude, Rio De Janeiro, Brazil; [Aktas, Bertal Huseyin] Brigham & Womens Hosp, Dept Med, Hematol Lab Translat, 75 Francis St, Boston, MA 02115 USA; [Aktas, Bertal Huseyin] Harvard Univ, Sch Med, Boston, MA USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lopes, UG (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Biofis Carlos Chagas Filho, Lab Parasitol Mol, Av Carlos Chagas Filho S-N, BR-21949902 Rio de Janeiro, RJ, Brazil.	lopesu@biof.ufrj.br	Dias Teixeira, Karina/J-4918-2017; Lopes, Ulisses Gazos/T-6634-2019; dos Santos, Guilherme Rodrigo Reis M/D-8868-2018	Dias Teixeira, Karina/0000-0002-6115-6768; dos Santos, Guilherme Rodrigo Reis M/0000-0001-8680-869X; Calegari Silva, Teresa Cristina/0000-0002-1656-3460				Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Calegari-Silva TC, 2009, IMMUNOL LETT, V127, P19, DOI 10.1016/j.imlet.2009.08.009; Chen T, 2011, NAT CHEM BIOL, V7, P610, DOI [10.1038/nchembio.613, 10.1038/NCHEMBIO.613]; Fros JJ, 2015, J GEN VIROL, V96, P580, DOI 10.1099/vir.0.071845-0; Fung TS, 2014, J VIROL, V88, P12752, DOI 10.1128/JVI.02138-14; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Inacio P, 2015, EMBO REP, V16, P955, DOI 10.15252/embr.201439979; Kaushansky A, 2015, EMBO REP, V16, P883, DOI 10.15252/embr.201540792; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; van 't Wout EFA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004946; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; World Health Organization/Tropical Disease Researchers, 2015, GLOB HLTH OBS GHO DA; Xin LJ, 2010, J IMMUNOL, V184, P7047, DOI 10.4049/jimmunol.0903273; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052	24	19	20	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1557	1565		10.1096/fj.15-281550	http://dx.doi.org/10.1096/fj.15-281550			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26678450	Green Published			2022-12-28	WOS:000372629100017
J	Ferre, CA; Davezac, N; Thouard, A; Peyrin, JM; Belenguer, P; Miquel, MC; Gonzalez-Dunia, D; Szelechowski, M				Ferre, Cecile A.; Davezac, Noelie; Thouard, Anne; Peyrin, Jean-Michel; Belenguer, Pascale; Miquel, Marie-Christine; Gonzalez-Dunia, Daniel; Szelechowski, Marion			Manipulation of the N-terminal sequence of the Borna disease virus X protein improves its mitochondrial targeting and neuroprotective potential	FASEB JOURNAL			English	Article						subcellular addressing; neuroprotection; nuclear export	OUTER-MEMBRANE; NUCLEAR IMPORT; HIV REV; DEGENERATION; FISSION; NEURONS; KINASE; SIGNAL; NEURODEGENERATION; LOCALIZATION	To favor their replication, viruses express proteins that target diverse mammalian cellular pathways. Due to the limited size of many viral genomes, such proteins are endowed with multiple functions, which require targeting to different subcellular compartments. One salient example is the X protein of Borna disease virus, which is expressed both at the mitochondria and in the nucleus. Moreover, we recently demonstrated that mitochondrial X protein is neuroprotective. In this study, we sought to examine the mechanisms whereby the X protein transits between subcellular compartments and to define its localization signals, to enhance its mitochondrial accumulation and thus, potentially, its neuroprotective activity. We transfected plasmids expressing fusion proteins bearing different domains of X fused to enhanced green fluorescent protein (eGFP) and compared their subcellular localization to that of eGFP. We observed that the 5-16 domain of X was responsible for both nuclear export and mitochondrial targeting and identified critical residues for mitochondrial localization. We next took advantage of these findings and constructed mutant X proteins that were targeted only to the mitochondria. Such mutants exhibited enhanced neuroprotective properties in compartmented cultures of neurons grown in microfluidic chambers, thereby confirming the parallel between mitochondrial accumulation of the X protein and its neuroprotective potential.-Ferre C. A., Davezac, N., Thouard, A., Peyrin, J. M., Belenguer, P., Miquel, M.-C., Gonzalez-Dunia, D., Szelechowski, M. Manipulation of the N-terminal sequence of the Borna disease virus X protein improves its mitochondrial targeting and neuroprotective potential. FASEB J. 30, 1523-1533 (2016). www.fasebj.org	[Ferre, Cecile A.; Thouard, Anne; Gonzalez-Dunia, Daniel; Szelechowski, Marion] CPTP, INSERM, Unite Mixte Rech UMR 1043, Toulouse, France; [Ferre, Cecile A.; Thouard, Anne; Gonzalez-Dunia, Daniel; Szelechowski, Marion] CNRS, UMR 5282, Toulouse, France; [Ferre, Cecile A.; Davezac, Noelie; Thouard, Anne; Belenguer, Pascale; Miquel, Marie-Christine; Gonzalez-Dunia, Daniel; Szelechowski, Marion] Univ Toulouse 3, F-31062 Toulouse, France; [Davezac, Noelie; Belenguer, Pascale; Miquel, Marie-Christine] Ctr Biol Dev, CNRS, UMR 5547, Toulouse, France; [Peyrin, Jean-Michel] Univ Paris 06, CNRS, UMR 8256, Biol Adaptat & Aging,Inst Biol Paris Seine, Paris, France; [Peyrin, Jean-Michel; Miquel, Marie-Christine] Univ Paris 06, Sorbonne Univ, Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Gonzalez-Dunia, D; Szelechowski, M (corresponding author), Univ Toulouse 3, CPTP, INSERM, UMR 1043,CNRS,UMR 5282,CHU Purpan, BP3028, F-31024 Toulouse 3, France.	daniel.dunia@inserm.fr; mszelechowski@gmail.com	Dunia, Daniel/K-1090-2014; Szelechowski, Marion/X-7343-2019	Dunia, Daniel/0000-0002-2837-7120; Peyrin, Jean-Michel/0000-0002-0108-1266; Peyrin, Jean-Michel/0000-0002-8705-8672; Miquel, Marie-Christine/0000-0002-9332-2572; , Szelechowski/0000-0002-2929-7413; Belenguer, Pascale/0000-0003-0229-5554	INSERM; Centre National de la Recherche Scientifique; INSERM Transfert CoPoC Fund; European Research Area Networks (ERA-NET) Network of European Funding for Neuroscience Research (NEURON) MicroDeg;  [ANR-12-EMMA-0016-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM Transfert CoPoC Fund; European Research Area Networks (ERA-NET) Network of European Funding for Neuroscience Research (NEURON) MicroDeg; 	The authors thank A. Betourne, R. Liblau, C. E. Malnou, and A. Saoudi (all from INSERM UMR 1043, Toulouse, France) for critical reading of the manuscript and insightful editorial comments; S. Allart and A. Canivet (CPTP Imaging platform) for technical assistance; E. Bonnaud (INSERM UMR 1043) for help in preparing primary neuronal cultures; and C. Didier (Centre National de la Recherche Scientifique, Toulouse, France) for the gift of the anti-cyclin B1 antibody. This work was supported by institutional grants from INSERM and Centre National de la Recherche Scientifique (to D.G.D.), funds from Project ANR-12-EMMA-0016-01 (to D.G.D. and J.M.P.), the INSERM Transfert CoPoC Fund (to D.G.D.), and funds from European Research Area Networks (ERA-NET) Network of European Funding for Neuroscience Research (NEURON) MicroDeg (to J.M.P.). The authors declare no conflicts of interest.	Al-Furoukh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103141; Bertholet AM, 2013, BRAIN, V136, P1518, DOI 10.1093/brain/awt060; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deleglise B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071103; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hayashi Y, 2009, MICROBES INFECT, V11, P394, DOI 10.1016/j.micinf.2009.01.006; Honda T, 2013, VIRUSES-BASEL, V5, P1978, DOI 10.3390/v5081978; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li YJ, 2013, INT J BIOCHEM CELL B, V45, P1546, DOI 10.1016/j.biocel.2013.05.012; Liang CY, 2015, NAT REV MICROBIOL, V13, P7, DOI 10.1038/nrmicro3369; Lipkin WI, 2011, VIRUS RES, V162, P162, DOI 10.1016/j.virusres.2011.09.036; Ma JW, 2011, ACTA BIOCH BIOPH SIN, V43, P583, DOI 10.1093/abbs/gmr048; Ma YL, 2008, J BIOL CHEM, V283, P11743, DOI 10.1074/jbc.M710494200; Magnifico S, 2013, FASEB J, V27, P4712, DOI 10.1096/fj.13-229781; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Shea CC, 2005, CELL CYCLE, V4, P883, DOI 10.4161/cc.4.7.1791; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Otera H., 2012, INT J CELL BIOL, V2012, DOI [10.1155/2012/821676, DOI 10.1155/2012/821676]; Poenisch M, 2004, J GEN VIROL, V85, P1895, DOI 10.1099/vir.0.80002-0; Poenisch M, 2007, J VIROL, V81, P7297, DOI 10.1128/JVI.02468-06; Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Suzuki H, 2002, J CELL SCI, V115, P1895; Szelechowski M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6181; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Urcuqui-Inchima S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-83; de Tudela MVP, 2015, J NEUROSCI, V35, P9287, DOI 10.1523/JNEUROSCI.4712-14.2015; Vincent I, 1997, J NEUROSCI, V17, P3588; Volmer R, 2006, PLOS PATHOG, V2, P195, DOI 10.1371/journal.ppat.0020019; Wang WZ, 2015, J BIOL CHEM, V290, P168, DOI 10.1074/jbc.M114.617167; Wolff T, 2002, J BIOL CHEM, V277, P12151, DOI 10.1074/jbc.M109103200; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	52	16	17	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1523	1533		10.1096/fj.15-279620	http://dx.doi.org/10.1096/fj.15-279620			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700735				2022-12-28	WOS:000372629100014
J	Castro, V; Bertrand, L; Luethen, M; Dabrowski, S; Lombardi, J; Morgan, L; Sharova, N; Stevenson, M; Blasig, IE; Toborek, M				Castro, Victor; Bertrand, Luc; Luethen, Mareen; Dabrowski, Sebastian; Lombardi, Jorge; Morgan, Laura; Sharova, Natalia; Stevenson, Mario; Blasig, Ingolf E.; Toborek, Michal			Occludin controls HIV transcription in brain pericytes via regulation of SIRT-1 activation	FASEB JOURNAL			English	Article						blood-brain barrier; human macrophage; metabolic regulation; NADH oxidase; tight junction protein	NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; TIGHT JUNCTION PROTEINS; UP-REGULATION; BARRIER; CELLS; IDENTIFICATION; KINASE; MACROPHAGES; METABOLISM	HIV invades the brain early after infection; however, its interactions with the cells of the blood-brain barrier (BBB) remain poorly understood. Our goal was to evaluate the role of occludin, one of the tight junction proteins that regulate BBB functions in HIV infection of BBB pericytes. We provide evidence that occludin levels largely control the metabolic responses of human pericytes to HIV. Occludin in BBB pericytes decreased by 10% during the first 48 h after HIV infection, correlating with increased nuclear translocation of the gene repressor C-terminal-binding protein (CtBP)-1 and NF kappa B-p65 activation. These changes were associated with decreased expression and activation of the class III histone deacetylase sirtuin (SIRT)-1. Occludin levels recovered 96 h after infection, restoring SIRT-1 and reducing HIV transcription to 20% of its highest values. We characterized occludin biochemically as a novel NADH oxidase that controls the expression and activation of SIRT-1. The inverse correlation between occludin and HIV transcription was then replicated in human primary macrophages and differentiated monocytic U937 cells, in which occludin silencing resulted in 75 and 250% increased viral transcription, respectively. Our work shows that occludin has previously unsuspected metabolic properties and is a target of HIV infection, opening the possibility of designing novel pharmacological approaches to control HIV transcription.	[Castro, Victor; Bertrand, Luc; Lombardi, Jorge; Morgan, Laura; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA; [Sharova, Natalia; Stevenson, Mario] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Luethen, Mareen] Free Univ Berlin, Dept Biol, Berlin, Germany; [Dabrowski, Sebastian; Blasig, Ingolf E.] Leibniz Inst Mol Pharmacol, Robert Rosslestr 10, D-13125 Berlin, Germany	University of Miami; University of Miami; Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Castro, V; Toborek, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA.; Blasig, IE (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rosslestr 10, D-13125 Berlin, Germany.	vcastrovillela@med.miami.edu; iblasig@fmp-berlin.de; mtoborek@med.miami.edu		Luthen, Mareen/0000-0001-5557-6419	U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grant [HL126559]; Institute of Drug Abuse [DA039576, DA027569]; Institute of Mental Health [MH098891, MH63022, MH072567]; Miami Center for AIDS Research - NIH Grant [P30AI073961]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072567, R01MH063022, R01MH098891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039576, R01DA027569, R01DA044579] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grant; Institute of Drug Abuse; Institute of Mental Health; Miami Center for AIDS Research - NIH Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Mr. N. Ramsingh (University of Miami Miller School of Medicine) for his assistance with MARVEL D3 modeling. This work was supported by the U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grant HL126559; Institute of Drug Abuse Grants DA039576 and DA027569; and Institute of Mental Health Grants MH098891, MH63022, and MH072567 and by the Miami Center for AIDS Research funded by NIH Grant P30AI073961. The authors declare no conflicts of interest.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Bal MS, 2012, J CELL BIOCHEM, V113, P934, DOI 10.1002/jcb.23422; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chaudhuri AD, 2013, FASEB J, V27, P3720, DOI 10.1096/fj.13-232678; Deng Y, 2010, ONCOGENE, V29, P6603, DOI 10.1038/onc.2010.406; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Gu Y, 2001, VIROLOGY, V286, P62, DOI 10.1006/viro.2001.0998; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Luo XY, 2015, J NEUROVIROL, V21, P66, DOI 10.1007/s13365-014-0304-0; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Nakagawa S, 2012, J CELL MOL MED, V16, P2950, DOI 10.1111/j.1582-4934.2012.01622.x; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Salmen S, 2010, CELL IMMUNOL, V263, P166, DOI 10.1016/j.cellimm.2010.03.012; Scuto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.159; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Shimizu F, 2008, J CELL PHYSIOL, V217, P388, DOI 10.1002/jcp.21508; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Walter JK, 2009, CELL MOL LIFE SCI, V66, P3655, DOI 10.1007/s00018-009-0150-z; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang HS, 2009, LIFE SCI, V85, P484, DOI 10.1016/j.lfs.2009.07.014	37	32	33	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1234	1246		10.1096/fj.15-277673	http://dx.doi.org/10.1096/fj.15-277673			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26601824	Green Published			2022-12-28	WOS:000370387800020
J	Zheng, M; Mitra, RN; Filonov, NA; Han, ZC				Zheng, Min; Mitra, Rajendra N.; Filonov, Nazar A.; Han, Zongchao			Nanoparticle-mediated rhodopsin cDNA but not intron-containing DNA delivery causes transgene silencing in a rhodopsin knockout model	FASEB JOURNAL			English	Article						genomic DNA; epigenetic; gene therapy; gene expression	ALZHEIMERS-DISEASE; NONVIRAL VECTORS; GENE-EXPRESSION; IN-VITRO; MUTATION; MICE; METHYLOME; DYSTROPHY; VARIANTS; ISLANDS	Previously, we compared the efficacy of nanoparticle (NP)-mediated intron-containing rhodopsin (sgRho) vs. intronless cDNA in ameliorating retinal disease phenotypes in a rhodopsin knockout (RKO) mouse model of retinitis pigmentosa. We showed that NP-mediated sgRho delivery achieved long-term expression and phenotypic improvement in RKO mice, but not NP housing cDNA. However, the protein level of the NP-sgRho construct was only 5-10% of wild-type at 8 mo postinjection. To have a better understanding of the reduced levels of long-term expression of the vectors, in the present study, we evaluated the epigenetic changes of subretinal delivering NP-cDNA vs. NP-sgRho in the RKO mouse eyes. Following the administration, DNA methylation and histone status of specific regions (bacteria plasmid backbone, promoter, rhodopsin gene, and scaffold/matrix attachment region) of the vectors were evaluated at various time points. We documented that epigenetic transgene silencing occurred in vector-mediated gene transfer, which were caused by the plasmid backbone and the cDNA of the transgene, but not the intron-containing transgene. No toxicity or inflammation was found in the treated eyes. Our results suggest that cDNA of the rhodopsin transgene and bacteria backbone interfered with the host defense mechanism of DNA methylation-mediated transgene silencing through heterochromatin-associated modifications.	[Zheng, Min; Mitra, Rajendra N.; Han, Zongchao] Univ N Carolina, Dept Ophthalmol, 125 Mason Farm Rd,2208 Marsico Hall, Chapel Hill, NC 27599 USA; [Filonov, Nazar A.; Han, Zongchao] Univ N Carolina, Carolina Inst NanoMed, Chapel Hill, NC 27599 USA; [Han, Zongchao] Univ N Carolina, Eshelman Sch Pharm, Mol Therapeut, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Han, ZC (corresponding author), Univ N Carolina, Dept Ophthalmol, 125 Mason Farm Rd,2208 Marsico Hall, Chapel Hill, NC 27599 USA.; Han, ZC (corresponding author), Univ N Carolina, Carolina Inst NanoMed, Chapel Hill, NC 27599 USA.	zongchao@med.unc.edu	Mitra, Rajendra/G-5502-2011	Mitra, Rajendra/0000-0003-0654-9654; Han, Zongchao/0000-0002-2019-395X	U.S. National Institutes of Health/National Eye Institute Grant [R21 EY024059]; Carolina Center of Cancer Nanotechnology Excellence; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY024059, R01EY026564] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute Grant; Carolina Center of Cancer Nanotechnology Excellence; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Sandy Janowski Barnhart, M.P.H. (Department of Ophthalmology, University of North Carolina at Chapel Hill) for her critical reading of the manuscript. The authors thank Drs. Alexander V. Kabanov (Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill) and Muna I. Naash (Department of Cell Biology, University of Oklahoma Health Sciences Center) for their generous technical support. The authors also thank Dr. Muayyad Al-Ubaidi (Department of Cell Biology, University of Oklahoma Health Sciences Center) for providing plasmid pMOPS1. The authors acknowledge the financial support of the U.S. National Institutes of Health/National Eye Institute Grant R21 EY024059 (to Z.H.), the Carolina Center of Cancer Nanotechnology Excellence (to Z.H.), and the Research to Prevent Blindness to the University of North Carolina Department of Ophthalmology. The authors declare no conflicts of interests.	Agrawal A, 2012, PEDIATR RES, V71, P633, DOI 10.1038/pr.2012.21; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Burgess A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045726; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Choi JK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r70; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; Dumesic PA, 2013, RNA BIOL, V10, P1653, DOI 10.4161/rna.26800; Ehrhardt A, 2003, HUM GENE THER, V14, P215, DOI 10.1089/10430340360535779; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farinelli P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.512; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Han ZC, 2015, FASEB J, V29, P2535, DOI 10.1096/fj.15-270363; Han ZC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052189; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Han ZC, 2012, NANOMEDICINE-UK, V7, P521, DOI [10.2217/NNM.11.158, 10.2217/nnm.11.158]; Harland M, 2001, HUM MOL GENET, V10, P2679, DOI 10.1093/hmg/10.23.2679; Huang Y, 2000, BLOOD CELL MOL DIS, V26, P598, DOI 10.1006/bcmd.2000.0339; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Janssen JC, 2000, BRAIN, V123, P894, DOI 10.1093/brain/123.5.894; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jovin IS, 2007, CARDIOVASCULAR GENETICS AND GENOMICS FOR THE CARDIOLOGIST, P195, DOI 10.1002/9780470691977.ch9; Koirala A, 2014, ADV EXP MED BIOL, V801, P703, DOI 10.1007/978-1-4614-3209-8_88; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; LAMB BT, 1995, NAT GENET, V9, P4, DOI 10.1038/ng0195-4; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Mahen R, 2014, MOL BIOL CELL, V25, P3610, DOI 10.1091/mbc.E14-06-1091; Manson AL, 1997, EMBO J, V16, P4238, DOI 10.1093/emboj/16.14.4238; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Palfi A, 2010, HUM GENE THER, V21, P311, DOI 10.1089/hum.2009.119; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Sears JE, 2001, AM J OPHTHALMOL, V132, P693, DOI 10.1016/S0002-9394(01)01179-5; Wahlin KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079140; Wang LN, 2014, J INTEGR MED-JIM, V12, P20, DOI 10.1016/S2095-4964(14)60003-0; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zhang YH, 2014, J INTEGR MED-JIM, V12, P483, DOI 10.1016/S2095-4964(14)60057-1; Zhao CY, 2007, J BIOL CHEM, V282, P20230, DOI 10.1074/jbc.M700180200	54	11	11	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1076	1086		10.1096/fj.15-280511	http://dx.doi.org/10.1096/fj.15-280511			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26564956	Green Published			2022-12-28	WOS:000370387800007
J	Labrador-Garrido, A; Cejudo-Guillen, M; Daturpalli, S; Leal, MM; Klippstein, R; De Genst, EJ; Villadiego, J; Toledo-Aral, JJ; Dobson, CM; Jackson, SE; Pozo, D; Roodveldt, C				Labrador-Garrido, Adahir; Cejudo-Guillen, Marta; Daturpalli, Soumya; Leal, Maria M.; Klippstein, Rebecca; De Genst, Erwin J.; Villadiego, Javier; Toledo-Aral, Juan J.; Dobson, Christopher M.; Jackson, Sophie E.; Pozo, David; Roodveldt, Cintia			Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the alpha-synuclein-elicited immune response	FASEB JOURNAL			English	Article						misfolding/amyloid disease; Parkinson; heat-shock protein; immunotherapy	PEPTIDYL-PROLYL ISOMERASES; HEAT-SHOCK PROTEINS; PARKINSONS-DISEASE; INNATE; MODEL; IMMUNOPHILINS; IMMUNOTHERAPY; IMMUNIZATION; AGGREGATION; ASSOCIATION	We have investigated the potential role of molecular chaperones as modulators of the immune response by using alpha-synuclein (alpha Syn) as an aggregation-prone model protein. We first performed an in vitro immunoscreening with 21 preselected candidate chaperones and selected 2 from this set as displaying immunological activity with differential profiles, Grp94/Gp96 and FKBP4/52. We then immunized mice with both chaperone/alpha-synuclein combinations using monomeric or oligomeric alpha-synuclein (M alpha Syn or O alpha Syn, respectively), and we characterized the immune response generated in each case. We found that Grp94 promoted aSyn-specific T-helper (T-h) 1/T(h)17 and IgG1 antibody responses (up to a 3-fold increase) with MaSyn and O alpha Syn, respectively, coupled to a T(h)2-type general phenotype (generating 2.5-fold higher IgG1/IgG2 levels). In addition, we observed that FKBP4 favored a Th1-skewed phenotype with MaSyn but strongly supported a T(h)2-type phenotype with OaSyn (with a 3-fold higher IL-10/IFN-gamma serum levels). Importantly, results from adoptive transfer of splenocytes from immunized animals in a Parkinson's disease mousemodel indicates that these effects are robust, stable in time, and physiologically relevant. Taken together, Grp94 and FKBP4 are able to generate differential immuneresponses to a-synuclein-based immunizations, depending both on the nature of the chaperone and on the aggregation state of a-synuclein. Our work reveals that several chaperones are potential modulators of the immune response and suggests that different chaperones could be exploited to redirect the amyloid-elicited immunity both for basic studies of the immunological processes associated with neurodegeneration and for immunotherapy of pathologies associated with protein misfolding and aggregation.	[Labrador-Garrido, Adahir; Cejudo-Guillen, Marta; Leal, Maria M.; Klippstein, Rebecca; Pozo, David; Roodveldt, Cintia] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Labrador-Garrido, Adahir; Cejudo-Guillen, Marta; Klippstein, Rebecca; Pozo, David] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain; [Villadiego, Javier; Toledo-Aral, Juan J.] Univ Seville, Sch Med, Dept Med Physiol & Biophys, Seville, Spain; [Daturpalli, Soumya; De Genst, Erwin J.; Dobson, Christopher M.; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Villadiego, Javier; Toledo-Aral, Juan J.] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Seville IBiS, Seville, Spain; [Villadiego, Javier; Toledo-Aral, Juan J.] Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla; University of Sevilla; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Roodveldt, C (corresponding author), Edificio Cabimer,Ave Amer Vespucio S-N,Cartuja 93, Seville 41092, Spain.	cintia.roodveldt@cabimer.es	Cejudo-Guillén, Marta/L-1941-2017; IBIS, TERAPIA CELULA/P-3297-2015; Roodveldt, Cintia/I-9118-2014; Pozo, David/C-2149-2017; Lasarte, María Magdalena Leal/AAB-3380-2020; Toledo-Aral, Juan J/F-2613-2015; Villadiego, Javier/F-2594-2015	Cejudo-Guillén, Marta/0000-0003-3320-5419; Roodveldt, Cintia/0000-0003-4124-8769; Pozo, David/0000-0002-3732-4960; Lasarte, María Magdalena Leal/0000-0001-5250-8680; Toledo-Aral, Juan J/0000-0001-7512-7135; Villadiego, Javier/0000-0003-2131-9013; Jackson, Sophie/0000-0002-7470-9800; Labrador-Garrido, Adahir/0000-0001-5098-9601	Carlos III Institute of Health of Spain (Spanish Ministry of Economy and Competitiveness) [CP10/00527, PI14-01600]; Fonds Europeen de Developpement Economique et Regional (FEDER) funds; Spanish Ministry of Economy and Competitiveness [SAF-2012/39720]; FEDER funds; Andalusian Ministry of Economy, Science and Innovation [P10-CTS-6928, P11-CTS-8161]; Andalusian Plan for Research, Development and Innovation (PAIDI) Program from the Andalusian Government [CTS-677]; Spanish Ministry of Education [AP-2009/3816]; Wellcome Trust; Medical Research Council; Biotechnology and Biological Sciences Research Council of the United Kingdom	Carlos III Institute of Health of Spain (Spanish Ministry of Economy and Competitiveness); Fonds Europeen de Developpement Economique et Regional (FEDER) funds; Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission); Andalusian Ministry of Economy, Science and Innovation; Andalusian Plan for Research, Development and Innovation (PAIDI) Program from the Andalusian Government; Spanish Ministry of Education(Spanish Government); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to Jose M. Valpuesta's group (Centro Nacional de Biotecnologia, Madrid, Spain) for kindly providing purified Hip protein. Financial support was provided by the Carlos III Institute of Health of Spain (Spanish Ministry of Economy and Competitiveness) according to the Strategic Action of Health (CP10/00527 to C.R.; PI14-01600 to D.P.), with cofunding by Fonds Europeen de Developpement Economique et Regional (FEDER) funds, from the Spanish Ministry of Economy and Competitiveness (SAF-2012/39720 to C.R.) with cofunding by FEDER funds, the Andalusian Ministry of Economy, Science and Innovation (P10-CTS-6928 and P11-CTS-8161 to D.P.), and the Andalusian Plan for Research, Development and Innovation (PAIDI) Program from the Andalusian Government (CTS-677 to D.P.). A.L.G. holds a Formacion del Profesorado Universitario (FPU) Predoctoral Fellowship from the Spanish Ministry of Education (AP-2009/3816). The work of E.J.D.G. and C.M.D. is supported by the Wellcome Trust, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council of the United Kingdom.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Binder RJ, 2014, J IMMUNOL, V193, P5765, DOI 10.4049/jimmunol.1401417; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Calderwood SK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00075; Chambraud B, 1996, J BIOL CHEM, V271, P32923, DOI 10.1074/jbc.271.51.32923; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Deleersnijder A, 2011, J BIOL CHEM, V286, P26687, DOI 10.1074/jbc.M110.182303; Di Domenico F, 2010, J NEUROSCI RES, V88, P3566, DOI 10.1002/jnr.22528; Gerard M, 2011, MOL NEUROBIOL, V44, P13, DOI 10.1007/s12035-011-8184-2; Ghochikyan A, 2014, NEUROSCI LETT, V560, P86, DOI 10.1016/j.neulet.2013.12.028; Giustiniani J, 2015, FASEB J, V29, P3171, DOI 10.1096/fj.14-268243; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; KATSIKIS PD, 1995, INT IMMUNOL, V7, P1287, DOI 10.1093/intimm/7.8.1287; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kurzawa-Akanbi M, 2012, J NEUROCHEM, V123, P298, DOI 10.1111/j.1471-4159.2012.07879.x; Labrador-Garrido A, 2014, IMMUN INFLAMM DIS, V2, P226, DOI 10.1002/iid3.39; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Munoz-Manchado AB, 2013, NEUROBIOL AGING, V34, P902, DOI 10.1016/j.neurobiolaging.2012.06.001; Nath PR, 2015, IMMUNOL LETT, V163, P120, DOI 10.1016/j.imlet.2014.11.002; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Randazzo M, 2012, INT J CANCER, V130, P2219, DOI 10.1002/ijc.27332; Reish HEA, 2015, J PARKINSON DIS, V5, P1, DOI 10.3233/JPD-140491; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Roodveldt C, 2011, NEW THERAPIES PARKIN, P57; Roodveldt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079160; Roodveldt C, 2012, BIOCHEMISTRY-US, V51, P8771, DOI 10.1021/bi300558q; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Rosser MFN, 2004, BIOCHEMISTRY-US, V43, P8835, DOI 10.1021/bi049539q; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Sanchez-Guajardo V, 2013, J NEUROPATH EXP NEUR, V72, P624, DOI 10.1097/NEN.0b013e31829768d2; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Srivastava Pramod K, 2005, Curr Oncol Rep, V7, P104, DOI 10.1007/s11912-005-0035-8; Srivastava Pramod K, 2012, Cancer Immun, V12, P1; Valera E, 2013, PHARMACOL THERAPEUT, V138, P311, DOI 10.1016/j.pharmthera.2013.01.013; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]	47	8	8	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					564	577		10.1096/fj.15-275131	http://dx.doi.org/10.1096/fj.15-275131			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443817				2022-12-28	WOS:000369391900010
J	Saigusa, T; Dang, YJ; Mullick, AE; Yeh, ST; Zile, MR; Baicu, CF; Bell, PD				Saigusa, Takamitsu; Dang, Yujing; Mullick, Adam E.; Yeh, Steve T.; Zile, Michael R.; Baicu, Catalin F.; Bell, P. Darwin			Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model	FASEB JOURNAL			English	Article						renin angiotensin system; antisense oligonucleotide; polycystic kidney disease; hypertension	BLOOD-PRESSURE; ANTISENSE OLIGODEOXYNUCLEOTIDES; IN-VIVO; DISEASE; RENIN; SYSTEM; INHIBITOR; CELL; HYPERTENSION; RATS	Activation of the intrarenal renin angiotensin system(RAS) is believed to play an important role in the development of hypertension and cystogenesis in autosomal dominant polycystic kidney disease (ADPKD). Results of clinical studies testing RAS inhibitors in slowing the progression of cystic disease in ADPKD are inconclusive, and we hypothesized that current RAS inhibitors do not adequately suppress intrarenal RAS. For this study, we compared a novel Gen 2 antisense oligonucleotide (ASO) that inhibits angiotensinogen (Agt) synthesis to lisinopril in adult conditional Pkd1 systemic-knockout mice, a model of ADPKD. Six weeks after Pkd1 global gene knockout, the mice were treated with Agt-ASO (66 mg/kg/wk), lisinopril (100 mg/kg/d), PBS (control), or scrambled ASO (66 mg/kg/wk) for 10 wk, followed by tissue collection. Agt ASO resulted in significant reduction in plasma, liver, and kidney Agt, and increased kidney renin compared with control treatments. Kidneys from Agt-ASO-treated mice were not as enlarged and showed reduced cystic volume compared with lisinopril or control treatments. Blood pressure was better controlled with lisinopril than with Agt-ASO. Agt-ASO suppressed cell proliferation in both cystic and noncystic cells compared with lisinopril and control treatments. However, Agt-ASO did not reduce cell proliferation in liver, which indicates that Agt-ASO targets cell signaling pathways that specifically suppresses cystogenesis in the kidney. These data suggest that Agt-ASO effectively attenuates intrarenal RAS and therefore can be a novel and effective agent for treating ADPKD.	[Saigusa, Takamitsu; Dang, Yujing; Bell, P. Darwin] Med Univ S Carolina, Div Nephrol, Charleston, SC 29425 USA; [Zile, Michael R.; Baicu, Catalin F.] Med Univ S Carolina, Div Cardiol, Charleston, SC 29425 USA; [Saigusa, Takamitsu; Dang, Yujing; Zile, Michael R.; Baicu, Catalin F.; Bell, P. Darwin] Ralph Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Mullick, Adam E.; Yeh, Steve T.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Isis Pharmaceuticals Inc	Saigusa, T (corresponding author), Med Univ S Carolina, Dept Med, Div Nephrol, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	saigusa@musc.edu; bellpd@musc.edu		Mullick, Adam/0000-0003-4600-961X; Zile, Michael/0000-0001-7076-221X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K08DK106465, P30 DK074038]; U.S. Department of Veterans Affairs Merit Award; Dialysis Clinic, Inc. (Nashville, TN, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038, K08DK106465] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); Dialysis Clinic, Inc. (Nashville, TN, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants K08DK106465 (to T.S.) and P30 DK074038 (to P.D.B.); U.S. Department of Veterans Affairs Merit Award (to P.D.B.); and a Dialysis Clinic, Inc. (Nashville, TN, USA) grant (to T.S. and P.D.B.). The authors declare no conflicts of interest.	Ahmad S, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0429-9; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Cao ZM, 2001, SEMIN NEPHROL, V21, P554, DOI 10.1053/snep.2001.26794; Celerier J, 2002, HYPERTENSION, V39, P224, DOI 10.1161/hy0202.103441; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; CHAPMAN AB, 1990, NEW ENGL J MED, V323, P1091, DOI 10.1056/NEJM199010183231602; Chapman AB, 2010, ADV CHRONIC KIDNEY D, V17, P153, DOI 10.1053/j.ackd.2010.01.001; GRAHAM PC, 1988, KIDNEY INT, V33, P1084, DOI 10.1038/ki.1988.115; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jafar TH, 2005, KIDNEY INT, V67, P265, DOI 10.1111/j.1523-1755.2005.00077.x; Kamiyama M, 2012, J HYPERTENS, V30, P2365, DOI 10.1097/HJH.0b013e3283598eed; KEITH DS, 1994, AM J KIDNEY DIS, V24, P491, DOI 10.1016/S0272-6386(12)80907-3; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kobori H, 2013, PFLUG ARCH EUR J PHY, V465, P3, DOI 10.1007/s00424-012-1143-6; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Loghman-Adham M, 2004, AM J PHYSIOL-RENAL, V287, pF775, DOI 10.1152/ajprenal.00370.2003; Makino N, 1998, HYPERTENSION, V31, P1166, DOI 10.1161/01.HYP.31.5.1166; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; McPherson EA, 2004, J AM SOC NEPHROL, V15, P493, DOI 10.1097/01.ASN.0000109782.28991.26; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Pohl M, 2010, J BIOL CHEM, V285, P41935, DOI 10.1074/jbc.M110.150284; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Ravichandran K, 2015, AM J PHYSIOL-RENAL, V308, pF349, DOI 10.1152/ajprenal.00478.2014; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Saigusa T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12405; Saigusa T, 2015, PHYSIOLOGY, V30, P195, DOI 10.1152/physiol.00032.2014; Sas KM, 2015, AM J PHYSIOL-RENAL, V309, pF79, DOI 10.1152/ajprenal.00652.2014; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; TOMITA N, 1995, HYPERTENSION, V26, P131, DOI 10.1161/01.HYP.26.1.131; TORRES VE, 1992, KIDNEY INT, V42, P364, DOI 10.1038/ki.1992.297; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Torres VE, 2010, CLIN J AM SOC NEPHRO, V5, P1312, DOI 10.2215/CJN.01360210; Wallace DP, 2011, BBA-MOL BASIS DIS, V1812, P1291, DOI 10.1016/j.bbadis.2010.11.005; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; WOLF G, 1993, J AM SOC NEPHROL, V3, P1531; Wu Congqing, 2011, N Am J Med Sci (Boston), V4, P183; Zafar I, 2007, AM J PHYSIOL-RENAL, V293, pF854, DOI 10.1152/ajprenal.00059.2007	42	23	23	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					370	379		10.1096/fj.15-279299	http://dx.doi.org/10.1096/fj.15-279299			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26391272	Green Published			2022-12-28	WOS:000367621000035
J	Yang, JW; Kim, HS; Im, JH; Kim, JW; Jun, DW; Lim, SC; Lee, K; Choi, JM; Kim, SK; Kang, KW				Yang, Jin Won; Kim, Hyo Seon; Im, Ji Hye; Kim, Ji Won; Jun, Dae Won; Lim, Sung Chul; Lee, Kyeong; Choi, Jong Min; Kim, Sang Kyum; Kang, Keon Wook			GPR119: a promising target for nonalcoholic fatty liver disease	FASEB JOURNAL			English	Article						AMPK; SREBP-1; steatosis	ACTIVATED PROTEIN-KINASE; GLUCAGON-LIKE PEPTIDE-1; HEPATIC STEATOSIS; COUPLED RECEPTOR; GLYCEMIC CONTROL; X RECEPTORS; INSULIN; AMPK; GLUCOSE; CELLS	Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver. G-protein-coupled receptor 119 (GPR119) is a promising target for type 2 diabetes. However, the role of GPR119 activation in hepatic steatosis and its precise mechanism has not been investigated. In primary cultured hepatocytes from wild-type and GPR119 knockout (KO) mice, expression of lipogenic enzymes was elevated in GPR119 KO hepatocytes. Treatment of hepatocytes and HepG2 cells with GPR119 agonists in phase 2 clinical trials (MBX-2982 [MBX] and GSK1292263) inhibited protein expression of both nuclear and total sterol regulatory element binding protein (SREBP)-1, a key lipogenesis transcription factor. Oral administration of MBX in mice fed a high-fat diet potently inhibited hepatic lipid accumulation and expression levels of SREBP-1 and lipogenesis-related genes, whereas the hepatic antilipogenesis effects of MBX were abolished in GPR119 KO mice. MBX activated AMPK and increased Ser-372 phosphorylation of SREBP-1c, an inhibitory form of SREBP-1c. Moreover, inhibition of AMPK recovered MBX-induced down-regulation of SREBP-1. These findings demonstrate for the first time that the GPR119 ligand alleviates hepatic steatosis by inhibiting SREBP-1-mediated lipogenesis in hepatocytes.	[Yang, Jin Won; Kim, Hyo Seon; Im, Ji Hye; Kim, Ji Won; Kang, Keon Wook] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Yang, Jin Won; Kim, Hyo Seon; Im, Ji Hye; Kim, Ji Won; Kang, Keon Wook] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Jun, Dae Won] Han Yang Univ, Dept Internal Med, Seoul, South Korea; [Lim, Sung Chul] Chosun Univ, Coll Med, Dept Pathol, Gwangju, South Korea; [Lee, Kyeong] Dongguk Univ, Coll Pharm, Goyang, South Korea; [Choi, Jong Min; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Chosun University; Dongguk University; Chungnam National University	Kang, KW (corresponding author), Seoul Natl Univ, Coll Pharm, Gwanakro 1, Seoul 151742, South Korea.	kwkang@snu.ac.kr	; Kim, Hyo Seon/B-3373-2018	Kim, Sang Kyum/0000-0001-5769-0792; Kim, Hyo Seon/0000-0003-1926-7840	National Research Foundation of Korea - Korean government [2014M3A9A8064408, 2012M3A9C1053532, 2007-005681]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	The authors acknowledge financial support from the National Research Foundation of Korea, funded by the Korean government (2014M3A9A8064408, 2012M3A9C1053532, and 2007-005681).	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Bonini J.A., 2002, U.S. Patent, Patent No. [6468756, 6,468,756-B1]; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Chu ZL, 2010, MOL ENDOCRINOL, V24, P161, DOI 10.1210/me.2009-0239; Cornall LM, 2013, MOL CELL ENDOCRINOL, V365, P108, DOI 10.1016/j.mce.2012.10.003; Cornall LM, 2013, EXPERT OPIN INV DRUG, V22, P487, DOI 10.1517/13543784.2013.775245; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hansen HS, 2012, TRENDS PHARMACOL SCI, V33, P374, DOI 10.1016/j.tips.2012.03.014; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hwahng SH, 2009, HEPATOLOGY, V49, P1913, DOI 10.1002/hep.22887; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027; Lan H, 2009, J ENDOCRINOL, V201, P219, DOI 10.1677/JOE-08-0453; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Odori S, 2013, METABOLISM, V62, P70, DOI 10.1016/j.metabol.2012.06.010; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Poor M, 2014, J PHOTOCH PHOTOBIO B, V132, P1, DOI 10.1016/j.jphotobiol.2014.01.016; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Xiao X, 2013, ACTA BIOCH BIOPH SIN, V45, P2, DOI 10.1093/abbs/gms112; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024; Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	39	32	35	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					324	335		10.1096/fj.15-273771	http://dx.doi.org/10.1096/fj.15-273771			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26399788				2022-12-28	WOS:000367621000031
J	Chakroun, I; Yang, DB; Girgis, J; Gunasekharan, A; Phenix, H; Kaern, M; Blais, A				Chakroun, Imane; Yang, Dabo; Girgis, John; Gunasekharan, Atchayaa; Phenix, Hilary; Kaern, Mads; Blais, Alexandre			Genome-wide association between Six4, MyoD, and the histone demethylase Utx during myogenesis	FASEB JOURNAL			English	Article						adult muscle regeneration; transcriptional regulation; histone methylation	MUSCLE FIBER-TYPE; 6 FAMILY GENES; SKELETAL-MUSCLE; SATELLITE CELLS; TRANSCRIPTION FACTOR; ADULT MUSCLE; EXPRESSION; MEF2; ACTIVATION; PROTEIN	Adult skeletalmuscles can regenerate after injury, due to the presence of satellite cells, a quiescent population of myogenic progenitor cells. Once activated, satellite cells repair the muscle damage by undergoing myogenic differentiation. The myogenic regulatory factors (MRFs) coordinate the process of progenitor differentiation in cooperation with other families of transcription factors (TFs). The Six1 and Six4 homeodomain TFs are expressed in developing and adult muscle and Six1 is critical for embryonic and adult myogenesis. However, the lack of a muscle developmental phenotype in Six4-null mice, which has been attributed to compensation by other Six family members, has discouraged further assessment of the role of Six4 during adult muscle regeneration. By employing genome-wide approaches to address the function of Six4 during adult skeletal myogenesis, we have identified a core set of muscle genes coordinately regulated in adult muscle precursors by Six4 and the MRF MyoD. Throughout the genome of differentiating adult myoblasts, the cooperation between Six4 and MyoD is associated with chromatin repressive mark removal by Utx, a demethylase of histone H3 trimethylated at lysine 27. Among the genes coordinately regulated by Six4 and MyoD are several genes critical for proper in vivo muscle regeneration, implicating a role of Six4 in this process. Using in vivo RNA interference of Six4, we expose an uncompensated function of this TF during muscle regeneration. Together, our results reveal a role for Six4 during adult muscle regeneration and suggest a widespread mechanism of cooperation between Six4 and MyoD.	[Chakroun, Imane; Yang, Dabo; Girgis, John; Gunasekharan, Atchayaa; Phenix, Hilary; Kaern, Mads; Blais, Alexandre] Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Chakroun, Imane; Yang, Dabo; Girgis, John; Gunasekharan, Atchayaa; Blais, Alexandre] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Phenix, Hilary] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Blais, A (corresponding author), Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	alexandre.blais@uottawa.ca	Kaern, Mads/GVU-6867-2022; Phenix, Hilary/AAE-9326-2019	Kaern, Mads/0000-0002-9371-666X; Blais, Alexandre/0000-0003-2446-1883; Girgis, John/0000-0003-2563-6905	Canadian Institutes of Health Research [MOP 119458]; Natural Sciences and Engineering Research Council of Canada; Alexander Graham Bell Doctoral Scholarship from Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander Graham Bell Doctoral Scholarship from Natural Sciences and Engineering Research Council of Canada	The authors thank Jeffrey Dilworth for discussions and reagents, Uzma Islam for help with cloning, Emeka Enwere for help with primary myoblast isolation and culture, and John Lunde for advice and technical help with muscle injury. The authors also thank Yubing Liu and Ellias Horner for helpful discussions, technical help, and editing the manuscript. This work was supported by a research grant from the Canadian Institutes of Health Research (MOP 119458 to A.B.), a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada (to I.C.), and by an Alexander Graham Bell Doctoral Scholarship from Natural Sciences and Engineering Research Council of Canada (to H.P.). I.C. and A.B. designed the experiments, performed bioinformatic analyses, and wrote the manuscript; I.C., D.Y., and J.G. implemented the animal work; D.Y. performed embryonic myosin heavy-chain immunostaining on tissues; D.Y. and J.G. performed hematoxylin and eosin staining; A.B., D.Y., and J.G. analyzed images of embryonic myosin heavy chain and hematoxylin and eosin staining; I.C. and A.G. performed luciferase assays; H.P. and M.K. analyzed luciferase data; and all other experiments, including gene expression profiling, chromatin immunoprecipitation, and chromatin immunoprecipitation followed by sequencing, were performed by I.C. The authors declare no conflicts of interest.	Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Benhaddou A, 2012, CELL DEATH DIFFER, V19, P220, DOI 10.1038/cdd.2011.87; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bharathy Narendra, 2013, Subcell Biochem, V61, P139, DOI 10.1007/978-94-007-4525-4_7; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blais A, 2015, J MOL BIOL, V427, P2023, DOI 10.1016/j.jmb.2015.02.009; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diao YR, 2012, CELL STEM CELL, V11, P231, DOI 10.1016/j.stem.2012.05.022; Dilworth FJ, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt59; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Ehlers ML, 2014, CELL REP, V8, P1639, DOI 10.1016/j.celrep.2014.08.035; Enwere EK, 2013, HUM MOL GENET, V22, P867, DOI 10.1093/hmg/dds493; Fougerousse F, 2002, J MUSCLE RES CELL M, V23, P255, DOI 10.1023/A:1020990825644; Giordani J, 2007, P NATL ACAD SCI USA, V104, P11310, DOI 10.1073/pnas.0611299104; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Gunther S, 2013, CELL STEM CELL, V13, P590, DOI 10.1016/j.stem.2013.07.016; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Le Grand F, 2012, J CELL BIOL, V198, P815, DOI 10.1083/jcb.201201050; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067762; Liu YB, 2012, NUCLEIC ACIDS RES, V40, P8227, DOI 10.1093/nar/gks587; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Meng ZX, 2013, NAT MED, V19, P640, DOI 10.1038/nm.3144; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Mueller AC, 2015, MOL CELL BIOL, V35, P498, DOI 10.1128/MCB.01079-14; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Niro C, 2010, DEV BIOL, V338, P168, DOI 10.1016/j.ydbio.2009.11.031; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ohto H, 1999, MOL CELL BIOL, V19, P6815; OLIVER G, 1995, DEVELOPMENT, V121, P693; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Ozaki H, 2001, MOL CELL BIOL, V21, P3343, DOI 10.1128/MCB.21.10.3343-3350.2001; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Richard AF, 2011, DEV BIOL, V359, P303, DOI 10.1016/j.ydbio.2011.08.010; Rocha-Viegas L, 2014, MOL CELL BIOL, V34, P3765, DOI 10.1128/MCB.00839-14; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; SHAFIQ SA, 1968, J ANAT, V103, P135; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Takanashi T, 1997, J NEUROL SCI, V145, P41, DOI 10.1016/S0022-510X(96)00237-7; von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Wang AHJ, 2013, EMBO J, V32, P1075, DOI 10.1038/emboj.2013.54; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Yajima H, 2010, EXP CELL RES, V316, P2932, DOI 10.1016/j.yexcr.2010.08.001; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	85	25	25	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4738	4755		10.1096/fj.15-277053	http://dx.doi.org/10.1096/fj.15-277053			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26229056				2022-12-28	WOS:000364514700029
J	Li, A; Ceballos-Diaz, C; DiNunno, N; Levites, Y; Cruz, PE; Lewis, J; Golde, TE; Chakrabarty, P				Li, Andrew; Ceballos-Diaz, Carolina; DiNunno, Nadia; Levites, Yona; Cruz, Pedro E.; Lewis, Jada; Golde, Todd E.; Chakrabarty, Paramita			IFN-gamma promotes tau phosphorylation without affecting mature tangles	FASEB JOURNAL			English	Article						interferon-gamma; neuroinflammation; tau tangle; GSK3 beta	GLIAL-NEURONAL INTERACTIONS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MOUSE MODEL; IN-VIVO; NEUROFIBRILLARY TANGLES; GENE-EXPRESSION; DOWN-REGULATION; UP-REGULATION; BETA-CATENIN	Inflammatory activation precedes and correlates with accumulating tau lesions in Alzheimer's disease and tauopathies. However, the relationship between neuroinflammation and etiology of pathologic tau remains elusive. To evaluate whether inflammatory signaling may promote or accelerate neurofibrillary tangle pathology, we explored the effect of recombinant adeno-associated virus (rAAV)-mediated overexpression of a master inflammatory cytokine, IFN-gamma, ont phosphorylation. In initial studies in primary neuroglial cultures, rAAV-mediated expression of IFN-gamma did not alter endogenous tau production or paired helical filament tau phosphorylation. Next, we tested the effect of rAAV-mediated expression of IFN-gamma in the brains of 2 mouse models of tauopathy: JNPL3 and rTg4510. In both models, IFN-gamma increased 1) signal transducer and activator of transcription 1 levels and gliosis, and 2) hyperphosphorylation and conformational alterations of soluble t compared with control cohorts. However, sarkosyl-insoluble phosphorylated tau levels and ubiquitin staining were unaltered in the IFN-gamma cohorts. Notably, IFN-gamma-induced t hyperphosphorylation was associated with release of the inhibitory effect of glycogen synthase kinase 3 beta function by decreasing Ser9 phosphorylation. Our data suggest that type II IFN signaling can promote tau phosphorylation by modulating cellular kinase activity, though this is insufficient in accelerating neuritic tangle pathology.	[Li, Andrew; Ceballos-Diaz, Carolina; DiNunno, Nadia; Levites, Yona; Cruz, Pedro E.; Lewis, Jada; Golde, Todd E.; Chakrabarty, Paramita] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Golde, TE (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, POB 100159, Gainesville, FL 32610 USA.	tgolde@ufl.edu; pchakrabarty@ufl.edu			NATIONAL INSTITUTE ON AGING [R01AG018454, U01AG046139] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG018454, U01 AG046139] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abbas N, 2002, J NEUROIMMUNOL, V126, P50, DOI 10.1016/S0165-5728(02)00050-4; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Hanger DP, 2014, J ALZHEIMERS DIS, V40, pS37, DOI 10.3233/JAD-132054; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; HICKS SP, 1946, J LAB CLIN MED, V31, P1375; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Komori T, 1999, BRAIN PATHOL, V9, P663; Kopeikina KJ, 2012, TRANSL NEUROSCI, V3, P223, DOI 10.2478/s13380-012-0032-y; Lee DC, 2013, NEUROPATH APPL NEURO, V39, P69, DOI 10.1111/nan.12002; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee J, 2002, NEUROMOL MED, V2, P29; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li YK, 2003, J NEUROSCI, V23, P1605; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Mastrangelo MA, 2009, AM J PATHOL, V175, P2076, DOI 10.2353/ajpath.2009.090059; Noble W, 2009, FASEB J, V23, P739, DOI 10.1096/fj.08-113795; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Santillo AF, 2011, EUR J NUCL MED MOL I, V38, P2202, DOI 10.1007/s00259-011-1895-9; Sasaki A, 2008, BRAIN RES, V1214, P159, DOI 10.1016/j.brainres.2008.02.084; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Sheffield LG, 2000, NEUROSCI LETT, V285, P165, DOI 10.1016/S0304-3940(00)01037-5; Sheng JG, 1997, J NEUROPATH EXP NEUR, V56, P285, DOI 10.1097/00005072-199703000-00007; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Zilka N, 2009, J NEUROIMMUNOL, V209, P16, DOI 10.1016/j.jneuroim.2009.01.013	47	21	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4384	4398		10.1096/fj.15-275834	http://dx.doi.org/10.1096/fj.15-275834			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26156074	Green Published			2022-12-28	WOS:000361367300026
J	Kaneko, I; Sabir, MS; Dussik, CM; Whitfield, GK; Karrys, A; Hsieh, JC; Haussler, MR; Meyer, MB; Pike, JW; Jurutka, PW				Kaneko, Ichiro; Sabir, Marya S.; Dussik, Christopher M.; Whitfield, G. Kerr; Karrys, Amitis; Hsieh, Jui-Cheng; Haussler, Mark R.; Meyer, Mark B.; Pike, J. Wesley; Jurutka, Peter W.			1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D	FASEB JOURNAL			English	Article						CNS; chromatin immunoprecipitation; neuropsychiatric disorders; cis-regulatory module; serotonin	D-RECEPTOR; HIPPOCAMPAL-NEURONS; RESPONSIVE ELEMENT; DOWN-REGULATION; ADIPOSE-TISSUE; 3T3-L1 CELLS; BRAIN; D-3; MICE; DIFFERENTIATION	To investigate vitamin D-related control of brain-expressed genes, candidate vitamin D responsive elements (VDREs) at -7/-10 kb in human tryptophan hydroxylase (TPH) 2 were probed. Both VDREs bound the vitamin D receptor (VDR)-retinoid X receptor (RXR) complex and drove reporter gene transcription in response to 1,25-dihydroxyvitamin D-3 (1,25D). Brain TPH2 mRNA, encoding the rate-limiting enzyme in serotonin synthesis, was induced 2.2-fold by 10 nM 1,25D in human U87 glioblastoma cells and 47.8-fold in rat serotonergic RN46A-B14 cells. 1,25D regulation of leptin (Lep), encoding a serotoninlike satiety factor, was also examined. In mouse adipocytes, 1,25D repressed leptin mRNA levels by at least 84%, whereas 1,25D induced leptin mRNA 15.1-fold in human glioblastoma cells. Chromatin immunoprecipitation sequencing analysis of the mouse Lep gene in response to 1,25D revealed a cluster of regulatory sites (cis-regulatory module; CRM) at -28 kb that 1,25D-dependently docked VDR, RXR, C/EBP beta, and RUNX2. This CRM harbored 3 VDREs and single C/EBP beta and RUNX2 sites. Therefore, the expression of human TPH2 and mouse Lep are governed by 1,25D, potentially via respective VDREs located at -7/-10 kb and -28 kb. These results imply that vitamin D affects brain serotonin concentrations, which may be relevant to psychiatric disorders, such as autism, and may control leptin levels and affect eating behavior.	[Kaneko, Ichiro; Whitfield, G. Kerr; Karrys, Amitis; Hsieh, Jui-Cheng; Haussler, Mark R.; Jurutka, Peter W.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA; [Kaneko, Ichiro; Sabir, Marya S.; Dussik, Christopher M.; Karrys, Amitis; Jurutka, Peter W.] Univ Arizona, Sch Math & Nat Sci, Phoenix, AZ USA; [Meyer, Mark B.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	University of Arizona; University of Arizona; University of Wisconsin System; University of Wisconsin Madison	Jurutka, PW (corresponding author), Sch Math & Nat Sci, 4701 W Thunderbird Rd, Phoenix, AZ 85306 USA.	pjurutka@asu.edu		Haussler, Mark/0000-0002-7097-1801				Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Cieslak K, 2014, SCHIZOPHR RES, V159, P543, DOI 10.1016/j.schres.2014.08.031; Confavreux CB, 2011, KIDNEY INT, V79, pS14, DOI 10.1038/ki.2011.25; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Groves NJ, 2013, BEHAV BRAIN RES, V241, P120, DOI 10.1016/j.bbr.2012.12.001; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hiroi R, 2013, J NEUROCHEM, V127, P487, DOI 10.1111/jnc.12401; Hsieh JC, 2003, ENDOCRINOLOGY, V144, P5065, DOI 10.1210/en.2003-0635; Jiang P, 2014, NUTRIENTS, V6, P6048, DOI 10.3390/nu6126048; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Kong J, 2013, J ENDOCRINOL, V216, P265, DOI 10.1530/JOE-12-0344; Lenicov FR, 2007, J NEUROCHEM, V103, P2047, DOI 10.1111/j.1471-4159.2007.04903.x; Lesch K.P., 2005, NOVART FDN SYMP, V268, P167; Lesch K. P., 2005, NOVART FDN SYMP, V268, P140; Lesch Klaus-Peter, 2005, Novartis Found Symp, V268, P111; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Malloy PJ, 2013, MOL ENDOCRINOL, V27, P1632, DOI 10.1210/me.2013-1037; Menendez C, 2001, J ENDOCRINOL, V170, P425, DOI 10.1677/joe.0.1700425; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Mix H, 2000, GUT, V47, P481, DOI 10.1136/gut.47.4.481; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Patrick RP, 2015, FASEB J, V29, P2207, DOI 10.1096/fj.14-268342; Patrick RP, 2014, FASEB J, V28, P2398, DOI 10.1096/fj.13-246546; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Pike J Wesley, 2014, Bonekey Rep, V3, P482, DOI 10.1038/bonekey.2013.216; Pike JW, 2010, J STEROID BIOCHEM, V121, P130, DOI 10.1016/j.jsbmb.2010.02.036; Shen WW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05282; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; TERPENING CM, 1991, MOL ENDOCRINOL, V5, P373, DOI 10.1210/mend-5-3-373; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Wrann CD, 2012, ADIPOCYTE, V1, P168, DOI 10.4161/adip.20574; Wrase J, 2006, COGN AFFECT BEHAV NE, V6, P53, DOI 10.3758/CABN.6.1.53; Yuksel RN, 2014, THER ADV PSYCHOPHARM, V4, P268, DOI 10.1177/2045125314553612; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	45	98	102	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4023	4035		10.1096/fj.14-269811	http://dx.doi.org/10.1096/fj.14-269811			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26071405				2022-12-28	WOS:000359915600036
J	Mattar, CN; Wong, AMS; Hoefer, K; Alonso-Ferrero, ME; Buckley, SMK; Howe, SJ; Cooper, JD; Waddington, SN; Chan, JKY; Rahim, AA				Mattar, Citra N.; Wong, Andrew M. S.; Hoefer, Klemens; Alonso-Ferrero, Maria E.; Buckley, Suzanne M. K.; Howe, Steven J.; Cooper, Jonathan D.; Waddington, Simon N.; Chan, Jerry K. Y.; Rahim, Ahad A.			Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates	FASEB JOURNAL			English	Article						perinatal; viral vectors; murine; macaques; metabolic diseases	IN-VIVO; THERAPY; VECTOR; TRANSDUCTION; BRAIN; EXPRESSION; EPITHELIA; FUTURE	Several acute monogenic diseases affect multiple body systems, causing death in childhood. The development of novel therapies for such conditions is challenging. However, improvements in gene delivery technology mean that gene therapy has the potential to treat such disorders. We evaluated the ability of the AAV9 vector to mediate systemic gene delivery after intravenous administration to perinatal mice and late-gestation nonhuman primates (NHPs). Titer-matched single-stranded (ss) and self-complementary (sc) AAV9 carrying the green fluorescent protein (GFP) reporter gene were intravenously administered to fetal and neonatal mice, with noninjected age-matched mice used as the control. Extensive GFP expression was observed in organs throughout the body, with the epithelial and muscle cells being particularly well transduced. ssAAV9 carrying the WPRE sequence mediated significantly more gene expression than its sc counterpart, which lacked the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) sequence. To examine a realistic scale-up to larger models or potentially patients for such an approach, AAV9 was intravenously administered to late-gestation NHPs by using a clinically relevant protocol. Widespread systemic gene expression was measured throughout the body, with cellular tropisms similar to those observed in the mouse studies and no observable adverse events. This study confirms that AAV9 can safely mediate systemic gene delivery in small and large animal models and supports its potential use in clinical systemic gene therapy protocols.	[Mattar, Citra N.; Chan, Jerry K. Y.] Natl Univ Singapore, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 117548, Singapore; [Wong, Andrew M. S.; Hoefer, Klemens; Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, Pediat Storage Disorders Lab, London WC2R 2LS, England; [Alonso-Ferrero, Maria E.; Howe, Steven J.] UCL, Inst Child Hlth, London WC1E 6HX, England; [Buckley, Suzanne M. K.; Waddington, Simon N.] UCL, Inst Womens Hlth, Gene Transfer Technol Grp, London WC1E 6HX, England; [Rahim, Ahad A.] UCL, UCL Sch Pharm, Dept Pharmacol, London WC1E 6HX, England; [Waddington, Simon N.] Univ Witwatersrand, Fac Hlth Sci, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa; [Chan, Jerry K. Y.] KK Womens & Childrens Tower, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol, Singapore, Singapore	National University of Singapore; University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Witwatersrand; KK Women's & Children's Hospital; National University of Singapore	Waddington, SN (corresponding author), UCL, Inst Womens Hlth, Gene Transfer Technol Grp, 86-96 Chenies Mews, London WC1E 6HX, England.	s.waddington@ucl.ac.uk	Cooper, Jonathan/V-9962-2019; rahim, abdul/AAC-6745-2021; Waddington, Simon/G-3778-2011	Cooper, Jonathan/0000-0003-1339-4750; rahim, abdul/0000-0002-0269-9156; Waddington, Simon/0000-0003-4970-4730; Mattar, Citra Nurfarah/0000-0003-0068-6957; Buckley, Suzanne/0000-0003-1286-1003	UK Medical Research Council Grant [G1000709]; UK Gauchers Association; Niemann-Pick Disease Group; National Brain Iron Accumulation Disorders Association; Medical Research Council [G1000709] Funding Source: researchfish; MRC [G1000709] Funding Source: UKRI	UK Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Gauchers Association; Niemann-Pick Disease Group; National Brain Iron Accumulation Disorders Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council Grant G1000709. A.A.R. and S.N.W. have also received support from the UK Gauchers Association. A.A.R. received support from the Niemann-Pick Disease Group and National Brain Iron Accumulation Disorders Association.	Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Berry SM, 2013, AM J OBSTET GYNECOL, V209, P170, DOI 10.1016/j.ajog.2013.07.014; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Buckley SMK, 2011, THER DELIV, V2, P461, DOI 10.4155/TDE.11.17; Calcedo R, 2011, CLIN VACCINE IMMUNOL, V18, P1586, DOI 10.1128/CVI.05107-11; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Coutelle Charles, 2012, Methods Mol Biol, V891, P1, DOI 10.1007/978-1-61779-873-3_1; David AL, 2008, BEST PRACT RES CL OB, V22, P203, DOI 10.1016/j.bpobgyn.2007.08.008; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Goker-Alpan O, 2011, MOL GENET METAB, V104, P438, DOI 10.1016/j.ymgme.2011.08.004; Haddad MR, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.27; Katwal AB, 2013, GENE THER, V20, P930, DOI 10.1038/gt.2013.16; Limberis MP, 2009, MOL THER, V17, P294, DOI 10.1038/mt.2008.261; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P697, DOI 10.1016/j.bpobgyn.2012.06.006; Mattar CN, 2011, EXPERT OPIN BIOL TH, V11, P1257, DOI 10.1517/14712598.2011.585153; Mattar CNZ, 2011, MOL THER, V19, P1950, DOI 10.1038/mt.2011.107; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Rahim AA, 2011, FASEB J, V25, P3505, DOI 10.1096/fj.11-182311; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Weatherall D., 2006, USE NONHUMAN PRIMATE	30	19	22	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3876	3888		10.1096/fj.14-269092	http://dx.doi.org/10.1096/fj.14-269092			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062602	Green Published			2022-12-28	WOS:000359915600023
J	Patel, C; Douard, V; Yu, SY; Gao, N; Ferraris, RP				Patel, Chirag; Douard, Veronique; Yu, Shiyan; Gao, Nan; Ferraris, Ronaldo P.			Transport, metabolism, and endosomal trafficking-dependent regulation of intestinal fructose absorption	FASEB JOURNAL			English	Article						GLUT5; ketohexokinase; Rab11a; sugar	GLUCOSE-ABSORPTION; UNITED-STATES; CELLS; EXPRESSION; INDUCTION; GENE; MICE; ACTIVATION; PATHWAY; SUGAR	Dietary fructose that is linked to metabolic abnormalities can up-regulate its own absorption, but the underlying regulatory mechanisms are not known. We hypothesized that glucose transporter (GLUT) protein, member 5 (GLUT5) is the primary fructose transporter and that fructose absorption via GLUT5, metabolism via ketohexokinase (KHK), as well as GLUT5 trafficking to the apical membrane via the Ras-related protein-in-brain 11 (Rab11)a-dependent endosomes are each required for regulation. Introducing fructose but not lysine and glucose solutions into the lumen increased by 2- to 10-fold the heterogeneous nuclear RNA, mRNA, protein, and activity levels of GLUT5 in adult wild-type mice consuming chow. Levels of GLUT5 were > 100-fold that of candidate apical fructose transporters GLUTs 7, 8, and 12 whose expression, and that of GLUT 2 and the sodium-dependent glucose transporter protein 1 (SGLT1), was not regulated by luminal fructose. GLUT5-knockout (KO) mice exhibited no facilitative fructose transport and no compensatory increases in activity and expression of SGLT1 and other GLUTs. Fructose could not up-regulate GLUT5 in GLUT5-KO, KHK-KO, and intestinal epithelial cell-specific Rab11a-KO mice. The fructose-specific metabolite glyceraldehyde did not increase GLUT5 expression. GLUT5 is the primary transporter responsible for facilitative absorption of fructose, and its regulation specifically requires fructose uptake and metabolism and normal GLUT5 trafficking to the apical membrane.	[Patel, Chirag; Douard, Veronique; Ferraris, Ronaldo P.] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Yu, Shiyan; Gao, Nan] Rutgers State Univ, Sch Arts & Sci, Dept Biol Sci, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick	Ferraris, RP (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 South Orange Ave,MSB H-621, Newark, NJ 07103 USA.	ferraris@njms.rutgers.edu	Douard, veronique/AAU-6271-2020; douard, veronique/U-2364-2018		U.S. National Science Foundation [IOS-1121049, 1456673]; U.S. National Institutes of Health Grant from the National Institute of Diabetes and Digestive and Kidney Diseases [DK085194, DK093809, DK102934]; National Cancer Institute [CA178599]; NATIONAL CANCER INSTITUTE [R21CA178599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102934, K01DK085194, R03DK093809] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health Grant from the National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to Drs. E. David, I. Monteiro, P. Tharabenjasin, and E. Topaktas [New Jersey Medical School (NJMS)] as well as to Ms. J. Lee (NJMS), C. Monteiro (NJMS), D. O'Neill (University of Alberta), and Mr. D. Simon (NJMS) for help with experiments and/or for valuable discussion. The authors are especially grateful to Profs. C. Cheeseman (University of Alberta), R. Johnson (University of Colorado), and J. Zuo (St. Jude's Children's Hospital) for the gifts of GLUT5 antibody, the KHK-KO, and the GLUT5-KO mice, respectively. C. P. maintained animal models, conducted all experiments, analyzed the data, and helped in experimental design and manuscript preparation. V.D. helped design the studies, perform experiments, analyze data, and finalize the manuscript. S.Y. helped maintain animals, perform experiments, and analyze data. N.G. analyzed data as well as revised and finalized the manuscript. R.P.F. helped design the experiment, coordinated activities of coauthors and collaborators, helped analyze all data, then revised as well as finalized the manuscript. This work was supported by U.S. National Science Foundation Grants IOS-1121049 and 1456673 (to R.P.F.). The study also received support with U.S. National Institutes of Health Grants DK085194, DK093809, DK102934 from the National Institute of Diabetes and Digestive and Kidney Diseases, and CA178599 from the National Cancer Institute (to N.G.). This work was performed in partial fulfillment of the Ph.D. degree in biomedical sciences at the Graduate School of Biomedical Sciences, Rutgers University for C.P. The authors declare no conflicts of interest.	Asipu A, 2003, DIABETES, V52, P2426, DOI 10.2337/diabetes.52.9.2426; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Cheeseman C, 2008, AM J PHYSIOL-ENDOC M, V295, pE238, DOI 10.1152/ajpendo.90394.2008; Corpe CP, 1998, BBA-MOL CELL RES, V1402, P229, DOI 10.1016/S0167-4889(97)00155-9; Cramm-Behrens CI, 2008, TRAFFIC, V9, P2206, DOI 10.1111/j.1600-0854.2008.00829.x; Cui XL, 2005, AM J PHYSIOL-GASTR L, V288, pG1310, DOI 10.1152/ajpgi.00550.2004; DAVIES J, 1994, BIOCHEM J, V304, P295, DOI 10.1042/bj3040295; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; DeBosch BJ, 2012, ENDOCRINOLOGY, V153, P4181, DOI 10.1210/en.2012-1541; Diggle CP, 2010, RHEUMATOLOGY, V49, P1056, DOI 10.1093/rheumatology/keq048; Douard V, 2008, ENDOCRINOLOGY, V149, P409, DOI 10.1210/en.2007-0906; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Gjymishka A, 2009, BIOCHEM J, V417, P695, DOI 10.1042/BJ20081706; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Honma K, 2013, BIOSCI BIOTECH BIOCH, V77, P2188, DOI 10.1271/bbb.130300; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jiang L, 2001, AM J PHYSIOL-GASTR L, V280, pG113, DOI 10.1152/ajpgi.2001.280.1.G113; Jiang L, 2001, AM J PHYSIOL-REG I, V281, pR1274, DOI 10.1152/ajpregu.2001.281.4.R1274; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; MacDonald CJ, 2009, J BIOL CHEM, V284, P22099, DOI 10.1074/jbc.M109.021063; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; Moran AW, 2014, J DAIRY SCI, V97, P4955, DOI 10.3168/jds.2014-8004; Pujol-Gimenez J, 2013, J PHYSIOL BIOCHEM, V69, P325, DOI 10.1007/s13105-012-0213-8; Rencurel F, 1996, BIOCHEM J, V314, P903, DOI 10.1042/bj3140903; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Sun Y, 2014, MOL BIOL CELL, V25, P1159, DOI 10.1091/mbc.E13-08-0493; Suzuki T, 2011, BIOCHEM J, V435, P43, DOI 10.1042/BJ20101987; Tharabenjasin P, 2014, AM J PHYSIOL-GASTR L, V306, pG1, DOI 10.1152/ajpgi.00263.2013; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wu XD, 2008, BRAIN RES, V1210, P20, DOI 10.1016/j.brainres.2008.02.094; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888	38	54	58	9	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4046	4058		10.1096/fj.15-272195	http://dx.doi.org/10.1096/fj.15-272195			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26071406	Green Published			2022-12-28	WOS:000359915600038
J	Russkamp, NF; Ruemmler, R; Roewe, J; Moore, BB; Ward, PA; Bosmann, M				Russkamp, Norman F.; Ruemmler, Robert; Roewe, Julian; Moore, Bethany B.; Ward, Peter A.; Bosmann, Markus			Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin	FASEB JOURNAL			English	Article						ARDS; polymorphonuclear neutrophils; C5aR1; maraviroc; cytokines	RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR MACROPHAGES; IN-VIVO; NEUTROPHIL RECRUITMENT; EPITHELIAL-CELLS; BINDING-PROTEIN; C5A RECEPTOR; P-SELECTIN; TNF-ALPHA; INFLAMMATION	Excessive activation of the complement system is detrimental in acute inflammatory disorders. In this study, we analyzed the role of complement-derived anaphylatoxins in the pathogenesis of experimental acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in C57BL/6J mice. Intratracheal administration of recombinant mouse complement component (C5a) caused alveolar inflammation with abundant recruitment of Ly6-G(+)CD11b(+) leukocytes to the alveolar spaces and severe alveolar-capillary barrier dysfunction (C5a-ALI; EC50[C5a] = 20 ng/g body weight). Equimolar concentrations of C3a or desarginated C5a (C5a(desArg)) did not induce alveolar inflammation. The severity of C5a-ALI was aggravated in C5-deficient mice. Depletion of Ly6-G(+) cells and use of C5aR1(-/-) bone marrow chimeras suggested an essential role of C5aR1(+) hematopoietic cells in C5a-ALI. Blockade of PI3K/Akt and MEK1/2 kinase pathways completely abrogated lung injury. The mechanistic description is that C5a altered the alveolar cytokine milieu and caused significant release of CC-chemokines. Mice with genetic deficiency of CC-chemokine receptor (CCR) type 5, the common receptor of chemokine (C-Cmotif) ligand (CCL) 3, CCL4, and CCL5, displayed reduced lung damage. Moreover, treatment with a CCR5 antagonist, maraviroc, was protective against C5a-ALI. In summary, our results suggest that the detrimental effects of C5a in this model are partly mediated through CCR5 activation downstream of C5aR1, which may be evaluated for potential therapeutic exploitation in ALI/ARDS.	[Russkamp, Norman F.; Ruemmler, Robert; Roewe, Julian; Bosmann, Markus] Univ Med Ctr Mainz, CTH, D-55131 Mainz, Germany; [Moore, Bethany B.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Moore, Bethany B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Johannes Gutenberg University of Mainz; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bosmann, M (corresponding author), Univ Med Ctr Mainz, CTH, Bldg 708,Room 2-032,Langenbeckstr 1, D-55131 Mainz, Germany.	markus.bosmann@unimedizin-mainz.de		Moore, Bethany/0000-0003-3051-745X; Bosmann, Markus/0000-0003-2773-1033	Deutsche Forschungsgemeinschaft Grant [BO3482/3-1]; Federal Ministry of Education and Research Grant - Mainz Research Funding Program (MAIFOR) of University Medical Center Mainz [BMBF-01EO1003]; Marie Curie Career Integration Grant of European Union [334486]; Boehringer Ingelheim Fonds; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM-29507, GM-61656]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Federal Ministry of Education and Research Grant - Mainz Research Funding Program (MAIFOR) of University Medical Center Mainz; Marie Curie Career Integration Grant of European Union; Boehringer Ingelheim Fonds(Boehringer Ingelheim); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Amanda Welton for technical assistance with HR-MRI acquisition and Lisa Kubacki for secretarial assistance. This work was supported by Deutsche Forschungsgemeinschaft Grant BO3482/3-1, Federal Ministry of Education and Research Grant BMBF-01EO1003, funding from the Mainz Research Funding Program (MAIFOR) of the University Medical Center Mainz, and a Marie Curie Career Integration Grant of the European Union (Project 334486) (all to M.B.); the Boehringer Ingelheim Fonds (to N.F.R. and R.R.); and U.S. National Institutes of Health, National Institute of General Medical Sciences Grants GM-29507 and GM-61656 (to P.A.W.). The authors are responsible for the contents of this publication and declare no conflicts of interest. Parts of the data of this paper were used by N.F.R. and R.R. for their M.D. theses (Doctor of Medicine degree).	Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bless NM, 2000, J IMMUNOL, V164, P2650, DOI 10.4049/jimmunol.164.5.2650; Bosmann M, 2014, EXPERT OPIN THER TAR, V18, P703, DOI 10.1517/14728222.2014.902938; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Bosmann M, 2013, EUR J IMMUNOL, V43, P1907, DOI 10.1002/eji.201243075; Bosmann M, 2012, J IMMUNOL, V188, P5086, DOI 10.4049/jimmunol.1102914; Bosmann M, 2012, FASEB J, V26, P2137, DOI 10.1096/fj.11-201640; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Bosmann M, 2011, SHOCK, V36, P396, DOI 10.1097/SHK.0b013e3182295f5f; Czermak BJ, 1999, J IMMUNOL, V162, P2321; Doerschuk CM, 1996, J IMMUNOL, V157, P4609; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Flierl MA, 2008, SHOCK, V29, P25, DOI 10.1097/shk.0b013e3180556a0b; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Grailer JJ, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00387; Grommes J, 2014, J INNATE IMMUN, V6, P111, DOI 10.1159/000353229; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Heller T, 1999, J IMMUNOL, V163, P985; HENSON PM, 1979, AM J PATHOL, V97, P93; Hubbard LLN, 2008, EXP LUNG RES, V34, P263, DOI 10.1080/01902140802022518; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Kambas K, 2008, J IMMUNOL, V180, P7368, DOI 10.4049/jimmunol.180.11.7368; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; LARSEN GL, 1980, AM J PATHOL, V100, P179; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Mueller-Ortiz SL, 2009, J IMMUNOL, V182, P6533, DOI 10.4049/jimmunol.0804207; Mulligan MS, 1997, J IMMUNOL, V158, P1857; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Price LC, 2012, AM J PHYSIOL-LUNG C, V302, pL803, DOI 10.1152/ajplung.00355.2011; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; ROBBINS RA, 1987, AM REV RESPIR DIS, V135, P651; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506; STIMLER NP, 1980, AM J PATHOL, V100, P327; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; TARLING JD, 1987, J LEUKOCYTE BIOL, V42, P443, DOI 10.1002/jlb.42.5.443; TILL GO, 1982, J CLIN INVEST, V69, P1126, DOI 10.1172/JCI110548; Trujillo G, 2013, J IMMUNOL, V191, P848, DOI 10.4049/jimmunol.1202941; WEBSTER RO, 1982, J CLIN INVEST, V70, P1177, DOI 10.1172/JCI110716; WETSEL RA, 1995, IMMUNOL LETT, V44, P183, DOI 10.1016/0165-2478(94)00212-A	52	31	33	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3762	3772		10.1096/fj.15-271635	http://dx.doi.org/10.1096/fj.15-271635			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25999468	Green Published, Green Submitted			2022-12-28	WOS:000359915600014
J	Buss, NAPS; Gavins, FNE; Cover, PO; Terron, A; Buckingham, JC				Buss, Nicholas A. P. S.; Gavins, Felicity N. E.; Cover, Patricia O.; Terron, Andrea; Buckingham, Julia C.			Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex	FASEB JOURNAL			English	Article						annexin A1; glucocorticoids; endotoxemia; inflammation; endocrine	PITUITARY-ADRENOCORTICAL RESPONSES; HEPATIC MICROVASCULAR DYSFUNCTION; SEVERE SEPSIS; SEPTIC SHOCK; ENDOTOXIN LIPOPOLYSACCHARIDE; GENE-EXPRESSION; IN-VITRO; KAPPA-B; CYTOKINE; ACTH	Hypothalamo-pituitary-adrenocortical dysfunction contributes to morbidity and mortality in a high proportion of patients with sepsis. Here, we provide new insights into the underlying adrenal pathology. Using a murine model of endotoxemia (LPS injection), we demonstrate that adrenal insufficiency is triggered early in the disease. LPS induced a local inflammatory response in the adrenal gland within 4 hours of administration, coupled with increased expression of mRNAs for annexin A1 (AnxA1) and the formyl peptide receptors [(Fprs) 1, 2, and 3], a loss of lipid droplets in cortical cells (index of availability of cholesterol, the substrate for steroidogenesis), and a failure to mount a steroidogenic response to ACTH. Deletion of AnxA1 or Fpr2/3 in mice prevented lipid droplet loss, but not leukocyte infiltration. LPS increased adrenal myeloid differentiation primary response gene 88 and TLR2 mRNA expression, but not lymphocyte antigen 96 or TLR4. By contrast, neutrophil depletion prevented leukocyte infiltration and increased AnxA1, Fpr1, and Fpr3 mRNAs but had no impact on lipid droplet loss. Our novel data demonstrate that AnxA1 and Fpr2 have a critical role in the manifestation of adrenal insufficiency in this model, through regulation of cholesterol ester storage, suggesting that pharmacologic interventions targeting the AnxA1/FPR/ALX pathway may provide a new approach for the maintenance of adrenal steroidogenesis in sepsis.	[Buss, Nicholas A. P. S.; Buckingham, Julia C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Diabet Endocrinol & Metab, London, England; [Gavins, Felicity N. E.; Cover, Patricia O.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, London, England; [Gavins, Felicity N. E.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, Shreveport, LA USA; [Terron, Andrea] GlaxoSmithKline, Safety Assessment, Ware, Herts, England; [Buckingham, Julia C.] Brunel Univ London, Uxbridge UB8 3PH, Middx, England	Imperial College London; Imperial College London; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; GlaxoSmithKline; Brunel University	Buckingham, JC (corresponding author), Brunel Univ London, Kingston Lane, Uxbridge UB8 3PH, Middx, England.	julia.buckingham@brunel.ac.uk	Gavins, Felicity N. E./AAU-6010-2020	Gavins, Felicity N. E./0000-0001-7008-5423; Buss, Nicholas/0000-0002-8226-4311	GlaxoSmithKline (Stevenage, United Kingdom); Higher Education Funding Council for England; GlaxoSmithKline; Medical Research Council [MC_PC_12015] Funding Source: researchfish; MRC [MC_PC_12015] Funding Source: UKRI	GlaxoSmithKline (Stevenage, United Kingdom)(GlaxoSmithKline); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to Ms. Stephanie Gresham, Ms. Daniela Spagnolo, Mr. Nicola Busti, and Mr. Colin Rantle for expert technical assistance. The authors also thank GlaxoSmithKline (Stevenage, United Kingdom) for funding the project. J.C.B. and P.O.C. are funded by the Higher Education Funding Council for England, F.N.E.G. was funded by the Higher Education Funding Council for England, and N.A.P.S.B. and A.T. were funded by GlaxoSmithKline. N.A.P.S.B. and F.N.E.G. share senior authorship of this article.	Almawi WY, 1996, J LEUKOCYTE BIOL, V60, P563, DOI 10.1002/jlb.60.5.563; Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Annane D, 2004, BMJ-BRIT MED J, V329, P480, DOI 10.1136/bmj.38181.482222.55; Annane D, 2002, CRIT CARE, V6, P190; Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; Briegel J, 1996, INTENS CARE MED, V22, P894; Buckingham JC, 2006, BRIT J PHARMACOL, V147, pS258, DOI 10.1038/sj.bjp.0706456; Cai BL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/642462; Chen R, 2005, J NEUROIMMUNOL, V163, P53, DOI 10.1016/j.jneuroim.2005.02.012; Claessens YE, 2007, CRIT CARE, V11, DOI 10.1186/cc6153; Connelly MA, 2009, MOL CELL ENDOCRINOL, V300, P83, DOI 10.1016/j.mce.2008.09.011; Cover PO, 2001, ENDOCRINE, V16, P123, DOI 10.1385/ENDO:16:2:123; CROXTALL JD, 1994, BIOCHEM PHARMACOL, V48, P1729, DOI 10.1016/0006-2952(94)90458-8; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Davies E, 2001, CLIN ENDOCRINOL, V54, P813, DOI 10.1046/j.1365-2265.2001.01264.x; Davies E, 2007, ENDOCRINOLOGY, V148, P1030, DOI 10.1210/en.2006-0732; de Salamanca AE, 2005, MICROBES INFECT, V7, P1077, DOI 10.1016/j.micinf.2005.02.016; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Gavins FNE, 2010, TRENDS PHARMACOL SCI, V31, P266, DOI 10.1016/j.tips.2010.04.001; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; GAYKEMA RPA, 1995, ENDOCRINOLOGY, V136, P4717, DOI 10.1210/en.136.10.4717; Grinevich V, 2001, J NEUROENDOCRINOL, V13, P711, DOI 10.1046/j.1365-2826.2001.00684.x; Hales KH, 2000, ENDOCRINOLOGY, V141, P4000, DOI 10.1210/en.141.11.4000; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hoshino K, 1999, J IMMUNOL, V162, P3749; John CD, 2007, FASEB J, V21, P1037, DOI 10.1096/fj.06-7299com; John CD, 2008, CURR OPIN PHARMACOL, V8, P765, DOI 10.1016/j.coph.2008.09.005; Liu N, 2011, INFLAMMATION, V34, P283, DOI 10.1007/s10753-010-9234-z; Lomnitski L, 2000, PHARMACOL TOXICOL, V87, P18, DOI 10.1111/j.0901-9928.2000.870104.x; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Calejman CM, 2011, MOL CELL ENDOCRINOL, V337, P1, DOI 10.1016/j.mce.2010.12.036; Matsumoto Y, 2002, SHOCK, V17, P411, DOI 10.1097/00024382-200205000-00012; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; Mehet DK, 2012, J NEUROENDOCRINOL, V24, P862, DOI 10.1111/j.1365-2826.2012.02285.x; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Norman KE, 2003, BLOOD, V101, P921, DOI 10.1182/blood-2001-12-0190; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Polito A, 2010, INTENS CARE MED, V36, P1852, DOI 10.1007/s00134-010-1987-1; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Singer G, 2007, J HEPATOL, V47, P799, DOI 10.1016/j.jhep.2007.07.021; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; SOLOMON S, 1991, J STEROID BIOCHEM, V40, P391, DOI 10.1016/0960-0760(91)90206-K; SZAFARCZYK A, 1985, AM J PHYSIOL, V249, pE219; Takemura T, 1997, BRAIN RES, V767, P181, DOI 10.1016/S0006-8993(97)00460-5; TAYLOR AD, 1995, NEUROENDOCRINOLOGY, V62, P19, DOI 10.1159/000126984; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Waechter V, 2012, J IMMUNOL, V188, P1856, DOI 10.4049/jimmunol.1101788; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; Xu J., 2010, NATL VITAL STAT REP, V58, P1; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	60	16	18	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2930	2942		10.1096/fj.14-268375	http://dx.doi.org/10.1096/fj.14-268375			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25818588				2022-12-28	WOS:000356859100022
J	Kaftanovskaya, EM; Lopez, C; Ferguson, L; Myhr, C; Agoulnik, AI				Kaftanovskaya, Elena M.; Lopez, Carolina; Ferguson, Lydia; Myhr, Courtney; Agoulnik, Alexander I.			Genetic ablation of androgen receptor signaling in fetal Leydig cell lineage affects Leydig cell functions in adult testis	FASEB JOURNAL			English	Article						cell differentiation; infertility; spermatogenesis; testis differentiation	MALE-MICE LACKING; TESTOSTERONE PRODUCTION; SERTOLI-CELLS; STEROIDOGENIC ENZYMES; INTERSTITIAL-CELLS; DIFFERENTIATION; EXPRESSION; CRYPTORCHIDISM; PROLIFERATION; PROGENITORS	It is commonly accepted that androgen-producing fetal Leydig cells (FLC) are substituted by adult Leydig cells (ALC) during perinatal testis development. The mechanisms influencing this process are unclear. We used mice with a retinoid acid receptor 2 promoter-Cre recombinase transgene (Rarb-cre) expressed in embryonic FLC precursors, but not in postnatal testis, and a dual fluorescent Cre recombinase reporter to label FLC and ALC in vivo. All FLC in newborn testis had the recombinant, whereas the majority of LC in adult testis had the nonrecombinant reporter. Primary LC cultures from adult testis had either recombinant (20%) or nonrecombinant (80%) cells, demonstrating that the FLC survive in adult testis and their ontogeny is distinct from ALC. Conditional inactivation of androgen receptor (AR) allele using the Rarb-cre transgene resulted in a 50% increase of AR-negative LC in adult testis. The mutant males became infertile with age, with all LC in older testis showing signs of incomplete differentiation, such as a large number of big lipid droplets, an increase of finger-like protrusions, and a misexpression of steroidogenic or FLC- and ALC-specific genes. We propose that the antiandrogenic exposure during early development may similarly result in an increase of FLC in adult testis, leading to abnormal LC differentiation.	[Kaftanovskaya, Elena M.; Lopez, Carolina; Ferguson, Lydia; Myhr, Courtney; Agoulnik, Alexander I.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA; [Agoulnik, Alexander I.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	State University System of Florida; Florida International University; Baylor College of Medicine	Agoulnik, AI (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, 11200 SW 8th St,AHCI 419B, Miami, FL 33199 USA.	aagoulni@fiu.edu	Agoulnik, Alexander/AAK-3213-2020	Agoulnik, Alexander/0000-0001-6587-6845	Herbert Wertheim College of Medicine, Florida International University; NATIONAL CANCER INSTITUTE [U01CA177711] Funding Source: NIH RePORTER	Herbert Wertheim College of Medicine, Florida International University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank R. Behringer (The University of Texas MD Anderson Cancer Center, Houston, TX, USA), K. De Gendt, and G. Verhoeven (Katholieke Universiteit Leuven, Leuven, Belgium) for providing Rarb-cre and Ar<SUP>fl</SUP> mice. This study was supported by funds from the Herbert Wertheim College of Medicine, Florida International University (to A. I. A.).	Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Ariyaratne HBS, 2000, BIOL REPROD, V62, P680, DOI 10.1095/biolreprod62.3.680; Baker PJ, 1997, MOL CELL ENDOCRINOL, V133, P127, DOI 10.1016/S0303-7207(97)00159-7; Barsoum IB, 2013, FASEB J, V27, P2657, DOI 10.1096/fj.12-225060; Bogatcheva NV, 2005, REPROD BIOMED ONLINE, V10, P49, DOI 10.1016/S1472-6483(10)60803-6; Boisen KA, 2001, ANN NY ACAD SCI, V948, P90; Chen HL, 2010, BIRTH DEFECTS RES C, V90, P272, DOI 10.1002/bdrc.20192; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DeFalco T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106138; DeFalco T, 2011, DEV BIOL, V352, P14, DOI 10.1016/j.ydbio.2011.01.011; Faria MJS, 2003, MICROSC MICROANAL, V9, P68, DOI 10.1017/S1431927603030101; Feng S, 2007, BIOL REPROD, V77, P671, DOI 10.1095/biolreprod.107.060442; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; Griffin DK, 2010, BIOL REPROD, V82, P1139, DOI 10.1095/biolreprod.109.082099; Griswold SL, 2009, SEX DEV, V3, P1, DOI 10.1159/000200077; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Houk CP, 2004, ENDOCRINOLOGY, V145, P1269, DOI 10.1210/en.2003-1046; Kaftanovskaya EM, 2013, J PATHOL, V230, P39, DOI 10.1002/path.4161; Kaftanovskaya EM, 2012, MOL ENDOCRINOL, V26, P598, DOI 10.1210/me.2011-1283; Kaftanovskaya EM, 2011, MOL ENDOCRINOL, V25, P170, DOI 10.1210/me.2010-0330; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; KERR JB, 1988, DEVELOPMENT, V103, P535; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kotula-Balak M, 2011, TOXICOL IN VITRO, V25, P1018, DOI 10.1016/j.tiv.2011.03.021; Lottrup G, 2014, HUM REPROD, V29, P1637, DOI 10.1093/humrep/deu124; MAJDIC G, 1995, J ENDOCRINOL, V147, P285, DOI 10.1677/joe.0.1470285; MOORE A, 1992, J ENDOCRINOL, V134, P247, DOI 10.1677/joe.0.1340247; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Hara L., FASEB J; O'Shaughnessy PJ, 2003, ENDOCRINOLOGY, V144, P3279, DOI 10.1210/en.2003-0277; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; SHAN LX, 1993, ENDOCRINOLOGY, V133, P2277, DOI 10.1210/en.133.5.2277; SHAN LX, 1995, ENDOCRINOLOGY, V136, P1686, DOI 10.1210/en.136.4.1686; Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Shen XH, 2012, GEN COMP ENDOCR, V177, P177, DOI 10.1016/j.ygcen.2012.03.007; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun J, 2011, J REPROD DEVELOP, V57, P433, DOI 10.1262/jrd.10-123N; Tai P, 2009, ENDOCRINOLOGY, V150, P3766, DOI 10.1210/en.2009-0207; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Wen Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE1131, DOI 10.1152/ajpendo.00425.2014; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Xu QQ, 2007, ENDOCRINE, V32, P96, DOI 10.1007/s12020-007-9015-0; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103	55	22	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2327	2337		10.1096/fj.14-263632	http://dx.doi.org/10.1096/fj.14-263632			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713029	Green Published			2022-12-28	WOS:000355209500011
J	Bourguignon, V; Flamion, B				Bourguignon, Virginie; Flamion, Bruno			Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover	FASEB JOURNAL			English	Article						glycosaminoglycan; extracellular matrix; sinusoidal endothelial cells; lymph nodes	JAAGSIEKTE SHEEP RETROVIRUS; CHONDROITIN SULFATE; PROCESSED FORMS; RAT-LIVER; RECEPTOR; ENDOCYTOSIS; EXPRESSION; CELLS; ACID; CLEARANCE	We studied the physiologic roles of the hyaluronidase (HYAL) 1 and HYAL2 in hyaluronan (HA) turnover. HA was localized and quantified using HA binding proteins in various tissues of Hyal1(-/-) and Hyal2(-/-) mice (knockout mice) as well as control mice. HA MW was determined using gel filtration chromatography. HA endocytosis in liver nonparenchymal cells (NPCs) was quantified in vivo. Both Hyal1 and Hyal2 knockout mice showed HA accumulation in peripheral tissues without changes in HA MW distribution. HYAL2 deficiency induced buildup of very high MW (>3.10(6) Da) HA in lymph and serum with severe lymph node distortion. The lack of HYAL2 also impaired high MW HA endocytosis by liver NPCs. HYAL1 deficiency led to a moderate increase in serum HA concentration without changes in HA MW distribution and to HA overload of liver NPCs. Wild-type C57BL/6 mice served as controls. In HA injection experiments, saline-injected mice served as additional controls. We conclude that: 1) HYAL1 and HYAL2 are both needed for tissue HA catabolism; 2) HYAL2 is required for high MW HA clearance in lymph nodes and plasma and for HA endocytosis by liver NPCs; and 3) the main role of HYAL1 is HA degradation within liver NPCs.Bourguignon, V., Flamion, B. Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.	[Bourguignon, Virginie; Flamion, Bruno] Univ Namur, Mol Physiol Res Unit, Namur Res Inst Life Sci, Namur, Belgium	University of Namur	Flamion, B (corresponding author), Univ Namur URPhyM, Rue Bruxelles 61, B-5000 Namur, Belgium.	bruno.flamion@unamur.be						Andre B, 2011, BIOCHEM BIOPH RES CO, V411, P175, DOI 10.1016/j.bbrc.2011.06.125; [Anonymous], CIBA FDN S; Boonen M, 2014, BIOCHEM BIOPH RES CO, V446, P1155, DOI 10.1016/j.bbrc.2014.03.070; Campo GM, 2012, ARCH BIOCHEM BIOPHYS, V518, P42, DOI 10.1016/j.abb.2011.12.005; Colombaro V, 2015, KIDNEY INT, V88, P61, DOI 10.1038/ki.2015.53; Colombaro V, 2015, ACTA HISTOCHEM, V117, P83, DOI 10.1016/j.acthis.2014.11.007; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; FRASER JRE, 1985, CELL TISSUE RES, V242, P505; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Gasingirwa MC, 2010, BIOCHEM J, V430, P305, DOI 10.1042/BJ20100711; Gopalakrishnan S, 2011, JOVE-J VIS EXP, DOI 10.3791/3138; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jadin L, 2012, MATRIX BIOL, V31, P81, DOI 10.1016/j.matbio.2011.11.002; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LAURENT TC, 1986, CIBA F SYMP, V124, P9; LAURENT UBG, 1991, EXP PHYSIOL, V76, P695, DOI 10.1113/expphysiol.1991.sp003536; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Machholz E, 2012, JOVE-J VIS EXP, DOI 10.3791/2771; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Onclinx C, 2015, HAEMATOLOGICA, V100, P1023, DOI 10.3324/haematol.2015.123828; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; Vigdorovich V, 2005, J VIROL, V79, P79, DOI 10.1128/JVI.79.1.79-86.2005; Weigel JA, 2003, J BIOL CHEM, V278, P9808, DOI 10.1074/jbc.M211462200	37	37	38	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2108	2114		10.1096/fj.201500178R	http://dx.doi.org/10.1096/fj.201500178R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26887442				2022-12-28	WOS:000376878300005
J	Han, SX; Kwong, S; Ge, RW; Kolatkar, PR; Woods, AE; Blanchet, G; Kini, RM				Han, Summer Xia; Kwong, Shiyang; Ge, Ruowen; Kolatkar, Prasanna R.; Woods, Anthony E.; Blanchet, Guillaume; Kini, R. Manjunatha			Regulation of expression of venom toxins: silencing of prothrombin activator trocarin D by AG-rich motifs	FASEB JOURNAL			English	Article						purine repeat sequences; transcriptional repression; toxin gene evolution	PHOSPHOLIPASE A(2) GENES; COAGULATION-FACTOR-XA; POLYCOMB GROUP PROTEINS; SNAKE-VENOM; MOLECULAR EVOLUTION; ACCELERATED EVOLUTION; TRANSCRIPTIONAL ACTIVATION; PHYLOGENETIC ANALYSIS; RESPONSE ELEMENT; 3-FINGER TOXINS	Trocarin D (TroD), a venom prothrombin activator from Tropidechis carinatus, shares similar structure and function with blood coagulation factor Xa [Tropidechis carinatus FX (TrFX) a]. Their distinct physiologic roles are due to their distinct expression patterns. The genes of TroD and TrFX are highly similar, except for promoter and intron 1, indicating that TroD has probably evolved by duplication of FX, the plasma counterpart. The promoter insertion in TroD accounts for the elevated but not venom gland-specific expression. Here we examined the roles of 3 insertions and 2 deletions in intron 1 of TroD in the regulation of expression using luciferase as a reporter. By systematic deletions, we showed that a 209 bp region within the second insertion silences expression in mammalian and unmilked venom gland cells. Through bioinformatics analysis, we identified 5 AG-rich motifs in this region. All except the 5th motif are important for silencing function. YY1, Sp3 and HMGB2 were identified to bind these AG-rich motifs and silence gene expression in mammalian cells. Similar AG-rich motif clusters are also found in other toxin genes but not in their physiologic counterparts. Thus, AG-rich motifs contribute to regulation of expression of TroD, and probably other toxin genes.Han, S. X., Kwong, S., Ge, R., Kolatkar, P. R., Woods, A. E., Blanchet, G., Kini, R. M. Regulation of expression of venom toxins: silencing of prothrombin activator trocarin D by AG-rich motifs.	[Han, Summer Xia; Kwong, Shiyang; Ge, Ruowen; Blanchet, Guillaume; Kini, R. Manjunatha] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Kolatkar, Prasanna R.] Hamad Bin Khalifa Univ, Qatar Fdn Educ Sci & Community Dev, Qatar Biomed Res Inst, Doha, Qatar; [Woods, Anthony E.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	National University of Singapore; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); University of South Australia	Kini, RM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Prot Sci Lab, Sci Dr 4, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Ge, Ruowen/D-8352-2012	Ge, Ruowen/0000-0002-0750-7336; Woods, Anthony/0000-0002-8208-4054; Kini, Manjunatha/0000-0002-6100-3251	National University of Singapore	National University of Singapore(National University of Singapore)	The authors thank anonymous referees for their constructive comments on this manuscript. The authors appreciate the help from Jessica Logan and Andrew Beck ( University of South Australia) and Nathan Dunstan and Luke Allen ( Venom Supplies Pty. Ltd., Tanunda, SA, Australia) for successful culture of primary venom gland cells. The authors also appreciate Sizun Jiang and Dr. Calista Ng (former members of P.R.K's group, Genome Institute of Singapore), and Dr. Li Chenyu (Department of Biological Sciences, National University of Singapore) for their insightful discussions. The authors are also thankful to Harald Kerkkamp (Leiden University, Leiden, The Netherlands) for providing necessary sequences of Ophiophagus hannah genes. Additionally, the authors thank Quan-zhi Ye (Department of Physics and Astronomy, The University of Western Ontario, London, ON, Canada) for kind help with time management and paper writing. This study was supported by an academic research grant from the National University of Singapore. The authors declare no conflicts of interest.	Abu Reza M, 2005, THROMB HAEMOSTASIS, V93, P40, DOI 10.1160/TH04-07-0435; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Chang LS, 1997, BIOCHEM BIOPH RES CO, V239, P756, DOI 10.1006/bbrc.1997.7549; Debrauwere H, 1997, BIOCHIMIE, V79, P577, DOI 10.1016/S0300-9084(97)82006-8; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Fujimi TJ, 2004, GENE, V332, P179, DOI 10.1016/j.gene.2004.02.050; Fujimi TJ, 2002, GENE, V292, P225, DOI 10.1016/S0378-1119(02)00682-0; Fujimi TJ, 2002, TOXICON, V40, P873, DOI 10.1016/S0041-0101(01)00272-0; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hargreaves AD, 2014, GENOME BIOL EVOL, V6, P2088, DOI 10.1093/gbe/evu166; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631; Junqueira-de-Azevedo ILM, 2015, MOL BIOL EVOL, V32, P754, DOI 10.1093/molbev/msu337; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Kini RM, 2011, J THROMB HAEMOST, V9, P195, DOI 10.1111/j.1538-7836.2011.04279.x; Kini R. M., 1999, VENOM PHOSPHOLIPASE; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kordis D, 1997, EUR J BIOCHEM, V246, P772, DOI 10.1111/j.1432-1033.1997.00772.x; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kwong S, 2009, THROMB HAEMOSTASIS, V102, P469, DOI 10.1160/TH09-03-0162; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Le TNM, 2005, THROMB HAEMOSTASIS, V93, P420, DOI 10.1160/TH040-11-0707; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Ma DH, 2002, ARCH BIOCHEM BIOPHYS, V404, P98, DOI 10.1016/S0003-9861(02)00245-X; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; MouradaSilva AM, 1996, J MOL EVOL, V43, P263, DOI 10.1007/PL00006085; NAKASHIMA K, 1993, P NATL ACAD SCI USA, V90, P5964, DOI 10.1073/pnas.90.13.5964; Ogawa T, 1995, J MOL EVOL, V41, P867; Ogbourne S, 1998, BIOCHEM J, V331, P1; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; PAINE MJI, 1992, TOXICON, V30, P379, DOI 10.1016/0041-0101(92)90534-C; Pawlak J, 2008, BIOCHIMIE, V90, P868, DOI 10.1016/j.biochi.2008.02.016; Petrykowska HM, 2008, GENOME RES, V18, P1238, DOI 10.1101/gr.073817.107; Qi HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124588; Rao VS, 2003, BIOCHEM J, V369, P635, DOI 10.1042/BJ20020889; Rao VS, 2002, THROMB HAEMOSTASIS, V88, P611, DOI 10.1055/s-0037-1613264; Reza MA, 2007, J THROMB HAEMOST, V5, P117, DOI 10.1111/j.1538-7836.2006.02266.x; Reza MA, 2006, J THROMB HAEMOST, V4, P1346, DOI 10.1111/j.1538-7836.2006.01969.x; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Sipos L, 2007, P NATL ACAD SCI USA, V104, P12416, DOI 10.1073/pnas.0703144104; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Weill L, 2003, J VIROL, V77, P2903, DOI 10.1128/JVI.77.5.2903-2914.2003; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022	64	4	4	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2411	2425		10.1096/fj.201600213R	http://dx.doi.org/10.1096/fj.201600213R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26985007				2022-12-28	WOS:000376878300029
J	Nguyen, LT; Chen, H; Pollock, CA; Saad, S				Nguyen, Long T.; Chen, Hui; Pollock, Carol A.; Saad, Sonia			Sirtuins-mediators of maternal obesity-induced complications in offspring?	FASEB JOURNAL			English	Review						fetal programming; metabolism; chronic diseases	HIGH-FAT DIET; PROMOTES CELL-SURVIVAL; ENDOPLASMIC-RETICULUM STRESS; BODY-MASS INDEX; OXIDATIVE STRESS; METABOLIC SYNDROME; GENE-EXPRESSION; REGULATES SIRT1; MITOCHONDRIAL DYSFUNCTION; SUPEROXIDE-DISMUTASE	Obesity is a complex metabolic disease, attributed to diverse and interactive genetic and environmental factors. The associated health consequences of obesity are pleiotropic, with individuals being more susceptible to chronic diseases such as type 2 diabetes mellitus, hypertension, and lipotoxicity-related chronic diseases. The contribution of maternal obesity to the offspring's predisposition to both obesity and its complications is increasingly recognized. Understanding the mechanisms underlying these "transmissible" effects is critical to develop therapeutic interventions to reduce the risk for "programmed" obesity. Sirtuins (SIRTs), particularly SIRT1 and SIRT3, are NAD+-dependent deacetylases that regulate metabolic balance and stress responses in both central and peripheral tissues, of which dysregulation is a well-established mediator for the development and effects of obesity. Nevertheless, their implication in the transmissible effects of maternal obesity across generations remains largely elusive. In this review, we examine multiple pathways and systems that are likely to mediate such effects, with particular emphasis on the role of SIRTs.-Nguyen, L. T., Chen, H., Pollock, C. A., Saad, S. Sirtuins-mediators of maternal obesity-induced complications in offspring? oFASEB J. 30, 1383-1390 (2016). www. asebj.org	[Nguyen, Long T.; Pollock, Carol A.; Saad, Sonia] Univ Sydney, Royal N Shore Hosp, Kolling Inst, Sydney, NSW 2006, Australia; [Chen, Hui] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Technology Sydney	Nguyen, LT (corresponding author), Royal N Shore Hosp, Kolling Inst, Level 9, St Leonards, NSW 2065, Australia.	lngu8923@uni.sydney.edu.au	Chen, Hui/R-6137-2019; Nguyen, Long/AAH-2433-2021; Chen, Hui/D-2005-2014	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Saad, Sonia/0000-0001-8067-8046; Nguyen, Long/0000-0002-0630-4959	University of Sydney; Amgen Research Scholarship	University of Sydney(University of Sydney); Amgen Research Scholarship	L.T.N. was supported by an Early Career Research Ph.D. Scholarship from the University of Sydney, and an Amgen Research Scholarship.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Borengasser SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084209; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cetrullo S, 2015, CRIT REV EUKAR GENE, V25, P59, DOI 10.1615/CritRevEukaryotGeneExpr.2015012975; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Cheng Y, 2014, J NEUROIMMUNOL, V269, P38, DOI 10.1016/j.jneuroim.2014.02.001; Costa CD, 2010, OBES SURG, V20, P633, DOI 10.1007/s11695-009-0052-z; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Dominguez J, 2007, AM J PHYSIOL-RENAL, V293, pF670, DOI 10.1152/ajprenal.00021.2007; Feng Y, 2015, J NEUROCHEM, V134, P668, DOI 10.1111/jnc.13172; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Garaulet M, 2012, INT J OBESITY, V36, P1436, DOI 10.1038/ijo.2011.270; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guarente L, 2000, GENE DEV, V14, P1021; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Jackson CM, 2012, AM J PHYSIOL-RENAL, V302, pF774, DOI 10.1152/ajprenal.00491.2011; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Koyama T, 2011, FREE RADICAL BIO MED, V51, P1258, DOI 10.1016/j.freeradbiomed.2011.05.028; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031394; Li HP, 2013, INT J CLIN EXP PATHO, V6, P650; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Modi N, 2011, PEDIATR RES, V70, P287, DOI 10.1203/PDR.0b013e318225f9b1; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; O'Reilly JR, 2013, CLIN ENDOCRINOL, V78, P9, DOI 10.1111/cen.12055; Okazaki M, 2010, ENDOCR J, V57, P403, DOI 10.1507/endocrj.K10E-004; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Qia LP, 2015, DIABETES, V64, P3111, DOI 10.2337/db14-1627; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Saben J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1, DOI 10.1152/ajpendo.00076.2013; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sasaki T, 2014, DIABETOLOGIA, V57, P819, DOI 10.1007/s00125-013-3140-5; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Turdi S, 2013, J MOL CELL CARDIOL, V55, P117, DOI 10.1016/j.yjmcc.2012.12.007; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; Wu LL, 2015, DEVELOPMENT, V142, P681, DOI 10.1242/dev.114850; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Yao HW, 2014, AM J PHYSIOL-LUNG C, V306, pL816, DOI 10.1152/ajplung.00323.2013; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang L, 2015, CELL CYCLE, V14, P2959, DOI 10.1080/15384101.2015.1026517; Zhu MJ, 2010, PLACENTA, V31, P387, DOI 10.1016/j.placenta.2010.02.002; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010	98	14	14	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1383	1390		10.1096/fj.15-280743	http://dx.doi.org/10.1096/fj.15-280743			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26667041				2022-12-28	WOS:000372629100002
J	Pool, LR; Wagner, RM; Scott, LL; RoyChowdhury, D; Berhane, R; Wu, C; Pearson, K; Sutton, JA; Schaffer, WT				Pool, Lindsay R.; Wagner, Robin M.; Scott, Lindsey L.; RoyChowdhury, Deepshikha; Berhane, Rediet; Wu, Charles; Pearson, Katrina; Sutton, Jennifer A.; Schaffer, Walter T.			Size and characteristics of the biomedical research workforce associated with US National Institutes of Health extramural grants	FASEB JOURNAL			English	Article						researcher census; occupation; career stage; educational attainment; personnel age distribution		The U.S. National Institutes of Health (NIH) annually invests approximately $22 billion in biomedical research through its extramural grant programs. Since fiscal year (FY) 2010, all persons involved in research during the previous project year have been required to be listed on the annual grant progress report. These new data have enabled the production of the first-ever census of the NIH-funded extramural research workforce. Data were extracted from All Personnel Reports submitted for NIH grants funded in FY 2009, including position title, months of effort, academic degrees obtained, and personal identifiers. Data were de-duplicated to determine a unique person count. Person-years of effort (PYE) on NIH grants were computed. In FY 2009, NIH funded 50,885 grant projects, which created 313,049 full- and part-time positions spanning all job functions involved in biomedical research. These positions were staffed by 247,457 people at 2,604 institutions. These persons devoted 121,465 PYE to NIH grant-supported research. Research project grants each supported 6 full- or part-time positions, on average. Over 20% of positions were occupied by postdoctoral researchers and graduate and undergraduate students. These baseline data were used to project workforce estimates for FYs 2010-2014 and will serve as a foundation for future research.	[Pool, Lindsay R.; Wagner, Robin M.; Pearson, Katrina; Sutton, Jennifer A.; Schaffer, Walter T.] NIH, Off Extramural Res, Off Director, Dept Hlth & Human Serv, Bethesda, MD USA; [Wagner, Robin M.] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA	Wagner, RM (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Sci Serv, 2500 Century Ctr Blvd NE,Room 5202,Mailstop E33, Atlanta, GA 30345 USA.	riw8@cdc.gov			NIH Evaluation Set-Aside Program [11-6002 OD-OER]	NIH Evaluation Set-Aside Program	The authors thank Drs. D. Hann, R. Ikeda, J. Onken, S. Rockey, R. Ulane, and D. Zuk for the insights and comments on drafts of this manuscript, provided by the U.S. National Institutes of Health (NIH) senior staff, and NIH financial specialist, S. Schiaffino, who provided able assistance in securing contract support for the study. This study was partially supported by a project, Reference Number 11-6002 OD-OER, funded by the NIH Evaluation Set-Aside Program, administered by the Office of Program Evaluation and Performance, Division of Program, Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The coauthors who were federal employees (L.R.P., R.M.W., J.A.S., K.P., and W.T.S.) conducted this research as part of their salaried duties. The work by L.L.S., D.R., R.B., and C.W. was contracted by the NIH. L.R.P., R.M.W., J.A.S., and W.T.S. conceived of and designed the study; L.R.P, L.L.S., D.R., R.B., C.W., K.P. and R.M.W. analyzed the data; L.R.P., R.M.W., K.P., J.A.S., and W.T.S. made significant contributions to interpretation of the results; and L.R.P. and R.M.W. wrote the manuscript. The OCR extraction of data was performed by Discovery Logic (Rockville, MD, USA), a Thomson Reuters business. Drs. L. Haak and J. Schnell served as the OCR project managers, and K. Barden, M. Cissel, and M. Probus performed the analyses. The authors declare no conflicts of interest.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Ehlrich E., 2011, EC ENGINE NIH RES EM; McGarvey W. E., 2008, MANY SCI DO NIH SUPP; Mishel L, 2012, STATE WORKING AM; Mokomva K., 2008, YOUR OWN BACKYARD NI; Office of Science Policy and Legislation, 1993, STAFF PATT NAT I HLT; ORCID Inc., 2014, WHAT IS ORCID; Polka JK, 2015, MOL BIOL CELL, V26, P1413, DOI 10.1091/mbc.E14-10-1432; Research Business Models Working Group U.S. National Institutes of Health, 2013, FED WID RES PROF PRO; Stephan P., 2012, EC SHAPES SCI; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272; U.S. Department ofHealth andHuman Services, 2012, PHS2590 US DEP HLTH; U.S. National Institutes of Health, 2006, EST MULT PRINC INV A; U.S. National Institutes of Health, 2010, PAR11050 US NAT I HL; U.S. National Institutes of Health, 2014, THE NIH DAT BOOK; U.S. National Institutes of Health, 2009, REV PHS 2590 DHHS PU; U.S. National Institutes of Health, 2014, TABL 106 NIH GRANTS; U.S. National Institutes of Health, 2010, PAR10257 US NAT I HL; U.S. National Institutes of Health, 2012, BIOM RES WORKF WORK; U.S. National Institutes of Health, 2010, TERMS COND NIH GRANT; U.S. National Institutes ofHealth, 2014, TABL 111 117 NUMB CO; U.S. National Science Foundation National Center for Science and Engineering Statistics, 2011, 12300 NSF US NAT SCI; Weinberg BA, 2014, SCIENCE, V344, P41, DOI 10.1126/science.1250055	23	10	10	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1023	1036		10.1096/fj.14-264358	http://dx.doi.org/10.1096/fj.14-264358			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26625903	Green Published, Green Submitted			2022-12-28	WOS:000370387800003
J	Jurczyk, A; Nowosielska, A; Przewozniak, N; Aryee, KE; DiIorio, P; Blodgett, D; Yang, CX; Campbell-Thompson, M; Atkinson, M; Shultz, L; Rittenhouse, A; Harlan, D; Greiner, D; Bortell, R				Jurczyk, Agata; Nowosielska, Anetta; Przewozniak, Natalia; Aryee, Ken-Edwin; DiIorio, Philip; Blodgett, David; Yang, Chaoxing; Campbell-Thompson, Martha; Atkinson, Mark; Shultz, Leonard; Rittenhouse, Ann; Harlan, David; Greiner, Dale; Bortell, Rita			Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic beta-cell function via glycogen synthase kinase-3 beta	FASEB JOURNAL			English	Article						insulin; secretion; diabetes; T2D	IMPAIRED GLUCOSE-TOLERANCE; DRUG-NAIVE PATIENTS; PROGENITOR PROLIFERATION; INSULIN-SECRETION; GENOMIC STRUCTURE; MOUSE MODELS; DISC1; EXPRESSION; PROTEIN; DISORDERS	Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes (T2D) than the general population (18-30 vs. 1.2-6.3%), independent of body mass index and antipsychotic medication, suggesting shared genetic components may contribute to both diseases. The cause of this association remains unknown. Mutations in disrupted in schizophrenia 1 (DISC1) increase the risk of developing psychiatric disorders [logarithm (base 10) of odds = 7.1]. Here, we identified DISC1 as a major player controlling pancreatic beta-cell proliferation and insulin secretion via regulation of glycogen synthase kinase-3 beta (GSK3 beta). DISC1 expression was enriched in developing mouse and human pancreas and adult beta- and ductal cells. Loss of DISC1 function, through siRNA-mediated depletion or expression of a dominant-negative truncation that models the chromosomal translocation of human DISC1 in schizophrenia, resulted in decreased beta-cell proliferation (3 vs. 1%; P < 0.01), increased apoptosis (0.1 vs. 0.6%; P < 0.01), and glucose intolerance in transgenic mice. Insulin secretion was reduced (0.5 vs. 0.1 ng/ml; P < 0.05), and critical beta-cell transcription factors Pdx1 and Nkx6.1 were significantly decreased. Impaired DISC1 allowed inappropriate activation of GSK3 beta in beta cells, and antagonizing GSK3 beta (SB216763; IC50 = 34.3 nM) rescued the beta-cell defects. These results uncover an unexpected role for DISC1 in normal beta-cell physiology and suggest that DISC1 dysregulation contributes to T2D independently of its importance for cognition.	[Jurczyk, Agata; Przewozniak, Natalia; Aryee, Ken-Edwin; Blodgett, David; Yang, Chaoxing; Harlan, David; Greiner, Dale; Bortell, Rita] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Nowosielska, Anetta] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Rittenhouse, Ann] Univ Massachusetts, Sch Med, Microbiol & Physiol Syst MaPS, Worcester, MA 01605 USA; [DiIorio, Philip] Univ Massachusetts, Dept Publ Hlth, Amherst, MA 01003 USA; [Campbell-Thompson, Martha; Atkinson, Mark] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Shultz, Leonard] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst; State University System of Florida; University of Florida; Jackson Laboratory	Bortell, R (corresponding author), Univ Massachusetts, Sch Med, 368 Plantat St,AS7-2055, Worcester, MA 01605 USA.	rita.bortell@umassmed.edu	Campbell-Thompson, Martha/A-7584-2010	Campbell-Thompson, Martha/0000-0001-6878-1235	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK089572]; Leona M. and Harry B. Helmsley Charitable Trust [2012PG-T1D018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089572] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Linda Leehy, Linda Paquin, and Rabia Lidstrom for technical support, and Aldo Rossini and Laura Alonso for their advice and guidance. This work was supported by U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grant U01 DK089572, and the Leona M. and Harry B. Helmsley Charitable Trust Grant 2012PG-T1D018.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams P. F., 1995, VITAL HLTH STAT, V10, P82; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Alberti KGMM, 1996, DIABETIC MED, V13, P927, DOI 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Cash-Padgett T, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00113; Chadda RK, 2013, J PHARMACOL PHARMACO, V4, P176, DOI 10.4103/0976-500X.114596; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De Hert M, 2006, Clin Pract Epidemiol Ment Health, V2, P14; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Harris LW, 2013, PSYCHONEUROENDOCRINO, V38, P752, DOI 10.1016/j.psyneuen.2012.09.009; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Henquin JC, 2008, DIABETES OBES METAB, V10, P1, DOI 10.1111/j.1463-1326.2008.00968.x; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Millar JK, 2000, GENOMICS, V67, P69, DOI 10.1006/geno.2000.6239; MUKHERJEE S, 1989, LANCET, V1, P495; Mussmann R, 2007, J BIOL CHEM, V282, P12030, DOI 10.1074/jbc.M609637200; Newburn EN, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.31; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Palo OM, 2007, HUM MOL GENET, V16, P2517, DOI 10.1093/hmg/ddm207; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Pletnikov MV, 2009, PROG BRAIN RES, V179, P35, DOI 10.1016/S0079-6123(09)17905-0; Porteous D, 2008, CURR OPIN GENET DEV, V18, P229, DOI 10.1016/j.gde.2008.07.005; Rampino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099892; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x; Stein J, 2013, ISLETS, V5, P156, DOI 10.4161/isl.25605; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Su P, 2014, NEURON, V84, P1302, DOI 10.1016/j.neuron.2014.11.007; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Venkatasubramanian G, 2007, AM J PSYCHIAT, V164, P1557, DOI 10.1176/appi.ajp.2007.07020233; Wang JJ, 2010, SCHIZOPHR RES, V124, P49, DOI 10.1016/j.schres.2010.09.013; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065711	56	13	14	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					983	993		10.1096/fj.15-279810	http://dx.doi.org/10.1096/fj.15-279810			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26546129	Green Published			2022-12-28	WOS:000369391900044
J	Drake, JC; Wilson, RJ; Yan, Z				Drake, Joshua C.; Wilson, Rebecca J.; Yan, Zhen			Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle	FASEB JOURNAL			English	Review						PGC-1 proportional to; biogenesis; remodeling; mitophagy	ACTIVATED PROTEIN-KINASE; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; SLOW-TWITCH MUSCLE; ENDURANCE EXERCISE; IN-VIVO; TRANSCRIPTIONAL CONTROL; PGC-1-ALPHA PROMOTER; CONTRACTILE ACTIVITY; OXIDATIVE CAPACITY; ENERGY-EXPENDITURE	Exercise training enhances physical performance and confers health benefits, largely through adaptations in skeletal muscle. Mitochondrial adaptation, encompassing coordinated improvements in quantity (content) and quality (structure and function), is increasingly recognized as a key factor in the beneficial outcomes of exercise training. Exercise training has long been known to promote mitochondrial biogenesis, but recent work has demonstrated that it has a profound impact on mitochondrial dynamics (fusion and fission) and clearance (mitophagy), as well. In this review, we discuss the various mechanisms through which exercise training promotes mitochondrial quantity and quality in skeletal muscle.-Drake, J. C., Wilson, R. J., Yan, Z. Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle. FASEB J. 30, 13-22 (2016). www.fasebj.org	[Drake, Joshua C.; Wilson, Rebecca J.; Yan, Zhen] Univ Virginia, Sch Med, Ctr Skeletal Muscle Res, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Yan, Z (corresponding author), 409 Lane Rd,MR4-6041A, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu		Yan, Zhen/0000-0002-4826-9813; Wilson, Rebecca/0000-0001-5884-0705	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR050429] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2008, AM J PHYSIOL-CELL PH, V295, pC288, DOI 10.1152/ajpcell.00104.2008; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Boppart MD, 2000, J PHYSIOL-LONDON, V526, P663, DOI 10.1111/j.1469-7793.2000.00663.x; Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0; Caffin F, 2013, J PHYSIOL-LONDON, V591, P6017, DOI 10.1113/jphysiol.2013.263079; Campello S, 2014, BBA-BIOENERGETICS, V1837, P451, DOI 10.1016/j.bbabio.2013.11.010; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674; Crane JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081879; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Ding H, 2010, BBA-GEN SUBJECTS, V1800, P250, DOI 10.1016/j.bbagen.2009.08.007; Drake JC, 2013, J GERONTOL A-BIOL, V68, P1493, DOI 10.1093/gerona/glt047; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jamart C, 2013, AM J PHYSIOL-ENDOC M, V305, pE964, DOI 10.1152/ajpendo.00270.2013; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Johnson ML, 2015, J GERONTOL A-BIOL, V70, P1386, DOI 10.1093/gerona/glu221; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; Kroczynska B, 2011, J BIOL CHEM, V286, P1147, DOI 10.1074/jbc.M110.183566; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Laker RC, 2014, DIABETES, V63, P1605, DOI [10.2337/db14-0135, 10.2337/db13-1614]; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lindholm ME, 2014, EPIGENETICS-US, V9, P1557, DOI 10.4161/15592294.2014.982445; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu Y, 2013, CELL SIGNAL, V25, P1877, DOI 10.1016/j.cellsig.2013.05.005; Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155; Miller BF, 2012, AM J PHYSIOL-ENDOC M, V302, pE496, DOI 10.1152/ajpendo.00578.2011; Miranda L, 2008, PFLUG ARCH EUR J PHY, V455, P1129, DOI 10.1007/s00424-007-0368-2; Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Noakes T, 2012, NATURE, V487, P295, DOI 10.1038/487295a; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pagano AF, 2014, MED SCI SPORT EXER, V46, P1314, DOI 10.1249/MSS.0000000000000237; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rose AJ, 2005, J PHYSIOL-LONDON, V569, P223, DOI 10.1113/jphysiol.2005.097154; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Ryder JW, 2000, J BIOL CHEM, V275, P1457, DOI 10.1074/jbc.275.2.1457; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Saleem A, 2014, AM J PHYSIOL-CELL PH, V306, pC241, DOI 10.1152/ajpcell.00270.2013; Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Scheele C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-74; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smith BK, 2013, J PHYSIOL-LONDON, V591, P1551, DOI 10.1113/jphysiol.2012.245944; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Ye L, 2013, AGING-US, V5, P539, DOI 10.18632/aging.100576; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu X. C., 2014, SCI CHINA EARTH SCI, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083080; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang Y., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.ENGGE0.2014.08.024; Zhang Y, 2012, J BIOL CHEM, V287, P9855, DOI 10.1074/jbc.M111.329359; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	101	122	127	3	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					13	22		10.1096/fj.15-276337	http://dx.doi.org/10.1096/fj.15-276337			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26370848	Green Published			2022-12-28	WOS:000367621000003
J	Garrison, HH; Justement, LB; Gerbi, SA				Garrison, Howard H.; Justement, Louis B.; Gerbi, Susan A.			Biomedical science postdocs: an end to the era of expansion	FASEB JOURNAL			English	Article						workforce; training; employment	EDUCATION; US	After > 3 decades of steady growth, the number of biological and medical science postdoctorates at doctoral degree-granting institutions recently began to decline. From 2010 through 2013, the most recent survey years, the postdoctoral population decreased from 40,970 to 38,719, a loss of 5.5%. This decline represents a notable departure from the previous long-standing increases in the number of postdoctorates in the biomedical workforce. The rate of contraction appears to be accelerating in the most recent survey years, and this has important implications for the biomedical workforce.-Garrison, H. H., Justement, L. B., Gerbi, S. A. Biomedical science postdocs: an end to the era of expansion.	[Garrison, Howard H.] Federat Amer Soc Expt Biol, Off Publ Affairs, Bethesda, MD 20816 USA; [Justement, Louis B.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Gerbi, Susan A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	University of Alabama System; University of Alabama Birmingham; Brown University	Garrison, HH (corresponding author), Federat Amer Soc Expt Biol, Off Publ Affairs, 9650 Rockville Pike, Bethesda, MD 20816 USA.	hgarrison@faseb.org		Garrison, Howard/0000-0001-9455-3527; Justement, Louis/0000-0001-7058-867X				Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; American Association for the Advancement of Science, 2015, SCI CAR MYIDP IND DE; Association of American Medical Colleges, 2014, AAMC DATA BOOK; Federation of American Societies for Experimental Biology, 2015, SUST DISC BIOL MED S; Federation of American Societies for Experimental Biology, 2015, NIH RES FUND TRENDS; Federation of American Societies for Experimental Biology, 2011, FED FUND BIOM REL LI; Garrison HH, 2005, FASEB J, V19, P1938, DOI 10.1096/fj.05-1203ufm; Garrison HH, 2015, ED EMPLOYMENT BIOL M; Gerbi SA, 2001, SCIENCE, V292, P1489, DOI 10.1126/science.1059268; National Institute of General Medical Sciences, 2011, INV FUT NAT I GEN ME; National Institutes of Health, 2013, NIH DIR BIOM RES OWR; National Institutes of Health, 2015, NAT I GEN MED SCI AD; National Institutes of Health Office of Extramural Research, 2015, IMPR GRAD STUD POSTD; National Postdoctoral Association, 2012, NIH BIOM RES WORKF; National Research Council, 2005, BRIDG IND FOST IND N; National Research Council, 2000, ENH POSTD EXP SCI EN; National Research Council, 2014, POSTD EXP REV; National Science Foundation, 2010, SURV DOCTR REC; National Science Foundation, 2008, SURVEY DOCTORATE REC; National Science Foundation, 2012, SURVEY EARNED DOCTOR, P2010; Rodgers BD, 2013, FASEB J, V27, P4678, DOI 10.1096/fj.13-235762; Rovner SL, 2015, CHEM ENG NEWS, V93, P27; U.S. Department of State Bureau of Consular Affairs, 2015, NON VIS STAT NON WOR; Working Group of the Advisory Committee to the Director, 2012, BIOM RES WORKF WORK	24	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					41	44		10.1096/fj.15-280552	http://dx.doi.org/10.1096/fj.15-280552			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443818				2022-12-28	WOS:000367621000006
J	Hijazi, A; Guan, HY; Cernea, M; Yang, KP				Hijazi, Ayten; Guan, Haiyan; Cernea, Maria; Yang, Kaiping			Prenatal exposure to bisphenol A disrupts mouse fetal lung development	FASEB JOURNAL			English	Article						endocrine-disrupting chemical; environmental exposure; lung maturation; glucocorticoid signaling	RESPIRATORY-DISTRESS; CELL-PROLIFERATION; GENE; DIFFERENTIATION; EXPRESSION; INFLAMMATION; MATURATION; WHEEZE; ASTHMA; ALTERS	Developmental exposure to bisphenol A (BPA) is associated with lung dysfunction and diseases. However, it is unknown if this association has a fetal origin. The present study addressed this important question by examining the effects of BPA on fetal lung development. BPA was administered to pregnant mice via diet from embryonic day (E) 7.5 to E18.5. Fetal lungs were analyzed at E18.5 for changes in structure and expression of key molecular markers of lung maturation. Our main findings were as follows: BPA severely retards fetal lung maturation, as evidenced by diminished alveolar airspace (15% of control) and thickened septa, hallmarks of lung immaturity; this immaturity is characterized by aberrant alveolar epithelial type I cell differentiation because expression of the type I cell marker, aquaporin 5, but not type II cell markers, is dramatically reduced (16% of control); and the effects of BPA are likely mediated through the glucocorticoid signaling pathway because the expression of epithelial sodium channel gamma and glutathione peroxidase, 2 well-known glucocorticoid target genes, is down-regulated in BPA-exposed fetal lungs, and, importantly, maternal dexamethasone administration rescues the lung immaturity phenotype. Taken together, these findings demonstrate that BPA disrupts fetal lung maturation, thus suggesting a fetal origin for BPA-induced lung diseases.	Univ Western Ontario, Dept Obstet & Gynaecol, Childrens Hlth Res Inst, London, ON, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, Childrens Hlth Res Inst, London, ON, Canada; Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Yang, KP (corresponding author), Childrens Hlth Res Inst, Victoria Res Labs, Room A5-132,800 Commissioners Rd East, Victoria, ON N6C 2V5, Canada.	kyang@uwo.ca			Canadian Institutes of Health Research [MOP-79484]; Children's Health Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Health Foundation	The authors thank F. Beier, D. Hardy, S. Gill, F. Possmayer, and R. Tirona (Western University, London, ON, Canada) for helpful discussions. This work was supported by the Canadian Institutes of Health Research (Operating Grant MOP-79484), and M.C. was the recipient of a postdoctoral fellowship from Children's Health Foundation.	BARLOW SM, 1974, J ENDOCRINOL, V60, P473, DOI 10.1677/joe.0.0600473; Bauer SM, 2012, TOXICOL SCI, V130, P82, DOI 10.1093/toxsci/kfs227; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Calhoun KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085894; Chapalamadugu KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089096; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; Divakaran K, 2014, TOXICOL SCI, V141, P292, DOI 10.1093/toxsci/kfu126; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Elsworth JD, 2013, NEUROTOXICOLOGY, V35, P113, DOI 10.1016/j.neuro.2013.01.001; Erden ES, 2014, EUR REV MED PHARMACO, V18, P3477; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; Grier David G, 2004, Treat Respir Med, V3, P295, DOI 10.2165/00151829-200403050-00004; Im SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058511; IRIS, 2012, 80057 IRIS CASRN; Kim KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111383; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Lee MD, 1997, CHEST, V111, pS111, DOI 10.1378/chest.111.6_Supplement.111S; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Nakajima Y, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-8; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; O'Brien E, 2014, J DEV ORIG HLTH DIS, V5, P121, DOI 10.1017/S204017441400004X; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Pei LM, 2011, NAT MED, V17, P1466, DOI 10.1038/nm.2450; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Roelofs MJE, 2015, TOXICOLOGY, V329, P10, DOI 10.1016/j.tox.2015.01.003; Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Selvaratnam J, 2013, AM J PHYSIOL-ENDOC M, V305, pE727, DOI 10.1152/ajpendo.00157.2013; Spanier AJ, 2014, JAMA PEDIATR, V168, P1131, DOI 10.1001/jamapediatrics.2014.1397; Spanier AJ, 2014, J PEDIATR-US, V164, P1403, DOI 10.1016/j.jpeds.2014.02.026; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Veiga-Lopez A, 2013, ENDOCRINOLOGY, V154, P1873, DOI 10.1210/en.2012-2129; Wadia PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063902; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Yang HH, 2002, DEVELOPMENT, V129, P2233; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	57	24	24	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4968	4977		10.1096/fj.15-270942	http://dx.doi.org/10.1096/fj.15-270942			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26283537				2022-12-28	WOS:000365523600022
J	Ting, PY; Johnson, CW; Fang, C; Cao, XQ; Graeber, TG; Mattos, C; Colicelli, J				Ting, Pamela Y.; Johnson, Christian W.; Fang, Cong; Cao, Xiaoqing; Graeber, Thomas G.; Mattos, Carla; Colicelli, John			Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding	FASEB JOURNAL			English	Article						GTPase; signal transduction; RIN1; RAF1	NUCLEOTIDE EXCHANGE FACTOR; K-RAS; GTPASE ACTIVITY; BCR-ABL; RIN1; PROTEIN; ACTIVATION; PROMOTES; KINASES; SWITCH	RAS proteins are signal transduction gatekeepers that mediate cell growth, survival, and differentiation through interactions with multiple effector proteins. The RAS effector RAS- and RAB-interacting protein 1 (RIN1) activates its own downstream effectors, the small GTPase RAB5 and the tyrosine kinase Abelson tyrosine-protein kinase (ABL), to modulate endocytosis and cytoskeleton remodeling. To identify ABL substrates downstream of RAS-to-RIN1 signaling, we examined human HEK293T cells over-expressing components of this pathway. Proteomic analysis revealed several novel phosphotyrosine peptides, including Harvey rat sarcoma oncogene (HRAS)-pTyr(137). Here we report that ABL phosphorylates tyrosine 137 of H-, K-, and NRAS. Increased RIN1 levels enhanced HRAS-Tyr(137) phosphorylation by nearly 5-fold, suggesting that RAS-stimulated RIN1 can drive ABL-mediated RAS modification in a feedback circuit. Tyr(137) is well conserved among RAS orthologs and is part of a transprotein H-bond network. Crystal structures of HRAS(Y137F) and HRAS(Y137E) revealed conformation changes radiating from the mutated residue. Although consistent with Tyr(137) participation in allosteric control of HRAS function, the mutations did not alter intrinsic GTP hydrolysis rates in vitro. HRAS-Tyr(137) phosphorylation enhanced HRAS signaling capacity in cells, however, as reflected by a 4-fold increase in the association of phosphorylated HRAS(G12V) with its effector protein RAF proto-oncogene serine/threonine protein kinase 1 (RAF1). These data suggest that RAS phosphorylation at Tyr(137) allosterically alters protein conformation and effector binding, providing a mechanism for effector-initiated modulation of RAS signaling.	[Ting, Pamela Y.; Cao, Xiaoqing; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Mol Biol Inst,Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Johnson, Christian W.; Mattos, Carla] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Fang, Cong; Graeber, Thomas G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Metabol & Prote Ctr,Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Fang, Cong; Graeber, Thomas G.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northeastern University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Colicelli, J (corresponding author), Univ Calif Los Angeles, Box 951737,350C BSRB, Los Angeles, CA 90095 USA.	colicelli@mednet.ucla.edu		Johnson, Christian/0000-0002-6521-3803; Graeber, Thomas/0000-0001-8574-9181	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant [CA136699]; Ruth L. Kirschstein National Research Service Award Grant [GM007185]; Whitcome Training Fellowship; U.S. National Science Foundation Grant [MCB-1244203]; NIH NCI Grant [CA168585]; American Cancer Society Research Scholar Award [RSG-12-257-01-TBE]; U.S. National Center for Advancing Translational Sciences Grant [UL1TR000124]; University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA136699, P01CA168585] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1244203] Funding Source: National Science Foundation	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant; Ruth L. Kirschstein National Research Service Award Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Training Fellowship; U.S. National Science Foundation Grant(National Science Foundation (NSF)); NIH NCI Grant; American Cancer Society Research Scholar Award(American Cancer Society); U.S. National Center for Advancing Translational Sciences Grant; University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Drs. James Wohlschlegel and Ajay Vashisht for helpful discussions and insight into RAS binding partners, Dr. Greg Buhrman for initial guidance in performing the hydrolysis rates experiments, and Dr. Paul Swartz for help with data collection for the RAS<SUP>Y137E</SUP> mutant. The authors also thank the following colleagues for generously sharing key reagents: Dr. Shawn Li (pDEST15 RASA1-C SH2), Dr. John Kuriyan (pProExHT-HRAS), and Dr. Frank McCormick [pGEX-KG-RafRBD(1-149)]. This work was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant CA136699 (to J.C.); the Ruth L. Kirschstein National Research Service Award Grant GM007185 (to P.T.); the Whitcome Training Fellowship (to P.T.); the U.S. National Science Foundation Grant MCB-1244203 (to C.M.); NIH NCI Grant CA168585 (to T.G.G.); American Cancer Society Research Scholar Award RSG-12-257-01-TBE (to T.G.G.); U.S. National Center for Advancing Translational Sciences Grant UL1TR000124 (to T.G.G.), and University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center for support of the Molecular Screening Shared Resource. The coordinates and structure factors for the X-ray crystal structures have been deposited in the PDB with the following codes: HRAS<SUP>Y137E</SUP>-GppNHp, PDB code 4XVQ; and HRAS<SUP>Y137F</SUP>-GppNHp, PDB code 4XVR.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Balaji Kavitha, 2013, Commun Integr Biol, V6, pe25421, DOI 10.4161/cib.25421; Balaji K, 2012, J CELL SCI, V125, P5887, DOI 10.1242/jcs.113688; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Buhrman G, 2003, STRUCTURE, V11, P747, DOI 10.1016/S0969-2126(03)00128-X; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Bunda S, 2014, P NATL ACAD SCI USA, V111, pE3785, DOI 10.1073/pnas.1406559111; BUSS JE, 1986, MOL CELL BIOL, V6, P116, DOI 10.1128/MCB.6.1.116; Cao XQ, 2008, J BIOL CHEM, V283, P31401, DOI 10.1074/jbc.M804002200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Dhaka A, 2003, J NEUROSCI, V23, P748; Dzudzor B, 2010, MOL CELL NEUROSCI, V43, P108, DOI 10.1016/j.mcn.2009.09.012; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang P, 2012, TUMOR BIOL, V33, P1511, DOI 10.1007/s13277-012-0402-7; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hu HL, 2008, MOL CELL BIOL, V28, P1573, DOI 10.1128/MCB.01087-07; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Johnson CW, 2013, ENZYMES, V33, P41, DOI 10.1016/B978-0-12-416749-0.00003-8; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kearney BN, 2014, J MOL BIOL, V426, P611, DOI 10.1016/j.jmb.2013.10.036; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Lock P, 1999, J BIOL CHEM, V274, P22775, DOI 10.1074/jbc.274.32.22775; NEAL SE, 1988, J BIOL CHEM, V263, P19718; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash A, 2006, MOL CELL PROTEOMICS, V5, P423, DOI 10.1074/mcp.M500133-MCP200; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Shan GY, 2012, TUMOR BIOL, V33, P847, DOI 10.1007/s13277-011-0311-1; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Thai M, 2011, LEUKEMIA, V25, P290, DOI 10.1038/leu.2010.268; Tomshine JC, 2009, J BIOL CHEM, V284, P26331, DOI 10.1074/jbc.M109.033514; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Wang Q, 2012, ACTA HISTOCHEM, V114, P463, DOI 10.1016/j.acthis.2011.08.008; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Wang Y, 2001, METHOD ENZYMOL, V332, P139; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yu HF, 2012, TUMOR BIOL, V33, P1557, DOI 10.1007/s13277-012-0409-0; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	61	25	26	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3750	3761		10.1096/fj.15-271510	http://dx.doi.org/10.1096/fj.15-271510			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25999467	Green Published			2022-12-28	WOS:000359915600013
J	Gardebjer, EM; Anderson, ST; Pantaleon, M; Wlodek, ME; Moritz, KM				Gardebjer, Emelie M.; Anderson, Stephen T.; Pantaleon, Marie; Wlodek, Mary E.; Moritz, Karen M.			Maternal alcohol intake around the time of conception causes glucose intolerance and insulin insensitivity in rat offspring, which is exacerbated by a postnatal high-fat diet	FASEB JOURNAL			English	Article						developmental programming; metabolic pathways; diabetes; gluconeogenesis; gene expression	GROWTH RESTRICTION; SKELETAL-MUSCLE; IN-UTERO; FETAL; RESISTANCE; PREGNANCY; EXPOSURE; METHYLATION; DISEASE; ETHANOL	Alcohol consumption throughout pregnancy can cause metabolic dysregulation, including glucose intolerance in progeny. This study determined if periconceptional (PC) alcohol (12% v/v in a liquid diet) (PC:EtOH) consumed exclusively around conception results in similar outcomes in Sprague-Dawley rats. Control (C) rats were given a liquid diet containing no alcohol but matched to ensure equal caloric intake. PC maternal alcohol intake (from 4 days before conception until day 4 of gestation), resulted in offspring with elevated fasting plasma glucose (similar to 10-25%, P < 0.05), impaired glucose tolerance (P < 0.05), and decreased insulin sensitivity (P < 0.01) at 6 months of age. This was associated with increased hepatic gluconeogenesis and sex-specific alterations in peripheral protein kinase B (AKT) signaling. These changes were accompanied by increased mRNA expression of DNA methyltransferases (DNMTs) 1, 3a, and 3b (1.5- to 1.9-fold, P < 0.05) in fetal liver in late gestation, suggesting PC: EtOH may cause epigenetic changes that predispose offspring to metabolic dysfunction. Exposure to a postnatal (PN) high-fat and cholesterol diet (HFD) from 3 months of age caused hyperinsulinemia (similar to 2-fold increase, P < 0.001) and exacerbated the metabolic dysfunction in male offspring exposed to PC:EtOH but had no additive effects in females. Given many women may drink alcohol while planning a pregnancy, it is crucial to increase public awareness regarding the effects of alcohol consumption around conception on offspring health.	[Gardebjer, Emelie M.; Anderson, Stephen T.; Pantaleon, Marie; Moritz, Karen M.] Univ Queensland, Biomed Sci, St Lucia, Qld 4072, Australia; [Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia	University of Queensland; University of Melbourne	Moritz, KM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	k.moritz@uq.edu.au	wlodek, Mary/A-8939-2019; Anderson, Stephen T/F-5281-2013; Moritz, Karen/G-2508-2015	wlodek, Mary/0000-0002-8490-9099; Anderson, Stephen T/0000-0002-1176-4394; Moritz, Karen/0000-0002-8085-0034	National Health and Medical Research Council of Australia [1046137]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the funding provided by the National Health and Medical Research Council of Australia (1046137), and thank Kerri Tyrell, School of Biomedical Sciences, The University of Queensland, for expert assistance with the insulin assay.	ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; CARO JF, 1995, HORM METAB RES, V27, P19, DOI 10.1055/s-2007-979899; Chen L, 2004, J APPL PHYSIOL, V96, P167, DOI 10.1152/japplphysiol.00751.2003; Chen L, 2003, METABOLISM, V52, P454, DOI 10.1053/meta.2003.50073; Chen L, 2003, ENDOCRINOLOGY, V144, P500, DOI 10.1210/en.2002-220623; Colvin L, 2007, ALCOHOL CLIN EXP RES, V31, P276, DOI 10.1111/j.1530-0277.2006.00303.x; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Desai M, 1997, AM J PHYSIOL-GASTR L, V272, pG1083, DOI 10.1152/ajpgi.1997.272.5.G1083; Devaskar SU, 2007, REV ENDOCR METAB DIS, V8, P105, DOI 10.1007/s11154-007-9050-4; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; DUNCAN MH, 1995, LANCET, V346, P120, DOI 10.1016/S0140-6736(95)92143-5; Gardebjer EM, 2014, PLACENTA, V35, P50, DOI 10.1016/j.placenta.2013.10.008; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Haycock PC, 2009, BIOL REPROD, V81, P618, DOI 10.1095/biolreprod.108.074682; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Kafer GR, 2011, CELL REPROGRAM, V13, P391, DOI 10.1089/cell.2011.0011; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Lie S, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.109751; LOPEZTEJERO D, 1989, ALCOHOL, V6, P469, DOI 10.1016/0741-8329(89)90054-2; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Naimi TS, 2003, PEDIATRICS, V111, P1136; Peadon E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-584; Perkins A, 2013, INT J DEV NEUROSCI, V31, P391, DOI 10.1016/j.ijdevneu.2013.03.010; Probyn ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059718; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; Shelley P, 2009, AM J PHYSIOL-REG I, V297, pR675, DOI 10.1152/ajpregu.00146.2009; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Siebel AL, 2008, ENDOCRINOLOGY, V149, P3067, DOI 10.1210/en.2008-0128; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; WOLEVER TMS, 1986, AM J CLIN NUTR, V43, P167, DOI 10.1093/ajcn/43.1.167; Yao XH, 2006, J APPL PHYSIOL, V100, P642, DOI 10.1152/japplphysiol.01115.2005; Yao XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059680; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	48	47	48	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2690	2701		10.1096/fj.14-268979	http://dx.doi.org/10.1096/fj.14-268979			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25733565				2022-12-28	WOS:000356859100002
J	Hussaarts, L; Garcia-Tardon, N; van Beek, L; Heemskerk, MM; Haeberlein, S; van der Zon, GC; Ozir-Fazalalikhan, A; Berbee, JFP; van Dijk, KW; van Harmelen, V; Yazdanbakhsh, M; Guigas, B				Hussaarts, Leonie; Garcia-Tardon, Noemi; van Beek, Lianne; Heemskerk, Mattijs M.; Haeberlein, Simone; van der Zon, Gerard C.; Ozir-Fazalalikhan, Arifa; Berbee, Jimmy F. P.; van Dijk, Ko Willems; van Harmelen, Vanessa; Yazdanbakhsh, Maria; Guigas, Bruno			Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice	FASEB JOURNAL			English	Article						immunometabolism; eosinophils; type 2 inflammation; Schistosoma mansoni	TUMOR-NECROSIS-FACTOR; T-CELLS; INFLAMMATION; FAT; RESISTANCE; EOSINOPHILS; RECRUITMENT; MODULATION; ADIPOCYTES; INHIBITION	Chronic low-grade inflammation associated with obesity contributes to insulin resistance and type 2 diabetes. Helminth parasites are the strongest natural inducers of type 2 immune responses, and short-lived infection with rodent nematodes was reported to improve glucose tolerance in obesemice. Here, we investigated the effects of chronic infection (12 weeks) with Schistosoma mansoni, a helminth that infects millions of humans worldwide, on whole-body metabolic homeostasis and white adipose tissue (WAT) immune cell composition in high-fat diet-induced obeseC57BL/6male mice. Our data indicate that chronic helminth infection reduced body weight gain (-62%), fat mass gain (-89%), and adipocyte size; lowered whole-body insulin resistance (-23%) and glucose intolerance (-16%); and improved peripheral glucose uptake (+25%) andWATinsulin sensitivity. Analysis of immune cell composition by flow cytometry and quantitative PCR (qPCR) revealed that S. mansoni promoted strong increases in WAT eosinophils and alternatively activated (M2) macrophages. Importantly, injections with S. mansoni-soluble egg antigens (SEA) recapitulated the beneficial effect of parasite infection on whole-body metabolic homeostasis and induced type 2 immune responses inWAT and liver. Taken together, we provide novel data suggesting that chronic helminth infection and helminth-derived molecules protect against metabolic disorders by promoting a T helper 2 (Th2) response, eosinophilia, and WAT M2 polarization.	[Hussaarts, Leonie; Garcia-Tardon, Noemi; Haeberlein, Simone; Ozir-Fazalalikhan, Arifa; Yazdanbakhsh, Maria; Guigas, Bruno] Leiden Univ, Med Ctr, Dept Parasitol, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [van Beek, Lianne; Heemskerk, Mattijs M.; van Dijk, Ko Willems; van Harmelen, Vanessa] Leiden Univ, Med Ctr, Dept Human Genet, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [van der Zon, Gerard C.; Guigas, Bruno] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Guigas, B (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, POB 9600,Postal Zone L4-Q, NL-2300 RC Leiden, Netherlands.	b.g.a.guigas@lumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Haeberlein, Simone/AAM-2685-2020; Ozir-Fazalalikhan, A/V-5436-2018; Guigas, Bruno/M-2515-2015; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021	Yazdanbakhsh, Maria/0000-0002-7666-1441; Ozir-Fazalalikhan, A/0000-0002-0613-8372; Guigas, Bruno/0000-0002-8856-5799; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van Harmelen, Vanessa/0000-0003-0111-9858	European Federation for the Study of Diabetes; EFSD/Lilly Research Grant; Scientific Programme Indonesia-Netherlands-The Royal Netherlands Academy of Sciences [KNAW-57-SPIN3-JRP]; EU [HEALTH-F3-2009-241642]; Dutch Organization for Scientific Research [91214131]; Leiden University Medical Center	European Federation for the Study of Diabetes; EFSD/Lilly Research Grant; Scientific Programme Indonesia-Netherlands-The Royal Netherlands Academy of Sciences; EU(European Commission); Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Leiden University Medical Center	The authors thank Bart Everts (Leiden University Medical Center, Leiden, The Netherlands) for critically reading the manuscript. This work was supported by an EFSD/Lilly Research Grant Fellowship from the European Federation for the Study of Diabetes (to B.G.), a Scientific Programme Indonesia-Netherlands-The Royal Netherlands Academy of Sciences Grant (SPIN-KNAW; KNAW-57-SPIN3-JRP; to M.Y. and B.G.), the EU-funded project IDEA (HEALTH-F3-2009-241642; to M.Y.), a ZonMW TOP Grant from the Dutch Organization for Scientific Research (91214131; to M.Y. and B.G.), and a grant from the Board of Directors of the Leiden University Medical Center (to V.V.H.).	Ackermans MT, 2001, J CLIN ENDOCR METAB, V86, P2220, DOI 10.1210/jc.86.5.2220; Aravindhan V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000707; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen YH, 2013, J CLIN ENDOCR METAB, V98, pE283, DOI 10.1210/jc.2012-2517; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-0298; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hussaarts L, 2011, J ALLERGY CLIN IMMUN, V128, P733, DOI 10.1016/j.jaci.2011.05.012; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Morinaga H., 2014, DIABETES; Movita D, 2012, J LEUKOCYTE BIOL, V92, P723, DOI 10.1189/jlb.1111566; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Okano M, 1999, J IMMUNOL, V163, P6712; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; van den Berg SAA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-24; Wammes LJ, 2014, LANCET INFECT DIS, V14, P1150, DOI 10.1016/S1473-3099(14)70771-6; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wiria AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004140; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; World Health Organization, 2013, SCHIST; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13	52	126	130	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3027	3039		10.1096/fj.14-266239	http://dx.doi.org/10.1096/fj.14-266239			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25852044				2022-12-28	WOS:000356859100030
J	Montealegre, S; Venugopalan, V; Fritzsche, S; Kulicke, C; Hein, Z; Springer, S				Montealegre, Sebastian; Venugopalan, Vaishnavi; Fritzsche, Susanne; Kulicke, Corinna; Hein, Zeynep; Springer, Sebastian			Dissociation of beta 2-microglobulin determines the surface quality control of major histocompatibility complex class I molecules	FASEB JOURNAL			English	Article						endocytosis; receptor recycling; Brefeldin A; peptide	HEAVY-CHAINS; MHC MOLECULES; CELL-SURFACE; MONOCLONAL-ANTIBODIES; CONSTITUTIVE ENDOCYTOSIS; BREFELDIN-A; PEPTIDE; ANTIGEN; HLA; ASSOCIATION	Major histocompatibility complex class I proteins, which present antigenic peptides to cytotoxic T lymphocytes at the surface of all nucleated cells, are endocytosed and destroyed rapidly once their peptide ligand has dissociated. The molecular mechanism of this cellular quality control process, which prevents rebinding of exogenous peptides andthus erroneous immuneresponses, is unknown. To identify the nature of the decisive step in endocytic sorting of class I molecules and its location, we have followed the removal of optimally and suboptimally peptide-loaded murine H-2K(b) class I proteins from the cell surface. We find that the binding of their light chain, beta(2)-microglobulin (beta(2)m), protects them from endocytic destruction. Thus, the extended survival of suboptimally loaded K-b molecules at 25 degrees C is attributed to decreased dissociation of beta(2)m. Because all forms of K-b are constantly internalized but little beta(2)m-receptive heavy chain is present at the cell surface, it is likely that beta(2)m dissociation and recognition of the heavy chain for lysosomal degradation take place inanendocytic compartment.	[Montealegre, Sebastian; Venugopalan, Vaishnavi; Fritzsche, Susanne; Kulicke, Corinna; Hein, Zeynep; Springer, Sebastian] Jacobs Univ Bremen, Dept Life Sci & Chem, D-28759 Bremen, Germany	Jacobs University	Hein, Z (corresponding author), Jacobs Univ Bremen, Dept Life Sci & Chem, Campus Ring, D-28759 Bremen, Germany.	hein@jacobs-university.de; sebastian.springer@queens.oxon.org	Springer, Sebastian/AAJ-7036-2021	Springer, Sebastian/0000-0002-5527-6149; Venugopalan, Vaishnavi/0000-0001-6772-6787	Deutsche Forschungsgemeinschaft [SP583/2-3, 7-1]; German Academic Exchange Service; Thyssen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Thyssen Foundation	The authors thank Ursula Wellbrock for excellent technical assistance; Henri de la Salle for cells; and Linda Janssen, Venkat Raman Ramnarayan, and Malgorzata Garstka for discussions. The work was supported by the Deutsche Forschungsgemeinschaft (SP583/2-3 and 7-1 to S.S.), the German Academic Exchange Service (to S.M.), and the Thyssen Foundation (to Z.H.).	ANDERSON KS, 1993, J IMMUNOL, V151, P3407; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Boulanger DSM, 2010, J IMMUNOL, V184, P73, DOI 10.4049/jimmunol.0803489; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; DAY PM, 1995, IMMUNITY, V2, P137, DOI 10.1016/S1074-7613(95)80014-X; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; Edidin M, 1997, IMMUNOGENETICS, V46, P41, DOI 10.1007/s002510050240; Fritzsche S, 2013, MOL IMMUNOL, V55, P126, DOI 10.1016/j.molimm.2012.11.001; Gakamsky DM, 1999, BIOCHEMISTRY-US, V38, P12165, DOI 10.1021/bi9905821; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; Hein Z, 2014, J CELL SCI, V127, P2885, DOI 10.1242/jcs.145334; HOCHMAN JH, 1991, J IMMUNOL, V146, P1862; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; KUBOTA K, 1984, J IMMUNOL, V133, P3203; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LJUNGGREN HG, 1989, J IMMUNOL, V142, P2911; Machold RP, 1996, J EXP MED, V184, P2251, DOI 10.1084/jem.184.6.2251; MADRIGAL JA, 1991, J EXP MED, V174, P1085, DOI 10.1084/jem.174.5.1085; Mahmutefendic H, 2002, AM J REPROD IMMUNOL, V48, P87, DOI 10.1034/j.1600-0897.2002.01134.x; Mahmutefendic H, 2013, MOL IMMUNOL, V55, P149, DOI 10.1016/j.molimm.2012.10.008; Mahmutefendic H, 2011, INT J BIOCHEM CELL B, V43, P504, DOI 10.1016/j.biocel.2010.12.002; MATKO J, 1994, J IMMUNOL, V152, P3353; Merzougui N, 2011, EMBO REP, V12, P1257, DOI 10.1038/embor.2011.203; MOTAL UMA, 1993, EUR J IMMUNOL, V23, P3224, DOI 10.1002/eji.1830231227; MOTAL UMA, 1993, SCAND J IMMUNOL, V38, P395, DOI 10.1111/j.1365-3083.1993.tb01743.x; MYERS NB, 1989, J IMMUNOL, V142, P2751; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; ORTIZNAVARRETE V, 1991, P NATL ACAD SCI USA, V88, P3594, DOI 10.1073/pnas.88.9.3594; OTTEN GR, 1992, J IMMUNOL, V148, P3723; PARKER KC, 1992, J IMMUNOL, V149, P1896; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; ROCK KL, 1991, CELL, V65, P611, DOI 10.1016/0092-8674(91)90093-E; Saini SK, 2013, MOL IMMUNOL, V54, P386, DOI 10.1016/j.molimm.2013.01.004; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Shields MJ, 1999, MOL IMMUNOL, V36, P561, DOI 10.1016/S0161-5890(99)00077-2; STAM NJ, 1986, J IMMUNOL, V137, P2299; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; Tuli A, 2009, J BIOL CHEM, V284, P34296, DOI 10.1074/jbc.M109.039727; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; Zagorac GB, 2012, J CELL PHYSIOL, V227, P2953, DOI 10.1002/jcp.23042	58	17	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2780	2788		10.1096/fj.14-268094	http://dx.doi.org/10.1096/fj.14-268094			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782992				2022-12-28	WOS:000356859100010
J	Han, ZC; Banworth, MJ; Makkia, R; Conley, SM; Al-Ubaidi, MR; Cooper, MJ; Naash, MI				Han, Zongchao; Banworth, Marcellus J.; Makkia, Rasha; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Cooper, Mark J.; Naash, Muna I.			Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype	FASEB JOURNAL			English	Article						gene therapy; retinal gene therapy; cDNA; vector engineering	RECOMBINANT ADENOASSOCIATED VIRUS; GENE-TRANSFER; IN-VIVO; MESSENGER-RNA; RETINAL FUNCTION; KNOCKOUT MICE; MOUSE MODEL; EXPRESSION; THERAPY; REPLACEMENT	Mutations in the rhodopsin gene cause retinal degeneration and clinical phenotypes including retinitis pigmentosa (RP) and congenital stationary night blindness. Effective gene therapies have been difficult to develop, however, because generating precise levels of rhodopsin expression is critical; overexpression causes toxicity, and underexpression would result in incomplete rescue. Current gene delivery strategies routinely use cDNA-based vectors for gene targeting; however, inclusion of noncoding components of genomic DNA (gDNA) such as introns may help promote more endogenous regulation of gene expression. Here we test the hypothesis that inclusion of genomic sequences from the rhodopsin gene can improve the efficacy of rhodopsin gene therapy in the rhodopsin knockout (RKO) mouse model of RP. We utilize our compacted DNA nanoparticles (NPs), which have the ability to transfer larger and more complex genetic constructs, to deliver murine rhodopsin cDNA or gDNA. We show functional and structural improvements in RKO eyes for up to 8 months after NP-mediated gDNA but not cDNA delivery. Importantly, in addition to improvements in rod function, we observe significant preservation of cone function at time points when cones in the RKO model are degenerated. These results suggest that inclusion of native expression elements, such as introns, can significantly enhance gene expression and therapeutic efficacy and may become an essential option in the array of available gene delivery tools.	[Han, Zongchao; Banworth, Marcellus J.; Makkia, Rasha; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Cooper, Mark J.] Copernicus Therapeut Inc, Cleveland, OH USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Han, ZC (corresponding author), Univ N Carolina, Dept Ophthalmol, 125 Mason Farm Rd,2208 Marsico Hall,CB 7362, Chapel Hill, NC 27599 USA.	zongchao@med.unc.edu			U.S. National Institutes of Health National Eye Institute [R21EY024059, EY018656, EY22778, EY018137]; Oklahoma Center for the Advancement of Science and Technology; Knights Templar Eye Foundation; Carolina Center of Cancer Nanotechnology Excellence; North Carolina Translational and Clinical Sciences; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022778, R01EY018137, R21EY024059, R01EY018656] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; Knights Templar Eye Foundation; Carolina Center of Cancer Nanotechnology Excellence; North Carolina Translational and Clinical Sciences; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Miles Merwin and Junjing Guo (both at the University of Oklahoma Health Sciences Center) for their technical assistance. This work was supported by the U.S. National Institutes of Health National Eye Institute (R21EY024059-ZH, EY018656-MIN and EY22778-MIN, EY018137-MRA), the Oklahoma Center for the Advancement of Science and Technology (Z.H., M.I.N., S.M.C.), the Knights Templar Eye Foundation (Z.H., S.M.C.), the Carolina Center of Cancer Nanotechnology Excellence and the North Carolina Translational and Clinical Sciences (Z.H.), and the Research to Prevent Blindness to the University of North Carolina Department Of Ophthalmology. M.J.C. is an employee of Copernicus Therapeutics and holds stock in the company. The remaining authors declare no conflicts of interest.	ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; AMY CM, 1992, P NATL ACAD SCI USA, V89, P1105, DOI 10.1073/pnas.89.3.1105; Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; Chadderton N, 2009, MOL THER, V17, P593, DOI 10.1038/mt.2008.301; Ding XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007410; FARABAUGH PJ, 1993, CELL, V74, P591, DOI 10.1016/0092-8674(93)90507-M; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; GRUSS P, 1979, P NATL ACAD SCI USA, V76, P4317, DOI 10.1073/pnas.76.9.4317; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Han ZC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052189; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Han ZC, 2012, NANOMEDICINE-UK, V7, P521, DOI [10.2217/NNM.11.158, 10.2217/nnm.11.158]; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Jackson DA, 2006, MOL THER, V14, P613, DOI 10.1016/j.ymthe.2006.03.026; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Koirala A, 2013, J CONTROL RELEASE, V172, P745, DOI 10.1016/j.jconrel.2013.08.299; Koirala A, 2013, HUM MOL GENET, V22, P1632, DOI 10.1093/hmg/ddt013; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Millington-Ward S, 2011, MOL THER, V19, P642, DOI 10.1038/mt.2010.293; Nicoud M, 2007, J GENE MED, V9, P1015, DOI 10.1002/jgm.1115; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; O'Reilly M, 2007, AM J HUM GENET, V81, P127, DOI 10.1086/519025; Palfi A, 2010, HUM GENE THER, V21, P311, DOI 10.1089/hum.2009.119; Piechaczek C, 1999, NUCLEIC ACIDS RES, V27, P426, DOI 10.1093/nar/27.2.426; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Smith AJ, 2009, TRENDS GENET, V25, P156, DOI 10.1016/j.tig.2009.02.003; Stehle IM, 2003, CHROMOSOME RES, V11, P413, DOI 10.1023/A:1024962308071; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Yurek DM, 2009, CELL TRANSPLANT, V18, P1183, DOI 10.3727/096368909X12483162196881; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007	43	34	35	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2535	2544		10.1096/fj.15-270363	http://dx.doi.org/10.1096/fj.15-270363			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713057	Green Published, Bronze			2022-12-28	WOS:000355209500030
J	Hibino, N; Mejias, D; Pietris, N; Dean, E; Yi, T; Best, C; Shinoka, T; Breuer, C				Hibino, Narutoshi; Mejias, Dane; Pietris, Nicholas; Dean, Ethan; Yi, Tai; Best, Cameron; Shinoka, Toshiharu; Breuer, Christopher			The innate immune system contributes to tissue-engineered vascular graft performance	FASEB JOURNAL			English	Article						macrophage; NK cell; platelet; stenosis	MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTIMAL HYPERPLASIA; ARTERIAL INJURY; NEOINTIMAL HYPERPLASIA; BALLOON INJURY; DEFICIENT MICE; BONE-MARROW; P-SELECTIN; MACROPHAGE; AUTOGRAFTS	The first clinical trial of tissue-engineered vascular grafts (TEVGs) identified stenosis as the primary cause of graft failure. In this study, we aimed to elucidate the role of the host immune response in the development of stenosis using a murine model of TEVG implantation. We found that the C.B-17 wild-type (WT) mouse (control) undergoes a dramatic stenotic response, which is nearly completely abolished in the immunodeficient SCID/beige (bg) variant. SCID mice, which lack an adaptive immune system due to the absence of T and B lymphocytes, experienced rates of stenosis comparable to WT controls (average luminal diameter, WT: 0.071 +/- 0.035 mm, SCID: 0.137 +/- 0.032 mm, SCID/bg: 0.804 +/- 0.039 mm; P < 0.001). The bg mutation is characterized by NK cell and platelet dysfunction, and systemic treatment of WT mice with either NK cell-neutralizing (anti-NK 1.1 antibody) or antiplatelet (aspirin/Plavix [clopidogrel bisulfate]; Asp/Pla) therapy achieved nearly half the patency observed in the SCID/bg mouse (NK Ab: 0.356 +/- 0.151 mm, Asp/Pla: 0.452 +/- 0.130 mm). Scaffold implantation elicited a blunted immune response in SCID/bg mice, as demonstrated by macrophage number and mRNA expression of proinflammatory cytokines in TEVG explants. Implicating the initial innate immune response as a critical factor in graft stenosis may provide a strategy for prognosis and therapy of second-generation TEVGs.	[Hibino, Narutoshi; Mejias, Dane; Pietris, Nicholas; Dean, Ethan] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT USA; [Yi, Tai; Best, Cameron; Shinoka, Toshiharu; Breuer, Christopher] Nationwide Childrens Hosp, Tissue Engn Program, Columbus, OH USA	Yale University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Breuer, C (corresponding author), 700 Childrens Dr,WB4151, Columbus, OH 43205 USA.	christopher.breuer@nationwidechildrens.org		Breuer, Christopher/0000-0003-0987-3898	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant [R01HL0988228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098228] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant R01HL0988228.	Andersen HO, 1999, ARTERIOSCL THROM VAS, V19, P1687, DOI 10.1161/01.ATV.19.7.1687; Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Barron MK, 1997, CIRCULATION, V96, P3587; de Vries MR, 2013, J MOL CELL CARDIOL, V64, P51, DOI 10.1016/j.yjmcc.2013.08.009; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; FERNS GAA, 1991, AM J PATHOL, V138, P1045; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; GALLIN JI, 1974, BLOOD, V43, P201, DOI 10.1182/blood.V43.2.201.201; Gaspardone A, 1998, AM J CARDIOL, V82, P515, DOI 10.1016/S0002-9149(98)00370-1; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030; Hibino N., 2010, J THORAC CARDIOVASC, V139, pe1; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; HOLLAND JM, 1976, P SOC EXP BIOL MED, V151, P32; IMAM SH, 1992, CURR MICROBIOL, V25, P1, DOI 10.1007/BF01570075; Manka D, 2001, CIRCULATION, V103, P1000; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7; Mori E, 2002, CIRCULATION, V105, P2905, DOI 10.1161/01.CIR.0000018603.67989.71; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nieponice A, 2010, TISSUE ENG PT A, V16, P1215, DOI [10.1089/ten.tea.2009.0427, 10.1089/ten.TEA.2009.0427]; NOVAK EK, 1984, BLOOD, V63, P536; RODER JC, 1979, J IMMUNOL, V123, P2168; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Roque M, 2002, ARTERIOSCL THROM VAS, V22, P554, DOI 10.1161/hq0402.105720; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0; Smyth SS, 2001, CIRCULATION, V103, P2501; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B	35	46	46	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2431	2438		10.1096/fj.14-268334	http://dx.doi.org/10.1096/fj.14-268334			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25713026	Green Published			2022-12-28	WOS:000355209500020
J	Reed, DM; Paschalaki, KE; Starke, RD; Mohamed, NA; Sharp, G; Fox, B; Eastwood, D; Bristow, A; Ball, C; Vessillier, S; Hansel, TT; Thorpe, SJ; Randi, AM; Stebbings, R; Mitchell, JA				Reed, Daniel M.; Paschalaki, Koralia E.; Starke, Richard D.; Mohamed, Nura A.; Sharp, Giles; Fox, Bernard; Eastwood, David; Bristow, Adrian; Ball, Christina; Vessillier, Sandrine; Hansel, Trevor T.; Thorpe, Susan J.; Randi, Anna M.; Stebbings, Richard; Mitchell, Jane A.			An autologous endothelial cell: peripheral blood mononuclear cell assay that detects cytokine storm responses to biologics	FASEB JOURNAL			English	Article						stem cells; TGN1412; coculture; personalized medicine	MONOCLONAL-ANTIBODY TGN1412; IN-VITRO; RELEASE SYNDROME; PROGENITOR CELLS; TRIAL; THERAPY; DISEASE; RISK; VIVO	There is an urgent unmet need for human tissue bioassays to predict cytokine storm responses to biologics. Current bioassays that detect cytokine storm responses in vitro rely on endothelial cells, usually from umbilical veins or cell lines, cocultured with freshly isolated peripheral blood mononuclear cells (PBMCs) from healthy adult volunteers. These assays therefore comprise cells from 2 separate donors and carry the disadvantage of mismatched tissues and lack the advantage of personalized medicine. Current assays also do not fully delineate mild (such as Campath) and severe (such as TGN1412) cytokine storm-inducing drugs. Here, we report a novel bioassay where endothelial cells grown from stem cells in the peripheral blood (blood outgrowth endothelial cells) and PBMCs from the same donor can be used to create an autologous coculture bioassay that responds by releasing a plethora of cytokines to authentic TGN1412 but only modestly to Campath and not to control antibodies such as Herceptin, Avastin, and Arzerra. This assay performed better than the traditional mixed donor assay in terms of cytokine release to TGN1412 and, thus, we suggest provides significant advancement and a definitive system by which biologics can be tested and paves the way for personalized medicine.	[Reed, Daniel M.; Mohamed, Nura A.; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Hammersmith Hosp, Dept Cardiothorac Pharmacol,Vasc Biol Sect, London SW3 6LY, England; [Paschalaki, Koralia E.; Starke, Richard D.; Randi, Anna M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Hammersmith Hosp, Vasc Sci, London SW3 6LY, England; [Mohamed, Nura A.] Qatar Fdn Res & Dev Div, Doha, Qatar; [Sharp, Giles; Fox, Bernard; Eastwood, David; Bristow, Adrian; Ball, Christina; Vessillier, Sandrine; Thorpe, Susan J.] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Hansel, Trevor T.] St Marys Hosp, Imperial Clin Resp Res Unit, London, England; [Stebbings, Richard] Medimmune, Cambridge, England	Imperial College London; Imperial College London; National Institute for Biological Standards & Control; Imperial College London; AstraZeneca; Medimmune	Mitchell, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inst Cardiovasc Med Sci, Vasc Biol, Dovehouse St, London SW3 6LY, England.	j.a.mitchell@imperial.ac.uk	Mohamed, Nura/AAR-5025-2020; Stebbings, Richard/E-2117-2013; Paschalaki, Koralia/B-4465-2018; Vessillier, Sandrine/E-2502-2013	Stebbings, Richard/0000-0001-9628-2708; Fox, Bernard/0000-0001-6362-5196; Paschalaki, Koralia/0000-0002-4114-6140; Vessillier, Sandrine/0000-0002-9697-1834	Medical Research Council; Wellcome Trust Programme Grant [0852551Z108/Z]; Roche Limited (West Sussex, United Kingdom); MRC [G0600868] Funding Source: UKRI; British Heart Foundation [FS/10/47/28393] Funding Source: researchfish; Medical Research Council [G0600868] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); Roche Limited (West Sussex, United Kingdom); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge Drs. Graham Clarke and Margaret Rainer (Quintiles Drug Research Unit, London, United Kingdom) for helpful discussions. The authors also acknowledge Ms. Stefania Mataragka, Ms. Hime Gashaw, and Mr. Neil Galloway-Phillips for technical support. The authors thank the staff and patients at the Maternity Unit at the Royal Oldham Hospital (Oldham, United Kingdom) for donating umbilical cords, and donors of blood for blood outgrowth endothelial cell and peripheral blood mononuclear cell preparations. This work was funded by the Medical Research Council and a Wellcome Trust Programme Grant (0852551Z108/Z to J.A.M.). D.M.R. and J.A.M. are associated with the following patent filed in Europe: WO2014147216. J.A.M. has previously received consultancy fees from Roche Limited (West Sussex, United Kingdom).	Bailey L, 2013, J PHARMACOL TOX MET, V68, P231, DOI 10.1016/j.vascn.2012.12.003; Ball C, 2012, J IMMUNOL, V189, P5831, DOI 10.4049/jimmunol.1201795; Chung CH, 2008, ONCOLOGIST, V13, P725, DOI 10.1634/theoncologist.2008-0012; Czuczman MS, 2012, BLOOD, V119, P3698, DOI 10.1182/blood-2011-09-378323; Eastwood D, 2013, BRIT J CLIN PHARMACO, V76, P299, DOI 10.1111/bcp.12165; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; Findlay L, 2011, J IMMUNOL METHODS, V371, P134, DOI 10.1016/j.jim.2011.06.022; Findlay L, 2011, CYTOKINE, V55, P141, DOI 10.1016/j.cyto.2011.03.019; Findlay L, 2010, J IMMUNOL METHODS, V352, P1, DOI 10.1016/j.jim.2009.10.013; HUANG EH, 1994, TRANSPLANTATION, V57, P703, DOI 10.1097/00007890-199403150-00012; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Reed DM, 2014, BIOCHEM BIOPH RES CO, V455, P172, DOI 10.1016/j.bbrc.2014.10.140; Reed DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091119; Starke RD, 2013, BLOOD, V121, P2773, DOI 10.1182/blood-2012-06-435727; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Stebbings R, 2013, J IMMUNOTOXICOL, V10, P75, DOI 10.3109/1547691X.2012.711783; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Thill M, 2008, INVEST OPHTH VIS SCI, V49, P2696, DOI 10.1167/iovs.07-0955; Thorpe SJ, 2013, CYTOKINE, V64, P471, DOI 10.1016/j.cyto.2013.07.009; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; Wing MG, 1996, J CLIN INVEST, V98, P2819, DOI 10.1172/JCI119110; Wolf B, 2012, CYTOKINE, V60, P828, DOI 10.1016/j.cyto.2012.08.018	25	19	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2595	2602		10.1096/fj.14-268144	http://dx.doi.org/10.1096/fj.14-268144			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25746794				2022-12-28	WOS:000355209500035
J	Gu, HM; Fisher, AJ; Mickler, EA; Duerson, F; Cummings, OW; Peters-Golden, M; Twigg, HL; Woodruff, TM; Wilkes, DS; Vittal, R				Gu, Hongmei; Fisher, Amanda J.; Mickler, Elizabeth A.; Duerson, Frank, III; Cummings, Oscar W.; Peters-Golden, Marc; Twigg, Homer L., III; Woodruff, Trent M.; Wilkes, David S.; Vittal, Ragini			Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis	FASEB JOURNAL			English	Article						C5b-9; TGF-beta 1; BMP; decorin; IPF	GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; COMPLEMENT ACTIVATION; TGF-BETA; C5A-MEDIATED RELEASE; EXPRESSION; CELLS; TGF-BETA-1; RESPONSES	Complement activation, an integral arm of innate immunity, may be the critical link to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Whereas we have previously reported elevated anaphylatoxinscomplement component 3a (C3a) and complement component 5a (C5a)in IPF, which interact with TGF- and augment epithelial injury in vitro, their role in IPF pathogenesis remains unclear. The objective of the current study is to determine the mechanistic role of the binding of C3a/C5a to their respective receptors (C3aR and C5aR) in the progression of lung fibrosis. In normal primary human fetal lung fibroblasts, C3a and C5a induces mesenchymal activation, matrix synthesis, and the expression of their respective receptors. We investigated the role of C3aR and C5aR in lung fibrosis by using bleomycin-injured mice with fibrotic lungs, elevated local C3a and C5a, and overexpression of their receptors via pharmacologic and RNA interference interventions. Histopathologic examination revealed an arrest in disease progression and attenuated lung collagen deposition (Masson's trichrome, hydroxyproline, collagen type I 1 chain, and collagen type I 2 chain). Pharmacologic or RNA interference-specific interventions suppressed complement activation (C3a and C5a) and soluble terminal complement complex formation (C5b-9) locally and active TGF-1 systemically. C3aR/C5aR antagonists suppressed local mRNA expressions of tgfb2, tgfbr1/2, ltbp1/2, serpine1, tsp1, bmp1/4, pdgfbb, igf1, but restored the proteoglycan, dcn. Clinically, compared with pathologically normal human subjects, patients with IPF presented local induction of C5aR, local and systemic induction of soluble C5b-9, and amplified expression of C3aR/C5aR in lesions. The blockade of C3aR and C5aR arrested the progression of fibrosis by attenuating local complement activation and TGF-/bone morphologic protein signaling as well as restoring decorin, which suggests a promising therapeutic strategy for patients with IPF.Gu, H., Fisher, A. J., Mickler, E. A., Duerson, F., III, Cummings, O. W., Peters-Golden, M., Twigg, H. L., III, Woodruff, T. M., Wilkes, D. S., Vittal, R. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.	[Gu, Hongmei; Fisher, Amanda J.; Mickler, Elizabeth A.; Duerson, Frank, III; Twigg, Homer L., III; Wilkes, David S.] Indiana Univ Sch Med, Dept Med, Div Pulm & Crit Care Med, Indianapolis, IN 46202 USA; [Cummings, Oscar W.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Twigg, Homer L., III; Wilkes, David S.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Peters-Golden, Marc; Vittal, Ragini] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Queensland; University of Michigan System; University of Michigan	Vittal, R (corresponding author), Dept Med, Div Pulm & Crit Care Med, 6240 MSRB 3,1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	rvittal@med.umich.edu	Woodruff, Trent M/B-4861-2009; 张, 志芳/P-1635-2016; Woodruff, Trent/AAS-4629-2020; VITTAL, RAGINI/AAE-9052-2020	Woodruff, Trent M/0000-0003-1382-911X; 张, 志芳/0000-0001-8313-9240; Woodruff, Trent/0000-0003-1382-911X; 	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01-HL109288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094311, R01HL109288] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant R01-HL109288 ( to R. V.). D. S. W. is a cofounder of ImmuneWorks, Inc., a biotechnology company involved in developing therapeutics for various forms of lung diseases. The remaining authors declare no conflicts of interest.	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Andonegui G, 2012, AM J PHYSIOL-LUNG C, V303, pL788, DOI 10.1152/ajplung.00008.2012; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Atkinson C, 2008, J IMMUNOL, V180, P1231, DOI 10.4049/jimmunol.180.2.1231; Azuma A, 2005, AM J RESP CELL MOL, V32, P93, DOI 10.1165/rcmb.2003-0374OC; Baelder R, 2005, J IMMUNOL, V174, P783, DOI 10.4049/jimmunol.174.2.783; Ballanti E, 2013, IMMUNOL RES, V56, P477, DOI 10.1007/s12026-013-8422-y; Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Bhandary YP, 2013, AM J PATHOL, V183, P131, DOI 10.1016/j.ajpath.2013.03.022; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Braun MC, 2004, J IMMUNOL, V173, P4190, DOI 10.4049/jimmunol.173.6.4190; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Choi JE, 2009, AM J RESP CRIT CARE, V179, P212, DOI 10.1164/rccm.200802-228OC; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Crass T, 1996, EUR J IMMUNOL, V26, P1944, DOI 10.1002/eji.1830260840; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Das D, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-9; de Boer JD, 2014, INNATE IMMUN-LONDON, V20, P618, DOI 10.1177/1753425913503387; DREISIN RB, 1978, NEW ENGL J MED, V298, P353, DOI 10.1056/NEJM197802162980701; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Duehrkop C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072059; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Floreani AA, 1998, J IMMUNOL, V160, P5073; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Grgurevic L, 2011, J AM SOC NEPHROL, V22, P681, DOI 10.1681/ASN.2010070722; Gu HM, 2014, FASEB J, V28, P4223, DOI 10.1096/fj.13-247650; Hao JM, 1999, J MOL CELL CARDIOL, V31, P667, DOI 10.1006/jmcc.1998.0902; HAVILAND DL, 1995, J IMMUNOL, V154, P1861; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; HOMMA S, 1995, AM J RESP CRIT CARE, V152, P2084, DOI 10.1164/ajrccm.152.6.8520779; Huang WT, 2015, EXP GERONTOL, V61, P62, DOI 10.1016/j.exger.2014.11.018; Hutchinson John P, 2014, Ann Am Thorac Soc, V11, P1176, DOI 10.1513/AnnalsATS.201404-145OC; Jahanyar J, 2007, J HEART LUNG TRANSPL, V26, P34, DOI 10.1016/j.healun.2006.10.005; Jiang X, 2015, AM J TRANSPLANT, V15, P1768, DOI 10.1111/ajt.13189; Khan MA, 2013, P NATL ACAD SCI USA, V110, P6061, DOI 10.1073/pnas.1217991110; Khan MA, 2013, ADV EXP MED BIOL, V735, P233, DOI 10.1007/978-1-4614-4118-2_16; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Lam AP, 2014, AM J RESP CRIT CARE, V190, P185, DOI 10.1164/rccm.201401-0079OC; Li L, 2015, METABOLISM, V64, P597, DOI 10.1016/j.metabol.2015.01.014; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113639; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Lu Y, 2014, ONCOL REP, V32, P2817, DOI 10.3892/or.2014.3489; MELICONI R, 1990, CLIN IMMUNOL IMMUNOP, V57, P64, DOI 10.1016/0090-1229(90)90022-I; Molloy EL, 2008, GROWTH FACTORS, V26, P12, DOI 10.1080/08977190801987166; Monsinjon T, 2001, FEBS LETT, V487, P339, DOI 10.1016/S0014-5793(00)02320-6; Nishiura H, 2009, LAB INVEST, V89, P676, DOI 10.1038/labinvest.2009.27; Nisihara RM, 2013, HUM IMMUNOL, V74, P907, DOI 10.1016/j.humimm.2013.04.030; Peake PW, 1999, KIDNEY INT, V56, P1729, DOI 10.1046/j.1523-1755.1999.00722.x; Polosukhin VV, 2012, EXP LUNG RES, V38, P135, DOI 10.3109/01902148.2012.658595; Rutkowski MJ, 2010, INFLAMM RES, V59, P897, DOI 10.1007/s00011-010-0220-6; Schaefer M, 2005, J BIOL CHEM, V280, P42113, DOI 10.1074/jbc.M508146200; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Sendler M, 2015, GASTROENTEROLOGY, V149, P765, DOI 10.1053/j.gastro.2015.05.012; Shimizukawa M, 2003, AM J PHYSIOL-LUNG C, V284, pL526, DOI 10.1152/ajplung.00131.2002; SICILIANO SJ, 1990, J BIOL CHEM, V265, P19568; Smadja DM, 2014, PATHOL BIOL, V62, P391, DOI 10.1016/j.patbio.2014.07.006; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Sun SH, 2011, AM J RESP CELL MOL, V45, P834, DOI 10.1165/rcmb.2010-0444OC; Suzuki H, 2013, J IMMUNOL, V191, P4431, DOI 10.4049/jimmunol.1202242; Syed SN, 2009, EUR J IMMUNOL, V39, P3343, DOI 10.1002/eji.200939884; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434; Tornetta MA, 1997, J IMMUNOL, V158, P5277; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Vittal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076451; Vittal R, 2013, AM J RESP CELL MOL, V49, P47, DOI 10.1165/rcmb.2012-0389OC; Vittal R, 2013, AM J PHYSIOL-LUNG C, V304, pL401, DOI 10.1152/ajplung.00080.2012; Wang L, 2014, FREE RADICAL BIO MED, V70, P155, DOI 10.1016/j.freeradbiomed.2014.01.015; Westall GP, 2008, J HEART LUNG TRANSPL, V27, P722, DOI 10.1016/j.healun.2008.03.018; Wollin L, 2015, EUR RESPIR J, V45, P1434, DOI 10.1183/09031936.00174914; Wyatt TA, 1999, AM J RESP CELL MOL, V21, P283, DOI 10.1165/ajrcmb.21.2.3636; Zhang HY, 1996, AM J PATHOL, V148, P527; ZHANG K, 1995, AM J PATHOL, V147, P352; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001; Zhou XL, 2013, AM J PHYSIOL-RENAL, V305, pF957, DOI 10.1152/ajprenal.00344.2013; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5	86	39	40	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2336	2350		10.1096/fj.201500044	http://dx.doi.org/10.1096/fj.201500044			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26956419	Green Published, Green Submitted			2022-12-28	WOS:000376878300023
J	Zhang, Y; Lu, T; Wong, M; Wang, XY; Stodieck, L; Karouia, F; Story, M; Wu, HL				Zhang, Ye; Lu, Tao; Wong, Michael; Wang, Xiaoyu; Stodieck, Louis; Karouia, Fathi; Story, Michael; Wu, Honglu			Transient gene and microRNA expression profile changes of confluent human fibroblast cells in spaceflight	FASEB JOURNAL			English	Article						microgravity; omics; cell growth condition	NF-KAPPA-B; HEPATOCYTE GROWTH-FACTOR; SIMULATED MICROGRAVITY; SIGNALING PATHWAY; PROLIFERATION; CYTOSKELETON; ACTIVATION; HYPERGRAVITY; GRAVITY; DIFFERENTIATION	Microgravity, or an altered gravity environment different from the 1 g of the Earth, has been shown to influence global gene expression patterns and protein levels in cultured cells. However, most of the reported studies that have been conducted in space or by using simulated microgravity on the ground have focused on the growth or differentiation of these cells. It has not been specifically addressed whether nonproliferating cultured cells will sense the presence of microgravity in space. In an experiment conducted onboard the International Space Station, confluent human fibroblast cells were fixed after being cultured in space for 3 and 14 d, respectively, to investigate changes in gene and microRNA (miRNA) expression profiles in these cells. Results of the experiment showed that on d 3, both the flown and ground cells were still proliferating slowly, as measured by the percentage of Ki-67(+) cells. Gene and miRNA expression data indicated activation of NF-B and other growth-related pathways that involve hepatocyte growth factor and VEGF as well as the down-regulation of the Let-7 miRNA family. On d 14, when the cells were mostly nonproliferating, the gene and miRNA expression profile of the flight sample was indistinguishable from that of the ground sample. Comparison of gene and miRNA expressions in the d 3 samples, with respect to d 14, revealed that most of the changes observed on d 3 were related to cell growth for both the flown and ground cells. Analysis of cytoskeletal changes via immunohistochemistry staining of the cells with antibodies for -tubulin and fibronectin showed no difference between the flown and ground samples. Taken together, our study suggests that in true nondividing human fibroblast cells in culture, microgravity experienced in space has little effect on gene and miRNA expression profiles.Zhang, Y., Lu, T., Wong, M., Wang, X., Stodieck, L., Karouia, F., Story, M., Wu, H. Transient gene and microRNA expression profile changes of confluent human fibroblast cells in spaceflight.	[Zhang, Ye; Lu, Tao; Wong, Michael; Wu, Honglu] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Zhang, Ye] Wyle Labs, Houston, TX USA; [Zhang, Ye] NASA, Kennedy Space Ctr, Cape Canaveral, FL USA; [Lu, Tao] Univ Houston Clear Lake, Houston, TX USA; [Wang, Xiaoyu; Story, Michael] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Stodieck, Louis] BioServe Space Technol, Boulder, CO USA; [Karouia, Fathi] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Karouia, Fathi] Univ Calif San Francisco, San Francisco, CA 94143 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); University of Houston System; University of Houston; University of Houston Clear Lake; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California San Francisco	Wu, HL (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	honglu.wu-1@nasa.gov	Story, Michael/AAX-2864-2021	Story, Michael/0000-0001-6522-4169; Wong, Michael/0000-0002-0949-4102; Karouia, Fathi/0000-0002-1142-9684	NASA Fundamental Space Biology Program	NASA Fundamental Space Biology Program	The authors thank Stefanie Countryman, Jon Beno, Mark Rupert, and Shankini Doraisingam (BioServe Space Technologies), with whom this work was done in collaboration. The authors thank Ashleigh Ruggles and Satyanand Narayan [Kennedy Space Center, National Aeronautics and Space Administration (NASA)], and Kevin Sato (NASA Ames Research Center) for support during various phases of the project. The authors also thank Astronaut Thomas Mashburn for performing experiments onboard the ISS. This work was supported by the NASA Fundamental Space Biology Program.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Allen Jeffrey D, 2009, J Cancer Sci Ther, V1, P25; Boonstra J, 1999, FASEB J, V13, pS35, DOI 10.1096/fasebj.13.9001.s35; Buravkova LB, 2001, ACTA ASTRONAUT, V48, P647, DOI 10.1016/S0094-5765(01)00023-6; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Ciofani G, 2012, J BIOSCI BIOENG, V113, P258, DOI 10.1016/j.jbiosc.2011.09.025; Clement JQ., 2007, J GRAVIT PHYSL, V14, P121; Cooper D, 2001, IN VITRO CELL DEV-AN, V37, P63; Dai ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063661; Di Fiore R, 2014, INT J ONCOL, V45, P2013, DOI 10.3892/ijo.2014.2618; Ding LH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-372; Gao Y, 2015, J RADIAT RES, V56, P872, DOI 10.1093/jrr/rrv050; Gasparri F, 2004, J BIOMOL SCREEN, V9, P232, DOI 10.1177/1087057103262836; Genchi GG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/748121; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Grimm D, 2014, EXPERT REV PROTEOMIC, V11, P465, DOI 10.1586/14789450.2014.926221; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hao NB, 2015, CANCER LETT, V361, P57, DOI 10.1016/j.canlet.2015.02.043; Hargens AR, 2013, EUR J APPL PHYSIOL, V113, P2183, DOI 10.1007/s00421-012-2523-5; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Hughes-Fulford M, 1998, Gravit Space Biol Bull, V11, P51; Hughes-Fulford M, 2015, FASEB J, V29, P4893, DOI 10.1096/fj.15-277392; Iwasaki T, 2015, INT J ONCOL, V46, P1543, DOI 10.3892/ijo.2015.2867; Jia LF, 2014, ORAL ONCOL, V50, P1062, DOI 10.1016/j.oraloncology.2014.07.010; Kwon O, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128718; Lee KH, 2012, CLIN EXP METASTAS, V29, P263, DOI 10.1007/s10585-011-9449-x; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083083; Luna C, 2009, MOL VIS, V15, P2488; Luu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070604; Malato Y, 2012, GASTROENTEROLOGY, V143, P1597, DOI 10.1053/j.gastro.2012.08.030; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Matsui T, 2015, OR SURG OR MED OR PA, V120, P436, DOI 10.1016/j.oooo.2015.06.002; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; MIWA M, 1991, BONE MINER, V14, P15, DOI 10.1016/0169-6009(91)90099-L; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Nichols HL, 2006, PHYSIOL GENOMICS, V26, P163, DOI 10.1152/physiolgenomics.00323.2005; Ohnishi Ken, 2004, Biol Sci Space, V18, P201, DOI 10.2187/bss.18.201; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; Phan LM, 2015, CANCER RES, V75, P4131, DOI 10.1158/0008-5472.CAN-14-3707; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Santi S., 2002, J GRAVIT PHYSL, V9, P283; Sciola L, 1999, ADV SPACE RES, V24, P801, DOI 10.1016/S0273-1177(99)00078-2; Semov A, 2002, FASEB J, V16, P899, DOI 10.1096/fj.01-1002fje; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Sonnenfeld Gerald, 2003, Rev Environ Health, V18, P1; Stowe RP, 2011, AVIAT SPACE ENVIR MD, V82, P627, DOI 10.3357/ASEM.2980.2011; TSCHOPP A, 1983, EXPERIENTIA, V39, P1323, DOI 10.1007/BF01990088; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; Vassy J., 2001, FASEB Journal, V15, P1104; Vidyasekar P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135958; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Ward NE, 2006, J CELL BIOCHEM, V99, P1187, DOI 10.1002/jcb.20988; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Wu H, 2006, RADIAT RES, V166, P583, DOI 10.1667/RR0535.1; Xie HX, 2015, ORAL ONCOL, V51, P991, DOI 10.1016/j.oraloncology.2015.08.007; Xie Y, 2009, BIOINFORMATICS, V25, P751, DOI 10.1093/bioinformatics/btp040; Yao P, 2004, J HEPATOL, V40, P391, DOI 10.1016/j.jhep.2003.11.001; Zhang CC, 2012, ARCH ORAL BIOL, V57, P1395, DOI 10.1016/j.archoralbio.2012.04.010; Zhang KX, 2014, INT J CLIN EXP PATHO, V7, P5701	68	23	26	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2211	2224		10.1096/fj.201500121	http://dx.doi.org/10.1096/fj.201500121			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26917741				2022-12-28	WOS:000376878300014
J	Abedini, A; Zamberlam, G; Lapointe, E; Tourigny, C; Boyer, A; Paquet, M; Hayashi, K; Honda, H; Kikuchi, A; Price, C; Boerboom, D				Abedini, Atefeh; Zamberlam, Gustavo; Lapointe, Evelyne; Tourigny, Catherine; Boyer, Alexandre; Paquet, Marilene; Hayashi, Kanako; Honda, Hiroaki; Kikuchi, Akira; Price, Christopher; Boerboom, Derek			WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling	FASEB JOURNAL			English	Article						female fertility; conditional gene targeting; microarray	DEPENDENT PROTEIN-KINASE; BETA-CATENIN; FEMALE FERTILITY; FRIZZLED HOMOLOGS; BINDING PROTEIN; EXPRESSION; PHOSPHORYLATION; PATHWAY; GASTRULATION; MICE	Whereas the roles of the canonical wingless type MMTV(mouse mammary tumor virus) integration site family (WNT) signaling pathway in the regulation of ovarian follicle growth and steroidogenesis are now established, noncanonical WNT signaling in the ovary has been largely overlooked. Noncanonical WNTs, including WNT5a and WNT11, are expressed in granulosa cells (GCs) and are differentially regulated throughout follicle development, but their physiologic roles remain unknown. Using conditional gene targeting, we found that GC-specific inactivation of Wnt5a (but not Wnt11) results in the female subfertility associated with increased follicular atresia and decreased rates of ovulation. Microarray analyses have revealed that WNT5a acts to down-regulate the expression of FSH-responsive genes in vitro, and corresponding increases in the expression of these genes have been found in the GCs of conditional knockout mice. Unexpectedly, we found that WNT5a regulates its target genes not by signaling via the WNT/Ca2+ or planar cell polarity pathways, but rather by inhibiting the canonical pathway, causing both beta-catenin (CTNNB1) and cAMP responsive element binding (CREB) protein levels to decrease via a glycogen synthase kinase-3 beta-dependent mechanism. We further found that WNT5a prevents follicle-stimulating hormone and luteinizing protein from up-regulating the CTNNB1 and CREB proteins and their target genes, indicating that WNT5a functions as a physiologic inhibitor of gonadotropin signaling. Together, these findings identify WNT5a as a key regulator of follicle development and gonadotropin responsiveness.-Abedini, A., Zamberlam, G., Lapointe, E., Tourigny, C., Boyer, A., Paquet, M., Hayashi, K., Honda, H., Kikuchi, A., Price, C., Boerboom, D. WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling. FASEB J. 30, 1534-1547 (2016). www.fasebj.org	[Abedini, Atefeh; Zamberlam, Gustavo; Lapointe, Evelyne; Tourigny, Catherine; Boyer, Alexandre; Paquet, Marilene; Price, Christopher; Boerboom, Derek] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada; [Hayashi, Kanako] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Honda, Hiroaki] Hiroshima Univ, Dept Dis Model, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Kikuchi, Akira] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Osaka, Japan	Universite de Montreal; Southern Illinois University System; Southern Illinois University; Hiroshima University; Osaka University	Boerboom, D (corresponding author), Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada.	derek.boerboom@umontreal.ca	Paquet, Marilene/L-3414-2019; Price, Christopher/A-6383-2012	Paquet, Marilene/0000-0002-3562-4636; Price, Christopher/0000-0002-6727-8280; Hayashi, Kanako/0000-0002-5028-799X; Zamberlam, Gustavo/0000-0002-0089-9955	Canadian Institutes of Health Research [MOP-102508]; Canada Research Chair in Ovarian Molecular Biology and Functional Genomics; U. S. National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R03-HD058222]; NIH NICHD (SCCPRR) [U54-HD28934]; Reseau Quebecois en Reproduction; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058222] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Ovarian Molecular Biology and Functional Genomics(Canada Research Chairs); U. S. National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH NICHD (SCCPRR); Reseau Quebecois en Reproduction; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Ms. M. Girard (Universite de Montreal) for assistance with mouse colony management. This work was supported by Operating Grant MOP-102508 from the Canadian Institutes of Health Research and the Canada Research Chair in Ovarian Molecular Biology and Functional Genomics (to D.B.) and U. S. National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Grant R03-HD058222 (to K.H.). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by NIH NICHD (SCCPRR) Grant U54-HD28934. A.A. was supported by a graduate studentship from the Reseau Quebecois en Reproduction.	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Abedini A, 2015, MOL CELL ENDOCRINOL, V403, P39, DOI 10.1016/j.mce.2015.01.017; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Boyer A, 2009, CARCINOGENESIS, V30, P869, DOI 10.1093/carcin/bgp051; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Finnson KW, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096396; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hayashi K, 2011, BIOL REPROD, V84, P308, DOI 10.1095/biolreprod.110.088161; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Komiya Yuko, 2008, Organogenesis, V4, P68; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lapointe E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102608; Lapointe Evelyne, 2011, Front Biosci (Schol Ed), V3, P276, DOI 10.2741/s151; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Polakis P, 2000, GENE DEV, V14, P1837; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Rico C, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115634; Roy L, 2009, ENDOCRINOLOGY, V150, P5036, DOI 10.1210/en.2009-0771; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Sanchez AM, 2014, FERTIL STERIL, V101, P1688, DOI 10.1016/j.fertnstert.2014.02.040; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; ZELEZNIK AJ, 1974, ENDOCRINOLOGY, V95, P818, DOI 10.1210/endo-95-3-818	55	41	43	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1534	1547		10.1096/fj.15-280313	http://dx.doi.org/10.1096/fj.15-280313			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26667040	Green Published			2022-12-28	WOS:000372629100015
J	Quinn, MA; Cidlowski, JA				Quinn, Matthew A.; Cidlowski, John A.			Endogenous hepatic glucocorticoid receptor signaling coordinates sex-biased inflammatory gene expression	FASEB JOURNAL			English	Article						sexual dimorphism; liver; nanostring; inflammation; corticosteroid	PRIMARY SJOGRENS-SYNDROME; UTERINE EPITHELIAL-CELLS; NF-KAPPA-B; GROWTH-HORMONE; GENDER-DIFFERENCES; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; ANTIINFLAMMATORY ACTION; ESTRADIOL ANTAGONISM; MOUSE-LIVER; IN-VIVO	An individual's sex affects gene expression and many inflammatory diseases present in a sex-biased manner. Glucocorticoid receptors (GRs) are regulators of inflammatory genes, but their role in sex-specific responses is unclear. Our goal was to evaluate whether GR differentially regulates inflammatory gene expression in male and female mouse liver. Twenty-five percent of the 251 genes assayed by nanostring analysis were influenced by sex. Of these baseline sexually dimorphic inflammatory genes, 82% was expressed higher in female liver. Pathway analyses defined pattern-recognition receptors as the most sexually dimorphic pathway. We next exposed male and female mice to the proinflammatory stimulus LPS. Female mice had 177 genes regulated by treatment with LPS, whereas males had 149, with only 66% of LPS-regulated genes common between the sexes. To determine the contribution of GR to sexually dimorphic inflammatory genes we performed nanostring analysis on liver-specific GR knockout (LGRKO) mice in the presence or absence of LPS. Comparing LGRKO to GR(flox/flox) revealed that 36 genes required GR for sexually dimorphic expression, whereas 24 genes became sexually dimorphic in LGRKO. Fifteen percent of LPS-regulated genes in GR(flox/flox) were not regulated in male and female LGRKO mice treated with LPS. Thus, GR action is influenced by sex to regulate inflammatory gene expression.	[Quinn, Matthew A.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, NIH, MD F3-07,POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Signal Transduct Lab, NIH, MD F3-07,POB 12233, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	NIH NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES090079, ZIAES090057] Funding Source: NIH RePORTER	NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. D. W. Cain for technical assistance and critical reading of the manuscript and the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Genomics Core for help with the nanostring analysis. This research was supported by the Intramural Research Program of the NIH NIEHS. The authors declare no conflicts of interest.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elakovic I, 2011, BRAIN RES, V1384, P61, DOI 10.1016/j.brainres.2011.01.078; Garcia-Rodriguez S, 2013, J EUR ACAD DERMATOL, V27, P242, DOI 10.1111/j.1468-3083.2011.04372.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghazeeri G, 2011, AM J REPROD IMMUNOL, V66, P163, DOI 10.1111/j.1600-0897.2011.01052.x; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Hoekstra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080441; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Huang QH, 1998, AM J PHYSIOL-REG I, V275, pR524, DOI 10.1152/ajpregu.1998.275.2.R524; Ishikawa I, 2000, AM J KIDNEY DIS, V35, P1072, DOI 10.1016/S0272-6386(00)70042-4; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Kawakami A, 2007, J RHEUMATOL, V34, P1019; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Kinoshita PF, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0218-z; Kovacs WJ, 2011, NAT REV RHEUMATOL, V7, P307, DOI 10.1038/nrrheum.2010.231; Kwok SK, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3780; Lahita R G, 1999, Curr Opin Rheumatol, V11, P352, DOI 10.1097/00002281-199909000-00005; Lamason R, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-2; Laz EV, 2004, MOL CELL PROTEOMICS, V3, P1170, DOI 10.1074/mcp.M400102-MCP200; LOW SC, 1993, J ENDOCRINOL, V139, P27, DOI 10.1677/joe.0.1390027; LOW SC, 1994, J ENDOCRINOL, V143, P541, DOI 10.1677/joe.0.1430541; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; McFarlane IG, 2004, HEPATOL RES, V28, P171, DOI 10.1016/j.hepres.2003.12.002; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oakley RH, 2013, P NATL ACAD SCI USA, V110, P17035, DOI 10.1073/pnas.1302546110; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Quax RA, 2013, NAT REV ENDOCRINOL, V9, P670, DOI 10.1038/nrendo.2013.183; Quinn M, 2012, AM J PHYSIOL-GASTR L, V302, pG182, DOI 10.1152/ajpgi.00205.2011; Radwan M, 2010, J IMMUNOL, V185, P3544, DOI 10.4049/jimmunol.0904000; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schott J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004368; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Sevilla LM, 2010, MOL ENDOCRINOL, V24, P2166, DOI 10.1210/me.2010-0183; SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; Silverman MN, 2013, MOL PSYCHIATR, V18, P1006, DOI 10.1038/mp.2012.131; Spachidou MP, 2007, CLIN EXP IMMUNOL, V147, P497, DOI 10.1111/j.1365-2249.2006.03311.x; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TURNER BB, 1985, BRAIN RES, V343, P16, DOI 10.1016/0006-8993(85)91153-9; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Waxman D J, 2000, Novartis Found Symp, V227, P61; Waxman DJ., 2000, NOVART FDN SYMP, V227, P75; Whirledge S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111054; Whirledge S, 2013, ENDOCRINOLOGY, V154, P499, DOI 10.1210/en.2012-1748; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11	66	30	30	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					971	982		10.1096/fj.15-278309	http://dx.doi.org/10.1096/fj.15-278309			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26581598	Green Published			2022-12-28	WOS:000369391900043
J	Wichner, K; Stauss, D; Kampfrath, B; Kruger, K; Muller, G; Rehm, A; Lipp, M; Hopken, UE				Wichner, Katharina; Stauss, Dennis; Kampfrath, Branka; Krueger, Kerstin; Mueller, Gerd; Rehm, Armin; Lipp, Martin; Hoepken, Uta E.			Dysregulated development of IL-17-and IL-21-expressing follicular helper T cells and increased germinal center formation in the absence of ROR gamma t	FASEB JOURNAL			English	Article						T(h)17-cell differentiation; proinflammatory cytokines; B-cell-activating factor; germinal center reaction	REGULATORY NETWORK; CYTOKINE MILIEU; DIFFERENTIATION; ALPHA; IRF4; INTERLEUKIN-17; INHIBITION; ARTHRITIS; EXPANSION; LUPUS	Interleukin 17-producing helper T (T(h)17) cells have been widely defined by the lineage transcription factor retinoid-related orphan receptor (ROR)gamma t. Pathophysiologically, these cells play a crucial role in autoimmune diseases and have been linked to dysregulated germinal center (GC) reactions and autoantibody production. In this study, we used gene expression and flow cytometric analyses for the characterization of Ror gamma t(-/-) and Ror gamma t(-/-)Il21(RFP/+) mice to demonstrate a previously unknown transcriptional flexibility in the development of IL-17-producing Th-cell subsets. We found an accumulation of follicular T-h (Tf-h) cells by 5.2-fold, spontaneous 13-fold higher GC formation, decreased frequency of follicular Foxp3(+) T-regulatory (T-reg) cells (50%), and a 3.4-fold increase in the number of proliferating follicular Bcells inROR gamma t-deficient vs. wild-typemice. Dysregulated B-cell responseswere associated with enhanced production of IL-17 (6.4-fold), IL-21 (2.2-fold), and B-cell-activating factor (BAFF) (2-fold) and were partially rescued by adoptive transfer of T-reg cells. In an unexpected finding, we detected ROR gamma t-independent IL-17 expression in ICOS+ CXCR5(+) Tf-h and in ICOS+ CXCR5(-)T(h) cells. Based on the observed high Irf4 and Batf gene expression, we suggest that CD4(+) T-cell transcription factors other than ROR gamma t can cooperatively induce differentiation of IL-17-producing Th cells, including T(h)17-like Tfh-cell subsets. We conclude that the occurrence of aberrant Tfh and follicular T-reg cells support spontaneous GC formation and dysregulated B-cell responses in ROR gamma t-deficientmice.-	[Wichner, Katharina; Stauss, Dennis; Kampfrath, Branka; Krueger, Kerstin; Mueller, Gerd; Lipp, Martin; Hoepken, Uta E.] Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, Berlin, Germany; [Rehm, Armin] Max Delbruck Ctr Mol Med, Dept Hematol Oncol & Tumorimmunol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hopken, UE (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	uhoepken@mdc-berlin.de		Lipp, Martin/0000-0002-0087-2672	Collaborative Research Centres from the German Research Foundation (DFG) [SFB 633, TR 52]	Collaborative Research Centres from the German Research Foundation (DFG)	The authors thank D. R. Littman (New York University of Medicine, New York, NY, USA) and H. J. Fehling (University Clinics Ulm, Ulm, Germany) for providing the Rorgt<SUP>-/-</SUP> and the ROSA/tdRFP mouse strains, respectively; A. Waisman (University Medicine Mainz, Mainz, Germany) and Kurt Reifenberg [German Cancer Research Center (DKFZ), Heidelberg, Germany] for support in generating the IL-21 Cre mouse strain; H.-D. Chang and J. Zimmermann (DRFZ, Berlin, Germany) for helpful discussions; and H. Schwede and K. Gerlach (Max-Delbruck-Center for Molecular Medicine, Berlin, Germany) for excellent technical assistance. This work was supported by Collaborative Research Centres Grants SFB 633 (to U.E.H. and M.L.) and TR 52 (to G.M. and M.L.) from the German Research Foundation (DFG). The authors declare no conflicts of interest.	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Coquery CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102284; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Fischer JAA, 2015, ARTHRITIS RHEUMATOL, V67, P51, DOI 10.1002/art.38896; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim YU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120294; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rolf J, 2010, J IMMUNOL, V184, P6563, DOI 10.4049/jimmunol.1000202; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Tilley SL, 2007, J IMMUNOL, V178, P3208, DOI 10.4049/jimmunol.178.5.3208; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wichner K, 2013, J AUTOIMMUN, V47, P58, DOI 10.1016/j.jaut.2013.08.007; Wu HY, 2009, LUPUS, V18, P586, DOI 10.1177/0961203308100511; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2010, CELL MOL IMMUNOL, V7, P198, DOI 10.1038/cmi.2010.18; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zwerina K, 2012, EUR J IMMUNOL, V42, P413, DOI 10.1002/eji.201141871	46	20	21	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					761	774		10.1096/fj.15-274001	http://dx.doi.org/10.1096/fj.15-274001			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26499265				2022-12-28	WOS:000369391900026
J	Toivola, DM; Habtezion, A; Misiorek, JO; Zhang, LX; Nystrom, JH; Sharpe, O; Robinson, WH; Kwan, R; Omary, MB				Toivola, Diana M.; Habtezion, Aida; Misiorek, Julia O.; Zhang, Linxing; Nystrom, Joel H.; Sharpe, Orr; Robinson, William H.; Kwan, Raymond; Omary, M. Bishr			Absence of keratin 8 or 18 promotes antimitochondrial autoantibody formation in aging male mice	FASEB JOURNAL			English	Article						autoimmune liver disease; GDH; HMGCS2; ALDH; intermediate filaments	SIMPLE EPITHELIAL KERATINS; INTERMEDIATE-FILAMENTS; LIVER FIBROSIS; RESISTANCE; APOPTOSIS; VARIANTS; FAS; IDENTIFICATION; DEHYDROGENASE; PREDISPOSES	Human mutations in keratin 8 (K8) and keratin 18 (K18), the intermediate filament proteins of hepatocytes, predispose to several liver diseases. K8-null mice develop chronic liver injury and fragile hepatocytes, dysfunctional mitochondria, and Th2-type colitis. We tested the hypothesis that autoantibody formation accompanies the liver damage that associates with K8/K18 absence. Sera from wild-type control, K8-null, and K18-null mice were analyzed by immunoblotting and immunofluorescence staining of cell and mouse tissue homogenates. Autoantibodies to several antigens were identified in 81% of K8-null male mice 8 mo or older. Similar autoantibodies were detected in aging K18-null male mice that had a related liver phenotype but normal colon compared with K8-null mice, suggesting that the autoantibodies are linked to liver rather than colonic disease. However, these autoantibodies were not observed in nontransgenic mice subjected to 4 chronic injury models. The autoantigens are ubiquitous and partition with mitochondria. Mass spectrometry and purified protein analysis identified, mitochondrial HMG-CoA synthase, aldehyde dehydrogenase, and catalase as the primary autoantigens, and glutamate dehydrogenase and epoxide hydrolase-2 as additional autoantigens. Therefore, absence of the hepatocyte keratins results in production of anti-mitochondrial autoantibodies (AMA) that recognize proteins involved in energy metabolism and oxidative stress, raising the possibility that AMA may be found in patients with keratin mutations that associate with liver and other diseases.	[Toivola, Diana M.; Misiorek, Julia O.; Nystrom, Joel H.] Abo Akad Univ, Dept Sci & Engn, Dept Biosci, FIN-20520 Turku, Finland; [Toivola, Diana M.; Misiorek, Julia O.; Nystrom, Joel H.] Abo Akad Univ, Dept Cell Biol, FIN-20520 Turku, Finland; [Habtezion, Aida; Zhang, Linxing] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Sharpe, Orr; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA; [Sharpe, Orr; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Kwan, Raymond; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kwan, Raymond; Omary, M. Bishr] Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI USA	Abo Akademi University; Abo Akademi University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Toivola, DM (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6A, FIN-20520 Turku, Finland.	dtoivola@abo.fi		Toivola, Diana M./0000-0001-7165-9839; Nystrom, Joel Henrik/0000-0002-3514-6064; Omary, Bishr/0000-0002-8624-2347; Misiorek, Julia Oliwia/0000-0001-6263-4461; Robinson, William/0000-0003-4385-704X	U.S. National Institutes of Health [DK47918, K08-DK069385, DK56339, DK34933]; Academy of Finland [140759/126161, 266582]; Sigrid Juselius Foundation; Liv och Halsa Foundation; EU FP7 IRG; AAU Center of Excellence; Turku Doctoral Programme for Biomedical Sciences; Makarna Agneta och Carl-Erik Olin Foundation; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339, P30DK034933, K08DK069385, R01DK047918] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa Foundation; EU FP7 IRG; AAU Center of Excellence; Turku Doctoral Programme for Biomedical Sciences; Makarna Agneta och Carl-Erik Olin Foundation; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Helene Baribault and Thomas Magin for providing the K8<SUP>-/-</SUP> and K18<SUP>-/-</SUP> mice, respectively, and P. J. Utz for fruitful discussions. Che-Hong Chen is acknowledged for assistance with the 2D-PAGE. The authors also thank Matilda Holm, Neeraj Prabhakar, Jolanta Lundgren, and Helena Saarento for technical assistance. This work was supported by U.S. National Institutes of Health Grants DK47918 (to M.B.O.), K08-DK069385 (to A.H.), DK56339 (Stanford University), and DK34933 (University of Michigan); Academy of Finland #140759/126161 and 266582, Sigrid Juselius Foundation, Liv och Halsa Foundation, EU FP7 IRG, and AAU Center of Excellence (D.M.T.); Turku Doctoral Programme for Biomedical Sciences (J.O.M.); Makarna Agneta och Carl-Erik Olin Foundation (J.H.N.); and the U.S. Department of Veterans Affairs (M.B.O.). The authors declare no conflicts of interest.	Ballot E, 2003, CLIN CHEM, V49, P634, DOI 10.1373/49.4.634; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Edassery SL, 2010, FERTIL STERIL, V94, P2636, DOI 10.1016/j.fertnstert.2010.04.012; Fallatah Hind I, 2011, Comp Hepatol, V10, P9, DOI 10.1186/1476-5926-10-9; Fickert P, 2009, HEPATOLOGY, V50, P893, DOI 10.1002/hep.23068; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Gossard AA, 2012, J GASTROENTEROL, V47, P498, DOI 10.1007/s00535-012-0586-z; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Hanada S, 2008, HEPATOLOGY, V48, P943, DOI 10.1002/hep.22436; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Helenius TO, 2015, MOL BIOL CELL, V26, P2298, DOI 10.1091/mbc.E14-02-0736; Herszenyi L, 2012, DIGEST DIS, V30, P201, DOI 10.1159/000336702; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Hohenester S, 2013, HEPATOLOGY, V58, P828, DOI 10.1002/hep.26243; Karaca M, 2011, NEUROCHEM INT, V59, P510, DOI 10.1016/j.neuint.2011.03.024; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leifeld L, 2009, EUR J CLIN INVEST, V39, P481, DOI 10.1111/j.1365-2362.2009.02133.x; Loranger A, 1997, AM J PATHOL, V151, P1673; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Mathew J, 2013, EXP CELL RES, V319, P474, DOI 10.1016/j.yexcr.2012.11.011; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Nakanishi T, 2006, J CHROMATOGR B, V838, P15, DOI 10.1016/j.jchromb.2006.04.009; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Odaka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075101; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Orth T, 1998, CLIN EXP IMMUNOL, V112, P507; Orth T, 2000, J HEPATOL, V33, P862, DOI 10.1016/S0168-8278(00)80116-6; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Strnad P, 2008, GASTROENTEROLOGY, V134, P1169, DOI 10.1053/j.gastro.2008.01.035; Strnad P, 2006, HEPATOLOGY, V43, P1354, DOI 10.1002/hep.21211; Strnad P, 2012, CURR OPIN GASTROEN, V28, P209, DOI 10.1097/MOG.0b013e3283525cb8; Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tao GZ, 2007, CLIN GASTROENTEROL H, V5, P857, DOI 10.1016/j.cgh.2007.02.017; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhong BH, 2009, HEPATOLOGY, V50, P546, DOI 10.1002/hep.23041	57	11	12	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5081	5089		10.1096/fj.14-269795	http://dx.doi.org/10.1096/fj.14-269795			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26399787	Green Submitted, Green Published			2022-12-28	WOS:000365523600031
J	Zhang, XL; Li, DF; Fleming, J; Wang, LW; Zhou, Y; Wang, DC; Zhang, XE; Bi, LJ				Zhang, Xiao-Li; Li, De-Feng; Fleming, Joy; Wang, Li-Wei; Zhou, Ying; Wang, Da-Cheng; Zhang, Xian-En; Bi, Li-Jun			Core component EccB1 of the Mycobacterium tuberculosis type VII secretion system is a periplasmic ATPase	FASEB JOURNAL			English	Article						virulence; ESX-1; crystal structure	PROTEIN; VIRULENCE; MEMBRANE; COMPLEX; ESX-1; IMMUNOGENICITY; PATHOGENICITY; MECHANISM; APPARATUS; DOCKING	Pathogenic mycobacteria transport virulence factors across their complex cell wall via a type VII secretion system (T7SS)/early secreted antigenic target-6 of kDa secretion system (ESX). ESX conserved component (Ecc) B, a core component of the T7SS architecture, is predicted to be a membrane bound protein, but little is known about its structure and function. Here, we characterize EccB1, showing that it is an ATPase with no sequence or structural homology to other ATPases located in the cell envelope of Mycobacterium tuberculosis H37Rv. We obtained the crystal structure of an EccB1-DN72 truncated transmembrane helix and performed modeling and ATP docking studies, showing that EccB1 likely exists as a hexamer. Sequence alignment and ATPase activity determination of EccB1 homologues indicated the presence of 3 conserved motifs in the N- and C-terminals of EccB1-DN72 that assemble together between 2 membrane proximal domains of the EccB1-DN72 monomer. Models of the EccB1 hexamer show that 2 of the conserved motifs are involved in ATPase activity and form an ATP binding pocket located on the surface of 2 adjacent molecules. Our results suggest that EccB may act as the energy provider in the transport of T7SS virulence factors and may be involved in the formation of a channel across the mycomembrane.	[Zhang, Xiao-Li; Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Zhang, Xiao-Li; Li, De-Feng; Fleming, Joy; Wang, Li-Wei; Zhou, Ying; Wang, Da-Cheng; Zhang, Xian-En; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Wuhan 430071, Peoples R China; [Zhang, Xiao-Li; Li, De-Feng; Fleming, Joy; Wang, Li-Wei; Zhou, Ying; Wang, Da-Cheng; Zhang, Xian-En; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Wuhan 430071, Peoples R China; [Zhang, Xiao-Li] Chinese Acad Sci, Grad Sch, Wuhan 430071, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Zhang, XE (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	zhangxe@sun5.ibp.ac.cn; blj@ibp.ac.cn	ZHANG, Xian-En/AAJ-5579-2021	Zhang, Xian-En/0000-0003-1347-3168	National Basic Research Program of China [2011CB910300, 2012CB518700, 2013CB911500]; Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health [2013ZX10003006, 2012ZX10003002]; Chinese Academy of Sciences [KJZD-EW-L02, XDB08020200]; National Natural Science Foundation of China [31170132, 31270792]	National Basic Research Program of China(National Basic Research Program of China); Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors express their appreciation to the staff at the Shanghai Synchrotron Radiation Facility of China for assistance with collecting protein diffraction data, and thank Yi Han and Sheng-Quan Liu from the Institute of Biophysics, Chinese Academy of Sciences, for their assistance in data collection, Xiao-Xia Yu and Xiao-Qian Xie for assistance with protein purification, Hong-Jie Zhang and Wen-Jing Wei for help with the ATPase activity assay, and Hong-Tai Zhang for helpful discussions on the manuscript. This work was supported by grants from the National Basic Research Program of China (2011CB910300, 2012CB518700, 2013CB911500), the Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health (2013ZX10003006 and 2012ZX10003002), the Chinese Academy of Sciences (KJZD-EW-L02, XDB08020200), and the National Natural Science Foundation of China (31170132, 31270792).	Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bitter W, 2014, CELL HOST MICROBE, V16, P430, DOI 10.1016/j.chom.2014.09.010; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bitter W, 2009, TRENDS MICROBIOL, V17, P337, DOI 10.1016/j.tim.2009.05.007; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Das C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027980; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eurosurveillance editorial team, 2013, EUROSURVEILLANCE, V18, P39; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gey Van Pittius N. C., 2001, GENOME BIOL, V2; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEUPOLD CM, 1983, EUR J BIOCHEM, V135, P237, DOI 10.1111/j.1432-1033.1983.tb07643.x; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026743; Luthra A, 2008, J BIOL CHEM, V283, P36532, DOI 10.1074/jbc.M807144200; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Ramsdell TL, 2015, J MOL BIOL, V427, P1119, DOI 10.1016/j.jmb.2014.06.013; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Solomonson M, 2013, J BIOL CHEM, V288, P17782, DOI 10.1074/jbc.M113.462036; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; Tao J, 2013, NUCLEIC ACIDS RES, V41, P2370, DOI 10.1093/nar/gks1351; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van der Woude AD, 2014, CURR TOP MICROBIOL, V374, P109, DOI 10.1007/82_2012_298; WINANS SC, 1989, J BACTERIOL, V171, P1616, DOI 10.1128/jb.171.3.1616-1622.1989	45	19	19	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4804	4814		10.1096/fj.15-270843	http://dx.doi.org/10.1096/fj.15-270843			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26396239				2022-12-28	WOS:000365523600008
J	Bedard, N; Jammoul, S; Moore, T; Wykes, L; Hallauer, PL; Hastings, KEM; Stretch, C; Baracos, V; Chevalier, S; Plourde, M; Coyne, E; Wing, SS				Bedard, Nathalie; Jammoul, Samer; Moore, Tamara; Wykes, Linda; Hallauer, Patricia L.; Hastings, Kenneth E. M.; Stretch, Cynthia; Baracos, Vickie; Chevalier, Stephanie; Plourde, Marie; Coyne, Erin; Wing, Simon S.			Inactivation of the ubiquitin-specific protease 19 deubiquitinating enzyme protects against muscle wasting	FASEB JOURNAL			English	Article						cachexia; sarcopenia; deubiquitylation	RAT SKELETAL-MUSCLE; BODY-MASS INDEX; NF-KAPPA-B; GENE-EXPRESSION; CANCER CACHEXIA; ATROPHY; MICE; USP19; DENERVATION; PROTEOLYSIS	The ubiquitin system plays a critical role in muscle wasting. Previous work has focused on the roles of ubiquitination. However, a role for deubiquitination in this process has not been established. Because ubiquitin-specific protease (USP) 19 deubiquitinating enzyme is induced in skeletal muscle in many catabolic conditions, we generated USP19 knockout (KO) mice. These mice lost less muscle mass than wild-type (WT) animals in response to glucocorticoids, a common systemic cause of muscle atrophy as well as in response to denervation, a model of disuse atrophy. KO mice retained more strength and had less myofiber atrophy with both type I and type IIb fibers being protected. Rates of muscle protein synthesis were similar in WT and KO mice, suggesting that the sparing of atrophy was attributed to suppressed protein degradation. Consistent with this, expression of the ubiquitin ligases MuRF1 and MAFbx/atrogin-1 as well as several autophagy genes was decreased in the muscles of catabolic KO mice. Expression of USP19 correlates with that of MuRF1 and MAFbx/atrogin-1 in skeletal muscles from patients with lung cancer or gastrointestinal cancer, suggesting that USP19 is involved in human muscle wasting. Inhibition of USP19 may be a useful approach to the treatment of many muscle-wasting conditions.	[Bedard, Nathalie; Jammoul, Samer; Moore, Tamara; Plourde, Marie; Coyne, Erin; Wing, Simon S.] McGill Univ, Ctr Hlth, Dept Med, Polypeptide Lab, Montreal, PQ H4A 3J1, Canada; [Chevalier, Stephanie] McGill Univ, Ctr Hlth, Dept Med, Crabtree Nutr Labs, Montreal, PQ H4A 3J1, Canada; [Hallauer, Patricia L.; Hastings, Kenneth E. M.] McGill Univ, Montreal Neurol Inst, Mol Genet Lab, Montreal, PQ H4A 3J1, Canada; [Wykes, Linda] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; [Stretch, Cynthia; Baracos, Vickie] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	McGill University; McGill University; McGill University; McGill University; University of Alberta	Wing, SS (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1001 Decarie Blvd,Room E02-7232, Montreal, PQ H4A 3J1, Canada.	simon.wing@mcgill.ca	Chevalier, Stephanie/AAA-5386-2021; Plourde, Marie-Claude/GQA-4616-2022	Stretch, Cynthia/0000-0002-5152-2728	Canadian Institutes of Health Research [SSW-MOP82734, SC-PET69773, KEMH-57864]; Terry Fox Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute	This work was supported by grants from the Canadian Institutes of Health Research (SSW-MOP82734, SC-PET69773, and KEMH-57864) and the Terry Fox Research Institute (to S.S.W.).	Anker SD, 1999, CHEST, V115, P836, DOI 10.1378/chest.115.3.836; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2013, FASEB J, V27, P3572, DOI 10.1096/fj.13-230375; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harding SV, 2010, PEDIATR RES, V67, P268, DOI 10.1203/PDR.0b013e3181cb8e49; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu Q, 2011, J CELL BIOCHEM, V112, P2307, DOI 10.1002/jcb.23151; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Ogawa M, 2013, BRIT J NUTR, V109, P1349, DOI 10.1017/S0007114512003297; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Stretch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065380; Sundaram P, 2009, AM J PHYSIOL-ENDOC M, V297, pE1283, DOI 10.1152/ajpendo.00409.2009; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Wiles B, 2015, MOL BIOL CELL, V26, P913, DOI 10.1091/mbc.E14-06-1129; Wing SS, 2011, CRIT REV CL LAB SCI, V48, P49, DOI 10.3109/10408363.2011.586171; Wing SS, 2005, INT J BIOCHEM CELL B, V37, P2075, DOI 10.1016/j.biocel.2004.11.011; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	33	31	36	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3889	3898		10.1096/fj.15-270579	http://dx.doi.org/10.1096/fj.15-270579			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26048142				2022-12-28	WOS:000359915600024
J	Li, N; Mruk, DD; Wong, CKC; Lee, WM; Han, DS; Cheng, CY				Li, Nan; Mruk, Dolores D.; Wong, Chris K. C.; Lee, Will M.; Han, Daishu; Cheng, C. Yan			Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis	FASEB JOURNAL			English	Article						actin microfilaments; blood-testis barrier; spermatid adhesion	GERM CELL-INTERACTIONS; FOCAL ADHESION KINASE; SERTOLI-CELL; BARRIER DYNAMICS; SEMINIFEROUS EPITHELIUM; ADHERENS JUNCTIONS; SPERMATID TRANSPORT; COMPLEX; ORGANIZATION; EXPRESSION	Ectoplasmic specialization (ES) is an actin-junction in the seminiferous epithelium of adult mammalian testes. ES is restricted to the Sertoli-spermatid (apical ES) interface, as well as the Sertoli cellp-cell (basal ES) interface at the blood-testis barrier (BTB). ES is typified by the presence of an array of bundles of actin microfilaments near the Sertoli cell plasma membrane. These actin microfilament bundles require rapid debundling to convert them from a bundled to branched/unbundled configuration and vice versa to confer plasticity to support the transport of 1) spermatids in the adluminal compartment and 2) preleptotene spermatocytes at the BTB while maintaining cell adhesion. Plastin 3 is one of the plastin family members abundantly found in yeast, plant and animal cells that confers actin microfilaments their bundled configuration. Herein, plastin 3 was shown to be a component of the apical and basal ES in the rat testis, displaying spatiotemporal expression during the epithelial cycle. A knockdown (KD) of plastin 3 in Sertoli cells by RNA interference using an in vitro model to study BTB function showed that a transient loss of plastin 3 perturbed the Sertoli cell tight junction-permeability barrier, mediated by changes in the localization of basal ES proteins N-cadherin and beta-catenin. More importantly, these changes were the result of an alteration of the actin microfilaments, converting from their bundled to branched configuration when examined microscopically, and validated by biochemical assays that quantified actin-bundling and polymerization activity. Moreover, these changes were confirmed by studies in vivo by plastin 3 KD in the testis in which mis-localization of N-cadherin and beta-catenin was also detected at the BTB, concomitant with defects in the transport of spermatids and phagosomes and a disruption of cell adhesion most notably in elongated spermatids due to a loss of actin-bundling capability at the apical ES, which in turn affected localization of adhesion protein complexes at the site. In summary, plastin 3 is a regulator of actin microfilament bundles at the ES in which it dictates the configuration of the filamentous actin network by assuming either a bundled or unbundled/branched configuration via changes in its spatiotemporal expression during the epithelial cycle.	[Li, Nan; Mruk, Dolores D.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA; [Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Han, Daishu] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Sch Basic Med, Beijing 100730, Peoples R China	Population Council; Hong Kong Baptist University; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Lee, Will M/D-2357-2009; wong, chris/GSN-0962-2022	Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (Project 5) [R01 HD056034, U54 HD029990]; Hong Kong Baptist University [LSK/14-15/P06]; National Natural Science Foundation of China Research Grants Council of Hong Kong Joint Research Scheme [N_HKU 717/12, RGC 771513]; University of Hong Kong Committee on Research and Conference Grants Seed Funding; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (Project 5); Hong Kong Baptist University; National Natural Science Foundation of China Research Grants Council of Hong Kong Joint Research Scheme(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); University of Hong Kong Committee on Research and Conference Grants Seed Funding; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD056034 and U54 HD029990 Project 5) both to C.Y.C.; Hong Kong Baptist University (LSK/14-15/P06) to C.K.C.W.; National Natural Science Foundation of China Research Grants Council of Hong Kong Joint Research Scheme (Grant N_HKU 717/12, RGC 771513); and University of Hong Kong Committee on Research and Conference Grants Seed Funding, both to W.M.L.	Babich A, 2013, IMMUNOL REV, V256, P80, DOI 10.1111/imr.12123; Beardsley A, 2006, J ENDOCRINOL, V190, P759, DOI 10.1677/joe.1.06867; Cao YY, 2014, J HUM GENET, V59, P24, DOI 10.1038/jhg.2013.111; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; Cheng C Yan, 2011, Spermatogenesis, V1, P99; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2011, BIOCHEM J, V435, P553, DOI 10.1042/BJ20102121; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; CLERMONT Y, 1987, ANN NY ACAD SCI, V513, P1, DOI 10.1111/j.1749-6632.1987.tb24994.x; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; GALDIERI M, 1981, J ANDROL, V2, P249; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; GROVE BD, 1989, J CELL SCI, V93, P309; HESS RA, 1990, BIOL REPROD, V43, P517, DOI 10.1095/biolreprod43.3.517; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; JANECKI A, 1992, TOXICOL APPL PHARM, V112, P51, DOI 10.1016/0041-008X(92)90278-Z; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Lee NPY, 2004, J ANDROL, V25, P200; Lee NPY, 2003, ENDOCRINOLOGY, V144, P3114, DOI 10.1210/en.2002-0167; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lie PPY, 2011, FASEB J, V25, P1244, DOI 10.1096/fj.10-169995; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lui WY, 2003, ENDOCRINOLOGY, V144, P1139, DOI 10.1210/en.2002-0211; Lui WY, 2003, BIOL REPROD, V68, P1597, DOI 10.1095/biolreprod.102.011387; Lyon AN, 2014, HUM MOL GENET, V23, P1990, DOI 10.1093/hmg/ddt595; Michel L, 2013, BLOOD, V121, P1477, DOI 10.1182/blood-2012-10-460535; Miyakawa T, 2012, BIOCHEM BIOPH RES CO, V429, P137, DOI 10.1016/j.bbrc.2012.10.126; Mok KW, 2013, FASEB J, V27, P1137, DOI 10.1096/fj.12-212977; Morley SC, 2013, IMMUNOL REV, V256, P48, DOI 10.1111/imr.12102; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Mulvihill BM, 2010, CLIN BIOMECH, V25, P491, DOI 10.1016/j.clinbiomech.2010.01.006; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nicholls PK, 2009, ENDOCRINOLOGY, V150, P2481, DOI 10.1210/en.2008-1048; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; PALOMBI F, 1992, BIOL REPROD, V47, P1173, DOI 10.1095/biolreprod47.6.1173; Qian XJ, 2014, SEMIN CELL DEV BIOL, V30, P75, DOI 10.1016/j.semcdb.2014.04.018; Qian XJ, 2013, ENDOCRINOLOGY, V154, P1907, DOI 10.1210/en.2012-2269; Qiu LL, 2013, TOXICOL SCI, V135, P229, DOI 10.1093/toxsci/kft129; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; Russell LD, 1993, SERTOLI CELL, P365; Salanova M, 1998, BIOL REPROD, V58, P371, DOI 10.1095/biolreprod58.2.371; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Shinomiya Hiroto, 2012, Int J Cell Biol, V2012, P213492, DOI 10.1155/2012/213492; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Su LL, 2011, P NATL ACAD SCI USA, V108, P19623, DOI 10.1073/pnas.1111414108; Suetsugu S, 2013, SEMIN CELL DEV BIOL, V24, P267, DOI 10.1016/j.semcdb.2013.01.006; van Dijk FS, 2013, NEW ENGL J MED, V369, P1529, DOI 10.1056/NEJMoa1308223; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Vogl AW, 2000, ARCH HISTOL CYTOL, V63, P1, DOI 10.1679/aohc.63.1; Wan HT, 2014, SEMIN CELL DEV BIOL, V30, P65, DOI 10.1016/j.semcdb.2014.04.013; Wan HT, 2014, ENDOCRINOLOGY, V155, P249, DOI 10.1210/en.2013-1657; Wan HT, 2013, AM J PHYSIOL-ENDOC M, V305, pE687, DOI 10.1152/ajpendo.00254.2013; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6; Wolski KM, 2005, J ANDROL, V26, P354, DOI 10.2164/jandrol.04142; Xiao X, 2014, PHYSIOLOGY, V29, P286, DOI 10.1152/physiol.00001.2014; Xiao X, 2013, AM J PHYSIOL-ENDOC M, V304, pE145, DOI 10.1152/ajpendo.00422.2012; Xiao XA, 2011, INT J BIOCHEM CELL B, V43, P651, DOI 10.1016/j.biocel.2011.01.008; Yan Cheng C., 2015, SERTOLI CELL BIOL, Ved., P333, DOI [10.1016/B978-0-12-417047-6.00012-0, DOI 10.1016/B978-0-12-417047-6.00012.0, DOI 10.1016/B978-0-12-417047-6.00012-0]; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Yan HHN, 2005, P NATL ACAD SCI USA, V102, P11722, DOI 10.1073/pnas.0503855102; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326	75	30	33	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3788	3805		10.1096/fj.14-267997	http://dx.doi.org/10.1096/fj.14-267997			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26048141	Green Published			2022-12-28	WOS:000359915600016
J	Shilo, V; Ben-Dov, IZ; Nechama, M; Silver, J; Naveh-Many, T				Shilo, Vitali; Ben-Dov, Iddo Z.; Nechama, Morris; Silver, Justin; Naveh-Many, Tally			Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia	FASEB JOURNAL			English	Article						secondary hyperparathyroidism; calcium-sensing receptor; renal failure	HORMONE GENE-EXPRESSION; SECONDARY HYPERPARATHYROIDISM; CDNA LIBRARIES; CALCIUM; RECEPTOR; MODEL; FGF23; RATS; CALCIMIMETICS; MORPHOGENESIS	MicroRNAs (miRNAs) down-regulate gene expression and have vital roles in biology but their functions in the parathyroid are unexplored. To study this, we generated parathyroid-specific Dicer1 knockout (PT-Dicer(-/-) 2) mice where parathyroid miRNA maturation is blocked. Remarkably, the PT-Dicer(-/-) mice did not increase serum parathyroid hormone (PTH) in response to acute hypocalcemia compared with the >5-fold increase in controls. PT-Dicer(-/-) glands cultured in low-calcium medium secreted 5-fold less PTH at 1.5 h than controls. Chronic hypocalcemia increased serum PTH >4-fold less in PT-Dicer(-/-) mice compared with control mice with no increase in PTH mRNA levels and parathyroid cell proliferation compared with the 2-to 3-fold increase in hypocalcemic controls. Moreover, uremic PT-Dicer(-/-) mice increased serum PTH and FGF23 significantly less than uremic controls. Therefore, stimulation of the parathyroid by both hypocalcemia and uremia is dependent upon intact dicer function and miRNAs. In contrast, the PT-Dicer(-/-) mice responded normally to activation of the parathyroid calcium-sensing receptor (Casr) by both hypercalcemia and a calcimimetic that decreases PTH secretion, demonstrating that they are dicer-independent. Therefore, miRNAs are essential for the response of the parathyroid to both acute and chronic hypocalcemia and uremia, the major stimuli for PTH secretion.	[Shilo, Vitali; Ben-Dov, Iddo Z.; Silver, Justin; Naveh-Many, Tally] Hadassah Hebrew Univ Med Ctr, Serv Nephrol, Minerva Ctr Calcium & Bone Metab, Jerusalem, Israel; [Nechama, Morris] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Hebrew University of Jerusalem; Harvard University; Beth Israel Deaconess Medical Center	Naveh-Many, T (corresponding author), Hadassah Hebrew Univ Hosp, Nephrol, IL-91120 Ein Kerem, Israel.	tally@cc.huji.ac.il	Ben-Dov, Iddo/F-3282-2010	Ben-Dov, Iddo/0000-0002-9180-3604	Israel Academy of Science [358/12]; Amgen; Harold and Ethel Pupkewitz Research Fund; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]	Israel Academy of Science; Amgen(Amgen); Harold and Ethel Pupkewitz Research Fund; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	The authors thank Eran Horenstein (Weizmann Institute, Rehovot, Israel) for the Dicer<SUP>lox/lox</SUP> mice and for helpful discussions. Valuable technical assistance was provided by Chofit Chai and Sivan Reytan (Hadassah, Jerusalem, Israel). This work was supported by the Israel Academy of Science (Grant 358/12 to T.N.-M.), Amgen, and the Harold and Ethel Pupkewitz Research Fund. I.Z.B.-D. was supported by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (Grant No. 41/11).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BROWN EM, 1983, J CLIN ENDOCR METAB, V56, P572, DOI 10.1210/jcem-56-3-572; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Corbetta S, 2010, ENDOCR-RELAT CANCER, V17, P135, DOI 10.1677/ERC-09-0134; Dueck A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-123; Farazi TA, 2012, METHODS, V58, P171, DOI 10.1016/j.ymeth.2012.07.020; Fox J, 1999, J PHARMACOL EXP THER, V290, P473; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hansen D, 2012, NEPHROL DIAL TRANSPL, V27, P2263, DOI 10.1093/ndt/gfr668; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Imanishi Y, 2002, J BONE MINER RES, V17, P1656, DOI 10.1359/jbmr.2002.17.9.1656; Imanishi Y, 2001, J CLIN INVEST, V107, P1093, DOI 10.1172/JCI10523; Jia T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-116; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; KILAV R, 1995, J CLIN INVEST, V96, P327, DOI 10.1172/JCI118038; Kilav R, 2001, J BIOL CHEM, V276, P8727, DOI 10.1074/jbc.M005471200; Kolbert CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052517; Komaba H, 2010, CLIN J AM SOC NEPHRO, V5, P2305, DOI 10.2215/CJN.02110310; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lavi-Moshayoff V, 2009, AM J PHYSIOL-RENAL, V297, pF713, DOI 10.1152/ajprenal.00161.2009; Levi R, 2006, J AM SOC NEPHROL, V17, P107, DOI 10.1681/ASN.2005070679; Libutti SK, 2003, CANCER RES, V63, P8022; MACISAAC RJ, 1991, ENDOCRINOLOGY, V129, P757, DOI 10.1210/endo-129-2-757; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Meir T, 2009, AM J PHYSIOL-RENAL, V297, pF1192, DOI 10.1152/ajprenal.00360.2009; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Moallem E, 1998, J BIOL CHEM, V273, P5253, DOI 10.1074/jbc.273.9.5253; NAVEHMANY T, 1995, J CLIN INVEST, V96, P1786, DOI 10.1172/JCI118224; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Olauson H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003975; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Rahbari R, 2011, ANN SURG ONCOL, V18, P1158, DOI 10.1245/s10434-010-1359-7; Ritter CS, 2011, J MOL ENDOCRINOL, V46, P63, DOI 10.1677/JME-10-0128; Silver J, 2002, AM J PHYSIOL-RENAL, V283, pF367, DOI 10.1152/ajprenal.00061.2002; Slatopolsky E, 2001, AM J KIDNEY DIS, V37, pS54, DOI 10.1053/ajkd.2001.20740; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053	49	21	24	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3964	3976		10.1096/fj.15-274191	http://dx.doi.org/10.1096/fj.15-274191			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26054367				2022-12-28	WOS:000359915600031
J	Di Giacomo, D; De Domenico, E; Sette, C; Geremia, R; Grimaldi, P				Di Giacomo, Daniele; De Domenico, Emanuela; Sette, Claudio; Geremia, Raffaele; Grimaldi, Paola			Type 2 cannabinoid receptor contributes to the physiological regulation of spermatogenesis	FASEB JOURNAL			English	Article						endocannabinoid system; histone methylation; meiosis; retinoic acid	FOLLICLE-STIMULATING-HORMONE; RETINOIC ACID; ENDOCANNABINOID SYSTEM; MEIOTIC INITIATION; EPIGENETIC EVENTS; MESSENGER-RNA; DIFFERENTIATION; SPERMATOGONIA; IDENTIFICATION; INVOLVEMENT	Type 2 cannabinoid receptor (CB2) has been proposed to play a pivotal role in meiotic entry of male germcells, similar to retinoic acid (RA). In this study, we showed that activation of CB2 with the specific agonist JWH133 [3-(1',1'-dimethylbutyl)-1-deoxy-8-THC] (IC50 10(-6) M) mimics epigenetic events induced by RA (IC50 1027 M) in spermatogonia. Both JWH133 and RA treatments stimulate the expression of the meiotic genes c-Kit and Stra8, by up-regulating H3K4me3 and down-regulating H3K9me2 levels in genomic regions flanking the transcription start site. Moreover, both agents increase the expression of Prdm9, the gene encoding a meiosis-specific histone, H3K4me3 methyltransferase, which marks hotspots of recombination in prophase I, thus resulting in a global increase in H3K4me3. Notably, prolonged administration of JWH133 to immature 7 dpp CD-1 mice induced an acceleration of the onset of spermatogenesis, whereas the specific CB2 antagonist delayed germ cell differentiation. Thus, both hyper- and hypostimulation of CB2 disrupted the temporal dynamics of the spermatogenic cycle. These findings highlight the importance of proper CB2 signaling for the maintenance of a correct temporal progression of spermatogenesis and suggest a possible adverse effect of cannabis in deregulating this process.-Di Giacomo, D., De Domenico, E., Sette, C., Geremia, R., Grimaldi, P. Type 2 cannabinoid receptor contributes to the physiological regulation of spermatogenesis. FASEB J. 30, 1453-1463 (2016). www.fasebj.org	[Di Giacomo, Daniele; De Domenico, Emanuela; Sette, Claudio; Geremia, Raffaele; Grimaldi, Paola] Univ Roma Tor Vergata, Sect Anat, Dept Biomed & Prevent, Rome, Italy; [Sette, Claudio] Fdn Santa Lucia, Lab Neuroembryol, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia	Grimaldi, P (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.	p.grimaldi@med.uniroma2.it	GRIMALDI, PAOLA/AAJ-7920-2020; Grimaldi, Paola/AAW-8721-2020	GRIMALDI, PAOLA/0000-0001-6724-7604; DE DOMENICO, EMANUELA/0000-0002-8937-605X	Grant PRIN from the Italian Ministry of Education; Agenzia Spaziale Italiana	Grant PRIN from the Italian Ministry of Education; Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	The authors thank Dr. M. Barchi and Dr. M. Faieta (Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Italy) for suggestions with nuclear spreads preparation and analysis and Dr. F. Botti (Department of Clinical Sciences and Translational Medicine-University of Rome "Tor Vergata", Italy) for assistance with histological preparation. This work was supported in part by Grant PRIN 2011 from the Italian Ministry of Education (to R.G.) and Agenzia Spaziale Italiana. The authors declare no conflicts of interest.	Akhmetshina A, 2009, ARTHRITIS RHEUM-US, V60, P1129, DOI 10.1002/art.24395; Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Busada JT, 2015, DEV BIOL, V397, P140, DOI 10.1016/j.ydbio.2014.10.020; Cacciola G, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105726; Chioccarelli T, 2010, ENDOCRINOLOGY, V151, P5017, DOI 10.1210/en.2010-0133; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Cobellis G, 2006, BIOL REPROD, V75, P82, DOI 10.1095/biolreprod.106.051730; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Godmann M, 2007, BIOL REPROD, P208; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Grimaldi P, 2012, CELL MOL LIFE SCI, V69, P4177, DOI 10.1007/s00018-012-1074-6; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; Griswold MD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096610; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lewis SEM, 2012, INT J ANDROL, V35, P731, DOI 10.1111/j.1365-2605.2012.01259.x; Maccarrone M, 2003, ENDOCRINOLOGY, V144, P20, DOI 10.1210/en.2002-220544; Meccariello R, 2006, MOL REPROD DEV, V73, P551, DOI 10.1002/mrd.20434; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; ROSSI P, 1993, DEV BIOL, V155, P68, DOI 10.1006/dbio.1993.1007; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wang Y, 2007, ENDOCRINOLOGY, V148, P2233, DOI 10.1210/en.2006-1206; Wenger T, 1999, J NEUROENDOCRINOL, V11, P873; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	44	24	24	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1453	1463		10.1096/fj.15-279034	http://dx.doi.org/10.1096/fj.15-279034			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26671998				2022-12-28	WOS:000372629100008
J	Friedline, RH; Ko, HJ; Jung, DY; Lee, Y; Bortell, R; Dagdeviren, S; Patel, PR; Hu, XD; Inashima, K; Kearns, C; Tsitsilianos, N; Shafiq, U; Shultz, LD; Lee, KW; Greiner, DL; Kim, JK				Friedline, Randall H.; Ko, Hwi Jin; Jung, Dae Young; Lee, Yongjin; Bortell, Rita; Dagdeviren, Sezin; Patel, Payal R.; Hu, Xiaodi; Inashima, Kunikazu; Kearns, Caitlyn; Tsitsilianos, Nicholas; Shafiq, Umber; Shultz, Leonard D.; Lee, Ki Won; Greiner, Dale L.; Kim, Jason K.			Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet-induced obesity and insulin resistance	FASEB JOURNAL			English	Article						glucose metabolism; energy balance; diabetes mouse models	SCID MOUSE; MODEL; INFLAMMATION; MACROPHAGES; SENSITIVITY; ENGRAFTMENT; DEFICIENT; IMMUNITY; TYPE-1	Obesity is characterized by a dysregulated immune system, which may causally associate with insulin resistance and type 2 diabetes. Despite widespread use of nonobese diabetic (NOD) mice, NOD with severe combined immunodeficiency (scid) mutation (SCID) mice, and SCID bearing a null mutation in the IL-2 common chain receptor (NSG) mice as animal models of human diseases including type 1 diabetes, the underlying metabolic effects of a genetically altered immune system are poorly understood. For this, we performed a comprehensive metabolic characterization of these mice fed chow or after 6 wk of a high-fat diet. We found that NOD mice had similar to 50% less fat mass and were 2-fold more insulin sensitive, as measured by hyperinsulinemic-euglycemic clamp, than C57BL/6 wild-type mice. SCID mice were also more insulin sensitive with increased muscle glucose metabolism and resistant to diet-induced obesity due to increased energy expenditure (similar to 10%) and physical activity (similar to 40%) as measured by metabolic cages. NSG mice were completely protected from diet-induced obesity and insulin resistance with significant increases in glucose metabolism in peripheral organs. Our findings demonstrate an important role of genetic background, lymphocytes, and cytokine signaling in diet-induced obesity and insulin resistance.	[Friedline, Randall H.; Ko, Hwi Jin; Jung, Dae Young; Lee, Yongjin; Bortell, Rita; Dagdeviren, Sezin; Patel, Payal R.; Hu, Xiaodi; Inashima, Kunikazu; Kearns, Caitlyn; Tsitsilianos, Nicholas; Shafiq, Umber; Greiner, Dale L.; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantation St,AS9-1041, Worcester, MA 01605 USA; [Bortell, Rita; Greiner, Dale L.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Lee, Ki Won] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; Seoul National University (SNU); Seoul National University (SNU)	Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantation St,AS9-1041, Worcester, MA 01605 USA.	jason.kim@umassmed.edu	Lee, Ki Won/M-4114-2018; Dagdeviren, Sezin/CAI-5833-2022; Dagdeviren, Sezin/I-9277-2019	Kim, Jason/0000-0002-7185-042X	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, R01-DK079999, R24-DK090963, U24-DK093000, U01-DK089572, UC4-DK1-4218]; American Diabetes Association Research Award [7-07-RA-80]; Helmsley Charitable Trust [2012PG-T1D018, 2015PG-T1D057]; National Leap Research Program through the National Research Foundation of Korea - Ministry of Science, International Cooperation and Future Planning of Korea [2010-0029233]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration (Seoul, Republic of Korea) [PJ008187]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK093000, U24DK093000, R24DK090963, R01DK079999, R01DK080756, U01DK089572] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association Research Award(American Diabetes Association); Helmsley Charitable Trust; National Leap Research Program through the National Research Foundation of Korea - Ministry of Science, International Cooperation and Future Planning of Korea; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration (Seoul, Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jung Yeon Kwon (University of Massachusetts Medical School) for editorial assistance in manuscript preparation. This study was supported by U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK080756, R01-DK079999, R24-DK090963, and U24-DK093000 (to J.K.K.), and U01-DK089572 and UC4-DK1-4218 (to L.D.S. and D.L.G.); American Diabetes Association Research Award 7-07-RA-80 (to J.K.K.); Helmsley Charitable Trust Grants 2012PG-T1D018 and 2015PG-T1D057 (to L.D.S. and D.L.G.); National Leap Research Program Grant 2010-0029233 (to K.W.L.) through the National Research Foundation of Korea funded by the Ministry of Science, International Cooperation and Future Planning of Korea, and Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008187), Rural Development Administration (Seoul, Republic of Korea). The authors declare no conflicts of interest.	Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Behan JW, 2013, OBESITY, V21, P1380, DOI 10.1002/oby.20159; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Gaber AO, 2004, TRANSPL P, V36, P1108, DOI 10.1016/j.transproceed.2004.04.055; Greiner DL, 2011, ANN NY ACAD SCI, V1245, P55, DOI 10.1111/j.1749-6632.2011.06318.x; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; LEITER EH, 1987, AM J PATHOL, V128, P380; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Parish Rebecca, 2005, Curr Diab Rep, V5, P177, DOI 10.1007/s11892-005-0006-3; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; van der Loo JCM, 1998, BLOOD, V92, P2556, DOI 10.1182/blood.V92.7.2556.2556_2556_2570; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	28	9	9	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1328	1338		10.1096/fj.15-280610	http://dx.doi.org/10.1096/fj.15-280610			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644351	Green Published			2022-12-28	WOS:000370387800028
J	Schroder, H; Komljenovic, D; Hecker, M; Korff, T				Schroeder, Hannes; Komljenovic, Dorde; Hecker, Markus; Korff, Thomas			Transdermal drug targeting and functional imaging of tumor blood vessels in the mouse auricle	FASEB JOURNAL			English	Article						angiogenesis; blood vessel growth; bortezomib; mouse model; perfusion	UBIQUITIN-PROTEASOME SYSTEM; FLOW-INDUCED DILATION; ANTIANGIOGENIC THERAPY; DOPPLER ULTRASOUND; MULTIPLE-MYELOMA; MULTICELLULAR SPHEROIDS; COMPUTED-TOMOGRAPHY; ACTIVATOR PROTEIN-1; GENE-EXPRESSION; MICRO-CT	Subcutaneously growing tumors are widely utilized to study tumor angiogenesis and the efficacy of antiangiogenic therapies in mice. To additionally assess functional and morphologic alterations of the vasculature in the periphery of a growing tumor, we exploited the easily accessible and hierarchically organized vasculature of the mouse auricle. By site-specific subcutaneous implantation of a defined preformed mouse B16/F0 melanoma aggregate, a solid tumor nodule developed within 14 d. Growth of the tumor nodule was accompanied by a 4-fold increase in its perfusion as well as a 2-to 4-fold elevated diameter and perfusion of peripheral blood vessels that had connected to the tumor capillary microvasculature. By transdermal application of the anticancer drug bortezomib, tumor growth was significantly diminished by about 50% without provoking side effects. Moreover, perfusion and tumor microvessel diameter as well as growth and perfusion of arterial or venous blood vessels supplying or draining the tumor microvasculature were decreased under these conditions by up to 80%. Collectively, we observed that the progressive tumor growth is accompanied by the enlargement of supplying and draining extratumoral blood vessels. This process was effectively suppressed by bortezomib, thereby restricting the perfusion capacity of both extra and intratumoral blood vessels.	[Schroeder, Hannes; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany; [Komljenovic, Dorde] German Canc Res Ctr, Dept Med Phys Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Korff, T (corresponding author), Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB TR 23]; Heidelberg University Faculty of Medicine; Krebs und Scharlach Stiftung Mannhein	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg University Faculty of Medicine; Krebs und Scharlach Stiftung Mannhein	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (SFB TR 23, project sections C5, C6, and Z1, Ursula M. Handel Animal Welfare Award), the Postdoc Fellowship Program of the Heidelberg University Faculty of Medicine, and the Krebs und Scharlach Stiftung Mannhein. The authors acknowledge the excellent technical assistance of G. Scheib (Heidelberg University) and K. Oehme (DKFZ, Heidelberg). Y. Sun (DKFZ, Heidelberg) is acknowledged for help in CT image processing.	Amiri KI, 2004, CANCER RES, V64, P4912, DOI 10.1158/0008-5472.CAN-04-0673; Barringhaus Kurt G, 2007, Exp Clin Cardiol, V12, P119; Brahimi-Horn C, 2001, TRENDS CELL BIOL, V11, pS32, DOI 10.1016/S0962-8924(01)02126-2; Bzyl J, 2013, EUR RADIOL, V23, P468, DOI 10.1007/s00330-012-2594-z; Carew JS, 2008, CANCER RES, V68, P4783, DOI 10.1158/0008-5472.CAN-07-6483; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Drews O, 2010, CIRC RES, V107, P1094, DOI 10.1161/CIRCRESAHA.110.222364; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Eisa F, 2012, EUR RADIOL, V22, P900, DOI 10.1007/s00330-011-2318-9; FALCONE JC, 1993, AM J PHYSIOL, V264, pH653, DOI 10.1152/ajpheart.1993.264.2.H653; Feldner A, 2011, FASEB J, V25, P3613, DOI 10.1096/fj.11-185975; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Goertz DE, 2002, CANCER RES, V62, P6371; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; KUO L, 1990, AM J PHYSIOL, V259, pH1063, DOI 10.1152/ajpheart.1990.259.4.H1063; Lashinger LM, 2005, CANCER RES, V65, P4902, DOI 10.1158/0008-5472.CAN-04-3701; Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; MUELLERKLIESER W, 1987, J CANCER RES CLIN, V113, P101, DOI 10.1007/BF00391431; Pagan J, 2013, CIRC RES, V112, P1046, DOI 10.1161/CIRCRESAHA.112.300521; Palmowski M, 2008, CANCER RES, V68, P7042, DOI 10.1158/0008-5472.CAN-08-0285; Pascarella L, 2005, J VASC SURG, V41, P303, DOI 10.1016/j.jvs.2004.10.038; Patan S, 2001, CIRC RES, V89, P732, DOI 10.1161/hh2001.097872; Pfisterer L, 2014, FASEB J, V28, P3518, DOI 10.1096/fj.14-250464; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Prior BM, 2004, AM J PHYSIOL-HEART C, V287, pH2434, DOI 10.1152/ajpheart.00398.2004; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Scholz Dimitri, 2001, Angiogenesis, V4, P247, DOI 10.1023/A:1016094004084; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Soriano GP, 2014, ANTIOXID REDOX SIGN, V21, P2419, DOI 10.1089/ars.2013.5794; Tung D, 2011, PHARMACOLOGY, V88, P100, DOI 10.1159/000330067; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; van Es RJJ, 1999, LAB ANIM-UK, V33, P175, DOI 10.1258/002367799780578372; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; Xuan JW, 2007, CANCER RES, V67, P2830, DOI 10.1158/0008-5472.CAN-06-3944; YUHAS JM, 1977, CANCER RES, V37, P3639; ZAMORA PO, 1980, CANCER RES, V40, P4631	47	2	2	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					923	932		10.1096/fj.15-279240	http://dx.doi.org/10.1096/fj.15-279240			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26546130				2022-12-28	WOS:000369391900039
J	Zarpelon, AC; Rodrigues, FC; Lopes, AH; Souza, GR; Carvalho, TT; Pinto, LG; Xu, DM; Ferreira, SH; Alves, JC; McInnes, IB; Ryffel, B; Quesniaux, VFJ; Reverchon, F; Mortaud, S; Menuet, A; Liew, FY; Cunha, FQ; Cunha, TM; Verri, WA				Zarpelon, Ana C.; Rodrigues, Francielle C.; Lopes, Alexandre H.; Souza, Guilherme R.; Carvalho, Thacyana T.; Pinto, Larissa G.; Xu, Damo; Ferreira, Sergio H.; Alves-Filho, Jose C.; McInnes, Iain B.; Ryffel, Bernhard; Quesniaux, Valerie F. J.; Reverchon, Flora; Mortaud, Stephane; Menuet, Arnaud; Liew, Foo Y.; Cunha, Fernando Q.; Cunha, Thiago M.; Verri, Waldiceu A., Jr.			Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain	FASEB JOURNAL			English	Article						hyperalgesia; glial cells; MAPK; mTOR; NF-kappa B	NECROSIS-FACTOR-ALPHA; LONG-TERM POTENTIATION; INFLAMMATORY PAIN; INDUCED ARTHRITIS; IMMUNE-RESPONSES; NERVE INJURY; TNF-ALPHA; MICE; INTERLEUKIN-33; MECHANISMS	Neuropathic pain from injury to the peripheral and CNS represents a major health care issue. We have investigated the role of IL-33/IL-33 receptor (ST2) signaling in experimental models of neuropathic pain in mice. Chronic constriction injury (CCI) of the sciatic nerve induced IL-33 production in the spinal cord. IL-33/citrine reporter mice revealed that oligodendrocytes are the main cells expressing IL-33 within the spinal cord together with a minor expression by neurons, microglia. and astrocytes. CCI-induced mechanical hyperalgesia was reduced in IL-33R (ST2) (-/-) mice compared with wild-type (WT) mice. Intrathecal treatment of WT mice with soluble IL-33 receptor (IL-33 decoy receptor) markedly reduced CCI-induced hyperalgesia. Consistent with these observations, intrathecal injection of IL-33 enhanced CCI hyperalgesia and induced hyperalgesia in naive mice. IL-33-mediated hyperalgesia during CCI was dependent on a reciprocal relationship with TNF-alpha and IL-1 beta. IL-33-induced hyperalgesia was markedly attenuated by inhibitors of PI3K, mammalian target of rapamycin, MAPKs (p38, ERK, and JNK), NF-kappa B, and also by the inhibitors of glial cells (microglia and astrocytes). Furthermore, targeting these signaling pathways and cells inhibited IL-33-induced TNF-alpha a and IL-1 beta production in the spinal cord. Our study, therefore, reveals an important role of oligodendrocyte-derived IL-33 in neuropathic pain.-Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., Xu, D., Ferreira, S. H., Alves-Filho, J. C., McInnes, I. B., Ryffel, B., Quesniaux, V. F. J., Reverchon, F., Mortaud, S., Menuet, A., Liew, F. Y., Cunha, F. Q., Cunha, T. M., Verri, Jr., W. A. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB J. 30, 54-65 (2016). www.fasebj.org	[Zarpelon, Ana C.; Rodrigues, Francielle C.; Carvalho, Thacyana T.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, BR-86057970 Londrina, Parana, Brazil; [Lopes, Alexandre H.; Souza, Guilherme R.; Pinto, Larissa G.; Ferreira, Sergio H.; Alves-Filho, Jose C.; Cunha, Fernando Q.; Cunha, Thiago M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil; [Xu, Damo; McInnes, Iain B.; Liew, Foo Y.] Univ Glasgow, Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow, Lanark, Scotland; [Ryffel, Bernhard; Quesniaux, Valerie F. J.; Reverchon, Flora; Mortaud, Stephane; Menuet, Arnaud] Ctr Natl Rech Sci Expt & Mol Immunol & Neurogenet, Unites Mixtes Rech 7355, Orleans, France; [Ryffel, Bernhard; Quesniaux, Valerie F. J.; Reverchon, Flora; Mortaud, Stephane; Menuet, Arnaud] Univ Orleans, Immunol & Neurogenet Expt & Mol, Orleans, France; [Liew, Foo Y.] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China	Universidade Estadual de Londrina; Universidade de Sao Paulo; University of Glasgow; Universite de Orleans; Soochow University - China	Verri, WA (corresponding author), Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Rod Celso Garcia Cid Pr 445,KM 380, BR-86057970 Londrina, Parana, Brazil.	waldiceujr@yahoo.com.br	Cunha, Fernando Q/M-3090-2014; Pinto, Larissa Garcia/ADL-0928-2022; WA, Verri/I-1330-2013; de Carvalho, Thacyana Teixeira/AAJ-7187-2020; Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Thiago M/B-7729-2012	Pinto, Larissa Garcia/0000-0002-3619-907X; WA, Verri/0000-0003-2756-9283; de Carvalho, Thacyana Teixeira/0000-0002-8580-6200; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Cunha, Thiago M/0000-0003-1084-0065; Cunha, Fernando Queiroz/0000-0003-4755-1670; Mortaud, Stephane/0000-0003-0873-4781; Reverchon, Flora/0000-0003-1642-4775	Miniterio da Ciencia, Tecnologia e Inovacao; Secretaria da Ciencia, Secretaria da Ciencia, Tecnologia e Ensino Superior; Fundacao Araucaria; Parana State Government; Sao Paulo Research Foundation [2011/19670-0, 2013/08216-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Financiadora de Estudo e Projetos-Apoio a Infraestrutura (CT-INFRA) [01.13.0049.00]; Fundacao Araucaria/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Curitiba, Brazil); European Union [HEALTH-F4-2011-281608]; Scan Design Foundation	Miniterio da Ciencia, Tecnologia e Inovacao; Secretaria da Ciencia, Secretaria da Ciencia, Tecnologia e Ensino Superior; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Parana State Government; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudo e Projetos-Apoio a Infraestrutura (CT-INFRA); Fundacao Araucaria/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Curitiba, Brazil); European Union(European Commission); Scan Design Foundation	The authors thank Giuliana Francisco, Ieda Schivo, and Sergio Rosa (Universidade de Sao Paulo, Sao Paulo, Brazil) for technical assistance. Miniterio da Ciencia, Tecnologia e Inovacao; Secretaria da Ciencia, Secretaria da Ciencia, Tecnologia e Ensino Superior; Fundacao Araucaria; Parana State Government; Sao Paulo Research Foundation under grant agreements 2011/19670-0 (Thematic Project) and 2013/08216-2 (Center for Research in Inflammatory Disease); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; and Financiadora de Estudo e Projetos-Apoio a Infraestrutura (CT-INFRA 01/2011; process 01.13.0049.00) grants supported this study. A.C.Z. received a postdoctoral fellowship from Fundacao Araucaria/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Curitiba, Brazil). This work was supported by the European Union Seventh Framework Programme (FP7-2007-2013) under grant agreement HEALTH-F4-2011-281608 (TIMER). The Centre National de la Recherche Scientifique International Associated Laboratory 1047, and the 2010 International Association for the Study of Pain Early Career Grant funded by the Scan Design Foundation by Inger and Jens Bruun also supported this study. The authors declare no conflicts of interest.	Balato A, 2014, ARCH DERMATOL RES, V306, P299, DOI 10.1007/s00403-014-1447-9; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Draleau Ks, 2014, J Pain Relief, VSuppl 3, P003; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Echeverry S, 2008, PAIN, V135, P37, DOI 10.1016/j.pain.2007.05.002; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gritsch S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6472; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Gruber-Schoffnegger D, 2013, J NEUROSCI, V33, P6540, DOI 10.1523/JNEUROSCI.5087-12.2013; Han P, 2013, NEUROSCIENCE, V241, P59, DOI 10.1016/j.neuroscience.2013.03.019; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Leung BP, 2004, J IMMUNOL, V173, P145, DOI 10.4049/jimmunol.173.1.145; Li P, 2015, CLIN EXP DERMATOL, V40, P163, DOI 10.1111/ced.12464; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu YL, 2007, NEUROPHARMACOLOGY, V52, P708, DOI 10.1016/j.neuropharm.2006.09.011; Ma WY, 2012, EXPERT OPIN THER TAR, V16, P527, DOI 10.1517/14728222.2012.680955; Magro DAC, 2013, BRAZ J MED BIOL RES, V46, P601, DOI 10.1590/1414-431X20132894; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Salmond RJ, 2012, J ALLERGY CLIN IMMUN, V130, P1159, DOI 10.1016/j.jaci.2012.05.018; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Taniguchi K, 2013, J INVEST ALLERG CLIN, V23, P428; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110; Zhang HJ, 2010, J NEUROSCI, V30, P12844, DOI 10.1523/JNEUROSCI.2437-10.2010; Zhao J, 2013, NEUROSCIENCE, V253, P172, DOI 10.1016/j.neuroscience.2013.08.026	45	95	99	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					54	65		10.1096/fj.14-267146	http://dx.doi.org/10.1096/fj.14-267146			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26310268				2022-12-28	WOS:000367621000008
J	Huang, CX; Chen, N; Wu, XJ; Huang, CH; He, Y; Tang, R; Wang, WM; Wang, HL				Huang, Chun-Xiao; Chen, Nan; Wu, Xin-Jie; Huang, Cui-Hong; He, Yan; Tang, Rong; Wang, Wei-Min; Wang, Huan-Ling			The zebrafish miR-462/miR-731 cluster is induced under hypoxic stress via hypoxia-inducible factor 1 alpha and functions in cellular adaptations	FASEB JOURNAL			English	Article						cell survival; embryonic development; low oxygen; hypoxamir	TRANSCRIPTION FACTORS; RESPONSIVE MICRORNAS; TUMOR-SUPPRESSOR; MESSENGER-RNAS; EARLY EMBRYOS; CANCER CELLS; EXPRESSION; PROLIFERATION; HIF-1-ALPHA; GROWTH	Hypoxia, a unique and essential environmental stress, evokes highly coordinated cellular responses, and hypoxia-inducible factor (HIF) 1 in the hypoxia signaling pathway, an evolutionarily conserved cellular signaling pathway, acts as a master regulator of the transcriptional response to hypoxic stress. MicroRNAs (miRNAs), a major class of posttranscriptional gene expression regulators, also play pivotal roles in orchestrating hypoxia-mediated cellular adaptations. Here, global miRNA expression profiling and quantitative real-time PCR indicated that the up-regulation of the miR-462/miR-731 cluster in zebrafish larvae is induced by hypoxia. It was further validated that miR-462 and miR-731 are up-regulated in a Hif-1a-mediated manner under hypoxia and specifically target ddx5 and ppm1da, respectively. Overexpression of miR-462 and miR-731 represses cell proliferation through blocking cell cycle progress of DNA replication, and induces apoptosis. In situ detection revealed that the miR-462/miR-731 cluster is highly expressed in a consistent and ubiquitous manner throughout the early developmental stages. Additionally, the transcripts become restricted to the notochord, pharyngeal arch, liver, and gut regions from postfertiliztion d 3 to 5. These data highlight a previously unidentified role of the miR-462/miR-731 cluster as a crucial signalingmediator for hypoxia-mediated cellular adaptations and provide some insights into the potential function of the cluster during embryonic development.	[Huang, Chun-Xiao; Chen, Nan; Wu, Xin-Jie; Huang, Cui-Hong; He, Yan; Tang, Rong; Wang, Wei-Min; Wang, Huan-Ling] Huazhong Agr Univ, Key Lab Freshwater Anim Breeding, Wuhan, Hubei, Peoples R China; [Huang, Chun-Xiao; Chen, Nan; Wu, Xin-Jie; Huang, Cui-Hong; He, Yan; Tang, Rong; Wang, Wei-Min; Wang, Huan-Ling] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Fishery, Wuhan, Hubei, Peoples R China; [Tang, Rong; Wang, Wei-Min; Wang, Huan-Ling] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Wang, HL (corresponding author), Huazhong Agr Univ, Coll Fishery, 1 Shizishan St, Wuhan 430070, Hu, Peoples R China.	hbauwhl@hotmail.com	Li, Dapeng/K-6315-2018	Li, Dapeng/0000-0002-8232-3094	National Science Foundation of China [30901099]; Fundamental Research Funds for the Central Universities [2013PY067]; Scientific Research Foundation for Returned Scholars; Ministry of Education of China; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation [2013SC10]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Ministry of Education of China(Ministry of Education, China); Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation	This work was supported in part by the National Science Foundation of China (30901099), the Fundamental Research Funds for the Central Universities (2013PY067), Scientific Research Foundation for Returned Scholars, Ministry of Education of China, and Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation (2013SC10).	Agrawal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-686; Barckmann B, 2013, BBA-GENE REGUL MECH, V1829, P714, DOI 10.1016/j.bbagrm.2012.12.011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brock M, 2015, INT J BIOCHEM CELL B, V61, P129, DOI 10.1016/j.biocel.2015.02.002; CHAN SC, 2010, CELL CYCLE, V9, P9; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cohen A, 2014, ZEBRAFISH, V11, P462, DOI 10.1089/zeb.2013.0873; Courtnay R, 2015, MOL BIOL REP, V42, P841, DOI 10.1007/s11033-015-3858-x; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Feng JL, 2014, J CELL MOL MED, V18, P2125, DOI 10.1111/jcmm.12398; Fuller-Pace FV, 2013, BBA-GENE REGUL MECH, V1829, P756, DOI 10.1016/j.bbagrm.2013.03.004; GAO JL, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/354143; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Greco S, 2014, ANTIOXID REDOX SIGN, V21, P1164, DOI 10.1089/ars.2014.6083; Guimbellot JS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-15; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hatano K, 2015, NUCLEIC ACIDS RES, V43, P4075, DOI 10.1093/nar/gkv273; He GD, 2014, ASIA PAC J CLIN NUTR, V23, P174, DOI 10.6133/apjcn.2014.23.1.14; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Howell JC, 2013, MOL VIS, V19, P544; Imanirad P, 2013, BLOOD CELL MOL DIS, V51, P256, DOI 10.1016/j.bcmd.2013.08.005; Ishikawa K, 2014, INT J MOL SCI, V15, P2971, DOI 10.3390/ijms15022971; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kelly TJ, 2011, MOL CELL BIOL, V31, P2696, DOI 10.1128/MCB.01242-10; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lau K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110698; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lin TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101980; Liu FL, 2015, PLANT CELL ENVIRON, V38, P1357, DOI 10.1111/pce.12484; Lu YF, 2015, EXP CELL RES, V334, P173, DOI 10.1016/j.yexcr.2015.03.027; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mazurek A, 2012, CANCER DISCOV, V2, P812, DOI 10.1158/2159-8290.CD-12-0116; Minton DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120649; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Nathaniel TI, 2015, BRAIN RES BULL, V114, P1, DOI 10.1016/j.brainresbull.2015.02.006; Nathaniel TI, 2015, J EXP NEUROSCI, V9, P1, DOI 10.4137/JEN.S22512; Ortmann B, 2014, CELL MOL LIFE SCI, V71, P3569, DOI 10.1007/s00018-014-1645-9; Ouchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088086; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Piriyapongsa J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-61; Rebucci M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0349-6; Schaffer K, 2015, FEBS J, V282, P2260, DOI 10.1111/febs.13270; Seok JK, 2014, NUCLEIC ACIDS RES, V42, P8062, DOI 10.1093/nar/gku515; Shan FB, 2014, J CELL PHYSIOL, V229, P1511, DOI 10.1002/jcp.24593; Sinha M, 2015, ANTIOXID REDOX SIGN, V22, P1257, DOI 10.1089/ars.2014.6065; Span PN, 2015, SEMIN NUCL MED, V45, P101, DOI 10.1053/j.semnuclmed.2014.10.002; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun XJ, 2015, CLIN ORTHOP RELAT R, V473, P907, DOI 10.1007/s11999-014-3842-0; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Svoboda P, 2010, RNA BIOL, V7, P559, DOI 10.4161/rna.7.5.12940; Tal TL, 2012, FASEB J, V26, P1452, DOI 10.1096/fj.11-194464; Tang HB, 2012, FASEB J, V26, P4710, DOI 10.1096/fj.11-197467; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Tomlinson RE, 2015, BONE, V73, P98, DOI 10.1016/j.bone.2014.12.015; Val AL, 2015, COMP BIOCHEM PHYS A, V184, P125, DOI 10.1016/j.cbpa.2015.02.020; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xi H, 2014, FEBS LETT, V588, P3390, DOI 10.1016/j.febslet.2014.07.030; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yu ZY, 2013, MOL MED REP, V8, P287, DOI 10.3892/mmr.2013.1493; Yuan J, 2015, BIOCHEM BIOPH RES CO, V457, P171, DOI 10.1016/j.bbrc.2014.12.078; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang ZH, 2015, STEM CELL REP, V4, P645, DOI 10.1016/j.stemcr.2015.02.009	80	26	27	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4901	4913		10.1096/fj.14-267104	http://dx.doi.org/10.1096/fj.14-267104			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26265472				2022-12-28	WOS:000365523600016
J	Tzenaki, N; Aivaliotis, M; Papakonstanti, EA				Tzenaki, Niki; Aivaliotis, Michalis; Papakonstanti, Evangelia A.			Focal adhesion kinase phosphorylates the phosphatase and tensin homolog deleted on chromosome 10 under the control of p110 delta phosphoinositide-3 kinase	FASEB JOURNAL			English	Article						tyrosine phosphorylation; tumor suppressor; RhoA; ROCK	TUMOR-SUPPRESSOR; INSULIN-RESISTANCE; PROTEIN STABILITY; PI3K ISOFORMS; PTEN; RHOA; CELL; ACTIVATION; CANCER; FAK	The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor protein is regulated by various mechanisms that are not fully understood. This includes regulation by Tyr phosphorylation by a mechanism that remains elusive. Here, we show that focal adhesion kinase (FAK) phosphorylates PTEN in vitro, in cell-free systems and in cells. Furthermore, by mass spectrometry, we identified Tyr336 on PTEN as being phosphorylated by FAK. Tyr336 phosphorylation increased phosphatase activity, protein-lipid interaction, and protein stability of PTEN. In cells, including primary mouse macrophages and human cancer cell lines, FAK was found to be negatively regulated by p110 delta phosphoinositide-3 kinase (PI3K), whereas the activation of FAK was positively regulated by RhoA-associated kinase (ROCK). Indeed, the phosphorylation of FAK was unexpectedly increased in macrophages derived frommice expressing kinase-dead p110 delta. Pharmacologic inactivation of RhoA/ROCK reduced the phosphorylation of FAK to normal levels in cells with genetically inactivated p110 delta. Likewise, pharmacologic inactivation of FAK reduced the phosphorylation of PTEN in cells expressing kinase-dead p110 delta and restored the functional defects of p110 delta inactivation, including Akt phosphorylation and cell proliferation. This work identifies FAK as a target of p110 delta PI3K that links RhoA with PTEN and establishes for the first time that PTEN is a substrate of FAK-mediated Tyr phosphorylation.	[Tzenaki, Niki; Papakonstanti, Evangelia A.] Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece; [Aivaliotis, Michalis] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece	University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Papakonstanti, EA (corresponding author), Univ Crete, Fac Med, Room 2B-14, Iraklion 71003, Greece.	epapak@med.uoc.gr	; Aivaliotis, Michalis/D-4841-2011	Papakonstanti, Evangelia/0000-0002-7119-6026; Aivaliotis, Michalis/0000-0003-1173-7705	Research Committee of the University of Crete [KA 4059]; Ministry of Education and Religious Affairs, Amaroysioy, Greece [4078]; European Union; BIOSYS research project, Action KRIPIS [MIS-448301, 2013SE01380036]; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund/European Commission; Seventh Framework Programme [229823]	Research Committee of the University of Crete; Ministry of Education and Religious Affairs, Amaroysioy, Greece; European Union(European Commission); BIOSYS research project, Action KRIPIS; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund/European Commission; Seventh Framework Programme(European Commission)	The authors are grateful to Nikos Kountourakis for his help with sample preparation for nLC-MS/MS. The authors are also grateful to Shiaw-Yih Lin for the PTEN<SUP>Tyr336F</SUP> plasmid and to Bart Vanhaesebroeck for his critical reading of the manuscript. This work was supported by the Research Committee of the University of Crete (KA 4059) and by the programme National Strategic Reference Framework 2007-2013, "Education & Lifelong Learning" (Action ARISTEIA II, Project No. 4078) of the Ministry of Education and Religious Affairs, Amaroysioy, Greece, cofinanced by Greece and the European Union. Part of this work was supported by the BIOSYS research project, Action KRIPIS, project No. MIS-448301 (2013SE01380036), which was funded by the General Secretariat for Research and Technology, Ministry of Education, Greece and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, National Strategic Reference Framework 2007-2013)/European Commission, and by the Seventh Framework Programme agreement 229823 Capacities-FP7-REGPOT-2008-1/project "ProFI" (to M.A.).	Aivaliotis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004777; Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bisht B, 2007, DIABETOLOGIA, V50, P1058, DOI 10.1007/s00125-007-0591-6; Bisht B, 2008, J PHYSIOL-LONDON, V586, P3825, DOI 10.1113/jphysiol.2008.157107; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carr HS, 2013, MOL CELL BIOL, V33, P2773, DOI 10.1128/MCB.00175-13; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chaturvedi LS, 2011, AM J PHYSIOL-CELL PH, V301, pC1224, DOI 10.1152/ajpcell.00518.2010; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Foukas LC, 2013, EMBO MOL MED, V5, P563, DOI 10.1002/emmm.201201953; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Giorgio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018128; Goundiam O, 2012, CELL BIOL INT, V36, P311, DOI 10.1042/CBI20110069; Gupta A, 2012, MOL BIOL CELL, V23, P3882, DOI 10.1091/mbc.E12-05-0337; Harishchandra RK, 2015, METHODS, V77-78, P125, DOI 10.1016/j.ymeth.2015.02.004; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Huynh Mai-Loan, 2009, V519, P507, DOI 10.1007/978-1-59745-281-6_34; Kostourou V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3020; Koul D, 2002, ONCOGENE, V21, P2357, DOI 10.1038/sj/onc/1205296; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Nakamura J, 2008, BIOCHEM BIOPH RES CO, V374, P699, DOI 10.1016/j.bbrc.2008.07.123; Nelson VLB, 2014, AM J PHYSIOL-ENDOC M, V306, pE1205, DOI 10.1152/ajpendo.00625.2013; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Okkenhaug K, 2002, SCIENCE, V297, P1031; Owen JL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00159; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sinnett-Smith J, 2001, EXP CELL RES, V266, P292, DOI 10.1006/excr.2001.5219; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smith GC, 2012, BIOCHEM J, V442, P161, DOI 10.1042/BJ20111913; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Tavora B, 2010, EMBO MOL MED, V2, P516, DOI 10.1002/emmm.201000106; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Tups A, 2010, J NEUROENDOCRINOL, V22, P534, DOI 10.1111/j.1365-2826.2010.01975.x; Tzenaki N, 2012, FASEB J, V26, P2498, DOI 10.1096/fj.11-198192; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang SY, 2011, AM J PHYSIOL-CELL PH, V300, pC657, DOI 10.1152/ajpcell.00377.2010; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Yagi Y, 2006, EUR J PHARMACOL, V536, P19, DOI 10.1016/j.ejphar.2006.02.024; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yim JH, 2007, CELL DEATH DIFFER, V14, P1872, DOI 10.1038/sj.cdd.4402204; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	66	16	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4840	4852		10.1096/fj.15-274589	http://dx.doi.org/10.1096/fj.15-274589			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26251180				2022-12-28	WOS:000365523600011
J	Pushpakumar, S; Kundu, S; Narayanan, N; Sen, U				Pushpakumar, Sathnur; Kundu, Sourav; Narayanan, Nithya; Sen, Utpal			DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney	FASEB JOURNAL			English	Article						epigenetics; renal fibrosis; 5-aza-2'-deoxycytidine; matrix metalloproteinase	CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; DIFFERENTIAL REGULATION; TISSUE INHIBITOR; DIETARY-FOLATE; HOMOCYSTEINE; METHYLATION; METALLOPROTEINASES; HYPERTENSION; EPIGENETICS	Hyperhomocysteinemia (HHcy) is prevalent in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Emerging studies suggest that epigenetic mechanisms contribute to the development and progression of fibrosis in CKD. HHcy and its intermediates are known to alter the DNA methylation pattern, which is a critical regulator of epigenetic information. In this study, we hypothesized that HHcy causes renovascular remodeling by DNA hypermethylation, leading to glomerulosclerosis. We also evaluated whether the DNA methylation inhibitor, 5-aza-2'-deoxycytidine (5-Aza) could modulate extracellular matrix (ECM) metabolism and reduce renovascular fibrosis. C57BL/6J (wild-type) and cystathionine-beta-synthase (CBS+/-) mice, treated without or with 5-Aza (0.5 mg/kg body weight, i.p.), were used. CBS+/- mice showed high plasma Hcy levels, hypertension, and significant glomerular and arteriolar injury. 5-Aza treatment normalized blood pressureandreversed renal injury. CBS+/- mice showed global hypermethylation and up-regulation of DNAmethyltransferase-1 and -3a. Methylation-specific PCR showed an imbalance between matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and -2 and also increased collagen and galectin-3 expression. 5-Aza reduced abnormal DNA methylation and restored the MMP-9/TIMP-1, -2 balance. In conclusion, our data suggest that during HHcy, abnormal DNA methylation and an imbalance between MMP-9 and TIMP-1 and -2 lead to ECM remodeling and renal fibrosis.	[Pushpakumar, Sathnur; Kundu, Sourav; Narayanan, Nithya; Sen, Utpal] Univ Louisville, Dept Physiol & Biophys, Sch Med, Louisville, KY 40292 USA	University of Louisville	Pushpakumar, S (corresponding author), 500 South Preston St,HSC-A,1115, Louisville, KY 40292 USA.	sbpush01@louisville.edu; u0sen001@louisville.edu	Kundu, Sourav/J-1531-2015	KUNDU, SOURAV/0000-0001-9027-5734; Narayanan, Nithya/0000-0001-9110-0311	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL-104103]; American Heart Association Scientist Development [15SDG25840013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104103] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Scientist Development(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL-104103 (to U.S.); and American Heart Association Scientist Development Grant 15SDG25840013 (to S.P.). S.P. designed the experiment, acquired data, and wrote the manuscript. S.K. researched data and contributed to methods. N.N. contributed to treatment and data collection. U.S. contributed to research design and discussion. The authors declare no conflicts of interest.	Ahmed AK, 2007, KIDNEY INT, V71, P755, DOI 10.1038/sj.ki.5002108; Amarnath K, 2003, TALANTA, V60, P1229, DOI 10.1016/S0039-9140(03)00232-7; Atamer A, 2008, J NEPHROL, V21, P924; BADER R, 1980, PATHOL RES PRACT, V167, P204, DOI 10.1016/S0344-0338(80)80051-3; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Beckerman P, 2014, NEPHROL DIAL TRANSPL, V29, P1821, DOI 10.1093/ndt/gfu026; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Chaturvedi P, 2014, PHYSIOL GENOMICS, V46, P245, DOI 10.1152/physiolgenomics.00168.2013; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Dang ZX, 2012, TRANSPLANTATION, V93, P477, DOI 10.1097/TP.0b013e318242f40a; Davis CD, 2003, J NUTR, V133, P2907, DOI 10.1093/jn/133.9.2907; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Dong Z, 2001, INT J CANCER, V93, P507, DOI 10.1002/ijc.1358; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809; Gonzalez-Avila G, 1998, PATHOBIOLOGY, V66, P196, DOI 10.1159/000028023; Higgins DF, 2014, J AM SOC NEPHROL, V25, P865, DOI 10.1681/ASN.2014010006; Huang YC, 2011, TOXICOL LETT, V201, P62, DOI 10.1016/j.toxlet.2010.12.006; Ingrosso D, 2009, BBA-GEN SUBJECTS, V1790, P892, DOI 10.1016/j.bbagen.2008.11.010; Jadavji NM, 2014, BIOCHEM J, V461, P205, DOI 10.1042/BJ20131568; Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Kumagai H, 2002, KIDNEY INT, V62, P1219, DOI 10.1046/j.1523-1755.2002.00558.x; Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li NJ, 2002, HYPERTENSION, V39, P443, DOI 10.1161/hy02t2.102992; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776; MAI M, 1993, HYPERTENSION, V22, P754, DOI 10.1161/01.HYP.22.5.754; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Marti F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-733; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Narayanan N, 2014, FASEB J, V28, P3411, DOI 10.1096/fj.14-250183; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Pushpakumar S., 2013, J HYPERTENS, V31, P2281; Pushpakumar S, 2013, J HYPERTENS, V31, P2270, DOI 10.1097/HJH.0b013e3283649b33; Pushpakumar SB, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.63; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sen U, 2008, AM J PHYSIOL-ENDOC M, V295, pE1205, DOI 10.1152/ajpendo.90534.2008; Sen U, 2011, AM J PHYSIOL-CELL PH, V300, pC155, DOI 10.1152/ajpcell.00143.2010; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Shastry S, 2007, KIDNEY INT, V71, P304, DOI 10.1038/sj.ki.5002031; Smyth LJ, 2014, EPIGENETICS-US, V9, P366, DOI 10.4161/epi.27161; Sohn KJ, 2003, CARCINOGENESIS, V24, P81, DOI 10.1093/carcin/24.1.81; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; SuttonTyrrell K, 1997, CIRCULATION, V96, P1745, DOI 10.1161/01.CIR.96.6.1745; Tbahriti Hadja Fatima, 2013, World J Nephrol, V2, P31, DOI 10.5527/wjn.v2.i2.31; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; van Guldener C, 2005, CLIN CHEM LAB MED, V43, P1026, DOI 10.1515/CCLM.2005.180; van Guldener C, 2006, NEPHROL DIAL TRANSPL, V21, P1161, DOI 10.1093/ndt/gfl044; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Wing MR, 2014, NEPHROL DIAL TRANSPL, V29, P864, DOI 10.1093/ndt/gft537; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Zhang DH, 2015, ARTERIOSCL THROM VAS, V35, P71, DOI 10.1161/ATVBAHA.114.303899; Zhou SY, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-134	70	32	34	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4713	4725		10.1096/fj.15-272443	http://dx.doi.org/10.1096/fj.15-272443			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26224753	Green Published			2022-12-28	WOS:000364514700027
J	Vandal, M; White, PJ; Chevrier, G; Tremblay, C; St-Amour, I; Planel, E; Marette, A; Calon, F				Vandal, Milene; White, Phillip J.; Chevrier, Genevieve; Tremblay, Cyntia; St-Amour, Isabelle; Planel, Emmanuel; Marette, Andre; Calon, Frederic			Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid; insulin; pancreas	ISLET AMYLOID POLYPEPTIDE; APOLIPOPROTEIN-E GENOTYPE; A-BETA; DIABETES-MELLITUS; INSULIN-RESISTANCE; TRANSGENIC MICE; METABOLIC SYNDROME; COGNITIVE DECLINE; AMYLIN RECEPTOR; INCREASED RISK	Alzheimer's disease (AD) has been associated with type II diabetes (T2D) and obesity in several epidemiologic studies. To determine whether AD neuropathology can cause peripheral metabolic impairments, we investigated metabolic parameters in the triple-transgenic (3xTg)-AD mouse model of AD, compared with those in nontransgenic (non-Tg) controls, at 6, 8, and 14 mo of age. We found a more pronounced cortical A beta accumulation (2- and 3.5-fold increase in A beta 42 in the soluble and insoluble protein fractions, respectively) in female 3xTg-AD mice than in the males. Furthermore, female 3xTg-AD mice displayed a significant deterioration in glucose tolerance (AUC, +118% vs. non-Tg mice at 14 mo). Fasting plasma insulin levels rose 2.5-fold from 6 to 14mo of age in female 3xTg-AD mice. Glucose intolerance and cortical amyloid pathology worsened with age, and both were more pronounced in the females. Pancreatic amyloidopathy was revealed and could underlie the observed deficit in glycemic response in 3xTg-AD mice. The present results suggest that AD-like neuropathology extends to the pancreas in the 3xTg-AD mouse, leading to glucose intolerance and contributing to a pathologic self-amplifying loop between AD and T2D.	[Vandal, Milene; St-Amour, Isabelle; Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Vandal, Milene; White, Phillip J.; Marette, Andre; Calon, Frederic] Univ Laval, Inst Nutraceut & Aliments Fonct, Quebec City, PQ, Canada; [White, Phillip J.; Chevrier, Genevieve; Marette, Andre] Univ Laval, Fac Med, Dept Med, Axe Cardiol, Quebec City, PQ, Canada; [Vandal, Milene; Tremblay, Cyntia; St-Amour, Isabelle; Planel, Emmanuel; Calon, Frederic] CHUL, Ctr Rech, Axe Neurosci, Quebec City, PQ, Canada; [White, Phillip J.] Duke Mol Physiol Inst, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [White, Phillip J.; Chevrier, Genevieve; Marette, Andre] Inst Univ Pneumol & Cardiol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Calon, F (corresponding author), CHU Q, Ctr Rech, Pavillon CHUL,2705,Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.		White, Phillip J/H-3048-2019; Calon, Frederic/AAF-4390-2020	White, Phillip J/0000-0002-0957-425X; St-Amour, Isabelle/0000-0003-2042-804X; Marette, Andre/0000-0003-3950-5973; Planel, Emmanuel/0000-0001-5128-0565; Calon, Frederic/0000-0002-4203-0887	Canadian Institutes of Health Research (CIHR) [MOP 102532, IAO 74443]; Alzheimer Society Canada; Canada Foundation for Innovation (CFI); Fonds de la Recherche en Sante du Quebec (FRQ-S); CIHR scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de la Recherche en Sante du Quebec (FRQ-S); CIHR scholarship(Canadian Institutes of Health Research (CIHR))	This study was made possible by funding from the Canadian Institutes of Health Research (CIHR) (MOP 102532 and IAO 74443), the Alzheimer Society Canada, and the Canada Foundation for Innovation (CFI). F.C. is supported by a salary award from the Fonds de la Recherche en Sante du Quebec (FRQ-S). M.V. was supported by a CIHR scholarship. M.V. designed the experiments; performed the animal experiments, insulin ELISA, immunofluorescence, and data analyses; and wrote the first versions of the paper. P.J.W. contributed to experimental design. G.C. performed the ELISA for the C-peptide. C.T. and I.S.A. performed the ELISA for A beta. C.T. performed the Western blot analysis for cortical tau. A.M. contributed to experiment design and data interpretation. F.C. conceived the experimental design, obtained funding, and wrote the paper.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Bomba M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.139; Bories C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046111; BRANDT MR, 1977, CLIN ENDOCRINOL, V6, P167, DOI 10.1111/j.1365-2265.1977.tb02008.x; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Craft S, 1999, NEUROENDOCRINOLOGY, V70, P146, DOI 10.1159/000054469; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; El Khoury NB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00022; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; FABER OK, 1978, J CLIN INVEST, V62, P197, DOI 10.1172/JCI109106; FERRANNINI E, 1983, AM J PHYSIOL, V244, pE517; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Jimenez-Palomares M, 2012, AM J PHYSIOL-ENDOC M, V302, pE1373, DOI 10.1152/ajpendo.00500.2011; JOHNSTON DG, 1977, LANCET, V1, P10; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kalaria RN, 2009, NAT REV NEUROL, V5, P305, DOI 10.1038/nrneurol.2009.72; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura R, 2012, J NEUROSCI, V32, P17401, DOI 10.1523/JNEUROSCI.3028-12.2012; Lebbadi M, 2011, J ALZHEIMERS DIS, V27, P853, DOI 10.3233/JAD-2011-111010; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luchsinger JA, 2012, ALZ DIS ASSOC DIS, V26, P101, DOI 10.1097/WAD.0b013e318222f0d4; Masciopinto F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.189; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Mody N, 2011, DIABETOLOGIA, V54, P2143, DOI 10.1007/s00125-011-2160-2; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nugent DA, 2008, TOXICOL PATHOL, V36, P529, DOI 10.1177/0192623308318209; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Papon MA, 2013, DIABETES, V62, P609, DOI 10.2337/db12-0187; Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P733, DOI 10.1037/a0012520; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Raffaitin C, 2009, DIABETES CARE, V32, P169, DOI 10.2337/dc08-0272; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; SCHWARTZ P, 1965, T NEW YORK ACAD SCI, V27, P393, DOI 10.1111/j.2164-0947.1965.tb02977.x; Seeliger J, 2012, J MOL BIOL, V421, P348, DOI 10.1016/j.jmb.2012.01.048; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579; Sponarova J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003308; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Tremblay C, 2007, J ALZHEIMERS DIS, V12, P377; Upadhaya AR, 2012, NEUROBIOL AGING, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Yan LM, 2014, CURR PHARM DESIGN, V20, P1182, DOI 10.2174/13816128113199990064; Zhang S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010386.pub2; Zhang Y, 2013, DIABETES, V62, P1159, DOI 10.2337/db12-0670	78	62	62	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4273	4284		10.1096/fj.14-268482	http://dx.doi.org/10.1096/fj.14-268482			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26108977				2022-12-28	WOS:000361367300017
J	Yang, NL; Baban, B; Isales, CM; Shi, XM				Yang, Nianlan; Baban, Babak; Isales, Carlos M.; Shi, Xing-Ming			Crosstalk between bone marrow-derived mesenchymal stem cells and regulatory T cells through a glucocorticoid-induced leucine zipper/developmental endothelial locus-1-dependent mechanism	FASEB JOURNAL			English	Article						bone marrow microenvironment; immune suppressive; bone loss	ZIPPER GILZ; STROMAL CELLS; TGF-BETA; OSTEOGENIC DIFFERENTIATION; DENDRITIC CELLS; MOUSE MODEL; DEL-1; EXPRESSION; GENE; INFLAMMATION	Bone marrow is a reservoir for regulatory T (T-reg) cells, but how T-reg cells are regulated in that environment remains poorly understood. We show that expression of glucocorticoid (GC)-induced leucine zipper (GILZ) in bone marrow mesenchymal lineage cells or bone marrow-derived mesenchymal stem cells (BMSCs) increases the production of T-reg cells via a mechanism involving the up-regulation of developmental endothelial locus-1 (Del-1), an endogenous leukocyte-endothelial adhesion inhibitor. We found that the expression of Del-1 is increased similar to 4-fold in the bone tissues of GILZ transgenic (Tg) mice, and this increase is coupled with a significant increase in the production of IL-10 (2.80 vs. 0.83) and decrease in the production of IL-6 (0.80 vs. 2.33) and IL-12 (0.25 vs. 1.67). We also show that GILZ-expressing BMSCs present antigen in away that favors T-reg cells. These results indicate that GILZ plays a critical role mediating the crosstalk between BMSCs and T-reg in the bone marrow microenvironment. These data, together with our previous findings that overexpression of GILZ in BMSCs antagonizes TNF-alpha-elicited inflammatory responses, suggest that GILZ plays important roles in bone-immune cell communication and BMSC immune suppressive functions.	[Yang, Nianlan; Isales, Carlos M.; Shi, Xing-Ming] Georgia Regents Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Baban, Babak] Georgia Regents Univ, Dept Oral Biol, Augusta, GA 30912 USA; [Isales, Carlos M.; Shi, Xing-Ming] Georgia Regents Univ, Dept Orthopaed Surg, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Shi, XM (corresponding author), Georgia Regents Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA 2003, Augusta, GA 30912 USA.	bbaban@gru.edu; xshi@gru.edu	Isales, Carlos/J-9902-2013	Isales, Carlos/0000-0002-4480-3484	U.S. National Institutes of Health (NIH) National Institute on Aging Grant [R01AG046248]; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [R01DK076045]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046248] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging Grant; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute on Aging Grant R01AG046248 and the NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK076045. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Baban B, 2013, EXP MOL PATHOL, V95, P288, DOI 10.1016/j.yexmp.2013.09.002; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cathelin D, 2013, CYTOTHERAPY, V15, P740, DOI 10.1016/j.jcyt.2013.02.005; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Choi Eun Young, 2009, Immune Netw, V9, P153, DOI 10.4110/in.2009.9.5.153; Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1222, DOI [10.1089/ten.tea.2013.0241, 10.1089/ten.TEA.2013.0241]; Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1235, DOI [10.1089/ten.tea.2013.0242, 10.1089/ten.TEA.2013.0242]; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Ge XH, 2013, CELL BIOL INT, V37, P675, DOI 10.1002/cbin.10084; He LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031717; Khader SA, 2012, NAT IMMUNOL, V13, P433, DOI 10.1038/ni.2290; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Liu YL, 2012, CELL IMMUNOL, V276, P144, DOI 10.1016/j.cellimm.2012.05.001; Luz-Crawford P, 2015, ARTHRITIS RHEUMATOL, V67, P1514, DOI 10.1002/art.39069; Mozaffari MS, 2012, J NUTR BIOCHEM, V23, P977, DOI 10.1016/j.jnutbio.2011.05.004; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pan GD, 2014, J BIOL CHEM, V289, P19373, DOI 10.1074/jbc.M113.535237; Papadopoulou A, 2012, ANN RHEUM DIS, V71, P1733, DOI 10.1136/annrheumdis-2011-200985; Riccardi C, 1999, CELL DEATH DIFFER, V6, P1182, DOI 10.1038/sj.cdd.4400609; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang JH, 2008, J AUTOIMMUN, V30, P222, DOI 10.1016/j.jaut.2007.10.001; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhao ED, 2012, ONCOIMMUNOLOGY, V1, P152, DOI 10.4161/onci.1.2.18480; Zhao YF, 2014, MOL MED REP, V9, P1583, DOI 10.3892/mmr.2014.1988; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	37	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3954	3963		10.1096/fj.15-273664	http://dx.doi.org/10.1096/fj.15-273664			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26038125	Green Published			2022-12-28	WOS:000359915600030
J	Wang, YQ; Fukuda, T; Isaji, T; Lu, JS; Im, S; Hang, QL; Gu, W; Hou, SC; Ohtsubo, K; Gu, JG				Wang, Yuqin; Fukuda, Tomohiko; Isaji, Tomoya; Lu, Jishun; Im, Sanghun; Hang, Qinglei; Gu, Wei; Hou, Sicong; Ohtsubo, Kazuaki; Gu, Jianguo			Loss of alpha 1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways	FASEB JOURNAL			English	Article						N-glycosylation; glycosyltransferase; cell proliferation	INDUCED HEPATOCARCINOGENESIS; COMPENSATORY PROLIFERATION; ACQUIRED-RESISTANCE; CORE FUCOSYLATION; FUCOSE; CANCER; GROWTH; MECHANISMS; MET; EXPRESSION	Up-regulation of core fucosylation catalyzed by alpha 1,6-fucosyltransferase (Fut8) has been observed in hepatocellular carcinoma (HCC). Here, to explore the role of Fut8 expression in hepatocarcinogensis, we established the chemical-induced HCC models in the male wildtype (WT; Fut8(+/+)), hetero (Fut8(+/-)), and knockout (KO; Fut8(-/-)) mice by use of diethylnitrosamine (DEN) and pentobarbital (PB). In the Fut8(+/+) and Fut8(+/-) mice, multiple large and vascularized nodules were induced with an increased expression of Fut8 after DEN and PB treatment. However, the formation of HCC in Fut8(-/-) mice was suppressed almost completely. This potent inhibitory effect of Fut8 deficiency on tumorigenesis was also confirmed by the abolished tumor formation of Fut8 KO human hepatoma cell line cells by use of a xenograft tumor model. Furthermore, loss of the Fut8 gene resulted in attenuated responses to epidermal growth factor (EGF) and hepatocyte growth factor (HGF) in the HepG2 cell line, which provides the possible mechanisms for the contribution of Fut8 to hepatocarcinogensis. Taken together, our study clearly demonstrated that core fucosylation acts as a critical functional modulator in the liver and implicated Fut8 as a prognostic marker, as well as a novel, therapeutic target for HCC.	[Wang, Yuqin; Fukuda, Tomohiko; Isaji, Tomoya; Lu, Jishun; Im, Sanghun; Hang, Qinglei; Gu, Wei; Hou, Sicong; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan; [Ohtsubo, Kazuaki; Gu, Jianguo] Kumamoto Univ, Fac Life Sci, Dept Analyt Biochem, Kumamoto 860, Japan	Tohoku Medical & Pharmaceutical University; Kumamoto University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021; Hang, Qinglei/GOP-0218-2022	Hang, Qinglei/0000-0003-0419-6621	Challenging Exploratory Research Grant [15K14408]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [15H04354];  [24590087];  [23790363]; Grants-in-Aid for Scientific Research [15K14408] Funding Source: KAKEN	Challenging Exploratory Research Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Yuka Kobayashi (J-Oil Mills, Tokyo, Japan) for providing the PhoSL, Dr. Maeda Kento (Kumamoto University, Japan) for technical assistance, and Dr. Lucas Revillon (Tohoku Pharmaceutical University) for the language modification of this manuscript. This work was partially supported by a Grant-in-Aid for Scientific Research 15H04354 to J.G. and 24590087 to T.F.; Challenging Exploratory Research Grant 15K14408 to J.G.; Young Scientists (B) Grant 23790363 to K.O.; Japan Society for the Promotion of Science; and Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Biname F, 2008, MOL BIOL CELL, V19, P945, DOI 10.1091/mbc.E07-09-0967; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fang M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-215; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; HUTCHINSON WL, 1991, HEPATOLOGY, V13, P683, DOI 10.1002/hep.1840130412; Jacinto FV, 2007, DNA REPAIR, V6, P1155, DOI 10.1016/j.dnarep.2007.03.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Noda K, 2003, CANCER RES, V63, P6282; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Takahashi T, 2000, INT J CANCER, V88, P914, DOI 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wang MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06145; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Yamashita F, 1996, GASTROENTEROLOGY, V111, P996, DOI 10.1016/S0016-5085(96)70067-7; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhu AX, 2010, ANN SURG ONCOL, V17, P1247, DOI 10.1245/s10434-010-0975-6	46	63	68	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3217	3227		10.1096/fj.15-270710	http://dx.doi.org/10.1096/fj.15-270710			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25873065				2022-12-28	WOS:000358796900011
J	Tang, WG; Song, P; Cao, ZY; Wang, P; Zhu, GP				Tang, Wang-Gang; Song, Ping; Cao, Zheng-Yu; Wang, Peng; Zhu, Guo-Ping			A unique homodimeric NAD(+)-linked isocitrate dehydrogenase from the smallest autotrophic eukaryote Ostreococcus tauri	FASEB JOURNAL			English	Article						adaptation; coenzyme specificity determinants; kinetics; phylogenetic analysis	INDUCED OXIDATIVE DAMAGE; MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; CELLULAR DEFENSE; CLUSTAL-W; NAD; IDENTIFICATION; CHLAMYDOMONAS; SUBUNIT; PROTEIN	In eukaryotes, NAD(+)-dependent isocitrate dehydrogenase (IDH) is strictly mitochondrial and is a key enzyme in the Krebs cycle. To date, all known NAD(+)-specific IDHs (NAD-IDHs) in the mitochondria are believed to be heteromeric in solution. Here, a unique homodimeric NAD-IDH from Ostreococcus tauri (OtIDH), the smallest autotrophic picoeukaryote, was unveiled. Active OtIDH has a molecular weight of similar to 93 kDa with each subunit of 46.7 kDa. In the presence of Mn2+ and Mg2+, OtIDH displayed 42-fold and 51-fold preference for NAD(+) over NADP(+), respectively. Interestingly, OtIDH exhibited a sigmoidal kinetic behavior in response to isocitrate unlike other homodimeric homologs, and a remarkably high affinity for isocitrate (S-0.5 < 10 mu M) unlike other heterooligomeric homologs. Furthermore, its coenzyme specificity can be completely converted from NAD(+) (ancient trait) to NADP(+) (adaptive trait) by rational mutagenesis based on the evolutionary trace. Mutants D344R and D344R/M345H displayed a 15-fold and 72-fold preference for NADP(+) over NAD(+), respectively, indicating that D344 and M345 are the determinants of NAD(+) specificity. These findings also suggest that OtIDH may be an ancestral form of type II IDHs (all reported members are NADP(+)-linked enzymes) and may have evolved into NADP(+)-dependent IDH for adaptation to the increased demand of NADPH under carbon starvation.	[Tang, Wang-Gang; Song, Ping; Cao, Zheng-Yu; Wang, Peng; Zhu, Guo-Ping] Anhui Normal Univ, Coll Life Sci, Inst Mol Biol & Biotechnol, Wuhu 241000, Peoples R China	Anhui Normal University	Zhu, GP (corresponding author), Anhui Normal Univ, Coll Life Sci, Inst Mol Biol & Biotechnol, Wuhu 241000, Peoples R China.	gpz1996@yahoo.com	Wang, Peng/I-8770-2018; Tang, Wang-gang/AAO-6768-2021; Wang, Peng/AAW-9052-2020	Wang, Peng/0000-0002-5598-0996; Tang, Wang-gang/0000-0002-1440-1847; Wang, Peng/0000-0002-5598-0996; Zhu, Guo-ping/0000-0002-1877-4501	National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [31170005, 31400003]; Natural Science Foundation of Anhui Province of China [1308085QC67]; Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China [KJ2013A128]; Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (Chinese Academy of Sciences) [GRE-KF11-07]; Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources	National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province); Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China; Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (Chinese Academy of Sciences); Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources	The authors are grateful to J.-Y. Zang and M.-H. Wu (University of Science and Technology of China, Hefei, China) for their help with protein structure homology modeling. This work was supported by the National High Technology Research and Development Program ("863" Program: 2012AA02A708), the National Natural Science Foundation of China (31170005; 31400003), the Natural Science Foundation of Anhui Province of China (1308085QC67), the Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China (KJ2013A128), the Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (Chinese Academy of Sciences) (GRE-KF11-07), and Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources.	Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Corpas FJ, 1999, PLANT PHYSIOL, V121, P921, DOI 10.1104/pp.121.3.921; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Dange M, 2010, J BIOL CHEM, V285, P20520, DOI 10.1074/jbc.M110.115386; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; FIEUW S, 1995, PLANT PHYSIOL, V107, P905, DOI 10.1104/pp.107.3.905; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; Imada K, 2008, PROTEINS, V70, P63, DOI 10.1002/prot.21486; Inoue H, 2002, FEMS MICROBIOL LETT, V214, P127, DOI 10.1111/j.1574-6968.2002.tb11335.x; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; KEYS DA, 1990, J BACTERIOL, V172, P4280, DOI 10.1128/jb.172.8.4280-4287.1990; Kim HJ, 2005, FREE RADICAL RES, V39, P441, DOI 10.1080/10715760500066265; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Kim YO, 1999, J BIOL CHEM, V274, P36866, DOI 10.1074/jbc.274.52.36866; Lancien M, 1998, PLANT J, V16, P325, DOI 10.1046/j.1365-313x.1998.00305.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemaitre T, 2007, PLANT PHYSIOL, V144, P1546, DOI 10.1104/pp.107.100677; Lemaitre T, 2006, PLANT CELL PHYSIOL, V47, P634, DOI 10.1093/pcp/pcj030; Lin AP, 2011, BIOCHEMISTRY-US, V50, P230, DOI 10.1021/bi101401h; Lin AP, 2003, J BIOL CHEM, V278, P12864, DOI 10.1074/jbc.M300154200; Martinez-Rivas JM, 1998, PLANT PHYSIOL, V118, P249, DOI 10.1104/pp.118.1.249; MARTINEZRIVAS JM, 1994, J PLANT PHYSIOL, V143, P129, DOI 10.1016/S0176-1617(11)81676-7; MCINTOSH CA, 1992, PLANT PHYSIOL, V100, P69, DOI 10.1104/pp.100.1.69; Mondal S., 2013, ADV BIOSCI BIOTECHNO, V4, P751, DOI DOI 10.4236/abb.2013.46099; Peers G, 2008, PLANT CELL, V20, P502, DOI 10.1105/tpc.107.056556; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodriguez-Arnedo A, 2005, PROTEIN J, V24, P259, DOI 10.1007/s10930-005-6746-8; Schrodinger L. L. C, 2010, PYMOL MOL GRAPHICS S; Soundar S, 2006, J BIOL CHEM, V281, P21073, DOI 10.1074/jbc.M602956200; Steen IH, 2002, ARCH MICROBIOL, V178, P297, DOI 10.1007/s00203-002-0439-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEZUKA T, 1983, PLANT PHYSIOL, V72, P959, DOI 10.1104/pp.72.4.959; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058918; Wang P, 2012, FEMS MICROBIOL LETT, V327, P134, DOI 10.1111/j.1574-6968.2011.02467.x; Wrenger C, 2003, EUR J BIOCHEM, V270, P1775, DOI 10.1046/j.1432-1033.2003.03536.x; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	48	13	14	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2462	2472		10.1096/fj.14-257014	http://dx.doi.org/10.1096/fj.14-257014			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25724193				2022-12-28	WOS:000355209500023
J	Liu, ZY; Zou, MH				Liu, Zhaoyu; Zou, Ming-hui			Macrophage Liver Kinase B-1 Interacts with IKK beta and Inhibits Inflammatory Signaling in Response to LPS	FASEB JOURNAL			English	Meeting Abstract	Experimental Biology Meeting	MAR 28-APR 01, 2015	Boston, MA	Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, ASIP, ASN, ASPET					[Liu, Zhaoyu; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Biochem & Mol Biol, Norman, OK 73019 USA; [Liu, Zhaoyu; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Mol Med, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman			Kahn, Richard/ABD-2666-2020; liu, zhao/GXV-6141-2022	Kahn, Richard/0000-0002-0259-0601; West, Andrew/0000-0002-3034-4061	NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA13148, P30 CA013148] Funding Source: Medline; NINDS NIH HHS [R01 NS064934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))			0	39	39	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29			1		718.8				10.1096/fj.15-277095	http://dx.doi.org/10.1096/fj.15-277095			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CS0BT	26396237	Green Published			2022-12-28	WOS:000361722701183
J	van Otterdijk, SD; Michels, KB				van Otterdijk, Sanne D.; Michels, Karin B.			Transgenerational epigenetic inheritance in mammals: how good is the evidence?	FASEB JOURNAL			English	Review						DNA methylation; intrauterine exposure; reprogramming; imprinting; IAP elements	DNA METHYLATION; PRENATAL EXPOSURE; ACTIVE DEMETHYLATION; PATERNAL GENOME; GENE-EXPRESSION; MOUSE; STRESS; DYNAMICS; SMOKING; METHYLTRANSFERASE	Epigenetics plays an important role in orchestrating key biologic processes. Epigenetic marks, including DNA methylation, histones, chromatin structure, and noncoding RNAs, are modified throughout life in response to environmental and behavioral influences. With each new generation, DNA methylation patterns are erased in gametes and reset after fertilization, probably to prevent these epigenetic marks from being transferred from parents to their offspring. However, some recent animal studies suggest an apparent resistance to complete erasure of epigenetic marks during early development, enabling transgenerational epigenetic inheritance. Whether there are similar mechanisms in humans remains unclear, with the exception of epigenetic imprinting. Nevertheless, a distinctly different mechanism-namely, intrauterine exposure to environmental stressors that may affect establishment of the newly composing epigenetic patterns after fertilization-is often confused with transgenerational epigenetic inheritance. In this review, we delineate the definition of and requirement for transgenerational epigenetic inheritance, differentiate it from the consequences of intrauterine exposure, and discuss the available evidence in both animal models and humans.	[van Otterdijk, Sanne D.; Michels, Karin B.] Univ Med Ctr Freiburg, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [Michels, Karin B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA USA; [Michels, Karin B.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Michels, KB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, 221 Longwood Ave, Boston, MA 02115 USA.	kmichels@bwh.harvard.edu						Alkemade FE, 2010, AM J PATHOL, V176, P542, DOI 10.2353/ajpath.2010.090031; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Buiting K, 2003, AM J HUM GENET, V72, P571, DOI 10.1086/367926; Bygren LO, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-12; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Casas E, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00330; Chavez SL, 2014, HUM MOL GENET, V23, P4970, DOI 10.1093/hmg/ddu212; Christensen Brock C., 2011, Frontiers in Genetics, V2, P84, DOI 10.3389/fgene.2011.00084; Crichton J, 2014, CELL MOL LIFE SCI, V71, P1581, DOI 10.1007/s00018-013-1468-0; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Fedoriw A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008136; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gautrey HE, 2014, FASEB J, V28, P3261, DOI 10.1096/fj.13-246173; Geeleher P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-383; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Goodspeed D, 2015, FASEB J, V29, P807, DOI 10.1096/fj.14-259614; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Gordon L, 2011, EPIGENETICS-US, V6, P579, DOI 10.4161/epi.6.5.15072; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harris HR, 2013, INT J OBESITY, V37, P1356, DOI 10.1038/ijo.2013.101; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Huang YF, 2014, INT J MOL SCI, V15, P6298, DOI 10.3390/ijms15046298; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4; KAFRI T, 1993, P NATL ACAD SCI USA, V90, P10558, DOI 10.1073/pnas.90.22.10558; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Li Y, 2012, CHROMOSOME RES, V20, P769, DOI 10.1007/s10577-012-9311-2; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Maeyama H, 2015, J DEV ORIG HLTH DIS, V6, P105, DOI 10.1017/S2040174415000100; Marczylo EL, 2012, EPIGENETICS-US, V7, P432, DOI 10.4161/epi.19794; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Meng H, 2015, INT J BIOL SCI, V11, P604, DOI 10.7150/ijbs.11218; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; MuTHER Consortium, 2012, PLOS GENET, V8; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Padmanabhan N, 2013, CELL, V155, P81, DOI 10.1016/j.cell.2013.09.002; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pruis MGM, 2014, ACTA PHYSIOL, V210, P215, DOI 10.1111/apha.12197; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rhee KE, 2012, INT J PEDIAT, V2012, DOI DOI 10.1155/2012/463850; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Sakashita A, 2014, GENES CELLS, V19, P629, DOI 10.1111/gtc.12164; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2015, GENOME BIOL EVOL, V7, P1296, DOI 10.1093/gbe/evv073; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Sookoian S, 2013, PEDIATR RES, V73, P531, DOI 10.1038/pr.2013.2; St-Cyr S, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00145; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Talikka M, 2012, CRIT REV TOXICOL, V42, P877, DOI 10.3109/10408444.2012.725244; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; van de Werken C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6868; van Otterdijk SD, 2013, BIOCHEM SOC T, V41, P803, DOI 10.1042/BST20120358; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a; Ziller MJ, 2015, NATURE, V518, P355, DOI 10.1038/nature13990; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	97	108	111	2	81	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2457	2465		10.1096/fj.201500083	http://dx.doi.org/10.1096/fj.201500083			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27037350				2022-12-28	WOS:000379249500002
J	Bekhouche, M; Leduc, C; Dupont, L; Janssen, L; Delolme, F; Vadon-Le Goff, S; Smargiasso, N; Baiwir, D; Mazzucchelli, G; Zanella-Cleon, I; Dubail, J; De Pauw, E; Nusgens, B; Hulmes, DJS; Moali, C; Colige, A				Bekhouche, Mourad; Leduc, Cedric; Dupont, Laura; Janssen, Lauriane; Delolme, Frederic; Vadon-Le Goff, Sandrine; Smargiasso, Nicolas; Baiwir, Dominique; Mazzucchelli, Gabriel; Zanella-Cleon, Isabelle; Dubail, Johanne; De Pauw, Edwin; Nusgens, Betty; Hulmes, David J. S.; Moali, Catherine; Colige, Alain			Determination of the substrate repertoire of ADAMTS2, 3, and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF-beta signaling as primary targets	FASEB JOURNAL			English	Article						N-TAILS; betaglycan; LTBP1; DKK3	GROWTH-FACTOR-BETA; PROCOLLAGEN C-PROTEINASE; BOVINE DERMATOSPARAXIS; FIBRILLAR PROCOLLAGENS; GENE; ASSOCIATION; BETAGLYCAN; FIBROSIS; LYMPHANGIOGENESIS; THROMBOSPONDIN-1	A disintegrin and metalloproteinase with thrombospondin type I motif (ADAMTS) 2, 3, and 14 are collectively named procollagen N-proteinases (pNPs) because of their specific ability to cleave the aminopropeptide of fibrillar procollagens. Several reports also indicate that they could be involved in other biological processes, such as blood coagulation, development, and male fertility, but the potential substrates associated with these activities remain unknown. Using the recently described N-terminal amine isotopic labeling of substrate approach, we analyzed the secretomes of human fibroblasts and identified 8, 17, and 22 candidate substrates for ADAMTS2, 3, and 14, respectively. Among these newly identified substrates, many are components of the extracellular matrix and/or proteins related to cell signaling such as latent TGF-beta binding protein 1, TGF-b RIII, and dickkopf-related protein 3. Candidate substrates for the 3 ADAMTS have been biochemically validated in different contexts, and the implication of ADAMTS2 in the control of TGF-b activity has been further demonstrated in human fibroblasts. Finally, the cleavage site specificity was assessed showing a clear and unique preference for non-polar or slightly hydrophobic amino acids. This work shows that the activities of the pNPs extend far beyond the classically reported processing of the aminopropeptide of fibrillar collagens and that they should now be considered as multilevel regulators of matrix deposition and remodeling.-Bekhouche, M., Leduc, C., Dupont, L., Janssen, L., Delolme, F., Vadon-LeGoff, S., Smargiasso, N., Baiwir, D., Mazzucchelli, G., Zanella-Cleon, I., Dubail, J., De Pauw, E., Nusgens, B., Hulmes, D. J. S., Moali, C., Colige, A. Determination of the substrate repertoire of ADAMTS2,3, and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF-b signaling as primary targets.	[Bekhouche, Mourad; Leduc, Cedric; Dupont, Laura; Janssen, Lauriane; Dubail, Johanne; Nusgens, Betty; Colige, Alain] Univ Liege, Lab Connect Tissues Biol, Liege, Belgium; [Smargiasso, Nicolas; Mazzucchelli, Gabriel; De Pauw, Edwin] Univ Liege, Mass Spectrometry Lab, GIGA Prote, Liege, Belgium; [Baiwir, Dominique] Univ Liege, GIGA Prote Facil, GIGA Interdisciplinary Cluster Appl Genoprote, Liege, Belgium; [Delolme, Frederic; Vadon-Le Goff, Sandrine; Hulmes, David J. S.; Moali, Catherine] Univ Lyon, CNRS, Tissue Biol & Therapeut Engn, Unite Mixte Rech 5305, Lyon, France; [Delolme, Frederic; Zanella-Cleon, Isabelle] Inst Biol & Chem Prot, Prot Sci Facil, Unite Mixte Serv 3444, Lyon, France; [Dubail, Johanne] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA	University of Liege; University of Liege; University of Liege; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Cleveland Clinic Foundation	Bekhouche, M; Colige, A (corresponding author), Lab Connect Tissues Biol, Tour Pathol B23-3,Ave Hop 3, B-4000 Sart Tilman Par Liege, Belgium.	mouradbekhouche2@gmail.com; acolige@ulg.ac.be	Dubail, Johanne/AAB-1980-2021; Bekhouche, Mourad/ABA-6557-2020; Bekhouche, Mourad/ABA-7355-2020; le goff, sandrine/AAE-1990-2019	Dubail, Johanne/0000-0001-9124-9765; Bekhouche, Mourad/0000-0003-3786-2563; Janssen, Lauriane/0000-0002-9896-0055; vadon-le goff, sandrine/0000-0002-4582-2273; De Pauw, Edwin/0000-0003-3475-1315; MOALI, Catherine/0000-0003-2479-4290; Mazzucchelli, Gabriel/0000-0002-8757-8133; Baiwir, Dominique/0000-0002-1622-0118	Incoming Postdoctoral-Marie Curie (COFUND) fellowship (Brussels, Belgium); Televie [7.4602.14]; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS) [T.0183.13]; Centre National de la Recherche Scientifique; University of Lyon	Incoming Postdoctoral-Marie Curie (COFUND) fellowship (Brussels, Belgium); Televie; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Lyon	The authors are grateful for support by the Incoming Postdoctoral-Marie Curie (COFUND) fellowship (Brussels, Belgium), the Televie (7.4602.14), Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS; T.0183.13), Centre National de la Recherche Scientifique, and University of Lyon. The authors thank Ulrich auf dem Keller (Eidgenossische Technische Hochschule Zurich, Zurich, Switzerland) for his help in running the analysis of N-terminomics data, Bart Devreese and Isabel Vandenberghe (Ghent University, Ghent, Belgium) for N-terminal Edman sequencing, Larry Fisher (U.S. National Institutes of Health) for the LF-69 rabbit antiserum, Antoine Heyres and Lola Vanoorschot for their technical support, and Christophe Deroanne for his advice in running the small interfering RNA experiments (all from the Laboratory of Connective Tissues Biology, University of Liege). M.B. performed the analysis of the terminal amine isotopic labeling of substrate data and the biochemical validations of new substrates; C.L. performed the biochemical validations and preparation of proteomic samples for a disintegrin and metalloproteinase with thrombospondin type I motif 3 and 14 experiments; L.D., L.J., and J.D. provided mouse samples; L.D. provided the conditional human embryonic kidney cells expressing the different procollagen N-proteinases; J.D. provided the human embryonic kidney cells expressing active or inactive disintegrin and metalloproteinase with thrombospondin type I motif 2; S.V.-L.G., D.J.S.H., and C.M. provided recombinant bone morphogenetic protein 1, procollagen C-proteinase enhancer, and miniprocollagen III; F.D. and I.Z.-C. performed the mass spectrometric analysis for a disintegrin and metalloproteinase with thrombospondin type I motif 2 (experiment A); F.D. performed the analyses with the Trans-Proteomic Pipeline; N.S., D.B., G.M., and E.D.P. performed the mass spectrometry analyses on the Q Exactive; S.V.-L.G., D.J.S.H., and B.N. gave advice during the experiments as well as critical reading of the manuscript; and M.B., C.M., and A.C. conceived and designed the experiments and wrote the paper. M.B. and C.L. are cofirst authors. Mass spectrometry proteomic data have been deposited to the ProteomeXchange Consortium via the Proteomics Identifications partner repository with the data set identifier PXD002354 and digital object identifier 10.6019/PXD002354. The authors declare no conflicts of interest.	Arning A, 2012, BLOOD, V120, P5231, DOI 10.1182/blood-2012-07-442038; Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Boivin WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033163; Bourd-Boittin K, 2011, HEPATOLOGY, V54, P2173, DOI 10.1002/hep.24598; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Das DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063603; Delolme F, 2015, CELL MOL LIFE SCI, V72, P1009, DOI 10.1007/s00018-014-1733-x; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dubail J, 2010, CELL MOL LIFE SCI, V67, P4213, DOI 10.1007/s00018-010-0431-6; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Fish PV, 2007, J MED CHEM, V50, P3442, DOI 10.1021/jm061010z; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Goertsches R, 2005, J NEUROIMMUNOL, V164, P140, DOI 10.1016/j.jneuroim.2005.04.005; Hofer TPJ, 2008, J MOL MED, V86, P323, DOI 10.1007/s00109-007-0284-0; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Janssen L, 2016, ANGIOGENESIS, V19, P53, DOI 10.1007/s10456-015-9488-z; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Kawano Y, 2006, ONCOGENE, V25, P6528, DOI 10.1038/sj.onc.1209661; Keller UAD, 2012, BIOL CHEM, V393, P1477, DOI 10.1515/hsz-2012-0269; Kesteloot F, 2007, HEPATOLOGY, V46, P1620, DOI 10.1002/hep.21868; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kleifeld O, 2011, NAT PROTOC, V6, P1578, DOI 10.1038/nprot.2011.382; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lee CW, 2012, J THROMB THROMBOLYS, V33, P362, DOI 10.1007/s11239-011-0673-7; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; LOHR KM, 1990, BLOOD, V76, P2117; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; Mendoza V, 2009, BIOCHEMISTRY-US, V48, P11755, DOI 10.1021/bi901528w; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; NUSGENS BV, 1992, NAT GENET, V1, P214, DOI 10.1038/ng0692-214; Poonpet T, 2013, GENET MOL RES, V12, P5301, DOI 10.4238/2013.November.7.5; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Rodriguez-Lopez J, 2009, OSTEOARTHR CARTILAGE, V17, P321, DOI 10.1016/j.joca.2008.07.012; Romero D, 2013, J CELL SCI, V126, P1858, DOI 10.1242/jcs.119388; Sengle G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002425; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200	49	52	53	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1741	1756		10.1096/fj.15-279869	http://dx.doi.org/10.1096/fj.15-279869			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26740262	Green Submitted			2022-12-28	WOS:000374879400006
J	Peeters, MC; Mos, I; Lenselink, EB; Lucchesi, M; IJzerman, AP; Schwartz, TW				Peeters, Miriam C.; Mos, Iris; Lenselink, Eelke B.; Lucchesi, Martina; IJzerman, Adriaan P.; Schwartz, Thue W.			Getting from A to B-exploring the activation motifs of the class B adhesion G protein-coupled receptor subfamily G member 4/GPR112	FASEB JOURNAL			English	Article						constitutive activity; receptor signaling; structure-function; relationship; activation mechanism; bioinformatics	YEAST; MUTAGENESIS; INSERTION; TERMINUS; SECRETIN; RESIDUES; AGONIST; BINDING; FAMILY; DOMAIN	The adhesion G protein-coupled receptors [ADGRs/class B2 G protein-coupled receptors (GPCRs)] constitute an ancient family of GPCRs that have recently been demonstrated to play important roles in cellular and developmental processes. Here, we describe a first insight into the structure-function relationship of ADGRs using the family member ADGR subfamily G member 4 (ADGRG4)/GPR112 as a model receptor. In a bioinformatics approach, we compared conserved, functional elements of the well-characterized class A and class B1 secretin-like GPCRs with the ADGRs. We identified several potential equivalent motifs and subjected those to mutational analysis. The importance of the mutated residues was evaluated by examining their effect on the high constitutive activity of the N-terminally truncated ADGRG4/GPR112 in a 1-receptor-1-G protein Saccharomyces cerevisiae screening system and was further confirmed in a transfected mammalian human embryonic kidney 293 cell line. We evaluated the results in light of the crystal structures of the class A adenosine A(2A) receptor and the class B1 corticotropin-releasing factor receptor 1. ADGRG4 proved to have functionally important motifs resembling class A, class B, and combined elements, but also a unique highly conserved ADGR motif (H3.33). Given the high conservation of these motifs and residues across the adhesion GPCR family, it can be assumed that these are general elements of ADGR function.	[Peeters, Miriam C.; Mos, Iris; Lenselink, Eelke B.; Lucchesi, Martina; IJzerman, Adriaan P.] Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands; [Peeters, Miriam C.; Schwartz, Thue W.] Univ Copenhagen, Sect Metab Receptol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	Leiden University; Leiden University - Excl LUMC; Novo Nordisk Foundation; University of Copenhagen	Peeters, MC (corresponding author), Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands.	m.c.peeters@lacdr.leidenuniv.nl	IJzerman, Ad/ABG-1353-2020	IJzerman, Ad/0000-0002-1182-2259; Lenselink, Bart/0000-0001-5459-2978; Schwartz, Thue W./0000-0002-0261-6904; Mos, Iris/0000-0003-1882-772X	NNF Center for Basic Metabolic Research [Schwartz Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0013655] Funding Source: researchfish	NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)		Arac D, 2012, ANN NY ACAD SCI, V1276, P1, DOI 10.1111/j.1749-6632.2012.06820.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beukers MW, 2004, MOL PHARMACOL, V65, P702, DOI 10.1124/mol.65.3.702; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Cordomi A, 2015, BIOCHEM PHARMACOL, V96, P237, DOI 10.1016/j.bcp.2015.05.015; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dromey Jasmin R., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P51, DOI 10.2174/187153008783928352; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frimurer TM, 1999, PROTEINS, V35, P375, DOI 10.1002/(SICI)1097-0134(19990601)35:4<375::AID-PROT1>3.0.CO;2-2; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Isberg V, 2014, NUCLEIC ACIDS RES, V42, pD422, DOI 10.1093/nar/gkt1255; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Kishore A., 2015, J BIOL CHEM; Knudsen SM, 2001, FEBS LETT, V503, P126, DOI 10.1016/S0014-5793(01)02716-8; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Olesnicky NS, 1999, EMBO J, V18, P2756, DOI 10.1093/emboj/18.10.2756; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Peeters MC, 2014, BIOCHEM PHARMACOL, V92, P348, DOI 10.1016/j.bcp.2014.08.022; Peeters MC, 2012, PURINERG SIGNAL, V8, P23, DOI 10.1007/s11302-011-9251-x; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sexton PM, 2013, NATURE, V499, P417, DOI 10.1038/nature12413; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110	49	14	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1836	1848		10.1096/fj.201500110	http://dx.doi.org/10.1096/fj.201500110			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26823453				2022-12-28	WOS:000374879400014
J	Moll, L; Ben-Gedalya, T; Reuveni, H; Cohen, E				Moll, Lorna; Ben-Gedalya, Tziona; Reuveni, Hadas; Cohen, Ehud			The inhibition of IGF-1 signaling promotes proteostasis by enhancing protein aggregation and deposition	FASEB JOURNAL			English	Article						neurodegeneration; chaperones; aggresome; protein degradation	LIFE-SPAN EXTENSION; C-ELEGANS; NEURODEGENERATIVE DISEASES; CAENORHABDITIS-ELEGANS; STRAUSSLER-SYNDROME; AUTOPHAGY GENES; AGE-ONSET; PROTEOTOXICITY; PROTEASOME; CELLS	The discovery that the alteration of aging by reducing the activity of the insulin/IGF-1 signaling (IIS) cascade protects nematodes and mice from neurodegeneration-linked, toxic protein aggregation (proteotoxicity) raises the prospect that IIS inhibitors bear therapeutic potential to counter neurodegenerative diseases. Recently, we reported that NT219, a highly efficient IGF-1 signaling inhibitor, protects model worms from the aggregation of amyloid beta peptide and polyglutamine peptides that are linked to the manifestation of Alzheimer's and Huntington's diseases, respectively. Here, we employed cultured cell systems to investigate whether NT219 promotes protein homeostasis (proteostasis) in mammalian cells and to explore its underlying mechanisms. We found that NT219 enhances the aggregation of misfolded prion protein and promotes its deposition in quality control compartments known as "aggresomes." NT219 also elevates the levels of certain molecular chaperones but, surprisingly, reduces proteasome activity and impairs autophagy. Our findings show that IGF-1 signaling inhibitors in general and NT219 in particular can promote proteostasis in mammalian cells by hyperaggregating hazardous proteins, thereby bearing the potential to postpone the onset and slow the progression of neurodegenerative illnesses in the elderly.	[Moll, Lorna; Ben-Gedalya, Tziona; Cohen, Ehud] Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Reuveni, Hadas] TyrNovo Ltd, Herzliya Pituach, Israel; [Ben-Gedalya, Tziona] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel	Hebrew University of Jerusalem; Microsoft; Hebrew University of Jerusalem; Hadassah University Medical Center	Cohen, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel.	ehudc@ekmd.huji.ac.il		Moll, Lorna/0000-0003-1194-7323; Cohen, Ehud/0000-0001-5552-7086	Rosetrees Trust; European Research Council (ERC) [281010]; Rosetrees Trust [M5-F1] Funding Source: researchfish	Rosetrees Trust(Rosetrees Trust); European Research Council (ERC)(European Research Council (ERC)); Rosetrees Trust(Rosetrees Trust)	This study was generously supported by the Rosetrees Trust (to E.C.) and the European Research Council (ERC#281010; to E.C.). E.C. and H.R. are listed as inventors in a pending patent application entitled "IGF-1R (licensed to TyrNovo) signaling pathway inhibitors useful in the treatment of neurodegenerative diseases." E.C. and L.M. designed and initiated this study; E.C., H.R., and L.M. wrote the manuscript; H.R. conducted the development of NT219; L.M. performed all of the experimental work; and T.B.-G. performed Western blot and immunofluorescence experiments.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; AMADUCCI L, 1994, CURR OPIN NEUROL, V7, P283, DOI 10.1097/00019052-199408000-00001; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Ben-Gedalya T, 2015, EMBO J, V34, P2820, DOI 10.15252/embj.201592042; Ben-Gedalya T, 2012, TRAFFIC, V13, P635, DOI 10.1111/j.1600-0854.2012.01330.x; Ben-Gedalya T, 2011, J CELL SCI, V124, P1891, DOI 10.1242/jcs.077693; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; El-Ami T, 2014, AGING CELL, V13, P165, DOI 10.1111/acel.12171; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gontier G, 2015, J NEUROSCI, V35, P11500, DOI 10.1523/JNEUROSCI.0343-15.2015; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hashimoto Y, 2009, GENES CELLS, V14, P717, DOI 10.1111/j.1365-2443.2009.01306.x; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Marques FC, 2015, ANNU REV PATHOL-MECH, V10, P1, DOI 10.1146/annurev-pathol-012414-040508; Matilainen O, 2013, CELL REP, V3, P1980, DOI 10.1016/j.celrep.2013.05.012; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Renna M, 2013, HUM MOL GENET, V22, P4528, DOI 10.1093/hmg/ddt300; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stout GJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.35; Streeter A, 2016, METHODS MOL BIOL, V1303, P161, DOI 10.1007/978-1-4939-2627-5_8; Teixeira-Castro A, 2011, HUM MOL GENET, V20, P2996, DOI 10.1093/hmg/ddr203; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Wilkinson DS, 2015, MOL CELL, V57, P55, DOI 10.1016/j.molcel.2014.11.019; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yamazaki M, 1999, ACTA NEUROPATHOL, V98, P506, DOI 10.1007/s004010051116; Zanusso G, 2003, J GEN VIROL, V84, P1047, DOI 10.1099/vir.0.18774-0; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076	54	15	16	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1656	1669		10.1096/fj.15-281675	http://dx.doi.org/10.1096/fj.15-281675			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26722006				2022-12-28	WOS:000372629100026
J	Steinberg, BE; Goldenberg, NM; Fairn, GD; Kuebler, WM; Slutsky, AS; Lee, WL				Steinberg, Benjamin E.; Goldenberg, Neil M.; Fairn, Gregory D.; Kuebler, Wolfgang M.; Slutsky, Arthur S.; Lee, Warren L.			Is basic science disappearing from medicine? The decline of biomedical research in the medical literature	FASEB JOURNAL			English	Article						scientific research; clinical practice; medical journals	CLINICAL-DIAGNOSIS; EDUCATION; FUTURE; INSTRUCTION	Explosive growth in our understanding of genomics and molecular biology have fueled calls for the pursuit of personalized medicine, the notion of harnessing biologic variability to provide patient-specific care. This vision will necessitate a deep understanding of the underlying pathophysiology in each patient. Medical journals play a pivotal role in the education of trainees and clinicians, yet we suspected that the amount of basic science in the top medical journals has been in decline. We conducted an automated search strategy in PubMed to identify basic science articles and calculated the proportion of articles dealing with basic science in the highest impact journals for 8 different medical specialties from 1994 to 2013. We observed a steep decline (40-60%) in such articles over time in almost all of the journals examined. This rapid decline in basic science from medical journals is likely to affect practitioners' understanding of and interest in the basic mechanisms of disease and therapy. In this Life Sciences Forum, we discuss why this decline may be occurring and what it means for the future of science and medicine.	[Steinberg, Benjamin E.; Goldenberg, Neil M.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Fairn, Gregory D.; Kuebler, Wolfgang M.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Slutsky, Arthur S.; Lee, Warren L.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Slutsky, Arthur S.; Lee, Warren L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Steinberg, Benjamin E.; Goldenberg, Neil M.; Fairn, Gregory D.; Kuebler, Wolfgang M.; Slutsky, Arthur S.; Lee, Warren L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Lee, WL (corresponding author), 30 Bond St,LKS Room 613, Toronto, ON M5B 1W8, Canada.	leew@smh.ca	Slutsky, Arthur/M-3325-2019	Kuebler, Wolfgang/0000-0003-4100-2961; Fairn, Greg/0000-0001-6508-168X; Lee, Warren/0000-0002-1788-6587	Canadian Institutes of Health Research [MOP 130564]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by Canadian Institutes of Health Research Grant MOP 130564 to W.L.L. B.E.S., N.M.G., W.L.L., G.F., A.S.S., and W.M.K. conducted and are responsible for the data analysis. W.L.L. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors reviewed and edited the manuscript. The authors declare no conflicts of interest.	Awasthi S, 2005, PLOS MED, V2, P606, DOI 10.1371/journal.pmed.0020207; Beck AH, 2004, JAMA-J AM MED ASSOC, V291, P2139, DOI 10.1001/jama.291.17.2139; Brass EP, 2009, J GEN INTERN MED, V24, P1251, DOI 10.1007/s11606-009-0998-5; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Custers EJFM, 2010, ADV HEALTH SCI EDUC, V15, P109, DOI 10.1007/s10459-008-9101-y; Finnerty EP, 2010, ACAD MED, V85, P349, DOI 10.1097/ACM.0b013e3181c88b09; Fontanarosa PB, 2015, JAMA-J AM MED ASSOC, V313, P145, DOI 10.1001/jama.2014.17937; Hotez PJ, 2003, AM J MED SCI, V325, P10, DOI 10.1097/00000441-200301000-00003; Jones Teresa H, 2007, BMC Pediatr, V7, P1, DOI 10.1186/1471-2431-7-1; Mylopoulos M, 2014, MED EDUC, V48, P667, DOI 10.1111/medu.12426; Opthof T, 2011, MED BIOL ENG COMPUT, V49, P613, DOI 10.1007/s11517-011-0783-6; Tjian R, 2015, JAMA-J AM MED ASSOC, V313, P133, DOI 10.1001/jama.2014.16543; Woods NN, 2006, ACAD MED, V81, pS124, DOI 10.1097/00001888-200610001-00031; Woods NN, 2005, MED EDUC, V39, P107, DOI 10.1111/j.1365-2929.2004.02036.x	14	11	11	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					515	518		10.1096/fj.15-281758	http://dx.doi.org/10.1096/fj.15-281758			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26467794				2022-12-28	WOS:000369391900005
J	Zhu, XZ; Zelmer, A; Kapfhammer, JP; Wellmann, S				Zhu, Xinzhou; Zelmer, Andrea; Kapfhammer, Josef P.; Wellmann, Sven			Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress	FASEB JOURNAL			English	Article						RNA-binding protein; hypothermia; unfolded protein response; apoptosis	CIRCADIAN GENE-EXPRESSION; CEREBRAL-ISCHEMIA; ER STRESS; HYPOTHERMIA; TRANSLATION; DEATH; SHOCK; KINASE; NEURODEGENERATION; DEPRIVATION	The cold-inducible RNA-binding motif protein 3 (RBM3) is involved in the protection of neurons in hypoxic-ischemic and neurodegenerative disorders. RBM3 belongs to a small group of proteins whose synthesis increases during hypothermia while global protein production is slowed down. To investigate the molecular mechanisms underlying RBM3 action, we subjected hippocampal organotypic slice cultures from RBM3 knockout mice to various stressors and found exuberant signaling of the endoplasmic reticulum (ER) stress pathway PRKR-like ER kinase (PERK)-eukaryotic translation initiation factor 2 alpha (eIF2 alpha)-CCAAT/enhancer-binding protein homologous protein (CHOP) as compared with wild-type mice. Further, blocking RBM3 expression in human embryonic kidney HEK293 cells by specific small interfering RNAs increased phosphorylation of PERK and eIF2 alpha, whereas overexpression of RBM3 prevented PERK-eIF2 alpha-CHOP signaling during ER stress induced by thapsigargin or tunicamycin. RBM3 did not affect expression of the ER stress sensor immunoglobulin binding protein/GRP78. However, based on affinity purification coupled with mass spectrometry, coimmunoprecipitation, and proximity ligation assay, we revealed that nuclear factor 90 (NF90) is a novel protein interactor of PERK and that this interaction is essential for RBM3-mediated regulation of PERK activity, which requires an RNA-dependent interaction. In conclusion, our data provide evidence for a central role of RBM3 in preventing cell death by inhibiting the PERK-eIF2 alpha-CHOP ER stress pathway through cooperation with NF90.	[Zhu, Xinzhou; Zelmer, Andrea; Wellmann, Sven] Univ Basel Childrens Hosp UKBB, Spitalstr 33, CH-4056 Basel, Switzerland; [Kapfhammer, Josef P.] Univ Basel, Dept Biomed, Inst Anat, Basel, Switzerland	University of Basel	Wellmann, S (corresponding author), Univ Basel Childrens Hosp UKBB, Spitalstr 33, CH-4056 Basel, Switzerland.	sven.wellmann@ukbb.ch	Wellmann, Sven/A-2771-2017	Kapfhammer, Josef/0000-0002-2404-5778	Swiss National Science Foundation [31003A_141007]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors sincerely thank Prof. Tadatsugu Taniguchi for providing RBM3 KO mice. This research is funded by the Swiss National Science Foundation (31003A_141007). The authors declare no conflicts of interest.	Al Chawaf A, 2007, NEUROSCIENCE, V144, P1241, DOI 10.1016/j.neuroscience.2006.09.062; Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bettaieb A, 2015, BBA-MOL CELL RES, V1853, P52, DOI 10.1016/j.bbamcr.2014.09.016; Bodalia A, 2013, ACTA PHARMACOL SIN, V34, P49, DOI 10.1038/aps.2012.139; Chaikam V, 2010, BMB REP, V43, P1, DOI 10.5483/BMBRep.2010.43.1.001; Chip S, 2014, JOVE-J VIS EXP, DOI 10.3791/52023; Chip S, 2013, J CEREBR BLOOD F MET, V33, P508, DOI 10.1038/jcbfm.2012.190; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; Knight JRP, 2015, BIOCHEM J, V465, P227, DOI 10.1042/BJ20141014; Kosakowska-Cholody T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.203; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053431; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Pilotte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028446; Poone GK, 2015, BRAIN SCI, V5, P178, DOI 10.3390/brainsci5020178; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rzechorzek NM, 2015, EBIOMEDICINE, V2, P528, DOI 10.1016/j.ebiom.2015.04.004; Schmal C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002986; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Sureban SM, 2008, ONCOGENE, V27, P4544, DOI 10.1038/onc.2008.97; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Wen X, 2014, J IMMUNOL, V192, P3753, DOI 10.4049/jimmunol.1302813; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yang W, 2009, EXP NEUROL, V219, P376, DOI 10.1016/j.expneurol.2009.07.009; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zargar R, 2015, RES VET SCI, V98, P51, DOI 10.1016/j.rvsc.2014.11.016	47	38	42	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					624	634		10.1096/fj.15-274639	http://dx.doi.org/10.1096/fj.15-274639			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26472337				2022-12-28	WOS:000369391900015
J	Perez-Aso, M; Mediero, A; Low, YC; Levine, J; Cronstein, BN				Perez-Aso, Miguel; Mediero, Aranzazu; Low, Yee Cheng; Levine, Jamie; Cronstein, Bruce N.			Adenosine A2A receptor plays an important role in radiation-induced dermal injury	FASEB JOURNAL			English	Article						ZM241385; skin; radiotherapy lesions; therapeutic	COLLAGEN VASCULAR-DISEASE; INDUCED ATP RELEASE; DELTA T-CELLS; IONIZING-RADIATION; A(2A) RECEPTORS; INDUCED FIBROSIS; PHARMACOLOGICAL BLOCKADE; CARDIAC FIBROBLASTS; LATE COMPLICATIONS; ENDOTHELIAL-CELLS	Ionizing radiation is a common therapeutic modality and following irradiation dermal changes, including fibrosis and atrophy, may lead to permanent changes. We have previously demonstrated that occupancy of A(2A) receptor (A(2A)R) stimulates collagen production, so we determined whether blockade or deletion of A(2A)R could prevent radiation-induced fibrosis. After targeted irradiation (40 Gy) of the skin of wild-type (WT) or A(2A)R knockout (A(2A)RKO) mice, the A(2A)R antagonist ZM241385 was applied daily for 28 d. In irradiated WT mice treated with the A(2A)R antagonist, there was a marked reduction in collagen content and skin thickness, and ZM241385 treatment reduced the number of myofibroblasts and angiogenesis. After irradiation, there is an increase in loosely packed collagen fibrils, which is significantly diminished by ZM241385. Irradiation also induced an increase in epidermal thickness, prevented by ZM241385, by increasing the number of proliferating keratinocytes. Similarly, in A2ARKO mice, the changes in collagen alignment, skin thickness, myofibroblast content, angiogenesis, and epidermal hyperplasia were markedly reduced following irradiation. Radiation-induced changes in the dermis and epidermis were accompanied by an infiltrate of T cells, which was prevented in both ZM241385-treated and A2ARKO mice. Radiation therapy is administered to a significant number of patients with cancer, and radiation reactions may limit this therapeutic modality. Our findings suggest that topical application of an A(2A)R antagonist prevents radiation dermatitis and may be useful in the prevention or amelioration of radiation changes in the skin.	[Perez-Aso, Miguel; Mediero, Aranzazu; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY 10016 USA; [Low, Yee Cheng; Levine, Jamie] NYU, Sch Med, Ctr Canc, New York, NY 10016 USA	New York University; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020	Mediero, Aranzazu/0000-0002-5368-574X; Pintor, Jesus/0000-0002-9191-7679; Perez-Aso, Miguel/0000-0002-4703-4182; Cronstein, Bruce/0000-0002-4295-7383	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR68593]; New York University-Health and Hospitals Corporation Clinical and Translational Science Institute [UL1TR000038]; Laura and Isaac Perlmutter Cancer Center; NIH National Cancer Institute Cancer Center Support grant [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR056672, R01AR056672, R01AR068593] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York University-Health and Hospitals Corporation Clinical and Translational Science Institute; Laura and Isaac Perlmutter Cancer Center; NIH National Cancer Institute Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR56672 and AR68593), New York University-Health and Hospitals Corporation Clinical and Translational Science Institute (UL1TR000038), the Laura and Isaac Perlmutter Cancer Center, and NIH National Cancer Institute Cancer Center Support grant (P30CA016087).	ABUSHAKRA M, 1993, J RHEUMATOL, V20, P1601; BENTZEN SM, 1989, RADIOTHER ONCOL, V15, P267, DOI 10.1016/0167-8140(89)90095-9; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Bordignon M, 2008, MOL MED REP, V1, P485; Chan ESL, 2006, ARTHRITIS RHEUM-US, V54, P2632, DOI 10.1002/art.21974; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Chen AM, 2001, CANCER J, V7, P480; Chen YH, 2004, AM J PHYSIOL-HEART C, V287, pH2478, DOI 10.1152/ajpheart.00217.2004; Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3; DECONNO F, 1991, J PAIN SYMPTOM MANAG, V6, P247, DOI 10.1016/0885-3924(91)90015-V; DEUSSEN A, 1993, AM J PHYSIOL, V264, pH692, DOI 10.1152/ajpheart.1993.264.3.H692; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Dubey RK, 1998, HYPERTENSION, V31, P943, DOI 10.1161/01.HYP.31.4.943; Duncan W, 1996, RADIOTHER ONCOL, V41, P203, DOI 10.1016/S0167-8140(96)01838-5; Fernandez P, 2008, AM J PATHOL, V172, P1675, DOI 10.2353/ajpath.2008.070952; Fernandez P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; HEAP BJ, 1973, J ANAT, V115, P315; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Holler V, 2009, J INVEST DERMATOL, V129, P1280, DOI 10.1038/jid.2008.360; HOPEWELL JW, 1990, INT J RADIAT BIOL, V57, P751, DOI 10.1080/09553009014550911; Huang DY, 2006, AM J PHYSIOL-RENAL, V291, pF282, DOI 10.1152/ajprenal.00113.2005; Islam MR, 2012, AM J PHYSIOL-CELL PH, V303, pC924, DOI 10.1152/ajpcell.00459.2011; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen JM, 2011, STRAHLENTHER ONKOL, V187, P378, DOI 10.1007/s00066-011-2224-8; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Katebi M, 2008, INFLAMMATION, V31, P299, DOI 10.1007/s10753-008-9078-y; Kumar S, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-40; Lataillade JJ, 2007, REGEN MED, V2, P785, DOI 10.2217/17460751.2.5.785; Lazzerini PE, 2012, J MOL MED, V90, P331, DOI 10.1007/s00109-011-0824-5; Lee JW, 2010, ARCH OTOLARYNGOL, V136, P714, DOI 10.1001/archoto.2010.107; MCDONALD S, 1995, INT J RADIAT ONCOL, V31, P1187, DOI 10.1016/0360-3016(94)00429-O; McQuestion Maurene, 2011, Semin Oncol Nurs, V27, pe1, DOI 10.1016/j.soncn.2011.02.009; Mendelsohn Felicia A, 2002, Adv Skin Wound Care, V15, P216, DOI 10.1097/00129334-200209000-00007; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Morris MM, 1997, J CLIN ONCOL, V15, P2728, DOI 10.1200/JCO.1997.15.7.2728; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Muller K, 2011, J DERMATOL SCI, V61, P199, DOI 10.1016/j.jdermsci.2011.01.003; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Perez-Aso M, 2014, FASEB J, V28, P802, DOI 10.1096/fj.13-241646; Perez-Aso M, 2013, PURINERG SIGNAL, V9, P573, DOI 10.1007/s11302-013-9368-1; Perez-Aso M, 2012, FASEB J, V26, P4254, DOI 10.1096/fj.12-209627; Phan C, 2003, CANCER J, V9, P461, DOI 10.1097/00130404-200311000-00005; Robertson C, 1998, INT J RADIAT ONCOL, V40, P319, DOI 10.1016/S0360-3016(97)00716-5; RODEMANN HP, 1995, RADIOTHER ONCOL, V35, P83, DOI 10.1016/0167-8140(95)01540-W; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Ryan JL, 2012, J INVEST DERMATOL, V132, P985, DOI 10.1038/jid.2011.411; Salvo N, 2010, CURR ONCOL, V17, P94; Schmuth M, 2001, ARCH DERMATOL, V137, P1019; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC	61	25	25	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					457	465		10.1096/fj.15-280388	http://dx.doi.org/10.1096/fj.15-280388			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26415936	Green Published			2022-12-28	WOS:000367621000042
J	Tauseef, M; Farazuddin, M; Sukriti, S; Rajput, C; Meyer, JO; Ramasamy, SK; Mehta, D				Tauseef, Mohammad; Farazuddin, Mohammad; Sukriti, Sukriti; Rajput, Charu; Meyer, James Otto; Ramasamy, Suresh Kumar; Mehta, Dolly			Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability	FASEB JOURNAL			English	Article						acute lung injury; thrombin; TRPC; VE-cadherin	OPERATED CA2+ ENTRY; LUNG VASCULAR-PERMEABILITY; VE-CADHERIN; TRPC1 EXPRESSION; INDUCED INCREASE; KAPPA-B; ACTIVATION; SPHINGOSINE-1-PHOSPHATE; SEPSIS; INFLUX	Stability of endothelial cell (EC) adherens junctions (AJs) is central for prevention of tissue edema, the hallmark of chronic inflammatory diseases including acute respiratory distress syndrome. Here, we demonstrate a previously unsuspected role of sphingosine kinase 1 (SPHK1) in the mechanism by which transient receptor potential channel 1 (Trpc1)-mediated Ca2+ entry destabilizes AJs. Trpc(-/-) monolayers showed a 2.2-fold increase in vascular endothelial (VE)-cadherin cell-surface expression above wild-type (WT) monolayers. Thrombin increased endothelial permeability (evident by a 5-fold increase in interendothelial gap area and 60% decrease in transendothelial electrical resistance) in WT but not Trpc1(-/-) ECs. Trpc1(-/-) mice resisted the hyperpermeability effects of the edemagenic agonists used and exhibited 60% less endotoxin-induced mortality. Because sphingosine-1-phosphate (S1P) strengthens AJs, we determined if TRPC1 functioned by inhibiting SPHK1 activity, which generates S1P. Intriguingly, Trpc1(-/-) ECs or ECs transducing a TRPC1-inactive mutant showed a 1.5-fold increase in basal SPHK1 expression compared with WT ECs, resulting in a 2-fold higher S1P level. SPHK1 inhibitor SK1-I decreased basal transendothelial electrical resistance more in WT ECs (48 and 72% reduction at 20 and 50 mu M, respectively) than in Trpc1(-/-) ECs. However, SK1-I pretreatment rescued thrombin-induced EC permeability in Trpc1(-/-) ECs. Thus, TRPC1 suppression of basal SPHK1 activity enables EC-barrier destabilization by edemagenic agonists.-Tauseef, M., Farazuddin, M., Sukriti, S., Rajput, C., Meyer, J. O., Ramasamy, S. K., Mehta, D. Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability. FASEB J. 30, 102-110 (2016). www.fasebj.org	[Mehta, Dolly] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.	dmehta@uic.edu	Farazuddin, Mohammad/AAI-2580-2021	Baweja, Sukriti/0000-0002-8677-9857	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL-71794, HL-84153, HL-060678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL084153, R01HL071794, P01HL077806, T32HL007829] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL-71794, HL-84153, and HL-060678. The authors thank I. S Ambudkar (NIH) for providing TRPC1 mutant constructs and V. Natarajan (University of Illinois, Chicago, IL, USA) for his gift of SPHK1 luciferase promoter. The authors also thank L. Birnbaumer (NIH) and A. Dietrich (Walther-Straub-Institute for Pharmacology and Toxicology, Munich, Germany) for providing TRPC1<SUP>-/-</SUP> mice.	Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BARNARD JW, 1995, J IMMUNOL, V155, P4876; Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Chavez A, 2015, J CELL SCI, V128, P878, DOI 10.1242/jcs.154476; Chavez A, 2011, INT REV CEL MOL BIO, V290, P205, DOI 10.1016/B978-0-12-386037-8.00001-6; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Cioffi DL, 2011, ANTIOXID REDOX SIGN, V15, P1567, DOI 10.1089/ars.2010.3740; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; Daneshjou N, 2015, J CELL BIOL, V209, P181, DOI 10.1083/jcb.20140910803202015c; DebRoy A, 2014, J BIOL CHEM, V289, P24188, DOI 10.1074/jbc.M114.570051; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dietrich A, 2010, THROMB HAEMOSTASIS, V103, P262, DOI 10.1160/TH09-08-0517; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gong H., 2015, J CLIN INVEST, V125, P1364; Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kim EY, 2014, FASEB J, V28, P4347, DOI 10.1096/fj.14-251611; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Komarova YA, 2012, MOL CELL, V48, P914, DOI 10.1016/j.molcel.2012.10.011; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marfe G, 2015, MINI-REV MED CHEM, V15, P300, DOI 10.2174/1389557515666150227105415; Mathew B, 2011, FASEB J, V25, P3388, DOI 10.1096/fj.11-183970; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014; Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Sammani S, 2010, AM J RESP CELL MOL, V43, P394, DOI 10.1165/rcmb.2009-0223OC; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; St Amant EV, 2012, CIRC RES, V111, P739, DOI 10.1161/CIRCRESAHA.112.269654; Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356; Sun XG, 2013, AM J PHYSIOL-LUNG C, V305, pL467, DOI 10.1152/ajplung.00010.2013; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Xiong YQ, 2014, CURR TOP MICROBIOL, V378, P85, DOI 10.1007/978-3-319-05879-5_4; Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778	60	14	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					102	110		10.1096/fj.15-275891	http://dx.doi.org/10.1096/fj.15-275891			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26316271	Green Published			2022-12-28	WOS:000367621000012
J	Wang, JW; Woodward, DF; Martos, JL; Cornell, CL; Carling, RW; Kingsley, PJ; Marnett, LJ				Wang, Jenny W.; Woodward, David F.; Martos, Jose L.; Cornell, Clive L.; Carling, Robert W.; Kingsley, Philip J.; Marnett, Lawrence J.			Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages	FASEB JOURNAL			English	Article						inflammation; NSAID; polypharmacology; receptor antagonism	RHEUMATOID-ARTHRITIS; PROSTAGLANDIN E(2); GENE-EXPRESSION; HUMAN MONOCYTES; INFLAMMATION; THERAPY; DRUGS; CELLS; CLASSIFICATION; PROSTACYCLIN	A polypharmacologic approach to prostanoid based anti-inflammatory therapeutics was undertaken in order to exploit both the anti-and proinflammatory properties attributed to the various prostanoid receptors. Multitargeting of selected prostanoid receptors yielded a prototype compound, compound 1 (AGN 211377), that antagonizes prostaglandin D-2 receptors (DPs) DP1 (49) and DP2 (558), prostaglandin E-2 receptors (EPs) EP1 (266) and EP4 (117), prostaglandin F-2 alpha receptor (FP) (61), and thromboxane A(2) receptor (TP) (11) while sparing EP2, EP3, and prostaglandin I-2 receptors (IPs); K-b values (in nanomoles) are given in parentheses. Compound 1 evoked a pronounced inhibition of cytokine/chemokine secretion from lipopolysaccharide or TNF-alpha stimulated primary human macrophages. These cytokine/chemokines included cluster of designation 40 receptor (CD40), epithelial-derived neutrophil-activating protein 78 (ENA-78), granulocyte colony stimulating factor (G-CSF), granulocyte macrophage colony stimulating factor (GM-CSF), IL-8, IL-18, monocyte chemotactic protein-1 (CCL2) (MCP-1), tissue plasminogen activator inhibitor (PAI-1), and regulated on activation, normal T cell expressed and secreted (RANTES). In contrast, the inhibitory effects of most antagonists selective for a single receptor were modest or absent, and selective EP2 receptor blockade increased cytokine release in some instances. Compound 1 also showed clear superiority to the cyclooxygenase inhibitors diclofenac and rofecoxib. These findings reveal that blockade of multiple prostanoid receptors, with absent antagonism of EP2 and IP, may provide more effective anti-inflammatory activity than global suppression of prostanoid synthesis or highly selective prostanoid receptor blockade. These investigations demonstrate the first working example of prostanoid receptor polypharmacology for potentially safer and more effective anti-inflammatory therapeutics by blocking multiple proinflammatory receptors while sparing those with anti-inflammatory activity.	[Wang, Jenny W.; Woodward, David F.] Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA 92715 USA; [Woodward, David F.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England; [Martos, Jose L.; Cornell, Clive L.; Carling, Robert W.] Selcia Ltd, Drug Discovery Dept, Ongar, Essex, England; [Kingsley, Philip J.; Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	AbbVie; Allergan; Imperial College London; Vanderbilt University	Woodward, DF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, Exhibit Rd, London SW7 2AZ, England.	david.woodward@imperial.ac.uk		Wang, Jenny W/0000-0003-0217-7275	Allergan, Inc.	Allergan, Inc.(AbbVieAllergan)	The authors thank E. Tang and J. Kangasmetsa for providing laboratory assistance, and C. Rouzer for expert editorial assistance. This work was financially supported by Allergan, Inc.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; ANDREAKOS ETH, 2004, RHEUMATOID ARTRITIS, P134; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; Ballantyne C, 2005, ATHEROSCLEROSIS SUPP, V6, P21, DOI 10.1016/j.atherosclerosissup.2005.02.005; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bolognesi ML, 2013, CURR MED CHEM, V20, P1639; Castellani ML, 2007, INT J IMMUNOPATH PH, V20, P447, DOI 10.1177/039463200702000303; Cirillo R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.010; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; Crofford L. J, 2004, RHEUMATOID ARTHRITIS, P268; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; Dimitroulas T, 2013, CLIN RHEUMATOL, V32, P1357, DOI 10.1007/s10067-013-2283-6; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jones RL, 2013, PROSTAG LEUKOTR ESS, V88, P321, DOI 10.1016/j.plefa.2013.01.007; Kingsley PJ, 2007, METHOD ENZYMOL, V433, P91, DOI 10.1016/s0076-6879(07)33005-X; Kingsley PJ, 2005, ANAL BIOCHEM, V343, P203, DOI 10.1016/j.ab.2005.05.005; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; Koch AE, 2001, ARTHRITIS RHEUM-US, V44, P31, DOI 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lee HY, 2006, ARTHRITIS RHEUM-US, V54, P1747, DOI 10.1002/art.21873; Matias I, 2004, J PHARMACOL EXP THER, V309, P745, DOI 10.1124/jpet.103.061705; MATTHEWS JS, 1993, BRIT J PHARMACOL, V108, P363, DOI 10.1111/j.1476-5381.1993.tb12810.x; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Morphy R, 2004, DRUG DISCOV TODAY, V9, P641, DOI 10.1016/S1359-6446(04)03163-0; Page TH, 2010, J IMMUNOL, V185, P3694, DOI 10.4049/jimmunol.1000906; Poloso NJ, 2013, MOL IMMUNOL, V54, P284, DOI 10.1016/j.molimm.2012.12.010; Ricciotti E, 2013, P NATL ACAD SCI USA, V110, pE183, DOI 10.1073/pnas.1219073110; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Sandoo A, 2011, RHEUMATOLOGY, V50, P2125, DOI 10.1093/rheumatology/ker275; Seldon PM, 2001, BRIT J PHARMACOL, V134, P58, DOI 10.1038/sj.bjp.0704238; Sobota RM, 2008, BIOCHEM J, V412, P65, DOI 10.1042/BJ20071572; Steinmeyer J, 2000, ARTHRITIS RES, V2, P379, DOI 10.1186/ar116; SWAYNE GTG, 1988, EUR J PHARMACOL, V152, P311, DOI 10.1016/0014-2999(88)90726-1; Takahashi HK, 2005, EUR J PHARMACOL, V517, P252, DOI 10.1016/j.ejphar.2005.05.020; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tilly P, 2014, CARDIOVASC RES, V101, P482, DOI 10.1093/cvr/cvt276; Venkataprasad N, 1996, J INFECT DIS, V174, P806, DOI 10.1093/infdis/174.4.806; Wang J. W., 2015, U.S. patent, Patent No. [US 8901159, 8901159]; Wang JW, 2013, INVEST OPHTH VIS SCI, V54, P4782, DOI 10.1167/iovs.13-12363; WANG W, 1995, HEPATOLOGY, V22, P921, DOI 10.1002/hep.1840220333; Wilson RJ, 2006, BRIT J PHARMACOL, V148, P326, DOI 10.1038/sj.bjp.0706726; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; ZHONG WW, 1995, IMMUNOLOGY, V84, P446	51	12	12	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					394	404		10.1096/fj.15-275610	http://dx.doi.org/10.1096/fj.15-275610			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26420849				2022-12-28	WOS:000367621000037
J	Alampour-Rajabi, S; El Bounkari, O; Rot, A; Muller-Newen, G; Bachelerie, F; Gawaz, M; Weber, C; Schober, A; Bernhagen, J				Alampour-Rajabi, Setareh; El Bounkari, Omar; Rot, Antal; Mueller-Newen, Gerhard; Bachelerie, Francoise; Gawaz, Meinrad; Weber, Christian; Schober, Andreas; Bernhagen, Juergen			MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis	FASEB JOURNAL			English	Article						chemokine receptor; chemokine; receptor complex; CD74; cytokine	MIGRATION INHIBITORY FACTOR; CHEMOKINE RECEPTOR; CELL-MIGRATION; BETA-ARRESTIN; CXCL12; ACTIVATION; SURVIVAL; LIGAND; CD74; DIMERIZATION	Macrophage migration-inhibitory factor (MIF) is a pleiotropic cytokine with chemokine-like functions and is a mediator in numerous inflammatory conditions. Depending on the context, MIF signals through 1 or more of its receptors cluster of differentiation (CD) 74, CXC-motif chemokine receptor (CXCR)2, and CXCR4. In addition, heteromeric receptor complexes have been identified. We characterized the atypical chemokine receptor CXCR7 as a novel receptor for MIF. MIF promoted human CXCR7 internalization up to 40%, peaking at 50-400 nM and 30 min, but CXCR7 internalization by MIF was not dependent on CXCR4. Yet, by coimmunoprecipitation, fluorescence microscopy, and a proximity ligation assay, CXCR7 was found to engage in MIF receptor complexes with CXCR4 and CD74, both after ectopic overexpression and in endogenous conditions in a human B-cell line. Receptor competition binding and coimmunoprecipitation studies combined with sulfo-SBED-biotintransfer provided evidence for a direct interaction between MIF and CXCR7. Finally, we demonstrated MIF/CXCR7-mediated functional responses. Blockade of CXCR7 suppressed MIF-mediated ERK- and zeta-chain-associated protein kinase (ZAP)-70 activation (from 2.1- to 1.2-fold and from 2.5- to 1.6-fold, respectively) and fully abrogated primary murine B-cell chemotaxis triggered by MIF, but not by CXCL12. B cells from Cxcr7(-/-) mice exhibited an ablated transmigration response to MIF, indicating that CXCR7 is essential for MIF-promoted B-cell migration. Our findings provide biochemical and functional evidence that MIF is an alternative ligand of CXCR7 and suggest a functional role of the MIF-CXCR7 axis in Blymphocyte migration.	[Alampour-Rajabi, Setareh; El Bounkari, Omar; Bernhagen, Juergen] Rhine Westphalia Tech Univ Aachen RWTH, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Mueller-Newen, Gerhard] Rhine Westphalia Tech Univ Aachen RWTH, Inst Biochem & Mol Biol, Aachen, Germany; [Mueller-Newen, Gerhard; Bernhagen, Juergen] Rhine Westphalia Tech Univ Aachen RWTH, IZKF, Aachen, Germany; [Rot, Antal] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Bachelerie, Francoise] Univ Paris 11, INSERM, UMR S 996, Lab Excellence Res Medicat & Innovat Therapeut, Clamart, France; [Gawaz, Meinrad] Univ Tubingen, Med Klin 3, Kardiol & Kreislauferkrankungen, Tubingen, Germany; [Weber, Christian; Schober, Andreas] Klinikum Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany; [Bernhagen, Juergen] Univ Munich, August Lenz Stiftung, Munich, Germany; [Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Weber, Christian] Partner Site Munich Heart Alliance, Deutches Zentrum Herz Kreislauf Forsch DZHK, Munich, Germany	University of York - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Eberhard Karls University of Tubingen; University of Munich; University of Munich; Maastricht University; German Centre for Cardiovascular Research; Munich Heart Alliance	Bernhagen, J (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Sch Med, Pauwelsstr 30, D-52074 Aachen, Germany.	jbernha-gen@ukaachen.de	BACHELERIE, FRANCOISE/F-8823-2013; Weber, Christian/AAW-2153-2020; Schober, Andreas/B-2866-2013	BACHELERIE, FRANCOISE/0000-0002-0399-3277; Weber, Christian/0000-0003-4610-8714; Schober, Andreas/0000-0001-7798-136X; Rot, Antal/0000-0002-9730-6166	Deutsche Forschungsgemeinschaft (DFG) [DFG-FOR809, SFB1123, KFO274]; Rhine-Westphalia Technical University of Aachen (RWTH) START Grant [691138]; Agence Nationale de la Recherche (Investissements d'Avenir) [ANR-10-LABX-0033-LERMIT]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rhine-Westphalia Technical University of Aachen (RWTH) START Grant; Agence Nationale de la Recherche (Investissements d'Avenir)(French National Research Agency (ANR))	The authors thank Dr. Madhumita Chatterjee (University of Tubingen, Tubingen, Germany) for stimulating discussions regarding this study. This study was supported by Deutsche Forschungsgemeinschaft (DFG) Grants DFG-FOR809 and SFB1123 (to J.B., C.W., and A.S.), and KFO274 (to M.G.), by Rhine-Westphalia Technical University of Aachen (RWTH) START Grant 691138 (to O.E.B); the Immunohistochemistry and Confocal Microscopy Unit, a core facility of Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University. F.B. is a member of the Laboratory of Excellence in Research on Medication and Innovative Therapeutics supported by a grant from Agence Nationale de la Recherche (Investissements d'Avenir -ANR-10-LABX-0033-LERMIT). The authors report no conflicts of interest.	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; Chatterjee M, 2013, J THROMB HAEMOST, V11, P1954, DOI 10.1111/jth.12404; Chatterjee M, 2014, CIRC RES, V115, P939, DOI 10.1161/CIRCRESAHA.115.305171; Chatterjee M, 2014, FASEB J, V28, P2864, DOI 10.1096/fj.14-249730; Costantini S, 2013, CYTOKINE, V64, P316, DOI 10.1016/j.cyto.2013.05.024; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Humpert ML, 2014, EUR J IMMUNOL, V44, P694, DOI 10.1002/eji.201343907; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Kleemann R, 2002, J INTERF CYTOK RES, V22, P351, DOI 10.1089/107999002753675785; Kraemer S, 2013, CURR MED CHEM, V20, P2524, DOI 10.2174/09298673113209990117; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Kumar R., 2012, CELL IMMUNOL, V290, P251; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; LAW NM, 1994, BIOCHEM BIOPH RES CO, V201, P458, DOI 10.1006/bbrc.1994.1723; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Lue HQ, 2011, CELL SIGNAL, V23, P135, DOI 10.1016/j.cellsig.2010.08.013; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rath D, 2014, EUR HEART J, V35, P386, DOI 10.1093/eurheartj/eht448; Ray P, 2012, INT J BIOCHEM CELL B, V44, P669, DOI 10.1016/j.biocel.2012.01.007; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shachar I, 2011, LEUKEMIA LYMPHOMA, V52, P1446, DOI 10.3109/10428194.2011.565437; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tillmann S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00115; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Watanabe K, 2010, ARTHRITIS RHEUM-US, V62, P3211, DOI 10.1002/art.27650; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	68	87	87	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4497	4511		10.1096/fj.15-273904	http://dx.doi.org/10.1096/fj.15-273904			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26139098				2022-12-28	WOS:000364514700010
J	Abuhatzira, L; Xu, HY; Tahhan, G; Boulougoura, A; Schaffer, AA; Notkins, AL				Abuhatzira, Liron; Xu, Huanyu; Tahhan, Georges; Boulougoura, Afroditi; Schaeffer, Alejandro A.; Notkins, Abner L.			Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2 beta, and GAD65	FASEB JOURNAL			English	Article						autoimmune diabetes; miRNA; miR-342; glucose-sensitive	PANCREATIC BETA-CELLS; RIP-CHIP; MIRNAS; ISLETS; EXPRESSION; IDENTIFICATION; COEXPRESSION; PHOSPHATASE; PATTERNS; REVEALS	Islet antigen (IA)-2, IA-2b, and glutamate decarboxylase (GAD65) are major autoantigens in type 1 diabetes (T1D). Autoantibodies to these autoantigens appear years before disease onset and are widely used as predictive markers. Little is known, however, about what regulates the expression of these autoantigens. The present experiments were initiated to test the hypothesis that microRNAs (miRNAs) can target and affect the levels of these autoantigens. Bioinformatics was used to identify miRNAs predicted to target the mRNAs coding IA-2, IA-2b, and GAD65. RNA interference for the miRNA processing enzyme Dicer1 and individual miRNA mimics and inhibitors were used to confirm the effect in mouse islets and MIN6 cells. We show that the imprinted 14q32 miRNA cluster contains 56 miRNAs, 32 of which are predicted to target the mRNAs of T1D autoantigens and 12 of which are glucose-sensitive. Using miRNA mimics and inhibitors, we confirmed that at least 7 of these miRNAs modulate the mRNA levels of the T1D autoantigens. Dicer1 knockdown significantly reduced the mRNA levels of all 3 autoantigens, further confirming the importance of miRNAs in this regulation. We conclude that miRNAs are involved in regulating the expression of the major T1D autoantigens.	[Abuhatzira, Liron; Xu, Huanyu; Tahhan, Georges; Boulougoura, Afroditi; Notkins, Abner L.] Natl Inst Dent & Craniofacial Res, Expt Med Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Abuhatzira, L (corresponding author), Natl Inst Dent & Craniofacial Res, Expt Med Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA.	abuhatzira@mail.nih.gov	Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Abuhatzira, Liron/0000-0002-2742-0908; , Afroditi/0000-0002-0161-3322	National Institute of Dental and Craniofacial Research; National Library of Medicine, U.S. National Institutes of Health (Bethesda, MD, USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000423] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Library of Medicine, U.S. National Institutes of Health (Bethesda, MD, USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank Dr. John Tsang for advice and meaningful discussions. This work was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, and by the Intramural Research Program of the National Library of Medicine, U.S. National Institutes of Health (Bethesda, MD, USA). L.A. and A.L.N. conceived of the project, designed and performed experiments, and wrote the manuscript. H.X., G.T., and A.B. performed experiments, participated in the discussions and reviewed the manuscript. A.A.S. performed the simulation, advised on other aspects of the bioinformatics and reviewed the manuscript. The authors declare no conflicts of interest.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Arvan P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007658; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BJORK E, 1992, J CLIN ENDOCR METAB, V75, P1574, DOI 10.1210/jc.75.6.1574; Bravo-Egana V, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/723614; Cai T, 2011, DIABETOLOGIA, V54, P2347, DOI 10.1007/s00125-011-2221-6; Caromile LA, 2010, J BIOL CHEM, V285, P10487, DOI 10.1074/jbc.M109.066563; Ceribelli A, 2012, CURR OPIN IMMUNOL, V24, P686, DOI 10.1016/j.coi.2012.07.011; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; HAGOPIAN WA, 1993, ENDOCRINOLOGY, V132, P2674, DOI 10.1210/en.132.6.2674; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Han B, 2012, ISRN ENDOCRINOL, V2012; Harashima SI, 2007, CLIN EXP IMMUNOL, V150, P49, DOI 10.1111/j.1365-2249.2007.03455.x; Hennessy E, 2010, BIOCHEM BIOPH RES CO, V396, P457, DOI 10.1016/j.bbrc.2010.04.116; Hezova R, 2010, CELL IMMUNOL, V260, P70, DOI 10.1016/j.cellimm.2009.10.012; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kapsogeorgou EK, 2011, J AUTOIMMUN, V37, P129, DOI 10.1016/j.jaut.2011.05.003; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Lakey JRT, 2001, CELL TRANSPLANT, V10, P697, DOI 10.3727/000000001783986279; Liu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005436; Mandemakers W, 2013, DIABETOLOGIA, V56, P1547, DOI 10.1007/s00125-013-2901-5; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Planas R, 2010, CLIN EXP IMMUNOL, V159, P23, DOI 10.1111/j.1365-2249.2009.04053.x; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Simion A, 2010, BIOCHEM BIOPH RES CO, V391, P293, DOI 10.1016/j.bbrc.2009.11.052; SORENSON RL, 1991, DIABETES, V40, P1365, DOI 10.2337/diabetes.40.11.1365; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Temple IK, 2010, REV ENDOCR METAB DIS, V11, P199, DOI 10.1007/s11154-010-9150-4; Tian JD, 2013, DIABETES, V62, P3760, DOI 10.2337/db13-0931; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1201, DOI 10.1152/ajpendo.00459.2006; Wang LL, 2012, ANTIVIR RES, V93, P270, DOI 10.1016/j.antiviral.2011.12.004; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zhu YX, 2013, DIABETES, V62, P3194, DOI 10.2337/db13-0151	47	22	23	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4374	4383		10.1096/fj.15-273649	http://dx.doi.org/10.1096/fj.15-273649			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148972	Green Published			2022-12-28	WOS:000361367300025
J	Giner, XC; Cotnoir-White, D; Mader, S; Levesque, D				Giner, Xavier C.; Cotnoir-White, David; Mader, Sylvie; Levesque, Daniel			Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors	FASEB JOURNAL			English	Article						nuclear receptors; pharmacological parameters; cofactor recruitment; receptor dimerization; protein conformation	ORPHAN NUCLEAR RECEPTORS; NGFI-B; DOCOSAHEXAENOIC ACID; RXR; AGONIST; BINDING; PROTEIN; NURR1; ACTIVATION; EXPRESSION	Retinoid X receptors (RXRs) play a role as master regulators because of their capacity to form heterodimers with other nuclear receptors (NRs). Accordingly, retinoid signaling is involved in multiple biologic processes, including development, cell differentiation, metabolism, and cell death. However, the role and function of RXRs in different heterodimer complexes remain unidentified, mainly because most RXR drugs (called rexinoids) are not selective of specific heterodimer complexes. The lack of selectivity strongly limits the use of rexinoids for specific therapeutic approaches. To better characterize rexinoids at specific NR complexes, we have developed and optimized luciferase (Luc) protein complementation(PCA)-based bioluminescence resonance energy transfer (BRET) assays that can directly measure recruitment of a coactivator (CoA) motif fused to yellow fluorescent protein (YFP) by specific NR dimers. To validate the assays, we compared rexinoid modulation of CoA recruitment by the RXR homodimer and by the heterodimers Nur77/RXR and Nurr1/RXR. Results revealed that some rexinoids display selective CoA recruitment activities with homo-or heterodimer complexes. In particular, SR11237 (BMS649) has stronger potency for recruitment of CoA motif and transcriptional activity with the heterodimer Nur77/RXR than other complexes. This technology should be useful in identifying new compounds with specificity for individual dimeric species formed by NRs.	[Giner, Xavier C.; Levesque, Daniel] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Giner, Xavier C.; Levesque, Daniel] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada; [Cotnoir-White, David; Mader, Sylvie] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Levesque, D (corresponding author), Univ Montreal, Fac Pharm, Pavillon Jean Coutu,CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	daniel.levesque.1@umontreal.ca		Levesque, Daniel/0000-0002-3019-3048	Groupe de Recherche Universitaire sur le Medicament (Universite de Montreal); Canadian Institute for Health Research [MOP125863, MOP130407]	Groupe de Recherche Universitaire sur le Medicament (Universite de Montreal); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Drs. H. Kagechika and K. Shudo (School of Biomedical Science, Tokyo Medical and Dental University and Research Foundation Itsuu Laboratory, Tokyo, Japan) for generously providing the HX600, HX630, and HX531 compounds; Dr. J. Drouin (Institut de Recherche Clinique de Montreal) for the beta RARE DR-5 element plasmid construct; and Dr. Michel Bouvier's Lab members at the Institut de Recherche en Immunologie et Cancerologie (Universite de Montreal, Montreal, QC, Canada) for helpful discussions for BRET-based assay optimizations. This work was supported by a grant from the Groupe de Recherche Universitaire sur le Medicament (Universite de Montreal; to D.L.) and by grants from the Canadian Institute for Health Research [MOP125863 (to S.M.) and to MOP130407 (to D.L.)]. The authors declare no conflicts of interest.	BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; BOEHM MF, 1994, J MED CHEM, V37, P2930, DOI 10.1021/jm00044a014; BOEHM MF, 1994, J MED CHEM, V37, P408, DOI 10.1021/jm00029a013; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Burris TP, 2013, PHARMACOL REV, V65, P710, DOI 10.1124/pr.112.006833; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; DUBOIS C, 2006, CHEMMEDCHEM, V1, P955, DOI DOI 10.1002/CMDC.200600078; Duplessis TT, 2009, METHODS MOL BIOL, V590, P253, DOI 10.1007/978-1-60327-378-7_16; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Ethier I, 2004, BIOL PSYCHIAT, V56, P522, DOI 10.1016/j.biopsych.2004.06.036; Farmer LJ, 2006, BIOORG MED CHEM LETT, V16, P2352, DOI 10.1016/j.bmcl.2005.12.003; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Goldstein JT, 2003, ARCH BIOCHEM BIOPHYS, V420, P185, DOI 10.1016/j.abb.2003.09.034; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Koterba Kristen L, 2006, Nucl Recept Signal, V4, pe021; Leibowitz MD, 2006, ENDOCRINOLOGY, V147, P1044, DOI 10.1210/en.2005-0690; Levesque D, 2007, TRENDS NEUROSCI, V30, P22, DOI 10.1016/j.tins.2006.11.006; Li X, 2012, BIOCHEM PHARMACOL, V83, P1445, DOI 10.1016/j.bcp.2012.02.021; Lippert WP, 2009, CHEMMEDCHEM, V4, P1143, DOI 10.1002/cmdc.200900090; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; Lupien M, 2007, MOL ENDOCRINOL, V21, P797, DOI 10.1210/me.2006-0074; Maira M, 1999, MOL CELL BIOL, V19, P7549; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martel C, 2010, RNA, V16, P585, DOI 10.1261/rna.1664210; Martin LJ, 2010, BIOL REPROD, V83, P3, DOI 10.1095/biolreprod.110.083824; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Michellys PY, 2004, BIOORG MED CHEM LETT, V14, P1593, DOI 10.1016/j.bmcl.2003.12.089; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Morishita K, 2009, BIOORG MED CHEM LETT, V19, P1001, DOI 10.1016/j.bmcl.2008.11.086; Morita K, 2005, BIOCHEM PHARMACOL, V71, P98, DOI 10.1016/j.bcp.2005.10.017; Mulero M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084569; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Sakaki J, 2007, BIOORG MED CHEM LETT, V17, P4808, DOI 10.1016/j.bmcl.2007.06.079; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Takamatsu K, 2008, CHEMMEDCHEM, V3, P454, DOI 10.1002/cmdc.200700265; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Wagner CE, 2009, J MED CHEM, V52, P5950, DOI 10.1021/jm900496b; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhao Yue, 2009, Drug Discov Today Dis Mech, V6, pe43	60	12	13	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4256	4267		10.1096/fj.14-259804	http://dx.doi.org/10.1096/fj.14-259804			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148973	Green Accepted			2022-12-28	WOS:000361367300015
J	Heinick, A; Husser, X; Himmler, K; Kirchhefer, U; Nunes, F; Schulte, JS; Seidl, MD; Rolfes, C; Dedman, JR; Kaetzel, MA; Gerke, V; Schmitz, W; Muller, FU				Heinick, Alexander; Husser, Xenia; Himmler, Kirsten; Kirchhefer, Uwe; Nunes, Frank; Schulte, Jan S.; Seidl, Matthias D.; Rolfes, Christina; Dedman, John R.; Kaetzel, Marcia A.; Gerke, Volker; Schmitz, Wilhelm; Mueller, Frank U.			Annexin A4 is a novel direct regulator of adenylyl cyclase type 5	FASEB JOURNAL			English	Article						cAMP; beta-AR stimulation; CRE-mediated transcription; CREB	ACTIVATED CHLORIDE CONDUCTANCE; LEFT-VENTRICULAR FUNCTION; SELF-ASSOCIATION; LIVING CELLS; HEART; IV; DISRUPTION; MEMBRANE; CREB; CALCIUM	Annexin A4 (AnxA4), a Ca2+- and phospholipid-binding protein, is up-regulated in the human failing heart. In this study, we examined the impact of AnxA4 on beta-adrenoceptor (beta-AR)/cAMP-dependent signal transduction. Expression of murine AnxA4 in human embryonic kidney (HEK)293 cells dose-dependently inhibited cAMP levels after direct stimulation of adenylyl cyclases (ACs) with forskolin (FSK), as determined with an exchange protein activated by cAMP-Forster resonance energy transfer (EPAC-FRET) sensor and an ELISA (control vs. +AnxA4: 1956 +/- 162 vs. 1304 +/- 185 fmol/mu g protein; n = 8). Disruption of the anxA4 gene led to a consistent increase in intracellular cAMP levels in isolated adult mouse cardiomyocytes, with heart-directed expression of the EPAC-FRET sensor, stimulated with FSK, and as determined by ELISA, also in mouse cardiomyocytes stimulated with the beta-AR agonist isoproterenol (ISO) (anxA4a(+/+) vs. anxA4a(-/-): 5.1 +/- 0.3 vs. 6.7 +/- 0.6 fmol/mu g protein) or FSK (anxA4a(+/+) vs. anxA4a(-/-): 1891 +/- 238 vs. 2796 +/- 343 fmol/mu g protein; n = 9-10). Coimmunoprecipitation experiments in HEK293 cells revealed a direct interaction of murine AnxA4 with human membrane-bound AC type 5 (AC5). As a functional consequence of AnxA4-mediated AC inhibition, AnxA4 inhibited the FSK-induced transcriptional activation mediated by the cAMP response element (CRE) in reporter gene studies (10-fold vs. control; n = 4 transfections) and reduced the FSK-induced phosphorylation of the CRE-binding protein (CREB) measured on Western blots (control vs. +AnxA4: 150 +/- 17% vs. 105 +/- 10%; n = 6) and by the use of the indicator of CREB activation caused by phosphorylation (ICAP)-FRET sensor, indicating CREB phosphorylation. Inactivation of AnxA4 in anxA4a(-/-) mice was associated with an increased cardiac response to beta-AR stimulation. Together, these results suggest that AnxA4 is a novel direct negative regulator of AC5, adding a new facet to the functions of annexins.	[Heinick, Alexander; Husser, Xenia; Himmler, Kirsten; Kirchhefer, Uwe; Nunes, Frank; Schulte, Jan S.; Seidl, Matthias D.; Rolfes, Christina; Schmitz, Wilhelm; Mueller, Frank U.] Univ Munster, Inst Pharmacol & Toxicol, D-48149 Munster, Germany; [Gerke, Volker] Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, D-48149 Munster, Germany; [Gerke, Volker] Univ Munster, Interdisciplinary Clin Res Ctr, D-48149 Munster, Germany; [Dedman, John R.; Kaetzel, Marcia A.] Univ Cincinnati, Genome Res Inst, Dept Genome Sci, Cincinnati, OH USA	University of Munster; University of Munster; University of Munster; University System of Ohio; University of Cincinnati	Heinick, A (corresponding author), Univ Munster, Inst Pharmacol & Toxicol, Domagkstr 12, D-48149 Munster, Germany.	a.heinick@uni-muenster.de		Heinick, Alexander/0000-0002-3770-105X; Schulte, Jan Sebastian/0000-0003-0336-2632	Deutsche Forschungsgemeinschaft (DFG) [Mu 1376/11-1, Ge 514/9-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Melanie Voss, Stefanie Triebel, Andrea Walter, Danuta Mitko, and Heidrun Sickler for excellent technical assistance. This study was supported by Deutsche Forschungsgemeinschaft (DFG) Grants Mu 1376/11-1 ( to F.U.M.) and Ge 514/9-1 ( to V.G.).	Alig J, 2009, P NATL ACAD SCI USA, V106, P12189, DOI 10.1073/pnas.0810332106; Arnold P, 2014, CRIT CARE MED, V42, pE32, DOI 10.1097/CCM.0b013e3182a63e01; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Boknik P, 2009, BRIT J PHARMACOL, V158, P1557, DOI 10.1111/j.1476-5381.2009.00441.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; CHAN HC, 1994, J BIOL CHEM, V269, P32464; Crosby KC, 2013, BIOPHYS J, V104, P1875, DOI 10.1016/j.bpj.2013.02.057; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; ESPINASSE I, 1995, J MOL CELL CARDIOL, V27, P1789, DOI 10.1016/0022-2828(95)90002-0; Friedrich MW, 2010, J BIOL CHEM, V285, P23283, DOI 10.1074/jbc.M110.124545; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GILMANSHIN R, 1994, BIOCHEMISTRY-US, V33, P8225, DOI 10.1021/bi00193a008; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guellich A, 2014, PFLUG ARCH EUR J PHY, V466, P1163, DOI 10.1007/s00424-014-1515-1; GULICK J, 1991, J BIOL CHEM, V266, P9180; GunteskiHamblin AM, 1996, AM J PHYSIOL-HEART C, V270, pH1091, DOI 10.1152/ajpheart.1996.270.3.H1091; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; KAETZEL MA, 1994, J BIOL CHEM, V269, P5297; Lai L, 2013, CIRCULATION, V127, P1692, DOI 10.1161/CIRCULATIONAHA.112.001212; Lee KW, 2002, J NEUROSCI, V22, P7931; Lewin G, 2009, CIRCULATION, V119, P79, DOI 10.1161/CIRCULATIONAHA.108.786533; Li BL, 2003, J BIOL CHEM, V278, P43276, DOI 10.1074/jbc.M306361200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Muller FU, 2002, FASEB J, V16, P103, DOI 10.1096/fj.02-0486fje; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piljic A, 2006, MOL BIOL CELL, V17, P3318, DOI 10.1091/mbc.E06-01-0041; Polouliakh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004189; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Schulte JS, 2012, AM J PHYSIOL-HEART C, V302, pH1998, DOI 10.1152/ajpheart.00057.2011; Tang T, 2006, BASIC RES CARDIOL, V101, P117, DOI 10.1007/s00395-005-0559-y; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Vatner SF, 2013, AM J PHYSIOL-HEART C, V305, pH1, DOI 10.1152/ajpheart.00080.2013; Vatner SF, 2009, CIRC J, V73, P195, DOI 10.1253/circj.CJ-08-0957; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; ZAKS WJ, 1991, BIOCHEMISTRY-US, V30, P9607, DOI 10.1021/bi00104a007	49	24	25	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3773	3787		10.1096/fj.14-269837	http://dx.doi.org/10.1096/fj.14-269837			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26023182				2022-12-28	WOS:000359915600015
J	Iyer, A; Brown, L; Whitehead, JP; Prins, JB; Fairlie, DP				Iyer, Abishek; Brown, Lindsay; Whitehead, Jonathan P.; Prins, Johannes B.; Fairlie, David P.			Nutrient and immune sensing are obligate pathways in metabolism, immunity, and disease	FASEB JOURNAL			English	Review						macrophage; Toll-like receptors; inflammation; obesity; diabetes	BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; TOLL-LIKE RECEPTORS; INDUCED INSULIN-RESISTANCE; NERVOUS-SYSTEM CONTROL; FATTY-ACIDS PRODUCE; INFLAMMATORY RESPONSES; SKELETAL-MUSCLE; FOOD-INTAKE; BETA-CELL	The growth and survival of multicellular organisms depend upon their abilities to acquire and metabolize nutrients, efficiently store and harness energy, and sense and fight infection. Systems for sensing and using nutrients have consequently coevolved alongside systems for sensing and responding to danger signals, including pathogens, and share many of the same cell signaling proteins and networks. Diets rich in carbohydrates and fats can overload these systems, leading to obesity, metabolic dysfunction, impaired immunity, and cardiovascular disease. Excessive nutrient intake promotes adiposity, typically altering adipocyte function and immune cell distribution, both of which trigger metabolic dysfunction. Here, we discuss novel mechanistic links between metabolism and immunity that underlie metabolic dysfunction in obesity. We aim to stimulate debate about how the endocrine and immune systems are connected through autocrine, paracrine, and neuroendocrine signaling in sophisticated networks that are only now beginning to be resolved. Understanding the expression and action of signaling proteins, together with modulating their receptors or pattern recognition using agonists or antagonists, will enable rational intervention in immunometabolism that may lead to novel treatments for obesity and metabolic dysfunction.	[Iyer, Abishek; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Brown, Lindsay] Univ So Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia; [Whitehead, Jonathan P.; Prins, Johannes B.] Univ Queensland, Mater Res Inst, Translat Res Inst, Brisbane, Qld 4072, Australia	University of Queensland; University of Southern Queensland; Mater Research; University of Queensland	Iyer, A (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	a.iyer@imb.uq.edu.au; d.fairlie@imb.uq.edu.au	Fairlie, David P/F-8865-2014; Iyer, Abishek/C-9767-2017; Prins, Johannes B/M-5884-2013; Prins, Johannes/I-3610-2019	Fairlie, David P/0000-0002-7856-8566; Iyer, Abishek/0000-0001-9533-5265; Prins, Johannes B/0000-0001-9497-927X; Prins, Johannes/0000-0001-9497-927X; Whitehead, Jonathan/0000-0003-3978-3148	Australian National Health and Medical Research Council [APP1028423, APP1084083, SPRF1027369]; University of Queensland Postdoctoral Fellowship; Queensland State Government (Collaboration and Innovation Fund) grant; Australian Research Council (ARC) Grant [DP130100629]; ARC Federation Fellowship [FF0668733]; ARC Centre of Excellence in Advanced Molecular Imaging aimed at better understanding the molecular basis of immunity [CE140100011]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Postdoctoral Fellowship(University of Queensland); Queensland State Government (Collaboration and Innovation Fund) grant; Australian Research Council (ARC) Grant(Australian Research Council); ARC Federation Fellowship(Australian Research Council); ARC Centre of Excellence in Advanced Molecular Imaging aimed at better understanding the molecular basis of immunity(Australian Research Council)	This work was supported by the Australian National Health and Medical Research Council through Grants APP1028423 (to D.P.F. and L.B.) and APP1084083 (to D.P.F., A.I., and J.B.P.), and an SPRF1027369 Fellowship (to D.P.F.); a University of Queensland Postdoctoral Fellowship (to A.I.); a Queensland State Government (Collaboration and Innovation Fund) grant (to D.P.F., J.P.W., and J.B.P.); and Australian Research Council (ARC) Grant DP130100629, ARC Federation Fellowship FF0668733, and the ARC Centre of Excellence in Advanced Molecular Imaging aimed at better understanding the molecular basis of immunity (CE140100011; all to D.P.F.). The authors declare no conflicts of interest.	Austin RL, 2008, DIABETES, V57, P2066, DOI 10.2337/db07-0763; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Bianco AC, 2013, LANCET DIABETES ENDO, V1, P250, DOI 10.1016/S2213-8587(13)70069-X; Bilan Phillip J., 2009, Archives of Physiology and Biochemistry, V115, P176, DOI 10.1080/13813450903079314; Bird L, 2014, NAT REV IMMUNOL, V14, DOI 10.1038/nri3588; Blakeney JS, 2007, CHEM REV, V107, P2960, DOI 10.1021/cr050984g; Blakeney JS, 2005, CURR MED CHEM, V12, P3027, DOI 10.2174/092986705774462888; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Brown L., 2010, DRUG DISCOV TODAY DI, V7, pe191, DOI [10.1016/j.ddmec.2010.12.001, DOI 10.1016/J.DDMEC.2010.12.001]; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Buhmann H, 2014, BEST PRACT RES CL GA, V28, P559, DOI 10.1016/j.bpg.2014.07.003; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Calfee CS, 2010, NATURE, V464, P41, DOI 10.1038/464041a; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; Cummings DE, 2009, INT J OBESITY, V33, pS33, DOI 10.1038/ijo.2009.15; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Duboc H, 2014, DIGEST LIVER DIS, V46, P302, DOI 10.1016/j.dld.2013.10.021; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dulloo AG, 2013, ANN NY ACAD SCI, V1302, P1, DOI 10.1111/nyas.12304; Eagle AR, 2010, J CLIN INVEST, V120, P3437, DOI 10.1172/JCI44721; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hohenhaus DM, 2013, IMMUNOBIOLOGY, V218, P1345, DOI 10.1016/j.imbio.2013.07.001; Holtmann G, 2014, BEST PRACT RES CL GA, V28, P967, DOI 10.1016/j.bpg.2014.10.001; Hommelberg PPH, 2011, CELL MOL LIFE SCI, V68, P1215, DOI 10.1007/s00018-010-0515-3; Hommelberg PPH, 2010, CURR OPIN CLIN NUTR, V13, P647, DOI 10.1097/MCO.0b013e32833f1acd; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Jeong HK, 2010, EXP MOL MED, V42, P823, DOI 10.3858/emm.2010.42.12.085; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Knauf C, 2008, DIABETES, V57, P2603, DOI 10.2337/db07-1788; Konturek SJ, 2003, J PHYSIOL PHARMACOL, V54, P293; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Lee JY, 2010, NUTR REV, V68, P38, DOI 10.1111/j.1753-4887.2009.00259.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Li P, 2010, NATURE, V464, P1287, DOI 10.1038/4641287a; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Marino M, 2011, GENE THER, V18, P109, DOI 10.1038/gt.2010.124; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; Matzinger D, 2000, GUT, V46, P688, DOI 10.1136/gut.46.5.689; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Min HS, 2014, KIDNEY RES CLIN PRAC, V33, P33, DOI 10.1016/j.krcp.2013.11.002; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nogueiras R, 2010, OBES REV, V11, P185, DOI 10.1111/j.1467-789X.2009.00669.x; Nunn Alistair V W, 2007, Nucl Recept, V5, P1; Ochoa-Cortes F, 2010, AM J PHYSIOL-GASTR L, V299, pG723, DOI 10.1152/ajpgi.00494.2009; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Penicaud L, 2010, ENDOCR DEV, V19, P84, DOI 10.1159/000316900; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Pimentel GD, 2014, MOL CELL ENDOCRINOL, V397, P15, DOI 10.1016/j.mce.2014.06.005; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Powell K, 2007, NATURE, V447, P525, DOI 10.1038/447525a; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rangel A, 2013, NAT NEUROSCI, V16, P1717, DOI 10.1038/nn.3561; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Ross R, 2008, DIABETES, V57, P2061, DOI 10.2337/db08-0206; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Samocha-Bonet D, 2012, TRENDS ENDOCRIN MET, V23, P116, DOI 10.1016/j.tem.2011.12.005; Samokhvalov V, 2009, AM J PHYSIOL-ENDOC M, V296, pE37, DOI 10.1152/ajpendo.90667.2008; Sandoval DA, 2010, SCIENCE, V328, P179, DOI 10.1126/science.1188876; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Seow V, 2013, J IMMUNOL, V191, P4308, DOI 10.4049/jimmunol.1301355; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shechter R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01254; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tamrakar AK, 2010, ENDOCRINOLOGY, V151, P5624, DOI 10.1210/en.2010-0437; Taylor R, 2013, DIABETES CARE, V36, P1047, DOI 10.2337/dc12-1805; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Tyndall JDA, 2005, CHEM REV, V105, P793, DOI 10.1021/cr040689g; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zierath D, 2010, NEUROCRIT CARE, V12, P274, DOI 10.1007/s12028-009-9270-4	143	19	19	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3612	3625		10.1096/fj.15-271155	http://dx.doi.org/10.1096/fj.15-271155			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26065858				2022-12-28	WOS:000359915600002
J	Jen, FEC; Djoko, KY; Bent, SJ; Day, CJ; McEwan, AG; Jennings, MP				Jen, Freda E-C.; Djoko, Karrera Y.; Bent, Stephen J.; Day, Christopher J.; McEwan, Alastair G.; Jennings, Michael P.			A genetic screen reveals a periplasmic copper chaperone required for nitrite reductase activity in pathogenic Neisseria	FASEB JOURNAL			English	Article						meningitis; gonorrhea; denitrification	OUTER-MEMBRANE PROTEIN; ANAEROBIC GROWTH; MECHANISMS; ANIA; LIPOPOLYSACCHARIDE; MODULATION; RESISTANCE; DOMAIN	Under conditions of low oxygen availability, Neisseria meningitidis and Neisseria gonorrhoeae are able to respire via a partial denitrification pathway in which nitrite is converted to nitrous oxide. In this process, nitrite reductase (AniA), a copper (Cu)-containing protein converts nitrite to NO, and this product is converted to nitrous oxide by nitric oxide reductase (NorB). NorB also confers protection against toxic NO, and so we devised a conditional lethal screen, using a norB mutant, to identify mutants that were resistant to nitrite-dependent killing. After random-deletion mutagenesis of N. meningitidis, this genetic screen identified a gene encoding a Cu chaperone that is essential for AniA function, AccA. Purified AccA binds one Cu (I) ion and also possesses a second binding site for Cu (II). This novel periplasmic Cu chaperone (AccA) appears to be essential for provision of Cu ions to AniA of pathogenic Neisseria to generate an active nitrite reductase. Apart from the Neisseria genus, AccA is distributed across a wide range of environmental Proteobacteria species.	[Jen, Freda E-C.; Day, Christopher J.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia; [Djoko, Karrera Y.; McEwan, Alastair G.] Univ Queensland, Sch Chem Mol Biosci, St Lucia, Qld, Australia; [Bent, Stephen J.] Univ Adelaide, Fac Sci, Mol & Biomed Sci, Adelaide, SA, Australia	Griffith University; University of Queensland; University of Adelaide	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus,Bldg G26,Parklands Dr, Southport, Qld 4215, Australia.	m.jennings@griffith.edu.au	Jennings, Michael P/G-4822-2013; Bent, Stephen/A-7094-2011	Jennings, Michael P/0000-0002-1027-4684; Bent, Stephen/0000-0003-1563-2855; Djoko, Karrera/0000-0001-9814-6515; McEwan, Alastair/0000-0002-2419-1003; Day, Christopher/0000-0001-7953-4408	Australian National Health and Medical Research Council Program Grant [565526]; Australian Research Council Discovery Project Grant [130103141]	Australian National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Project Grant(Australian Research Council)	This study was funded in part by the Australian National Health and Medical Research Council Program Grant 565526 (to M.P.J. and A.G.M.) and Australian Research Council Discovery Project Grant 130103141 (to M.P.J.).	Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; APICELLA MA, 1978, INFECT IMMUN, V20, P228, DOI 10.1128/IAI.20.1.228-234.1978; Aspholm M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001055; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Barth KR, 2009, MICROBIOL-SGM, V155, P4093, DOI 10.1099/mic.0.032961-0; Battistoni A, 2001, J BIOL CHEM, V276, P30315, DOI 10.1074/jbc.M010527200; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BERKS BC, 1994, EUR J BIOCHEM, V220, P117, DOI 10.1111/j.1432-1033.1994.tb18605.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CLARK VL, 1987, INFECT IMMUN, V55, P1359, DOI 10.1128/IAI.55.6.1359-1364.1987; Djoko KY, 2012, INFECT IMMUN, V80, P1065, DOI 10.1128/IAI.06163-11; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Falsetta ML, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00075; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; HOEHN GT, 1992, INFECT IMMUN, V60, P4695, DOI 10.1128/IAI.60.11.4695-4703.1992; Hopper AC, 2013, J BACTERIOL, V195, P2518, DOI 10.1128/JB.02300-12; Householder TC, 2000, INFECT IMMUN, V68, P5241, DOI 10.1128/IAI.68.9.5241-5246.2000; Ieva R, 2005, J BACTERIOL, V187, P3421, DOI 10.1128/JB.187.10.3421-3430.2005; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; KNAPP JS, 1984, INFECT IMMUN, V46, P176, DOI 10.1128/IAI.46.1.176-181.1984; Ku SC, 2009, BIOCHEM BIOPH RES CO, V378, P84, DOI 10.1016/j.bbrc.2008.11.025; Mattle D, 2013, J MOL BIOL, V425, P2299, DOI 10.1016/j.jmb.2013.03.008; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rowland JL, 2012, TUBERCULOSIS, V92, P202, DOI 10.1016/j.tube.2011.12.006; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Seib KL, 2003, FEBS LETT, V546, P411, DOI 10.1016/S0014-5793(03)00632-X; Serventi F, 2012, J BIOL CHEM, V287, P38812, DOI 10.1074/jbc.M112.406173; Shewell LK, 2013, BIOCHEM BIOPH RES CO, V431, P215, DOI 10.1016/j.bbrc.2012.12.132; Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Unemo M, 2011, ANN NY ACAD SCI, V1230, pE19, DOI 10.1111/j.1749-6632.2011.06215.x; vanderLey P, 1996, MOL MICROBIOL, V19, P1117, DOI 10.1046/j.1365-2958.1996.464992.x; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; Warren MJ, 2004, FEMS IMMUNOL MED MIC, V41, P43, DOI 10.1016/j.femsim.2004.01.002; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j	41	10	10	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3828	3838		10.1096/fj.15-270751	http://dx.doi.org/10.1096/fj.15-270751			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26031293	Green Published			2022-12-28	WOS:000359915600019
J	Chabowska-Kita, A; Trabczynska, A; Korytko, A; Kaczmarek, MM; Kozak, LP				Chabowska-Kita, Agnieszka; Trabczynska, Anna; Korytko, Agnieszka; Kaczmarek, Monika M.; Kozak, Leslie P.			Low ambient temperature during early postnatal development fails to cause a permanent induction of brown adipocytes	FASEB JOURNAL			English	Article						sympathetic activity; diet-induced obesity; recombinant inbred mice; brown adipocyte involution; microarray gene expression	WHITE ADIPOSE-TISSUE; DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; GENE-EXPRESSION; BODY-WEIGHT; NERVOUS-SYSTEM; ENERGY-BALANCE; MUS-MUSCULUS; FAT DEPOTS; MICE	The brown adipocyte phenotype (BAP) in white adipose tissue (WAT) is transiently induced in adult mammals in response to reduced ambient temperature. Since it is unknown whether a cold challenge can permanently induce brown adipocytes (BAs), we reared C57BL/6J (B6) and AxB8/PgJ (AxB8) mice at 17 or 29 degrees C from birth to weaning, to assess the BAP in young and adult mice. Energy balance measurements showed that 17 degrees C reduced fat mass in the preweaning mice by increasing energy expenditure and suppressed diet-induced obesity in adults. Microarray analysis of global gene expression of inguinal fat (ING) from 10-day-old (D) mice indicates that expression at 17 degrees C vs. 29 degrees C was not different. Between 10 and 21 days of age, the BAP was induced coincident with morphologic remodeling of ING and marked changes in expression of neural development genes (e.g., Akap 12 and Ngfr). Analyses of Ucp1 mRNA and protein showed that 17 degrees C transiently increased the BAP in ING from 21D mice; however, BAs were unexpectedly present in mice reared at 29 degrees C. The involution of the BAP in WAT occurred after weaning inmice reared at 23 degrees C. Therefore, the capacity to stimulate thermogenically competent BAs in WAT is set by a temperature-independent, genetically controlled program between birth and weaning.	[Chabowska-Kita, Agnieszka; Trabczynska, Anna; Korytko, Agnieszka; Kaczmarek, Monika M.; Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Kozak, LP (corresponding author), Polish Acad Sci, Ul Tuwima 10, PL-10748 Olsztyn, Poland.	l.kozak@pan.olsztyn.pl	Korytko, Agnieszka/H-7200-2017; KACZMAREK, Monika Marzena/AAS-2271-2020; Kaczmarek, Monika/N-4892-2015; Caly, Anna/C-5611-2019	Korytko, Agnieszka/0000-0002-0137-7649; KACZMAREK, Monika Marzena/0000-0002-8213-4381; Kaczmarek, Monika/0000-0002-8213-4381; Caly, Anna/0000-0002-7687-4471; Chabowska-Kita, Agnieszka/0000-0003-3884-579X	Foundation for Polish Science; Programme WELCOME [WELCOME/2010-4/3]; EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project [FP7-REGPOT-2010-1-264103]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Programme WELCOME; EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project	This work was supported by grants from the Foundation for Polish Science; Programme WELCOME (WELCOME/2010-4/3, Nutrition and ambient temperature during early development can reduce susceptibility to obesity); and EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project (FP7-REGPOT-2010-1-264103) (all to L.P.K.).	Amorim BS, 2009, J ENDOCRINOL, V203, P291, DOI 10.1677/JOE-08-0539; Bal N. C., 2012, NAT MED, V18, P1857; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BATCHELDER P, 1983, PHYSIOL BEHAV, V31, P97, DOI 10.1016/0031-9384(83)90102-6; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Clarke KJ, 2012, BBA-BIOENERGETICS, V1817, P1759, DOI 10.1016/j.bbabio.2012.03.035; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; COUSIN B, 1992, J CELL SCI, V103, P931; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Harshaw C, 2012, PHYSIOL BEHAV, V106, P670, DOI 10.1016/j.physbeh.2012.05.002; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; JACOBSSON A, 1994, AM J PHYSIOL-REG I, V267, pR999, DOI 10.1152/ajpregu.1994.267.4.R999; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Jin SH, 2004, J COMP NEUROL, V477, P300, DOI 10.1002/cne.20263; Johnson MS, 2001, J EXP BIOL, V204, P1967; Klein R, 2014, CURR OPIN NEUROBIOL, V27, P16, DOI 10.1016/j.conb.2014.02.006; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Lasar D, 2013, BBA-MOL CELL BIOL L, V1831, P960, DOI 10.1016/j.bbalip.2013.01.016; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Morrison SF, 2000, J NEUROSCI, V20, P9264; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Piontek J, 2003, J BIOL CHEM, V278, P38970, DOI 10.1074/jbc.M306749200; Pope M, 2014, ACTA PHYSIOL, V210, P20, DOI 10.1111/apha.12053; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; ROTHWELL NJ, 1984, J PHYSIOL-LONDON, V355, P457, DOI 10.1113/jphysiol.1984.sp015431; Schmidt M, 2003, INT J DEV NEUROSCI, V21, P125, DOI 10.1016/S0736-5748(03)00030-3; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; SILVERMAN J, 1992, LAB ANIM, V26, P127, DOI 10.1258/002367792780745832; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Voigt A, 2013, MOL NUTR FOOD RES, V57, P1423, DOI 10.1002/mnfr.201200671; Walden TB, 2010, BIOCHEM BIOPH RES CO, V397, P146, DOI 10.1016/j.bbrc.2010.05.053; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	60	16	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3238	3252		10.1096/fj.15-271395	http://dx.doi.org/10.1096/fj.15-271395			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25896784	Green Published			2022-12-28	WOS:000358796900013
J	Li, PP; Shi, JX; Zhang, P; Wang, K; Li, JL; Liu, HJ; Zhou, Y; Xu, X; Hao, J; Sun, XY; Pang, XW; Li, Y; Wu, HN; Chen, XP; Ge, Q				Li, Pingping; Shi, Junxiu; Zhang, Peng; Wang, Ke; Li, Jinglong; Liu, Hongju; Zhou, Yu; Xu, Xi; Hao, Jie; Sun, Xiuyuan; Pang, Xuewen; Li, Yan; Wu, Hounan; Chen, Xiaoping; Ge, Qing			Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibility	FASEB JOURNAL			English	Article						IL-10; neutrophil; microbiota	IMMUNE-SYSTEM DYSREGULATION; HEAD-DOWN TILT; SHORT-DURATION; BED REST; CYTOKINE PRODUCTION; SPACEFLIGHT; MUCOSAL; CELLS; INFLAMMATION; DEFICIENCY	The immune systems can be altered by spaceflight in many aspects, but microgravity-related mucosal immune changes and its clinical significance have not been well studied. The purpose of this study was to investigate whether simulated microgravity influences the intestinal homeostasis and increases the susceptibility to colon inflammation. The hindlimb unloading (HU) mouse model was used to simulate the microgravity condition. Three percent dextran sulfate sodium (DSS) was given to mice to induce colitis. Compared to ground control (Ctrl) mice, the HU ones revealed an impaired intestinal homeostasis and increased susceptibility to DSS-induced colitis. This includes an early-onset, 4-fold expansion of segmented filamentous bacteria (SFB), more than 2-fold decrease in regulatory T (T-reg) cell numbers and IL-10 production, similar to 2-fold increase in colonic IL-1 beta expression, 2-fold increase in circulating neutrophils, and colonic neutrophil infiltration. The application of antibiotics ameliorated the T-reg and IL-10 reductions but did not significantly dampen neutrophilia and elevated expression of colonic IL-1 beta. These results indicate that the intestinal microflora and innate immune system both respond to simulated microgravity and together, contribute to the proinflammatory shift in the gut microenvironment. The data also emphasize the necessity for evaluating the susceptibility to inflammatory bowel diseases (IBDs) in distant space travels.	[Li, Pingping; Shi, Junxiu; Wang, Ke; Zhou, Yu; Xu, Xi; Hao, Jie; Sun, Xiuyuan; Pang, Xuewen; Li, Yan; Ge, Qing] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing 100191, Peoples R China; [Wu, Hounan] Peking Univ, Hlth Sci Ctr, Med & Hlth Analyt Ctr, Beijing 100191, Peoples R China; [Zhang, Peng; Liu, Hongju; Chen, Xiaoping] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Li, Jinglong] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Li, Jinglong] Shaanxi Normal Univ, Key Lab Modern Teaching Technol, Xian, Peoples R China	Peking University; Peking University; Shaanxi Normal University; Shaanxi Normal University	Ge, Q (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Sch Basic Med Sci, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	xpchen2009@163.com; qingge@bjmu.edu.cn	Li, Ping/GYV-4914-2022; Shi, Junxiu/GXH-8588-2022; Shi, Junxiu/M-1393-2019		Natural Basic Research Program of China [2011CB711000, 2010CB945300]; National Natural Science Foundation of China [31270935, 81471525, 31171144, 81272177]; Beijing Natural Science Foundation [5152010]; State Key Laboratory Grant of Space Medicine Fundamentals and Application [SMFA10A01]	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); State Key Laboratory Grant of Space Medicine Fundamentals and Application	The authors thank Professors Xiaohuan Guo (Qinghua University), Zhihua Liu (Institute of Biophysics, Chinese Academy of Sciences), Yu Zhang, Wenling Han, and Lu Wang (Peking University Health Science Center) for helpful discussions. This work was supported by grants from the Natural Basic Research Program of China (2011CB711000 and 2010CB945300; to Q.G.), National Natural Science Foundation of China (31270935 and 81471525, to Q.G.; 31171144 and 81272177, to X.C.), Beijing Natural Science Foundation (5152010; to Q.G.), and State Key Laboratory Grant of Space Medicine Fundamentals and Application (SMFA10A01; to X.C.). The authors declare no conflicts of interest.	Arunasri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057860; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bernstein CN, 2005, GASTROENTEROLOGY, V129, P827, DOI 10.1053/j.gastro.2005.06.021; Brazil JC, 2013, INFLAMM BOWEL DIS, V19, P1556, DOI 10.1097/MIB.0b013e318281f54e; Chakraborty N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-659; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian B, 2011, AVIAT SPACE ENVIR MD, V82, P857, DOI 10.3357/ASEM.3047.2011; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Foster JS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01340; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Furusawa Y, 2015, SEMIN IMMUNOPATHOL, V37, P17, DOI 10.1007/s00281-014-0455-3; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huang BL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00013; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kaur I, 2008, CLIN VACCINE IMMUNOL, V15, P1523, DOI 10.1128/CVI.00065-08; Kelsen J, 2012, CYTOKINE, V59, P403, DOI 10.1016/j.cyto.2012.04.032; Klaus D, 1997, MICROBIOL-SGM, V143, P449, DOI 10.1099/00221287-143-2-449; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Lynch SV, 2004, J BACTERIOL, V186, P8207, DOI 10.1128/JB.186.24.8207-8212.2004; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; McCarville JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068961; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Noor SO, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-134; Novoselova E. G., 2014, IMMUNOBIOLOGY, V220, P500; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; Sanz Y, 2014, ADV EXP MED BIOL, V817, P291, DOI 10.1007/978-1-4939-0897-4_14; SAWYER HR, 1992, J APPL PHYSIOL, V73, pS148, DOI 10.1152/jappl.1992.73.2.S148; Schmitt DA, 2000, PFLUG ARCH EUR J PHY, V441, pR79, DOI 10.1007/s004240000349; Schmitt DA, 1996, J INTERF CYTOK RES, V16, P151, DOI 10.1089/jir.1996.16.151; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Xiang L, 2010, APPL BIOCHEM BIOTECH, V162, P654, DOI 10.1007/s12010-009-8836-0; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077401; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	53	34	41	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3263	3273		10.1096/fj.15-271700	http://dx.doi.org/10.1096/fj.15-271700			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25877215				2022-12-28	WOS:000358796900015
J	Lopez-Abarrategui, C; McBeth, C; Mandal, SM; Sun, ZYJ; Heffron, G; Alba-Menendez, A; Migliolo, L; Reyes-Acosta, O; Garcia-Villarino, M; Nolasco, DO; Falcao, R; Cherobim, MD; Dias, SC; Brandt, W; Wessjohann, L; Starnbach, M; Franco, OL; Otero-Gonzalez, AJ				Lopez-Abarrategui, Carlos; McBeth, Christine; Mandal, Santi M.; Sun, Zhenyu J.; Heffron, Gregory; Alba-Menendez, Annia; Migliolo, Ludovico; Reyes-Acosta, Osvaldo; Garcia-Villarino, Monica; Nolasco, Diego O.; Falcao, Rosana; Cherobim, Mariana D.; Dias, Simoni C.; Brandt, Wolfgang; Wessjohann, Ludger; Starnbach, Michael; Franco, Octavio L.; Otero-Gonzalez, Anselmo J.			Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae)	FASEB JOURNAL			English	Article						antimicrobial peptide; Candida albicans; systemic candidiasis	HELICAL ANTIMICROBIAL PEPTIDES; HOST-DEFENSE PEPTIDES; C-TERMINAL REGIONS; CANDIDACIDAL MECHANISM; ANTIBACTERIAL ACTIVITY; MEMBRANE; NMR; CANDIDIASIS; PLANT; CELL	Antimicrobial peptides form part of the first line of defense against pathogens for many organisms. Current treatments for fungal infections are limited by drug toxicity and pathogen resistance. Cm-p5 (SRSE-LIVHQRLF), a peptide derived from the marine mollusk Cenchritis muricatus peptide Cm-p1, has a significantly increased fungistatic activity against pathogenic Candida albicans (minimal inhibitory concentration, 10 mu g/ml; EC50, 1.146 mu g/ml) while exhibiting low toxic effects against a cultured mammalian cell line. Cm-p5 as characterized by circular dichroism and nuclear magnetic resonance revealed an alpha-helical structure in membranemimetic conditions and a tendency to random coil folding in aqueous solutions. Additional studies modeling Cm-p5 binding to a phosphatidylserine bilayer in silico and isothermal titration calorimetry using lipid monophases demonstrated that Cm-p5 has a high affinity for the phospholipids of fungal membranes (phosphatidylserine and phosphatidylethanolamine), only moderate interactions with a mammalian membrane phospholipid, low interaction with ergosterol, and no interaction with chitin. Adhesion of Cm-p5 to living C. albicans cells was confirmed by fluorescence microscopy with FITC-labeled peptide. In a systemic candidiasis model in mice, intraperitoneal administration of Cm-p5 was unable to control the fungal kidney burden, although its low amphiphaticity could be modified to generate new derivatives with improved fungicidal activity and stability.	[Lopez-Abarrategui, Carlos; Garcia-Villarino, Monica; Otero-Gonzalez, Anselmo J.] Univ Havana, Fac Biol, Ctr Prot Studies, Havana, Cuba; [Alba-Menendez, Annia] Inst Trop Med Pedro Kouri, Branch Parasitol, Havana, Cuba; [Reyes-Acosta, Osvaldo] Ctr Genet Engn & Biotechnol, Lab Peptide Anal & Synth, Havana, Cuba; [McBeth, Christine; Starnbach, Michael] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol NRB, Boston, MA USA; [Sun, Zhenyu J.; Heffron, Gregory] Harvard Univ, Sch Med, Biomol NMR Lab, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Mandal, Santi M.] Vidyasagar Univ, Antiinfect Res Lab, Dept Microbiol, Midnapore, India; [Migliolo, Ludovico; Nolasco, Diego O.; Cherobim, Mariana D.; Dias, Simoni C.; Franco, Octavio L.] Univ Catolica Brasilia, Ctr Biochem & Prote Anal, Brasilia, DF, Brazil; [Falcao, Rosana] Brazil Agr Res Corp EMBRAPA, Natl Ctr Res Genet Resources & Biotechnol CENARGE, EMBRAPA, Brasilia, DF, Brazil; [Brandt, Wolfgang; Wessjohann, Ludger] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Saale, Germany; [Franco, Octavio L.] Univ Catolica Dom Bosco, Dept Biotechnol, Campo Grande, Brazil	Universidad de la Habana; Centro de Ingenieria Genetica y Biotecnologia; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vidyasagar University; Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Leibniz Institut fur Pflanzenbiochemie; Universidade Catolica Dom Bosco (UCDB)	Franco, OL (corresponding author), Univ Catolica Brasilia, Ctr Biochem & Prote Anal, SGAN 916,Av W5,Block C,Room 219, BR-70790160 Brasilia, DF, Brazil.	ocfranco@gmail.com	Wessjohann, Ludger/AAZ-3838-2021; Nolasco, Diego O/O-6743-2014; Nolasco, Diego O./D-1241-2017; Mandal, Santi M./AAF-7156-2020; Franco, Octavio L/T-3020-2017; MIGLIOLO, LUDOVICO/AAV-6913-2021	Nolasco, Diego O/0000-0001-7931-5475; Nolasco, Diego O./0000-0001-7931-5475; MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Mandal, Santi M/0000-0002-0119-7138; Franco, Octavio/0000-0001-9546-0525; Alba Menendez, Annia/0000-0003-3190-8786; Wessjohann, Ludger A./0000-0003-2060-8235; McBeth, Christine/0000-0002-1648-2417	International Foundation of Science (IFS), Sweden [F 4614, F/5199]; Organization for the Prohibition of Chemical Weapons (OPCW), The Netherlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039558] Funding Source: NIH RePORTER	International Foundation of Science (IFS), Sweden(International Foundation for Science); Organization for the Prohibition of Chemical Weapons (OPCW), The Netherlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank CNPq, FAPDF, FUNDECT, CAPES-MES, Brazil; International Foundation of Science (IFS), Sweden (F 4614 and F/5199 projects); and David Rockefeller Center for Latin American Studies (DRCLAS), Harvard University. It was also relevant the support of the Organization for the Prohibition of Chemical Weapons (OPCW), The Netherlands. Furthermore, they also appreciate the efforts of Dr. A. Porcel from the Leibniz Institute of Plant Biochemistry, Department of Bio-organic Chemistry, Halle (Saale), Germany, for her assistance with CD experiments. They also extend their sincerest thanks and appreciation to Dr. J. David, Richard Pearson Strong Professor of Tropical Public Health, Emeritus, Harvard School of Public Health, for his critical review and advice.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Andes D, 2005, METH MOLEC MED, V118, P111; Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Arnold Tamra M, 2010, Proc Am Thorac Soc, V7, P222, DOI 10.1513/pats.200906-048AL; Belguesmia Y, 2013, LETT APPL MICROBIOL, V56, P237, DOI 10.1111/lam.12037; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brandelli A, 2012, MINI-REV MED CHEM, V12, P731, DOI 10.2174/138955712801264774; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Caillon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075528; Cho J, 2012, J MICROBIOL BIOTECHN, V22, P1367, DOI 10.4014/jmb.1205.05040; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V2nd, P3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; Domingues TM, 2013, LANGMUIR, V29, P8609, DOI 10.1021/la401596s; Drew RH, 2013, EXPERT OPIN PHARMACO, V14, P2361, DOI 10.1517/14656566.2013.838217; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002; Helmerhorst EJ, 2001, J BIOL CHEM, V276, P5643, DOI 10.1074/jbc.M008229200; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Hetru C, 1997, Methods Mol Biol, V78, P35; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jiang ZQ, 2008, CHEM BIOL DRUG DES, V72, P483, DOI 10.1111/j.1747-0285.2008.00728.x; Keller R., 2004, COMPUTER AIDED RESON, V1; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lee J, 2010, J MICROBIOL BIOTECHN, V20, P1192, DOI 10.4014/jmb.1004.04041; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; Lequin O, 2003, BIOCHEMISTRY-US, V42, P10311, DOI 10.1021/bi034401d; Lopez-Abarrategui C, 2013, CURR PROTEIN PEPT SC, V14, P595; Lopez-Abarrategui C, 2012, BIOCHIMIE, V94, P968, DOI 10.1016/j.biochi.2011.12.016; Lupetti A, 2007, J INFECT DIS, V196, P1416, DOI 10.1086/522427; Mahalka AK, 2009, BBA-BIOMEMBRANES, V1788, P1600, DOI 10.1016/j.bbamem.2009.04.012; Mahata D, 2014, INT J BIOL MACROMOL, V69, P5, DOI 10.1016/j.ijbiomac.2014.05.017; Martins IM, 2011, J BIOL CHEM, V286, P3484, DOI 10.1074/jbc.M110.174300; Matejuk A, 2010, DRUG FUTURE, V35, P197, DOI 10.1358/dof.2010.035.03.1452077; MERRIFIELD B, 1986, SCIENCE, V232, P341, DOI 10.1126/science.3961484; Munoz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054813; MURPHY JB, 1960, BIOCHIM BIOPHYS ACTA, V45, P382, DOI 10.1016/0006-3002(60)91464-5; Pal T, 2006, INT J ANTIMICROB AG, V27, P525, DOI 10.1016/j.ijantimicag.2006.01.010; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Peman J, 2009, EXPERT REV ANTI-INFE, V7, P453, DOI [10.1586/eri.09.18, 10.1586/ERI.09.18]; Phoenix D.A., 2013, ANTIMICROBIAL PEPTID, DOI DOI 10.1002/9783527652853; Phoenix DA, 2002, MOL MEMBR BIOL, V19, P1, DOI 10.1080/09687680110103631; Polonelli L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034105; Poon IKH, 2014, ELIFE, V3, DOI 10.7554/eLife.01808; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Puri S, 2014, EUKARYOT CELL, V13, P958, DOI 10.1128/EC.00095-14; Pushpanathan M, 2012, J PEPT SCI, V18, P657, DOI 10.1002/psc.2445; Ribeiro PD, 2003, PEPTIDES, V24, P1807, DOI 10.1016/j.peptides.2003.08.021; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sikorska E, 2014, BBA-BIOMEMBRANES, V1838, P2625, DOI 10.1016/j.bbamem.2014.06.016; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Su YC, 2013, AMINO ACIDS, V44, P821, DOI 10.1007/s00726-012-1421-9; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Tavares PM, 2008, ANTIMICROB AGENTS CH, V52, P4522, DOI 10.1128/AAC.00448-08; van der Weerden NL, 2013, CELL MOL LIFE SCI, V70, P3545, DOI 10.1007/s00018-013-1260-1; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wilkinson S., 1988, MICROBIAL LIPIDS; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	66	31	33	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3315	3325		10.1096/fj.14-269860	http://dx.doi.org/10.1096/fj.14-269860			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921828	Green Published			2022-12-28	WOS:000358796900019
J	Bushman, JD; Ye, WL; Liman, ER				Bushman, Jeremy D.; Ye, Wenlei; Liman, Emily R.			A proton current associated with sour taste: distribution and functional properties	FASEB JOURNAL			English	Article						PKD2L1; ion channel; pH; acid; sensory transduction	INFLUENZA-A VIRUS; RECEPTOR-CELLS; TRANSIENT RECEPTOR; SELECTIVITY FILTER; INTRACELLULAR PH; ION-CHANNEL; VOLTAGE; PKD2L1; MOUSE; PATHWAYS	Sour taste is detected by taste receptor cells that respond to acids through yet poorly understood mechanisms. The cells that detect sour express the protein PKD2L1, which is not the sour receptor but nonetheless serves as a useful marker for sour cells. By use of mice in which the PKD2L1 promoter drives expression of yellow fluorescent protein, we previously reported that sour taste cells from circumvallate papillae in the posterior tongue express a proton current. To establish a correlation between this current and sour transduction, we examined its distribution by patch-clamp recording. We find that the current is present in PKD2L1-expressing taste cells from mouse circumvallate, foliate, and fungiform papillae but not in a variety of other cells, including spinal cord neurons that express PKD2L1. We describe biophysical properties of the current, including pH-dependent Zn2+ inhibition, lack of voltage-dependent gating, and activation atmodest pH values (6.5) that elicit action potentials in isolated cells. Consistent with a channel that is constitutively open, the cytosol of sour taste cells is acidified. These data define a functional signature for the taste cell proton current and indicate that its expression is mostly restricted to the subset of taste cells that detect sour.	[Bushman, Jeremy D.; Ye, Wenlei; Liman, Emily R.] Univ So Calif, Neurobiol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Liman, ER (corresponding author), Univ So Calif, Neurobiol Sect, 3641 Watt Way, Los Angeles, CA 90089 USA.	liman@usc.edu	Liman, Emily/AAC-7383-2021; Ye, Wenlei/S-1012-2016	Ye, Wenlei/0000-0002-4694-1493; liman, emily/0000-0003-4765-5496	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R01DC013741, F32DC013971]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC013971, R01DC013741] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Eric Mulhall for expert technical assistance and Radhika Palkar and David McKemy for assistance with isolating spinal neurons and for providing neuro2a cells. This work was supported by U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders Grants R01DC013741 (to E.R.L.) and F32DC013971 (to J.D.B.).	Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0799; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DeSimone JA, 2011, CHEM SENSES, V36, P389, DOI 10.1093/chemse/bjq148; Djenoune L., FRONT NEUROANAT, V8, P26; FOGEL M, 1972, P NATL ACAD SCI USA, V69, P690, DOI 10.1073/pnas.69.3.690; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Higuchi T, 2014, PFLUG ARCH EUR J PHY, V466, P1933, DOI 10.1007/s00424-013-1439-1; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Liu LJ, 2001, BRAIN RES, V923, P58, DOI 10.1016/S0006-8993(01)03190-0; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 1997, AM J PHYSIOL-CELL PH, V273, pC1008, DOI 10.1152/ajpcell.1997.273.3.C1008; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Morgan D, 2013, J GEN PHYSIOL, V142, P625, DOI 10.1085/jgp.201311045; Mould JA, 2000, J BIOL CHEM, V275, P31038, DOI 10.1074/jbc.M003663200; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Musset B, 2010, J PHYSIOL-LONDON, V588, P1435, DOI 10.1113/jphysiol.2010.188318; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Orts-Del'Immagine A, 2012, J PHYSIOL-LONDON, V590, P3719, DOI 10.1113/jphysiol.2012.227959; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Ramsey IS, 2010, NAT STRUCT MOL BIOL, V17, P869, DOI 10.1038/nsmb.1826; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shimizu T, 2011, PFLUG ARCH EUR J PHY, V461, P507, DOI 10.1007/s00424-011-0934-5; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007	48	29	30	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3014	3026		10.1096/fj.14-265694	http://dx.doi.org/10.1096/fj.14-265694			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857556	Green Published			2022-12-28	WOS:000356859100029
J	Steinckwich, N; Myers, P; Janardhan, KS; Flagler, ND; King, D; Petranka, JG; Putney, JW				Steinckwich, Natacha; Myers, Page; Janardhan, Kyathanahalli S.; Flagler, Norris D.; King, Debra; Petranka, John G.; Putney, James W.			Role of the store-operated calcium entry protein, STIM1, in neutrophil chemotaxis and infiltration into a murine model of psoriasis-inflamed skin	FASEB JOURNAL			English	Article						calcium signaling; chronic inflammatory disease; leukocyte migration	CA2+ INFLUX; ACTIVATION; INTEGRIN; CELLS; POLARIZATION; INFLAMMATION; MECHANISMS; MIGRATION; IMIQUIMOD	Stromal interaction molecule 1 (STIM1) is a Ca2+ sensor protein that initiates store-operated calcium entry (SOCE). STIM1 is known to be involved in the chemoattractant signaling pathway for FPR1 in cell lines, but its role in in vivo functioning of neutrophils is unclear. Plaque-type psoriasis is a chronic inflammatory skin disorder associated with chemoattractants driving neutrophils into the epidermis. We investigated the involvement of STIM1 in neutrophil chemotaxis in vitro, as well as during chronic psoriatic inflammation. To this end, we used conditional knockout (KO) mice lacking STIM1 in cells of myeloid lineage (STIM1(fl/fl) LysM-cre). We demonstrate that STIM1 is required for chemotaxis because of multiple chemoattractants in mouse neutrophils in vitro. Using an imiquimod-induced psoriasis-like skin model, we show that KO mice had less neutrophil infiltration in the epidermis than controls, whereas neither chemoattractant production in the epidermis nor macrophage migration was decreased. KO mice displayed a more rapid reversal of the outward signs of psoriasis (plaques). Thus, KO of STIM1 impairs neutrophil contribution to psoriatic inflammation. Our data provide new insights to our understanding of how STIM1 orchestrates the cellular behavior underlying chemotaxis and illustrate the important role of SOCE in a disease-related pathologic model.	[Steinckwich, Natacha; Petranka, John G.; Putney, James W.] NIEHS, Signal Transduct Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Myers, Page] NIEHS, Comparat Med Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Janardhan, Kyathanahalli S.] NIEHS, Integrated Syst Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Janardhan, Kyathanahalli S.; Flagler, Norris D.; King, Debra] NIEHS, Cellular & Mol Pathol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Janardhan, Kyathanahalli S.; Flagler, Norris D.; King, Debra] NIEHS, Natl Toxicol Program, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Flagler, Norris D.; King, Debra] NIEHS, Special Tech Grp, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA.	putney@niehs.nih.gov	Putney, James W/F-7247-2019	Putney, James W/0000-0002-3379-4789	Intramural Research Program of the NIH National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087, ZICES102546] Funding Source: NIH RePORTER	Intramural Research Program of the NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Drs. Michael Fessler and Xiaoling Li read the manuscript and provided useful comments. The authors thank Gary Bird for fruitful discussion. Mice carrying a floxed STIM1 gene were kindly provided by Dr. Masatsugu Ohora (Tokyo Medical and Dental University, Tokyo, Japan). The YFP-STIM1 construct that was subcloned into a viral vector was provided by Dr. Tobias Meyer (Stanford University, Stanford, CA, USA). The authors also thank Jeff Tucker and Agnes Janoshazi for assistance with the confocal microscopy; Carl Bortner and Maria Sifre for assistance with the flow cytometry; Diane D'Agostin for technical support in mouse colony management and in in situ hybridization experiments; Dr. Shyamal D. Peddada for assistance with statistical analyses; Negin Martin and Charles Romeo for help in producing lentiviral particles; and Julie Foley and the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences histology group members for support in histology. This research was supported by the Intramural Research Program of the NIH National Institute of Environmental Health Sciences. The authors declare no conflicts of interest.	Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Brechard S, 2009, BIOCHEM PHARMACOL, V78, P504, DOI 10.1016/j.bcp.2009.05.006; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Dixit N, 2011, J IMMUNOL, V187, P472, DOI 10.4049/jimmunol.1004197; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hellberg C, 1996, BIOCHEM J, V317, P403, DOI 10.1042/bj3170403; JACONI MEE, 1991, J CELL BIOL, V112, P1249, DOI 10.1083/jcb.112.6.1249; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Pettit EJ, 1997, BIOCHEM BIOPH RES CO, V230, P258, DOI 10.1006/bbrc.1996.5931; Reagan WJ, 2011, TOXICOL PATHOL, V39, P435, DOI 10.1177/0192623310396907; Rogalski C, 2002, J INVEST DERMATOL, V118, P49, DOI 10.1046/j.0022-202x.2001.01650.x; Schaff UY, 2008, ANN BIOMED ENG, V36, P632, DOI 10.1007/s10439-008-9453-8; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Schon M, 2007, CURR MED CHEM, V14, P681, DOI 10.2174/092986707780059625; Schon M, 2000, J INVEST DERMATOL, V114, P976, DOI 10.1046/j.1523-1747.2000.00953.x; Sesma JI, 2012, AM J PHYSIOL-CELL PH, V303, pC490, DOI 10.1152/ajpcell.00138.2012; Steinckwich N, 2011, J IMMUNOL, V186, P2182, DOI 10.4049/jimmunol.1001338; Su WH, 2000, BLOOD, V96, P3816, DOI 10.1182/blood.V96.12.3816.h8003816_3816_3822; Toichi E, 2000, J AM ACAD DERMATOL, V43, P391, DOI 10.1067/mjd.2000.103264; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Zhang H, 2014, BLOOD, V123, P2238, DOI 10.1182/blood-2012-08-450403; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zou WY, 2012, CELL PHYSIOL BIOCHEM, V30, P221, DOI 10.1159/000339059	35	26	27	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3003	3013		10.1096/fj.14-265215	http://dx.doi.org/10.1096/fj.14-265215			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837581	Green Published			2022-12-28	WOS:000356859100028
J	Tencerova, M; Aouadi, M; Vangala, P; Nicoloro, SM; Yawe, JC; Cohen, JL; Shen, YF; Garcia-Menendez, L; Pedersen, DJ; Gallagher-Dorval, K; Perugini, RA; Gupta, OT; Czech, MP				Tencerova, Michaela; Aouadi, Myriam; Vangala, Pranitha; Nicoloro, Sarah M.; Yawe, Joseph C.; Cohen, Jessica L.; Shen, Yuefei; Garcia-Menendez, Lorena; Pedersen, David J.; Gallagher-Dorval, Karen; Perugini, Richard A.; Gupta, Olga T.; Czech, Michael P.			Activated Kupffer cells inhibit insulin sensitivity in obese mice	FASEB JOURNAL			English	Article						small interfering RNA; liver macrophages; insulin resistance; hepatic steatosis	HEPATIC STEATOSIS; FATTY LIVER; IKK-BETA; RESISTANCE; MACROPHAGES; SIRNA; INFLAMMATION; FAILURE	Obesity promotes insulin resistance associated with liver inflammation, elevated glucose production, and type 2 diabetes. Although insulin resistance is attenuated in genetic mouse models that suppress systemic inflammation, it is not clear whether local resident macrophages in liver, denoted Kupffer cells (KCs), directly contribute to this syndrome. We addressed this question by selectively silencing the expression of the master regulator of inflammation, NF-kappa B, in KCs in obese mice. We used glucan-encapsulated small interfering RNA particles (GeRPs) that selectively silence gene expression in macrophages in vivo. Following intravenous injections, GeRPs containing siRNA against p65 of the NF-kappa B complex caused loss of NF-kappa B p65 expression in KCs without disrupting NF-kappa B in hepatocytes or macrophages in other tissues. Silencing of NF-kappa B expression in KCs in obese mice decreased cytokine secretion and improved insulin sensitivity and glucose tolerance without affecting hepatic lipid accumulation. Importantly, GeRPs had no detectable toxic effect. Thus, KCs are key contributors to hepatic insulin resistance in obesity and a potential therapeutic target formetabolic disease.	[Tencerova, Michaela; Aouadi, Myriam; Vangala, Pranitha; Nicoloro, Sarah M.; Yawe, Joseph C.; Cohen, Jessica L.; Shen, Yuefei; Garcia-Menendez, Lorena; Pedersen, David J.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Gallagher-Dorval, Karen; Perugini, Richard A.] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA; [Gupta, Olga T.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Aouadi, M (corresponding author), Karolinska Inst, Novum, Dept Med, Integrated Cardio Metab Ctr, Blickagangen 6, S-14157 Huddinge, Sweden.	myriam.aouadi@ki.se; michael.czech@umassmed.edu	Tencerova, Michaela/G-8089-2017	Tencerova, Michaela/0000-0001-8670-425X; Nicoloro, Sarah/0000-0002-8638-4556	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK085753, DK030898]; NIH National Institute of Allergy and Infectious Diseases [AI046629]; International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research; NIH NIDDK [DK325220, DK096948-02]; NIDDK under a Ruth L. Kirschstein National Research Service Award (NRSA) [F32DK098879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R01DK085753, R37DK030898, R01DK103047, F32DK098879, F31DK096948] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK under a Ruth L. Kirschstein National Research Service Award (NRSA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank members of their laboratory group for excellent discussion. The authors appreciate the help of Mary Rusckowski and Miles Smith at the small animal imaging core, and the staff of the Flow Cytometry Core, the Morphology Core, and Paul Furcinitti for the spinning disk confocal microscopy at the University of Massachusetts (UMass) Medical School. These studies were supported by grants to M.P.C. from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; DK085753 and DK030898), NIH National Institute of Allergy and Infectious Diseases (AI046629), and the International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research. The Morphology Core Facility at the UMass Medical School Diabetes and Endocrinology Research Center, funded by NIH NIDDK Grant DK325220 is also gratefully acknowledged. J.L.C. is supported by the NIDDK under a Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellowship (F32DK098879). J.C.Y. is supported by a predoctoral NRSA from the NIH NIDDK (DK096948-02). The authors declare no conflicts of interest.	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Beraza N, 2008, GUT, V57, P655, DOI 10.1136/gut.2007.134288; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Dolina JS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.63; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hoffmann F, 2009, GUT, V58, P1670, DOI 10.1136/gut.2008.165647; Jing YW, 2008, BBA-GEN SUBJECTS, V1780, P34, DOI 10.1016/j.bbagen.2007.09.015; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Lee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp758; Lian GW, 2006, EXP HEMATOL, V34, P348, DOI 10.1016/j.exphem.2005.12.004; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ogushi I, 2003, HEPATOLOGY, V38, P335, DOI 10.1053/jhep.2003.50298; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Ramadori G, 2001, EUR J GASTROEN HEPAT, V13, P777, DOI 10.1097/00042737-200107000-00004; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Tesz GJ, 2011, BIOCHEM J, V436, P351, DOI 10.1042/BJ20110352; Thobe BM, 2007, J CELL PHYSIOL, V210, P667, DOI 10.1002/jcp.20860; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	34	43	45	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2959	2969		10.1096/fj.15-270496	http://dx.doi.org/10.1096/fj.15-270496			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805830	Green Published			2022-12-28	WOS:000356859100024
J	Dalli, J; Ramon, S; Norris, PC; Colas, RA; Serhan, CN				Dalli, Jesmond; Ramon, Sesquile; Norris, Paul C.; Colas, Romain A.; Serhan, Charles N.			Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways	FASEB JOURNAL			English	Article						inflammation; resolution; leukocytes; infection	LIPID MEDIATORS; MACROPHAGE EFFEROCYTOSIS; INFLAMMATION; RESOLUTION; BIOSYNTHESIS; LEUKOTRIENES; MECHANISMS; INFECTION; DISEASE; ASPIRIN	Local mediators orchestrate the host response to both sterile and infectious challenge and resolution. Recent evidence demonstrates that maresin sulfido-conjugates actively resolve acute inflammation and promote tissue regeneration. In this report, we investigated self-limited infectious exudates for novel bioactive chemical signals in tissue regeneration and resolution. By use of spleens from Escherichia coli infected mice, self-resolving infectious exudates, human spleens, and blood from patients with sepsis, we identified 2 new families of potent molecules. Characterization of their physical properties and isotope tracking demonstrated that the bioactive structures contained a docosahexaenoate backbone and sulfido-conjugated triene or tetraene double-bond systems. Activated human phagocytes converted 17-hydro(peroxy)-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid to these bioactive molecules. Regeneration of injured planaria was accelerated with nanomolar amounts of 16-glutathionyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid and 16-cysteinylglycinyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid (Protectin sulfido-conjugates) or 8-glutathionyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid and 8-cysteinylglycinyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid (Resolvin sulfido-conjugates). Each protectin and resolvin sulfido-conjugate dose dependently (0.1-10 nM) stimulated human macrophage bacterial phagocytosis, phagolysosomal acidification, and efferocytosis. Together, these results identify 2 novel pathways and provide evidence for structural elucidation of new resolution moduli. These resolvin and protectin conjugates identified in mice and human infected tissues control host responses promoting catabasis.	Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Harvard Inst Med, 77 Ave Louis Pasteur,HIM 829, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu		Norris, Paul/0000-0003-2512-0829; Dalli, Jesmond/0000-0001-6328-3640	U.S. National Institutes of Health [P01GM095467]; Institut Merieux (Lyon, France); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Merieux (Lyon, France); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Mary Halm Small for expert assistance in manuscript preparation and Drs. Michael Levin and Junji Mokmura (Tufts University, Medford, MA, USA) for providing Dugesia japonica seed colonies and helpful discussions. This work was supported by the U.S. National Institutes of Health (Grant P01GM095467) and a Merieux Research Grant from the Institut Merieux (Lyon, France).	Bakhtiar L., 1999, CANON MED AL QANUN E; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Burr GO, 1930, J BIOL CHEM, V86, P0587; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Flannigan KL, 2014, P NATL ACAD SCI USA, V111, P13559, DOI 10.1073/pnas.1413390111; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; HAMMARSTROM S, 1980, BIOCHEM BIOPH RES CO, V92, P946, DOI 10.1016/0006-291X(80)90794-9; HAMMERSTROM S, 1980, FEBS LETT, V122, P83, DOI 10.1016/0014-5793(80)80407-8; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Majno G., 2004, CELLS TISSUES DIS PR; McCauley LK, 2014, J IMMUNOL, V193, P26, DOI 10.4049/jimmunol.1301945; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; Oh SF, 2011, BBA-MOL CELL BIOL L, V1811, P737, DOI 10.1016/j.bbalip.2011.06.007; ORNING L, 1981, EUR J BIOCHEM, V120, P41, DOI 10.1111/j.1432-1033.1981.tb05667.x; Rajasagi NK, 2011, J IMMUNOL, V186, P1735, DOI 10.4049/jimmunol.1003456; Rinaldo-Matthis A, 2012, BIOCHEMISTRY-US, V51, P848, DOI 10.1021/bi201402s; Russell DG, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, pXIII; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Sanchez-Alvarado A, 2006, CELL, V124, P241, DOI 10.1016/j.cell.2006.01.012; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	31	83	86	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2120	2136		10.1096/fj.14-268441	http://dx.doi.org/10.1096/fj.14-268441			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25713027	Green Published			2022-12-28	WOS:000354114600043
J	Merched, AJ; Daret, D; Li, L; Franzl, N; Sauvage-Merched, M				Merched, Aksam J.; Daret, Daniele; Li, Lan; Franzl, Nathalie; Sauvage-Merched, Maria			Specific autoantigens in experimental autoimmunity-associated atherosclerosis	FASEB JOURNAL			English	Article						phagocytosis; extracellular matrix; cytoskeleton; cell junctions	VALOSIN-CONTAINING PROTEIN; MIGRATION INHIBITORY FACTOR; HEAT-SHOCK PROTEINS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYOCARDIAL-INFARCTION; MOLECULAR CHAPERONES; INNATE IMMUNITY; AUTOPHAGY; DISEASE; DEFICIENT	Higher cardiovascular morbidity in patients with a wide range of autoimmune diseases highlights the importance of autoimmunity in promoting atherosclerosis. Our purpose was to investigate the mechanisms of accelerated atherosclerosis and identified vascular autoantigens targeted by autoimmunity. We created a mouse model of autoimmunity-associated atherosclerosis by transplanting bone marrow from FcRIIB knockout (FcRIIB(-/-)) mice into LDL receptor knockout mice. We characterized the cellular and molecular mechanisms of atherogenesis and identified specific aortic autoantigens using serologic proteomic studies. En face lesion area analysis showed more aggressive atherosclerosis in autoimmune mice compared with control mice (0.64 +/- 0.12 vs. 0.32 +/- 0.05 mm(2); P < 0.05, respectively). At the cellular level, FcRIIB(-/-) macrophages showed significant reduction (46-72%) in phagocytic capabilities. Proteomic analysis revealed circulating autoantibodies in autoimmune mice that targeted 25 atherosclerotic lesion proteins, including essential components of adhesion complex, cytoskeleton, and extracellular matrix, and proteins involved in critical functions and pathways. Microscopic examination of atherosclerotic plaques revealed essential colocalization of autoantibodies with endothelial cells, their adherence to basement membranes, the internal elastica lamina, and necrotic cores. The new vascular autoimmunosome may be a useful target for diagnostic and immunotherapeutic interventions in autoimmunity-associated diseases that have accelerated atherosclerosis.Merched, A. J., Daret, D., Li, L., Franzl, N., Sauvage-Merched, M. Specific autoantigens in experimental autoimmunity-associated atherosclerosis.	[Merched, Aksam J.] Univ Bordeaux, Dept Pharmaceut Sci, Bordeaux, France; [Merched, Aksam J.] Univ Bordeaux, INSERM, U1053, Bordeaux, France; [Merched, Aksam J.; Li, Lan] Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Daret, Daniele; Franzl, Nathalie] INSERM, U1034, Pessac, France; [Sauvage-Merched, Maria] Univ Hosp Bordeaux, Childrens Hosp, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Merched, AJ (corresponding author), UFR Pharm, Biol Cellulaire Lab, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	aksam.merched@u-bordeaux.fr		Merched, Aksam/0000-0003-4030-4538	American Heart Association [SDG 0730172N]; Marie Curie Actions (FP7 Intra-European Fellowship) [PIEF-GA-2009-237028]	American Heart Association(American Heart Association); Marie Curie Actions (FP7 Intra-European Fellowship)	This work received grant support from the American Heart Association (SDG 0730172N) and Marie Curie Actions (FP7 Intra-European Fellowship PIEF-GA-2009-237028; both to A. J. M.). The authors declare no conflicts of interest.	Amigorena S, 1999, IMMUNOL REV, V172, P279, DOI 10.1111/j.1600-065X.1999.tb01372.x; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Binder CJ, 2012, ADV EXP MED BIOL, V750, P2, DOI 10.1007/978-1-4614-3461-0_1; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Boldogh IR, 2001, P NATL ACAD SCI USA, V98, P3162, DOI 10.1073/pnas.051494698; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Burillo E, 2009, ATHEROSCLEROSIS, V207, P32, DOI 10.1016/j.atherosclerosis.2009.03.054; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Chiu CC, 2011, CLIN CANCER RES, V17, P4629, DOI 10.1158/1078-0432.CCR-10-2107; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; Chuang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037613; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; de la Cuesta F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003517; Debrand E, 2012, BIOCHEM BIOPH RES CO, V426, P190, DOI 10.1016/j.bbrc.2012.08.061; Denas G, 2015, AUTOIMMUN REV, V14, P214, DOI 10.1016/j.autrev.2014.11.003; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; Frieri M, 2016, AUTOIMMUN REV, V15, P16, DOI 10.1016/j.autrev.2015.08.007; Gatto M, 2013, AUTOIMMUN REV, V12, P523, DOI 10.1016/j.autrev.2012.09.003; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; GOULDING NJ, 1989, ANN RHEUM DIS, V48, P843, DOI 10.1136/ard.48.10.843; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hait WN, 2006, AUTOPHAGY, V2, P294, DOI 10.4161/auto.2857; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; HANSSON GK, 1980, EXP MOL PATHOL, V33, P302, DOI 10.1016/0014-4800(80)90028-3; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hollan I, 2013, AUTOIMMUN REV, V12, P1004, DOI 10.1016/j.autrev.2013.03.013; Jiang Y, 2000, IMMUNOGENETICS, V51, P429, DOI 10.1007/s002510050641; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kaess BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014529; KATSUDA S, 1992, ARTERIOSCLER THROMB, V12, P494, DOI 10.1161/01.ATV.12.4.494; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Koutouzis T, 2009, J PERIODONTOL, V80, P625, DOI 10.1902/jop.2009.080422; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Lague MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042470; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Lessard CJ, 2012, AM J HUM GENET, V90, P648, DOI 10.1016/j.ajhg.2012.02.023; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Liu GW, 2013, J LEUKOCYTE BIOL, V93, P511, DOI 10.1189/jlb.0812389; Lovely RS, 2011, ARTERIOSCL THROM VAS, V31, P2345, DOI 10.1161/ATVBAHA.111.232710; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Mendez-Fernandez YV, 2011, ATHEROSCLEROSIS, V214, P73, DOI 10.1016/j.atherosclerosis.2010.10.018; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Merched A, 2010, CARDIOVASC RES, V85, P853, DOI 10.1093/cvr/cvp347; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Merched AJ, 2011, J NUTRIGENET NUTRIGE, V4, P12, DOI 10.1159/000326890; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Narshi CB, 2011, LUPUS, V20, P5, DOI 10.1177/0961203310382429; Oikonomou KG, 2011, AUTOIMMUN REV, V10, P389, DOI 10.1016/j.autrev.2010.12.009; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Pandey S, 2013, MOL CELL PROTEOMICS, V12, P277, DOI 10.1074/mcp.M112.017087; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; PRUZANSKI W, 1994, J RHEUMATOL, V21, P252; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ramos PS, 2011, ARTHRITIS RHEUM-US, V63, P2049, DOI 10.1002/art.30356; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rekvig OP, 2012, AUTOIMMUN REV, V11, P596, DOI 10.1016/j.autrev.2011.10.021; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Rullo OJ, 2013, ANN RHEUM DIS, V72, P56, DOI 10.1136/annrheumdis-2012-202351; Santos LL, 2009, CLIN CHIM ACTA, V399, P1, DOI 10.1016/j.cca.2008.09.014; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; Sherer Y, 2000, APPL BIOCHEM BIOTECH, V83, P155, DOI 10.1385/ABAB:83:1-3:155; Sherer Y., 2000, APPL BIOCHEM BIOTECH, V83, P297; Silver KE, 2011, J IMMUNOL, V186, P816, DOI 10.4049/jimmunol.1002161; Skaggs BJ, 2012, NAT REV RHEUMATOL, V8, P214, DOI 10.1038/nrrheum.2012.14; Suzuki Ayako, 2010, Cancer Genomics & Proteomics, V7, P17; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Tahiri F, 2008, HEPATOLOGY, V47, P937, DOI 10.1002/hep.22149; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Teixeira PC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/868251; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wu MY, 2012, CELL RES, V22, P1003, DOI 10.1038/cr.2012.44; Wu TC, 2006, CELL STRESS CHAPERON, V11, P1, DOI 10.1379/CSC-155R.1; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50; Xu QB, 2012, AM J PHYSIOL-HEART C, V302, pH506, DOI 10.1152/ajpheart.00646.2011; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730; Zhang QB, 2013, J EXP MED, V210, P191, DOI 10.1084/jem.20111843; Zhao M, 2010, J IMMUNOL, V184, P2253, DOI 10.4049/jimmunol.0902654	96	12	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2123	2134		10.1096/fj.201500131	http://dx.doi.org/10.1096/fj.201500131			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26891734				2022-12-28	WOS:000376878300007
J	Zotz, JS; Wolbing, F; Lassnig, C; Kauffmann, M; Schulte, U; Kolb, A; Whitelaw, B; Muller, M; Biedermann, T; Huber, M				Zotz, Julia S.; Woelbing, Florian; Lassnig, Caroline; Kauffmann, Marlies; Schulte, Uwe; Kolb, Andreas; Whitelaw, Bruce; Mueller, Mathias; Biedermann, Tilo; Huber, Michael			CD13/aminopeptidase N is a negative regulator of mast cell activation	FASEB JOURNAL			English	Article						proinflammatory cytokines; degranulation; passive systemic anaphylaxis; receptor internalization; IgE receptor	AMINOPEPTIDASE-N; SIGNAL-TRANSDUCTION; SUBSTANCE-P; CD13; N/CD13; EXPRESSION; RECEPTOR; SURFACE; INHIBITORS; PATHWAYS	Antigen-induced mast cell (MC) activation via cross-linking of IgE-bound high-affinity receptors for IgE (Fc epsilon RI) underlies type I allergy and anaphylactic shock. Comprehensive knowledge of Fc epsilon RI regulation is thus required. We have identified a functional interaction between Fc epsilon RI and CD13 in murine MCs. Antigen-triggered activation of IgE-loaded Fc epsilon RI results in cocapping and cointernalization of CD13 and equivalent internalization rates of up to 40%. Cointernalization is not unspecific, because ligand-driven KIT internalization is not accompanied by CD13 internalization. Moreover, antibody-mediated cross-linking of CD13 causes IL-6 production in an Fc epsilon RI-dependent manner. These data are indicative of a functional interaction between Fc epsilon RI and CD13 on MCs. To determine the role of this interaction, CD13-deficient bone marrow-derived MCs (BMMCs) were analyzed. Intriguingly, antigen stimulation of CD13-deficient BMMCs results in significantly increased degranulation and proinflammatory cytokine production compared to wild-type cells. Furthermore, in a low-dose model of passive systemic anaphylaxis, antigen-dependent decrease in body temperature, reflecting the anaphylactic reaction, is substantially enhanced by the CD13 inhibitor bestatin (-5.9 +/- 0.6 degrees C) and by CD13 deficiency (-8.8 +/- 0.6 degrees C) in contrast to controls (-1.2 +/- 1.97 degrees C). Importantly, bestatin does not aggravate anaphylaxis in CD13-deficient mice. Thus, we have identified CD13 as a novel negative regulator of MC activation in vitro and in vivo.Zotz, J. S., Wolbing, F., Lassnig, C., Kauffmann, M., Schulte, U., Kolb, A., Whitelaw, B., Muller, M., Biedermann, T., Huber, M. CD13/aminopeptidase N is a negative regulator of mast cell activation.	[Zotz, Julia S.; Kauffmann, Marlies; Huber, Michael] Rhein Westfal TH Aachen, Inst Biochem & Mol Immunol, Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany; [Woelbing, Florian; Biedermann, Tilo] Tech Univ Munich, Dept Dermatol, D-80290 Munich, Germany; [Lassnig, Caroline; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Schulte, Uwe] Univ Freiburg, Inst Physiol 2, Hugstetter Str 55, D-79106 Freiburg, Germany; [Schulte, Uwe] Ctr Biol Signalling Studies Bioss, Freiburg, Germany; [Schulte, Uwe] Logopharm GmbH, March Buchheim, Germany; [Kolb, Andreas] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Whitelaw, Bruce] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Whitelaw, Bruce] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	RWTH Aachen University; RWTH Aachen University Hospital; Technical University of Munich; University of Veterinary Medicine Vienna; University of Freiburg; University of Aberdeen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Huber, M (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Immunol, Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany.	mhuber@ukaachen.de		Muller, Mathias/0000-0002-7879-3552; Kolb, Andreas/0000-0001-9056-5504; Biedermann, Tilo/0000-0002-5352-5105; Whitelaw, Bruce/0000-0002-2918-1605; LASSNIG, Caroline/0000-0001-7905-3620	Deutsche Forschungsgemeinschaft [HU794/5-1, BI696/3-3, SPP1394, SFB685]; BM-WFaGEN-AU project Austromouse; Austrian Federal Ministry Research and Science; Austrian Science Fund [SFB-F28]; Biotechnology and Biological Sciences Research Council [BBS/E/D/05251445, BBS/E/D/05251443, BBS/E/D/05251442, BBS/E/D/20221658, BBS/E/D/05251444] Funding Source: researchfish; BBSRC [BBS/E/D/05251443, BBS/E/D/20221658, BBS/E/D/05251444, BBS/E/D/05251445, BBS/E/D/05251442] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BM-WFaGEN-AU project Austromouse; Austrian Federal Ministry Research and Science; Austrian Science Fund(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge the excellent technical assistance of Kerstin Fehrenbach (Max Planck Institute for Immunobiology, Freiburg, Germany), Sabrina Schmohl (Department of Dermatology, Eberhard Karls University, Tubingen, Germany), and Yvonne Postma (Department of Dermatology, Eberhard Karls University). The authors are grateful to Dr. Gessner (Hannover Medical School, Hannover, Germany) for providing bone marrow from FcR gamma<SUP>+/+</SUP> and FcR gamma<SUP>-/-</SUP> littermates. This work was supported by the Grants HU794/5-1 (to M. H.), BI696/3-3 (to T. B.), SPP1394 (to M. H. and T. B.), and SFB685 (A06; to T. B.) from the Deutsche Forschungsgemeinschaft, as well as BM-WF<SUP>a</SUP>GEN-AU project Austromouse, Austrian Federal Ministry Research and Science, and Austrian Science Fund Grant SFB-F28 (to M.M.).	Barisas BG, 2007, BIOPHYS CHEM, V126, P209, DOI 10.1016/j.bpc.2006.05.026; BATHON JM, 1992, J CLIN INVEST, V90, P981, DOI 10.1172/JCI115975; Chen HJ, 1996, J IMMUNOL, V157, P2593; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dietrich N, 2010, P NATL ACAD SCI USA, V107, P8748, DOI 10.1073/pnas.0912551107; FAVALORO E, 1993, EXP HEMATOL, V21, P1695; FAVALORO EJ, 1988, BRIT J HAEMATOL, V69, P163, DOI 10.1111/j.1365-2141.1988.tb07618.x; FUJII H, 1995, CLIN EXP METASTAS, V13, P337; GALANOS C, 1975, EUR J BIOCHEM, V54, P603, DOI 10.1111/j.1432-1033.1975.tb04172.x; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Ghosh M, 2015, J IMMUNOL, V194, P4466, DOI 10.4049/jimmunol.1403133; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hennersdorf F, 2005, CELL RES, V15, P325, DOI 10.1038/sj.cr.7290301; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; JUNG K, 1984, BIOMED BIOCHIM ACTA, V43, P1357; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Keck S, 2011, J IMMUNOL, V186, P5478, DOI 10.4049/jimmunol.1000458; Kehlen A, 2003, CANCER RES, V63, P8500; Kolb AF, 2013, TRANSGENIC RES, V22, P425, DOI 10.1007/s11248-012-9654-7; LIU L, 1994, MOL CELL BIOL, V14, P6926, DOI 10.1128/MCB.14.10.6926; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Marschall JS, 2012, CELL SIGNAL, V24, P879, DOI 10.1016/j.cellsig.2011.12.007; MATSAS R, 1984, FEBS LETT, V175, P124, DOI 10.1016/0014-5793(84)80583-9; MATSUDA H, 1989, J IMMUNOL, V142, P927; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Mina-Osorio P, 2005, J LEUKOCYTE BIOL, V77, P1008, DOI 10.1189/jlb.1204714; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Morgan R, 2015, ARTHRITIS RHEUMATOL, V67, P74, DOI 10.1002/art.38878; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Patella V, 2000, J IMMUNOL, V164, P589, DOI 10.4049/jimmunol.164.2.589; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; RAZIN E, 1984, J IMMUNOL, V132, P1479; Riemann D, 2005, BIOCHEM BIOPH RES CO, V331, P1408, DOI 10.1016/j.bbrc.2005.04.061; Santos AN, 2000, CELL IMMUNOL, V201, P22, DOI 10.1006/cimm.2000.1629; Santos AN, 2000, BIOCHEM BIOPH RES CO, V269, P143, DOI 10.1006/bbrc.2000.2271; Schernthaner GH, 2005, ALLERGY, V60, P1248, DOI 10.1111/j.1398-9995.2005.00865.x; Schmitt C, 2013, BIOORGAN MED CHEM, V21, P2135, DOI 10.1016/j.bmc.2012.12.038; Shimizu T, 2002, ARTHRITIS RHEUM-US, V46, P2330, DOI 10.1002/art.10517; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Soderberg C, 1996, TRANSPLANTATION, V61, P594; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; VALENT P, 1990, INT ARCH ALLER A IMM, V91, P198, DOI 10.1159/000235115; von Kriegsheim A, 2008, METHODS MOL BIOL, V484, P177, DOI 10.1007/978-1-59745-398-1_12; Winnicka B, 2010, J LEUKOCYTE BIOL, V88, P347, DOI 10.1189/jlb.0210065; Wulfanger J, 2012, CARCINOGENESIS, V33, P781, DOI 10.1093/carcin/bgs091; XU Y, 1995, BIOCHEM BIOPH RES CO, V208, P664, DOI 10.1006/bbrc.1995.1390; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zhang X, 2011, CURR MED CHEM, V18, P5011, DOI 10.2174/092986711797535155; Ziaber J, 2000, MEDIAT INFLAMM, V9, P45; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	53	10	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2225	2235		10.1096/fj.201600278	http://dx.doi.org/10.1096/fj.201600278			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26936360				2022-12-28	WOS:000376878300015
J	Xie, CY; Cao, X; Chen, XB; Wang, D; Zhang, WK; Sun, Y; Hu, WB; Zhou, ZJ; Wang, Y; Huang, PB				Xie, Changyan; Cao, Xu; Chen, Xibing; Wang, Dong; Zhang, Wei Kevin; Sun, Ying; Hu, Wenbao; Zhou, Zijing; Wang, Yan; Huang, Pingbo			Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia	FASEB JOURNAL			English	Article						hypotonicity; ion channel; mechanosensitive; osmotic swelling	SENSITIVE CL-CHANNELS; ESSENTIAL COMPONENT; CHLORIDE CHANNELS; AIRWAY EPITHELIUM; PRIMARY CULTURES; ANION CHANNELS; CURRENTS; ACTIVATION; MUTATION; CELLS	Mutations of cysticfibrosis transmembrane conductance regulator (CFTR), an epithelial ligand-gated anion channel, are associated with the lethal genetic disease cystic fibrosis. The CFTR G551D mutation impairs ATP hydrolysis and thereby makes CFTR refractory to cAMP stimulation. Both wild-type (WT) and G551D CFTR have been implicated in regulatory volume decrease (RVD), but the underlying mechanism remains incompletely understood. Here, we show that the channel activity of both WT and G551D CFTR is directly stimulated by mechanical perturbation induced by cell swelling at the single-channel, cellular, and tissue levels. Hypotonicity activated CFTR single channels in cell-attached membrane patches and WT-CFTR-mediated short-circuit current (Isc) in Calu-3 cells, and this was independent of Ca2+ and cAMP/PKA signaling. Genetic suppression and ablation but not G551D mutation of CFTR suppressed the hypotonicity- and stretch-induced Isc in Calu-3 cells and mouse duodena. Moreover, ablation but not G551D mutation of the CFTR gene inhibited the RVD of crypts isolated from mouse intestine; more importantly, CFTR-specific blockers markedly suppressed RVD in both WT- and G551DCFTRmice, demonstrating for thefirst time that the channel activity of both WT and G551D CFTR is required for epithelial RVD. Our findings uncover a previously unrecognized mechanism underlying CFTR involvement in epithelial RVD and suggest that the mechanosensitivity of G551D CFTR might underlie the mild phenotypes resulting from this mutation.-Xie, C., Cao, X., Chen, X, Wang, D., Zhang, W. K., Sun, Y., Hu, W., Zhou, Z., Wang, Y., Huang, P. Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia. FASEB J. 30, 1579-1589 (2016). www.fasebj.org	[Xie, Changyan; Cao, Xu; Chen, Xibing; Wang, Dong; Zhang, Wei Kevin; Sun, Ying; Hu, Wenbao; Zhou, Zijing; Wang, Yan; Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	bohuangp@ust.hk	Sun, Ying/F-9124-2019; Zhang, Wei/M-4241-2019	Zhang, Wei/0000-0003-4960-6137; Huang, Pingbo/0000-0002-4560-8760	Hong Kong Research Grants Council [GRF660913, GRF16102415]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA035165] Funding Source: NIH RePORTER	Hong Kong Research Grants Council(Hong Kong Research Grants Council); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are grateful to B. Wainwright (University of Queensland, Brisbane, QLD, Australia) and D. M. Bedwell (University of Alabama at Birmingham, Birmingham, AL, USA) for generating and providing G551D CFTR mice, and to T. C. Hwang (University of Missouri, Columbia, MO, USA) for providing the cDNA of G551D CFTR. The authors thank K.-L. So for technical support. This work was supported by Hong Kong Research Grants Council (Grants GRF660913 and GRF16102415 to P.H.). The authors declare no conflicts of interest.	Amlal H, 2000, AM J PHYSIOL-RENAL, V279, pF532, DOI 10.1152/ajprenal.2000.279.3.F532; Ando-Akatsuka Y, 2002, PFLUG ARCH EUR J PHY, V445, P177, DOI 10.1007/s00424-002-0920-z; Bajnath RB, 1997, PFLUG ARCH EUR J PHY, V433, P276; Barriere H, 2003, AM J PHYSIOL-RENAL, V284, pF796, DOI 10.1152/ajprenal.00237.2002; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Belfodil R, 2003, AM J PHYSIOL-RENAL, V284, pF812, DOI 10.1152/ajprenal.00238.2002; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bond TD, 1998, J PHYSIOL-LONDON, V511, P45, DOI 10.1111/j.1469-7793.1998.045bi.x; Braunstein Gavin M, 2004, J Cyst Fibros, V3, P99, DOI 10.1016/j.jcf.2004.01.006; CHAN HC, 1992, AM J PHYSIOL, V262, pC1273, DOI 10.1152/ajpcell.1992.262.5.C1273; CHAN HC, 1992, J BIOL CHEM, V267, P8411; Comer DM, 2009, QJM-INT J MED, V102, P793, DOI 10.1093/qjmed/hcp120; Dagenais A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074565; De Smet P, 1998, AM J PHYSIOL-CELL PH, V275, pC189, DOI 10.1152/ajpcell.1998.275.1.C189; Delaney SJ, 1996, EMBO J, V15, P955, DOI 10.1002/j.1460-2075.1996.tb00432.x; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Diener M, 1996, PFLUG ARCH EUR J PHY, V432, P293, DOI 10.1007/s004240050136; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Gisolfi CV, 1998, J APPL PHYSIOL, V85, P1941, DOI 10.1152/jappl.1998.85.5.1941; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P3587, DOI 10.1073/pnas.93.8.3587; Gray Michael A, 2010, Cellscience, V7, P1; Hamill OP, 2007, CURR TOP MEMBR, V59, P191, DOI 10.1016/S1063-5823(06)59009-X; Harron SA, 2009, CAN J PHYSIOL PHARM, V87, P337, DOI [10.1139/Y09-009, 10.1139/y09-009]; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ichishima K, 2010, BRIT J PHARMACOL, V161, P193, DOI 10.1111/j.1476-5381.2010.00896.x; Joiner CH, 2007, BLOOD, V109, P1728, DOI 10.1182/blood-2006-04-018630; Krouse ME, 2004, AM J PHYSIOL-LUNG C, V287, pL1274, DOI 10.1152/ajplung.00036.2004; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Kunzelmann K, 2015, TRENDS BIOCHEM SCI, V40, P535, DOI 10.1016/j.tibs.2015.07.005; Lemoine JL, 2005, GENE THER, V12, P1275, DOI 10.1038/sj.gt.3302548; Liu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC343; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; MacVinish LJ, 2007, BRIT J PHARMACOL, V150, P1055, DOI 10.1038/sj.bjp.0707175; MCCANN JD, 1989, J GEN PHYSIOL, V94, P1015, DOI 10.1085/jgp.94.6.1015; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; Oceandy D, 2002, HUM MOL GENET, V11, P1059, DOI 10.1093/hmg/11.9.1059; Okada Y, 2004, PFLUG ARCH EUR J PHY, V448, P287, DOI 10.1007/s00424-004-1276-3; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Parad RB, 1996, J MED GENET, V33, P711, DOI 10.1136/jmg.33.8.711; Pedersen SF, 1998, J MEMBRANE BIOL, V163, P97, DOI 10.1007/s002329900374; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Sardini A, 2003, BBA-BIOMEMBRANES, V1618, P153, DOI 10.1016/j.bbamem.2003.10.008; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Schultz BD, 1996, AM J PHYSIOL-LUNG C, V271, pL192, DOI 10.1152/ajplung.1996.271.2.L192; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sun Y, 2012, J CELL SCI, V125, P4507, DOI 10.1242/jcs.105023; VALVERDE MA, 1995, P NATL ACAD SCI USA, V92, P9038, DOI 10.1073/pnas.92.20.9038; Valverde MA, 2000, CELL PHYSIOL BIOCHEM, V10, P321, DOI 10.1159/000016365; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P552, DOI 10.1007/BF00374885; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P434, DOI 10.1007/BF00374869; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Vennekens R, 1999, J PHYSIOL-LONDON, V515, P75, DOI 10.1111/j.1469-7793.1999.075ad.x; Voets T, 1999, P NATL ACAD SCI USA, V96, P5298, DOI 10.1073/pnas.96.9.5298; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Watt AP, 2005, THORAX, V60, P659, DOI 10.1136/thx.2004.038240; Zhang WK, 2010, NAT CELL BIOL, V12, P507, DOI 10.1038/ncb2053	67	6	6	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1579	1589		10.1096/fj.15-283002	http://dx.doi.org/10.1096/fj.15-283002			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26683699	Green Published			2022-12-28	WOS:000372629100019
J	Gavin, KM; Gutman, JA; Kohrt, WM; Wei, Q; Shea, KL; Miller, HL; Sullivan, TM; Erickson, PF; Helm, KM; Acosta, AS; Childs, CR; Musselwhite, E; Varella-Garcia, M; Kelly, K; Majka, SM; Klemm, DJ				Gavin, Kathleen M.; Gutman, Jonathan A.; Kohrt, Wendy M.; Wei, Qi; Shea, Karen L.; Miller, Heidi L.; Sullivan, Timothy M.; Erickson, Paul F.; Helm, Karen M.; Acosta, Alistaire S.; Childs, Christine R.; Musselwhite, Evelyn; Varella-Garcia, Marileila; Kelly, Kimberly; Majka, Susan M.; Klemm, Dwight J.			De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue	FASEB JOURNAL			English	Article						adipogenesis; stem cell; bone marrow; polymorphic microsatellite; short tandem repeat	CRE-MEDIATED RECOMBINATION; HEMATOPOIETIC STEM-CELLS; BONE-MARROW-CELLS; BODY-WEIGHT; WHITE; FAT; BROWN; EXPRESSION; LINEAGE; MUSCLE	White adipocytes in adults are typically derived from tissue resident mesenchymal progenitors. The recent identification of de novo production of adipocytes from bone marrow progenitor-derived cells in mice challenges this paradigm and indicates an alternative lineage specification that adipocytes exist. We hypothesized that alternative lineage specification of white adipocytes is also present in human adipose tissue. Bone marrow from transgenic mice in which luciferase expression is governed by the adipocyte-restricted adiponectin gene promoter was adoptively transferred to wild-type recipient mice. Light emission was quantitated in recipients by in vivo imaging and direct enzyme assay. Adipocytes were also obtained from human recipients of hematopoietic stem cell transplantation. DNA was isolated, and microsatellite polymorphisms were exploited to quantify donor/recipient chimerism. Luciferase emission was detected from major fat depots of transplanted mice. No light emission was observed from intestines, liver, or lungs. Up to 35% of adipocytes in humans were generated from donor marrow cells in the absence of cell fusion. Nontransplanted mice and stromal-vascular fraction samples were used as negative and positive controls for the mouse and human experiments, respectively. This study provides evidence for a nontissue resident origin of an adipocyte subpopulation in both mice and humans.	[Gavin, Kathleen M.; Kohrt, Wendy M.; Shea, Karen L.] Univ Colorado, Ctr Canc, Sch Med, Dept Med,Div Geriatr Med, Aurora, CO 80045 USA; [Gutman, Jonathan A.] Univ Colorado, Ctr Canc, Sch Med, Dept Med,Div Med Oncol, Aurora, CO 80045 USA; [Miller, Heidi L.; Sullivan, Timothy M.; Erickson, Paul F.; Klemm, Dwight J.] Univ Colorado, Ctr Canc, Sch Med, Dept Med,Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Helm, Karen M.; Acosta, Alistaire S.; Childs, Christine R.] Univ Colorado, Ctr Canc, Flow Cytometry Shared Resource, Aurora, CO 80045 USA; [Musselwhite, Evelyn; Varella-Garcia, Marileila] Univ Colorado, Ctr Canc, Mol Pathol Cytogenet Shared Resource, Aurora, CO 80045 USA; [Klemm, Dwight J.] Univ Colorado, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Anschutz Med Campus, Aurora, CO 80045 USA; [Klemm, Dwight J.] Univ Colorado, Colorado Obes Res Initiat, Anschutz Med Campus, Aurora, CO 80045 USA; [Wei, Qi; Kelly, Kimberly] Childrens Hosp Colorado, Mol Diagnost Lab, Aurora, CO USA; [Majka, Susan M.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Majka, Susan M.] Vanderbilt Univ, Sch Med, Ctr Stem Cell Biol, Nashville, TN 37212 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Vanderbilt University; Vanderbilt University	Klemm, DJ (corresponding author), Univ Colorado, Anschutz Med Campus,Res 2,Campus Box B-133, Aurora, CO 80045 USA.	dwight.klemm@ucdenver.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants [R01 DK078966, R21 DK092718]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [P50 HD073063]; NIH National Institute on Aging Grants [T32 AG000279, F32 AG046957]; NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards [UL1 TR001082]; NIH National Cancer Institute Centers for Common Disease Genomics Grant [P30 CA046934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD073063] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078966, R56DK078966, P30DK048520, R21DK092718, R01DK109547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG046957, T32AG000279] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; NIH National Institute on Aging Grants; NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards; NIH National Cancer Institute Centers for Common Disease Genomics Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. J. Lee Nelson and Vijayakrishna K. Gadi (Fred Hutchinson Cancer Research Center and University of Washington Medical Center, Seattle, WA, USA) for discussions on chimerism analysis in humans. They also thank Dr. Kristine Erlandson (University of Colorado Anschutz Medical Campus) for medical safety oversight of the project. This research was funded by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R01 DK078966 (to D.J.K.) and R21 DK092718 (to W.M.K.); and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant P50 HD073063 (to W.M.K.); and NIH National Institute on Aging Grants T32 AG000279 and F32 AG046957 (research fellowships to K.M.G.). This research was also supported in part by NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Grant UL1 TR001082 and NIH National Cancer Institute Centers for Common Disease Genomics Grant P30 CA046934. The authors declare no conflicts of interest.	Araujo IM, 2010, CRIT CARE MED, V38, P1733, DOI 10.1097/CCM.0b013e3181e796d2; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Blouin K, 2005, METABOLISM, V54, P1034, DOI 10.1016/j.metabol.2005.03.006; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Cereijo R, 2015, ANN MED, V47, P169, DOI 10.3109/07853890.2014.952328; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Coleman S R, 1998, Aesthet Surg J, V18, P388, DOI 10.1016/S1090-820X(98)70098-6; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Engfeldt P, 1988, Horm Metab Res Suppl, V19, P26; Fukata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062506; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Huh JW, 2011, AM J PHYSIOL-LUNG C, V301, pL255, DOI 10.1152/ajplung.00253.2010; Jackson KA, 2002, J CELL BIOCHEM, P1, DOI 10.1002/jcb.10045; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; JOHNSON PR, 1972, J LIPID RES, V13, P2; Katz LS, 2014, AM J PHYSIOL-ENDOC M, V307, pE335, DOI 10.1152/ajpendo.00075.2014; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Koh YJ, 2007, J CLIN INVEST, V117, P3684, DOI 10.1172/JCI32504; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; LAU DCW, 1990, INT J OBESITY, V14, P193; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Majka SM, 2014, METHOD ENZYMOL, V537, P281, DOI 10.1016/B978-0-12-411619-1.00015-X; Majka SM, 2012, ADIPOCYTE, V1, P215, DOI 10.4161/adip.21496; Majka SM, 2011, STEM CELLS, V29, P1034, DOI 10.1002/stem.653; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Mao M, 2010, SHOCK, V34, P196, DOI 10.1097/SHK.0b013e3181d49457; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; Montoliu L, 2000, TRANSGENIC RES, V9, P237, DOI 10.1023/A:1008995730285; Pascot A, 1999, DIABETES CARE, V22, P1471, DOI 10.2337/diacare.22.9.1471; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Prota LFM, 2010, CELL TRANSPLANT, V19, P965, DOI 10.3727/096368910X506845; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Ryden M, 2015, CELL METAB, V22, P408, DOI 10.1016/j.cmet.2015.06.011; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sera Y, 2009, EXP HEMATOL, V37, P1108, DOI 10.1016/j.exphem.2009.06.008; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tao W, 2007, STEM CELLS, V25, P670, DOI 10.1634/stemcells.2006-0553; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tomiyama K, 2008, STEM CELLS, V26, P330, DOI 10.1634/stemcells.2007-0567; Turlo KA, 2010, GENETICS, V186, P959, DOI 10.1534/genetics.110.121608; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Varlamov O, 2015, ENDOCRINOLOGY, V156, P80, DOI 10.1210/en.2014-1699; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wise AF, 2012, NEPHROLOGY, V17, P1, DOI 10.1111/j.1440-1797.2011.01501.x; Wueest S, 2009, DIABETOLOGIA, V52, P541, DOI 10.1007/s00125-008-1223-5; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Yeagy BA, 2011, PEDIATR NEPHROL, V26, P1427, DOI 10.1007/s00467-011-1789-x	68	36	36	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1096	1108		10.1096/fj.15-278994	http://dx.doi.org/10.1096/fj.15-278994			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26581599	Green Published			2022-12-28	WOS:000370387800009
J	Stauber, RH; Hahlbrock, A; Knauer, SK; Wunsch, D				Stauber, Roland H.; Hahlbrock, Angelina; Knauer, Shirley K.; Wuensch, Desiree			Cleaving for growth: threonine aspartase 1-a protease relevant for development and disease	FASEB JOURNAL			English	Review						proliferation; MLL; TFIIA; proteolysis	TRANSCRIPTION FACTOR TFIIA; MLL-MUTANT MICE; BINDING PROTEIN; ACTIVATED TRANSCRIPTION; YEAST TRANSCRIPTION; REPRESSION DOMAIN; DROSOPHILA EMBRYO; GENE-EXPRESSION; DRUG DISCOVERY; POLYMERASE-II	From the beginning of life, proteases are key to organismal development comprising morphogenesis, cellular differentiation, and cell growth. Regulated proteolytic activity is essential for the orchestration of multiple developmental pathways, and defects in protease activity can account for multiple disease patterns. The highly conserved protease threonine aspartase 1 is a member of such developmental proteases and critically involved in the regulation of complex processes, including segmental identity, head morphogenesis, spermatogenesis, and proliferation. Additionally, threonine aspartase 1 is overexpressed in numerous liquid as well as in solid malignancies. Although threonine aspartase 1 is able to cleave the master regulator mixed lineage leukemia protein as well as other regulatory proteins in humans, our knowledge of its detailed pathobiological function and the underlying molecular mechanisms contributing to development and disease is still incomplete. Moreover, neither effective genetic nor chemical inhibitors for this enzyme are available so far precluding the detailed dissection of the pathobiological functions of threonine aspartase 1. Here, we review the current knowledge of the structure-function relationship of threonine aspartase 1 and its mechanistic impact on substrate-mediated coordination of the cell cycle and development. We discuss threonine aspartase 1-mediated effects on cellular transformation and conclude by presenting a short overview of recent interference strategies.	[Stauber, Roland H.; Hahlbrock, Angelina; Wuensch, Desiree] Univ Med Ctr Mainz, Mol & Cellular Oncol, Dept Otorhinolaryngol Head & Neck Surg, D-55101 Mainz, Germany; [Knauer, Shirley K.] Univ Duisburg Essen, Ctr Med Biotechnol, Inst Mol Biol, Essen, Germany	Johannes Gutenberg University of Mainz; University of Duisburg Essen	Wunsch, D (corresponding author), Univ Med Ctr Mainz, Mol & Cellular Oncol, Langenbeckstr 1, D-55101 Mainz, Germany.	wuensch@uni-mainz.de	Gül, Désirée/AAB-5965-2022; Knauer, Shirley K/E-7931-2012	Knauer, Shirley K/0000-0003-4321-0924; Guel, Desiree/0000-0002-2446-5756	Intramural Research Funding of University Mainz; Zeiss foundation Chemical BioMedicine	Intramural Research Funding of University Mainz; Zeiss foundation Chemical BioMedicine	This work was supported by grants from the Intramural Research Funding of University Mainz and Zeiss foundation Chemical BioMedicine. The authors declare no conflicts of interest.	Bier C, 2012, FASEB J, V26, P3421, DOI 10.1096/fj.11-202432; Bier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034142; Bier C, 2011, TRAFFIC, V12, P703, DOI 10.1111/j.1600-0854.2011.01191.x; Bier C, 2011, J BIOL CHEM, V286, P3007, DOI 10.1074/jbc.M110.161646; Bolli N, 2007, CANCER RES, V67, P6230, DOI 10.1158/0008-5472.CAN-07-0273; Brix K., 2013, PROTEASES STRUCTURE; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Chen DY, 2012, CANCER RES, V72, P736, DOI 10.1158/0008-5472.CAN-11-2584; Chen DY, 2010, CANCER RES, V70, P5358, DOI 10.1158/0008-5472.CAN-10-0027; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Coleman RA, 1999, MOL CELL, V4, P451, DOI 10.1016/S1097-2765(00)80453-0; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; DEJONG J, 1993, GENE DEV, V7, P2220, DOI 10.1101/gad.7.11.2220; Dong YY, 2014, CELL RES, V24, P1354, DOI 10.1038/cr.2014.129; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hoiby T, 2004, EMBO J, V23, P3083, DOI 10.1038/sj.emboj.7600304; Hoiby T, 2007, BBA-GENE STRUCT EXPR, V1769, P429, DOI 10.1016/j.bbaexp.2007.04.008; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Huang M, 2006, INT J MOL MED, V17, P599; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018253; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Liedtke M., 2009, GENOME BIOL, V3, pR24; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; Malecova B, 2015, TRANSCR-AUSTIN, V6, P21, DOI 10.1080/21541264.2015.1052178; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Miura M, 2011, DEV GROWTH DIFFER, V53, P125, DOI 10.1111/j.1440-169X.2010.01228.x; Moore PA, 1999, MOL CELL BIOL, V19, P7610; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Oyama T, 2013, DEV CELL, V27, P188, DOI 10.1016/j.devcel.2013.09.025; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; STEWARD R, 1988, CELL, V55, P487, DOI 10.1016/0092-8674(88)90035-9; SUN XQ, 1994, GENE DEV, V8, P2336, DOI 10.1101/gad.8.19.2336; Suzuki H, 2015, NUCLEIC ACIDS RES, V43, P6285, DOI 10.1093/nar/gkv576; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Takeda S, 2015, J CLIN INVEST, V125, P1203, DOI 10.1172/JCI77075; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; van den Boom J, 2014, CHEMBIOCHEM, V15, P2233, DOI 10.1002/cbic.201402108; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wunsch D, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.22; Wunsch D, 2015, FASEB J, V29, P1973, DOI 10.1096/fj.14-262451; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	73	8	8	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1012	1022		10.1096/fj.15-270611	http://dx.doi.org/10.1096/fj.15-270611			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578689				2022-12-28	WOS:000370387800002
J	Tong, Q; Gong, AY; Zhang, XT; Lin, CC; Ma, SB; Chen, J; Hu, GK; Chen, XM				Tong, Qiang; Gong, Ai-Yu; Zhang, Xin-Tian; Lin, Chengchi; Ma, Shibin; Chen, Jing; Hu, Guoku; Chen, Xian-Ming			LincRNA-Cox2 modulates TNF-alpha-induced transcription of Il12b gene in intestinal epithelial cells through regulation of Mi-2/NuRD-mediated epigenetic histone modifications	FASEB JOURNAL			English	Article						LincRNAs; Il12b; Mi-2/NuRD complex; histone modifications; intestinal epithelium	INFLAMMATORY-BOWEL-DISEASE; LONG NONCODING RNA; NF-KAPPA-B; REMODELING COMPLEXES; MECHANISMS; ACTIVATION; EXPRESSION; MATURATION; REPRESSION; MI-2-BETA	Long intergenic noncoding RNAs (lincRNAs) can regulate the transcription of inflammatory genes and thus may represent a new group of inflammatory mediators with a potential pathogenic role in inflammatory diseases. Here, our genome-wide transcriptomic data show that TNF-alpha stimulation caused up-regulation of 171 lincRNAs and down-regulation of 196 lincRNAs in murine intestinal epithelial cells in culture. One of the up-regulated lincRNAs, lincRNA-Cox2, is an early-responsive lincRNA induced by TNF-alpha through activation of the NF-kappa B signaling pathway. Knockdown of lincRNA-Cox2 resulted in reprogramming of the gene expression profile in intestinal epithelial cells in response to TNF-alpha stimulation. Specifically, lincRNA-Cox2 silencing significantly (P < 0.05) enhanced the transcription of Il12b, a secondary late-responsive gene induced by TNF-alpha. Mechanistically, lincRNA-Cox2 promoted the recruitment of the Mi-2/nucleosome remodeling and deacetylase (Mi-2/NuRD) repressor complex to the Il12b promoter region. Recruitment of the Mi-2/NuRD complex was associated with decreased H3K27 acetylation and increased H3K27 dimethylation at the Il12b promoter region, which might contribute to Il12b trans-suppression by lincRNA-Cox2. Thus, our data demonstrate a novel mechanism of epigenetic modulation by lincRNA-Cox2 on Il12b transcription, supporting an important role for lincRNAs in the regulation of intestinal epithelial inflammatory responses.	[Tong, Qiang; Gong, Ai-Yu; Zhang, Xin-Tian; Lin, Chengchi; Ma, Shibin; Chen, Jing; Hu, Guoku; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Tong, Qiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan 430074, Peoples R China; [Hu, Guoku] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Peoples R China	Creighton University; Huazhong University of Science & Technology; University of Electronic Science & Technology of China	Chen, XM (corresponding author), Creighton Univ, Sch Med, Med Microbiol & Immunol, Criss 2,Room 529,2500 Calif Plaza, Omaha, NE 68178 USA.	xianmingchen@creighton.edu	Hu, Guoku/AAG-7233-2019	Hu, Guoku/0000-0002-4792-0416	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants [AI095532, AI116323]; Creighton Cancer and Smoking Development Award [LB595]; NIH National Center for Research Resources Grant [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095532, R01AI116323] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants; Creighton Cancer and Smoking Development Award; NIH National Center for Research Resources Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Barbara L. Bittner for assistance in writing the manuscript. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants AI095532 and AI116323 and by Creighton Cancer and Smoking Development Award LB595 (to X.-M.C.). This project was also supported by NIH National Center for Research Resources Grant G20RR024001. The authors declare no conflicts of interest.	Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Berthier-Vergnes O, 2005, FEBS LETT, V579, P3660, DOI 10.1016/j.febslet.2005.04.087; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; BLUTHE RM, 1994, PSYCHONEUROENDOCRINO, V19, P197, DOI 10.1016/0306-4530(94)90009-4; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cheroutre H, 2013, ADV EXP MED BIOL, V785, P43, DOI 10.1007/978-1-4614-6217-0_5; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dharmani Poonam, 2008, Curr Mol Pharmacol, V1, P195; Geisel J, 2014, J IMMUNOL, V192, P3530, DOI 10.4049/jimmunol.1300556; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Kast C, 2003, J BIOL CHEM, V278, P6787, DOI 10.1074/jbc.M210935200; Lantier L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003801; Mahida YR, 2004, BEST PRACT RES CL GA, V18, P241, DOI 10.1053/ybega.2004.438; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Morey L, 2008, MOL CELL BIOL, V28, P5912, DOI 10.1128/MCB.00467-08; Murakami T, 2000, J Atheroscler Thromb, V7, P39; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Pedersen J, 2014, WORLD J GASTROENTERO, V20, P64, DOI 10.3748/wjg.v20.i1.64; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Zhang H, 2008, J BIOL CHEM, V283, P22637, DOI 10.1074/jbc.M802129200; Zhang ZL, 2007, INT IMMUNOPHARMACOL, V7, P409, DOI 10.1016/j.intimp.2006.09.024	35	65	70	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1187	1197		10.1096/fj.15-279166	http://dx.doi.org/10.1096/fj.15-279166			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578685	Green Published			2022-12-28	WOS:000370387800016
J	Piegholdt, S; Rimbach, G; Wagner, AE				Piegholdt, Stefanie; Rimbach, Gerald; Wagner, Anika E.			The phytoestrogen prunetin affects body composition and improves fitness and lifespan in male Drosophila melanogaster	FASEB JOURNAL			English	Article						isoflavone; climbing activity; survival; metabolism	INNATE IMMUNE-RESPONSE; ADULT FAT-BODY; NF-KAPPA-B; DIETARY RESTRICTION; SEX-HORMONES; EXPRESSION; MODEL; DSIR2; AMPK; BACTERIAL	Dietary isoflavones, a group of secondary plant compounds that exhibit phytoestrogenic properties, are primarily found in soy. Prunetin, a representative isoflavone, was recently found to affect cell signaling in cultured cells; however, in vivo effects remain elusive. In this study, the model organism Drosophila melanogaster was used to investigate the effects of prunetin in vivo with respect to lifespan, locomotion, body composition, metabolism, and gut health. Adult flies were chronically administered a prunetin-supplemented diet. Prunetin improved median survival by 3 d, and climbing activity increased by 54% in males. In comparison with the females, male flies exhibited lower climbing activity, which was reversed by prunetin intake. Furthermore, prunetin-fed males exhibited increased expression of the longevity gene Sirtuin 1 (Sir2) (22%), as well as elevated AMPK activation (51%) and triglyceride levels (29%), whereas glucose levels decreased (36%). As females are long-lived compared with their male counterparts and exhibit higher triglyceride levels, prunetin apparently "feminizes" male flies via its estrogenicity. We conclude that the lifespan-prolonging effects of prunetin in the male fruit fly depend on changes in AMPK-regulated energy homeostasis via male "feminization." Collectively, we identified prunetin as a plant bioactive compound capable of improving health status and survival in male D. melanogaster.	[Piegholdt, Stefanie; Rimbach, Gerald; Wagner, Anika E.] Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6-8, D-24118 Kiel, Germany	University of Kiel	Wagner, AE (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6-8, D-24118 Kiel, Germany.	wagner@molecularnutrition.uni-kiel.de	Wagner, Anika/AAE-3579-2019; Rimbach, Gerald/A-7178-2011	Wagner, Anika/0000-0003-3047-7128; Rimbach, Gerald/0000-0001-7888-4684	DFG Cluster of Excellence "Inflammation at Interfaces" (MP VII)	DFG Cluster of Excellence "Inflammation at Interfaces" (MP VII)	The authors are grateful to N. J. Linford and S. D. Pletcher (Institute of Integrative Physiology, University of Michigan, Ann Arbor, MI, USA), and T. Roeder and C. Fink (Zoological Institute, Molecular Physiology, University of Kiel) for their support in fly husbandry and for providing fly stocks and C. Wagner (Research Center Borstel, Priority Area Allergy and Asthma, Borstel, Germany) for donating the mutant fly strain. This work was funded by the DFG Cluster of Excellence "Inflammation at Interfaces" (MP VII). S.P. and A.E.W. designed the research, and S.P. conducted the research and analyzed the data. All authors contributed to the writing of the paper, had primary responsibility for the final content, and have read and approved the final manuscript. The authors declare no conflicts of interest.	Ahn TG, 2013, BIOCHEM PHARMACOL, V85, P1525, DOI 10.1016/j.bcp.2013.02.020; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Bahadorani S, 2008, J GERONTOL A-BIOL, V63, P35, DOI 10.1093/gerona/63.1.35; Banerjee KK, 2013, MOL CELL BIOL, V33, P252, DOI 10.1128/MCB.00976-12; Banerjee KK, 2012, CELL REP, V2, P1485, DOI 10.1016/j.celrep.2012.11.013; Banerjee KK, 2012, AGING-US, V4, P206, DOI 10.18632/aging.100435; Bauer JH, 2009, AGING-US, V1, P38; Bazzell B, 2013, J EXP BIOL, V216, P859, DOI 10.1242/jeb.078758; Bland ML, 2010, DEV BIOL, V344, P293, DOI 10.1016/j.ydbio.2010.05.010; Branham WS, 2002, J NUTR, V132, P658, DOI 10.1093/jn/132.4.658; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Comitato R, 2015, CRIT REV FOOD SCI, V55, P227, DOI 10.1080/10408398.2011.651177; De Loof A, 1998, GEN COMP ENDOCR, V111, P245, DOI 10.1006/gcen.1998.7101; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; DuSell C. D., 2009, THESIS DUKE U DURHAM, P1; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Guntermann S, 2009, DEV COMP IMMUNOL, V33, P127, DOI 10.1016/j.dci.2008.07.021; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hillerns PI, 2005, Z NATURFORSCH C, V60, P649; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann J, 2013, AGING-US, V5, P315, DOI 10.18632/aging.100553; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Katewa SD, 2012, CELL METAB, V16, P97, DOI 10.1016/j.cmet.2012.06.005; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Lin WS, 2014, AGE, V36, P689, DOI 10.1007/s11357-013-9606-z; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Liu T, 2014, J INSECT PHYSIOL, V71, P1, DOI [10.1016/j.jinsphys.2014.09.008, 10.1673/031.014.66]; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Maggio M, 2014, CURR PHARM DESIGN, V20, P3119, DOI 10.2174/13816128113196660062; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Mortensen A, 2009, MOL NUTR FOOD RES, V53, pS266, DOI 10.1002/mnfr.200800478; Nakamura Y, 2001, J HEALTH SCI, V47, P394, DOI 10.1248/jhs.47.394; OSBORNE CK, 1995, J NATL CANCER I, V87, P746, DOI 10.1093/jnci/87.10.746; Ostberg T, 2003, BIOCHEMISTRY-US, V42, P6427, DOI 10.1021/bi027279b; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petrosyan A, 2007, BEHAV GENET, V37, P585, DOI 10.1007/s10519-007-9159-y; Piegholdt S, 2014, FREE RADICAL BIO MED, V70, P255, DOI 10.1016/j.freeradbiomed.2014.02.025; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rus F, 2013, EMBO J, V32, P1626, DOI 10.1038/emboj.2013.100; Schwanstecher C, 2011, HANDB EXP PHARMACOL, V203, P1, DOI 10.1007/978-3-642-17214-4_1; Schwedes C, 2011, J INSECT PHYSIOL, V57, P899, DOI 10.1016/j.jinsphys.2011.03.027; Sieber MH, 2015, CURR BIOL, V25, P993, DOI 10.1016/j.cub.2015.02.019; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006; Szeri F, 2009, BBA-BIOMEMBRANES, V1788, P402, DOI 10.1016/j.bbamem.2008.11.007; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Tricoire H, 2009, MECH AGEING DEV, V130, P547, DOI 10.1016/j.mad.2009.05.004; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Wang DY, 2014, BIOCHEM BIOPH RES CO, V446, P465, DOI 10.1016/j.bbrc.2014.02.133; Wardell SE, 2011, BIOCHEM PHARMACOL, V82, P122, DOI 10.1016/j.bcp.2011.03.031; Whitaker R, 2013, AGING-US, V5, P682, DOI 10.18632/aging.100599; Wu LP, 2001, GENETICS, V159, P189; Yu J, 2015, HUM MOL GENET, V24, P1493, DOI 10.1093/hmg/ddu557	64	21	23	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					948	958		10.1096/fj.15-282061	http://dx.doi.org/10.1096/fj.15-282061			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26538555				2022-12-28	WOS:000369391900041
J	Mazzalupo, S; Isoe, J; Belloni, V; Scaraffia, PY				Mazzalupo, Stacy; Isoe, Jun; Belloni, Virginia; Scaraffia, Patricia Y.			Effective disposal of nitrogen waste in blood-fed Aedes aegypti mosquitoes requires alanine aminotransferase	FASEB JOURNAL			English	Article						ammonia; gene silencing; protein expression; uric acid; RNA interference	PROTEIN CATABOLISM; AMMONIA METABOLISM; VECTOR; FRAGMENTATION; INHIBITION; EXPRESSION; PATHWAY; LARVAL; INSECT; URATE	To better understand the mechanisms responsible for the success of female mosquitoes in their disposal of excess nitrogen, we investigated the role of alanine aminotransferase (ALAT) in blood-fed Aedes aegypti. Transcript and protein levels from the 2 ALAT genes were analyzed in sucrose-and blood-fed A. aegypti tissues. ALAT1 and ALAT2 exhibit distinct expression patterns in tissues during the first gonotrophic cycle. Injection of female mosquitoes with either double-stranded RNA (dsRNA)-ALAT1 or dsRNA ALAT2 significantly decreased mRNA and protein levels of ALAT1 or ALAT2 in fat body, thorax, and Malpighian tubules compared with dsRNA firefly luciferase-injected controlmosquitoes. The silencing of either A. aegypti ALAT1 or ALAT2 caused unexpected phenotypes such as a delay in blood digestion, a massive accumulation of uric acid in the midgut posterior region, and a significant decrease of nitrogen waste excretion during the first 48 h after blood feeding. Concurrently, the expression of genes encoding xanthine dehydrogenase and ammonia transporter (Rhesus 50 glycoprotein) were significantly increased in tissues of both ALAT1- and ALAT2-deficient females. Moreover, perturbation of ALAT1 and ALAT2 in the female mosquitoes delayed oviposition and reduced egg production. These novel findings underscore the efficient mechanisms that blood-fed mosquitoes use to avoid ammonia toxicity and free radical damage.-Mazzalupo, S., Isoe, J., Belloni, V., Scaraffia, P. Y. Effective disposal of nitrogen waste in blood-fed Aedes aegypti mosquitoes requires alanine aminotransferase. FASEB J. 30, 111-120 (2016). www.fasebj.org	[Mazzalupo, Stacy; Isoe, Jun] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Belloni, Virginia; Scaraffia, Patricia Y.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, Dept Trop Med, New Orleans, LA USA	University of Arizona; Tulane University	Scaraffia, PY (corresponding author), Vector Borne Infect Dis Res Center, Dept Trop Med, 1430 Tulane Ave,SL-17,J Bennett Johnston Bldg, New Orleans, LA 70112 USA.	pscaraff@tulane.edu		Belloni, Virginia/0000-0001-9807-1912	Corine Adams Baines Professorship Award; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01AI088092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092] Funding Source: NIH RePORTER	Corine Adams Baines Professorship Award; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Louisiana Clinical & Translational Science Center (Baton Rouge, LA, USA) for statistical advice. This work was financially supported by the Corine Adams Baines Professorship Award, and U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant R01AI088092 (to P.Y.S.).	[Anonymous], 1992, BIOL MOSQUITOES DEV; Barros MP, 2000, PHOTOCHEM PHOTOBIOL, V71, P648, DOI 10.1562/0031-8655(2000)071&lt;0648:LAUMAA&gt;2.0.CO;2; Belloni V., 2014, PARASITE VECTOR, V7, P1; Benedict MQ, 1996, ANN ENTOMOL SOC AM, V89, P261, DOI 10.1093/aesa/89.2.261; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Beuster G, 2011, J BIOL CHEM, V286, P22323, DOI 10.1074/jbc.M110.205229; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; Bush DR, 2012, J MASS SPECTROM, V47, P1364, DOI 10.1002/jms.3063; Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; HAGEDORN HH, 1977, J INSECT PHYSIOL, V23, P203, DOI 10.1016/0022-1910(77)90030-0; Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703; Isoe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065393; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; LaNoue KF, 2001, J NEUROSCI RES, V66, P914, DOI 10.1002/jnr.10064; Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111; PAYNTER KT, 1984, J EXP ZOOL, V232, P51, DOI 10.1002/jez.1402320107; Pereira LOR, 2007, BIOCHEMISTRY-US, V46, P6822, DOI 10.1021/bi700011d; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Sinclair P. R., 2001, CURRENT PROTOCOLS TO, V8.3.1-8.3.7; Souza AVG, 1997, FREE RADICAL BIO MED, V22, P209, DOI 10.1016/S0891-5849(96)00293-6; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; von Dungern P, 2001, J INSECT PHYSIOL, V47, P131, DOI 10.1016/S0022-1910(00)00096-2; Wale PL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109256; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Wu Y, 2010, J INSECT PHYSIOL, V56, P1599, DOI 10.1016/j.jinsphys.2010.05.021; Zhang QF, 2005, J AM SOC MASS SPECTR, V16, P1192, DOI 10.1016/j.jasms.2005.03.052	36	16	16	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					111	120		10.1096/fj.15-277087	http://dx.doi.org/10.1096/fj.15-277087			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26310269	Green Published			2022-12-28	WOS:000367621000013
J	Csoka, B; Nemeth, ZH; Toro, G; Idzko, M; Zech, A; Koscso, B; Spolarics, Z; Antonioli, L; Cseri, K; Erdelyi, K; Pacher, P; Hasko, G				Csoka, Balazs; Nemeth, Zoltan H.; Toero, Gabor; Idzko, Marco; Zech, Andreas; Koscso, Balazs; Spolarics, Zoltan; Antonioli, Luca; Cseri, Karolina; Erdelyi, Katalin; Pacher, Pal; Hasko, Gyoergy			Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing	FASEB JOURNAL			English	Article						connexin; inflammasome; inflammation; pannexin; phagocytosis	INNATE; ACTIVATION; ADENOSINE; CHANNELS; CD39; INFLAMMASOME; NEUTROPHILS; INHIBITION; PYROPTOSIS; MORTALITY	Extracellular ATP binds to and signals through P2X7 receptors (P2X7Rs) to modulate immune function in both inflammasome-dependent and -independent manners. In this study, P2X7(-/-) mice, the pharmacological agonists ATP-magnesiumsalt (Mg-ATP; 100 mg/kg, EC50 approximate to 1.32 mM) and benzoylbenzoyl-ATP (Bz-ATP; 10 mg/kg, EC50 approximate to 285 mu M), and antagonist oxidized ATP (oxi-ATP; 40 mg/kg, IC50 approximate to 100 mu M) were used to show that P2X7R activation is crucial for the control of mortality, bacterial dissemination, and inflammation in cecal ligation and puncture-induced polymicrobial sepsis in mice. Our results with P2X7(-/-) bone marrow chimeric mice, adoptive transfer of peritoneal macrophages, and myeloid-specific P2X7(-/-) mice indicate that P2X7R signaling on macrophages is essential for the protective effect of P2X7Rs. P2X7R signaling protects through enhancing bacterial killing by macrophages, which is independent of the inflammasome. By using the connexin (Cx) channel inhibitor Gap27 (0.1 mg/kg, IC50 approximate to 0.25 mu M) and pannexin channel inhibitor probenecid (10 mg/kg, IC50 approximate to 11.7 mu M), we showed that ATP release through Cx is important for inhibiting inflammation and bacterial burden. In summary, targeting P2X7Rs provides a new opportunity for harnessing an endogenous protective immune mechanism in the treatment of sepsis.	[Csoka, Balazs; Nemeth, Zoltan H.; Toero, Gabor; Koscso, Balazs; Spolarics, Zoltan; Hasko, Gyoergy] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA; [Csoka, Balazs; Toero, Gabor; Spolarics, Zoltan; Hasko, Gyoergy] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA; [Idzko, Marco; Zech, Andreas] Univ Freiburg, Freiburg Univ Med Ctr, Dept Pneumol, D-79106 Freiburg, Germany; [Antonioli, Luca] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Cseri, Karolina] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, Debrecen, Hungary; [Erdelyi, Katalin; Pacher, Pal] NIAAA, NIH, Bethesda, MD USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Atlantic Health System; University of Freiburg; University of Pisa; University of Debrecen; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hasko, G (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	haskoge@njms.rutgers.edu	Zech, Andreas/ABB-3040-2021; Pacher, Pal/B-6378-2008	Pacher, Pal/0000-0001-7036-8108; Koscso, Balazs/0000-0001-9676-2066	U.S. National Institutes of Health (NIH) Grant from National Institute of General Medical Sciences [R01GM66189]; U.S. Army Medical Research and Materiel Command Grant [09065004/W81XWH-10-1-1015]; Hungarian Scientific Research Fund Grants (OTKA) [CK 78275, K109178]; Intramural Research Program of NIH, National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Grant from National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Materiel Command Grant(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Hungarian Scientific Research Fund Grants (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Intramural Research Program of NIH, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by U.S. National Institutes of Health (NIH) Grant R01GM66189 from the National Institute of General Medical Sciences, U.S. Army Medical Research and Materiel Command Grant 09065004/W81XWH-10-1-1015, and Hungarian Scientific Research Fund Grants (OTKA) CK 78275 and K109178 (all to G.H.) and by funding from the Intramural Research Program of the NIH, National Institute on Alcohol Abuse and Alcoholism (to P.P.). The authors declare no conflicts of interests.	Ali SR, 2011, IMMUNITY, V35, P34, DOI 10.1016/j.immuni.2011.04.015; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2009, CHEST; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chaves MM, 2014, J IMMUNOL, V192, P4765, DOI 10.4049/jimmunol.1301058; Chen QX, 2014, INNATE IMMUN-LONDON, V20, P290, DOI 10.1177/1753425913490575; Christenson K, 2008, J LEUKOCYTE BIOL, V83, P139, DOI 10.1189/jlb.0507276; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; Csoka B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006409; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eugenin EA, 2014, FEBS LETT, V588, P1389, DOI 10.1016/j.febslet.2014.01.030; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Gu BJ, 2013, FASEB J, V27, P1479, DOI 10.1096/fj.12-215368; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; King EG, 2014, LAB INVEST, V94, P4, DOI 10.1038/labinvest.2013.110; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Martel-Gallegos G, 2010, PURINERG SIGNAL, V6, P297, DOI 10.1007/s11302-010-9178-7; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Morandini Ana Carolina, 2014, Biomed J, V37, P169, DOI 10.4103/2319-4170.127803; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Santana PT, 2015, J INNATE IMMUN, V7, P417, DOI 10.1159/000371388; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2009, CURR PHARM DESIGN, V15, P1918, DOI 10.2174/138161209788453248; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	47	86	87	2	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3626	3637		10.1096/fj.15-272450	http://dx.doi.org/10.1096/fj.15-272450			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26060214	Green Published, Green Submitted			2022-12-28	WOS:000359915600003
J	Fiala, M; Halder, RC; Sagong, B; Ross, O; Sayre, J; Porter, V; Bredesen, DE				Fiala, Milan; Halder, Ramesh C.; Sagong, Bien; Ross, Olivia; Sayre, James; Porter, Verna; Bredesen, Dale E.			omega-3 Supplementation increases amyloid-beta phagocytosis and resolvin D1 in patients with minor cognitive impairment	FASEB JOURNAL			English	Article						specialized proresolving mediators; omega-3 fatty acids; minimental state examination; monocyte/macrophages; inflammatory genes	PRORESOLVING LIPID MEDIATORS; POLYUNSATURATED FATTY-ACIDS; ALZHEIMERS-DISEASE; MOUSE MODELS; THERAPEUTICS; INFLAMMATION; TRIAL; OMEGA-3-FATTY-ACIDS	We investigated the effects of 4-17 month supplementation with omega-3 fatty acids and antioxidants (Smartfish drink; Smartfish AS, Oslo, Norway) in 12 patients with minor cognitive impairment (MCI) [minimental state examination (MMSE) >= 19], 2 patients with pre-MCI (normal MMSE), and 7 patients with Alzheimer disease (AD) (MMSE <19). We measured the phagocytosis of amyloid-beta 1-42 (A beta) by flow cytometry and microscopy, the transcription of inflammatory genes by RT-PCR, the production of resolvin D1 (RvD1) by enzyme immunoassay, and the cognitive status by MMSE. In patients with MCI and pre-MCI, phagocytosis of A beta by monocytes increased from 530 to 1306 mean fluorescence intensity units (P = 0.016). The increase in patients with AD was not significant (N.S.). The lipidic mediator RvD1, which stimulates A beta phagocytosis in vitro, increased in macrophages in 80% of patients with MCI and pre-MCI (mean increase 9.95 pg/ml) (N.S.). Transcription of inflammatory genes' mRNAs was increased in a subgroup of patients with low transcription at baseline, whereas it was not significantly changed in patients with high transcription at baseline. The mean MMSE score of patients with MCI and pre-MCI was 25.9 at baseline and 25.7 after 4-17 months (N.S.). Our study is the first to show significant immune and biochemical effects of omega-3 fatty acids with antioxidants in patients with MCI. Cognitive benefits of omega-3 supplementation in patients with MCI should be tested in a clinical trial.	[Fiala, Milan; Halder, Ramesh C.; Sagong, Bien; Ross, Olivia] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA; [Sayre, James] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Porter, Verna; Bredesen, Dale E.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Fiala, M (corresponding author), 100 UCLA Med Plaza,Suite 220, Los Angeles, CA 90095 USA.	fiala@mednet.ucla.edu			Smartfish AS (Oslo, Norway)	Smartfish AS (Oslo, Norway)	The authors thank Veena Theendakara and Rammohan V. Rao for ApoE genotype testing. Smartfish AS (Oslo, Norway) provided the funding for publication and supplied the drink to patients who requested it. Smartfish was not involved in the design, analysis, interpretation of the data, or the decision to submit the manuscript for publication. M.F. received paid travel to meetings and honoraria for consultations from Smartfish.	Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Avagyan H, 2009, J NEUROIMMUNOL, V210, P67, DOI 10.1016/j.jneuroim.2009.02.015; Barberger-Gateau P, 2011, CURR ALZHEIMER RES, V8, P479, DOI 10.2174/156720511796391926; Bredesen DE, 2013, EMBO MOL MED, V5, P795, DOI 10.1002/emmm.201202307; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Lue LF, 1996, J NEUROPATH EXP NEUR, V55, P1083, DOI 10.1097/00005072-199655100-00008; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Otaegui-Arrazola A, 2014, EUR J NUTR, V53, P1, DOI 10.1007/s00394-013-0561-3; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shinto L, 2014, J ALZHEIMERS DIS, V38, P111, DOI 10.3233/JAD-130722; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Theendakara V, 2013, P NATL ACAD SCI USA, V110, P18303, DOI 10.1073/pnas.1314145110; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	24	47	49	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2681	2689		10.1096/fj.14-264218	http://dx.doi.org/10.1096/fj.14-264218			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805829				2022-12-28	WOS:000356859100001
J	Hiroyasu, S; Colburn, ZT; Jones, JCR				Hiroyasu, Sho; Colburn, Zachary T.; Jones, Jonathan C. R.			A hemidesmosomal protein regulates actin dynamics and traction forces in motile keratinocytes	FASEB JOURNAL			English	Article						cytoskeleton; lamella; lamellipodium; matrix adhesion; migration	BULLOUS-PEMPHIGOID ANTIGEN; CULTURED EPITHELIAL-CELLS; MYOSIN-II; LAMININ-332 ORGANIZATION; ALPHA-6-BETA-4 INTEGRIN; MECHANICAL-PROPERTIES; BETA-4 INTEGRIN; COLLAGEN-XVII; MIGRATION; EXPRESSION	During wound healing of the skin, keratinocytes disassemble hemidesmosomes and reorganize their actin cytoskeletons in order to exert traction forces on and move directionally over the dermis. Nonetheless, the transmembrane hemidesmosome component collagen XVII (ColXVII) is found in actin-rich lamella, situated behind the lamellipodium. A set of actin bundles, along which ColXVII colocalizes with actinin4, is present at each lamella. Knockdown of either ColXVII or actinin4 not only inhibits directed migration of keratinocytes but also relieves constraints on actin bundle retrograde movement at the site of lamella, such that actin bundle movement is enhanced more than 5-fold. Moreover, whereas control keratinocytes move in a stepwise fashion over a substrate by generating alternating traction forces, of up to 1.4 kPa, at each flank of the lamellipodium, ColXVII knockdown keratinocytes fail to do so. In summary, our data indicate that ColXVII-actinin4 complexes at the lamella of a moving keratinocyte regulate actin dynamics, thereby determining the direction of cell movement.Hiroyasu, S., Colburn, Z. T., Jones, J. C. R. A hemidesmosomal protein regulates actin dynamics and traction forces in motile keratinocytes.	[Hiroyasu, Sho; Colburn, Zachary T.; Jones, Jonathan C. R.] Washington State Univ, Sch Mol Biosci, BLS 202F,1770 NE Stadium Way, Pullman, WA 99164 USA	Washington State University	Jones, JCR (corresponding author), Washington State Univ, Sch Mol Biosci, BLS 202F,1770 NE Stadium Way, Pullman, WA 99164 USA.	jcr.jones@vetmed.wsu.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922; Hiroyasu, Sho/0000-0002-8290-2272	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR054184]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR054184). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Burnette DT, 2014, J CELL BIOL, V205, P83, DOI 10.1083/jcb.201311104; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Burton K, 1999, MOL BIOL CELL, V10, P3745, DOI 10.1091/mbc.10.11.3745; Deutsch A., 2012, FUNCTION REGULATION; Eddy RJ, 2000, J CELL SCI, V113, P1287; Eisenberg JL, 2013, J CELL SCI, V126, P3746, DOI 10.1242/jcs.128975; Eisenberg JL, 2011, RES REP BIOL, V2, P1, DOI 10.2147/RRB.S13178; Fogh BS, 2014, J HISTOCHEM CYTOCHEM, V62, P172, DOI 10.1369/0022155413517701; Franzke CW, 2006, J BIOL CHEM, V281, P30260, DOI 10.1074/jbc.M604464200; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hamill KJ, 2013, FASEB J, V27, P546, DOI 10.1096/fj.12-217406; Hamill KJ, 2011, J BIOL CHEM, V286, P26768, DOI 10.1074/jbc.M110.203646; Hamill KJ, 2009, MOL BIOL CELL, V20, P2954, DOI 10.1091/mbc.E09-01-0051; Harlow E., 1988, ANTIBODIES LAB MANUA; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; Hopkinson SB, 2000, MOL BIOL CELL, V11, P277, DOI 10.1091/mbc.11.1.277; Hopkinson SB, 2014, ADV WOUND CARE, V3, P247, DOI 10.1089/wound.2013.0489; Mousavi SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122094; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; KLATTE DH, 1989, J CELL BIOL, V109, P3377, DOI 10.1083/jcb.109.6.3377; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Kligys KR, 2012, J BIOL CHEM, V287, P17975, DOI 10.1074/jbc.M111.310458; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Loffek S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087263; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Nanba D, 2015, J CELL BIOL, V209, P305, DOI 10.1083/jcb.201409024; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Sawamura D, 2010, J DERMATOL, V37, P214, DOI 10.1111/j.1346-8138.2009.00800.x; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Stelkovics E, 2008, APPL IMMUNOHISTO M M, V16, P433, DOI 10.1097/PAI.0b013e318162f8aa; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Underwood RA, 2009, J HISTOCHEM CYTOCHEM, V57, P123, DOI 10.1369/jhc.2008.952176; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Walko G, 2015, CELL TISSUE RES, V360, P363, DOI 10.1007/s00441-014-2061-z; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152	50	23	23	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2298	2310		10.1096/fj.201500160R	http://dx.doi.org/10.1096/fj.201500160R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26936359	Green Published			2022-12-28	WOS:000376878300020
J	Lee, J; Machin, M; Russell, KE; Pavlidis, S; Zhu, J; Barnes, PJ; Chung, KF; Adcock, IM; Durham, AL				Lee, Jin; Machin, Matthew; Russell, Kirsty E.; Pavlidis, Stelios; Zhu, Jie; Barnes, Peter J.; Chung, Kian F.; Adcock, Ian M.; Durham, Andrew L.			Corticosteroid modulation of immunoglobulin expression and B-cell function in COPD	FASEB JOURNAL			English	Article						DUSP1; ERK; fluticasone propionate; LABA	OBSTRUCTIVE PULMONARY-DISEASE; DUAL-SPECIFICITY PHOSPHATASES; AIRWAY GENE-EXPRESSION; MAP KINASE; INHALED FLUTICASONE; LUNG-FUNCTION; GLUCOCORTICOIDS; EXACERBATIONS; TRANSCRIPTION; INFLAMMATION	We investigated changes in gene expression that occur in chronic obstructive pulmonary disease (COPD) after corticosteroid treatment and sought to identify the mechanisms that regulate these changes. Biopsy samples were taken from patients with COPD (Global Initiative for Chronic Obstructive Lung Disease stage I to II) before and after treatment with fluticasone propionate (FP)/salmeterol (SM) (50/500, 4 wk). Gene expression was measured by microarray and was confirmed by real-time reverse transcription-quantitative PCR (RT-qPCR). The effect of FP on IgG expression and B-cell proliferation in the presence of oxidative stress was also studied. FP/SM significantly increased the expression of 180 genes while repressing 343 genes. The top 5 down-regulated genes were associated with immunoglobulin production, whereas the immunomodulatory FK506 binding protein (FK506BP) was up-regulated. Genes including IL6, IL8, and TBET-encoding TBX21 were unaffected. FP reduced IgG protein and mRNA expression and proliferation of human B cells through the dephosphorylation of ERK1/2 via increased DUSP1 (dual-specificity protein phosphatase 1) expression. Consistent with in vivo data, oxidative stress did not prevent FP-induced suppression of IgG expression in human B cells in vitro. Changes in expression were validated by RT-qPCR and by gene set enrichment analysis in distinct COPD cohorts. FP may reduce the adaptive immune response in COPD and may be more effective in patients with an increased B-cell/antibody response indicated by high autoantibody titers.-Lee, J., Machin, M., Russell, K. E., Pavlidis, S., Zhu, J., Barnes, P. J., Chung, K. F., Adcock, I. M., Durham, A. L. Corticosteroid modulation of immunoglobulin expression and B-cell function in COPD. www.fasebj.org	[Lee, Jin; Machin, Matthew; Russell, Kirsty E.; Zhu, Jie; Barnes, Peter J.; Chung, Kian F.; Adcock, Ian M.; Durham, Andrew L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Pavlidis, Stelios] Janssen Res & Dev, High Wycombe, Bucks, England	Imperial College London; Johnson & Johnson	Durham, AL (corresponding author), Natl Heart & Lung Inst, Airways Dis Sect, Dovehouse St, London SW3 6LY, England.	a.durham@imperial.ac.uk	Adcock, Ian/L-3217-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Adcock, Ian/0000-0003-2101-8843; Machin, Matthew/0000-0002-9692-4552; Durham, Andrew/0000-0003-2372-4688; Barnes, Peter/0000-0002-5122-4018	Medical Research Council [G1001367/1]; Wellcome Trust [093080/Z/10/Z]; Interuniversity Attraction Poles Program Belgian State-Belgian Science Policy Project [P7/30]; National Institute for Health Research Respiratory Disease Biomedical Research Unit; Royal Brompton National Health Service (NHS) Foundation Trust; Imperial College London; GSK; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10148] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Interuniversity Attraction Poles Program Belgian State-Belgian Science Policy Project; National Institute for Health Research Respiratory Disease Biomedical Research Unit; Royal Brompton National Health Service (NHS) Foundation Trust; Imperial College London(General Electric); GSK(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The microarray data was carried out with the help of A. McLaren, B. P. Hayes, and C. Clayton at GlaxoSmithKline (GSK), and bronchial biopsy samples were obtained with the help of A. Torrego. I.M.A. is supported by the Medical Research Council (G1001367/1) and the Wellcome Trust (093080/Z/10/Z). I.M.A. is a member of Interuniversity Attraction Poles Program Belgian State-Belgian Science Policy Project P7/30. Research by I.M.A., P.J.B., K.F.C., and A.L.D. is supported in part by the National Institute for Health Research Respiratory Disease Biomedical Research Unit, Royal Brompton National Health Service (NHS) Foundation Trust, and Imperial College London. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. This work was funded by the Wellcome Trust (093080/Z/10/Z) and an unrestricted research grant from GSK. The sponsors had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Ayroldi E, 2012, FASEB J, V26, P4805, DOI 10.1096/fj.12-216382; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Barnes PJ, 2013, CURR MED CHEM, V20, P1531; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley P, 2004, EUR RESPIR J, V24, P206; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; CUPPS TR, 1985, J CLIN INVEST, V75, P754, DOI 10.1172/JCI111757; Duncan SR, 2010, AM J RESP CRIT CARE, V181, P4, DOI 10.1164/rccm.200910-1488ED; Durham AL, 2013, FASEB J, V27, P2367, DOI 10.1096/fj.12-217083; Fokkens WJ, 1999, ALLERGY, V54, P158, DOI 10.1034/j.1398-9995.1999.00747.x; Ford PA, 2010, CHEST, V137, P1338, DOI 10.1378/chest.09-2363; Georas Steve N, 2004, Proc Am Thorac Soc, V1, P215, DOI 10.1513/pats.200402-004MS; Gold MR, 2008, IMMUNITY, V28, P488, DOI 10.1016/j.immuni.2008.03.008; Gosman MME, 2006, EUR RESPIR J, V27, P60, DOI 10.1183/09031936.06.00007005; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hakim A, 2012, DRUGS, V72, P1299, DOI 10.2165/11634350-000000000-00000; Haque R, 2013, J ALLERGY CLIN IMMUN, V132, P1166, DOI 10.1016/j.jaci.2013.07.038; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Ito K., 2001, FASEB Journal, V15, P1110; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lim S, 1999, AM J RESP CRIT CARE, V159, P22, DOI 10.1164/ajrccm.159.1.9706006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maas A. K., 2010, F1000 MED REP, V2, P2; Macedo P, 2009, CLIN EXP ALLERGY, V39, P1668, DOI 10.1111/j.1365-2222.2009.03319.x; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Mercado N, 2011, J PHARMACOL EXP THER, V337, P465, DOI 10.1124/jpet.110.175950; NICE, 2010, CHRON OBSTR PULM DIS; Nunez B, 2011, AM J RESP CRIT CARE, V183, P1025, DOI 10.1164/rccm.201001-0029OC; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Reth M, 2014, ADV IMMUNOL, V122, P129, DOI 10.1016/B978-0-12-800267-4.00004-3; Si WZ, 2015, CANCER CELL, V27, P822, DOI 10.1016/j.ccell.2015.04.011; Statistical Solutions, POW SAMPL SIZ CALC; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; van den Berge M, 2014, THORAX, V69, P14, DOI 10.1136/thoraxjnl-2012-202878; Wedzicha JA, 2012, EUR RESPIR J, V40, P1545, DOI 10.1183/09031936.00048912; Williams AS, 2007, J PHARMACOL EXP THER, V322, P351, DOI 10.1124/jpet.107.121624; ZON LI, 1991, J BIOL CHEM, V266, P22948	54	22	23	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2014	2026		10.1096/fj.201500135	http://dx.doi.org/10.1096/fj.201500135			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26887440	Green Submitted			2022-12-28	WOS:000374879400028
J	Plecita-Hlavata, L; Engstova, H; Alan, L; Spacek, T; Dlaskova, A; Smolkova, K; Spackova, J; Tauber, J; Stradalova, V; Malinsky, J; Lessard, M; Bewersdorf, J; Jezek, P				Plecita-Hlavata, Lydie; Engstova, Hana; Alan, Lukas; Spacek, Tomas; Dlaskova, Andrea; Smolkova, Katarina; Spackova, Jitka; Tauber, Jan; Stradalova, Vendula; Malinsky, Jan; Lessard, Mark; Bewersdorf, Joerg; Jezek, Petr			Hypoxic HepG2 cell adaptation decreases ATP synthase dimers and ATP production in inflated cristae by mitofilin down-regulation concomitant to MICOS clustering	FASEB JOURNAL			English	Article						mitofilin; Mic60; OPA1; dSTORM 3D immunocytochemistry; electron microscopy; mitochondrial cristae morphology	MITOCHONDRIAL CONTACT SITE; OXIDATIVE-PHOSPHORYLATION; ORGANIZING SYSTEM; OUTER-MEMBRANE; COMPLEX-III; ELECTRON TOMOGRAPHY; MICROSCOPY REVEALS; CANCER; ARCHITECTURE; PROTEIN	The relationship of the inner mitochondrial membrane (IMM) cristae structure and intracristal space (ICS) to oxidative phosphorylation (oxphos) is not well understood. Mitofilin (subunit Mic60) of the mitochondrial contact site and cristae organizing system (MICOS) IMM complex is attached to the outer membrane (OMM) via the sorting and assembly machinery/topogenesis of mitochondrial outer membrane beta-barrel proteins (SAM/TOB) complex and controls the shape of the cristae. ATP synthase dimers determine sharp cristae edges, whereas trimeric OPA1 tightens ICS outlets. Metabolism is altered during hypoxia, and we therefore studied cristae morphology in HepG2 cells adapted to 5% oxygen for 72 h. Three dimensional (3D), super-resolution biplane fluorescence photoactivation localization microscopy with Eos-conjugated, ICS-located lactamase-beta indicated hypoxic ICS expansion with an unchanged OMM (visualized by Eos-mitochondrial fission protein-1). 3D direct stochastic optical reconstruction microscopy immunocytochemistry revealed foci of clustered mitofilin (but not MICOS subunit Mic19) in contrast to its even normoxic distribution. Mitofilin mRNA and protein decreased by similar to 20%. ATP synthase dimers vs. monomers and state-3/state-4 respiration ratios were lower during hypoxia. Electron microscopy confirmed ICS expansion (maximum in glycolytic cells), which was absent in reduced or OMM-detached cristae of OPA1- and mitofilin-silenced cells, respectively. Hypoxic adaptation is reported as rounding sharp cristae edges and expanding cristae width (ICS) by partialmitofilin/Mic60 down-regulation. Mitofilin-depleted MICOS detaches from SAM while remaining MICOS with mitofilin redistributes toward higher interdistances. This phenomenon causes partial oxphos dormancy in glycolytic cells via disruption of ATP synthase dimers.-Plecita-Hlavata, L., Engstova, H., Alan, L.,. Spacek, T., Dlaskova, A., Smolkova, K., Spackova, J., Tauber, J., Stradalova, V., Malinsky, J., Lessard, M., Bewersdorf, J., Jezek, P. Hypoxic HepG2 cell adaptation decreases ATP synthase dimers and ATP production in inflated cristae by mitofilin down-regulation concomitant to MICOS clustering. www.fasebj.org	[Plecita-Hlavata, Lydie; Engstova, Hana; Alan, Lukas; Spacek, Tomas; Dlaskova, Andrea; Smolkova, Katarina; Spackova, Jitka; Tauber, Jan; Jezek, Petr] Acad Sci Czech Republic, Inst Physiol, Dept Membrane Transport Biophys, Dept 75, Videnska 1083, CR-14220 Prague 4, Czech Republic; [Stradalova, Vendula; Malinsky, Jan] Acad Sci Czech Republic, Inst Expt Med, Microscopy Unit, Prague 14220 4, Czech Republic; [Lessard, Mark] Jackson Lab, Inst Mol Biophys, 600 Main St, Bar Harbor, ME 04609 USA; [Lessard, Mark; Bewersdorf, Joerg] Yale Univ, Dept Cell Biol, New Haven, CT USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Jackson Laboratory; Yale University	Jezek, P (corresponding author), Acad Sci Czech Republic, Inst Physiol, Membrane Transport Biophys, Dept 75, Videnska 1083, CR-14220 Prague 4, Czech Republic.	jezek@biomed.cas.cz	Dlaskova, Andrea/AAD-5955-2020; Alán, Lukáš/H-9063-2013; Engstova, Hana/C-1015-2012; Plecita-Hlavata, Lydie/C-1028-2012; Tauber, Jan/H-9066-2013; Smolková, Katarína/C-4290-2012; Malinsky, Jan/H-2484-2014; Šantorová, Jitka/C-8303-2012; Spacek, Tomas/C-4380-2012; Dlaskova, Andrea/C-1734-2012; Engstova, Hana/AAF-6522-2020; Jezek, Petr/B-9264-2012	Dlaskova, Andrea/0000-0002-8626-3703; Alán, Lukáš/0000-0001-7417-2620; Plecita-Hlavata, Lydie/0000-0003-0759-1731; Tauber, Jan/0000-0002-4711-5716; Smolková, Katarína/0000-0002-4734-0200; Malinsky, Jan/0000-0002-1433-0989; Spacek, Tomas/0000-0002-7020-8566; Engstova, Hana/0000-0001-6341-8242; Jezek, Petr/0000-0002-2720-9395; Bewersdorf, Joerg/0000-0002-4085-7020; Lessard, Mark/0000-0002-1927-2204	Grant Agency of the Czech Republic [13-02033S, 15-02022Y];  [AV0Z50110509];  [RVO67985823]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); ; 	The authors thank Dr. J. Zelenka for preparation of the Cy3B-conjugated secondary antibody, L. Joskova for excellent technical assistance with cell cultivation, J. Vaicova for the immunoblot analyses and blue native electrophoresis, and J. Smikova for the plasmid isolations. The project was supported by Grants 13-02033S (to P.J.) and 15-02022Y (to A.D.) from the Grant Agency of the Czech Republic, and by Research Projects AV0Z50110509 and RVO67985823. J.B. declares significant financial interest in Bruker Corp. and Hamamatsu Photonics K.K. The remaining authors declare no conflicts of interest.	Barbot M, 2015, CELL METAB, V21, P756, DOI 10.1016/j.cmet.2015.04.006; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bohnert M, 2015, CELL METAB, V21, P747, DOI 10.1016/j.cmet.2015.04.007; Bohnert M, 2012, MOL BIOL CELL, V23, P3948, DOI 10.1091/mbc.E12-04-0295; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Fanale D, 2013, BREAST CANCER RES TR, V140, P505, DOI 10.1007/s10549-013-2649-0; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guarani V, 2015, ELIFE, V4, DOI 10.7554/eLife.06265; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Harner ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01684; Hohr AIC, 2015, BBA-MOL CELL RES, V1853, P74, DOI 10.1016/j.bbamcr.2014.10.006; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; Jezek P, 2010, INT J BIOCHEM CELL B, V42, P604, DOI 10.1016/j.biocel.2009.11.008; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Korner C, 2012, MOL BIOL CELL, V23, P2143, DOI 10.1091/mbc.E11-10-0831; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Mannella CA, 2008, ANN NY ACAD SCI, V1147, P171, DOI 10.1196/annals.1427.020; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Neupert W, 2012, CELL, V149, P722, DOI 10.1016/j.cell.2012.04.010; Ott C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120213; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Plecita-Hlavata L, 2008, BBA-BIOENERGETICS, V1777, P834, DOI 10.1016/j.bbabio.2008.04.002; Polianskyte Z, 2009, P NATL ACAD SCI USA, V106, P18960, DOI 10.1073/pnas.0906734106; Schmidt R, 2009, NANO LETT, V9, P2508, DOI 10.1021/nl901398t; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Smolkova K, 2011, INT J BIOCHEM CELL B, V43, P950, DOI 10.1016/j.biocel.2010.05.003; Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; WESTERHOFF HV, 1984, FEBS LETT, V165, P1, DOI 10.1016/0014-5793(84)80002-2; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Yang RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep07990; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004	47	27	27	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1941	1957		10.1096/fj.201500176	http://dx.doi.org/10.1096/fj.201500176			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26887443				2022-12-28	WOS:000374879400022
J	Seko, D; Ogawa, S; Li, TS; Taimura, A; Ono, Y				Seko, Daiki; Ogawa, Shizuka; Li, Tao-Sheng; Taimura, Akihiro; Ono, Yusuke			mu-Crystallin controls muscle function through thyroid hormone action	FASEB JOURNAL			English	Article						skeletal muscle; muscle hypertrophy; muscle plasticity; fiber type	SKELETAL-MUSCLE; UNCOUPLING PROTEIN-3; GENE-EXPRESSION; SATELLITE CELLS; SLOW-TWITCH; DIFFERENTIATION; DYSTROPHY; THERAPY; NADPH	mu-Crystallin (Crym), a thyroid hormone-binding protein, is abnormally up-regulated in the muscles of patients with facioscapulohumeral muscular dystrophy, a dominantly inherited progressive myopathy. However, the physiologic function of Crym in skeletal muscle remains to be elucidated. In this study, Crym was preferentially expressed in skeletal muscle throughout the body. Crym-knockoutmice exhibited a significant hypertrophy of fast-twitch glycolytic type IIb fibers, causing an increase in grip strength and high intensity running ability in Crym-null mice. Genetic inactivation of Crym or blockade of Crym by siRNA-mediated knockdown up-regulated the gene expression of fast-glycolytic contractile fibers in satellite cell-derived myotubes in vitro. These alterations in Crym-inactivated muscle were rescued by inhibition of thyroid hormone, even though Crym is a positive regulator of thyroid hormone action in nonmuscle cells. The results demonstrated that Crym is a crucial regulator of muscle plasticity, controlling metabolic and contractile properties of myofibers, and thus the selective inactivation of Crym may be a potential therapeutic target for muscle-wasting diseases, such as muscular dystrophies and age-related sarcopenia.-Seko, D., Ogawa, S., Li, T.-S., Taimura, A., Ono, Y. mu-Crystallin controls muscle function through thyroid hormone action.	[Seko, Daiki; Ogawa, Shizuka; Li, Tao-Sheng; Ono, Yusuke] Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Seko, Daiki; Taimura, Akihiro] Grad Sch Fisheries & Environm Sci, Inst Environm Sci, Nagasaki, Japan	Nagasaki University	Ono, Y (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan.	yusuke-ono@nagasaki-u.ac.jp		Ono, Yusuke/0000-0002-4802-7507; Li, Tao-Sheng/0000-0002-7653-8873	Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency); Japan Society for the Promotion of Science [15H05368]; Sasagawa Scientific Research Foundation;  [25560338]	Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sasagawa Scientific Research Foundation; 	The authors thank Prof. S. Suzuki (Fukushima Medical University, Fukushima, Japan) for sharing the Crym<SUP>-/-</SUP> mouse line, and Dr. S. Masuda, Mr. T Hisamatsu, Mr. K. Yoshioka, Dr. R. Fujita, Dr. Y. Urata, and Dr. S. Goto for helpful discussions and technical support. This work was supported by the Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency), a Grant-in-Aid for Challenging Exploratory Research (Project No. 25560338), a Grant-in-Aid for Young Scientists A (Japan Society for the Promotion of Science; Project No. 15H05368), and the Sasagawa Scientific Research Foundation. D.S. performed the experiments, analyzed the data, and wrote the manuscript; S.O. performed the experiments and analyzed the data; T.L. and A.T. gave technical support. Y.O. designed and interpreted the data, assembled the input data and wrote the main manuscript; and all authors discussed the results and implications and commented on the manuscript. The authors declare no conflicts of interest.	Bahi L, 2005, J CELL PHYSIOL, V203, P589, DOI 10.1002/jcp.20273; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Borel F, 2014, FEBS J, V281, P1598, DOI 10.1111/febs.12726; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Clement K, 2002, GENOME RES, V12, P281, DOI 10.1101/gr.207702; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Dentice M, 2014, CELL METAB, V20, P1038, DOI 10.1016/j.cmet.2014.10.009; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Hallen A, 2011, J NEUROCHEM, V118, P379, DOI 10.1111/j.1471-4159.2011.07220.x; Imai H, 2010, INVEST OPHTH VIS SCI, V51, P3554, DOI 10.1167/iovs.09-3728; KIM RY, 1992, P NATL ACAD SCI USA, V89, P9292, DOI 10.1073/pnas.89.19.9292; Lassche S, 2013, NEUROLOGY, V80, P733, DOI 10.1212/WNL.0b013e318282513b; Lee Jang-Won, 2014, J Endocrinol Diabetes Obes, V2, P1046; Lek A, 2015, TRENDS MOL MED, V21, P295, DOI 10.1016/j.molmed.2015.02.011; Marsili A, 2010, ENDOCRINOLOGY, V151, P5952, DOI 10.1210/en.2010-0631; Masuda S, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12377; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; NWOYE L, 1982, AM J PHYSIOL, V242, pR401, DOI 10.1152/ajpregu.1982.242.3.R401; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; ORFALI KA, 1995, J MOL CELL CARDIOL, V27, P901, DOI 10.1016/0022-2828(95)90040-3; Reed PW, 2007, EXP NEUROL, V205, P583, DOI 10.1016/j.expneurol.2007.03.009; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Salvatore D, 2014, NAT REV ENDOCRINOL, V10, P206, DOI 10.1038/nrendo.2013.238; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Solanes G, 2005, BIOCHEM J, V386, P505, DOI 10.1042/BJ20041073; Suzuki S, 2007, TRENDS ENDOCRIN MET, V18, P286, DOI 10.1016/j.tem.2007.07.002; Suzuki S, 2007, MOL ENDOCRINOL, V21, P885, DOI 10.1210/me.2006-0403; Takeshige K, 2014, ENDOCR J, V61, P561, DOI 10.1507/endocrj.EJ13-0418; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Vie MP, 1997, MOL ENDOCRINOL, V11, P1728, DOI 10.1210/me.11.11.1728	36	25	27	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1733	1740		10.1096/fj.15-280933	http://dx.doi.org/10.1096/fj.15-280933			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26718889				2022-12-28	WOS:000374879400005
J	Patel, SA; Chaudhari, A; Gupta, R; Velingkaar, N; Kondratov, RV				Patel, Sonal A.; Chaudhari, Amol; Gupta, Richa; Velingkaar, Nikkhil; Kondratov, Roman V.			Circadian clocks govern calorie restriction-mediated life span extension through BMAL1-and IGF-1-dependent mechanisms	FASEB JOURNAL			English	Article						aging; gene expression; glucose; insulin; transcription; food anticipation	DIETARY-RESTRICTION; GENE-EXPRESSION; SIRT1; LONGEVITY; PATHWAY; METABOLISM; COMPONENT; PROTEINS; RHYTHMS; MOP3	Calorie restriction (CR) increases longevity in many species by unknown mechanisms. The circadian clock was proposed as a potential mediator of CR. Deficiency of the core component of the circadian clock-transcriptional factor BMAL1 (brain and muscle ARNT [aryl hydrocarbon receptor nuclear translocator]-like protein 1)-results in accelerated aging. Here we investigated the role of BMAL1 in mechanisms of CR. The 30% CR diet increased the life span of wild-type (WT) mice by 20% compared to mice on an ad libitum (AL) diet but failed to increase life span of Bmal1(-/-) mice. BMAL1 deficiency impaired CR-mediated changes in the plasma levels of IGF-1 and insulin. We detected a statistically significantly reduction of IGF-1 in CR vs. AL by 50 to 70% in WT mice at several daily time points tested, while in Bmal1(-/-) the reduction was not significant. Insulin levels in WT were reduced by 5 to 9%, while Bmal1(-/-) induced it by 10 to 35% at all time points tested. CR up-regulated the daily average expression of Bmal1 (by 150%) and its downstream target genes Periods (by 470% for Per1 and by 130% for Per2). We propose that BMAL1 is an important mediator of CR, and activation of BMAL1 might link CR mechanisms with biologic clocks.	[Kondratov, Roman V.] Cleveland State Univ, Dept Biol Geol & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA; [Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Kondratov, RV (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA.; Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA.	r.kondratov@csuohio.edu	Velingkaar, Nikkhil/ABC-8132-2020; Tulsian, Richa/L-5266-2019; Patel, Sonal/ABI-8347-2020	Velingkaar, Nikkhil/0000-0003-1571-0833; Patel, Sonal/0000-0003-2268-6114; Kondratov, Roman/0000-0003-3449-745X	U.S. National Institutes of Health/National Institute on Aging [1R01AG039547]; Center for Gene Regulation in Health and Disease (Cleveland State University); Cleveland State University; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010381] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center for Gene Regulation in Health and Disease (Cleveland State University); Cleveland State University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health/National Institute on Aging Grant 1R01AG039547, funds from the Center for Gene Regulation in Health and Disease (Cleveland State University) to R.V.K, and a Dissertation Research Award (Cleveland State University) to S.P. The authors thank J. Holcomb (Department of Mathematics, Cleveland State University), for help with statistical analysis. The authors also thank 2 anonymous reviewers for their helpful suggestions. The authors declare no conflicts of interest.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; Blagosklonny MV, 2010, CELL CYCLE, V9, P3151, DOI 10.4161/cc.9.16.13120; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gesing A, 2014, EXP GERONTOL, V58, P219, DOI 10.1016/j.exger.2014.08.010; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kitada M, 2013, BBA-GEN SUBJECTS, V1830, P4820, DOI 10.1016/j.bbagen.2013.06.014; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nogueira LM, 2012, CANCER MED-US, V1, P275, DOI 10.1002/cam4.23; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Taormina G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/308690; Wang Y, 2014, DIABETES METAB J, V38, P321, DOI 10.4093/dmj.2014.38.5.321	46	55	55	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1634	1642		10.1096/fj.15-282475	http://dx.doi.org/10.1096/fj.15-282475			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700733	Green Published			2022-12-28	WOS:000372629100024
J	Wei, SP; Roessler, BC; Icyuz, M; Chauvet, S; Tao, BL; Hartman, JL; Kirk, KL				Wei, Shipeng; Roessler, Bryan C.; Icyuz, Mert; Chauvet, Sylvain; Tao, Binli; Hartman, John L.; Kirk, Kevin L.			Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels	FASEB JOURNAL			English	Article						ABC transporter; ion channel; allostery; phosphorylation	CFTR CHLORIDE CHANNEL; NUCLEOTIDE-BINDING; ALLOSTERIC MODULATION; TRANSPORTER; MECHANISM; SITES; PORE; PHOSPHORYLATION; DIMERIZATION; HYDROLYSIS	The ABCC transporter subfamily includes pumps, the long and short multidrug resistance proteins (MRPs), and an ATP-gated anion channel, the cystic fibrosis transmembrane conductance regulator (CFTR). We show that despite their thermodynamic differences, these ABCC transporter subtypes use broadly similar mechanisms to couple their extracellular gates to the ATP occupancies of their cytosolic nucleotide binding domains. A conserved extracellular phenylalanine at this gate was a prime location for producing gain of function (GOF) mutants of a long MRP in yeast (Ycf1p cadmium transporter), a short yeast MRP (Yor1p oligomycin exporter), and human CFTR channels. Extracellular gate mutations rescued ATP binding mutants of the yeast MRPs and CFTR by increasing ATP sensitivity. Control ATPase-defective MRP mutants could not be rescued by this mechanism. A CFTR double mutant with an extracellular gate mutation plus a cytosolic GOF mutation was highly active (single-channel open probability >0.3) in the absence of ATP and protein kinase A, each normally required for CFTR activity. We conclude that all 3 ABCC transporter subtypes use similar mechanisms to couple their extracellular gates to ATP occupancy, and highly active CFTR channels that bypass defects in ATP binding or phosphorylation can be produced.	[Wei, Shipeng; Roessler, Bryan C.; Chauvet, Sylvain; Tao, Binli; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Icyuz, Mert; Hartman, John L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Genet, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd, Birmingham, AL 35294 USA.	klkirk@uab.edu	Icyuz, Mert/J-6598-2013	Icyuz, Mert/0000-0003-1681-0115; Hartman, John/0000-0003-1176-6469	U.S. National Institutes of Health [RO1 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK056796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank John Rodgers and Sean Santos (both at the University of Alabama at Birmingham, Birmingham, AL, USA) for assistance with the yeast growth curve analysis. This study was supported by U.S. National Institutes of Health Grant RO1 DK056796.	Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Burke D., 2000, METHODS YEAST GENETI; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; Falcon-Perez JM, 2001, J BACTERIOL, V183, P4761, DOI 10.1128/JB.183.16.4761-4770.2001; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Herlitze S, 2001, P NATL ACAD SCI USA, V98, P4699, DOI 10.1073/pnas.051628998; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kim IW, 2006, BIOCHEMISTRY-US, V45, P7605, DOI 10.1021/bi060308o; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 2000, BIOPHYS J, V78, P2973, DOI 10.1016/S0006-3495(00)76836-6; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, MOL PHARMACOL, V82, P1042, DOI 10.1124/mol.112.080267; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Okeyo G, 2013, J BIOL CHEM, V288, P17122, DOI 10.1074/jbc.M112.442582; Rodgers J, 2014, METHODS MOL BIOL, V1205, P187, DOI 10.1007/978-1-4939-1363-3_12; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Shah NA, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-3; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Szentpetery Z, 2004, ANTICANCER RES, V24, P449; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Tsui LC, 1991, CURR OPIN GENET DEV, V1, P4, DOI 10.1016/0959-437X(91)80032-H; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wei SP, 2014, J BIOL CHEM, V289, P19942, DOI 10.1074/jbc.M114.562116; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yeh HI, 2015, J GEN PHYSIOL, V145, P47, DOI 10.1085/jgp.201411272; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	52	11	11	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1247	1262		10.1096/fj.15-278382	http://dx.doi.org/10.1096/fj.15-278382			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26606940	Green Published			2022-12-28	WOS:000370387800021
J	Ren, JQ; Chen, YCI; Mackey, AM; Liu, PK				Ren, Jiaqian; Chen, Yinching I.; Mackey, Ashley M.; Liu, Philip K.			Imaging rhodopsin degeneration in vivo in a new model of ocular ischemia in living mice	FASEB JOURNAL			English	Article						chimeric MR CA; nanotechnology; retinopathy; target-guided delivery strategies	MANGANESE-ENHANCED MRI; DIABETIC-RETINOPATHY; CEREBRAL-ISCHEMIA; MOUSE RETINA; BRAINS; PROBES; AMPHETAMINE; HYPOTHERMIA; EXPOSURE; STROKE	Delivery of antibodies to monitor key biomarkers of retinopathy in vivo represents a significant challenge because living cells do not take up immunoglobulins to cellular antigens. We met this challenge by developing novel contrast agents for retinopathy, which we used with magnetic resonance imaging (MRI). Biotinylated rabbit polyclonal to chick IgY (rIgPxcIgY) and phosphorylthioate-modified oligoDNA (sODN) with random sequence (bio-sODN-Ran) were conjugated with NeutrAvidin-activated superparamagnetic iron oxide nanoparticles (SPION). The resulting Ran-SPION-rIgPxcIgY carries chick polyclonal to microtubule-associated protein 2 (MAP2) as Ran-SPION-rIgP/cIgY-MAP2, or torhodopsin (Rho) as anti-Rho-SPION-Ran. We examined the uptake of Ran-SPION-rIgP/cIgY-MAP2 or SPION-rIgP/cIgY-MAP2 in normal C57black6 mice (n = 3 each, 40 mu g/kg, i. c. v.); we found retention of Ran-SPION-rIgP/cIgY-MAP2 using molecular contrastenhanced MRI in vivo and validated neuronal uptake using Cy5-goat IgPxcIgY ex vivo. Applying this novel method to monitor retinopathy in a bilateral carotid artery occlusion-induced ocular ischemia, we observed pericytes (at d 2, using Gd-nestin, by eyedrop solution), significant photoreceptor degeneration (at d 20, using anti-Rho-SPION-Ran, eyedrops, P = 0.03, Student's t test), and gliosis in M " uller cells (at 6 mo, using SPION-glial fibrillary acidic protein administered by intraperitoneal injection) in surviving mice (n >= 5). Molecular contrastenhanced MRI results were confirmed by optical and electron microscopy. We conclude that chimera and molecular contrast-enhanced MRI provide sufficient sensitivity for monitoring retinopathy and for theranostic applications.-	[Ren, Jiaqian; Chen, Yinching I.; Liu, Philip K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Mackey, Ashley M.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Liu, PK (corresponding author), CNY149-13th St, Charlestown, MA 02129 USA.	philipl@mgh.harvard.edu			U.S. National Institutes of Health [R01EB013768, P30DK057521-14]; Boston Area, Diabetes Endocrinology Research Center;  [S10RR023009]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area, Diabetes Endocrinology Research Center; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. A. Kazlauskas (Schepens Eye Research Institute at the Massachusetts Eye and Ear Infirmary, Harvard Medical School), J. Blanks, and H. Prentice (Florida Atlantic University) for discussion of retinopathy; Dr. C.-M. Liu for sODN synthesis; and Drs. C. H. Liu, J. S. Yang, and S. Wu for MRI of the brain. This project was supported by U.S. National Institutes of Health Grants R01EB013768 (P. K. Liu), P30DK057521-14, the Boston Area, Diabetes Endocrinology Research Center (J. Avruch), and S10RR023009 (J. Ackerman).	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baker ML, 2010, STROKE, V41, P2143, DOI 10.1161/STROKEAHA.110.594317; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; Chan KC, 2012, MAGN RESON MED, V68, P1202, DOI 10.1002/mrm.24123; Chen JJ, 2011, NMR BIOMED, V24, P447, DOI 10.1002/nbm.1609; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; De Schryver ELLM, 2006, J NEUROL NEUROSUR PS, V77, P734, DOI 10.1136/jnnp.2005.085613; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dougherty CJ, 2008, MOL VIS, V14, P471; Gregory AD, 2010, J LEUKOCYTE BIOL, V88, P123, DOI 10.1189/jlb.0709499; Grosso A, 2011, J HYPERTENS, V29, P1667, DOI 10.1097/HJH.0b013e3283496655; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Liu CH, 2004, MAGN RESON MED, V51, P978, DOI 10.1002/mrm.20047; Liu CH, 2008, FASEB J, V22, P1193, DOI 10.1096/fj.07-9557com; Liu CH, 2007, FASEB J, V21, P3004, DOI 10.1096/fj.07-8203com; Liu CH, 2007, MOL IMAGING, V6, P156, DOI 10.2310/7290.2007.00011; Liu CH, 2014, FASEB J, V28, P464, DOI 10.1096/fj.13-234229; Liu CH, 2013, FASEB J, V27, P712, DOI 10.1096/fj.12-220061; Liu CH, 2012, FASEB J, V26, P1652, DOI 10.1096/fj.11-199547; Liu CH, 2009, J NEUROSCI, V29, P10663, DOI 10.1523/JNEUROSCI.2167-09.2009; Liu CH, 2009, J NEUROSCI, V29, P3508, DOI 10.1523/JNEUROSCI.5332-08.2009; Liu PK, 2011, METHODS MOL BIOL, V711, P363, DOI 10.1007/978-1-61737-992-5_18; LIU PK, 1994, ANN NEUROL, V36, P566, DOI 10.1002/ana.410360405; McMillan D E, 1997, Vasc Med, V2, P132; Nag TC, 2012, MICRON, V43, P759, DOI 10.1016/j.micron.2012.01.011; Pan CL, 2012, AMINO ACIDS, V43, P845, DOI 10.1007/s00726-011-1141-6; Ren J., 2015, GENE THER IN PRESS; Rey-Funes M, 2013, INVEST OPHTH VIS SCI, V54, P2836, DOI 10.1167/iovs.12-11198; Robison W G Jr, 1988, Adv Exp Med Biol, V246, P365; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	35	2	2	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					612	623		10.1096/fj.15-280677	http://dx.doi.org/10.1096/fj.15-280677			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443823	Green Published			2022-12-28	WOS:000369391900014
J	Murphy, KC; Stilhano, RS; Mitra, D; Zhou, DJ; Batarni, S; Silva, EA; Leach, JK				Murphy, Kaitlin C.; Stilhano, Roberta S.; Mitra, Debika; Zhou, Dejie; Batarni, Samir; Silva, Eduardo A.; Leach, J. Kent			Hydrogel biophysical properties instruct coculture-mediated osteogenic potential	FASEB JOURNAL			English	Article						fibrin; mesenchymal stem cell; ECFC; BMP-2; osteogenesis	ENDOTHELIAL PROGENITOR CELLS; COLONY-FORMING CELLS; ACID-BASED HYDROGEL; BONE REGENERATION; STEM-CELLS; IN-VIVO; BIOACTIVE GLASS; STROMAL CELLS; FIBRIN GELS; DIFFERENTIATION	Cell-based approaches for bone formation require instructional cues from the surrounding environment. As an alternative to pharmacological strategies or transplanting single cell populations, one approach is to coimplant populations that can establish a new vasculature and differentiate to bone-forming osteoblasts. Mesenchymal stem/stromal cells (MSCs) possess osteogenic potential and produce numerous angiogenic growth factors. Endothelial colony-forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis in vivo and may provide endogenous cues to support MSC function. We investigated the contribution of the carrier biophysical properties to instruct entrapped human MSCs and ECFCs to simultaneously promote their osteogenic and proangiogenic potential. Compared with gels containing MSCs alone, fibrin gels engineered with increased compressive stiffness simultaneously increased the osteogenic and proangiogenic potential of entrapped cocultured cells. ECFCs produced bone morphogenetic protein-2 (BMP-2), a potent osteoinductive molecule, and increases in BMP-2 secretion correlated with gel stiffness. Coculture of MSCs with ECFCs transduced to knockdown BMP-2 production abrogated the osteogenic response to levels observed with MSCs alone. These results demonstrate that physical properties of engineered hydrogels modulate the function of cocultured cells in the absence of inductive cues, thus increasing the translational potential of coimplantation to speed bone formation and repair.	[Murphy, Kaitlin C.; Stilhano, Roberta S.; Mitra, Debika; Zhou, Dejie; Batarni, Samir; Silva, Eduardo A.; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Leach, J. Kent] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Davis, CA 95616 USA; [Stilhano, Roberta S.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	University of California System; University of California Davis; University of California System; University of California Davis; Universidade Federal de Sao Paulo (UNIFESP)	Leach, JK (corresponding author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dri, Davis, CA 95616 USA.	jkleach@ucdavis.edu	Silva, Eduardo A./M-2711-2015; STILHANO, roberta/F-6923-2015	Silva, Eduardo A./0000-0003-3173-7622; STILHANO, roberta/0000-0002-0653-5968; Fogg, Kaitlin/0000-0003-3572-778X	U.S. National Institutes of Health; National Institute of Dental and Craniofacial Research [R03-DE021704]; AO Foundation (Davos, Switzerland) [C10-39L]; American Heart Association Western States Affiliate Pre-doctoral Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083894] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); AO Foundation (Davos, Switzerland); American Heart Association Western States Affiliate Pre-doctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant R03-DE021704, and the AO Foundation (Davos, Switzerland) (C10-39L to J.K.L.). K.M. was supported by the American Heart Association Western States Affiliate Pre-doctoral Fellowship. The authors declare no conflicts of interest.	American Academy of Orthopaedic Surgeons, 2000, MUSC INJ REP INC RIS; Bajada S, 2008, J TISSUE ENG REGEN M, V2, P169, DOI 10.1002/term.83; Binder BYK, 2014, TISSUE ENG PT A, V20, P1156, DOI [10.1089/ten.tea.2013.0487, 10.1089/ten.TEA.2013.0487]; Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662; Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029; Das A, 2011, TISSUE ENG PART B-RE, V17, P403, DOI [10.1089/ten.teb.2011.0190, 10.1089/ten.TEB.2011.0190]; Davis HE, 2011, ACTA BIOMATER, V7, P691, DOI 10.1016/j.actbio.2010.09.007; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; Dyer LA, 2014, TRENDS ENDOCRIN MET, V25, P472, DOI 10.1016/j.tem.2014.05.003; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875; Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013; Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033; He JW, 2012, TISSUE ENG PT A, V18, P1520, DOI [10.1089/ten.tea.2011.0127, 10.1089/ten.TEA.2011.0127]; Herzog DPE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/320123; Hoch AI, 2014, STEM CELL TRANSL MED, V3, P643, DOI 10.5966/sctm.2013-0196; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Joo HJ, 2015, INT J CARDIOL, V197, P33, DOI 10.1016/j.ijcard.2015.06.013; Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050; Kim J, 2009, J BIOMED MATER RES A, V88A, P967, DOI 10.1002/jbm.a.31947; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033; Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018; Lin RZ, 2014, P NATL ACAD SCI USA, V111, P10137, DOI 10.1073/pnas.1405388111; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Murphy KC, 2015, ANN BIOMED ENG, V43, P2010, DOI 10.1007/s10439-014-1227-x; Murphy Kaitlin C, 2012, BMC Res Notes, V5, P423, DOI 10.1186/1756-0500-5-423; Oelker AM, 2011, BIOMACROMOLECULES, V12, P1658, DOI 10.1021/bm200039s; Saleh FA, 2011, STEM CELLS DEV, V20, P391, DOI 10.1089/scd.2010.0168; Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937; Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815; Spotnitz William D, 2014, ISRN Surg, V2014, P203943, DOI 10.1155/2014/203943; Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047	46	16	16	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					477	486		10.1096/fj.15-279984	http://dx.doi.org/10.1096/fj.15-279984			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443826	Green Published			2022-12-28	WOS:000367621000044
J	Cai, Y; Ying, F; Song, EF; Wang, Y; Xu, AM; Vanhoutte, PM; Tang, EHC				Cai, Yin; Ying, Fan; Song, Erfei; Wang, Yu; Xu, Aimin; Vanhoutte, Paul M.; Tang, Eva Hoi-Ching			Mice lacking prostaglandin E receptor subtype 4 manifest disrupted lipid metabolism attributable to impaired triglyceride clearance	FASEB JOURNAL			English	Article						Creb-h; apolipoprotein; high-fat diet; hypertriglyceridemia; lipoprotein lipase	LIPOPROTEIN-LIPASE ACTIVITY; HIGH-DENSITY-LIPOPROTEIN; ELEMENT-BINDING PROTEIN; FATTY-ACID OXIDATION; EP4 RECEPTOR; CHEMOKINE PRODUCTION; HEPATIC LIPOGENESIS; ENERGY-METABOLISM; ADIPOSE-TISSUE; BONE-FORMATION	Upon high-fat feeding, prostaglandin E receptor subtype 4 (EP4)-knockout mice gain less body weight than their EP4(+/+) littermates. We investigated the cause of the lean phenotype. The mice showed a 68.8% reduction in weight gain with diminished fatmass thatwas not attributable to reduced food intake, fat malabsorption, or increased energy expenditure. Plasma triglycerides in themice were elevated by 244.9%. The increase in plasma triglycerides was independent of changes in hepatic very lowdensity lipoprotein (VLDL)-triglyceride production or intestinal chylomicron-triglyceride synthesis. However, VLDL-triglyceride clearance was drastically impaired in the EP4-knockout mice. The absence of EP4 in mice compromised the activation of lipoprotein lipase (LPL), the key enzyme responsible for trafficking of plasma triglycerides into peripheral tissues. Deficiency in EP4 reduced hepatic mRNA expression of the transcriptional factor cAMP response element binding protein H (by 36.8%) and LPL activators, including apolipoprotein (Apo)a5 (by 40.2%) and Apoc2 (by 61.3%). In summary, the lean phenotype of EP4-deficient mice resulted from reduction in adipose tissue and accretion of other peripheral organs caused by impaired triglyceride clearance. The findings identify a new metabolic dimension in the physiologic role played by endogenous EP4.	[Cai, Yin; Ying, Fan; Song, Erfei; Wang, Yu; Xu, Aimin; Vanhoutte, Paul M.; Tang, Eva Hoi-Ching] Univ Hong Kong, Dept Pharmacol & Pharm, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Tang, Eva Hoi-Ching] Univ Hong Kong, Dept Physiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Cai, Yin; Ying, Fan; Song, Erfei; Wang, Yu; Xu, Aimin; Vanhoutte, Paul M.; Tang, Eva Hoi-Ching] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Tang, EHC (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Li Ka Shing Fac Med, L2-26C,2-F Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	evatang1@hku.hk		Cai, Yin/0000-0002-7763-0612; wang, yu/0000-0001-8697-2940	Research Grant Council of Hong Kong SAR, China [HKU778012M]	Research Grant Council of Hong Kong SAR, China(Hong Kong Research Grants Council)	The authors thank Dr. Ching-Lung Cheung for helpful discussions on the use of ANCOVA. This work was supported by the Research Grant Council of Hong Kong SAR, China under the General Research Fund No. HKU778012M. The authors declare no conflict of interest.	Aoudjit L, 2006, AM J PHYSIOL-RENAL, V290, pF1534, DOI 10.1152/ajprenal.00267.2005; BEHR SR, 1988, DIABETES, V37, P1076, DOI 10.2337/diabetes.37.8.1076; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; CLARKE AR, 1985, BIOCHIM BIOPHYS ACTA, V827, P358, DOI 10.1016/0167-4838(85)90220-1; Davis RJ, 2004, BRIT J PHARMACOL, V141, P580, DOI 10.1038/sj.bjp.0705645; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Dvorak RV, 1998, NEUROLOGY, V51, P1386, DOI 10.1212/WNL.51.5.1386; Facemire CS, 2011, AM J PHYSIOL-RENAL, V301, pF1035, DOI 10.1152/ajprenal.00054.2011; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Foudi N, 2008, BRIT J PHARMACOL, V154, P1631, DOI 10.1038/bjp.2008.214; Frances DE, 2015, DIABETES, V64, P1522, DOI 10.2337/db14-0979; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; GREENBERG AS, 1992, CANCER RES, V52, P4113; Grompe M, 2003, SEMIN LIVER DIS, V23, P363; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Holla VR, 2011, J BIOL CHEM, V286, P30003, DOI 10.1074/jbc.M110.184697; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Inazumi T, 2011, J LIPID RES, V52, P1500, DOI 10.1194/jlr.M013615; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kim J, 2013, FASEB J, V27, P1657, DOI 10.1096/fj.12-224386; Kindel T, 2010, ATHEROSCLEROSIS SUPP, V11, P11, DOI 10.1016/j.atherosclerosissup.2010.03.003; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kovar J, 2004, PHYSIOL RES, V53, P61; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Mendez M, 2005, AM J PHYSIOL-HEART C, V288, pH2111, DOI 10.1152/ajpheart.00838.2004; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Muller TD, 2013, J CLIN INVEST, V123, P469, DOI 10.1172/JCI64209; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Mutoh M, 2002, CANCER RES, V62, P28; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; PETERSON J, 1990, P NATL ACAD SCI USA, V87, P909, DOI 10.1073/pnas.87.3.909; Qian JY, 2008, HYPERTENSION, V51, P560, DOI 10.1161/HYPERTENSIONAHA.107.102590; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sakamoto A, 2004, SHOCK, V22, P76, DOI 10.1097/01.shk.0000129338.99410.5d; Saraswathi V, 2013, METABOLISM, V62, P1673, DOI 10.1016/j.metabol.2013.07.007; Sasaoka R, 2004, BIOCHEM BIOPH RES CO, V318, P704, DOI 10.1016/j.bbrc.2004.04.080; Schweda F, 2004, AM J PHYSIOL-RENAL, V287, pF427, DOI 10.1152/ajprenal.00072.2004; Singh RK, 2012, J LIPID RES, V53, P1811, DOI 10.1194/jlr.M021881; Song KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/892491; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Srivastava V, 2012, EUR J IMMUNOL, V42, P912, DOI 10.1002/eji.201141965; Sugimoto Y, 2004, BIOCHEM BIOPH RES CO, V322, P911, DOI 10.1016/j.bbrc.2004.07.194; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tang EHC, 2015, J LIPID RES, V56, P358, DOI 10.1194/jlr.M054817; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Tang EHC, 2011, CARDIOVASC RES, V89, P234, DOI 10.1093/cvr/cvq262; Tang EHC, 2011, ARTERIOSCL THROM VAS, V31, P261, DOI 10.1161/ATVBAHA.110.216580; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Willecke F, 2015, ARTERIOSCL THROM VAS, V35, P102, DOI 10.1161/ATVBAHA.114.304615; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783	65	17	19	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4924	4936		10.1096/fj.15-274597	http://dx.doi.org/10.1096/fj.15-274597			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26271253				2022-12-28	WOS:000365523600018
J	Hughes-Fulford, M; Chang, TT; Martinez, EM; Li, CF				Hughes-Fulford, Millie; Chang, Tammy T.; Martinez, Emily M.; Li, Chai-Fei			Spaceflight alters expression of microRNA during T-cell activation	FASEB JOURNAL			English	Article						gene expression; microgravity; epigenetics; immune response	EPSTEIN-BARR-VIRUS; IMMUNE-RESPONSES; GENE-EXPRESSION; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; SPACE-FLIGHT; MICROGRAVITY; MIR-21; OVEREXPRESSION; PROLIFERATION	Altered immune function has been demonstrated in astronauts during spaceflights dating back to Apollo and Skylab; this could be a major barrier to long-term space exploration. We tested the hypothesis that spaceflight causes changes inmicroRNA (miRNA) expression. Human leukocytes were stimulated with mitogens on board the International Space Station using an onboard normal gravity control. Bioinformatics showed that miR-21 was significantly up-regulated 2-fold during early T-cell activation in normal gravity, and gene expression was suppressed under microgravity. This was confirmed using quantitative real-time PCR (n = 4). This is the first report that spaceflight regulates miRNA expression. Global microarray analysis showed significant (P < 0.05) suppression of 85 genes under microgravity conditions compared to normal gravity samples. EGR3, FASLG, BTG2, SPRY2, and TAGAP are biologically confirmed targets and are co-up-regulated with miR-21. These genes share common promoter regions with pre-mir-21; as the miR-21 matures and accumulates, it most likely will inhibit translation of its target genes and limit the immune response. These data suggest that gravity regulates T-cell activation not only by transcription promotion but also by blocking translation via noncoding RNA mechanisms. Moreover, this study suggests that T-cell activation itself may induce a sequence of gene expressions that is self-limited bymiR-21.	[Hughes-Fulford, Millie] San Francisco Dept Vet Affairs Med Ctr, Div Metab, Dept Med, Hughes Fulford Lab, San Francisco, CA USA; [Hughes-Fulford, Millie; Martinez, Emily M.; Li, Chai-Fei] Univ Calif San Francisco, Northern Calif Inst Res & Educ, San Francisco, CA 94143 USA; [Hughes-Fulford, Millie] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Chang, Tammy T.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA	Northern California Institute for Research & Education; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hughes-Fulford, M (corresponding author), Hughes Fulford Lab, MC 151F,4150 Clement St, San Francisco, CA 94121 USA.	milliehf@gmail.com		Hughes-Fulford, Millie/0000-0002-0756-068X	U.S. Veterans Affairs Biomedical Laboratory Research and Development Merit Review award; U.S. NASA Award [NCC2-1361]; NASA Award [NNX09AH21G]; CASIS; U.S. National Institutes of Health National Institute on Aging [5UH3AG037628]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093708, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UH3AG037628] Funding Source: NIH RePORTER	U.S. Veterans Affairs Biomedical Laboratory Research and Development Merit Review award; U.S. NASA Award; NASA Award; CASIS; U.S. National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a U.S. Veterans Affairs Biomedical Laboratory Research and Development Merit Review award to M.H.F., U.S. NASA Award NCC2-1361, NASA Award NNX09AH21G, CASIS, and primarily by U.S. National Institutes of Health National Institute on Aging Grant 5UH3AG037628.	Akkad DA, 2015, NEUROGENETICS, V16, P161, DOI 10.1007/s10048-015-0438-0; Ando Y, 2013, J AUTOIMMUN, V41, P111, DOI 10.1016/j.jaut.2012.12.013; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Berry C., 1975, BIOMEDICAL RESULTS A, P43; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Carissimi C, 2014, BIOCHIMIE, V107, P319, DOI 10.1016/j.biochi.2014.09.021; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Chusorn P, 2013, TUMOR BIOL, V34, P1579, DOI 10.1007/s13277-013-0688-0; COGOLI A, 1993, J LEUKOCYTE BIOL, V53, P569, DOI 10.1002/jlb.53.5.569; Cogoli A, 1997, Gravit Space Biol Bull, V10, P5; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; Kimsey S., 1977, BIOMEDICAL RESULTS S, P249; KONSTANT.IV, 1973, KOSM BIOL AVIAK MED+, V7, P35; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Martinez EM, 2015, AM J PHYSIOL-REG I, V308, pR480, DOI 10.1152/ajpregu.00449.2014; Ottoboni L, 2013, NEUROLOGY, V81, P1891, DOI 10.1212/01.wnl.0000436612.66328.8a; Payne DA, 1999, AVIAT SPACE ENVIR MD, V70, P1211; Pippia P, 1996, J BIOTECHNOL, V47, P215, DOI 10.1016/0168-1656(96)01387-9; Prasad P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031584; Qin XY, 2012, ONCOL LETT, V4, P1290, DOI 10.3892/ol.2012.896; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Stowe RP, 2011, J MED VIROL, V83, P1071, DOI 10.1002/jmv.22079; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Terra R, 2008, INT IMMUNOL, V20, P317, DOI 10.1093/intimm/dxm152; Viatte S, 2013, J RHEUMATOL, V40, P144, DOI 10.3899/jrheum.121034; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang JH, 2015, MOL MED REP, V12, P1810, DOI 10.3892/mmr.2015.3567	33	32	36	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4893	4900		10.1096/fj.15-277392	http://dx.doi.org/10.1096/fj.15-277392			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26276131	Green Published			2022-12-28	WOS:000365523600015
J	Grevengoed, TJ; Cooper, DE; Young, PA; Ellis, JM; Coleman, RA				Grevengoed, Trisha J.; Cooper, Daniel E.; Young, Pamela A.; Ellis, Jessica M.; Coleman, Rosalind A.			Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation	FASEB JOURNAL			English	Article						heart metabolism; glucose metabolism; lipid metabolism; beta-oxidation; ATP synthase	FATTY-ACID OXIDATION; ISCHEMIA-REPERFUSION INJURY; INDUCED HEART-FAILURE; ATP SYNTHASE BETA; PRESSURE-OVERLOAD; MAMMALIAN TARGET; PATHOLOGICAL HYPERTROPHY; RECEPTOR-ALPHA; MOUSE HEARTS; MTOR	Because hearts with a temporally induced knockout of acyl-CoA synthetase 1 (Acsl1(T-/-)) are virtually unable to oxidize fatty acids, glucose use increases 8-fold to compensate. This metabolic switch activates mechanistic target of rapamycin complex 1 (mTORC1), which initiates growth by increasing protein and RNA synthesis and fatty acid metabolism, while decreasing autophagy. Compared with controls, Acsl1(T-/-) hearts contained 3 times more mitochondria with abnormal structure and displayed a 35-43% lower respiratory function. To study the effects of mTORC1 activation on mitochondrial structure and function, mTORC1 was inhibited by treating Acsl1(T-/-) and littermate control mice with rapamycin or vehicle alone for 2 wk. Rapamycin treatment normalized mitochondrial structure, number, and the maximal respiration rate in Acsl1(T-/-) hearts, but did not improve ADP-stimulated oxygen consumption, which was likely caused by the 33-51% lower ATP synthase activity present in both vehicle-and rapamycin-treated Acsl1(T-/-) hearts. The turnover of microtubule associated protein light chain 3b in Acsl1(T-/-) hearts was 88% lower than controls, indicating a diminished rate of autophagy. Rapamycin treatment increased autophagy to a rate that was 3.1-fold higher than in controls, allowing the formation of autophagolysosomes and the clearance of damaged mitochondria. Thus, long-chain acyl-CoA synthetase isoform 1 (ACSL1) deficiency in the heart activated mTORC1, thereby inhibiting autophagy and increasing the number of damaged mitochondria.	[Grevengoed, Trisha J.; Cooper, Daniel E.; Young, Pamela A.; Ellis, Jessica M.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Coleman, RA (corresponding author), Univ N Carolina, MHRC, Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Grevengoed, Trisha/AAA-3980-2021	Grevengoed, Trisha/0000-0003-4433-3950	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK59935]; University of North Carolina Nutrition Obesity Research Center [DK056350]; NIH Heart, Lung, and Blood Institute [T32HL069768, T32-HL069768, 13PRE16910109, 0815054E]; American Heart Association Mid-Atlantic Division [12GRNT12030144]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK059935] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of North Carolina Nutrition Obesity Research Center; NIH Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Mid-Atlantic Division(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK59935 (to R.A.C.) and the University of North Carolina Nutrition Obesity Research Center DK056350, NIH Heart, Lung, and Blood Institute Predoctoral Training Grants T32HL069768 (to T.J.G.) and T32-HL069768 (to J.M.E.), predoctoral fellowships 13PRE16910109 (to T.J.G.) and 0815054E (to J.M.E.), and 12GRNT12030144 from the American Heart Association Mid-Atlantic Division (to R.A.C.). The authors declare no conflicts of interest.	Allard MF, 1997, CIRCULATION, V96, P676; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; ASCHENBRENNER V, 1970, BIOCHEM J, V119, P157, DOI 10.1042/bj1190157; Barger PM, 1999, AM J MED SCI, V318, P36, DOI 10.1097/00000441-199907000-00006; Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Choi JC, 2013, AUTOPHAGY, V9, P110, DOI 10.4161/auto.22403; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Das A, 2012, J MOL CELL CARDIOL, V53, P858, DOI 10.1016/j.yjmcc.2012.09.007; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Fullekrug J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00401; Goo CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045806; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; He L, 2012, CIRCULATION, V126, P1705, DOI 10.1161/CIRCULATIONAHA.111.075978; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; Jaishy B, 2015, J LIPID RES, V56, P546, DOI 10.1194/jlr.M055152; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kane LA, 2010, CIRC RES, V106, P504, DOI 10.1161/CIRCRESAHA.109.214155; Kane LA, 2009, J BIOENERG BIOMEMBR, V41, P145, DOI 10.1007/s10863-009-9218-6; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paul DS, 2014, BBA-MOL CELL BIOL L, V1841, P880, DOI 10.1016/j.bbalip.2014.03.001; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Rahman M, 2014, J CELL BIOL, V206, P289, DOI 10.1083/jcb.201404118; Ramos FJ, 2013, AUTOPHAGY, V9, P108, DOI 10.4161/auto.22401; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schwarzer M, 2013, AM J PHYSIOL-HEART C, V304, pH529, DOI 10.1152/ajpheart.00699.2012; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Sen S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.004796; Sharma S, 2007, CARDIOVASC RES, V76, P71, DOI 10.1016/j.cardiores.2007.05.004; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Tian R, 2003, CURR HYPERTENS REP, V5, P454, DOI 10.1007/s11906-003-0052-7; Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420; Willis MS, 2012, CIRC RES, V111, pE111, DOI 10.1161/CIRCRESAHA.112.265587; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Xu XH, 2014, HYPERTENSION, V63, P490, DOI 10.1161/HYPERTENSIONAHA.113.02219; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhu Y, 2013, AM J PHYSIOL-HEART C, V305, pH41, DOI 10.1152/ajpheart.00877.2012; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]	66	24	26	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4641	4653		10.1096/fj.15-272732	http://dx.doi.org/10.1096/fj.15-272732			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26220174	Green Published			2022-12-28	WOS:000364514700022
J	Kardinaal, AFM; van Erk, MJ; Dutman, AE; Stroeve, JHM; van de Steeg, E; Bijlsma, S; Kooistra, T; van Ommen, B; Wopereis, S				Kardinaal, Alwine F. M.; van Erk, Marjan J.; Dutman, Alice E.; Stroeve, Johanna H. M.; van de Steeg, Evita; Bijlsma, Sabina; Kooistra, Teake; van Ommen, Ben; Wopereis, Suzan			Quantifying phenotypic flexibility as the response to a high-fat challenge test in different states of metabolic health	FASEB JOURNAL			English	Article						clinical study; human physiology; nutrition; systems biology; eicosanoids	TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; WEIGHT-GAIN; BODY-WEIGHT; GLUCOSE; TISSUE; OXIDATION; ADIPOSE; PLASMA; MEN	Metabolism maintains homeostasis at chronic hypercaloric conditions, activating postprandial response mechanisms, which come at the cost of adaptation processes such as energy storage, eventually with negative health consequences. This study quantified the metabolic adaptation capacity by studying challenge response curves. After a high-fat challenge, the 8 h response curves of 61 biomarkers related to adipose tissue mass and function, systemic stress, metabolic flexibility, vascular health, and glucose metabolism was compared between 3 metabolic health stages: 10 healthy men, before and after 4 wk of highfat, high-calorie diet (1300 kcal/d extra), and 9 men with metabolic syndrome (MetS). The MetS subjects had increased fasting concentrations of biomarkers representing the 3 core processes, glucose, TG, and inflammation control, and the challenge response curves ofmost biomarkers were altered. After the 4 wk hypercaloric dietary intervention, these 3 processes were not changed, as compared with the preintervention state in the healthy subjects, whereas the challenge response curves of almost all endocrine, metabolic, and inflammatory processes regulating these core processes were altered, demonstrating major molecular physiologic efforts tomaintain homeostasis. This study thus demonstrates that change in challenge response is a more sensitive biomarker of metabolic resilience than are changes in fasting concentrations.	[Kardinaal, Alwine F. M.; van Erk, Marjan J.; Dutman, Alice E.; Stroeve, Johanna H. M.; van de Steeg, Evita; Bijlsma, Sabina; Kooistra, Teake; van Ommen, Ben; Wopereis, Suzan] Netherlands Org Appl Sci Res TNO, Microbiol Syst & Biol Grp, NL-3700 AJ Zeist, Netherlands	Netherlands Organization Applied Science Research	Wopereis, S (corresponding author), Netherlands Org Appl Sci Res TNO, Microbiol & Syst Biol, POB 360, NL-3700 AJ Zeist, Netherlands.	suzan.wopereis@tno.nl			TNO's Research Program on Healthy Nutrition	TNO's Research Program on Healthy Nutrition	The authors thank the volunteers for participating in the study and H. Fick, D. Rouwendaal, J. Jacobs, C. Hoeflaken, A. Speulman, L. van der Schuit, R. Schram, and I. Klopping (Microbiology Systems and Biology Group, TNO) for practical work. The study was funded through TNO's Research Program on Healthy Nutrition. A.K., M.V.E., B.V.O., and T.K. designed the research; A.D. conducted the research; A.D., S.B., S.W., J.S., and M.V.E. analyzed the data and performed statistical analysis; A.K., S.W., E.S., and M.V.E. wrote the manuscript. The authors declare no conflicts of interest.	Alligier M, 2012, J CLIN ENDOCR METAB, V97, pE183, DOI 10.1210/jc.2011-2314; Astrup A, 2011, OBES REV, V12, P859, DOI 10.1111/j.1467-789X.2011.00894.x; Balvers MGJ, 2012, METABOLOMICS, V8, P1130, DOI 10.1007/s11306-012-0421-9; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Esser D, 2013, J NUTR, V143, P843, DOI 10.3945/jn.113.174540; Esser D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053474; Faerch K, 2011, ACTA DIABETOL, V48, P349, DOI 10.1007/s00592-010-0245-x; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Kelder T, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.18; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Meierhofer D, 2014, J PROTEOME RES, V13, P5592, DOI 10.1021/pr5005828; Mori MA, 2010, DIABETES, V59, P2960, DOI 10.2337/db10-0367; Musso G, 2009, AM J CLIN NUTR, V89, P558, DOI 10.3945/ajcn.2008.26720; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Scheffer PG, 2011, EUR J CLIN NUTR, V65, P1242, DOI 10.1038/ejcn.2011.114; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Strassburg K, 2014, MOL NUTR FOOD RES, V58, P591, DOI 10.1002/mnfr.201300321; Stroeve JHM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0459-1; Tam CS, 2010, DIABETES, V59, P2164, DOI 10.2337/db10-0162; Teran-Garcia M, 2004, ATHEROSCLEROSIS, V173, P277, DOI 10.1016/j.athersclerosis.2003.12.016; TREMBLAY A, 1995, AM J CLIN NUTR, V61, P827, DOI 10.1093/ajcn/61.4.827; van Dijk SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041388; van Ommen B, 2008, GENES NUTR, V3, P51, DOI 10.1007/s12263-008-0084-3; van Ommen B, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0423-5; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Vilsboll T, 2003, J CLIN ENDOCR METAB, V88, P2706, DOI 10.1210/jc.2002-021873; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp KR, 2009, CURR OPIN LIPIDOL, V20, P45, DOI 10.1097/MOL.0b013e3283186f6f; Wopereis S, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-44; Wu Chung-Jung, 2004, Lipids Health Dis, V3, P17, DOI 10.1186/1476-511X-3-17; Wuesten O, 2005, DIABETES CARE, V28, P360, DOI 10.2337/diacare.28.2.360; Zwirska-Korczala K, 2007, J PHYSIOL PHARMACOL, V58, P13	36	55	56	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4600	4613		10.1096/fj.14-269852	http://dx.doi.org/10.1096/fj.14-269852			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26198450				2022-12-28	WOS:000364514700019
J	Lambrot, R; Lafleur, C; Kimmins, S				Lambrot, Romain; Lafleur, Christine; Kimmins, Sarah			The histone demethylase KDM1A is essential for the maintenance and differentiation of spermatogonial stem cells and progenitors	FASEB JOURNAL			English	Article						epigenetics; histone modifications; spermatogenesis	MALE GERM-CELLS; SEMEN QUALITY; SELF-RENEWAL; LSD1; METHYLATION; EXPRESSION; SPERM; POPULATION; CHROMATIN; PLZF	Little is known of the fundamental processes governed by epigenetic mechanisms in the supplier cells of spermatogenesis, the spermatogonial stem cells (SSCs). The histone H3 lysine demethylase KDM1A is expressed in spermatogonia. We hypothesized that KDM1A serves in transcriptional regulation of SSCs and fertility. Using a conditional deletion of Kdm1a [conditional knockout (cKO)] in mouse spermatogonia, we determined that Kdm1a is essential for spermatogenesis as adult cKO males completely lack germ cells. Analysis of postnatal testis development revealed that undifferentiated and differentiating spermatogonial populations form in Kdm1a-cKO animals, yet the majority fail to enter meiosis. Loss of germ cells in the cKO was rapid with none remaining by postnatal day (PND) 21. To gain insight into the mechanistic implications of Kdm1a ablation, we isolated PND 6 spermatogonia enriched for SSCs and analyzed their transcriptome by RNA sequencing. Loss of Kdm1a was associated with altered transcription of 1206 genes. Importantly, differentially expressed genes between control and Kdm1a-cKO animals included those that are essential for SSC and progenitormaintenance and spermatogonial differentiation. The complete loss of fertility and failure to establish spermatogenesis indicate that Kdm1a is a master controller of gene transcription in spermatogonia and is required for SSC and progenitor maintenance and differentiation.	[Lambrot, Romain; Lafleur, Christine; Kimmins, Sarah] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Kimmins, Sarah] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University	Kimmins, S (corresponding author), McGill Univ, Dept Anim Sci, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	sarah.kimmins@mcgill.ca			Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Drs. Michael G. Rosenfeld and Jianxun Wang for the Kdm1a<SUP>fl/fl</SUP> mice. They also thank Dr. Makoto Nagano (McGill University, Montreal, QC, Canada) for his advice and critical reading of the manuscript, Ken MacDonald (McGill University, Montreal, QC, Canada) for the flow cytometry, and Julien Tremblay (Genome Quebec, Montreal, QC, Canada) for bioinformatic support. This research was funded by the Canadian Institute of Health Research (to S.K.). R.L. and S.K. conceived and designed the experiments. R.L. and C.L. performed the experiments and analyzed the data. R.L. and S.K. wrote the manuscript. The authors declare no conflicts of interest.	Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366; AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chakraborty P, 2014, STEM CELLS, V32, P860, DOI 10.1002/stem.1584; Chan F, 2014, GENE DEV, V28, P1351, DOI 10.1101/gad.240465.114; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Fisch H, 1996, UROLOGY, V48, P909, DOI 10.1016/S0090-4295(96)00301-9; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Godmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012727; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Hao J, 2008, STEM CELLS, V26, P1587, DOI 10.1634/stemcells.2007-0502; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Kanatsu-Shinohara M, 2012, CELL STEM CELL, V11, P567, DOI 10.1016/j.stem.2012.06.011; Kaucher AV, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097386; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lambrot R, 2011, INT J ANDROL, V34, P110, DOI 10.1111/j.1365-2605.2010.01063.x; McCarrey JR, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110502; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Peters AHFM, 1997, CHROMOSOME RES, V5, P313, DOI 10.1023/B:CHRO.0000038762.60086.ef; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wu X, 2010, BIOL REPROD, V82, P1103, DOI 10.1095/biolreprod.109.083097; Yang QE, 2014, CURR TOP DEV BIOL, V107, P235, DOI 10.1016/B978-0-12-416022-4.00009-3; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang J, 2013, GENE DEV, V27, P749, DOI 10.1101/gad.210963.112; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	71	28	32	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4402	4416		10.1096/fj.14-267328	http://dx.doi.org/10.1096/fj.14-267328			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26243864				2022-12-28	WOS:000364514700002
J	Meguenani, M; Miljkovic-Licina, M; Fagiani, E; Ropraz, P; Hammel, P; Aurrand-Lions, M; Adams, RH; Christofori, G; Imhof, BA; Garrido-Urbani, S				Meguenani, Mehdi; Miljkovic-Licina, Marijana; Fagiani, Ernesta; Ropraz, Patricia; Hammel, Philippe; Aurrand-Lions, Michel; Adams, Ralf H.; Christofori, Gerhard; Imhof, Beat A.; Garrido-Urbani, Sarah			Junctional adhesion molecule B interferes with angiogenic VEGF/VEGFR2 signaling	FASEB JOURNAL			English	Article						tumor angiogenesis; aortic ring; endothelial cells	TUMOR ANGIOGENESIS; BLOOD-VESSELS; INTEGRIN ALPHA-V-BETA-3; ANTIANGIOGENIC THERAPY; PERICYTE INTERACTIONS; ENDOTHELIAL-CELLS; CANCER; GROWTH; METASTASIS; ANTIBODY	De novo formation of blood vessels is a pivotal mechanism during cancer development. During the past few years, antiangiogenic drugs have been developed to target tumor vasculature. However, because of limitations and adverse effects observed with current therapies, there is a strong need for alternative antiangiogenic strategies. Using specific anti-junctional adhesion molecule (JAM)-B antibodies and Jam-b-deficient mice, we studied the role in antiangiogenesis of JAM-B. We found that antibodies against murine JAM-B, an endothelium-specific adhesion molecule, inhibited microvessel outgrowth from ex vivo aortic rings and in vitro endothelial network formation. In addition, anti-JAM-B antibodies blocked VEGF signaling, an essential pathway for angiogenesis. Moreover, increased aortic ring branching was observed in aortas isolated from Jam-b-deficient animals, suggesting that JAM-B negatively regulates proangiogenic pathways. In mice, JAM-B expression was detected in de novo-formed blood vessels of tumors, but anti-JAM-B antibodies unexpectedly did not reduce tumor growth. Accordingly, JAM-B deficiency in vivo had no impact on blood vessel formation, suggesting that targeting JAM-B in vivo may be offset by other proangiogenic mechanisms. In conclusion, despite the promising effects observed in vitro, targeting JAM-B during tumor progression seems to be inefficient as a stand-alone antiangiogenesis therapy.	[Meguenani, Mehdi; Imhof, Beat A.; Garrido-Urbani, Sarah] Univ Geneva, Univ Med Ctr, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Fagiani, Ernesta; Christofori, Gerhard] Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland; [Aurrand-Lions, Michel] Ctr Rech Cancerol Marseille, INSERM, Unite Mixte Rech 1068, Marseille, France; [Aurrand-Lions, Michel] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Aurrand-Lions, Michel] Marseille Univ, Marseille, France; [Aurrand-Lions, Michel] CNRS, Unite Mixte Rech 7258, Marseille, France; [Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	University of Geneva; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Max Planck Society; University of Munster	Imhof, BA (corresponding author), Univ Med Ctr, Dept Pathol & Immunol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	beat.imhof@unige.ch; sarah.garrido-urbani@unige.ch	Aurrand-Lions, Michel/O-9953-2016; Adams, Ralf H/AAE-9274-2019	Aurrand-Lions, Michel/0000-0002-8361-3034; Garrido-Urbani, Sarah/0000-0002-7309-0137; Miljkovic-Licina, Marijana/0000-0001-9023-2208; Hammel, Pascal/0000-0002-4630-4996; Fagiani, Ernesta/0000-0003-1415-3510	Swiss National Foundation for Research [31003AB_135701, 310030_53456]; Oncosuisse [KFS-2914-02-2012]	Swiss National Foundation for Research(Swiss National Science Foundation (SNSF)); Oncosuisse	The authors thank Stephane Jemelin (University of Geneva, Geneva, Switzerland) and Boris P. Lee (University of Toronto, Toronto, ON, Canada) for their technical help; Paul Bradfield (University of Geneva, Geneva, Switzerland) for editing the manuscript; and Olivier Brun, Francois Prodon, and Sergei Stratchik (The Bioimaging Core Facility University of Geneva, Switzerland) for their help in microscopy and Metamorph and Imaris analyses. This work was funded by Grants 31003AB_135701 and 310030_53456 from the Swiss National Foundation for Research and Grant KFS-2914-02-2012 from Oncosuisse. The authors declare no conflicts of interest.	Arcangeli ML, 2012, FEBS LETT, V586, P4046, DOI 10.1016/j.febslet.2012.10.005; Arcangeli ML, 2011, BLOOD, V118, P4609, DOI 10.1182/blood-2010-12-323972; Aurrand-Lions M, 2004, J PATHOL, V203, P700, DOI 10.1002/path.1571; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bonner MY, 2014, FUTURE MED CHEM, V6, P1413, DOI [10.4155/FMC.14.86, 10.4155/fmc.14.86]; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; Donate C, 2013, CANCER RES, V73, P640, DOI 10.1158/0008-5472.CAN-12-1756; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fagiani E, 2011, CANCER RES, V71, P5717, DOI 10.1158/0008-5472.CAN-10-4635; Fisher KE, 2009, J CELL SCI, V122, P4558, DOI 10.1242/jcs.050724; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ibrahim N, 2012, ONCOL REP, V27, P1303, DOI 10.3892/or.2012.1675; Joko T, 2013, EXP EYE RES, V108, P23, DOI 10.1016/j.exer.2012.11.018; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Kodack DP, 2012, P NATL ACAD SCI USA, V109, pE3119, DOI 10.1073/pnas.1216078109; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Kusaba H, 2013, CANCER CHEMOTH PHARM, V71, P29, DOI 10.1007/s00280-012-2023-7; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Lamagna C, 2005, CANCER RES, V65, P5703, DOI 10.1158/0008-5472.CAN-04-4012; Legler DF, 2001, J CELL SCI, V114, P1545; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Ludwig RJ, 2009, IMMUNOLOGY, V128, P196, DOI 10.1111/j.1365-2567.2009.03100.x; Ludwig RJ, 2005, J INVEST DERMATOL, V125, P969, DOI 10.1111/j.0022-202X.2005.23912.x; MacMillan CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089770; Miljkovic-Licina M, 2012, MOL CANCER THER, V11, P2588, DOI 10.1158/1535-7163.MCT-12-0245; Mochin MT, 2015, MICROVASC RES, V97, P55, DOI 10.1016/j.mvr.2014.09.008; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Naik MU, 2014, BLOOD, V123, P1393, DOI 10.1182/blood-2013-04-496232; Naik MU, 2003, ARTERIOSCL THROM VAS, V23, P2165, DOI 10.1161/01.ATV.0000093982.84451.87; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Reynolds LE, 2010, NATURE, V465, P813, DOI 10.1038/nature09106; Ribatti D, 2012, DEV BIOL, V372, P157, DOI 10.1016/j.ydbio.2012.09.018; Rubenstein M, 2011, IN VIVO, V25, P725; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Seano G, 2014, NAT CELL BIOL, V16, P931, DOI 10.1038/ncb3036; Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824; Siekmann AF, 2013, EXP CELL RES, V319, P1255, DOI 10.1016/j.yexcr.2013.01.019; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Sweeney P, 2002, CLIN CANCER RES, V8, P2714; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tokuoka H, 2011, J BIOL CHEM, V286, P43549, DOI 10.1074/jbc.M111.284729; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Wong CWY, 2000, MOL BIOL CELL, V11, P3109, DOI 10.1091/mbc.11.9.3109; Xu CS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-148	64	9	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3411	3425		10.1096/fj.15-270223	http://dx.doi.org/10.1096/fj.15-270223			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911611				2022-12-28	WOS:000358796900028
J	Penzo, M; Rocchi, L; Brugiere, S; Carnicelli, D; Onofrillo, C; Coute, Y; Brigotti, M; Montanaro, L				Penzo, Marianna; Rocchi, Laura; Brugiere, Sabine; Carnicelli, Domenica; Onofrillo, Carmine; Coute, Yohann; Brigotti, Maurizio; Montanaro, Lorenzo			Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation	FASEB JOURNAL			English	Article						mRNA translation; pseudouridylation; ribosomal proteins	LINKED DYSKERATOSIS-CONGENITA; MESSENGER-RNA TRANSLATION; MEDIATED TRANSLATION; CANCER; IDENTIFICATION; METHYLATION; MECHANISM; COMPONENT; DEFECTS	Dyskerin is a pseudouridine (psi) synthase involved in fundamental cellular processes including uridine modification in rRNA and small nuclear RNA and telomere stabilization. Dyskerin functions are altered in X-linked dyskeratosis congenita (X-DC) and cancer. Dyskerin's role in rRNA pseudouridylation has been suggested to underlie the alterations in mRNA translation described in cells lacking dyskerin function, although relevant direct evidences are currently lacking. Our purpose was to establish definitely whether defective dyskerin function might determine an intrinsic ribosomal defect leading to an altered synthetic activity. Therefore, ribosomes from dyskerin-depleted human cells were purified and 1) added to a controlled reticulocyte cell-free system devoid of ribosomes to study mRNA translation; 2) analyzed for protein contamination and composition by mass spectrometry, 3) analyzed for global pseudouridylation levels. Ribosomes purified from dyskerin-depleted cells showed altered translational fidelity and internal ribosome entry site (IRES)-mediated translation. These ribosomes displayed reduced uridine modification, whereas they were not different in terms of protein contamination or ribosomal protein composition with respect to ribosomes from matched control cells with full dyskerin activity. In conclusion, lack of dyskerin function in human cells induces a defect in rRNA uridine modification, which is sufficient to alter ribosome activity.-Penzo, M., Rocchi, L., Brugiere, S., Carnicelli, D., Onofrillo, C., Coute, Y., Brigotti, M., Montanaro, L. Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation.	[Penzo, Marianna; Rocchi, Laura; Carnicelli, Domenica; Onofrillo, Carmine; Brigotti, Maurizio; Montanaro, Lorenzo] Univ Bologna, Dept Expt Diagnost & Specialty Med, Alma Mater Studiorum, I-40138 Bologna, Italy; [Brugiere, Sabine; Coute, Yohann] Univ Grenoble Alpes, Grenoble, France; [Brugiere, Sabine; Coute, Yohann] Inst Reg Travail Social, Commissariat Energie Atom, Grenoble, France; [Brugiere, Sabine; Coute, Yohann] INSERM, Biol Grande Echelle, Grenoble, France	University of Bologna; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Montanaro, L (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Alma Mater Studiorum, Via Massarenti 9, I-40138 Bologna, Italy.	maurizio.brigotti@unibo.it; lorenzo.montanaro@unibo.it	Montanaro, Lorenzo/I-4236-2019; Onofrillo, Carmine/X-7557-2019; Couté, Yohann/G-2695-2015; Brigotti, Maurizio/AAB-9007-2022; PENZO, MARIANNA/AAC-3264-2021	Montanaro, Lorenzo/0000-0001-9776-9518; Onofrillo, Carmine/0000-0002-1076-6419; Couté, Yohann/0000-0003-3896-6196; Brigotti, Maurizio/0000-0001-7429-744X; PENZO, MARIANNA/0000-0002-1738-9767; Onofrillo, Carmine/0000-0003-2537-6672; Sabine, BRUGIERE/0000-0002-0757-0968	Association for International Cancer Research [09-0083]; Associazione Italiana per la Ricerca sul Cancro [IG-11416]; Italian Ministry of Education, University and National Research Project [20104AE23N_002]; PRIME-XS project [262067]; European Union 7th Framework Programme; Pallotti Legacy for research on cancer; Worldwide Cancer Research [09-0083] Funding Source: researchfish	Association for International Cancer Research; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and National Research Project; PRIME-XS project; European Union 7th Framework Programme; Pallotti Legacy for research on cancer; Worldwide Cancer Research	The authors are in debt to Drs. D. Ruggero, B. Mazumder and J.-J. Diaz for providing reagents, and to Drs. O. Gandrillon, S. Giraud, A. T. Thu Lefebvre, and L. Grossier (Centre de Genetique et de Physiologie Moleculaire et Cellulaire, Lyon, France) for help in the preliminary part of the study and for discussion. The authors thank the Center for Applied Biomedical Research of S. Orsola-Malpighi University Hospital in Bologna for making available several instruments. This work has been supported by grants from the Association for International Cancer Research (09-0083), Associazione Italiana per la Ricerca sul Cancro (IG-11416), the Italian Ministry of Education, University and National Research Project (Grant 20104AE23N_002), the PRIME-XS project (Grant 262067), funded by the European Union 7th Framework Programme (awarded to L.M.), and Funds from the Pallotti Legacy for research on cancer (to L.M. and M.B.). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (31) with the data set identifier PXD001274.	ALLEN EH, 1962, J BIOL CHEM, V237, P760; Armistead J, 2014, FEBS LETT, V588, P1491, DOI 10.1016/j.febslet.2014.03.024; Bellodi C, 2013, CELL REP, V3, P1493, DOI 10.1016/j.celrep.2013.04.030; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Marcel V, 2013, CANCER CELL, V24, P318, DOI 10.1016/j.ccr.2013.08.013; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Montanaro L, 2010, CANCER RES, V70, P4767, DOI 10.1158/0008-5472.CAN-09-4024; MORRISEY J, 1972, ARCH BIOCHEM BIOPHYS, V152, P385, DOI 10.1016/0003-9861(72)90228-7; Narla A, 2011, INT J HEMATOL, V93, P144, DOI 10.1007/s12185-011-0776-0; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Parry EM, 2011, J MED GENET, V48, P327, DOI 10.1136/jmg.2010.085100; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Rocchi L, 2013, NUCLEIC ACIDS RES, V41, P8308, DOI 10.1093/nar/gkt587; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; SIERRA JM, 1974, P NATL ACAD SCI USA, V71, P2693, DOI 10.1073/pnas.71.7.2693; Thumati NR, 2013, HUM MUTAT, V34, P1698, DOI 10.1002/humu.22447; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	31	37	39	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3472	3482		10.1096/fj.15-270991	http://dx.doi.org/10.1096/fj.15-270991			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25934701				2022-12-28	WOS:000358796900033
J	Truong, LD; Trostel, J; Garcia, GE				Truong, Luan D.; Trostel, Jessica; Garcia, Gabriela E.			Absence of nicotinic acetylcholine receptor alpha 7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model	FASEB JOURNAL			English	Article						macrophages; cytokines; chemokines	ANTIBODY-ASSOCIATED GLOMERULONEPHRITIS; ISCHEMIA-REPERFUSION INJURY; CRESCENTIC GLOMERULONEPHRITIS; VAGUS NERVE; TNF-ALPHA; DIABETIC-NEPHROPATHY; GLOMERULAR INJURY; KNOCKOUT MICE; MAJOR SOURCE; DISEASE ROLE	Inflammation is regulated by endogenous mechanisms, including anti-inflammatory cytokines, adenosine, and the nicotinic acetylcholine receptor alpha 7 subunit (alpha 7nAChR). We investigated the role of alpha 7nAChR in protection against the progression of tissue injury in a model of severe, macrophage-mediated, cytokine-dependent antiglomerular basement membrane (GBM) glomerulonephritis (GN), in alpha 7nAChR-deficient (alpha 7(-/-)) mice. At d 7 after the injection of anti-GBM antibody, kidneys from alpha 7(-/-) mice displayed severe glomeruli (P < 0.0001) and tubulointerstitial lesions (P < 0.001) compared to kidneys from WT mice. An important finding was the presence of severe glomerulosclerosis in alpha 7(-/-) mice in this early phase of the disease. Kidneys of alpha 7(-/-) mice showed greater accumulation of inflammatory cells and higher expression of chemokines and cytokines than did those of WT mice. In addition, in alpha 7(-/-)fibrotic kidneys, the expression of fibrin, collagen, TGF-beta, and tissue inhibitor of metalloproteinase (TIMP)-2 increased, and the expression of TIMP3 declined. The increase in counterregulatory responses to inflammation in alpha 7(-/-) nephritic kidneys did not compensate for the lack of alpha 7nAChR. These findings indicate that alpha 7nAChR plays alpha key role in regulating the inflammatory response in anti-GBM GN and that disruption of the endogenous protective alpha 7nAChR amplifies inflammation to accelerate kidney damage and fibrosis.	[Truong, Luan D.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Garcia, Gabriela E.] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Truong, Luan D.] Baylor Coll Med, Methodist Hosp, Houston, TX 77030 USA; [Trostel, Jessica] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Garcia, GE (corresponding author), Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, 12700 East 19th Ave,Room 7103, Aurora, CO 80045 USA.	gabriela.garcia@ucdenver.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases George O'Brien Center [P50-DK064233, 1R01-DK082509]; Norman S. Coplon Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082509, P50DK064233] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases George O'Brien Center; Norman S. Coplon Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases George O'Brien Center Grants P50-DK064233 (to L.T. and G.E.G.) and 1R01-DK082509 (to G.E.G.), and a Norman S. Coplon Grant (to G.E.G.). The authors declare no conflicts of interest. We gratefully thank Dr. R. Johnson (University of Colorado Denver) for helpful comments and discussions regarding the manuscript.	Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Andres D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-49; BESEDOVSKY H, 1977, CLIN EXP IMMUNOL, V27, P1; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Chen SH, 1998, J EXP MED, V188, P193, DOI 10.1084/jem.188.1.193; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Feng LL, 2000, J CLIN INVEST, V105, P341, DOI 10.1172/JCI2869; FENG LL, 1995, J CLIN INVEST, V95, P1009, DOI 10.1172/JCI117745; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fiorentino L, 2013, EMBO MOL MED, V5, P441, DOI 10.1002/emmm.201201475; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Garcia GE, 2007, AM J PATHOL, V170, P1485, DOI 10.2353/ajpath.2007.060065; Garcia GE, 2011, KIDNEY INT, V80, P378, DOI 10.1038/ki.2011.101; Garcia GE, 2000, J LEUKOCYTE BIOL, V67, P577, DOI 10.1002/jlb.67.4.577; Garcia GE, 2003, AM J PATHOL, V162, P1061, DOI 10.1016/S0002-9440(10)63903-X; Gessi S, 2000, BRIT J PHARMACOL, V129, P2, DOI 10.1038/sj.bjp.0703045; Hertig A, 2004, J AM SOC NEPHROL, V15, P844, DOI 10.1097/01.ASN.0000115400.52705.83; HOLDSWORTH SR, 1981, J CLIN INVEST, V68, P686, DOI 10.1172/JCI110304; Ikezumi Y, 2003, KIDNEY INT, V63, P83, DOI 10.1046/j.1523-1755.2003.00717.x; Karkar AM, 2001, NEPHROL DIAL TRANSPL, V16, P518, DOI 10.1093/ndt/16.3.518; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Kawai H, 2002, J NEUROSCI, V22, P7903; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Lopez MG, 1998, P NATL ACAD SCI USA, V95, P14184, DOI 10.1073/pnas.95.24.14184; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Menghini R, 2012, DIABETES, V61, P454, DOI 10.2337/db11-0613; Mercer PF, 2013, BBA-MOL BASIS DIS, V1832, P1018, DOI 10.1016/j.bbadis.2012.12.013; Mielke JG, 2009, NEUROSCI RES, V65, P296, DOI 10.1016/j.neures.2009.08.003; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; Ogawa T, 1996, VIRCHOWS ARCH, V429, P283; Ortiz-Munoz G, 2010, J AM SOC NEPHROL, V21, P763, DOI 10.1681/ASN.2009060625; Panzer U, 2007, J AM SOC NEPHROL, V18, P2071, DOI 10.1681/ASN.2006111237; Rezonzew G, 2012, AM J PHYSIOL-RENAL, V303, pF304, DOI 10.1152/ajprenal.00661.2011; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Sassy-Prigent C, 2000, DIABETES, V49, P466, DOI 10.2337/diabetes.49.3.466; Silverstein DM, 2009, PEDIATR NEPHROL, V24, P1445, DOI 10.1007/s00467-008-1046-0; TANG WW, 1994, J CLIN INVEST, V93, P273, DOI 10.1172/JCI116956; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; TIPPING PG, 1988, J CLIN INVEST, V82, P1253, DOI 10.1172/JCI113723; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; van Maanen MA, 2010, ANN RHEUM DIS, V69, P1717, DOI 10.1136/ard.2009.118554; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WEIGENT DA, 1987, IMMUNOL REV, V100, P79, DOI 10.1111/j.1600-065X.1987.tb00528.x; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; WEXLER BC, 1957, ENDOCRINOLOGY, V61, P300, DOI 10.1210/endo-61-3-300; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xia YY, 1997, AM J PATHOL, V151, P375; XIA YY, 1993, AM J PHYSIOL, V264, pF774, DOI 10.1152/ajprenal.1993.264.5.F774; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Yeboah MM, 2008, AM J PHYSIOL-RENAL, V295, pF654, DOI 10.1152/ajprenal.90255.2008; Yokoyama H, 1997, NEPHRON, V76, P425, DOI 10.1159/000190225; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; YOSHIOKA K, 1990, J PATHOL, V162, P141, DOI 10.1002/path.1711620207	71	26	29	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3558	3570		10.1096/fj.14-262493	http://dx.doi.org/10.1096/fj.14-262493			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25985801	Green Published			2022-12-28	WOS:000358796900041
J	Wang, N; Docherty, F; Brown, HK; Reeves, K; Fowles, A; Lawson, M; Ottewell, PD; Holen, I; Croucher, PI; Eaton, CL				Wang, Ning; Docherty, Freyja; Brown, Hannah K.; Reeves, Kim; Fowles, Anne; Lawson, Michelle; Ottewell, Penelope D.; Holen, Ingunn; Croucher, Peter I.; Eaton, Colby L.			Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer	FASEB JOURNAL			English	Article						cell quiescence; CXCR4; metastatic niche	EXPRESSION; PROLIFERATION; PROGRESSION; INVASION; ANTIGEN; TISSUE; NICHE; CD133	This study aimed to identify subpopulations of prostate cancer cells that are responsible for the initiation of bone metastases. Using rapidly dividing human prostate cancer cell lines, we identified mitotically quiescent subpopulations (<1%), which we compared with the rapidly dividing populations for patterns of gene expression and for their ability to migrate to the skeletons of athymicmice. The study used 2-photon microscopy to map the presence/distribution of fluorescently labeled, quiescent cells and luciferase expression to determine the presence of growing bone metastases. We showed that the mitotically quiescent cells were very significantly more tumorigenic in forming bone metastases than fast-growing cells (55 vs. 15%) and had a unique gene expression profile. The quiescent cells were not uniquely stem cell like, with no expression of CD133 but had the same level expression of other putative prostate stem cell markers (CD44 and integrins alpha 2/beta 1), when compared to the rapidly proliferating population. In addition, mitotic quiescence was associated with very high levels of C-X-C chemokine receptor type 4 (CXCR4) production. Inhibition of CXCR4 activity altered the homing of quiescent tumor cells to bone. Our studies suggest that mitotic dormancy is a unique phenotype that facilitates tumor cell colonization of the skeleton in prostate cancer.	[Wang, Ning; Docherty, Freyja; Brown, Hannah K.; Fowles, Anne; Eaton, Colby L.] Univ Sheffield, Sch Med, Dept Human Metab, Sheffield S10 2RX, S Yorkshire, England; [Reeves, Kim] Paterson Inst Canc Res, Breakthrough Breast Canc Res Unit, Manchester M20 9BX, Lancs, England; [Lawson, Michelle; Ottewell, Penelope D.; Holen, Ingunn] Univ Sheffield, Sch Med, Dept Oncol, Sheffield S10 2RX, S Yorkshire, England; [Croucher, Peter I.] Garvan Inst Med Res, Bone Biol Div, Sydney, NSW, Australia	University of Sheffield; Paterson Institute for Cancer Research; University of Sheffield; Garvan Institute of Medical Research	Eaton, CL (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Acad Unit Bone Biol, D Floor,Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	c.l.eaton@sheffield.ac.uk	Lawson, Michelle/M-6095-2019	Lawson, Michelle/0000-0002-5446-923X; Ottewell, Penelope/0000-0002-4826-0771; Holen, Ingunn/0000-0002-8759-6913; WANG, NING/0000-0002-2663-7515; Croucher, Peter/0000-0002-7102-2413	Cancer Research UK; Yorkshire Cancer Research; Mrs. Janice Gibson and the Ernest Heine Family Foundation; Cancer Research UK [11991] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research; Mrs. Janice Gibson and the Ernest Heine Family Foundation; Cancer Research UK(Cancer Research UK)	The authors thank Cancer Research UK for its generous financial support and Yorkshire Cancer Research for funding in vivo imaging equipment (IVIS). The authors are grateful to the following for technical support: Miss Orla Gallagher, Mr. Darren Lath, Susan Clark, and Kay Hopkins. P.I.C. is supported by Mrs. Janice Gibson and the Ernest Heine Family Foundation. The authors declare no conflicts of interest.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colombel M, 2012, PROSTATE, V72, P713, DOI 10.1002/pros.21473; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Dutta A, 2014, CANCER RES, V74, P1598, DOI 10.1158/0008-5472.CAN-13-1796; Eaton CL, 2010, PROSTATE, V70, P875, DOI 10.1002/pros.21121; Germann M, 2012, STEM CELLS, V30, P1076, DOI 10.1002/stem.1087; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Jung K, 1997, INT J CANCER, V74, P220, DOI 10.1002/(SICI)1097-0215(19970422)74:2<220::AID-IJC14>3.0.CO;2-H; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nutter F, 2014, ENDOCR-RELAT CANCER, V21, P327, DOI 10.1530/ERC-13-0158; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pellacani D, 2013, ADV EXP MED BIOL, V777, P167, DOI 10.1007/978-1-4614-5894-4_11; Pellacani D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-94; Pola C, 2013, CANCER RES, V73, P4571, DOI 10.1158/0008-5472.CAN-13-0218; Polson ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2627; Reinertsen T, 2012, APMIS, V120, P558, DOI 10.1111/j.1600-0463.2011.02865.x; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Sheng X, 2013, ONCOL LETT, V5, P787, DOI 10.3892/ol.2012.1090; Shiozawa Y, 2011, CLIN CANCER RES, V17, P5553, DOI 10.1158/1078-0432.CCR-10-2505; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Wang N, 2014, J BONE MINER RES, V29, P2688, DOI 10.1002/jbmr.2300; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Williamson SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048944; Yumoto K, 2014, CYTOM PART A, V85A, P548, DOI 10.1002/cyto.a.22434; Zhang L, 2010, CANCER GENE THER, V17, P171, DOI 10.1038/cgt.2009.59	29	37	37	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3141	3150		10.1096/fj.14-266379	http://dx.doi.org/10.1096/fj.14-266379			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888599	Green Published			2022-12-28	WOS:000358796900004
J	Gherbi, K; May, LT; Baker, JG; Briddon, SJ; Hill, SJ				Gherbi, Karolina; May, Lauren T.; Baker, Jillian G.; Briddon, Stephen J.; Hill, Stephen J.			Negative cooperativity across beta(1)-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 beta(1)-adrenoceptor binding conformation	FASEB JOURNAL			English	Article						dissociation; receptor dimerization; GPCR; allosterism	PROTEIN-COUPLED RECEPTORS; BETA-BLOCKERS; IN-VIVO; AGONIST; SITE; VISUALIZATION; DIMERIZATION; RADIOLIGAND; RESIDUES; STATES	At the beta(1)-adrenoceptor, CGP 12177 potently antagonizes agonist responses at the primary high-affinity catecholamine conformation while also exerting agonist effects of its own through a secondary low-affinity conformation. A recent mutagenesis study identified transmembrane region (TM) 4 of the beta(1)-adrenoceptor as key for this low-affinity conformation. Others suggested that TM4 has a role in beta(1)-adrenoceptor oligomerization. Here, assessment of the dissociation rate of a fluorescent analog of CGP 12177 [bordifluoropyrromethane-tetramethylrhodamine-(+/-) CGP 12177 (BODIPY-TMR-CGP)] at the human beta(1)-adrenoceptor expressed in Chinese hamster ovary cells revealed negative cooperative interactions between 2 distinct beta(1)-adrenoceptor conformations. The dissociation rate of 3 nM BODIPY-TMR-CGP was 0.09 +/- 0.01 min(-1) in the absence of competitor ligands, and this was enhanced 2.2- and 2.1-fold in the presence of 1 mu M CGP 12177 and 1 mu M propranolol, respectively. These effects on the BODIPY-TMR-CGP dissociation rate were markedly enhanced in beta(1)-adrenoceptor homodimers constrained by bimolecular fluorescence complementation (9.8- and 9.9-fold for 1 mu M CGP 12177 and 1 mu M propranolol, respectively) and abolished in beta(1)-adrenoceptors containing TM4 mutations vital for the second conformation pharmacology. This study suggests that negative cooperativity across a beta(1)-adrenoceptor homodimer may be responsible for generating the low-affinity pharmacology of the secondary beta(1)-adrenoceptor conformation.	[Gherbi, Karolina; May, Lauren T.; Baker, Jillian G.; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Cell Signalling Res Grp, Nottingham NG7 2UH, England	University of Nottingham	Hill, SJ (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Cell Signalling Res Grp, C Floor, Nottingham NG7 2UH, England.	stephen.hill@nottingham.ac.uk	Hill, Stephen J/M-6243-2018; Hill, Stephen/N-6753-2013	Hill, Stephen J/0000-0002-4424-239X; Hill, Stephen/0000-0002-4424-239X; May, Lauren/0000-0002-4412-1707; Briddon, Stephen/0000-0001-8514-0827; Gherbi, Karolina/0000-0002-2280-6852	Medical Research Council [G0800006]; MRC [G0800006] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Medical Research Council for financial support (G0800006).	Baker JG, 2003, MOL PHARMACOL, V63, P1312, DOI 10.1124/mol.63.6.1312; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baker JG, 2008, MOL PHARMACOL, V74, P1246, DOI 10.1124/mol.108.048371; Baker JG, 2014, MOL PHARMACOL, V85, P811, DOI 10.1124/mol.114.091587; Baker JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077582; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Gherbi K, 2014, BRIT J PHARMACOL, V171, P5431, DOI 10.1111/bph.12858; Granneman JG, 2001, AM J PHYSIOL-ENDOC M, V280, pE199, DOI 10.1152/ajpendo.2001.280.2.E199; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002649; Joseph SS, 2004, N-S ARCH PHARMACOL, V369, P525, DOI 10.1007/s00210-004-0884-y; Joseph SS, 2004, BRIT J PHARMACOL, V142, P51, DOI 10.1038/sj.bjp.0705753; KAUMANN AJ, 1989, TRENDS PHARMACOL SCI, V10, P316, DOI 10.1016/0165-6147(89)90065-5; Kaumann AJ, 2001, N-S ARCH PHARMACOL, V363, P87, DOI 10.1007/s002100000336; Kaumann AJ, 2008, PHARMACOL THERAPEUT, V118, P303, DOI 10.1016/j.pharmthera.2008.03.009; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Konkar AA, 2000, J PHARMACOL EXP THER, V294, P923; Lowe MD, 2002, BRIT J PHARMACOL, V135, P451, DOI 10.1038/sj.bjp.0704450; May LT, 2010, MOL PHARMACOL, V77, P678, DOI 10.1124/mol.109.063065; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; May LT, 2011, FASEB J, V25, P3465, DOI 10.1096/fj.11-186296; May LT, 2010, MOL PHARMACOL, V78, P511, DOI 10.1124/mol.110.064493; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Molenaar P, 2007, CLIN EXP PHARMACOL P, V34, P1020, DOI 10.1111/j.1440-1681.2007.04730.x; Pak MD, 1996, J RECEPT SIGNAL TR R, V16, P1, DOI 10.3109/10799899609039938; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Sarsero D, 1998, BRIT J PHARMACOL, V123, P371, DOI 10.1038/sj.bjp.0701609; Sarsero D, 2003, N-S ARCH PHARMACOL, V367, P10, DOI 10.1007/s00210-002-0652-9; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; Vauquelin G, 2010, EXPERT OPIN DRUG DIS, V5, P927, DOI 10.1517/17460441.2010.512037; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x	36	29	29	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2859	2871		10.1096/fj.14-265199	http://dx.doi.org/10.1096/fj.14-265199			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837585	Green Published, hybrid			2022-12-28	WOS:000356859100016
J	Suh, J; Moncaster, JA; Wang, LR; Hafeez, I; Herz, J; Tanzi, RE; Goldstein, LE; Guenette, SY				Suh, Jaehong; Moncaster, Juliet A.; Wang, Lirong; Hafeez, Imran; Herz, Joachim; Tanzi, Rudolph E.; Goldstein, Lee E.; Guenette, Suzanne Y.			FE65 and FE65L1 amyloid precursor protein-binding protein compound null mice display adult-onset cataract and muscle weakness	FASEB JOURNAL			English	Article						APP; congenital muscular dystrophy; extracellular matrix; laminin; lens	APP FAMILY-MEMBERS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; MYOTONIC-DYSTROPHY; BRAIN-DEVELOPMENT; SKELETAL-MUSCLE; MAMMALIAN FE65; DEFICIENT MICE; BETA	FE65 and FE65L1 are cytoplasmic adaptor proteins that bind a variety of proteins, including the amyloid precursor protein, and that mediate the assembly of multimolecular complexes. We previously reported that FE65/FE65L1 double knockout (DKO) mice display disorganized laminin in meningeal fibroblasts and a cobblestone lissencephaly-like phenotype in the developing cortex. Here, we examined whether loss of FE65 and FE65L1 causes ocular and muscular deficits, 2 phenotypes that frequently accompany cobblestone lissencephaly. Eyes of FE65/FE65L1 DKO mice develop normally, but lens degeneration becomes apparent in young adult-mice. Abnormal lens epithelial cell migration, widespread small vacuole formation, and increased laminin expression underneath lens capsules suggest impaired interaction between epithelial cells and capsular extracellular matrix in DKO lenses. Cortical cataracts develop in FE65L1 knockout (KO) mice aged 16 months or more but are absent in wild-type or FE65 KO mice. FE65 family KO mice show attenuated grip strength, and the nuclei of DKO muscle cells frequently locate in the middle of muscle fibers. These findings reveal that FE65 and FE65L1 are essential for the maintenance of lens transparency, and their loss produce phenotypes in brain, eye, and muscle that are comparable to the clinical features of congenital muscular dystrophies in humans.	[Suh, Jaehong; Wang, Lirong; Hafeez, Imran; Tanzi, Rudolph E.; Guenette, Suzanne Y.] Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Genet & Aging Res Unit,Dept Neurol,Med Sch, Boston, MA 02129 USA; [Moncaster, Juliet A.; Goldstein, Lee E.] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Suh, J (corresponding author), Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Genet & Aging Res Unit,Dept Neurol,Med Sch, 114 16th St, Boston, MA 02129 USA.	suh.jaehong@mgh.harvard.edu; suzanne.guenette@gmail.com	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Moncaster, Juliet/0000-0002-7849-4325	U.S. National Institutes of Health; Korea Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank D. Romano for her technical assistance in muscle pathology experiments. The authors also thank M. Lawlor (Boston Children Hospital) for his advice on muscle tissue preparation and C. Vanderburg (Massachusetts General Hospital) for his scientific expertise and advice on the muscle study. This work was supported by grants from the U.S. National Institutes of Health (to S.Y.G. and R.E.T.) and by a fellowship from the Korea Research Foundation (to J.S.).	Bassez G, 2008, J NEUROPATH EXP NEUR, V67, P319, DOI 10.1097/NEN.0b013e31816b4acc; Beebe DC, 2008, SEMIN CELL DEV BIOL, V19, P125, DOI 10.1016/j.semcdb.2007.08.014; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Beyreuther K, 1996, ANN NY ACAD SCI, V777, P74, DOI 10.1111/j.1749-6632.1996.tb34403.x; Bimonte M, 2004, EUR J NEUROSCI, V20, P1483, DOI 10.1111/j.1460-9568.2004.03611.x; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; daCunha RP, 1996, AM J OPHTHALMOL, V122, P236, DOI 10.1016/S0002-9394(14)72015-X; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357; Dumanis SB, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-9; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Forni PE, 2011, J NEUROSCI, V31, P480, DOI 10.1523/JNEUROSCI.4698-10.2011; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Frederikse PH, 2002, AM J PATHOL, V161, P1985, DOI 10.1016/S0002-9440(10)64475-6; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Greiling TMS, 2008, SEMIN CELL DEV BIOL, V19, P94, DOI 10.1016/j.semcdb.2007.10.011; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Jun G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043728; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Kerbage C., AM J ALZHEI IN PRESS; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Mendell JR, 2006, PEDIATR DEVEL PATHOL, V9, P427, DOI 10.2350/06-07-0127.1; Meng Hui, 2014, J Vis Exp, DOI 10.3791/51586; Michael R, 2013, EXP EYE RES, V106, P5, DOI 10.1016/j.exer.2012.10.012; Minopoli G, 2012, IUBMB LIFE, V64, P936, DOI 10.1002/iub.1094; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; NARINDRASORASAK S, 1992, LAB INVEST, V67, P643; Nensa FM, 2014, MOL CELL PROTEOMICS, V13, P475, DOI 10.1074/mcp.M113.029280; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; Ralston E, 2006, J CELL PHYSIOL, V209, P874, DOI 10.1002/jcp.20780; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rodrigues ADC, 2007, MICROSURG, V27, P664, DOI 10.1002/micr.20428; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Schoser BGH, 2004, MUSCLE NERVE, V29, P275, DOI 10.1002/mus.10545; Sciandra F, 2007, TRENDS BIOTECHNOL, V25, P262, DOI 10.1016/j.tibtech.2007.04.002; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Suh J, 2011, J NEUROCHEM, V119, P377, DOI 10.1111/j.1471-4159.2011.07419.x; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Truscott RJW, 2003, INT J BIOCHEM CELL B, V35, P1500, DOI 10.1016/S1357-2725(03)00145-6; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang Y, 2009, LEARN MEMORY, V16, P537, DOI 10.1101/lm.1499309; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zambrano N, 2002, J CELL SCI, V115, P1411; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	63	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2628	2639		10.1096/fj.14-261453	http://dx.doi.org/10.1096/fj.14-261453			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757569	Green Published			2022-12-28	WOS:000355209500038
J	Taher, M; Nakao, S; Zandi, S; Melhorn, MI; Hayes, KC; Hafezi-Moghadam, A				Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hayes, K. C.; Hafezi-Moghadam, Ali			Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2	FASEB JOURNAL			English	Article						lymphangiogenesis; LYVE-1; podoplanin; macrophages; VEGF-C	E-DEFICIENT MICE; VASA VASORUM NEOVASCULARIZATION; LYMPHANGIOGENIC FACTORS; PLAQUE PROGRESSION; ANGIOGENESIS; INFLAMMATION; ATHEROGENESIS; MECHANISMS; EXPRESSION; ARTERIES	The role of lymphatics in atherosclerosis is not yet understood. Here, we investigate lymphatic growth dynamics and marker expression in atherosclerosis in apolipoprotein E-deficient (apoE(-/-)) mice. The prolymphangiogenic growth factor, VEGF-C, was elevated in atherosclerotic aortic walls. Despite increased VEGF-C, we found that adventitial lymphatics regress during the course of formation of atherosclerosis (P < 0.01). Similar to lymphatic regression, the number of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1(+)) macrophages decreased in the aortic adventitia of apoE(-/-) mice with atherosclerosis (P < 0.01). Intimal lymphatics in the atherosclerotic lesions exhibited an atypical phenotype, with the expression of podoplanin and VEGF receptor 3 (VEGFR-3) but not of LYVE-1 and prospero homeobox protein 1. In the aortas of atherosclerotic animals, we found markedly increased soluble VEGFR-2. We hypothesized that the elevated soluble VEGFR-2 that was found in the aortas of apoE(-/-) mice with atherosclerosis binds to and diminishes the activity of VEGF-C. This trapping mechanism explains, despite increased VEGF-C in the atherosclerotic aortas, how adventitial lymphatics regress. Lymphatic regression impedes the drainage of lipids, growth factors, inflammatory cytokines, and immune cells. Insufficient lymphatic drainage could thus exacerbate atherosclerosis formation. Our study contributes new insights to previously unknown dynamic changes of adventitial lymphatics. Targeting soluble VEGFR-2 in atherosclerosis may provide a new strategy for the liberation of endogenous VEGF-C and the prevention of lymphatic regression.	[Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Brigham & Womens Hosp, Ctr Excellence Funct & Mol Imaging, 75 Francis St, Boston, MA 02115 USA; [Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Angiogenesis Lab, Boston, MA 02114 USA; [Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA; [Taher, Mahdi] Charite, Med Ctr, Inst Biochem, Berlin, Germany; [Hayes, K. C.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Brandeis University	Hafezi-Moghadam, A (corresponding author), Brigham & Womens Hosp, 45 Francis St, Boston, MA 02115 USA.	ahm@bwh.harvard.edu		Hafezi-Moghadam, Ali/0000-0002-5336-0697; Taher, Mahdi/0000-0001-8454-9751; Zandi, Souska/0000-0001-9351-4278	DP3 IMPACT award from U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK108238]; DiaComp award; German Academic Exchange Service-DAAD; Bausch Lomb; Japan Eye Bank Association; Tear Film and Ocular Surface Society Young Investigator Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK108238] Funding Source: NIH RePORTER	DP3 IMPACT award from U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant; DiaComp award; German Academic Exchange Service-DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Bausch Lomb; Japan Eye Bank Association; Tear Film and Ocular Surface Society Young Investigator Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Malaysian Palm Oil Board. This work was supported by a DP3 IMPACT award from U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK108238; a DiaComp award (to A.H.-M.); an overseas doctoral fellowship from the German Academic Exchange Service-DAAD (to M.T.); an overseas Research Fellowship Award from Bausch & Lomb; a fellowship award from the Japan Eye Bank Association; and a Tear Film and Ocular Surface Society Young Investigator Fellowship (to S.N.).	Aspelund A, 2016, CIRC RES, V118, P515, DOI 10.1161/CIRCRESAHA.115.306544; Cueni LN, 2010, BLOOD, V116, P4376, DOI 10.1182/blood-2010-04-278564; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Drechsler M, 2015, ARTERIOSCL THROM VAS, V35, P1050, DOI 10.1161/ATVBAHA.114.304649; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Grzegorek I, 2014, LYMPHAT RES BIOL, V12, P222, DOI 10.1089/lrb.2013.0048; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Kutkut I, 2015, EUR J CLIN INVEST, V45, P100, DOI 10.1111/eci.12372; Langheinrich AC, 2006, ARTERIOSCL THROM VAS, V26, P347, DOI 10.1161/01.ATV.0000196565.38679.6d; Liu ZL, 2014, NUCL MED BIOL, V41, P785, DOI 10.1016/j.nucmedbio.2014.08.004; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Nakao S, 2012, FASEB J, V26, P808, DOI 10.1096/fj.11-183897; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Nakao S, 2011, BLOOD, V117, P1081, DOI 10.1182/blood-2010-02-267427; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tanaka K, 2011, ATHEROSCLEROSIS, V215, P366, DOI 10.1016/j.atherosclerosis.2011.01.016; Veerman KJ, 2013, ATHEROSCLEROSIS, V227, P250, DOI 10.1016/j.atherosclerosis.2013.01.018; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Vuorio T, 2014, ARTERIOSCL THROM VAS, V34, P1162, DOI 10.1161/ATVBAHA.114.302528; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603	30	18	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2490	2499		10.1096/fj.201500112	http://dx.doi.org/10.1096/fj.201500112			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006449	Green Published			2022-12-28	WOS:000379249500005
J	Nilsson, TK; Hurtig-Wennlof, A; Sjostrom, M; Herrmann, W; Obeid, R; Owen, JR; Zeisel, S				Nilsson, Torbjorn K.; Hurtig-Wennlof, Anita; Sjostrom, Michael; Herrmann, Wolfgang; Obeid, Rima; Owen, Jennifer R.; Zeisel, Steven			Plasma 1-carbon metabolites and academic achievement in 15-yr-old adolescents	FASEB JOURNAL			English	Article						betaine; choline; folate; school grades	EMBRYONIC-DEVELOPMENT ALTERS; CHOLINE AVAILABILITY; DIETARY REQUIREMENTS; MOUSE HIPPOCAMPUS; FOLATE; SUPPLEMENTATION; MEMORY; GENE; RATS; NEURODEVELOPMENT	Academic achievement in adolescents is correlated with 1-carbon metabolism (1-CM), as folate intake is positively related and total plasma homocysteine (tHcy) negatively related to academic success. Because another 1-CM nutrient, choline is essential for fetal neurocognitive development, we hypothesized that choline and betaine could also be positively related to academic achievement in adolescents. In a sample of 15-yr-old children (n = 324), we measured plasma concentrations of homocysteine, choline, and betaine and genotyped them for 2 polymorphisms with effects on 1-CM, methylenetetrahydrofolate reductase (MTHFR) 677C>T, rs1801133, and phosphatidylethanolamine N-methyltransferase (PEMT), rs12325817 (G>C). The sum of school grades in 17 major subjects was used as an outcome measure for academic achievement. Lifestyle and family socioeconomic status (SES) data were obtained from questionnaires. Plasma choline was significantly and positively associated with academic achievement independent of SES factors (paternal education and income, maternal education and income, smoking, school) and of folate intake (P = 0.009, R-2 = 0.285). With the addition of the PEMT rs12325817 polymorphism, the association value was only marginally changed. Plasma betaine concentration, tHcy, and the MTHFR 677C>T polymorphism did not affect academic achievement in any tested model involving choline. Dietary intake of choline is marginal in many adolescents and may be a public health concern.	[Nilsson, Torbjorn K.] Umea Univ, Dept Med Biosci Clin Chem, S-90185 Umea, Sweden; [Hurtig-Wennlof, Anita] Univ Orebro, Fac Med & Hlth, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Sjostrom, Michael] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Herrmann, Wolfgang; Obeid, Rima] Saarland Univ Hosp, Dept Clin Chem & Lab Med, Homburg, Germany; [Owen, Jennifer R.; Zeisel, Steven] Univ N Carolina, Inst Nutr Res, Kannapolis, NC USA; [Zeisel, Steven] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	Umea University; Orebro University; Karolinska Institutet; Universitatsklinikum des Saarlandes; University of North Carolina; University of North Carolina; University of North Carolina Chapel Hill	Nilsson, TK (corresponding author), Umea Univ, Dept Med Biosci Clin Chem, S-90185 Umea, Sweden.	torbjorn.nilsson@umu.se	Obeid, Rima/AAR-9906-2020		U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK56350]; Orebro Lans Landsting, Nyckelfonden, Orebro; Umea University; Stockholm County Council; Swedish Heart and Lung Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Orebro Lans Landsting, Nyckelfonden, Orebro; Umea University; Stockholm County Council(Stockholm County Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (DK56350, to S.Z.); Orebro Lans Landsting, Nyckelfonden, Orebro, and Umea University (to T.N.); the Stockholm County Council, and the Swedish Heart and Lung Foundation (to M.S.). The authors declare no conflicts of interest.	Albright CD, 2005, DEV BRAIN RES, V159, P149, DOI 10.1016/j.devbrainres.2005.07.002; Albright CD, 2003, NUTR NEUROSCI, V6, P129, DOI 10.1080/1028415031000084418; Anjos T, 2013, EUR J NUTR, V52, P1825, DOI 10.1007/s00394-013-0560-4; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; Borjel AK, 2006, CLIN CHEM LAB MED, V44, P161, DOI 10.1515/CCLM.2006.029; Breimer LH, 2012, SCAND J CLIN LAB INV, V72, P185, DOI 10.3109/00365513.2012.657230; Calkins K, 2011, CURR PROB PEDIATR AD, V41, P158, DOI 10.1016/j.cppeds.2011.01.001; Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; DAVIS KL, 1980, ARCH NEUROL-CHICAGO, V37, P49, DOI 10.1001/archneur.1980.00500500079013; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Gueant JL, 2013, TRENDS ENDOCRIN MET, V24, P279, DOI 10.1016/j.tem.2013.01.010; Kirsch SH, 2010, J CHROMATOGR B, V878, P3338, DOI 10.1016/j.jchromb.2010.10.016; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; MOHS RC, 1980, PSYCHIAT RES, V2, P149, DOI 10.1016/0165-1781(80)90071-2; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Nilsson TK, 2011, PEDIATRICS, V128, pE358, DOI 10.1542/peds.2010-1481; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922; Savendahl L, 1997, AM J CLIN NUTR, V66, P622, DOI 10.1093/ajcn/66.3.622; SITARAM N, 1978, SCIENCE, V201, P274, DOI 10.1126/science.351808; SITARAM N, 1978, LIFE SCI, V22, P1555, DOI 10.1016/0024-3205(78)90011-5; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Stover PJ, 2011, J NUTRIGENET NUTRIGE, V4, P293, DOI 10.1159/000334586; UELAND PM, 1993, CLIN CHEM, V39, P1764; Vennemann FBC, 2015, BRIT J NUTR, V114, P2046, DOI 10.1017/S0007114515003700; Villa I, 2007, PUBLIC HEALTH NUTR, V10, P311, DOI 10.1017/S1368980007352476; Wennlof AH, 2005, SCAND J CLIN LAB INV, V65, P65, DOI 10.1080/00365510410003110; Wennlof AH, 2003, PUBLIC HEALTH NUTR, V6, P291, DOI 10.1079/PHN2002425; Yan JA, 2011, AM J CLIN NUTR, V93, P348, DOI 10.3945/ajcn.110.005975; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	37	4	5	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1683	1688		10.1096/fj.15-281097	http://dx.doi.org/10.1096/fj.15-281097			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26728177	Green Submitted, Green Published			2022-12-28	WOS:000372629100028
J	Terrazas, C; Varikuti, S; Kimble, J; Moretti, E; Boyaka, PN; Satoskar, AR				Terrazas, Cesar; Varikuti, Sanjay; Kimble, Jennifer; Moretti, Ellen; Boyaka, Prosper N.; Satoskar, Abhay R.			IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani	FASEB JOURNAL			English	Article						granuloma; monocytes; neutrophils; gamma delta T cells; T(h)17	T-CELLS; MONOCYTE MIGRATION; TRYPANOSOMA-CRUZI; IMMUNE-RESPONSE; TGF-BETA; INFECTION; GRANULOMA; INTERLEUKIN-4; REQUIREMENT; MACROPHAGES	Leishmania donovani is an intracellular parasite that infects professional phagocytes and causes visceral leishmaniasis (VL). The immune response during VL has been extensively studied in the context of T-helper (T-h)1 and T(h)2 responses. Immunity against this parasite is dependent on IFN-gamma production and subsequent macrophage activation, and the T(h)2 response promotes granuloma formation. The cytokine IL-17A is associated with neutrophilic inflammation. Depletion of neutrophils during experimental VL results in enhanced parasitic loads. Furthermore, although patients resistant to VL showed enhanced levels of IL-17A in circulation, little is known about the role of IL-17A during VL infection. Here, we used IL-17A-deficient mice and IL-17A reporter mice to address the role of IL-17A during VL. IL-17A(-/-) mice were highly resistant to VL infection, showing decreased parasites in the liver and spleen. This unexpected phenotype was associated with enhanced IFN-gamma production by T cells and decreased accumulation of neutrophils and monocytes, resulting in reduced number of granulomas. We also found gamma delta T and T(h)17 cells as the main IL-17A(+) cells during VL infection. Our data reveal an unexpected role of IL-17A rendering susceptibility against L. donovani by regulating the IFN-gamma response and promoting detrimental inflammation.	[Terrazas, Cesar; Varikuti, Sanjay; Kimble, Jennifer; Moretti, Ellen; Satoskar, Abhay R.] Ohio State Univ, Dept Pathol, 1645 Neil Ave, Columbus, OH 43210 USA; [Boyaka, Prosper N.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Boyaka, Prosper N.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Terrazas, C; Satoskar, AR (corresponding author), Ohio State Univ, Dept Pathol, 1645 Neil Ave, Columbus, OH 43210 USA.	cterrazas.05@gmail.com; abhay.satoskar@osumc.edu	Satoskar, Abhay/AAB-7748-2019	Boyaka, Prosper/0000-0001-6857-9088	U.S. National Institute of Health, National Institute of Allergy and Infectious Diseases Grant [R01 AI043197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101323] Funding Source: NIH RePORTER	U.S. National Institute of Health, National Institute of Allergy and Infectious Diseases Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Yoichiro Iwakura (Department of Biophysics and Biochemistry, The University of Tokyo, Tokyo, Japan) for providing the IL-17A<SUP>-/-</SUP> mice and Dr. Tracey L. Papenfuss (Department of Veterinary Biosciences, The Ohio State University) for evaluation of granuloma. P.B. was supported by U.S. National Institute of Health, National Institute of Allergy and Infectious Diseases Grant R01 AI043197.	Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Barin JG, 2012, EUR J IMMUNOL, V42, P726, DOI 10.1002/eji.201141737; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; CERVIA JS, 1993, INFECT IMMUN, V61, P1330, DOI 10.1128/IAI.61.4.1330-1333.1993; Chatelain R, 1999, PARASITE IMMUNOL, V21, P423, DOI 10.1046/j.1365-3024.1999.00240.x; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Erdmann H, 2013, IMMUNOBIOLOGY, V218, P910, DOI 10.1016/j.imbio.2012.10.005; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Guiton R, 2010, J INFECT DIS, V202, P427, DOI 10.1086/653738; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Matthews DJ, 2000, J IMMUNOL, V164, P1458, DOI 10.4049/jimmunol.164.3.1458; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; McFarlane E, 2011, J INFECT DIS, V204, P36, DOI 10.1093/infdis/jir080; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGwire BS, 2014, QJM-INT J MED, V107, P7, DOI 10.1093/qjmed/hct116; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Murray HW, 2008, INFECT IMMUN, V76, P4088, DOI 10.1128/IAI.00490-08; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Murray HW, 2001, INT J EXP PATHOL, V82, P249, DOI 10.1046/j.1365-2613.2001.00199.x; Nascimento M. S. L., 2014, J INFECT DIS, V211; Oghumu S, 2014, EUR J IMMUNOL, V44, P450, DOI 10.1002/eji.201343477; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Rosas LE, 2006, J IMMUNOL, V177, P22, DOI 10.4049/jimmunol.177.1.22; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Silverpil E, 2011, INFLAMMATION, V34, P1, DOI 10.1007/s10753-010-9201-8; Smelt SC, 2000, J IMMUNOL, V164, P3681, DOI 10.4049/jimmunol.164.7.3681; Sousa LMA, 2014, PARASITE IMMUNOL, V36, P13, DOI 10.1111/pim.12078; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Terrazas C, 2015, J IMMUNOL METHODS, V423, P93, DOI 10.1016/j.jim.2015.04.022; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wilson ME, 1998, J IMMUNOL, V161, P6148; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200	47	40	41	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1135	1143		10.1096/fj.15-277202	http://dx.doi.org/10.1096/fj.15-277202			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26581600	Green Published			2022-12-28	WOS:000370387800012
J	Kobayashi, K; Tanaka, T; Okada, S; Morimoto, Y; Matsumura, S; Manio, MCC; Inoue, K; Kimura, K; Yagi, T; Saito, Y; Fushiki, T; Inoue, H; Matsumoto, M; Nabeshima, Y				Kobayashi, Kanako; Tanaka, Tomohiro; Okada, Sadanori; Morimoto, Yuki; Matsumura, Shigenobu; Manio, Mark Christian C.; Inoue, Kazuo; Kimura, Kumi; Yagi, Takashi; Saito, Yoshihiko; Fushiki, Tohru; Inoue, Hiroshi; Matsumoto, Michihiro; Nabeshima, Yo-ichi			Hepatocyte beta-Klotho regulates lipid homeostasis but not body weight in mice	FASEB JOURNAL			English	Article						bile acid; cholesterol; fibroblast growth factor; metabolomics; triglyceride	BILE-ACID SYNTHESIS; GROWTH-FACTOR 21; SIMULTANEOUS QUANTIFICATION; ENERGY-EXPENDITURE; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; EXPRESSION; TRIGLYCERIDE; METABOLISM	beta-Klotho (beta-Kl), a transmembrane protein expressed in the liver, pancreas, adipose tissues, and brain, is essential for feedback suppression of hepatic bile acid synthesis. Because bile acid is a key regulator of lipid and energy metabolism, we hypothesized potential and tissue-specific roles of beta-Kl in regulating plasma lipid levels and body weight. By crossing beta-kl(-/-) mice with newly developed hepatocyte-specific beta-kl transgenic (Tg) mice, we generated mice expressing beta-kl solely in hepatocytes (beta-kl2/2/Tg). Gene expression, metabolomic, and in vivo flux analyses consistently revealed that plasma level of cholesterol, which is over-excreted into feces as bile acids in beta-kl2/2, ismaintained in beta-kl2/2 mice by enhanced de novo cholesterogenesis. No compensatory increase in lipogenesis was observed, despite markedly decreased plasma triglyceride. Along with enhanced bile acid synthesis, these lipid dysregulations in beta-kl2/2 were completely reversed in beta-kl2/2/Tgmice. In contrast, reduced body weight and resistance to diet-induced obesity in beta-kl2/2 mice were not reversed by hepatocyte-specific restoration of beta-Kl expression. We conclude that beta-Kl in hepatocytes is necessary and sufficient for lipid homeostasis, whereas nonhepatic beta-Kl regulates energy metabolism. We further demonstrate that in a condition with excessive cholesterol disposal, a robust compensatory mechanism maintains cholesterol levels but not triglyceride levels in mice.	[Kobayashi, Kanako; Tanaka, Tomohiro; Nabeshima, Yo-ichi] Fdn Biomed Res & Innovat, Lab Mol Life Sci, Kobe, Hyogo, Japan; [Tanaka, Tomohiro] Kyoto Univ, Med Innovat Ctr, Sakyo Ku, Kyoto, Japan; [Morimoto, Yuki] Kyoto Univ, Dept Pathol & Tumor Biol, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Matsumura, Shigenobu; Manio, Mark Christian C.; Inoue, Kazuo; Fushiki, Tohru] Kyoto Univ, Nutr Chem Lab, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Okada, Sadanori; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan; [Kimura, Kumi; Inoue, Hiroshi] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Brain Liver Interface Med Res Ctr, Dept Physiol & Metab, Kanazawa, Ishikawa, Japan; [Yagi, Takashi; Matsumoto, Michihiro] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Res Inst, Dept Mol Metab Regulat,Shinjuku Ku, Tokyo, Japan	Institute for Biomedical Research & Innovation (IBRI); Kyoto University; Kyoto University; Kyoto University; Nara Medical University; Kanazawa University; National Center for Global Health & Medicine - Japan	Nabeshima, Y (corresponding author), Fdn Biomed Res & Innovat, Lab Mol Life Sci, Chuo Ku, Kobe Hybrid Business Ctr Bldg,2F,6-7-6 Minatojima, Kobe, Hyogo 6500047, Japan.	nabemr@lmls-kobe.org	Matsumura, Shigenobu/Z-2088-2019	Inoue, Hiroshi/0000-0002-7724-6637; Kobayashi, Kanako/0000-0003-4565-6604	Japan Society for the Promotion of Science [20-3988]; Ministry of Education, Culture, Sports, Science and Technology [22790859, 24591355]; Health and Labor Sciences Research grant from the Ministry of Health, Labor and Welfare; Fujiwara Memorial Foundation; Suzuken Memorial Foundation; Foundation for Research into Metabolic Disorders; Japan Diabetes Foundation; Takeda Science Foundation; Okinaka Memorial Institute; Kanae Foundation for the Promotion of Medical Science; Banyu Foundation;  [22229003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research grant from the Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Fujiwara Memorial Foundation; Suzuken Memorial Foundation; Foundation for Research into Metabolic Disorders; Japan Diabetes Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Okinaka Memorial Institute; Kanae Foundation for the Promotion of Medical Science; Banyu Foundation; 	The authors are grateful to all staff of the animal facility center at Kyoto University and RIKEN Center for Developmental Biology for their help and to Dr. R. D. Palmiter (University of Washington, Seattle, WA, USA) for providing mouse albumin promoter construct; Dr. J. Y. L. Chiang (Northeast Ohio Medical University, Rootstown, OH, USA) for technical advice on in vivo flux analysis; M. Washida (Foundation for Biomedical Research and Innovation), M. Nakagawa, and S. Maki for technical assistance; and A. Imura, Y.-K. Nabeshima, R. Maeda, Y. Hashimoto, N. Nakamura (Foundation for Biomedical Research and Innovation), K. Tomiyama, and S. Ito (Kyoto University) for critical suggestions and discussions. This work was supported by a Grant-in-Aid for Scientific Research (S) 22229003 (to Y. N.); and funding from the Japan Society for the Promotion of Science fellows (Grant 20-3988 to T.T.), for Young Scientists (B) (Grant 22790859 to T.T.), and for Scientific Research (C) (Grant 24591355 to T.T.) from the Ministry of Education, Culture, Sports, Science and Technology, as well as a Health and Labor Sciences Research grant (to T.T.) from the Ministry of Health, Labor and Welfare and research grants (to T.T.) from Fujiwara Memorial Foundation, Suzuken Memorial Foundation, Foundation for Research into Metabolic Disorders, Japan Diabetes Foundation, Takeda Science Foundation, Okinaka Memorial Institute, Kanae Foundation for the Promotion of Medical Science, and Banyu Foundation. The authors declare no conflicts of interest.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; ANGELIN B, 1978, J LIPID RES, V19, P1017; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Chatterjee C, 2011, AM J PATHOL, V178, P1429, DOI 10.1016/j.ajpath.2010.12.050; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; EINARSSON K, 1974, J CLIN INVEST, V54, P1301, DOI 10.1172/JCI107876; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Fukatsu Y, 2009, ENDOCRINOLOGY, V150, P2683, DOI 10.1210/en.2008-1647; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Gao L, 2007, J CHROMATOGR B, V853, P303, DOI 10.1016/j.jchromb.2007.03.029; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Matsuoka N, 2001, AM J PHYSIOL-ENDOC M, V280, pE334, DOI 10.1152/ajpendo.2001.280.2.E334; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Moen CJA, 2007, J LIPID RES, V48, P2182, DOI 10.1194/jlr.M700009-JLR200; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; SEMENKOVICH CF, 1989, J LIPID RES, V30, P423; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Tanaka T, 2005, DIABETES, V54, P2365, DOI 10.2337/diabetes.54.8.2365; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Usui S, 2002, J LIPID RES, V43, P805; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	49	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					849	862		10.1096/fj.15-274449	http://dx.doi.org/10.1096/fj.15-274449			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26514166	Green Submitted			2022-12-28	WOS:000369391900033
J	Deschemin, JC; Noordine, ML; Remot, A; Willemetz, A; Afif, C; Canonne-Hergaux, F; Langella, P; Karim, Z; Vaulont, S; Thomas, M; Nicolas, G				Deschemin, Jean-Christophe; Noordine, Marie-Louise; Remot, Aude; Willemetz, Alexandra; Afif, Clement; Canonne-Hergaux, Francois; Langella, Philippe; Karim, Zoubida; Vaulont, Sophie; Thomas, Muriel; Nicolas, Gael			The microbiota shifts the iron sensing of intestinal cells	FASEB JOURNAL			English	Article						microbes; iron transporters; iron storage; ferroportin	GUT MICROBIOTA; COLONIC EPITHELIUM; EXPRESSION; INFLAMMATION; PROTEINS; MUCOSA; SUPPLEMENTATION; FERROPORTIN; METABOLISM; ABSORPTION	The amount of iron in the diet directly influences the composition of the microbiota. Inversely, the effects of the microbiota on iron homeostasis have been little studied. So, we investigate whether the microbiota itself may alter host iron sensing. Duodenal cytochrome b and divalent metal transporter 1, involved in apical iron uptake, are 8- and 10-fold, respectively, more abundant in the duodenum of germ-free (GF) mice than in mice colonized with a microbiota. In contrast, the luminal exporter ferroportin is 2-fold less abundant in GF. The overall signature of microbiota on iron-related proteins is similar in the colon. The colonization does not modify systemic parameters as plasma transferrin saturation (20%), plasma ferritin (150ng/L), and liver (85 mu g/g) iron load. Commensal organisms (Bacteroides thetaiotaomicron VPI-5482 and Faecalibacterium prausnitzii A2-165) and a probiotic strain (Streptococcus thermophilus LMD-9) led to up to 12-fold induction of ferritin in colon. Our data suggest that the intestinal cells of GF mice are depleted of iron and that following colonization, the epithelial cells favor iron storage. This study is the first to demonstrate that gut microbes induce a specific iron-related protein signature, highlighting new aspects of the crosstalk between the microbiota and the intestinal epithelium.-Deschemin, J.-C., Noordine, M.-L., Remot, A., Willemetz, A., Afif, C., Canonne-Hergaux, F., Langella, P., Karim, Z., Vaulont, S., Thomas, M., Nicolas, G. The microbiota shifts the iron sensing of intestinal cells. FASEB J. 30, 252-261 (2016). www.fasebj.org	[Deschemin, Jean-Christophe; Willemetz, Alexandra; Vaulont, Sophie] INSERM, Inst Cochin, U1016, Paris, France; [Deschemin, Jean-Christophe; Willemetz, Alexandra; Vaulont, Sophie] CNRS, Unite Mixte Rech 8104, Paris, France; [Deschemin, Jean-Christophe; Willemetz, Alexandra; Vaulont, Sophie] Univ Paris 05, Paris, France; [Nicolas, Gael] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Deschemin, Jean-Christophe; Willemetz, Alexandra; Karim, Zoubida; Vaulont, Sophie; Nicolas, Gael] Lab Excellence GR Ex, Paris, France; [Noordine, Marie-Louise; Remot, Aude; Afif, Clement; Langella, Philippe; Thomas, Muriel] INRA, F-78350 Jouy En Josas, France; [Noordine, Marie-Louise; Remot, Aude; Afif, Clement; Langella, Philippe; Thomas, Muriel] AgroParisTech, Jouy En Josas, France; [Noordine, Marie-Louise; Remot, Aude; Afif, Clement; Langella, Philippe; Thomas, Muriel] Commensal & Probiot Host Interact Lab, Unite Mixte Rech 1319, Microbiol Alimentat Serv Sante, Jouy En Josas, France; [Canonne-Hergaux, Francois] Ctr Physiopathol Toulouse Purpan, INSERM, U1043, Toulouse, France; [Canonne-Hergaux, Francois] Univ Toulouse 3, Univ Toulouse, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France; [Canonne-Hergaux, Francois] CNRS, U5282, Toulouse, France; [Karim, Zoubida; Nicolas, Gael] Ctr Rech Inflammat, INSERM, U1149, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Thomas, M (corresponding author), INRA, Unite Mixte Rech 1319, Microbiol Alimentat Serv Sante, F-78350 Jouy En Josas, France.	muriel.thomas@jouy.inra.fr; gael.nicolas@inserm.fr	thomas, muriel/HDO-3887-2022; Canonne-Hergaux, Francois/L-5363-2016; Langella, Philippe/N-8368-2017; Vaulont, Sophie/O-6732-2017; CANONNE-HERGAUX, François/AAC-2073-2020; NICOLAS, Gaël/X-9555-2019; NICOLAS, Gaël/D-7611-2013; Thomas, Muriel/D-9164-2015	Canonne-Hergaux, Francois/0000-0002-0621-2157; Langella, Philippe/0000-0001-5960-4341; CANONNE-HERGAUX, François/0000-0002-0621-2157; NICOLAS, Gaël/0000-0002-1671-8274; NICOLAS, Gaël/0000-0002-1671-8274; Deschemin, Jean-Christophe/0000-0002-1256-8459; Thomas, Muriel/0000-0002-7608-3274; Remot, Aude/0000-0001-9896-3216; KARIM, Zoubida/0000-0002-3724-5592	French National Research Agency "Blanc" program [2010 1130 01]; Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency [ANR-11-LABX-0051, ANR-11-IDEX-0005-02]; Institut National de la Recherche Agronomique; European Union [267196]	French National Research Agency "Blanc" program(French National Research Agency (ANR)); Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency(French National Research Agency (ANR)); Institut National de la Recherche Agronomique; European Union(European Commission)	The authors thank Nicolas Sorhaindo (Centre de Recherche sur l'Inflammation) for plasma determinations. The authors also thank the staff of the Anaxem (Microbiologie de l'Alimentation au Service de la Sante) animal facility. This study was supported by grants from the French National Research Agency "Blanc" program (2010 1130 01) and from the Laboratory of Excellence GR-Ex (ANR-11-LABX-0051), which is funded by the "Investissements d'avenir" program of the French National Research Agency (ANR-11-IDEX-0005-02). A.R. was supported by an Institut National de la Recherche Agronomique young scientist contract (Contrat Jeune Scientifique Institut National de la Recherche Agronomique) and the European Union, in the framework of the Marie-Curie FP7 COFUND People Program, through the award of an AgreenSkills fellowship under grant agreement number 267196. J.-C.D., M.-L.N., A.R. ,A.W., C.A., G.N., and M.T. carried out experiments. F.C.-H. and A.W. participated in the analysis of Western blotting, and F.C.-H. provided divalent metal transporter 1 antibody. Z.K. participated in the analysis of iron, ferritin, and transferrin dosages. P.L., S.V., M.T., and G.N. conceived the study and participated in its design, coordination, and financial support. G.N. and M.T. wrote the manuscript. M.T. and G.N. share co-senior authorship of this article. All authors read and approved the final manuscript. The authors declare no conflicts of interest.	Blachier F, 2007, CAN J PHYSIOL PHARM, V85, P185, DOI 10.1139/Y07-007; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Buhnik-Rosenblau K, 2012, BIOMETALS, V25, P883, DOI 10.1007/s10534-012-9555-5; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Cherbuy C, 2004, EUR J BIOCHEM, V271, P87, DOI 10.1046/j.1432-1033.2003.03908.x; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; El Aidy S, 2013, GUT, V62, P1306, DOI 10.1136/gutjnl-2011-301955; El Aidy S, 2013, ISME J, V7, P743, DOI 10.1038/ismej.2012.142; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Frazer DM, 2007, AM J PHYSIOL-GASTR L, V293, pG525, DOI 10.1152/ajpgi.00579.2006; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Guo XC, 2014, CHEMOSPHERE, V112, P1, DOI 10.1016/j.chemosphere.2014.03.068; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kortman GAM, 2014, FEMS MICROBIOL REV, V38, P1202, DOI 10.1111/1574-6976.12086; Lacroix C, 2015, CURR OPIN BIOTECH, V32, P149, DOI 10.1016/j.copbio.2014.12.009; Marciano R, 2015, BRIT J NUTR, V113, P901, DOI 10.1017/S0007114514004334; Miquel S, 2015, MBIO, V6, DOI 10.1128/mBio.00300-15; Moulouel B, 2013, KIDNEY INT, V84, P756, DOI 10.1038/ki.2013.142; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; PIZARRO F, 1987, AM J CLIN NUTR, V45, P484, DOI 10.1093/ajcn/45.2.484; REDDY BS, 1972, J NUTR, V102, P101, DOI 10.1093/jn/102.1.101; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Shanmugam NKN, 2014, J IMMUNOL, V193, P1398, DOI 10.4049/jimmunol.1400278; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028789; Tomas J, 2015, ISME J, V9, P46, DOI 10.1038/ismej.2014.111; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Tomas Julie, 2012, Animal Health Research Reviews, V13, P54, DOI 10.1017/S1466252312000072; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Turpin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057711; Vazquez-Gutierrez P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-014-0334-z; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200	49	57	60	2	62	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					252	261		10.1096/fj.15-276840	http://dx.doi.org/10.1096/fj.15-276840			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26370847				2022-12-28	WOS:000367621000025
J	Jeggle, P; Hofschroer, V; Maase, M; Bertog, M; Kusche-Vihrog, K				Jeggle, Pia; Hofschroeer, Verena; Maase, Martina; Bertog, Marko; Kusche-Vihrog, Kristina			Aldosterone synthase knockout mouse as a model for sodium-induced endothelial sodium channel up-regulation in vascular endothelium	FASEB JOURNAL			English	Article						mineralocorticoid receptor; ENaC; atomic force microscopy	NITRIC-OXIDE SYNTHASE; MINERALOCORTICOID RECEPTORS; INDEPENDENT REGULATION; COLLECTING DUCT; BLOOD-PRESSURE; ENAC; DYSFUNCTION; CELLS; MICE; RAT	Recently, a novel feedforward activation of the endothelial epithelial sodium channel (ENaC) [endothelial sodium channel (EnNaC)] by sodium was reported that counteracts ENaC function in kidney. In the absence of aldosterone, a rise in extracellular sodium (> 145 mM) increases EnNaC surface abundance, thereby stiffening the cortex of vascular endothelial cells (ECs) in vitro. The latter reduces the release of NO-the hallmark of endothelial dysfunction. Here, we test whether high extracellular sodium per se increases EnNaC expression and cortical stiffness in an aldosterone synthase (Cyp11b2)-deficient (AS(-/-)) mouse model. Therefore, we employed in situ ECs of ex vivo aorta preparations from wild-type (WT) and AS(-/-). EnNaC surface expression (-16%) and cortical stiffness (-22%) were reduced in AS(-/-), compared with WT, whereas NO secretion was exclusively detectable in AS(-/-). EnNaC inhibition with benzamil decreased stiffness in both, while mineralocorticoid receptor antagonism diminished stiffness only in the WT. In the absence of aldosterone, high sodium (150 mM) increased EnNaC surface expression ex vivo (plus 19%) and cortical stiffness ex vivo (plus 41%) and in vivo (plus 44%). Application of aldosterone adjusted the stiffness of AS(-/-) to the WT level. We conclude that high sodium per se determines EnNaC expression and consequently endothelial cortical nanomechanics, thus likely contributing to endothelial dysfunction.-Jeggle, P., Hofschroer, V., Maase, M., Bertog, M., Kusche-Vihrog, K. Aldosterone synthase knockout mouse as a model for sodium-induced endothelial sodium channel up-regulation in vascular endothelium. FASEB J. 30, 45-53 (2016). www.fasebj.org	[Jeggle, Pia; Hofschroeer, Verena; Maase, Martina; Kusche-Vihrog, Kristina] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Bertog, Marko] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany	University of Munster; University of Erlangen Nuremberg	Kusche-Vihrog, K (corresponding author), Univ Munster, Inst Physiol 2, Robert Koch Str 27b, D-48149 Munster, Germany.	kusche@uni-muenster.de			Deutsche Forschungsgemeinschaft [KU 1496/7-1, OB 63/17-1, Koselleck-OB 63/18]; Innovative Medical Research of the University of Munster Medical School [KU 120808]; Else-Kroner-Fresenius Stiftung [2010 A116]; Centre of Excellence (Cells in Motion), University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medical Research of the University of Munster Medical School; Else-Kroner-Fresenius Stiftung; Centre of Excellence (Cells in Motion), University of Munster	The authors thank Professors Hans Oberleithner (Institute of Physiology II, University of Munster, Munster, Germany) and Christoph Korbmacher (Institute of Physiology, University of Erlangen, Erlangen, Germany) for their support in this study and Marianne Wilhelmi and Sergej Handel (Institute of Physiology II, University of Munster) for their excellent work on the mouse aorta preparations. The authors are grateful to Manfred Fobker (Center of Laboratory Medicine, University of Munster) for the quantification of the plasma aldosterone concentration. This paper is dedicated to the late Professor Hugh de Wardener (Imperial College London, London, United Kingdom), who discussed and commented on our data. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KU 1496/7-1, OB 63/17-1, and Koselleck-OB 63/18), Innovative Medical Research of the University of Munster Medical School (KU 120808), Else-Kroner-Fresenius Stiftung (2010 A116), and by the Centre of Excellence (Cells in Motion), University of Munster. The authors are grateful to COST Action TD1002 as well as COST Action BM1301 for supporting networking activities. The authors declare no conflicts of interest.	Bertog M, 2008, J PHYSIOL-LONDON, V586, P459, DOI 10.1113/jphysiol.2007.140459; Bragulat E, 2001, HYPERTENSION, V37, P444, DOI 10.1161/01.HYP.37.2.444; Cat AND, 2010, FASEB J, V24, P2454, DOI 10.1096/fj.09-147926; Delcayre C, 2000, KIDNEY INT, V57, P1346, DOI 10.1046/j.1523-1755.2000.00973.x; Druppel V, 2013, FASEB J, V27, P3652, DOI 10.1096/fj.13-228312; DuPont JJ, 2014, HYPERTENSION, V63, P632, DOI 10.1161/HYPERTENSIONAHA.113.01273; DuPont JJ, 2013, J HYPERTENS, V31, P530, DOI 10.1097/HJH.0b013e32835c6ca8; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Farquharson CAJ, 2002, CLIN SCI, V103, P425, DOI 10.1042/cs1030425; Fels J, 2010, BBA-MOL BASIS DIS, V1802, P1193, DOI 10.1016/j.bbadis.2010.03.006; Fels J, 2010, PFLUG ARCH EUR J PHY, V460, P915, DOI 10.1007/s00424-010-0871-8; Frindt G, 2012, AM J PHYSIOL-RENAL, V302, pF20, DOI 10.1152/ajprenal.00480.2011; Fuller PJ, 2000, KIDNEY INT, V57, P1256, DOI 10.1046/j.1523-1755.2000.00959.x; Funder JW, 2010, BBA-MOL BASIS DIS, V1802, P1188, DOI 10.1016/j.bbadis.2010.08.005; Funder JW, 2006, HYPERTENSION, V47, P634, DOI 10.1161/01.HYP.0000203732.03784.3b; Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9; Jaffe IZ, 2014, HYPERTENSION, V63, P915, DOI 10.1161/HYPERTENSIONAHA.114.01997; Jeggle P, 2013, HYPERTENSION, V61, P1053, DOI 10.1161/HYPERTENSIONAHA.111.199455; Kasas S, 2008, PFLUG ARCH EUR J PHY, V456, P13, DOI 10.1007/s00424-008-0448-y; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Korte S, 2012, PFLUG ARCH EUR J PHY, V463, P269, DOI 10.1007/s00424-011-1038-y; Kusche-Vihrog K, 2008, PFLUG ARCH EUR J PHY, V455, P849, DOI 10.1007/s00424-007-0341-0; Kusche-Vihrog K, 2014, PFLUG ARCH EUR J PHY, V466, P851, DOI 10.1007/s00424-013-1356-3; Kusche-Vihrog K, 2011, HYPERTENSION, V57, P231, DOI 10.1161/HYPERTENSIONAHA.110.163444; Lee G, 2005, ENDOCRINOLOGY, V146, P2650, DOI 10.1210/en.2004-1102; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Nagata D, 2006, HYPERTENSION, V48, P165, DOI 10.1161/01.HYP.0000226054.53527.bb; NARAYFEJESTOTH A, 1990, AM J PHYSIOL, V259, pF672, DOI 10.1152/ajprenal.1990.259.4.F672; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; Ni ZM, 2001, AM J HYPERTENS, V14, P155, DOI 10.1016/S0895-7061(00)01234-6; Nicco C, 2001, HYPERTENSION, V38, P1143, DOI 10.1161/hy1001.092641; Oberleithner H, 2006, ACTA PHYSIOL, V187, P305, DOI 10.1111/j.1748-1716.2006.01574.x; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Oberleithner H, 2006, J CELL SCI, V119, P1926, DOI 10.1242/jcs.02886; Perez FR, 2009, HYPERTENSION, V53, P1000, DOI 10.1161/HYPERTENSIONAHA.108.128520; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Silvestre JS, 1998, J BIOL CHEM, V273, P4883, DOI 10.1074/jbc.273.9.4883; Stowasser M, 2005, J CLIN ENDOCR METAB, V90, P5070, DOI 10.1210/jc.2005-0681; Struthers AD, 2004, HEART, V90, P1229, DOI 10.1136/hrt.2003.025312; TAKEDA R, 1995, STEROIDS, V60, P120, DOI 10.1016/0039-128X(94)00026-9; Wang S, 2009, MICROCIRCULATION, V16, P276, DOI 10.1080/10739680802653150; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Warnock DG, 2013, HYPERTENSION, V61, P952, DOI 10.1161/HYPERTENSIONAHA.113.00768; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; YOUNG M, 1995, AM J PHYSIOL-ENDOC M, V269, pE657, DOI 10.1152/ajpendo.1995.269.4.E657; Zatschler B, 2009, J VASC SURG, V50, P397, DOI 10.1016/j.jvs.2009.04.064	49	17	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					45	53		10.1096/fj.14-259606	http://dx.doi.org/10.1096/fj.14-259606			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26324851				2022-12-28	WOS:000367621000007
J	Pedram, A; Razandi, M; Blumberg, B; Levin, ER				Pedram, Ali; Razandi, Mahnaz; Blumberg, Bruce; Levin, Ellis Robert			Membrane and nuclear estrogen receptor a collaborate to suppress adipogenesis but not triglyceride content	FASEB JOURNAL			English	Article						BMSCs; preadipocytes; adipocyte hypertrophy; kinase activation; ChREBP	BODY-FAT DISTRIBUTION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; OBESOGEN TRIBUTYLTIN; REPLACEMENT THERAPY; GLUCOSE-METABOLISM; PRENATAL EXPOSURE; ALPHA; BETA	Estrogen and estrogen receptor (ER)-alpha suppress visceral fat development through actions in several organs via unclear mechanisms that we sought to identify. Using mice that express only nuclear ER-alpha [nuclear-only ER-alpha (NOER) mice] or plasma membrane ER-alpha[membrane-only ER-alpha (MOER) mice], we found that 10-wk-old mice that lacked either receptor pool showed extensive abdominal visceral fat deposition and weight gain compared with wild-type (WT) mice. Differentiation of cultured bone marrow stem cells (BMSCs) into the adipocyte lineage was suppressed by 17-beta-estradiol (E2) in WT female mice but not in NOER or MOER mice. This finding correlated with E2 inhibition of prominent differentiation genes in WT BMSCs. In contrast, triglyceride content in differentiated BMSCs or 3T3-L1 cells was suppressed as a result of membrane ER-alpha signaling through several kinases to inhibit carbohydrate response element-binding protein-alpha and -beta. We concluded that extranuclear and nuclear ER-alpha collaborate to suppress adipocyte development, but inhibition of lipid synthesis in mature cells does not involve nuclear ER-alpha.-Pedram, A., Razandi, M., Blumberg, B., Levin, E. R. Membrane and nuclear estrogen receptor a collaborate to suppress adipogenesis but not triglyceride content. FASEB J. 30, 230-240 (2016). www.fasebj.org	[Pedram, Ali; Razandi, Mahnaz; Levin, Ellis Robert] Vet Affairs Med Ctr, Div Endocrinol, Long Beach, CA USA; [Blumberg, Bruce] Univ Calif Irvine, Dept Dev & Cell Biol, Long Beach, CA 90822 USA; [Levin, Ellis Robert] Univ Calif Irvine, Dept Med, Long Beach, CA 90822 USA; [Levin, Ellis Robert] Univ Calif Irvine, Dept Biochem, Long Beach, CA 90822 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Levin, ER (corresponding author), Univ Calif Irvine, Long Beach Vet Affairs Med Ctr, Med Serv 111-I,5901 E 7th St, Long Beach, CA 90822 USA.	ellis.levin@va.gov			Research Service of the Department of Veteran's Affairs; U.S. National Institutes of Health [CA-10036]; Institute of Cancer Research; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002316] Funding Source: NIH RePORTER	Research Service of the Department of Veteran's Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the Research Service of the Department of Veteran's Affairs (to E.R.L), and Grant CA-10036 from the U.S. National Institutes of Health, Institute of Cancer Research (to E.R.L.). A.P. and M.R. performed the research, and E.R.L. and B.B. designed the research and analyzed the data. E.R.L. wrote the paper. B.B. is a named inventor on U.S. patents 5,861,274; 6,200,802; 6,815,168; and 7,250,273 related to PPAR-gamma. The remaining authors declare no conflicts of interest.	Anderson LA, 2001, J CLIN ENDOCR METAB, V86, P5045, DOI 10.1210/jc.86.10.5045; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Harris HA, 2002, ENDOCRINOLOGY, V143, P4172, DOI 10.1210/en.2002-220403; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hong JN, 2011, INT J ONCOL, V39, P1443, DOI 10.3892/ijo.2011.1162; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kirchner S, 2010, MOL ENDOCRINOL, V24, P526, DOI 10.1210/me.2009-0261; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lapid K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6196; Levin ER, 2014, AM J PHYSIOL-ENDOC M, V307, pE133, DOI 10.1152/ajpendo.00626.2013; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Okura T, 2003, INT J OBESITY, V27, P1020, DOI 10.1038/sj.ijo.0802378; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pedram A, 2014, DEV CELL, V29, P482, DOI 10.1016/j.devcel.2014.04.016; Pedram A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004013; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Pedram A, 2009, J BIOL CHEM, V284, P3488, DOI 10.1074/jbc.M806249200; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Razandi M, 2013, ONCOGENE, V32, P3274, DOI 10.1038/onc.2012.335; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Seidlova-Wuttke D, 2008, BONE, V43, P849, DOI 10.1016/j.bone.2008.07.237; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Tiano JP, 2012, ENDOCRINOLOGY, V153, P2997, DOI 10.1210/en.2011-1980; Trogden BG, 2009, BIOORG MED CHEM LETT, V19, P485, DOI 10.1016/j.bmcl.2008.11.043; UTIAN WH, 1987, AM J OBSTET GYNECOL, V156, P1280, DOI 10.1016/0002-9378(87)90164-5; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Yonezawa R, 2012, AM J PHYSIOL-ENDOC M, V303, pE445, DOI 10.1152/ajpendo.00638.2011	39	58	59	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					230	240		10.1096/fj.15-274878	http://dx.doi.org/10.1096/fj.15-274878			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26373802	Green Published, Green Submitted			2022-12-28	WOS:000367621000023
J	Gulati, S; Balderes, D; Kim, C; Guo, ZMA; Wilcox, L; Area-Gomez, E; Snider, J; Wolinski, H; Stagljar, I; Granato, JT; Ruggles, KV; DeGiorgis, JA; Kohlwein, SD; Schon, EA; Sturley, SL				Gulati, Sonia; Balderes, Dina; Kim, Christine; Guo, Zhongmin A.; Wilcox, Lisa; Area-Gomez, Estela; Snider, Jamie; Wolinski, Heimo; Stagljar, Igor; Granato, Juliana T.; Ruggles, Kelly V.; DeGiorgis, Joseph A.; Kohlwein, Sepp D.; Schon, Eric A.; Sturley, Stephen L.			ATP-binding cassette transporters and sterol O-acyltransferases interact at membrane microdomains to modulate sterol uptake and esterification	FASEB JOURNAL			English	Article						cholesteryl ester; sterol transport; ABC transporter; lipid droplet	A-CHOLESTEROL ACYLTRANSFERASE; YEAST SACCHAROMYCES-CEREVISIAE; HUMAN ABCG1 TRANSPORTER; ACYL-COENZYME; PLASMA-MEMBRANE; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; PROTEINS; COA	A key component of eukaryotic lipid homeostasis is the esterification of sterols with fatty acids by sterol O-acyltransferases (SOATs). The esterification reactions are allosterically activated by their sterol substrates, the majority of which accumulate at the plasma membrane. We demonstrate that in yeast, sterol transport from the plasma membrane to the site of esterification is associated with the physical interaction of the major SOAT, acylcoenzyme A: cholesterol acyltransferase (ACAT)-related enzyme (Are) 2p, with 2 plasma membrane ATP-binding cassette (ABC) transporters: Aus1p and Pdr11p. Are2p, Aus1p, and Pdr11p, unlike the minor acyltransferase, Are1p, colocalize to sterol and sphingolipid-enriched, detergent-resistant microdomains (DRMs). Deletion of either ABC transporter results in Are2p relocalization to detergent-soluble membrane domains and a significant decrease (53-36%) in esterification of exogenous sterol. Similarly, in murine tissues, the SOAT1/Acat1 enzyme and activity localize to DRMs. This subcellular localization is diminished upon deletion of murine ABC transporters, such as Abcg1, which itself is DRM associated. We propose that the close proximity of sterol esterification and transport proteins to each other combined with their residence in lipid-enriched membrane microdomains facilitates rapid, high-capacity sterol transport and esterification, obviating any requirement for soluble intermediary proteins.	[Gulati, Sonia; Balderes, Dina; Guo, Zhongmin A.; Wilcox, Lisa; Ruggles, Kelly V.; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Area-Gomez, Estela; Schon, Eric A.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Schon, Eric A.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Kim, Christine] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kim, Christine] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Snider, Jamie; Stagljar, Igor] Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Wolinski, Heimo; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, BioTechMed Graz, Graz, Austria; [Granato, Juliana T.; DeGiorgis, Joseph A.] Providence Coll, KDepartment Biol, Providence, RI 02918 USA; [Granato, Juliana T.; DeGiorgis, Joseph A.; Sturley, Stephen L.] Marine Biol Lab, Woods Hole, MA 02543 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of Toronto; University of Graz; Providence College; Marine Biological Laboratory - Woods Hole	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, 630 West 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Kohlwein, Sepp Dieter/0000-0002-1030-0598; Moon, Christine/0000-0001-8717-2435; Wolinski, Heimo/0000-0002-1583-6092; Area, Estela/0000-0002-0962-1570; Ruggles, Kelly/0000-0002-0152-0863	American Heart Association; Ara Parseghian Medical Research Foundation; University of Notre Dame; U.S. National Institutes of Health (NIH) [DK54320]; John Douglas French Alzheimer Foundation; NIH [K01AG045335]; American Health Assistance Foundation; Ellison Medical Foundation; Alzheimer Drug Discovery Foundation; U.S. Department of Defense [W911NF-12-1-9159, W911F-15-1-0169]; Canadian Foundation for Innovation; Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Heart and Stroke Foundation; Cystic Fibrosis Foundation; Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada; Novartis; NIH National Institute of General Medical Sciences [2 P20 GM103430]; Austrian Science Funds; Fonds zur Forderung der Wissenschaftlichen Forschung [F3005 LIPOTOX]; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG045335] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ara Parseghian Medical Research Foundation; University of Notre Dame; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Douglas French Alzheimer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Alzheimer Drug Discovery Foundation; U.S. Department of Defense(United States Department of Defense); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Novartis(Novartis); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Funds(Austrian Science Fund (FWF)); Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors appreciate the technical assistance of Abraham Sturley and provision of reagents or helpful discussions with Andrew Munkacsi, Liz Miller, Elisabeth Tarling, and Peter Edwards. This work was supported by the American Heart Association, Ara Parseghian Medical Research Foundation, University of Notre Dame, and U.S. National Institutes of Health (NIH) Grant DK54320 (to S.L.S.); the John Douglas French Alzheimer Foundation and NIH Grant K01AG045335 (to E.A.-G.); American Health Assistance Foundation, Ellison Medical Foundation, Alzheimer Drug Discovery Foundation, U.S. Department of Defense Grants W911NF-12-1-9159 and W911F-15-1-0169 (to E.A.S.); Canadian Foundation for Innovation, Canadian Institutes of Health Research, Canadian Cancer Society Research Institute, Heart and Stroke Foundation, Cystic Fibrosis Foundation, Ontario Genomics Institute, Natural Sciences and Engineering Research Council of Canada, and Novartis (to J.S. and I.S.); the Canadian Institutes of Health Research (to L.W.); an Institutional Development Award from the NIH National Institute of General Medical Sciences, Grant 2 P20 GM103430 (to J.A.D. and J.T.G.); and the Austrian Science Funds, Fonds zur Forderung der Wissenschaftlichen Forschung [Project F3005 LIPOTOX (to S.D.K.)].	Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; BILLHEIMER JT, 1990, J BIOL CHEM, V265, P8632; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Finley Jr R. L., 1995, GENE PROBES PRACTICA, P169; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Gulati S., 2011, THESIS, P84; Gulati S, 2010, PROG LIPID RES, V49, P353, DOI 10.1016/j.plipres.2010.03.003; Guo ZM, 2001, J LIPID RES, V42, P1282; Jensen-Pergakes K, 2001, J BACTERIOL, V183, P4950, DOI 10.1128/JB.183.17.4950-4957.2001; Kawasaki T, 1998, BIOCHEM BIOPH RES CO, V244, P347, DOI 10.1006/bbrc.1998.8268; Khelef N, 1998, J BIOL CHEM, V273, P11218, DOI 10.1074/jbc.273.18.11218; Khelef N, 2000, ARTERIOSCL THROM VAS, V20, P1769; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Koh JLY, 2010, NUCLEIC ACIDS RES, V38, pD502, DOI 10.1093/nar/gkp820; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lei XF, 2010, J ATHEROSCLER THROMB, V17, P740, DOI 10.5551/jat.4416; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; LISCUM L, 1995, J BIOL CHEM, V270, P15443, DOI 10.1074/jbc.270.26.15443; Marek M, 2011, J BIOL CHEM, V286, P21835, DOI 10.1074/jbc.M111.244525; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Neufeld Edward B, 2014, Biology (Basel), V3, P866, DOI 10.3390/biology3040866; Neufeld Edward B, 2014, Biology (Basel), V3, P781, DOI 10.3390/biology3040781; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sano O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109886; Scheffer GL, 2000, CANCER RES, V60, P2589; Schneiter R, 2007, BIOCHIMIE, V89, P255, DOI 10.1016/j.biochi.2006.07.022; Skiba PJ, 1996, J BIOL CHEM, V271, P13392, DOI 10.1074/jbc.271.23.13392; Snider J, 2013, NAT CHEM BIOL, V9, P565, DOI [10.1038/NCHEMBIO.1293, 10.1038/nchembio.1293]; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Tarling EJ, 2012, BBA-MOL CELL BIOL L, V1821, P386, DOI 10.1016/j.bbalip.2011.07.011; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; TAVANI DM, 1982, J LIPID RES, V23, P774; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Vaughan AM, 2009, J LIPID RES, V50, P285, DOI 10.1194/jlr.M800366-JLR200; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang HY, 1997, J BIOL CHEM, V272, P3980, DOI 10.1074/jbc.272.7.3980; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	55	18	18	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4682	4694		10.1096/fj.14-264796	http://dx.doi.org/10.1096/fj.14-264796			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26220175	Green Published			2022-12-28	WOS:000364514700025
J	Apro, W; Moberg, M; Hamilton, DL; Ekblom, B; Rooyackers, O; Holmberg, HC; Blomstrand, E				Apro, William; Moberg, Marcus; Hamilton, D. Lee; Ekblom, Bjorn; Rooyackers, Olav; Holmberg, Hans-Christer; Blomstrand, Eva			Leucine does not affect mechanistic target of rapamycin complex 1 assembly but is required for maximal ribosomal protein s6 kinase 1 activity in human skeletal muscle following resistance exercise	FASEB JOURNAL			English	Article						mTORC1 assembly; S6K1 kinase activity; protein synthesis	CHAIN AMINO-ACIDS; RAG GTPASES; TRANSLATION INITIATION; MOLECULAR-MECHANISMS; ENDURANCE EXERCISE; MAMMALIAN TARGET; MESSENGER-RNA; NEONATAL PIGS; IN-VIVO; MTORC1	We examined how the stimulatory effect of leucine on the mechanistic target of rapamycin complex 1 (mTORC1) pathway is affected by the presence of the remaining essential amino acids (EAAs). Nine male subjects performed resistance exercise on 4 occasions and were randomly supplied EAAs with leucine, EAAs without leucine (EAA-Leu), leucine alone, or flavored water (placebo; control). Muscle biopsies were taken from the vastus lateralis before and 60 and 90 min after exercise. Biopsies were analyzed for protein phosphorylation, kinase activity, protein-protein interactions, amino acid concentrations, and tracer incorporation. Leucine alone stimulated ribosomal protein s6 kinase 1 (S6K1) phosphorylation similar to 280% more than placebo and EAA-Leu after exercise. Moreover, this response was enhanced by 60-75% after intake of EAAs compared with that of leucine alone (P < 0.05). Kinase activity of S6K1 reflected that of S6K1 phosphorylation; 60 min after exercise, the activity was elevated 3.3- and 4.2-fold with intake of leucine alone and with EAAs, respectively (P < 0.05). The interaction between mammalian target of rapamycin and regulatory-associated protein of mammalian target of rapamycin was unaltered in response to both resistance exercise and amino acid provision. Leucine alone stimulates mTORC1 signaling, although this response is enhanced by other EAAs and does not appear to be caused by alterations inmTORC1 assembly.	[Apro, William; Moberg, Marcus; Ekblom, Bjorn; Blomstrand, Eva] Swedish Sch Sport & Hlth Sci, Astrand Lab, SE-11486 Stockholm, Sweden; [Apro, William; Rooyackers, Olav] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Blomstrand, Eva] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hamilton, D. Lee] Univ Stirling, Hlth & Exercise Sci Res Grp, Stirling FK9 4LA, Scotland; [Holmberg, Hans-Christer] Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Ostersund, Sweden	Swedish School of Sport & Health Sciences; Karolinska Institutet; Karolinska Institutet; University of Stirling; Mid-Sweden University	Apro, W (corresponding author), Swedish Sch Sport & Hlth Sci, Box 5626, SE-11486 Stockholm, Sweden.	william.apro@gih.se	Moberg, Marcus/AAU-5487-2021; Apro, William/AAZ-4717-2020	Moberg, Marcus/0000-0003-3747-0148; Apro, William/0000-0003-1942-2919; Holmberg, Hans-Christer/0000-0002-3814-6246; Hamilton, David/0000-0002-5620-4788	Swedish National Centre for Research in Sports; Swedish School of Sport and Health Sciences (Stockholm, Sweden); Karolinska Institutet (Stockholm, Sweden)	Swedish National Centre for Research in Sports; Swedish School of Sport and Health Sciences (Stockholm, Sweden); Karolinska Institutet (Stockholm, Sweden)	The amino acids were kindly provided by Ajinomoto (Tokyo, Japan). The authors gratefully acknowledge Drs. Veronique Chotteau and Atefeh Shokri (KTH Royal Institute of Technology, Stockholm, Sweden) for providing the HEK293 cells. This project was funded by grants from the Swedish National Centre for Research in Sports, the Swedish School of Sport and Health Sciences (Stockholm, Sweden), and funds from the Karolinska Institutet (Stockholm, Sweden).	Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; ALVESTRAND A, 1990, EUR J CLIN INVEST, V20, P293, DOI 10.1111/j.1365-2362.1990.tb01858.x; Antharavally BS, 2004, ANAL BIOCHEM, V329, P276, DOI 10.1016/j.ab.2004.02.049; Anthony JC, 2000, J NUTR, V130, P2413; Apro W, 2010, ACTA PHYSIOL, V200, P237, DOI 10.1111/j.1748-1708.2010.02151.x; Apro W, 2015, AM J PHYSIOL-ENDOC M, V308, pE470, DOI 10.1152/ajpendo.00486.2014; Apro W, 2013, AM J PHYSIOL-ENDOC M, V305, pE22, DOI 10.1152/ajpendo.00091.2013; Astrand P.O., 1986, TXB WORK PHYSL PHYSL; Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Beachle T. R., 2000, ESSENTIALS STRENGTH; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Borgenvik M, 2012, AM J PHYSIOL-ENDOC M, V302, pE510, DOI 10.1152/ajpendo.00353.2011; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Churchward-Venne TA, 2014, AM J CLIN NUTR, V99, P276, DOI 10.3945/ajcn.113.068775; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Dickinson JM, 2011, J NUTR, V141, P856, DOI 10.3945/jn.111.139485; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; ERIKSSON LS, 1983, CLIN SCI, V65, P491, DOI 10.1042/cs0650491; ERIKSSON S, 1981, CLIN SCI, V60, P95, DOI 10.1042/cs0600095; Escobar J, 2005, AM J PHYSIOL-ENDOC M, V288, pE914, DOI 10.1152/ajpendo.00510.2004; Escobar J, 2007, AM J PHYSIOL-ENDOC M, V293, pE1615, DOI 10.1152/ajpendo.00302.2007; Glynn EL, 2010, J NUTR, V140, P1970, DOI 10.3945/jn.110.127647; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Gundermann DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1198, DOI 10.1152/ajpendo.00600.2013; HAGENFELDT L, 1980, CLIN SCI, V59, P173, DOI 10.1042/cs0590173; HENRIKSSON KG, 1979, ACTA NEUROL SCAND, V59, P317; Hong-Brown LQ, 2012, AM J PHYSIOL-CELL PH, V302, pC1557, DOI 10.1152/ajpcell.00407.2011; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Karlsson HKR, 2004, AM J PHYSIOL-ENDOC M, V287, pE1, DOI 10.1152/ajpendo.00430.2003; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, pE645, DOI 10.1152/ajpendo.00413.2004; Kumar V, 2009, J PHYSIOL-LONDON, V587, P211, DOI 10.1113/jphysiol.2008.164483; LI JB, 1978, BIOCHIM BIOPHYS ACTA, V544, P351, DOI 10.1016/0304-4165(78)90103-4; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mascher H, 2011, ACTA PHYSIOL, V202, P175, DOI 10.1111/j.1748-1716.2011.02274.x; McGlory C, 2014, J APPL PHYSIOL, V116, P504, DOI 10.1152/japplphysiol.01072.2013; Moberg M, 2014, APPL PHYSIOL NUTR ME, V39, P183, DOI 10.1139/apnm-2013-0244; Moore DR, 2011, ACTA PHYSIOL, V201, P365, DOI 10.1111/j.1748-1716.2010.02187.x; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; NAIR KS, 1992, AM J PHYSIOL, V263, pE928, DOI 10.1152/ajpendo.1992.263.5.E928; PFEIFER R, 1983, AM LAB, V15, P78; Rasmussen BB, 2003, EXERC SPORT SCI REV, V31, P127, DOI 10.1097/00003677-200307000-00005; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekulic A, 2000, CANCER RES, V60, P3504; SMITH K, 1992, AM J PHYSIOL, V262, pE372, DOI 10.1152/ajpendo.1992.262.3.E372; Smith K, 1998, AM J PHYSIOL-ENDOC M, V275, pE73, DOI 10.1152/ajpendo.1998.275.1.E73; Suryawan A, 2008, AM J PHYSIOL-ENDOC M, V295, pE868, DOI 10.1152/ajpendo.90314.2008; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tipton KD, 2009, APPL PHYSIOL NUTR ME, V34, P151, DOI 10.1139/H09-006; Wilkinson DJ, 2013, J PHYSIOL-LONDON, V591, P2911, DOI 10.1113/jphysiol.2013.253203; Wilson FA, 2011, AMINO ACIDS, V40, P157, DOI 10.1007/s00726-010-0629-9; Wilson FA, 2010, J NUTR, V140, P264, DOI 10.3945/jn.109.113621	63	25	26	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4358	4373		10.1096/fj.15-273474	http://dx.doi.org/10.1096/fj.15-273474			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26169935				2022-12-28	WOS:000361367300024
J	Olmeda, B; Garcia-Alvarez, B; Gomez, MJ; Martinez-Calle, M; Cruz, A; Perez-Gil, J				Olmeda, Barbara; Garcia-Alvarez, Begona; Gomez, Manuel J.; Martinez-Calle, Marta; Cruz, Antonio; Perez-Gil, Jesus			A model for the structure and mechanism of action of pulmonary surfactant protein B	FASEB JOURNAL			English	Article						saposin; air-liquid interface; lipid transport; lung; lipid-protein interaction	SAPOSIN-LIKE PROTEINS; N-TERMINAL SEGMENT; SP-C; LUNG SURFACTANT; SECONDARY STRUCTURE; PHOSPHOLIPID FILMS; CRYSTAL-STRUCTURES; NMR STRUCTURE; CUBIC PHASES; MEMBRANES	Surfactant protein B (SP-B), from the saposin-like family of proteins, is essential to facilitate the formation and proper performance of surface active films at the air-liquid interface of mammalian lungs, and lack of or deficiency in this protein is associated with lethal respiratory failure. Despite its importance, neither a structural model nor a molecular mechanism of SP-B is available. The purpose of the present work was to purify and characterize native SP-B supramolecular assemblies to provide a model supporting structure-function features described for SP-B. Purification of porcine SP-B using detergent-solubilized surfactant reveals the presence of 10 nm ring-shaped particles. These rings, observed by atomic force and electron microscopy, would be assembled by oligomerization of SP-B as a multimer of dimers forming a hydrophobically coated ring at the surface of phospholipid membranes or monolayers. Docking of rings from neighboring membranes would lead to formation of SP-B-based hydrophobic tubes, competent to facilitate the rapid flow of surface active lipids both between membranes and between surfactant membranes and the interface. A similar sequential assembly of dimers, supradimeric oligomers and phospholipid-loaded tubes could explain the activity of other saposins with colipase, cytolysin, or antibiotic activities, offering a common framework to understand the range of functions carried out by saposins.	[Olmeda, Barbara; Garcia-Alvarez, Begona; Martinez-Calle, Marta; Cruz, Antonio; Perez-Gil, Jesus] Univ Complutense, Fac Biol, Dept Bioquim, E-28040 Madrid, Spain; [Gomez, Manuel J.] CSIC, Ctr Astrobiol INTA, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Perez-Gil, J (corresponding author), Univ Complutense, Fac Biol, Dept Bioquim & Biol Mol, Jose Antonio Novais 2, E-28040 Madrid, Spain.	jperezgil@bio.ucm.es	Martínez-Calle, Marta/C-5930-2018; Cruz, Antonio/H-2881-2015; Olmeda, Bárbara/H-1440-2015; Garcia-Alvarez, Begoña/K-1409-2016; Calle, Marta Martínez/H-1451-2015; Gómez, Manuel J/F-8854-2016; Perez-Gil, Jesus/H-3102-2019	Martínez-Calle, Marta/0000-0003-1198-2532; Cruz, Antonio/0000-0002-0465-4111; Olmeda, Bárbara/0000-0001-6004-1603; Garcia-Alvarez, Begoña/0000-0003-3774-1999; Calle, Marta Martínez/0000-0003-1198-2532; Gómez, Manuel J/0000-0002-4111-4835; Perez-Gil, Jesus/0000-0003-3587-7147	Spanish Ministry of Economy [BIO2012-30733]; Regional Government of Madrid [S2013/MlT-2807]	Spanish Ministry of Economy(Spanish Government); Regional Government of Madrid	The authors sincerely thank Prof. Stephen Hall (Oregon Health and Science University, Portland, OR, USA), Prof. Johanna Floros, (Pennsylvania State University at Hershey, Hershey, PA, USA), Prof. Valery Booth (Memorial University of Newfoundland, St. John's, NL, Canada), Prof. Thomas Haller (Medical University of Innsbruck, Innsbruck, Austria), and Prof. Sandra Orgeig (University of South Australia, Adelaide, SA, Australia), for fruitful discussions on the SP-B model. The assistance of Dr. J. Antonio Enriquez (National Center of Cardiovascular Research, Madrid, Spain), with the analysis by blue native electrophoresis of supramolecular protein complexes, is also recognized. The authors are also indebted to Drs. German Rivas, Carlos Alfonso, and Oscar Llorca (Centro de Investigaciones Biologicas, Madrid, Spain), for technical assistance with analytical centrifugation and electron microscopy, respectively. The authors also acknowledge the technical assistance and infrastructure from Centro Nacional de Microscopia Avanzada (Madrid, Spain) during the electron microscopy and AFM experiments. This work has been supported by grants from the Spanish Ministry of Economy (BIO2012-30733) and the Regional Government of Madrid (S2013/MlT-2807).	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; ANDERSSON M, 1995, FEBS LETT, V362, P328, DOI 10.1016/0014-5793(95)00268-E; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banares-Hidalgo A, 2014, BBA-BIOMEMBRANES, V1838, P1738, DOI 10.1016/j.bbamem.2014.03.016; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Bernardinode la Serna J., 2013, FARADAY DISCUSS, V161, P535; Bernardinode la Serna J., 2013, FARADAY DISCUSS, V161, P563; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bryksa BC, 2011, J BIOL CHEM, V286, P28265, DOI 10.1074/jbc.M111.252619; Bunger H, 2001, PROTEIN EXPRES PURIF, V23, P319, DOI 10.1006/prep.2001.1510; Cabre EJ, 2012, BBA-BIOMEMBRANES, V1818, P1717, DOI 10.1016/j.bbamem.2012.03.008; Cabre EJ, 2009, BIOPHYS J, V97, P768, DOI 10.1016/j.bpj.2009.04.057; Chavarha M, 2013, BIOPHYS J, V104, P594, DOI 10.1016/j.bpj.2012.12.041; Chavarha M, 2012, LANGMUIR, V28, P16596, DOI 10.1021/la3025364; Chavarha M, 2010, BIOPHYS J, V98, P1549, DOI 10.1016/j.bpj.2009.12.4302; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cruz A, 2004, BIOPHYS J, V86, P308, DOI 10.1016/S0006-3495(04)74106-5; Cruz Antonio, 2007, V400, P439; Farver RS, 2010, BIOPHYS J, V99, P1773, DOI 10.1016/j.bpj.2010.06.076; Flach CR, 2003, BIOPHYS J, V85, P340, DOI 10.1016/S0006-3495(03)74478-6; Follows D, 2007, BBA-BIOMEMBRANES, V1768, P228, DOI 10.1016/j.bbamem.2006.10.004; Foster CD, 2003, AM J RESP CELL MOL, V29, P259, DOI 10.1165/rcmb.2002-0149OC; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Ikegami M, 2002, J APPL PHYSIOL, V93, P505, DOI 10.1152/japplphysiol.01137.2001; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Krol S, 2000, BIOPHYS J, V79, P904, DOI 10.1016/S0006-3495(00)76346-6; Kurutz JW, 2002, BIOCHEMISTRY-US, V41, P9627, DOI 10.1021/bi016077x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Lipp MM, 1996, SCIENCE, V273, P1196, DOI 10.1126/science.273.5279.1196; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mingarro I, 2008, CURR MED CHEM, V15, P393, DOI 10.2174/092986708783497364; MUNFORD RS, 1995, J LIPID RES, V36, P1653; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Olmeda B, 2013, EUR BIOPHYS J BIOPHY, V42, P209, DOI 10.1007/s00249-012-0858-9; Olmeda B, 2010, BBA-BIOMEMBRANES, V1798, P1281, DOI 10.1016/j.bbamem.2010.03.008; Parra E, 2013, BIOPHYS J, V104, P146, DOI 10.1016/j.bpj.2012.11.014; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; PEREZGIL J, 1993, BIOCHIM BIOPHYS ACTA, V1168, P261, DOI 10.1016/0005-2760(93)90181-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce B, 2005, BIOINFORMATICS, V21, P1472, DOI 10.1093/bioinformatics/bti229; Piknova B, 2002, CURR OPIN STRUC BIOL, V12, P487, DOI 10.1016/S0959-440X(02)00352-4; Popovic K, 2012, P NATL ACAD SCI USA, V109, P2908, DOI 10.1073/pnas.1115743109; Rodriguez-Capote K, 2001, AM J PHYSIOL-LUNG C, V281, pL231, DOI 10.1152/ajplung.2001.281.1.L231; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rugonyi S, 2008, RESP PHYSIOL NEUROBI, V163, P244, DOI 10.1016/j.resp.2008.05.018; Ryan MA, 2005, BIOCHEMISTRY-US, V44, P861, DOI 10.1021/bi0485575; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schurch D, 2010, BIOPHYS J, V99, P3290, DOI 10.1016/j.bpj.2010.09.039; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serrano AG, 2006, BIOPHYS J, V90, P238, DOI 10.1529/biophysj.105.073403; Serrano AG, 2005, BIOCHEMISTRY-US, V44, P417, DOI 10.1021/bi048781u; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; VANDENBUSSCHE G, 1992, BIOCHEMISTRY-US, V31, P9169, DOI 10.1021/bi00153a008; Wang YD, 2003, BIOCHEMISTRY-US, V42, P4015, DOI 10.1021/bi027344h; Weaver TE, 1999, BIOL NEONATE, V76, P15, DOI 10.1159/000047041; Wustneck N, 2003, BIOPHYS J, V84, P1940, DOI 10.1016/S0006-3495(03)75002-4; Wustneck R, 2005, ADV COLLOID INTERFAC, V117, P33, DOI 10.1016/j.cis.2005.05.001; Zaltash S, 2000, BBA-BIOMEMBRANES, V1466, P179, DOI 10.1016/S0005-2736(00)00199-1; Zaltash S, 2001, BIOL CHEM, V382, P933, DOI 10.1515/BC.2001.116	72	39	41	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4236	4247		10.1096/fj.15-273458	http://dx.doi.org/10.1096/fj.15-273458			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26089319				2022-12-28	WOS:000361367300013
J	Kadoya, H; Satoh, M; Sasaki, T; Taniguchi, S; Takahashi, M; Kashihara, N				Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Taniguchi, Shun'ichiro; Takahashi, Masafumi; Kashihara, Naoki			Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice	FASEB JOURNAL			English	Article						chronic inflammation; kidney; mineralocorticoid receptor; mitochondria; reactive oxygen species	OXIDATIVE STRESS; ANGIOTENSIN-II; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; DEFICIENCY; PROMOTES; INJURY; NLRP3-INFLAMMASOME; SPIRONOLACTONE; HYPERGLYCEMIA	High levels of aldosterone impair renal function by activating proinflammatory and profibrotic pathways. However, the molecular mechanism underlying aldosterone-induced inflammation and fibrosis is unknown. Inflammasome activation contributes to chronic kidney disease. We hypothesized that aldosterone induces renal tubulointerstitial inflammation and fibrosis by activating the inflammasome. Infusing wild-type mice with aldosterone (0.25 mg/kg/d) caused tubulointerstitial damage, increased expression of inflammasome components, caspase 1 activation, and overproduction of IL-1 beta and IL-18. These changes were suppressed by eplerenone treatment (100 mg/kg/d) in wild-type mice or in mice deficient in apoptosis-associated speck-like protein with a caspase-recruitment domain (ASC). Caspase 1-positive and F4/80-positive cells colocalized in the interstitium. Bone marrow transplantation using ASC-deficient mice indicated that inflammasome activation in macrophages mediated aldosterone-induced renal fibrosis. IL-18 was detected in culture supernatants of macrophages treated with aldosterone, and mitochondria-derived reactive oxygen species activated the inflammasome in these macrophages. Our results indicate that exposure of macrophages to high levels of aldosterone resulted in the activation of inflammasomes via the mitochondria-derived reactive oxygen species. Thus, inflammasome activation in macrophages may serve as a new therapeutic target for chronic kidney disease.	[Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Sch, Dept Hypertens & Nephrol, Kurashiki, Okayama 7010192, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano 390, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan	Kawasaki Medical School; Shinshu University; Jichi Medical University	Satoh, M (corresponding author), Kawasaki Med Sch, Dept Hypertens & Nephrol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	msatoh@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science [24390218, 24591220]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank E. Yorimasa and M. Yokohata for animal care, S. Hanada and K. Satoh (Kawasaki Medical School) for their help with in vitro assays, and M. Takahashi (Jichi Medical University) for invaluable research advice. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24390218 to N.K. and 24591220 to M.S.).	Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Dooley R, 2012, MOL CELL ENDOCRINOL, V350, P223, DOI 10.1016/j.mce.2011.07.019; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Guney I, 2009, RENAL FAILURE, V31, P779, DOI 10.3109/08860220903150312; Hagiwara H, 2006, FEBS LETT, V580, P4463, DOI 10.1016/j.febslet.2006.07.015; Han SY, 2006, J AM SOC NEPHROL, V17, P1362, DOI 10.1681/ASN.2005111196; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Kuwabara A, 2010, DIABETOLOGIA, V53, P2056, DOI 10.1007/s00125-010-1810-0; Lee SH, 2009, AM J PHYSIOL-RENAL, V297, pF1381, DOI 10.1152/ajprenal.00101.2009; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Luo P, 2013, DIABETOLOGIA, V56, P901, DOI 10.1007/s00125-012-2814-8; Luther JM, 2012, KIDNEY INT, V82, P643, DOI 10.1038/ki.2012.170; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Nakamura T, 2009, HYPERTENSION, V54, P544, DOI 10.1161/HYPERTENSIONAHA.109.135392; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Nolly MB, 2014, J MOL CELL CARDIOL, V67, P60, DOI 10.1016/j.yjmcc.2013.12.004; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Ptinopoulou AG, 2013, HYPERTENS RES, V36, P91, DOI 10.1038/hr.2012.157; Quinn S, 2014, STEROIDS, V81, P43, DOI 10.1016/j.steroids.2013.11.005; Remuzzi G, 2008, J AM SOC NEPHROL, V19, P1459, DOI 10.1681/ASN.2007101079; Schjoedt KJ, 2004, DIABETOLOGIA, V47, P1936, DOI 10.1007/s00125-004-1542-0; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Tokuyama H, 2012, INT J OBESITY, V36, P1062, DOI 10.1038/ijo.2011.232; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wuhl E, 2011, NAT REV NEPHROL, V7, P434, DOI 10.1038/nrneph.2011.73; Yoneda T, 2007, AM J HYPERTENS, V20, P1329, DOI 10.1016/j.amjhyper.2007.09.001; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	43	45	48	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3899	3910		10.1096/fj.15-271734	http://dx.doi.org/10.1096/fj.15-271734			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26054366				2022-12-28	WOS:000359915600025
J	Lee, J; Taylor, SEB; Smeriglio, P; Lai, J; Maloney, WJ; Yang, F; Bhutani, N				Lee, Jieun; Taylor, Sarah E. B.; Smeriglio, Piera; Lai, Janice; Maloney, William J.; Yang, Fan; Bhutani, Nidhi			Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells	FASEB JOURNAL			English	Article						hiPSC-derived chondrocytes; prechondrogenic population; cartilage regeneration	CARTILAGE; FIBROBLASTS; SOX9; DIFFERENTIATION; EXPRESSION; SPECIFICATION; BONE	Regeneration of human cartilage is inherently inefficient; an abundant autologous source, such as human induced pluripotent stem cells (hiPSCs), is therefore attractive for engineering cartilage. We report a growth factor-based protocol for differentiating hiPSCs into articular-like chondrocytes (hiChondrocytes) within 2weeks, with an overall efficiency >90%. The hiChondrocytes are stable and comparable to adult articular chondrocytes in global gene expression, extracellular matrix production, and ability to generate cartilage tissue in vitro and in immune-deficient mice. Molecular characterization identified an early SRY (sex-determining region Y) box (Sox)9(low) cluster of differentiation (CD)44(low)CD140(low) prechondrogenic population during hiPSC differentiation. In addition, 2 distinct Sox9-regulated gene networks were identified in the Sox9(low) and Sox9(high) populations providing novel molecular insights into chondrogenic fate commitment and differentiation. Our findings present a favorable method for generating hiPSC-derived articular-like chondrocytes. The hiChondrocytes are an attractive cell source for cartilage engineering because of their abundance, autologous nature, and potential to generate articular-like cartilage rather than fibrocartilage. In addition, hiChondrocytes can be excellent tools for modeling human musculoskeletal diseases in a dish and for rapid drug screening.	[Lee, Jieun; Taylor, Sarah E. B.; Smeriglio, Piera; Lai, Janice; Maloney, William J.; Yang, Fan; Bhutani, Nidhi] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA USA; [Lai, Janice] Stanford Univ, Sch Med, Dept Mech Engn, Stanford, CA USA; [Yang, Fan] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Bhutani, N (corresponding author), 300 Pasteur Dr,Edwards Bldg,R164, Stanford, CA 94305 USA.	nbhutani@stanford.edu	Yang, Fan/GYU-4249-2022; Smeriglio, Piera/AAK-9870-2021	Smeriglio, Piera/0000-0002-3430-6839	U.S. National Institutes of Health S10 Shared Instrument Grant [S10RR027431-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027431] Funding Source: NIH RePORTER	U.S. National Institutes of Health S10 Shared Instrument Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank Prof. John P. Cooke (Methodist Hospital Research Institute), Profs. Renee Reijo Pera (Montana State University), and Drs. Vittorio Sebastiano (Stanford University) and Arwen Hunter (Stem Cell Technologies) for help with hiPSC generation and Natalia Kosovilka (Stanford University School of Medicine Protein and Nucleic Acid Facility) for running the microarrays. FACS data were performed on an instrument in the shared FACS facility obtained using U.S. National Institutes of Health S10 Shared Instrument Grant S10RR027431-01. No financial support or other benefits have been obtained from any commercial sources for this study. The authors declare no conflicts of interest.	Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Lai JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep03553; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lohmander LS, 2007, LANCET, V370, P2082, DOI 10.1016/S0140-6736(07)61879-0; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Pelttari K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009688; Smeriglio P, 2015, TISSUE ENG PT A, V21, P147, DOI [10.1089/ten.tea.2014.0070, 10.1089/ten.TEA.2014.0070]; Stoddart MJ, 2009, REGEN MED, V4, P81, DOI 10.2217/17460751.4.1.81; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor SEB, 2014, ARTHRITIS RHEUMATOL, V66, P90, DOI 10.1002/art.38200; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200	36	32	34	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3399	3410		10.1096/fj.14-269720	http://dx.doi.org/10.1096/fj.14-269720			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911615	Green Published			2022-12-28	WOS:000358796900027
J	Murthy, S; Larson-Casey, JL; Ryan, AJ; He, C; Kobzik, L; Carter, AB				Murthy, Shubha; Larson-Casey, Jennifer L.; Ryan, Alan J.; He, Chao; Kobzik, Lester; Carter, A. Brent			Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure	FASEB JOURNAL			English	Article						MARCO; mitochondria; asbestos	ALVEOLAR MACROPHAGES; CHRYSOTILE ASBESTOS; BINDING-RECEPTOR; SURFACE-CHARGE; SR-AI/II; MARCO; PARTICLES; BACTERIA; INFLAMMATION; DOMAIN	Alternative activation of alveolar macrophages is linked to fibrosis following exposure to asbestos. The scavenger receptor, macrophage receptor with collagenous structure (MARCO), provides innate immune defense against inhaled particles and pathogens; however, a receptor for asbestos has not been identified. We hypothesized that MARCO acts as an initial signaling receptor for asbestos, polarizes macrophages to a profibrotic M2 phenotype, and is required for the development of asbestos-induced fibrosis. Compared with normal subjects, alveolar macrophages isolated from patients with asbestosis express higher amounts of MARCO and have greater profibrotic polarization. Arginase 1 (40-fold) and IL-10 (265-fold) were higher in patients. In vivo, the genetic deletion of MARCO attenuated the profibrotic environment and pulmonary fibrosis in mice exposed to chrysotile. Moreover, alveolar macrophages from MARCO(-/-) mice polarize to an M1 phenotype, whereas wild-type mice have higher Ym1 (>3.0-fold) and nearly 7-fold more active TGF-beta 1 in bronchoalveolar lavage (BAL) fluid (BALF). Arg(432) and Arg(434) in domain V of MARCO are required for the polarization of macrophages to a profibrotic phenotype as mutation of these residues reduced FIZZ1 expression (17-fold) compared with cells expressing MARCO. These observations demonstrate that a macrophage membrane protein regulates the fibrotic response to lung injury and suggest a novel target for therapeutic intervention.-Murthy, S., Larson-Casey, J. L., Ryan, A. J., He, C., Kobzik, L., Carter, A. B. Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure.	[Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent] Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [He, Chao; Carter, A. Brent] Carver Coll Med, Dept Radiat Oncol, Iowa City, IA USA; [He, Chao; Carter, A. Brent] Carver Coll Med, Grad Program Free Radical & Radiat Biol, Iowa City, IA USA; [Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Human Toxicol, Iowa City, IA USA; [Carter, A. Brent] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Alabama Birmingham, Birmingham, AL 35294 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Alabama System; University of Alabama Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, 404 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	bcarter1@uab.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant [2R01ES015981-07]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant [1BX001135-03]; NIH Grant [University of Alabama at Birmingham (UAB) O'Brien Acute Kidney Injury Center] [P30 DK079337]; UAB Lung Health Center; UAB Center for Free Radical Biology; NATIONAL CANCER INSTITUTE [T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant; NIH Grant [University of Alabama at Birmingham (UAB) O'Brien Acute Kidney Injury Center]; UAB Lung Health Center; UAB Center for Free Radical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant 2R01ES015981-07 (to A.B.C.) and the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant 1BX001135-03 (to A.B.C.). For the GSH and GSSG analysis, the authors thank the Targeted Metabolomics and Proteonomics Laboratory supported by NIH Grant P30 DK079337 [University of Alabama at Birmingham (UAB) O'Brien Acute Kidney Injury Center], the UAB Lung Health Center, and the UAB Center for Free Radical Biology.	Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.2006-0128OC; Arredouani MS, 2004, CELL MOL BIOL, V50, P657; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; BALES RC, 1985, ENVIRON SCI TECHNOL, V19, P1213, DOI 10.1021/es00142a013; Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Chen YY, 2006, J BIOL CHEM, V281, P12767, DOI 10.1074/jbc.M513628200; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Karo-Atar D, 2013, AM J RESP CELL MOL, V48, P456, DOI 10.1165/rcmb.2012-0329OC; LIGHT WG, 1977, NATURE, V265, P537, DOI 10.1038/265537a0; Magnan A, 1998, ALLERGY, V53, P1092, DOI 10.1111/j.1398-9995.1998.tb03821.x; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Mukhopadhyay S, 2006, EUR J IMMUNOL, V36, P940, DOI 10.1002/eji.200535389; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; RESNICK D, 1993, J BIOL CHEM, V268, P3538; SCHEULE RK, 1989, AM J RESP CELL MOL, V1, P313, DOI 10.1165/ajrcmb/1.4.313; SCHWARTZ DA, 1993, AM REV RESPIR DIS, V148, P68, DOI 10.1164/ajrccm/148.1.68; SESHAN K, 1983, ENVIRON HEALTH PERSP, V53, P143, DOI 10.2307/3429625; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Thakur SA, 2009, TOXICOL SCI, V107, P238, DOI 10.1093/toxsci/kfn210; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; van der Laan LJW, 1999, J IMMUNOL, V162, P939; WRIGHT A, 1983, ENVIRON HEALTH PERSP, V51, P147, DOI 10.1289/ehp.8351147	43	70	75	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3527	3536		10.1096/fj.15-271304	http://dx.doi.org/10.1096/fj.15-271304			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25953850	Green Published			2022-12-28	WOS:000358796900038
J	Smeriglio, P; Alonso-Martin, S; Masciarelli, S; Madaro, L; Iosue, I; Marrocco, V; Relaix, F; Fazi, F; Marazzi, G; Sassoon, DA; Bouche, M				Smeriglio, Piera; Alonso-Martin, Sonia; Masciarelli, Silvia; Madaro, Luca; Iosue, Ilaria; Marrocco, Valeria; Relaix, Frederic; Fazi, Francesco; Marazzi, Giovanna; Sassoon, David A.; Bouche, Marina			Phosphotyrosine phosphatase inhibitor bisperoxovanadium endows myogenic cells with enhanced muscle stem cell functions via epigenetic modulation of Sca-1 and Pw1 promoters	FASEB JOURNAL			English	Article						cell reprogramming; muscle regeneration; PW1 interstitial cells; muscle cell fate; cell stemness	SKELETAL-MUSCLE; SATELLITE CELLS; SELF-RENEWAL; PROGENITOR CELLS; REGENERATION; EXPANSION; DIFFERENTIATION; MICE; TRANSPLANTATION; PLURIPOTENCY	Understanding the regulation of the stem cell fate is fundamental for designing novel regenerative medicine strategies. Previous studies have suggested that pharmacological treatments with small molecules provide a robust and reversible regulation of the stem cell program. Previously, we showed that treatment with a vanadium compound influences muscle cell fate in vitro. In this study, we demonstrate that treatment with the phosphotyrosine phosphatase inhibitor bisperoxovanadium (BpV) drives primary muscle cells to a poised stem cell stage, with enhanced function in muscle regeneration in vivo following transplantation into injured muscles. Importantly, BpV-treated cells displayed increased self-renewal potential in vivo and replenished the niche in both satellite and interstitial cell compartments. Moreover, we found that BpV treatment induces specific activating chromatin modifications at the promoter regions of genes associated with stem cell fate, including Sca-1 and Pw1. Thus, our findings indicate that BpV resets the cell fate program by specific epigenetic regulations, such that the committed myogenic cell fate is redirected to an earlier progenitor cell fate stage, which leads to an enhanced regenerative stem cell potential.-Smeriglio, P., Alonso-Martin, S., Masciarelli, S., Madaro, L., Iosue, I., Marrocco, V., Relaix, F., Fazi, F., Marazzi, G., Sassoon, D. A., Bouche, M. Phosphotyrosine phosphatase inhibitor bisperoxovanadium endows myogenic cells with enhanced muscle stem cell functions via epigenetic modulation of Sca-1 and Pw1 promoters. FASEB J. 30, 1404-1415 (2016). www.fasebj.org	[Smeriglio, Piera; Marazzi, Giovanna; Sassoon, David A.] Univ Paris 06, Stem Cells & Regenerat Med, Inst Cardiometab & Nutr, Unite Mixte Rech Sante 1166,INSERM,Sorbonne Univ, Paris, France; [Smeriglio, Piera; Masciarelli, Silvia; Madaro, Luca; Iosue, Ilaria; Marrocco, Valeria; Fazi, Francesco; Bouche, Marina] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Unit Histol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Alonso-Martin, Sonia; Relaix, Frederic] Inst Mondor Rech Biomed, INSERM, U955, Creteil, France; [Alonso-Martin, Sonia; Relaix, Frederic] Univ Paris Est Creteil, Fac Med, Creteil, France; [Relaix, Frederic] Univ Paris 06, Sorbonne Univ, INSERM, Unite Mixte Rech Sante 974,CNRS,FRE3617,Ctr Res M, Paris, France; [Relaix, Frederic] Etab Francais Sang, Creteil, France; [Relaix, Frederic] Univ Paris Est, Ecole Natl Vet Alfort, Maison Alfort, France; [Smeriglio, Piera] Stanford Univ, Dept Orthoped Surg, Stanford, CA 94305 USA; [Madaro, Luca] IRCCS Fdn Santa Lucia, Dept Epigenet & Pharmacol, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ecole Nationale Veterinaire d'Alfort (ENVA); Stanford University; IRCCS Santa Lucia	Sassoon, DA (corresponding author), Univ Paris 06, Stem Cells & Regenerat Med, Inst Cardiometab & Nutr, Unite Mixte Rech Sante 1166,INSERM,Sorbonne Univ, Paris, France.; Bouche, M (corresponding author), Univ Roma La Sapienza, DAHFMO, Unit Histol, Via A Scarpa 14, I-00161 Rome, Italy.; Sassoon, DA (corresponding author), Univ Paris 06, INSERM, Sorbonne Univ, Stem Cells & Regenerat Med,ICAN,UMRS 1166, F-75634 Paris, France.	david.a.sassoon@gmail.com; marina.bouche@uniroma1.it	Smeriglio, Piera/AAK-9870-2021; Alonso-Martin, Sonia/L-2751-2019; Alonso-Martin, Sonia/F-3021-2013; Madaro, Luca/ABE-4683-2021; Madaro, Luca/K-4629-2016; Fazi, Francesco/K-5304-2018; SASSOON, David A/G-2502-2013	Alonso-Martin, Sonia/0000-0002-3254-0365; Alonso-Martin, Sonia/0000-0002-3254-0365; Madaro, Luca/0000-0003-0839-5724; Madaro, Luca/0000-0003-0839-5724; Fazi, Francesco/0000-0003-2910-7912; SASSOON, David A/0000-0001-6074-048X; MASCIARELLI, SILVIA/0000-0002-6738-6281; Relaix, Frederic/0000-0003-1270-1472; Bouche, Marina/0000-0002-0938-5360; Smeriglio, Piera/0000-0002-3430-6839; Marazzi, giovanna/0000-0002-5388-1038	French Ministry of Research "Chaired Excellence"; Muscular Dystrophy Association of America; European Community [Health-F5-2009-223098]; ENDOSTEM (Activation of Vasculature Associated Stem Cells for the Repair and Maintenance of Muscle Tissue) [241440]; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir) [ANR-10-LABX-73]; IHU-ICAN projects; Italian Ministry for University and Research; Sapienza University of Rome; French Association against Myopathies (AFM); Telethon Italy; Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome; Duchenne Parent Project (Amsterdam, The Netherlands)	French Ministry of Research "Chaired Excellence"; Muscular Dystrophy Association of America(Muscular Dystrophy Association); European Community(European Commission); ENDOSTEM (Activation of Vasculature Associated Stem Cells for the Repair and Maintenance of Muscle Tissue); Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir)(French National Research Agency (ANR)); IHU-ICAN projects; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; French Association against Myopathies (AFM)(Association Francaise contre les Myopathies); Telethon Italy(Fondazione Telethon); Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Duchenne Parent Project (Amsterdam, The Netherlands)(Netherlands Government)	The authors thank Edgar Gomes (Myology Institute, Paris, France) for his generous gift of GFP-H1-C2cell line; Antonio Musaro (Department of Anatomy, Histology, Forensic Medicine, and Orthopedics, Sapienza University of Rome, Italy) for his guidance and input in this project; Andrew Ho (Baxter Laboratory for Stem Cell Biology, Stanford University, Stanford, CA, USA); and Biliana Lozanoska-Ochser and Mario Molinaro (Department of Anatomy, Histology, Forensic Medicine, and Orthopedics, Sapienza University of Rome, Italy) for critical reading and editing of this manuscript. The authors also thank C. Blanc and B. Hoareau (Flow Cytometry Core CyPS, Pierre and Marie Curie University, Pitie-Salpetriere Hospital, Paris, France) for their assistance and help in sorting strategies. This work was supported by the French Ministry of Research "Chaired Excellence" and the Muscular Dystrophy Association of America to D.A.S. and the European Community Seventh Framework Program projects OPTISTEM (Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases contract number Health-F5-2009-223098) and ENDOSTEM (Activation of Vasculature Associated Stem Cells for the Repair and Maintenance of Muscle Tissue-agreement number 241440). D.A.S. acknowledges support from the Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir; ANR-10-LABX-73) and the IHU-ICAN projects. M.B. acknowledges support from the Italian Ministry for University and Research, the Sapienza University of Rome, the French Association against Myopathies (AFM), and the Telethon Italy. Piera Smeriglio was supported by a doctoral fellowship from Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome; Luca Madaro was recipient of a postdoctoral fellowship from Duchenne Parent Project (Amsterdam, The Netherlands). The authors declare no conflicts of interest.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bonfanti C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7364; Cadot B, 2012, EMBO REP, V13, P741, DOI 10.1038/embor.2012.89; Castaldi L, 2007, FASEB J, V21, P3573, DOI 10.1096/fj.06-7454com; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Choi MC, 2014, EMBO REP, V15, P1175, DOI 10.15252/embr.201439195; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deasy BM, 2002, STEM CELLS, V20, P50, DOI 10.1634/stemcells.20-1-50; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Kim WH, 2012, ACS CHEM BIOL, V7, P732, DOI 10.1021/cb200532v; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Liadaki K, 2012, J HISTOCHEM CYTOCHEM, V60, P31, DOI 10.1369/0022155411428991; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; Motohashi N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00001; Mu XD, 2011, AM J PATHOL, V179, P931, DOI 10.1016/j.ajpath.2011.05.004; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Paliwal P, 2011, CHEM BIOL, V18, P1153, DOI 10.1016/j.chembiol.2011.07.012; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Segales J, 2015, FEBS J, V282, P1571, DOI 10.1111/febs.13065; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Sousa-Victor P, 2011, TOXICOL MECH METHOD, V21, P334, DOI 10.3109/15376516.2011.557873; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wu J, 2014, NATURE, V516, P172, DOI 10.1038/516172a; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	62	4	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1404	1415		10.1096/fj.15-275420	http://dx.doi.org/10.1096/fj.15-275420			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26672000				2022-12-28	WOS:000372629100004
J	Maeda, M; Hasegawa, H; Sugiyama, M; Hyodo, T; Ito, S; Chen, D; Asano, E; Masuda, A; Hasegawa, Y; Hamaguchi, M; Senga, T				Maeda, Masao; Hasegawa, Hitoki; Sugiyama, Mai; Hyodo, Toshinori; Ito, Satoko; Chen, Dan; Asano, Eri; Masuda, Akio; Hasegawa, Yoshinori; Hamaguchi, Michinari; Senga, Takeshi			Arginine methylation of ubiquitin-associated protein 2-like is required for the accurate distribution of chromosomes	FASEB JOURNAL			English	Article						PRMT1; mitosis; kinetochore; UBAP2L	SPINDLE-ASSEMBLY CHECKPOINT; KINETOCHORE-MICROTUBULE INTERFACE; REGULATE MITOTIC PROGRESSION; METHYLTRANSFERASE 7 PRMT7; CELL-DIVISION; CANCER-CELLS; AURORA-B; CENP-E; MITOSIS; BUBR1	Proper bioriented attachment of microtubules and kinetochores is essential for the precise distribution of duplicated chromosomes to each daughter cell. An aberrant kinetochore-microtubule attachment results in chromosome instability, which leads to cellular transformation or apoptosis. In this article, we show that ubiquitin-associated protein 2-like (UBAP2L) is necessary for correct kinetochore-microtubule attachment. Depletion of UBAP2L inhibited chromosome alignment in metaphase and delayed progression to anaphase by activating spindle assembly checkpoint signaling. In addition, UBAP2L knockdown increased side-on attachment of kinetochores along the microtubules and suppressed stable kinetochore fiber formation. A proteomics analysis identified protein arginine methyltransferase (PRMT) 1 as a direct interaction partner of UBAP2L. UBAP2L has an arginine-and glycine-rich motif called the RGG/RG or GAR motif in the N terminus. Biochemical analysis confirmed that arginine residues in the RGG/RG motif of UBAP2L were directly methylated by PRMT1. Finally, we demonstrated that the RGG/RG motif of UBAP2L is essential for the proper alignment of chromosomes in metaphase for the accurate distribution of chromosomes. Our results show a possible role for arginine methylation in UBAP2L for the progression of mitosis.	[Maeda, Masao; Hasegawa, Hitoki; Sugiyama, Mai; Hyodo, Toshinori; Ito, Satoko; Chen, Dan; Asano, Eri; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan; [Masuda, Akio] Nagoya Univ, Grad Sch Med, Div Neurogenet, Nagoya, Aichi 4668550, Japan; [Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University	Senga, T (corresponding author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp	Hasegawa, Yoshinori/I-1277-2012	Hyodo, Toshinori/0000-0003-3046-5338; Maeda, Masao/0000-0001-5936-5790	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25650063, 2306]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank the members of the Division of Cancer Biology for technical assistance and helpful discussions. This research was funded by Grants 25650063 and 2306 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.S.).	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Baumgartner R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003598; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Bordeleau ME, 2014, BLOOD, V124, P2362, DOI 10.1182/blood-2014-01-548651; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Davidovic L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003367; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Feng Y, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609271; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Hasegawa H, 2013, J CELL SCI, V126, P3627, DOI 10.1242/jcs.124818; Hofmann JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074851; Jiang H, 2014, DEV CELL, V28, P268, DOI 10.1016/j.devcel.2013.12.013; Kahyo T, 2011, ONCOGENE, V30, P4453, DOI 10.1038/onc.2011.152; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Kruse T, 2013, J CELL SCI, V126, P1086, DOI 10.1242/jcs.122481; Kuniyoshi H, 2002, GENETICS, V162, P1775; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li D, 2014, ONCOL REP, V32, P1578, DOI 10.3892/or.2014.3360; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Park I, 2013, J CELL BIOL, V202, P295, DOI 10.1083/jcb.201210099; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Shrestha RL, 2013, CURR BIOL, V23, P2440, DOI 10.1016/j.cub.2013.11.015; Shrestha RL, 2013, CURR BIOL, V23, P1514, DOI 10.1016/j.cub.2013.06.040; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Sze KMF, 2008, CANCER RES, V68, P9194, DOI 10.1158/0008-5472.CAN-08-2600; Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; van Leuken RJ, 2008, CELL CYCLE, V7, P2710, DOI 10.4161/cc.7.17.6553; Varma D, 2012, J CELL SCI, V125, P5927, DOI 10.1242/jcs.093724; Wang YC, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29027; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Weng MT, 2012, P NATL ACAD SCI USA, V109, pE3659, DOI 10.1073/pnas.1207673110; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	51	17	17	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					312	323		10.1096/fj.14-268987	http://dx.doi.org/10.1096/fj.14-268987			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26381755				2022-12-28	WOS:000367621000030
J	Pedroza, M; Le, TT; Lewis, K; Karmouty-Quintana, H; To, S; George, AT; Blackburn, MR; Tweardy, DJ; Agarwal, SK				Pedroza, Mesias; Le, Thuy T.; Lewis, Katherine; Karmouty-Quintana, Harry; To, Sarah; George, Anuh T.; Blackburn, Michael R.; Tweardy, David J.; Agarwal, Sandeep K.			STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation	FASEB JOURNAL			English	Article						fibrosis; STAT3; epithelial injury; myofibroblast	GROWTH-FACTOR-BETA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MESENCHYMAL INTERACTIONS; POTENTIAL ROLE; INTERLEUKIN-6; IL-6; ACTIVATION; EXPRESSION; MICE; INFLAMMATION	Lung fibrosis is the hallmark of the interstitial lung diseases. Alveolar epithelial cell (AEC) injury is a key step that contributes to a profibrotic microenvironment. Fibroblasts and myofibroblasts subsequently accumulate and deposit excessive extracellular matrix. In addition to TGF-beta, the IL-6 family of cytokines, which signal through STAT-3, may also contribute to lung fibrosis. In the current manuscript, the extent to which STAT-3 inhibition decreases lung fibrosis is investigated. Phosphorylated STAT-3 was elevated in lung biopsies from patients with idiopathic pulmonary fibrosis and bleomycin (BLM)-induced fibrotic murine lungs. C-188-9, a small molecule STAT-3 inhibitor, decreased pulmonary fibrosis in the intraperitoneal BLM model as assessed by arterial oxygen saturation (control, 84.4 +/- 1.3%; C-188-9, 94.4 +/- 0.8%), histology (Ashcroft score: untreated, 5.4 +/- 0.25; C-188-9, 3.3 +/- 0.14), and attenuated fibrotic markers such as diminished alpha-smooth muscle actin, reduced collagen deposition. In addition, C-188-9 decreased the expression of epithelial injury markers, including hypoxia-inducible factor-1 alpha (HIF-1 alpha) and plasminogen activator inhibitor-1 (PAI-1). In vitro studies show that inhibition of STAT-3 decreased IL-6- and TGF-beta-induced expression of multiple genes, including HIF-1 alpha and PAI-1, in AECs. Furthermore, C-188-9 decreased fibroblast-to-myofibroblast differentiation. Finally, TGF-beta stimulation of lung fibroblasts resulted in SMAD2/SMAD3-dependent phosphorylation of STAT-3. These findings demonstrate that STAT-3 contributes to the development of lung fibrosis and suggest that STAT-3 may be a therapeutic target in pulmonary fibrosis.	[Pedroza, Mesias; To, Sarah; George, Anuh T.; Agarwal, Sandeep K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Lewis, Katherine; Tweardy, David J.] Baylor Coll Med, Dept Infect Dis, Houston, TX 77030 USA; [Le, Thuy T.; Karmouty-Quintana, Harry; Blackburn, Michael R.] Univ Texas Hlth Sci Ctr Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Agarwal, SK (corresponding author), Biol Inflammat Ctr, Dept Pathol & Immunol, Dept Med, Sect Immunol Allergy & Rheumatol, One Baylor Plaza,Suite 672E,MS BCM285, Houston, TX 77030 USA.	skagarwa@bcm.edu	Tweardy, David/L-3929-2019; Karmouty-Quintana, Harry/ABC-9144-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; Blackburn, Michael/0000-0002-1394-9966	U.S. Department of Defense, Peer Reviewed Medical Research Program Grant [W81XWH-12-1-0516]; U.S. National Institutes of Health [R01AR062056, K08AR054404, 2T32AI053831-11A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI053831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062056, K08AR054404] Funding Source: NIH RePORTER	U.S. Department of Defense, Peer Reviewed Medical Research Program Grant; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. Department of Defense, Peer Reviewed Medical Research Program Grant W81XWH-12-1-0516 (to M.P. and S.K.A.), and U.S. National Institutes of Health Grants R01AR062056 (to S.K.A., S.T., and A.T.G.), K08AR054404 (to S.K.A.), and 2T32AI053831-11A1 (to M.P.).	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Ataie-Kachoie P, 2014, J CLIN PATHOL, V67, P932, DOI 10.1136/jclinpath-2014-202493; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Borok Z, 2014, AM J RESP CELL MOL, V50, P853, DOI 10.1165/rcmb.2014-0089PS; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Dai B, 2013, CELL PHYSIOL BIOCHEM, V32, P960, DOI 10.1159/000354499; Dave B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030207; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Deng PY, 2013, BIOL PHARM BULL, V36, P1540, DOI 10.1248/bpb.b13-00235; Dong ZX, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0012-4; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; ELIAS JA, 1991, J IMMUNOL, V146, P3437; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Gao SY, 2014, LIFE SCI, V114, P20, DOI 10.1016/j.lfs.2014.07.037; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gourh P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2821; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Horowitz JC, 2006, SEMIN RESP CRIT CARE, V27, P600, DOI 10.1055/s-2006-957332; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kasembeli MM, 2009, FRONT BIOSCI-LANDMRK, V14, P1010, DOI 10.2741/3292; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Lee AS, 2014, RESP MED, V108, P955, DOI 10.1016/j.rmed.2014.03.015; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Lynch J.P., 1998, FISHMANS PULMONARY D, P1069; Ma XQ, 2013, AFR J TRADIT COMPLEM, V10, P442, DOI 10.4314/ajtcam.v10i3.10; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Namba T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027296; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; PANOS RJ, 1990, AM J MED, V88, P396, DOI 10.1016/0002-9343(90)90495-Y; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Pinart M, 2009, RESP PHYSIOL NEUROBI, V166, P41, DOI 10.1016/j.resp.2009.01.002; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Rochester CL, 1996, J IMMUNOL, V156, P4449; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Sheppard D, 2001, J CLIN INVEST, V107, P1501, DOI 10.1172/JCI13318; Shigekawa M, 2011, BIOCHEM BIOPH RES CO, V406, P614, DOI 10.1016/j.bbrc.2011.02.105; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tang WL, 1996, J CLIN INVEST, V98, P2845, DOI 10.1172/JCI119113; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xu CP, 2015, J PROTEOMICS, V114, P234, DOI 10.1016/j.jprot.2014.11.002; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC; Zhou X, 2015, J CELL MOL MED, V19, P1103, DOI 10.1111/jcmm.12506; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	67	97	100	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					129	140		10.1096/fj.15-273953	http://dx.doi.org/10.1096/fj.15-273953			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26324850	Green Published			2022-12-28	WOS:000367621000015
J	Singh, D; Trivedi, AK; Rani, S; Panda, S; Kumar, V				Singh, Devraj; Trivedi, Amit Kumar; Rani, Sangeeta; Panda, Satchidananda; Kumar, Vinod			Circadian timing in central and peripheral tissues in a migratory songbird: dependence on annual life-history states	FASEB JOURNAL			English	Article						black-headed bunting; Bmal1; circadian genes; Clock; cryptochrome	GENE-EXPRESSION; CLOCK GENES; SUPRACHIASMATIC NUCLEUS; EMBERIZA-MELANOCEPHALA; SEASONAL REPRODUCTION; RESPONSE ELEMENT; PARS TUBERALIS; RESTLESSNESS; BIRDS; TRANSCRIPTION	Predictable seasonal change in photoperiod triggers a sequential change in the daily activity-rest pattern, adaptive for migration in several bird species. The night-migratory black-headed bunting (Emberiza melanocephala) is day active under short photoperiods (8 h light: 16 h dark, short day sensitive). Under long photoperiods (16 h light: 8 h dark), the buntings are initially day active (long day premigratory) but subsequently become intensely night active (long day migratory) and after few weeks again return to a day active pattern (long day refractory). However, it is unclear how the daily expression of circadian genes changes during photoperiod-induced seasonal life-history states (LHSs). We measured period 2 (Per2), cryptochrome 1 (Cry1), brain and muscle arnt-like protein 1 (Bmal1), and circadian locomotor output cycles kaput (Clock) mRNA expressions in various neural and peripheral tissues of buntings in different LHSs and discovered differences of similar to 2 to 6 h in the phase and 2- to 4-fold in amplitude of circadian oscillations of Per2, Cry1, and Bmal1 between photoperiod-induced LHSs. Phase relationship in mRNA oscillations was altered between oscillator components in the circadian pacemaker system (retina, pineal, hypothalamus) as well as in the peripheral (liver, muscle) tissues. These results show for the first time altered waveforms of clock gene expressions in all tissues in parallel with behavioral shifts and suggest the involvement of circadian system in photoperiod induction of seasonal LHSs in a migratory species.	[Singh, Devraj; Trivedi, Amit Kumar; Rani, Sangeeta; Kumar, Vinod] Univ Delhi, Ctr Excellence Biol Rhythms Res, Intensificat Res High Prior Areas, Dept Sci & Technol, Delhi 110007, India; [Singh, Devraj; Trivedi, Amit Kumar; Rani, Sangeeta; Kumar, Vinod] Univ Delhi, Indo US Ctr Biol Timing, Delhi 110007, India; [Singh, Devraj; Trivedi, Amit Kumar; Kumar, Vinod] Univ Delhi, Dept Zool, Delhi 110007, India; [Rani, Sangeeta] Univ Lucknow, Dept Zool, Lucknow 226007, Uttar Pradesh, India; [Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA	University of Delhi; University of Delhi; University of Delhi; Lucknow University; Salk Institute	Kumar, V (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	drvkumar11@yahoo.com	Trivedi, Amit/AAF-4018-2021	Trivedi, Amit/0000-0003-0985-3088	Department of Biotechnology [New Delhi, India] [BT/PR4984/MED/30/752/2012]; Science and Engineering Research Board [New Delhi, India] [IR/SO/LU-02/2005, SR/SO/AS-50/2010]; Indo-U.S. Joint Center on Biological Timing; University of Delhi-Department of Science and Technology Promotion of University Research and Scientific Excellence (DU-DST PURSE); NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Department of Biotechnology [New Delhi, India](Department of Biotechnology (DBT) India); Science and Engineering Research Board [New Delhi, India]; Indo-U.S. Joint Center on Biological Timing; University of Delhi-Department of Science and Technology Promotion of University Research and Scientific Excellence (DU-DST PURSE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to M. Gorman (University of California, San Diego, CA, USA) who helped to analyze the present results. Generous funding from the Department of Biotechnology [New Delhi, India (BT/PR4984/MED/30/752/2012)], Science and Engineering Research Board [New Delhi, India (IR/SO/LU-02/2005, SR/SO/AS-50/2010)], Indo-U.S. Joint Center on Biological Timing, and University of Delhi-Department of Science and Technology Promotion of University Research and Scientific Excellence (DU-DST PURSE) funding is acknowledged.	Bartell PA, 2005, J BIOL RHYTHM, V20, P538, DOI 10.1177/0748730405281826; Caprioli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035140; Cermakian N, 2002, CURR OPIN NEUROBIOL, V12, P359, DOI 10.1016/S0959-4388(02)00347-1; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Falvey E, 1996, BIOL CHEM, V377, P797; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GWINNER E, 1978, OIKOS, V30, P364, DOI 10.2307/3543485; Gwinner E., 1986, CIRCANNUAL RHYTHMS, Vfirst; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Helm B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0016; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kumar V, 2004, BIOL RHYTHM RES, V35, P121, DOI 10.1080/09291010412331313287; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Liedvogel M, 2009, MOL ECOL, V18, P2444, DOI 10.1111/j.1365-294X.2009.04204.x; Lincoln G, 2002, P NATL ACAD SCI USA, V99, P13890, DOI 10.1073/pnas.212517599; Lincoln GA, 2003, J ENDOCRINOL, V179, P1, DOI 10.1677/joe.0.1790001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Misra M, 2004, REPROD NUTR DEV, V44, P341, DOI 10.1051/rnd:2004039; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Ramenofsky M, 2014, HORM BEHAV, V66, P148, DOI 10.1016/j.yhbeh.2014.04.012; Rani S, 2006, CURR SCI INDIA, V91, P1093; Singh D, 2013, CHRONOBIOL INT, V30, P1208, DOI 10.3109/07420528.2013.810632; Stevenson TJ, 2011, P ROY SOC B-BIOL SCI, V278, P2477, DOI 10.1098/rspb.2010.2181; Trivedi AK, 2014, J BIOL RHYTHM, V29, P332, DOI 10.1177/0748730414549766; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yasuo S, 2004, ENDOCRINOLOGY, V145, P1612, DOI 10.1210/en.2003-1285	28	38	40	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4248	4255		10.1096/fj.15-275339	http://dx.doi.org/10.1096/fj.15-275339			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26103987	Green Published			2022-12-28	WOS:000361367300014
J	Thorimbert, V; Konig, D; Marro, J; Ruggiero, F; Jazwinska, A				Thorimbert, Valentine; Koenig, Desiree; Marro, Jan; Ruggiero, Florence; Jazwinska, Anna			Bone morphogenetic protein signaling promotes morphogenesis of blood vessels, wound epidermis, and actinotrichia during fin regeneration in zebrafish	FASEB JOURNAL			English	Article						blastemal; wound epithelium; regenerative angiogenesis	SONIC-HEDGEHOG; DEDIFFERENTIATION; BLASTEMA; TISSUE; DIFFERENTIATION; DORSOMORPHIN; ANGIOGENESIS; INDUCTION; GROWTH; CELLS	Zebrafish fin regeneration involves initial formation of the wound epidermis and the blastema, followed by tissue morphogenesis. The mechanisms coordinating differentiation of distinct tissues of the regenerate are poorly understood. Here, we applied pharmacologic and transgenic approaches to address the role of bone morphogenetic protein (BMP) signaling during fin restoration. To map the BMP transcriptional activity, we analyzed the expression of the evolutionarily conserved direct phospho-Smad1 target gene, id1, and its homologs id2a and id3. This analysis revealed the BMP activity in the distal blastema, wound epidermis, osteoblasts, and blood vessels of the regenerate. Blocking the BMP function with a selective chemical inhibitor of BMP type I receptors, DMH1, suppressed id1 and id3 expression and arrested regeneration after blastema formation. We identified several previously uncharacterized functions of BMP during fin regeneration. Specifically, BMP signaling is required for remodeling of plexus into structured blood vessels in the rapidly growing regenerate. It organizes the wound epithelium by triggering wnt5b expression and promoting Collagen XIV-A deposition into the basement membrane. BMP represents the first known signaling that induces actinotrichia formation in the regenerate. Our data reveal a multifaceted role of BMP for coordinated morphogenesis of distinct tissues during regeneration of a complex vertebrate appendage.	[Thorimbert, Valentine; Koenig, Desiree; Marro, Jan; Jazwinska, Anna] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Ruggiero, Florence] Ecole Normale Super Lyon, Inst Genom Fonct, F-69364 Lyon, France	University of Fribourg; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Jazwinska, A (corresponding author), Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland.	anna.jazwinska@unifr.ch	Jazwinska, Anna/M-8705-2016	Jazwinska, Anna/0000-0003-3881-9284; Konig, Desiree/0000-0001-8411-8951; RUGGIERO, Florence/0000-0003-2915-5359	Swiss National Science Foundation [310030_159995, CRSII3_147675]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank V. Zimmermann for excellent technical assistance and for fish care; C. Pfefferli, B. Chassot, and A.-S. de Preux Charles for critical reading of the manuscript; M. Affolter, S. Seyfried, and G. Weidinger for providing transgenic fish; and F.R. for collagen XIV-A antibody. This work was supported by the Swiss National Science Foundation (Grants 310030_159995 and CRSII3_147675).	Bader HL, 2013, J BIOL CHEM, V288, P6777, DOI 10.1074/jbc.M112.430637; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Duran I, 2011, DEV BIOL, V354, P160, DOI 10.1016/j.ydbio.2011.03.014; Engers DW, 2013, BIOORG MED CHEM LETT, V23, P3248, DOI 10.1016/j.bmcl.2013.03.113; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Huang CC, 2003, DEV BIOL, V264, P263, DOI 10.1016/j.ydbio.2003.08.016; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Laux DW, 2011, DEV DYNAM, V240, P682, DOI 10.1002/dvdy.22558; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Pfefferli C, 2015, REGENERATION, V2, P72, DOI 10.1002/reg2.33; Pfefferli C, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-30; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713, DOI 10.1073/pnas.122571799; Simon A, 2013, WIRES DEV BIOL, V2, P291, DOI 10.1002/wdev.73; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Stewart S, 2014, CELL REP, V6, P482, DOI 10.1016/j.celrep.2014.01.010; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wehner D, 2015, TRENDS GENET, V31, P336, DOI 10.1016/j.tig.2015.03.012; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137	46	31	31	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4299	4312		10.1096/fj.15-272955	http://dx.doi.org/10.1096/fj.15-272955			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148971	Green Submitted			2022-12-28	WOS:000361367300019
J	Vasen, G; Battistone, MA; Croci, DO; Brukman, NG; Munoz, MW; Stupirski, JC; Rabinovich, GA; Cuasnicu, PS				Vasen, Gustavo; Agustina Battistone, Maria; Croci, Diego O.; Brukman, Nicolas G.; Weigel Munoz, Mariana; Stupirski, Juan C.; Rabinovich, Gabriel A.; Cuasnicu, Patricia S.			The galectin-1-glycan axis controls sperm fertilizing capacity by regulating sperm motility and membrane hyperpolarization	FASEB JOURNAL			English	Article						acrosome reaction; capacitation; fertilization; glycosylation	MATERNAL-FETAL INTERFACE; ZONA-PELLUCIDA; MOUSE SPERM; AUXILIARY SUBUNIT; ACROSOME REACTION; HUMAN SPERMATOZOA; VOLUME REGULATION; FLOW-CYTOMETRY; N-GLYCANS; IN-VITRO	Lectin-glycan recognition systems play central roles in many physiologic and pathologic processes. We identified a role for galectin-1 (Gal-1), a highly conserved glycan-binding protein, in the control of sperm function. We found that Gal-1 is expressed in the epididymis and associates with sperm during epididymal maturation. Exposure of sperm to Gal-1 resulted in glycan-dependent modulation of the acrosome reaction (AR), a key event in the fertilization process. Gal-1-deficient (Lgals1(-/-)) mice revealed the essential contribution of this lectin for full sperm fertilizing ability both in vitro and in vivo. Mechanistically, Lgals1(-/-) sperm exhibited defects in their ability to develop hyperactivation, a vigorous motility required for penetration of the egg vestments. Moreover, Lgals1(-/-) sperm showed a decreased ability to control cell volume and to undergo progesterone-induced AR, phenotypes that were rescued by exposure of the cells to recombinant Gal-1. Interestingly, the AR defect was associated with a deficiency in sperm membrane potential hyperpolarization. Our study highlights the relevance of the Gal-1-glycan axis in sperm function with critical implications in mammalian reproductive biology.	[Vasen, Gustavo; Agustina Battistone, Maria; Croci, Diego O.; Brukman, Nicolas G.; Weigel Munoz, Mariana; Stupirski, Juan C.; Rabinovich, Gabriel A.; Cuasnicu, Patricia S.] Inst Biol & Med Expt IBYME CONICET, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Cuasnicu, PS (corresponding author), Inst Biol & Med Expt IBYME CONICET, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.	pcuasnicu@ibyme.conicet.gov.ar	Croci, Diego/AAJ-5709-2021; Brukman, Nicolas/ABD-4071-2020	Croci, Diego/0000-0002-8623-0645; Brukman, Nicolas Gaston/0000-0002-9865-2503; Vasen, Gustavo/0000-0002-5968-2312	World Health Organization-Research Management Group [H9/TSA/037]; Argentinean National Scientific and Technical Research Council (CONICET) [PIP 2009-290]; National Agency for Promotion of Scientific and Technological Investigations [PICT 2011-2023, PICT 2012-2440]; Fundacion Sales	World Health Organization-Research Management Group; Argentinean National Scientific and Technical Research Council (CONICET); National Agency for Promotion of Scientific and Technological Investigations; Fundacion Sales	The authors thank D.J. Cohen for critical reading. This study was supported by grants from World Health Organization-Research Management Group (H9/TSA/037 to P.S.C.), the Argentinean National Scientific and Technical Research Council (CONICET) (PIP 2009-290 to P.S.C.), the National Agency for Promotion of Scientific and Technological Investigations (PICT 2011-2023 to P.S.C., PICT 2012-2440 to G.A.R.), and Fundacion Sales (to G.A.R). G.A.R. and P.S.C. share senior authorship.	Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Boryshpolets S, 2015, HUM REPROD, V30, P884, DOI 10.1093/humrep/dev002; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brewis IA, 2000, J ANDROL, V21, P238; Busso D, 2007, BIOL REPROD, V76, P701, DOI 10.1095/biolreprod.106.056770; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Copits BA, 2014, J PHYSIOL-LONDON, V592, P2079, DOI 10.1113/jphysiol.2013.269597; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Dettin L, 2003, BIOL REPROD, V68, P51, DOI 10.1095/biolreprod.102.006361; Easton RL, 2000, J BIOL CHEM, V275, P7731, DOI 10.1074/jbc.275.11.7731; Escoffier J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127266; Figueiras-Fierro D, 2013, J CELL PHYSIOL, V228, P590, DOI 10.1002/jcp.24166; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; Freitag N, 2013, P NATL ACAD SCI USA, V110, P11451, DOI 10.1073/pnas.1303707110; Hasegawa A, 2008, AM J REPROD IMMUNOL, V60, P187, DOI 10.1111/j.1600-0897.2008.00611.x; Hoodbhoy T, 2005, J BIOL CHEM, V280, P12721, DOI 10.1074/jbc.M413569200; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006; Karmakar S, 2005, J BIOL CHEM, V280, P28623, DOI 10.1074/jbc.M414140200; Kolundzic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028514; Kopcow HD, 2008, P NATL ACAD SCI USA, V105, P18472, DOI 10.1073/pnas.0809233105; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Lee MY, 2009, CELL MOL LIFE SCI, V66, P1467, DOI 10.1007/s00018-009-8691-8; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Mortimer ST, 1996, HUM REPROD, V11, P1049; Okabe M, 2007, CELL MOL LIFE SCI, V64, P1945, DOI 10.1007/s00018-007-7037-7; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Phillips B, 1996, BIOL REPROD, V55, P548, DOI 10.1095/biolreprod55.3.548; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Ramhorst RE, 2012, GLYCOBIOLOGY, V22, P1374, DOI 10.1093/glycob/cws104; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; Tirado-Gonzalez I, 2013, MOL HUM REPROD, V19, P43, DOI 10.1093/molehr/gas043; Towbin H, 1992, Biotechnology, V24, P145; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Walzel H, 2004, GLYCOBIOLOGY, V14, P871, DOI 10.1093/glycob/cwh101; Wang JF, 2009, J IMMUNOL, V182, P4036, DOI 10.4049/jimmunol.0802981; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291; Williams SA, 2011, ENDOCRINOLOGY, V152, P1057, DOI 10.1210/en.2010-0917; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Xin AJ, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-10; Yang CT, 2011, P NATL ACAD SCI USA, V108, P19419, DOI 10.1073/pnas.1111104108; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Yeung CH, 2002, BIOL REPROD, V67, P269, DOI 10.1095/biolreprod67.1.269; Yeung CH, 2009, BIOL REPROD, V80, P350, DOI 10.1095/biolreprod.108.071928; Zeng XH, 2015, P NATL ACAD SCI USA, V112, P2599, DOI 10.1073/pnas.1423869112; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108	58	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4189	4200		10.1096/fj.15-270975	http://dx.doi.org/10.1096/fj.15-270975			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26136479				2022-12-28	WOS:000361367300009
J	Yang, W; Zhang, M; Chi, XJ; Liu, XY; Qin, B; Cui, S				Yang, Wei; Zhang, Meng; Chi, Xiaojing; Liu, Xiuying; Qin, Bo; Cui, Sheng			An intramolecular bond at cluster of differentiation 81 ectodomain is important for hepatitis C virus entry	FASEB JOURNAL			English	Article						HCV entry; HCV host tropism; CD81; HCV coreceptors	EXTRACELLULAR DOMAIN; BINDING-SITE; CD81; TETRASPANINS; IDENTIFICATION; INFECTION; CLAUDIN-1; LOOP; E2	Hepatitis C virus (HCV) infection is one of the leading causes of chronic liver diseases; however, HCV vaccine remains unavailable to date. One main obstacle is the lack of an efficient small animal model. Cluster of differentiation 81 (CD81) is an essential entry coreceptor for HCV species specificity to humans, though the underlying mechanisms are yet to be fully elucidated. We performed structural, biophysical, and virologic studies on HCV nonpermissive CD81s from mice and African green monkeys [mouse cluster of differentiation 81 (mCD81) and African green monkey cluster of differentiation 81 (agmCD81)] and compared with human cluster of differentiation 81 (hCD81). We discovered an intramolecular hydrogen bond (Gln188-N epsilon 2-H: Glu196-O epsilon 2, 2 angstrom, 124 degrees) within the large extracellular loop (LEL) of mCD81 and a salt bridge (Lys188-N zeta: Asp196-O delta 2, 2.4 angstrom) within agmCD81-LEL between residues 188 and 196. This structural feature is missing in hCD81. We demonstrated that the introduction of a single 188-196 bond to hCD81 impaired its binding affinity to HCV envelope glycoprotein 2 (HCV E2) and significantly decreased HCV pseudoviral particle (HCVpp) entry efficiency (4.92- to 8.42-fold) and cell culture-grown HCV (HCVcc) infectivity (4.55-fold), despite the availability of Phe186. For HCV nonpermissive CD81s, the introduction of Phe186 by Leu186F substitution alone was insufficient to confer HCV permissiveness. The disruption of the original 188-196 bond and Leu186F substitution were both required for potent binding to HCV E2 HCVpp entry efficiency and HCVcc infectivity. Our structural and biophysical analyses suggest that the intramolecular 188-196 bond restricts the intrinsic conformational dynamics of D-helix of CD81-LEL, which is essential for HCV entry, thus impairs HCV permissiveness. Our findings reveal a novel molecular determinant for HCV entry in addition to the well-characterized Phe186 and provide further guideline for selecting an HCV small animal model.	[Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yang, Wei] Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, W (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	wyang@ipb.pumc.edu.cn; cui.sheng@ipb.pumc.edu.cn	Cui, Sheng/AAQ-1721-2020; Sheng, CUI/M-6405-2013	Sheng, CUI/0000-0001-6329-3582; Yang, Wei/0000-0003-0162-4221	National Basic Research Program of China (973 Program) [2011CB504900, 2015CB554301, 2011CB504800]; National Science and Technology Major Project of China [2012ZX10002007-003, 2013ZX10004601]; National Natural Science Foundation of China [81471954, 81271831]; New Century Excellent Talents in University [NCET-13-0069]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13007]; Peking Union Medical College Youth Fund by Fundamental Research Funds for the Central Universities [3332013118]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Peking Union Medical College Youth Fund by Fundamental Research Funds for the Central Universities	W.Y. and S.C. share cosenior authorship of this article. The authors thank Swiss Light Source (PX beamlines; Villigen, Switzerland) and Shanghai Synchrotron Radiation Facility (beamline BL17U; Shanghai, China) for beam time allowance. The authors thank Professors T. Wakita, H. Greenberg, C. Rice, S. Lemon, and F. Cosset for providing cell lines and reagents. This study was supported by National Basic Research Program of China (973 Program) (2011CB504900, 2015CB554301, and 2011CB504800), the National Science and Technology Major Project of China (2012ZX10002007-003 and 2013ZX10004601), National Natural Science Foundation of China (81471954 and 81271831), New Century Excellent Talents in University (NCET-13-0069), Program for Changjiang Scholars and Innovative Research Team in University (IRT13007), and by Peking Union Medical College Youth Fund supported by the Fundamental Research Funds for the Central Universities (3332013118). Coordinates and structure factors for hCD81-LEL, mCD81-LEL, and agmCD81b-LEL were deposited into the PDB with the identification codes 3X0E, 3X0F, and 3X0G, respectively.	Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; El Omari K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5874; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Harman C, 2015, J VIROL, V89, P492, DOI 10.1128/JVI.01661-14; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Jamshad M, 2008, PROTEIN EXPRES PURIF, V57, P206, DOI 10.1016/j.pep.2007.10.013; Jones EL, 2011, BIOCHEM SOC T, V39, P506, DOI 10.1042/BST0390506; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; LEVY S, 1991, J BIOL CHEM, V266, P14597; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Masciopinto F, 2001, VIRUS RES, V80, P1, DOI 10.1016/S0168-1702(01)00245-3; Monk Peter N., 2012, Infectious Disorders - Drug Targets, V12, P4; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rajesh S, 2012, J VIROL, V86, P9606, DOI 10.1128/JVI.00559-12; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Si YH, 2012, HEPATOLOGY, V56, P507, DOI 10.1002/hep.25685; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Swadling L, 2013, EXPERT OPIN BIOL TH, V13, P1109, DOI 10.1517/14712598.2013.791277; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; van Spriel AB, 2011, BIOCHEM SOC T, V39, P512, DOI 10.1042/BST0390512; WHO, HEP C FACT SHEETS; Xie ZC, 1998, VIROLOGY, V244, P513, DOI 10.1006/viro.1998.9127; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200	36	6	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4214	4226		10.1096/fj.15-272880	http://dx.doi.org/10.1096/fj.15-272880			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26116703				2022-12-28	WOS:000361367300011
J	Di Natale, C; Scognamiglio, PL; Cascella, R; Cecchi, C; Russo, A; Leone, M; Penco, A; Relini, A; Federici, L; Di Matteo, A; Chiti, F; Vitagliano, L; Marasco, D				Di Natale, Concetta; Scognamiglio, Pasqualina Liana; Cascella, Roberta; Cecchi, Cristina; Russo, Anna; Leone, Marilisa; Penco, Amanda; Relini, Annalisa; Federici, Luca; Di Matteo, Adele; Chiti, Fabrizio; Vitagliano, Luigi; Marasco, Daniela			Nucleophosmin contains amyloidogenic regions that are able to form toxic aggregates under physiological conditions	FASEB JOURNAL			English	Article						beta aggregate; acute myeloid leukemia; circular dichroism spectroscopy; AFM; MTT assay	ACUTE MYELOID-LEUKEMIA; C-TERMINAL DOMAIN; NUCLEOLAR PROTEIN; DENATURED STATE; HISTONE CHAPERONE; NPM1 GENE; MUTATIONS; STABILITY; MUTANT; IDENTIFICATION	Nucleophosmin (NPM)-1 is a multifunctional protein involved in a variety of biologic processes and has been implicated in the pathogenesis of several human malignancies. To gain insight into the role of isolated fragments in NPM1 activities, we dissected the C-terminal domain (CTD) into its helical fragments. In this study, we observed the unexpected structural behavior of the peptide fragment corresponding to helix (H) 2 (residues 264-277). This peptide has a strong tendency to form amyloidlike assemblies endowed with fibrillar morphology and beta-sheet structure, under physiologic conditions, as shown by circular dichroism, thioflavin T, and Congo red binding assays; dynamic light scattering; and atomic force microscopy. The aggregates are also toxic to neuroblastoma cells, as determined using 3-(4;5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction and Ca2+ influx assays. We also found that the extension of the H2 sequence beyond its N terminus, comprising the connecting loop with H1, delayed aggregation and its associated cytotoxicity, suggesting that contiguous regions of H2 have a protective role in preventing aggregation. Our findings and those in the literature suggest that the helical structures present in the CTD are important in preventing harmful aggregation. These findings could elucidate the pathogenesis of acute myeloid leukemia (AML) caused by NPM1 mutants. Because the CTD is not properly folded in these mutants, we hypothesize that the aggregation propensity of this NPM1 region is involved in the pathogenesis of AML. Preliminary assays on NPM1-Cter-MutA, the most frequent AML-CTD mutation, revealed its significant propensity for aggregation. Thus, the aggregation phenomena should be seriously considered in studies aimed at unveiling the molecular mechanisms of this pathology.	[Di Natale, Concetta; Scognamiglio, Pasqualina Liana; Russo, Anna; Marasco, Daniela] Univ Naples Federico II, Dept Pharm, Diagnost & Farmaceut Mol Soc Cooperat Responsabil, I-80134 Naples, Italy; [Scognamiglio, Pasqualina Liana; Leone, Marilisa; Vitagliano, Luigi; Marasco, Daniela] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioatt, I-80134 Naples, Italy; [Cascella, Roberta; Cecchi, Cristina; Chiti, Fabrizio] Univ Florence, Biochem Sect, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy; [Leone, Marilisa; Vitagliano, Luigi] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Penco, Amanda; Relini, Annalisa] Univ Genoa, Dept Phys, Genoa, Italy; [Federici, Luca] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Di Matteo, Adele] CNR, Inst Mol Biol & Pathol, Rome, Italy	University of Naples Federico II; University of Naples Federico II; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Genoa; G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Marasco, D (corresponding author), Univ Naples Federico II, Dept Pharm, Via Mezzocannone 16, I-80134 Naples, Italy.	daniela.marasco@unina.it	Relini, Annalisa/AHC-3105-2022; Scognamiglio, Pasqualina Liana/X-9429-2019; Di Matteo, Adele/AAC-8338-2019; Cascella, Roberta/K-5122-2016	Scognamiglio, Pasqualina Liana/0000-0002-1444-8039; Di Matteo, Adele/0000-0002-5921-7365; LEONE, MARILISA/0000-0002-3811-6960; Cecchi, Cristina/0000-0001-8387-7737; Di Natale, Concetta/0000-0002-2874-6539; RELINI, ANNALISA/0000-0002-4040-9279; daniela, Marasco/0000-0002-6618-2949; Cascella, Roberta/0000-0001-9856-6843	Regione Campania Rete integrated network for the biotechnology applied to molecules with pharmacological activity; FarmaBioNet, intervention biotechnology for the development of new drugs (Bando per la Realizzazione della Rete delle Biotecnologie Campane, Obiettivo Operativo 2.1 POR Campania)	Regione Campania Rete integrated network for the biotechnology applied to molecules with pharmacological activity; FarmaBioNet, intervention biotechnology for the development of new drugs (Bando per la Realizzazione della Rete delle Biotecnologie Campane, Obiettivo Operativo 2.1 POR Campania)	This work was funded in part by Regione Campania Rete integrated network for the biotechnology applied to molecules with pharmacological activity; FarmaBioNet, the intervention biotechnology for the development of new drugs (Bando per la Realizzazione della Rete delle Biotecnologie Campane, Obiettivo Operativo 2.1 POR Campania).	Ahmad B, 2011, PROTEIN ENG DES SEL, V24, P553, DOI 10.1093/protein/gzr018; Arcovito A, 2014, J BIOL CHEM, V289, P21230, DOI 10.1074/jbc.M114.565010; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; Bolli N, 2009, LEUKEMIA, V23, P501, DOI 10.1038/leu.2008.326; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Chiarella S, 2013, BIOCHEM BIOPH RES CO, V435, P64, DOI 10.1016/j.bbrc.2013.04.038; Chiarella S, 2013, NUCLEIC ACIDS RES, V41, P3228, DOI 10.1093/nar/gkt001; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, HAEMATOLOGICA, V92, P519, DOI 10.3324/haematol.11007; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V108, P1999, DOI 10.1182/blood-2006-03-007013; Falini B, 2011, BLOOD, V117, P1109, DOI 10.1182/blood-2010-08-299990; Falini B, 2009, CURR OPIN ONCOL, V21, P573, DOI 10.1097/CCO.0b013e3283313dfa; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; KANG YJ, 1975, CANCER RES, V35, P1470; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Kourie JI, 2001, CHEM-BIOL INTERACT, V138, P1, DOI 10.1016/S0009-2797(01)00228-9; Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504; Leong SM, 2010, BLOOD, V116, P3286, DOI 10.1182/blood-2009-12-256149; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Marasco D, 2015, INT J MOL SCI, V16, P7394, DOI 10.3390/ijms16047394; Marasco D, 2013, BIOCHEM BIOPH RES CO, V430, P523, DOI 10.1016/j.bbrc.2012.12.002; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Okuwaki M, 2012, NUCLEIC ACIDS RES, V40, P4861, DOI 10.1093/nar/gks162; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pitiot AS, 2007, LEUKEMIA, V21, P1564, DOI 10.1038/sj.leu.2404679; Poletto M, 2014, MOL BIOL CELL, V25, P1641, DOI 10.1091/mbc.E13-12-0717; Rahimi F, 2008, CURR ALZHEIMER RES, V5, P319, DOI 10.2174/156720508784533358; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scaloni F, 2010, P NATL ACAD SCI USA, V107, P5447, DOI 10.1073/pnas.0910516107; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; Scognamiglio PL, 2014, BBA-GEN SUBJECTS, V1840, P2050, DOI 10.1016/j.bbagen.2014.02.017; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Yun JP, 2007, BRIT J CANCER, V96, P477, DOI 10.1038/sj.bjc.6603574	54	46	46	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3689	3701		10.1096/fj.14-269522	http://dx.doi.org/10.1096/fj.14-269522			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25977257	Green Submitted			2022-12-28	WOS:000359915600008
J	Krukovets, I; Legerski, M; Sul, P; Stenina-Adognravi, O				Krukovets, Irene; Legerski, Matthew; Sul, Pavel; Stenina-Adognravi, Olga			Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist	FASEB JOURNAL			English	Article						extracellular matrix; thrombospondin; vascular complications; diabetes; neovascularization	MMTV-WNT-1 TRANSGENIC MICE; MOUSE MAMMARY-TUMOR; DIABETES-MELLITUS; HEART-DISEASE; CELL-LINES; EXPRESSION; RISK; THROMBOSPONDIN-1; HYPEROSMOLARITY	Abnormal angiogenesis in multiple tissues is a key characteristic of the vascular complications of diabetes. However, angiogenesis may be increased in one tissue but decreased in another in the same patient at the same time point in the disease. The mechanisms of aberrant angiogenesis in diabetes are not understood. There are no selective therapeutic approaches to target increased neovascularization without affecting physiologic angiogenesis and angiogenesis in ischemic tissues. We recently reported a novel miRNA-dependent pathway that up-regulates angiogenesis in response to hyperglycemia in a cell-and tissue-specific manner. The goal of the work described herein was to test whether systemic administration of an antagonist of miR-467 would prevent hyperglycemia-induced local angiogenesis in a tissue-specific manner. We examined the effect of the antagonist on hyperglycemia-induced tumor growth and angiogenesis and on skin wound healing in mouse models of diabetes. Our data demonstrated that the systemic injection of the antagonist prevented hyperglycemia-induced angiogenesis and growth of mouse and human breast cancer tumors, where the miR-467 pathway was active in hyperglycemia. In tissues where the miR-467-dependent mechanism was not activated by hyperglycemia, there was no effect of the antagonist: the systemic injection did not affect skin wound healing or the growth of prostate tumors. The data show that systemic administration of the miR-467 antagonist could be a breakthrough approach in the treatment and prevention of diabetes-associated breast cancer in a tissue-specific manner without affecting physiologic angiogenesis and angiogenesis in ischemic tissues.	[Krukovets, Irene; Legerski, Matthew; Sul, Pavel; Stenina-Adognravi, Olga] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stenina-Adognravi, O (corresponding author), Cleveland Clin, Dept Mol Cardiol, 9500 Euclid Ave,NB50-66, Cleveland, OH 44195 USA.	stenino@ccf.org		Sul, Pavel/0000-0002-3149-722X; , Olga/0000-0002-1256-0545	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant [R01-HL117216]; U.S. NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [R01-DK067532]; U.S. NIH National Cancer Institute Grant [CA177771]; Scott Hamilton Cares Foundation; NATIONAL CANCER INSTITUTE [R01CA177771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067532] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant; U.S. NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; U.S. NIH National Cancer Institute Grant; Scott Hamilton Cares Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Ms. Nadia Hoppe (Department of Slavic Languages and Literatures, University of Illinois at Urbana-Champaign) for technical help with the manuscript preparation and editorial assistance. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01-HL117216, U.S. NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK067532, U.S. NIH National Cancer Institute Grant CA177771, and by funds from the Scott Hamilton Cares Foundation.	Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Bhattacharyya S, 2008, J BIOL CHEM, V283, P5699, DOI 10.1074/jbc.M706435200; Bhattacharyya S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005967; BIELEFELD DR, 1983, AM J PHYSIOL, V245, pE568, DOI 10.1152/ajpendo.1983.245.6.E568; Bordeleau L, 2011, CANCER-AM CANCER SOC, V117, P1812, DOI 10.1002/cncr.25595; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CHOOI KF, 1994, CANCER RES, V54, P6434; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Driver JA, 2010, AM J EPIDEMIOL, V172, P299, DOI 10.1093/aje/kwq127; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Engel S, 2003, NEW ENGL J MED, V348, P2294; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Habib SL, 2013, ISRN ONCOL; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jang YC, 1999, WOUND REPAIR REGEN, V7, P375, DOI 10.1046/j.1524-475X.1999.00375.x; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Klein SA, 1999, J SURG RES, V82, P268, DOI 10.1006/jsre.1998.5551; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; McFarland MS, 2010, PHARMACOTHERAPY, V30, P1159, DOI 10.1592/phco.30.11.1159; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Polednak Anthony P, 2010, J Registry Manag, V37, P57; ROCKWELL SC, 1972, J NATL CANCER I, V49, P735; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SICILIANO MJ, 1979, CANCER RES, V39, P919; Simon D, 2010, DIABETES METAB, V36, P182, DOI 10.1016/j.diabet.2010.04.001; Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97; Turner EL, 2011, INT J CANCER, V128, P440, DOI 10.1002/ijc.25360; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; WACHTEL TJ, 1991, J GEN INTERN MED, V6, P495, DOI 10.1007/BF02598216; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wotton CJ, 2011, DIABETOLOGIA, V54, P527, DOI 10.1007/s00125-010-1987-2; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102	43	16	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3726	3736		10.1096/fj.14-267799	http://dx.doi.org/10.1096/fj.14-267799			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018675	Green Published			2022-12-28	WOS:000359915600011
J	Crow, M; Khovanov, N; Kelleher, JH; Sharma, S; Grant, AD; Bogdanov, Y; Wood, JN; McMahon, SB; Denk, F				Crow, Megan; Khovanov, Nikita; Kelleher, Jayne H.; Sharma, Simone; Grant, Andrew D.; Bogdanov, Yury; Wood, John N.; McMahon, Stephen B.; Denk, Franziska			HDAC4 is required for inflammation-associated thermal hypersensitivity	FASEB JOURNAL			English	Article						epigenetics; pain; nerve growth factor; transcription	HISTONE DEACETYLASE 4; NEUROPATHIC PAIN; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; AXON REGENERATION; MEMORY FORMATION; GENE DELETION; HYPERALGESIA; MICROARRAY; GROWTH	Transcriptional alterations are characteristic of persistent pain states, but the key regulators remain elusive. HDAC4 is a transcriptional corepressor that has been linked to synaptic plasticity and neuronal excitability, mechanisms that may be involved in peripheral and central sensitization. Using a conditional knockout (cKO) strategy in mice, we sought to determine whether the loss of HDAC4 would have implications for sensory neuron transcription and nociception. HDAC4 was found to be largely unnecessary for transcriptional regulation of naive sensory neurons but was essential for appropriate transcriptional responses after injury, with Calca and Trpv1 expression consistently down-regulated in HDAC4 cKO compared to levels in the littermate controls (0.2-0.44-fold change, n = 4 in 2 separate experiments). This down-regulation corresponded to reduced sensitivity to 100 nM capsaicin in vitro (IC50 = 230 +/- 20 nM, 76 +/- 4.4% wild-type capsaicin responders vs. 56.9 +/- 4.7% HDAC4 cKO responders) and to reduced thermal hypersensitivity in the complete Freund's adjuvant (CFA) model of inflammatory pain (1.3-1.4-fold improvement over wild-type controls; n = 5-12, in 2 separate experiments). These data indicate that HDAC4 is a novel inflammatory pain mediator and may be a good therapeutic target, capable of orchestrating the regulation of multiple downstream effectors.	[Crow, Megan; Khovanov, Nikita; Kelleher, Jayne H.; Grant, Andrew D.; McMahon, Stephen B.; Denk, Franziska] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Sharma, Simone] UCL Genom, London, England; [Bogdanov, Yury; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England	University of London; King's College London; University of London; University College London; University of London; University College London	Crow, M (corresponding author), Kings Coll London, Wolfson CARD, Neurorestorat Grp, Guys Campus,18-20 Newcomen St, London SE1 1UL, England.	megan.crow@kcl.ac.uk	Denk, Franziska/A-4212-2010; Grant, Andrew/A-8819-2008	Denk, Franziska/0000-0003-4883-4234; McMahon, Stephen/0000-0003-4656-5536; Grant, Andrew/0000-0002-7032-3716; Bogdanov, Yury/0000-0003-4667-5890	Medical Research Council [G0901905] Funding Source: Medline; Wellcome Trust [101054, 102645, 097903] Funding Source: Medline; MRC [G0901905] Funding Source: UKRI; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; BENBASSAT J, 1959, ARCH INT PHARMACOD T, V122, P434; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chauchereau A, 2004, ONCOGENE, V23, P8777, DOI 10.1038/sj.onc.1208128; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Lau J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-100; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Liu MH, 2012, REPROD SCI, V19, P360, DOI 10.1177/1933719111424453; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JW, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-438; Ma CHE, 2011, J CLIN INVEST, V121, P4332, DOI 10.1172/JCI58675; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rajan I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006612; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; Ren Ke, 1999, ILAR J, V40, P111; Samad OA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-45; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Thakur M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00087; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang WH, 2011, ANAT REC, V294, P1025, DOI 10.1002/ar.21389; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	40	25	25	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3370	3378		10.1096/fj.14-264440	http://dx.doi.org/10.1096/fj.14-264440			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903105	Green Published			2022-12-28	WOS:000358796900024
J	van Dijk, IA; Nazmi, K; Bolscher, JGM; Veerman, ECI; Stap, J				van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.; Stap, Jan			Histatin-1, a histidine-rich peptide in human saliva, promotes cell-substrate and cell-cell adhesion	FASEB JOURNAL			English	Article						cell spreading; transepithelial resistance; barrier function	CANDIDA-ALBICANS; PROTEINS; DISEASE; LINE; POLYPEPTIDES; ANTIFUNGAL; INTEGRINS; BINDING; CACO-2; FAMILY	Histatins (Hsts) are histidine-rich peptides exclusively present in the saliva of higher primates. In this study, we explored the effects ofHsts on cell-substrate and cell-cell adhesion. Histatin (Hst)-1 caused a significant (>2-fold) increase (EC50 = 1 mu M) in the ability of human adherent cells to attach and spread, even in conditions that impaired cell spreading. Other tested Hsts did not stimulate cell spreading, indicating a specific effect of Hst1. The effect of Hst1 on cell-cell adhesion was investigated by using transepithelial resistance (TER) measurements in the human cell line Caco-2, a widely used model for the epithelial layer. We found that 10 mM Hst1 caused a 20% increase in TER compared to the negative control, indicating a function for Hst1 in intercellular cell adhesion and epithelial integrity. A role for Hst1 in both cellsubstrate and cell-cell adhesion is highly conceivable, because these 2 modes of adhesion are closely related via shared components and connected signaling pathways.	[van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, NL-1100 DE Amsterdam, Netherlands; [van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [van Dijk, Irene A.; Stap, Jan] Univ Amsterdam, Acad Med Ctr, Van Leeuwenhoek Ctr Adv Microscopy, Core Facil Cellular Imaging, NL-1100 DE Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Stap, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 15,POB 22700, NL-1100 DE Amsterdam, Netherlands.	j.stap@amc.uva.nl	Bolscher, Jan/ABF-6102-2021	Bolscher, Jan/0000-0001-5669-6164	Dutch Organization for Scientific Research (NWO) [ALW2PJ/09070]; University of Amsterdam	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); University of Amsterdam	The authors thank the Department of Virology, Academic Medical Center (AMC), University of Amsterdam, The Netherlands, for providing the Caco-2 cell line; and the following people, also affiliated with the AMC: Ing. Ilse Vogels, for helping to set up the ARPE-19 experiments; Dr. Laura Ferrando, for introducing the Caco-2 transepithelial barrier model and for many helpful suggestions; Dr. Ron Hoebe, for providing the TimelapseAnalyse software for analysis of the time-lapse movies; Prof. Wouter de Jonge and Francisca van Leeuwen-Hilbers, for providing the xCELLigence system and helping to set up the experiments; and Shawn Meyers, M.Sc., for proofreading the manuscript. This work was supported by Grant ALW2PJ/09070 from the Dutch Organization for Scientific Research (NWO) and by a grant from the University of Amsterdam for research into the focal point of oral infections and inflammation.	Avery JK, 2002, ORAL DEV HISTOLOGY; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Helmerhorst EJ, 1997, BIOCHEM J, V326, P39, DOI 10.1042/bj3260039; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Huang SH, 1999, J CELL BIOCHEM, V75, P327, DOI 10.1002/(SICI)1097-4644(19991101)75:2<327::AID-JCB14>3.3.CO;2-7; Johnson DA, 2000, ARCH ORAL BIOL, V45, P731, DOI 10.1016/S0003-9969(00)00047-9; LAL K, 1992, J ACQ IMMUN DEF SYND, V5, P904; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; MACKAY BJ, 1984, INFECT IMMUN, V44, P695, DOI 10.1128/IAI.44.3.695-701.1984; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Naurato N, 1999, J AGR FOOD CHEM, V47, P2229, DOI 10.1021/jf981044i; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Punna S, 2005, BIOCONJUGATE CHEM, V16, P1536, DOI 10.1021/bc0501496; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; SABATINI LM, 1989, BIOCHEM BIOPH RES CO, V160, P495, DOI 10.1016/0006-291X(89)92460-1; Schambony A, 2004, DIFFERENTIATION, V72, P307, DOI 10.1111/j.1432-0436.2004.07207002.x; STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; VANDERSPEK JC, 1990, ARCH ORAL BIOL, V35, P137, DOI 10.1016/0003-9969(90)90175-A; VANDERSPEK JC, 1989, AM J HUM GENET, V45, P381; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wetzel F, 2011, EUR BIOPHYS J BIOPHY, V40, P1109, DOI 10.1007/s00249-011-0723-2; XU L, 1992, ORAL MICROBIOL IMMUN, V7, P127, DOI 10.1111/j.1399-302X.1992.tb00524.x; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341	39	26	28	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3124	3132		10.1096/fj.14-266825	http://dx.doi.org/10.1096/fj.14-266825			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903106				2022-12-28	WOS:000358796900002
J	Heiss, M; Hellstrom, M; Kalen, M; May, T; Weber, H; Hecker, M; Augustin, HG; Korff, T				Heiss, Maximilian; Hellstrom, Mats; Kalen, Mattias; May, Tobias; Weber, Holger; Hecker, Markus; Augustin, Hellmut G.; Korff, Thomas			Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro	FASEB JOURNAL			English	Article						HUVEC; VEGF; tip cells	INHIBITS SPROUTING ANGIOGENESIS; EXPRESSION; PROTEIN; RECEPTOR; CD34; DIFFERENTIATION; MIGRATION; EXHIBIT; MODELS; DOMAIN	Given the need for robust and cost-efficient in vitro models to study angiogenesis and reproducibly analyze potential pro-and antiangiogenic compounds in preclinical studies, we developed a 3-dimensional in vitro angiogenesis assay that is based on collagen gel-embedded, size-defined spheroids generated from cultured human umbilical vein endothelial cells (HUVECs). Despite its wide distribution, limitations, sensitivity, robustness, and improvements, the capacity of this assay for functional screening purposes has not been elucidated thus far. By using time-lapse video microscopy, we show that tip cells lead the formation of capillary-like and partially lumenized sprouts originating from the spheroids. Angiogenic sprouting from spheroids generated from 5 different primary cultured human endothelial cell types was induced by physiologic concentrations of vascular endothelial cell growth factor 165. Based on this assay system, we determined the capacity of 880 approved drugs to interfere with or boost angiogenic sprouting, thereby assessing their putative angiogenesis-related side effects or novel applications. However, although this assay allowed for a rapid and reproducible determination of functional IC50 values of individual compounds, the sprouting results were partially affected by the HUVEC passage number and donor variability. To overcome this limitation, immortalized HUVECs (iHUVECs) showing a more homogenous response in terms of proliferation and sprouting over multiple population doublings were used in the course of this study. Collectively, the spheroid-based angiogenesis assay provides a sensitive and versatile tool to study the impact of pro-and antiangiogenic determinants on multiple steps of the angiogenic cascade. It is compatible with different endothelial cell types and allows use of iHUVECs to improve its overall robustness.	[Heiss, Maximilian; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, D-69120 Heidelberg, Germany; [Hellstrom, Mats; Kalen, Mattias] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [May, Tobias] InSCREENeX GmbH, Braunschweig, Germany; [Weber, Holger] ProQinase GmbH, Freiburg, Germany; [Augustin, Hellmut G.] Heidelberg Univ, Med Fac Mannheim CBTM, Div Vasc Biol & Tumor Angiogenesis, D-69120 Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr Heidelberg, Div Vasc Oncol & Metastasis, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Uppsala University; ProQinase; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Korff, T (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242	Deutsche Forschungsgemeinschaft (Ursula M. Handel Animal Welfare Award) [SFB TR 23]	Deutsche Forschungsgemeinschaft (Ursula M. Handel Animal Welfare Award)	The authors gratefully acknowledge the excellent technical assistance provided by Ender Serbest and Gudrun Scheib. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB TR 23, project sections A3, C5 and C6; Ursula M. Handel Animal Welfare Award).	Adam MG, 2013, CIRC RES, V113, P1206, DOI 10.1161/CIRCRESAHA.113.301686; Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Asif AR, 2009, J PROTEOME RES, V8, P3161, DOI 10.1021/pr800998k; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; BAUMHUETER S, 1994, BLOOD, V84, P2554; Cattaruzza M, 2004, CIRC RES, V95, P841, DOI 10.1161/01.RES.0000145359.47708.2f; Cines DB, 1998, BLOOD, V91, P3527; DELIA D, 1993, BLOOD, V81, P1001; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; FINA L, 1990, BLOOD, V75, P2417; Gautier B, 2011, CHEM BIOL, V18, P1631, DOI 10.1016/j.chembiol.2011.10.016; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hada K, 2012, BIOORGAN MED CHEM, V20, P1442, DOI 10.1016/j.bmc.2011.12.058; IruelaArispe ML, 1997, THROMB HAEMOSTASIS, V78, P672; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Korff T, 1999, J CELL SCI, V112, P3249; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Morin KT, 2013, EXP CELL RES, V319, P2409, DOI 10.1016/j.yexcr.2013.06.006; Nacak TG, 2007, CIRC RES, V100, P1155, DOI 10.1161/01.RES.0000265844.56493.ac; PAULY RR, 1992, CIRCULATION, V86, P68; Seki M, 2000, INT J ONCOL, V17, P525; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; Weber H, 2008, TOXICOL IN VITRO, V22, P531, DOI 10.1016/j.tiv.2007.09.014; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zhong L, 2005, BBA-GEN SUBJECTS, V1722, P254, DOI 10.1016/j.bbagen.2004.12.015	32	120	122	3	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3076	3084		10.1096/fj.14-267633	http://dx.doi.org/10.1096/fj.14-267633			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857554				2022-12-28	WOS:000356859100034
J	Kiriakidis, S; Henze, AT; Kruszynska-Ziaja, I; Skobridis, K; Theodorou, V; Paleolog, EM; Mazzone, M				Kiriakidis, Serafim; Henze, Anne-Theres; Kruszynska-Ziaja, Ilona; Skobridis, Konstantinos; Theodorou, Vassiliki; Paleolog, Ewa M.; Mazzone, Massimiliano			Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival	FASEB JOURNAL			English	Article						angiogenesis; Notch2; apoptosis	HYPOXIA-INDUCIBLE FACTOR; ANKYRIN REPEAT DOMAIN; TUMOR-SUPPRESSOR PROTEIN; ASPARAGINYL HYDROXYLASE; RHEUMATOID-ARTHRITIS; KAPPA-B; NOTCH; ANGIOGENESIS; GROWTH; CANCER	Factor-inhibiting hypoxia-inducible factor (HIF)-1 (FIH-1) is an asparaginyl beta-hydroxylase enzyme that was initially found to hydroxylate the HIF-alpha, preventing its transcriptional activity and leading to adaptive responses to hypoxia. More recently, other substrates, such as neurogenic locus notch homolog (Notch), have been found to be alternative FIH targets, but the biologic relevance of this regulation was never investigated. Given the key function of Notch in angiogenesis, we here investigate the role of FIH/Notch signaling in endothelial cells. We report that FIH-1 silencing in HUVECs results in reduced growth and increased apoptosis. The knockdown of FIH is associated with increased Notch2 activity, leading to enhanced expression of the Notch target hairy/enhancer-of-split related with YRPW motif protein 1 (Hey-1). Consistent with recent findings showing that Notch2 suppresses survivin (a key inhibitor of apoptosis), FIH targeting in HUVECs leads to selective repression of survivin in endothelial cells, thus promoting cell apoptosis and growth arrest. Our data support the concept that FIH-1 may interact with Notch2 and repress its activity, thereby playing a critical role in controlling the survival of vascular endothelial cells. These findings might pave the way toward novel, antiangiogenic strategies in disorders that are characterized by excessive vascular growth, such as cancer and rheumatoid arthritis.	[Kiriakidis, Serafim; Kruszynska-Ziaja, Ilona; Paleolog, Ewa M.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Henze, Anne-Theres; Mazzone, Massimiliano] Vlaams Inst Biotechnol, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Leuven, Belgium; [Henze, Anne-Theres; Mazzone, Massimiliano] Katholieke Univ Leuven, Dept Oncol, Lab Mol Oncol & Angiogenesis, Vesalius Res Ctr, Leuven, Belgium; [Skobridis, Konstantinos; Theodorou, Vassiliki] Univ Ioannina, Dept Chem, Sect Organ Chem & Biochem, GR-45110 Ioannina, Greece	University of Oxford; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Ioannina	Kiriakidis, S (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Botnar Res Ctr, NDORMS, Windmill Rd, Oxford OX3 7LD, England.	serafim.kiriakidis@kennedy.ox.ac.uk; massimiliano.mazzone@vib-kuleuven.be		Mazzone, Massimiliano/0000-0001-8824-4015	Kennedy Institute of Rheumatology trustees; Arthritis Research UK; Research Foundation Flanders (FWO) [G.0718.10N]; Stichting tegen Kanker [2010-169]; FWO fellowship	Kennedy Institute of Rheumatology trustees; Arthritis Research UK(Versus Arthritis); Research Foundation Flanders (FWO)(FWO); Stichting tegen Kanker; FWO fellowship(FWO)	The authors (S.K., I.K.-Z., and E.M.P.) are grateful to the Kennedy Institute of Rheumatology trustees for funding the work and acknowledge the assistance of Sofia Konisti for Western blotting techniques and Parisa Amjadi for FACS analysis. The Kennedy Institute of Rheumatology is supported by Arthritis Research UK. This work was also supported by grants from Research Foundation Flanders (FWO; G.0718.10N) and Stichting tegen Kanker (2010-169) to M.M. A.-H.T. is supported by an FWO fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.K. dedicates this manuscript to his late mentor Dr. Hem Chandra Jha (Institute of Physiological Chemistry, University of Bonn, Germany), who sadly and unexpected passed away in September 2013. S.K., A.T.H., I.K-Z., K.S., and V.T. performed the experimental studies and data analysis. S.K., M.M., and E.M.P. oversaw the conception and design of the study. All authors contributed to the writing of the manuscript and have read and approved the final manuscript. The authors declare no conflicts of interest.	Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Coulon C, 2010, ARTERIOSCL THROM VAS, V30, P2331, DOI 10.1161/ATVBAHA.110.214106; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Grosjean J, 2006, BIOCHEM BIOPH RES CO, V340, P984, DOI 10.1016/j.bbrc.2005.12.095; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Khan MN, 2011, BRIT J CANCER, V104, P1151, DOI 10.1038/bjc.2011.73; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Larsen H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3934; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; Mesri M, 2001, AM J PATHOL, V158, P1757, DOI 10.1016/S0002-9440(10)64131-4; Muz B, 2012, ARTHRITIS RHEUM-US, V64, P2856, DOI 10.1002/art.34479; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pelletier J, 2012, ONCOGENE, V31, P2989, DOI 10.1038/onc.2011.471; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Quillard T, 2010, BIOCHEM PHARMACOL, V80, P2032, DOI 10.1016/j.bcp.2010.07.010; Quillard T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008244; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Tran J, 1999, BIOCHEM BIOPH RES CO, V264, P781, DOI 10.1006/bbrc.1999.1589; Wang MM, 2011, INT J BIOCHEM CELL B, V43, P1550, DOI 10.1016/j.biocel.2011.08.005; Wilkins SE, 2012, J BIOL CHEM, V287, P8769, DOI 10.1074/jbc.M111.294678; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	54	21	21	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2814	2827		10.1096/fj.14-252379	http://dx.doi.org/10.1096/fj.14-252379			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837583				2022-12-28	WOS:000356859100013
J	Seferovic, MD; Goodspeed, DM; Chu, DM; Krannich, LA; Gonzalez-Rodriguez, PJ; Cox, JE; Aagaard, KM				Seferovic, Maxim D.; Goodspeed, Danielle M.; Chu, Derrick M.; Krannich, Laura A.; Gonzalez-Rodriguez, Pablo J.; Cox, James E.; Aagaard, Kjersti M.			Heritable IUGR and adult metabolic syndrome are reversible and associated with alterations in the metabolome following dietary supplementation of 1-carbon intermediates	FASEB JOURNAL			English	Article						DOHaD; metabolism; placental insufficiency; epigenomics	INTRAUTERINE GROWTH-RETARDATION; LOW-BIRTH-WEIGHT; TRANSGENERATIONAL EPIGENETIC INHERITANCE; IMPROVES INSULIN SENSITIVITY; ONE-CARBON METABOLISM; RAT SKELETAL-MUSCLE; DNA METHYLATION; DIABETES-MELLITUS; GENE-EXPRESSION; FETAL-GROWTH	Metabolic syndrome (MetS), following intrauterine growth restriction (IUGR), is epigenetically heritable. Recently, we abrogated the F2 adult phenotype with essential nutrient supplementation (ENS) of intermediates along the 1-carbon pathway. With the use of the same grandparental uterine artery ligation model, we profiled the F2 serum metabolome at weaning [postnatal day (d)21; n = 76] and adulthood (d160; n = 12) to test if MetS is preceded by alterations in the metabolome. Indicative of developmentally programmed MetS, adult F2, formerly IUGR rats, were obese (621 vs. 461g; P < 0.0001), dyslipidemic (133 vs. 67 mg/dl; P < 0.001), and glucose intolerant (26 vs. 15 mg/kg/min; P < 0.01). Unbiased gas chromatography-mass spectrometry (GC-MS) profiling revealed 34 peaks corresponding to 12 nonredundant metabolites and 9 unknowns to be changing at weaning [false discovery rate (FDR) < 0.05]. Markers of later-inlife MetS included citric acid, glucosamine, myoinositol, and proline (P < 0.03). Hierarchical clustering revealed grouping by IUGR lineage and supplementation at d21 and d160. Weanlings grouped distinctly for ENS and IUGR by partial least-squares discriminate analysis (PLS-DA; P < 0.01), whereas paternal and maternal IUGR(IUGR(pat)/IUGR(mat), respectively) control-fed rats, destined for MetS, had a distinct metabolome at weaning (randomForest analysis; class error < 0.1) and adulthood (PLS-DA; P < 0.05). In sum, we have found that alterations in the metabolome accompany heritable IUGR, precede adult-onset MetS, and are partially amenable to dietary intervention.	[Seferovic, Maxim D.; Goodspeed, Danielle M.; Krannich, Laura A.; Gonzalez-Rodriguez, Pablo J.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chu, Derrick M.; Aagaard, Kjersti M.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Cox, James E.] Univ Utah, Dept Biochem, Salt Lake City, UT USA; [Cox, James E.] Univ Utah, Metabol Core, Salt Lake City, UT USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Aagaard, KM (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, One Baylor Plaza,Jones 314, Houston, TX 77030 USA.	aagaardt@bcm.edu			U.S. National Institutes of Health (NIH) [DP21DP2OD001500-01]; NIH National Center for Infectious Diseases Reproductive Scientist Development Program [5K12HD00849]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK089201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Infectious Diseases Reproductive Scientist Development Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. National Institutes of Health (NIH) Grant DP21DP2OD001500-01, "Mapping the Fetal Primate Epigenome and Metabolome," and the NIH National Center for Infectious Diseases Reproductive Scientist Development Program Grant 5K12HD00849, "Transgenerational Growth Restriction through Altered Placental Epigenetics" (both to K.M.A.). The authors thank Dr. Jun Ma for his statistical consultation, Drs. Melissa Suter and Amanda Prince, and Mr. Derek O'Neil for insightful review of the manuscript.	Alexandre-Gouabau MC, 2013, J PROTEOME RES, V12, P2764, DOI 10.1021/pr400122v; Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Almholt K, 2003, ONCOGENE, V22, P4389, DOI 10.1038/sj.onc.1206601; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Atherton HJ, 2006, PHYSIOL GENOMICS, V27, P178, DOI 10.1152/physiolgenomics.00060.2006; Banister CE, 2011, EPIGENETICS-US, V6, P920, DOI 10.4161/epi.6.7.16079; Barberini L, 2014, J MATERN-FETAL NEO M, V27, P20, DOI 10.3109/14767058.2014.954786; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Baserga M, 2005, AM J PHYSIOL-REG I, V289, pR1348, DOI 10.1152/ajpregu.00211.2005; Baserga M, 2007, AM J PHYSIOL-REG I, V292, pR1943, DOI 10.1152/ajpregu.00558.2006; Baserga M, 2006, AM J PHYSIOL-REG I, V291, pR412, DOI 10.1152/ajpregu.00880.2005; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chang HB, 2011, J NUTR BIOCHEM, V22, P1172, DOI 10.1016/j.jnutbio.2010.10.003; CLEMENTS RS, 1977, DIABETES, V26, P215, DOI 10.2337/diabetes.26.3.215; Cooney CA, 2002, J NUTR, V132, p2393S; Cordero P, 2013, MOL GENET METAB, V110, P388, DOI 10.1016/j.ymgme.2013.08.022; Cox J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.041; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; Croze ML, 2013, J NUTR BIOCHEM, V24, P457, DOI 10.1016/j.jnutbio.2012.01.008; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; D'Anna R, 2013, DIABETES CARE, V36, P854, DOI 10.2337/dc12-1371; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dessi A, 2011, J MATERN-FETAL NEO M, V24, P36, DOI 10.3109/14767058.2011.605868; Dodson RB, 2014, AM J PHYSIOL-HEART C, V306, pH429, DOI 10.1152/ajpheart.00472.2013; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Ertel NH, 2003, DIABETES CARE, V26, P549, DOI 10.2337/diacare.26.2.549; Favretto D, 2012, ANAL BIOANAL CHEM, V402, P1109, DOI 10.1007/s00216-011-5540-z; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Ganu RS, 2012, ILAR J, V53, P306, DOI 10.1093/ilar.53.3-4.306; Gao KG, 2012, AMINO ACIDS, V42, P2207, DOI 10.1007/s00726-011-0960-9; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Goodspeed D, 2015, FASEB J, V29, P807, DOI 10.1096/fj.14-259614; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Ivorra C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-142; Koklu E, 2007, ACTA PAEDIATR, V96, P1858, DOI 10.1111/j.1651-2227.2007.00531.x; Krzywinski M, 2012, BRIEF BIOINFORM, V13, P627, DOI 10.1093/bib/bbr069; Lane RH, 1998, PEDIATR RES, V43, P563, DOI 10.1203/00006450-199805000-00001; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016; Lane RH, 1999, AM J PHYSIOL-ENDOC M, V276, pE135, DOI 10.1152/ajpendo.1999.276.1.E135; Lane RH, 1996, PEDIATR RES, V39, P390, DOI 10.1203/00006450-199603000-00003; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Lumey LH, 1997, AM J PUBLIC HEALTH, V87, P1962, DOI 10.2105/AJPH.87.12.1962; Luo ZC, 2012, J CLIN ENDOCR METAB, V97, P1720, DOI 10.1210/jc.2011-3296; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Mateo RD, 2007, J NUTR, V137, P652, DOI 10.1093/jn/137.3.652; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Nissen PM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/378268; OGATA ES, 1986, METABOLISM, V35, P970, DOI 10.1016/0026-0495(86)90064-8; OGATA ES, 1985, PEDIATR RES, V19, P32, DOI 10.1203/00006450-198501000-00010; Ortmeyer HK, 1996, OBES RES, V4, P569, DOI 10.1002/j.1550-8528.1996.tb00271.x; Osborne-Majnik A, 2013, CLIN OBSTET GYNECOL, V56, P622, DOI 10.1097/GRF.0b013e31829cb99a; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Qatanani M, 2013, DIABETES, V62, P855, DOI 10.2337/db12-0399; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Regnault TRH, 2010, EXP BIOL MED, V235, P999, DOI 10.1258/ebm.2010.009360; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Santamaria A, 2012, CLIMACTERIC, V15, P490, DOI 10.3109/13697137.2011.631063; Sanz-Cortes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080121; Short KR, 2004, NEW ENGL J MED, V350, P2419; Simonen PP, 2002, DIABETES CARE, V25, P1511, DOI 10.2337/diacare.25.9.1511; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; St-Pierre J, 2012, EPIGENETICS-US, V7, P1125, DOI 10.4161/epi.21855; Story L, 2013, EUR J OBSTET GYN R B, V170, P77, DOI 10.1016/j.ejogrb.2013.05.006; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Suter MA, 2013, MOL HUM REPROD, V19, P1, DOI 10.1093/molehr/gas050; Teeninga N, 2008, NEPHROL DIAL TRANSPL, V23, P1615, DOI 10.1093/ndt/gfm829; Thamotharan M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1270, DOI 10.1152/ajpendo.00462.2006; Thompson JA, 2011, J PHYSIOL-LONDON, V589, P3319, DOI 10.1113/jphysiol.2011.210625; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Trygg J., 2005, ANAL CHEM, V77, P8086; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Watson JA, 2010, EPIGENETICS-US, V5, P293, DOI 10.4161/epi.5.4.11684; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; Zhao Y, 2014, EUR J HUM GENET, V22, P734, DOI 10.1038/ejhg.2013.226	100	16	17	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2640	2652		10.1096/fj.14-266387	http://dx.doi.org/10.1096/fj.14-266387			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757570	Green Published			2022-12-28	WOS:000355209500039
J	Wei, YJ; Zhang, JF; Li, ZG; Gow, A; Chung, KF; Hu, M; Sun, ZS; Zeng, LM; Zhu, T; Jia, G; Li, XQ; Duarte, M; Tang, XY				Wei, Yongjie; Zhang, Junfeng (Jim); Li, Zhigang; Gow, Andrew; Chung, Kian Fan; Hu, Min; Sun, Zhongsheng; Zeng, Limin; Zhu, Tong; Jia, Guang; Li, Xiaoqian; Duarte, Marlyn; Tang, Xiaoyan			Chronic exposure to air pollution particles increases the risk of obesity and metabolic syndrome: findings from a natural experiment in Beijing	FASEB JOURNAL			English	Article						chronic inflammation; metabolic dysfunction; particulate matter	TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MACROPHAGE INFILTRATION; MOUSE MODEL; INFLAMMATION; ASSOCIATION; INTERLEUKIN-10; PROTEIN; UPDATE	Epidemiologic evidence suggests that air pollution is a risk factor for childhood obesity. Limited experimental data have shown that early-life exposure to ambient particles either increases susceptibility to diet-induced weight gain in adulthood or increases insulin resistance, adiposity, and inflammation. However, no data have directly supported a link between air pollution and non-diet-induced weight increases. In a rodent model, we found that breathing Beijing's highly polluted air resulted in weight gain and cardiorespiratory and metabolic dysfunction. Compared to those exposed to filtered air, pregnant rats exposed to unfiltered Beijing air were significantly heavier at the end of pregnancy. At 8 wk old, the offspring prenatally and postnatally exposed to unfiltered air were significantly heavier than those exposed to filtered air. In both rat dams and their offspring, after continuous exposure to unfiltered air we observed pronounced histologic evidence for both perivascular and peribronchial inflammation in the lungs, increased tissue and systemic oxidative stress, dyslipidemia, and an enhanced proinflammatory status of epididymal fat. Results suggest that TLR2/4-dependent inflammatory activation and lipid oxidation in the lung can spill over systemically, leading to metabolic dysfunction and weight gain.Wei, Y., Zhang, J., Li, Z., Gow, A., Chung, K. F., Hu, M., Sun, Z., Zeng, L., Zhu, T., Jia, G., Li, X., Duarte, M., Tang, X. Chronic exposure to air pollution particles increases the risk of obesity and metabolic syndrome: findings from a natural experiment in Beijing.	[Wei, Yongjie; Hu, Min; Zeng, Limin; Zhu, Tong; Tang, Xiaoyan] Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China; [Wei, Yongjie; Li, Zhigang; Li, Xiaoqian] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria, Beijing, Peoples R China; [Wei, Yongjie; Li, Zhigang; Li, Xiaoqian] Chinese Res Inst Environm Sci, Risk Assessment & Environm Stand Inst, Beijing, Peoples R China; [Zhang, Junfeng (Jim); Duarte, Marlyn] Duke Univ, Nicholas Sch Environm, Box 90328,308 Res Dr, Durham, NC 27708 USA; [Zhang, Junfeng (Jim); Duarte, Marlyn] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Zhang, Junfeng (Jim)] Duke Kunshan Univ, Kunshan, Peoples R China; [Gow, Andrew] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Sun, Zhongsheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China; [Jia, Guang] Peking Univ, Dept Occupat & Environm Hlth Sci, Sch Publ Hlth, Beijing 100871, Peoples R China	Peking University; Chinese Research Academy of Environmental Sciences; Chinese Research Academy of Environmental Sciences; Duke University; Duke University; Duke Kunshan University; Rutgers State University New Brunswick; Imperial College London; Chinese Academy of Sciences; Peking University	Tang, XY (corresponding author), Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China.; Zhang, JF (corresponding author), Duke Univ, Nicholas Sch Environm, Box 90328,308 Res Dr, Durham, NC 27708 USA.; Zhang, JF (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	junfeng.zhang@duke.edu; xytang@pku.edu.cn	Zeng, Limin/D-3948-2013; HU, Min/D-1037-2011; Wei, Yongjie/G-1007-2010; Gow, Andrew/AAR-2309-2020; Zhang, Junfeng/AAJ-9183-2020; Chung, Kian Fan/B-1872-2012; ZHU, TONG/H-6501-2011; Sun, Zhongsheng/AAS-4883-2020	HU, Min/0000-0003-4816-9123; Gow, Andrew/0000-0003-0876-5158; Zhang, Junfeng/0000-0003-3759-6672; Chung, Kian Fan/0000-0001-7101-1426; ZHU, TONG/0000-0002-2752-7924; Sun, Zhongsheng/0000-0002-7640-5026	National Natural Science Foundation of China [21190051, 21477119]; State Key Joint Laboratory of Environment Simulation and Pollution Control [13K03ESPCP]; China Postdoctoral Science Foundation [201003010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Natural Science Foundation of China ( 21190051, 21477119), the Open Fund of the State Key Joint Laboratory of Environment Simulation and Pollution Control ( 13K03ESPCP), and the China Postdoctoral Science Foundation ( 201003010).	Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Charles BA, 2011, J CLIN ENDOCR METAB, V96, pE2018, DOI 10.1210/jc.2011-1497; Chavey C, 2009, AGING-US, V1, P674, DOI 10.18632/aging.100064; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; FRANKEL EN, 1983, BIOCHIM BIOPHYS ACTA, V754, P264, DOI 10.1016/0005-2760(83)90141-8; GRUNFELD C, 1991, BIOTHERAPY, V3, P143, DOI 10.1007/BF02172087; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jerrett M, 2010, PREV MED, V50, pS50, DOI 10.1016/j.ypmed.2009.09.026; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Lee YS, 2012, DIABETOLOGIA, V55, P2456, DOI 10.1007/s00125-012-2592-3; Mendez R, 2013, AM J TRANSL RES, V5, P224; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Thiering E, 2013, DIABETOLOGIA, V56, P1696, DOI 10.1007/s00125-013-2925-x; Weldy CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088582; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	23	138	143	6	63	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2115	2122		10.1096/fj.201500142	http://dx.doi.org/10.1096/fj.201500142			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26891735	Green Published			2022-12-28	WOS:000376878300006
J	Li, D; Yang, WP; Yang, F; Liu, HA; Zhu, ZX; Lian, KQ; Lei, CQ; Li, S; Liu, XT; Zheng, HX; Shu, HB				Li, Dan; Yang, Wenping; Yang, Fan; Liu, Huanan; Zhu, Zixiang; Lian, Kaiqi; Lei, Caoqi; Li, Shu; Liu, Xiangtao; Zheng, Haixue; Shu, Hongbing			The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-beta signaling pathway	FASEB JOURNAL			English	Article						Aphthovirus; innate immunity; pathogen	ADAPTER PROTEIN; INNATE IMMUNITY; KAPPA-B; ACTIVATION; RECOGNITION; IRF-3; MAVS; INVOLVEMENT; INFECTION; CLEAVAGE	Foot-and-mouth disease is a frequently occurring disease of cloven-hoofed animals that is caused by infection with the foot-and-mouth virus (FMDV). FMDV circumvents the type-I IFN response by expressing proteins that antagonize cellular innate immunity, such as leader protease and 3C protease. We identified the FMDV structural protein VP3 as a negative regulator of the virus-triggered IFN-beta signaling pathway. Expression of FMDV VP3 inhibited the Sendai virus-triggered activation of IFN regulatory factor-3 and the expression of retinoic acid-inducible gene-I/melanoma differentiation-associated protein-5. Transient transfection and coimmunoprecipitation confirmed that the structural protein VP3 interacts with virus-induced signaling adapter (VISA), which is dependent on the C-terminal aa 111-220 of VP3. In addition, we found that FMDV VP3 inhibits the expression of VISA by disrupting its mRNA. Taken together, our findings reveal a novel strategy used by the structural VP3 protein of FMDV to evade host innate immunity.-Li, D., Yang, W., Yang, F., Liu, H., Zhu, Z., Lian, K., Lei, C., Li, S., Liu, X., Zheng, H., Shu, H. The VP3 structural protein of foot-andmouth disease virus inhibits the IFN-beta signaling pathway.	[Li, Dan; Yang, Wenping; Yang, Fan; Liu, Huanan; Zhu, Zixiang; Lian, Kaiqi; Liu, Xiangtao; Zheng, Haixue] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Natl Foot & Mouth Dis Reference Lab, Lanzhou, Peoples R China; [Lei, Caoqi; Li, Shu; Shu, Hongbing] Wuhan Univ, Med Res Inst, Collaborat Innovat Ctr Viral Immunol, Wuhan 430072, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Med Res Inst, Collaborat Innovat Ctr Viral Immunol, Wuhan 430072, Peoples R China.; Zheng, HX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Biotechnol, Lanzhou, Peoples R China.	haixuezheng@163.com; shuh@whu.edu.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Natural Science Foundation of China [31402179, 31302118]; Gansu Science Foundation for Distinguished Young Scholars [145RJDA328]; National Science and Technology [2015BAD12B04]; Key Technologies Research and Development Program of Gansu Province [1302NKDA027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Science Foundation for Distinguished Young Scholars; National Science and Technology; Key Technologies Research and Development Program of Gansu Province	The authors thank other members of H.S.'s laboratory for stimulating discussions and technical help. This work was supported by National Natural Science Foundation of China (Grants 31402179 and 31302118), Gansu Science Foundation for Distinguished Young Scholars (Grant 145RJDA328), National Science and Technology (Support Project 2015BAD12B04), and Key Technologies Research and Development Program of Gansu Province (Grant 1302NKDA027). The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Borca MV, 2012, VIROLOGY, V422, P37, DOI 10.1016/j.virol.2011.09.031; Chinsangaram J, 1999, J VIROL, V73, P9891, DOI 10.1128/JVI.73.12.9891-9898.1999; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; de los Santos T, 2007, J VIROL, V81, P12803, DOI 10.1128/JVI.01467-07; DEVANEY MA, 1988, J VIROL, V62, P4407, DOI 10.1128/JVI.62.11.4407-4409.1988; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Du YJ, 2014, J VIROL, V88, P4908, DOI 10.1128/JVI.03668-13; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; JENSEN MJ, 1993, VIROLOGY, V193, P604, DOI 10.1006/viro.1993.1168; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W; Kumar M, 2011, J VIROL, V85, P987, DOI 10.1128/JVI.01825-10; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li XY, 2013, VET MICROBIOL, V166, P35, DOI 10.1016/j.vetmic.2013.04.028; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; MARQUARDT O, 1991, J VIROL METHODS, V33, P267, DOI 10.1016/0166-0934(91)90026-V; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moniwa M, 2007, J VET DIAGN INVEST, V19, P9, DOI 10.1177/104063870701900103; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nfon CK, 2008, VIRAL IMMUNOL, V21, P68, DOI 10.1089/vim.2007.0097; Ng MHJ, 2011, J IMMUNOL, V187, P6473, DOI 10.4049/jimmunol.1100719; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; SELLERS RF, 1968, ARCH GES VIRUSFORSCH, V23, P1, DOI 10.1007/BF01242108; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Wang D, 2010, BIOCHEM BIOPH RES CO, V399, P72, DOI 10.1016/j.bbrc.2010.07.044; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	45	46	56	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1757	1766		10.1096/fj.15-281410	http://dx.doi.org/10.1096/fj.15-281410			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26813975				2022-12-28	WOS:000374879400007
J	Stanga, S; Zanou, N; Audouard, E; Tasiaux, B; Contino, S; Vandermeulen, G; Rene, F; Loeffler, JP; Clotman, F; Gailly, P; Dewachter, I; Octave, JN; Kienlen-Campard, P				Stanga, Serena; Zanou, Nadege; Audouard, Emilie; Tasiaux, Bernadette; Contino, Sabrina; Vandermeulen, Gaelle; Rene, Frederique; Loeffler, Jean-Philippe; Clotman, Frederic; Gailly, Philippe; Dewachter, Ilse; Octave, Jean-Noel; Kienlen-Campard, Pascal			APP-dependent glial cell line-derived neurotrophic factor gene expression drives neuromuscular junction formation	FASEB JOURNAL			English	Article						gene transcription; Alzheimer's disease; APP knockout mice; nerve-muscle coculture; muscle electroporation	AMYLOID PRECURSOR PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; INCLUSION-BODY MYOSITIS; SKELETAL-MUSCLE CELLS; INTRACELLULAR DOMAIN; DNA ELECTROTRANSFER; ALZHEIMERS-DISEASE; DEFICIENT MICE; MOUSE MODEL; BETA-APP	Besides its crucial role in the pathogenesis of Alzheimer's disease, the knowledge of amyloid precursor protein (APP) physiologic functions remains surprisingly scarce. Here, we show that APP regulates the transcription of the glial cell line-derived neurotrophic factor (GDNF). APP-dependent regulation of GDNF expression affects muscle strength, muscular trophy, and both neuronal and muscular differentiation fundamental for neuromuscular junction (NMJ) maturation in vivo. In a nerve-muscle coculture model set up to modelize NMJ formation in vitro, silencing of muscular APP induces a 30% decrease in secreted GDNF levels and a 40% decrease in the total number of NMJs together with a significant reduction in the density of acetylcholine vesicles at the presynaptic site and in neuronal maturation. These defects are rescued by GDNF expression inmuscle cells in the conditions where muscular APP has been previously silenced. Expression of GDNF in muscles of amyloid precursor protein null mice corrected the aberrant synaptic morphology of NMJs. Our findings highlight for the first time that APP-dependent GDNF expression drives the process of NMJ formation, providing new insights into the link between APP gene regulatory network and physiologic functions.-Stanga, S., Zanou, N., Audouard, E., Tasiaux, B., Contino, S., Vandermeulen, G., Rene , F., Loeffler, J.-P., Clotman, F., Gailly, P., Dewachter, I., Octave, J.-N., Kienlen-Campard, P. APP-dependent glial cell line-derived neurotrophic factor gene expression drives neuromuscular junction formation.	[Stanga, Serena; Tasiaux, Bernadette; Contino, Sabrina; Dewachter, Ilse; Octave, Jean-Noel; Kienlen-Campard, Pascal] Catholic Univ Louvain, Inst Neurosci, Alzheimer Res Grp, B-1200 Brussels, Belgium; [Zanou, Nadege; Gailly, Philippe] Catholic Univ Louvain, Inst Neurosci, Lab Cell Physiol, B-1200 Brussels, Belgium; [Audouard, Emilie; Clotman, Frederic] Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, B-1200 Brussels, Belgium; [Vandermeulen, Gaelle] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium; [Rene, Frederique; Loeffler, Jean-Philippe] Univ Strasbourg, INSERM, Unite Mecanismes Centraux & Peripher Neurodegener, Strasbourg, France	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kienlen-Campard, P (corresponding author), Catholic Univ Louvain, Inst Neurosci, IONS CEMO, Ave Mounier 53 Bte B1-53-02, B-1200 Brussels, Belgium.	pascal.kienlen-campard@uclouvain.be	LOEFFLER, Jean-Philippe/AAS-4401-2020; Stanga, Serena/AAP-1558-2020; Dewachter, Ilse/AAZ-5661-2020	Dewachter, Ilse/0000-0001-7202-515X; Stanga, Serena/0000-0003-1454-0713; Vandermeulen, Gaelle/0000-0002-8696-9642; Kienlen-Campard, Pascal/0000-0003-1086-2942	Belgian Fonds National pour la Recherche Scientifique; S.A.O./F.R.A. Stichting voor Alzheimer Onderzoek/Foundation for Research on Alzheimer's disease; Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy [IAP-P7/16, IAP-P7/13]; Fondation Medicale Reine Elisabeth; Action de Recherche Concertee [14/19-059]	Belgian Fonds National pour la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); S.A.O./F.R.A. Stichting voor Alzheimer Onderzoek/Foundation for Research on Alzheimer's disease; Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy; Fondation Medicale Reine Elisabeth; Action de Recherche Concertee	The authors are grateful to Bart de Strooper (Katholieke Universiteit Leuven, Leuven, Belgium) for the kind gift of mouse embryonic fibroblast cells. The authors kindly acknowledge Laetitia El Haylani (Alzheimer Research Group, Universite Catholique de Louvain, Institute of Neuroscience, Brussels, Belgium) for her skillful technical assistance. This work was supported by a grant from the Belgian Fonds National pour la Recherche Scientifique (to S.S.), by the S.A.O./F.R.A. Stichting voor Alzheimer Onderzoek/Foundation for Research on Alzheimer's disease (to P.K.-C.), Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy (IAP-P7/16 and IAP-P7/13 to J.-N.O., P.K.-C., and P.G.), Fondation Medicale Reine Elisabeth (to J.-N.O., I.D., and P.K.-C.), and Action de Recherche Concertee (14/19-059 to P.K.-C.). F.C. is a research associate, and N.Z. is a postdoctoral researcher of the Belgian Fonds National pour la Recherche Scientifique.	Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; Audouard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050509; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Bloquel C, 2004, J GENE MED, V6, pS11, DOI 10.1002/jgm.508; Boger HA, 2006, EXP NEUROL, V202, P336, DOI 10.1016/j.expneurol.2006.06.006; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Caldwell JH, 2013, MECH DEVELOP, V130, P433, DOI 10.1016/j.mod.2012.11.001; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Caumont AS, 2006, J NEUROCHEM, V97, P128, DOI 10.1111/j.1471-4159.2006.03711.x; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Decock M, 2015, FEBS OPEN BIO, V5, P763, DOI 10.1016/j.fob.2015.09.002; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hicks DA, 2013, J BIOL CHEM, V288, P26039, DOI 10.1074/jbc.M113.461269; Huysseune S, 2009, FASEB J, V23, P4158, DOI 10.1096/fj.09-140012; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Koistinen H, 2006, MUSCLE NERVE, V34, P444, DOI 10.1002/mus.20612; Konishi Y, 2014, J NEUROSCI, V34, P13127, DOI 10.1523/JNEUROSCI.2582-13.2014; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Lie DC, 1998, NEUROSCI LETT, V250, P87, DOI 10.1016/S0304-3940(98)00434-0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Littrell OM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.013; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Nagano M, 2003, NEUROSCI RES, V45, P391, DOI 10.1016/S0168-0102(03)00010-5; Nalivaeva N N, 2012, Int J Alzheimers Dis, V2012, P383796, DOI 10.1155/2012/383796; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Senechal Y, 2007, J NEUROCHEM, V102, P1928, DOI 10.1111/j.1471-4159.2007.04672.x; Shariati SAM, 2013, FEBS LETT, V587, P2036, DOI 10.1016/j.febslet.2013.05.026; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Straten G, 2009, J ALZHEIMERS DIS, V18, P331, DOI 10.3233/JAD-2009-1146; Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599; Suzuki H, 1998, J COMP NEUROL, V402, P303; Tintignac LA, 2015, PHYSIOL REV, V95, P809, DOI 10.1152/physrev.00033.2014; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Vandermeulen G, 2007, J CONTROL RELEASE, V124, P81, DOI 10.1016/j.jconrel.2007.08.010; Vianney JM, 2011, BRAIN RES, V1390, P1, DOI 10.1016/j.brainres.2011.03.030; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Waldron E, 2008, EXP CELL RES, V314, P2419, DOI 10.1016/j.yexcr.2008.05.003; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Wong SHA, 2005, NEUROMUSCULAR DISORD, V15, P630, DOI 10.1016/j.nmd.2005.04.008; Yang LX, 2004, NEUROSCIENCE, V128, P497, DOI 10.1016/j.neuroscience.2004.06.067; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	63	21	21	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1696	1711		10.1096/fj.15-278739	http://dx.doi.org/10.1096/fj.15-278739			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26718890	Green Submitted			2022-12-28	WOS:000374879400002
J	Vangansewinkel, T; Geurts, N; Quanten, K; Nelissen, S; Lemmens, S; Geboes, L; Dooley, D; Vidal, PM; Pejler, G; Hendrix, S				Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Pejler, Gunnar; Hendrix, Sven			Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6	FASEB JOURNAL			English	Article						CNS trauma; mMCP6; ECM remodeling; gene expression; improved outcome	CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCANS; AXONAL REGENERATION; GLIAL SCAR; BETA-TRYPTASE; ABC PROMOTES; MATRIX; INFLAMMATION; BRAIN; MICE	An important barrier for axon regeneration and recovery after traumatic spinal cord injury (SCI) is attributed to the scar that is formed at the lesion site. Here, we investigated the effect of mouse mast cell protease (mMCP) 6, a mast cell (MC)-specific tryptase, on scarring and functional recovery after a spinal cord hemisection injury. Functional recovery was significantly impaired in both MC-deficient and mMCP6-knockout (mMCP6(-/-)) mice after SCI compared with wild-type control mice. This decrease in locomotor performance was associated with an increased lesion size and excessive scarring at the injury site. Axon growth-inhibitory chondroitin sulfate proteoglycans and the extracellular matrix components fibronectin, laminin, and collagen IV were significantly up-regulated in MC-deficient and mMCP6(-/-) mice, with an increase in scar volume between 23 and 32%. A degradation assay revealed that mMCP6 directly cleaves fibronectin and collagen IV in vitro. In addition, gene expression levels of the scar components fibronectin, aggrecan, and collagen IV were increased up to 6.8-fold in mMCP6(-/-) mice in the subacute phase after injury. These data indicate that endogenous mMCP6 has scar-suppressing properties after SCI via indirect cleavage of axon growth-inhibitory scar components and alteration of the gene expression profile of these factors.-Vangansewinkel, T., Geurts, N., Quanten, K., Nelissen, S., Lemmens, S., Geboes, L., Dooley, D., Vidal, P. M., Pejler, G., Hendrix, S. Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6. www.fasebj.org	[Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Hendrix, Sven] Hasselt Univ, Biomed Res Inst, Dept Morphol, Diepenbeek, Belgium; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Vidal, Pia M.] Univ Hlth Network, Div Genet & Dev, Krembil Neurosci Ctr, Toronto, ON, Canada	Hasselt University; Swedish University of Agricultural Sciences; Uppsala University; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hendrix, S (corresponding author), Martelarenlaan 42, B-3500 Hasselt, Belgium.	sven.hendrix@uhasselt.be	Vidal, Pia M./U-8401-2019; Hendrix, Sven/F-4059-2010; Vangansewinkel, Tim/N-4308-2017	Vidal, Pia M./0000-0001-9885-3076; Hendrix, Sven/0000-0003-2344-7369; Dooley, Dearbhaile/0000-0001-5337-1831	Deutsche Forschungsgemeinschaft [SPP1394]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO) [G.0389.12, G0A5813, G.0834.11N, G0A58113, 1.2.917.14N]; Agentschap voor Innovatie door Wetenschap en Technologie [101517]; COST Action Mast Cells and Basophils-Targets for Innovative Therapies [BM1007]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO); Agentschap voor Innovatie door Wetenschap en Technologie; COST Action Mast Cells and Basophils-Targets for Innovative Therapies	The authors thank Dr. David Lee (Novartis Pharma, Basel, Switzerland) and Dr. Peter Nigrovic (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for providing the mMCP6<SUP>-/-</SUP> mice, and Dr. Leen Timmermans (Hasselt University) for her help with the qPCR analysis and immunohistochemistry. This study was supported in part by grants from Deutsche Forschungsgemeinschaft (SPP1394), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO; G.0389.12, G0A5813, G.0834.11N, and G0A58113 to S.H., and 1.2.917.14N to N.G.), and from Agentschap voor Innovatie door Wetenschap en Technologie (101517 to T.V.). This work has also benefited from the support of the COST Action BM1007 Mast Cells and Basophils-Targets for Innovative Therapies.	Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Didangelos A, 2014, J NEUROSCI, V34, P16424, DOI 10.1523/JNEUROSCI.2927-14.2014; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Douaiher J, 2014, ADV IMMUNOL, V122, P211, DOI 10.1016/B978-0-12-800267-4.00006-7; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Fajardo I, 2003, J IMMUNOL, V171, P1493, DOI 10.4049/jimmunol.171.3.1493; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Hermanns S, 2006, ADV EXP MED BIOL, V557, P177; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Liu XB, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/627831; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Loske P, 2012, J NEUROCHEM, V120, P1084, DOI 10.1111/j.1471-4159.2012.07657.x; Lundequist A, 2006, BIOL CHEM, V387, P1513, DOI 10.1515/BC.2006.189; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mullan CS, 2008, AM J RESP CELL MOL, V38, P600, DOI 10.1165/rcmb.2007-0082OC; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Nelissen S, 2013, ACTA NEUROPATHOL, V125, P637, DOI 10.1007/s00401-013-1092-y; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Polajeva J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025222; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Ribatti D, 2015, EXP CELL RES, V332, P157, DOI 10.1016/j.yexcr.2014.11.014; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal PM, 2013, CYTOKINE GROWTH F R, V24, P1, DOI 10.1016/j.cytogfr.2012.08.008; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Yang XP, 2010, LEUKEMIA LYMPHOMA, V51, P1550, DOI 10.3109/10428194.2010.496013; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu YJ, 2015, J NEUROTRAUM, V32, P1158, DOI 10.1089/neu.2014.3703	74	21	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2040	2057		10.1096/fj.201500114R	http://dx.doi.org/10.1096/fj.201500114R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26917739				2022-12-28	WOS:000374879400030
J	LaBarge, SA; Migdal, CW; Buckner, EH; Okuno, H; Gertsman, I; Stocks, B; Barshop, BA; Nalbandian, SR; Philp, A; McCurdy, CE; Schenk, S				LaBarge, Samuel A.; Migdal, Christopher W.; Buckner, Elisa H.; Okuno, Hiroshi; Gertsman, Ilya; Stocks, Ben; Barshop, Bruce A.; Nalbandian, Sarah R.; Philp, Andrew; McCurdy, Carrie E.; Schenk, Simon			p300 is not required for metabolic adaptation to endurance exercise training	FASEB JOURNAL			English	Article						acetyltransferase; physiology; metabolomics; mitochondria; knockout	PROTEIN LYSINE ACETYLATION; SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HISTONE MODIFICATIONS; INSULIN SENSITIVITY; SIRTUIN 1; MYOD; CBP; COACTIVATOR	The acetyltransferase, E1a-binding protein (p300), is proposed to regulate various aspects of skeletal muscle development, metabolism, and mitochondrial function, via its interaction with numerous transcriptional regulators and other proteins. Remarkably, however, the contribution of p300 to skeletal muscle function and metabolism, in vivo, is poorly understood. To address this, we used Cre-LoxP methodology to generate mice with skeletal muscle-specific knockout of E1a-binding protein (mKO). mKO mice were indistinguishable from their wild-type/floxed littermates, with no differences in lean mass, skeletal muscle structure, fiber type, respirometry flux, or metabolites of fatty acid and amino acid metabolism. Ex vivo muscle function in extensor digitorum longus and soleus muscles, including peak stress and time to fatigue, as well as in vivo running capacity were also comparable. Moreover, expected adaptations to a 20 d voluntary wheel running regime were not compromised in mKO mice. Taken together, these findings demonstrate that p300 is not required for the normal development or functioning of adult skeletal muscle, nor is it required for endurance exercise-mediated mitochondrial adaptations.	[LaBarge, Samuel A.; Migdal, Christopher W.; Buckner, Elisa H.; Okuno, Hiroshi; Nalbandian, Sarah R.; Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, Sch Med, 9500 Gilman Dr,MC0863, La Jolla, CA 92093 USA; [Gertsman, Ilya; Barshop, Bruce A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Stocks, Ben; Philp, Andrew] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Edgbaston, England; [McCurdy, Carrie E.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Birmingham; University of Oregon	Schenk, S (corresponding author), Univ Calif San Diego, Dept Orthopaed Surg, Sch Med, 9500 Gilman Dr,MC0863, La Jolla, CA 92093 USA.	sschenk@ucsd.edu		McCurdy, Carrie/0000-0003-1177-9040; Philp, Andrew/0000-0003-3860-4136; Schenk, Simon/0000-0002-8224-3203	U.S. National Institutes of Health [R01 AG043120, R24 HD050837, P30 DK063491, P30 AR058878]; UCSD Frontiers of Innovation Scholars Program; Biotechnology and Biological Sciences Research Council [BB/L023547/1]; BBSRC [BB/L023547/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043120] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Frontiers of Innovation Scholars Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors sincerely thank Shannon Bremner [Department of Orthopaedic Surgery, University of California San Diego (UCSD)] for expertise and technical assistance with muscle mechanics testing. The authors also thank the UCSD Animal Care Program Phenotyping Core for Comprehensive Lab Animals Monitoring System measurements and Dr. Jianhua Shao (Department of Pediatrics, UCSD) for use of the magnetic resonance imaging machine. This work was supported in part by U.S. National Institutes of Health Grants R01 AG043120 (National Institute on Aging), R24 HD050837 (Eunice Kennedy Shriver National Institute of Child Health and Human Development), P30 DK063491 (National Institute of Diabetes and Digestive and Kidney Diseases via a Pilot and Feasibility Award from the UCSD/University of California, Los Angeles, Los Angeles, CA, USA/Cedars-Sinai, Los Angeles, CA, USA/Salk Diabetes Research Center), P30 AR058878 to (National Institute of Arthritis and Musculoskeletal and Skin Diseases; to S.S.), a postdoctoral fellowship from the UCSD Frontiers of Innovation Scholars Program (to SAL.), and a Biotechnology and Biological Sciences Research Council Award (BB/L023547/1; to A.P.). S.A.L. and S.S. conceived and designed the experiments; SAL., C.W.M., E.H.B., H.O., B.S., S.R.N., C.E.M., and S.S. conducted experiments and contributed to data analysis presented in Figs. 1-7; I.G. and B.A.B. performed metabolomics analysis, and B.S. and A.P. analyzed data in Fig. 4; SAL., C.W.M., and S.S. prepared the figures; S.A.L. wrote the manuscript, which was edited by S.S.; and all authors reviewed the results and approved the final version of the manuscript. S.S. is associated with the Biomedical Sciences Graduate Program (School of Medicine, UCSD). The authors declare no conflicts of interest.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Chan HM, 2001, J CELL SCI, V114, P2363; Chicco AJ, 2014, J EXP BIOL, V217, P2947, DOI 10.1242/jeb.105916; Chleboun GS, 1997, ACTA ANAT, V159, P147; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Gertsman I, 2014, METABOLOMICS, V10, P312, DOI 10.1007/s11306-013-0582-1; Goodman RH, 2000, GENE DEV, V14, P1553; Hatazawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129084; Hatazawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091006; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; Menzies K, 2013, J MOL ENDOCRINOL, V51, pT101, DOI 10.1530/JME-13-0140; Minamoto VB, 2007, DEV MED CHILD NEUROL, V49, P907, DOI 10.1111/j.1469-8749.2007.00907.x; Nakagawa Y, 2009, CIRC RES, V105, P746, DOI 10.1161/CIRCRESAHA.109.206037; Philp A., 2014, AM J PHYSL CELL PHYS, V307, pC763; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Spinazzi M, 2011, MITOCHONDRION, V11, P893, DOI 10.1016/j.mito.2011.07.006; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Tsusaka T, 2014, GENES CELLS, V19, P766, DOI 10.1111/gtc.12176; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; White AT, 2014, AM J PHYSIOL-ENDOC M, V307, pE764, DOI 10.1152/ajpendo.00001.2014; White AT, 2012, AM J PHYSIOL-ENDOC M, V303, pE308, DOI 10.1152/ajpendo.00054.2012; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan H, 2014, ACTA PHYSIOL, V212, P283, DOI 10.1111/apha.12395; Yuan LWC, 2002, ONCOGENE, V21, P2253, DOI 10.1038/sj.onc.1205283; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	62	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1623	1633		10.1096/fj.15-281741	http://dx.doi.org/10.1096/fj.15-281741			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26712218	Green Published			2022-12-28	WOS:000372629100023
J	Nakayama, T; Mikoshiba, K; Akagawa, K				Nakayama, Takahiro; Mikoshiba, Katsuhiko; Akagawa, Kimio			The cell- and tissue-specific transcription mechanism of the TATA-less syntaxin 1A gene	FASEB JOURNAL			English	Article						histone H3 acetylation; class I HDAC; epigenetic regulation; neuronal disorder; SP1	NF-KAPPA-B; HPC-1/SYNTAXIN 1A; NEURONAL EXPRESSION; BINDING-PROTEIN; RECEPTOR GENE; SP1; PROMOTER; SEQUENCE; ACTIVATION; REQUIRES	Syntaxin 1A (Stx1a) plays an important role in regulation of neuronal synaptic function. To clarify the mechanism of basic transcriptional regulation and neuron-specific transcription of Stx1a we cloned the Stx1a gene from rat, in which knowledge of the expression profile was accumulated, and elucidated that Stx1a consisting of 10 exons, possesses multiple transcription initiation sites and a 204-bp core promoter region (CPR) essential for transcription inPC12 cells. TheTATA-less, conserved, GC-rich CPR has 2 specific protein (SP) sites that bind SP1 and are responsible for 65% of promoter activity. The endogenous CPR, including 23 CpG sites, is not methylated in PC12 cells, which express Stx1a and fetal rat skin keratinocyte (FRSK) cells, which do not, although an exogenous methylated CPR suppresses reporter activity in both lines. TrichostatinA(TSA) and class I histone deacetylase (HDAC) inhibitors, but not 5-azacytidine, induce Stx1a in FRSK cells. Acetylated histone H3 only associates to the CPR in FRSK cells after TSAaddition, whereas the high acetylated histone H3-CPR association in PC12 cells was unchanged following treatment. HDAC inhibitor induction of Stx1a was negated by mithramycin A and deletion/mutation of 2 SP sites. HDAC1, HDAC2, and HDAC8 detach from the CPR when treated with TSA in FRSK cells and are associated with the CPR in lungs, and acetylated histone H3 associates to this region in the brain. In the first study characterizing a syntaxin promoter, we show that association of SP1 and acetylated histone H3 toCPR is important for Stx1a transcription and that HDAC1, HDAC2, and HDAC8 decide cell/tissue specificity in a suppressive manner.	[Nakayama, Takahiro; Akagawa, Kimio] Kyorin Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Neurodev Disorder Res Grp, Dev Neurobiol Lab, Saitama, Japan	Kyorin University; RIKEN	Nakayama, T (corresponding author), Kyorin Univ, Dept Cell Physiol, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	nakayama@ks.kyorin-u.ac.jp	Nakayama, Takahiro/AAE-8953-2019	Nakayama, Takahiro/0000-0003-3064-3536	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology in Japan [19300133]; Promotion and Mutual Aid Corporation for Private Schools of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	The authors are grateful to Ms. Masumi Sanada for practical assistance with cell culture and molecular biology techniques and are greatly indebted to Dr. Guntram Suske for providing the plasmids pPac-vector and pPac-Sp1. This study was supported in part by a grant-in-aid from the Japan Society for the Promotion of Science for Japanese Junior Scientists (to T.N.), a grant-in-aid for scientific research (B) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (19300133), and a grant-in-aid from the Promotion and Mutual Aid Corporation for Private Schools of Japan (to K.A.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Bedford FK, 1998, J NEUROSCI, V18, P6186; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Borges K, 2001, J BIOL CHEM, V276, P25929, DOI 10.1074/jbc.M009105200; Brasse-Lagnel C, 2003, J BIOL CHEM, V278, P52504, DOI 10.1074/jbc.M306752200; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Fujino I, 1997, NEUROSCI RES, V28, P243, DOI 10.1016/S0168-0102(97)00050-3; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Fujiwara T, 2010, EUR J NEUROSCI, V32, P99, DOI 10.1111/j.1460-9568.2010.07269.x; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hermon P, 2007, PLANT MOL BIOL, V64, P387, DOI 10.1007/s11103-007-9160-0; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; INOUE A, 1992, J BIOL CHEM, V267, P10613; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Jin HJ, 2014, J BIOL CHEM, V289, P34743, DOI 10.1074/jbc.M114.576702; Johnson AA, 2013, J NEUROSCI, V33, P7535, DOI 10.1523/JNEUROSCI.3739-12.2013; Kumar P, 2014, J BIOL CHEM, V289, P6991, DOI 10.1074/jbc.M113.511444; Kushima Y, 1997, J MOL NEUROSCI, V8, P19, DOI 10.1007/BF02736860; LATCHMAN DS, 1998, EUKARYOTIC TRANSCRIP; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094523; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; MARUYAMA K, 1994, GENE, V138, P171; Matlhagela K, 2005, J BIOL CHEM, V280, P334, DOI 10.1074/jbc.M411415200; Mishima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090004; Mishima T, 2012, J NEUROSCI, V32, P381, DOI 10.1523/JNEUROSCI.2911-11.2012; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; Nakayama T, 1998, CYTOGENET CELL GENET, V82, P49, DOI 10.1159/000015063; Nakayama T, 1997, GENOMICS, V42, P173, DOI 10.1006/geno.1997.4650; Nguyen HN, 2005, NEUROREPORT, V16, P731, DOI 10.1097/00001756-200505120-00015; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Sambrook J., 2001, MOL CLONING; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; TAGAYA M, 1995, J BIOL CHEM, V270, P15930, DOI 10.1074/jbc.270.27.15930; Teng FYH, 2001, GENOME BIOL, V2; Watanabe T, 1999, J BIOCHEM-TOKYO, V125, P685, DOI 10.1093/oxfordjournals.jbchem.a022337; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Wong CYA, 2011, J BIOL CHEM, V286, P25813, DOI 10.1074/jbc.M110.211292; Wood IC, 1999, BIOCHEM J, V340, P475, DOI 10.1042/0264-6021:3400475; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x	59	5	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					525	543		10.1096/fj.15-275529	http://dx.doi.org/10.1096/fj.15-275529			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26391271				2022-12-28	WOS:000369391900007
J	Roux, A; Gilbert, S; Loranger, A; Marceau, N				Roux, Alexandra; Gilbert, Stephane; Loranger, Anne; Marceau, Normand			Impact of keratin intermediate filaments on insulin-mediated glucose metabolism regulation in the liver and disease association	FASEB JOURNAL			English	Review						cell signaling; cytoskeleton; hepatocyte; hormone receptor; protein kinases	SIMPLE EPITHELIAL-CELLS; PROTEIN-KINASE-C; LIPID RAFTS; GLYCOGEN-SYNTHASE; INTRACELLULAR-DISTRIBUTION; RECEPTOR SUBSTRATE-1; RAT HEPATOCYTES; ADIPOSE-TISSUE; RESISTANCE; CYTOSKELETON	In all cells, a tight regulation exists between glucose uptake and utilization to prevent diseases related to its perturbedmetabolism. In insulin-targeted cells, such as hepatocytes, proper glucose utilization requires an elaborate interplay between the insulin receptor, the glucose transporter, and mitochondria that involves the participation of actin microfilaments and microtubules. In addition, there is increasing evidence of an involvement of the third cytoskeletal network provided by intermediate filaments (IFs). Keratins belong to themultigene family of IF proteins, coordinately expressed as distinct pairs within the context of epithelial cell differentiation. Hepatocyte IFs are made up of the [keratin (K) 8/K18] pair only, whereas pancreatic beta-cell IFs additionally include small amounts of K7. There are accumulating examples of K8/K18 involvement in the glucose-insulin cross-talk, including the modulation of plasma glucose levels, insulin release from pancreatic beta-cells, and insulin-mediated glucose uptake and glycogen production in hepatocytes after a K8/K18 loss. This review integrates the mechanistic features that support such an impact of K8/K18 IFs on insulin-dependent glucose metabolism regulation in liver and its implication in glucose-or insulin-associated diseases.	Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Marceau, Normand] Ctr Hosp Univ Quebec, Ctr Rech, 9 McMahon, Quebec City, PQ G1R 2J6, Canada	Laval University; Laval University	Marceau, N (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech, 9 McMahon, Quebec City, PQ G1R 2J6, Canada.	normand.marceau@crchudequebec.ulaval.ca			Canadian Institutes of Health Research [MOP15529]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank A. Anderson and D. Richard for proofreading. The original work from this laboratory is supported by the Canadian Institutes of Health Research (MOP15529).	Ahmed MH, 2006, DIABETES RES CLIN PR, V72, P110, DOI 10.1016/j.diabres.2005.09.009; Alam CM, 2013, J CELL SCI, V126, P5635, DOI 10.1242/jcs.132795; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Balbis A, 2004, J BIOL CHEM, V279, P39348, DOI 10.1074/jbc.M404280200; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; BLESSING M, 1993, J CELL BIOL, V120, P743, DOI 10.1083/jcb.120.3.743; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Demo E, 2007, J HEPATOL, V46, P492, DOI 10.1016/j.jhep.2006.09.022; Desbuquois Bernard, 2014, Biologie Aujourd hui, V208, P137, DOI 10.1051/jbio/2014016; Eisenberg ML, 2005, CELL PHYSIOL BIOCHEM, V15, P51, DOI 10.1159/000083638; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Foti Michelangelo, 2004, Novartis Found Symp, V262, P125; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Gilbert S, 2004, MOL CELL BIOL, V24, P7072, DOI 10.1128/MCB.24.16.7072-7081.2004; Gilbert S, 2008, APOPTOSIS, V13, P1479, DOI 10.1007/s10495-008-0274-x; Gilbert S, 2012, APOPTOSIS, V17, P880, DOI 10.1007/s10495-012-0733-2; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Green KJ, 2005, ADV PROTEIN CHEM, V70, P143, DOI 10.1016/S0065-3233(04)70006-6; Guldiken N, 2015, LIVER INT, V35, P1203, DOI 10.1111/liv.12608; Hamer I, 2002, DIABETOLOGIA, V45, P657, DOI 10.1007/s00125-002-0798-5; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Hickman IJ, 2007, AM J MED, V120, P829, DOI 10.1016/j.amjmed.2007.03.025; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Kawaguchi T, 2011, WORLD J HEPATOL, V3, P99, DOI 10.4254/wjh.v3.i5.99; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002; Koster S, 2015, CURR OPIN CELL BIOL, V32, P82, DOI 10.1016/j.ceb.2015.01.001; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lauro D, 1998, NAT GENET, V20, P294, DOI 10.1038/3112; Lavoie L, 1999, J BIOL CHEM, V274, P28279, DOI 10.1074/jbc.274.40.28279; Lee J, 2013, BIOL OPEN, V2, P695, DOI 10.1242/bio.20134606; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Marceau N, 2001, BIOCHEM CELL BIOL, V79, P543, DOI 10.1139/bcb-79-5-543; Marceau N., 2011, CELLULAR DOMAINS, P267; Marceau N., 2014, INTERMEDIATE FILAMEN; Marceau N, 2007, EXP CELL RES, V313, P2265, DOI 10.1016/j.yexcr.2007.03.038; Mashukova A, 2009, J CELL SCI, V122, P2491, DOI 10.1242/jcs.046979; Mathew J., 2009, THESIS U LAVAL; Mathew J, 2008, FREE RADICAL BIO MED, V45, P413, DOI 10.1016/j.freeradbiomed.2008.04.031; Mathew J, 2013, EXP CELL RES, V319, P474, DOI 10.1016/j.yexcr.2012.11.011; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moley KH, 2000, APOPTOSIS, V5, P99, DOI 10.1023/A:1009697908332; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; OMARY MB, 1992, J CELL BIOL, V117, P583, DOI 10.1083/jcb.117.3.583; Oshima RG, 2007, EXP CELL RES, V313, P1981, DOI 10.1016/j.yexcr.2007.04.007; Paramio JM, 2001, MOL CELL BIOL, V21, P7449, DOI 10.1128/MCB.21.21.7449-7459.2001; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; REMPEL A, 1994, BBA-GENE STRUCT EXPR, V1219, P660, DOI 10.1016/0167-4781(94)90225-9; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SCHUBART UK, 1984, J CELL BIOL, V98, P1001, DOI 10.1083/jcb.98.3.1001; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sharma S, 2007, CARDIOVASC RES, V76, P71, DOI 10.1016/j.cardiores.2007.05.004; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Stahley SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087809; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang RF, 2013, BBA-MOL CELL RES, V1833, P3195, DOI 10.1016/j.bbamcr.2013.09.007; Wiche G, 1998, J CELL SCI, V111, P2477; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Withers DJ, 2000, ENDOCRINOLOGY, V141, P1917, DOI 10.1210/en.141.6.1917; Wood TE, 2008, MOL CANCER THER, V7, P3546, DOI 10.1158/1535-7163.MCT-08-0569; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yuan T, 2007, CELL RES, V17, P772, DOI 10.1038/cr.2007.73	100	11	11	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					491	502		10.1096/fj.15-277905	http://dx.doi.org/10.1096/fj.15-277905			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26467793				2022-12-28	WOS:000369391900002
J	Song, TY; Zheng, YM; Vincent, PA; Cai, DS; Rosenberg, P; Wang, YX				Song, Tengyao; Zheng, Yun-Min; Vincent, Peter A.; Cai, Dongsheng; Rosenberg, Paul; Wang, Yong-Xiao			Canonical transient receptor potential 3 channels activate NF-kappa B to mediate allergic airway disease via PKC-alpha/I kappa B-alpha and calcineurin/I kappa B-beta pathways	FASEB JOURNAL			English	Article						ion channel; signaling pathway; AIAD	SMOOTH-MUSCLE-CELLS; PULMONARY ARTERIAL-HYPERTENSION; KINASE-C-ALPHA; PROTEIN-KINASE; LENTIVIRAL VECTORS; FUNCTIONAL-ROLE; ASTHMA; INHIBITION; EXPRESSION; TRPC3	The purpose of this study was to determine the role of canonical transient receptor potential 3 (TRPC3) channel in allergen-induced airway disease (AIAD) and its underlying signaling mechanisms. The procedures included (1) intravenous injection of lentiviral TRPC3 channel or nonsilencing short hairpin ribonucleic acid (shRNA) to make the channel knockdown (KD) or control mice, (2) allergen sensitization/challenge to induce AIAD, (3) patch-clamp recording and Ca2+ imaging to examine the channel activity, and (4) gene manipulations and other methods to determine the underlying signaling mechanisms. The findings are that (1) intravenous or intranasal delivery of TRPC3 channel lentiviral shRNAs or blocker 1-[4-[(2,3,3-trichloro-1-oxo-2-propen-1-yl) amino] phenyl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid prevents AIAD in mice, (2) TRPC3 channel KD and overexpression, respectively, blocks and augments protein kinase C-alpha/nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor-alpha (PKC-alpha/I kappa B-alpha)-mediated or calcineurin/I kappa B-beta-dependent, NF-kappa B-dependent allergen-induced airway smooth muscle cell (ASMC) hyperproliferation and cyclin D1 (an important cell proliferation molecule) induction, and (3) the changes of the major molecules of the PKC-alpha/I kappa B alpha- and calcineurin/I kappa B-beta-dependent NF-kappa B signaling pathways are also observed in asthmatic human ASMCs. The conclusions are that TRPC3 channels plays an essential role in AIAD via the PKC-alpha/I kappa B-alpha- and calcineurin/I kappa B-beta-dependent NF-kappa B signaling pathways, and lentiviral shRNA or inhibitor of TRPC3 channels may become novel and effective treatments for AIAD.-Song, T., Zheng, Y.-M., Vincent, P. A., Cai, D., Rosenberg, P., Wang, Y.-X. Canonical transient receptor potential 3 channels activate NF-kB to mediate allergic airway disease via PKC-alpha/I kappa B-alpha and calcineurin/I kappa B-beta pathways. FASEB J. 30, 214-229 (2016). www.fasebj.org	[Song, Tengyao; Zheng, Yun-Min; Vincent, Peter A.; Wang, Yong-Xiao] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Rosenberg, Paul] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Albany Medical College; Yeshiva University; Albert Einstein College of Medicine; Duke University	Wang, YX (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	wangy@mail.amc.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL071000, HL108232]; American Heart Association [0340160N, 0630236N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075190, R01HL071000, R01HL122865, R01HL108232] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL071000 and HL108232 (to Y.-X.W.), as well as American Heart Association Established Investigator Awards 0340160N (to Y.-X.W.) and 0630236N (to Y.-M.Z.). The authors thank Dennis Metzger, Ph.D., for assisting with experiments with the FlexiVent system and Qinghua Liu, M.D., Ph.D. for providing help with initial experiments.	[Anonymous], 2014, CALCIUM SIGNALING AI; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Barnes PJ, 2012, SEMIN RESP CRIT CARE, V33, P685, DOI 10.1055/s-0032-1326965; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Du CL, 2010, EXP LUNG RES, V36, P201, DOI 10.3109/01902140903290022; Furuya Y, 2014, J VIROL, V88, P9166, DOI 10.1128/JVI.00265-14; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; Hai CM, 2007, CURR MED CHEM, V14, P67, DOI 10.2174/092986707779313507; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Herron CR, 2011, AM J PHYSIOL-HEART C, V300, pH36, DOI 10.1152/ajpheart.00812.2010; Jansen L. J., 2014, CALCIUM SIGNALING AI, P195; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kumar P, 2011, CURR GENE THER, V11, P144, DOI 10.2174/156652311794940782; Lam Hilaire C, 2011, J Vis Exp, DOI 10.3791/2513; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Liu QH, 2009, P NATL ACAD SCI USA, V106, P11418, DOI 10.1073/pnas.0813307106; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Poteser M, 2011, P NATL ACAD SCI USA, V108, P10556, DOI 10.1073/pnas.1106183108; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Said SI, 2010, EUR RESPIR J, V35, P730, DOI 10.1183/09031936.00097109; Smedlund K, 2010, CIRC RES, V106, P1479, DOI 10.1161/CIRCRESAHA.109.213314; Song T., 2014, CALCIUM SIGNALING AI, P393; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vertegaal ACO, 2000, CELL SIGNAL, V12, P759, DOI 10.1016/S0898-6568(00)00133-9; Walczak-Drzewiecka A, 2008, J IMMUNOL, V181, P1665, DOI 10.4049/jimmunol.181.3.1665; Wang YX, 2011, ADV EXP MED BIOL, V704, P731, DOI 10.1007/978-94-007-0265-3_38; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Xiao JH, 2010, AM J RESP CELL MOL, V43, P17, DOI 10.1165/rcmb.2009-0091OC; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458	31	19	20	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					214	229		10.1096/fj.15-274860	http://dx.doi.org/10.1096/fj.15-274860			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26373801	Green Published			2022-12-28	WOS:000367621000022
J	Zwart, SR; Gregory, JF; Zeisel, SH; Gibson, CR; Mader, TH; Kinchen, JM; Ueland, PM; Ploutz-Snyder, R; Heer, MA; Smith, SM				Zwart, Sara R.; Gregory, Jesse F.; Zeisel, Steven H.; Gibson, Charles R.; Mader, Thomas H.; Kinchen, Jason M.; Ueland, Per M.; Ploutz-Snyder, Robert; Heer, Martina A.; Smith, Scott M.			Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes	FASEB JOURNAL			English	Article							POLYCYSTIC-OVARY-SYNDROME; IDIOPATHIC INTRACRANIAL HYPERTENSION; SECONDARY PSEUDOTUMOR CEREBRI; DURATION SPACE-FLIGHT; METHYLENETETRAHYDROFOLATE REDUCTASE; BED REST; HOMOCYSTEINE; POLYMORPHISMS; TESTOSTERONE; METABOLISM	Ophthalmic changes have occurred in a subset of astronauts on International Space Station missions. Visual deterioration is considered the greatest human health risk of spaceflight. Affected astronauts exhibit higher concentrations of 1-carbon metabolites (e.g., homocysteine) before flight. We hypothesized that genetic variations in 1-carbon metabolism genes contribute to susceptibility to ophthalmic changes in astronauts. We investigated 5 polymorphisms in the methionine synthase reductase (MTRR), methylenetetrahydrofolate reductase (MTHFR), serine hydroxymethyltransferase (SHMT), and cystathionine beta-synthase (CBS) genes and their association with ophthalmic changes after flight in 49 astronauts. The number of G alleles of MTRR 66 and C alleles of SHMT1 1420 both contributed to the odds of visual disturbances. Preflight dehydroepiandrosterone was positively associated with cotton wool spots, and serum testosterone response during flight was associated with refractive change. Block regression showed that B-vitamin status and genetics were significant predictors of many of the ophthalmic outcomes that we observed. In one example, genetics trended toward improving (P = 0.10) and B-vitamin status significantly improved (P < 0.001) the predictive model for refractive change after flight. We document an association between MTRR 66 and SHMT1 1420 polymorphisms and spaceflight-induced vision changes. This line of research could lead to therapeutic options for both space travelers and terrestrial patients.-Zwart, S. R., Gregory, J. F., Zeisel, S. H., Gibson, C. R., Mader, T. H., Kinchen, J. M., Ueland, P. M., Ploutz-Snyder, R., Heer, M. A., Smith, S. M. Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes. FASEB J. 30, 141-148 (2016). www.fasebj.org	[Zwart, Sara R.; Ploutz-Snyder, Robert] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA; [Gregory, Jesse F.] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Zeisel, Steven H.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC USA; [Gibson, Charles R.] Coastal Eye Associates, Webster, TX USA; [Kinchen, Jason M.] Metabolon Inc, Durham, NC USA; [Ueland, Per M.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Heer, Martina A.] Univ Bonn, Dept Nutr & Food Sci, Nutrit Physiol, Bonn, Germany; [Smith, Scott M.] NASA, Lyndon B Johnson Space Ctr, Biomed Res & Environm Sci Div, Houston, TX 77058 USA	Universities Space Research Association (USRA); State University System of Florida; University of Florida; University of North Carolina; Metabolon; University of Bergen; University of Bonn; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Smith, SM (corresponding author), NASA, Lyndon B Johnson Space Ctr, Attn Mail Code SK3,2101 NASA Pkwy, Houston, TX 77058 USA.	scott.m.smith@nasa.gov	Heer, Martina/Q-4959-2019; Kinchen, Jason/ABC-5663-2021; Ueland, Per M/C-7340-2013	Heer, Martina/0000-0001-5534-911X; Ueland, Per Magne/0000-0002-1903-0571; Kinchen, Jason/0000-0001-8430-2265	NASA Human Research Program's Human Health and Countermeasures Element; German Federal Ministry for Economics and Technology/DLR Forschung unter Weltraumbedingungen [50WB0931]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK56350]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NASA Human Research Program's Human Health and Countermeasures Element; German Federal Ministry for Economics and Technology/DLR Forschung unter Weltraumbedingungen; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank the astronauts for their participation in and support of this study; the staff of the NASA Johnson Space Center Nutritional Biochemistry Laboratory for their assistance in all aspects of the project; the ISS Medical Project, specifically T. Bauer, for help with coordinating the project; the NASA Lifetime Surveillance of Astronaut Health team for their help with eye- and vision-related data; and J. Krauhs for editorial assistance. This project was funded by the NASA Human Research Program's Human Health and Countermeasures Element, by the German Federal Ministry for Economics and Technology/DLR Forschung unter Weltraumbedingungen Grant 50WB0931 (to M.A.H.), and by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK56350 (to S.H.Z.). S.M.S., S.R.Z., and M.A.H. designed the research; S.M.S. and S.R.Z. oversaw data collection and management of the biological sample collections and analyses; C.R.G. and T.H.M. oversaw data collection and management of the vision and related data; J.M.K. conducted metabolomics analyses; and R.P.S. performed statistical analysis; and all authors were involved in interpreting the data and preparing the manuscript. All authors read and approved the final manuscript. S.M.S. had primary responsibility for the content of the final version. The authors declare no conflicts of interest.	Avisar I., 2012, SCI CAIRO, V2012; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; Davis SR, 2005, J NUTR, V135, P1040, DOI 10.1093/jn/135.5.1040; Demir M, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/752186; Finsterer J, 2007, GYNECOL ENDOCRINOL, V23, P179, DOI 10.1080/09513590701237290; Garcia-Minguillan CJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0435-1; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; Glueck CJ, 2005, J LAB CLIN MED, V145, P72, DOI 10.1016/j.lab.2004.09.011; Grodnitskaya EE, 2012, GYNECOL ENDOCRINOL, V28, P186, DOI 10.3109/09513590.2011.589927; Heimark D, 2014, ENDOCR J, V61, P111, DOI 10.1507/endocrj.EJ13-0423; JONES KJ, 1988, METAB BRAIN DIS, V3, P1, DOI 10.1007/BF01001350; Kapoor KG, 2009, CLIN EXP OPTOM, V92, P519, DOI 10.1111/j.1444-0938.2009.00423.x; Klein A, 2013, CURR EYE RES, V38, P972, DOI 10.3109/02713683.2013.799214; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Kurzrock R, 2007, MED HYPOTHESES, V68, P480, DOI 10.1016/j.mehy.2006.03.057; Lakshmi SVV, 2013, CELL BIOCHEM BIOPHYS, V67, P353, DOI 10.1007/s12013-011-9322-1; Liang S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/560183; Liu DM, 2014, HUM REPROD, V29, P2764, DOI 10.1093/humrep/deu282; Loverro G, 2002, GYNECOL OBSTET INVES, V53, P157, DOI 10.1159/000058367; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Maleedhu P, 2014, J CLIN DIAGN RES, V8, P31, DOI 10.7860/JCDR/2014/7070.3999; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Marshall-Bowman K, 2013, ACTA ASTRONAUT, V87, P77, DOI 10.1016/j.actaastro.2013.01.014; Mowl AD, 2009, CLIN EXP OPTOM, V92, P449, DOI 10.1111/j.1444-0938.2009.00404.x; Nilsson TK, 2014, MOL MED REP, V10, P2706, DOI 10.3892/mmr.2014.2521; Ornek N, 2015, J OBSTET GYNAECOL RE, V41, P1080, DOI 10.1111/jog.12673; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; SANBORN TA, 1975, ENDOCRINOLOGY, V97, P1000, DOI 10.1210/endo-97-4-1000; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Shin SH, 2014, PEDIATR INT, V56, P411, DOI 10.1111/ped.12266; Sirek AS, 2014, AVIAT SPACE ENVIR MD, V85, P3, DOI 10.3357/ASEM.3750.2014; Smith SM, 2012, J CLIN ENDOCR METAB, V97, P270, DOI 10.1210/jc.2011-2233; Sprung VS, 2013, J PHYSIOL-LONDON, V591, P1475, DOI 10.1113/jphysiol.2012.246918; Wenner MM, 2013, AM J PHYSIOL-ENDOC M, V305, pE818, DOI 10.1152/ajpendo.00343.2013; Yilmaz M, 2005, HUM REPROD, V20, P2414, DOI 10.1093/humrep/dei070; Zwart SR, 2009, J APPL PHYSIOL, V107, P54, DOI 10.1152/japplphysiol.91136.2008; Zwart SR, 2013, AM J CLIN NUTR, V98, P217, DOI 10.3945/ajcn.112.056465; Zwart SR, 2012, J NUTR, V142, P427, DOI 10.3945/jn.111.154245	38	29	30	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					141	148		10.1096/fj.15-278457	http://dx.doi.org/10.1096/fj.15-278457			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26316272	Green Published, Green Submitted			2022-12-28	WOS:000367621000016
J	Chadwick, JA; Hauck, JS; Lowe, J; Shaw, JJ; Guttridge, DC; Gomez-Sanchez, CE; Gomez-Sanchez, EP; Rafael-Fortney, JA				Chadwick, Jessica A.; Hauck, J. Spencer; Lowe, Jeovanna; Shaw, Jeremiah J.; Guttridge, Denis C.; Gomez-Sanchez, Celso E.; Gomez-Sanchez, Elise P.; Rafael-Fortney, Jill A.			Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target	FASEB JOURNAL			English	Article						aldosterone; gene expression microarray; muscular dystrophy; spironolactone; steroid hormone receptors	DUCHENNE MUSCULAR-DYSTROPHY; CONVERTING-ENZYME-INHIBITORS; GENE-EXPRESSION; MONOCLONAL-ANTIBODIES; HEART-FAILURE; TNF-ALPHA; IN-VIVO; C-FOS; ALDOSTERONE; MOUSE	Early treatment with heart failure drugs lisinopril and spironolactone improves skeletal muscle pathology in Duchenne muscular dystrophy (DMD) mouse models. The angiotensin converting enzyme inhibitor lisinopril and mineralocorticoid receptor (MR) antagonist spironolactone indirectly and directly target MR. The presence and function of MR in skeletal muscle have not been explored. MR mRNA and protein are present in all tested skeletal muscles from both wild-typemice and DMD mouse models. MR expression is cell autonomous in both undifferentiated myoblasts and differentiated myotubes from mouse and human skeletal muscle cultures. To test for MR function in skeletal muscle, global gene expression analysis was conducted on human myotubes treated with MR agonist (aldosterone; EC50 1.3 nM) or antagonist (spironolactone; IC50 1.6 nM), and 53 gene expression differences were identified. Five differences were conserved in quadriceps muscles from dystrophic mice treated with spironolactone plus lisinopril (IC50 0.1 nM) compared with untreated controls. Genes down-regulated morethan 2-fold by MR antagonism included FOS, ANKRD1, and GADD45B, with known roles in skeletal muscle, in addition to NPR3 and SERPINA3, bona fide targets of MR in other tissues. MR is a novel drug target in skeletal muscle and use of clinically safe antagonists may be beneficial for muscle diseases.	[Chadwick, Jessica A.; Hauck, J. Spencer; Lowe, Jeovanna; Shaw, Jeremiah J.; Rafael-Fortney, Jill A.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Chadwick, Jessica A.; Hauck, J. Spencer; Lowe, Jeovanna; Shaw, Jeremiah J.; Rafael-Fortney, Jill A.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Guttridge, Denis C.] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Gomez-Sanchez, Celso E.] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA; [Gomez-Sanchez, Elise P.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Rafael-Fortney, JA (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 410 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	rafael-fortney.1@osu.edu		Guttridge, Denis/0000-0002-7276-6609; Hauck, J. Spencer/0000-0003-1722-8709	U.S. National Institutes of Health [R01 NS082868, R01 HL116533, T32 NS077984]; Department of Defense [MD120063]; Center for Muscle Health and Neuromuscular Disorders at The Ohio State University (OSU); Center for Muscle Health and Neuromuscular Disorders at Nationwide Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082868, T32NS077984] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Center for Muscle Health and Neuromuscular Disorders at The Ohio State University (OSU); Center for Muscle Health and Neuromuscular Disorders at Nationwide Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health [R01 NS082868 and R01 HL116533 (to J.R.F.), and T32 NS077984 (to J.A.C.)], Department of Defense [MD120063 (to J.R.F.)], and the Center for Muscle Health and Neuromuscular Disorders at The Ohio State University (OSU) and Nationwide Children's Hospital. The authors thank The Ohio State Microarray Core, and in particular S. Warner, for microarray processing and analysis; Pfizer for supplying eplerenone under their Compound Transfer Program; K. J. Ladner (OSU) for RNA preparation for mouse microarray; A. Wodarcyk (OSU) for technical assistance in mouse maintenance, dissections, and genotyping; and S. Swager (OSU) for assistance with confocal imaging.	Anand-Srivastava MB, 2005, PEPTIDES, V26, P1044, DOI 10.1016/j.peptides.2004.09.023; Angelini Corrado, 2012, Acta Myol, V31, P9; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Baker PE, 2006, NEUROGENETICS, V7, P81, DOI 10.1007/s10048-006-0031-7; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Casey WM, 2008, BIOMARKERS, V13, P364, DOI [10.1080/13547500801903545, 10.1080/13547500801903545 ]; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Chitnis AS, 2012, J COMP EFFECT RES, V1, P195, DOI [10.2217/CER.12.5, 10.2217/cer.12.5]; Clyne CD, 2009, MOL CELL ENDOCRINOL, V302, P81, DOI 10.1016/j.mce.2008.11.030; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Delyani JA, 2001, CARDIOVASC DRUG REV, V19, P185; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; El Haddad M, 2012, J CELL SCI, V125, P6147, DOI 10.1242/jcs.115220; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Garriz JMR, 2009, ENDOCRINOLOGY, V150, P1294, DOI 10.1210/en.2008-1036; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gomez-Sanchez CE, 2011, STEROIDS, V76, P1541, DOI 10.1016/j.steroids.2011.09.004; Gomez-Sanchez EP, 2009, J HISTOCHEM CYTOCHEM, V57, P633, DOI 10.1369/jhc.2009.953059; Gomez-Sanchez EP, 2004, CURR OPIN NEPHROL HY, V13, P191, DOI 10.1097/00041552-200403000-00007; Hawkins UA, 2012, CURR HYPERTENS REP, V14, P573, DOI 10.1007/s11906-012-0297-0; Jaisser F., 2010, U.S. Patent Application, Patent No. 20110257140; Janssen PML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088360; Kim JH, 2014, HEPATOLOGY, V59, P695, DOI 10.1002/hep.26683; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Lastra G, 2008, AM J PHYSIOL-ENDOC M, V295, pE110, DOI 10.1152/ajpendo.00258.2007; Latouche C, 2010, ENDOCRINOLOGY, V151, P4467, DOI 10.1210/en.2010-0237; Laure L, 2009, FEBS J, V276, P669, DOI 10.1111/j.1742-4658.2008.06814.x; LOCASCIO V, 1995, CALCIFIED TISSUE INT, V56, P109, DOI 10.1007/BF00296340; Lother A, 2015, ANNU REV PHARMACOL, V55, P289, DOI 10.1146/annurev-pharmtox-010814-124302; Lowe J., 2015, J NEUROMUSC IN PRESS; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Nakada C, 2003, LAB INVEST, V83, P711, DOI 10.1097/01.LAB.0000067484.35298.1A; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Rafael-Fortney JA, 2011, CIRCULATION, V124, P582, DOI 10.1161/CIRCULATIONAHA.111.031716; Raman SV, 2015, LANCET NEUROL, V14, P153, DOI 10.1016/S1474-4422(14)70318-7; Rogerson FM, 2004, CLIN EXP PHARMACOL P, V31, P704, DOI 10.1111/j.1440-1681.2004.04079.x; RUBIN H, 1990, J BIOL CHEM, V265, P1199; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tamargo J, 2014, SEMIN NEPHROL, V34, P285, DOI 10.1016/j.semnephrol.2014.04.005; Ueda K, 2014, BIOCHEM BIOPH RES CO, V445, P132, DOI 10.1016/j.bbrc.2014.01.125; Vasques GA, 2014, HORM RES PAEDIAT, V82, P222, DOI 10.1159/000365049; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; WEINBERGER C, 1987, CLIN PHYSIOL BIOCH, V5, P179; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Young MJ, 2012, MOL CELL ENDOCRINOL, V350, P248, DOI 10.1016/j.mce.2011.09.008; Zennaro MC, 2001, MOL ENDOCRINOL, V15, P1586, DOI 10.1210/me.15.9.1586; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	58	32	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4544	4554		10.1096/fj.15-276782	http://dx.doi.org/10.1096/fj.15-276782			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26178166	Green Published			2022-12-28	WOS:000364514700014
J	He, M; Zheng, B; Zhang, Y; Zhang, XH; Wang, C; Yang, Z; Sun, Y; Wu, XL; Wen, JK				He, Ming; Zheng, Bin; Zhang, Yu; Zhang, Xin-Hua; Wang, Chang; Yang, Zhan; Sun, Yan; Wu, Xiao-Li; Wen, Jin-Kun			KLF4 mediates the link between TGF-beta 1-induced gene transcription and H3 acetylation in vascular smooth muscle cells	FASEB JOURNAL			English	Article						p300; PTEN; p38 MAPK; p21 promoter; phosphorylation	TUMOR-SUPPRESSOR PTEN; HISTONE ACETYLATION; EXPRESSION; INHIBITION; PATHWAY; PROTEIN; PHOSPHORYLATION; RECRUITMENT; CHROMATIN; PROMOTER	Transcriptional activation by transcription factors is coupled with histone acetylation and chromatin remodeling. However, the relationship between TGF-beta 1-induced gene transcription by Kruppel-like factor (KLF)-4 and histone acetylation remains unknown. In our study, KLF4 overexpression or knockdown, respectively increased or decreased H3 acetylation and p300 occupancy, which is concentrated in the region containing TGF-beta 1 control elements (TCEs) of the genes by TGF-beta 1 regulation during vascular smooth muscle cell (VSMC) differentiation. Coimmunoprecipitation and glutathione S-transferase pull-down assays showed that phosphatase and tensin homolog (PTEN) formed a complex with KLF4 to inhibit the phosphorylation of the latter in basal conditions. After TGF-beta 1 signaling activation, PTEN was phosphorylated by p38 MAPK or PI3K/Akt signaling, phosphorylated PTEN lost its ability to dephosphorylate KLF4, and the cofactors interacting with KLF4 switched from PTEN to p300. Then, KLF4-p300 complexes were recruited toKLF4-binding sites of the gene promoter of VSMCs, to acetylate histone H3 and activate transcription. In addition, phosphorylated KLF4 enhanced p300 histone acetyltransferase (HAT) activity via the p38 MAPK pathway, which may be responsible for H3 acetylation. Taken together, the results of our study reveal a novel mechanism whereby KLF4 mediates the link between TGF-beta 1-induced gene transcription activation and H3 acetylation during VSMC differentiation.	[He, Ming; Zheng, Bin; Zhang, Yu; Zhang, Xin-Hua; Wang, Chang; Yang, Zhan; Sun, Yan; Wu, Xiao-Li; Wen, Jin-Kun] Hebei Med Univ, China Adm Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [He, Ming] Hebei Univ Chinese Med, Inst Chinese Integrat Med, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei University of Chinese Medicine	Wen, JK (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, 361 Zhongshan East Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Yang, Zhan/GQG-9995-2022	Yang, Zhan/0000-0001-7191-2910; Wen, Jinkun/0000-0002-8453-4549	National Basic Research Program of China [2012CB518601]; Natural Science Foundation of China [31271396, 31271244, 31301136]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB518601 and Natural Science Foundation of China Grants 31271396, 31271244, and 31301136. The authors declare no conflicts of interest.	Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; He JM, 2010, BIOCHEM BIOPH RES CO, V397, P513, DOI 10.1016/j.bbrc.2010.05.146; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Nemenoff RA, 2011, ARTERIOSCL THROM VAS, V31, P1300, DOI 10.1161/ATVBAHA.111.223701; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Spin JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014301; Stiehl DP, 2007, CANCER RES, V67, P2256, DOI 10.1158/0008-5472.CAN-06-3985; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Williamson I, 2011, DEV CELL, V21, P17, DOI 10.1016/j.devcel.2011.06.008; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Wygrecka M, 2012, AM J RESP CELL MOL, V47, P614, DOI 10.1165/rcmb.2012-0097OC; Yu K, 2011, CARDIOVASC RES, V90, P464, DOI 10.1093/cvr/cvr017; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhang XH, 2012, ARTERIOSCL THROM VAS, V32, P1015, DOI 10.1161/ATVBAHA.111.244962; Zheng B, 2011, CELL RES, V21, P1487, DOI 10.1038/cr.2011.34	34	37	38	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4059	4070		10.1096/fj.15-272658	http://dx.doi.org/10.1096/fj.15-272658			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26082460				2022-12-28	WOS:000359915600039
J	Cydzik, M; Abdul-Wahid, A; Park, S; Bourdeau, A; Bowden, K; Prodeus, A; Kollara, A; Brown, TJ; Ringuette, MJ; Gariepy, J				Cydzik, Marzena; Abdul-Wahid, Aws; Park, Soyeon; Bourdeau, Annie; Bowden, Katherine; Prodeus, Aaron; Kollara, Alexandra; Brown, Theodore J.; Ringuette, Maurice J.; Gariepy, Jean			Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis	FASEB JOURNAL			English	Article						HUVECs; signal transduction; surface plasmon resonance	ENDOTHELIAL GROWTH-FACTOR; CALCIUM-BINDING; EXTRACELLULAR-MATRIX; PROCOLLAGEN-I; SPARC; CELLS; BM-40; CALMODULIN; DOMAIN; VASCULOGENESIS	VEGF-A (VEGF) drives angiogenesis through activation of downstream effectors to promote endothelial cell proliferation and migration. Although VEGF binds both VEGF receptor 1 (R1) and receptor 2 (R2), its proangiogenic effects are attributed to R2. Secreted protein, acidic, rich in cysteine (SPARC) is a matricellular glycoprotein thought to inhibit angiogenesis by preventing VEGF from activating R1, but not R2. Because R2 rather than R1 mediates proangiogenic activities of VEGF, the role of human SPARC in angiogenesis was reevaluated. We confirm that association of SPARC with VEGF inhibits VEGF-induced HUVEC adherence, motility, and proliferation in vitro and blocks VEGF-induced blood vessel formation ex vivo. SPARC decreases VEGF-induced phosphorylation of R2 and downstream effectors ERK, Akt, and p38 MAPK as shown by Western blot and/or phosphoflow analysis. Surface plasmon resonance indicates that SPARC binds slowly to VEGF (0.865 +/- 0.023 x 10(4) M-1 s(-1)) with a K-d of 150 nM, forming a stable complex that dissociates slowly (1.26 +/- 0.0033 x 10(-3) s(-1)). Only domain III of SPARC binds VEGF, exhibiting a 15-fold higher affinity than full-length SPARC. These findings support a model whereby SPARC regulates angiogenesis by sequestering VEGF, thus restricting the activation of R2 and the subsequent activation of downstream targets critical for endothelial cell functions-Cydzik, M., Abdul-Wahid, A., Park, S., Bourdeau, A., Bowden, K., Prodeus, A., Kollara, A., Brown, T. J., Ringuette, M. J., Gari ' epy, J. Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis.	[Cydzik, Marzena; Abdul-Wahid, Aws; Bourdeau, Annie; Prodeus, Aaron; Gariepy, Jean] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Cydzik, Marzena; Abdul-Wahid, Aws; Prodeus, Aaron; Gariepy, Jean] Univ Toronto, Dept Med Biophys & Pharmaceut Sci, Toronto, ON M5S 1A1, Canada; [Park, Soyeon; Bowden, Katherine; Ringuette, Maurice J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 1A1, Canada; [Bourdeau, Annie] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada; [Kollara, Alexandra; Brown, Theodore J.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5S 1A1, Canada; [Kollara, Alexandra; Brown, Theodore J.] Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Gariepy, J (corresponding author), Sunnybrook Res Inst, 2075 Bayview Ave,Room M7-434, Toronto, ON M4N 3M5, Canada.	gariepy@sri.utoronto.ca	Brown, Theodore J./E-2192-2013	Brown, Theodore J./0000-0002-3074-4516; Prodeus, Aaron/0000-0002-0719-3891	Canadian Institutes of Health; Natural Sciences and Engineering Research Council of the Canada Collaborative Health Research Program; Canadian Institutes of Health Research [MOP126160, MOP125862]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of the Canada Collaborative Health Research Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Drs. Yutaka Amemiya and Arun Seth, from the Sunnybrook Research Institute Genomics Core Facility, for help with digital reverse transcription-polymerase chain reaction. This study was supported by the Canadian Institutes of Health and the Natural Sciences and Engineering Research Council of the Canada Collaborative Health Research Program (to M.J.R., T.J.B., and J.G.), and by operating grants from the Canadian Institutes of Health Research (MOP126160 to A.B., and MOP125862 to J.G.).	Abdul-Wahid A, 2014, MOL ONCOL, V8, P337, DOI 10.1016/j.molonc.2013.12.002; Abdul-Wahid A, 2012, INT J CANCER, V131, P2839, DOI 10.1002/ijc.27582; ANDERSON WB, 1985, CURR TOP CELL REGUL, V27, P455; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Baratta C.A., 2013, EVOLUTION EXTRACELLU, P191, DOI [10.1007/978-3-642-36002-2_7, DOI 10.1007/978-3-642-36002-2_7]; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; Bhoopathi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036093; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977; DAMJANOVSKI S, 1994, INT J DEV BIOL, V38, P439; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; Ganji PN, 2013, ANGIOGENESIS, V16, P903, DOI 10.1007/s10456-013-9364-7; GOPALAKRISHNA R, 1985, BIOCHIM BIOPHYS ACTA, V844, P265, DOI 10.1016/0167-4889(85)90099-0; Gorantla B, 2013, ANGIOGENESIS, V16, P85, DOI 10.1007/s10456-012-9301-1; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kato Y, 2001, BIOCHEM BIOPH RES CO, V287, P422, DOI 10.1006/bbrc.2001.5622; Kearney JB, 2002, BLOOD, V99, P2397, DOI 10.1182/blood.V99.7.2397; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; Margulies David H., 1993, Journal of Molecular Recognition, V6, P59, DOI 10.1002/jmr.300060204; MAURER P, 1992, EUR J BIOCHEM, V205, P233, DOI 10.1111/j.1432-1033.1992.tb16773.x; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; McCluskey AJ, 2007, PROTEIN SCI, V16, P2726, DOI 10.1110/ps.072894407; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; PERETZ D, 1992, BIOCHEM BIOPH RES CO, V182, P1340, DOI 10.1016/0006-291X(92)91880-Y; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Reed MJ, 2005, J CELL PHYSIOL, V204, P800, DOI 10.1002/jcp.20348; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; TERMAN BI, 1994, GROWTH FACTORS, V11, P187, DOI 10.3109/08977199409046916; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Zhang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044618	43	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3493	3505		10.1096/fj.15-271775	http://dx.doi.org/10.1096/fj.15-271775			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921830				2022-12-28	WOS:000358796900035
J	Wu, B; Capilato, J; Pham, MP; Walker, J; Spur, B; Rodriguez, A; Perez, LJ; Yin, K				Wu, Benedict; Capilato, Joseph; Pham, Michelle P.; Walker, Jean; Spur, Bernd; Rodriguez, Ana; Perez, Lark J.; Yin, Kingsley			Lipoxin A(4) augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition	FASEB JOURNAL			English	Article						neutrophils; phagocytosis; bacteria; phagocytosis	TUMOR-NECROSIS-FACTOR; ACUTE LUNG INJURY; NEUTROPHIL APOPTOSIS; IN-VIVO; MACROPHAGE SUPPRESSION; 15-EPI-LIPOXIN A(4); BIOFILM FORMATION; ESCHERICHIA-COLI; GENE-EXPRESSION; STABLE ANALOGS	Bacterial infections can quickly turn into sepsis, with its attendant clinical sequelae of inflammation, tissue injury, and organ failure. Paradoxically, sustained inflammation in sepsis may lead to immune suppression, because of which the host is unable to clear the existing infection. Use of agents that suppress the inflammatory response may accelerate host immune suppression, whereas use of traditional antibiotics does not significantly affect inflammation. In this study, we investigated whether lipoxin A(4) (LXA(4)), a specialized, proresolution lipid mediator, could increase neutrophil phagocytic activity as well as reduce bacterial virulence. Using the mouse cecal ligation and puncture (CLP) model of sepsis, the administration of LXA(4) (7 g/kg i.v.) 1 h after surgery increased neutrophil phagocytic ability and Fc receptor I (CD64) expression. Ex vivo studies have confirmed that the direct addition of LXA(4) to CLP neutrophils increased phagocytic ability but not CD64 expression. LXA(4) did not affect neutrophils taken from control mice in which CD64 expression was minimal. Taken together with in vivo data, these results suggest that LXA(4) directly augments CD64-mediated neutrophil phagocytic ability but does not directly increase neutrophil CD64 expression. Bacterial communication and virulence is regulated by quorum sensing inducers. In Pseudomonas aeruginosa, virulence is induced with release of various virulence factors, by N-3-oxododecanolyl homoserine lactone binding to the quorum sensing receptor, LasR. We show that LXA(4) is an inhibitor of LasR in P. aeruginosa and that it decreases the release of pyocyanin exotoxin. These results suggest that LXA(4) has the novel dual properties of increasing host defense and decreasing pathogen virulence by inhibiting quorum sensing.Wu, B., Capilato, J., Pham, M. P., Walker, J., Spur, B., Rodriguez, A., Perez, L. J., Yin, K. Lipoxin A(4) augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition.	[Wu, Benedict; Walker, Jean; Spur, Bernd; Rodriguez, Ana; Yin, Kingsley] Rowan Univ, Dept Cell Biol, Sch Osteopath Med, 2 Med Ctr Dr, Stratford, NJ 08084 USA; [Capilato, Joseph; Pham, Michelle P.; Perez, Lark J.] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ USA	Rowan University; Rowan University School of Osteopathic Medicine; Rowan University	Yin, K (corresponding author), Rowan Univ, Dept Cell Biol, Sch Osteopath Med, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	yinki@rowan.edu		Spur, Bernd/0000-0002-7581-4741; Perez, Lark/0000-0002-6920-7996; Rodriguez Rosich, Ana/0000-0002-4802-2845; Wu, Benedict/0000-0003-4829-5912	Mary Elizabeth Groff Foundation; Rowan University	Mary Elizabeth Groff Foundation; Rowan University	This work was supported by the Mary Elizabeth Groff Foundation ( to K. Y.), and by startup funding from Rowan University ( to L.J.P.).	Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; AYALA A, 1992, CIRC SHOCK, V36, P191; AYALA A, 1992, ARCH SURG-CHICAGO, V127, P191; Ayala A., 1992, ARCH SURG-CHICAGO, V127, P196; Bannenberg G, 2004, BRIT J PHARMACOL, V143, P43, DOI 10.1038/sj.bjp.0705912; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cid J, 2011, EUR J CLIN MICROBIOL, V30, P845, DOI 10.1007/s10096-011-1164-7; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Danikas DD, 2008, CLIN EXP IMMUNOL, V154, P87, DOI 10.1111/j.1365-2249.2008.03737.x; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dransfield I, 2005, CELL DEATH DIFFER, V12, P1363, DOI 10.1038/sj.cdd.4401695; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; El Kebir D, 2007, J IMMUNOL, V179, P616, DOI 10.4049/jimmunol.179.1.616; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Ellaban E, 2004, CELL IMMUNOL, V231, P103, DOI 10.1016/j.cellimm.2004.12.010; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; Fink MP, 2014, NAT REV DRUG DISCOV, V13, P741, DOI 10.1038/nrd4368; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Geske GD, 2007, J AM CHEM SOC, V129, P13613, DOI 10.1021/ja074135h; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Glucksam-Galnoy Y, 2013, J IMMUNOL, V191, P337, DOI 10.4049/jimmunol.1300368; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Hussein OA, 2010, IMMUNOL INVEST, V39, P699, DOI 10.3109/08820139.2010.491520; Indik Z K, 1995, Semin Immunol, V7, P45, DOI 10.1016/1044-5323(95)90007-1; INDIK ZK, 1994, EXP HEMATOL, V22, P599; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; LEE TH, 1989, CLIN SCI, V77, P195, DOI 10.1042/cs0770195; Leonard MO, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015795.74094.91; Lesic B, 2007, PLOS PATHOG, V3, P1229, DOI 10.1371/journal.ppat.0030126; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liaw WJ, 2005, SHOCK, V23, P88, DOI 10.1097/01.shk.0000145937.70085.89; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Lowery CA, 2010, J MED CHEM, V53, P7467, DOI 10.1021/jm901742e; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Maderna P, 2002, AM J PATHOL, V160, P2275, DOI 10.1016/S0002-9440(10)61175-3; Mishra M, 2012, CELL MICROBIOL, V14, P95, DOI 10.1111/j.1462-5822.2011.01704.x; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Moore JD, 2015, J AM CHEM SOC, V137, P14626, DOI 10.1021/jacs.5b06728; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'Brien KT, 2015, ACS MED CHEM LETT, V6, P162, DOI 10.1021/ml500459f; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Pahuja M, 2008, SHOCK, V29, P754, DOI 10.1097/SHK.0b013e31815d0c8f; Paunel-Gorgulu A, 2012, MOL MED, V18, P325, DOI 10.2119/molmed.2011.00380; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Prince LR, 2008, J IMMUNOL, V180, P3502, DOI 10.4049/jimmunol.180.5.3502; Qureshi SS, 2001, CLIN EXP IMMUNOL, V125, P258, DOI 10.1046/j.1365-2249.2001.01596.x; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Reddy RC, 2001, INFECT IMMUN, V69, P1394, DOI 10.1128/IAI.69.3.1394-1401.2001; Ribechini E, 2009, EUR J IMMUNOL, V39, P3538, DOI 10.1002/eji.200939530; Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Rodriguez A, 2000, TETRAHEDRON LETT, V41, P823, DOI 10.1016/S0040-4039(99)02201-7; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Serhan CN, 2004, RHEUM DIS CLIN N AM, V30, P69, DOI 10.1016/S0889-857X(03)00117-0; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Sorensen R U, 1987, Antibiot Chemother (1971), V39, P113; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Ueda T, 2014, CRIT CARE MED, V42, pE288, DOI 10.1097/CCM.0000000000000162; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Walker J, 2011, SHOCK, V36, P410, DOI 10.1097/SHK.0b013e31822798c1; Wu B, 2015, PROSTAG LEUKOTR ESS, V94, P55, DOI 10.1016/j.plefa.2014.11.005; Wu B, 2013, PROSTAG LEUKOTR ESS, V89, P47, DOI 10.1016/j.plefa.2013.04.005; Yang Q, 2013, INFECT IMMUN, V81, P1751, DOI 10.1128/IAI.01409-12	81	33	34	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2400	2410		10.1096/fj.201500029R	http://dx.doi.org/10.1096/fj.201500029R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26965685				2022-12-28	WOS:000376878300028
J	Mikolajczyk, TP; Nosalski, R; Szczepaniak, P; Budzyn, K; Osmenda, G; Skiba, D; Sagan, A; Wu, J; Vinh, A; Marvar, PJ; Guzik, B; Podolec, J; Drummond, G; Lob, HE; Harrison, DG; Guzik, TJ				Mikolajczyk, Tomasz P.; Nosalski, Ryszard; Szczepaniak, Piotr; Budzyn, Klaudia; Osmenda, Grzegorz; Skiba, Dominik; Sagan, Agnieszka; Wu, Jing; Vinh, Antony; Marvar, Paul J.; Guzik, Bartlomiej; Podolec, Jakub; Drummond, Grant; Lob, Heinrich E.; Harrison, David G.; Guzik, Tomasz J.			Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension	FASEB JOURNAL			English	Article						blood pressure; endothelial function; vascular inflammation; immune activation; superoxide	II-DEPENDENT HYPERTENSION; GAMMA-DELTA-T; ADIPOSE-TISSUE; INTERFERON-GAMMA; BLOOD-PRESSURE; MICE; OBESITY; KIDNEY; INJURY; ATHEROSCLEROSIS	Recent studies have emphasized the role of perivascular inflammation in cardiovascular disease. We studied mechanisms of perivascular leukocyte infiltration in angiotensin II (Ang II)-induced hypertension and their links to vascular dysfunction. Chronic Ang II infusion in mice increased immune cell content of T cells (255 +/- 130 to 1664 +/- 349 cells/mg; P < 0.01), M1 and M2 macrophages, and dendritic cells in perivascular adipose tissue. In particular, the content of T lymphocytes bearing CC chemokine receptor (CCR) 1, CCR3, and CCR5 receptors for RANTES chemokine was increased by Ang II (CCR1, 15.6 +/- 1.5% vs. 31 +/- 5%; P < 0.01). Hypertension was associated with an increase in perivascular adipose tissue expression of the chemokine RANTES (relative quantification, 1.2 +/- 0.2 vs. 3.5 +/- 1.1; P < 0.05), which induced T-cell chemotaxis and vascular accumulation of T cells expressing the chemokine receptors CCR1, CCR3, and CCR5. Mechanistically, RANTES(-/-) knockout protected against vascular leukocyte, and in particular T lymphocyte infiltration (26 +/- 5% in wild type Ang II vs. 15 +/- 4% in RANTES(-/-)), which was associated with protection from endothelial dysfunction induced by Ang II. This effect was linked with diminished infiltration of IFN-gamma-producing CD8(+) and double-negative CD3(+)CD4(-)CD8(-) T cells in perivascular space and reduced vascular oxidative stress while FoxP3(+) T-regulatory cells were unaltered. IFN-gamma ex vivo caused significant endothelial dysfunction, which was reduced by superoxide anion scavenging. In a human cohort, a significant inverse correlation was observed between circulating RANTES levels as a biomarker and vascular function measured as flow-mediated dilatation (R = -0.3, P < 0.01) or endothelial injury marker von Willebrand factor (R = +0.3; P < 0.01). Thus, chemokine RANTES is important in the regulation of vascular dysfunction through modulation of perivascular inflammation.-Mikolajczyk, T. P., Nosalski, R., Szczepaniak, P., Budzyn, K., Osmenda, G., Skiba, D., Sagan, A., Wu, J., Vinh, A., Marvar, P. J., Guzik, B., Podolec, J., Drummond, G., Lob, H. E., Harrison, D. G., Guzik, T. J. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. www.fasebj.org	[Mikolajczyk, Tomasz P.; Nosalski, Ryszard; Szczepaniak, Piotr; Osmenda, Grzegorz; Skiba, Dominik; Sagan, Agnieszka; Guzik, Bartlomiej; Podolec, Jakub; Guzik, Tomasz J.] Jagiellonian Univ, Dept Internal Med, Krakow, Poland; [Mikolajczyk, Tomasz P.; Nosalski, Ryszard; Szczepaniak, Piotr; Skiba, Dominik; Sagan, Agnieszka; Guzik, Tomasz J.] Univ Glasgow, British Heart Fdn Ctr Excellence, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Budzyn, Klaudia; Vinh, Antony; Drummond, Grant] Monash Univ, Dept Pharmacol, Melbourne, Vic 3004, Australia; [Wu, Jing; Harrison, David G.] Vanderbilt Univ, Dept Med, Sch Med, Div Clin Pharmacol, Nashville, TN USA; [Marvar, Paul J.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Lob, Heinrich E.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	Jagiellonian University; University of Glasgow; Monash University; Vanderbilt University; George Washington University; Cornell University	Guzik, TJ (corresponding author), Univ Glasgow, British Heart Fdn Ctr Excellence, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	tomasz.guzik@glasgow.ac.uk	Mikolajczyk, Tomasz/AFQ-2278-2022; Skiba, Dominik S/X-1190-2019; Skiba, Dominik S/X-6617-2019; Skiba, Dominik S/S-3510-2016; Nosalski, Ryszard/AAG-2611-2019; Guzik, Tomasz Jan/AAM-5007-2020; Wu, Jing/AAH-2288-2022; Wu, Jing/ADF-5420-2022; Guzik, BartÅomiej/AAP-4826-2020; Vinh, Antony/I-1563-2014	Mikolajczyk, Tomasz/0000-0002-7990-2896; Skiba, Dominik S/0000-0002-5910-2955; Skiba, Dominik S/0000-0002-5910-2955; Skiba, Dominik S/0000-0002-5910-2955; Nosalski, Ryszard/0000-0003-4661-8773; Wu, Jing/0000-0003-2013-2863; Wu, Jing/0000-0003-2013-2863; Guzik, BartÅomiej/0000-0002-0630-8394; Drummond, Grant/0000-0001-8556-9738; Guzik, Tomasz/0000-0002-5039-7849; Vinh, Antony/0000-0001-8367-6134; Szczepaniak, Piotr/0000-0003-2622-7337; Podolec, Jakub/0000-0001-9169-3428	Polish National Science Centre [2011/03/B/NZ4/02454]; Foundation for Polish Science Welcome [FNP/2009/Welcome02]; Wellcome Trust; Mobility Plus; British Heart Foundation Centre for Excellence	Polish National Science Centre; Foundation for Polish Science Welcome; Wellcome Trust(Wellcome TrustEuropean Commission); Mobility Plus; British Heart Foundation Centre for Excellence	This work was supported in part by the Polish National Science Centre (Agreement 2011/03/B/NZ4/02454); the Foundation for Polish Science Welcome (FNP/2009/Welcome02; to G.O., T.M., and T.G.); an International Senior Research Fellowship from the Wellcome Trust (to T.J.G.); Mobility Plus (to A.S., T.M., and D.S.); and the British Heart Foundation Centre for Excellence.	Agrewala JN, 2007, J BIOL CHEM, V282, P6106, DOI 10.1074/jbc.M608266200; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Crowley SD, 2010, HYPERTENSION, V55, P99, DOI 10.1161/HYPERTENSIONAHA.109.144964; De Miguel C, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0507-z; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gao YJ, 2007, CURR PHARM DESIGN, V13, P2185; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Ji H, 2014, HYPERTENSION, V64, P573, DOI 10.1161/HYPERTENSIONAHA.114.03663; Kirabo A, 2014, J CLIN INVEST, V124, P4642, DOI 10.1172/JCI74084; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kossmann S, 2013, ARTERIOSCL THROM VAS, V33, P1313, DOI 10.1161/ATVBAHA.113.301437; Kraus BJ, 2015, FASEB J, V29, P3133, DOI 10.1096/fj.14-266064; Lee DL, 2006, AM J PHYSIOL-HEART C, V290, pH935, DOI 10.1152/ajpheart.00708.2005; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Li YL, 2014, HYPERTENSION, V64, P305, DOI 10.1161/HYPERTENSIONAHA.113.02604; Lu C, 2011, EUR J PHARMACOL, V656, P68, DOI 10.1016/j.ejphar.2011.01.023; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Manea SA, 2014, J CELL MOL MED, V18, P1467, DOI 10.1111/jcmm.12289; Margaritis M, 2013, CIRCULATION, V127, P2209, DOI 10.1161/CIRCULATIONAHA.112.001133; Marko L, 2012, HYPERTENSION, V60, P1430, DOI 10.1161/HYPERTENSIONAHA.112.199265; Marques RE, 2013, EXPERT OPIN THER TAR, V17, P1439, DOI 10.1517/14728222.2013.837886; Mateo T, 2006, J IMMUNOL, V176, P5577, DOI 10.4049/jimmunol.176.9.5577; Mattson DL, 2013, AM J PHYSIOL-REG I, V304, pR407, DOI 10.1152/ajpregu.00304.2012; Omar A, 2014, ARTERIOSCL THROM VAS, V34, P1631, DOI 10.1161/ATVBAHA.114.303030; Peng XG, 2015, J PATHOL, V235, P79, DOI 10.1002/path.4430; Pons H, 2013, AM J PHYSIOL-RENAL, V304, pF289, DOI 10.1152/ajprenal.00517.2012; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rudemiller N, 2014, HYPERTENSION, V63, P559, DOI 10.1161/HYPERTENSIONAHA.113.02191; Saleh MA, 2015, J CLIN INVEST, V125, P1189, DOI 10.1172/JCI76327; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Takemori K, 2007, HYPERTENSION, V49, P365, DOI 10.1161/01.HYP.0000255576.16089.b9; Uemura Y, 2015, FASEB J, V29, P141, DOI 10.1096/fj.14-258129; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; WIRSEN C, 1964, NATURE, V202, P913, DOI 10.1038/202913a0; Wolf G, 1997, J CLIN INVEST, V100, P1047, DOI 10.1172/JCI119615; Wolkow PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108587; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zhang JD, 2014, HYPERTENSION, V64, P1275, DOI 10.1161/HYPERTENSIONAHA.114.03863	42	148	158	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1987	1999		10.1096/fj.201500088R	http://dx.doi.org/10.1096/fj.201500088R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26873938	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000374879400026
J	Martinez-Moreno, JM; Herencia, C; de Oca, AM; Munoz-Castaneda, JR; Rodriguez-Ortiz, ME; Diaz-Tocados, JM; Peralbo-Santaella, E; Camargo, A; Canalejo, A; Rodriguez, M; Velasco-Gimena, F; Almaden, Y				Martinez-Moreno, Julio M.; Herencia, Carmen; Montes de Oca, Addy; Munoz-Castaneda, Juan R.; Encarnacion Rodriguez-Ortiz, M.; Diaz-Tocados, Juan M.; Peralbo-Santaella, Esther; Camargo, Antonio; Canalejo, Antonio; Rodriguez, Mariano; Velasco-Gimena, Francisco; Almaden, Yolanda			Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells	FASEB JOURNAL			English	Article						calcitriol; NF-kappa B; paricalcitol; TNF-alpha; VDR	CHRONIC KIDNEY-DISEASE; TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; NF-KAPPA-B; CARDIOVASCULAR-DISEASE; TNF-ALPHA; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; MONOCYTIC CELLS; D ANALOGS	Clinical and epidemiologic studies reveal an association between vitamin D deficiency and increased risk of cardiovascular disease. Because vascular smooth muscle cell (VSMC)-derived tissue factor (TF) is suggested to be critical for arterial thrombosis, we investigated whether the vitamin D molecules calcitriol and paricalcitol could reduce the expression of TF induced by the proinflammatory cytokine TNF-alpha in human aortic VSMCs. We found that, compared with controls, incubation with TNF-alpha increased TF expression and procoagulant activity in a NF-kappa B-dependent manner, as deduced from the increased nuclear translocation of nuclear factor kappa-light-chain-enhancer of activated B cells protein 65 (p65-NF-kappa B) and direct interaction of NF-kappa B to the TF promoter. This was accompanied by the up-regulation of TF signaling mediator protease-activated receptor 2 (PAR-2) expression and by the down-regulation of vitamin D receptor expression in a miR-346-dependent way. However, addition of calcitriol or paricalcitol blunted the TNF-alpha-induced TF expression and activity (2.01 +/- 0.24 and 1.32 +/- 0.14 vs. 3.02 +/- 0.39 pmol/mg protein, P < 0.05), which was associated with down-regulation of NF-kappa B signaling and PAR-2 expression, as well as with restored levels of vitamin D receptor and enhanced expression of TF pathway inhibitor. Our data suggest that inflammation promotes a prothrombotic state through the up-regulation of TF function in VSMCs and that the beneficial cardiovascular effects of vitamin D may be partially due to decreases in TF expression and its activity in VSMCs.	[Martinez-Moreno, Julio M.; Herencia, Carmen; Montes de Oca, Addy; Diaz-Tocados, Juan M.] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Metab & Vasc Calcificat Unit, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Rodriguez, Mariano] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Serv Nephrol, Cordoba, Spain; [Peralbo-Santaella, Esther] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Microscopy Cyt & Sci Imaging Unit, Cordoba, Spain; [Camargo, Antonio; Almaden, Yolanda] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain; [Velasco-Gimena, Francisco] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hematol Serv, Cordoba, Spain; [Encarnacion Rodriguez-Ortiz, M.] Fdn Jimenez Diaz, IIS, Spanish Renal Res Network REDinREN, Lab Nephrol, E-28040 Madrid, Spain; [Camargo, Antonio; Almaden, Yolanda] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Cordoba, Spain; [Canalejo, Antonio] Univ Huelva, Dept Environm Biol & Publ Hlth, Huelva, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Huelva	Velasco-Gimena, F (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hematol Serv, Cordoba, Spain.	francisco.velasco.sspa@juntadeandalucia.es	Herencia, Carmen/AAA-6843-2020; Camargo, Antonio/G-9720-2015; Canalejo, Antonio/L-8407-2014; Muñoz-Castañeda, Juan R./AFQ-3443-2022; Martínez, Julio Manuel/AAA-6724-2020; Tocados, Juan Miguel Díaz/I-8254-2018	Camargo, Antonio/0000-0002-0415-4184; Canalejo, Antonio/0000-0003-2098-8960; Martínez, Julio Manuel/0000-0002-1945-5078; Diaz Tocados, Juan Miguel/0000-0001-5192-5212; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Rodriguez, Mariano/0000-0002-9380-6614	AbbVie Pharmaceutical; Plan Nacional of I+D+I; Consejeria de Salud [SAS111221]; Consejeria de Innovacion, Ciencia y Empresa of Junta de Andalucia [P11-CVI-7925]; National Institute of Health Carlos III; Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia); Amgen; Fresenius; AbbVie; Shire; Instituto de Salud Carlos III-Subdireccion General of Evaluacion - FEDER (European Regional Development's funds); Fomento de la Investigacion - FEDER (European Regional Development's funds) [FIS 11/02055]	AbbVie Pharmaceutical(AbbVie); Plan Nacional of I+D+I; Consejeria de Salud; Consejeria de Innovacion, Ciencia y Empresa of Junta de Andalucia(Junta de Andalucia); National Institute of Health Carlos III; Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia)(Junta de Andalucia); Amgen(Amgen); Fresenius; AbbVie(AbbVie); Shire; Instituto de Salud Carlos III-Subdireccion General of Evaluacion - FEDER (European Regional Development's funds); Fomento de la Investigacion - FEDER (European Regional Development's funds)	The authors acknowledge financial support from AbbVie Pharmaceutical. Financial support was also obtained from Plan Nacional of I+D+I 2008-2011 and Instituto de Salud Carlos III-Subdireccion General of Evaluacion and Fomento de la Investigacion (FIS 11/02055), cogranted by FEDER (European Regional Development's funds), Consejeria de Salud (SAS111221), Consejeria de Innovacion, Ciencia y Empresa (P11-CVI-7925) of Junta de Andalucia. M.E.R.-O. is a recipient of a "Sara Borrell" research contract from the National Institute of Health Carlos III. Y.A. is a senior researcher supported by the Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia). M.R. received research grants from Amgen and Fresenius and lecture fees from Amgen, AbbVie, Shire, and Fresenius.	Agmon-Levin N, 2011, ANN RHEUM DIS, V70, P145, DOI 10.1136/ard.2010.134817; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Al Mheid I, 2013, EUR HEART J, V34, P3691, DOI 10.1093/eurheartj/eht166; Bastarache JA, 2011, EXP LUNG RES, V37, P509, DOI 10.3109/01902148.2011.605512; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Bover J, 2011, KIDNEY INT SUPPL, V1, P122, DOI 10.1038/kisup.2011.28; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Broze GJ, 2003, J THROMB HAEMOST, V1, P1671, DOI 10.1046/j.1538-7836.2003.00391.x; BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90; Chen YZ, 2014, INFLAMM BOWEL DIS, V20, P1910, DOI 10.1097/MIB.0000000000000158; Chen YZ, 2011, ARCH BIOCHEM BIOPHYS, V507, P241, DOI 10.1016/j.abb.2010.12.020; Chitalia VC, 2013, CIRCULATION, V127, P365, DOI 10.1161/CIRCULATIONAHA.112.118174; Chung J, 2007, LAB INVEST, V87, P540, DOI 10.1038/labinvest.3700550; Cirillo P, 2005, CARDIOVASC RES, V68, P47, DOI 10.1016/j.cardiores.2005.05.010; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Guebre-Egziabher F, 2003, NEPHROLOGIE, V24, P383; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; Li YD, 2009, J BIOL CHEM, V284, P4473, DOI 10.1074/jbc.M806010200; Loeffen R, 2012, J THROMB HAEMOST, V10, P1207, DOI 10.1111/j.1538-7836.2012.04782.x; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Mackman N, 2008, ARTERIOSCL THROM VAS, V28, P601, DOI 10.1161/ATVBAHA.108.165050; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; MITSUHASHI T, 1991, J CLIN INVEST, V87, P1889, DOI 10.1172/JCI115213; Navarro-Gonzalez JF, 2009, CLIN J AM SOC NEPHRO, V4, P1646, DOI 10.2215/CJN.02420409; Nie M, 2005, J IMMUNOL, V175, P478, DOI 10.4049/jimmunol.175.1.478; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Ocak G, 2010, J THROMB HAEMOST, V8, P2428, DOI 10.1111/j.1538-7836.2010.04048.x; Ohsawa M, 2000, CIRCULATION, V102, P2867; Osterud B, 2012, THROMB RES, V129, P274, DOI 10.1016/j.thromres.2011.11.049; Owens AP, 2010, THROMB HAEMOSTASIS, V104, P432, DOI 10.1160/TH09-11-0771; Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655; Rao LVM, 2012, J THROMB HAEMOST, V10, P2242, DOI 10.1111/jth.12003; Ruf W, 1999, THROMB HAEMOSTASIS, V82, P175; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Schmidlin Fabien, 2001, Current Opinion in Pharmacology, V1, P575, DOI 10.1016/S1471-4892(01)00099-6; Shen L, 2012, EXP THER MED, V3, P530, DOI 10.3892/etm.2011.432; TAUBMAN MB, 1993, J CLIN INVEST, V91, P547, DOI 10.1172/JCI116234; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tukaj S, 2012, ACTA BIOCHIM POL, V59, P395; Wang L, 2009, BLOOD, V113, P705, DOI 10.1182/blood-2007-05-090944; Wu JB, 2008, ARTERIOSCL THROM VAS, V28, P698, DOI 10.1161/ATVBAHA.107.160903; Wu SQ, 2005, AM J PHYSIOL-HEART C, V289, pH873, DOI 10.1152/ajpheart.00993.2004; Wu-Wong JR, 2007, J VASC RES, V44, P11, DOI 10.1159/000097812; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Xie CQ, 2011, VITAM HORM, V87, P321, DOI 10.1016/B978-0-12-386015-6.00034-2; Xiong M, 2012, AM J PHYSIOL-RENAL, V303, pF1107, DOI 10.1152/ajprenal.00151.2012; Yisireyili M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109268	51	42	43	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1367	1376		10.1096/fj.15-272872	http://dx.doi.org/10.1096/fj.15-272872			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26700731				2022-12-28	WOS:000370387800031
J	Dalliere, N; Bhatla, N; Luedtke, Z; Ma, DKK; Woolman, J; Walker, RJ; Holden-Dye, L; O'Connor, V				Dalliere, Nicolas; Bhatla, Nikhil; Luedtke, Zara; Ma, Dengke K.; Woolman, Jonathan; Walker, Robert J.; Holden-Dye, Lindy; O'Connor, Vincent			Multiple excitatory and inhibitory neural signals converge to fine-tune Caenorhabditis elegans feeding to food availability	FASEB JOURNAL			English	Article						behavioral plasticity; fasting; glutamate; neuropeptide; UNC-31	PHARYNGEAL NERVOUS-SYSTEM; DENSE-CORE VESICLE; C-ELEGANS; GLUTAMATERGIC NEUROTRANSMISSION; MASS-SPECTROMETRY; GENE FAMILIES; UNC-31 CAPS; BODY-FAT; NEUROPEPTIDE; CIRCUIT	How an animal matches feeding to food availability is a key question for energy homeostasis. We addressed this in the nematode Caenorhabditis elegans, which couples feeding to the presence of its food (bacteria) by regulating pharyngeal activity (pumping). We scored pumping in the presence of food and over an extended time course of food deprivation in wild-type and mutant worms to determine the neural substrates of adaptive behavior. Removal of food initially suppressed pumping but after 2 h this was accompanied by intermittent periods of high activity. We show pumping is fine-tuned by context-specific neural mechanisms and highlight a key role for inhibitory glutamatergic and excitatory cholinergic/peptidergic drives in the absence of food. Additionally, the synaptic protein UNC-31 [calcium-activated protein for secretion (CAPS)] acts through an inhibitory pathway not explained by previously identified contributions of UNC-31/CAPS to neuropeptide or glutamate transmission. Pumping was unaffected by laser ablation of connectivity between the pharyngeal and central nervous system indicating signals are either humoral or intrinsic to the enteric system. This framework in which control is mediated through finely tuned excitatory and inhibitory drives resonates with mammalian hypothalamic control of feeding and suggests that fundamental regulation of this basic animal behavior may be conserved through evolution from nematode to human.	[Dalliere, Nicolas; Luedtke, Zara; Woolman, Jonathan; Walker, Robert J.; Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England; [Bhatla, Nikhil; Ma, Dengke K.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Bhatla, Nikhil; Ma, Dengke K.] MIT, Dept Biol, Cambridge, MA USA	University of Southampton; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Holden-Dye, L (corresponding author), Univ Southampton, Life Sci Bldg 85,Highfield Campus, Southampton SO17 1BJ, Hants, England.	lmhd@soton.ac.uk		O'Connor, Vincent/0000-0003-3185-5709; Holden-Dye, Lindy/0000-0002-9704-1217	Gerald Kerkut Charitable Trust; U.S. National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117461] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Gerald Kerkut Charitable Trust; U.S. National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to Richard Komuniecki for providing the C. elegans eat-4;egl-3 double mutant. N.D. and Z.L. were supported by Ph.D. studentships funded by the Gerald Kerkut Charitable Trust. C. elegans strains were provided by the C. elegans Genetics Center, which is funded by U.S. National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; AVERY L, 1993, J EXP BIOL, V175, P283; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Avery Leon, 1993, Genetics, V134, P455; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; Calvo AC, 2011, BIOCHEM J, V434, P133, DOI 10.1042/BJ20101561; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; CHALFIE M, 1985, J NEUROSCI, V5, P956; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Cheong MC, 2015, ELIFE, V4, DOI 10.7554/eLife.06683; Cunningham KA, 2012, CELL METAB, V16, P113, DOI 10.1016/j.cmet.2012.05.014; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Dwyer DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063851; Fang-Yen C, 2012, METHOD CELL BIOL, V107, P177, DOI 10.1016/B978-0-12-394620-1.00006-0; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; Friedman JM, 2010, NAT MED, V16, P1100, DOI 10.1038/nm1010-1100; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Holden-Dye L, 2013, PROTEIN PEPTIDE LETT, V20, P636, DOI 10.2174/0929866511320060004; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Jacob TC, 2003, J NEUROSCI, V23, P2122; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Keane J, 2003, GENETICS, V164, P153; Lau HE, 2014, INVERTEBR NEUROSCI, V14, P71, DOI 10.1007/s10158-013-0166-9; Lee JH, 2014, MOL CELL BIOL, V34, P4165, DOI 10.1128/MCB.00722-14; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Leinwand SG, 2013, NAT NEUROSCI, V16, P1461, DOI 10.1038/nn.3511; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Li C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00150; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Mitchell P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010422; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Packham R, 2010, INVERTEBR NEUROSCI, V10, P47, DOI 10.1007/s10158-010-0107-9; Papaioannou S, 2005, J NEUROBIOL, V65, P304, DOI 10.1002/neu.20201; Papaioannou S, 2008, ACTA BIOL HUNG, V59, P189, DOI 10.1556/ABiol.59.2008.Suppl.28; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shingai R, 2000, NEUROSCI RES, V38, P71, DOI 10.1016/S0168-0102(00)00148-6; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Song BM, 2013, ELIFE, V2, DOI 10.7554/eLife.00329; Song BM, 2012, J NEUROSCI, V32, P1920, DOI 10.1523/JNEUROSCI.2064-11.2012; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Werner KM, 2014, J BIOL CHEM, V289, P26566, DOI 10.1074/jbc.M114.573832; Yoshida M, 2014, J NEUROSCI RES, V92, P671, DOI 10.1002/jnr.23345; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zaslaver A, 2015, P NATL ACAD SCI USA, V112, P1185, DOI 10.1073/pnas.1423656112	80	18	18	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					836	848		10.1096/fj.15-279257	http://dx.doi.org/10.1096/fj.15-279257			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26514165	Green Published			2022-12-28	WOS:000369391900032
J	Bertoldi, I; Faleri, A; Galli, B; Lo Surdo, P; Liguori, A; Norais, N; Santini, L; Masignani, V; Pizza, M; Giuliani, MM				Bertoldi, Isabella; Faleri, Agnese; Galli, Barbara; Lo Surdo, Paola; Liguori, Alessia; Norais, Nathalie; Santini, Laura; Masignani, Vega; Pizza, Mariagrazia; Giuliani, Marzia Monica			Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components	FASEB JOURNAL			English	Article						MenB vaccine; bactericidal epitope; epitope mapping; meningococcal antigen; hydrogen-deuterium exchange	MENINGOCOCCAL SEROGROUP-B; BACTERICIDAL ANTIBODIES; INTRANASAL IMMUNIZATION; NADA; MENINGITIDIS; COMPLEMENT; IGG; ACTIVATION; DIVERSITY; MOLECULES	Neisseria adhesin A (NadA) is one of the antigens of Bexsero, the recently licensed multicomponent vaccine against serogroup B Neisseria meningitidis (MenB). NadA belongs to the class of oligomeric coiled-coil adhesins and is able to mediate adhesion and invasion of human epithelial cells. As a vaccine antigen, NadA has been shown to induce high levels of bactericidal antibodies; however, the domains important for protective response are still unknown. In order to further investigate its immunogenic properties, we have characterized the murine IgG1 mAb (6E3) that was able to recognize the 2 main antigenic variants of NadA on the surface of MenB strains. The epitope targeted by mAb 6E3 was mapped by hydrogen-deuterium exchange mass spectrometry and shown to be located on the coiled-coil stalk region of NadA(aa 206-249). Although no serum bactericidal activity was observed for murine IgG1 mAb 6E3, functional activity was restored when using chimeric antibodies in which the variable regions of the murine mAb 6E3 were fused to human IgG3 constant regions, thus confirming the protective nature of the mAb 6E3 epitope. The use of chimeric antibody molecules will enable future investigations of complement-mediated antibody functionality independently of the Fc-mediated differences in complement activation.-Bertoldi, I., Faleri, A., Galli, B., Lo Surdo, P., Liguori, A., Norais, N., Santini, L., Masignani, V., Pizza, M., Giuliani, M. M. Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components. FASEB J. 30, 93-101 (2016). www.fasebj.org	[Bertoldi, Isabella; Faleri, Agnese; Galli, Barbara; Lo Surdo, Paola; Liguori, Alessia; Norais, Nathalie; Santini, Laura; Masignani, Vega; Pizza, Mariagrazia; Giuliani, Marzia Monica] GlaxoSmithKline, Novartis Vaccines & Diagnost, Siena, Italy	GlaxoSmithKline; Novartis	Giuliani, MM (corresponding author), Novartis Vaccines & Diagnost, Via Fiorentina 1, I-53100 Siena, Italy.	marzia.m.giuliani@gsk.com			University of Bologna (Bologna, Italy)	University of Bologna (Bologna, Italy)	The authors thank Enrico Malito, Matthew Bottomley, and Davide Serruto for useful discussions and critical reading of the draft. The authors also thank Roberto Petracca, Giulietta Maruggi, Giacomo Romagnoli, Eva Grassi, and Daniele Veggi for kindly providing reagents used in this study. The authors are grateful to Luca Fagnocchi for the generation of the nadR knockout strains and Alessia Biolchi for experimental support. Strain M14933 was kindly provided by the Active Bacterial Core surveillance team (Atlanta, GA, USA); strains B3937 and 5/99 by Dominique A. Caugant (Norwegian Institute of Public Health, Oslo, Norway); strain BZ83 by Richard Moxon (University of Oxford, Oxford, United Kingdom); NMB by Dan Granoff (Children's Hospital Oakland Research Institute, Oakland, CA, USA); and M01-0240320 by the Health Protection Agency (Public Health Laboratory, Manchester, United Kingdom). A.L. held a Novartis Academy Ph.D. fellowship at the University of Bologna (Bologna, Italy). All authors are employees of Novartis Vaccines and Diagnostics, GlaxoSmithKline.	Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Borrow R, 2005, CLIN DIAGN LAB IMMUN, V12, P970, DOI 10.1128/CDLI.12.8.970-976.2005; Bowe F, 2004, INFECT IMMUN, V72, P4052, DOI 10.1128/IAI.72.7.4052-4060.2004; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Brier S, 2012, BIOCHEMISTRY-US, V51, P6738, DOI 10.1021/bi300656w; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Ciabattini A, 2008, VACCINE, V26, P4244, DOI 10.1016/j.vaccine.2008.05.049; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Fagnocchi L, 2013, INFECT IMMUN, V81, P560, DOI 10.1128/IAI.01085-12; Fagnocchi L, 2012, J BACTERIOL, V194, P460, DOI 10.1128/JB.06161-11; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; Hager-Braun C, 2005, EXPERT REV PROTEOMIC, V2, P745, DOI 10.1586/14789450.2.5.745; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; KILAR F, 1985, EUR J BIOCHEM, V147, P17, DOI 10.1111/j.1432-1033.1985.tb08712.x; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Loo L, 2008, CANCER J, V14, P149, DOI 10.1097/PPO.0b013e318173a5d5; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Lux A, 2013, J CLIN IMMUNOL, V33, pS4, DOI 10.1007/s10875-012-9782-0; Magagnoli C, 2009, VACCINE, V27, P2156, DOI 10.1016/j.vaccine.2009.01.099; Malito E, 2014, P NATL ACAD SCI USA, V111, P17128, DOI 10.1073/pnas.1419686111; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Mani AR, 2007, J BIOL CHEM, V282, P29114, DOI 10.1074/jbc.M704270200; Metruccio MME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000710; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; NORMANSELL DE, 1987, DIAGN CLIN IMMUNOL, V5, P115; Pillay V, 2011, NEW BIOTECHNOL, V28, P518, DOI 10.1016/j.nbt.2011.03.021; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Waldmann TA, 2006, ADV IMMUNOL, V90, P83, DOI 10.1016/S0065-2776(06)90003-0; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025	36	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					93	101		10.1096/fj.15-273813	http://dx.doi.org/10.1096/fj.15-273813			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26304221				2022-12-28	WOS:000367621000011
J	Kang, CH; Lee, SY; Park, JH; Lee, Y; Jung, HS; Chi, YH; Jung, YJ; Chae, HB; Shin, MR; Kim, WY; Yun, DJ; Lee, SY				Kang, Chang Ho; Lee, Sun Yong; Park, Joung Hun; Lee, Yuno; Jung, Hyun Suk; Chi, Yong Hun; Jung, Young Jun; Chae, Ho Byoung; Shin, Mi Rim; Kim, Woe Yeon; Yun, Dae-Jin; Lee, Sang Yeol			Stress-driven structural and functional switching of Ypt1p from a GTPase to a molecular chaperone mediates thermo tolerance in Saccharomyces cerevisiae	FASEB JOURNAL			English	Article						heat shock; small GTPase; structural change	PLASMA-MEMBRANE FLUIDITY; HEAT-SHOCK RESPONSE; OXIDATIVE STRESS; EXTREMOPHILIC YEASTS; PROTEIN; THIOREDOXIN; ARABIDOPSIS; REDOX; EXPRESSION; REDUCTASE	Guanosine triphosphatases (GTPases) function as molecular switches in signal transduction pathways that enable cells to respond to extracellular stimuli. Saccharomyces cerevisiae yeast protein two 1 protein (Ypt1p) is a monomeric small GTPase that is essential for endoplasmic reticulum-to-Golgi trafficking. By size-exclusion chromatography, SDS-PAGE, and native PAGE, followed by immunoblot analysis with an anti-Ypt1p antibody, we found that Ypt1p structurally changed from low-molecular-weight (LMW) forms to high-molecular-weight (HMW) complexes after heat shock. Based on our results, Ypt1p exhibited dual functions both as a GTPase and a molecular chaperone, and furthermore, heat shock induced a functional switch from that of a GTPase to a molecular chaperone driven by the structural change from LMW to HMW forms. Subsequently, we found, by using a galactose-inducible expression system, that conditional overexpression of YPT1 in yeast cells enhanced the thermotolerance of cells by increasing the survival rate at 55 degrees C by similar to 60%, compared with the control cells expressing YPT1 in the wild-type level. Altogether, our results suggest that Ypt1p is involved in the cellular protection process under heat stress conditions. Also, these findings provide new insight into the in vivo roles of small GTP-binding proteins and have an impact on research and the investigation of human diseases.	[Kang, Chang Ho; Lee, Sun Yong; Park, Joung Hun; Lee, Yuno; Chi, Yong Hun; Jung, Young Jun; Chae, Ho Byoung; Shin, Mi Rim; Kim, Woe Yeon; Yun, Dae-Jin; Lee, Sang Yeol] Gyeongsang Natl Univ, Div Appl Life Sci, 501 Jinju Daero, Jinju 660701, South Korea; [Kang, Chang Ho; Lee, Sun Yong; Park, Joung Hun; Lee, Yuno; Chi, Yong Hun; Jung, Young Jun; Chae, Ho Byoung; Shin, Mi Rim; Kim, Woe Yeon; Yun, Dae-Jin; Lee, Sang Yeol] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea; [Jung, Hyun Suk] Korea Basic Sci Inst, Div Electron Microscop Res, Daejeon, South Korea; [Jung, Hyun Suk] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon, South Korea	Gyeongsang National University; Gyeongsang National University; Korea Basic Science Institute (KBSI); Kangwon National University	Lee, SY (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, 501 Jinju Daero, Jinju 660701, South Korea.	sylee@gnu.ac.kr		Yun, Dae-Jin/0000-0002-3638-6043; Kang, Chang Ho/0000-0003-4342-5247	Cooperative Research Program for Agriculture Science and Technology Development; Rural Development Administration [PJ007850]; Basic Science Research Program, through the National Research Foundation, Ministry of Education, Science, and Technology (Seoul, South Korea) [2012R1A1A2044337]	Cooperative Research Program for Agriculture Science and Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Basic Science Research Program, through the National Research Foundation, Ministry of Education, Science, and Technology (Seoul, South Korea)	This work was supported by funds from the Cooperative Research Program for Agriculture Science and Technology Development, Grant PJ007850 from the Rural Development Administration, and Grant 2012R1A1A2044337 from the Basic Science Research Program, through the National Research Foundation, which is funded by the Ministry of Education, Science, and Technology (Seoul, South Korea).	Adesokan AA, 2004, J MED CHEM, V47, P821, DOI 10.1021/jm0301890; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; Braun P, 2003, TRENDS BIOTECHNOL, V21, P383, DOI 10.1016/S0167-7799(03)00189-6; Butterfield DA, 1999, METHOD ENZYMOL, V309, P746; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Castells-Roca L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017272; Chae HB, 2013, MOL PLANT, V6, P323, DOI 10.1093/mp/sss105; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Cheong NE, 1999, PLANT MOL BIOL, V40, P825, DOI 10.1023/A:1006271823973; Clement AB, 2010, FREE RADICAL BIO MED, V48, P1236, DOI 10.1016/j.freeradbiomed.2010.02.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaestel A, 2006, HANDB EXP PHARM, V172, P93; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Hajheidari M, 2007, J PROTEOME RES, V6, P1451, DOI 10.1021/pr060570j; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Kim KS, 2002, FREE RADICAL BIO MED, V32, P544, DOI 10.1016/S0891-5849(02)00741-4; Langlais C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-64; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Mayer MP, 2012, CELL, V148, P843, DOI 10.1016/j.cell.2012.02.029; Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010; Moraitis C, 2004, YEAST, V21, P313, DOI 10.1002/yea.1078; Park JH, 2011, NEW PHYTOL, V191, P692, DOI 10.1111/j.1469-8137.2011.03734.x; Park SK, 2009, PLANT PHYSIOL, V150, P552, DOI 10.1104/pp.109.135426; Richardson CJ, 1998, MOL CELL BIOL, V18, P827, DOI 10.1128/MCB.18.2.827; Scheper W, 2007, NEUROPATH APPL NEURO, V33, P523, DOI 10.1111/j.1365-2990.2007.00846.x; SEGEV N, 1987, MOL CELL BIOL, V7, P2367, DOI 10.1128/MCB.7.7.2367; Seo HS, 2003, J BIOCHEM MOL BIOL, V36, P196; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Turk M, 2007, FEMS YEAST RES, V7, P550, DOI 10.1111/j.1567-1364.2007.00209.x; Turk M, 2011, FUNGAL BIOL-UK, V115, P950, DOI 10.1016/j.funbio.2011.04.006; Van der Spoel D., 2006, GROMACS USER MANUAL; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Zhang BL, 2001, J BIOL CHEM, V276, P8958, DOI 10.1074/jbc.M008720200	52	7	7	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4424	4434		10.1096/fj.15-270140	http://dx.doi.org/10.1096/fj.15-270140			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26169936				2022-12-28	WOS:000364514700004
J	Zhou, HX; Gao, SG; Duan, XX; Liang, S; Scott, DA; Lamont, RJ; Wang, HZ				Zhou, Huaxin; Gao, Shegan; Duan, Xiaoxian; Liang, Shuang; Scott, David A.; Lamont, Richard J.; Wang, Huizhi			Inhibition of serum- and glucocorticoid-inducible kinase 1 enhances TLR-mediated inflammation and promotes endotoxin-driven organ failure	FASEB JOURNAL			English	Article						SGK1; inflammatory cytokines; TAK1; LPS	TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; NF-KAPPA-B; PROTEIN-KINASE; SIGNALING PATHWAYS; CYTOKINE PRODUCTION; PI3K-AKT PATHWAY; IMMUNE-SYSTEM; TAK1; ACTIVATION	Serum- and glucocorticoid-regulated kinase (SGK) 1 is associated with several important pathologic conditions and plays a modulatory role in adaptive immune responses. However, the involvement and functional role of SGK1 in innate immune responses remain entirely unknown. In this study, we establish that SGK1 is a novel and potent negative regulator of TLR-induced inflammation. Pharmacologic inhibition of SGK1 or suppression by small interfering RNA enhances proinflammatory cytokine (TNF, IL-12, and IL-6) production in TLR-engaged monocytes, a result confirmed in Cre-loxP-mediated SGK1-deficient cells. SGK1 inhibition or gene deficiency results in increased phosphorylation of IKK, I kappa B alpha, and NF-kappa B p65 in LPS-stimulated cells. Enhanced NF-kappa B p65 DNA binding also occurs upon SGK1 inhibition. The subsequent enhancement of proinflammatory cytokines is dependent on the phosphorylation of TGF-beta-activated kinase 1 (TAK1), as confirmed by TAK1 gene silencing. In vivo relevance was established in a murine endotoxin model, in which we found that SGK1 inhibition aggravates the severity of multiple organ damage and enhances the inflammatory response by heightening both proinflammatory cytokine levels and neutrophil infiltration. These findings have identified an anti-inflammatory function of SGK1, elucidated the underlying intracellular mechanisms, and establish, for the first time, that SGK1 holds potential as a novel target for intervention in the control of inflammatory diseases.	[Zhou, Huaxin; Duan, Xiaoxian; Liang, Shuang; Scott, David A.; Lamont, Richard J.; Wang, Huizhi] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA; [Gao, Shegan] Henan Univ Sci & Technol, Affiliated Hosp 1, Inst Canc, Dept Oncol, Luoyang, Peoples R China; [Scott, David A.; Wang, Huizhi] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; Henan University of Science & Technology; University of Louisville	Lamont, RJ (corresponding author), Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, 501 South Preston St,Room 263D, Louisville, KY 40202 USA.	rich.lamont@louisville.edu; hhwang01@louisville.edu	Wang, Huizhi/M-8229-2015; Wang, Huizhi/AAA-3874-2020; Scott, David/GYU-8656-2022	Scott, David A./0000-0003-1007-2756	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research [DE023633, DE017921, DE011111, DE017680]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017921, R01DE011111, R37DE011111, R21DE023633, R01DE017680] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by Grants DE023633 (to H.W.), DE017921 and DE011111 (to R.J.L.), and DE017680 (to D.A.S.) from the U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research.	Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Blunt MD, 2012, CURR OPIN PHARMACOL, V12, P444, DOI 10.1016/j.coph.2012.02.015; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Burgon J, 2014, J IMMUNOL, V192, P1796, DOI 10.4049/jimmunol.1300087; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Courties G, 2010, BLOOD, V116, P3505, DOI 10.1182/blood-2010-02-269605; de Seigneux S, 2008, J BIOL CHEM, V283, P25671, DOI 10.1074/jbc.M803812200; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gu MD, 2014, J IMMUNOL, V192, P2846, DOI 10.4049/jimmunol.1302537; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Hosoi T, 2005, AUTON NEUROSCI-BASIC, V120, P104, DOI 10.1016/j.autneu.2004.11.012; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li Liwu, 2004, Curr Drug Targets Inflamm Allergy, V3, P81, DOI 10.2174/1568010043483863; Lu XQ, 2014, NEPHROLOGY, V19, P307, DOI 10.1111/nep.12225; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; O'Neill LAJ, 2008, NAT IMMUNOL, V9, P459, DOI 10.1038/ni0508-459; PERLSTEIN RS, 1993, ENDOCRINOLOGY, V132, P946, DOI 10.1210/en.132.3.946; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Troutman TD, 2012, CELL CYCLE, V11, P3559, DOI 10.4161/cc.21572; Wagner JG, 1999, J LEUKOCYTE BIOL, V66, P10, DOI 10.1002/jlb.66.1.10; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104; Zheng H, 2013, J BIOL CHEM, V288, P819, DOI 10.1074/jbc.M112.412643	54	21	23	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3737	3749		10.1096/fj.15-270462	http://dx.doi.org/10.1096/fj.15-270462			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25993992	Green Published			2022-12-28	WOS:000359915600012
J	Arnold, P; Schmidt, F; Prox, J; Zunke, F; Pietrzik, C; Lucius, R; Becker-Pauly, C				Arnold, Philipp; Schmidt, Frederike; Prox, Johannes; Zunke, Friederike; Pietrzik, Claus; Lucius, Ralph; Becker-Pauly, Christoph			Calcium negatively regulates meprin beta activity and attenuates substrate cleavage	FASEB JOURNAL			English	Article						protease; APP; amyloid beta; protein folding	AMYOTROPHIC-LATERAL-SCLEROSIS; METALLOPROTEASE MEPRIN; ALPHA-SUBUNIT; IN-VIVO; PEPTIDE; ACTIVATION; INHIBITORS; MEMBRANE; PROTEASE; BINDING	The meprin beta metalloproteinase is an important enzyme in extracellular matrix turnover, inflammation, and neurodegeneration in humans and mice. Previous studies showed a diminished cleavage of certain meprin beta substrates in the presence of calcium, although the mechanism was not clear. With the help of a specific fluorogenic peptide assay and the human amyloid precursor protein as substrate, we demonstrated that the influence of calcium is most likely a direct effect on human meprin beta itself. Analyzing the crystal structures of pro- and mature meprin b helped to identify a cluster of negatively charged amino acids forming a potential calcium binding site. Mutation of 2 of these residues (D204A and D245A) led to severe differences in proteolytic activity and cellular localization of meprin beta. D245A was almost completely inactive and largely stored into intracellular vesicles, indicating severe misfolding of the protein. Astonishingly, D204A was not transported to the cell surface, but exhibited strong beta-secretase activity, resulting in massive accumulation of A beta-peptides. This could be explained by constitutive maturation of this meprin beta mutant already in the early secretory pathway. We hypothesize that lacking D204 abrogates the capability of binding calcium in the catalytic domain, an important step for proper folding of the propeptide and subsequent inhibition of the protease. This is supported by the inhibition constant of calcium for meprin beta (inhibitory constant 50 = 11 mM), which resembles the physiologic concentrations found in the endoplasmic reticulum. For instance, it was shown for amyotrophic lateral sclerosis that a loss of calcium in the endoplasmic reticulum leads to the misfolding of calcium-dependent proteins, which might also be relevant for proper function of meprin beta.-Arnold, P., Schmidt, F., Prox, J., Zunke, F., Pietrzik, C., Lucius, R., Becker-Pauly, C. Calcium negatively regulates meprin beta activity and attenuates substrate cleavage.	[Arnold, Philipp; Lucius, Ralph] Univ Kiel, Inst Anat, Kiel, Germany; [Schmidt, Frederike; Prox, Johannes; Zunke, Friederike; Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Kiel, Germany; [Pietrzik, Claus] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, D-55122 Mainz, Germany	University of Kiel; University of Kiel; Johannes Gutenberg University of Mainz	Arnold, P (corresponding author), Christian Albrechts Univ Kiel CAU, Inst Anat, Otto Hahn Pl 8, D-24118 Kiel, Germany.	p.arnold@anat.uni-kiel.de	Lucius, Ralph/B-1614-2010; Becker-Pauly, Christoph/B-7569-2011	Zunke, Friederike/0000-0002-0408-6388	German Research Foundation (DFG) [SFB877, BE 4086/2-1, PI 379/6-1]; medical faculty of the Christian-Albrecht's University (Kiel, Germany)	German Research Foundation (DFG)(German Research Foundation (DFG)); medical faculty of the Christian-Albrecht's University (Kiel, Germany)	The authors thank Xavier Gomis-Ruth (Barcelona, Spain) for the pdb file of membrane-bound dimeric meprin beta and Michael Schwake (Bielefeld, Germany) for providing the Limp-2 antibody. This work was supported by the German Research Foundation (DFG) Grant SFB877 "Proteolysis as a Regulatory Event in Pathophysiology" (project A9), Grant BE 4086/2-1 (to C.B.-P.), Grant PI 379/6-1 (to C.U.P.), and by a young research investigator grant of the medical faculty of the Christian-Albrecht's University (Kiel, Germany) (to P.A.).	Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Brini M, 2013, METAL IONS LIFE SCI, V12, P119, DOI 10.1007/978-94-007-5561-1_5; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Chen DZ, 2000, BIOCHEMISTRY-US, V39, P1256, DOI 10.1021/bi992245y; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Kato YS, 2013, BIOL CHEM, V394, P55, DOI 10.1515/hsz-2012-0152; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Millar AW, 1998, BRIT J CLIN PHARMACO, V45, P21, DOI 10.1046/j.1365-2125.1998.00639.x; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Prell T, 2013, CELL CALCIUM, V54, P132, DOI 10.1016/j.ceca.2013.05.007; Prox J, 2015, MATRIX BIOL, V44-46, P7, DOI 10.1016/j.matbio.2015.01.010; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Siedlecka M, 1999, P NATL ACAD SCI USA, V96, P903, DOI 10.1073/pnas.96.3.903; SOMLYO AP, 1985, NATURE, V314, P622, DOI 10.1038/314622a0; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STOCKER W, 1988, BIOCHEMISTRY-US, V27, P5026; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Wang LL, 2014, EMBO J, V33, P594, DOI 10.1002/embj.201386523; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x	31	16	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3549	3557		10.1096/fj.15-272310	http://dx.doi.org/10.1096/fj.15-272310			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25957281				2022-12-28	WOS:000358796900040
J	Grossman, H; Chuderland, D; Ninio-Many, L; Hasky, N; Kaplan-Kraicer, R; Shalgi, R				Grossman, Hadas; Chuderland, Dana; Ninio-Many, Lihi; Hasky, Noa; Kaplan-Kraicer, Ruth; Shalgi, Ruth			A novel regulatory pathway in granulosa cells, the LH/human chorionic gonadotropin-microRNA-125a-3p-Fyn pathway, is required for ovulation	FASEB JOURNAL			English	Article						ovary; miRNA; Src family kinases; migration	FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; MICRORNA EXPRESSION; OOCYTE COMPLEXES; FYN KINASE; IDENTIFICATION; ACTIVATION; MIGRATION; RECEPTOR; STEROIDOGENESIS	Granulosa cells support the developing oocytes and serve as transducers of the ovulatory stimulus induced by LH surge. Fyn kinase is expressed in granulosa cells, though its role in these cells has not been studied. In human embryonic kidney 293T cells, microRNA (miR)-125a-3p down-regulates Fyn expression, causing a decrease in cells' migratory ability. Our aim was to explore the role of miR-125a-3p and Fyn in granulosa cells toward ovulation, focusing on migration as a possible mechanism. We demonstrate expression of miR-125a-3p and Fyn in mouse mural granulosa cells of preovulatory follicles and miR-125a-3p-induced down-regulation of Fyn expression in a granulosa cell line (rat). Administration of human chorionic gonadotropin (hCG; LH analog) caused a 75% decrease in the in vivo miR-125a-3p: Fyn mRNA ratio, followed by a 2-fold increased migratory ability of mural granulosa cells. In the hCG-treated granulosa cell line, miR-125a-3p expression was decreased, followed by Fyn up-regulation and phosphorylation of focal adhesion kinase and paxillin, enabling cell migration. An in vivo interference with miR-125a-3p: Fyn mRNA ratio in granulosa cells by intrabursal injections of Fyn small interfering RNA or miR-125a-3p mimic caused a 33 or 55% decrease in the number of ovulated oocytes, respectively. These observations reveal a new regulatory pathway in mural granulosa cells under the regulation of LH/hCG. Modulation of cell migration may account for the significance of the LH/hCG-miR-125a-3p-Fyn pathway to ovulation.	[Grossman, Hadas; Chuderland, Dana; Ninio-Many, Lihi; Hasky, Noa; Kaplan-Kraicer, Ruth; Shalgi, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Shalgi, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	shalgir@post.tau.ac.il			Israel Science Foundation [470/14]	Israel Science Foundation(Israel Science Foundation)	The authors are grateful to Professor Ruth Asheri-Padan and Reut Ohana (Tel Aviv University) for their valuable help with the in situ hybridization technique used in this study. This work was partially supported by a grant from the Israel Science Foundation (No. 470/14 to R.S.). H.G. performed this work in partial fulfillment of the requirements for a Ph.D. degree. H.G. developed the concept, designed and carried out the experiments, organized the data, performed the statistical analyses, and wrote the manuscript. D.C. and L.N.-M. participated in the study design and discussed the manuscript. N.H. performed and analyzed the immunohistochemistry assay. R.K.-K. assisted with the intrabursal injections and helped with drafting the manuscript. R.S. conceived the study, participated in its design and coordination, helped draft the manuscript, and supervised the study. All authors read the final manuscript and approved it. The authors declare no conflicts of interest.	Akison LK, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097345; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chuderland D, 2013, HUM REPROD, V28, P1626, DOI 10.1093/humrep/det027; Cohen-Fredarow A, 2014, MOL ENDOCRINOL, V28, P1039, DOI 10.1210/me.2013-1400; Donadeu FX, 2012, J ENDOCRINOL, V215, P323, DOI 10.1530/JOE-12-0252; Duggavathi R, 2009, SCIENCE, V324, P890, DOI 10.1126/science.1174130; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Franz MB, 2013, ARCH GYNECOL OBSTET, V287, P819, DOI 10.1007/s00404-012-2642-6; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Huang B, 2013, INT J ONCOL, V42, P1734, DOI 10.3892/ijo.2013.1861; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kawashima I, 2012, ENDOCRINOLOGY, V153, P3949, DOI 10.1210/en.2012-1059; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Levi M, 2010, REPRODUCTION, V140, P827, DOI 10.1530/REP-10-0312; Levi M, 2010, CELL CYCLE, V9, P1577, DOI 10.4161/cc.9.8.11299; McGinnis LK, 2011, MOL REPROD DEV, V78, P831, DOI 10.1002/mrd.21326; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mizutani T, 2006, MOL ENDOCRINOL, V20, P619, DOI 10.1210/me.2005-0277; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Ninio-Many L, 2013, J CELL SCI, V126, P2867, DOI 10.1242/jcs.123414; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Puttabyatappa M, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115717; Rolaki A, 2007, AM J PATHOL, V170, P1561, DOI 10.2353/ajpath.2007.060926; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Sang Q, 2013, J CLIN ENDOCR METAB, V98, P3068, DOI 10.1210/jc.2013-1715; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; SUH BS, 1992, J CELL BIOL, V119, P439, DOI 10.1083/jcb.119.2.439; Wayne CM, 2007, MOL ENDOCRINOL, V21, P1940, DOI 10.1210/me.2007-0020; Xu D, 2012, CELL SIGNAL, V24, P282, DOI 10.1016/j.cellsig.2011.09.013; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335	39	17	18	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3206	3216		10.1096/fj.14-269449	http://dx.doi.org/10.1096/fj.14-269449			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921829				2022-12-28	WOS:000358796900010
J	Karunadharma, PP; Basisty, N; Chiao, YA; Dai, DF; Drake, R; Levy, N; Koh, WJ; Emond, MJ; Kruse, S; Marcinek, D; Maccoss, MJ; Rabinovitch, PS				Karunadharma, Pabalu P.; Basisty, Nathan; Chiao, Ying Ann; Dai, Dao-Fu; Drake, Rachel; Levy, Nick; Koh, William J.; Emond, Mary J.; Kruse, Shane; Marcinek, David; Maccoss, Michael J.; Rabinovitch, Peter S.			Respiratory chain protein turnover rates in mice are highly heterogeneous but strikingly conserved across tissues, ages, and treatments	FASEB JOURNAL			English	Article						aging; caloric restriction; mitochondria; proteostasis; rapamycin	MITOCHONDRIAL-COMPLEX-I; EXTENDS LIFE-SPAN; QUALITY-CONTROL; CALORIE RESTRICTION; CYTOCHROME-C; CRYSTAL-STRUCTURE; SHORT-TERM; RAPAMYCIN; LIVER; STABILITY	The mitochondrial respiratory chain (RC) produces most of the cellular ATP and requires strict quality-control mechanisms. To examine RC subunit proteostasis in vivo, we measured RC protein half-lives (HLs) in mice by liquid chromatography-tandemmass spectrometry with metabolic [H-2(3)]-leucine heavy isotope labeling under divergent conditions. We studied 7 tissues/fractions of young and old mice on control diet or one of 2 diet regimens (caloric restriction or rapamycin) that altered protein turnover (42 conditions in total). We observed a 6.5-fold difference in mean HL across tissues and an 11.5-fold difference across all conditions. Normalization to the mean HL of each condition showed that relative HLs were conserved across conditions (Spearman's r = 0.57; P < 10(-4)), but were highly heterogeneous between subunits, with a 7.3-fold mean range overall, and a 2.2- to 4.6-fold range within each complex. To identify factors regulating this conserved distribution, we performed statistical analyses to study the correlation of HLs to the properties of the subunits. HLs significantly correlated with localization within the mitochondria, evolutionary origin, location of protein-encoding, and ubiquitination levels. These findings challenge the notion that all subunits in a complex turnover at comparable rates and suggest that there are common rules governing the differential proteolysis of RC protein subunits under divergent cellular conditions.	[Karunadharma, Pabalu P.; Basisty, Nathan; Chiao, Ying Ann; Dai, Dao-Fu; Drake, Rachel; Levy, Nick; Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Koh, William J.; Emond, Mary J.] Univ Washington, Dept Environm Hlth & Biostat, Seattle, WA 98195 USA; [Kruse, Shane; Marcinek, David] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Maccoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Karunadharma, Pabalu P.] Scripps Res Inst, Jupiter, FL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Scripps Research Institute	Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, 1959 NE Pacific St,HSB K081, Seattle, WA 98195 USA.	petersr@u.washington.edu	Koh, William/GYU-1574-2022; Basisty, Nathan B/J-9294-2014; kruse, shane/L-8717-2014; Dai, Dao-Fu/AAB-7547-2022; Dai, Dao-Fu/AAM-4396-2021	Basisty, Nathan B/0000-0001-6173-1139; kruse, shane/0000-0001-6344-0650; Dai, Dao-Fu/0000-0001-7724-321X; Drake, Rachel/0000-0002-1699-9192	U.S. National Institutes of Health (NIH) [P30 AG0132280]; National Institute on Aging [R01 AG038550]; National Heart, Lung, and Blood Institute [R01 HL101186]; Ellison Medical Foundation [AG-SS-2535-10]; American Federation for Aging Research Breakthroughs in Gerontology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038550, P30AG013280, T32AG000057] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ellison Medical Foundation(Lawrence Ellison Foundation); American Federation for Aging Research Breakthroughs in Gerontology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Jeanne Fredrickson, Cathy Styer, Lauren Uhde, Calvin Ngo, and Tony Chen for assistance in mouse euthanasia and protein extraction; Martin Jarvos for RP blood measurements; and Drs. Leo Pallanck and Evvie Vincow for valuable suggestions and careful review of the manuscript. Support was provided by U.S. National Institutes of Health (NIH) Grant P30 AG0132280 and R01 AG038550 from the National Institute on Aging, and R01 HL101186 from the National Heart, Lung, and Blood Institute; by Ellison Medical Foundation Grant AG-SS-2535-10; and by funding from the American Federation for Aging Research Breakthroughs in Gerontology (to P.S.R.). Y.A.C. is a Glenn/American Federation for Aging Research postdoctoral fellow for Translational Research on Aging. The authors declare no conflicts of interest.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Bereiter-Hahn J, 2010, INT REV CEL MOL BIO, V284, P1, DOI 10.1016/S1937-6448(10)84001-8; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dai DF, 2014, AGING CELL, V13, P529, DOI 10.1111/acel.12203; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Drake JC, 2013, J GERONTOL A-BIOL, V68, P1493, DOI 10.1093/gerona/glt047; FLETCHER MJ, 1961, BIOCHIM BIOPHYS ACTA, V51, P356, DOI 10.1016/0006-3002(61)90177-9; FLETCHER MJ, 1961, J GERONTOL, V16, P255, DOI 10.1093/geronj/16.3.255; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; Genova Maria Luisa, 2003, Ital J Biochem, V52, P58; Gledhill JR, 2006, BIOCHEM SOC T, V34, P989, DOI 10.1042/BST0340989; Goard CA, 2014, ONCOGENE, V33, P2690, DOI 10.1038/onc.2013.228; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Hoopmann MR, 2007, ANAL CHEM, V79, P5620, DOI 10.1021/ac0700833; Hsieh EJ, 2012, MOL CELL PROTEOMICS, V11, P1468, DOI 10.1074/mcp.O112.017699; Hsieh EJ, 2010, J PROTEOME RES, V9, P1138, DOI 10.1021/pr900816a; Huth W, 2002, BIOCHEM J, V364, P275, DOI 10.1042/bj3640275; Huynen MA, 2013, BBA-BIOENERGETICS, V1827, P224, DOI 10.1016/j.bbabio.2012.08.001; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kall L, 2009, BIOINFORMATICS, V25, P964, DOI 10.1093/bioinformatics/btp021; Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317; Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lau E, 2012, CIRC RES, V110, P1174, DOI 10.1161/CIRCRESAHA.112.268359; Lionaki E, 2013, J PROTEOMICS, V92, P181, DOI 10.1016/j.jprot.2013.03.022; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Miller BF, 2013, J GERONTOL A-BIOL, V68, P530, DOI 10.1093/gerona/gls219; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Nelson CJ, 2014, PLANT PHYSIOL, V166, P91, DOI 10.1104/pp.114.243014; Nelson CJ, 2013, J PROTEOME RES, V12, P3449, DOI 10.1021/pr400304r; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Sukhorukov VM, 2010, BBA-BIOMEMBRANES, V1798, P2022, DOI 10.1016/j.bbamem.2010.07.016; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851	62	45	45	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3582	3592		10.1096/fj.15-272666	http://dx.doi.org/10.1096/fj.15-272666			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25977255	Green Published			2022-12-28	WOS:000358796900043
J	Schwalm, C; Jamart, C; Benoit, N; Naslain, D; Premont, C; Prevet, J; Van Thienen, R; Deldicque, L; Francaux, M				Schwalm, Celine; Jamart, Cecile; Benoit, Nicolas; Naslain, Damien; Premont, Christophe; Prevet, Jeremy; Van Thienen, Ruud; Deldicque, Louise; Francaux, Marc			Activation of autophagy in human skeletal muscle is dependent on exercise intensity and AMPK activation	FASEB JOURNAL			English	Article						cathepsin; cycling; fasting; LC3b; p62/SQSTM1	REGULATE AUTOPHAGY; PROTEIN-KINASE; MESSENGER-RNA; DEGRADATION; DENERVATION; ADAPTATIONS; MECHANISMS; PATHWAYS; MICE	In humans, nutrient deprivation and extreme endurance exercise both activate autophagy. We hypothesized that cumulating fasting and cycling exercise would potentiate activation of autophagy in skeletal muscle. Well-trained athletes were divided into control (n = 8), low-intensity (LI, n = 8), and high-intensity (HI, n = 7) exercise groups and submitted to fed and fasting sessions. Muscle biopsy samples were obtained from the vastus lateralis before, at the end, and 1 h after a 2 h LI or HI bout of exercise. Phosphorylation of ULK1(Ser317) was higher after exercise (P < 0.001). In both the fed and the fasted states, LC3bII protein level and LC3bII/I were decreased after LI and HI (P < 0.05), while p62/SQSTM1 was decreased only 1 h after HI (P < 0.05), indicating an increased autophagic flux after HI. The autophagic transcriptional program was also activated, as evidenced by the increased level of LC3b, p62/SQSTM1, GabarapL1, and Cathepsin L mRNAs observed after HI but not after LI. The increased autophagic flux after HI exercise could be due to increased AMP-activated protein kinase alpha (AMPK alpha) activity, as both AMPK alpha(Thr172) and ACC(Ser79) had a higher phosphorylation state after HI (P < 0.001). In summary, the most effective strategy to activate autophagy in human skeletal muscle seems to rely on exercise intensity more than diet.-Schwalm, C., Jamart, C., Benoit, N., Naslain, D., Premont, C., Prevet, J., Van Thienen, R., Deldicque, L., Francaux, M. Activation of autophagy in human skeletal muscle is dependent on exercise intensity and AMPK activation.	[Schwalm, Celine; Jamart, Cecile; Benoit, Nicolas; Naslain, Damien; Premont, Christophe; Prevet, Jeremy; Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain La Neuve, Belgium; [Van Thienen, Ruud; Deldicque, Louise] Katholieke Univ Leuven, Dept Kinesiol, Exercise Physiol Res Grp, Leuven, Belgium	Universite Catholique Louvain; KU Leuven	Francaux, M (corresponding author), Catholic Univ Louvain, Pl Pierre Coubertin,1 Bte L8 10-01, B-1348 Louvain La Neuve, Belgium.	marc.francaux@uclouvain.be		Deldicque, Louise/0000-0003-3393-5278; Francaux, Marc/0000-0001-8182-1588	Delhaize Chair of the Louvain Foundation	Delhaize Chair of the Louvain Foundation	The authors thank C. Bugli (Louvain School of Statistics, Biostatistics and Actuarial Sciences, Louvain-la-Neuve, Belgium) for her assistance in the statistical analyses. This research was supported by a grant from the Delhaize Chair of the Louvain Foundation.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Grumati Paolo, 2012, Cells, V1, P325, DOI 10.3390/cells1030325; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jamart C, 2013, AM J PHYSIOL-ENDOC M, V305, pE964, DOI 10.1152/ajpendo.00270.2013; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; Jamart C, 2012, J APPL PHYSIOL, V112, P1529, DOI 10.1152/japplphysiol.00952.2011; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim YA, 2012, J PHYSIOL BIOCHEM, V68, P229, DOI 10.1007/s13105-011-0135-x; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mofarrahi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047265; Moresi V, 2012, P NATL ACAD SCI USA, V109, P1649, DOI 10.1073/pnas.1121159109; O'Leary MFN, 2012, AM J PHYSIOL-CELL PH, V303, pC447, DOI 10.1152/ajpcell.00451.2011; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; SCHIAFFINO S, 1972, J ULTRA MOL STRUCT R, V39, P1, DOI 10.1016/S0022-5320(72)80002-9; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Van Thienen R, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.286; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	43	99	105	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3515	3526		10.1096/fj.14-267187	http://dx.doi.org/10.1096/fj.14-267187			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25957282				2022-12-28	WOS:000358796900037
J	Aghamohammadzadeh, R; Zhang, YY; Stephens, TE; Arons, E; Zaman, P; Polach, KJ; Matar, M; Yung, LM; Yu, PB; Bowman, FP; Opotowsky, AR; Waxman, AB; Loscalzo, J; Leopold, JA; Maron, BA				Aghamohammadzadeh, Reza; Zhang, Ying-Yi; Stephens, Thomas E.; Arons, Elena; Zaman, Paula; Polach, Kevin J.; Matar, Majed; Yung, Lai-Ming; Yu, Paul B.; Bowman, Frederick P.; Opotowsky, Alexander R.; Waxman, Aaron B.; Loscalzo, Joseph; Leopold, Jane A.; Maron, Bradley A.			Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension	FASEB JOURNAL			English	Article						vascular remodeling; pulmonary vascular disease; kinase signaling	INSULIN-RESISTANCE; S6 KINASE; RECEPTOR; APOPTOSIS; PROLIFERATION; ACTIVATION; IMPROVES; PROTEIN; MTORC1; PHOSPHORYLATION	Activation of the mammalian target of rapamycin complex 1 (mTORC1) subunit Raptor induces cell growth and is a downstream target of Akt. Elevated levels of aldosterone activate Akt, and, in pulmonary arterial hypertension (PAH), correlate with pulmonary arteriole thickening, which suggests that mTORC1 regulation by aldosterone may mediate adverse pulmonary vascular remodeling. We hypothesized that aldosterone-Raptor signaling induces abnormal pulmonary artery smooth muscle cell (PASMC) survival patterns to promote PAH. Remodeled pulmonary arterioles from SU-5416/hypoxia-PAH rats and monocrotaline-PAH rats with hyperaldosteronism expressed increased levels of the Raptor target, p70S6K, which provided a basis for investigating aldosterone-Raptor signaling in human PASMCs. Aldosterone (10(-9) to 10(-7) M) increased Akt/mTOR/Raptor to activate p70S6K and increase proliferation, viability, and apoptosis resistance in PASMCs. In PASMCs transfected with Raptor-small interfering RNA or treated with spironolactone/eplerenone, aldosterone or pulmonary arterial plasma from patients with PAH failed to increase p70S6K activation or to induce cell survival in vitro. Optimal inhibition of pulmonary arteriole Raptor was achieved by treatment with Staramine-monomethoxy polyethylene glycol that was formulated with Raptor-small interfering RNA plus spironolactone in vivo, which decreased arteriole muscularization and pulmonary hypertension in 2 experimental animal models of PAH in vivo. Up-regulation of mTORC1 by aldosterone is a critical pathobiologic mechanism that controls PASMC survival to promote hypertrophic vascular remodeling and PAH.	[Aghamohammadzadeh, Reza; Zhang, Ying-Yi; Stephens, Thomas E.; Arons, Elena; Zaman, Paula; Yung, Lai-Ming; Yu, Paul B.; Bowman, Frederick P.; Opotowsky, Alexander R.; Loscalzo, Joseph; Leopold, Jane A.; Maron, Bradley A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA USA; [Waxman, Aaron B.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA USA; [Polach, Kevin J.; Matar, Majed] Cels Corp, Lawrenceville, NJ USA; [Opotowsky, Alexander R.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Maron, Bradley A.] Boston Vet Affairs Healthcare Syst, Dept Cardiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Maron, BA (corresponding author), 77 Ave Louis Pasteur,NRB Rm 0630-N, Boston, MA 02115 USA.	bmaron@partners.org	Waxman, Aaron/I-8659-2019; Yu, Paul B./J-7540-2019; Waxman, Aaron/L-7450-2019; Loscalzo, Joseph/ABD-8980-2021; Opotowsky, Alexander/AAL-1481-2020	Waxman, Aaron/0000-0001-7797-0361; Yu, Paul B./0000-0003-2145-4944; Opotowsky, Alexander/0000-0002-6107-2281; Aghamohammadzadeh, Reza/0000-0002-6058-9078; Bowman, Frederick/0000-0001-8143-879X	British Heart Foundation; C.R.T Fellowship [FS/10/42/28372]; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) [1K08HL11207-01A1]; American Heart Association Grant [AHA 15GRNT25080016]; Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund (CMREF); Klarman Foundation at Brigham and Women's Hospital; Gilead Young Scholars Foundation; Dunlevie Family Fund; NIH NHLBI Grant [1U01HL125215-01, R37 HL061795, HL108630, U54HL119145, PPGHL048743]; Gilead Sciences; Actelion Pharmaceuticals; British Heart Foundation [FS/10/42/28372] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125215, U01HL108630, U54HL119145, R01HL131910, K08HL111207, R37HL061795, R01HL139613] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); C.R.T Fellowship; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Grant(American Heart Association); Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund (CMREF); Klarman Foundation at Brigham and Women's Hospital; Gilead Young Scholars Foundation; Dunlevie Family Fund; NIH NHLBI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Gilead Sciences(Gilead Sciences); Actelion Pharmaceuticals; British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the British Heart Foundation and a C.R.T Fellowship (FS/10/42/28372) (to R.A.); the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) Grant 1K08HL11207-01A1, American Heart Association Grant AHA 15GRNT25080016, the Pulmonary Hypertension Association, the Cardiovascular Medical Research and Education Fund (CMREF), the Klarman Foundation at Brigham and Women's Hospital, and the Gilead Young Scholars Foundation (to B.A.M.); by the Dunlevie Family Fund (to A.R.O.); by NIH NHLBI Grant 1U01HL125215-01 (to J.A.L.); and by NIH NHLBI Grants R37 HL061795, HL108630 (MAPGEN), U54HL119145, and PPGHL048743 (to J.L.). B.A.M. is involved with investigator-initiated research that is supported by Gilead Sciences. A.R.O. is involved with investigator-initiated research that is supported by Actelion Pharmaceuticals.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Chen XP, 2016, CIRCULATION, V133, P82, DOI 10.1161/CIRCULATIONAHA.115.016133; Duan YH, 2015, AMINO ACIDS, V47, P857, DOI 10.1007/s00726-015-1937-x; Fattori R, 2003, LANCET, V361, P247, DOI 10.1016/S0140-6736(03)12275-1; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; French CJ, 2009, FASEB J, V23, P1177, DOI 10.1096/fj.08-116509; Frump AL, 2015, AM J PHYSIOL-LUNG C, V308, pL873, DOI 10.1152/ajplung.00006.2015; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Gerasimovskaya EV, 2005, J BIOL CHEM, V280, P1838, DOI 10.1074/jbc.M409466200; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; HEI YJ, 1994, J BIOL CHEM, V269, P7816; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Jia GH, 2014, AM J PHYSIOL-REG I, V307, pR1198, DOI 10.1152/ajpregu.00262.2014; Kirsch T, 2013, HYPERTENSION, V61, P501, DOI 10.1161/HYPERTENSIONAHA.111.196832; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Lee CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116393; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Li LX, 2015, INT J MOL MED, V36, P316, DOI 10.3892/ijmm.2015.2224; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maron BA, 2015, CIRCULATION, V131, P2079, DOI 10.1161/CIRCULATIONAHA.114.006980; Maron BA, 2014, CIRCULATION, V130, P168, DOI 10.1161/CIRCULATIONAHA.113.007690; Maron BA, 2013, EUR J HEART FAIL, V15, P277, DOI 10.1093/eurjhf/hfs173; Maron BA, 2012, CIRCULATION, V126, P963, DOI 10.1161/CIRCULATIONAHA.112.094722; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; McLendon JM, 2015, J CONTROL RELEASE, V210, P67, DOI 10.1016/j.jconrel.2015.05.261; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Mill C, 2014, ARTERIOSCL THROM VAS, V34, P2449, DOI 10.1161/ATVBAHA.114.303922; Oshiro N, 2014, J BIOL CHEM, V289, P2658, DOI 10.1074/jbc.M113.528505; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Preston IR, 2013, AM J PHYSIOL-LUNG C, V304, pL678, DOI 10.1152/ajplung.00300.2012; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Sakurabayashi-Kitade S, 2009, ATHEROSCLEROSIS, V206, P54, DOI 10.1016/j.atherosclerosis.2009.01.039; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Seyfarth HJ, 2013, PULM CIRC, V3, P632, DOI 10.1086/674311; Sherajee SJ, 2012, ARTERIOSCL THROM VAS, V32, P257, DOI 10.1161/ATVBAHA.111.240697; Su HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062399; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Thompson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085495; Wallace E, 2015, AM J RESP CRIT CARE, V191, P1432, DOI 10.1164/rccm.201412-2148OC; Wang B, 2015, CELL PHYSIOL BIOCHEM, V35, P116, DOI 10.1159/000369680; Wang L, 2013, PULM CIRC, V3, P654, DOI 10.1086/674310; Wang W, 2014, J CELL PHYSIOL, V229, P2117, DOI 10.1002/jcp.24670; White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511	48	34	36	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2511	2527		10.1096/fj.201500042	http://dx.doi.org/10.1096/fj.201500042			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006450	Green Published			2022-12-28	WOS:000379249500007
J	Lim, SC; Hroudova, J; Van Bergen, NJ; Sanchez, MIGL; Trounce, IA; McKenzie, M				Lim, Sze Chern; Hroudova, Jana; Van Bergen, Nicole J.; Sanchez, M. Isabel G. Lopez; Trounce, Ian A.; McKenzie, Matthew			Loss of mitochondrial DNA-encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly	FASEB JOURNAL			English	Article						blue native PAGE; oxidative phosphorylation; respiratory chain; supercomplex	RESPIRATORY-CHAIN SUPERCOMPLEXES; OXIDATIVE-PHOSPHORYLATION; MAMMALIAN MITOCHONDRIA; OXPHOS COMPLEXES; MUTATIONS; SUBUNITS; DISEASE; DEFICIENCY; GENE; IDENTIFICATION	Mitochondrial complex I (NADH:ubiquinone oxidoreductase) must be assembled precisely from 45 protein subunits for it to function correctly. One of its mitochondrial DNA (mtDNA) encoded subunits, ND1, is incorporated during the early stages of complex I assembly. However, little is known about how mutations in ND1 affect this assembly process. We found that in human 143B cybrid cells carrying a homoplasmic MT-ND1 mutation, ND1 protein could not be translated. As a result, the early stages of complex I assembly were disrupted, with mature complex I undetectable and complex I-linked respiration severely reduced to 2.0% of control levels. Interestingly, complex IV (ferrocytochrome c:oxygen oxidoreductase) steady-state levels were also reduced to 40.3%, possibly due to its diminished stability in the absence of respiratory supercomplex formation. This was in comparison with 143B cybrid controls (that contained wild-type mtDNA on the same nuclear background), which exhibited normal complex I, complex IV, and supercomplex assembly. We conclude that the loss of ND1 stalls complex I assembly during the early stages of its biogenesis, which not only results in the loss of mature complex I but also disrupts the stability of complex IV and the respiratory supercomplex to cause mitochondrial dysfunction.Lim, S. C., Hroudova, J., Van Bergen, N. J., Lopez Sanchez, M. I. G., Trounce, I. A., McKenzie, M. Loss of mitochondrial DNA-encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly.	[Lim, Sze Chern; McKenzie, Matthew] Hudson Inst Med Res, Ctr Genet Dis, Melbourne, Vic 3168, Australia; [Hroudova, Jana] Charles Univ Prague, Fac Med 1, Dept Psychiat, Prague, Czech Republic; [Van Bergen, Nicole J.; Sanchez, M. Isabel G. Lopez; Trounce, Ian A.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Van Bergen, Nicole J.; Sanchez, M. Isabel G. Lopez; Trounce, Ian A.] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia; [McKenzie, Matthew] Monash Univ, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Charles University Prague; General University Hospital Prague; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Monash University	McKenzie, M (corresponding author), Hudson Inst Med Res, Ctr Genet Dis, Melbourne, Vic 3168, Australia.	matthew.mckenzie@hudson.org.au	Hroudová, Jana/J-4067-2017; McKenzie, Matthew/H-4926-2019; Sanchez, Isabel G Lopez/A-5472-2019; Lim, Sze Chern/I-6763-2013	Hroudová, Jana/0000-0001-5448-1717; McKenzie, Matthew/0000-0001-7508-1800; Sanchez, Isabel G Lopez/0000-0002-1528-5964; Trounce, Ian/0000-0002-1070-8892; Lim, Sze Chern/0000-0003-0312-9937	Poxon Neurosurgical Foundation; Australian National Health and Medical Research Council [APP1061472]; Wagstaff Bequest of the Royal Victorian Eye and Ear Hospital; Australian Research Council; William Buckland Foundation; Monash University; Group of Eight Fellowship; Czech Republic award [PRVOUK-P26/LF1/4]; Victorian Government Infrastructure Program	Poxon Neurosurgical Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wagstaff Bequest of the Royal Victorian Eye and Ear Hospital; Australian Research Council(Australian Research Council); William Buckland Foundation; Monash University(Monash University); Group of Eight Fellowship; Czech Republic award; Victorian Government Infrastructure Program	This work was supported in part by the Poxon Neurosurgical Foundation (to M. M. and I. A. T.), the Australian National Health and Medical Research Council (APP1061472 to I. A. T.), the Wagstaff Bequest of the Royal Victorian Eye and Ear Hospital (to I. A. T.), the Australian Research Council Future Fellowship Scheme (to M. M.), the William Buckland Foundation (to M. M.), Monash University (to M. M.), a Group of Eight Fellowship (to J. H.), and Czech Republic award PRVOUK-P26/LF1/4 (to J. H.). The Centre for Eye Research Australia and the Hudson Institute of Medical Research receive support from the Victorian Government Infrastructure Program.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bridges HR, 2011, BIOCHEM SOC T, V39, P799, DOI 10.1042/BST0390799; Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; CLARKE S, 1976, J BIOL CHEM, V251, P950; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Cortes NG, 2012, HUM MUTAT, V33, P681, DOI 10.1002/humu.22023; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gasparre G, 2011, CANCER RES, V71, P6220, DOI 10.1158/0008-5472.CAN-11-1042; Gershoni M, 2010, J MOL BIOL, V404, P158, DOI 10.1016/j.jmb.2010.09.029; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Horton TM, 1996, GENE CHROMOSOME CANC, V15, P95, DOI 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Iommarini L, 2013, INT J BIOCHEM CELL B, V45, P47, DOI 10.1016/j.biocel.2012.05.016; Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Lim SC, 2014, AM J HUM GENET, V94, P209, DOI 10.1016/j.ajhg.2013.12.015; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114; Mayr JA, 2008, CLIN CANCER RES, V14, P2270, DOI 10.1158/1078-0432.CCR-07-4131; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; McKenzie M, 2014, HUM MUTAT, V35, P1476, DOI 10.1002/humu.22694; McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Perales-Clemente E, 2010, MOL CELL BIOL, V30, P3038, DOI 10.1128/MCB.00025-10; Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566; Saada A, 2012, J INHERIT METAB DIS, V35, P125, DOI 10.1007/s10545-011-9348-y; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495; TUSCHEN G, 1990, J MOL BIOL, V213, P845, DOI 10.1016/S0022-2836(05)80268-2; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001; Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407	63	33	34	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2236	2248		10.1096/fj.201500137R	http://dx.doi.org/10.1096/fj.201500137R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26929434				2022-12-28	WOS:000376878300016
J	Elenbaas, JS; Maitra, D; Liu, Y; Lentz, SI; Nelson, B; Hoenerhoff, MJ; Shavit, JA; Omary, MB				Elenbaas, Jared S.; Maitra, Dhiman; Liu, Yang; Lentz, Stephen I.; Nelson, Bradley; Hoenerhoff, Mark J.; Shavit, Jordan A.; Omary, M. Bishr			A precursor-inducible zebrafish model of acute protoporphyria with hepatic protein aggregation and multiorganelle stress	FASEB JOURNAL			English	Article						autophagy; endoplasmic reticulum stress; protoporphyrin IX; unfolded protein response	ENDOPLASMIC-RETICULUM STRESS; ONE-ELECTRON REDUCTION; ERYTHROPOIETIC PROTOPORPHYRIA; LIVER-DISEASE; IRON CHELATION; BODY FORMATION; ER STRESS; HEME; FERROCHELATASE; PORPHYRIA	Protoporphyria is a metabolic disease that causes excess production of protoporphyrin IX (PP-IX), the final biosynthetic precursor to heme. Hepatic PP-IX accumulationmay leadtoend-stage liver disease. Wetested the hypothesis that systemic administration of porphyrin precursors to zebrafish larvae results in protoporphyrin accumulation and a reproducible nongenetic porphyria model. Retro-orbital infusion of PP-IX or the iron chelator deferoxamine mesylate (DFO), with the first committed heme precursor a-aminolevulinic acid (ALA), generates high levels of PP-IX in zebrafish larvae. Exogenously infused or endogenously produced PP-IX accumulates preferentially in the liver of zebrafish larvae and peaks 1 to 3 d after infusion. Similar to patients with protoporphyria, PP-IX is excreted through the biliary system. Porphyrin accumulation in zebrafish liver causes multiorganelle protein aggregation as determined by mass spectrometry and immunoblotting. Endoplasmic reticulum stress and induction of autophagy were noted in zebrafish larvae and corroborated in 2 mouse models of protoporphyria. Furthermore, electron microscopy of zebrafish livers from larvae administered ALA + DFO showed hepatocyte auto-phagosomes, nuclear membrane ruffling, and porphyrin-containing vacuoles with endoplasmic reticulum distortion. In conclusion, systemic administration of the heme pre-cursors PP-IX or ALA+ DFO into zebrafish larvae provides a new model of acute protoporphyria with consequent hepatocyte protein aggregation and proteotoxic multiorganelle alterations and stress.	[Elenbaas, Jared S.; Maitra, Dhiman; Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Liu, Yang; Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Div Pediat Hematol & Oncol, Ann Arbor, MI 48109 USA; [Lentz, Stephen I.; Nelson, Bradley; Omary, M. Bishr] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hoenerhoff, Mark J.] Univ Michigan, Unit Lab Anim Med, In Vivo Anim Core, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Omary, MB (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7744 Med Sci Bldg 2,1137 Catherine St, Ann Arbor, MI 48109 USA.	mbishr@med.umich.edu		Omary, Bishr/0000-0002-8624-2347; , dhiman/0000-0002-8775-2963; Elenbaas, Jared/0000-0002-9612-7764; Lentz, Stephen/0000-0003-1686-7998; Liu, Yang/0000-0002-0413-5637	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK52951]; Department of Veterans Affairs; NIH National Heart, Lung, and Blood Institute [R01-HL124232]; NIH NIDDK Institutional [DK034933, DK020572]; University of Michigan Protein Folding Diseases Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951, P60DK020572, P30DK020572, P30DK034933] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs(US Department of Veterans Affairs); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NIDDK Institutional; University of Michigan Protein Folding Diseases Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant R01-DK52951 and the Department of Veterans Affairs (M.B.O.); NIH National Heart, Lung, and Blood Institute Grant R01-HL124232 (J.A.S.); and NIH NIDDK Institutional Grants DK034933 and DK020572 to the University of Michigan. The authors thank S. E. Whitesall and L. G. D'Alecy for assistance with the HPLC analysis, the University of Michigan Unit for Laboratory Animal Medicine In Vivo Animal Core for their assistance with obtaining histological sections of zebrafish larvae, and V. Basrur for carrying out the MS analysis with support from the University of Michigan Protein Folding Diseases Initiative. The authors declare no conflicts of interest.	Afonso S, 1999, FREE RADICAL RES, V31, P161, DOI 10.1080/10715769900300711; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Balwani M, 2012, BLOOD, V120, P4496, DOI 10.1182/blood-2012-05-423186; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; BOTTOMLEY SS, 1975, J LAB CLIN MED, V86, P126; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Cinaroglu A, 2011, HEPATOLOGY, V54, P495, DOI 10.1002/hep.24396; Curnow A, 2007, J ENVIRON PATHOL TOX, V26, P89; Davies R, 2005, AM J PATHOL, V166, P1041, DOI 10.1016/S0002-9440(10)62325-5; Dooley K. A., 2008, EXP HEMATOL, V36, P1132; Elder GH, 2009, CELL MOL BIOL, V55, P118, DOI 10.1170/T861; Goldsmith JR, 2013, DIS MODEL MECH, V6, P146, DOI 10.1242/dmm.009852; Gross U, 2000, J INHERIT METAB DIS, V23, P641, DOI 10.1023/A:1005645624262; Gross U, 1998, PHOTODERMATOL PHOTO, V14, P52, DOI 10.1111/j.1600-0781.1998.tb00011.x; GSCHNAIT F, 1975, J INVEST DERMATOL, V65, P290, DOI 10.1111/1523-1747.ep12598357; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Komatsu Hirokazu, 2000, Medical Electron Microscopy, V33, P32, DOI 10.1007/s007950000005; KONINGSBERGER JC, 1995, J HEPATOL, V22, P57, DOI 10.1016/0168-8278(95)80260-6; Kwan R, 2012, FASEB J, V26, P2318, DOI 10.1096/fj.11-198580; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; MACDONALD DM, 1981, BRIT J DERMATOL, V104, P7, DOI 10.1111/j.1365-2133.1981.tb01705.x; MAGNUS IA, 1969, J INVEST DERMATOL, V53, P400, DOI 10.1038/jid.1969.167; Maitra D, 2015, J BIOL CHEM, V290, P23711, DOI 10.1074/jbc.M114.636001; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Meerman L, 2000, SCAND J GASTROENTERO, V35, P79; MOREHOUSE KM, 1990, ARCH BIOCHEM BIOPHYS, V283, P306, DOI 10.1016/0003-9861(90)90647-H; MOREHOUSE KM, 1987, ARCH BIOCHEM BIOPHYS, V257, P276, DOI 10.1016/0003-9861(87)90567-4; NAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P281, DOI 10.1073/pnas.89.1.281; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PLEWINSKA M, 1991, AM J HUM GENET, V49, P167; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SARKANY RPE, 1994, LANCET, V343, P1394, DOI 10.1016/S0140-6736(94)92525-9; SASSA S, 1983, J CLIN INVEST, V71, P625, DOI 10.1172/JCI110809; Sassa S, 1996, INT J HEMATOL, V63, P167; SHEMIN D, 1970, NATURWISSENSCHAFTEN, V57, P185, DOI 10.1007/BF00592970; Singla A, 2013, J CELL SCI, V126, P3105, DOI 10.1242/jcs.123026; Singla A, 2012, HEPATOLOGY, V56, P322, DOI 10.1002/hep.25664; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; THOMPSON RP, 1973, GUT, V14, P934, DOI 10.1136/gut.14.12.934; TODD DJ, 1991, AM J DIS CHILD, V145, P971, DOI 10.1001/archpedi.1991.02160090021011; TSUNOO C, 1987, J HEPATOL, V5, P85, DOI 10.1016/S0168-8278(87)80065-X; Vacaru AM, 2014, DIS MODEL MECH, V7, P823, DOI 10.1242/dmm.014472; Valdes PA, 2010, PHOTOCHEM PHOTOBIOL, V86, P471, DOI 10.1111/j.1751-1097.2009.00664.x; VANSTEVENINCK J, 1988, BIOCHEM J, V250, P197, DOI 10.1042/bj2500197; Vo AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074682; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Whatley SD, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016121; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	63	14	15	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1798	1810		10.1096/fj.201500111R	http://dx.doi.org/10.1096/fj.201500111R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839379	Green Submitted, Green Published			2022-12-28	WOS:000374879400011
J	Kapetanovic, R; Bokil, NJ; Achard, MES; Ong, CLY; Peters, KM; Stocks, CJ; Phan, MD; Monteleone, M; Schroder, K; Irvine, KM; Saunders, BM; Walker, MJ; Stacey, KJ; McEwan, AG; Schembri, MA; Sweet, MJ				Kapetanovic, Ronan; Bokil, Nilesh J.; Achard, Maud E. S.; Ong, Cheryl-lynn Y.; Peters, Kate M.; Stocks, Claudia J.; Minh-Duy Phan; Monteleone, Mercedes; Schroder, Kate; Irvine, Katharine M.; Saunders, Bernadette M.; Walker, Mark J.; Stacey, Katryn J.; McEwan, Alastair G.; Schembri, Mark A.; Sweet, Matthew J.			Salmonella employs multiple mechanisms to subvert the TLR-inducible zinc-mediated antimicrobial response of human macrophages	FASEB JOURNAL			English	Article						bacterial pathogens; innate immunity; metal ions; trafficking pathways	ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; MURINE MODEL; TYPHIMURIUM; COPPER; METAL; SUPPLEMENTATION; HOMEOSTASIS; DEFICIENCY	We aimed to characterize antimicrobial zinc trafficking within macrophages and to determine whether the professional intramacrophage pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) subverts this pathway. Using both Escherichia coli and S. Typhimurium, we show that TLR signaling promotes the accumulation of vesicular zinc within primary human macrophages. Vesicular zinc is delivered to E. coli to promote microbial clearance, whereas S. Typhimurium evades this response via Salmonella pathogenicity island (SPI)-1. Even in the absence of SPI-1 and the zinc exporter ZntA, S. Typhimurium resists the innate immune zinc stress response, implying the existence of additional host subversion mechanisms. We also demonstrate the combinatorial antimicrobial effects of zinc and copper, a pathway that S. Typhimurium again evades. Our use of complementary tools and approaches, including confocal microscopy, direct assessment of intramacrophage bacterial zinc stress responses, specific E. coli and S. Typhimurium mutants, and inductively coupled plasma mass spectroscopy, has enabled carefully controlled characterization of this novel innate immune antimicrobial pathway. In summary, our study provides new insights at the cellular level into the well-documented effects of zinc in promoting host defense against infectious disease, as well as the complex host subversion strategies employed by S. Typhimurium to combat this pathway.-Kapetanovic, R., Bokil, N. J., Achard, M. E. S., Ong, C.-L. Y., Peters, K. M., Stocks, C. J., Phan, M.-D., Monteleone, M., Schroder, K., Irvine, K. M., Saunders, B. M., Walker, M. J., Stacey, K. J., McEwan, A. G., Schembri, M. A., Sweet, M. J. Salmonella employs multiple mechanisms to subvert the TLR-inducible zinc-mediated antimicrobial response of human macrophages. www.fasebj.org	[Kapetanovic, Ronan; Bokil, Nilesh J.; Stocks, Claudia J.; Monteleone, Mercedes; Schroder, Kate; Sweet, Matthew J.] Univ Queensland, IMB, Brisbane, Qld, Australia; [Kapetanovic, Ronan; Bokil, Nilesh J.; Stocks, Claudia J.; Monteleone, Mercedes; Schroder, Kate; Irvine, Katharine M.; Sweet, Matthew J.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld, Australia; [Kapetanovic, Ronan; Bokil, Nilesh J.; Achard, Maud E. S.; Ong, Cheryl-lynn Y.; Peters, Kate M.; Stocks, Claudia J.; Minh-Duy Phan; Monteleone, Mercedes; Schroder, Kate; Walker, Mark J.; Stacey, Katryn J.; McEwan, Alastair G.; Schembri, Mark A.; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Achard, Maud E. S.; Ong, Cheryl-lynn Y.; Peters, Kate M.; Minh-Duy Phan; Walker, Mark J.; Stacey, Katryn J.; McEwan, Alastair G.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Irvine, Katharine M.] Univ Queensland, Sch Med, Woolloongabba, Qld, Australia; [Saunders, Bernadette M.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Technology Sydney	Sweet, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	m.sweet@imb.uq.edu.au	Kapetanovic, Ronan/GRO-1748-2022; kapetanovic, ronan/G-8322-2012; Monteleone, Maria/J-1813-2014; Schembri, Mark A/C-7262-2009; Irvine, Katharine M/A-5559-2011; Phan, Minh-Duy/I-9147-2012; Schroder, Kate/C-6132-2008; Ong, Cheryl-lynn Y/C-5238-2014; Stocks, Claudia J/S-8733-2019; Sweet, Matthew J/F-2229-2011; Stocks, Claudia J/C-8020-2017; Bokil, Nilesh/C-8568-2012	Kapetanovic, Ronan/0000-0002-2908-1014; kapetanovic, ronan/0000-0002-2908-1014; Monteleone, Maria/0000-0003-0777-3965; Schembri, Mark A/0000-0003-4863-9260; Irvine, Katharine M/0000-0002-6716-1605; Phan, Minh-Duy/0000-0002-3426-1044; Schroder, Kate/0000-0001-9261-3805; Ong, Cheryl-lynn Y/0000-0001-6036-6889; Stocks, Claudia J/0000-0001-6120-2851; Sweet, Matthew J/0000-0002-0406-8139; Stocks, Claudia J/0000-0001-6120-2851; McEwan, Alastair/0000-0002-2419-1003; Stacey, Katryn/0000-0002-3992-7802; Bokil, Nilesh/0000-0003-3202-9249; Saunders, Bernadette/0000-0003-0540-4445; Walker, Mark/0000-0001-7423-2769	National Health and Medical Research Council of Australia (NHMRC) [ID631531, APP1065391, ID631386]; NHMRC [APP1107914]; Australian Research Council (ARC) [FT100100662]; ARC Discovery Early Career Researcher Award Fellowship [DE1310470]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC Discovery Early Career Researcher Award Fellowship(Australian Research Council)	This work was supported by project grants (ID631531, APP1065391) from the National Health and Medical Research Council of Australia (NHMRC). M.J.S. is supported by an NHMRC Senior Research Fellowship (APP1107914). M.J.W. is supported by an NHMRC Principal Research Fellowship (ID631386). M.A.S. is supported by an Australian Research Council (ARC) Future Fellowship (FT100100662). R.K. is supported by an ARC Discovery Early Career Researcher Award Fellowship (DE1310470). Microscopy was performed at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, University of Queensland, which was established with the support of the Australian Cancer Research Foundation. The authors thank Dr. Wan-Ping Hu (School of Earth Sciences, University of Queensland) for conducting the ICP-MS analysis, Prof. Paul Bernhardt (School of Chemistry and Molecular Biosciences, University of Queensland) for the synthesis of CS1, Dr. Nick Hamilton for his help with ImageJ software, Claire Pitts for her assistance with some experiments, Dr. Brian Chan (Centenary Institute, NSW, Australia) for critical review of the manuscript, and the Australian Red Cross Blood Service for providing buffy coats for the isolation of human monocytes.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Allsopp LP, 2012, INFECT IMMUN, V80, P321, DOI 10.1128/IAI.05322-11; Bao SY, 2010, AM J PHYSIOL-LUNG C, V298, pL744, DOI 10.1152/ajplung.00368.2009; Behnsen J, 2015, TRENDS IMMUNOL, V36, P112, DOI 10.1016/j.it.2014.12.003; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bokil NJ, 2011, IMMUNOBIOLOGY, V216, P1164, DOI 10.1016/j.imbio.2011.05.011; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Brawn LC, 2007, CELL HOST MICROBE, V1, P63, DOI 10.1016/j.chom.2007.02.001; Brieger A, 2013, J IMMUNOL, V191, P1808, DOI 10.4049/jimmunol.1301261; Cerasi M, 2014, METALLOMICS, V6, P845, DOI 10.1039/c3mt00352c; COYLE P, 1994, BIOCHEM J, V303, P781, DOI 10.1042/bj3030781; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diaz-Ochoa VE, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00002; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Eijkelkamp BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089427; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Giacomodonato MN, 2007, MICROBIOL-SGM, V153, P1221, DOI 10.1099/mic.0.2006/002758-0; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Knoell DL, 2009, CRIT CARE MED, V37, P1380, DOI 10.1097/CCM.0b013e31819cefe4; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; Lundberg U, 1999, J BACTERIOL, V181, P3433, DOI 10.1128/JB.181.11.3433-3437.1999; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mayer LS, 2014, METALLOMICS, V6, P1288, DOI 10.1039/c4mt00051j; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nowak JE, 2012, PEDIATR CRIT CARE ME, V13, pE323, DOI 10.1097/PCC.0b013e31824fbd90; Ong CLY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10799; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Perez JM, 2006, BIOL RES, V39, P661, DOI 10.4067/S0716-97602006000500009; Prasad AS, 2008, MOL MED, V14, P353, DOI 10.2119/2008-00033.Prasad; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Stafford S. L., 2013, BIOSCI REP, V33; Sweet M. J., 2010, REGULATION INNATE IM, P1; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Valavi E, 2011, INDIAN J PEDIATR, V78, P1079, DOI 10.1007/s12098-011-0458-1; van der Heijden J, 2012, FUTURE MICROBIOL, V7, P685, DOI [10.2217/FMB.12.49, 10.2217/fmb.12.49]; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	64	50	50	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1901	1912		10.1096/fj.201500061	http://dx.doi.org/10.1096/fj.201500061			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839376				2022-12-28	WOS:000374879400019
J	Petrovich, E; Feigelson, SW; Stoler-Barak, L; Hatzav, M; Solomon, A; Bar-Shai, A; Ilan, N; Li, JP; Engelhardt, B; Vlodavsky, I; Alon, R				Petrovich, Ekaterina; Feigelson, Sara W.; Stoler-Barak, Liat; Hatzav, Miki; Solomon, Adam; Bar-Shai, Amir; Ilan, Neta; Li, Jin-Ping; Engelhardt, Britta; Vlodavsky, Israel; Alon, Ronen			Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs	FASEB JOURNAL			English	Article						beta(2) integrin; heparanase; heparan sulfate; inflammation	INTERCELLULAR-ADHESION MOLECULE-1; LEUKOCYTE SEQUESTRATION; T-CELLS; RECRUITMENT; HEPARANASE; ROLES; INTEGRINS; DEFORMABILITY; DIAPEDESIS; MIGRATION	The pulmonary vasculature constitutively expresses the integrin lymphocyte function-associated antigen-1 ligands intercellular adhesion molecule (ICAM)-1 and -2. In this study, effector T cells were temporarily entrapped by the lung vasculature on their way to inflamed lymph nodes, and this entrapment was strongly reduced in ICAM-1 and -2 double-deficient mice (79 and 86% reduction for CD8(+) and CD4(+) effectors, respectively, compared with wild-type mice). Although the pulmonary vasculature has been suggested to be masked by the heparan sulfate-containing glycocalyx, which is susceptible to heparanase-mediated shedding, lung and lymphocyte heparanase have been found to be unnecessary for this entrapment. Systemic LPS induced rapid neutrophil entrapment in the lung vasculature, but in contrast to T-cell entrapment, this sequestration was ICAM-1, ICAM-2, and heparanase independent. Furthermore, neutrophil migration into the bronchoalveolar space induced by LPS inhalation and LPS-induced leakage of red blood cells into this space were not dependent on lung ICAMs or heparanase activity. Nevertheless, heparanase was critical for neutrophil accumulation in smoke-exposed lungs. Our results indicate that, whereas T cells use ICAM-1 and -2 for temporary pulmonary entrapment, neutrophils get sequestered and extravasate into inflamed lungs independent of ICAMs. This is the first demonstration that the pulmonary vasculature is differentially recognized by T cells and neutrophils.-Petrovich, E., Feigelson, S. W., Stoler-Barak, L., Hatzav, M., Solomon, A., Bar-Shai, A., Ilan, N., Li, J.-P., Engelhardt, B., Vlodavsky, I., Alon, R. Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs.	[Petrovich, Ekaterina; Feigelson, Sara W.; Stoler-Barak, Liat; Hatzav, Miki; Solomon, Adam; Bar-Shai, Amir; Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel; [Li, Jin-Ping] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Uppsala University; University of Bern	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022; Engelhardt, Britta/K-7267-2014	Engelhardt, Britta/0000-0003-3059-9846; Alon, Ronen/0000-0001-9161-6369; solomon, adam/0000-0003-1263-0707; Kopitman, Ekaterina/0000-0002-6050-6404	German-Israeli Foundation; Israel Science Foundation; U.S.-Israel Binational Science Foundation; Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; Swiss National Science Foundation	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. U. Deutsch and Ms. C. Blatti (University of Bern) for expert technical support. R.A. is an incumbent of the Linda Jacobs Chair in Immune and Stem Cell Research, and his research is supported by the German-Israeli Foundation; the Israel Science Foundation; the U.S.-Israel Binational Science Foundation; the Flight Attendant Medical Research Institute Foundation; a research grant from Mr. and Mrs. W. Glied and the Minerva Foundation, Germany. B.E. is funded by the Swiss National Science Foundation. The authors declare no conflicts of interest.	Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002; Burns JA, 2001, AM J PATHOL, V158, P1809, DOI 10.1016/S0002-9440(10)64137-5; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Cohen SJ, 2013, BLOOD, V122, P2609, DOI 10.1182/blood-2013-04-495036; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; DOERSCHUK CM, 1992, AM J RESP CELL MOL, V7, P140, DOI 10.1165/ajrcmb/7.2.140; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Drost EM, 2002, EUR J IMMUNOL, V32, P393, DOI 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895; GEBB SA, 1995, J APPL PHYSIOL, V79, P493, DOI 10.1152/jappl.1995.79.2.493; Gorina R, 2014, J IMMUNOL, V192, P324, DOI 10.4049/jimmunol.1300858; Hermano E, 2012, CELL MOL LIFE SCI, V69, P2501, DOI 10.1007/s00018-012-0930-8; Kadioglu A, 2011, J IMMUNOL, V186, P5907, DOI 10.4049/jimmunol.1001533; Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312; Kuebler WM, 1999, J VASC RES, V36, P282, DOI 10.1159/000025656; Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679; Lehmann JCU, 2003, J IMMUNOL, V171, P2588, DOI 10.4049/jimmunol.171.5.2588; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Moreland JG, 2002, AM J RESP CELL MOL, V27, P474, DOI 10.1165/rcmb.4694; Morris A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127032; Nakav S, 2012, AM J RESP CELL MOL, V46, P313, DOI 10.1165/rcmb.2011-0181OC; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Smits NC, 2010, ANAT REC, V293, P955, DOI 10.1002/ar.20895; Stoler-Barak L, 2015, FASEB J, V29, P2010, DOI 10.1096/fj.14-265447; Tanaka H, 2002, MICROVASC RES, V63, P81, DOI 10.1006/mvre.2001.2368; Vlodavsky I, 2013, MATRIX BIOL, V32, P220, DOI 10.1016/j.matbio.2013.03.001; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	39	11	11	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1767	1778		10.1096/fj.201500046	http://dx.doi.org/10.1096/fj.201500046			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26823454				2022-12-28	WOS:000374879400008
J	Lyu, L; Whitcomb, EA; Jiang, SH; Chang, ML; Gu, YM; Duncan, MK; Cvekl, A; Wang, WL; Limi, S; Reneker, LW; Shang, F; Du, LF; Taylor, A				Lyu, Lei; Whitcomb, Elizabeth A.; Jiang, Shuhong; Chang, Min-Lee; Gu, Yumei; Duncan, Melinda K.; Cvekl, Ales; Wang, Wei-Lin; Limi, Saima; Reneker, Lixing W.; Shang, Fu; Du, Linfang; Taylor, Allen			Unfolded-protein response-associated stabilization of p27(Cdkn1b) interferes with lens fiber cell denucleation, leading to cataract	FASEB JOURNAL			English	Article						ubiquitin; cell cycle; endoplasmic reticulum stress; nuclear disassembly	DEPENDENT KINASE INHIBITOR; MOUSE EYE LENS; A-TYPE LAMINS; ENDOPLASMIC-RETICULUM; ER STRESS; PHOSPHORYLATION SITES; UBIQUITIN LIGASE; CDK INHIBITORS; NUCLEAR LAMINA; P27(KIP1)	Failure of lens fiber cell denucleation (LFCD) is associated with congenital cataracts, but the pathobiology awaits elucidation. Recent work has suggested that mechanisms that direct the unidirectional process of LFCD are analogous to the cyclic processes associated with mitosis. We found that lens-specific mutations that elicit an unfolded-protein response (UPR) in vivo accumulate p27(Cdkn1b), show cyclin-dependent kinase (Cdk)-1 inhibition, retain their LFC nuclei, and are cataractous. Although a UPR was not detected in lenses expressing K6W-Ub, they also accumulated p27 and showed failed LFCD. Induction of a UPR in human lens epithelial cells (HLECs) also induced accumulation of p27 associated with decreased levels of S-phase kinase-associated protein (Skp)-2, a ubiquitin ligase that regulates mitosis. These cells also showed decreased lamin A/C phosphorylation and metaphase arrest. The suppression of lamin A/C phosphorylation and metaphase transition induced by the UPR was rescued by knockdown of p27. Taken together, these data indicate that accumulation of p27, whether related to the UPR or not, prevents the phosphorylation of lamin A/C and LFCD in maturing LFCs in vivo, as well as in dividing HLECs. The former leads to cataract and the latter to metaphase arrest. These results suggest that accumulation of p27 is a common mechanism underlying retention of LFC nuclei.	[Lyu, Lei; Du, Linfang] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresource & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China; [Lyu, Lei; Whitcomb, Elizabeth A.; Jiang, Shuhong; Chang, Min-Lee; Gu, Yumei; Shang, Fu; Taylor, Allen] Tufts Univ, Jean Mayer USDA, Human Nutr Res Ctr Aging, Lab Nutr & Vis Res, Boston, MA 02111 USA; [Duncan, Melinda K.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Cvekl, Ales; Wang, Wei-Lin; Limi, Saima] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Reneker, Lixing W.] Univ Missouri, Sch Med, Dept Ophthalmol, Columbia, MO USA	Sichuan University; Tufts University; United States Department of Agriculture (USDA); University of Delaware; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Missouri System; University of Missouri Columbia	Du, LF (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresource & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.; Taylor, A (corresponding author), Tufts Univ, USDA, Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	dulinfang@scu.edu.cn; allen.taylor@tufts.edu	Jiang, Shuhong/C-1596-2019; Jiang, Shuhong/AAQ-7147-2021	Duncan, Melinda/0000-0003-1570-322X; Jiang, Shuhong/0000-0003-3659-5950	U.S. Department of Agriculture, Agricultural Research Service [58-1950-4-003]; U.S. National Institutes of Health, National Eye Institute [EY13250, EY11717]; China Scholarship Council; NATIONAL EYE INSTITUTE [R29EY011717, R01EY013250, R01EY026979, R01EY015279, R01EY011717] Funding Source: NIH RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); China Scholarship Council(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. S. Nagata for providing the DNAse II beta antibody; Dr. P. Gonczy for the gift of the pNUMA antibody; and Dr. S. Rowan, L. Bailey, and Z. Crosser for critical reading and suggestions during the preparation of the manuscript. This work was supported by U.S. Department of Agriculture, Agricultural Research Service Agreement 58-1950-4-003; U.S. National Institutes of Health, National Eye Institute Grants EY13250 and EY11717; and the China Scholarship Council.	Adhikari D, 2012, HUM MOL GENET, V21, P2476, DOI 10.1093/hmg/dds061; Alapure BV, 2012, EXP EYE RES, V102, P28, DOI 10.1016/j.exer.2012.06.004; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLOEMENDAL H, 1977, SCIENCE, V197, P127, DOI 10.1126/science.877544; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen MF, 2011, P NATL ACAD SCI USA, V108, P9119, DOI 10.1073/pnas.1100028108; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Cui XK, 2013, BBA-MOL BASIS DIS, V1832, P1167, DOI 10.1016/j.bbadis.2013.03.007; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; Davidson PM, 2014, TRENDS CELL BIOL, V24, P247, DOI 10.1016/j.tcb.2013.11.004; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Firtina Z, 2011, GENE EXPR PATTERNS, V11, P135, DOI 10.1016/j.gep.2010.10.005; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Francis Peter J, 2004, Curr Opin Ophthalmol, V15, P10, DOI 10.1097/00055735-200402000-00003; FUKUSHI S, 1969, J BIOL CHEM, V244, P2041; Gao CY, 1999, EXP EYE RES, V69, P695, DOI 10.1006/exer.1999.0749; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gonzalez JM, 2011, BIOCHEM SOC T, V39, P1758, DOI 10.1042/BST20110653; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu R, 2008, MOL BIOL CELL, V19, P4602, DOI 10.1091/mbc.E07-11-1137; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kotak S, 2013, EMBO J, V32, P2517, DOI 10.1038/emboj.2013.172; Kotoshiba S, 2014, BBA-MOL CELL RES, V1843, P436, DOI 10.1016/j.bbamcr.2013.11.005; Liu Q, 2006, MOL VIS, V12, P931; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mall M, 2012, J CELL BIOL, V198, P981, DOI 10.1083/jcb.201205103; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Reneker LW, 2011, INVEST OPHTH VIS SCI, V52, P2100, DOI 10.1167/iovs.10-5650; Robinson ML, 1995, DEVELOPMENT, V121, P3959; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Tane S, 2014, BIOCHEM BIOPH RES CO, V443, P1105, DOI 10.1016/j.bbrc.2013.12.109; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang WL, 2010, MOL BIOL CELL, V21, P2453, DOI 10.1091/mbc.E09-12-1031; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U	59	23	23	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1087	1095		10.1096/fj.15-278036	http://dx.doi.org/10.1096/fj.15-278036			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26590164	Green Published			2022-12-28	WOS:000370387800008
J	Brown, RSE; Wyatt, AK; Herbison, RE; Knowles, PJ; Ladyman, SR; Binart, N; Banks, WA; Grattan, DR				Brown, Rosemary S. E.; Wyatt, Amanda K.; Herbison, Ryan E.; Knowles, Penelope J.; Ladyman, Sharon R.; Binart, Nadine; Banks, William A.; Grattan, David R.			Prolactin transport into mouse brain is independent of prolactin receptor	FASEB JOURNAL			English	Article						blood-brain barrier; choroid plexus; lactation	LUTEINIZING-HORMONE SECRETION; IMMUNOREACTIVE PROLACTIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; MESSENGER-RNA; MATERNAL-BEHAVIOR; RAT HYPOTHALAMUS; LH-SECRETION; GENE; EXPRESSION	The anterior pituitary hormone prolactin exerts important physiologic actions in the brain. However, the mechanism by which prolactin crosses the blood-brain barrier and enters the brain is not completely understood. On the basis of high expression of the prolactin receptor in the choroid plexus, it has been hypothesized that the receptor may bind to prolactin in the blood and translocate it into the cerebrospinal fluid (CSF). This study aimed to test this hypothesis by investigating transport of I-125-labeled prolactin (I-125-prolactin) into the brain of female mice in the presence and absence of the prolactin receptor (PRLR-/-). Peripherally administered prolactin rapidly activates brain neurons, as evidenced by prolactin-induced phosphorylation of signal transducer and activator of transcription 5 (pSTAT5) in neurons within 30 min of administration. The transport of prolactin into the brain was saturable, with transport effectively blocked only by a very high dose of unlabeled ovine prolactin. Transport was regulated, as in lactating mice with chronically elevated levels of prolactin, the rate of I-125-prolactin transport into the brain was significantly increased compared to nonlactating controls. There was no change in the rate of I-125-prolactin transport into the brain in PRLR-/- mice lacking functional prolactin receptors compared to control mice, indicating transport is independent of the prolactin receptor. These data suggest that prolactin transport into the brain involves another as yet unidentified transporter molecule. Because CSF levels of I-125-prolactin were very low, even up to 90 min after administration, the data suggest that CSF is not the major route by which blood prolactin gains access to neurons in the brain.	[Brown, Rosemary S. E.; Wyatt, Amanda K.; Herbison, Ryan E.; Knowles, Penelope J.; Ladyman, Sharon R.; Grattan, David R.] Univ Otago, Ctr Neurendocrinol, Dunedin 9054, New Zealand; [Brown, Rosemary S. E.; Wyatt, Amanda K.; Herbison, Ryan E.; Knowles, Penelope J.; Ladyman, Sharon R.; Grattan, David R.] Univ Otago, Dept Anat, Otago Sch Med Sci, Dunedin 9054, New Zealand; [Binart, Nadine] Fac Med Paris Sud, INSERM, U1185, Le Kremlin Bicetre, France; [Banks, William A.] Vet Affairs Puget Sound Hlth Care Ctr, Ctr Geriatr Res Educ & Clin, Seattle, WA USA; [Banks, William A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA	University of Otago; University of Otago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle	Grattan, DR (corresponding author), Univ Otago, Dept Anat, POB 913, Dunedin 9054, New Zealand.	dave.grattan@otago.ac.nz	Binart, Nadine/F-2949-2013; Grattan, David/M-4307-2019; Banks, William A/K-1330-2017	Binart, Nadine/0000-0002-5606-3866; Grattan, David/0000-0001-5606-2559; Banks, William A/0000-0002-0496-3619; wyatt, amanda/0000-0003-1107-3857; Ladyman, Sharon/0000-0003-3578-6763; Brown, Rosemary/0000-0001-6775-3072	Marsden Fund	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by a grant from the Marsden Fund, administered by the Royal Society of New Zealand.	Augustine RA, 2003, J MOL ENDOCRINOL, V31, P221, DOI 10.1677/jme.0.0310221; Bakowska JC, 2003, MOL BRAIN RES, V116, P50, DOI 10.1016/S0169-328X(03)00213-4; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; Balland E, 2014, CELL METAB, V19, P293, DOI 10.1016/j.cmet.2013.12.015; Banks WA, 2003, AM J PHYSIOL-ENDOC M, V285, pE10, DOI 10.1152/ajpendo.00468.2002; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Banks WA, 2012, ENDOCRINOLOGY, V153, P4111, DOI 10.1210/en.2012-1435; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bouilly J, 2012, MOL CELL ENDOCRINOL, V356, P80, DOI 10.1016/j.mce.2011.05.004; BRIDGES RS, 1990, P NATL ACAD SCI USA, V87, P8003, DOI 10.1073/pnas.87.20.8003; BRIDGES RS, 1985, SCIENCE, V227, P782, DOI 10.1126/science.3969568; Brown RSE, 2011, BIOL REPROD, V84, P826, DOI 10.1095/biolreprod.110.089185; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Chang WP, 1996, P NATL ACAD SCI USA, V93, P5947, DOI 10.1073/pnas.93.12.5947; Clapp C., 1994, P NATL ACAD SCI USA, V91, P10384; COHENBECKER IR, 1986, NEUROENDOCRINOLOGY, V42, P328, DOI 10.1159/000124459; DEVITO WJ, 1992, ENDOCRINOLOGY, V131, P2154, DOI 10.1210/en.131.5.2154; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; DEVITO WJ, 1987, NEUROENDOCRINOLOGY, V46, P155, DOI 10.1159/000124813; DEVITO WJ, 1988, NEUROENDOCRINOLOGY, V47, P284, DOI 10.1159/000124926; DUTT A, 1994, NEUROENDOCRINOLOGY, V59, P413, DOI 10.1159/000126686; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; FOX SR, 1987, NEUROENDOCRINOLOGY, V46, P350, DOI 10.1159/000124844; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; FUXE K, 1977, SCIENCE, V196, P899, DOI 10.1126/science.323973; Goupille O, 1997, MOL CELL ENDOCRINOL, V127, P155, DOI 10.1016/S0303-7207(97)04005-7; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Grattan DR, 2015, J ENDOCRINOL, V226, pT101, DOI 10.1530/JOE-15-0213; GRATTAN DR, 1994, J ENDOCRINOL, V143, P165, DOI 10.1677/joe.0.1430165; Grattan DR, 2001, ENDOCRINOLOGY, V142, P3935, DOI 10.1210/en.142.9.3935; Halperin J, 2008, MOL ENDOCRINOL, V22, P513, DOI 10.1210/me.2007-0399; Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Langlet F, 2013, CELL METAB, V17, P607, DOI 10.1016/j.cmet.2013.03.004; Lerant A, 2001, BRAIN RES, V904, P259, DOI 10.1016/S0006-8993(01)02470-2; LESUEUR L, 1991, P NATL ACAD SCI USA, V88, P824, DOI 10.1073/pnas.88.3.824; LOGIN IS, 1977, BRAIN RES, V132, P477, DOI 10.1016/0006-8993(77)90196-2; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; NICHOLSON G, 1980, BRAIN RES, V190, P447, DOI 10.1016/0006-8993(80)90287-5; NOEL MB, 1993, PHYSIOL BEHAV, V54, P151, DOI 10.1016/0031-9384(93)90057-M; ONEAL KD, 1994, J BIOL CHEM, V269, P26076; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; PARK SK, 1991, NEUROENDOCRINOLOGY, V53, P404, DOI 10.1159/000125748; Pi XJ, 1998, MOL BRAIN RES, V59, P1, DOI 10.1016/S0169-328X(98)00109-0; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; Sapsford TJ, 2012, J COMP NEUROL, V520, P1062, DOI 10.1002/cne.22775; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Schuler LA, 1997, ENDOCRINOLOGY, V138, P3187, DOI 10.1210/en.138.8.3187; SHIVERS BD, 1989, NEUROENDOCRINOLOGY, V49, P23, DOI 10.1159/000125086; Tabata H, 2012, J MOL ENDOCRINOL, V48, P169, DOI 10.1530/JME-11-0122; WALSH RJ, 1990, J ANAT, V168, P137; WALSH RJ, 1978, SCIENCE, V201, P1041, DOI 10.1126/science.684427; WALSH RJ, 1987, ENDOCRINOLOGY, V120, P1846, DOI 10.1210/endo-120-5-1846; Yip SH, 2012, J NEUROENDOCRINOL, V24, P1484, DOI 10.1111/j.1365-2826.2012.02357.x	57	48	49	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					1002	1010		10.1096/fj.15-276519	http://dx.doi.org/10.1096/fj.15-276519			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26567005				2022-12-28	WOS:000369391900046
J	Thompson, CL; Wiles, A; Poole, CA; Knight, MM				Thompson, Clare L.; Wiles, Anna; Poole, C. Anthony; Knight, Martin M.			Lithium chloride modulates chondrocyte primary cilia and inhibits Hedgehog signaling	FASEB JOURNAL			English	Article						cilia length; osteoarthritis; Arl13b	INTRAFLAGELLAR TRANSPORT; ARTICULAR-CARTILAGE; FLAGELLAR LENGTH; INDIAN HEDGEHOG; ALPHA-TUBULIN; UP-REGULATION; PROTEIN; DEGRADATION; MECHANISM; PATHWAY	Lithium chloride (LiCl) exhibits significant therapeutic potential as a treatment for osteoarthritis. Hedgehog signaling is activated in osteoarthritis, where it promotes chondrocyte hypertrophy and cartilage matrix catabolism. Hedgehog signaling requires the primary cilium such that maintenance of this compartment is essential for pathway activity. Here we report that LiCl (50 mM) inhibits Hedgehog signaling in bovine articular chondrocytes such that the induction of GLI1 and PTCH1 expression is reduced by 71 and 55%, respectively. Pathway inhibition is associated with a 97% increase in primary cilia length from 2.09 +/- 0.7 mu m in untreated cells to 4.06 +/- 0.9 mu m in LiCl-treated cells. We show that cilia elongation disrupts trafficking within the axoneme with a 38% reduction in Arl13b ciliary localization at the distal region of the cilium, consistent with the role of Arl13b in modulating Hedgehog signaling. In addition, we demonstrate similar increases in cilia length in human chondrocytes in vitro and after administration of dietary lithium to Wistar rats in vivo. Our data provide new insights into the effects of LiCl on chondrocyte primary cilia and Hedgehog signaling and shows for the first time that pharmaceutical targeting of the primary cilium may have therapeutic benefits in the treatment of osteoarthritis.	[Thompson, Clare L.; Knight, Martin M.] Queen Mary Univ London, Sch Engn & Mat Sci, Inst Bioengn, London, England; [Wiles, Anna; Poole, C. Anthony] Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	University of London; Queen Mary University London; University of Otago	Thompson, CL (corresponding author), Queen Mary Univ London, Sch Engn & Mat Sci, London E1 4NS, England.	clare.l.thompson@qmul.ac.uk	Thompson, Clare/AAD-9583-2021	Knight, Martin/0000-0003-3755-1597	AO Foundation [S-12-15K]; Medical Research Council (Swindon, United Kingdom) [MR/L002876/1]; Royal Society of New Zealand; MRC [MR/L002876/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [E17114] Funding Source: researchfish; Medical Research Council [MR/L002876/1] Funding Source: researchfish	AO Foundation; Medical Research Council (Swindon, United Kingdom); Royal Society of New Zealand(Royal Society of New Zealand); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by funding from the AO Foundation (project S-12-15K) and the Medical Research Council (Swindon, United Kingdom) (MR/L002876/1). C.A.P. was supported by the Royal Society of New Zealand through a James Cook Research Fellowship. We are grateful to Humphreys and Sons for supplying the bovine forefeet. The authors thank G. Davis and team (University of Otago) who conducted the animal studies.	Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Blair HJ, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-14; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chowdhury T. T., 2001, BIOCHEM BIOPH RES CO, V285, P1168; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cruz C, 2010, DEVELOPMENT, V137, P4271, DOI 10.1242/dev.051714; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Farnum CE, 2011, ANAT REC, V294, P533, DOI 10.1002/ar.21330; Forty L, 2014, BRIT J PSYCHIAT, V205, P465, DOI 10.1192/bjp.bp.114.152249; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Goodwin FK, 1999, AUST NZ J PSYCHIAT, V33, pS54, DOI 10.1111/j.1440-1614.1999.00669.x; Haycraft C. J., 2005, PLOS GENET, V1, pe53, DOI DOI 10.1371/JOURNAL.PGEN.0010053; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Hsu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107512; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hui W, 2010, RHEUMATOLOGY, V49, P2043, DOI 10.1093/rheumatology/keq217; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Keady BT, 2012, DEV CELL, V22, P940, DOI 10.1016/j.devcel.2012.04.009; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lenox RH, 2000, J CLIN PSYCHIAT, V61, P5; Li R, 2015, J PHARM PHARMACOL, V67, P963, DOI 10.1111/jphp.12379; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Litherland GJ, 2014, ARTHRITIS RHEUMATOL, V66, P2175, DOI 10.1002/art.38681; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Ludington WB, 2013, P NATL ACAD SCI USA, V110, P3925, DOI 10.1073/pnas.1217354110; Mahjoub MR, 2012, CURR BIOL, V22, P1628, DOI 10.1016/j.cub.2012.06.057; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; McGlashan SR, 2008, DEV DYNAM, V237, P2013, DOI 10.1002/dvdy.21501; McGlashan SR, 2007, MATRIX BIOL, V26, P234, DOI 10.1016/j.matbio.2006.12.003; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Minashima T, 2014, ARTHRITIS RHEUMATOL, V66, P1228, DOI 10.1002/art.38373; Miyoshi K, 2009, BIOCHEM BIOPH RES CO, V388, P757, DOI 10.1016/j.bbrc.2009.08.099; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nakakura T, 2015, MED MOL MORPHOL, V48, P44, DOI 10.1007/s00795-014-0076-x; NAKAMURA S, 1987, CELL STRUCT FUNCT, V12, P369, DOI 10.1247/csf.12.369; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048773; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Peng ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061457; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Poole CA, 2001, J ANAT, V199, P393, DOI 10.1046/j.1469-7580.2001.19940393.x; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Thompson CL, 2014, OSTEOARTHR CARTILAGE, V22, P490, DOI 10.1016/j.joca.2013.12.016; Thompson CL, 2015, J ORTHOP RES, V33, P1552, DOI 10.1002/jor.22913; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Vuolo L, 2015, J CELL SCI, V128, P2928, DOI 10.1242/jcs.172635; Wann AKT, 2014, CELL SIGNAL, V26, P1735, DOI 10.1016/j.cellsig.2014.04.004; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Williams RSB, 2000, TRENDS PHARMACOL SCI, V21, P61, DOI 10.1016/S0165-6147(99)01428-5; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Zhang CM, 2014, INT J MOL SCI, V15, P7250, DOI 10.3390/ijms15057250; Zhou JM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4437; Zinke J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0294-4	71	35	36	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					716	726		10.1096/fj.15-274944	http://dx.doi.org/10.1096/fj.15-274944			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26499268	Green Published, hybrid			2022-12-28	WOS:000369391900022
J	Zhang, ZZ; Liu, L; Wu, SN; Xing, D				Zhang, Zhenzhen; Liu, Lei; Wu, Shengnan; Xing, Da			Drp1, Mff, Fis1, and MiD51 are coordinated to mediate mitochondrial fission during UV irradiation-induced apoptosis	FASEB JOURNAL			English	Article						MIEF1; mitochondrial fragmentation; GTP-binding; oligomerization; Bax	BAX; FUSION; RECRUITMENT; DYNAMICS; MID49; PHOSPHORYLATION; TRANSLOCATION; ASSOCIATION; INHIBITION; ACTIVATION	Mitochondrial fission and proteins vital to this process play essential roles in apoptosis. Several mitochondrial outer membrane proteins, including mitochondrial fission protein 1 (Fis1), mitochondrial fission factor (Mff) and mitochondrial dynamics of 51 kDa protein (MiD51), also known as mitochondrial elongation factor 1 (MEIF1), have been reported to promote mitochondrial fission by recruiting the GTPase dynamin-related protein 1 (Drp1). However, it remains unclear how these fission factors coordinate to control apoptotic mitochondrial fission. Molecular studies have suggested the existence of interaction between Mff and Drp1, but fundamental questions remain concerning their function. In the present study, we reported that the phosphorylation status of Drp1-Ser(637) was essential for its interaction with Mff. UV stimulation induced a decrease in cytoplasmic and mitochondrial Drp1 phosphorylation on Ser(637) and enhanced the interaction between Drp1 and Mff, resulting in mitochondrial fragmentation. Simultaneously, the interaction increased markedly between Fis1 and MiD51/MIEF1, whereas the interaction between Drp1 and MiD51/MIEF1 decreased significantly after UV irradiation, which suggests that Fis1 competitively binds to MiD51/MIEF1 to activate Drp1 indirectly. Moreover, Mff-Drp1 binding and Mff-mediated recruitment of Drp1 to mitochondria did not require Bax during UV stimulation. Our study revealed a novel role of Mff in regulation of mitochondrial fission and showed how the fission proteins are orchestrated to mediate the fission process during apoptosis.	S China Normal Univ, Minist Educ, Key Lab Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China; S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China	South China Normal University; South China Normal University	Xing, D (corresponding author), S China Normal Univ, Coll Biophoton, Guangzhou 510631, Guangdong, Peoples R China.	xingda@scnu.edu.cn		Zhang, Zhenzhen/0000-0002-9885-7453	National Basic Research Program of China [2011CB910402, 2010CB732602]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0829]; National Natural Science Foundation of China [81101741, 31101028]	National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. Y. Gotoh (University of Tokyo, Yayoi, Tokyo, Japan) for the pDsRed-Mit plasmid; Dr. A. M. van der Bliek (David Geffen School of Medicine at University of California, Los Angeles) for the pHA-Drp1 and pMyc-Mff plasmids; Dr. J.-C. Martinou (University of Geneva) for the pHis-hFis1 plasmid; Dr. L. Scorrano (University of Geneva Medical School) for Drp1-Ser637A-YFP and Drp1-Ser637D-YFP; and Dr. R.J. Youle (U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke) for the pGFP-Bax plasmid. This research is supported by Grants 2011CB910402 and 2010CB732602 from the National Basic Research Program of China, Grant IRT0829 from the Program for Changjiang Scholars and Innovative Research Team in University, and Grants 81101741 and 31101028 from the National Natural Science Foundation of China. The authors declare no conflicts of interest.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Loson OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wang XW, 2009, FEBS LETT, V583, P1873, DOI 10.1016/j.febslet.2009.04.045; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wu SN, 2011, J CELL PHYSIOL, V226, P530, DOI 10.1002/jcp.22362; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang YJ, 2009, MOL BIOL CELL, V20, P3077, DOI 10.1091/mbc.E08-11-1109; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	45	70	81	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					466	476		10.1096/fj.15-274258	http://dx.doi.org/10.1096/fj.15-274258			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26432782				2022-12-28	WOS:000367621000043
J	Adada, MM; Canals, D; Jeong, N; Kelkar, AD; Hernandez-Corbacho, M; Pulkoski-Gross, MJ; Donaldson, JC; Hannun, YA; Obeid, LM				Adada, Mohamad M.; Canals, Daniel; Jeong, Nara; Kelkar, Ashwin D.; Hernandez-Corbacho, Maria; Pulkoski-Gross, Michael J.; Donaldson, Jane C.; Hannun, Yusuf A.; Obeid, Lina M.			Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth facetor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion	FASEB JOURNAL			English	Article						Spns2; cell adhesion; alkaline ceramidase 2	ERM PROTEINS; SPHINGOLIPID METABOLISM; PLASMA-MEMBRANE; RECEPTOR; MIGRATION; 1-PHOSPHATE; ACTIVATION; TRANSLOCATION; INHIBITOR; CARCINOMA	The bioactive sphingolipid sphingosine-1-phosphate (S1P) mediates cellular proliferation, mitogenesis, inflammation, and angiogenesis. These biologies are mediated through S1P binding to specific GPCRs [sphingosine-1-phosphate receptor (S1PR)1-5] and some other less well-characterized intracellular targets. Ezrinradixin- moesin (ERM) proteins, a family of adaptor molecules linking the cortical actin cytoskeleton to the plasma membrane, are emerging as critical regulators of cancer invasion via regulation of cell morphology and motility. Recently, we identified S1P as an acute ERM activator (via phosphorylation) through its action on S1PR2. In this work, we dissect the mechanism of S1P generation downstream of epidermal growth factor (EGF) leading to ERM phosphorylation and cancer invasion. Using pharmacologic inhibitors, small interfering RNA technologies, and genetic approaches, we demonstrate that sphingosine kinase (SK) 2, and not SK1, is essential and sufficient in EGF-mediated ERM phosphorylation in HeLa cells. In fact, knocking down SK2 decreased ERM activation 2.5-fold. Furthermore, we provide evidence that SK2 is necessary to mediate EGF-induced invasion. In addition, overexpressing SK2 causes a 2-fold increase in HeLa cell invasion. Surprisingly, and for the first time, we find that this event, although dependent on S1PR2 activation, does not generate and does not require extracellular S1P secretion, therefore introducing a potential novel model of autocrine/intracrine action of S1P that still involves its GPCRs. These results define new mechanistic insights for EGF-mediated invasion and novel actions of SK2, therefore setting the stage for novel targets in the treatment of growth factor-driven malignancies.	[Adada, Mohamad M.; Canals, Daniel; Jeong, Nara; Kelkar, Ashwin D.; Hernandez-Corbacho, Maria; Pulkoski-Gross, Michael J.; Donaldson, Jane C.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11784 USA; [Adada, Mohamad M.; Canals, Daniel; Jeong, Nara; Kelkar, Ashwin D.; Hernandez-Corbacho, Maria; Pulkoski-Gross, Michael J.; Donaldson, Jane C.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11784 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, North Port, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Obeid, LM (corresponding author), SUNY Stony Brook, Dept Med, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11784 USA.	lina.obeid@stonybrookmedicine.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021	Canals, Daniel/0000-0002-9293-5123; Pulkoski-Gross, Michael/0000-0003-4644-1795; Adada, Mohamad/0000-0002-2988-2081	U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health [GM097741, PO1CA097132]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518, R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank all the members of the Lipid Cancer Lab for their comments during data presentation. The authors also thank Mrs. Janet Allopenna for her help in tagging the WT sphingosine kinase 2 construct with the MYC tag, and Lpath for the generous gift of the Sphingomab antibody. The Sphingomab antibody was obtained through a material transfer agreement between LPath Inc. (San Diego, CA, USA) and the Research Foundation for the State University of New York. The authors also thank Dr. Cungui Mao and Ms. Ruijuan Xu for their generous gift of the ACER2 DNA construct, as well as the HeLa cells stably overexpressing ACER2. This work was supported by a U.S. Veterans Affairs Merit Award and U.S. National Institutes of Health Grants GM097741 (National Institute of General Medical Sciences) and PO1CA097132 (National Cancer Institute) all to L.M.O. M.M.A., D.C., Y.A.H., and L.M.O. participated in research design. M.M.A. and D.C. prepared the analytic tools. M.M.A., D.C., N.J., M.J.P.-G., M.H.-C., and A.D.K. conducted the experiments. M.M.A., D.C., Y.A.H., and L.M.O. wrote or contributed to the writing of the manuscript. The authors declare no conflicts of interest.	Adada M, 2014, BBA-MOL CELL BIOL L, V1841, P727, DOI 10.1016/j.bbalip.2013.07.002; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Beljanski V, 2011, INVEST NEW DRUG, V29, P1132, DOI 10.1007/s10637-010-9452-0; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Bradley E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110119; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Don AS, 2009, BIOCHEM BIOPH RES CO, V380, P87, DOI 10.1016/j.bbrc.2009.01.075; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Fukuhara Shigetomo, 2013, Seikagaku, V85, P269; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044543; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2002, FEBS LETT, V532, P97, DOI 10.1016/S0014-5793(02)03636-0; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hisano Y, 2013, BIOL OPEN, V2, P789, DOI 10.1242/bio.20134994; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lai WQ, 2009, J IMMUNOL, V183, P2097, DOI 10.4049/jimmunol.0804376; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Maines Lynn W., 2010, Inflammopharmacology, V18, P73, DOI 10.1007/s10787-010-0032-x; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; O'Sullivan C, 2013, TRENDS PHARMACOL SCI, V34, P401, DOI 10.1016/j.tips.2013.05.002; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Sun DF, 2012, CANCER LETT, V319, P182, DOI 10.1016/j.canlet.2012.01.012; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Waters D, 2006, FASEB J, V20, pA1058; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	61	52	56	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4654	4669		10.1096/fj.15-274340	http://dx.doi.org/10.1096/fj.15-274340			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26209696	Green Published			2022-12-28	WOS:000364514700023
J	Alawi, KM; Aubdool, AA; Liang, LH; Wilde, E; Vepa, A; Psefteli, MP; Brain, SD; Keeble, JE				Alawi, Khadija M.; Aubdool, Aisah A.; Liang, Lihuan; Wilde, Elena; Vepa, Abhinav; Psefteli, Maria-Paraskevi; Brain, Susan D.; Keeble, Julie E.			The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature	FASEB JOURNAL			English	Article						TRPV1; thermogenesis; brown adipose tissue	BROWN ADIPOSE-TISSUE; ADRENERGIC-RECEPTOR; CAPSAICIN RECEPTOR; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; ADAPTIVE THERMOGENESIS; INFLAMMATORY RESPONSE; TRPV1 ANTAGONIST; THYROID-HORMONE; COLD-EXPOSURE; D-AMPHETAMINE	Transient receptor potential vanilloid 1 (TRPV1) is involved in sensory nerve nociceptive signaling. Recently, it has been discovered that TRPV1 receptors also regulate basal body temperature in multiple species from mice to humans. In the present study, we investigated whether TRPV1 modulates basal sympathetic nervous system (SNS) activity. C57BL6/J wild-type (WT) mice and TRPV1 knockout (KO) mice were implanted with radiotelemetry probes for measurement of core body temperature. AMG9810 (50 mg/kg) or vehicle (2% DMSO/5% Tween 80/10 ml/kg saline) was injected intraperitoneally. Adrenoceptor antagonists or vehicle (5 ml/kg saline) was injected subcutaneously. In WT mice, the TRPV1 antagonist, AMG9810, caused significant hyperthermia, associated with increased noradrenaline concentrations in brown adipose tissue. The hyperthermia was significantly attenuated by the beta-adrenoceptor antagonist propranolol, the mixed alpha- /beta-adrenoceptor antagonist labetalol, and the alpha(1)-adrenoceptor antagonist prazosin. TRPV1 KO mice have a normal basal body temperature, indicative of developmental compensation. D-Amphetamine (potent sympathomimetic) caused hyperthermia in WT mice, which was reduced in TRPV1 KO mice, suggesting a decreased sympathetic drive in KOs. This study provides new evidence that TRPV1 controls thermoregulation upstream of the SNS, providing a potential therapeutic target for sympathetic hyperactivity thermoregulatory disorders.	[Alawi, Khadija M.; Vepa, Abhinav; Psefteli, Maria-Paraskevi; Keeble, Julie E.] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Alawi, Khadija M.; Aubdool, Aisah A.; Liang, Lihuan; Wilde, Elena; Brain, Susan D.] Kings Coll London, British Heart Fdn, Cardiovasc Ctr Excellence, London SE1 9NH, England; [Alawi, Khadija M.; Aubdool, Aisah A.; Liang, Lihuan; Wilde, Elena; Brain, Susan D.] Kings Coll London, Ctr Integrat Biomed, Cardiovasc Div, London SE1 9NH, England	University of London; King's College London; University of London; King's College London; University College London; University of London; King's College London	Keeble, JE (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Franklin Wilins Bldg,150 Stamford St, London SE1 9NH, England.	julie.keeble@kcl.ac.uk		Brain, Susan/0000-0002-9684-8342; PSEFTELI, PARASKEVI-MARIA/0000-0001-8892-3800; Aubdool, Dr. Aisah/0000-0002-4712-9421; Keeble, Julie/0000-0002-8891-1129; Vepa, Abhinav/0000-0001-5858-1109	Medical Research Council; Biotechnology and Biological Sciences Research Council Capacity Building Award in Integrative Mammalian Biology; British Heart Foundation; National Centre for Replacement, Reduction, and Refinement; Versus Arthritis [20264, 19296] Funding Source: researchfish; National Centre for the Replacement [NC/K001531/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council Capacity Building Award in Integrative Mammalian Biology(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); National Centre for Replacement, Reduction, and Refinement; Versus Arthritis(Versus Arthritis); National Centre for the Replacement	K.M.A. was supported by the Medical Research Council. A. A. A., J.E.K., and L.L. were supported by a Biotechnology and Biological Sciences Research Council Capacity Building Award in Integrative Mammalian Biology. A. A. A. was further supported by the British Heart Foundation. E.W. was supported by the National Centre for Replacement, Reduction, and Refinement.	Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bankson MG, 2001, J PHARMACOL EXP THER, V297, P846; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bexis S, 2008, BRIT J PHARMACOL, V153, P591, DOI 10.1038/sj.bjp.0707590; Bexis S, 2009, BRIT J PHARMACOL, V158, P259, DOI 10.1111/j.1476-5381.2009.00186.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carvalho F, 2001, ARCH TOXICOL, V75, P465, DOI 10.1007/s002040100264; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen BY, 2012, FASEB J, V26, P2531, DOI 10.1096/fj.11-199505; Connor TJ, 2004, IMMUNOLOGY, V111, P357, DOI 10.1111/j.0019-2805.2004.01847.x; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Darracq L, 1998, J NEUROSCI, V18, P2729; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Docherty JR, 2010, BRIT J PHARMACOL, V160, P1029, DOI 10.1111/j.1476-5381.2010.00722.x; FABER JE, 1988, CIRC RES, V62, P37, DOI 10.1161/01.RES.62.1.37; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; FoellmiAdams LA, 1996, BIOCHEM PHARMACOL, V52, P693, DOI 10.1016/0006-2952(96)00345-0; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; GULATI N, 1980, ARCH INT PHARMACOD T, V246, P251; GULATI OP, 1980, ARCH INT PHARMACOD T, V243, P255; Honore P, 2009, PAIN, V142, P27, DOI 10.1016/j.pain.2008.11.004; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lowell BB, 1997, ANNU REV MED, V48, P307; Marshall NJ, 2013, HYPERTENSION, V61, P246, DOI 10.1161/HYPERTENSIONAHA.112.201434; Mills EM, 2003, NATURE, V426, P403, DOI 10.1038/426403a; MILNER RE, 1989, AM J PHYSIOL, V256, pR42, DOI 10.1152/ajpregu.1989.256.1.R42; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; MOELLER H, 1964, Nature, V201, P1233; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; RIVA E, 1991, BRIT J PHARMACOL, V104, P823, DOI 10.1111/j.1476-5381.1991.tb12513.x; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; RUBIO A, 1995, ENDOCRINOLOGY, V136, P3267, DOI 10.1210/en.136.8.3267; RUBIO A, 1995, ENDOCRINOLOGY, V136, P3277, DOI 10.1210/en.136.8.3277; Ryu V, 2015, J NEUROSCI, V35, P2181, DOI 10.1523/JNEUROSCI.3306-14.2015; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Schmidt LS, 2010, PSYCHOPHARMACOLOGY, V207, P547, DOI 10.1007/s00213-009-1685-2; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Steiner AA, 2007, J NEUROSCI, V27, P7459, DOI 10.1523/JNEUROSCI.1483-07.2007; Tamayo N, 2008, J MED CHEM, V51, P2744, DOI 10.1021/jm7014638; TARIQ M, 1989, LIFE SCI, V44, P951, DOI 10.1016/0024-3205(89)90494-3; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tuominen JA, 1996, J INTERN MED, V239, P399, DOI 10.1046/j.1365-2796.1996.473824000.x; Ueta CB, 2012, J ENDOCRINOL, V214, P359, DOI 10.1530/JOE-12-0155; Westermann Jurgen, 2002, Clin Lab, V48, P61; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAMAHARA J, 1985, J PHARMACOBIO-DYNAM, V8, P591; Yamashita H, 2008, J BIOCHEM, V143, P385, DOI 10.1093/jb/mvm233; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541	58	44	46	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4285	4298		10.1096/fj.15-272526	http://dx.doi.org/10.1096/fj.15-272526			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26136480	hybrid, Green Published			2022-12-28	WOS:000361367300018
J	Zhou, C; Yang, GD; Chen, M; He, L; Xiang, LS; Ricupero, C; Mao, JJ; Ling, JQ				Zhou, Chen; Yang, Guodong; Chen, Mo; He, Ling; Xiang, Lusai; Ricupero, Christopher; Mao, Jeremy J.; Ling, Junqi			Lhx6 and Lhx8: cell fate regulators and beyond	FASEB JOURNAL			English	Review						LIM homeobox genes; neurogenesis; tooth development; palatogenesis; transcriptional regulation	LIM-HOMEOBOX GENE; FOREBRAIN CHOLINERGIC NEURONS; HOMEODOMAIN TRANSCRIPTION FACTORS; POTENTIAL TUMOR-SUPPRESSOR; PREMATURE OVARIAN FAILURE; 1ST BRANCHIAL ARCH; MOTOR-NEURON; BASAL FOREBRAIN; CLEFT-PALATE; STEM-CELLS	As transcription factors of the lines (LIN)-11/Islet (Isl)-1/mitosis entry checkpoint (MEC)-3 (LIM)-homeobox subfamily, LIM homeobox (Lhx) 6 and -8 are remarkably conserved and involved in the morphogenesis of multiple organ systems. Lhx6 and -8 play overlapping and distinctive roles, but in general act as cell fate mediators and in turn are regulated by several transcriptional factors, such as sonic hedgehog, fibroblast growth factors, and wingless-int (Wnt)/beta-catenin. In this review, we first summarize Lhx6 and -8 distributions in development and then explore how Lhx6 and -8 act as transcription factors and coregulators of cell lineage specification. Known Lhx6 and -8 functions and targets are outlined in neurogenesis, craniofacial development, and germ cell differentiation. The underlying mechanisms of Lhx6 and -8 in regulating cell fate remain elusive. Whether Lhx6 and -8 affect functions in tissues and organs other than neural, craniofacial, oocytes, and germ cells is largely unexplored. Taken together, Lhx6 and -8 are important regulators of cell lineage specification and may act as one of the pivotal mediators of stem cell fate. Undoubtedly, future investigations of Lhx6 and -8 biologywill continue to yield fascinating insights into tissue development and homeostasis, in addition to their putative roles in tissue regeneration and ageing.	[Zhou, Chen; Yang, Guodong; Chen, Mo; He, Ling; Xiang, Lusai; Ricupero, Christopher; Mao, Jeremy J.] Columbia Univ, Med Ctr, Ctr Craniofacial Regenerat, New York, NY 10032 USA; [Zhou, Chen; He, Ling; Xiang, Lusai; Ling, Junqi] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Chen; He, Ling; Xiang, Lusai; Ling, Junqi] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China	Columbia University; Sun Yat Sen University; Sun Yat Sen University	Mao, JJ (corresponding author), Columbia Univ, Med Ctr, 630 W 168 St,PH7E CDM, New York, NY 10032 USA.	jmao@columbia.edu; lingjq@mail.sysu.edu.cn	He, Ling/J-9078-2019	He, Ling/0000-0002-8692-7530	U.S. National Institutes of Health (NIH) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR065023]; U.S. NIH from the National Institute of Dental Research (NIDR) [R01DE023112]; Guangdong Pioneer Grant [52000-3210002]; NIDR [NIH/K12DE023583]; National Natural Science Foundation of China [81170932]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023112, K12DE023583] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; U.S. NIH from the National Institute of Dental Research (NIDR); Guangdong Pioneer Grant; NIDR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank R. Birdie, Q. Guo, and J. Melendez (Center for Craniofacial Regeneration, Columbia University Medical Center, New York, NY, USA) for administrative and technical assistance. This article was supported by U.S. National Institutes of Health (NIH) Grant R01AR065023 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, U.S. NIH Grant R01DE023112 from the National Institute of Dental Research (NIDR), and Guangdong Pioneer Grant (52000-3210002) (to J.J.M.); NIDR Grant NIH/K12DE023583 (to M.C.); and National Natural Science Foundation of China Grant 81170932 (to J.L.).	Abellan A, 2009, J COMP NEUROL, V515, P465, DOI 10.1002/cne.22083; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Asbreuk CHJ, 2002, NEUROSCIENCE, V109, P287, DOI 10.1016/S0306-4522(01)00466-3; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bachy I, 2006, DEV BIOL, V291, P218, DOI 10.1016/j.ydbio.2005.10.023; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Boncinelli E, 1997, CURR OPIN GENET DEV, V7, P331, DOI 10.1016/S0959-437X(97)80146-3; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Cho HH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004280; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Choi YS, 2007, BIOL REPROD, P91; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Denaxa M, 2009, DEV BIOL, V333, P324, DOI 10.1016/j.ydbio.2009.07.001; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Elshatory Y, 2008, J NEUROSCI, V28, P3291, DOI 10.1523/JNEUROSCI.5730-07.2008; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Estecio MRH, 2006, ONCOGENE, V25, P5018, DOI 10.1038/sj.onc.1209509; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; Garcia-Lopez M, 2008, J COMP NEUROL, V506, P46, DOI 10.1002/cne.21524; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Inoue M, 2006, ANAT EMBRYOL, V211, P247, DOI 10.1007/s00429-006-0078-0; Jagarlamudi K, 2012, MOL CELL ENDOCRINOL, V356, P31, DOI 10.1016/j.mce.2011.07.049; Jeon S, 2010, GENES GENOM, V32, P397, DOI 10.1007/s13258-010-0008-7; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jung S, 2011, INT J ONCOL, V38, P859, DOI 10.3892/ijo.2011.904; Jung S, 2010, ONCOL REP, V23, P1675, DOI 10.3892/or_00000811; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Kikuchi Y, 1997, NEURON, V18, P369, DOI 10.1016/S0896-6273(00)81239-8; Kim JY, 2011, J ORAL PATHOL MED, V40, P250, DOI 10.1111/j.1600-0714.2010.00970.x; Kitanaka JI, 1998, GENOMICS, V49, P307, DOI 10.1006/geno.1998.5203; Landin Malt A., 2014, J BIOL CHEM, V289, P30289, DOI DOI 10.1074/JBC.M114.592014; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Liu W. B., CELL DEATH DIS, V4, pe882; Liu WB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.366; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Manabe T, 2007, CELL DEATH DIFFER, V14, P1080, DOI 10.1038/sj.cdd.4402106; Manabe T, 2005, J NEUROCHEM, V94, P723, DOI 10.1111/j.1471-4159.2005.03261.x; Manabe T, 2008, INT J DEV NEUROSCI, V26, P249, DOI 10.1016/j.ijdevneu.2007.11.004; Mandler M, 2001, DEV BIOL, V240, P548, DOI 10.1006/dbio.2001.0490; Mao JJ, 2012, CELL STEM CELL, V11, P291, DOI 10.1016/j.stem.2012.08.010; Marin O, 2000, J NEUROSCI, V20, P6063; Matsumoto K, 1996, NEUROSCI LETT, V204, P113, DOI 10.1016/0304-3940(96)12341-7; Matsumoto K, 1996, NEUROSCI LETT, V211, P147, DOI 10.1016/0304-3940(96)12749-X; Matsumura K, 2011, BIOCHEM BIOPH RES CO, V404, P1076, DOI 10.1016/j.bbrc.2010.12.116; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; MITCHELL LE, 1995, AM J HUM GENET, V57, P1130; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Neves G, 2013, CEREB CORTEX, V23, P1811, DOI 10.1093/cercor/bhs159; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Priam F, 2005, ARCH ORAL BIOL, V50, P271, DOI 10.1016/j.archoralbio.2004.10.007; Qin YY, 2008, FERTIL STERIL, V89, P1012, DOI 10.1016/j.fertnstert.2007.04.017; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Scheele C, 2014, ADIPOCYTE, V3, P54, DOI 10.4161/adip.26520; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Shi JH, 2012, IN VITRO CELL DEV-AN, V48, P603, DOI 10.1007/s11626-012-9562-4; Shibaguchi T, 2003, ARCH HISTOL CYTOL, V66, P95, DOI 10.1679/aohc.66.95; Suzumori N, 2007, CURR MED CHEM, V14, P353, DOI 10.2174/092986707779941087; TAIRA M, 1995, TRENDS GENET, V11, P431, DOI 10.1016/S0168-9525(00)89139-8; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Tucker AS, 1999, DEVELOPMENT, V126, P51; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0; Vogt D, 2014, NEURON, V82, P350, DOI 10.1016/j.neuron.2014.02.030; Walden TB, 2010, BIOCHEM BIOPH RES CO, V397, P146, DOI 10.1016/j.bbrc.2010.05.053; Wanaka A, 1997, DEV NEUROSCI-BASEL, V19, P97, DOI 10.1159/000111191; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Wu L, 2008, CELLS TISSUES ORGANS, V187, P103, DOI 10.1159/000110079; Xiang LN, 2014, STEM CELL RES THER, V5, DOI [10.1186/scrt473, 10.1186/scrt525]; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; Zhang LJ, 2012, GENE, V506, P1, DOI 10.1016/j.gene.2012.06.093; Zhang Y, 2002, Orthod Craniofac Res, V5, P65, DOI 10.1034/j.1600-0544.2002.02198.x; Zhang ZC, 2013, J BIOL CHEM, V288, P2485, DOI 10.1074/jbc.M112.402933; Zhao YG, 2014, DEV BIOL, V385, P94, DOI 10.1016/j.ydbio.2013.10.010; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002; Zhu F., 2008, SICHUAN DA XUE XUE B, V39, P297; Zhu Feng, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P286; Zirzow S, 2009, DEV BIOL, V336, P145, DOI 10.1016/j.ydbio.2009.09.020	101	24	24	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4083	4091		10.1096/fj.14-267500	http://dx.doi.org/10.1096/fj.14-267500			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148970	Green Published			2022-12-28	WOS:000361367300001
J	Billet, A; Jia, YL; Jensen, T; Riordan, JR; Hanrahan, JW				Billet, Arnaud; Jia, Yanlin; Jensen, Tim; Riordan, John R.; Hanrahan, John W.			Regulation of the cystic fibrosis transmembrane conductance regulator anion channel by tyrosine phosphorylation	FASEB JOURNAL			English	Article						Src; Pyk2; R domain	PROTEIN-KINASE-A; NUCLEOTIDE-BINDING DOMAIN; CFTR CHLORIDE CHANNEL; R-DOMAIN; PSEUDOMONAS-AERUGINOSA; ATP HYDROLYSIS; CL-CHANNEL; ACTIVATION; CELLS; SITES	The cystic fibrosis transmembrane conductance regulator (CFTR) channel is activated by PKA phosphorylation of a regulatory domain that interacts dynamically with multiple CFTR domains and with other proteins. The large number of consensus sequences for phosphorylation by PKA has naturally focused most attention on regulation by this kinase. We report here that human CFTR is also phosphorylated by the tyrosine kinases p60c-Src (proto-oncogene tyrosine-protein kinase) and the proline-rich tyrosine kinase 2 (Pyk2), and they can also cause robust activation of quiescent CFTR channels. In excised patch-clamp experiments, CFTR activity during exposure to Src or Pyk2 reached similar to 80% of that stimulated by PKA. Exposure to PKA after Src or Pyk2 caused a further increase to the level induced by PKA alone, implying a common limiting step. Channels became spontaneously active when v-Src or the catalytic domain of Pyk2 was coexpressed with CFTR and were further stimulated by the tyrosine phosphatase inhibitor dephostatin. Exogenous Src also activated 15SA-CFTR, a variant that lacks 15 potential PKA sites and has little response to PKA. PKA-independent activation by tyrosine phosphorylation has implications for the mechanism of regulation by the R domain and for the physiologic functions of CFTR.	[Billet, Arnaud; Jia, Yanlin; Hanrahan, John W.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Billet, Arnaud; Jia, Yanlin; Hanrahan, John W.] McGill Univ, Cyst Fibrosis Translat Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Jensen, Tim; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Jensen, Tim; Riordan, John R.] Univ N Carolina, Cyst Fibrosis Res Ctr, Chapel Hill, NC USA; [Hanrahan, John W.] McGill Univ, Ctr Hosp, Res Inst, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; McGill University	Billet, A (corresponding author), McGill Univ, Dept Physiol, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	arnaud.billet@mcgill.ca	Billet, Arnaud/AAZ-3834-2020; billet, arnaud/P-9503-2016; Hanrahan, John/AGG-1926-2022	Hanrahan, John/0000-0001-9080-2039	Groupe d'Etude des Proteines Membranaire; Groupe de Recherche Axe sur la Structure des Proteines; McGill Canadian Institutes of Health Research Program in Chemical Biology; McGill Faculty of Medicine; Respiratory Health Network of Centers of Excellence; Canadian Lung Association/Medical Research Council; Canadian Cystic Fibrosis Foundation; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK051870]; U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [P01 HL 10873-01]; Canadian Institutes of Health Research [MOP-126156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER	Groupe d'Etude des Proteines Membranaire; Groupe de Recherche Axe sur la Structure des Proteines; McGill Canadian Institutes of Health Research Program in Chemical Biology; McGill Faculty of Medicine; Respiratory Health Network of Centers of Excellence; Canadian Lung Association/Medical Research Council; Canadian Cystic Fibrosis Foundation; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.B. was supported by fellowships from the Groupe d'Etude des Proteines Membranaire, Groupe de Recherche Axe sur la Structure des Proteines, McGill Canadian Institutes of Health Research Program in Chemical Biology, and McGill Faculty of Medicine. Y.J. was supported by the Respiratory Health Network of Centers of Excellence and fellowships from the Canadian Lung Association/Medical Research Council and Canadian Cystic Fibrosis Foundation. This work was funded by grants from the U.S. National Institutes of Health [R01-DK051870 (National Institute of Diabetes and Digestive and Kidney Diseases) and P01 HL 10873-01 (National Heart, Lung, and Blood Institute) to J.R.R.] and Canadian Institutes of Health Research (MOP-126156; to J.W.H.).	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Alshafie W, 2014, AM J PHYSIOL-CELL PH, V307, pC107, DOI 10.1152/ajpcell.00296.2013; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Billet A, 2013, J PHYSIOL-LONDON, V591, P5273, DOI 10.1113/jphysiol.2013.261909; Billet A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.479360; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Bozoky Z, 2013, FEBS J, V280, P4407, DOI 10.1111/febs.12422; Cesaro L, 2013, AMINO ACIDS, V45, P1423, DOI 10.1007/s00726-013-1613-y; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2004, P NATL ACAD SCI USA, V101, P390, DOI 10.1073/pnas.0303411101; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Esen M, 2001, INFECT IMMUN, V69, P281, DOI 10.1128/IAI.69.1.281-287.2001; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Fischer H, 1996, BIOPHYS J, V71, P3073, DOI 10.1016/S0006-3495(96)79501-2; Gadsby David C., 1999, Physiological Reviews, V79, pS77; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; HWANG TC, 1993, J GEN PHYSIOL, V101, P629, DOI 10.1085/jgp.101.5.629; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Liang LH, 2011, J NANOMATER, V2011, DOI 10.1155/2011/670857; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Luz S, 2014, J BIOL CHEM, V289, P15080, DOI 10.1074/jbc.M114.563742; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Marshall WS, 2009, J EXP BIOL, V212, P2365, DOI 10.1242/jeb.030015; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; RIORDAN JR, 1989, SCIENCE, V245, P1066; Seibert FS, 1999, BBA-BIOMEMBRANES, V1461, P275, DOI 10.1016/S0005-2736(99)00163-7; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Venerando A, 2014, CELL MOL LIFE SCI, V71, P2193, DOI 10.1007/s00018-014-1581-8; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Yamamoto S, 2007, J PHYSIOL SCI, V57, P85, DOI 10.2170/physiolsci.RP011406	52	18	18	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3945	3953		10.1096/fj.15-273151	http://dx.doi.org/10.1096/fj.15-273151			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062600	Green Published			2022-12-28	WOS:000359915600029
J	Hao, J; Bao, XX; Jin, B; Wang, XJ; Mao, ZB; Li, XP; Wei, LH; Shen, DH; Wang, JL				Hao, Juan; Bao, Xiaoxia; Jin, Bo; Wang, Xiujuan; Mao, Zebin; Li, Xiaoping; Wei, Lihui; Shen, Danhua; Wang, Jian-Liu			Ca2+ channel subunit alpha 1D promotes proliferation and migration of endometrial cancer cells mediated by 17 beta-estradiol via the G protein-coupled estrogen receptor	FASEB JOURNAL			English	Article						calcium; endometrial carcinoma; Cav1.3; ERK1/2; rapid signaling effect	ELEMENT-BINDING PROTEIN; CALCIUM-CHANNELS; RESPONSE ELEMENT; PROSTATE-CANCER; SIGNALING PATHWAY; CARCINOMA-CELLS; ACTIVATION; MECHANISMS; EXPRESSION; MEMBRANE	Calcium and calcium channels are closely related to the estrogen-induced nongenomic effect of endometrial carcinoma, but the specific role of calcium channels is unknown. This study aimed to explore the expression and the biologic effect of the L-type calcium channel in endometrial carcinoma cells and to clarify the molecular mechanism of the relationship between L-type calcium channels and estrogen. The immunohistochemical results showed that Ca2+ channel subunit alpha 1D (Cav1.3) expression was high in atypical hyperplasia (1.90 +/- 0.35) and endometrial carcinoma tissues (2.05 +/- 0.82) but weak (0.80 +/- 0.15) in benign endometrial tissues (P < 0.05). Treatment with 17 beta-estradiol rapidly increased Cav1.3 expression in a dose-and time-dependent manner, and 100 nM cell-impermeable beta-estradiol-6-(O-carboxymethyl) oxime: bovine serum albumin also promoted Cav1.3 expression. Transfection with small interfering RNA against G protein-coupled estrogen receptor (GPER) suppressed estrogen-induced up-regulation of Cav1.3 compared with control cells and markedly reduced the estrogen-induced phosphorylation of ERK1/2 and CREB. Knocking down the Cav1.3 significantly suppressed estrogen-stimulated Ca2+ influx, cell proliferation, and migration in endometrial cancer cells. Taken together, Cav1.3 was overexpressed in atypical hyperplasia and endometrial carcinoma, and the estrogen-induced phosphorylation of downstream molecular ERK1/2 and CREB is the result of activation of the GPER pathway. L-type channel Cav1.3 is required for estrogen-stimulated Ca2+ influx and contributes broadly to the development of endometrial cancer. The Cav1.3 channel may be a new target for endometrial carcinoma treatment.	[Hao, Juan; Bao, Xiaoxia; Li, Xiaoping; Wei, Lihui; Wang, Jian-Liu] Peking Univ, Peoples Hosp, Dept Obstet & Gynaecol, Beijing 100044, Peoples R China; [Shen, Danhua] Peking Univ, Peoples Hosp, Dept Pathol, Beijing 100044, Peoples R China; [Jin, Bo; Wang, Xiujuan; Mao, Zebin] Peking Univ, Dept Biochem & Mol Biol, Beijing 100044, Peoples R China	Peking University; Peking University; Peking University	Wang, JL (corresponding author), Peking Univ, Peoples Hosp, Dept Obstet & Gynaecol, 11 Xi Zhi Men South St, Beijing 100044, Peoples R China.	wangjianliu@pkuph.edu.cn	wei, li/GSD-3630-2022; 黎, 伟/GXM-4040-2022	Wang, Jianliu/0000-0003-0338-0427	National Natural Science Foundation of China [30973182, 81272869]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Kewei Wang and his team for technical support. This work was supported by National Natural Science Foundation of China Grants 30973182 and 81272869. The authors declare no conflicts of interest.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bao Xiao-xia, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P212; Bao XX, 2012, CHINESE MED J-PEKING, V125, P3120, DOI 10.3760/cma.j.issn.0366-6999.2012.17.028; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Bertolesi GE, 2002, MOL PHARMACOL, V62, P210, DOI 10.1124/mol.62.2.210; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Brewer LD, 2009, J NEUROSCI, V29, P6058, DOI 10.1523/JNEUROSCI.5253-08.2009; Bulayeva NN, 2005, AM J PHYSIOL-ENDOC M, V288, pE388, DOI 10.1152/ajpendo.00349.2004; Bulayeva NN, 2004, STEROIDS, V69, P181, DOI 10.1016/j.steroids.2003.12.003; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Chen RB, 2014, UROL ONCOL-SEMIN ORI, V32, P524, DOI 10.1016/j.urolonc.2013.05.011; Coiret G, 2005, FEBS LETT, V579, P2995, DOI 10.1016/j.febslet.2005.02.085; Doolan CM, 2000, BRIT J PHARMACOL, V129, P1375, DOI 10.1038/sj.bjp.0703193; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Engh A, 2012, FRONT BIOSCI-LANDMRK, V17, P1613, DOI 10.2741/4007; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Ferret S, 2001, MOL CELL ENDOCRINOL, V176, P77, DOI 10.1016/S0303-7207(01)00464-6; Gackiere F, 2008, J BIOL CHEM, V283, P10162, DOI 10.1074/jbc.M707159200; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Giordano TP, 2010, J NEUROSCI, V30, P17051, DOI 10.1523/JNEUROSCI.2255-10.2010; Guo RX, 2006, J STEROID BIOCHEM, V99, P9, DOI 10.1016/j.jsbmb.2005.11.013; Haverstick DM, 2000, CANCER RES, V60, P1002; Huang J, 2004, MOL CELL ENDOCRINOL, V218, P65, DOI 10.1016/j.mce.2003.12.005; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Naguro I., 2004, SIGNAL TRANSDUCT, V4, P195; Olson SH, 2012, CANCER EPIDEM BIOMAR, V21, P753, DOI 10.1158/1055-9965.EPI-11-0735; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Saltzman BS, 2008, AM J EPIDEMIOL, V167, P607, DOI 10.1093/aje/kwm333; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Shapovalov G, 2013, RECENT PAT ANTI-CANC, V8, P18; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skrzypczak M, 2013, STEROIDS, V78, P1087, DOI 10.1016/j.steroids.2013.07.007; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Sun LF, 2013, GYNECOL OBSTET INVES, V75, P68, DOI 10.1159/000339933; Tashiro H, 2014, CURR OBSTET GYNECOL, V3, P9, DOI 10.1007/s13669-013-0074-3; Taylor JT, 2008, CANCER LETT, V267, P116, DOI 10.1016/j.canlet.2008.03.032; Tsai CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072999; Ullrich ND, 2007, BIOCHEM BIOPH RES CO, V361, P522, DOI 10.1016/j.bbrc.2007.07.054; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Watson C S, 1999, Sci STKE, V1999, pPE1, DOI 10.1126/stke.1999.12.pe1; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017	52	50	54	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2883	2893		10.1096/fj.14-265603	http://dx.doi.org/10.1096/fj.14-265603			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805831				2022-12-28	WOS:000356859100018
J	Leibowitch, J; Mathez, D; de Truchis, P; Ledu, D; Melchior, JC; Carcelain, G; Izopet, J; Perronne, C; David, JR				Leibowitch, Jacques; Mathez, Dominique; de Truchis, Pierre; Ledu, Damien; Melchior, Jean Claude; Carcelain, Guislaine; Izopet, Jacques; Perronne, Christian; David, John R.			Four days a week or less on appropriate anti-HIV drug combinations provided long-term optimal maintenance in 94 patients: the ICCARRE project	FASEB JOURNAL			English	Article						medical ethics; deontology; adjusted posology	ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; VIROLOGICAL FAILURE; HIV-1-INFECTED PATIENTS; INDUCTION THERAPY; INFECTED PATIENTS; LATENT RESERVOIR; INTERRUPTION; REPLICATION; ADHERENCE	Short, intraweekly cycles of anti-HIV combinations have provided intermittent, effective therapy (on 48 patients) (1). The concept is now extended to 94 patients on treatment, 4 days per week or less, over a median of 2.7 discontinuous treatment years per patient. On suppressive combinations, 94 patients volunteered to treatment, 5 and 4 days perweek, or reduced stepwise to 4, 3, 2, and 1 days per week in 94, 84, 66, and 12 patients, respectively, on various triple, standard, antiviral combinations, or nonregistered, quadruple, antiviral combinations. Ninety-four patients on treatment 4 days per week aggregated 165 intermittent treatment years; no viral breakthrough was observed over 87 average treatment weeks per patient, 63 of 94 having passed 2.5 intermittent treatment years on any of the antiviral combinations prescribed. On the hyperintermittent treatment of 3, 2, and 1 days per week, HIV RNA surged>50 copies, 4 weeks apart, in 18 instances (6.8 viral escapes/100 hyperdiscontinuous maintenance years). Viral escapes could have been a result of erratic adherence (EA) to regimen or follow-up (3 patients)-drug taken at half of the daily recommended dosage (8 patients) and/or overlooked archival-resistant HIVs from antecedent treatment failures (6 patients). Aside from the above circumstances, HIV unexpectedly rebounded in 3 patients on 2 days per week treatment and 1 patient on 1 day per week treatment, posting 2.2 intrinsic viral escapes/100 highly discontinuous treatment years. All 18 escapes were eventually reversed by 7 days per week salvage combinations, and 11 of 18 patients have been back for a second course of intermittent therapy, 4 days per week or less. Both cell-activation markers on the surface of T lymphocytes and cell-bound HIV DNA levels remained stable or declined. CD4/CD8 ratios rose to >= 1 in 35% of patients, whereas CD4 counts went >= 500/mu l in 75%. These values were previously 7 and 40%, respectively, on 7 days per week therapy. In our aging, long, HIV-enduring, multitreated patient cohort, treatment 4 days per week and less over 421 intermittent treatment years reduced prescription medicines by 60%-equivalent to 3 drug-free/3 virus-free remission year per patient-actually sparing (sic)3 million on just 94 patients at the cost of 2.2 intrinsic viral failure/100 hyperintermittent treatment years. At no risk of viral escape, maintenance therapy, 4 days per week, would quasiuniversally offer 40% cuts off of current over-prescriptions.	[Leibowitch, Jacques; Mathez, Dominique; de Truchis, Pierre; Ledu, Damien; Melchior, Jean Claude; Perronne, Christian] Hop Raymond Poincare, F-92380 Garches, France; [Carcelain, Guislaine] Hop La Pitie Salpetriere, Paris, France; [Izopet, Jacques] Purpan Hosp, Toulouse, France; [David, John R.] Harvard Univ, Sch Med, TH Chan Sch Pub Hlth, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health	Leibowitch, J (corresponding author), Hop Raymond Poincare, 104 Blvd Raymond Poincare, F-92380 Garches, France.	jacques.leibowitch@rpc.aphp.fr		IZOPET, JACQUES/0000-0002-8462-3234				American College of Physicians, 2012, ACP ETH MAN; Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; [Anonymous], 2011, CLIN MAN TREATM HIV; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Baril J, 2014, HIV MED, V15, P301, DOI 10.1111/hiv.12118; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Boulassel MR, 2012, J CLIN VIROL, V53, P29, DOI 10.1016/j.jcv.2011.09.018; Boyle A, 2012, J INT AIDS SOC, V15, P11, DOI 10.7448/IAS.15.6.18121; Charpentier C, 2012, J ANTIMICROB CHEMOTH, V67, P2231, DOI 10.1093/jac/dks191; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Ferguson NM, 2005, J ROY SOC INTERFACE, V2, P349, DOI 10.1098/rsif.2005.0037; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fourati S, 2014, J ANTIMICROB CHEMOTH, V69, P753, DOI 10.1093/jac/dkt428; Gantner P, 2014, SCAND J INFECT DIS, V46, P838, DOI 10.3109/00365548.2014.947318; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Gatell J, 2007, CLIN INFECT DIS, V44, P1484, DOI 10.1086/517497; Ghosn J, 2010, ANTIVIR THER, V15, P993, DOI 10.3851/IMP1666; Gianotti N, 2012, J ANTIMICROB CHEMOTH, V67, P213, DOI 10.1093/jac/dkr422; Giuntini R, 2010, HIV MED, V11, P40, DOI 10.1111/j.1468-1293.2009.00740.x; Glass TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029186; Guiguet M, 2012, AIDS, V26, P2345, DOI 10.1097/QAD.0b013e32835646e0; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hocqueloux L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049289; Izopet J, 2002, VIROLOGY, V302, P393, DOI 10.1006/viro.2002.1621; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kaulich-Bartz J, 2013, AIDS, V27, P1641, DOI 10.1097/QAD.0b013e3283601199; Kent SJ, 2012, AIDS RES HUM RETROV, V28, P761, DOI [10.1089/aid.2012.0017, 10.1089/AID.2012.0017]; KESANIEMI YA, 1990, AM J CLIN NUTR, V51, P1007, DOI 10.1093/ajcn/51.6.1007; Lambert-Niclot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041390; Ledergerber B, 2011, HIV MED, V12, P279, DOI 10.1111/j.1468-1293.2010.00880.x; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Leibowitch J, 2010, FASEB J, V24, P1649, DOI 10.1096/fj.09-148676; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Molina JM, 2014, HIV MED, V15, P57, DOI 10.1111/hiv.12071; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUID US ANT AG HIV 1; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Piketty C, 2010, J MED VIROL, V82, P1819, DOI 10.1002/jmv.21907; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Reynolds SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010307; Rokx C, 2015, CLIN INFECT DIS, V60, P143, DOI 10.1093/cid/ciu763; Rudy BJ, 2009, AIDS RES HUM RETROV, V25, P555, DOI 10.1089/aid.2008.0203; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tseng A, 2012, AM J HEALTH-SYST PH, V69, P1284, DOI 10.2146/ajhp110721; Tseng AL, 2013, ANTIVIR THER, V18, P735, DOI 10.3851/IMP2685; Wilson IB, 2013, JAIDS-J ACQ IMM DEF, V64, P448, DOI 10.1097/QAI.0000000000000025; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210; Zehnacker L, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/724958; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	68	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2223	2234		10.1096/fj.14-260315	http://dx.doi.org/10.1096/fj.14-260315			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25833895				2022-12-28	WOS:000355209500002
J	Sasso, O; Migliore, M; Habrant, D; Armirotti, A; Albani, C; Summa, M; Moreno-Sanz, G; Scarpelli, R; Piomelli, D				Sasso, Oscar; Migliore, Marco; Habrant, Damien; Armirotti, Andrea; Albani, Clara; Summa, Maria; Moreno-Sanz, Guillermo; Scarpelli, Rita; Piomelli, Daniele			Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage	FASEB JOURNAL			English	Article						anandamide; cannabinoid receptor; inflammatory bowel disease; multitarget inhibitors	ENDOGENOUS CANNABINOID SYSTEM; BOWEL-DISEASE; EXPERIMENTAL COLITIS; ENDOCANNABINOID OXYGENATION; ULCERATIVE-COLITIS; RECEPTOR AGONIST; LIPID MEDIATORS; PAIN INITIATION; CROHNS-DISEASE; CB2 RECEPTORS	The ability of nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit cyclooxygenase (Cox)-1 and Cox-2 underlies the therapeutic efficacy of these drugs, as well as their propensity to damage the gastrointestinal (GI) epithelium. This toxic action greatly limits the use of NSAIDs in inflammatory bowel disease (IBD) and other chronic pathologies. Fatty acid amide hydrolase (FAAH) degrades the endocannabinoid anandamide, which attenuates inflammation and promotes GI healing. Here, we describe the first class of systemically active agents that simultaneously inhibit FAAH, Cox-1, and Cox-2 with high potency and selectivity. The class prototype 4 (ARN2508) is potent at inhibiting FAAH, Cox-1, and Cox-2 (median inhibitory concentration: FAAH, 0.031 +/- 0.002 mu M; Cox-1, 0.012 +/- 0.002 mu M; and Cox-2, 0.43 +/- 0.025 mu M) but does not significantly interact with a panel of >100 off targets. After oral administration in mice, ARN2508 engages its intended targets and exerts profound therapeutic effects in models of intestinal inflammation. Unlike NSAIDs, ARN2508 causes no gastric damage and indeed protects the GI from NSAID-induced damage through a mechanism that requires FAAH inhibition. Multitarget FAAH/Cox blockade may provide a transformative approach to IBD and other pathologies in which FAAH and Cox are overactive.	[Sasso, Oscar; Migliore, Marco; Habrant, Damien; Armirotti, Andrea; Albani, Clara; Summa, Maria; Scarpelli, Rita; Piomelli, Daniele] Ist Italiano Tecnol, Dept Drug Discovery & Dev, Genoa, Italy; [Moreno-Sanz, Guillermo; Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol & Biol Chem, Irvine, CA 92697 USA	Istituto Italiano di Tecnologia - IIT; University of California System; University of California Irvine; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	piomelli@uci.edu	Armirotti, Andrea/AAB-3284-2019; Scarpelli, Rita/O-9422-2015	Armirotti, Andrea/0000-0002-3766-8755; Summa, Maria/0000-0002-8410-2607	U.S. National Institutes of Health National Institute on Drug Abuse [DA012413]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Drs. Angelo Reggiani and Tiziano Bandiera for helpful discussions; Ms. Sine Mandrup-Bertozzi, Ms. Silvia Venzano, and Mr. Luca Goldoni for technical help; and the U.S. National Institutes of Health National Institute on Drug Abuse (Grant DA012413 to D.P.) for financial support. D.P., R.S., M.M., and D.H. are inventors on patent application WO2014023643, filed by the University of California-Irvine (Irvine, CA, USA) and the Istituto Italiano di Tecnologia, which protects novel compounds disclosed in this paper.	Araldi D, 2013, P NATL ACAD SCI USA, V110, P3603, DOI 10.1073/pnas.1220668110; Bayly CI, 1999, BIOORG MED CHEM LETT, V9, P307, DOI 10.1016/S0960-894X(98)00717-3; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Blackler RW, 2014, CURR OPIN PHARMACOL, V19, P11, DOI 10.1016/j.coph.2014.05.008; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531; Chiurchiu V, 2013, ANN NEUROL, V73, P626, DOI 10.1002/ana.23875; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Cluny NL, 2010, J PHARMACOL EXP THER, V334, P973, DOI 10.1124/jpet.110.169946; Costa-Romero M, 2008, INFLAMM BOWEL DIS, V14, P1462, DOI 10.1002/ibd.20450; Di Paola R, 2010, J LEUKOCYTE BIOL, V88, P291, DOI 10.1189/jlb.0110053; Di Sabatino A, 2011, MUCOSAL IMMUNOL, V4, P574, DOI 10.1038/mi.2011.18; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Favia AD, 2012, J MED CHEM, V55, P8807, DOI 10.1021/jm3011146; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Hoffmann JC, 2002, PATHOBIOLOGY, V70, P121, DOI 10.1159/000068143; Holt S, 2007, EUR J PHARMACOL, V565, P26, DOI 10.1016/j.ejphar.2007.02.051; Johnson DS, 2011, ACS MED CHEM LETT, V2, P91, DOI 10.1021/ml100190t; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LAURITSEN K, 1988, GUT, V29, P1316, DOI 10.1136/gut.29.10.1316; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Maccarrone M, 2001, FUNCT NEUROL, V16, P53; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Mileni M, 2010, J MOL BIOL, V400, P743, DOI 10.1016/j.jmb.2010.05.034; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morphy R, 2006, J MED CHEM, V49, P4961, DOI 10.1021/jm0603015; Naidu PS, 2009, J PHARMACOL EXP THER, V329, P48, DOI 10.1124/jpet.108.143487; Patrono C, 2009, MOL INTERV, V9, P31, DOI 10.1124/mi.9.1.8; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Riccardi L, 2009, SHOCK, V31, P308, DOI 10.1097/SHK.0b013e31818339e7; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; RISDALL PC, 1978, XENOBIOTICA, V8, P691, DOI 10.3109/00498257809069581; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Russo R, 2007, EUR J PHARMACOL, V566, P117, DOI 10.1016/j.ejphar.2007.03.007; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Sasso O, 2012, PHARMACOL RES, V65, P553, DOI 10.1016/j.phrs.2012.02.012; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shi Y, 2011, WORLD J GASTROENTERO, V17, P3733, DOI 10.3748/wjg.v17.i32.3733; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suarez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037729; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; Wallace JL, 2004, J PHARMACOL EXP THER, V309, P626, DOI 10.1124/jpet.103.063453; Wallace JL, 2012, BRIT J PHARMACOL, V165, P67, DOI 10.1111/j.1476-5381.2011.01509.x; WILSON DE, 1991, J CLIN GASTROENTEROL, V13, pS65, DOI 10.1097/00004836-199112001-00011; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026	56	53	54	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2616	2627		10.1096/fj.15-270637	http://dx.doi.org/10.1096/fj.15-270637			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757568	Green Submitted, Green Published			2022-12-28	WOS:000355209500037
J	Black, KE; Berdyshev, E; Bain, G; Castelino, FV; Shea, BS; Probst, CK; Fontaine, BA; Bronova, I; Goulet, L; Lagares, D; Ahluwalia, N; Knipe, RS; Natarajan, V; Tager, AM				Black, Katharine E.; Berdyshev, Evgeny; Bain, Gretchen; Castelino, Flavia V.; Shea, Barry S.; Probst, Clemens K.; Fontaine, Benjamin A.; Bronova, Irina; Goulet, Lance; Lagares, David; Ahluwalia, Neil; Knipe, Rachel S.; Natarajan, Viswanathan; Tager, Andrew M.			Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis	FASEB JOURNAL			English	Article						ectonucleotide pyrophosphatase; phosphodiesterase 2; lysophospholipase D; lysophosphatidylcholine; bleomycin; mouse model	LYSOPHOSPHOLIPASE-D; SPHINGOSINE 1-PHOSPHATE; LIPID MEDIATORS; VASCULAR LEAK; HAIR-GROWTH; LPA; ENZYME; EXPRESSION; IDENTIFICATION; INFLAMMATION	Lysophosphatidic acid (LPA) is an important mediator of pulmonary fibrosis. In blood and multiple tumor types, autotaxin produces LPA from lysophosphatidylcholine (LPC) via lysophospholipase D activity, but alternative enzymatic pathways also exist for LPA production. We examined the role of autotaxin (ATX) in pulmonary LPA production during fibrogenesis in a bleomycin mouse model. We found that bleomycin injury increases the bronchoalveolar lavage (BAL) fluid levels of ATX protein 17-fold. However, the LPA and LPC species that increase in BAL of bleomycin-injured mice were discordant, inconsistent with a substrate-product relationship between LPC and LPA in pulmonary fibrosis. LPA species with longer chain polyunsaturated acyl groups predominated in BAL fluid after bleomycin injury, with 22:5 and 22:6 species accounting for 55 and 16% of the total, whereas the predominant BAL LPC species contained shorter chain, saturated acyl groups, with 16:0 and 18:0 species accounting for 56 and 14% of the total. Further, administration of the potent ATX inhibitor PAT-048 to bleomycin-challenged mice markedly decreased ATX activity systemically and in the lung, without effect on pulmonary LPA or fibrosis. Therefore, alternative ATX-independent pathways are likely responsible for local generation of LPA in the injured lung. These pathways will require identification to therapeutically target LPA production in pulmonary fibrosis.Black, K. E., Berdyshev, E., Bain, G., Castelino, F. V., Shea, B. S., Probst, C. K., Fontaine, B. A., Bronova, I., Goulet, L., Lagares, D., Ahluwalia, N., Knipe, R. S., Natarajan, V., Tager, A. M. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.	[Black, Katharine E.; Shea, Barry S.; Probst, Clemens K.; Fontaine, Benjamin A.; Lagares, David; Ahluwalia, Neil; Knipe, Rachel S.; Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA USA; [Black, Katharine E.; Castelino, Flavia V.; Shea, Barry S.; Probst, Clemens K.; Fontaine, Benjamin A.; Lagares, David; Ahluwalia, Neil; Knipe, Rachel S.; Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA USA; [Castelino, Flavia V.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Berdyshev, Evgeny; Bronova, Irina; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL USA; [Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Berdyshev, Evgeny; Bronova, Irina] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Bain, Gretchen; Goulet, Lance] PharmAkea Inc, San Diego, CA USA; [Shea, Barry S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Jewish Health; Brown University	Tager, AM (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Pulm & Crit Care Med, CNY149-8301,149 Thirteenth St, Charlestown, MA 02129 USA.	amtager@partners.org		Lagares, David/0000-0002-7317-8796; Bain, Gretchen/0000-0001-7513-9486	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [R01HL108975]; Office of the Director [P01HL098050, S10OD010660]; National Center for Research Resources; National Center for Advancing Translational Sciences, NIH National Center for Advancing Translational Sciences [UL1TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108975, P01HL098050] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010660] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH National Center for Advancing Translational Sciences; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the support of U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant R01HL108975 (to A. M. T.); Grant P01HL098050 and Grant S10OD010660 from the Office of the Director (for ESI-LC/MS/MS equipment) (to V. N. and E. B.). The authors also gratefully acknowledge assistance with the analyses performed by the Harvard Clinical and Translational Science Center (Harvard Catalyst), which is supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH National Center for Advancing Translational Sciences Grant UL1TR001102, and financial contributions from Harvard University and its affiliated academic healthcare centers. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University, and its affiliated academic healthcare centers, or the NIH. K. E. B. and A. M. T. conceived the project, designed the studies, and wrote the manuscript. K. E. B. performed and analyzed experiments investigating ATX or phospholipase activity, concentration, and expression. G. B. and L. G. designed and analyzed PAT-048 pharmacodynamic and pharmacokinetic analyses. E. B., I. B., and V. N. performed the LC/MS analysis of LPA and LPC. F. V. C. and B. S. S assisted with experimental design and data acquisition. R. S. K., C. K. P., and B. A. F. performed the animal experiments and assisted with data acquisition; D. L. and N. A. performed the FTY720 animal experiments and assisted with the experimental design. E. B., G. B., B. S. S., N. A., and V. N. also reviewed and intellectually contributed to the manuscript. G. B. and L. G. receive income and own equity in PharmAkea, Inc., and A. M. T. is a member of the PharmAkea scientific advisory board.	Ahluwalia N, 2014, AM J RESP CRIT CARE, V190, P867, DOI 10.1164/rccm.201403-0509PP; Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; BEHR J, 1993, THORAX, V48, P736, DOI 10.1136/thx.48.7.736; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Funke M, 2012, AM J RESP CELL MOL, V46, P355, DOI 10.1165/rcmb.2010-0155OC; Georas SN, 2007, CLIN EXP ALLERGY, V37, P311, DOI 10.1111/j.1365-2222.2006.02626.x; Grisanti L, 2013, J INVEST DERMATOL, V133, P2332, DOI 10.1038/jid.2013.140; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Huang LS, 2013, AM J RESP CELL MOL, V49, P912, DOI 10.1165/rcmb.2013-0070OC; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Khalil MB, 2010, MASS SPECTROM REV, V29, P877, DOI 10.1002/mas.20294; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Montesi SB, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-5; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; Nakamura K, 2007, CLIN BIOCHEM, V40, P274, DOI 10.1016/j.clinbiochem.2006.10.009; Nakanaga K, 2014, J BIOCHEM, V155, P235, DOI 10.1093/jb/mvt114; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nishimasu H, 2012, TRENDS PHARMACOL SCI, V33, P138, DOI 10.1016/j.tips.2011.12.004; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; North EJ, 2009, BIOORGAN MED CHEM, V17, P3433, DOI 10.1016/j.bmc.2009.03.030; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Pasternack SM, 2009, J INVEST DERMATOL, V129, P2772, DOI 10.1038/jid.2009.154; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Shea Barry S, 2012, Proc Am Thorac Soc, V9, P102, DOI 10.1513/pats.201201-005AW; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Shimizu Y, 2014, AM J PATHOL, V184, P1593, DOI 10.1016/j.ajpath.2014.01.029; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009	46	35	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2435	2450		10.1096/fj.201500197R	http://dx.doi.org/10.1096/fj.201500197R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	27006447	Green Published			2022-12-28	WOS:000376878300031
J	Ichiki, T; Koga, T; Okuno, T; Saeki, K; Yamamoto, Y; Yamamoto, H; Sakaguchi, M; Yokomizo, T				Ichiki, Takako; Koga, Tomoaki; Okuno, Toshiaki; Saeki, Kazuko; Yamamoto, Yasuhiko; Yamamoto, Hiroshi; Sakaguchi, Masakiyo; Yokomizo, Takehiko			Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE)	FASEB JOURNAL			English	Article						chemotaxis; GPCR; lipid mediator	PROTEIN-COUPLED RECEPTOR; INDUCED AIRWAY HYPERRESPONSIVENESS; NECROSIS-FACTOR-ALPHA; T-CELL RECRUITMENT; B-4 RECEPTOR; REGULATED KINASE; HUMAN NEUTROPHILS; KAPPA-B; EOSINOPHIL ACCUMULATION; HOST-DEFENSE	Leukotriene B-4 (LTB4) receptor 1 (BLT1), a high-affinity GPCR for LTB4, plays important roles in acute and chronic inflammatory diseases. Although the LTB4-BLT1 axis is known to promote inflammation, no studies have defined the binding proteins that modulate LTB4-BLT1 signaling. In this study, the receptor for advanced glycation end products (RAGE) interacted with BLT1 in human cervical epithelial HeLa cells. RAGE increased LTB4-BLT1-dependent ERK phosphorylation and inhibited LTB4-BLT1-dependent activation of NF-kB and up-regulation of proinflammatory cytokines and chemokines. RAGE-dependent inhibition of NF-kB was blunted by treatment with an MEK inhibitor, suggesting that RAGE suppresses LTB4-BLT1-dependent NF-kB signaling by enhancing the MEK-ERK pathway. Meanwhile, in a chemotaxis assay of mouse bone marrow-derived neutrophils, the velocity of LTB4-dependent neutrophil migration was attenuated by soluble RAGE, which is an inhibitory decoy protein for RAGE signaling, in a dose-dependent manner (0.2-5 mg/ml), or by RAGE deficiency. Furthermore, both LTB4-dependent ERK phosphorylation in neutrophils and LTB4-dependent neutrophil accumulation in a murine peritonitis model were significantly attenuated in RAGE-deficient mice compared with C57BL/6J wild-type mice, indicating that RAGE potentiates LTB4-dependent neutrophil migration by enhancing ERK phosphorylation. Our results demonstrate that RAGE interacts with BLT1 and modulates LTB4-BLT1 signaling through potentiation of the MEK-ERK pathway.	[Ichiki, Takako; Koga, Tomoaki; Okuno, Toshiaki; Saeki, Kazuko; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 1138421, Japan; [Yamamoto, Yasuhiko; Yamamoto, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan; [Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008530, Japan	Juntendo University; Kanazawa University; Okayama University	Koga, T; Yokomizo, T (corresponding author), Juntendo Univ, Dept Biochem, Sch Med, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	tkoga@juntendo.ac.jp; yokomizotky@umin.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22116001, 22116002, 15H05901, 15H05904, 15H04708, 25860223, 24590386, 15K08316, 24102522, 25460374]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Takeda Science Foundation; Foundation of Strategic Research Projects in Private Universities from MEXT [S1311011]; Institute for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation of Strategic Research Projects in Private Universities from MEXT; Institute for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank J. Miyazaki (Osaka University, Osaka, Japan) for supplying the pCXN2 expression vector (26), J. Takasaki (Astellas Pharmaceuticals, Tokyo, Japan) for supplying YM-254890 (35), and the members of our laboratories for advice and helpful discussions. T.I. is a Research Fellow of the Japan Society for the Promotion of Science. This work was supported by Grants-in-Aid for Scientific Research 22116001, 22116002, 15H05901, 15H05904, and 15H04708 (to T.Y.); 25860223 (to T.K.); 24590386 and 15K08316 (to K.S.); and 24102522 and 25460374 (to T.O.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and by the Naito Foundation, the Ono Medical Research Foundation, the Uehara Memorial Foundation, the Mitsubishi Foundation, and the Takeda Science Foundation. This study was supported in part by Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from MEXT and a grant from the Institute for Environmental and Gender-Specific Medicine. The authors declare no conflicts of interest.	Achouiti A, 2013, CRIT CARE, V17, DOI 10.1186/cc13162; Akirav EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095678; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Devchand PR, 2003, FASEB J, V17, P652, DOI 10.1096/fj.02-0770com; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Forbes JM, 2004, DIABETES, V53, P1813, DOI 10.2337/diabetes.53.7.1813; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Fuhler GM, 2005, J LEUKOCYTE BIOL, V77, P257, DOI 10.1189/jlb.0504306; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lindsay MA, 1998, J LEUKOCYTE BIOL, V64, P555, DOI 10.1002/jlb.64.4.555; Masuda K, 1999, BIOCHEM J, V342, P79, DOI 10.1042/0264-6021:3420079; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Moraes J, 2010, ATHEROSCLEROSIS, V212, P406, DOI 10.1016/j.atherosclerosis.2010.06.009; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Nakamae-Akahori M, 2006, IMMUNOLOGY, V119, P393, DOI 10.1111/j.1365-2567.2006.02448.x; Nam YH, 2012, INFLAMM RES, V61, P97, DOI 10.1007/s00011-011-0425-3; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Okuno T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117888; Patnode ML, 2014, J EXP MED, V211, P1281, DOI 10.1084/jem.20132336; Peters-Golden M, 1999, CLIN REV ALLERG IMMU, V17, P261, DOI 10.1007/BF02737609; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Soares EM, 2013, J IMMUNOL, V190, P1614, DOI 10.4049/jimmunol.1202932; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toda A, 1999, BIOCHEM BIOPH RES CO, V262, P806, DOI 10.1006/bbrc.1999.1284; Ueno H, 2010, ATHEROSCLEROSIS, V211, P431, DOI 10.1016/j.atherosclerosis.2010.04.006; van den Berg JM, 2001, J LEUKOCYTE BIOL, V69, P467; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Woo CH, 2003, J IMMUNOL, V170, P6273, DOI 10.4049/jimmunol.170.12.6273; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Yamamoto Yasuhiko, 2013, Front Endocrinol (Lausanne), V4, P105, DOI 10.3389/fendo.2013.00105; Yamamoto Y, 2012, J DIABETES INVEST, V3, P107, DOI 10.1111/j.2040-1124.2011.00191.x; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yeh PY, 2004, J BIOL CHEM, V279, P26143, DOI 10.1074/jbc.M402362200; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	69	23	24	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1811	1822		10.1096/fj.201500117	http://dx.doi.org/10.1096/fj.201500117			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26813973	Green Submitted			2022-12-28	WOS:000374879400012
J	Jang, H; Banerjee, A; Chavan, TS; Lu, SY; Zhang, J; Gaponenko, V; Nussinov, R				Jang, Hyunbum; Banerjee, Avik; Chavan, Tanmay S.; Lu, Shaoyong; Zhang, Jian; Gaponenko, Vadim; Nussinov, Ruth			The higher level of complexity of K-Ras4B activation at the membrane	FASEB JOURNAL			English	Article						KRAS; GDP/GTP exchange; farnesyl insertion; signaling; phospholipids	AMYLOID ION CHANNELS; ATOMIC-FORCE MICROSCOPY; MOLECULAR-DYNAMICS SIMULATIONS; EFFECTOR-BINDING SITE; SMALL GTPASE K-RAS4B; ALL-D-ENANTIOMER; H-RAS PROTEIN; HYPERVARIABLE REGION; LIPID-BILAYERS; ALZHEIMERS-DISEASE	Is nucleotide exchange sufficient to activate K-Ras4B? To signal, oncogenic rat sarcoma (Ras) anchors in the membrane and recruits effectors by exposing its effector lobe. With the use of NMR and molecular dynamics (MD) simulations, we observed that in solution, farnesylated guanosine 5'-diphosphate (GDP)-bound K-Ras4B is predominantly autoinhibited by its hypervariable region (HVR), whereas the GTP-bound state favors an activated, HVR-released state. On the anionic membrane, the catalytic domain adopts multiple orientations, including parallel (similar to 180 degrees) and perpendicular (similar to 90 degrees) alignments of the allosteric helices, with respect to the membrane surface direction. In the autoinhibited state, the HVR is sandwiched between the effector lobe and the membrane; in the active state, with membrane-anchored farnesyl and unrestrained HVR, the catalytic domain fluctuates reinlessly, exposing its effector-binding site. Dimerization and clustering can reduce the fluctuations. This achieves preorganized, productive conformations. Notably, we also observe HVR-autoinhibited K-Ras4B-GTP states, with GDP-bound-like orientations of the helices. Thus, we propose that the GDP/GTP exchange may not be sufficient for activation; instead, our results suggest that the GDP/GTP exchange, HVR sequestration, farnesyl insertion, and orientation/localization of the catalytic domain at the membrane conjointly determine the active or inactive state of K-Ras4B. Importantly, K-Ras4B-GTP can exist in active and inactive states; on its own, GTP binding may not compel K-Ras4B activation.	[Jang, Hyunbum; Lu, Shaoyong; Nussinov, Ruth] Natl Canc Inst Frederick, Basic Sci Program, Leidos Biomed Res, Frederick Natl Lab Canc Res,Canc & Inflammat Prog, Frederick, MD USA; [Banerjee, Avik] Univ Illinois, Dept Chem, Chicago, IL USA; [Chavan, Tanmay S.; Gaponenko, Vadim] Univ Illinois, Dept Med Chem, Chicago, IL USA; [Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA; [Lu, Shaoyong; Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Chavan, Tanmay S.] Stanford Univ, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University; Tel Aviv University; Sackler Faculty of Medicine; Stanford University	Gaponenko, V (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.; Nussinov, R (corresponding author), Natl Canc Inst Frederick, Frederick Natl Lab Canc Res, Leidos Biomed Res, 1050 Boyles St, Frederick, MD 21702 USA.	vadimg@uic.edu; nussinor@helix.nih.gov	Gaponenko, Vadim/K-9729-2019; Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Banerjee, Avik/0000-0002-0668-5480; Chavan, Tanmay/0000-0002-2702-6863; Nussinov, Ruth/0000-0002-8115-6415; Gaponenko, Vadim/0000-0002-7891-9223	American Cancer Society [RGS-09-057-01-GMC]; U.S. National Institutes of Health [NIH] [R01 CA135341, R01 CA188427, R21 HL118588]; NIH Frederick National Laboratory for Cancer Research [HHSN261200800001E]; NIH Intramural Research Program, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA188427, ZIABC010440, ZIABC010441, R01CA135341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL118588] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Frederick National Laboratory for Cancer Research; NIH Intramural Research Program, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge the generous support from the American Cancer Society (Grant RGS-09-057-01-GMC) and the U.S. National Institutes of Health [NIH; Grants R01 CA135341, R01 CA188427 (National Cancer Institute), and R21 HL118588 (National Heart, Lung, and Blood Institute); to V.G.]. This project has been funded, in whole or in part, with federal funds from the NIH Frederick National Laboratory for Cancer Research, under Contract HHSN261200800001E. This research was supported, in part, by the NIH Intramural Research Program, Frederick National Lab, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. All simulations had been performed with the use of the high-performance computational facilities of the Biowulf PC/Linux cluster at the NIH (https://hpc.nih.gov/). H.J. and A.B. are co-first authors.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Capone R, 2012, J CHEM THEORY COMPUT, V8, P1143, DOI 10.1021/ct200885r; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Capone R, 2010, BIOPHYS J, V98, P2644, DOI 10.1016/j.bpj.2010.02.024; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Chavan TS, 2015, BIOPHYS J, V109, P2602, DOI 10.1016/j.bpj.2015.09.034; Chavan TS, 2014, METHODS MOL BIOL, V1120, P19, DOI 10.1007/978-1-62703-791-4_2; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Connelly L, 2012, BIOCHEMISTRY-US, V51, P3031, DOI 10.1021/bi300257e; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gillman AL, 2014, J PHYS CHEM B, V118, P7335, DOI 10.1021/jp5040954; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Grayson P, 2003, BIOPHYS J, V85, P36, DOI 10.1016/S0006-3495(03)74452-X; Guin S, 2015, ACTA PHARMACOL SIN, V36, P291, DOI 10.1038/aps.2014.129; Gupta K, 2013, BIOPHYS J, V105, P2093, DOI 10.1016/j.bpj.2013.09.040; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hildebrandt ER, 2013, BIOCHEMISTRY-US, V52, P6601, DOI 10.1021/bi400647c; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jang H, 2004, BIOPHYS J, V87, P129, DOI 10.1529/biophysj.104.039602; Jang H, 2008, BIOPHYS J, V95, P4631, DOI 10.1529/biophysj.108.134551; Jang H, 2008, PROTEINS, V72, P299, DOI 10.1002/prot.21925; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Jang H, 2014, CHEM SOC REV, V43, P6750, DOI 10.1039/c3cs60459d; Jang H, 2013, J PHYS CHEM B, V117, P11518, DOI 10.1021/jp405389n; Jang H, 2013, J CHEM THEORY COMPUT, V9, P822, DOI 10.1021/ct300916f; Jang H, 2010, J MOL BIOL, V404, P917, DOI 10.1016/j.jmb.2010.10.025; Jang H, 2010, J PHYS CHEM B, V114, P9445, DOI 10.1021/jp104073k; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Jang H, 2009, BIOPHYS J, V97, P3029, DOI 10.1016/j.bpj.2009.09.014; Janosi L, 2010, BIOPHYS J, V99, P3666, DOI 10.1016/j.bpj.2010.10.031; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Lu SY, 2015, J BIOL CHEM, V290, P28887, DOI 10.1074/jbc.M115.664755; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Mustata M, 2009, J AM CHEM SOC, V131, P14938, DOI 10.1021/ja9049299; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Vogel A, 2010, BBA-BIOMEMBRANES, V1798, P275, DOI 10.1016/j.bbamem.2009.09.023; WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631; Woolf TB, 1996, PROTEINS, V24, P92; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200	60	58	58	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1643	1655		10.1096/fj.15-279091	http://dx.doi.org/10.1096/fj.15-279091			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26718888	Green Published			2022-12-28	WOS:000372629100025
J	Uchida, K; Demirkhanyan, L; Asuthkar, S; Cohen, A; Tominaga, M; Zakharian, E				Uchida, Kunitoshi; Demirkhanyan, Lusine; Asuthkar, Swapna; Cohen, Alejandro; Tominaga, Makoto; Zakharian, Eleonora			Stimulation-dependent gating of TRPM3 channel in planar lipid bilayers	FASEB JOURNAL			English	Article						reconstituted system; pregnenolone sulfate; nifedipine; clotrimazole; PIP2	POTENTIAL MELASTATIN 3; VANILLOID 1 TRPV1; RECEPTOR; ACTIVATION; PHOSPHOINOSITIDES; EXPRESSION; AGONISTS; PROTEIN; CELLS; HEAT	The transient receptor potential melastatin (TRPM)-3 channel is critical for various physiologic processes. In somatosensory neurons, TRPM3 has been implicated in temperature perception and inflammatory hyperalgesia, whereas in pancreatic beta-cells the channel has been linked to glucose-induced insulin release. As a typical representative of the TRP family, TRPM3 is highly polymodal. In cells, it is activated by heat and chemical agonists, including pregnenolone sulfate (PS) and nifedipine (Nif). To define the nuances of TRPM3 channel activity and its modulators, we succeeded in incorporating the TRPM3 protein into planar lipid bilayers. We found that phosphatidylinositol-4,5-bisphosphate (PIP2) or clotrimazole is necessary for channel opening by PS. Unlike PS, the presence of Nif alone sufficed to induce TRPM3 activity and demonstrated distinct gating behavior. We also performed an extensive thermodynamic analysis of TRPM3 activation and found that TRPM3 exhibited slight temperature sensitivity in the bilayers. In the absence of other agonists TRPM3 channels remained closed upon heat-induced stimulation, but opened in the presence of PIP2, although with only a low open-probability profile. Together, our results elucidate the details peculiar to TRPM3 channel function in an isolated system. We confirmed its direct gating by PS and PIP2, but found a lack of the strong intrinsic temperature sensitivity common to other thermosensitive TRP channels.	[Uchida, Kunitoshi; Demirkhanyan, Lusine; Asuthkar, Swapna; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA; [Uchida, Kunitoshi; Tominaga, Makoto] Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi, Japan; [Uchida, Kunitoshi; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Hayama, Kanagawa, Japan; [Cohen, Alejandro] Dalhousie Univ, Life Sci Res Inst, Prote & Mass Spectrometry Core Facil, Halifax, NS, Canada	University of Illinois System; University of Illinois Peoria; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Dalhousie University	Uchida, K; Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.; Uchida, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	kuchida@nips.ac.jp; zakharel@uic.edu		Cohen, Alejandro/0000-0001-8646-8525	Young Researcher Overseas Visit Program Expenses from The Graduate University for Advanced Studies; U.S. National Institutes of Health/National Institute of General Medicine Sciences [R01GM098052];  [25871061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052] Funding Source: NIH RePORTER	Young Researcher Overseas Visit Program Expenses from The Graduate University for Advanced Studies; U.S. National Institutes of Health/National Institute of General Medicine Sciences; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank N. Fukuta and C. Saito (National Institute of Physiological Sciences) for technical assistance, the laboratory members for helpful discussions, and H. Sahakyan (Bradley University) for proofreading the manuscript. This work was supported by Young Researcher Overseas Visit Program Expenses from The Graduate University for Advanced Studies (to K.U.); Grant-in-Aid 25871061 for Young Scientists (B) (to K.U.); and U.S. National Institutes of Health/National Institute of General Medicine Sciences Grant R01GM098052 (to E. Z).	Asuthkar S, 2015, J BIOL CHEM, V290, P2670, DOI 10.1074/jbc.M114.610873; Asuthkar S, 2015, J BIOL CHEM, V290, P2659, DOI 10.1074/jbc.M114.610824; Badheka D, 2015, J GEN PHYSIOL, V146, P65, DOI 10.1085/jgp.201411336; Drews A, 2014, BRIT J PHARMACOL, V171, P1019, DOI 10.1111/bph.12521; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Held K, 2015, P NATL ACAD SCI USA, V112, pE1363, DOI 10.1073/pnas.1419845112; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Oberwinkler J, 2014, HANDB EXP PHARMACOL, V222, P427, DOI 10.1007/978-3-642-54215-2_17; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sun XH, 2015, J BIOL CHEM, V290, P4741, DOI 10.1074/jbc.M114.611459; Toth BI, 2015, J GEN PHYSIOL, V146, P51, DOI 10.1085/jgp.201411339; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vriens J, 2014, NAT CHEM BIOL, V10, P188, DOI [10.1038/NCHEMBIO.1428, 10.1038/nchembio.1428]; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	26	22	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1306	1316		10.1096/fj.15-281576	http://dx.doi.org/10.1096/fj.15-281576			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26655382	Green Published			2022-12-28	WOS:000370387800026
J	Zhao, YL; Schwartz, EA; Palmer, GM; Zennadi, R				Zhao, Yulin; Schwartz, Evan A.; Palmer, Gregory M.; Zennadi, Rahima			MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease	FASEB JOURNAL			English	Article						sickle red cells; leukocytes; MEK inhibitors; adhesion	ACTIVATED PROTEIN-KINASE; FOCAL CEREBRAL-ISCHEMIA; IN-VIVO; POLYMORPHONUCLEAR LEUKOCYTES; HOMOTYPIC ADHESION; ENDOTHELIAL-CELLS; HUMAN NEUTROPHILS; POTENTIAL ROLE; HEART-FAILURE; MAP KINASE	In sickle cell disease (SCD), treatment of recurrent vasoocclusive episodes, leading to pain crises and organ damage, is still a therapeutic challenge. Vasoocclusion is caused primarily by adherence of homozygous for hemoglobin S (SS) red blood cells (SSRBCs) and leukocytes to the endothelium. We tested the therapeutic benefits of MEK1/2 inhibitors in reversing vasoocclusion in nude and humanized SCD mouse models of acute vasoocclusive episodes using intravital microscopy. Administration of 0.2, 0.3, 1, or 2 mg/kg MEK1/2 inhibitor to TNF-alpha-pretreated nude mice before human SSRBC infusion inhibited SSRBC adhesion in inflamed vessels, prevented the progression of vasoocclusion, and reduced SSRBC organ sequestration. By use of a more clinically relevant protocol, 0.3 or 1 mg/kg MEK1/2 inhibitor given to TNF-alpha-pretreated nude mice after human SSRBC infusion and onset of vasoocclusion reversed SSRBC adhesion and vasoocclusion and restored blood flow. In SCD mice, 0.025, 0.05, or 0.1 mg/kg MEK1/2 inhibitor also reversed leukocyte and erythrocyte adhesion after the inflammatory trigger of vasoocclusion and improved microcirculatory blood flow. Cell adhesion was reversed by shedding of endothelial E-selectin, P-selectin, and v3 integrin, and leukocyte CD44 and 2 integrin. Thus, MEK1/2 inhibitors, by targeting the adhesive function of SSRBCs and leukocytes, could represent a valuable therapeutic intervention for acute sickle cell vasoocclusive crises.	[Zhao, Yulin; Schwartz, Evan A.; Zennadi, Rahima] Duke Univ, Med Ctr, Div Hematol, Durham, NC 27710 USA; [Palmer, Gregory M.; Zennadi, Rahima] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Palmer, Gregory M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Zennadi, R (corresponding author), Duke Univ, Med Ctr, Box 2615, Durham, NC 27710 USA.	rahima.zennadi@duke.edu	Palmer, Gregory M/C-6910-2008	Palmer, Gregory M/0000-0003-2955-8297	U.S. National Blood Foundation; Duke School of Medicine; GlaxoSmithKline	U.S. National Blood Foundation; Duke School of Medicine; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by award from the U.S. National Blood Foundation, bridge funding from Duke School of Medicine, and research funding from GlaxoSmithKline (to R.Z.).	Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Cai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019559; Capodici C, 1998, J CLIN INVEST, V102, P165, DOI 10.1172/JCI592; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Chantrathammachart P, 2012, BLOOD, V120, P636, DOI 10.1182/blood-2012-04-424143; Chiou E, 2015, INT J BIOCHEM CELL B, V65, P40, DOI 10.1016/j.biocel.2015.05.013; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Fadlon E, 1998, BLOOD, V91, P266, DOI 10.1182/blood.V91.1.266.266_266_274; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Hebbel RP, 1997, J CLIN INVEST, V100, pS83; Herrera-Garcia A, 2013, EUR J IMMUNOL, V43, P55, DOI 10.1002/eji.201242805; Ichioka S, 2007, WOUND REPAIR REGEN, V15, P572, DOI 10.1111/j.1524-475X.2007.00265.x; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907, DOI 10.1097/01.WCB.0000132690.96836.7F; Iverson C., 2008, ASCO NCI ANN M MOL M; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Jozsef L, 2002, BRIT J PHARMACOL, V135, P1167, DOI 10.1038/sj.bjp.0704561; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368; King MR, 2004, ANN BIOMED ENG, V32, P803, DOI 10.1023/B:ABME.0000030256.37022.02; Kohno Michiaki, 2003, Prog Cell Cycle Res, V5, P219; KURANTSINMILLS J, 1987, MICROVASC RES, V34, P152, DOI 10.1016/0026-2862(87)90050-1; Lai HH, 2011, PAIN, V152, P2117, DOI 10.1016/j.pain.2011.05.017; Landsberger M, 2007, ATHEROSCLEROSIS, V190, P43, DOI 10.1016/j.atherosclerosis.2006.02.009; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Li J, 2014, J CLIN INVEST, V124, P1483, DOI 10.1172/JCI72305; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; Milella Michele, 2003, Rev Clin Exp Hematol, V7, P160; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Pignatelli P, 2005, BLOOD, V106, P1992, DOI 10.1182/blood-2005-03-1247; Pillinger MH, 1996, J BIOL CHEM, V271, P12049, DOI 10.1074/jbc.271.20.12049; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; THOMPSON HL, 1993, BIOCHEM J, V290, P483, DOI 10.1042/bj2900483; Townes T M, 1989, Prog Clin Biol Res, V316A, P47; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Wang N, 2011, J CELL BIOCHEM, V112, P1920, DOI 10.1002/jcb.23112; Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074; Weekes CD, 2013, CLIN CANCER RES, V19, P1232, DOI 10.1158/1078-0432.CCR-12-3529; WORTHEN GS, 1994, J CLIN INVEST, V94, P815, DOI 10.1172/JCI117401; Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zennadi R, 2008, BLOOD, V112, P3474, DOI 10.1182/blood-2008-01-134346; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101; Zennadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110306; Zennadi R, 2012, BLOOD, V119, P1217, DOI 10.1182/blood-2011-03-344440; Zouki C, 2001, FASEB J, V15, P25	49	7	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1171	1186		10.1096/fj.15-278481	http://dx.doi.org/10.1096/fj.15-278481			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631480				2022-12-28	WOS:000370387800015
J	Cho, Y; Hazen, BC; Gandra, PG; Ward, SR; Schenk, S; Russell, AP; Kralli, A				Cho, Yoshitake; Hazen, Bethany C.; Gandra, Paulo G.; Ward, Samuel R.; Schenk, Simon; Russell, Aaron P.; Kralli, Anastasia			Perm1 enhances mitochondrial biogenesis, oxidative capacity, and fatigue resistance in adult skeletal muscle	FASEB JOURNAL			English	Article						oxidative metabolism; angiogenesis; endurance exercise responses; skeletal muscle plasticity	PROLIFERATOR-ACTIVATED-RECEPTOR; TRANSCRIPTIONAL COACTIVATOR PGC-1; FIBER-TYPE; PROTEIN-KINASE; NUCLEAR RECEPTOR; GENE-EXPRESSION; KEY REGULATOR; ERR-ALPHA; SIRTUIN 1; PGC-1-ALPHA	Skeletal muscle mitochondrial content and oxidative capacity are important determinants of muscle function and whole-body health. Mitochondrial content and function are enhanced by endurance exercise and impaired in states or diseases where muscle function is compromised, such as myopathies, muscular dystrophies, neuromuscular diseases, and age-related muscle atrophy. Hence, elucidating the mechanisms that control muscle mitochondrial content and oxidative function can provide new insights into states and diseases that affect muscle health. In past studies, we identified Perm1 (PPARGC1- and ESRR-induced regulator, muscle 1) as a gene induced by endurance exercise in skeletal muscle, and regulating mitochondrial oxidative function in cultured myotubes. The capacity of Perm1 to regulate muscle mitochondrial content and function in vivo is not yet known. In this study, we use adeno-associated viral (AAV) vectors to increase Perm1 expression in skeletal muscles of 4-wk-old mice. Compared to control vector, AAV1-Perm1 leads to significant increases in mitochondrial content and oxidative capacity (by 40-80%). Moreover, AAV1-Perm1-transduced muscles show increased capillary density and resistance to fatigue (by 33 and 31%, respectively), without prominent changes in fiber-type composition. These findings suggest that Perm1 selectively regulates mitochondrial biogenesis and oxidative function, and implicate Perm1 in muscle adaptations that also occur in response to endurance exercise.	[Cho, Yoshitake; Hazen, Bethany C.; Gandra, Paulo G.; Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ward, Samuel R.; Schenk, Simon] Univ Calif San Diego, Sch Med, Dept Orthoped Surg, La Jolla, CA 92093 USA; [Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Australia	Scripps Research Institute; University of California System; University of California San Diego; Deakin University	Kralli, A (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kralli@scripps.edu		Schenk, Simon/0000-0002-8224-3203; Russell, Aaron/0000-0002-7323-9501	U.S. National Institutes of Health (NIH); American Heart Association [12POST8610009, 14SDG17790005, 14POST20450112]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095686]; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30AR061303]; NIH/National Institute of Child Health and Human Development [R24 HD050837]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105126, R01DK095686] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016357] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Erica Young, Dr. Marin Gantner, and members of the Saez laboratory for technical help and discussions; Dr. Espen Spangenburg (University of Maryland, College Park, MD, USA) for help and discussions on the study of single FDB fibers; Mary Esparza and Shannon Bremner for technical assistance; Dr. Malcolm Wood (The Scripps Research Institute) for the electron microscopy studies; and Drs. Erin Brown and Shizuko Tachibana for helpful discussions and critical reading of the manuscript. This work was supported by U.S. National Institutes of Health (NIH) and American Heart Association awards: American Heart Association 12POST8610009 and 14SDG17790005 to Y.C.; American Heart Association 14POST20450112 to P.G.G.; NIH/National Institute of Diabetes and Digestive and Kidney Diseases R01DK095686 to A.K.; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases P30AR061303; and NIH/National Institute of Child Health and Human Development R24 HD050837.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Chleboun GS, 1997, ACTA ANAT, V159, P147; Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Louboutin JP, 2005, J GENE MED, V7, P442, DOI 10.1002/jgm.686; Matsakas A, 2013, FASEB J, V27, P4004, DOI 10.1096/fj.13-228296; Matsakas A, 2012, CIRC RES, V110, P1087, DOI 10.1161/CIRCRESAHA.112.266478; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Minamoto VB, 2007, DEV MED CHILD NEUROL, V49, P907, DOI 10.1111/j.1469-8749.2007.00907.x; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mokbel N, 2013, BRAIN, V136, P494, DOI 10.1093/brain/aws348; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rose AJ, 2003, J PHYSIOL-LONDON, V553, P303, DOI 10.1113/jphysiol.2003.054171; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Sakamoto K, 2002, J APPL PHYSIOL, V93, P369, DOI 10.1152/japplphysiol.00167.2002; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schild M, 2015, J PROTEOMICS, V122, P119, DOI 10.1016/j.jprot.2015.03.028; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2011, CANCER RES, V71, P2518, DOI 10.1158/0008-5472.CAN-10-1315; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	64	28	28	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					674	687		10.1096/fj.15-276360	http://dx.doi.org/10.1096/fj.15-276360			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481306	Green Submitted, Green Published			2022-12-28	WOS:000369391900019
J	Yang, X; Scott, HA; Monickaraj, F; Xu, J; Ardekani, S; Nitta, CF; Cabrera, A; McGuire, PG; Mohideen, U; Das, A; Ghosh, K				Yang, Xiao; Scott, Harry A.; Monickaraj, Finny; Xu, Jun; Ardekani, Soroush; Nitta, Carolina F.; Cabrera, Andrea; McGuire, Paul G.; Mohideen, Umar; Das, Arup; Ghosh, Kaustabh			Basement membrane stiffening promotes retinal endothelial activation associated with diabetes	FASEB JOURNAL			English	Article						lysyl oxidase; matrix stiffness; nitric oxide; inflammation; diabetic retinopathy	LYSYL OXIDASE; EXTRACELLULAR-MATRIX; PLASMINOGEN-ACTIVATOR; MACULAR EDEMA; EXPRESSION; CELL; INFLAMMATION; FIBRONECTIN; RETINOPATHY; PERMEABILITY	Endothelial activation is a hallmark of the high-glucose (HG)-induced retinal inflammation associated with diabetic retinopathy (DR). However, precisely how HG induces retinal endothelial activation is not fully understood. We hypothesized that HG-induced upregulation of lysyl oxidase (LOX), a collagen-cross-linking enzyme, in retinal capillary endothelial cells (ECs) enhances subendothelial basement membrane (BM) stiffness, which, in turn, promotes retinal EC activation. Diabetic C57BL/6 mice exhibiting a 70 and 50% increase in retinal intercellular adhesion molecule (ICAM)-1 expression and leukocyte accumulation, respectively, demonstrated a 2-fold increase in the levels of BM collagen IV and LOX, key determinants of capillary BM stiffness. Using atomic force microscopy, we confirmed that HG significantly enhances LOX-dependent subendothelial matrix stiffness in vitro, which correlated with an similar to 2.5-fold increase in endothelial ICAM-1 expression, a 4-fold greater monocyte-EC adhesion, and an similar to 2-fold alteration in endothelial NO (decrease) and NF-kappa B activation (increase). Inhibition of LOX-dependent subendothelial matrix stiffening alone suppressed HG-induced retinal EC activation. Finally, using synthetic matrices of tunable stiffness, we demonstrated that subendothelial matrix stiffening is necessary and sufficient to promote EC activation. These findings implicate BM stiffening as a critical determinant of HG-induced retinal EC activation and provide a rationale for examining BM stiffness and underlying mechano-transduction pathways as therapeutic targets for diabetic retinopathy.	[Yang, Xiao; Scott, Harry A.; Ardekani, Soroush; Cabrera, Andrea; Ghosh, Kaustabh] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92507 USA; [Xu, Jun; Mohideen, Umar] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92507 USA; [Monickaraj, Finny; Nitta, Carolina F.; Das, Arup] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [McGuire, Paul G.] Univ New Mexico, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Nitta, Carolina F.; Das, Arup] New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of New Mexico; University of New Mexico	Ghosh, K (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92507 USA.	kghosh@engr.ucr.edu	Xu, Jun/N-8564-2018	Xu, Jun/0000-0001-7735-9554	University of California, Riverside (UCR) Bourns College of Engineering; U. S. National Institutes of Health, National Eye Institute [R01EY022327]; NATIONAL EYE INSTITUTE [R01EY022327] Funding Source: NIH RePORTER	University of California, Riverside (UCR) Bourns College of Engineering; U. S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Initial Complement Funds provided by the University of California, Riverside (UCR) Bourns College of Engineering (to K.G.) and U. S. National Institutes of Health, National Eye Institute Grant R01EY022327 (to A.D.). X.Y., H.A.S., and K.G. disclose a UCR invention. The remaining authors report no conflicts of interest.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Azad N, 2014, DIABETES CARE, V37, P501, DOI 10.2337/dc13-1193; Bandello F, 2014, OPHTHALMIC RES, V52, P89, DOI 10.1159/000362764; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chang KC, 2006, EUR J CLIN INVEST, V36, P1, DOI 10.1111/j.1365-2362.2006.01588.x; Chronopoulos A, 2011, CURR EYE RES, V36, P747, DOI 10.3109/02713683.2011.585735; Chronopoulos A, 2010, DIABETES, V59, P3159, DOI 10.2337/db10-0365; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Goldsbury CS, 2009, CURR PROTOC PROTEIN; Grant MB, 1996, EXP EYE RES, V63, P233, DOI 10.1006/exer.1996.0112; Halfter W, 2015, FEBS J, V282, P4466, DOI 10.1111/febs.13495; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Iliaki E, 2009, INVEST OPHTH VIS SCI, V50, P4898, DOI 10.1167/iovs.08-2013; Ito H, 2001, J BIOL CHEM, V276, P24023, DOI 10.1074/jbc.M100861200; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Kothapalli D, 2012, CELL REP, V2, P1259, DOI 10.1016/j.celrep.2012.09.018; Kowluru RA, 2015, PROG RETIN EYE RES, V48, P40, DOI 10.1016/j.preteyeres.2015.05.001; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Lehenkari P P, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400001575; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li QH, 2010, INVEST OPHTH VIS SCI, V51, P5240, DOI 10.1167/iovs.09-5147; Ljubimov AV, 1996, J HISTOCHEM CYTOCHEM, V44, P1469, DOI 10.1177/44.12.8985139; Lutty GA, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12979; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Marchina E, 1996, INT J BIOCHEM CELL B, V28, P1141, DOI 10.1016/1357-2725(96)00055-6; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; O'Day RF, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-123; Orr AW, 2005, J CELL BIOL, V169, P191, DOI 10.1083/jcb.200410073; OXLUND H, 1989, DIABETOLOGIA, V32, P748, DOI 10.1007/BF00274536; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; ROY S, 1994, J CLIN INVEST, V93, P438, DOI 10.1172/JCI116979; Scholl ZN, 2014, J BIOL CHEM, V289, P28607, DOI 10.1074/jbc.M114.582049; Shimizu M, 1997, BBA-PROTEIN STRUCT M, V1339, P53, DOI 10.1016/S0167-4838(96)00214-2; Shirwany NA, 2012, FRONT BIOSCI-LANDMRK, V17, P1140, DOI 10.2741/3978; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; To M, 2013, EXP EYE RES, V116, P298, DOI 10.1016/j.exer.2013.09.011; TRACHE A, 2008, CURR PROTOC MICROBIO, pCH2; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	54	36	38	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					601	611		10.1096/fj.15-277962	http://dx.doi.org/10.1096/fj.15-277962			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443820	Green Published			2022-12-28	WOS:000369391900013
J	Strom, J; Xu, BB; Tian, XQ; Chen, QM				Strom, Joshua; Xu, Beibei; Tian, Xiuqing; Chen, Qin M.			Nrf2 protects mitochondrial decay by oxidative stress	FASEB JOURNAL			English	Article						cell survival; loss of mitochondria; transcription factor; mitochondrial outer membrane	PROCEDURAL MYOCARDIAL INJURY; TRANSCRIPTION FACTOR NRF2; HEME OXYGENASE-1; CELL-DEATH; PERMEABILITY TRANSITION; BIOGENESIS; ACTIVATION; AUTOPHAGY; ANTIOXIDANT; FISSION	Sublethal levels of oxidative stress are commonly associated with various pathophysiological conditions. Cardiomyocytes have the highest content of mitochondria among all cell types, allowing the study of mitochondria in cells surviving oxidative stress and address whether nuclear factor-erythroid-derived 2-related factor 2 (Nrf2) can reverse these changes. Mitochondria normally exist in elaborated networks, which were replaced by predominately individual punctuate mitochondria 24 h after exposure to a nonlethal dose of H2O2. Electron microscopy revealed that cells surviving H2O2 show swelling of mitochondria with disorganized cristae and areas of condensation. Measurements of functional mitochondria showed a H2O2 dose-dependent decrease over a course of 5 d. At the protein and mRNA levels, cells surviving H2O2 treatment show a reduction of mitochondrial components, cytochrome c, and cytochrome b. Nrf2 overexpression prevented H2O2 from inducing mitochondria morphologic changes and reduction of cytochrome b/c. Although Nrf2 is known as a transcription factor regulating antioxidant and detoxification genes, Nrf2 overexpression did not significantly reduce the level of protein oxidation. Instead, Nrf2 was found to associate with the outer mitochondrial membrane. Mitochondria prepared from the myocardium of Nrf2 knockout mice are more sensitive to permeability transition. Our data suggest that Nrf2 protects mitochondria from oxidant injury likely through direct interaction with mitochondria.-Strom, J., Xu, B., Tian, X., Chen, Q. M. Nrf2 protects mitochondrial decay by oxidative stress. FASEB J. 30, 66-80 (2016). www.fasebj.org	[Strom, Joshua; Xu, Beibei; Tian, Xiuqing; Chen, Qin M.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA	University of Arizona	Chen, QM (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	qchen@email.arizona.edu		Strom, Joshua/0000-0003-1236-1877	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01 HL089958]; NIH National Institute of Environmental Sciences [R21 ES017473, T32 ES007091]; NIH National Institute of General Medicine Sciences [R01 GM111337]; University of Arizona Sarver Heart Center Anonymous Award for Heart Failure Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007091, R21ES017473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111337] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Environmental Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of General Medicine Sciences; University of Arizona Sarver Heart Center Anonymous Award for Heart Failure Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01 HL089958, NIH National Institute of Environmental Sciences Grants R21 ES017473 and T32 ES007091, and NIH National Institute of General Medicine Sciences Grant R01 GM111337 and a University of Arizona Sarver Heart Center Anonymous Award for Heart Failure Research.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Athale J, 2012, FREE RADICAL BIO MED, V53, P1584, DOI 10.1016/j.freeradbiomed.2012.08.009; Babu GG, 2011, EUR HEART J, V32, P23, DOI 10.1093/eurheartj/ehq393; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Bolisetty S, 2013, AM J PHYSIOL-RENAL, V305, pF255, DOI 10.1152/ajprenal.00160.2013; Borillo GA, 2010, CIRC RES, V106, P1265, DOI 10.1161/CIRCRESAHA.109.212035; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; Caballero-Caballero A, 2013, J NEUROCHEM, V124, P749, DOI 10.1111/jnc.12133; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen QM, 2002, ONCOGENE, V21, P5313, DOI 10.1038/sj.onc.1205644; Chen QM, 2000, ARCH BIOCHEM BIOPHYS, V373, P242, DOI 10.1006/abbi.1999.1558; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Cooper MP, 2013, CIRCULATION, V127, P1932, DOI 10.1161/CIRCULATIONAHA.113.003177; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Darvekar SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085262; Dement GA, 2005, EXP CELL RES, V307, P388, DOI 10.1016/j.yexcr.2005.04.004; Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Goldhaber J.I., 1997, MYOCARDIUM, Vsecond, P325; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Ludtmann MHR, 2014, BIOCHEM J, V457, P415, DOI 10.1042/BJ20130863; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ogita K, 2003, J NEUROSCI RES, V73, P794, DOI 10.1002/jnr.10720; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; OPIE LH, 1989, CIRCULATION, V80, P1049, DOI 10.1161/01.CIR.80.4.1049; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Purdom S, 2005, J PHARMACOL EXP THER, V312, P1179, DOI 10.1124/jpet.104.077057; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Purdom-Dickinson SE, 2007, J MOL CELL CARDIOL, V42, P159, DOI 10.1016/j.yjmcc.2006.09.012; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Tu Victoria C, 2003, Cardiovasc Toxicol, V3, P119, DOI 10.1385/CT:3:2:119; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]	69	82	86	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					66	80		10.1096/fj.14-268904	http://dx.doi.org/10.1096/fj.14-268904			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26340923	Green Published			2022-12-28	WOS:000367621000009
J	Magnone, M; Ameri, P; Salis, A; Andraghetti, G; Emionite, L; Murialdo, G; De Flora, A; Zocchi, E				Magnone, Mirko; Ameri, Pietro; Salis, Annalisa; Andraghetti, Gabriella; Emionite, Laura; Murialdo, Giovanni; De Flora, Antonio; Zocchi, Elena			Microgram amounts of abscisic acid in fruit extracts improve glucose tolerance and reduce insulinemia in rats and in humans	FASEB JOURNAL			English	Article						plasma glucose; plasma insulin; apricots; OGTT; standard B&L	CYCLIC ADP-RIBOSE; 2ND-MESSENGER; INFLAMMATION	2-Cis,4-trans-abscisic acid (ABA) is a plant hormone that is present also in animals. Several lines of evidence suggest that ABA contributes to the regulation of glycemia in mammals: nanomolar ABA stimulates insulin release from beta-pancreatic cells and glucose transporter-4-mediated glucose uptake by myoblasts and adipocytes in vitro; plasma ABA increases in normal human subjects, but not in diabetic patients, after a glucose load for an oral glucose tolerance test (OGTT). The presence of ABA in fruits prompted an exploration of the bioavailability of dietary ABA and the effect of ABA-rich fruit extracts on glucose tolerance. Rats underwent an OGTT, with or without 1 mu g/kg ABA, either synthetic or present in a fruit extract. Human volunteers underwent an OGTT or a standard breakfast and lunch, with or without a fruit extract, yielding an ABA dose of 0.85 or 0.5 mu g/kg, respectively. Plasma glucose, insulin, and ABA were measured at different time points. Oral ABA at 0.5-1 mu g/kg significantly lowered glycemia and insulinemia in rats and in humans. Thus, the glycemia-lowering effect of low-dose ABA in vivo does not depend on an increased insulin release. Low-dose ABA intake may be proposed as an aid to improving glucose tolerance in patients with diabetes who are deficient in or resistant to insulin.	[Magnone, Mirko; Salis, Annalisa; De Flora, Antonio; Zocchi, Elena] DIMES, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Magnone, Mirko; Salis, Annalisa; De Flora, Antonio; Zocchi, Elena] DIMES, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Ameri, Pietro; Andraghetti, Gabriella; Murialdo, Giovanni] DIMES, Dept Internal Med, I-16132 Genoa, Italy; [Emionite, Laura] Azienda Osped Univ San Martino, Ist Sci Tumori, Ist Ricovero & Cura Carattere Sci, Anim Facil, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Magnone, M (corresponding author), DIMES, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	mirko.magnone@unige.it; ezocchi@unige.it	Emionite, Laura/AAB-3120-2020; Ameri, Pietro/K-8556-2016; Salis, Annalisa/R-9241-2018	Emionite, Laura/0000-0002-5199-6384; Ameri, Pietro/0000-0001-7167-7287; Salis, Annalisa/0000-0002-3082-2908	Italian Ministry of Education, University and Scientific Research [2010MCLBCZ]; Compagnia di S. Paolo [2012-ID-ROL316]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Compagnia di S. Paolo(Compagnia di San Paolo)	This work was supported in part by Grant 2010MCLBCZ from the Italian Ministry of Education, University and Scientific Research [Fondazione Carige (Cassa di Risparmio di Genova e Imperia), Genoa, Italy], and by Grant 2012-ID-ROL316 from Compagnia di S. Paolo (all to E.Z.). The authors declare no conflicts of interest.	Ameri P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115992; Bruzzone S., 2012, MESSENGER, V1, P141; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Bruzzone S, 2012, J CELL PHYSIOL, V227, P2502, DOI 10.1002/jcp.22987; De Flora A., 2014, MESSENGER, V3, P86, DOI DOI 10.1166/MSR.2014.1029; Gomez-Cadenas A, 2002, PHYTOCHEM ANALYSIS, V13, P228, DOI 10.1002/pca.640; Greenberg A. S., 2006, AM J CLIN NUTR, V83, p461S; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ledford H, 2013, NATURE, V504, P198, DOI 10.1038/504198a; Li HH, 2011, BIOCHEM PHARMACOL, V82, P701, DOI 10.1016/j.bcp.2011.06.042; Magnone M, 2012, FASEB J, V26, P1261, DOI 10.1096/fj.11-187351; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Scarfi S, 2009, STEM CELLS, V27, P2469, DOI 10.1002/stem.173; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Tossi V, 2012, TRENDS PLANT SCI, V17, P510, DOI 10.1016/j.tplants.2012.05.007	21	49	50	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4783	4793		10.1096/fj.15-277731	http://dx.doi.org/10.1096/fj.15-277731			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26243865				2022-12-28	WOS:000365523600006
J	Attur, M; Yang, Q; Shimada, K; Tachida, Y; Nagase, H; Mignatti, P; Statman, L; Palmer, G; Kirsch, T; Beier, F; Abramson, SB				Attur, Mukundan; Yang, Qing; Shimada, Kohei; Tachida, Yuki; Nagase, Hiroyuki; Mignatti, Paolo; Statman, Lauren; Palmer, Glyn; Kirsch, Thorsten; Beier, Frank; Abramson, Steven B.			Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13	FASEB JOURNAL			English	Article						posttraumatic osteoarthritis; chondrocytes; Wnt signaling; ADAMTS	ARTICULAR-CARTILAGE; GENE-EXPRESSION; INFLAMMATORY MEDIATORS; BONE; CHONDROCYTES; REVEALS; DESTRUCTION; PROGRESSION; MECHANISMS; PATHWAYS	We investigated the role of periostin, an extracellular matrix protein, in the pathophysiology of osteoarthritis (OA). In OA, dysregulated gene expression and phenotypic changes in articular chondrocytes culminate in progressive loss of cartilage fromthe joint surface. The molecular mechanisms underlying this process are poorly understood. We examined periostin expression by immunohistochemical analysis of lesional and nonlesional cartilage from human and rodent OA knee cartilage. In addition, we used small interfering (si) RNA and adenovirus transduction of chondrocytes to knock down and up-regulate periostin levels, respectively, and analyzed its effect on matrix metalloproteinase (MMP)-13, a disintegrin and MMP with thrombospondin motifs (ADAMTS)-4, and type II collagen expression. We found high periostin levels in human and rodent OA cartilage. Periostin increased MMP-13 expression dose [1-10 mu g/ml (EC50 0.5-1 mu g/ml)] and time (24-72 h) dependently, significantly enhanced expression of ADAMTS4 mRNA, and promoted cartilage degeneration through collagen and proteoglycan degradation. Periostin induction of MMP-13 expression was inhibited by CCT031374 hydrobromide, an inhibitor of the canonical Wnt/beta-catenin signaling pathway. In addition, siRNA-mediated knockdown of endogenous periostin blocked constitutive MMP-13 expression. These findings implicate periostin as a catabolic protein that promotes cartilage degeneration in OA by up-regulating MMP-13 through canonical Wnt signaling.	[Attur, Mukundan; Yang, Qing; Mignatti, Paolo; Statman, Lauren; Palmer, Glyn; Abramson, Steven B.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY USA; [Mignatti, Paolo] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Kirsch, Thorsten] NYU, Sch Med, Dept Orthopaed Surg, New York, NY 10016 USA; [Kirsch, Thorsten] NYU, Langone Med Ctr, New York, NY USA; [Shimada, Kohei; Tachida, Yuki; Nagase, Hiroyuki] Daiichi Sankyo Co Ltd, Frontier Res Labs, Tokyo, Japan; [Palmer, Glyn] Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL USA; [Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	New York University; New York University; New York University; New York University; NYU Langone Medical Center; Daiichi Sankyo Company Limited; State University System of Florida; University of Florida; Western University (University of Western Ontario)	Attur, M (corresponding author), NYU, Hosp Joint Dis, Div Rheumatol, 301 East 17th St,Suite 1410, New York, NY 10003 USA.	mukundan.attur@nyumc.org	Beier, Frank/G-4595-2013; Kirsch, Thorsten/GQP-1157-2022; Attur, Mukundan/O-1578-2019; Beier, Frank/T-4734-2019	Beier, Frank/0000-0002-8505-7537; Attur, Mukundan/0000-0001-7080-8118; Beier, Frank/0000-0002-8505-7537; Abramson, Steven/0000-0002-0668-6344; Mignatti, Paolo/0000-0002-8157-457X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR054817]; U.S. NIH National Cancer Institute [R01-CA136715]; Daiichi Sankyo Co., Ltd. (Tokyo, Japan); NATIONAL CANCER INSTITUTE [R01CA136715] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054817] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Daiichi Sankyo Co., Ltd. (Tokyo, Japan)(Daiichi Sankyo Company Limited); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01-AR054817 (to S.B.A.) and U.S. NIH National Cancer Institute Grant R01-CA136715 (to P.M.); and by a research grant from Daiichi Sankyo Co., Ltd. (Tokyo, Japan). K.S., Y.T., and H.N. are employees of Daiichi Sankyo Co., Ltd. The authors declare no conflicts of interests.	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; AMIN AR, 1995, J EXP MED, V182, P2097, DOI 10.1084/jem.182.6.2097; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Attur M, 2011, OSTEOARTHR CARTILAGE, V19, P1158, DOI 10.1016/j.joca.2011.06.006; Attur M. G., 2002, Current Issues in Molecular Biology, V4, P129; Attur MG, 2001, ARTHRITIS RHEUM-US, V44, P578, DOI 10.1002/1529-0131(200103)44:3<578::AID-ANR106>3.3.CO;2-Z; Attur M, 2013, CURR OPIN RHEUMATOL, V25, P136, DOI 10.1097/BOR.0b013e32835a9381; Attur M, 2012, ARTHRITIS RHEUM-US, V64, P1940, DOI 10.1002/art.34360; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P363; Blom AB, 2010, CURR DRUG TARGETS, V11, P620; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bove SE, 2006, OSTEOARTHR CARTILAGE, V14, P1041, DOI 10.1016/j.joca.2006.05.001; Campbell KA, 2013, ARTHRITIS RHEUM-US, V65, P3120, DOI 10.1002/art.38182; Chou CH, 2013, OSTEOARTHR CARTILAGE, V21, P450, DOI 10.1016/j.joca.2012.11.016; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fosang AJ, 2011, BEST PRACT RES CL RH, V25, P751, DOI 10.1016/j.berh.2011.11.010; Gardiner MD, 2015, OSTEOARTHR CARTILAGE, V23, P616, DOI 10.1016/j.joca.2014.12.014; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; HANDLEY CJ, 1995, METHOD ENZYMOL, V248, P47; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kikuchi Y, 2014, AM J PATHOL, V184, P859, DOI 10.1016/j.ajpath.2013.11.012; Li YP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/916530; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007; Loeser RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054633; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Lotz M, 2012, OSTEOARTHR CARTILAGE, V20, P192, DOI 10.1016/j.joca.2011.11.015; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Lourido L, 2014, J PROTEOME RES, V13, P6096, DOI 10.1021/pr501024p; Maldonado M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284873; Mariani E, 2014, INT J MOL SCI, V15, P8667, DOI 10.3390/ijms15058667; Marie PJ, 2014, TRENDS ENDOCRIN MET, V25, P567, DOI 10.1016/j.tem.2014.06.009; McCann JC, 2009, AM J CLIN NUTR, V90, P889, DOI 10.3945/ajcn.2009.27930; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Minashima T, 2014, ARTHRITIS RHEUMATOL, V66, P1228, DOI 10.1002/art.38373; Misra D, 2013, AM J MED, V126, P243, DOI 10.1016/j.amjmed.2012.10.011; Nagase H, 2013, OSTEOARTHR CARTILAGE, V21, P514, DOI 10.1016/j.joca.2012.12.013; Olex AL, 2014, GENE, V542, P38, DOI 10.1016/j.gene.2014.03.022; Orecchia P, 2011, EUR J CANCER, V47, P2221, DOI 10.1016/j.ejca.2011.04.026; Sandell LJ, 2007, ARTHRITIS RHEUM, V56, P2474, DOI 10.1002/art.22760; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; van der Kraan PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2896; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; Watanabe T, 2012, ARCH ORAL BIOL, V57, P52, DOI 10.1016/j.archoralbio.2011.07.010; Wen W, 2010, J DENT RES, V89, P1439, DOI 10.1177/0022034510378684; Yang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041994; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhang RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032356; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	59	38	42	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4107	4121		10.1096/fj.15-272427	http://dx.doi.org/10.1096/fj.15-272427			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26092928	Green Published			2022-12-28	WOS:000361367300003
J	Joo, Y; Schumacher, B; Landrieu, I; Bartel, M; Smet-Nocca, C; Jang, A; Choi, HS; Jeon, NL; Chang, KA; Kim, HS; Ottmann, C; Suh, YH				Joo, Yuyoung; Schumacher, Benjamin; Landrieu, Isabelle; Bartel, Maria; Smet-Nocca, Caroline; Jang, Ahram; Choi, Hee Soon; Jeon, Noo Li; Chang, Keun-A; Kim, Hye-Sun; Ottmann, Christian; Suh, Yoo-Hun			Involvement of 14-3-3 in tubulin instability and impaired axon development is mediated by Tau	FASEB JOURNAL			English	Article						protein-protein interactions; Alzheimer's disease; phosphorylation; X-ray crystallography; NMR spectroscopy	PROTEIN-PROTEIN INTERACTIONS; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL ACTIVATION; PHOSPHORYLATION SITES; NMR ASSIGNMENT; IDENTIFICATION; 14-3-3-PROTEINS; MICROTUBULES; BINDING	14-3-3 proteins act as adapters that exert their function by interacting with their various protein partners. 14-3-3 proteins have been implicated in a variety of human diseases including neurodegenerative diseases. 14-3-3 proteins have recently been reported to be abundant in the neurofibrillary tangles (NFTs) observed inside the neurons of brains affected by Alzheimer's disease (AD). These NFTs are mainly constituted of phosphorylated Tau protein, a microtubule-associated protein known to bind 14-3-3. Despite this indication of 14-3-3 protein involvement in the AD pathogenesis, the role of 14-3-3 in the Tauopathy remains to be clarified. In the present study, we shed light on the role of 14-3-3 proteins in the molecular pathways leading to Tauopathies. Overexpression of the 14-3-3s isoform resulted in a disruption of the tubulin cytoskeleton and prevented neuritic outgrowth in neurons. NMR studies validated the phosphorylated residues pSer214 and pSer324 in Tau as the 2 primary sites for 14-3-3binding, with the crystal structure of 14-3-3 sigma in complex with Tau-pSer214 and Tau-pSer324 revealing the molecular details of the interaction. These data suggest a rationale for a possible pharmacologic intervention of the Tau/14-3-3 interaction.	[Joo, Yuyoung; Jang, Ahram; Choi, Hee Soon; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Joo, Yuyoung; Jang, Ahram; Choi, Hee Soon; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Med Res Council, Neurosci Res Inst, Seoul, South Korea; [Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul, South Korea; [Joo, Yuyoung; Chang, Keun-A] Gachon Univ, Coll Med, Dept Pharmacol, Inchon, South Korea; [Schumacher, Benjamin; Bartel, Maria; Ottmann, Christian] Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany; [Landrieu, Isabelle; Smet-Nocca, Caroline] Univ Lille, Ctr Natl Rech Sci, Unit Mixte Rech 8576, Villeneuve Dascq, France; [Ottmann, Christian] Eindhoven Univ Technol, Biol Chem Lab, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Ottmann, Christian] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Choi, Hee Soon; Suh, Yoo-Hun] Korea Brain Res Inst, Daegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gachon University; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Eindhoven University of Technology; Eindhoven University of Technology; Korea Brain Research Institute (KBRI)	Ottmann, C (corresponding author), Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany.	c.ottmann@tue.nl; yhsuh@kbri.re.kr	Landrieu, Isabelle/AAF-8495-2019; Smet-Nocca, Caroline/U-3427-2019; Smet-Nocca, Caroline/G-2868-2012	Landrieu, Isabelle/0000-0002-4883-2637; Smet-Nocca, Caroline/0000-0002-9793-0882; Smet-Nocca, Caroline/0000-0002-9793-0882; Bartel, Maria/0000-0001-8131-1078	AstraZeneca; BayerCrop Science; Bayer Healthcare; Boehringer Ingelheim; Merck KGaA; Conversing Research Center Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2009-0082268]; Korea Research Foundation - Korean government [KRF-2008-621-H00002]; National Research Foundation of Korea - Korean Government (Ministry of Education, Science and Technology) [NRF-2011-355-E00089]; Establishment and Operation of Korea Brain Research Institute basic research program of the Ministry of Science, Internal Cooperation and Future Planning [2231-415]; 14-3-3STABS European Union [286418]; French Laboratory of Excellency Distalz; Region Nord; Centre national de la recherche scientifique; Pasteur Institute of Lille; European Community (Fonds Europeen de Developpement Regional; FEDER); French Research Ministry; University of Sciences and Technologies of Lille 1; Tres Grand Equipement Resonance Magnetique Nucleaire Tres Hauts Champs, France [FR-3050]	AstraZeneca(AstraZeneca); BayerCrop Science; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Merck KGaA(Merck & Company); Conversing Research Center Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Korea Research Foundation - Korean government(National Research Foundation of KoreaKorean Government); National Research Foundation of Korea - Korean Government (Ministry of Education, Science and Technology); Establishment and Operation of Korea Brain Research Institute basic research program of the Ministry of Science, Internal Cooperation and Future Planning; 14-3-3STABS European Union; French Laboratory of Excellency Distalz; Region Nord(Region Hauts-de-France); Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community (Fonds Europeen de Developpement Regional; FEDER); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille 1; Tres Grand Equipement Resonance Magnetique Nucleaire Tres Hauts Champs, France	C.O. thanks AstraZeneca, BayerCrop Science, Bayer Healthcare, Boehringer Ingelheim, and Merck KGaA for support. This functional research was additionally supported by the Conversing Research Center Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2009-0082268), the Korea Research Foundation grant funded by the Korean government (KRF-2008-621-H00002), National Research Foundation of Korea grant funded by the Korean Government (Ministry of Education, Science and Technology; NRF-2011-355-E00089), the Establishment and Operation of Korea Brain Research Institute basic research program of the Ministry of Science, Internal Cooperation and Future Planning (2231-415), the 14-3-3STABS European Union Project 286418, and the French Laboratory of Excellency Distalz. The nuclear magnetic resonance facilities were funded by the Region Nord, Centre national de la recherche scientifique, Pasteur Institute of Lille, European Community (Fonds Europeen de Developpement Regional; FEDER), French Research Ministry, and the University of Sciences and Technologies of Lille 1. The authors acknowledge support from the Tres Grand Equipement Resonance Magnetique Nucleaire Tres Hauts Champs (FR-3050, France). I.L., Y.-H.S., and C.O. conceived the project and wrote the manuscript. Y.J. and B.S. performed most of the experimental work. M.B. performed biophysical experiments. C.S.-N. performed nuclear magnetic resonance experiments. The authors declare no conflicts of interest.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Anders C, 2013, CHEM BIOL, V20, P583, DOI 10.1016/j.chembiol.2013.03.015; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; Camoni L, 2011, BIOCHEM J, V436, P429, DOI 10.1042/BJ20102037; Campenot RB, 1996, J CELL BIOL, V135, P701, DOI 10.1083/jcb.135.3.701; Chun J, 2004, MOL CELLS, V18, P360; Corradi V, 2010, BIOORG MED CHEM LETT, V20, P6133, DOI 10.1016/j.bmcl.2010.08.019; de Vries-van Leeuwen IJ, 2010, CANCER LETT, V293, P198, DOI 10.1016/j.canlet.2010.01.009; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Gordon-Weeks PR, 2004, NAT CELL BIOL, V6, P390, DOI 10.1038/ncb0504-390; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; De Vries-van Leeuwen IJ, 2013, P NATL ACAD SCI USA, V110, P8894, DOI 10.1073/pnas.1220809110; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Lippens G, 2004, CHEMBIOCHEM, V5, P73, DOI 10.1002/cbic.200300763; Matthews TA, 2005, NEUROSCI LETT, V384, P211, DOI 10.1016/j.neulet.2005.04.101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Ottmann C, 2009, J MOL BIOL, V386, P913, DOI 10.1016/j.jmb.2009.01.005; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Rajagopalan S, 2010, NUCLEIC ACIDS RES, V38, P893, DOI 10.1093/nar/gkp1041; Rose R, 2010, ANGEW CHEM INT EDIT, V49, P4129, DOI 10.1002/anie.200907203; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; Sluchanko NN, 2009, FEBS LETT, V583, P2739, DOI 10.1016/j.febslet.2009.07.043; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Wu H, 2010, ANGEW CHEM INT EDIT, V49, P6528, DOI 10.1002/anie.201003257; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229; Zeidler M, 2000, ANN NEUROL, V47, P683, DOI 10.1002/1531-8249(200005)47:5<683::AID-ANA25>3.0.CO;2-V; Zhao J, 2011, P NATL ACAD SCI USA, V108, P16212, DOI 10.1073/pnas.1100012108	53	49	49	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4133	4144		10.1096/fj.14-265009	http://dx.doi.org/10.1096/fj.14-265009			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26103986				2022-12-28	WOS:000361367300005
J	Kang, CH; Goodman, CA; Hornberger, TA; Ji, LL				Kang, Chounghun; Goodman, Craig A.; Hornberger, Troy A.; Ji, Li Li			PGC-1 alpha overexpression by in vivo transfection attenuates mitochondrial deterioration of skeletal muscle caused by immobilization	FASEB JOURNAL			English	Article						atrophy; inflammation; oxidative stress	UBIQUITIN LIGASE; COACTIVATOR PGC-1; OXIDATIVE STRESS; BED-REST; ATROPHY; EXPRESSION; DISUSE; BIOGENESIS; PROTEIN; EXERCISE	Prolonged immobilization (IM) causes skeletal muscle atrophy characterized by mitochondrial deterioration and proteolysis. Muscle remobilization (RM) increases reactive oxygen species generation, proinflammatory cytokine expression, and oxidative stress, preventing muscle from quick recovery. Thus, we hypothesized that overexpression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) via in vivo transfection would promote mitochondrial biogenesis and antioxidant defense, thus ameliorating the aforementioned deteriorations in a mouse model with 14-d IM followed by 5-d RM. PGC-1 alpha transfection in tibialis anterior muscle resulted in a 7.2-and 4-fold increase in PGC-1 alpha content in cytosol and nucleus, respectively. Mitochondrial biogenic (cytochrome c, mitochondrial transcription factor A), morphologic (mitochondrial density, mDNA/nDNA ratio), and functional (cytochrome c oxidase activity, ATP synthesis rate) markers, as well as fiber cross-sectional area, significantly increased in IM-RM muscle by PGC-1 alpha overexpression. These effects were accompanied by an 18% decrease in H2O2, 30% decrease in nuclear factor-kB-DNA binding, and 25% reduction of IL-1 beta and-6 production in IM-RMmuscle. There was a 34% increase in superoxide dismutase-2 activity, along with a 3.5-fold increase in NAD-dependent deacetylase sirtuin-3 expression caused by enhanced PGC-1 alpha-estrogen-related receptor a binding. Our findings highlighted the importance of PGC-1 alpha in protecting muscle from metabolic and redox disturbances caused by IM.	[Kang, Chounghun; Ji, Li Li] Univ Minnesota Twin Cities, Sch Kinesiol, Lab Physiol Hyg & Exercise Sci, Minneapolis, MN USA; [Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Ji, LL (corresponding author), Lab Physiol Hyg & Exercise Sci, 1900 Univ Ave, Minneapolis, MN 55455 USA.	llji@umn.edu	Goodman, Craig/H-8085-2019	Goodman, Craig/0000-0002-5874-7743	Wisconsin Alumni Research Foundation; University of Minnesota Office of Vice-President for Research; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	Wisconsin Alumni Research Foundation; University of Minnesota Office of Vice-President for Research; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was supported in part by grants from the Wisconsin Alumni Research Foundation and the University of Minnesota Office of Vice-President for Research (to L.L.J.), and a U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057347 (to T.A.H.). The authors declare no conflicts of interest.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Falk DJ, 2006, J APPL PHYSIOL, V101, P1017, DOI 10.1152/japplphysiol.00104.2006; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kang C, 2013, J APPL PHYSIOL, V115, P1618, DOI 10.1152/japplphysiol.01354.2012; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; KONDO H, 1993, AM J PHYSIOL, V265, pE839, DOI 10.1152/ajpendo.1993.265.6.E839; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; LEBLANC AD, 1992, J APPL PHYSIOL, V73, P2172, DOI 10.1152/jappl.1992.73.5.2172; Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Liu J, 2014, FREE RADICAL BIO MED, V69, P116, DOI 10.1016/j.freeradbiomed.2014.01.003; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	46	51	55	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4092	4106		10.1096/fj.14-266619	http://dx.doi.org/10.1096/fj.14-266619			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26178167	Green Published			2022-12-28	WOS:000361367300002
J	Nomura, T; Cox, CD; Bavi, N; Sokabe, M; Martinac, B				Nomura, Takeshi; Cox, Charles D.; Bavi, Navid; Sokabe, Masahiro; Martinac, Boris			Unidirectional incorporation of a bacterial mechanosensitive channel into liposomal membranes	FASEB JOURNAL			English	Article						MscS; reconstitution; patch clamp fluorometry; electrophysiology; finite element simulation	ESCHERICHIA-COLI MSCS; ION-CHANNEL; RECONSTITUTION METHOD; CYTOPLASMIC DOMAIN; LIGAND-BINDING; PATCH-CLAMP; ACTIVATION; MECHANISM; PURIFICATION; PROTEINS	The bacterial mechanosensitive channel of small conductance (MscS) plays a crucial role in the protection of bacterial cells against hypo-osmotic shock. The functional characteristics of MscS have been extensively studied using liposomal reconstitution. This is a widely used experimental paradigm and is particularly important for mechanosensitive channels as channel activity can be probed free from cytoskeletal influence. A perpetual issue encountered using this paradigm is unknown channel orientation. Here we examine the orientation of MscS in liposomes formed using 2 ion channel reconstitution methods employing the powerful combination of patch clamp electrophysiology, confocal microscopy, and continuum mechanics simulation. Using the previously determined electrophysiological and pharmacological properties of MscS, we were able to determine that in liposomes, independent of lipid composition, MscS adopts the same orientation seen in native membranes. These results strongly support the idea that these specific methods result in uniform incorporation of membrane ion channels and caution against making assumptions about mechanosensitive channel orientation using the stimulus type alone.	[Nomura, Takeshi; Cox, Charles D.; Bavi, Navid; Martinac, Boris] Victor Chang Cardiac Res Inst, Mechanosensory Biophys Lab, Mol Cardiol & Biophys Div, Darlinghurst, NSW 2010, Australia; [Nomura, Takeshi] Kyushu Nutr Welf Univ, Grad Sch Hlth Sci, Dept Phys Therapy, Fac Rehabil, Kitakyushu, Fukuoka, Japan; [Bavi, Navid; Martinac, Boris] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Mechanobiol Lab, Nagoya, Aichi 4648601, Japan	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Nagoya University	Martinac, B (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia.	b.martinac@victorchang.edu.au	Martinac, Boris/A-7178-2018; Cox, Charles D/GEC-3720-2022; Bavi, Navid/AAU-4729-2021; Sokabe, Masahiro/I-1565-2012	Martinac, Boris/0000-0001-8422-7082; Cox, Charles D/0000-0002-3802-6746; Bavi, Navid/0000-0001-7040-0710; 	National Health & Medical Research Council of Australia [APP1047980]; Yamada Science Foundation; Office of Health and Medical Research, NSW State Government, Australia; University of New South Wales for the International Postgraduate Award (UIPA); Australian Government; Grants-in-Aid for Scientific Research [15K21745] Funding Source: KAKEN	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Yamada Science Foundation; Office of Health and Medical Research, NSW State Government, Australia; University of New South Wales for the International Postgraduate Award (UIPA); Australian Government(Australian GovernmentCGIAR); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Paul R. Rohde and Maryrose Constantine (Victor Chang Cardiac Research Institute, Sydney, Australia) for technical assistance. The authors also thank Prof. I. R. Booth (University of Aberdeen, Aberdeen, UK) for his generous donation of the MJF465 strain. This study was supported by the National Health & Medical Research Council of Australia (APP1047980) and Yamada Science Foundation. This work was also supported in part by funds from the Office of Health and Medical Research, NSW State Government, Australia. The authors also thank the University of New South Wales for the International Postgraduate Award (UIPA) (to N.B.). This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government. The authors declare no competing financial interests.	Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, BIOPHYS J, V92, P2771, DOI 10.1529/biophysj.106.098715; Anishkin A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454120; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Battle AR, 2009, FEBS LETT, V583, P407, DOI 10.1016/j.febslet.2008.12.033; Bavi N, 2014, P NATL ACAD SCI USA, V111, P13864, DOI 10.1073/pnas.1409011111; Bavi O, 2014, CHANNELS, V8, P344, DOI 10.4161/chan.29572; Berrier C, 2013, J BIOL CHEM, V288, P27307, DOI 10.1074/jbc.M113.478321; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; Boer M, 2011, BIOCHEMISTRY-US, V50, P4087, DOI 10.1021/bi1019435; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Cox CD, 2015, PFLUG ARCH EUR J PHY, V467, P3, DOI 10.1007/s00424-014-1522-2; Cox CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3137; Cox CD, 2014, CHANNELS, V8, P5, DOI 10.4161/chan.27107; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; Das N, 2013, NAT PROTOC, V8, P2256, DOI 10.1038/nprot.2013.129; DEAMER DW, 1982, J MOL EVOL, V18, P203, DOI 10.1007/BF01733047; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Gamini R, 2011, BIOPHYS J, V101, P80, DOI 10.1016/j.bpj.2011.05.042; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; Kamaraju K, 2011, J GEN PHYSIOL, V138, P49, DOI 10.1085/jgp.201110606; KELLER BU, 1988, PFLUG ARCH EUR J PHY, V411, P94, DOI 10.1007/BF00581652; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Maksaev G, 2011, J GEN PHYSIOL, V138, P641, DOI 10.1085/jgp.201110723; Malcolm HR, 2011, BIOPHYS J, V101, P345, DOI 10.1016/j.bpj.2011.05.058; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Martinac B, 2010, METHODS MOL BIOL, V606, P31, DOI 10.1007/978-1-60761-447-0_4; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; Petrov E, 2013, BIOPHYS J, V104, P1426, DOI 10.1016/j.bpj.2013.01.055; Rowe I, 2014, J GEN PHYSIOL, V143, P543, DOI 10.1085/jgp.201311114; Slavchov RI, 2014, J PHYS CHEM B, V118, P12660, DOI 10.1021/jp506965v; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; Teng J., 2014, PFLUGERS AR IN PRESS; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18180, DOI 10.1073/pnas.1207977109; Zhong DL, 2013, BIOCHEMISTRY-US, V52, P5415, DOI 10.1021/bi400790j	53	23	23	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4334	4345		10.1096/fj.15-275198	http://dx.doi.org/10.1096/fj.15-275198			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26116700				2022-12-28	WOS:000361367300022
J	Lee, EJ; Park, EY; Mun, H; Chang, E; Ko, JY; Kim, DY; Park, JH				Lee, Eun Ji; Park, Eun Young; Mun, HyoWon; Chang, EunSun; Ko, Je Yeong; Kim, Do Yeon; Park, Jong Hoon			Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation	FASEB JOURNAL			English	Article						ADPKD; sRAGE; MAPK	CYST GROWTH; IN-VITRO; RAGE; ACTIVATION; PROTEINS; ADPKD; PKD1; INACTIVATION; PATHOGENESIS; INFLAMMATION	Autosomal polycystic kidney disease (ADPKD) is a highly prevalent genetic renal disorder in which epithelial-lining fluid-filledcysts appear in kidneys. It is accompanied by hyperactivation of cell proliferation, interstitial inflammation, and fibrosis around the cyst lining cells, finally reaching end-stage renal disease. Previously, we found high expression of ligands stimulating the receptor for advanced glycation end products (RAGE) in ADPKD mice. Furthermore, gene silencing of RAGE was revealed to cause reduction of cystogenesis via down-regulation of cell proliferation in vitro, and intravenous administration of anti-RAGE adenovirus in vivo also displayed alleviation of the disease. Here, we attempted to identify the role of soluble RAGE (sRAGE) in inhibiting the progression of ADPKD using 2 different ADPKD mouse models. sRAGE is an endogenously expressed form of RAGE that has no membrane-anchoring domain, thereby giving it the ability to neutralize the ligands that stimulate RAGE signals. Both overexpression of sRAGE and sRAGE treatment blocked RAGE-mediated cell proliferation in vitro. In addition, sRAGE-injected ADPKD mice showed reduced cysts accompanied by enhanced renal function, inhibition of cell proliferation, inflammation, and fibrosis. These positive therapeutic effects of sRAGE displayed little liver toxicity, suggesting it as a new potential therapeutic target of ADPKD with low side effects.-Lee, E. J., Park, E. Y., Mun, H., Chang, E., Ko, J. Y., Kim, D. Y., Park, J. H. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.	[Lee, Eun Ji; Park, Eun Young; Mun, HyoWon; Chang, EunSun; Ko, Je Yeong; Kim, Do Yeon; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea	Sookmyung Women's University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea.	parkjh@sookmyung.ac.kr			Bio & Medical Technology Development Program [2010-0019867, 2012M3A9D1054519]; Basic Science Research Program [2012 R1A1A2043225, 2013R1A2A1A01011908]; Mid-career Researcher Program of the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea [2012-043084]	Bio & Medical Technology Development Program; Basic Science Research Program; Mid-career Researcher Program of the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea	This work was supported by the Bio & Medical Technology Development Program (2010-0019867 and 2012M3A9D1054519), Basic Science Research Program (2012 R1A1A2043225 and 2013R1A2A1A01011908), and Mid-career Researcher Program (2012-043084) of the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT and Future Planning of Korea.	Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ko JY, 2013, BMB REP, V46, P73, DOI 10.5483/BMBRep.2013.46.2.022; Lariviere WB, 2015, TRANSL RES, V165, P488, DOI 10.1016/j.trsl.2014.11.003; Lee EJ, 2014, NEPHROLOGY, V19, P471, DOI 10.1111/nep.12261; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Lin LG, 2012, J CANCER RES CLIN, V138, P11, DOI 10.1007/s00432-011-1067-0; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Nakamura T, 2012, AM J MED SCI, V343, P46, DOI 10.1097/MAJ.0b013e31821f0552; Nakamura T, 2011, BLOOD PURIFICAT, V32, P139, DOI 10.1159/000325731; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Norman J, 2011, BBA-MOL BASIS DIS, V1812, P1327, DOI 10.1016/j.bbadis.2011.06.012; Novalic Z, 2012, J AM SOC NEPHROL, V23, P842, DOI 10.1681/ASN.2011040340; Park EY, 2014, J BIOL CHEM, V289, P9254, DOI 10.1074/jbc.M113.514166; Park EY, 2010, AM J NEPHROL, V32, P169, DOI 10.1159/000315859; Ramasamy R, 2012, VASC PHARMACOL, V57, P160, DOI 10.1016/j.vph.2012.06.004; Raphael KL, 2009, KIDNEY INT, V75, P626, DOI 10.1038/ki.2008.659; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Ta MHT, 2013, NEPHROLOGY, V18, P317, DOI 10.1111/nep.12045; Yamaguchi T, 2010, AM J PHYSIOL-RENAL, V299, pF944, DOI 10.1152/ajprenal.00387.2010; Zhu P, 2013, INT J MOL MED, V31, P763, DOI 10.3892/ijmm.2013.1286	29	16	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3506	3514		10.1096/fj.15-272302	http://dx.doi.org/10.1096/fj.15-272302			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25934702				2022-12-28	WOS:000358796900036
J	Nelson, J; Wu, Y; Jiang, XH; Berretta, R; Houser, S; Choi, E; Wang, JF; Huang, J; Yang, XF; Wang, H				Nelson, Jun; Wu, Yi; Jiang, Xiaohua; Berretta, Remus; Houser, Steven; Choi, Eric; Wang, Jingfeng; Huang, Jian; Yang, Xiaofeng; Wang, Hong			Hyperhomocysteinemia suppresses bone marrow CD34(+)/VEGF receptor 2(+) cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of beta 1-integrin in progenitor cell migration and adhesion	FASEB JOURNAL			English	Article						vascular remodeling; cell therapy; endothelial repair	CYSTATHIONINE BETA-SYNTHASE; STEM-CELLS; UREMIC TOXINS; REENDOTHELIALIZATION; HOMOCYSTEINE; TRANSPLANTATION; DEFICIENT; GROWTH; DIFFERENTIATION; ATHEROSCLEROSIS	Hyperhomocysteinemia (HHcy) impairs re-endothelialization and accelerates vascular remodeling. The role of CD34(+)/VEGF receptor (VEGFR) 2(+) progenitor cells (PCs) in vascular repair in HHcy is unknown. We studied the effect of HHcy on PCs and its role in vascular repair in severe HHcy (similar to 150 mu M), which was induced in cystathionine-beta synthase heterozygous mice fed a high-methionine diet for 8 weeks. Vascular injury was introduced by carotid air-dry endothelium-denudation. CD34(+)/VEGFR2(+) cells were examined by flow cytometry. HHcy reduced bonemarrow (BM) CD34(+)/VEGFR2(+) cells and suppressed replenishment of postinjury CD34(+)/VEGFR2(+) cells in peripheral blood (PB). Donor green fluorescent protein-positive PC homing to the injured vessel was reduced in HHcy after CD34(+) PCs from enhanced green fluorescent protein mice were adoptively transferred following carotid injury. CD34(+) PC transfusion partially reversed HHcy-suppressed re-endothelialization and HHcy-induced neointimal formation. Furthermore, homocysteine (Hcy) inhibited proliferation, adhesion, and migration and suppressed beta 1-integrin expression and activity in human CD34(+) endothelial colony-forming cells (ECFCs) isolated from PBs in a dose-dependent manner. A functional-activating beta 1-integrin antibody rescued Hcy-suppressed adhesion and migration in CD34(+) ECFCs. In conclusion, HHcy reduces BM CD34(+)/VEGFR2(+) generation and suppresses CD34(+)/VEGFR2(+) cell mobilization and homing to the injured vessel via beta 1-integrin inhibition, which partially contributes to impaired re-endothelialization and vascular remodeling.	[Nelson, Jun; Jiang, Xiaohua; Choi, Eric; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Ctr Metab Dis Res, Philadelphia, PA 19140 USA; [Nelson, Jun; Jiang, Xiaohua; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Wu, Yi; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Berretta, Remus; Houser, Steven; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Berretta, Remus; Houser, Steven] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Choi, Eric] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19140 USA; [Wang, Jingfeng] Zhongshan Univ, Sch Med, Sun Yixian Mem Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Huang, Jian] Temple Univ, Sch Med, Dept Pathol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wang, H (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Ctr Metab Dis Res, 3500 North Broad St, Philadelphia, PA 19140 USA.	hongw@temple.edu	wang, jing/GRS-7509-2022		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL67033, HL77288, HL82774, HL110764, HL117654, HL9445, HL108910, HL116917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110764, R01HL077288, R01HL108910, R01HL116917, F32HL009445, R01HL067033, R01HL117654, R01HL082774] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the contributions of Catherine Yu (Department of Genetics and Molecular Biology, North-western University, Evanston, IL, USA) and Valeria Chernaya (Department of Biology, Temple University, Philadelphia, PA, USA) for English editing. This work was supported in part by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL67033, HL77288, HL82774, HL110764, and HL117654 (to H.W.), and HL9445, HL108910, and HL116917 (to X.Y.). The authors declare no conflicts of interest.	Alam MM, 2009, J CEREBR BLOOD F MET, V29, P157, DOI 10.1038/jcbfm.2008.99; Bogdanski P, 2012, CLIN CHEM LAB MED, V50, P1107, DOI 10.1515/cclm-2011-0856; Breen DM, 2009, ARTERIOSCL THROM VAS, V29, P1060, DOI 10.1161/ATVBAHA.109.185447; Carmeliet P, 1997, AM J PATHOL, V150, P761; Chen JZ, 2004, J MOL CELL CARDIOL, V36, P233, DOI 10.1016/j.yjmcc.2003.10.005; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Delva P, 2007, J HYPERTENS, V25, P127, DOI 10.1097/HJH.0b013e3280109271; Duan HX, 2006, THROMB HAEMOSTASIS, V96, P807, DOI 10.1160/TH06-04-0199; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Hagensen MK, 2012, CARDIOVASC RES, V93, P223, DOI 10.1093/cvr/cvr278; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hohenstein B, 2010, NEPHROL DIAL TRANSPL, V25, P3170, DOI 10.1093/ndt/gfq200; Huang CY, 2011, ACTA CARDIOL, V66, P773, DOI 10.1080/AC.66.6.2136962; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Jamaluddin MS, 2007, BLOOD, V110, P3648, DOI 10.1182/blood-2007-06-096701; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; Jourde-Chiche N, 2009, J THROMB HAEMOST, V7, P1576, DOI 10.1111/j.1538-7836.2009.03540.x; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kokubo T, 2007, J VASC SURG, V45, p33A, DOI 10.1016/j.jvs.2007.02.069; Korta K, 2013, POSTEP HIG MED DOSW, V67, P982, DOI 10.5604/17322693.1067258; Liao D, 2006, CIRC RES, V99, P598, DOI 10.1161/01.RES.0000242559.42077.22; Lin HH, 2009, J THROMB HAEMOST, V7, P1401, DOI 10.1111/j.1538-7836.2009.03478.x; Mano R, 2009, ATHEROSCLEROSIS, V204, P544, DOI 10.1016/j.atherosclerosis.2008.09.035; McIlhenny SE, 2010, TISSUE ENG PT A, V16, P245, DOI [10.1089/ten.tea.2009.0238, 10.1089/ten.TEA.2009.0238]; Nakajima M, 2006, CELL BIOL INT, V30, P239, DOI 10.1016/j.cellbi.2005.11.003; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Tan HM, 2006, CARDIOVASC RES, V69, P253, DOI 10.1016/j.cardiores.2005.08.016; Trabetti E, 2008, J APPL GENET, V49, P267, DOI 10.1007/BF03195624; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang H, 2004, CIRC RES, V94, P843, DOI 10.1161/01.RES.0000120864.21172.5A; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang H, 1997, J BIOL CHEM, V272, P25380, DOI 10.1074/jbc.272.40.25380; Wara AK, 2013, ARTERIOSCL THROM VAS, V33, P1552, DOI 10.1161/ATVBAHA.112.300655; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Weiss Daniel J, 2006, Proc Am Thorac Soc, V3, P193, DOI 10.1513/pats.200601-013MS; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Wu Y, 2010, J THROMB HAEMOST, V8, P185, DOI 10.1111/j.1538-7836.2009.03662.x; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]	50	25	26	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3085	3099		10.1096/fj.14-267989	http://dx.doi.org/10.1096/fj.14-267989			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25854700	Green Published			2022-12-28	WOS:000356859100035
J	Seo, YA; Wessling-Resnick, M				Seo, Young Ah; Wessling-Resnick, Marianne			Ferroportin deficiency impairs manganese metabolism in flatiron mice	FASEB JOURNAL			English	Article						iron metabolism; hepcidin; manganese transport	IRON EXPORTER; INTRACELLULAR TRAFFICKING; SH-SY5Y CELLS; HEPCIDIN; TRANSPORTER; DISEASE; PARKINSONISM; MUTATIONS; SLC30A10; EFFLUX	We examined the physiologic role of ferroportin (Fpn) in manganese (Mn) export using flatiron (ffe/+) mice, a genetic model of Fpn deficiency. Blood (0.0123 vs. 0.0107 mg/kg; P = 0.0003), hepatic (1.06 vs. 0.96 mg/kg; P = 0.0125), and bile Mn levels (79 vs. 38 mg/kg; P = 0.0204) were reduced in ffe/+ mice compared to +/+ controls. Erythrocyte Mn-superoxide dismutase was also reduced at 6 (0.154 vs. 0.096, P = 0.0101), 9 (0.131 vs. 0.089, P = 0.0162), and 16 weeks of age (0.170 vs. 0.090 units/mg protein/min; P < 0.0001). Mn-54 uptake after intragastric gavage was markedly reduced in ffe/+ mice (0.0187 vs. 0.0066% dose; P = 0.0243), while clearance of injected isotope was similar in ffe/+ and +/+ mice. These values were compared to intestinal absorption of Fe-59, which was significantly reduced in ffe/+ mice (8.751 vs. 3.978% dose; P = 0.0458). The influence of the ffe mutation was examined in dopaminergic SH-SY5Y cells and human embryonic HEK293T cells. While expression of wild-type Fpn reversed Mn-induced cytotoxicity, ffe mutant H32R failed to confer protection. These combined results demonstrate that Fpn plays a central role in Mn transport and that flatiron mice provide an excellent genetic model to explore the role of this exporter in Mn homeostasis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wessling-Resnick, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis & Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu	Seo, Young Ah/AAT-5022-2020	Seo, Young Ah/0000-0003-3884-0665	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [R01ES0146380, K99ES024340]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES024340, R01ES014638, R00ES024340] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the U.S. National Institutes of Health, National Institute of Environmental Health Sciences to M.W.R. (R01ES0146380) and Y.A.S. (K99ES024340).	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Bartnikas TB, 2012, BIOMETALS, V25, P677, DOI 10.1007/s10534-012-9520-3; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; Boserup MW, 2011, BIOMETALS, V24, P357, DOI 10.1007/s10534-010-9405-2; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Chua ACG, 1997, J COMP PHYSIOL B, V167, P361, DOI 10.1007/s003600050085; DeWitt MR, 2013, BIOCHEM BIOPH RES CO, V432, P1, DOI 10.1016/j.bbrc.2013.01.058; DONALDSON J, 1987, NEUROTOXICOLOGY, V8, P451; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; FINLEY JW, 1994, AM J CLIN NUTR, V60, P949, DOI 10.1093/ajcn/60.6.949; Fitsanakis VA, 2010, NEUROTOX RES, V18, P124, DOI 10.1007/s12640-009-9130-1; Frumkin H, 1997, AM J IND MED, V31, P107; Golub MS, 2012, NEUROTOXICOL TERATOL, V34, P220, DOI 10.1016/j.ntt.2011.11.002; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; HONG JS, 1984, ENVIRON RES, V34, P242, DOI 10.1016/0013-9351(84)90092-6; KIM J, 2013, NATL GEOGR, V224, P8; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215; Lahousse SA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-41; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li XL, 2013, BIOMETALS, V26, P941, DOI 10.1007/s10534-013-9670-y; Liu SC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-21; Lucchini R, 1997, ENVIRON RES, V73, P175, DOI 10.1006/enrs.1997.3702; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MENA I, 1969, NEUROLOGY, V19, P1000, DOI 10.1212/WNL.19.10.1000; Mitchell CJ, 2014, AM J PHYSIOL-CELL PH, V306, pC450, DOI 10.1152/ajpcell.00348.2013; Morello A, 2007, BRAIN RES BULL, V74, P406, DOI 10.1016/j.brainresbull.2007.07.011; Nong A, 2008, J TOXICOL ENV HEAL A, V71, P413, DOI 10.1080/15287390701838697; Park Bo-Yeon, 2008, Nutr Res Pract, V2, P317, DOI 10.4162/nrp.2008.2.4.317; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Pietrangelo A, 2011, SEMIN LIVER DIS, V31, P302, DOI 10.1055/s-0031-1286061; Pipemo A, 2007, BLOOD, V110, P4096, DOI 10.1182/blood-2007-06-096503; Prahalad AK, 1999, TOXICOL APPL PHARM, V158, P81, DOI 10.1006/taap.1999.8701; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Seo YA, 2013, NEUROTOXICOLOGY, V38, P67, DOI 10.1016/j.neuro.2013.06.002; Soundararajan R, 2008, J BIOL CHEM, V283, P2231, DOI 10.1074/jbc.M703583200; Sriram K, 2010, ARCH TOXICOL, V84, P521, DOI 10.1007/s00204-010-0525-9; Thomas C, 2004, GUT, V53, P44, DOI 10.1136/gut.53.1.44; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; Tran TT, 2002, NEUROTOXICOLOGY, V23, P635, DOI 10.1016/S0161-813X(02)00091-8; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Tussing-Humphreys L., 2012, J ACAD NUTR DIET, V112, P762; Tussing-Humphreys L, 2012, J ACAD NUTR DIET, V112, P391, DOI 10.1016/j.jada.2011.08.038; Xie L, 2012, AM J PHYSIOL-CELL PH, V303, pC81, DOI 10.1152/ajpcell.00281.2011; YAMADA M, 1986, ACTA NEUROPATHOL, V70, P273, DOI 10.1007/BF00686083; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Yonashiro R, 2012, P NATL ACAD SCI USA, V109, P2382, DOI 10.1073/pnas.1114985109; ZAYED J, 1994, AM IND HYG ASSOC J, V55, P53, DOI 10.1202/0002-8894(1994)055<0053:OAEEOG>2.0.CO;2; Zohn IE, 2007, BLOOD, V109, P4174, DOI 10.1182/blood-2007-01-066068; Zumerle S, 2014, BLOOD, V123, P3646, DOI 10.1182/blood-2014-01-550467	63	33	34	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2726	2733		10.1096/fj.14-262592	http://dx.doi.org/10.1096/fj.14-262592			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25782988	Green Published			2022-12-28	WOS:000356859100005
J	Van Landeghem, L; Santoro, MA; Mah, AT; Krebs, AE; Dehmer, JJ; McNaughton, KK; Helmrath, MA; Magness, ST; Lund, PK				Van Landeghem, Laurianne; Santoro, M. Agostina; Mah, Amanda T.; Krebs, Adrienne E.; Dehmer, Jeffrey J.; McNaughton, Kirk K.; Helmrath, Michael A.; Magness, Scott T.; Lund, P. Kay			IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations	FASEB JOURNAL			English	Article						irradiation; tissue regeneration; actively cycling ISCs; facultative/reserve ISCs	GLUCAGON-LIKE PEPTIDE-2; SHORT-BOWEL SYNDROME; PROGENITOR CELLS; DNA-DAMAGE; IN-VITRO; EXPRESSION MARKS; EPITHELIAL-CELLS; TRANSGENIC MICE; GROWTH-FACTORS; CANCER CELLS	Insulin-like growth factor 1 (IGF1) has potent trophic effects on normal or injured intestinal epithelium, but specific effects on intestinal stem cells (ISCs) are undefined. We used Sox9-enhanced green fluorescent protein (EGFP) reportermice that permit analyses of both actively cycling ISCs (Sox9-EGFP(Low)) and reserve/facultative ISCs (Sox9-EGFP(High)) to study IGF1 action on ISCs in normal intestine or during crypt regeneration after high-dose radiation-induced injury. We hypothesized that IGF1 differentially regulates proliferation and gene expression in actively cycling and reserve/facultative ISCs. IGF1 was delivered for 5 days using subcutaneously implanted mini-pumps in uninjured mice or after 14 Gy abdominal radiation. ISC numbers, proliferation, and transcriptome were assessed. IGF1 increased epithelial growth in nonirradiated mice and enhanced crypt regeneration after radiation. In uninjured and regenerating intestines, IGF1 increased total numbers of Sox9-EGFP(Low) ISCs and percentage of these cells in M-phase. IGF1 increased percentages of Sox9-EGFP(High) ISCs in S-phase but did not expand this population. Microarray revealed that IGF1 activated distinct gene expression signatures in the 2 Sox9-EGFP ISC populations. In vitro IGF1 enhanced enteroid formation by Sox9-EGFP(High) facultative ISCs but not Sox9-EGFP(Low) actively cycling ISCs. Our data provide new evidence that IGF1 activates 2 ISC populations via distinct regulatory pathways to promote growth of normal intestinal epithelium and crypt regeneration after irradiation.	[Van Landeghem, Laurianne; Santoro, M. Agostina; Krebs, Adrienne E.; McNaughton, Kirk K.; Magness, Scott T.; Lund, P. Kay] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Mah, Amanda T.; Lund, P. Kay] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Dehmer, Jeffrey J.] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Helmrath, Michael A.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Magness, Scott T.] Univ N Carolina, North Carolina State Biomed Engn, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill	Lund, PK (corresponding author), 6336 MBRB CB 7545,111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	empk@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021; Van Landeghem, Laurianne/K-2430-2015; Van+Landeghem, Laurianne/AAG-7334-2019; , UNC Flow Cytometry Core/AGU-9839-2022	Van+Landeghem, Laurianne/0000-0001-7408-3521; Magness, Scott/0000-0002-2746-1224	University of North Carolina (UNC) Flow Cytometry core facility [P30-CA06086]; Histology Research Core Facilities of the Center for Gastrointestinal Biology and Disease [P30-DK034987]; North Carolina Biotechnology Center; National Cancer Center; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK040247-19, R01-DK091427, R03-DK089126]; NIH National Institute on Aging Grant [R01-AG041198-01]; SanteDige Foundation; Genomics and Bioinformatics core of the UNC Lineberger Comprehensive Cancer Center; Michael Hooker Microscopy Facility; Department of Cell Biology and Physiology (UNC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, R03DK089126, R01DK040247, K01DK080181, R01DK091427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041198] Funding Source: NIH RePORTER	University of North Carolina (UNC) Flow Cytometry core facility; Histology Research Core Facilities of the Center for Gastrointestinal Biology and Disease; North Carolina Biotechnology Center; National Cancer Center; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging Grant; SanteDige Foundation; Genomics and Bioinformatics core of the UNC Lineberger Comprehensive Cancer Center; Michael Hooker Microscopy Facility; Department of Cell Biology and Physiology (UNC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Barry Udis, Michael Chua, Neil Kramarcy, Ashley Ezzell, Adam Gracz, Josh Robbs, and Eric Blue for technical assistance. This work was assisted by services from the University of North Carolina (UNC) Flow Cytometry core facility (Grant P30-CA06086), the Genomics and Bioinformatics core of the UNC Lineberger Comprehensive Cancer Center, the Michael Hooker Microscopy Facility, the Histology Research Core Facilities of the Center for Gastrointestinal Biology and Disease (Grant P30-DK034987), and the Department of Cell Biology and Physiology (UNC). This work was supported by grants from the North Carolina Biotechnology Center and the National Cancer Center (to L.V.L.), U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK040247-19 (to P.K.L.), and R01-DK091427 and R03-DK089126 (to S.T.M.), NIH National Institute on Aging Grant R01-AG041198-01 (to P.K.L.), and funding from the SanteDige Foundation (to L.V.L.). The authors declare no conflicts of interest.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Bortvedt SF, 2012, CURR OPIN GASTROEN, V28, P89, DOI 10.1097/MOG.0b013e32835004c6; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Coutts AS, 2009, P NATL ACAD SCI USA, V106, P19872, DOI 10.1073/pnas.0906785106; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dube PE, 2007, AM J PHYSIOL-ENDOC M, V293, pE460, DOI 10.1152/ajpendo.00149.2007; Farrell CL, 1998, CANCER RES, V58, P933; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Garrison AP, 2009, AM J PHYSIOL-GASTR L, V296, pG643, DOI 10.1152/ajpgi.90588.2008; Ge RT, 2015, SCI REP-UK, V5, DOI 10.1038/srep07735; Gillingham MB, 2003, AM J PHYSIOL-REG I, V284, pR363, DOI 10.1152/ajpregu.00247.2002; Goetz EM, 2011, ONCOGENE, V30, P3745, DOI 10.1038/onc.2011.92; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; HENDRY JH, 1992, RADIAT RES, V132, P115, DOI 10.2307/3578342; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Howarth GS, 1997, SCAND J GASTROENTERO, V32, P1118, DOI 10.3109/00365529709002990; Howarth GS, 1998, SCAND J GASTROENTERO, V33, P180; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Karrich JJ, 2012, BLOOD, V119, P5191, DOI 10.1182/blood-2011-07-370239; Katoh M, 2002, INT J MOL MED, V10, P683; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Kuemmerle JF, 2006, AM J PHYSIOL-GASTR L, V290, pG1194, DOI 10.1152/ajpgi.00345.2005; Lakshmikuttyamma A, 2008, ONCOGENE, V27, P3831, DOI 10.1038/onc.2008.8; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; LEMMEY AB, 1994, GROWTH FACTORS, V10, P243, DOI 10.3109/08977199409010990; Leri A, 1999, CIRC RES, V84, P752; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Lund PK, 2012, GASTROENTEROLOGY, V143, P1144, DOI 10.1053/j.gastro.2012.09.021; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; McMellen ME, 2010, SEMIN PEDIATR SURG, V19, P35, DOI 10.1053/j.sempedsurg.2009.11.010; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Osuka S, 2013, STEM CELLS, V31, P627, DOI 10.1002/stem.1328; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Qiu W, 2010, ONCOGENE, V29, P1622, DOI 10.1038/onc.2009.451; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; STEEB CB, 1995, GUT, V37, P630, DOI 10.1136/gut.37.5.630; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Thelen K, 2009, J PHARM PHARMACOL, V61, P541, DOI [10.1211/jpp.61.05.0002, 10.1211/jpp/61.05.0002]; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Landeghem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051310; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wilkins HR, 2002, AM J PHYSIOL-GASTR L, V283, pG457, DOI 10.1152/ajpgi.00019.2002; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xu HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012112; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	76	50	50	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2828	2842		10.1096/fj.14-264010	http://dx.doi.org/10.1096/fj.14-264010			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837582	Green Published			2022-12-28	WOS:000356859100014
J	Cecon, E; Chen, M; Marcola, M; Fernandes, PAC; Jockers, R; Markus, RP				Cecon, Erika; Chen, Min; Marcola, Marina; Fernandes, Pedro A. C.; Jockers, Ralf; Markus, Regina P.			Amyloid beta peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway	FASEB JOURNAL			English	Article						Alzheimer disease; nuclear factor kappa B	NF-KAPPA-B; PROTEIN-COUPLED RECEPTORS; ALZHEIMERS-DISEASE; NICOTINIC RECEPTORS; MOUSE MODEL; TNF-ALPHA; DYSFUNCTION; OLIGOMERS; IMMUNE; INFLAMMATION	Melatonin is the hormone produced by the pineal gland known to regulate physiologic rhythms and to display immunomodulatory and neuroprotective properties. It has been reported that Alzheimer disease patients show impaired melatonin production and altered expression of the 2 G protein-coupled melatonin receptors (MTRs), MT1 and MT2, but the underlying mechanisms are not known. Here we evaluated whether this dysfunction of the melatonergic system is directly caused by amyloid beta peptides (A beta(1-40) and A beta(1-42)). A beta treatment of rat pineal glands elicited an inflammatory response within the gland, evidenced by the up-regulation of 52 inflammatory genes, and decreased the production of melatonin up to 75% compared to vehicle-treated glands. Blocking NF-kappa B activity prevented this effect. Exposure of HEK293 cells stably expressing recombinant MT1 or MT2 receptors to A beta lead to a 40% reduction in [I-125] iodomelatonin binding to MT1. ERK1/2 activation triggered by MTRs, but not by the beta(2)-adrenergic receptor, was markedly impaired by A beta in HEK293 transfected cells, as well as in primary rat endothelial cells expressing endogenous MTRs. Our data reveal the melatonergic system as a new target of A beta, opening new perspectives to Alzheimer disease diagnosis and therapeutic intervention.	[Cecon, Erika; Marcola, Marina; Fernandes, Pedro A. C.; Markus, Regina P.] Univ Sao Paulo, Inst Biosci, Chronopharmacol Lab, Sao Paulo, Brazil; [Cecon, Erika; Chen, Min; Jockers, Ralf] INSERM, Inst Cochin, U1016, Paris, France; [Cecon, Erika; Chen, Min; Jockers, Ralf] CNRS, Unite Mixte Rech 8104, Paris, France; [Cecon, Erika; Chen, Min; Jockers, Ralf] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Markus, RP (corresponding author), Rua Matao 101,Travessa 14, BR-05508090 Sao Paulo, Brazil.	rpmarkus@usp.br	Marçola, Marina/D-4097-2015; Cecon, Erika/F-9842-2014; Jockers, Ralf/P-2272-2017; Cecon, Erika/AAG-9413-2020; Markus, Regina P/K-2954-2012; Cecon, Erika/B-3444-2016; Fernandes, Pedro/L-1869-2013; Markus, Regina P./AAC-1505-2021; Jockers, Ralf/Q-2100-2019	Cecon, Erika/0000-0003-2387-9313; Jockers, Ralf/0000-0002-4354-1750; Cecon, Erika/0000-0003-2387-9313; Markus, Regina P/0000-0003-4606-6120; Cecon, Erika/0000-0003-2387-9313; Markus, Regina P./0000-0003-4606-6120; Jockers, Ralf/0000-0002-4354-1750	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/13691-1, 2007/07871-6]; Brazilian Ministry of Education (CNPq) [480097/2013-5]; Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20130326503]; Association pour la Recherch sur le Cancer [SFI20121205906]; Agence Nationale pour la Recherche (ANR) Recherches Partenariales et Innovation Biomedicale [MED-HET-REC-2]; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Who Am I? Laboratory of Excellence [ANR-11-LABX-0071]; French government through its Investments for the Future program [ANR-11-IDEX-0005-01]; Sao Paulo Research Foundation (FAPESP) [2009/17923-9, 2011/01304-8]; overseas study program of the Guangzhou Elite Project; Guangzhou Pharmaceutical Company Limited	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Ministry of Education (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Association pour la Recherch sur le Cancer; Agence Nationale pour la Recherche (ANR) Recherches Partenariales et Innovation Biomedicale(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Who Am I? Laboratory of Excellence; French government through its Investments for the Future program(French National Research Agency (ANR)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); overseas study program of the Guangzhou Elite Project; Guangzhou Pharmaceutical Company Limited	The authors gratefully thank D. Aparecida Moura (technical fellow, Brazilian National Council for Research in Science and Technology; CNPq 3778555/2013-8) and E. Braga Fernandes for technical support. This work was supported by grants to R.P.M. from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2013/13691-1; 2007/07871-6) and from the Brazilian Ministry of Education (CNPq 480097/2013-5). This work was also performed within the Departement Hopital-Universitaire Autoimmune and Hormonal Diseases and supported by grants to R.J. from the Fondation pour la Recherche Medicale (Equipe FRM DEQ20130326503), Association pour la Recherch sur le Cancer No SFI20121205906, Agence Nationale pour la Recherche (ANR) Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2," Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, and the Who Am I? Laboratory of Excellence, No. ANR-11-LABX-0071, funded by the French government through its Investments for the Future program, operated by the ANR under Grant ANR-11-IDEX-0005-01. E.C. and M.M. were supported by a doctoral fellowship from the Sao Paulo Research Foundation (FAPESP; 2009/17923-9; 2011/01304-8); M.C. was supported by a doctoral fellowship from the overseas study program of the Guangzhou Elite Project and the Guangzhou Pharmaceutical Company Limited. R.P.M. is a senior fellow of CNPq (304637/2013-0).	AbdAlla S, 2009, J BIOL CHEM, V284, P6566, DOI 10.1074/jbc.M808277200; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Cardinali DP, 2010, CURR NEUROPHARMACOL, V8, P218, DOI 10.2174/157015910792246209; CARNEIRO RCG, 1991, J PHARMACOL EXP THER, V259, P614; Carvalho-Sousa Claudia Emanuele, 2011, Front Endocrinol (Lausanne), V2, P10, DOI 10.3389/fendo.2011.00010; Cecon E, 2011, RECENT PATENTS ENDOC, V5, P91, DOI 10.2174/187221411799015381; CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Corrales A, 2014, J PINEAL RES, V56, P51, DOI 10.1111/jpi.12097; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Cruz-Machado SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040142; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Espino J, 2013, J PINEAL RES, V54, P442, DOI 10.1111/jpi.12042; Feng Z, 2004, J PINEAL RES, V37, P257, DOI 10.1111/j.1600-079X.2004.00164.x; Feng Z, 2004, J PINEAL RES, V37, P129, DOI 10.1111/j.1600-079X.2004.00144.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Ferreira ZS, 2003, PHARMACOLOGY, V69, P33, DOI 10.1159/000071264; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Janickova H, 2013, NEUROPHARMACOLOGY, V67, P272, DOI 10.1016/j.neuropharm.2012.11.014; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson J, 2006, NEUROSCI LETT, V393, P23, DOI 10.1016/j.neulet.2005.09.040; Lin L, 2013, INT J MOL SCI, V14, P14575, DOI 10.3390/ijms140714575; Ling ZQ, 2009, J ALZHEIMERS DIS, V16, P287, DOI 10.3233/JAD-2009-0949; Liu RY, 1999, J CLIN ENDOCR METAB, V84, P323, DOI 10.1210/jc.84.1.323; Liu S, 2011, MOL ENDOCRINOL, V25, P1301, DOI 10.1210/me.2010-0455; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Lyros E, 2014, CURR ALZHEIMER RES, V11, P18, DOI 10.2174/1567205010666131119235254; Magri F, 1997, CHRONOBIOL INT, V14, P385, DOI 10.3109/07420529709001459; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; Markus RP, 2013, INT J MOL SCI, V14, P10979, DOI 10.3390/ijms140610979; Markus RP, 2010, PHARMACOL THERAPEUT, V126, P251, DOI 10.1016/j.pharmthera.2010.02.009; Markus RP, 2003, J PHARMACOL EXP THER, V305, P525, DOI 10.1124/jpet.102.045625; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Muxel SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052010; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; O'Neal-Moffitt G, 2014, NEUROSCIENCE, V277, P506, DOI 10.1016/j.neuroscience.2014.07.018; Pinato L, BRAIN STRUCT FUNCT; Polimeni G, 2014, FRONT BIOSCI-LANDMRK, V19, P429, DOI 10.2741/4217; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; Rosales-Corral SA, 2012, J PINEAL RES, V52, P167, DOI 10.1111/j.1600-079X.2011.00937.x; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Savaskan E, 2005, J PINEAL RES, V38, P10, DOI 10.1111/j.1600-079X.2004.00169.x; Seeman P, 2011, SYNAPSE, V65, P1289, DOI 10.1002/syn.20957; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Takano M, 2013, NEUROSCI LETT, V534, P85, DOI 10.1016/j.neulet.2012.11.010; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Tosini G, 2014, BIOESSAYS, V36, P778, DOI 10.1002/bies.201400017; Walls KC, 2012, J BIOL CHEM, V287, P30317, DOI 10.1074/jbc.M112.365890; Wu YH, 2003, J CLIN ENDOCR METAB, V88, P5898, DOI 10.1210/jc.2003-030833; Wu YH, 2007, NEUROBIOL AGING, V28, P1239, DOI 10.1016/j.neurobiolaging.2006.06.002; Zhu LQ, 2004, J PINEAL RES, V37, P71, DOI 10.1111/j.1600-079X.2004.00136.x; Zlotos DP, 2014, J MED CHEM, V57, P3161, DOI 10.1021/jm401343c	69	40	41	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2566	2582		10.1096/fj.14-265678	http://dx.doi.org/10.1096/fj.14-265678			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757565				2022-12-28	WOS:000355209500033
J	Roundhill, E; Turnbull, D; Burchill, S				Roundhill, Elizabeth; Turnbull, Doug; Burchill, Susan			Localization of MRP-1 to the outer mitochondrial membrane by the chaperone protein HSP90 beta	FASEB JOURNAL			English	Article						ABC transporter; Ewing's sarcoma; doxorubicin; multidrug resistance	EWINGS-SARCOMA FAMILY; SMALL-MOLECULE; CANCER CELLS; PROTEASOMAL DEGRADATION; EXPRESSION; INHIBITOR; HEAT-SHOCK-PROTEIN-90; RESISTANCE; TUMOR; HSP90-ALPHA	Overexpression of plasma membrane multidrug resistance-associated protein 1 (MRP-1) in Ewing's sarcoma (ES) predicts poor outcome. MRP-1 is also expressed in mitochondria, and we have examined the submitochondrial localization of MRP-1 and investigated the mechanism of MRP-1 transport and role of this organelle in the response to doxorubicin. The mitochondrial localization of MRP-1 was examined in ES cell lines by differential centrifugation and membrane solubilization by digitonin. Whether MRP-1 is chaperoned by heat shock proteins (HSPs) was investigated by immuno-precipitation, immunofluorescence microscopy, and HSP knockout using small hairpin RNA and inhibitors (apoptozole, 17-AAG, and NVPAUY). The effect of disrupting mitochondrial MRP-1-dependent efflux activity on the cytotoxic effect of doxorubicin was investigated by counting viable cell number. Mitochondrial MRP-1 is glycosylated and localized to the outer mitochondrial membrane, where it is coexpressed with HSP90. MRP-1 binds to both HSP90 and HSP70, although only inhibition of HSP90 beta decreases expression of MRP-1 in the mitochondria. Disruption of mitochondrial MRP-1-dependent efflux significantly increases the cytotoxic effect of doxorubicin (combination index, <0.9). For the first time, we have demonstrated that mitochondrial MRP-1 is expressed in the outer mitochondrial membrane and is a client protein of HSP90 beta, where it may play a role in the doxorubicin-induced resistance of ES.-Roundhill, E., Turnbull, D., Burchill, S. Localization of MRP-1 to the outer mitochondrial membrane by the chaperone protein HSP90 beta.	[Roundhill, Elizabeth; Burchill, Susan] St James Univ Hosp, Leeds Inst Canc & Pathol, Childrens Canc Res Grp, Beckett St, Leeds LS9 7TF, W Yorkshire, England; [Turnbull, Doug] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Saint James's University Hospital; Newcastle University - UK	Roundhill, E (corresponding author), St James Univ Hosp, Leeds Inst Canc & Pathol, Childrens Canc Res Grp, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	e.a.roundhill@leeds.ac.uk		Turnbull, Doug/0000-0002-8878-9901	Yorkshire Cancer Research [L352]	Yorkshire Cancer Research	This work was supported by Grant L352 from Yorkshire Cancer Research (to S.B.). The authors declare no conflicts of interest.	Ambati SR, 2014, MOL ONCOL, V8, P323, DOI 10.1016/j.molonc.2013.12.005; Banerji U, 2005, CLIN CANCER RES, V11, P7023, DOI 10.1158/1078-0432.CCR-05-0518; Barker LM, 2005, J CLIN ONCOL, V23, P4354, DOI 10.1200/JCO.2005.05.105; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Cechetto JD, 2000, EXP CELL RES, V260, P30, DOI 10.1006/excr.2000.4983; Chen Y, 2010, BIOCHEM BIOPH RES CO, V394, P798, DOI 10.1016/j.bbrc.2010.03.077; Clarke PA, 2000, ONCOGENE, V19, P4125, DOI 10.1038/sj.onc.1203753; Costantino E, 2009, CANCER LETT, V279, P39, DOI 10.1016/j.canlet.2009.01.018; DANIELE RP, 1976, P NATL ACAD SCI USA, V73, P3599, DOI 10.1073/pnas.73.10.3599; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; Gao LL, 2013, J VIROL, V87, P13640, DOI 10.1128/JVI.02006-13; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Gesualdi NM, 2007, STRESS, V10, P342, DOI 10.1080/10253890701314863; Henderson MJ, 2011, J NATL CANCER I, V103, P1236, DOI 10.1093/jnci/djr256; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; Inai Y, 1997, CELL STRUCT FUNCT, V22, P555, DOI 10.1247/csf.22.555; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Jiang H, 2014, INT J CLIN EXP PATHO, V7, P3305; Kato T, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2015.04.019; KLEUSER B, 1985, CANCER RES, V45, P3022; Ko SK, 2015, CHEM BIOL, V22, P391, DOI 10.1016/j.chembiol.2015.02.004; Langer T, 2003, CELL BIOL INT, V27, P47, DOI 10.1016/S1065-6995(02)00256-1; Luo DX, 2013, J BIOL CHEM, V288, P36733, DOI 10.1074/jbc.M113.514877; Lv MM, 2014, TUMOR BIOL, V35, P10773, DOI 10.1007/s13277-014-2377-z; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Martins AS, 2008, CANCER RES, V68, P6260, DOI 10.1158/0008-5472.CAN-07-3074; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mehta A, 2013, FEBS OPEN BIO, V3, P271, DOI 10.1016/j.fob.2013.06.002; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Myatt SS, 2005, CLIN CANCER RES, V11, P3136, DOI 10.1158/1078-0432.CCR-04-2050; Mycielska M.E., 2014, J CELL BIOL CELL MET, V1, P2, DOI [10.24966/CBCM-1943/100002, DOI 10.24966/CBCM-1943/100002]; Oda Y, 1997, J CANCER RES CLIN, V123, P237, DOI 10.1007/s004320050053; Ogi H, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.12; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; ROBINSON A, 1987, BIOCHEM J, V246, P249, DOI 10.1042/bj2460249; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Roundhill E, 2013, BRIT J CANCER, V109, P195, DOI 10.1038/bjc.2013.168; Roundhill EA, 2012, BRIT J CANCER, V106, P1224, DOI 10.1038/bjc.2012.40; Roundhill E. A., 2014, RESISTANCE TARGETED, P27; Russell JS, 2003, CLIN CANCER RES, V9, P3749; Sarangi U, 2012, DRUG TARGET INSIGHT, V6, P19, DOI 10.4137/DTI.S9943; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shinohara Y, 2002, EUR J BIOCHEM, V269, P5224, DOI 10.1046/j.1432-1033.2002.03229.x; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; Smith AC, 2012, NUCLEIC ACIDS RES, V40, pD1160, DOI 10.1093/nar/gkr1101; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Solazzo M, 2006, EXP CELL RES, V312, P4070, DOI 10.1016/j.yexcr.2006.09.005; Sun J, 2015, BIOORG MED CHEM LETT, V25, P3129, DOI 10.1016/j.bmcl.2015.06.009; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Vishal C, 2011, DRUG TARGET INSIGHT, V5, P11, DOI 10.4137/DTI.S6582; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Williams DR, 2008, ANGEW CHEM INT EDIT, V47, P7466, DOI 10.1002/anie.200802801; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yano M, 1996, JPN J CANCER RES, V87, P908, DOI 10.1111/j.1349-7006.1996.tb02119.x; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006	64	10	10	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1712	1723		10.1096/fj.15-283408	http://dx.doi.org/10.1096/fj.15-283408			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26722004				2022-12-28	WOS:000374879400003
J	Pon, CK; Lane, JR; Sloan, EK; Halls, ML				Pon, Cindy K.; Lane, J. Robert; Sloan, Erica K.; Halls, Michelle L.			The beta(2)-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion	FASEB JOURNAL			English	Article						adrenergic receptor; GPCR; metastasis; stress	BETA-ADRENERGIC RECEPTORS; G-PROTEIN; ANTIHYPERTENSIVE MEDICATIONS; SIGNALING PATHWAY; ESTROGEN-RECEPTOR; ADENYLATE-CYCLASE; TUMOR-GROWTH; MAP KINASE; BLOCKERS; PHOSPHORYLATION	Activation of the sympathetic nervous system by stress increases breast cancer metastasis in vivo. Preclinical studies suggest that stress activates beta-adrenoceptors (beta ARs) to enhance metastasis from primary tumors and that beta-blockers may be protective in breast cancer. However, the subtype of beta AR that mediates this effect, as well as the signaling mechanisms underlying increased tumor cell dissemination, remain unclear. We show that the beta(2)AR is the only functionally relevant beta AR subtype in the highly metastatic human breast cancer cell line MDA-MB-231HM. beta(2)AR activation results in elevated cAMP (formoterol pEC(50) 9.86 +/- 0.32), increased intracellular Ca2+ (formoterol pEC(50) 8.20 +/- 0.33) and reduced phosphorylated ERK (pERK; formoterol pIC(50) 11.62 +/- 0.31). We demonstrate that a highly amplified positive feedforward loop between the cAMP and Ca2+ pathways is responsible for efficient inhibition of basal pERK. Importantly, activation of the beta(2)AR increased invasion (formoterol area under the curve [AUC] relative to vehicle: 1.82 +/- 0.36), which was dependent on the cAMP/Ca2+ loop (formoterol AUC in the presence of 2'5'-dideoxyadenosine 0.64 +/- 0.03, or BAPTA-AM 0.45 +/- 0.23) but independent of inhibition of basal pERK1/2 (vehicle AUC with U0126 0.60 +/- 0.30). Specifically targeting the positive feedforward cAMP/Ca2+ loop may be beneficial for the development of therapeutics to slow disease progression in patients with breast cancer.	[Pon, Cindy K.; Lane, J. Robert; Sloan, Erica K.; Halls, Michelle L.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, 381 Royal Parade, Parkville, Vic 3052, Australia; [Sloan, Erica K.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr, Los Angeles, CA 90024 USA; [Sloan, Erica K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Sloan, Erica K.] Peter MacCallum Canc Ctr, Div Canc Surg, East Melbourne, Vic, Australia	Monash University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center	Halls, ML (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, 381 Royal Parade, Parkville, Vic 3052, Australia.	michelle.halls@monash.edu		Sloan, Erica/0000-0002-2355-1433; Lane, J. Robert/0000-0002-7361-7875	National Health and Medical Research Council R. D. Wright Fellowship (Canberra, ACT, Australia) [1061687]; Drug Discovery Biology Theme Strategic grant; Australian National Health and Medical Research Council [1008865]; U.S. National Institutes of Health/National Cancer Institute [CA160890]; National Breast Cancer Foundation [ECR-11-11]; NATIONAL CANCER INSTITUTE [R01CA160890] Funding Source: NIH RePORTER	National Health and Medical Research Council R. D. Wright Fellowship (Canberra, ACT, Australia); Drug Discovery Biology Theme Strategic grant; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank R. J. Summers (Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University) and members of the laboratories of M.L.H. and E.K.S. for critical discussion. This work was supported by a National Health and Medical Research Council R. D. Wright Fellowship (1061687; Canberra, ACT, Australia) to M.L.H., a Drug Discovery Biology Theme Strategic grant to M.L.H., J.R.L., and E.K.S., and funding from the Australian National Health and Medical Research Council (1008865), the U.S. National Institutes of Health/National Cancer Institute (CA160890), and the National Breast Cancer Foundation (ECR-11-11).	ABRAMSON SN, 1988, BIOCHEM PHARMACOL, V37, P4289, DOI 10.1016/0006-2952(88)90609-0; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Barron TI, 2012, THER ADV MED ONCOL, V4, P113, DOI 10.1177/1758834012439738; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Beindl W, 1996, MOL PHARMACOL, V50, P415; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Beristain AG, 2015, ONCOGENE, V34, P1160, DOI 10.1038/onc.2014.41; Berridge M J, 1975, Adv Cyclic Nucleotide Res, V6, P1; Botteri E, 2013, BREAST CANCER RES TR, V140, P567, DOI 10.1007/s10549-013-2654-3; Bruzzone A, 2014, FASEB J, V28, P1342, DOI 10.1096/fj.13-239285; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Carie AE, 2007, ONCOGENE, V26, P3777, DOI 10.1038/sj.onc.1210172; Chang XZ, 2008, BREAST CANCER RES TR, V111, P65, DOI 10.1007/s10549-007-9761-y; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Dezong Gao, 2014, J Cancer Res Ther, V10, P998, DOI 10.4103/0973-1482.137664; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Ganz PA, 2011, BREAST CANCER RES TR, V129, P549, DOI 10.1007/s10549-011-1505-3; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Ivonnet P, 2015, BRIT J PHARMACOL, V172, P173, DOI 10.1111/bph.12934; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Lamkin DM, 2012, BRAIN BEHAV IMMUN, V26, P635, DOI 10.1016/j.bbi.2012.01.013; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li CI, 2013, JAMA INTERN MED, V173, P1629, DOI 10.1001/jamainternmed.2013.9071; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Liu W., 2015, ONCOTARGET, DOI 10.18632/oncotarget.5849; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONDOS C, 1977, P NATL ACAD SCI USA, V74, P5482, DOI 10.1073/pnas.74.12.5482; Madden KS, 2011, BREAST CANCER RES TR, V130, P747, DOI 10.1007/s10549-011-1348-y; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Ostapkowicz A, 2006, MOL CANCER THER, V5, P238, DOI 10.1158/1535-7163.MCT-05-0226; Pinero CP, 2012, BRIT J PHARMACOL, V166, P721, DOI 10.1111/j.1476-5381.2011.01791.x; Powe DG, 2011, BREAST CANCER RES TR, V130, P457, DOI 10.1007/s10549-011-1371-z; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; RASMUSSEN H, 1981, CALCIUM CAMP SYNARCH; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sorensen GV, 2013, J CLIN ONCOL, V31, P2265, DOI 10.1200/JCO.2012.43.9190; Spychala J, 2004, CLIN CANCER RES, V10, P708, DOI 10.1158/1078-0432.CCR-0811-03; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; VANDEWALLE B, 1990, J CANCER RES CLIN, V116, P303, DOI 10.1007/BF01612908; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Willoughby D, 2012, J CELL SCI, V125, P5850, DOI 10.1242/jcs.111427; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Wright PT, 2014, J MOL CELL CARDIOL, V67, P38, DOI 10.1016/j.yjmcc.2013.12.003; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; XIAO RP, 1995, MOL PHARMACOL, V47, P322	65	40	43	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1144	1154		10.1096/fj.15-277798	http://dx.doi.org/10.1096/fj.15-277798			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578688	Green Published			2022-12-28	WOS:000370387800013
J	Lee, HJ; Lee, HC; Kim, YM; Hwang, YS; Park, YH; Park, TS; Han, JY				Lee, Hong Jo; Lee, Hyung Chul; Kim, Young Min; Hwang, Young Sun; Park, Young Hyun; Park, Tae Sub; Han, Jae Yong			Site-specific recombination in the chicken genome using Flipase recombinase-mediated cassette exchange	FASEB JOURNAL			English	Article						transgene integration; piggyBac transposition; transgenic chicken; primordial germ cell	PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; TRANSGENIC CHICKENS; EGG-WHITE; EXPRESSION; PROMOTER; MICE; PIGGYBAC; PROTEIN; LINE	Targeted genome recombination has been applied in diverse research fields and has a wide range of possible applications. In particular, the discovery of specific loci in the genome that support robust and ubiquitous expression of integrated genes and the development of genome-editing technology have facilitated rapid advances in various scientific areas. In this study, we produced transgenic (TG) chickens that can induce recombinase-mediated gene cassette exchange (RMCE), one of the site-specific recombination technologies, and confirmed RMCE in TG chicken-derived cells. As a result, we established TG chicken lines that have, Flipase (Flp) recognition target (FRT) pairs in the chicken genome, mediated by piggyBac transposition. The transgene integration patterns were diverse in each TG chicken line, and the integration diversity resulted in diverse levels of expression of exogenous genes in each tissue of the TG chickens. In addition, the replaced gene cassette was expressed successfully and maintained by RMCE in the FRT predominant loci of TGchicken-derived cells. These results indicate that targeted genome recombination technology with RMCE could be adaptable to TG chicken models and that the technology would be applicable to specific gene regulation by cis-element insertion and customized expression of functional proteins at predicted levels without epigenetic influence.	[Lee, Hong Jo; Lee, Hyung Chul; Kim, Young Min; Hwang, Young Sun; Park, Young Hyun; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151921, South Korea; [Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun, Gangwon Do, South Korea; [Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang Gun, Gangwon Do, South Korea; [Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Nagano, Japan	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Shinshu University	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151921, South Korea.	jaehan@snu.ac.kr		Park, Young Hyun/0000-0003-2482-9211; Hwang, Young Sun/0000-0002-6443-9579	Cooperative Research Program for Agriculture Science and Technology Development (Rural Development Administration, Seoul, Korea) [PJ010533012015]; National Research Foundation of Korea [2015R1A3A2033826]	Cooperative Research Program for Agriculture Science and Technology Development (Rural Development Administration, Seoul, Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was performed with the support of Project PJ010533012015 of the Cooperative Research Program for Agriculture Science and Technology Development (Rural Development Administration, Seoul, Korea) and a National Research Foundation of Korea Grant No. 2015R1A3A2033826 (Ministry of Science, ICT and Future Planning, Seoul, Korea). The authors declare no conflicts of interest.	Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Graham Catriona, 2009, Biotechnology Journal, V4, P108, DOI 10.1002/biot.200800200; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Jang HJ, 2013, MOL BIOTECHNOL, V54, P177, DOI 10.1007/s12033-012-9560-5; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Laible G, 2015, BIOTECHNOL J, V10, P109, DOI 10.1002/biot.201400193; Lee SH, 2013, POULTRY SCI, V92, P2396, DOI 10.3382/ps.2013-03223; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; LOVE J, 1994, BIO-TECHNOL, V12, P60, DOI 10.1038/nbt0194-60; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Ohtsuka M, 2014, METHODS MOL BIOL, V1194, P3, DOI 10.1007/978-1-4939-1215-5_1; Oishi I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-5; Park KE, 2014, REPROD FERT DEVELOP, V26, P65, DOI 10.1071/RD13258; Park SH, 2010, THERIOGENOLOGY, V74, P805, DOI 10.1016/j.theriogenology.2010.04.005; Park TS, 2015, FASEB J, V29, P2386, DOI 10.1096/fj.14-264739; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Radhakrishnan P, 2008, INT J BIOCHEM CELL B, V40, P1944, DOI 10.1016/j.biocel.2008.02.014; Roebroek AJM, 2006, MOL CELL BIOL, V26, P605, DOI 10.1128/MCB.26.2.605-616.2006; SALTER DW, 1986, POULTRY SCI, V65, P1445, DOI 10.3382/ps.0651445; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Schusser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080108; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	38	19	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					555	563		10.1096/fj.15-274712	http://dx.doi.org/10.1096/fj.15-274712			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443821				2022-12-28	WOS:000369391900009
J	Marchesi, VT				Marchesi, Vincent T.			Gain-of-function somatic mutations contribute to inflammation and blood vessel damage that lead to Alzheimer dementia: a hypothesis	FASEB JOURNAL			English	Article						amyloid; oxidative damage; ischemia	DNA	Amyloid deposits are a characteristic feature of advanced Alzheimer dementia (AD), but whether they initiate the disease or are a consequence of it remains an unsettled question. To explore an alternative pathogenic-mechanism, I propose that the triggering events that begin the pathogenic cascade are not amyloid deposits but damaged blood vessels caused by inflammatory reactions that lead to ischemia, amyloid accumulation, axonal degeneration, synaptic loss, and eventually irreversible neuronal cell death. Inflammation and blood vessel damage are well recognized complications of AD, but what causes them and why the cerebral microvasculature is affected have never been adequately addressed. Because heritable autosomal dominant mutations of NLRP3, APP, TREX1, NOTCH3, and Col4A1 are known to provoke inflammatory reactions and damage the brain in a wide variety of diseases, I propose that one or more low abundant, gain-of-function somatic mutations of the same 5 gene families damage the microvasculature of the brain that leads to dementia. This implies that the pathogenic triggers that lead to AD are derived not from external invaders or amyloid but from oxidative damage of our own genes.	[Marchesi, Vincent T.] Yale Univ, Sch Med, Dept Pathol, 295 Congress Ave,BCMM 109,POB 9812, New Haven, CT 06510 USA	Yale University	Marchesi, VT (corresponding author), Yale Univ, Sch Med, Dept Pathol, 295 Congress Ave,BCMM 109,POB 9812, New Haven, CT 06510 USA.	vincent.marchesi@yale.edu						Ahn J, 2014, J IMMUNOL, V193, P4634, DOI 10.4049/jimmunol.1401337; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Calero M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00138; Craggs LJL, 2014, BRAIN PATHOL, V24, P495, DOI 10.1111/bpa.12177; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; Dempsey A, 2015, VIROLOGY, V479, P146, DOI 10.1016/j.virol.2015.03.013; Federico A, 2005, NEUROL SCI, V26, P117, DOI 10.1007/s10072-005-0444-3; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Frigerio CS, 2015, ALZHEIMERS DEMENT, V11, P1265, DOI 10.1016/j.jalz.2015.02.007; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hunter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036893; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346; Nakagawa K, 2015, ANN RHEUM DIS, V74, P603, DOI 10.1136/annrheumdis-2013-204361; Pamphlett R, 2004, MED HYPOTHESES, V62, P679, DOI 10.1016/j.mehy.2003.11.023; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Saczynski JS, 2008, J GERONTOL A-BIOL, V63, P848, DOI 10.1093/gerona/63.8.848; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043	22	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					503	506		10.1096/fj.15-282285	http://dx.doi.org/10.1096/fj.15-282285			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527064				2022-12-28	WOS:000369391900003
J	Cheng, J; Dackor, RT; Bradbury, JA; Li, H; DeGraff, LM; Hong, LK; King, D; Lih, FB; Gruzdev, A; Edin, ML; Travlos, GS; Flake, GP; Tomer, KB; Zeldin, DC				Cheng, Jennifer; Dackor, Ryan T.; Bradbury, J. Alyce; Li, Hong; DeGraff, Laura M.; Hong, Lee K.; King, Debra; Lih, Fred B.; Gruzdev, Artiom; Edin, Matthew L.; Travlos, Gregory S.; Flake, Gordon P.; Tomer, Kenneth B.; Zeldin, Darryl C.			Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis	FASEB JOURNAL			English	Article						prostaglandins; airway hyperresponsiveness; lipopolysaccharide; bleomycin	INDUCED PULMONARY-FIBROSIS; PROSTAGLANDIN E-2 PRODUCTION; EPITHELIAL-CELLS; DEFICIENT MICE; MOUSE LUNG; LIPOPOLYSACCHARIDE; EXPRESSION; PROTECTS; SYNTHASE; INJURY	Cyclooxygenase (COX)-2 has been shown to be involved in regulating basal airway function, bacterial LPS-induced airway hyperresponsiveness (AHR) and lung inflammation, and bleomycin-induced lung fibrosis; however, the cellular source of COX-2 that underlies these effects is unknown. We generated mice with alveolar type II (ATII) cell-specific knockdown of COX-2 (AT2CC(-/-)), to examine the role of ATII cell-derived prostaglandins (PGs) in these processes. Specific knockdown of COX-2 was confirmed by real-time RT-PCR and Western blot analyses. LC/MS/MS analysis showed that ATII cells produced PGs. Basal airway responsiveness of AT2CC(-/-) mice was decreased compared to that of wild-type (WT) mice. LPS-induced hypothermic response, infiltration of inflammatory cells into the airway, and lung inflammation were enhanced in AT2CC(-/-) mice relative to WT controls; however, LPS-induced AHR and proinflammatory cytokine and chemokine expression were similar between the genotypes. After 21 d of bleomycin administration, AT2CC(-/-) mice behaved in a manner similar to WT mice. Thus, ATII cell-derived COX-2 plays an important role in regulating basal airway function and LPS-induced lung inflammation, but does not play a role in bleomycin-induced fibrosis. These findings provide insight into the cellular source of COX-2 related to these lung phenotypes.-Cheng, J., Dackor, R. T., Bradbury, J. A., Li, H., DeGraff, L. M., Hong, L. K., King, D., Lih, F. B., Gruzdev, A., Edin, M. L., Travlos, G. S., Flake, G. P., Tomer, K. B., Zeldin, D. C. Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis. FASEB J. 30, 160-173 (2016). www.fasebj.org	[Cheng, Jennifer; Dackor, Ryan T.; Bradbury, J. Alyce; Li, Hong; DeGraff, Laura M.; Hong, Lee K.; King, Debra; Lih, Fred B.; Gruzdev, Artiom; Edin, Matthew L.; Travlos, Gregory S.; Flake, Gordon P.; Tomer, Kenneth B.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zeldin, DC (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,Bldg 101,Rm A214, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019; Li, Hong/ABE-3959-2021	Zeldin, Darryl C/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X; Hong, Lee/0000-0003-0002-8858	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES050167, Z01 ES025034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034, ZICES102425, ZIAES025043, ZICES102505, ZICES102546, Z01ES050167] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institutes of Health, National Institute of Environmental Health Sciences, Intramural Research Program Grants Z01 ES050167 (to K.B.T.) and Z01 ES025034 (to D.C.Z.). The authors declare no conflicts of interest.	Bauer AK, 2000, CARCINOGENESIS, V21, P543, DOI 10.1093/carcin/21.4.543; Bonner JC, 2000, AM J PHYSIOL-LUNG C, V278, pL209, DOI 10.1152/ajplung.2000.278.1.L209; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; Card JW, 2007, AM J RESP CELL MOL, V37, P300, DOI 10.1165/rcmb.2007-0057OC; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; deMoraes VLG, 1996, BRIT J PHARMACOL, V117, P1792; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; Ermert L, 2000, AM J PATHOL, V156, P1275, DOI 10.1016/S0002-9440(10)64998-X; Farkas L, 2011, AM J RESP CELL MOL, V45, P1, DOI 10.1165/rcmb.2010-0365TR; Galvin JR, 2009, J THORAC IMAG, V24, P274, DOI 10.1097/RTI.0b013e3181c1abb7; Garantziotis S, 2004, J CLIN INVEST, V114, P319, DOI 10.1172/jci200422497; Hartney JM, 2006, AM J PHYSIOL-LUNG C, V290, pL105, DOI 10.1152/ajplung.00221.2005; Held HD, 2000, AM J RESP CRIT CARE, V162, P1547, DOI 10.1164/ajrccm.162.4.9912079; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Ishikawa TO, 2011, CARCINOGENESIS, V32, P417, DOI 10.1093/carcin/bgq268; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kihara Y, 2014, BIOPHYS J, V106, P966, DOI 10.1016/j.bpj.2014.01.015; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; LEE SH, 1992, J BIOL CHEM, V267, P25934; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Lescuyer P, 2005, ELECTROPHORESIS, V26, P4563, DOI 10.1002/elps.200500292; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Marcet B, 2007, EUR J PHARMACOL, V566, P167, DOI 10.1016/j.ejphar.2007.04.003; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V284, P203, DOI 10.1006/bbrc.2001.4927; Narasimha AJ, 2010, ARTERIOSCL THROM VAS, V30, P260, DOI 10.1161/ATVBAHA.109.198762; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Ragolia L, 2007, PROSTAG OTH LIPID M, V83, P25, DOI 10.1016/j.prostaglandins.2006.09.006; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Swedin L, 2010, PROSTAG OTH LIPID M, V92, P44, DOI 10.1016/j.prostaglandins.2010.02.004; Zeldin DC, 2001, AM J RESP CELL MOL, V25, P457, DOI 10.1165/ajrcmb.25.4.4505	36	17	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					160	173		10.1096/fj.14-268458	http://dx.doi.org/10.1096/fj.14-268458			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26396235	Green Published			2022-12-28	WOS:000367621000018
J	Cerrato, CP; Pirisinu, M; Vlachos, EN; Langel, U				Cerrato, Carmine Pasquale; Pirisinu, Marco; Vlachos, Efstathios Nikolaos; Langel, Ulo			Novel cell-penetrating peptide targeting mitochondria	FASEB JOURNAL			English	Article						mitochondrial targeting; ROS reduction; mitochondrial membrane potential; antioxidant activity	HUMAN IMMUNODEFICIENCY VIRUS; ANTIOXIDANTS; PROTEIN; SUPEROXIDE; ANALOGS; GLUTATHIONE; PREDICTION; MEMBRANES; DELIVERY; BILAYERS	Cell-penetrating peptides (CPPs) are short, nontoxic peptides with cationic and/or amphipathic properties able to cross the cellular membrane. CPPs are used for the delivery of awide variety of cargoes, such as proteins, oligonucleotides, and therapeuticmolecules. The aim of the present study was to synthesize unusually small novel CPPs targeting mitochondria based on the Szeto-Schiller peptide (SS-31) to influence intramitochondrial processes and to improve the biologic effects. All the peptides used were synthesized manually using 9-fluorenylmethyloxycarbonyl chemistry. In the first part of the study, HeLa 705, U87, and bEnd. 3 cells were used as in vitro delivery model. Cells were incubated for 24 h at 37 degrees C and 5% CO2 with different concentrations of our peptides. Cell proliferation assay was performed to evaluate cell viability. Biologic effects such as mitochondrial membrane potential and antioxidant activity were evaluated. H2O2 was used as positive control. Uptake studies were performed using peptides conjugated with 5(6)-carboxyfluorescein (FAM). Fluorescent microscopy was used to determine presence and localization of peptides into the cells. Isolated mitochondria from pretreated cells and mitochondria treated after isolation were used to confirmthe targeting ability of the peptide. Uptake of FAM alone was used as negative control. Microscopy studies confirmed the ability of peptides to penetrate cell. Localization analysis showed increase in uptake by35% compared with SS-31. Mitochondrial CPP 1 (mtCPP-1) had no effect on mitochondrial membrane potential and prevented reactive oxygen species formation in bEnd. 3 cells by 2-fold compared with SS-31. No cytotoxicity was observed even at high concentration (100 mu M). These data suggest that mtCPP-1 is a mitochondrial CPP and protect mitochondria from oxidative damage due to its own antioxidant activities.	[Cerrato, Carmine Pasquale; Pirisinu, Marco; Vlachos, Efstathios Nikolaos; Langel, Ulo] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden; [Pirisinu, Marco] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy	Stockholm University; University of Sassari	Cerrato, CP (corresponding author), Stockholm Univ, Dept Neurochem, Svante Arrhenius Vag 16B, SE-10691 Stockholm, Sweden.	carmine@neurochem.su.se	Cerrato, Carmine Pasquale/Y-5180-2019; Pirisinu, Marco/AAR-5399-2021; Langel, Ulo/K-9773-2018	Cerrato, Carmine Pasquale/0000-0001-7769-6905; Pirisinu, Marco/0000-0002-7834-4386; Langel, Ulo/0000-0001-6107-0844				Cartier R, 2002, GENE THER, V9, P157, DOI 10.1038/sj.gt.3301635; Chen H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S14; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gauuan PJF, 2002, BIOORGAN MED CHEM, V10, P3013, DOI 10.1016/S0968-0896(02)00153-0; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Horobin RW, 2007, J CONTROL RELEASE, V121, P125, DOI 10.1016/j.jconrel.2007.05.040; Kaminaga Y, 2003, FEBS LETT, V555, P311, DOI 10.1016/S0014-5793(03)01265-1; Mahon KP, 2007, CHEM BIOL, V14, P923, DOI 10.1016/j.chembiol.2007.07.011; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Rosania GR, 2003, CURR TOP MED CHEM, V3, P659, DOI 10.2174/1568026033452410; Ross MF, 2004, BIOCHEM SOC T, V32, P1072, DOI 10.1042/BST0321072; Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Soomets Ursel, 2005, V298, P241; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Tieu K, 2003, IUBMB LIFE, V55, P329, DOI 10.1080/1521654032000114320; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	29	72	72	2	84	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4589	4599		10.1096/fj.14-269225	http://dx.doi.org/10.1096/fj.14-269225			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26195590				2022-12-28	WOS:000364514700018
J	Oh, SK; Shin, JO; Baek, JI; Lee, J; Bae, JW; Ankamerddy, H; Kim, MJ; Huh, TL; Ryoo, ZY; Kim, UK; Bok, J; Lee, KY				Oh, Se-Kyung; Shin, Jeong-Oh; Baek, Jeong-In; Lee, Jinwook; Bae, Jae Woong; Ankamerddy, Harinarayana; Kim, Myoung-Jin; Huh, Tae-Lin; Ryoo, Zae-Young; Kim, Un-Kyung; Bok, Jinwoong; Lee, Kyu-Yup			Pannexin 3 is required for normal progression of skeletal development in vertebrates	FASEB JOURNAL			English	Article						chondrocytes; osteoblasts; differentiation; mineralization	GAP-JUNCTION PROTEINS; INTRAMEMBRANOUS BONE; CARTILAGE; DIFFERENTIATION; ZEBRAFISH; FAMILY; CELLS; CALCIFICATION; OSSIFICATION; OSTEOBLASTS	The vertebrate skeletal system has various functions, including support, movement, protection, and the production of blood cells. The development of cartilage and bones, the core components of the skeletal system, is mediated by systematic inter- and intracellular communication among multiple signaling pathways in differentiating progenitors and the surrounding tissues. Recently, Pannexin (Panx) 3 has been shown to play important roles in bone development in vitro by mediating multiple signaling pathways, although its roles in vivo have not been explored. In this study, we generated and analyzed Panx3 knockout mice and examined the skeletal phenotypes of panx3 morphant zebrafish. Panx3(-/-) embryos exhibited delays in hypertrophic chondrocyte differentiation and osteoblast differentiation as well as the initiation of mineralization, resulting in shortened long bones in adulthood. The abnormal progression of hypertrophic chondrogenesis appeared to be associated with the sustained proliferation of chondrocytes, which resulted from increased intracellular cAMP levels. Similarly, osteoblast differentiation and mineralization were delayed in panx3 morphant zebrafish. Taken together, our results provide evidence of the crucial roles of Panx3 in vertebrate skeletal development in vivo.	[Oh, Se-Kyung; Lee, Jinwook; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Daegu, South Korea; [Oh, Se-Kyung; Lee, Jinwook; Kim, Un-Kyung] Kyungpook Natl Univ, Creat BioRes Grp, Sch Life Sci, PLUS Project BrainKorea21, Daegu, South Korea; [Kim, Myoung-Jin; Huh, Tae-Lin; Ryoo, Zae-Young] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Daegu, South Korea; [Lee, Kyu-Yup] Kyungpook Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu 702721, South Korea; [Shin, Jeong-Oh; Bae, Jae Woong; Ankamerddy, Harinarayana; Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, PLUS Project Med Sci BrainKorea21, Seoul 120752, South Korea; [Baek, Jeong-In] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Yonsei University; Yonsei University Health System; University of Pennsylvania	Bok, J (corresponding author), Yonsei Univ, Coll Med, Dept Anat, Seoul 120752, South Korea.	bokj@yuhs.ac; kylee@knu.ac.kr	RYOO, ZAEYOUNG/AAQ-1573-2020; Bok, Jinwoong/M-2834-2019; Ankamreddy, Harinarayana/AFQ-5718-2022	Bok, Jinwoong/0000-0003-1958-1872; Ankamreddy, Harinarayana/0000-0002-2859-087X	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning [2013R1A2A2A01067405]; Bio and Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning [2014M3A9D5073865]; Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI14C0384]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning; Bio and Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology and Future Planning; Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea	The authors thank Byeonghyeon Lee and Tae-Jun Kwon for technical assistance and the Korea Zebrafish Resource Bank for providing the zebrafish lines. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technology and Future Planning (2013R1A2A2A01067405; to K.-Y.L.), the Bio and Medical Technology Development Program of the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technology and Future Planning (2014M3A9D5073865; to J.B. and U.-K.K.), and the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (HI14C0384; to K.-Y.L.).	ANDERSON HC, 1967, J CELL BIOL, V35, P81, DOI 10.1083/jcb.35.1.81; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; BERNARD GW, 1969, AM J ANAT, V125, P271, DOI 10.1002/aja.1001250303; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; BONUCCI E, 1967, J ULTRA MOL STRUCT R, V20, P33, DOI 10.1016/S0022-5320(67)80034-0; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chaible LM, 2011, TOXICOL PATHOL, V39, P1046, DOI 10.1177/0192623311422075; Franz-Odendaal TA, 2011, FRONT BIOSCI-LANDMRK, V16, P2734, DOI 10.2741/3882; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Hall BK, 1995, INT J DEV BIOL, V39, P881; Hauptmann G, 2000, METH MOL B, V137, P139; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim YI, 2013, MOL CELLS, V36, P145, DOI 10.1007/s10059-013-0117-7; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, J INVEST DERMATOL, V134, P2026, DOI 10.1038/jid.2014.86; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; RUANGVORAVAT CP, 1992, DEV DYNAM, V194, P261, DOI 10.1002/aja.1001940403; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thouverey C, 2011, J PROTEOMICS, V74, P1123, DOI 10.1016/j.jprot.2011.04.005; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; Zhang ML, 2008, BONE, V43, P511, DOI 10.1016/j.bone.2008.04.021; Zhou XY, 2012, INT J BIOL SCI, V8, P778, DOI 10.7150/ijbs.4538	37	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4473	4484		10.1096/fj.15-273722	http://dx.doi.org/10.1096/fj.15-273722			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26183770				2022-12-28	WOS:000364514700008
J	Jonker, SS; Louey, S; Giraud, GD; Thornburg, KL; Faber, JJ				Jonker, Sonnet S.; Louey, Samantha; Giraud, George D.; Thornburg, Kent L.; Faber, J. Job			Timing of cardiomyocyte growth, maturation, and attrition in perinatal sheep	FASEB JOURNAL			English	Article						apoptosis; cell number; fetus; neonate; proliferation	CARDIAC MYOCYTES; FETAL SHEEP; POSTNATAL MATURATION; ARTERIAL-PRESSURE; DNA-SYNTHESIS; PLOIDY LEVEL; ADULT SHEEP; CELL-DEATH; HEART; APOPTOSIS	Studies in altricial rodents attribute dramatic changes in perinatal cardiomyocyte growth, maturation, and attrition to stimuli associated with birth. Our purpose was to determine whether birth is a critical trigger controlling perinatal cardiomyocyte growth, maturation and attrition in a precocial large mammal, sheep (Ovis aries). Hearts from 0-61 d postnatal lambs were dissected or enzymatically dissociated. Cardiomyocytes were measured by micromorphometry, cell cycle activity assessed by immunohistochemistry, and nuclear number counted after DNA staining. Integration of this new data with published fetal data from our laboratory demonstrate that a newly appreciated >30% decrease in myocyte number occurred in the last 10 d of gestation (P < 0.0005) concomitant with an increase in cleaved poly (ADP-ribose) polymerase 1 (P < 0.05), indicative of apoptosis. Bisegmental linear regressions show that most changes in myocyte growth kinetics occur before birth (median = 15.2 d; P < 0.05). Right ventricular but not left ventricular cell number increases in the neonate, by 68% between birth and 60 d postnatal (P = 0.028). We conclude that in sheep few developmental changes in cardiomyocytes result from birth, excepting the different postnatal degrees of free wall hypertrophy between the ventricles. Furthermore, myocyte number is reduced in both ventricles immediately before term, but proliferation increases myocyte number in the neonatal right ventricle.	[Jonker, Sonnet S.; Louey, Samantha; Giraud, George D.; Thornburg, Kent L.; Faber, J. Job] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, Portland, OR 97239 USA; [Giraud, George D.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Jonker, SS (corresponding author), Oregon Hlth & Sci Univ, 3303 SW Bond Ave,Mailcode CH14T, Portland, OR 97239 USA.	jonkers@ohsu.edu	; Louey, Samantha/A-1381-2009	Jonker, Sonnet/0000-0002-1097-2562; Louey, Samantha/0000-0002-2628-0085	Eunice Kennedy Shriver National Institute of Child Health and Human Development; Office of the Director of the U.S. National Institutes of Health (NIH) [P01-HD-34430, K12-HD-043488, R01-HD-071068]; M. Lowell Edwards Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071068, K12HD043488, P01HD034430] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director of the U.S. National Institutes of Health (NIH); M. Lowell Edwards Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Kevin Hearn and Adrienne Wilburn for technical assistance, and Debra Anderson for editorial assistance. The Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Office of the Director of the U.S. National Institutes of Health (NIH), under award numbers P01-HD-34430, K12-HD-043488 and R01-HD-071068, and the M. Lowell Edwards Endowment funded this research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adler C P, 1975, Recent Adv Stud Cardiac Struct Metab, V6, P343; ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6; Adler CP, 1996, VIRCHOWS ARCH, V429, P159; Austin A, 1995, J ANAT, V187, P641; Bensley JG, 2010, EUR HEART J, V31, P2058, DOI 10.1093/eurheartj/ehq104; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bishopric NH, 2002, PEDIATR RES, V52, P322, DOI 10.1203/01.PDR.0000025655.48089.B9; BRILLANTES AMB, 1994, CIRC RES, V75, P503, DOI 10.1161/01.RES.75.3.503; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Carabello BA, 2002, J CARD FAIL, V8, pS258, DOI 10.1054/jcaf.2002.129250; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Choi JH, 2002, PEDIATR RES, V52, P325, DOI 10.1203/01.PDR.0000025654.32501.3D; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; DAWES GS, 1980, J PHYSIOL-LONDON, V309, P405, DOI 10.1113/jphysiol.1980.sp013516; Fernandez E, 2001, DEV DYNAM, V221, P302, DOI 10.1002/dvdy.1139; Fisher D. A., 1994, TXB FETAL PHYSL, P359; *GRAPHPAD SOFTW IN, F TEST WORKS COMP MO; Hamaguchi S, 2013, J PHARMACOL SCI, V123, P167, DOI 10.1254/jphs.13099FP; James TN, 1998, ANNU REV PHYSIOL, V60, P309, DOI 10.1146/annurev.physiol.60.1.309; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Jonker SS, 2007, AM J PHYSIOL-REG I, V292, pR913, DOI 10.1152/ajpregu.00484.2006; KAJSTURA J, 1995, EXP CELL RES, V219, P110, DOI 10.1006/excr.1995.1211; Karimi M, 2004, J THORAC CARDIOV SUR, V127, P490, DOI 10.1016/j.jtcvs.2003.07.052; KLIEGMAN RM, 1981, PEDIATR RES, V15, P945, DOI 10.1203/00006450-198106000-00013; Lewandowski AJ, 2013, CIRCULATION, V128, P713, DOI 10.1161/CIRCULATIONAHA.113.002583; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; PINSON CW, 1987, J DEV PHYSIOL, V9, P253; RUDOLPH AM, 1970, CIRCULATION, V41, P343, DOI 10.1161/01.CIR.41.2.343; Rudolph AM, 2001, CONGENITAL DIS HEART, P3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SMOLICH JJ, 1989, AM J PHYSIOL, V257, pH1, DOI 10.1152/ajpheart.1989.257.1.H1; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; TEITEL DF, 1987, PEDIATR RES, V22, P557, DOI 10.1203/00006450-198711000-00017; Walker D. W., 1994, TXB FETAL PHYSL, P298; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	40	38	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4346	4357		10.1096/fj.15-272013	http://dx.doi.org/10.1096/fj.15-272013			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26139099	Green Published			2022-12-28	WOS:000361367300023
J	Ye, F; Chen, CG; Qin, J; Liu, J; Zheng, CY				Ye, Fang; Chen, Chuguang; Qin, Jian; Liu, Jie; Zheng, Congyi			Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China	FASEB JOURNAL			English	Article						authentication; STR analysis; misidentification; misuse; HeLa	HELA-CELLS; AUTHENTICATION; CULTURES; MISIDENTIFICATION; IDENTIFICATION; END	Cell lines are widely used as in vitro model systems in biologic and medical research. However, much of the research has been invalidated by the unwitting use of false cell lines. A significant proportion of the research involving human cell lines was initiated in China. Paradoxically, the cell lines used in China have never been authenticated. Here, we present a comprehensive survey of cross-contamination in 380 samples from 113 independent sources in China using short tandem repeat profiling methods. High levels of cross-contamination were uncovered (95 of 380, 25%). Notable false cell lines (e.g., KB and WISH) are still actively used under their false identity and tissue attributions. Most strikingly, 85.51% of lines established in China were misidentified (59 of 69) and accounted for over half of the misidentifications (59 of 95, 62.11%). Further, 93.22% of the contaminants in cell lines established in laboratories of China were HeLa cells or a possible hybrid of HeLa with an unknown cell line. Results from these misidentified lines have been published in thousands of potentially erroneous articles and may have distorted the findings visible to the scientific community. False lines have been used in drug screening, potentially leading to unusable or even harmful therapeutic strategies. We also noted the causes of contamination and provided suggestions for remediation.	[Ye, Fang; Zheng, Congyi] Wuhan Univ, China Ctr Type Culture Collect, Wuhan 430072, Hubei, Peoples R China; [Ye, Fang; Zheng, Congyi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Chen, Chuguang; Qin, Jian; Liu, Jie] Beijing Microread Genet Co Ltd, Beijing, Peoples R China	Wuhan University; Wuhan University	Zheng, CY (corresponding author), Wuhan Univ, China Ctr Type Culture Collect, 299 Bayi Rd, Wuhan 430072, Hubei, Peoples R China.	cctcc202@whu.edu.cn			National Infrastructure of Natural Resources for Science and Technology Program [2011-572]; National Natural Sciences Foundation of China [31370185]	National Infrastructure of Natural Resources for Science and Technology Program; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank I. C. Bruce and L. Kang for editing work, and Y. Ou, M. Jia, and X. Zhou for the literature search and document retrieval. This work was supported by grants from the National Infrastructure of Natural Resources for Science and Technology Program (2011-572) and the National Natural Sciences Foundation of China (31370185).	[Anonymous], 2009, NATURE, V457, P935, DOI 10.1038/457935b; Capes-Davis A, 2013, INT J CANCER, V132, P2510, DOI 10.1002/ijc.27931; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Chan SYY, 2008, INT J CANCER, V122, P2169, DOI 10.1002/ijc.23374; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Chen S., 2009, INT J BLOOD TRANSFUS, V32, P342; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Dirks WG, 2005, ALTEX-ALTERN TIEREXP, V22, P103; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Gartler S M, 1967, Natl Cancer Inst Monogr, V26, P167; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; LAVAPPA KS, 1976, NATURE, V259, P211, DOI 10.1038/259211a0; Lucey BP, 2009, ARCH PATHOL LAB MED, V133, P1463, DOI 10.1043/1543-2165-133.9.1463; MacLeod RAF, 1999, INT J CANCER, V83, P555; Markovic O, 1998, IN VITRO CELL DEV-AN, V34, P1; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; MASTERS JRW, 1988, BRIT J CANCER, V57, P284, DOI 10.1038/bjc.1988.61; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; Phuchareon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006040; STACEY GN, 1992, NATURE, V357, P261, DOI 10.1038/357261a0; Stacey GN, 2000, NATURE, V403, P356, DOI 10.1038/35000394; THACKER J, 1988, SOMAT CELL MOLEC GEN, V14, P519, DOI 10.1007/BF01535307	27	60	64	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4268	4272		10.1096/fj.14-266718	http://dx.doi.org/10.1096/fj.14-266718			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26116706				2022-12-28	WOS:000361367300016
J	Michalska, K; Steen, AD; Chhor, G; Endres, M; Webber, AT; Bird, J; Lloyd, KG; Joachimiak, A				Michalska, Karolina; Steen, Andrew D.; Chhor, Gekleng; Endres, Michael; Webber, Austen T.; Bird, Jordan; Lloyd, Karen G.; Joachimiak, Andrzej			New aminopeptidase from "microbial dark matter" archaeon	FASEB JOURNAL			English	Article						carbon cycle; marine sediments; single-cell genomics; detrital proteins	ACID ESTER HYDROLASE; LIGATION-INDEPENDENT CLONING; HIGH-THROUGHPUT; CRYSTAL-STRUCTURE; GENE-EXPRESSION; LIC VECTORS; PROTEINS; MODEL; CRYSTALLOGRAPHY; PURIFICATION	Marine sediments host a large population of diverse, heterotrophic, uncultured microorganisms with unknown physiologies that control carbon flow through organic matter decomposition. Recently, single-cell genomics uncovered new key players in these processes, such as the miscellaneous crenarchaeotal group. These widespread archaea encode putative intra- and extracellular proteases for the degradation of detrital proteins present in sediments. Here, we show that one of these enzymes is a self-compartmentalizing tetrameric aminopeptidase with a preference for cysteine and hydrophobic residues at the N terminus of the hydrolyzed peptide. The ability to perform detailed characterizations of enzymes from native subsurface microorganisms, without requiring that those organisms first be grown in pure culture, holds great promise for understanding key carbon transformations in the environment as well as identifying new enzymes for biomedical and biotechnological applications.	[Michalska, Karolina; Chhor, Gekleng; Endres, Michael; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Michalska, Karolina; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA; [Steen, Andrew D.; Bird, Jordan; Lloyd, Karen G.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Steen, Andrew D.; Webber, Austen T.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Chicago	Joachimiak, A (corresponding author), Argonne Natl Lab, Biosci Div, Struct Biol Ctr, 9700 South Cass Ave,Bldg 446, Argonne, IL 60439 USA.	andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209; Bird, Jordan/0000-0001-5753-6058	U.S. National Institutes of Health, National Institute of General Medical Sciences [GM094585]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Center for Dark Energy Biosphere Investigations [157595, 36202823]; U.S. Department of Energy Office of Science laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Center for Dark Energy Biosphere Investigations; U.S. Department of Energy Office of Science laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Robert Jedrzejczak (Argonne National Laboratory) for discussion of cloning strategy, Dr. Gyorgy Babnigg (Argonne National Laboratory) for help in designing the cloning construct, Katlyn Fayman (Argonne National Laboratory) for help with protein purification, members of the Structural Biology Center at Argonne National Laboratory for their help with data collection at the 19-Insertion Device Beamline, Dr. Steven Wilhelm (University of Tennessee Department of Microbiology) for provision of lab space to A.D.S., and Dr. B. B. Jorgensen and the staff of the Center for Geomicrobiology at Aarhus University (Aarhus, Denmark) for providing amplified genomic deoxyribonucleic acid. This work was supported by the following funds: U.S. National Institutes of Health, National Institute of General Medical Sciences Grant GM094585 (to A.J.); the U.S. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357 (to A.J.); and Center for Dark Energy Biosphere Investigations Grants 157595 (to K.G.L.) and 36202823 (to A.D.S.). This work is Center for Dark Energy Biosphere Investigation Contribution 268. The submitted manuscript has been created by UChicago Argonne, Limited Liability Company, Operator of Argonne National Laboratory ("Argonne"). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barends TRM, 2006, J BIOL CHEM, V281, P5804, DOI 10.1074/jbc.M511187200; Barends TRM, 2003, ACTA CRYSTALLOGR D, V59, P2237, DOI 10.1107/S0907444903020729; Barends TRM, 2003, J BIOL CHEM, V278, P23076, DOI 10.1074/jbc.M302246200; Bricogne G., 2011, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2013, Journal of Structural and Functional Genomics, V14, P135, DOI 10.1007/s10969-013-9163-9; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Hartmann EM, 2014, MAR GENOM, V17, P35, DOI 10.1016/j.margen.2014.04.003; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Krest'ianova I N, 1990, Biokhimiia, V55, P2226; Kurochkina VB, 2013, APPL BIOCHEM MICRO+, V49, P672, DOI 10.1134/S0003683813080036; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsen NA, 2002, NAT STRUCT BIOL, V9, P17, DOI 10.1038/nsb742; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Rigolet P, 2002, STRUCTURE, V10, P1383, DOI 10.1016/S0969-2126(02)00851-1; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Stols Lucy, 2004, Journal of Structural and Functional Genomics, V5, P95, DOI 10.1023/B:JSFG.0000029196.87615.6e; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WALLIS M, 1973, BIOCHIM BIOPHYS ACTA, V310, P388, DOI 10.1016/0005-2795(73)90120-7; Wilson K., 1978, ACTA CRYSTALLOGR A, V34, P517, DOI DOI 10.1107/S0567739478001114; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Zarubina SA, 2013, ACTA NATURAE, V5, P62, DOI 10.32607/20758251-2013-5-4-62-70	41	11	11	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4071	4079		10.1096/fj.15-272906	http://dx.doi.org/10.1096/fj.15-272906			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26062601	Green Published, Bronze			2022-12-28	WOS:000359915600040
J	Barreto-Ortiz, SF; Fradkin, J; Eoh, J; Trivero, J; Davenport, M; Ginn, B; Mao, HQ; Gerecht, S				Barreto-Ortiz, Sebastian F.; Fradkin, Jamie; Eoh, Joon; Trivero, Jacqueline; Davenport, Matthew; Ginn, Brian; Hai-Quan Mao; Gerecht, Sharon			Fabrication of 3-dimensional multicellular microvascular structures	FASEB JOURNAL			English	Article						extracellular matrix; fibrin; microfiber; endothelial cell; perivascular cell	VASCULAR SMOOTH-MUSCLE; EXTRACELLULAR-MATRIX; BLOOD-VESSEL; IN-VITRO; TISSUE; FIBRIN; MORPHOGENESIS; MECHANISMS; ALIGNMENT; NETWORKS	Despite current advances in engineering blood vessels over 1 mm in diameter and the existing wealth of knowledge regarding capillary bed formation, studies for the development of microvasculature, the connecting bridge between them, have been extremely limited so far. Here, we evaluate the use of 3-dimensional (3D) microfibers fabricated by hydrogel electrospinning as templates for microvascular structure formation. We hypothesize that 3D microfibers improve extracellular matrix (ECM) deposition from vascular cells, enabling the formation of freestanding luminal multicellular microvasculature. Compared to 2-dimensional cultures, we demonstrate with confocal microscopy and RT-PCR that fibrin microfibers induce an increased ECM protein deposition by vascular cells, specifically endothelial colony-forming cells, pericytes, and vascular smooth muscle cells. These ECM proteins comprise different layers of the vascular wall including collagen types I, III, and IV, as well as elastin, fibronectin, and laminin. We further demonstrate the achievement of multicellular microvascular structures with an organized endothelium and a robust multicellular perivascular tunica media. This, along with the increased ECM deposition, allowed for the creation of self-supporting multilayered microvasculature with a distinct circular lumen following fibrin microfiber core removal. This approach presents an advancement toward the development of human microvasculature for basic and translational studies.	[Barreto-Ortiz, Sebastian F.; Fradkin, Jamie; Eoh, Joon; Trivero, Jacqueline; Davenport, Matthew; Gerecht, Sharon] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Barreto-Ortiz, Sebastian F.; Fradkin, Jamie; Eoh, Joon; Trivero, Jacqueline; Davenport, Matthew; Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Fradkin, Jamie; Eoh, Joon; Hai-Quan Mao] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Ginn, Brian; Hai-Quan Mao; Gerecht, Sharon] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Ginn, Brian; Hai-Quan Mao] Johns Hopkins Sch Med, Translat Tissue Engn Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Gerecht, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	gerecht@jhu.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835; Eoh, Joon/0000-0002-9890-4598; Mao, Hai-Quan/0000-0002-4262-9988	U.S. National Institutes of Health [R01HL107938, U54CA143868]; W.W. Smith Charitable Trust grant; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107938] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.W. Smith Charitable Trust grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Andrew Mao and Patrick Pena for assisting with cell culture and sample preparation. This research was partially funded by U.S. National Institutes of Health Grants R01HL107938 (National Heart, Lung, and Blood Institute) and U54CA143868 (National Cancer Institute); and a W.W. Smith Charitable Trust grant (to S.G.).	Abaci HE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04951; Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI [10.1089/ten.tea.2009.0708, 10.1089/ten.TEA.2009.0708]; ANONICK PK, 1992, ARTERIOSCLER THROMB, V12, P708, DOI 10.1161/01.ATV.12.6.708; Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428; Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110; Barreto-Ortiz SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081061; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Clark RAF, 2003, J INVEST DERMATOL, V121, pXXI, DOI 10.1046/j.1523-1747.2003.12575.x; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Dickinson LE, 2010, SOFT MATTER, V6, P5109, DOI 10.1039/c0sm00233j; Gao J, 2008, J BIOMED MATER RES A, V85A, P1120, DOI 10.1002/jbm.a.32028; Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; He JK, 2013, ADV HEALTHC MATER, V2, P1108, DOI 10.1002/adhm.201200404; HIBBS RG, 1958, AM HEART J, V56, P662, DOI 10.1016/0002-8703(58)90209-6; Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46; Kim JA, 2006, J CEREBR BLOOD F MET, V26, P209, DOI 10.1038/sj.jcbfm.9600181; Kobayashi A, 2007, BIOCHEM BIOPH RES CO, V358, P692, DOI 10.1016/j.bbrc.2007.04.206; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; LAURIE GW, 1982, J CELL BIOL, V95, P340, DOI 10.1083/jcb.95.1.340; Li YH, 2014, BIOTECHNOL ADV, V32, P347, DOI 10.1016/j.biotechadv.2013.11.007; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Lodish H, 2000, MOL CELL BIOL; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Marieb E.N., 2007, HUMAN ANATOMY PHYSL; Mecham RP, 1997, J BIOL CHEM, V272, P18071, DOI 10.1074/jbc.272.29.18071; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Montano I, 2010, TISSUE ENG PT A, V16, P269, DOI [10.1089/ten.tea.2008.0550, 10.1089/ten.TEA.2008.0550]; Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021; Pocock G, 2013, HUM PHYSIOL+; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Roy S, 2010, CURR EYE RES, V35, P1045, DOI 10.3109/02713683.2010.514659; Standring S., 2021, GRAYS ANATOMY ANATOM; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002; Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006; Verbridge SS, 2013, J BIOMED MATER RES A, V101, P2948, DOI 10.1002/jbm.a.34587; Wanjare M, 2014, STEM CELL REP, V2, P561, DOI 10.1016/j.stemcr.2014.03.004; Wanjare M, 2013, BIOTECHNOL J, V8, P434, DOI 10.1002/biot.201200199; WEBER K, 1973, ARCH DERMATOL FORSCH, V248, P29, DOI 10.1007/BF00594710; Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625; YEN A, 1976, J INVEST DERMATOL, V66, P131, DOI 10.1111/1523-1747.ep12481678; Zhang SM, 2014, BIOMATERIALS, V35, P3243, DOI 10.1016/j.biomaterials.2013.12.081; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	58	22	23	0	57	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3302	3314		10.1096/fj.14-263343	http://dx.doi.org/10.1096/fj.14-263343			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25900808	Green Published			2022-12-28	WOS:000358796900018
J	Boucher, D; Vu, T; Bain, AL; Tagliaro-Jahns, M; Shi, W; Lane, SW; Khanna, KK				Boucher, Didier; Vu, Therese; Bain, Amanda L.; Tagliaro-Jahns, Marina; Shi, Wei; Lane, Steven W.; Khanna, Kum Kum			Ssb2/Nabp1 is dispensable for thymic maturation, male fertility, and DNA repair in mice	FASEB JOURNAL			English	Article						knockout mouse model; thymopoiesis; testis development; DNA damage response	STRAND BREAK REPAIR; BINDING-PROTEINS; DAMAGE; HSSB1; PHOSPHORYLATION; PARTICIPATE; RECRUITMENT; MAINTENANCE; COMPLEXES	SSB1 and SSB2 are newly identified singlestranded (ss) DNAbinding proteins that play a crucial role in genome maintenance in humans. We recently generated a knockout mouse model of Ssb1 and revealed its essential role for neonatal survival. Notably, we found compensatory up-regulation of Ssb2 protein levels in multiple tissues of conditional Ssb1(-/-) mice, suggesting functional compensation between these 2 proteins. We report here the first description of Ssb2(-/-) knockout mice. Surprisingly, unlike Ssb1 knockout mice, Ssb2(-/-) mice are viable and fertile and do not exhibit marked phenotypic changes when compared with their Ssb2(+/+) and Ssb2(+/-) littermates. Notably, we did not detect any pathologic changes in the thymus, spleen, or testes, tissues with the most abundant expression of Ssb2. Moreover, Ssb2(-/-) mouse embryonic fibroblasts (MEFs) did not show any sensitivity to DNA-damaging agents, or defects in DNA repair capacity. However, we observed modest up-regulation of Ssb1 levels in Ssb2(-/-) MEFs as well as in Ssb2(-/-) thymus and spleen, suggesting that Ssb1 is likely able to compensate for the loss of Ssb2 in mice. Altogether, our results show that Ssb2 is dispensable for embryogenesis and adult tissue homeostasis, including thymopoiesis, splenic development, male fertility, and DNA repair in mice.	[Boucher, Didier; Bain, Amanda L.; Tagliaro-Jahns, Marina; Shi, Wei; Khanna, Kum Kum] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Herston, Qld 4006, Australia; [Vu, Therese; Lane, Steven W.] QIMR Berghofer Med Res Inst, Translat Leukaemia Res, Herston, Qld 4006, Australia; [Vu, Therese] Univ Queensland, Brisbane, Qld, Australia; [Tagliaro-Jahns, Marina] Ctr Natl Rech Sci 3559, Inst Natl Rech Agron, Inst Jean Pierre Bourgin, Equipes Rech Labellisees,Saclay Plant Sci,UMR 131, Versailles, France	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Khanna, KK (corresponding author), QIMR Berghofer Med Res Inst, Signal Transduct Lab, 300 Herston Rd, Herston, Qld 4006, Australia.	kumkum.khanna@qimrberghofer.edu.au	Shi, Wei/AAX-6450-2021	Shi, Wei/0000-0002-0378-8361; Vu, Therese/0000-0003-2831-2957; Khanna, Kum Kum/0000-0001-8650-5381; Boucher, Didier/0000-0002-7964-0881	Australian Research Council [DP109661]; National Health and Medical Research Council (NHMRC) [1031327]; Leukaemia Foundation; Cure Cancer Australia Foundation	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation; Cure Cancer Australia Foundation	The authors thank Stephen Miles and the QIMR Berghofer Animal Facility for technical assistance, and Dr. John Finnie for assistance with histopathological analysis. This work is supported by an Australian Research Council discovery grant (DP109661) and National Health and Medical Research Council (NHMRC) project grant (1031327) awarded to K.K.K. K.K.K. is supported by an NHMRC Senior Principle Research Fellowship. S.W.L. gratefully acknowledges funding from the NHMRC, Leukaemia Foundation, and Cure Cancer Australia Foundation.	Ashton NW, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-9; Bain AL, 2013, CELL RES, V23, P744, DOI 10.1038/cr.2013.63; Bee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069061; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Feldhahn N, 2012, EMBO J, V31, P4045, DOI 10.1038/emboj.2012.247; Gibb B, 2014, NAT STRUCT MOL BIOL, V21, P893, DOI 10.1038/nsmb.2886; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Gu P, 2013, CELL RES, V23, P705, DOI 10.1038/cr.2013.31; Hadjantonakis Anna-Katerina, 2008, V461, P111, DOI 10.1007/978-1-60327-483-8_8; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/573936; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janbandhu VC, 2014, CELL CYCLE, V13, P462, DOI 10.4161/cc.27271; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Kang HS, 2006, BIOCHEM J, V397, P89, DOI 10.1042/BJ20051781; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Lemaitre C, 2014, DNA REPAIR, V19, P163, DOI 10.1016/j.dnarep.2014.03.015; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Ochi T, 2014, DNA REPAIR, V17, P98, DOI 10.1016/j.dnarep.2014.02.010; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P3643, DOI 10.1093/nar/gkq1340; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P1692, DOI 10.1093/nar/gkq1098; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Shi W, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003298; Sinha M, 2008, MOL CELL, V30, P803, DOI 10.1016/j.molcel.2008.04.015; Skaar JR, 2009, J CELL BIOL, V187, P25, DOI 10.1083/jcb.200907026; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zhang F, 2013, J CELL SCI, V126, P4850, DOI 10.1242/jcs.132514; Zhang F, 2009, J BIOL CHEM, V284, P30408, DOI 10.1074/jbc.M109.039404	36	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3326	3334		10.1096/fj.14-269944	http://dx.doi.org/10.1096/fj.14-269944			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25917330				2022-12-28	WOS:000358796900020
J	Buras, ED; Yang, LN; Saha, P; Kim, J; Mehta, P; Yang, YS; Hilsenbeck, S; Kojima, H; Chen, WH; Smith, CW; Chan, L				Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Mehta, Pooja; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Smith, C. Wayne; Chan, Lawrence			Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice	FASEB JOURNAL			English	Article						inflammation; obesity; diabetes; glucose	NECROSIS-FACTOR-ALPHA; TNF-ALPHA; ADIPOCYTE DEATH; OBESITY; CELLS; EXPRESSION; INFLAMMATION; INFILTRATION; DYSFUNCTION; SENSITIVITY	Adipose tissue macrophages (ATMs) play an important role in the pathogenesis of obese type 2 diabetes. High-fat diet (HFD)-induced obesity has been shown to lead to ATM accumulation in rodents; however, the impact of hyperglycemia on ATMdynamics in HFD-fed type 2 diabetic models has not been studied. We previously showed that hyperglycemia induces the appearance of proinsulin (PI)-producing proinflammatory bone marrow (BM)-derived cells (PI-BMDCs) in rodents. We fed a 60% HFD to C57BL6/J mice to produce an obese type 2 diabetes model. Absent in chow-fed animals, PI-BMDCs account for 60% of the ATMs in the type 2 diabetic mice. The PI-ATM subset expresses TNF-alpha and other inflammatory markers, and is highly enriched within crownlike structures (CLSs). We found that amelioration of hyperglycemia by different hypoglycemic agents forestalled PI-producing ATM accumulation and adipose inflammation in these animals. We developed a diphtheria toxin receptor-based strategy to selectively ablate PI-BMDCs among ATMs. Application of the maneuver in HFD-fed type 2 diabetic mice was found to lead to near total disappearance of complex CLSs and reversal of insulin resistance and hepatosteatosis in these animals. In sum, we have identified a novel ATM subset in type 2 diabetic rodents that underlies systemic insulin resistance.-Buras, E. D., Yang, L., Saha, P., Kim, J., Mehta, P., Yang, Y., Hilsenbeck, S., Kojima, H., Chen, W., Smith, C. W., Chan, L. Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice.	[Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Mehta, Pooja; Smith, C. Wayne] USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Kojima, Hideto] Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Otsu, Shiga 52021, Japan	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); Shiga University of Medical Science	Chan, L (corresponding author), Baylor Coll Med, Diabet Res Ctr, R614,One Baylor Plaza, Houston, TX 77030 USA.	lchan@bcm.edu	Chen, Wenhao/J-6553-2019	Chen, Wenhao/0000-0002-0626-3739	U.S. National Institutes of Health (NIH) [National Heart, Lung and Blood Institute (NHLBI)] [R01-HL51586]; Diabetes Research Center [P30-DK079638]; Core Laboratories at Baylor College of Medicine; Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA); Frank and Cindy Liu Family Foundation; Cunningham (Chris, Casey and Jennifer) Family Foundation; T.T. & W.F. Chao Global Foundation; American Diabetes Association [1-14-MN-01]; NIH NHLBI training Grant [T32-HL66991]; Medical Scientist Training Program at Baylor College of Medicine; U.S. National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases) [DK105527]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066991, R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, P30DK079638] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) [National Heart, Lung and Blood Institute (NHLBI)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Diabetes Research Center; Core Laboratories at Baylor College of Medicine; Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA); Frank and Cindy Liu Family Foundation; Cunningham (Chris, Casey and Jennifer) Family Foundation; T.T. & W.F. Chao Global Foundation; American Diabetes Association(American Diabetes Association); NIH NHLBI training Grant; Medical Scientist Training Program at Baylor College of Medicine; U.S. National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge Vishal Kaila and Shinasuki Kusui for help with experiments, Vijay Yechoor for advice on experiments and provision of MIP-GFP mice, and Herbert Virgin for provision of iDTR mice. In addition, the authors thank Dr. Benny Hung-Junn Chang and Dr. Christina Camell for advice on experiments, and Sand Yu-Chih Ku and Leslie Wu for administrative help. This work was supported by the U.S. National Institutes of Health (NIH) Grants R01-HL51586 [National Heart, Lung and Blood Institute (NHLBI)] and DK105527 (National Institute of Diabetes and Digestive and Kidney Diseases) to L.C., the Diabetes Research Center (P30-DK079638) and its Core Laboratories at Baylor College of Medicine, the Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA), the Frank and Cindy Liu Family Foundation, the Cunningham (Chris, Casey and Jennifer) Family Foundation, the T.T. & W.F. Chao Global Foundation, and the American Diabetes Association (Grant 1-14-MN-01) to L.C. J.K. was supported by a NIH NHLBI training Grant T32-HL66991, and E.B. was supported by the Medical Scientist Training Program at Baylor College of Medicine. The authors declare no competing financial interests.	Aljada A, 2006, METABOLISM, V55, P1177, DOI 10.1016/j.metabol.2006.04.016; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chang WT, 2012, FOOD CHEM, V134, P972, DOI 10.1016/j.foodchem.2012.03.002; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dandona P, 2009, J AM COLL CARDIOL, V53, pS14, DOI 10.1016/j.jacc.2008.10.038; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Fujimiya M, 2007, P NATL ACAD SCI USA, V104, P4030, DOI 10.1073/pnas.0700220104; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Gerner RR, 2013, CAN J PHYSIOL PHARM, V91, P867, DOI 10.1139/cjpp-2013-0050; Gonzalez F, 2006, J ENDOCRINOL, V188, P521, DOI 10.1677/joe.1.06579; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Katagi M, 2014, FEBS LETT, V588, P1080, DOI 10.1016/j.febslet.2014.02.030; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Odegaard JI, 2013, CELL METAB, V18, P767, DOI 10.1016/j.cmet.2013.11.011; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Urabe H, 2015, DIABETOLOGIA, V58, P402, DOI 10.1007/s00125-014-3440-4; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yong J, 2011, DIABETES, V60, P1383, DOI 10.2337/db10-0907; Yoon J, 2011, DIABETOLOGIA, V54, P1252, DOI 10.1007/s00125-011-2055-2; Zhang HH, 2001, J CLIN ENDOCR METAB, V86, P2817, DOI 10.1210/jc.86.6.2817	48	11	12	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3537	3548		10.1096/fj.15-271452	http://dx.doi.org/10.1096/fj.15-271452			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25953849	Green Published			2022-12-28	WOS:000358796900039
J	Reid, AT; Anderson, AL; Roman, SD; McLaughlin, EA; McCluskey, A; Robinson, PJ; Aitken, RJ; Nixon, B				Reid, Andrew T.; Anderson, Amanda L.; Roman, Shaun D.; McLaughlin, Eileen A.; McCluskey, Adam; Robinson, Phillip J.; Aitken, R. John; Nixon, Brett			Glycogen synthase kinase 3 regulates acrosomal exocytosis in mouse spermatozoa via dynamin phosphorylation	FASEB JOURNAL			English	Article						acrosome reaction; sperm maturation; epididymal dense bodies	BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; MALE REPRODUCTIVE-TRACT; SPERM MOTILITY; SERINE PHOSPHORYLATION; PHOSPHATASE 1; MEMBRANE; IDENTIFICATION; CAPACITATION; HEAT-SHOCK-PROTEIN-1; CHAPERONES	The dynamin family of GTPases has been implicated as novel regulators of the acrosome reaction, a unique exocytotic event that is essential for fertilization. Dynamin activity during the acrosome reaction is accompanied by phosphorylation of key serine residues. We now tested the hypothesis that glycogen synthase kinase 3 (GSK3) is the protein kinase responsible for dynamin phosphorylation at these phosphosites in mouse spermatozoa. Pharmacologic inhibition of GSK3 inmature mouse spermatozoa (CHIR99021: IC50 = 6.7 nM) led to a significant reduction in dynamin phosphorylation (10.3% vs. 27.3%; P < 0.001), acrosomal exocytosis (9.7% vs. 25.7%; P < 0.01), and in vitro fertilization (53% vs. 100%; P < 0.01). GSK3 was shown to be present in developing germ cells where it colocalized with dynamin in the peri-acrosomal domain. However, additional GSK3 was acquired by maturing mouse spermatozoa within the male reproductive tract, via a novel mechanism involving direct interaction of sperm heads with extracellular structures known as epididymal dense bodies. These data reveal a novel mode for the cellular acquisition of a protein kinase and identify a key role for GSK3 in the regulation of sperm maturation and acrosomal exocytosis.	[Reid, Andrew T.; Anderson, Amanda L.; Roman, Shaun D.; McLaughlin, Eileen A.; Aitken, R. John; Nixon, Brett] Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia; [McCluskey, Adam] Univ Newcastle, Sch Environm & Life Sci, Discipline Chem, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Newcastle; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Nixon, B (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Univ Dr, Callaghan, NSW 2308, Australia.	brett.nixon@newcastle.edu.au	McLaughlin, Eileen A/G-7620-2013; Roman, Shaun/AFR-5087-2022; Robinson, Phillip J/G-4008-2011; Aitken, Robert John/AAY-8238-2020; McLaughlin, Eileen/AAF-5588-2021; Nixon, Brett/B-5121-2012; ROMAN, SHAUN/G-7047-2013	Robinson, Phillip J/0000-0002-7878-0313; Aitken, Robert John/0000-0002-9152-156X; McLaughlin, Eileen/0000-0002-5837-3876; Nixon, Brett/0000-0003-2745-8188; ROMAN, SHAUN/0000-0002-7758-7757; Reid, Andrew/0000-0001-5751-7025; McCluskey, Adam/0000-0001-7125-863X	National Health and Medical Research Council of Australia; Hunter Medical Research Institute; University of Newcastle	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; University of Newcastle	The authors are grateful for financial support from the National Health and Medical Research Council of Australia (to P.J.R. and A.M.), the Hunter Medical Research Institute (to B.N. and E.A.M.), and the University of Newcastle (to B.N., E.A.M., and A.M.). The authors declare no conflicts of interest.	Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; AITKEN RJ, 1993, J ANDROL, V14, P132; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Ando S, 2005, MOL CELL ENDOCRINOL, V245, P1, DOI 10.1016/j.mce.2005.09.011; Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Aquila S, 2005, J CLIN ENDOCR METAB, V90, P4753, DOI 10.1210/jc.2004-2233; Asquith KL, 2005, BIOL REPROD, V72, P328, DOI 10.1095/biolreprod.104.034470; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Ballester J, 2000, MOL REPROD DEV, V56, P207, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;207::AID-MRD12&gt;3.0.CO;2-4; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dun MD, 2011, J BIOL CHEM, V286, P36875, DOI 10.1074/jbc.M110.188888; Dun Matthew D, 2010, Handb Exp Pharmacol, P139, DOI 10.1007/978-3-642-02062-9_9; Etter G, 2014, HIPPOCAMPUS, V24, P725, DOI 10.1002/hipo.22280; Frayne J, 1998, MOL REPROD DEV, V49, P454, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;454::AID-MRD13&gt;3.0.CO;2-U; Guo TB, 2003, J ANDROL, V24, P332; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Haidl G, 1997, HUM REPROD, V12, P2720, DOI 10.1093/humrep/12.12.2720; Holz RW, 2013, SCIENCE, V339, P1392, DOI 10.1126/science.1236005; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Jones R, 2007, ASIAN J ANDROL, V9, P438, DOI 10.1111/j.1745-7262.2007.00282.x; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Li K, 2013, REPRODUCTION, V146, P135, DOI 10.1530/REP-13-0127; Lin MJ, 2006, BIOL REPROD, V75, P588, DOI 10.1095/biolreprod.106.052712; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Monclus MDLA, 2007, ANAT REC, V290, P814, DOI 10.1002/ar.20555; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Nakamura N, 2010, BIOL REPROD, V82, P504, DOI 10.1095/biolreprod.109.080580; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; NIKOLOPOULOU M, 1985, BIOCHIM BIOPHYS ACTA, V815, P486, DOI 10.1016/0005-2736(85)90377-3; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Redgrove KA, 2011, DEV BIOL, V356, P460, DOI 10.1016/j.ydbio.2011.05.674; Reid AT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392803; Rosales JL, 2004, J BIOL CHEM, V279, P1224, DOI 10.1074/jbc.M310867200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Somanath PR, 2004, J ANDROL, V25, P605; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tardif S, 2012, MOL HUM REPROD, V18, P298, DOI 10.1093/molehr/gas009; Vemuganti SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-285; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vijayaraghavan S, 2000, BIOL REPROD, V62, P1647, DOI 10.1095/biolreprod62.6.1647; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Yano R, 2010, J ANDROL, V31, P201, DOI 10.2164/jandrol.109.007880; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892	53	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2872	2882		10.1096/fj.14-265553	http://dx.doi.org/10.1096/fj.14-265553			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25808536				2022-12-28	WOS:000356859100017
J	Ren, YS; Han, XL; Ho, SP; Harris, SE; Cao, ZG; Economides, AN; Qin, CL; Ke, HZ; Liu, M; Feng, JQ				Ren, Yinshi; Han, Xianglong; Ho, Sunita P.; Harris, Stephen E.; Cao, Zhengguo; Economides, Aris N.; Qin, Chunlin; Ke, Huazhu; Liu, Min; Feng, Jian Q.			Removal of SOST or blocking its product sclerostin rescues defects in the periodontitis mouse model	FASEB JOURNAL			English	Article						PDL; periostin; alveolar bone	INCREASES BONE-FORMATION; POSTMENOPAUSAL WOMEN; MONOCLONAL-ANTIBODY; TARGETED DELETION; DIABETES-MELLITUS; MINERAL DENSITY; IN-VIVO; MICE; DISEASE; DENTIN	Understanding periodontal ligament (PDL) biology and developing an effective treatment for bone and PDL damage due to periodontitis have been long-standing aims in dental medicine. Here, we first demonstrated by cell lineage tracing and mineral double-labeling approaches that murine PDL progenitor cells display a 2- and 3-fold higher mineral deposition rate than the periosteum and endosteum at the age of 4 weeks, respectively. We next proved that the pathologic changes in osteocytes (Ocys; changes from a spindle shape to round shape with a >50% reduction in the dendrite number/length, and an increase in SOST) are the key pathologic factors responsible for bone and PDL damage in periostin-null mice (a periodontitis animal model) using a newly developed 3-dimensional FITC-Imaris technique. Importantly, we proved that deleting the Sost gene (a potent inhibitor of WNT signaling) or blocking sclerostin function by using the mAb in this periodontitis model significantly restores bone and PDL defects (n = 4-5; P < 0.05). Together, identification of the key contribution of the PDL in normal alveolar bone formation, the pathologic changes of the Ocys in periodontitis bone loss, and the novel link between sclerostin and Wnt signaling in the PDL will aid future drug development in the treatment of patients with periodontitis.	[Ren, Yinshi; Han, Xianglong; Qin, Chunlin; Feng, Jian Q.] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Han, Xianglong] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu, Sichuan, Peoples R China; [Ho, Sunita P.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Harris, Stephen E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [Cao, Zhengguo] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Cao, Zhengguo] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Economides, Aris N.] Regeneron Pharmaceut, Tarrytown, NY USA; [Ke, Huazhu; Liu, Min] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Sichuan University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Wuhan University; Wuhan University; Regeneron; Amgen	Ho, SP (corresponding author), Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, 707 Parnassus Ave, San Francisco, CA 94143 USA.	sunita.ho@ucsf.edu; jfeng@bcd.tamhsc.edu	Ho, Sunita P/B-1084-2008	Cao, Zhengguo/0000-0002-4261-9034; Ren, Yinshi/0000-0003-3361-6015; Economides, Aris/0000-0002-6508-8942	NIH [DE018486, DE022789, R01DE022032-01A1]; National Natural Science Foundation of China Grant [81371172]; Amgen and Union chimique belge Pharma Research funds; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025014, R01DE018486, R56DE022789, R01DE022032, R01DE024797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Amgen and Union chimique belge Pharma Research funds; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. Simon J. Conway (Indiana University, Indianapolis, IN, USA) for providing the periostin knockout mice and Dr. Gabriela G. Loots (Lawrence Livermore National Laboratory, Livermore, CA, USA) for providing the Sost-knockout mice. The authors also thank Dr. Larry Fisher [U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research, Bethesda, MD, USA] for providing the anti-decorin and biglycan antibodies. The authors gratefully acknowledge Ying Liu's excellent scanning electron microscopy work and Mrs. Jeanne Santa Cruz for her English grammar editing. This study was supported in part by NIH Grants DE018486 and DE022789 (to J.Q.F.) and R01DE022032-01A1 (to S.P.H.), National Natural Science Foundation of China Grant 81371172 (to X.H.), and Amgen and Union chimique belge Pharma Research funds (to J.Q.F.). M.L. and H.K. are Amgen employees and stockholders.	Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Ciani C, 2009, BONE, V44, P1015, DOI 10.1016/j.bone.2009.01.376; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collette NM, 2012, P NATL ACAD SCI USA, V109, P14092, DOI 10.1073/pnas.1207188109; Costa AG, 2014, EXPERT OPIN BIOL TH, V14, P697, DOI 10.1517/14712598.2014.895808; de Souza DM, 2010, J APPL ORAL SCI, V18, P493, DOI 10.1590/S1678-77572010000500011; Douglass C W, 1993, Adv Dent Res, V7, P25; Eddleston A, 2009, J BONE MINER RES, V24, P1662, DOI [10.1359/JBMR.090403, 10.1359/jbmr.090403]; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fox C H, 1992, Curr Opin Dent, V2, P5; FOX CH, 1994, J PERIODONTOL, V65, P676, DOI 10.1902/jop.1994.65.7.676; Hallmon W W, 1992, Diabetes Educ, V18, P310, DOI 10.1177/014572179201800409; Hurng JM, 2011, BIOMATERIALS, V32, P7106, DOI 10.1016/j.biomaterials.2011.06.021; Jawad MU, 2013, J ORTHOP RES, V31, P155, DOI 10.1002/jor.22186; Khader YS, 2006, J DIABETES COMPLICAT, V20, P59, DOI 10.1016/j.jdiacomp.2005.05.006; Kucher U, 2014, INT J ORAL SCI, V6, P70, DOI 10.1038/ijos.2014.12; Kuhr A, 2004, J PERIODONTAL RES, V39, P101, DOI 10.1111/j.1600-0765.2004.00710.x; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lim WH, 2014, J PERIODONTAL RES, V49, P751, DOI 10.1111/jre.12158; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; Chavarry NGM, 2009, ORAL HLTH PREV DENT, V7, P107; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; McColm J, 2014, J BONE MINER RES, V29, P935, DOI 10.1002/jbmr.2092; Mealey BL, 2000, PERIODONTOL, V44, P127, DOI DOI 10.1111/J.1600-0757.2006.00193.X; MILLER SC, 1985, J DENT RES, V64, P1062, DOI 10.1177/00220345850640080701; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ren Y, 2014, CONNECT TISSUE RES, V55, P129, DOI 10.3109/03008207.2014.923879; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Roguljic H, 2013, J DENT RES, V92, P709, DOI 10.1177/0022034513493434; Salvi GE, 2008, J CLIN PERIODONTOL, V35, P398, DOI 10.1111/j.1600-051X.2008.01282.x; Taut AD, 2013, J BONE MINER RES, V28, P2347, DOI 10.1002/jbmr.1984; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8	42	48	51	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2702	2711		10.1096/fj.14-265496	http://dx.doi.org/10.1096/fj.14-265496			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25757567	Green Published			2022-12-28	WOS:000356859100003
J	Chen, Q; Zhang, LP; de Crombrugghe, B; Krahe, R				Chen, Qin; Zhang, Liping; de Crombrugghe, Benoit; Krahe, Ralf			Mesenchyme-specific overexpression of nucleolar protein 66 in mice inhibits skeletal growth and bone formation	FASEB JOURNAL			English	Article						histone demethylase; transgenic mice; IGF1R/Akt signaling pathway; osterix	TRANSCRIPTION FACTOR OSTERIX; OSTEOBLAST DIFFERENTIATION; LUNG-CANCER; EXPRESSION; INSULIN; PATHWAYS; CBFA1; CELLS; SOX9; NO66	Previous studies showed that nucleolar protein 66 (NO66), the Jumonji C-domain-containing histone demethylase for methylated histone H3K4 and H3K36 (H3K36me), negatively regulates osteoblast differentiation in vitro by inhibiting the activity of transcription factor osterix (Osx). However, whether NO66 affects mammalian skeletogenesis in vivo is not yet known. Here, we generated transgenic (TG) mice overexpressing a flag-tagged NO66 transgene driven by the Prx1 (paired related homeobox 1) promoter. We found that NO66 overexpression in Prx1-expressing mesenchymal cells inhibited skeletal growth and bone formation. The inhibitory phenotype was associated with >50% decreases in chondrocyte/osteoblast proliferation and differentiation. Moreover, we found that in bones of NO66-TGmice, expression of Igf1, Igf1 receptor (Igf1r), runt-related transcription factor 2, and Osx was significantly down-regulated (P < 0.05). Consistent with these results, we observed >50% reduction in levels of phosphorylated protein kinase B (Akt) and H3K36me3 in bones of NO66-TG mice, suggesting an inverse correlation between NO66 histone demethylase and the activity of IGF1R/Akt signaling. This correlation was further confirmed by in vitro assays of C2C12 cells with NO66 overexpression. We propose that the decrease in the IGF1R/Akt signaling pathway in mice with mesenchymal overexpression of NO66 may contribute in part to the inhibition of skeletal growth and bone formation.	[Chen, Qin; Zhang, Liping; de Crombrugghe, Benoit; Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	qchen1@mdanderson.org			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [R01 AR49072]; Cancer Prevention & Research Institute of Texas Grant [CPRIT-IIRA RP130054]; MD Anderson Cancer Center Support Grant [CA016672]; Rolanette and Berdon Lawrence Bone Research Award; Children Sarcoma Initiative; Triumph Over Kid Cancer Foundation; Dr. and Mrs. Harold Selzman; Satellite Health and American Diabetic Association [1-11-BS-194]; Pilot/Feasibility award of the Diabetes Research Center at Baylor College of Medicine [P30-DK079638]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; Cancer Prevention & Research Institute of Texas Grant; MD Anderson Cancer Center Support Grant; Rolanette and Berdon Lawrence Bone Research Award; Children Sarcoma Initiative; Triumph Over Kid Cancer Foundation; Dr. and Mrs. Harold Selzman; Satellite Health and American Diabetic Association; Pilot/Feasibility award of the Diabetes Research Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Zhaoping Zhang for microinjection, Dr. James Martin for providing the paired related homeobox 1-promoter plasmid and paired related homeobox 1-Cre mice, and Jiangling Dong (Northwest University for Nationalities, Lanzhou, China) for technical assistance. This study was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01 AR49072 (to B.D.C.), the Cancer Prevention & Research Institute of Texas Grant CPRIT-IIRA RP130054 (to R.K.), the MD Anderson Cancer Center Support Grant CA016672, the 2012 Rolanette and Berdon Lawrence Bone Research Award (to Q.C.), the Children Sarcoma Initiative and the Triumph Over Kid Cancer Foundation (to Q.C.), the Dr. and Mrs. Harold Selzman, the Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association (1-11-BS-194), and the Pilot/Feasibility award of the Diabetes Research Center (P30-DK079638) at Baylor College of Medicine (to L.Z.). B.D.C. and R.K. shared senior authorship of this work.	Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chen Q, 2004, J BIOL CHEM, V279, P17667, DOI 10.1074/jbc.M311678200; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058104; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dong QZ, 2013, AM J PATHOL, V182, P954, DOI 10.1016/j.ajpath.2012.11.019; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eilbracht J, 2004, MOL BIOL CELL, V15, P1816, DOI 10.1091/mbc.e03-08-0623; Ge WS, 2011, STEM CELLS, V29, P1112, DOI 10.1002/stem.663; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Suzuki C, 2007, MOL CANCER THER, V6, P542, DOI 10.1158/1535-7163.MCT-06-0659; Wang YM, 2011, J BONE MINER RES, V26, P1437, DOI 10.1002/jbmr.359; Zhang W, 2012, CELL BIOCHEM FUNCT, V30, P297, DOI 10.1002/cbf.2801; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	30	6	6	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2555	2565		10.1096/fj.14-258970	http://dx.doi.org/10.1096/fj.14-258970			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25746793	Green Published			2022-12-28	WOS:000355209500032
J	Pederson, T				Pederson, Thoru			Molecular Biology of the Gene	FASEB JOURNAL			English	Book Review									[Pederson, Thoru] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Pederson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	thoru.pederson@umassmed.edu						Haynes R., 1948, MOL BIOL LIFE INTRO; Oncley J. L., 1959, BIOPHYSICAL SCI STUD; Pederson T, 2005, FASEB J, V19, P1583, DOI 10.1096/fj.05-1002ufm; Pederson T., 2011, BIOGRAPHICAL MEMOIRS; Pederson T, 2012, MOL BIOL CELL, V23, P3281, DOI 10.1091/mbc.E12-06-0448; Pederson T, 2012, FASEB J, V26, P967, DOI 10.1096/fj.12-0301ufm; Pederson T, 2011, FASEB J, V25, P2512, DOI 10.1096/fj.11-0802; Portugal F. H., 1977, A CENTURY OF DNA; Ptashne M., 1986, A GENETIC SWITCH; Steitz J. A., 2003, INSPIRING SCI J WATS, P159; Stent G., 1963, MOL BIOL BACTERIAL V; Watson J. D., 1965, MOL BIOL GENE; Watson J.D., 1968, DOUBLE HELIX PERSONA; Weatherall DJ., 2011, FASEB J, V25, P2513; WEAVER W, 1938, ANN REPORT ROCKEFELL, P203	15	4	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4399	4401		10.1096/fj.15-1101ufm	http://dx.doi.org/10.1096/fj.15-1101ufm			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26527575				2022-12-28	WOS:000364514700001
